PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cheng, Y; Ho, RLKY; Chan, KC; Kan, R; Tung, E; Lung, HL; Yau, WL; Cheung, AKL; Ko, JMY; Zhang, ZF; Luo, DZ; Feng, ZB; Chen, S; Guan, XY; Kwong, D; Stanbridge, EJ; Lung, ML				Cheng, Y.; Ho, R. L. K. Y.; Chan, K. C.; Kan, R.; Tung, E.; Lung, H. L.; Yau, W. L.; Cheung, A. K. L.; Ko, J. M. Y.; Zhang, Z. F.; Luo, D. Z.; Feng, Z. B.; Chen, S.; Guan, X. Y.; Kwong, D.; Stanbridge, E. J.; Lung, M. L.			Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma	ONCOGENE			English	Article							TUMOR-SUPPRESSOR GENE; ENDOTHELIAL-GROWTH-FACTOR; EPIGENETIC INACTIVATION; CHROMOSOME 3P21.3; LUNG-CANCER; THROMBOSPONDIN-1; EXPRESSION; VEGF; P53; HYPERMETHYLATION	Zinc-finger, MYND-type containing 10 (ZMYND10), or more commonly called BLU, expression is frequently downregulated in nasopharyngeal carcinoma (NPC) and many other tumors due to promoter hypermethylation. Functional evidence shows that the BLU gene inhibits tumor growth in animal assays, but the detailed molecular mechanism responsible for this is still not well understood. In current studies, we find that 93.5% of early-stage primary NPC tumors show downregulated BLU expression. Using a PCR array, overexpression of the BLU gene was correlated to the angiogenesis network in NPC cells. Moreover, expression changes of the MMP family, VEGF and TSP1, were often detected in different stages of NPC, suggesting the possibility that BLU may be directly involved in the microenvironment and anti-angiogenic activity in NPC development. Compared with vector-alone control cells, BLU stable transfectants, derived from poorly-differentiated NPC HONE1 cells, suppress VEGF165, VEGF189 and TSP1 expression at both the RNA and protein levels, and significantly reduce the secreted VEGF protein in these cells, reflecting an unknown regulatory mechanism mediated by the BLU gene in NPC. Cells expressing BLU inhibited cellular invasion, migration and tube formation. These in vitro results were further confirmed by in vivo tumor suppression and a matrigel plug angiogenesis assay in nude mice. Tube-forming ability was clearly inhibited, when the BLU gene is expressed in these cells. Up to 70-90% of injected tumor cells expressing increased exogenous BLU underwent cell death in animal assays. Overexpressed BLU only inhibited VEGF165 expression in differentiated squamous NPC HK1 cells, but also showed an anti-angiogenic effect in the animal assay, revealing a complicated mechanism regulating angiogenesis and the microenvironment in different NPC cell lines. Results of these studies indicate that alteration of BLU gene expression influences anti-angiogenesis pathways and is important for the development of NPC.	[Cheng, Y.; Ho, R. L. K. Y.; Chan, K. C.; Kan, R.; Tung, E.; Lung, H. L.; Cheung, A. K. L.; Ko, J. M. Y.; Guan, X. Y.; Kwong, D.; Lung, M. L.] Univ Hong Kong, Ctr Nasopharyngeal Carcinoma Res, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Yau, W. L.] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Z. F.; Luo, D. Z.; Feng, Z. B.; Chen, S.] Guangxi Med Univ, Dept Pathol, Guangxi, Peoples R China; [Stanbridge, E. J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of Hong Kong; Chinese University of Hong Kong; Guangxi Medical University; University of California System; University of California Irvine	Cheng, Y (corresponding author), Univ Hong Kong, Dept Clin Oncol, Ctr Nasopharyngeal Carcinoma Res, Li Ka Shing Fac Medicne, L6-02 Lab Bldg,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	yuecheng@hotmail.com; mlilung@hku.hk	Chan, Ka Chung/HHR-8759-2022; Ko, Josephine/U-2972-2019; Cheng, Yue/Z-4456-2019; Lung, Maria Li/C-4495-2009; /A-3639-2009	Ko, Josephine/0000-0002-7997-331X; Lung, Maria Li/0000-0003-2559-3626; /0000-0003-1874-9805	General Research Fund [HKU762912M]; Research Grants Council of Hong Kong Special Administrative Region, China	General Research Fund; Research Grants Council of Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	We thank Dr Didier Trono for plasmid 12254, pWPI, and Dr Jack Lawler for plasmid 12993, pGEM2 hTSP-1, Addgene, USA. We also thank the Tissue Bank of NPC Area of Excellence Scheme for NPC samples. This work was supported by the General Research Fund (Project number: HKU762912M to Yue Cheng), Research Grants Council of Hong Kong Special Administrative Region, China.	Abe M, 2005, CANCER RES, V65, P828; Agathanggelou A, 2003, ONCOGENE, V22, P1580, DOI 10.1038/sj.onc.1206243; Ancelin M, 2004, LAB INVEST, V84, P502, DOI 10.1038/labinvest.3700053; Ancelin M, 2002, P NATL ACAD SCI USA, V99, P6023, DOI 10.1073/pnas.082110999; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Chan KC, 2011, INT J CANCER, V129, P1826, DOI 10.1002/ijc.25855; Cheng Y, 1998, P NATL ACAD SCI USA, V95, P3042, DOI 10.1073/pnas.95.6.3042; Cheng Y, 2000, GENE CHROMOSOME CANC, V28, P82, DOI 10.1002/(SICI)1098-2264(200005)28:1<82::AID-GCC10>3.0.CO;2-8; Cheng Y, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-44; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; do Outeiro-Bernstein MAF, 2002, MATRIX BIOL, V21, P311, DOI 10.1016/S0945-053X(02)00010-0; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Herve MA, 2005, EXP CELL RES, V309, P24, DOI 10.1016/j.yexcr.2005.05.022; Hesson L, 2004, ONCOGENE, V23, P2408, DOI 10.1038/sj.onc.1207407; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Hui EP, 2002, CLIN CANCER RES, V8, P2595; Ji W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013442; Kaur S, 2010, J BIOL CHEM, V285, P38923, DOI 10.1074/jbc.M110.172304; Koo BH, 2010, AM J PATHOL, V176, P1494, DOI 10.2353/ajpath.2010.090655; Krishna SM, 2006, VIRUS RES, V115, P85, DOI 10.1016/j.virusres.2005.07.010; Lai HC, 2007, GYNECOL ONCOL, V104, P629, DOI 10.1016/j.ygyno.2006.10.003; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Lee YJ, 2010, CANCER RES, V70, P948, DOI 10.1158/0008-5472.CAN-09-3094; Lerman MI, 2000, CANCER RES, V60, P6116; Linderholm B, 2000, INT J CANCER, V89, P51, DOI 10.1002/(SICI)1097-0215(20000120)89:1<51::AID-IJC9>3.3.CO;2-#; Liu XQ, 2003, INT J CANCER, V106, P60, DOI 10.1002/ijc.11166; Lo PHY, 2010, CANCER RES, V70, P5567, DOI 10.1158/0008-5472.CAN-09-4510; Lo PHY, 2006, CANCER LETT, V234, P184, DOI 10.1016/j.canlet.2005.03.036; Lung HL, 2012, TUMOR SUPPRESSOR GEN, P53; Lung HL, 2008, INT J CANCER, V123, P401, DOI 10.1002/ijc.23528; Lung HL, 2012, SEMIN CANCER BIOL, V22, P87, DOI 10.1016/j.semcancer.2011.11.002; Mane DR, 2013, APPL IMMUNOHISTO M M, V21, P431, DOI 10.1097/PAI.0b013e31827c00e1; Marsit CJ, 2005, INT J CANCER, V114, P219, DOI 10.1002/ijc.20714; Miyata Y, 2013, INT J MOL SCI, V14, P12249, DOI 10.3390/ijms140612249; Nucera C, 2010, P NATL ACAD SCI USA, V107, P10649, DOI 10.1073/pnas.1004934107; Park ST, 2013, BIOCHEM BIOPH RES CO, V435, P153, DOI 10.1016/j.bbrc.2013.04.061; Peng XW, 2010, ANTI-CANCER DRUG, V21, P381, DOI 10.1097/CAD.0b013e3283363980; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Sargiannidou I, 2001, EXP BIOL MED, V226, P726, DOI 10.1177/153537020222600803; SUN Y, 1992, P NATL ACAD SCI USA, V89, P6516, DOI 10.1073/pnas.89.14.6516; Tischoff I, 2005, INT J CANCER, V115, P684, DOI 10.1002/ijc.20944; Trudel D, 2003, CANCER RES, V63, P8511; Tuszynski GP, 1996, BIOESSAYS, V18, P71, DOI 10.1002/bies.950180113; Wilgus TA, 2012, J INVEST DERMATOL, V132, P493, DOI 10.1038/jid.2011.343; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Yang YJ, 2012, J CANCER RES CLIN, V138, P729, DOI 10.1007/s00432-012-1151-0; Yau WL, 2006, INT J CANCER, V119, P2821, DOI 10.1002/ijc.22232; Yoo HJ, 2013, INT J BIOCHEM CELL B, V45, P1236, DOI 10.1016/j.biocel.2013.04.001; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zaslavsky A, 2010, BLOOD, V115, P4605, DOI 10.1182/blood-2009-09-242065; Zhang XN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-267	56	11	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4219	4228		10.1038/onc.2014.353	http://dx.doi.org/10.1038/onc.2014.353			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25347745	Green Published, hybrid			2022-12-26	WOS:000359199800008
J	Chekan, JR; Kwon, IH; Agarwal, V; Dodd, D; Revindran, V; Mackie, RI; Cann, I; Nair, SK				Chekan, Jonathan R.; Kwon, In Hyuk; Agarwal, Vinayak; Dodd, Dylan; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac; Nair, Satish K.			Structural and Biochemical Basis for Mannan Utilization by Caldanaerobius polysaccharolyticus Strain ATCC BAA-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Biofuel; Cellulose; Crystal Structure; Plant Cell Wall	THERMOANAEROBACTERIUM-POLYSACCHAROLYTICUM; THERMOPHILIC BACTERIUM; PHOSPHORYLASES; EXPRESSION; DIVERSITY; SOFTWARE; CHECKING; SYSTEMS; PHENIX; ZEAE	Background: The thermophilic bacterium Caldanaerobius polysaccharolyticus can utilize mannan polysaccharides found in plant hemicellulose. Results: The mannan degradation gene cluster contains a solute-binding protein with an unexpected tolerance for linear and branched manno-oligosaccharides. Conclusion: Structural studies reveal a binding site optimized for linear and branched mannotriose. Significance: The self-contained mannan-utilizing cluster can be utilized for engineering efforts for the conversion of mannan-containing hemicellulose into cellulosic biofuels. Hemicelluloses, the polysaccharide component of plant cell walls, represent one of the most abundant biopolymers in nature. The most common hemicellulosic constituents of softwoods, such as conifers and cycads, are mannans consisting of a 1,4-linked -mannopyranosyl main chain with branch decorations. Efforts toward the utilization of hemicellulose for bioconversion into cellulosic biofuels have resulted in the identification of several families of glycoside hydrolases that can degrade mannan. However, effective biofermentation of manno-oligosaccharides is limited by a lack of appropriate uptake route in ethanologenic organisms. Here, we used transcriptome sequencing to gain insights into mannan degradation by the thermophilic anaerobic bacterium Caldanaerobius polysaccharolyticus. The most highly up-regulated genes during mannan fermentation occur in a cluster containing several genes encoding enzymes for efficient mannan hydrolysis as well as a solute-binding protein (CpMnBP1) that exhibits specificity for short mannose polymers but exhibited the flexibility to accommodate branched polysaccharide decorations. Co-crystal structures of CpMnBP1 in complex with mannobiose (1.4-angstrom resolution) and mannotriose (2.2-angstrom resolution) revealed the molecular rationale for chain length and oligosaccharide specificity. Calorimetric analysis of several active site variants confirmed the roles of residues critical to the function of CpMnBP1. This work represents the first biochemical characterization of a mannose-specific solute-binding protein and provides a framework for engineering mannan utilization capabilities for microbial fermentation.	[Chekan, Jonathan R.; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Kwon, In Hyuk; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Dodd, Dylan; Cann, Isaac] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Chekan, Jonathan R.; Dodd, Dylan; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Dodd, Dylan; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cann, I (corresponding author), Univ Illinois, Inst Genom Biol 3408, Energy Biosci Inst, Urbana, IL 61801 USA.	icann@illinois.edu; snair@illinois.edu	Nair, Satish/AAY-2510-2021; Agarwal, Vinayak/L-5688-2017; Chekan, Jonathan/AAN-8499-2020	Chekan, Jonathan/0000-0003-4651-0594; Dodd, Dylan/0000-0001-6210-6239	Energy Biosciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	Energy Biosciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Energy Biosciences Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Cann IKO, 1999, J BACTERIOL, V181, P1643, DOI 10.1128/JB.181.5.1643-1651.1999; Cann IKO, 2001, INT J SYST EVOL MICR, V51, P293, DOI 10.1099/00207713-51-2-293; Chauhan PS, 2012, APPL MICROBIOL BIOT, V93, P1817, DOI 10.1007/s00253-012-3887-5; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Du J, 2011, J IND MICROBIOL BIOT, V38, P873, DOI 10.1007/s10295-011-0970-3; Du J, 2010, MOL BIOSYST, V6, P2150, DOI 10.1039/c0mb00007h; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Han YJ, 2012, J BIOL CHEM, V287, P34946, DOI 10.1074/jbc.M112.391532; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Jang YS, 2012, BIOTECHNOL ADV, V30, P989, DOI 10.1016/j.biotechadv.2011.08.015; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee SJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00092; Lee YJ, 2008, INT J SYST EVOL MICR, V58, P666, DOI 10.1099/ijs.0.65329-0; Mizutani K, 2012, APPL ENVIRON MICROB, V78, P4781, DOI 10.1128/AEM.07457-11; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Oyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080448; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Popper ZA, 2008, CURR OPIN PLANT BIOL, V11, P286, DOI 10.1016/j.pbi.2008.02.012; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; St John FJ, 2006, APPL ENVIRON MICROB, V72, P1496, DOI 10.1128/AEM.72.2.1496-1506.2006; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	38	12	12	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34965	34977		10.1074/jbc.M114.579904	http://dx.doi.org/10.1074/jbc.M114.579904			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342756	Green Published, hybrid			2022-12-26	WOS:000346260800045
J	Sogin, EM; Anderson, P; Williams, P; Chen, CS; Gates, RD				Sogin, Emilia M.; Anderson, Paul; Williams, Philip; Chen, Chii-Shiarng; Gates, Ruth D.			Application of H-1-NMR Metabolomic Profiling for Reef-Building Corals	PLOS ONE			English	Article							ENVIRONMENTAL METABOLOMICS; IDENTIFICATION; SPECTRA; NMR; METABOLITES; ACCLIMATIZATION; BIOSYNTHESIS; TEMPERATURE; ORGANISMS; DIVERSITY	In light of global reef decline new methods to accurately, cheaply, and quickly evaluate coral metabolic states are needed to assess reef health. Metabolomic profiling can describe the response of individuals to disturbance (i.e., shifts in environmental conditions) across biological models and is a powerful approach for characterizing and comparing coral metabolism. For the first time, we assess the utility of a proton-nuclear magnetic resonance spectroscopy (H-1-NMR)-based metabolomics approach in characterizing coral metabolite profiles by 1) investigating technical, intra-, and inter-sample variation, 2) evaluating the ability to recover targeted metabolite spikes, and 3) assessing the potential for this method to differentiate among coral species. Our results indicate H-1-NMR profiling of Porites compressa corals is highly reproducible and exhibits low levels of variability within and among colonies. The spiking experiments validate the sensitivity of our methods and showcase the capacity of orthogonal partial least squares discriminate analysis (OPLS-DA) to distinguish between profiles spiked with varying metabolite concentrations (0 mM, 0.1 mM, and 10 mM). Finally, H-1-NMR metabolomics coupled with OPLS-DA, revealed species-specific patterns in metabolite profiles among four reef-building corals (Pocillopora damicornis, Porites lobata, Montipora aequituberculata, and Seriatopora hystrix). Collectively, these data indicate that H-1-NMR metabolomic techniques can profile reef-building coral metabolomes and have the potential to provide an integrated picture of the coral phenotype in response to environmental change.	[Sogin, Emilia M.; Gates, Ruth D.] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Sogin, Emilia M.; Williams, Philip] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Anderson, Paul] Coll Charleston, Charleston, SC 29401 USA; [Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Checheng, Taiwan	University of Hawaii System; University of Hawaii Manoa; College of Charleston; National Museum of Marine Biology & Aquarium	Sogin, EM (corresponding author), Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	esogin@hawaii.edu		Williams, Philip/0000-0001-8987-0683; Sogin, Emilia/0000-0001-7533-3705	National Science Foundation East Asian and Pacific Summer Institute [OISE-1107948]; National Science Foundation Experimental Program to Stimulate Competitive Research Hawaii [EPS-0903833]; Directorate For Geosciences [1236905] Funding Source: National Science Foundation; Office Of The Director [0903833] Funding Source: National Science Foundation	National Science Foundation East Asian and Pacific Summer Institute; National Science Foundation Experimental Program to Stimulate Competitive Research Hawaii; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by funding from the National Science Foundation East Asian and Pacific Summer Institute to EMS, Award # OISE-1107948, URL: www.nsf.gov/eapsi. It was also supported by the National Science Foundation Experimental Program to Stimulate Competitive Research Hawaii, Award # EPS-0903833, www.nsf.gov/epscor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PE, 2011, METABOLOMICS, V7, P179, DOI 10.1007/s11306-010-0242-7; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bharti SK, 2012, QUANTITATIVE ANAL CH, V35, P5; Boroujerdi AFB, 2009, ENVIRON SCI TECHNOL, V43, P7658, DOI 10.1021/es901675w; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CROSSLAND CJ, 1991, CORAL REEFS, V10, P55, DOI 10.1007/BF00571824; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046801; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Ellis RP, 2014, ENVIRON SCI TECHNOL, V48, P7044, DOI 10.1021/es501601w; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Field KJ, 2011, PHYSIOL PLANTARUM, V142, P352, DOI 10.1111/j.1399-3054.2011.01480.x; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Gates RD, 1999, AM ZOOL, V39, P30; Gaude E, 2013, CURR METABOL, V1, P180, DOI 10.2174/2213235X11301020005; Gordon BR, 2013, METHODS MOL BIOL, V1055, P129, DOI 10.1007/978-1-62703-577-4_10; Gordon BR, 2010, MAR DRUGS, V8, P2546, DOI 10.3390/md8102546; Grivet JP, 2009, PROG NUCL MAG RES SP, V54, P1, DOI 10.1016/j.pnmrs.2008.02.001; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Hammer KM, 2012, COMP BIOCHEM PHYS D, V7, P292, DOI 10.1016/j.cbd.2012.06.001; Hines A, 2007, ENVIRON SCI TECHNOL, V41, P3375, DOI 10.1021/es062745w; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jacob D, 2013, ANAL BIOANAL CHEM, V405, P5049, DOI 10.1007/s00216-013-6852-y; Lin CY, 2007, METABOLOMICS, V3, P55, DOI 10.1007/s11306-006-0043-1; Lin CY, 2009, AQUAT TOXICOL, V95, P230, DOI 10.1016/j.aquatox.2009.09.006; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Martin-Pastor M, 2014, J AGR FOOD CHEM, V62, P1190, DOI 10.1021/jf4044869; Meyer E, 2012, BIOL BULL-US, V223, P44, DOI 10.1086/BBLv223n1p44; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Motti C, 2012, J MARINE SCI RES DEV, V2, P3; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parsons HM, 2009, ANALYST, V134, P478, DOI 10.1039/b808986h; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Raina JB, 2013, NATURE, V502, P677, DOI 10.1038/nature12677; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Rosenblum ES, 2006, ENVIRON SCI TECHNOL, V40, P7077, DOI 10.1021/es061354e; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; SEBENS KP, 1994, AM ZOOL, V34, P115; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Tapiolas DM, 2010, CORAL REEFS, V29, P621, DOI 10.1007/s00338-010-0608-3; Tapiolas DM, 2013, J EXP MAR BIOL ECOL, V443, P85, DOI 10.1016/j.jembe.2013.02.037; Tarrant AM, 2003, COMP BIOCHEM PHYS B, V136, P473, DOI 10.1016/S1096-4959(03)00253-7; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tuffnail W, 2009, METABOLOMICS, V5, P33, DOI 10.1007/s11306-008-0143-1; Tulpan D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-400; Viant MR, 2006, AQUAT TOXICOL, V77, P359, DOI 10.1016/j.aquatox.2006.01.009; Ward JL, 2010, METABOLOMICS, V6, P263, DOI 10.1007/s11306-010-0200-4; Wu HF, 2010, AQUAT TOXICOL, V100, P339, DOI 10.1016/j.aquatox.2010.08.005; Xi YX, 2008, ANAL CHIM ACTA, V614, P127, DOI 10.1016/j.aca.2008.03.024; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yost DM, 2013, ZOOLOGY, V116, P262, DOI 10.1016/j.zool.2013.06.001; Zheng C, 2011, BIOINFORMATICS, V27, P1637, DOI 10.1093/bioinformatics/btr118	65	27	27	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111274	10.1371/journal.pone.0111274	http://dx.doi.org/10.1371/journal.pone.0111274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354140	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200066
J	Alvite, G; Garrido, N; Kun, A; Paulino, M; Esteves, A				Alvite, Gabriela; Garrido, Natalia; Kun, Alejandra; Paulino, Margot; Esteves, Adriana			Towards an Understanding of Mesocestoides vogae Fatty Acid Binding Proteins' Roles	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; GENE-EXPRESSION; LIVER; ALPHA; PHOSPHATIDYLCHOLINE; LOCALIZATION; EVOLUTION; NUCLEI; FAMILY; GAMMA	Two fatty acid binding proteins, MvFABPa and MvFABPb were identified in the parasite Mesocestoides vogae (Platyhelmithes, Cestoda). Fatty acid binding proteins are small intracellular proteins whose members exhibit great diversity. Proteins of this family have been identified in many organisms, of which Platyhelminthes are among the most primitive. These proteins have particular relevance in flatworms since de novo synthesis of fatty acids is absent. Fatty acids should be captured from the media needing an efficient transport system to uptake and distribute these molecules. While HLBPs could be involved in the shuttle of fatty acids to the surrounding host tissues and convey them into the parasite, FABPs could be responsible for the intracellular trafficking. In an effort to understand the role of MvFABPs in fatty acid transport of M. vogae larvae, we analysed the intracellular localization of both MvFABPs and the co-localization with in vivo uptake of fatty acid analogue BODIPY FL C-16. Immunohistochemical studies on larvae sections using specific antibodies, showed a diffuse cytoplasmic distribution of each protein with some expression in nuclei and mitochondria. MvFABPs distribution was confirmed by mass spectrometry identification from 2D-electrophoresis of larvae subcellular fractions. This work is the first report showing intracellular distribution of MvFABPs as well as the co-localization of these proteins with the BODIPY FL C-16 incorporated from the media. Our results suggest that fatty acid binding proteins could target fatty acids to cellular compartments including nuclei. In this sense, M. vogae FABPs could participate in several cellular processes fulfilling most of the functions attributed to vertebrate's counterparts.	[Alvite, Gabriela; Garrido, Natalia; Kun, Alejandra; Esteves, Adriana] Univ Republica, Fac Ciencias, Secc Bioquim, Montevideo, Uruguay; [Kun, Alejandra] Inst Invest Biol Clemente Estable, Montevideo, Uruguay; [Paulino, Margot] Univ Republica, Fac Quim, Ctr Bioinformat Estruct DETEMA, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay	Esteves, A (corresponding author), Univ Republica, Fac Ciencias, Secc Bioquim, Montevideo, Uruguay.	aesteves@fcien.edu.uy	González, Alejandra Elizabeth Kun/AAB-7929-2019	González, Alejandra Elizabeth Kun/0000-0002-7070-0171	Programa de Desarrollo de las Ciencias Basicas; Comision Sectorial de Investigacion Cientifica [4003]; Agencia Nacional de Investigacion e Innovacion [FCE2007_57]	Programa de Desarrollo de las Ciencias Basicas; Comision Sectorial de Investigacion Cientifica; Agencia Nacional de Investigacion e Innovacion	This work was supported by Programa de Desarrollo de las Ciencias Basicas (www.pedeciba.edu.uy, AE), Comision Sectorial de Investigacion Cientifica (www.csic.edu.uy. N degrees 4003; 2008-2010, AE), Agencia Nacional de Investigacion e Innovacion (www.anii.org.uy FCE2007_57, GA and CAP fellowship), and Agencia Nacional de Investigacion e Innovacion (www.anii.org.uy FCE2007_57, GA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alvite G, 2008, FEBS J, V275, P107, DOI 10.1111/j.1742-4658.2007.06179.x; Antony P, 2000, NEUROCHEM RES, V25, P1073, DOI 10.1023/A:1007613827552; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Babin PJ, 2009, FATTY ACID BINDING P, P17; Britos L, 2007, EXP PARASITOL, V116, P95, DOI 10.1016/j.exppara.2006.11.008; CHAN L, 1985, J BIOL CHEM, V260, P2629; Chemical Computing Group Inc, 2007, MOE MOL OP ENV VERS; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; COOPER TG, 1969, J BIOL CHEM, V244, P3507; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; Esteves A, 1997, INT J PARASITOL, V27, P1013, DOI 10.1016/S0020-7519(97)00071-4; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; HESS E, 1980, Z PARASITENKD, V61, P135, DOI 10.1007/BF00925460; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; Hunt AN, 2001, J BIOL CHEM, V276, P8492, DOI 10.1074/jbc.M009878200; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Kim SH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001868; LALONDE JM, 1994, FASEB J, V8, P1240, DOI 10.1096/fasebj.8.15.8001736; Layerenza JP, 2013, BIOCHIM BIOPHYS ACTA, V1831, p3 27; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mate SM, 2006, CAN J PHYSIOL PHARM, V84, P459, DOI 10.1139/Y05-097; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McIntosh AL, 2009, ARCH BIOCHEM BIOPHYS, V485, P160, DOI 10.1016/j.abb.2009.03.004; MEYER F, 1966, J BIOL CHEM, V241, P4224; OCHMAN H, 1988, GENETICS, V120, P621; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Opperman M, 1992, MONOCLONAL ANTIBODIE, P258; Pegorier JP, 2004, J NUTR, V134, p2444S, DOI 10.1093/jn/134.9.2444S; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; SACCHETTINI JC, 1988, J BIOL CHEM, V263, P5815; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Schleicher CH, 1995, BIOCHEM MOL BIOL INT, V36, P1117; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Schwenk R, 2010, PROSTAG LEUKOTR ESS, V82, P49; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; SEUBERT W, 1968, BIOCHIM BIOPHYS ACTA, V164, P498, DOI 10.1016/0005-2760(68)90180-X; Silvarrey C, 2012, THESIS MONTEVIDEO UR; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Smith JD, 1988, IN VITRO CULTURE PAR; Smyth JD, 1989, PHYSL BIOCH CESTODES, P53; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thumser AE, 2007, MOL CELL BIOCHEM, V299, P67, DOI 10.1007/s11010-005-9041-2; VEERKAMP JH, 1993, PROSTAG LEUKOTR ESS, V49, P887, DOI 10.1016/0952-3278(93)90174-U; Vinaud MC, 2007, EXP PARASITOL, V116, P335, DOI 10.1016/j.exppara.2007.01.013; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WARD CW, 1970, J PARASITOL, V56, P1009, DOI 10.2307/3277526; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; XU ZH, 1993, J BIOL CHEM, V268, P7874; Zheng YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077636	57	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111204	10.1371/journal.pone.0111204	http://dx.doi.org/10.1371/journal.pone.0111204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347286	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900055
J	Lv, HQ; Han, JQ; Liu, J; Zheng, JG; Liu, RL; Zhong, DX				Lv, Hongqiang; Han, Jiuqiang; Liu, Jun; Zheng, Jiguang; Liu, Ruiling; Zhong, Dexing			CarSPred: A Computational Tool for Predicting Carbonylation Sites of Human Proteins	PLOS ONE			English	Article							OXIDATIVE STRESS; POSTTRANSLATIONAL MODIFICATIONS; IDENTIFICATION; QUANTIFICATION; SELECTION; DAMAGE	Protein carbonylation is one of the most pervasive oxidative stress-induced post-translational modifications (PTMs), which plays a significant role in the etiology and progression of several human diseases. It has been regarded as a biomarker of oxidative stress due to its relatively early formation and stability compared with other oxidative PTMs. Only a subset of proteins is prone to carbonylation and most carbonyl groups are formed from lysine (K), arginine (R), threonine (T) and proline (P) residues. Recent advancements in analysis of the PTM by mass spectrometry provided new insights into the mechanisms of protein carbonylation, such as protein susceptibility and exact modification sites. However, the experimental approaches to identifying carbonylation sites are costly, time-consuming and capable of processing a limited number of proteins, and there is no bioinformatics method or tool devoted to predicting carbonylation sites of human proteins so far. In the paper, a computational method is proposed to identify carbonylation sites of human proteins. The method extracted four kinds of features and combined the minimum Redundancy Maximum Relevance (mRMR) feature selection criterion with weighted support vector machine (WSVM) to achieve total accuracies of 85.72%, 85.95%, 83.92% and 85.72% for K, R, T and P carbonylation site predictions respectively using 10-fold cross-validation. The final optimal feature sets were analysed, the position-specific composition and hydrophobicity environment of flanking residues of modification sites were discussed. In addition, a software tool named CarSPred has been developed to facilitate the application of the method. Datasets and the software involved in the paper are available at https://sourceforge.net/projects/hqlstudio/files/CarSPred-1.0/.	[Lv, Hongqiang; Han, Jiuqiang; Liu, Jun; Zheng, Jiguang; Liu, Ruiling; Zhong, Dexing] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian 710049, Peoples R China	Xi'an Jiaotong University	Han, JQ (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian 710049, Peoples R China.	jqhan@mail.xjtu.edu.cn; eeliujun@gmail.com			National Natural Science Foundation of China [61105021]; Ph.D. Program Foundation of the Ministry of Education of China [20110201110010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Program Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from National Natural Science Foundation of China (No. 61105021) and Ph.D. Program Foundation of the Ministry of Education of China (No. 20110201110010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachi A, 2013, CHEM REV, V113, P596, DOI 10.1021/cr300073p; Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658; Baraibar MA, 2013, J PROTEOMICS, V92, P63, DOI 10.1016/j.jprot.2013.05.008; Bollineni RC, 2011, J PROTEOMICS, V74, P2338, DOI 10.1016/j.jprot.2011.07.002; Bollineni RC, 2014, FREE RADICAL BIO MED, V68, P186, DOI 10.1016/j.freeradbiomed.2013.11.030; Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4; BREIMAN L, 1992, INT STAT REV, V60, P291, DOI 10.2307/1403680; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen X, 2013, BIOINFORMATICS, V29, P1614, DOI 10.1093/bioinformatics/btt196; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Chung C, 2011, BIOINFORMATICS, V27, P797, DOI 10.1093/bioinformatics/btr017; Colzani M, 2013, J PROTEOMICS, V92, P28, DOI 10.1016/j.jprot.2013.03.030; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Fedorova M, 2014, MASS SPECTROM REV, V33, P79, DOI 10.1002/mas.21381; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Gianazza E, 2007, AMINO ACIDS, V33, P51, DOI 10.1007/s00726-006-0410-2; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; LAXTON RR, 1978, J THEOR BIOL, V70, P51, DOI 10.1016/0022-5193(78)90302-8; Maisonneuve E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007269; Mendez D, 2010, J PROTEOME RES, V9, P5770, DOI 10.1021/pr100555v; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rao RSP, 2011, PROTEOMICS, V11, P4166, DOI 10.1002/pmic.201100223; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Saha I, 2012, AMINO ACIDS, V43, P583, DOI 10.1007/s00726-011-1106-9; Tang YR, 2007, PROTEIN ENG DES SEL, V20, P405, DOI 10.1093/protein/gzm035; Trost B, 2013, BIOINFORMATICS, V29, P686, DOI 10.1093/bioinformatics/btt031; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Xue B, 2012, PLOS ONE, V7	33	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111478	10.1371/journal.pone.0111478	http://dx.doi.org/10.1371/journal.pone.0111478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347395	gold, Green Submitted, Green Published			2022-12-26	WOS:000347994900080
J	Beas-Luna, R; Novak, M; Carr, MH; Tinker, MT; Black, A; Caselle, JE; Hoban, M; Malone, D; Iles, A				Beas-Luna, Rodrigo; Novak, Mark; Carr, Mark H.; Tinker, Martin T.; Black, August; Caselle, Jennifer E.; Hoban, Michael; Malone, Dan; Iles, Alison			An Online Database for Informing Ecological Network Models: http://kelpforest.ucsc.edu	PLOS ONE			English	Article							ALTERNATIVE STATES; FOOD WEBS; KELP; MANAGEMENT; PATTERN	Ecological network models and analyses are recognized as valuable tools for understanding the dynamics and resiliency of ecosystems, and for informing ecosystem-based approaches to management. However, few databases exist that can provide the life history, demographic and species interaction information necessary to parameterize ecological network models. Faced with the difficulty of synthesizing the information required to construct models for kelp forest ecosystems along the West Coast of North America, we developed an online database (http://kelpforest.ucsc.edu/) to facilitate the collation and dissemination of such information. Many of the database's attributes are novel yet the structure is applicable and adaptable to other ecosystem modeling efforts. Information for each taxonomic unit includes stage-specific life history, demography, and body-size allometries. Species interactions include trophic, competitive, facilitative, and parasitic forms. Each data entry is temporally and spatially explicit. The online data entry interface allows researchers anywhere to contribute and access information. Quality control is facilitated by attributing each entry to unique contributor identities and source citations. The database has proven useful as an archive of species and ecosystem-specific information in the development of several ecological network models, for informing management actions, and for education purposes (e.g., undergraduate and graduate training). To facilitate adaptation of the database by other researches for other ecosystems, the code and technical details on how to customize this database and apply it to other ecosystems are freely available and located at the following link (https://github.com/kelpforest-cameo/databaseui).	[Beas-Luna, Rodrigo; Carr, Mark H.; Tinker, Martin T.; Hoban, Michael; Malone, Dan] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Novak, Mark; Iles, Alison] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Tinker, Martin T.] US Geol Survey, Western Ecol Res Ctr, Santa Cruz, CA USA; [Black, August; Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Cruz; Oregon State University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara	Carr, MH (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	mhcarr@ucsc.edu	Beas, Rodrigo/G-9046-2018; Novak, Mark/E-2194-2012; Tinker, Martin T/D-3249-2018; Hoban, Mykle/AAF-8562-2020	Beas, Rodrigo/0000-0002-7266-3394; Novak, Mark/0000-0002-7881-4253; Tinker, Martin T/0000-0002-3314-839X; Hoban, Mykle/0000-0002-2514-3599	Comparative Analysis of Marine Ecosystem Organization (CAMEO) program - National Science Foundation [OCE-1041454, OCE-10411489]; Comparative Analysis of Marine Ecosystem Organization (CAMEO) program - U.S. National Marine Fisheries Service of the National Oceanic and Atmospheric Administration [OCE-1041454, OCE-10411489]; Consejo Nacional de Ciencia y Tecnologia; University of California Institute for Mexico; University of California Santa Cruz, Open Access Fund; Directorate For Geosciences [1041454] Funding Source: National Science Foundation; Division Of Ocean Sciences [1041489] Funding Source: National Science Foundation	Comparative Analysis of Marine Ecosystem Organization (CAMEO) program - National Science Foundation; Comparative Analysis of Marine Ecosystem Organization (CAMEO) program - U.S. National Marine Fisheries Service of the National Oceanic and Atmospheric Administration; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California Institute for Mexico; University of California Santa Cruz, Open Access Fund; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was supported by the Comparative Analysis of Marine Ecosystem Organization (CAMEO) program, jointly supported by the National Science Foundation and the U.S. National Marine Fisheries Service of the National Oceanic and Atmospheric Administration (award # OCE-1041454 and OCE-10411489). Additional support for Rodrigo Beas-Luna was provided by the Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) and the University of California Institute for Mexico (www.ucmexus.ucr.edu). Funding for Open Access provided by the University of California Santa Cruz, Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2012, J APPL ECOL, V49, P63, DOI 10.1111/j.1365-2664.2011.02064.x; Baskett ML, 2010, ECOLOGY, V91, P1763, DOI 10.1890/09-0515.1; Beas-Luna R, 2014, BOT MAR, V57, P73, DOI 10.1515/bot-2013-0114; Boit A, 2012, ECOL LETT, V15, P594, DOI 10.1111/j.1461-0248.2012.01777.x; Borrett SR, 2014, ECOL MODEL, V7158, P1; Byrnes JE, 2011, GLOBAL CHANGE BIOL, V17, P2513, DOI 10.1111/j.1365-2486.2011.02409.x; CAILLIET GM, 2000, BIOL CHARACTERISTICS; Carr MH, ECOSYSTEMS CALIFORNI; Caselle JE, 2011, CAN J FISH AQUAT SCI, V68, P288, DOI 10.1139/F10-140; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Dambacher JM, 2009, FISH FISH, V10, P305, DOI 10.1111/j.1467-2979.2008.00323.x; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dunstan PK, 2006, ECOLOGY, V87, P2842, DOI 10.1890/0012-9658(2006)87[2842:LRCVAI]2.0.CO;2; EBELING AW, 1985, MAR BIOL, V84, P287, DOI 10.1007/BF00392498; Espinosa-Romero MJ, 2010, THESIS U BRIT COLUMB; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gerber LR, 2003, ECOL APPL, V13, pS47; Graham Michael, 2008, P103; Holker F, 2007, SCIENCE, V316, P1285, DOI 10.1126/science.1139114; Hudson L, 2013, P R SOC BIOL, V19; JOHNSON CR, 1988, ECOL MONOGR, V58, P129, DOI 10.2307/1942464; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Levins R, 1974, ANN N Y ACAD SCI, V231; Ling S, 2009, P NATL ACAD SCI USA, P1; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; Marzloff MP, 2013, ECOL MODEL, V258, P16, DOI 10.1016/j.ecolmodel.2013.02.022; Marzloff MP, 2011, ECOL MODEL, V222, P2651, DOI 10.1016/j.ecolmodel.2011.03.040; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Morales P, 2005, GLOBAL CHANGE BIOL, V11, P2211, DOI 10.1111/j.1365-2486.2005.01036.x; Ortiz M, 2010, AQUAT CONSERV, V20, P58, DOI 10.1002/aqc.1047; Plaganyi E, 2007, FAO FISH TECH PAP, V477, P107; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; SCHIEL DR, 1986, OCEANOGR MAR BIOL, V24, P265; Schiel DR, BIOL ECOLOGY GIANT K; Springer YP, 2010, OCEANOGR MAR BIOL, V48, P1; Starr R. M., 2002, TRENDS FISHERIES FIS; Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	45	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109356	10.1371/journal.pone.0109356	http://dx.doi.org/10.1371/journal.pone.0109356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343723	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500013
J	Panuzzo, C; Crivellaro, S; Carra, G; Guerrasio, A; Saglio, G; Morotti, A				Panuzzo, Cristina; Crivellaro, Sabrina; Carra, Giovanna; Guerrasio, Angelo; Saglio, Giuseppe; Morotti, Alessandro			BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; STEM-CELLS; CANCER	Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the t(9;22) translocation coding for the chimeric protein p210 BCR-ABL. The tumor suppressor PTEN plays a critical role in the pathogenesis of CML chronic phase, through non genomic loss of function mechanisms, such as protein down-regulation and impaired nuclear/cytoplasmic shuttling. Here we demonstrate that BCR-ABL promotes PTEN downregulation through a MEK dependent pathway. Furthermore, we describe a novel not recurrent N212D-PTEN point mutation found in the EM2 blast crisis cell line.	[Panuzzo, Cristina; Crivellaro, Sabrina; Carra, Giovanna; Guerrasio, Angelo; Saglio, Giuseppe; Morotti, Alessandro] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Turin, Italy	University of Turin	Morotti, A (corresponding author), Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Turin, Italy.	alessandro.morotti@unito.it	Morotti, Alessandro/J-7590-2018; Carrà, Giovanna/ABF-4205-2020	Morotti, Alessandro/0000-0002-8407-2903; Carrà, Giovanna/0000-0002-6263-6800; Saglio, Giuseppe/0000-0002-1046-3514; CRIVELLARO, Sabrina/0000-0002-9672-8885; Panuzzo, Cristina/0000-0002-2814-6453	Giovani Ricercatori-Ricerca Finalizzata, ministero della salute; AIRC	Giovani Ricercatori-Ricerca Finalizzata, ministero della salute; AIRC(Fondazione AIRC per la ricerca sul cancro)	This research was supported by Giovani Ricercatori-Ricerca Finalizzata, ministero della salute 2010 to AM, and AIRC to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm A, 2000, EUR J HAEMATOL, V65, P109, DOI 10.1034/j.1600-0609.2000.90181.x; Correia NC, 2014, EUR J CANCER, V50, P216, DOI 10.1016/j.ejca.2013.08.017; Georgescu MM, 2000, CANCER RES, V60, P7033; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Huang FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088298; Keeshan K, 2003, BRIT J HAEMATOL, V123, P34, DOI 10.1046/j.1365-2141.2003.04538.x; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Morotti A, 2014, LEUKEMIA, V28, P1326, DOI 10.1038/leu.2013.370; Morotti A, 2014, EXPERT OPIN BIOL TH, V14, P287, DOI 10.1517/14712598.2014.867323; Pellicano F, 2011, LEUKEMIA, V25, P1159, DOI 10.1038/leu.2011.67; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827	15	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110682	10.1371/journal.pone.0110682	http://dx.doi.org/10.1371/journal.pone.0110682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343485	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500047
J	Chaturvedi, AK; Patel, MK; Mishra, A; Tiwari, V; Jha, B				Chaturvedi, Amit Kumar; Patel, Manish Kumar; Mishra, Avinash; Tiwari, Vivekanand; Jha, Bhavanath			The SbMT-2 Gene from a Halophyte Confers Abiotic Stress Tolerance and Modulates ROS Scavenging in Transgenic Tobacco	PLOS ONE			English	Article							HEAVY-METAL STRESS; SALICORNIA-BRACHIATA; EXTREME HALOPHYTE; OXIDATIVE STRESS; HETEROLOGOUS EXPRESSION; TYPE-2 METALLOTHIONEIN; PLANT-REGENERATION; ECTOPIC EXPRESSION; ACCUMULATION; TRANSFORMATION	Heavy metals are common pollutants of the coastal saline area and Salicornia brachiata an extreme halophyte is frequently exposed to various abiotic stresses including heavy metals. The SbMT-2 gene was cloned and transformed to tobacco for the functional validation. Transgenic tobacco lines (L2, L4, L6 and L13) showed significantly enhanced salt (NaCl), osmotic (PEG) and metals (Zn++, Cu++ and Cd++) tolerance compared to WT plants. Transgenic lines did not show any morphological variation and had enhanced growth parameters viz. shoot length, root length, fresh weight and dry weight. High seed germination percentage, chlorophyll content, relative water content, electrolytic leakage and membrane stability index confirmed that transgenic lines performed better under salt (NaCl), osmotic (PEG) and metals (Zn++, Cu++ and Cd++) stress conditions compared to WT plants. Proline, H2O2 and lipid peroxidation (MDA) analyses suggested the role of SbMT-2 in cellular homeostasis and H2O2 detoxification. Furthermore in vivo localization of H2O2 and O-2(-); and elevated expression of key antioxidant enzyme encoding genes, SOD, POD and APX evident the possible role of SbMT-2 in ROS scavenging/detoxification mechanism. Transgenic lines showed accumulation of Cu++ and Cd++ in root while Zn++ in stem under stress condition. Under control (unstressed) condition, Zn++ was accumulated more in root but accumulation of Zn++ in stem under stress condition suggested that SbMT-2 may involve in the selective translocation of Zn++ from root to stem. This observation was further supported by the up-regulation of zinc transporter encoding genes NtZIP1 and NtHMA-A under metal ion stress condition. The study suggested that SbMT-2 modulates ROS scavenging and is a potential candidate to be used for phytoremediation and imparting stress tolerance.	[Chaturvedi, Amit Kumar; Patel, Manish Kumar; Mishra, Avinash; Tiwari, Vivekanand; Jha, Bhavanath] CSIR, Discipline Marine Biotechnol & Ecol, Cent Salt & Marine Chem Res Inst, Bhavnagar, Gujarat, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI)	Mishra, A (corresponding author), CSIR, Discipline Marine Biotechnol & Ecol, Cent Salt & Marine Chem Res Inst, Bhavnagar, Gujarat, India.	avinash@csmcri.org; bjha@csmcri.org	Chaturvedi, Amit k/J-5187-2012; Mishra, Avinash/C-3210-2009; Patel, Manish Kumar/I-6335-2017; Mishra, Avinash/AAG-2961-2019; TIWARI, VIVEKANAND/AAD-9738-2020	Mishra, Avinash/0000-0003-0342-010X; Patel, Manish Kumar/0000-0001-5250-1008; Mishra, Avinash/0000-0003-0342-010X; TIWARI, VIVEKANAND/0000-0002-0464-6031; Chaturvedi, Amit Kumar/0000-0003-0867-6542	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [BSC0109-SIMPLE]	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council of Scientific and Industrial Research (CSIR, www.csir.res.in), Government of India, New Delhi (BSC0109-SIMPLE; Senior Research Fellowship to AKC and VT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZG, 2006, J EXP BOT, V57, P3575, DOI 10.1093/jxb/erl102; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Chary NS, 2008, ECOTOX ENVIRON SAFE, V69, P513, DOI 10.1016/j.ecoenv.2007.04.013; Chaturvedi AK, 2012, GENE, V499, P280, DOI 10.1016/j.gene.2012.03.001; Cherian S, 2005, ENVIRON SCI TECHNOL, V39, P9377, DOI 10.1021/es051134l; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Hassinen VH, 2009, J EXP BOT, V60, P187, DOI 10.1093/jxb/ern287; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang GY, 2010, AQUAT TOXICOL, V99, P86, DOI 10.1016/j.aquatox.2010.04.004; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jha B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071136; Jha B, 2012, J AGR FOOD CHEM, V60, P4320, DOI 10.1021/jf203632v; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Joshi M, 2012, IND CROP PROD, V35, P313, DOI 10.1016/j.indcrop.2011.06.024; Joshi M, 2011, IND CROP PROD, V33, P67, DOI 10.1016/j.indcrop.2010.09.002; Kholodova V, 2010, SOIL BIOL, V19, P163, DOI 10.1007/978-3-642-02436-8_8; Kumar G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloriente I.D. Rodriguez, 2010, PLANT SCI, V178, P327; Mishra A, 2013, CARBOHYD POLYM, V92, P1942, DOI 10.1016/j.carbpol.2012.11.055; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; SAIRAM RK, 1994, PLANT GROWTH REGUL, V14, P173, DOI 10.1007/BF00025220; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Seth CS, 2012, PLANT CELL ENVIRON, V35, P334, DOI 10.1111/j.1365-3040.2011.02338.x; Shi J, 2010, TREE PHYSIOL, V30, P914, DOI 10.1093/treephys/tpq030; Siemianowski O, 2014, J EXP BOT, V65, P1125, DOI 10.1093/jxb/ert471; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2014, MAR BIOTECHNOL, V16, P321, DOI 10.1007/s10126-013-9548-6; Singh N, 2010, PLANT CELL TISS ORG, V103, P1, DOI 10.1007/s11240-010-9746-0; Sreenivasulu N, 2007, GENE, V388, P1, DOI 10.1016/j.gene.2006.10.009; Tewari RK, 2002, PLANT SCI, V162, P381, DOI 10.1016/S0168-9452(01)00578-7; Tiwari V, 2015, APPL BIOCHEM BIOTECH, V175, P436, DOI 10.1007/s12010-014-1286-3; Tiwari V, 2014, PLANT CELL PHYSIOL, V55, P201, DOI 10.1093/pcp/pct172; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Turchi A, 2012, PLANT SCI, V183, P50, DOI 10.1016/j.plantsci.2011.11.008; Udawat P, 2014, GENE, V536, P163, DOI 10.1016/j.gene.2013.11.020; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Xia Y, 2012, J HAZARD MATER, V233, P65, DOI 10.1016/j.jhazmat.2012.06.047; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yang Z, 2009, PLANT MOL BIOL, V70, P219, DOI 10.1007/s11103-009-9466-1; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhu JH, 2010, PLANT PHYSIOL BIOCH, V48, P710, DOI 10.1016/j.plaphy.2010.04.004	48	69	72	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111379	10.1371/journal.pone.0111379	http://dx.doi.org/10.1371/journal.pone.0111379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340650	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800104
J	Duan, QQ; Jiang, W; Ding, M; Lin, Y; Huang, DF				Duan, Qingqing; Jiang, Wu; Ding, Ming; Lin, Ye; Huang, Danfeng			Light Affects the Chloroplast Ultrastructure and Post-Storage Photosynthetic Performance of Watermelon (Citrullus lanatus) Plug Seedlings	PLOS ONE			English	Article							LOW-TEMPERATURE STORAGE; IN-VITRO; QUALITY PRESERVATION; SHIPPING PERFORMANCE; CARBOHYDRATE STATUS; BROCCOLI SEEDLINGS; GROWTH SUPPRESSION; RESPONSES; LEAVES; DARK	Watermelon [Citrullus lanatus (Thunb.) Matsum. and Nakai] plug seedlings were stored at 15 degrees C in the light at a photosynthetic photon flux density of 15 mu mol.m(-2).s(-1) or in darkness for 6 days, to evaluate their chloroplast ultrastructure, and associated photosynthetic characteristics. Storage in the dark caused swelling, disordered granal arrangement, and starch grain disappearance in the chloroplasts. In contrast, the chloroplasts stored in the light were relatively normal. As a result, the light-stored seedlings had a significantly higher chlorophyll content, Fv/Fm, and Pn than did dark-stored seedlings. Regardless of whether the seedlings were stored in light or darkness, the Gs and Ls of the seedlings significantly decreased, while the Ci obviously increased when the Pn decreased after 6 days of storage. This result suggests that the decreased Pn is not solely a stomatal effect, as the effects on the chloroplasts contributed to this photosynthetic inhibition. Six days after transplanting, seedlings that were stored in the light or darkness for 2 or 4 days showed complete recovery of chloroplast ultrastructure, chlorophyll content, Fv/Fm, Gs and Pn. When the storage period increased to 6 days, the dark-stored seedlings had a significantly lower Fv/Fm and Pn than the light-stored and control seedlings 6 days after transplanting, which was mainly ascribed to incomplete recovery of chloroplast ultrastructure. Furthermore, the light-stored seedlings exhibited a significantly higher shoot dry weight during storage and a higher percentage dry weight increase after transplanting than the dark-stored seedlings. These effects were enhanced by prolonged storage (4 to 6 days). This study demonstrated that dim light during storage is beneficial for maintaining chloroplast ultrastructure as well as photosynthetic efficiency in watermelon seedlings, thus contributing to the rapid recovery of post-storage photosynthetic performance, which ensures the transplant quality of the seedlings after removal from storage.	[Duan, Qingqing; Jiang, Wu; Lin, Ye; Huang, Danfeng] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Plant Sci, Shanghai 200030, Peoples R China; [Duan, Qingqing; Jiang, Wu; Lin, Ye; Huang, Danfeng] Minist Agr, Key Lab Urban Agr South, Shanghai, Peoples R China; [Ding, Ming] Northwest A&F Univ, Dept Hort, Yangling, Peoples R China	Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Huang, DF (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Plant Sci, Shanghai 200030, Peoples R China.	hdf@sjtu.edu.cn			National High-tech Research & Development Program of China [2012AA101903]; National Natural Science Foundation of China [61233006]; National Science-tech Support Plan Project [2011BAD43B02]; Shanghai Graduate Education and Innovation Program (Horticulture)	National High-tech Research & Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science-tech Support Plan Project; Shanghai Graduate Education and Innovation Program (Horticulture)	This work was supported by funds from the National High-tech Research & Development Program of China (Grant No. 2012AA101903), National Natural Science Foundation of China (No. 61233006), the National Science-tech Support Plan Project (Grant No. 2011BAD43B02), and Shanghai Graduate Education and Innovation Program (Horticulture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2003, SCI AGR SINICA, V37, P268; Ananieva K, 2004, PHYSIOL PLANTARUM, V122, P133, DOI 10.1111/j.1399-3054.2004.00378.x; BAKA Z A M, 1991, Beitraege zur Biologie der Pflanzen, V66, P271; BESSEMBINDER JJE, 1993, PLANT CELL TISS ORG, V33, P121, DOI 10.1007/BF01983224; Bondada BR, 1998, PHOTOSYNTHETICA, V35, P467, DOI 10.1023/A:1006980806057; Chen GX, 2004, PHOTOSYNTHETICA, V42, P573, DOI 10.1007/S11099-005-0015-0; Ding M, 2011, HORTSCIENCE, V46, P993, DOI 10.21273/HORTSCI.46.7.993; Doncheva S, 2008, AGR FOOD SCI, V10, P59; FAO, 2014, FAOSTAT DOM PROD CRO; Harper RC, 2010, PLANT BIOSYST, V144, P769, DOI 10.1080/11263504.2010.502727; Holcomb EJ, 1994, BEDDING PLANTS, VIV, P399; Hou JY, 2011, J AM SOC HORTIC SCI, V136, P364, DOI 10.21273/JASHS.136.5.364; Hou JY, 2010, J AM SOC HORTIC SCI, V135, P183, DOI 10.21273/JASHS.135.2.183; Huang Jun, 2007, Yingyong Shengtai Xuebao, V18, P352; Jiang W, 2012, SCI HORTIC-AMSTERDAM, V148, P23, DOI 10.1016/j.scienta.2012.09.016; Justus I, 2010, SCI HORTIC-AMSTERDAM, V125, P47, DOI 10.1016/j.scienta.2010.02.020; Kaczperski MP, 1996, HORTSCIENCE, V31, P361, DOI 10.21273/HORTSCI.31.3.361; KUBOTA C, 1995, SCI HORTIC-AMSTERDAM, V61, P193, DOI 10.1016/0304-4238(94)00717-T; Kubota C, 2002, SCI HORTIC-AMSTERDAM, V94, P13, DOI 10.1016/S0304-4238(01)00382-X; KUBOTA C, 1994, HORTSCIENCE, V29, P1191, DOI 10.21273/HORTSCI.29.10.1191; Kubota C, 1997, POSTHARVEST BIOL TEC, V12, P165, DOI 10.1016/S0925-5214(97)00047-1; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mena-Petite A, 2003, TREES-STRUCT FUNCT, V17, P133, DOI 10.1007/s00468-002-0216-0; Migge A, 1999, PHOTOSYNTHETICA, V36, P107, DOI 10.1023/A:1007074921833; Oguchi R, 2005, PLANT CELL ENVIRON, V28, P916, DOI 10.1111/j.1365-3040.2005.01344.x; Park JS, 2009, EUR J HORTIC SCI, V74, P21; Peng Q, 2009, J RARE EARTH, V27, P304, DOI 10.1016/S1002-0721(08)60238-0; Peri PL, 2007, AGRON J, V99, P1502, DOI 10.2134/agronj2006.0347; Sato F, 2004, SCI HORTIC-AMSTERDAM, V101, P349, DOI 10.1016/j.scienta.2003.11.018; Shao QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085996; Spundova M, 2003, J PLANT PHYSIOL, V160, P1051, DOI 10.1078/0176-1617-00902; STITT M, 1981, PLANT PHYSIOL, V68, P755, DOI 10.1104/pp.68.3.755; Su V, 2001, SCI HORTIC-AMSTERDAM, V87, P311, DOI 10.1016/S0304-4238(00)00187-4; VIDAL D, 1990, AM J BOT, V77, P1149, DOI 10.2307/2444625; Walles B, 1975, STUD FOREST SUECICA, V127, P2; Wang YongJian, 2001, Acta Horticulturae Sinica, V28, P230; Wilson S. B., 2000, Journal of Vegetable Crop Production, V6, P51, DOI 10.1300/J068v06n02_07; Wilson SB, 1998, HORTSCIENCE, V33, P1253, DOI 10.21273/HORTSCI.33.7.1253; Wilson SB, 1998, HORTSCIENCE, V33, P1258, DOI 10.21273/HORTSCI.33.7.1258; Yang XS, 2010, J HORTIC SCI BIOTECH, V85, P323, DOI 10.1080/14620316.2010.11512675; Yao YC, 2007, SCI AGR SINICA, V4, P855	41	18	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111165	10.1371/journal.pone.0111165	http://dx.doi.org/10.1371/journal.pone.0111165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340859	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800090
J	Mejard, R; Thierry, B				Mejard, Regis; Thierry, Benjamin			Systematic Study of the Surface Plasmon Resonance Signals Generated by Cells for Sensors with Different Characteristic Lengths	PLOS ONE			English	Article							LIVING CELLS; REAL-TIME; REFRACTIVE-INDEX; SPR; ADHESION	The objectives of this study were to establish an in-depth understanding of the signals induced by mammalian cells in surface plasmon resonance (SPR) sensing. To this end, two plasmonic structures with different propagation and penetration distances were used: conventional surface plasmon resonance and long-range surface plasmon resonance. Long-range SPR showed a lesser sensitivity to the absolute number of round cells but a greater resolution due to its very narrow spectral dip. The effect of cell spreading was also investigated and the resonance angle of long-range SPR was mostly insensitive unlike in the conventional SPR counterpart. Experimental data was compared with suitable models used in the SPR literature. Although these simple averaging models could be used to describe some of the experimental data, important deviations were observed which could be related to the fact that they do not take into consideration critical parameters such as plasmon scattering losses, which is particularly crucial in the case of long-range SPR structures. The comparison between conventional and long-range SPR for cellular schemes revealed important fundamental differences in their responses to the presence of cells, opening new horizons for SPR-based cell assays. From this study, long-range SPR is expected to be more sensitive towards both the detection of intracellular events resulting from biological stimulation and the detection of microorganisms captured from complex biological samples.	[Mejard, Regis; Thierry, Benjamin] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA, Australia	University of South Australia	Thierry, B (corresponding author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes Campus, Mawson Lakes, SA, Australia.	Benjamin.thierry@unisa.edu.au	Thierry, benjamin/B-2785-2009	Thierry, benjamin/0000-0002-6757-2842	Australian Research Council Discovery grant [0881254]	Australian Research Council Discovery grant(Australian Research Council)	This work was supported by the Australian Research Council Discovery grant ID 0881254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARER R, 1954, Q J MICROSC SCI, V95, P399; Berger CEH, 1999, OPT COMMUN, V167, P183, DOI 10.1016/S0030-4018(99)00309-0; Beuthan J, 1996, PHYS MED BIOL, V41, P369, DOI 10.1088/0031-9155/41/3/002; Boss D, 2012, QUANTITATIVE MEASURE; Chabot V, 2013, BIOSENS BIOELECTRON, V50, P125, DOI 10.1016/j.bios.2013.06.018; Cottier K, 2008, APPL PHYS B-LASERS O, V91, P319, DOI 10.1007/s00340-008-2994-6; Dostalek J, 2007, PLASMONICS, V2, P97, DOI 10.1007/s11468-007-9037-8; Giebel KF, 1999, BIOPHYS J, V76, P509, DOI 10.1016/S0006-3495(99)77219-X; Golosovsky M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116143; Huang CJ, 2012, BIOMATERIALS, V33, P3626, DOI 10.1016/j.biomaterials.2012.01.059; Jenkins ATA, 2005, J R SOC INTERFACE, V2, P255, DOI 10.1098/rsif.2005.0030; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Liang XJ, 2007, SENSOR ACTUAT A-PHYS, V133, P349, DOI 10.1016/j.sna.2006.06.045; Mejard R, 2014, TRAC TRENDS ANAL CHE; Mejard R, 2013, OPT MATER, V35, P2507, DOI 10.1016/j.optmat.2013.07.011; Michaelis S, 2013, BIOSENS BIOELECTRON, V49, P63, DOI 10.1016/j.bios.2013.04.042; Milgram S, 2012, METHODS, V56, P326, DOI 10.1016/j.ymeth.2011.10.016; Ramsden JJ, 2009, J RECEPT SIG TRANSD, V29, P211, DOI 10.1080/10799890903064119; RAMSDEN JJ, 1995, CYTOMETRY, V19, P97, DOI 10.1002/cyto.990190202; RAMSDEN JJ, 1994, BIOTECHNOL BIOENG, V43, P939, DOI 10.1002/bit.260431007; Shevchenko Y, 2014, BIOSENS BIOELECTRON, V56, P359, DOI 10.1016/j.bios.2014.01.018; Stojanovic I, 2014, BIOSENS BIOELECTRON, V52, P36, DOI 10.1016/j.bios.2013.08.027; Taylor A, 2005, WRITING EARLY AMERICAN HISTORY, P202; Toma M, 2012, PLASMONICS, V7, P293, DOI 10.1007/s11468-011-9306-4; Vala M, 2009, SENSOR ACTUAT B-CHEM, V139, P59, DOI 10.1016/j.snb.2008.08.029; Viitala T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072192; Voros J, 2000, BIOSENS BIOELECTRON, V15, P423, DOI 10.1016/S0956-5663(00)00102-0; Wang Y, 2010, BIOSENS BIOELECTRON, V25, P1663, DOI 10.1016/j.bios.2009.12.003; Yanase Y, 2007, BIOSENS BIOELECTRON, V22, P1081, DOI 10.1016/j.bios.2006.03.011; Yanase Y, 2012, BIOSENS BIOELECTRON, V32, P62, DOI 10.1016/j.bios.2011.11.023; Yashunsky V, 2010, BIOPHYS J, V99, P4028, DOI 10.1016/j.bpj.2010.10.017; Ziblat R, 2006, BIOPHYS J, V90, P2592, DOI 10.1529/biophysj.105.072090	32	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e107978	10.1371/journal.pone.0107978	http://dx.doi.org/10.1371/journal.pone.0107978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340583	gold, Green Submitted, Green Published			2022-12-26	WOS:000343662800004
J	Park, H; Kevany, BM; Dyer, DH; Thomas, MG; Forest, KT				Park, Hyunjun; Kevany, Brian M.; Dyer, David H.; Thomas, Michael G.; Forest, Katrina T.			A Polyketide Synthase Acyltransferase Domain Structure Suggests a Recognition Mechanism for Its Hydroxymalonyl-Acyl Carrier Protein Substrate	PLOS ONE			English	Article							PRODRUG ACTIVATION MECHANISM; BACILLUS-CEREUS UW85; COA-ACP TRANSACYLASE; EXTENDER UNITS; GENE-CLUSTER; CRYSTAL-STRUCTURE; ZWITTERMICIN-A; FATTY-ACID; BIOSYNTHESIS; SPECIFICITY	We have previously shown that the acyl transferase domain of ZmaA (ZmaA-AT) is involved in the biosynthesis of the aminopolyol polyketide/nonribosomal peptide hybrid molecule zwittermicin A from cereus UW85, and that it specifically recognizes the precursor hydroxymalonyl-acyl carrier protein (ACP) and transfers the hydroxymalonyl extender unit to a downstream second ACP via a transacylated AT domain intermediate. We now present the X-ray crystal structure of ZmaA-AT at a resolution of 1.7 angstrom. The structure shows a patch of solvent-exposed hydrophobic residues in the area where the AT is proposed to interact with the precursor ACP. We addressed the significance of the AT/ACP interaction in precursor specificity of the AT by testing whether malonyl-or methylmalonyl-ACP can be recognized by ZmaA-AT. We found that the ACP itself biases extender unit selection. Until now, structural information for ATs has been limited to ATs specific for the CoA-linked precursors malonyl-CoA and (2S)-methylmalonyl-CoA. This work contributes to polyketide synthase engineering efforts by expanding our knowledge of AT/substrate interactions with the structure of an AT domain that recognizes an ACP-linked substrate, the rare hydroxymalonate. Our structure suggests a model in which ACP interaction with a hydrophobic motif promotes secondary structure formation at the binding site, and opening of the adjacent substrate pocket lid to allow extender unit binding in the AT active site.	[Park, Hyunjun; Kevany, Brian M.; Dyer, David H.; Thomas, Michael G.; Forest, Katrina T.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Thomas, MG (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	thomas@bact.wisc.edu; forest@bact.wisc.edu			National Institutes of Health [GM100346, AI065850, GM59721]; U.S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Argonne National Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100346, R01GM059721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health grants GM100346 (to MGT and KTF), AI065850 (to MGT) and GM59721 (to KTF). Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; Bian XY, 2013, CHEMBIOCHEM, V14, P1194, DOI 10.1002/cbic.201300208; Brotherton CA, 2013, J AM CHEM SOC, V135, P3359, DOI 10.1021/ja312154m; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Chan YA, 2006, P NATL ACAD SCI USA, V103, P14349, DOI 10.1073/pnas.0603748103; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Chan YA, 2010, BIOCHEMISTRY-US, V49, P3667, DOI 10.1021/bi100141n; Chan YA, 2009, METHOD ENZYMOL, V459, P143, DOI 10.1016/S0076-6879(09)04607-2; Dutta S, 2014, NATURE, V510, P512, DOI 10.1038/nature13423; Emmert EAB, 2004, APPL ENVIRON MICROB, V70, P104, DOI 10.1128/AEM.70.1.104-113.2004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; HANDELSMAN J, 1990, APPL ENVIRON MICROB, V56, P713, DOI 10.1128/AEM.56.3.713-718.1990; Haydock SF, 2005, MICROBIOL-SGM, V151, P3161, DOI 10.1099/mic.0.28194-0; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; HE HY, 1994, TETRAHEDRON LETT, V35, P2499, DOI 10.1016/S0040-4039(00)77154-1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kevany BM, 2009, APPL ENVIRON MICROB, V75, P1144, DOI 10.1128/AEM.02518-08; Liew CW, 2012, J BIOL CHEM, V287, P23203, DOI 10.1074/jbc.M112.362210; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reeves CD, 2001, BIOCHEMISTRY-US, V40, P15464, DOI 10.1021/bi015864r; Reimer D, 2011, NAT CHEM BIOL, V7, P888, DOI [10.1038/NCHEMBIO.688, 10.1038/nchembio.688]; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; Rogers EW, 2008, ANGEW CHEM INT EDIT, V47, P8086, DOI 10.1002/anie.200801561; Rogers EW, 2007, ORG LETT, V9, pC11, DOI 10.1021/ol062804a; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Silo-Suh LA, 1998, CURR MICROBIOL, V37, P6; SILOSUH LA, 1994, APPL ENVIRON MICROB, V60, P2023, DOI 10.1128/AEM.60.6.2023-2030.1994; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; Tsai SC, 2009, METHOD ENZYMOL, V459, P17, DOI 10.1016/S0076-6879(09)04602-3; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wong FT, 2011, BIOCHEMISTRY-US, V50, P6539, DOI 10.1021/bi200632j; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2	42	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110965	10.1371/journal.pone.0110965	http://dx.doi.org/10.1371/journal.pone.0110965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340352	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800073
J	Sacchi, A; Rinaldi, A; Tumino, N; Casetti, R; Agrati, C; Turchi, F; Bordoni, V; Cimini, E; Martini, F				Sacchi, Alessandra; Rinaldi, Alessandra; Tumino, Nicola; Casetti, Rita; Agrati, Chiara; Turchi, Federica; Bordoni, Veronica; Cimini, Eleonora; Martini, Federico			HIV Infection of Monocytes-Derived Dendritic Cells Inhibits V gamma 9V delta 2 T Cells Functions	PLOS ONE			English	Article							CD69; ACTIVATION; ANTIGENS; REPLICATION; LYMPHOCYTES; MODULATION; MATURATION; RESPONSES; IMMATURE; IMMUNITY	DCs act as sentinel cells against incoming pathogens and represent the most potent antigen presenting cells, having the unique capability to prime naive T cells. In addition to their role in induction of adaptive immune responses, DC are also able to activate innate cells as gamma delta T cells; in particular, a reciprocal crosstalk between DC and gamma delta T cells was demonstrated. However, whether HIV infection may alter DC-V gamma 9V delta 2 T cells cross-talk was not yet described. To clarify this issue, we cultured activated V gamma 9V delta 2 T cells with HIV infected monocyte derived DC (MoDC). After 5 days we evaluated MoDC phenotype, and V gamma 9V delta 2 T cells activation and proliferation. In our model, V gamma 9V delta 2 T cells were not able to proliferate in response to HIV-infected MoDC, although an up-regulation of CD69 was observed. Upon phosphoantigens stimulation, V gamma 9V delta 2 T cells proliferation and cytokine production were inhibited when cultured with HIV-infected MoDC in a cell-contact dependent way. Moreover, HIV-infected MoDC are not able to up-regulate CD86 molecules when cultured with activated V gamma 9V delta 2 T cells, compared with uninfected MoDC. Further, activated V gamma 9V delta 2 T cells are not able to induce HLA DR up-regulation and CCR5 down-regulation on HIV-infected MoDC. These data indicate that HIV-infected DC alter the capacity of V gamma 9V delta 2 T cells to respond to their antigens, pointing out a new mechanisms of induction of V gamma 9V delta 2 T cells anergy carried out by HIV, that could contribute to immune evasion.	[Sacchi, Alessandra; Rinaldi, Alessandra; Tumino, Nicola; Casetti, Rita; Agrati, Chiara; Turchi, Federica; Bordoni, Veronica; Cimini, Eleonora; Martini, Federico] Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy; [Tumino, Nicola] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata	Sacchi, A (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy.	alessandra.sacchi@inmi.it	Casetti, Rita/K-8631-2016; Cimini, Eleonora/K-8878-2016; Tumino, Nicola/Y-4761-2019; Sacchi, Alessandra/K-7782-2016; bordoni, veronica/K-8614-2016	Casetti, Rita/0000-0002-7574-8780; Cimini, Eleonora/0000-0002-2659-0868; Tumino, Nicola/0000-0003-3773-8829; Sacchi, Alessandra/0000-0003-4964-386X; bordoni, veronica/0000-0002-1747-2245				Alter G, 2011, TRENDS IMMUNOL, V32, P219, DOI 10.1016/j.it.2011.02.003; AUTRAN B, 1989, CLIN EXP IMMUNOL, V75, P206; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boudova S, 2012, J INFECT DIS, V205, P1448, DOI 10.1093/infdis/jis217; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Devilder MC, 2006, J IMMUNOL, V176, P1386, DOI 10.4049/jimmunol.176.3.1386; Dieli F, 2004, EUR J IMMUNOL, V34, P3227, DOI 10.1002/eji.200425368; Enders PJ, 2003, AIDS RES HUM RETROV, V19, P21, DOI 10.1089/08892220360473934; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Frleta D, 2012, J CLIN INVEST, V122, P4685, DOI 10.1172/JCI64439; Gougeon ML, 2011, CURR OPIN HIV AIDS, V6, P364, DOI 10.1097/COH.0b013e328349b089; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Ismaili J, 2002, CLIN IMMUNOL, V103, P296, DOI 10.1006/clim.2002.5218; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Lamana A, 2011, J INVEST DERMATOL, V131, P1503, DOI 10.1038/jid.2011.54; LANG F, 1995, J IMMUNOL, V154, P5986; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Manches O, 2014, TRENDS IMMUNOL, V35, P114, DOI 10.1016/j.it.2013.10.003; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Martini F, 2002, J INFECT DIS, V186, P847, DOI 10.1086/342410; Martino A, 2005, J CLIN IMMUNOL, V25, P230, DOI 10.1007/s10875-005-4080-8; Martino A, 2007, J IMMUNOL, V179, P3057, DOI 10.4049/jimmunol.179.5.3057; Meraviglia S, 2010, J IMMUNOL, V185, P1770, DOI 10.4049/jimmunol.1000966; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925; Poccia F, 1996, J IMMUNOL, V157, P449; Poccia F., 2002, Current Molecular Medicine (Hilversum), V2, P769, DOI 10.2174/1566524023361880; Sacchi A, 2009, J INFECT DIS, V199, P432, DOI 10.1086/596047; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wallace M, 1997, MOL MED, V3, P60, DOI 10.1007/BF03401668	41	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111095	10.1371/journal.pone.0111095	http://dx.doi.org/10.1371/journal.pone.0111095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340508	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800084
J	Santegoets, KCM; Wenink, MH; van den Berg, WB; Radstake, TRDJ				Santegoets, Kim C. M.; Wenink, Mark H.; van den Berg, Wim B.; Radstake, Timothy R. D. J.			Fc Gamma Receptor IIb on GM-CSF Macrophages Controls Immune Complex Mediated Inhibition of Inflammatory Signals	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; T-CELLS; DENDRITIC CELLS; TYPE-2 MACROPHAGES; SYNOVIAL TISSUE; RII EXPRESSION; ISOFORMS; SPECIFICITY; INVOLVEMENT	Background: In rheumatoid arthritis (RA) macrophages play a major role in amplifying synovial inflammation. Important activating signals are those induced by Toll-like receptor (TLR) ligands and by activated T cells. The balance between activating and inhibitory Fc gamma receptors (Fc gamma Rs) on macrophages might be crucial in modulating these inflammatory responses. The purpose of this study was to determine Fc gamma R expression on pro- and anti-inflammatory macrophages (gmM phi and mM phi, respectively) and identify functional consequences on immune complex uptake and macrophage activation. Methods: Human monocytes were isolated and differentiated into gmM phi and mM phi. A full Fc gamma R characterization of both macrophage subtypes was performed and uptake of fluorescent immune complexes (ICs) was determined. Fc gamma RIIb isoforms were determined by qPCR. Macrophages were stimulated via different TLRs or cytokine activated T cells in the presence or absence of ICs and cytokine production was determined. Blocking studies were performed to look into the pathways involved. Results: mM phi expressed high levels of the activating Fc gamma RIIa and Fc gamma RIII and low levels of the inhibitory Fc gamma RIIb, while the Fc gamma R balance on gmM phi was shifted towards the inhibitory Fc gamma RIIb. This was accompanied by a clear increase in Fc gamma RIIb1 mRNA expression in gmM phi. This resulted in higher IC uptake by mM phi compared to gmM phi. Furthermore, Fc gamma R-mediated stimulation of gmM phi inhibited TLR2, 3, 4 and 7/8 mediated cytokine production via Fc gamma RIIb and PI3K signaling. In addition, gmM phi but not mM phi produced TNF alpha upon co-culture with cytokine activated T cells, which was reduced by IC binding to Fc gamma RIIb. The latter was dependent on PI3K signaling and COX2. Conclusions: Fc gamma R expression patterns on gmM phi and mM phi are significantly different, which translates in clear functional differences further substantiating Fc gamma RIIb as an interesting target for inflammation control in RA and other autoimmune/inflammatory diseases.	[Santegoets, Kim C. M.; Wenink, Mark H.; Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Santegoets, Kim C. M.; Wenink, Mark H.; Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Santegoets, Kim C. M.; Wenink, Mark H.; van den Berg, Wim B.; Radstake, Timothy R. D. J.] Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Radstake, TRDJ (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	T.R.D.J.Radstake@umcutrecht.nl	van den Berg, W.B./H-8010-2014; Santegoets, Kim/S-4267-2017		Dutch Arthritis Foundation (Reumafonds) [NR 09-1-3-4]; VENI; VIDI grant (NWO, Dutch science foundation)	Dutch Arthritis Foundation (Reumafonds); VENI(Netherlands Organization for Scientific Research (NWO)); VIDI grant (NWO, Dutch science foundation)	This work was supported by the Dutch Arthritis Foundation (Reumafonds) [NR 09-1-3-4] and a VENI and VIDI grant (NWO, Dutch science foundation) given to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Agbanoma G, 2012, J IMMUNOL, V188, P1307, DOI 10.4049/jimmunol.1100625; Ambarus CA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3796; Bewarder N, 1996, MOL CELL BIOL, V16, P4735; Blom AB, 2003, ARTHRITIS RHEUM, V48, P1002, DOI 10.1002/art.10871; Brennan FM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2390; Brennan FM, 2002, ARTHRITIS RHEUM, V46, P31, DOI 10.1002/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BUDDE P, 1994, J BIOL CHEM, V269, P30636; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Joshi T, 2006, MOL IMMUNOL, V43, P839, DOI 10.1016/j.molimm.2005.06.037; Kennedy A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00052; Magnusson SE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2206; MIETTINEN HM, 1989, CELL, V58, P317, DOI 10.1016/0092-8674(89)90846-5; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; Petkova SB, 2006, J EXP MED, V203, P275, DOI 10.1084/jem.20051951; Radstake TRDJ, 2005, ANN RHEUM DIS, V64, P1737, DOI 10.1136/ard.2004.034405; Radstake TRDJ, 2004, ANN RHEUM DIS, V63, P1556, DOI 10.1136/ard.2003.016550; Radstake TRDJ, 2004, ANN RHEUM DIS, V63, P696, DOI 10.1136/ard.2003.010033; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Sacre SM, 2008, J IMMUNOL, V181, P8002, DOI 10.4049/jimmunol.181.11.8002; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Shi B, 2012, ANN RHEUM DIS, V71, P1411, DOI 10.1136/annrheumdis-2011-200899; Stefanescu RN, 2004, J CLIN IMMUNOL, V24, P315, DOI 10.1023/B:JOCI.0000029105.47772.04; Su KH, 2007, J IMMUNOL, V178, P3272, DOI 10.4049/jimmunol.178.5.3272; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Ultaigh SNA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3261; VANDENHERIKOUDIJK IE, 1994, J IMMUNOL, V152, P574; Vandooren B, 2009, ARTHRITIS RHEUM-US, V60, P966, DOI 10.1002/art.24406; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wenink MH, 2009, J IMMUNOL, V183, P4509, DOI 10.4049/jimmunol.0900153; XU WD, 1989, J CLIN INVEST, V83, P876, DOI 10.1172/JCI113971; Zhang Y, 2009, J IMMUNOL, V182, P554, DOI 10.4049/jimmunol.182.1.554	37	9	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110966	10.1371/journal.pone.0110966	http://dx.doi.org/10.1371/journal.pone.0110966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340460	gold, Green Submitted, Green Published			2022-12-26	WOS:000343662800074
J	Westermeier, F; Salomon, C; Farias, M; Arroyo, P; Fuenzalida, B; Saez, T; Salsoso, R; Sanhueza, C; Guzman-Gutierrez, E; Pardo, F; Leiva, A; Sobrevia, L				Westermeier, Francisco; Salomon, Carlos; Farias, Marcelo; Arroyo, Pablo; Fuenzalida, Barbara; Saez, Tamara; Salsoso, Rocio; Sanhueza, Carlos; Guzman-Gutierrez, Enrique; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis			Insulin requires normal expression and signaling of insulin receptor A to reverse gestational diabetes-reduced adenosine transport in human umbilical vein endothelium	FASEB JOURNAL			English	Article						endothelial dysfunction; human placenta; nucleoside membrane transport	SLC29A1 PROMOTER ACTIVITY; IGF-I; ISOFORMS; RESISTANCE; MELLITUS; WOMEN	Reduced adenosine uptake via human equilibrative nucleoside transporter 1 (hENT1) in human umbilical vein endothelial cells (HUVECs) from gestational diabetes mellitus (GDM) is reversed by insulin by restoring hENT1 expression. Insulin receptors A (IR-A) and B (IR-B) are expressed in HUVECs, and GDM results in higher IR-A mRNA expression vs. cells from normal pregnancies. We studied whether the reversal of GDM effects on transport by insulin depends on restoration of IR-A expression. We specifically measured hENT1 expression [mRNA, protein abundance, SLC29A1 (for hENT1) promoter activity] and activity (adenosine transport kinetics) and the role of IR-A/IR-B expression and signaling [total and phosphorylated 42 and 44 kDa mitogen-activated protein kinases (p44/42(mapk)) and Akt] in IR-A, IR-B, and IR-A/B knockdown HUVECs from normal (n = 33) or GDM (n = 33) pregnancies. GDM increases IR-A/IR-B mRNA expression (1.8-fold) and p44/ 42(mapk): Akt activity (2.7-fold) ratios. Insulin reversed GDM-reduced hENT1 expression and maximal transport capacity (V-max/K-m), and GDM-increased IR-A/IR-BmRNA expression and p44/42(mapk): Akt activity ratios to values in normal pregnancies. Insulin's effect was abolished in IR-A or IR-A/B knockdown cells. Thus, insulin requires normal IR-A expression and p44/42(mapk)/Akt signaling to restore GDM-reduced hENT1 expression and activity in HUVECs. This could be a protective mechanism for the placental macrovascular endothelial dysfunction seen in GDM.	[Westermeier, Francisco; Salomon, Carlos; Farias, Marcelo; Arroyo, Pablo; Fuenzalida, Barbara; Saez, Tamara; Salsoso, Rocio; Sanhueza, Carlos; Guzman-Gutierrez, Enrique; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, Div Obstet & Gynaecol,CMPL, Santiago 8330024, Chile; [Westermeier, Francisco] Univ Chile, Fac Chem & Pharmaceut Sci, Adv Ctr Chron Dis ACCDIS, Santiago, Chile; [Salomon, Carlos; Sobrevia, Luis] Univ Queensland, Fac Med & Biomed Sci, UQCCR, Herston, Qld, Australia; [Guzman-Gutierrez, Enrique] Univ San Sebastian, Fac Hlth Sci, Concepcion, Chile; [Sobrevia, Luis] Univ Seville, Fac Pharm, Seville, Spain	Pontificia Universidad Catolica de Chile; Universidad de Chile; University of Queensland; Universidad San Sebastian; University of Sevilla	Sobrevia, L (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Sch Med, Div Obstet & Gynaecol,CMPL, POB 114-D, Santiago 8330024, Chile.	sobrevia@med.puc.cl	Fuenzalida, Barbara/GXF-7867-2022; Westermeier, Francisco/AAL-4145-2021; Rodriguez, Maria/AAB-1401-2021; Sobrevia, Luis/H-9608-2016; Farias, Marcelo/R-6063-2019; Salomon, Carlos F/L-2167-2013; Guzman-Gutierrez, Enrique/H-3536-2016	Westermeier, Francisco/0000-0002-4476-4198; Farias, Marcelo/0000-0003-0473-2295; Salomon, Carlos F/0000-0003-4474-0046; salsoso, rocio/0000-0002-8218-1882; Sobrevia, Luis/0000-0001-5802-2243; Guzman-Gutierrez, Enrique/0000-0001-6589-5667; Fuenzalida, Barbara/0000-0002-5128-570X				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Brierley GV, 2010, ENDOCRINOLOGY, V151, P1418, DOI 10.1210/en.2009-1006; Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4; Colomiere M, 2009, EUR J ENDOCRINOL, V160, P567, DOI 10.1530/EJE-09-0031; EBINA Y, 1985, P NATL ACAD SCI USA, V82, P8014, DOI 10.1073/pnas.82.23.8014; Farias M, 2006, J CELL PHYSIOL, V208, P451, DOI 10.1002/jcp.20680; Farias M, 2010, CARDIOVASC RES, V86, P45, DOI 10.1093/cvr/cvp410; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Guzman-Gutierrez E, 2014, MICROCIRCULATION, V21, P26, DOI 10.1111/micc.12077; Guzman-Gutierrez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041705; Hiden U, 2009, CURR VASC PHARMACOL, V7, P460, DOI 10.2174/157016109789043973; Li GL, 2005, ENDOCRINOLOGY, V146, P4690, DOI 10.1210/en.2005-0505; Maguire MH, 1998, J CHROMATOGR B, V707, P33, DOI 10.1016/S0378-4347(97)00581-1; Malaguarnera R, 2012, ENDOCRINOLOGY, V153, P2152, DOI 10.1210/en.2011-1843; Malaguarnera R, 2011, J CLIN ENDOCR METAB, V96, P766, DOI 10.1210/jc.2010-1255; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Osses N, 1995, REPROD FERT DEVELOP, V7, P1499, DOI 10.1071/RD9951499; Phy JL, 2004, J CLIN ENDOCR METAB, V89, P3561, DOI 10.1210/jc.2003-031888; Salomon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040578; San Martin R, 2006, PLACENTA, V27, P1, DOI 10.1016/j.placenta.2005.01.011; Santoro M, 2013, MOL CELL BIOCHEM, V380, P259, DOI 10.1007/s11010-013-1681-z; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Singh SK, 2011, GROWTH FACTORS, V29, P278, DOI 10.3109/08977194.2011.616200; Sobrevia L, 2011, PLACENTA, V32, pS159, DOI 10.1016/j.placenta.2010.12.011; Sobrevia L., 2009, MEMBRANE TRANSPORTER, P1; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Vasquez G, 2004, J PHYSIOL-LONDON, V560, P111, DOI 10.1113/jphysiol.2004.068288; Wang QW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059845; Wang YH, 2013, J OBSTET GYNAECOL RE, V39, P647, DOI 10.1111/j.1447-0756.2012.02009.x; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007	35	39	40	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					37	49		10.1096/fj.14-254219	http://dx.doi.org/10.1096/fj.14-254219			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25351985				2022-12-26	WOS:000347378600005
J	Olausson, KH; Nister, M; Lindstrom, MS				Olausson, Karl Holmberg; Nister, Monica; Lindstrom, Mikael S.			Loss of Nucleolar Histone Chaperone NPM1 Triggers Rearrangement of Heterochromatin and Synergizes with a Deficiency in DNA Methyltransferase DNMT3A to Drive Ribosomal DNA Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methyltransferase; Heterochromatin; Histone; Histone Chaperone; Histone Modification; Nucleolus; p53; Ribosome Assembly	TUMOR-SUPPRESSOR; RNA GENES; ACTINOMYCIN-D; PROTEIN; NUCLEOPHOSMIN; ARF; B23; METHYLATION; CHROMATIN; BIOGENESIS	Background: NPM1 is a nucleolar histone chaperone mutated in cancer. Results: NPM1-deficient cells display rearrangement of perinucleolar heterochromatin, and simultaneous knockdown of NPM1 and DNMT3A enhances transcription of ribosomal DNA. Conclusion: NPM1 loss disrupts heterochromatin organization around the nucleolus. Significance: Rearrangement of heterochromatin in NPM1-deficient cells may be of importance in tumor development. Nucleoli are prominent nuclear structures assembled and organized around actively transcribed ribosomal DNA (rDNA). The nucleolus has emerged as a platform for the organization of chromatin enriched for repressive histone modifications associated with repetitive DNA. NPM1 is a nucleolar protein required for the maintenance of genome stability. However, the role of NPM1 in nucleolar chromatin dynamics and ribosome biogenesis remains unclear. We found that normal fibroblasts and cancer cells depleted of NPM1 displayed deformed nucleoli and a striking rearrangement of perinucleolar heterochromatin, as identified by immunofluorescence staining of trimethylated H3K9, trimethylated H3K27, and heterochromatin protein 1 (HP1/CBX3). By co-immunoprecipitation we found NPM1 associated with HP1 and core and linker histones. Moreover, NPM1 was required for efficient tethering of HP1-enriched chromatin to the nucleolus. We next tested whether the alterations in perinucleolar heterochromatin architecture correlated with a difference in the regulation of rDNA. U1242MG glioma cells depleted of NPM1 presented with altered silver staining of nucleolar organizer regions, coupled to a modest decrease in H3K9 di- and trimethylation at the rDNA promoter. rDNA transcription and cell proliferation were sustained in these cells, indicating that altered organization of heterochromatin was not secondary to inhibition of rDNA transcription. Furthermore, knockdown of DNA methyltransferase DNMT3A markedly enhanced rDNA transcription in NPM1-depleted U1242MG cells. In summary, this study highlights a function of NPM1 in the spatial organization of nucleolus-associated heterochromatin.	[Olausson, Karl Holmberg; Nister, Monica; Lindstrom, Mikael S.] Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Pathol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Lindstrom, MS (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Dept Oncol Pathol, Canc Ctr Karolinska, CCK R8 05, SE-17176 Stockholm, Sweden.	mikael.lindstrom@ki.se	Lindström, Mikael S/AAA-1451-2019	Lindström, Mikael S/0000-0003-1148-8497	Karolinska Institutet; Ake Wiberg Foundation; Magnus Bergvall Foundation; VR-MH from the Swedish Research Council [K2012-99X-21969-01-3]; Swedish Cancer Society; Cancer Society in Stockholm; Swedish Research Council; Stockholm County Council	Karolinska Institutet(Karolinska Institutet); Ake Wiberg Foundation; Magnus Bergvall Foundation; VR-MH from the Swedish Research Council(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council)	This work was supported by the Karolinska Institutet, the Ake Wiberg Foundation, the Magnus Bergvall Foundation, and VR-MH Project K2012-99X-21969-01-3 from the Swedish Research Council (to M. S. L.).; Supported by grants from Karolinska Institutet, the Swedish Cancer Society, the Cancer Society in Stockholm, the Swedish Research Council, and the Stockholm County Council.	Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Bartova E, 2010, J HISTOCHEM CYTOCHEM, V58, P391, DOI 10.1369/jhc.2009.955435; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Canudas S, 2011, GENE DEV, V25, P1807, DOI 10.1101/gad.17325211; Cheng K, 2007, ONCOGENE, V26, P7391, DOI 10.1038/sj.onc.1210549; Choong ML, 2009, CELL CYCLE, V8, P2810, DOI 10.4161/cc.8.17.9503; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Enomoto T, 2006, J BIOL CHEM, V281, P18463, DOI 10.1074/jbc.M602788200; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Fawal M, 2006, BLOOD, V108, P2780, DOI 10.1182/blood-2006-04-014902; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Gadad SS, 2011, BIOCHEMISTRY-US, V50, P2780, DOI 10.1021/bi101835J; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Galetzka D, 2006, J CELL BIOCHEM, V98, P885, DOI 10.1002/jcb.20798; Gao Q, 2011, P NATL ACAD SCI USA, V108, P18061, DOI 10.1073/pnas.1114946108; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guerrero PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016401; Guetg C, 2012, EPIGENETICS-US, V7, P811, DOI 10.4161/epi.21072; Hamperl S, 2013, BBA-GENE REGUL MECH, V1829, P405, DOI 10.1016/j.bbagrm.2012.12.007; Hernandez-Hernandez A, 2012, CYTOGENET GENOME RES, V136, P89, DOI 10.1159/000335752; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Horakova AH, 2010, CHROMOSOMA, V119, P227, DOI 10.1007/s00412-009-0252-2; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Kwon SH, 2008, MOL CELLS, V26, P217; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Lee SY, 2005, BIOCHEM J, V388, P7, DOI 10.1042/BJ20042033; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li KK, 2013, SEMIN HEMATOL, V50, P48, DOI 10.1053/j.seminhematol.2013.01.005; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Lindstrom MS, 2006, CELL BIOCHEM BIOPHYS, V46, P79, DOI 10.1385/CBB:46:1:79; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; LUBITZ W, 1980, INT J CANCER, V25, P53, DOI 10.1002/ijc.2910250107; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Majumder S, 2006, J BIOL CHEM, V281, P22062, DOI 10.1074/jbc.M601155200; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; NISTER M, 1986, CANCER RES, V46, P332; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Padeken J, 2013, CELL CYCLE, V12, P3455, DOI 10.4161/cc.26697; Padeken J, 2013, MOL CELL, V50, P236, DOI 10.1016/j.molcel.2013.03.002; Park G, 2010, PROTEIN J, V29, P213, DOI 10.1007/s10930-010-9242-8; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Percipalle P, 2012, METHODS MOL BIOL, V809, P519, DOI 10.1007/978-1-61779-376-9_34; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rickards B, 2007, MOL CELL BIOL, V27, P937, DOI 10.1128/MCB.01584-06; ROUSSEL P, 1994, EXP CELL RES, V214, P465, DOI 10.1006/excr.1994.1283; Roy DM, 2014, PROTEIN CELL, V5, P265, DOI 10.1007/s13238-014-0031-6; Salminen A, 2009, BIOCHEM BIOPH RES CO, V378, P6, DOI 10.1016/j.bbrc.2008.11.023; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Takada Y, 2011, DEVELOPMENT, V138, P4207, DOI 10.1242/dev.064444; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yao Z, 2010, ONCOGENE, V29, P1821, DOI 10.1038/onc.2009.473; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou Xiang, 2012, Genes Cancer, V3, P298, DOI 10.1177/1947601912455200; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	84	32	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34601	34619		10.1074/jbc.M114.569244	http://dx.doi.org/10.1074/jbc.M114.569244			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349213	hybrid, Green Published			2022-12-26	WOS:000346260800019
J	Yu, TZ; Wang, L; Lee, H; O'Brien, DK; Bronk, SF; Gores, GJ; Yoon, Y				Yu, Tianzheng; Wang, Li; Lee, Hakjoo; O'Brien, Dawn K.; Bronk, Steven F.; Gores, Gregory J.; Yoon, Yisang			Decreasing Mitochondrial Fission Prevents Cholestatic Liver Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bile Acid; Cell Death; Liver; Mitochondria; Reactive Oxygen Species (ROS); DLP1; Drp1; Cholestasis; Mitochondrial Fission; Mitochondrial Fusion	BILE-DUCT LIGATION; ISOLATED RAT HEPATOCYTES; ACID-INDUCED APOPTOSIS; OXYGEN SPECIES PRODUCTION; DYNAMIN-RELATED PROTEIN-1; DOMINANT OPTIC ATROPHY; SALT-INDUCED APOPTOSIS; PERMEABILITY TRANSITION; OXIDATIVE STRESS; MAMMALIAN-CELLS	Background: Bile acid-induced hepatocyte injury causes cholestatic liver disease. Results: Inhibiting mitochondrial fission prevents bile acid-induced hepatocyte death, and liver-specific decrease of mitochondrial fission in vivo limits bile duct ligation-induced liver injury and fibrosis. Conclusion: Controlling mitochondrial morphology is an effective strategy to decrease bile acid-induced liver injury. Significance: Mitochondrial fission is a new target to control cholestatic liver disease. Mitochondria frequently change their shape through fission and fusion in response to physiological stimuli as well as pathological insults. Disrupted mitochondrial morphology has been observed in cholestatic liver disease. However, the role of mitochondrial shape change in cholestasis is not defined. In this study, using in vitro and in vivo models of bile acid-induced liver injury, we investigated the contribution of mitochondrial morphology to the pathogenesis of cholestatic liver disease. We found that the toxic bile salt glycochenodeoxycholate (GCDC) rapidly fragmented mitochondria, both in primary mouse hepatocytes and in the bile transporter-expressing hepatic cell line McNtcp.24, leading to a significant increase in cell death. GCDC-induced mitochondrial fragmentation was associated with an increase in reactive oxygen species (ROS) levels. We found that preventing mitochondrial fragmentation in GCDC by inhibiting mitochondrial fission significantly decreased not only ROS levels but also cell death. We also induced cholestasis in mouse livers via common bile duct ligation. Using a transgenic mouse model inducibly expressing a dominant-negative fission mutant specifically in the liver, we demonstrated that decreasing mitochondrial fission substantially diminished ROS levels, liver injury, and fibrosis under cholestatic conditions. Taken together, our results provide new evidence that controlling mitochondrial fission is an effective strategy for ameliorating cholestatic liver injury.	[Yu, Tianzheng; Wang, Li; Lee, Hakjoo; O'Brien, Dawn K.; Yoon, Yisang] Georgia Regents Univ, Dept Physiol, Med Coll Georgia, Augusta, GA 30912 USA; [Bronk, Steven F.; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	University System of Georgia; Augusta University; Mayo Clinic	Yoon, Y (corresponding author), Georgia Regents Univ, Dept Physiol, Med Coll Georgia, 1120 15th St, Augusta, GA 30912 USA.	yyoon@gru.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439	National Institutes of Health [DK061991, DK41876]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041876, R01DK061991, P30DK084567, R01DK041876, R37DK041876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants DK061991 (to Y. Y.) and DK41876 (to G. J. G.).	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; ANWER MS, 1988, HEPATOLOGY, V8, P887, DOI 10.1002/hep.1840080430; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; BEUERS U, 1993, GASTROENTEROLOGY, V104, P604, DOI 10.1016/0016-5085(93)90433-D; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065455; Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Fang YW, 2004, HEPATOLOGY, V40, P961, DOI 10.1002/hep.20385; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Fickert P, 2005, J HEPATOL, V42, P378, DOI 10.1016/j.jhep.2004.10.016; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Galloway CA, 2012, DIABETES, V61, P2093, DOI 10.2337/db11-1640; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gujral JS, 2004, HEPATOLOGY, V40, P998, DOI 10.1002/hep.20380; Gupta S, 2004, J BIOL CHEM, V279, P5821, DOI 10.1074/jbc.M310979200; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; Jhun BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060810; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; KWO P, 1995, AM J PHYSIOL-GASTR L, V268, pG613, DOI 10.1152/ajpgi.1995.268.4.G613; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lin TK, 2012, APOPTOSIS, V17, P871, DOI 10.1007/s10495-012-0732-3; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Mitchell C, 2011, LAB INVEST, V91, P273, DOI 10.1038/labinvest.2010.163; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Rehman H, 2008, J PHARMACOL EXP THER, V327, P699, DOI 10.1124/jpet.108.143578; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Roberts LR, 1997, GASTROENTEROLOGY, V113, P1714, DOI 10.1053/gast.1997.v113.pm9352877; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Rolo AP, 2000, TOXICOL SCI, V57, P177, DOI 10.1093/toxsci/57.1.177; SCHAFFNER F, 1971, GASTROENTEROLOGY, V60, P888; Serviddio G, 2004, HEPATOLOGY, V39, P711, DOI 10.1002/hep.20101; SOKOL RJ, 1995, GASTROENTEROLOGY, V109, P1249, DOI 10.1016/0016-5085(95)90585-5; Sokol RJ, 2001, PEDIATR RES, V49, P519, DOI 10.1203/00006450-200104000-00014; SPIVEY JR, 1993, J CLIN INVEST, V92, P17, DOI 10.1172/JCI116546; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; THIBAULT N, 1993, BIOCHEM PHARMACOL, V45, P289, DOI 10.1016/0006-2952(93)90063-3; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Webster CRL, 1998, HEPATOLOGY, V27, P1324, DOI 10.1002/hep.510270519; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	65	28	29	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34074	34088		10.1074/jbc.M114.588616	http://dx.doi.org/10.1074/jbc.M114.588616			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342755	Green Published, hybrid			2022-12-26	WOS:000346077600033
J	MacDonald, EC; Frost, EH; MacNeil, SM; Hamilton, DJ; Barbeau, MA				MacDonald, Elizabeth C.; Frost, Elisabeth H.; MacNeil, Stephanie M.; Hamilton, Diana J.; Barbeau, Myriam A.			Behavioral Response of Corophium volutator to Shorebird Predation in the Upper Bay of Fundy, Canada	PLOS ONE			English	Article							MIGRATING SEMIPALMATED SANDPIPERS; REDSHANK TRINGA-TOTANUS; RISK TRADE-OFF; PREY AVAILABILITY; CALIDRIS-PUSILLA; VERTICAL-DISTRIBUTION; REPRODUCTIVE-BIOLOGY; ARENARIUM CRUSTACEA; ILYANASSA-OBSOLETA; AVOIDANCE-BEHAVIOR	Predator avoidance is an important component of predator-prey relationships and can affect prey availability for foraging animals. Each summer, the burrow-dwelling amphipod Corophium volutator is heavily preyed upon by Semipalmated Sandpipers (Calidris pusilla) on mudflats in the upper Bay of Fundy, Canada. We conducted three complementary studies to determine if adult C. volutator exhibit predator avoidance behavior in the presence of sandpipers. In a field experiment, we monitored vertical distribution of C. volutator adults in bird exclosures and adjacent control plots before sandpipers arrived and during their stopover. We also made polymer resin casts of C. volutator burrows in the field throughout the summer. Finally, we simulated shorebird pecking in a lab experiment and observed C. volutator behavior in their burrows. C. volutator adults were generally distributed deeper in the sediment later in the summer (after sandpipers arrived). In August, this response was detectably stronger in areas exposed to bird predation than in bird exclosures. During peak predator abundance, many C. volutator adults were beyond the reach of feeding sandpipers (>1.5 cm deep). However, burrow depth did not change significantly throughout the summer. Detailed behavioral observations indicated that C. volutator spent more time at the bottom of their burrow when exposed to a simulated predator compared to controls. This observed redistribution suggests that C. volutator adults move deeper into their burrows as an anti-predator response to the presence of sandpipers. This work has implications for predators that feed on burrow-dwelling invertebrates in soft-sediment ecosystems, as density may not accurately estimate prey availability.	[MacDonald, Elizabeth C.; Frost, Elisabeth H.; Hamilton, Diana J.] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [MacNeil, Stephanie M.; Barbeau, Myriam A.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada	Mount Allison University; University of New Brunswick	MacDonald, EC (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	ecmacdonald@mta.ca			Natural Sciences and Engineering Research Council of Canada; Canada Summer Jobs Program; Mprime (a Network of Centres of Excellence for the mathematical sciences); New Brunswick Wildlife Trust Fund; Science Horizons Youth Internship Program (Environment Canada); Mount Allison Biology Department Ruggles-Gates Undergraduate Research Fellowship; Mount Allison University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Summer Jobs Program; Mprime (a Network of Centres of Excellence for the mathematical sciences); New Brunswick Wildlife Trust Fund; Science Horizons Youth Internship Program (Environment Canada); Mount Allison Biology Department Ruggles-Gates Undergraduate Research Fellowship; Mount Allison University	Funding was provided by Natural Sciences and Engineering Research Council of Canada (Discovery Grants to DJH and MAB and Undergraduate Summer Research Award to EHF), the Canada Summer Jobs Program, Mprime (a Network of Centres of Excellence for the mathematical sciences), New Brunswick Wildlife Trust Fund, the Science Horizons Youth Internship Program (Environment Canada), Mount Allison Biology Department Ruggles-Gates Undergraduate Research Fellowship (to field assistant C. E. Gilroy) and Mount Allison University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backwell PRY, 1998, ANIM BEHAV, V55, P1659, DOI 10.1006/anbe.1997.0713; Barbeau MA, 2009, J CRUSTACEAN BIOL, V29, P491, DOI 10.1651/08-3067.1; Barrett K., 2008, SPSS INTERMEDIATE ST, V3rd ed.; Beauchamp G, 2006, WATERBIRDS, V29, P221, DOI 10.1675/1524-4695(2006)29[221:STAWFI]2.0.CO;2; Beauchamp G, 2005, ETHOLOGY, V111, P785, DOI 10.1111/j.1439-0310.2005.01095.x; Beauchamp G, 2007, OECOLOGIA, V154, P403, DOI 10.1007/s00442-007-0818-8; Beauchamp G, 2009, OECOLOGIA, V161, P651, DOI 10.1007/s00442-009-1398-6; BOATES JS, 1995, ECOSCIENCE, V2, P123, DOI 10.1080/11956860.1995.11682276; BOATES JS, 1989, CAN J ZOOL, V67, P457, DOI 10.1139/z89-066; Boates JS, 1980, THESIS ACADIA U WOLF; Boudreau MR, 2012, MAR ECOL PROG SER, V465, P137, DOI 10.3354/meps09897; Bringloe TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069091; Brodin T, 2004, ECOLOGY, V85, P2927, DOI 10.1890/03-3120; Burnham J.P., 2002, MODEL SELECTION MULT; CAMPBELL JI, 1974, EXPERIENTIA, V30, P1396, DOI 10.1007/BF01919655; CHARNOV EL, 1976, AM NAT, V110, P247, DOI 10.1086/283062; Cheverie AV, 2014, J SEA RES IN PRESS; Coffin MRS, 2012, J EXP MAR BIOL ECOL, V418, P12, DOI 10.1016/j.jembe.2012.03.002; Coulthard ME, 2011, J EXP MAR BIOL ECOL, V397, P161, DOI 10.1016/j.jembe.2010.12.001; Crewe TL, 2001, ESTUAR COAST SHELF S, V53, P151, DOI 10.1006/ecss.2001.0795; De Backer A, 2010, HELGOLAND MAR RES, V64, P63, DOI 10.1007/s10152-009-0167-6; Dill LM, 1997, BEHAV ECOL, V8, P186, DOI 10.1093/beheco/8.2.186; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; Drolet D, 2012, J SEA RES, V70, P1, DOI 10.1016/j.seares.2012.02.001; Drolet D, 2009, J CRUSTACEAN BIOL, V29, P51, DOI 10.1651/08-3010.1; Durell SEALD, 2000, BIOL REV, V75, P503; FISH JD, 1979, J MAR BIOL ASSOC UK, V59, P355, DOI 10.1017/S002531540004265X; Flynn AM, 2010, J EXP MAR BIOL ECOL, V383, P32, DOI 10.1016/j.jembe.2009.10.017; Forbes MR, 1996, CAN J ZOOL, V74, P1479, DOI 10.1139/z96-162; Gilroy CE, 2012, THESIS MOUNT ALLISON; Gingras MK, 2002, PALAIOS, V17, P206, DOI 10.1669/0883-1351(2002)017<0206:RCOMBP>2.0.CO;2; GOSSCUSTARD JD, 1977, J ANIM ECOL, V46, P21, DOI 10.2307/3944; GOSSCUSTARD JD, 1980, ARDEA, V68, P31; GOSSCUSTARD JD, 1970, J ANIM ECOL, V39, P91, DOI 10.2307/2891; GRATTO GW, 1984, CAN J ZOOL, V62, P1889, DOI 10.1139/z84-276; Gratto-Trevor C, 2012, WATERBIRDS, V35, P83, DOI 10.1675/063.035.0109; Griffiths CL, 2006, J EXP MAR BIOL ECOL, V331, P91, DOI 10.1016/j.jembe.2005.10.002; Hamilton DJ, 2006, HYDROBIOLOGIA, V567, P285, DOI 10.1007/s10750-006-0062-y; Hamilton DJ, 2003, CAN J ZOOL, V81, P1358, DOI 10.1139/Z03-130; Hicklin PW, 2012, WATERBIRDS, V35, P74, DOI 10.1675/063.035.0108; HICKLIN PW, 1984, CAN J ZOOL, V62, P2201, DOI 10.1139/z84-321; HICKLIN PW, 1987, WILSON BULL, V99, P540; HILL C, 1987, OIKOS, V49, P221, DOI 10.2307/3566029; Holohan BA, 1998, ESTUARIES, V21, P466, DOI 10.2307/1352844; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; HUNTLY N, 1991, ANNU REV ECOL SYST, V22, P477, DOI 10.1146/annurev.ecolsys.22.1.477; Keppel G, 1991, DESIGN ANAL RES HDB; Kicklighter CE, 2007, OECOLOGIA, V151, P161, DOI 10.1007/s00442-006-0567-0; Kruse I, 2000, HYDROBIOLOGIA, V426, P43, DOI 10.1023/A:1003955523468; Lawrie SM, 1998, J EXP MAR BIOL ECOL, V224, P237, DOI 10.1016/S0022-0981(97)00199-8; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Limia J, 1997, J MAR BIOL ASSOC UK, V77, P409, DOI 10.1017/S0025315400071769; Lindquist N, 1996, ECOL MONOGR, V66, P431, DOI 10.2307/2963489; MacDonald EC, 2012, CONDOR, V114, P135, DOI 10.1525/cond.2012.100246; Manzur T, 2014, J ANIM ECOL, V83, P923, DOI 10.1111/1365-2656.12199; Mathews SL, 1992, ECOGRAPHY, V15, P393; McCurdy DG, 2005, J CRUSTACEAN BIOL, V25, P558, DOI 10.1651/C-2539.1; McCurdy DG, 2000, OIKOS, V88, P301, DOI 10.1034/j.1600-0706.2000.880208.x; McPeek MA, 2004, AM NAT, V163, pE88, DOI 10.1086/382755; MEADOWS PS, 1966, J ZOOL, V150, P387; Meerhoff M, 2007, FRESHWATER BIOL, V52, P1009, DOI 10.1111/j.1365-2427.2007.01748.x; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; MENGE BA, 1981, ECOL MONOGR, V51, P429, DOI 10.2307/2937323; MILLS A, 1980, MAR BIOL, V58, P153, DOI 10.1007/BF00396127; Minderman J, 2006, J ANIM ECOL, V75, P713, DOI 10.1111/j.1365-2656.2006.01092.x; MYERS JP, 1980, CAN J ZOOL, V58, P1564, DOI 10.1139/z80-216; Neima SG, 2014, THESIS MOUNT ALLISON; Norusis M., 2008, SPSS 16 0 ADV STAT P; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Paterson RA, 2013, ANIM BEHAV, V86, P1301, DOI 10.1016/j.anbehav.2013.09.036; PEER DL, 1986, NETH J SEA RES, V20, P359, DOI 10.1016/0077-7579(86)90003-7; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Quinn JT, 2012, CAN J ZOOL, V90, P1181, DOI 10.1139/Z2012-086; R Core Team, 2020, R LANG ENV STAT COMP; RAFFAELLI D, 1987, ESTUAR COAST SHELF S, V24, P1, DOI 10.1016/0272-7714(87)90002-3; Riisgard HU, 2007, MAR BIOL RES, V3, P421, DOI 10.1080/17451000701696302; Robar NDP, 2006, THESIS MOUNT ALLISON; Robar NDP, 2007, WATERBIRDS, V30, P116, DOI 10.1675/1524-4695(2007)030[0116:AMFEHU]2.0.CO;2; SELMAN J, 1988, ANIM BEHAV, V36, P1542, DOI 10.1016/S0003-3472(88)80226-4; SPSS Inc, 2006, SPSS VERS 16 0; Stillman RA, 2000, BEHAV ECOL, V11, P597, DOI 10.1093/beheco/11.6.597; STODDARD PK, 1983, ANIM BEHAV, V31, P173, DOI 10.1016/S0003-3472(83)80186-9; Strobbe F, 2011, BEHAV ECOL SOCIOBIOL, V65, P241, DOI 10.1007/s00265-010-1032-y; Tallqvist M, 2001, MAR ECOL PROG SER, V212, P183, DOI 10.3354/meps212183; Vader W, 1964, NETH J SEA RES, V2, P189; Vieira EA, 2012, J EXP MAR BIOL ECOL, V412, P126, DOI 10.1016/j.jembe.2011.11.011; Wallace EH, 2008, THESIS MOUNT ALLISON; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WILSON WH, 1989, J EXP MAR BIOL ECOL, V132, P221, DOI 10.1016/0022-0981(89)90129-9; WILSON WH, 1990, ANNU REV ECOL SYST, V21, P221, DOI 10.1146/annurev.ecolsys.21.1.221; Winer B.J., 1991, STAT PRINCIPLES EXPT; Yates MG, 2000, J ANIM ECOL, V69, P314, DOI 10.1046/j.1365-2656.2000.00394.x; Zar JH, 1999, BIOSTATISTICAL ANAL; ZWARTS L, 1989, MAR ECOL PROG SER, V56, P255, DOI 10.3354/meps056255	96	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110633	10.1371/journal.pone.0110633	http://dx.doi.org/10.1371/journal.pone.0110633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354218	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200031
J	Xiao, QG; Tan, YH; Guo, Y; Yang, HK; Mao, F; Xie, RF; Wang, BF; Lei, T; Guo, DS				Xiao, Qungen; Tan, Yihu; Guo, Yang; Yang, Hongkuan; Mao, Feng; Xie, Ruifan; Wang, Baofeng; Lei, Ting; Guo, Dongsheng			Soluble LRIG2 Ectodomain Is Released from Glioblastoma Cells and Promotes the Proliferation and Inhibits the Apoptosis of Glioblastoma Cells In Vitro and In Vivo in a Similar Manner to the Full-Length LRIG2	PLOS ONE			English	Article							NEGATIVE REGULATOR; GLIOMA-CELLS; MALIGNANT GLIOMAS; TUMOR-SUPPRESSOR; DOWN-REGULATION; BREAST-CANCER; GROWTH; EXPRESSION; RECEPTOR; SURVIVAL	The human leucine-rich repeats and immunoglobulin-like domains (LRIG) gene family contains LRIG1, 2 and 3, encoding integral membrane proteins with an ectodomain, a transmembrane domain and a cytoplasmic tail. LRIG1 negatively regulates multiple receptor tyrosine kinases signaling including the epidermal growth factor receptor (EGFR) and is a proposed tumor suppressor. The soluble LRIG1 ectodomain is demonstrated to be shed naturally and inhibit the progression of glioma. However, little is known regarding the functions of LRIG2. In oligodendroglioma, LRIG2 expression is associated with poor survival, suggesting that LRIG2 might have different functions compared with LRIG1. Since soluble LRIG1 ectodomain has a similar function to the full-length LRIG1, we hypothesize that the different roles exerted by LRIG2 and LRIG1 result from the difference of their ectodomains. Here, we addressed the functions of LRIG2 and LRIG2 ectodomain in the proliferation and apoptosis of glioma and the possible underlying mechanisms. Firstly, we found that LRIG2 expression levels positively correlated with the grade of glioma. Further, we demonstrated for the first time that soluble LRIG2 ectodomain was capable of being released from glioblastoma cells and exerted a pro-proliferative effect. Overexpression of LRIG2 ectodomain promoted the proliferation and inhibited the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2. Both full-length LRIG2 and LRIG2 ectodomain were found to physically interact with EGFR, enhance the activation of EGFR and its downstream PI3 K/Akt pathway. To our knowledge, this is the first report demonstrating that soluble LRIG2 ectodomain is capable of being released from glioblastoma cells and exerts a similar role to the full-length LRIG2 in the regulation of EGFR signaling in the progression of glioblastoma. LRIG2 ectodomain, with potent pro-tumor effects, holds promise for providing a new therapeutic target for the treatment of glioblastoma.	[Wang, Baofeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurosurg, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Sino German Neurooncol Mol Lab, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, BF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurosurg, Wuhan 430074, Peoples R China.	wbf620@163.com	Mao, Feng/B-8280-2019		National Natural Science Foundation of China [81001116, 81372711]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (grant number 81001116, 81372711; URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirlak B, 2003, J NEURO-ONCOL, V63, P129, DOI 10.1023/A:1023906316524; Cai MJ, 2009, CANCER LETT, V278, P104, DOI 10.1016/j.canlet.2009.01.001; Effenberger T, 2014, FASEB J; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Guo DS, 2004, GENOMICS, V84, P157, DOI 10.1016/j.ygeno.2004.01.013; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Hedman H, 2010, ACTA ONCOL, V49, P812, DOI 10.3109/0284186X.2010.492789; Holmlund C, 2004, GENE, V332, P35, DOI 10.1016/j.gene.2004.02.002; Holmlund C, 2009, NEUROPATHOLOGY, V29, P242, DOI 10.1111/j.1440-1789.2008.00970.x; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; Johansson M, 2013, NEURO-ONCOLOGY, V15, P1200, DOI 10.1093/neuonc/not054; Ju HQ, 2011, EUR J PHARMACOL, V666, P26, DOI 10.1016/j.ejphar.2011.05.020; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lindstrom AK, 2008, INT J GYNECOL CANCER, V18, P312, DOI 10.1111/j.1525-1438.2007.01021.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mao F, 2013, INT J ONCOL, V42, P1081, DOI 10.3892/ijo.2013.1776; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Rondahl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073635; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Wang BF, 2009, CANCER BIOL THER, V8, P1018, DOI 10.4161/cbt.8.11.8375; Wang Y, 2013, BRIT J CANCER, V108, P1765, DOI 10.1038/bjc.2013.138; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xie RF, 2013, ONCOL REP, V29, P177, DOI 10.3892/or.2012.2102; Yang HK, 2011, J HUAZHONG U SCI-MED, V31, P667, DOI 10.1007/s11596-011-0579-9; Ye F, 2009, J NEURO-ONCOL, V94, P183, DOI 10.1007/s11060-009-9836-1; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005	33	20	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111419	10.1371/journal.pone.0111419	http://dx.doi.org/10.1371/journal.pone.0111419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353163	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200079
J	Brunetto, MR; Cavallone, D; Oliveri, F; Moriconi, F; Colombatto, P; Coco, B; Ciccorossi, P; Rastelli, C; Romagnoli, V; Cherubini, B; Teilum, MW; Blondal, T; Bonino, F				Brunetto, Maurizia Rossana; Cavallone, Daniela; Oliveri, Filippo; Moriconi, Francesco; Colombatto, Piero; Coco, Barbara; Ciccorossi, Pietro; Rastelli, Carlotta; Romagnoli, Veronica; Cherubini, Beatrice; Teilum, Maria Wrang; Blondal, Thorarinn; Bonino, Ferruccio			A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN; PEGINTERFERON ALPHA-2A; PCR; INTERFERON; MANAGEMENT; PLASMA; SYSTEM; TM4	Background and Aims: The virus/host interplay mediates liver pathology in chronic HBV infection. MiRNAs play a pivotal role in virus/host interactions and are detected in both serum and HBsAg-particles, but studies of their dynamics during chronic infection and antiviral therapy are missing. We studied serum miRNAs during different phases of chronic HBV infection and antiviral treatment. Methods: MiRNAs were profiled by miRCURY-LNA-Universal-RT-miRNA-PCR (Exiqon-A/S) and qPCR-panels-I/II-739-miRNA-assays and single-RT-q-PCRs. Two cohorts of well-characterized HBsAg-carriers were studied (median follow-up 34-52 months): a) training-panel (141 sera) and HBsAg-particles (32 samples) from 61 HBsAg-carriers and b) validation-panel (136 sera) from 84 carriers. Results: Thirty-one miRNAs were differentially expressed in inactive-carriers (IC) and chronic-hepatitis-B (CHB) with the largest difference for miR-122-5p, miR-99a-5p and miR-192-5p (liver-specific-miRNAs), over-expressed in both sera and HBsAg-particles of CHB (ANOVA/U-test p-values: <0.000001/0.000001; <0.000001/0.000003; <0.000001/0.000005, respectively) and significantly down-regulated during-and after-treatment in sustained-virological-responders (SVR). MiRNA-profiles of IC and SVR clustered in the heatmap. Liver-miRNAs were combined with miR-335, miR-126 and miR-320a (internal controls) to build a MiR-B-Index with 100% sensitivity, 83.3% and 92.5% specificity (-1.7 cut-off) in both training and validation cohorts to identify IC. MiR-B-Index (-5.72, -20.43/14.38) correlated with ALT (49, 10/2056 U/l, rho = -0.497, p<0.001), HBV-DNA (4.58, undetectable/>8.3 Log(10) IU/mL, rho = -0.732, p<0.001) and HBsAg (3.40, 0.11/5.49 Log(10) IU/mL, rho = -0.883, p<0.001). At multivariate analysis HBV-DNA (p = 0.002), HBsAg (p<0.001) and infection-phase (p<0.001), but not ALT (p = 0.360) correlated with MiR-B-Index. In SVR to Peg-IFN/NUCs MiR-B-Index improved during-therapy and post-treatment reaching IC-like values (5.32, -1.65/10.91 vs 6.68, 0.54/9.53, p = 0.324) beckoning sustained HBV-immune-control earlier than HBsAg-decline. Conclusions: Serum miRNA profile change dynamically during the different phases of chronic HBV infection. We identified a miRNA signature associated with both natural-occurring and therapy-induced immune control of HBV infection. The MiR-B-Index might be a useful biomarker for the early identification of the sustained switch from CHB to inactive HBV-infection in patients treated with antivirals.	[Brunetto, Maurizia Rossana; Cavallone, Daniela; Oliveri, Filippo; Moriconi, Francesco; Colombatto, Piero; Coco, Barbara; Ciccorossi, Pietro; Rastelli, Carlotta; Romagnoli, Veronica; Cherubini, Beatrice] Univ Hosp Pisa, Reference Ctr Tuscany Region Chron Liver Dis & Ca, Lab Mol Genet & Pathol Hepatitis Viruses, Hepatol Unit, Pisa, Italy; [Teilum, Maria Wrang; Blondal, Thorarinn] Exiqon AS, Div Dx & Serv, Copenhagen, Denmark; [Bonino, Ferruccio] Univ Hosp Pisa, Gen Med Unit 2, Pisa, Italy	University of Pisa; Azienda Ospedaliero Universitaria Pisana; Exiqon; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Brunetto, MR (corresponding author), Univ Hosp Pisa, Reference Ctr Tuscany Region Chron Liver Dis & Ca, Lab Mol Genet & Pathol Hepatitis Viruses, Hepatol Unit, Pisa, Italy.	brunettomaurizia@gmail.com	Oliveri, Filippo/GRX-9884-2022; Bonino, Ferruccio/C-6036-2018; Brunetto, Maurizia/AAU-2906-2020; Cavallone, Daniela/AAB-2660-2019	Oliveri, Filippo/0000-0002-9794-7203; Bonino, Ferruccio/0000-0001-9942-0328; Brunetto, Maurizia/0000-0001-8364-9152; Cavallone, Daniela/0000-0001-6718-9571; Colombatto, Piero/0000-0002-5419-4109	CUCCs-grant of Tuscany Region Italy	CUCCs-grant of Tuscany Region Italy	The study was supported in part by the 2010-CUCCs-grant of Tuscany Region Italy (FB). All the additional source of support were internal to our organization (i.e. funding dedicated to research internal to our Liver Unit). The funders had no direct role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; BONINO F, 1986, GASTROENTEROLOGY, V90, P1268, DOI 10.1016/0016-5085(86)90395-1; Brunetto MR, 2013, J HEPATOL, V59, P1153, DOI 10.1016/j.jhep.2013.07.017; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cheng M, 2013, J VIROL, V87, P9707, DOI 10.1128/JVI.00802-13; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; Hayes CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047490; Hu J, 2013, TRANSPLANTATION, V95, P991, DOI 10.1097/TP.0b013e31828618d8; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Janssen HLA, 2012, GUT, V61, P641, DOI 10.1136/gutjnl-2011-301096; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Novellino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031952; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; van der Meer AJ, 2013, J VIRAL HEPATITIS, V20, P158, DOI 10.1111/jvh.12001; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733	34	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110782	10.1371/journal.pone.0110782	http://dx.doi.org/10.1371/journal.pone.0110782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350115	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100040
J	Alvarez-Berastegui, D; Ciannelli, L; Aparicio-Gonzalez, A; Reglero, P; Hidalgo, M; Lopez-Jurado, JL; Tintore, J; Alemany, F				Alvarez-Berastegui, Diego; Ciannelli, Lorenzo; Aparicio-Gonzalez, Alberto; Reglero, Patricia; Hidalgo, Manuel; Luis Lopez-Jurado, Jose; Tintore, Joaquin; Alemany, Francisco			Spatial Scale, Means and Gradients of Hydrographic Variables Define Pelagic Seascapes of Bluefin and Bullet Tuna Spawning Distribution	PLOS ONE			English	Article							GULF-OF-MEXICO; THUNNUS-THYNNUS; HABITAT; LARVAE; FISH; MARINE; PATTERN; METRICS; MODEL	Seascape ecology is an emerging discipline focused on understanding how features of the marine habitat influence the spatial distribution of marine species. However, there is still a gap in the development of concepts and techniques for its application in the marine pelagic realm, where there are no clear boundaries delimitating habitats. Here we demonstrate that pelagic seascape metrics defined as a combination of hydrographic variables and their spatial gradients calculated at an appropriate spatial scale, improve our ability to model pelagic fish distribution. We apply the analysis to study the spawning locations of two tuna species: Atlantic bluefin and bullet tuna. These two species represent a gradient in life history strategies. Bluefin tuna has a large body size and is a long-distant migrant, while bullet tuna has a small body size and lives year-round in coastal waters within the Mediterranean Sea. The results show that the models performance incorporating the proposed seascape metrics increases significantly when compared with models that do not consider these metrics. This improvement is more important for Atlantic bluefin, whose spawning ecology is dependent on the local oceanographic scenario, than it is for bullet tuna, which is less influenced by the hydrographic conditions. Our study advances our understanding of how species perceive their habitat and confirms that the spatial scale at which the seascape metrics provide information is related to the spawning ecology and life history strategy of each species.	[Alvarez-Berastegui, Diego; Tintore, Joaquin] Balear Islands Coastal Observing & Forecasting Sy, Palma De Mallorca, Balearic Island, Spain; [Ciannelli, Lorenzo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Aparicio-Gonzalez, Alberto; Reglero, Patricia; Hidalgo, Manuel; Luis Lopez-Jurado, Jose; Alemany, Francisco] Ctr Oceanog Balears, Inst Espanol Oceanogra, Palma De Mallorca, Balearic Island, Spain; [Tintore, Joaquin] CSIC, Inst Adv Studies IMEDEA, Esporles, Spain; [Tintore, Joaquin] Univ Balearic Isl, Esporles, Spain	Oregon State University; Spanish Institute of Oceanography; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears	Alvarez-Berastegui, D (corresponding author), Balear Islands Coastal Observing & Forecasting Sy, Palma De Mallorca, Balearic Island, Spain.	dalvarez@socib.es	Hidalgo, Manuel/B-8023-2015; Reglero, Patricia/L-9031-2014	Hidalgo, Manuel/0000-0002-3494-9658; Alemany, F. (Francisco)/0000-0001-6265-5545; Aparicio-Gonzalez, A. (Alberto)/0000-0003-1280-0243; Alvarez-Berastegui, Diego/0000-0003-1304-7185; Reglero, P. (Patricia)/0000-0002-1093-4750; Tintore, Joaquin/0000-0002-6311-0093	Project "PERSEUS'' - Seventh Framework Program for Research (FP7) under theme "Oceans Tomorrow'' [287600]; Spanish Foundation for Science and Technology, under the project "BALEARES'' [CTM2009-07944/MAR]; Science, Engineering and Education for Sustainability NSF-Wide Investment (SEES) Research Coordination Network, "Sustainability of Marine Renewable Resources in Subarctic Systems Under Incumbent Environmental Variability and Human Exploitation'' [1140207]; Council for Economy and Competitiveness of the Balearic Islands Government [AAEE0022/08]	Project "PERSEUS'' - Seventh Framework Program for Research (FP7) under theme "Oceans Tomorrow''; Spanish Foundation for Science and Technology, under the project "BALEARES''; Science, Engineering and Education for Sustainability NSF-Wide Investment (SEES) Research Coordination Network, "Sustainability of Marine Renewable Resources in Subarctic Systems Under Incumbent Environmental Variability and Human Exploitation''; Council for Economy and Competitiveness of the Balearic Islands Government	The development of this study was supported by the Project "PERSEUS'' financed by the Seventh Framework Program for Research (FP7) under theme "Oceans Tomorrow'', grant Agreement No. 287600 (http://www.perseus-fp7.eu/), the Spanish Foundation for Science and Technology, under the project "BALEARES'' Grant number: CTM2009-07944/MAR (http://www.fecyt.es/fecyt/home.do) and the Science, Engineering and Education for Sustainability NSF-Wide Investment (SEES) Research Coordination Network, Grant 1140207 "Sustainability of Marine Renewable Resources in Subarctic Systems Under Incumbent Environmental Variability and Human Exploitation'' (http://grantome.com/grant/NSF/OCE-1140207). Hydrographic data used in the study were provided by IBAMAR (http://www.ba.ieo.es/ibamar) a public data base founded by the Council for Economy and Competitiveness of the Balearic Islands Government (http://www.caib.es/govern/organigrama/area.do?coduo=6&lang=es), grant number AAEE0022/08. The research was developed under the framework of the BLUEFIN TUNA Project driven by the Balearic Island Observing and Forecasting System (www.socib.es) and the Spanish Institute of Oceanography (www.ieo.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Bakun A, 2013, FISH FISH, V14, P424, DOI 10.1111/faf.12002; Balbin R, 2014, J MARINE SYST, V138, P51, DOI 10.1016/j.jmarsys.2013.12.007; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bostrom C, 2011, MAR ECOL PROG SER, V427, P191, DOI 10.3354/meps09051; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cushman SA, 2008, ECOL INDIC, V8, P691, DOI 10.1016/j.ecolind.2007.12.002; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P83, DOI 10.1007/978-4-431-87771-4_5; de la Gandara F, 2013, 14 CONGR NAC AC GIJ, P181; Druon JN, 2011, MAR ECOL PROG SER, V439, P223, DOI 10.3354/meps09321; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Gordoa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090691; Hidalgo M, 2012, P ROY SOC B-BIOL SCI, V279, P275, DOI 10.1098/rspb.2011.0750; Hinchey EK, 2008, LANDSCAPE ECOL, V23, P1, DOI 10.1007/s10980-007-9141-3; Hobday AJ, 2006, FISHERIES MANAG ECOL, V13, P365, DOI 10.1111/j.1365-2400.2006.00515.x; Ingram GW, 2008, SCRS2008086 ICCAT; Ingram Jr GW, 2013, INT COMM CONS ATL CO, V69, P1057; Juza M, 2013, J GEOPHYS RES-OCEANS, V118, P6621, DOI 10.1002/2013JC009231; Juzza M, 2014, GEOPH RES ABSTR, V16; LAVIOLETTE PE, 1990, J GEOPHYS RES-OCEANS, V95, P1559, DOI 10.1029/JC095iC02p01559; Lehodey P, 2008, PROG OCEANOGR, V78, P304, DOI 10.1016/j.pocean.2008.06.004; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Mannocci L, 2014, ECOGRAPHY, V37, P261, DOI 10.1111/j.1600-0587.2013.00317.x; Muhling BA, 2013, MAR ECOL PROG SER, V486, P257, DOI 10.3354/meps10397; Muhling BA, 2011, ICES J MAR SCI, V68, P1051, DOI 10.1093/icesjms/fsr008; Muhling BA, 2010, FISH OCEANOGR, V19, P526, DOI 10.1111/j.1365-2419.2010.00562.x; Pascual A, 2013, SCI MAR, V77, P19, DOI 10.3989/scimar.03740.15A; Phillips AJ, 2014, ICES J MARI IN PRESS; Pittman SJ, 2011, MAR ECOL PROG SER, V427, P187, DOI 10.3354/meps09139; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; R Development Core Team R, 2011, R LANG ENV STAT COMP; Reglero P, 2014, MAR ECOL PROG SER, V501, P207, DOI 10.3354/meps10666; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Reglero P, MARINE ECOLOGY PROGR, V433, P205; Reglero P, 2013, SCI MAR, V77, P585, DOI 10.3989/scimar.03759.28A; Rodriguez JM, 2013, DEEP-SEA RES PT I, V77, P11, DOI 10.1016/j.dsr.2013.03.002; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Sabates A, 2001, SCI MAR, V65, P95, DOI 10.3989/scimar.2001.65n295; Steele JH, 1989, LANDSCAPE ECOL, V3, P185, DOI 10.1007/BF00131537; Tintore J, 2013, MAR TECHNOL SOC J, V47, P101, DOI 10.4031/MTSJ.47.1.10; Torres AP, 2011, J PLANKTON RES, V33, P1793, DOI 10.1093/plankt/fbr078; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Wedding LM, 2011, MAR ECOL PROG SER, V427, P219, DOI 10.3354/meps09119; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Wu J., 2012, ECOLOGICAL SYSTEMS, DOI [10.1007/978-1-4614-5755-8_11, DOI 10.1007/978-1-4614-5755-8_11]; Wu JG, 2006, SCALING AND UNCERTAINTY ANALYSIS IN ECOLOGY: METHODS AND APPLICATIONS, P17, DOI 10.1007/1-4020-4663-4_2	51	28	29	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109338	10.1371/journal.pone.0109338	http://dx.doi.org/10.1371/journal.pone.0109338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347411	Green Published, gold			2022-12-26	WOS:000347994900008
J	Fukamachi, K; Iigo, M; Hagiwara, Y; Shibata, K; Futakuchi, M; Alexander, DB; Hino, O; Suzui, M; Tsuda, H				Fukamachi, Katsumi; Iigo, Masaaki; Hagiwara, Yoshiaki; Shibata, Koji; Futakuchi, Mitsuru; Alexander, David B.; Hino, Okio; Suzui, Masumi; Tsuda, Hiroyuki			Rat N-ERC/Mesothelin as a Marker for In Vivo Screening of Drugs against Pancreas Cancer	PLOS ONE			English	Article							ONCOGENE TRANSGENIC RATS; DUCTAL ADENOCARCINOMAS; MOLECULAR-CLONING; OVARIAN-CARCINOMA; C-ERC/MESOTHELIN; SERIAL ANALYSIS; ELISA SYSTEM; TUMOR-MARKER; EKER RAT; MESOTHELIOMA	Pancreatic ductal adenocarcinoma (PDA) is a highly lethal disease, which is usually diagnosed in an advanced stage. We have established transgenic rats carrying a mutated K-ras gene controlled by Cre/loxP activation. The animals develop PDA which is histopathologically similar to that in humans. Previously, we reported that serum levels of N-ERC/mesothelin were significantly higher in rats bearing PDA than in controls. In the present study, to determine whether serum levels of N-ERC/mesothelin correlated with tumor size, we measured N-ERC/mesothelin levels in rats bearing PDA. Increased serum levels of N-ERC/mesothelin correlated with increased tumor size. This result indicates an interrelationship between the serum level of N-ERC/mesothelin and tumor size. We next investigated the effect of chemotherapy on serum N-ERC/mesothelin levels. Rat pancreatic cancer cells were implanted subcutaneously into the flank of NOD-SCID mice. In the mice treated with 200 mg/kg gemcitabine, tumor weight and the serum level of N-ERC/mesothelin were significantly decreased compared to controls. These results suggest that serum N-ERC/mesothelin measurements might be useful for monitoring response to therapy.	[Fukamachi, Katsumi; Shibata, Koji; Futakuchi, Mitsuru; Suzui, Masumi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Toxicol, Nagoya, Aichi, Japan; [Iigo, Masaaki; Alexander, David B.; Tsuda, Hiroyuki] Nagoya City Univ, Nanotoxicol Project, Nagoya, Aichi, Japan; [Hagiwara, Yoshiaki] Immunobiol Labs, Fujioka, Gunma, Japan; [Shibata, Koji] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4648601, Japan; [Hino, Okio] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 113, Japan	Nagoya City University; Nagoya City University; Nagoya University; Juntendo University	Fukamachi, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Mol Toxicol, Nagoya, Aichi, Japan.	kfukamac@med.nagoya-cu.ac.jp	Futakuchi, Mitsuru/S-2441-2019	Futakuchi, Mitsuru/0000-0001-8647-583X	Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) from Japan Science and Technology Agency; Japan Society for the Promotion of Science; Research in Nagoya City University; Aichi Cancer Research Foundation; Program for developing the supporting system for upgrading the education and research from the Ministry of Education, Culture, Sports, Science and Technology; Cancer Research from the Ministry of Health, Labour and Welfare [17S-6, 20S-8]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) from Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research in Nagoya City University; Aichi Cancer Research Foundation(Aichi Cancer Research Foundation); Program for developing the supporting system for upgrading the education and research from the Ministry of Education, Culture, Sports, Science and Technology; Cancer Research from the Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) from Japan Science and Technology Agency; a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science; a Grant-in-Aid for Research in Nagoya City University; the Aichi Cancer Research Foundation; the Program for developing the supporting system for upgrading the education and research from the Ministry of Education, Culture, Sports, Science and Technology; and a Grant-in-Aid for Cancer Research (17S-6, 20S-8) from the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, CLIN CANCER RES, V7, P3862; CARLSSON G, 1983, J CANCER RES CLIN, V105, P20, DOI 10.1007/BF00391826; CHANG K, 1994, INT J CANCER, V57, P90, DOI 10.1002/ijc.2910570117; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Fujii S, 2012, BIOCHEM BIOPH RES CO, V417, P1074, DOI 10.1016/j.bbrc.2011.12.099; Fukamachi K, 2013, GENESIS, V51, P268, DOI 10.1002/dvg.22371; Fukamachi K, 2009, BIOCHEM BIOPH RES CO, V390, P636, DOI 10.1016/j.bbrc.2009.10.019; Hagiwara Y, 2008, CANCER SCI, V99, P666, DOI 10.1111/j.1349-7006.2008.00731.x; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; HINO O, 1995, J CANCER RES CLIN, V121, P602, DOI 10.1007/BF01197777; Hough CD, 2000, CANCER RES, V60, P6281; Inami K, 2008, ONCOL REP, V20, P1375, DOI 10.3892/or_00000155; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Mori T, 2013, J THORAC DIS, V5, P145, DOI 10.3978/j.issn.2072-1439.2013.03.03; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Onda M, 2006, CLIN CANCER RES, V12, P4225, DOI 10.1158/1078-0432.CCR-06-0472; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1418, DOI 10.1097/00000478-200311000-00003; Saeki H, 2012, ONCOL LETT, V4, P637, DOI 10.3892/ol.2012.796; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Shiomi K, 2008, CLIN CANCER RES, V14, P1431, DOI 10.1158/1078-0432.CCR-07-1613; Shiomi K, 2006, CANCER SCI, V97, P928, DOI 10.1111/j.1349-7006.2006.00246.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tajima K, 2008, ANTICANCER RES, V28, P3933; Tanaka H, 2010, CANCER SCI, V101, P341, DOI 10.1111/j.1349-7006.2009.01410.x; Ueda S, 2006, CARCINOGENESIS, V27, P2497, DOI 10.1093/carcin/bgl090; Yabushita S, 2013, PANCREAS, V42, P1034, DOI 10.1097/MPA.0b013e3182883624; Yabushita S, 2013, CARCINOGENESIS, V34, P1251, DOI 10.1093/carcin/bgt053; Yabushita S, 2012, PANCREAS, V41, P1013, DOI 10.1097/MPA.0b013e31824ac3a5; Yamashita Y, 2000, BIOCHEM BIOPH RES CO, V275, P134, DOI 10.1006/bbrc.2000.3280	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111481	10.1371/journal.pone.0111481	http://dx.doi.org/10.1371/journal.pone.0111481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347530	Green Submitted, Green Published, gold			2022-12-26	WOS:000347994900081
J	Spasojevic, M; Paredes-Juarez, GA; Vorenkamp, J; de Haan, BJ; Schouten, AJ; de Vos, P				Spasojevic, Milica; Paredes-Juarez, Genaro A.; Vorenkamp, Joop; de Haan, Bart J.; Schouten, Arend Jan; de Vos, Paul			Reduction of the Inflammatory Responses against Alginate-Poly-L-Lysine Microcapsules by Anti-Biofouling Surfaces of PEG-b-PLL Diblock Copolymers	PLOS ONE			English	Article							MICROENCAPSULATED PANCREATIC-ISLETS; MOLECULAR-WEIGHT CUTOFF; POLYLYSINE MICROCAPSULES; FIBROTIC OVERGROWTH; HOST-REACTION; RAT ISLETS; IN-VIVO; CELLS; BIOCOMPATIBILITY; CAPSULES	Large-scale application of alginate-poly-L-lysine (alginate-PLL) capsules used for microencapsulation of living cells is hampered by varying degrees of success, caused by tissue responses against the capsules in the host. A major cause is proinflammatory PLL which is applied at the surface to provide semipermeable properties and immunoprotection. In this study, we investigated whether application of poly(ethylene glycol)-block-poly(L-lysine hydrochloride) diblock copolymers (PEG-b-PLL) can reduce the responses against PLL on alginate-matrices. The application of PEG-b-PLL was studied in two manners: (i) as a substitute for PLL or (ii) as an anti-biofouling layer on top of a proinflammatory, but immunoprotective, semipermeable alginate-PLL100 membrane. Transmission FTIR was applied to monitor the binding of PEG-b-PLL. When applied as a substitute for PLL, strong host responses in mice were observed. These responses were caused by insufficient binding of the PLL block of the diblock copolymers confirmed by FTIR. When PEG-b-PLL was applied as an anti-biofouling layer on top of PLL100 the responses in mice were severely reduced. Building an effective anti-biofouling layer required 50 hours as confirmed by FTIR, immunocytochemistry and XPS. Our study provides new insight in the binding requirements of polyamino acids necessary to provide an immunoprotective membrane. Furthermore, we present a relatively simple method to mask proinflammatory components on the surface of microcapsules to reduce host responses. Finally, but most importantly, our study illustrates the importance of combining physicochemical and biological methods to understand the complex interactions at the capsules' surface that determine the success or failure of microcapsules applicable for cell-encapsulation.	[Spasojevic, Milica; Vorenkamp, Joop; Schouten, Arend Jan] Univ Groningen, Dept Polymer Chem, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Spasojevic, Milica; Paredes-Juarez, Genaro A.; de Haan, Bart J.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Spasojevic, Milica; Paredes-Juarez, Genaro A.; de Haan, Bart J.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Sect Med Biol,Div Immunoendocrinol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	de Vos, P (corresponding author), Univ Groningen, Dept Pathol, Groningen, Netherlands.	P.de.Vos@umcg.nl	de Vos, Paul/A-3170-2013; Paredes, Genaro A/R-6633-2016; Institute, Zernike/W-7033-2019	Paredes, Genaro A/0000-0002-6621-7830; de vos, paul/0000-0001-9618-2408	Kollf institute; Juvenile Diabetes research foundation	Kollf institute; Juvenile Diabetes research foundation(Juvenile Diabetes Research Foundation)	This work was supported by a project from The Kollf institute and the Juvenile Diabetes research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER P, 1994, EXP NEUROL, V126, P151, DOI 10.1006/exnr.1994.1053; Basta G, 2004, TRANSPL IMMUNOL, V13, P289, DOI 10.1016/j.trim.2004.10.003; Bruns H, 2013, CLIN TRANSPLANT, V27, P30, DOI 10.1111/ctr.12153; Bunger CM, 2005, BIOMATERIALS, V26, P2353, DOI 10.1016/j.biomaterials.2004.07.017; BYSTRICKY S, 1991, CARBOHYD POLYM, V15, P299, DOI 10.1016/0144-8617(91)90044-D; CHANG PL, 1993, HUM GENE THER, V4, P433, DOI 10.1089/hum.1993.4.4-433; CIESLINSKI DA, 1994, BIOTECHNOL BIOENG, V43, P678, DOI 10.1002/bit.260430718; COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S; COROMILI V, 1993, BIOMAT ARTIF CELL IM, V21, P427, DOI 10.3109/10731199309117382; de Haan BJ, 2011, J BIOMED MATER RES A, V98A, P394, DOI 10.1002/jbm.a.33123; de Haan BJ, 2003, CELL TRANSPLANT, V12, P617, DOI 10.3727/000000003108747226; De Haan BJ, 2002, BIOTECHNIQUES, V32, P612, DOI 10.2144/02323rr03; De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381; de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345; de Vos P, 2003, DIABETOLOGIA, V46, P666, DOI 10.1007/s00125-003-1087-7; de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8; de Vos P, 2002, J BIOMED MATER RES, V60, P252, DOI 10.1002/jbm.10060; de Vos P, 2007, J BIOMED MATER RES A, V80A, P813, DOI 10.1002/jbm.a.30979; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039; de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014; DEENEN GJ, 1987, J IMMUNOL, V139, P702; DeVos P, 1997, BIOMATERIALS, V18, P1085, DOI 10.1016/S0142-9612(97)00040-9; DeVos P, 1996, TRANSPLANTATION, V62, P888, DOI 10.1097/00007890-199610150-00003; DeVos P, 1996, TRANSPLANTATION, V62, P893, DOI 10.1097/00007890-199610150-00004; DeVos P, 1997, DIABETOLOGIA, V40, P262; DEVOS P, 1994, TRANSPLANT P, V26, P782; DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Goto Y, 2008, BIOMACROMOLECULES, V9, P828, DOI 10.1021/bm701161d; Hesse M.S., 1997, STARCH STARKE, V49, P257, DOI [10.1002/star.19970490613, DOI 10.1002/STAR.19970490613]; Holland NB, 1998, NATURE, V392, P799, DOI 10.1038/33894; HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73; KING GA, 1987, BIOTECHNOL PROGR, V3, P231, DOI 10.1002/btpr.5420030407; KOO J, 1993, INT J ARTIF ORGANS, V16, P557, DOI 10.1177/039139889301600710; Leblond FA, 1996, BIOMATERIALS, V17, P2097, DOI 10.1016/0142-9612(96)00027-0; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291; Omer A, 2003, XENOTRANSPLANTATION, V10, P240, DOI 10.1034/j.1399-3089.2003.01150.x; Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048; Orive G, 2005, J BIOMED MATER RES B, V74B, P429, DOI 10.1002/jbm.b.30146; Orive G, 2014, NAT MED, V20, P233, DOI 10.1038/nm.3486; Paredes-Juarez GA, 2013, J CONTROL RELEASE, V172, P983, DOI 10.1016/j.jconrel.2013.09.009; Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; Robitaille R, 2000, J BIOMED MATER RES, V50, P420, DOI 10.1002/(SICI)1097-4636(20000605)50:3<420::AID-JBM17>3.0.CO;2-S; Rokstad AM, 2013, BIOMATERIALS, V34, P621, DOI 10.1016/j.biomaterials.2012.10.012; Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011; Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010; SAWHNEY AS, 1993, BIOMATERIALS, V14, P1008, DOI 10.1016/0142-9612(93)90194-7; SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V; SKJAKBRAEK G, 1989, BIOTECHNOL BIOENG, V33, P90, DOI 10.1002/bit.260330112; Smelt MJ, 2012, PANCREAS, V41, P39, DOI 10.1097/MPA.0b013e31821fc90c; Sobol M, 2013, J BIOMED MATER RES A, V101, P1907, DOI 10.1002/jbm.a.34500; Spasojevic M, 2014, J BIOMED MATER RES A, V102, P1887, DOI 10.1002/jbm.a.34863; STOKKE BT, 1991, MACROMOLECULES, V24, P4637, DOI 10.1021/ma00016a026; Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800; Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006; Tam SK, 2011, J BIOMED MATER RES A, V98A, P40, DOI 10.1002/jbm.a.33047; Tatarkiewicz K, 2001, DIABETOLOGIA, V44, P646, DOI 10.1007/s001250051672; Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1; Thu B, 1997, CARBOHYD RES, V297, P101, DOI 10.1016/S0008-6215(96)00257-1; Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2; ULUDAG H, 1993, CELL TRANSPLANT, V2, P175, DOI 10.1177/096368979300200210; Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3; van Hoogmoed CG, 2003, J BIOMED MATER RES A, V67A, P172, DOI 10.1002/jbm.a.10086; van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336; VANDENBOSSCHE GMR, 1993, J PHARM PHARMACOL, V45, P115, DOI 10.1111/j.2042-7158.1993.tb03694.x; VANDENBOSSCHE GMR, 1993, J PHARM PHARMACOL, V45, P121, DOI 10.1111/j.2042-7158.1993.tb03695.x; VANDENBOSSCHE GMR, 1991, J PHARM PHARMACOL, V43, P275, DOI 10.1111/j.2042-7158.1991.tb06683.x; VANDENBOSSCHE GMR, 1993, BIOTECHNOL BIOENG, V42, P381, DOI 10.1002/bit.260420316; Weir GC, 2013, DIABETOLOGIA, V56, P1458, DOI 10.1007/s00125-013-2921-1; Xu Y, 2009, BIOMACROMOLECULES, V10, P267, DOI 10.1021/bm801279y	73	34	34	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109837	10.1371/journal.pone.0109837	http://dx.doi.org/10.1371/journal.pone.0109837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347191	Green Published, gold			2022-12-26	WOS:000347994900014
J	Stepanenko, OV; Stepanenko, OV; Kuznetsova, IM; Verkhusha, VV; Turoverov, KK				Stepanenko, Olesya V.; Stepanenko, Olga V.; Kuznetsova, Irina M.; Verkhusha, Vladislav V.; Turoverov, Konstantin K.			Sensitivity of Superfolder GFP to Ionic Agents	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; BINDING PROTEIN; ENVIRONMENTAL SENSITIVITY; GUANIDINE-HYDROCHLORIDE; CHROMOPHORE FORMATION; CRYSTAL-STRUCTURE; PROTON-TRANSFER; STABILITY; MUTANT; MATURATION	Superfolder variant of the green fluorescent protein (sfGFP) became a favorite probe for examination of the unfolding-refolding processes of fluorescent proteins with beta-barrel structure owing to its reversible unfolding in comparison with other fluorescent proteins. Its benefit is the proper folding even in fusion constructions with poorly folded polypeptides. We noticed that guanidine thiocyanate affects not only the structure of protein but its chromophore directly. Therefore we studied the influence of ionic denaturants and salts including guanidine thiocyanate, guanidine hydrochloride, sodium chloride and sodium thiocyanate on spectral features of sfGFP. It was shown that moderate amounts of the studied agents do not disrupt sfGFP structure but provoke pronounced alteration of its spectral characteristics. Changes in absorption and CD spectra in visible spectral range indicate the specific binding of SCN- and Cl- anions in the sfGFP chromophore vicinity. The anion binding results in the redistribution of sfGFP molecules with neutral and anionic chromophores. This also hinders the proton transfer in the chromophore excited state, considerably decreasing the fluorescence intensity of sfGFP. Our results indicate that when ionic denaturants are used in the studies of fluorescent protein folding their effect on fluorophore charge state should be taken into account.	[Stepanenko, Olesya V.; Stepanenko, Olga V.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia; [Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Verkhusha, Vladislav V.] Univ Helsinki, Inst Biomed, Dept Biochem & Dev Biol, Helsinki, Finland; [Kuznetsova, Irina M.; Turoverov, Konstantin K.] St Petersburg State Polytech Univ, Dept Biophys, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Yeshiva University; Albert Einstein College of Medicine; University of Helsinki; Peter the Great St. Petersburg Polytechnic University	Turoverov, KK (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	kkt@incras.ru	Stepanenko, Olga/S-3427-2017; Kuznetsova, Irina M./R-9844-2017; Stepanenko, Olesya V/S-3433-2017; Verkhusha, Vladislav/AAU-7784-2020; Turoverov, Konstantin/S-2079-2016	Kuznetsova, Irina M./0000-0002-3336-4834; Verkhusha, Vladislav/0000-0002-2083-8121; Turoverov, Konstantin/0000-0002-6977-1896; Stepanenko, Olga/0000-0002-9145-3480; Stepanenko, Olesya/0000-0003-3779-6711	Russian Foundation of Basic Research [12-04-31469]; Russian Federation; Russian Academy of Sciences; Academy of Finland [263371, 266992]; US National Institutes of Health [GM073913, CA164468]; NATIONAL CANCER INSTITUTE [R01CA164468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073913] Funding Source: NIH RePORTER	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation); Russian Academy of Sciences(Russian Academy of Sciences); Academy of Finland(Academy of Finland); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by the grants from the Russian Foundation of Basic Research (12-04-31469 to Olesya V. Stepanenko), the scholarships of the President of Russian Federation (to Olesya V. Stepanenko and Olga V. Stepanenko), the MCB Program of Russian Academy of Sciences (to K.K.T.), the Academy of Finland (263371 and 266992 to V.V.V.) and the US National Institutes of Health (GM073913 and CA164468 to V.V.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews BT, 2009, J MOL BIOL, V392, P218, DOI 10.1016/j.jmb.2009.06.072; Arosio D, 2007, BIOPHYS J, V93, P232, DOI 10.1529/biophysj.106.102319; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bizzarri R, 2007, BIOCHEMISTRY-US, V46, P5494, DOI 10.1021/bi602646r; Bizzarri R, 2009, ANAL BIOANAL CHEM, V393, P1107, DOI 10.1007/s00216-008-2515-9; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Cotlet M, 2006, CHEMPHYSCHEM, V7, P250, DOI 10.1002/cphc.200500247; Di Donato M, 2011, PHYS CHEM CHEM PHYS, V13, P16295, DOI 10.1039/c1cp20387h; Fang C, 2009, NATURE, V462, P200, DOI 10.1038/nature08527; Fok MV, 1972, ANN PN LEBEDEV PHYS, P3; Fonin AV, 2014, PLOS ONE IN PRESS; Frommer WB, 2009, CHEM SOC REV, V38, P2833, DOI 10.1039/b907749a; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hsu STD, 2010, J BIOL CHEM, V285, P4859, DOI 10.1074/jbc.M109.000695; Ibraheem A, 2010, CURR OPIN CHEM BIOL, V14, P30, DOI 10.1016/j.cbpa.2009.09.033; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Kuznetsova IM, 2002, BIOCHEMISTRY-US, V41, P13127, DOI 10.1021/bi026412x; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Maddalo SL, 2006, PHOTOCHEM PHOTOBIOL, V82, P367, DOI 10.1562/2005-04-11-RA-485; Mishin AS, 2008, BIOCHEMISTRY-US, V47, P4666, DOI 10.1021/bi702130s; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Seward HE, 2009, CHEM SOC REV, V38, P2842, DOI 10.1039/b901355p; Shcherbakova DM, 2012, ANGEW CHEM INT EDIT, V51, P10724, DOI 10.1002/anie.201200408; Staiano M, 2005, BIOCHEMISTRY-US, V44, P5625, DOI 10.1021/bi0478300; Staiano M, 2007, BIOCHEMISTRY-US, V46, P11120, DOI 10.1021/bi7008129; Stepanenko OV, 2013, INT REV CEL MOL BIO, V302, P221, DOI 10.1016/B978-0-12-407699-0.00004-2; Stepanenko OV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048809; Stepanenko OV, 2011, BIOTECHNIQUES, V51, P313, DOI 10.2144/000113765; Stepanenko OV, 2010, SPECTROSC-INT J, V24, P367, DOI 10.1155/2010/935656; Stepanenko OV, 2011, J PHYS CHEM B, V115, P9022, DOI 10.1021/jp204555h; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Stepartenko OV, 2008, PROTEINS, V73, P539, DOI 10.1002/prot.22089; Subach FV, 2011, NAT METHODS, V8, P1019, DOI [10.1038/nmeth.1776, 10.1038/NMETH.1776]; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Turoverov K K, 1998, Tsitologiia, V40, P806; Wachter RM, 2000, J MOL BIOL, V301, P157, DOI 10.1006/jmbi.2000.3905; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; Weber W, 1999, P NATL ACAD SCI USA, V96, P6177, DOI 10.1073/pnas.96.11.6177	49	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110750	10.1371/journal.pone.0110750	http://dx.doi.org/10.1371/journal.pone.0110750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347822	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900028
J	Wang, JB; Yang, J; Mao, S; Chai, XQ; Hu, YL; Hou, XG; Tang, YH; Bi, C; Li, X				Wang, Jiabin; Yang, Jian; Mao, Song; Chai, Xiaoqiang; Hu, Yuling; Hou, Xugang; Tang, Yiheng; Bi, Cheng; Li, Xiao			MitProNet: A Knowledgebase and Analysis Platform of Proteome, Interactome and Diseases for Mammalian Mitochondria	PLOS ONE			English	Article							COMPLEX I DEFICIENCY; SYSTEMATIC CHARACTERIZATION; SUBUNIT COMPOSITION; NETWORK ANALYSIS; GENE-EXPRESSION; GLOBAL SURVEY; DATABASE; MOUSE; IDENTIFICATION; DYSFUNCTION	Mitochondrion plays a central role in diverse biological processes in most eukaryotes, and its dysfunctions are critically involved in a large number of diseases and the aging process. A systematic identification of mitochondrial proteomes and characterization of functional linkages among mitochondrial proteins are fundamental in understanding the mechanisms underlying biological functions and human diseases associated with mitochondria. Here we present a database MitProNet which provides a comprehensive knowledgebase for mitochondrial proteome, interactome and human diseases. First an inventory of mammalian mitochondrial proteins was compiled by widely collecting proteomic datasets, and the proteins were classified by machine learning to achieve a high-confidence list of mitochondrial proteins. The current version of MitProNet covers 1124 high-confidence proteins, and the remainders were further classified as middle-or low-confidence. An organelle-specific network of functional linkages among mitochondrial proteins was then generated by integrating genomic features encoded by a wide range of datasets including genomic context, gene expression profiles, protein-protein interactions, functional similarity and metabolic pathways. The functional-linkage network should be a valuable resource for the study of biological functions of mitochondrial proteins and human mitochondrial diseases. Furthermore, we utilized the network to predict candidate genes for mitochondrial diseases using prioritization algorithms. All proteins, functional linkages and disease candidate genes in MitProNet were annotated according to the information collected from their original sources including GO, GEO, OMIM, KEGG, MIPS, HPRD and so on. MitProNet features a user-friendly graphic visualization interface to present functional analysis of linkage networks. As an up-to-date database and analysis platform, MitProNet should be particularly helpful in comprehensive studies of complicated biological mechanisms underlying mitochondrial functions and human mitochondrial diseases. MitProNet is freely accessible at http://bio.scu.edu.cn:8085/MitProNet.	[Wang, Jiabin; Yang, Jian; Mao, Song; Chai, Xiaoqiang; Hu, Yuling; Hou, Xugang; Tang, Yiheng; Bi, Cheng; Li, Xiao] Sichuan Univ, Sichuan Key Lab Mol Biol & Biotechnol, Key Lab Bioresource & Ecoenvironm, Coll Life Sci,Minist Educ, Chengdu 610064, Peoples R China	Sichuan University	Li, X (corresponding author), Sichuan Univ, Sichuan Key Lab Mol Biol & Biotechnol, Key Lab Bioresource & Ecoenvironm, Coll Life Sci,Minist Educ, Chengdu 610064, Peoples R China.	lix@scu.edu.cn			National Natural Science Foundation of China [61001149]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX10005001-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China	This work was supported partially by National Natural Science Foundation of China (Grant No. 61001149) and the National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant No. 2012ZX10005001-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu S, 2006, BIOINFORMATICS, V22, P485, DOI 10.1093/bioinformatics/btk009; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Bordych C, 2013, PLANT BIOLOGY, V15, P686, DOI 10.1111/plb.12027; Bousette N, 2009, J PROTEOME RES, V8, P1887, DOI 10.1021/pr800845a; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Catalano D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-36; Catherman AD, 2013, MOL CELL PROTEOMICS, V12, P3465, DOI 10.1074/mcp.M113.030114; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chappell NP, 2012, J PROTEOME RES, V11, P4605, DOI 10.1021/pr300403d; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chen XL, 2013, PROTEOMICS, V13, P3030, DOI 10.1002/pmic.201200448; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Distler AM, 2008, PROTEOMICS, V8, P4066, DOI 10.1002/pmic.200800102; Dwyer TM, 1999, BIOCHEMISTRY-US, V38, P9735, DOI 10.1021/bi9903906; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Facecchia K, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/683728; Fang XP, 2008, ELECTROPHORESIS, V29, P2215, DOI 10.1002/elps.200700609; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Goncalves JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049634; Gregersen N, 2012, J INHERIT METAB DIS, V35, P715, DOI 10.1007/s10545-012-9480-3; Gu ZG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-335; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hansen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026634; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jin JH, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-67; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Lefort N, 2009, J PROTEOMICS, V72, P1046, DOI 10.1016/j.jprot.2009.06.011; Linghu Bolan, 2013, Methods Mol Biol, V939, P215, DOI 10.1007/978-1-62703-107-3_14; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Loeffen JLCM, 1998, BIOCHEM BIOPH RES CO, V253, P415, DOI 10.1006/bbrc.1998.9786; LOMAX MI, 1991, GENOMICS, V10, P1, DOI 10.1016/0888-7543(91)90476-U; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Nitsch D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-460; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmfeldt J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-20; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Reifschneider NH, 2006, J PROTEOME RES, V5, P1117, DOI 10.1021/pr0504440; Reja R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S20; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Scott MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-239; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Siddiqui AS, 2005, P NATL ACAD SCI USA, V102, P18485, DOI 10.1073/pnas.0509455102; Smith AC, 2009, MOL CELL PROTEOMICS, V8, P1324, DOI 10.1074/mcp.M800373-MCP200; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Traish AM, 2011, HORM MOL BIOL CLIN I, V8, P431, DOI 10.1515/HMBCI.2011.132; Triepels R, 2000, HUM GENET, V106, P385, DOI 10.1007/s004390000278; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Wolfe LA, 2010, J INHERIT METAB DIS, V33, pS481, DOI 10.1007/s10545-010-9246-8; Wu L, 2007, MOL CELL PROTEOMICS, V6, P1343, DOI 10.1074/mcp.M700017-MCP200; Xie J, 2005, PROTEOMICS, V5, P2981, DOI 10.1002/pmic.200401191; Zhang J, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-S9-S5, 10.1186/1471-2105-11-s9-s5]; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851	91	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111187	10.1371/journal.pone.0111187	http://dx.doi.org/10.1371/journal.pone.0111187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347823	gold, Green Submitted, Green Published			2022-12-26	WOS:000347994900052
J	Xie, H; Zhang, YH; Zhang, PP; Wang, JM; Wu, Y; Wu, XR; Netoff, T; Jiang, YW				Xie, Han; Zhang, Yuehua; Zhang, Pingping; Wang, Jingmin; Wu, Ye; Wu, Xiru; Netoff, Theoden; Jiang, Yuwu			Functional Study of NIPA2 Mutations Identified from the Patients with Childhood Absence Epilepsy	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; NMDA RESPONSES; NEURONS; CHANNELS; CACNA1H; BINDING; BLOCK; GENE	Recently many genetic mutations that are associated with epilepsy have been identified. The protein NIPA2 ( non-imprinted in Prader-Willi/Angelman syndrome region protein 2) is a highly selective magnesium transporter encoded by the gene NIPA2 in which we have found three mutations (p.I178F, p.N244S and p.N334_E335insD) within a population of patients with childhood absence epilepsy (CAE). In this study, immunofluorescence labeling, inductively coupled plasma-optical emission spectroscopy (ICP-OES), MTT metabolic rate detection and computational modeling were utilized to elucidate how these mutations result in CAE. We found in cultured neurons that NIPA2 (wild-type) proteins were localized to the cell periphery, whereas mutant proteins were not effectively trafficked to the cell membrane. Furthermore, we found a decrease in intracellular magnesium concentration in the neurons transfected with mutant NIPA2, but no effect on the survival of neurons. To understand how low intracellular magnesium resulted in hyperexcitability, we built and analyzed a computational model to simulate the effects of mutations. The model suggested that lower intracellular magnesium concentration enhanced synaptic N-methyl-D-aspartate receptor (NMDAR) currents. This study primarily reveals that a selective magnesium transporter NIPA2 may play a role in the pathogenesis of CAE.	[Xie, Han; Zhang, Yuehua; Zhang, Pingping; Wang, Jingmin; Wu, Ye; Wu, Xiru; Jiang, Yuwu] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Netoff, Theoden] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	Peking University; University of Minnesota System; University of Minnesota Twin Cities	Netoff, T (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	tnetoff@umn.edu; drjiangyw@gmail.com	jiang, yu/HGU-0029-2022; han, xie/AAO-9359-2021	Netoff, Theoden/0000-0002-0115-1930; Zhang, Yuehua/0000-0003-1432-5423	National Natural Science Fund of China [81271439]; National Key Research Project "973'' [2012CB944602]; National Science Funding [1135581]; Epilepsy Foundation [190960]; China Scholarship Council Program [201206010800]; Academic Scholarship for Doctoral Candidates (Ministry of Education, P.R. China); Directorate For Engineering [0954797] Funding Source: National Science Foundation	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Key Research Project "973''(National Basic Research Program of China); National Science Funding; Epilepsy Foundation; China Scholarship Council Program(China Scholarship Council); Academic Scholarship for Doctoral Candidates (Ministry of Education, P.R. China); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Natural Science Fund of China (Grant Number 81271439 to Y.J.); National Key Research Project "973'', sub-project (Grant No. 2012CB944602 to Y.J.); National Science Funding (Grant Number 1135581 to T.N.); Epilepsy Foundation (Grant Number 190960 to T.N.); China Scholarship Council Program (Student Number 201206010800 to H.X.); Academic Scholarship for Doctoral Candidates (Ministry of Education, P.R. China to H.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botzolakis EJ, 2011, MOL CELL NEUROSCI, V46, P122, DOI 10.1016/j.mcn.2010.08.012; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; COAN EJ, 1985, NEUROSCI LETT, V53, P21, DOI 10.1016/0304-3940(85)90091-6; CREST M, 1993, J PHYSIOL-LONDON, V465, P265, DOI 10.1113/jphysiol.1993.sp019676; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Ferre S, 2011, CURR OPIN NEPHROL HY, V20, P169, DOI 10.1097/MNH.0b013e3283435ee4; Futatsugi Y, 1998, BRAIN DEV-JPN, V20, P75, DOI 10.1016/S0387-7604(97)00107-1; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Goytain A, 2008, AM J PHYSIOL-CELL PH, V295, pC944; Goytain A, 2007, J BIOL CHEM, V282, P8060, DOI 10.1074/jbc.M610314200; Hildebrand MS, 2014, HUM GENET, V133, P673, DOI 10.1007/s00439-013-1414-0; HUSSAIN RF, 1993, J IMMUNOL METHODS, V160, P89, DOI 10.1016/0022-1759(93)90012-V; Jiang YW, 2014, HUM GENET, V133, P675, DOI 10.1007/s00439-014-1428-2; Jiang YW, 2012, HUM GENET, V131, P1217, DOI 10.1007/s00439-012-1149-3; Li-Smerin YY, 2001, J PHYSIOL-LONDON, V533, P729, DOI 10.1111/j.1469-7793.2001.t01-1-00729.x; Liang JM, 2006, NEUROSCI LETT, V406, P27, DOI 10.1016/j.neulet.2006.06.073; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Peloquin JB, 2006, EPILEPSIA, V47, P655, DOI 10.1111/j.1528-1167.2006.00482.x; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Yang YC, 2010, J PHYSIOL-LONDON, V588, P633, DOI 10.1113/jphysiol.2009.178913; Yu J, 2010, J ALZHEIMERS DIS, V20, P1091, DOI 10.3233/JAD-2010-091444; Zhao JL, 2008, J NEUROSCI, V28, P13938, DOI 10.1523/JNEUROSCI.4668-08.2008	25	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109749	10.1371/journal.pone.0109749	http://dx.doi.org/10.1371/journal.pone.0109749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347071	gold, Green Submitted, Green Published			2022-12-26	WOS:000347994900013
J	Ball, LG; Hanna, MD; Lambrecht, AD; Mitchell, BA; Ziola, B; Cobb, JA; Xiao, W				Ball, Lindsay G.; Hanna, Michelle D.; Lambrecht, Amanda D.; Mitchell, Bryan A.; Ziola, Barry; Cobb, Jennifer A.; Xiao, Wei			The Mre11-Rad50-Xrs2 Complex Is Required for Yeast DNA Postreplication Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; MRE11 COMPLEX; MRE11/RAD50/XRS2 COMPLEX; END RESECTION; S-PHASE; DAMAGE; UBIQUITIN; PROTEINS	Yeast DNA postreplication repair (PRR) bypasses replication-blocking lesions to prevent damage-induced cell death. PRR employs two different mechanisms to bypass damaged DNA, namely translesion synthesis (TLS) and error-free PRR, which are regulated via sequential ubiquitination of proliferating cell nuclear antigen (PCNA). We previously demonstrated that error-free PRR utilizes homologous recombination to facilitate template switching. To our surprise, genes encoding the Mre11-Rad50-Xrs2 (MRX) complex, which are also required for homologous recombination, are epistatic to TLS mutations. Further genetic analyses indicated that two other nucleases involved in double-strand end resection, Sae2 and Exo1, are also variably required for efficient lesion bypass. The involvement of the above genes in TLS and/or error-free PRR could be distinguished by the mutagenesis assay and their differential effects on PCNA ubiquitination. Consistent with the observation that the MRX complex is required for both branches of PRR, the MRX complex was found to physically interact with Rad18 in vivo. In light of the distinct and overlapping activities of the above nucleases in the resection of double-strand breaks, we propose that the interplay between distinct single-strand nucleases dictate the preference between TLS and error-free PRR for lesion bypass.	[Ball, Lindsay G.; Hanna, Michelle D.; Lambrecht, Amanda D.; Mitchell, Bryan A.; Xiao, Wei] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Ball, Lindsay G.; Cobb, Jennifer A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Ziola, Barry] Univ Saskatchewan, Dept Pathol & Lab Med, Saskatoon, SK, Canada; [Xiao, Wei] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	University of Saskatchewan; University of Calgary; University of Saskatchewan; Capital Normal University	Xiao, W (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	wei.xiao@usask.ca		Xiao, Wei/0000-0001-7568-0782	Canadian Institutes of Health Research [MOP-93612]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04580]; University of Saskatchewan Arthur Smyth Memorial Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan Arthur Smyth Memorial Scholarship	This work was supported by the Canadian Institutes of Health Research operating grant MOP-93612 and the Natural Sciences and Engineering Research Council of Canada Discovery Grant No. RGPIN-2014-04580 to WX. LGB was the recipient of the University of Saskatchewan Arthur Smyth Memorial Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2001, J BIOL CHEM, V276, P37027, DOI 10.1074/jbc.M106179200; [Anonymous], 2005, MOL BIOL CELL, V16, P597, DOI 10.1097/mbc.E04-09-0782; Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Barbour L, 2000, GENOME, V43, P910, DOI 10.1139/gen-43-5-910; Barbour L, 2006, MOL MICROBIOL, V59, P637, DOI 10.1111/j.1365-2958.2005.04965.x; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Barbour L, 2006, GENETICS, V174, P1789, DOI 10.1534/genetics.106.056283; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Bonetti D, 2009, MOL CELL, V35, P70, DOI 10.1016/j.molcel.2009.05.015; Bressan DA, 1998, GENETICS, V150, P591; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Liberti SE, 2004, MOL CANCER RES, V2, P427; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; McKee AHZ, 1997, GENETICS, V146, P797; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; Prinz S, 1997, GENETICS, V146, P781; ROCHE H, 1994, GENETICS, V137, P637; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sherman F, 1983, COLD SPRING HARBOR; Steininger S, NUCL ACIDS RES, V38, P1853; Steininger S, 2008, DNA REPAIR, V7, P1563, DOI 10.1016/j.dnarep.2008.06.004; Tittel-Elmer M, 2009, EMBO J, V28, P1142, DOI 10.1038/emboj.2009.60; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tran PT, 2007, DNA REPAIR, V6, P1572, DOI 10.1016/j.dnarep.2007.05.004; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Xiao W, 1999, MUTAT RES-DNA REPAIR, V435, P1, DOI 10.1016/S0921-8777(99)00034-8; Xiao W, 1996, CURR GENET, V30, P461, DOI 10.1007/s002940050157; Yanagihara H, 2011, MOL CELL, V43, P788, DOI 10.1016/j.molcel.2011.07.026; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	65	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109292	10.1371/journal.pone.0109292	http://dx.doi.org/10.1371/journal.pone.0109292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343618	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943500012
J	Macdonald, SPJ; Stone, SF; Neil, CL; van Eeden, PE; Fatovich, DM; Arendts, G; Brown, SGA				Macdonald, Stephen P. J.; Stone, Shelley F.; Neil, Claire L.; van Eeden, Pauline E.; Fatovich, Daniel M.; Arendts, Glenn; Brown, Simon G. A.			Sustained Elevation of Resistin, NGAL and IL-8 Are Associated with Severe Sepsis/Septic Shock in the Emergency Department	PLOS ONE			English	Article							REGIONAL PRO-ADRENOMEDULLIN; MIGRATION INHIBITORY FACTOR; C-REACTIVE PROTEIN; SEVERE SEPSIS; INFLAMMATORY MARKERS; RISK STRATIFICATION; ORGAN DYSFUNCTION; CRITICAL ILLNESS; PROCALCITONIN; SURVIVAL	Objective: To identify biomarkers which distinguish severe sepsis/septic shock from uncomplicated sepsis in the Emergency Department (ED). Methods: Patients with sepsis underwent serial blood sampling, including arrival in the ED and up to three subsequent time points over the first 24 hours. Messenger RNA (mRNA) levels of 13 genes representing arms of the innate immune response, organ dysfunction or shock were measured in peripheral blood leucocytes using quantitative PCR, and compared with healthy controls. Serum protein concentrations of targets differentially expressed between uncomplicated sepsis and severe sepsis/septic shock were then measured at each time point and compared between the two patient groups. Results: Of 27 participants (median age 66 years, (IQR 35, 78)), 10 had uncomplicated sepsis and 17 had sepsis with organ failure (14 septic shock; 3 had other sepsis-related organ failures). At the time of first sample collection in the ED, gene expression of Interleukin (IL)-10 and Neutrophil Gelatinase Associated Lipocalin (NGAL) were significantly higher in severe sepsis than uncomplicated sepsis. Expression did not significantly change over time for any target gene. Serum concentrations of IL-6, IL-8, IL-10, NGAL and Resistin were significantly higher in severe sepsis than uncomplicated sepsis at the time of first sample collection in the ED, but only IL-8, NGAL and Resistin were consistently higher in severe sepsis compared to uncomplicated sepsis at all time points up to 24 h after presentation. Conclusions: These mediators, produced by both damaged tissues and circulating leukocytes, may have important roles in the development of severe sepsis. Further work will determine whether they have any value, in addition to clinical risk parameters, for the early identification of patients that will subsequently deteriorate and/or have a higher risk of death.	[Macdonald, Stephen P. J.; Stone, Shelley F.; Neil, Claire L.; van Eeden, Pauline E.; Fatovich, Daniel M.; Arendts, Glenn; Brown, Simon G. A.] Harry Perkins Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia; [Macdonald, Stephen P. J.; Stone, Shelley F.; Neil, Claire L.; van Eeden, Pauline E.; Fatovich, Daniel M.; Arendts, Glenn; Brown, Simon G. A.] Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Discipline Emergency Med, Perth, WA 6009, Australia; [Macdonald, Stephen P. J.] Armadale Hlth Serv, Emergency Dept, Perth, WA, Australia; [Fatovich, Daniel M.; Arendts, Glenn; Brown, Simon G. A.] Royal Perth Hosp, Emergency Dept, Perth, WA 6001, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; Royal Perth Hospital; University of Western Australia	Stone, SF (corresponding author), Harry Perkins Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia.	Shelley.Stone@uwa.edu.au	Macdonald, Stephen PJ/H-5339-2014; van Eeden, Pauline/O-8713-2014; Fatovich, Daniel/J-5510-2013	Macdonald, Stephen/0000-0001-9921-4620; Fatovich, Daniel/0000-0001-9414-6905; Arendts, Glenn/0000-0001-7830-7756	NHMRC Career Development Fellowship Award [ID1023265]; Royal Perth Hospital Medical Research Foundation; University of Western Australia	NHMRC Career Development Fellowship Award(National Health and Medical Research Council (NHMRC) of Australia); Royal Perth Hospital Medical Research Foundation; University of Western Australia	SB is supported by a NHMRC Career Development Fellowship Award ID1023265. Additional funding was received from the Royal Perth Hospital Medical Research Foundation and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arendts G, 2012, EMERG MED AUSTRALAS, V24, P31, DOI 10.1111/j.1742-6723.2011.01500.x; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7768; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brenner T, 2010, J SURG RES, V164, pE163, DOI 10.1016/j.jss.2010.05.004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carson SS, 2003, CRIT CARE CLIN, V19, P605, DOI 10.1016/S0749-0704(03)00051-4; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christ-Crain M, 2005, CRIT CARE, V9, pR816, DOI 10.1186/cc3885; Constantin JM, 2010, J CRIT CARE, V25; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Freund Y, 2012, BIOMARKERS; Gille-Johnson P, 2012, SCAND J INFECT DIS, V44, P745, DOI 10.3109/00365548.2012.689846; Gustafsson A, 2012, BIOMARK INSIGHTS, V7, P39, DOI 10.4137/BMI.S9460; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; Ip M, 2007, DIAGN MICR INFEC DIS, V59, P131, DOI 10.1016/j.diagmicrobio.2007.04.019; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Kofoed K, 2007, CRIT CARE, V11, DOI 10.1186/cc5723; Lentini P, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/856401; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lichtenstern C, 2012, CURR OPIN INFECT DIS, V25, P328, DOI 10.1097/QCO.0b013e3283522038; Lindig S, 2013, INT J ANTIMICROB AG, V42, pS2, DOI 10.1016/j.ijantimicag.2013.04.012; Lvovschi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028870; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Nakamura T, 2009, PHARMACOL RES, V60, P515, DOI 10.1016/j.phrs.2009.05.002; Pang SS, 2006, CELL MOL IMMUNOL, V3, P29; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Punyadeera Chamindie, 2010, J Emerg Trauma Shock, V3, P26, DOI 10.4103/0974-2700.58666; Shapiro NI, 2010, ANN EMERG MED, V56, P52, DOI 10.1016/j.annemergmed.2010.02.010; Shapiro NI, 2009, CRIT CARE MED, V37, P96, DOI 10.1097/CCM.0b013e318192fd9d; Stone SF, 2009, J ALLERGY CLIN IMMUN, V124, P786, DOI 10.1016/j.jaci.2009.07.055; Strehlow MC, 2006, ANN EMERG MED, V48, P326, DOI 10.1016/j.annemergmed.2006.05.003; Sunden-Cullberg J, 2007, CRIT CARE MED, V35, P1536, DOI 10.1097/01.CCM.0000266536.14736.03; Travaglino F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-184; Wong HR, 2014, CRIT CARE MED, V42, P781, DOI 10.1097/CCM.0000000000000106	36	66	67	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110678	10.1371/journal.pone.0110678	http://dx.doi.org/10.1371/journal.pone.0110678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343379	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500045
J	Novack, L; Kogan, S; Gimpelevich, L; Howell, M; Borer, A; Kelly, CP; Leffler, DA; Novack, V				Novack, Lena; Kogan, Slava; Gimpelevich, Larisa; Howell, Michael; Borer, Abraham; Kelly, Ciaran P.; Leffler, Daniel A.; Novack, Victor			Acid Suppression Therapy Does Not Predispose to Clostridium difficile Infection: The Case of the Potential Bias	PLOS ONE			English	Article							PROTON-PUMP INHIBITORS; RISK-FACTORS; DIARRHEA; DISEASE; EPIDEMIC; ASSOCIATION; MORBIDITY; MORTALITY; COLITIS	Objective: An adverse effect of acid-suppression medications on the occurrence of Clostridium difficile infection (CDI) has been a common finding of many, but not all studies. We hypothesized that association between acid-suppression medications and CDI is due to the residual confounding in comparison between patients with infection to those without, predominantly from non-tested and less sick subjects. We aimed to evaluate the effect of acid suppression therapy on incidence of CDI by comparing patients with CDI to two control groups: not tested patients and patients suspected of having CDI, but with a negative test. Methods: We conducted a case-control study of adult patients hospitalized in internal medicine department of tertiary teaching hospital between 2005-2010 for at least three days. Controls from each of two groups (negative for CDI and non-tested) were individually matched (1:1) to cases by primary diagnosis, Charlson comorbidity index, year of hospitalization and gender. Primary outcomes were diagnoses of International Classification of Diseases (ICD-9)-coded CDI occurring 72 hours or more after admission. Results: Patients with CDI were similar to controls with a negative test, while controls without CDI testing had lower clinical severity. In multivariable analysis, treatment by acid suppression medications was associated with CDI compared to those who were not tested (OR = 1.88, p-value = 0.032). Conversely, use of acid suppression medications in those who tested negative for the infection was not associated with CDI risk as compared to the cases (OR = 0.66; p = 0.059). Conclusions: These findings suggest that the reported epidemiologic associations between use of acid suppression medications and CDI risk may be spurious. The control group choice has an important impact on the results. Clinical differences between the patients with CDI and those not tested and not suspected of having the infection may explain the different conclusions regarding the acid suppression effect on CDI risk.	[Novack, Lena; Gimpelevich, Larisa] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel; [Kogan, Slava; Novack, Victor] Ben Gurion Univ Negev, Soroka Univ, Med Ctr, Clin Res Ctr, IL-84105 Beer Sheva, Israel; [Howell, Michael] Univ Chicago Med, Chicago, IL USA; [Borer, Abraham] Soroka Univ, Med Ctr, Infect Dis Unit, Beer Sheva, Israel; [Kelly, Ciaran P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Leffler, Daniel A.] Beth Israel Deaconess Med Ctr, Celiac Ctr, Div Gastroenterol, Boston, MA 02215 USA	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Novack, L (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel.	novack@bgu.ac.il	Howell, Michael/B-8065-2009; NOVACK, LENA/AAH-8343-2021	Howell, Michael/0000-0001-7003-6971; NOVACK, LENA/0000-0003-3748-2632				Aseeri M, 2008, AM J GASTROENTEROL, V103, P2308, DOI 10.1111/j.1572-0241.2008.01975.x; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Cadle RM, 2007, AM J HEALTH-SYST PH, V64, P2359, DOI 10.2146/ajhp060629; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choudhry MN, 2008, QJM-INT J MED, V101, P445, DOI 10.1093/qjmed/hcn035; Cunningham R, 2008, J HOSP INFECT, V70, P1, DOI 10.1016/j.jhin.2008.04.023; Dalton BR, 2009, ALIMENT PHARM THER, V29, P626, DOI 10.1111/j.1365-2036.2008.03924.x; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Gujja D, 2009, ALIMENT PHARM THER, V29, P635, DOI 10.1111/j.1365-2036.2008.03914.x; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Jump RLP, 2007, ANTIMICROB AGENTS CH, V51, P2883, DOI 10.1128/AAC.01443-06; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kwok CS, 2012, AM J GASTROENTEROL, V107, P1011, DOI 10.1038/ajg.2012.108; Kyne L, 2002, INFECT CONT HOSP EP, V23, P653, DOI 10.1086/501989; McFarland LV, 2008, NAT CLIN PRACT GASTR, V5, P40, DOI 10.1038/ncpgasthep1029; McFarland LV, 2007, CLIN INFECT DIS, V45, P1141, DOI 10.1086/522187; Miller MA, 2002, INFECT CONT HOSP EP, V23, P137, DOI 10.1086/502023; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Oake N, 2010, ARCH INTERN MED, V170, P1804, DOI 10.1001/archinternmed.2010.405; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Pakyz AL, 2014, J ANTIMICROB CHEMOTH, V69, P1127, DOI 10.1093/jac/dkt489; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; PIERCE PF, 1982, J INFECT DIS, V145, P269, DOI 10.1093/infdis/145.2.269; Pohl JF, 2012, CURR OPIN PEDIATR, V24, P627, DOI 10.1097/MOP.0b013e328355a3e1; Rashid S, 2012, ISRN GASTROENTEROL; Shah S, 2000, QJM-MON J ASSOC PHYS, V93, P175, DOI 10.1093/qjmed/93.3.175; Surawicz CM, 2013, GUIDELINES DIAGNOSIS; UpToDate, ANT C DIFF PPI; Warmy M, 2005, LANCET, V366, P9491; Yearsley KA, 2006, ALIMENT PHARM THER, V24, P613, DOI 10.1111/j.1365-2036.2006.03015.x	31	38	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110790	10.1371/journal.pone.0110790	http://dx.doi.org/10.1371/journal.pone.0110790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343667	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500055
J	Yisireyili, M; Saito, S; Abudureyimu, S; Adelibieke, Y; Ng, HY; Nishijima, F; Takeshita, K; Murohara, T; Niwa, T				Yisireyili, Maimaiti; Saito, Shinichi; Abudureyimu, Shaniya; Adelibieke, Yelixiati; Ng, Hwee-Yeong; Nishijima, Fuyuhiko; Takeshita, Kyosuke; Murohara, Toyoaki; Niwa, Toshimitsu			Indoxyl Sulfate-Induced Activation of (Pro)renin Receptor Promotes Cell Proliferation and Tissue Factor Expression in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							NF-KAPPA-B; OSTEOBLAST-SPECIFIC PROTEINS; REGULATES RENAL EXPRESSION; FIBROTIC GENE-EXPRESSION; OXIDATIVE STRESS; PRORENIN RECEPTOR; UP-REGULATION; UREMIC SERUM; ANGIOTENSIN; SENESCENCE	Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular disease (CVD). (Pro) renin receptor (PRR) is activated in the kidney of CKD. The present study aimed to determine the role of indoxyl sulfate (IS), a uremic toxin, in PRR activation in rat aorta and human aortic smooth muscle cells (HASMCs). We examined the expression of PRR and renin/prorenin in rat aorta using immunohistochemistry. Both CKD rats and IS-administrated rats showed elevated expression of PRR and renin/prorenin in aorta compared with normal rats. IS upregulated the expression of PRR and prorenin in HASMCs. N-acetylcysteine, an antioxidant, and diphenyleneiodonium, an inhibitor of nicotinamide adenine dinucleotide phosphate oxidase, suppressed IS-induced expression of PRR and prorenin in HASMCs. Knock down of organic anion transporter 3 (OAT3), aryl hydrocarbon receptor (AhR) and nuclear factor-kappa B p65 (NF-kappa B p65) with small interfering RNAs inhibited IS-induced expression of PRR and prorenin in HASMCs. Knock down of PRR inhibited cell proliferation and tissue factor expression induced by not only prorenin but also IS in HASMCs. Conclusion: IS stimulates aortic expression of PRR and renin/prorenin through OAT3-mediated uptake, production of reactive oxygen species, and activation of AhR and NF-kappa B p65 in vascular smooth muscle cells. IS-induced activation of PRR promotes cell proliferation and tissue factor expression in vascular smooth muscle cells.	[Yisireyili, Maimaiti; Saito, Shinichi; Abudureyimu, Shaniya; Adelibieke, Yelixiati; Niwa, Toshimitsu] Nagoya Univ, Grad Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan; [Nishijima, Fuyuhiko] Kureha Co, Biomed Res Labs, Tokyo, Japan; [Yisireyili, Maimaiti; Takeshita, Kyosuke; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Ng, Hwee-Yeong] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Ng, Hwee-Yeong] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Niwa, Toshimitsu] Shubun Univ, Fac Hlth & Nutr, Aichi, Japan	Nagoya University; Nagoya University; Chang Gung Memorial Hospital; Chang Gung University	Niwa, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan.	tniwa@med.nagoya.u-ac.jp	Takeshita, Kyosuke/AAD-9515-2020; Murohara, Toyoaki/M-4958-2014; Takeshita, Kyosuke/B-7008-2012	Takeshita, Kyosuke/0000-0002-8283-3799; Takeshita, Kyosuke/0000-0002-8283-3799	Aichi Kidney Foundation; Kureha Corporation, Japan	Aichi Kidney Foundation; Kureha Corporation, Japan	This work was supported by the research grant from Aichi Kidney Foundation, and a grant from Kureha Corporation, Japan. The funder provided support in the form of salaries for FN, but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the 'author contributions' section.	Adelibieke Y, 2013, CIRC J, V77, P1326, DOI 10.1253/circj.CJ-12-0884; Adijiang A, 2008, NEPHROL DIAL TRANSPL, V23, P1892, DOI 10.1093/ndt/gfm861; Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Batenburg WW, 2011, HYPERTENSION, V58, P1111, DOI 10.1161/HYPERTENSIONAHA.111.180737; Bolati D, 2012, J RENAL NUTR, V22, P176, DOI 10.1053/j.jrn.2011.10.015; Chitalia VC, 2013, CIRCULATION, V127, P365, DOI 10.1161/CIRCULATIONAHA.112.118174; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; Greco CM, 2012, CARDIOVASC RES, V95, P366, DOI 10.1093/cvr/cvs204; HILGERS KF, 1993, HYPERTENSION, V21, P1030, DOI 10.1161/01.HYP.21.6.1030; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; INAGAMI T, 1991, BLOOD VESSELS, V28, P217; KATO H, 1993, HYPERTENSION, V21, P446, DOI 10.1161/01.HYP.21.4.446; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; Liu G, 2011, J HYPERTENS, V29, P696, DOI 10.1097/HJH.0b013e328343c62b; Miyazaki T, 1997, KIDNEY INT, V52, pS15; Muller DN, 1998, BASIC RES CARDIOL, V93, P7; Muteliefu G, 2009, J RENAL NUTR, V19, P29, DOI 10.1053/j.jrn.2008.10.014; Muteliefu G, 2012, AM J PHYSIOL-CELL PH, V303, pC126, DOI 10.1152/ajpcell.00329.2011; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Niwa T, 1997, KIDNEY INT, V52, pS23; NIWA T, 1988, CLIN CHEM, V34, P2264; NIWA T, 1994, J LAB CLIN MED, V124, P96; Niwa T, 2011, THER APHER DIAL, V15, P120, DOI 10.1111/j.1744-9987.2010.00882.x; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Saito S, 2014, ENDOCRINOLOGY; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Sallee M, 2014, TOXINS, V6, P934, DOI 10.3390/toxins6030934; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Shimizu H, 2013, LIFE SCI, V92, P143, DOI 10.1016/j.lfs.2012.11.012; Shimizu H, 2012, AM J NEPHROL, V36, P184, DOI 10.1159/000341515; Shimizu H, 2012, LIFE SCI, V90, P525, DOI 10.1016/j.lfs.2012.01.013; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1110, DOI 10.1152/ajpcell.00217.2010; Siragy HM, 2008, EXP PHYSIOL, V93, P709, DOI 10.1113/expphysiol.2007.040550; TAKII Y, 1985, HYPERTENSION, V7, P236, DOI 10.1161/01.HYP.7.2.236; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Watanabe I, 2013, CIRC J, V77, P224, DOI 10.1253/circj.CJ-12-0647; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; Yisireyili M, 2013, LIFE SCI, V92, P1180, DOI 10.1016/j.lfs.2013.05.008	47	39	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109268	10.1371/journal.pone.0109268	http://dx.doi.org/10.1371/journal.pone.0109268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343458	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500010
J	Marstaller, L; Burianova, H; Sowman, PF				Marstaller, Lars; Burianova, Hana; Sowman, Paul F.			High Gamma Oscillations in Medial Temporal Lobe during Overt Production of Speech and Gestures	PLOS ONE			English	Article							WORKING-MEMORY; BAND SYNCHRONIZATION; RECOGNITION MEMORY; EPISODIC MEMORY; VERB GENERATION; THETA; SYSTEMS; HIPPOCAMPAL; RETRIEVAL; DYNAMICS	The study of the production of co-speech gestures (CSGs), i.e., meaningful hand movements that often accompany speech during everyday discourse, provides an important opportunity to investigate the integration of language, action, and memory because of the semantic overlap between gesture movements and speech content. Behavioral studies of CSGs and speech suggest that they have a common base in memory and predict that overt production of both speech and CSGs would be preceded by neural activity related to memory processes. However, to date the neural correlates and timing of CSG production are still largely unknown. In the current study, we addressed these questions with magnetoencephalography and a semantic association paradigm in which participants overtly produced speech or gesture responses that were either meaningfully related to a stimulus or not. Using spectral and beamforming analyses to investigate the neural activity preceding the responses, we found a desynchronization in the beta band (15-25 Hz), which originated 900 ms prior to the onset of speech and was localized to motor and somatosensory regions in the cortex and cerebellum, as well as right inferior frontal gyrus. Beta desynchronization is often seen as an indicator of motor processing and thus reflects motor activity related to the hand movements that gestures add to speech. Furthermore, our results show oscillations in the high gamma band (50-90 Hz), which originated 400 ms prior to speech onset and were localized to the left medial temporal lobe. High gamma oscillations have previously been found to be involved in memory processes and we thus interpret them to be related to contextual association of semantic information in memory. The results of our study show that high gamma oscillations in medial temporal cortex play an important role in the binding of information in human memory during speech and CSG production.	[Marstaller, Lars; Burianova, Hana] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Marstaller, Lars] Univ Queensland, ARC Sci Learning Res Ctr, Brisbane, Qld, Australia; [Burianova, Hana; Sowman, Paul F.] Macquarie Univ, ARC Ctr Excellence Cognit & Disorders, Sydney, NSW 2109, Australia; [Sowman, Paul F.] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia	University of Queensland; University of Queensland; Macquarie University; Macquarie University	Marstaller, L (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.	l.marstaller@uq.edu.au	Sowman, Paul/H-3352-2019; Marstaller, Lars/F-8434-2014	Sowman, Paul/0000-0002-3863-6675; Marstaller, Lars/0000-0003-2814-5474; Burianova, Hana/0000-0003-2051-9494	international Macquarie University research scholarship	international Macquarie University research scholarship	LM was supported by an international Macquarie University research scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Axmacher N, 2007, J NEUROSCI, V27, P7807, DOI 10.1523/JNEUROSCI.0962-07.2007; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Burianova H, 2007, J COGNITIVE NEUROSCI, V19, P1520, DOI 10.1162/jocn.2007.19.9.1520; Burke JF, 2013, J NEUROSCI, V33, P292, DOI 10.1523/JNEUROSCI.2057-12.2013; Cheyne DO, 2013, EXP NEUROL, V245, P27, DOI 10.1016/j.expneurol.2012.08.030; de Ruiter J.P., 2000, LANGUAGE GESTURE, P284, DOI DOI 10.1017/CBO9780511620850.018; Dipoppa M, 2013, P NATL ACAD SCI USA, V110, P12828, DOI 10.1073/pnas.1303270110; Doesburg SM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00195; Duzel E, 2003, J NEUROSCI, V23, P9439; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; Goldin-Meadow S, 2001, PSYCHOL SCI, V12, P516, DOI 10.1111/1467-9280.00395; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Jeneson A, 2012, LEARN MEMORY, V19, P15, DOI 10.1101/lm.024018.111; Jensen O, 2006, NEUROSCIENCE, V139, P237, DOI 10.1016/j.neuroscience.2005.06.004; Kado H, 1999, IEEE T APPL SUPERCON, V9, P4057, DOI 10.1109/77.783918; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; Kita S, 2003, J MEM LANG, V48, P16, DOI 10.1016/S0749-596X(02)00505-3; Korzeniewska A, 2011, NEUROIMAGE, V56, P2218, DOI 10.1016/j.neuroimage.2011.03.030; Kroes MCW, 2012, NEUROSCI BIOBEHAV R, V36, P1646, DOI 10.1016/j.neubiorev.2012.02.014; Lundqvist M, 2011, J COGNITIVE NEUROSCI, V23, P3008, DOI 10.1162/jocn_a_00029; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Marstaller L, 2013, PSYCHON B REV, V20, P496, DOI 10.3758/s13423-012-0365-0; Martin T, 2007, INT J PSYCHOPHYSIOL, V64, P247, DOI 10.1016/j.ijpsycho.2006.09.010; McNeill D., 1992, HAND MIND WHAT GESTU; Mellem MS, 2013, BRAIN LANG, V127, P440, DOI 10.1016/j.bandl.2013.09.003; Muthukumaraswamy SD, 2013, FRONTIERS HUMAN NEUR, V7; Nee DE, 2007, NEUROIMAGE, V38, P740, DOI 10.1016/j.neuroimage.2007.07.066; Nee DE, 2011, NEUROIMAGE, V54, P1540, DOI 10.1016/j.neuroimage.2010.09.002; Nieuwenhuis ILC, 2012, CEREB CORTEX, V22, P2622, DOI 10.1093/cercor/bhr338; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Oztekin I, 2009, J COGNITIVE NEUROSCI, V21, P1967, DOI 10.1162/jocn.2008.21146; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Pang EW, 2011, NEUROSCI LETT, V490, P215, DOI 10.1016/j.neulet.2010.12.055; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Sakai K, 2004, CEREB CORTEX, V14, P914, DOI 10.1093/cercor/bhh050; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Segal JB, 2003, NEUROLOGY, V61, P252, DOI 10.1212/01.WNL.0000073145.08816.E2; Serruya MD, 2012, CEREB CORTEX; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Uehara G, 2003, IEICE T ELECTRON, VE86C, P43; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Watson HC, 2013, J NEUROSCI, V33, P4192, DOI 10.1523/JNEUROSCI.2075-12.2013; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zion-Golumbic E, 2010, J COGNITIVE NEUROSCI, V22, P263, DOI 10.1162/jocn.2009.21251	57	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111473	10.1371/journal.pone.0111473	http://dx.doi.org/10.1371/journal.pone.0111473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340347	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000343662800109
J	Rajkumar, P; Aisenberg, WH; Acres, OW; Protzko, RJ; Pluznick, JL				Rajkumar, Premraj; Aisenberg, William H.; Acres, Omar W.; Protzko, Ryan J.; Pluznick, Jennifer L.			Identification and Characterization of Novel Renal Sensory Receptors	PLOS ONE			English	Article							MAMMALIAN ODORANT RECEPTORS; PROTEIN-COUPLED RECEPTORS; BLOOD-PRESSURE REGULATION; BITTER TASTE RECEPTORS; OLFACTORY RECEPTOR; FUNCTIONAL EXPRESSION; GENE-EXPRESSION; GUT MICROBIOTA; EPITHELIAL-CELLS; VALPROIC ACID	Recent studies have highlighted the important roles that "sensory'' receptors (olfactory receptors, taste receptors, and orphan "GPR'' receptors) play in a variety of tissues, including the kidney. Although several studies have identified important roles that individual sensory receptors play in the kidney, there has not been a systematic analysis of the renal repertoire of sensory receptors. In this study, we identify novel renal sensory receptors belonging to the GPR (n = 76), olfactory receptor (n = 6), and taste receptor (n = 11) gene families. A variety of reverse transcriptase (RT)-PCR screening strategies were used to identify novel renal sensory receptors, which were subsequently confirmed using gene-specific primers. The tissue-specific distribution of these receptors was determined, and the novel renal ORs were cloned from whole mouse kidney. Renal ORs that trafficked properly in vitro were screened for potential ligands using a dual-luciferase ligand screen, and novel ligands were identified for Olfr691. These studies demonstrate that multiple sensory receptors are expressed in the kidney beyond those previously identified. These results greatly expand the known repertoire of renal sensory receptors. Importantly, the mRNA of many of the receptors identified in this study are expressed highly in the kidney (comparable to well-known and extensively studied renal GPCRs), and in future studies it will be important to elucidate the roles that these novel renal receptors play in renal physiology.	[Rajkumar, Premraj; Aisenberg, William H.; Acres, Omar W.; Protzko, Ryan J.; Pluznick, Jennifer L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Pluznick, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	jpluznick@jhmi.edu		Aisenberg, William/0000-0002-8715-1439	NIH [DK081610]; National Kidney Foundation, Maryland; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK081610, R00DK081610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation, Maryland; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from the NIH (DK081610 to J.L.P.) and the minigrant from the National Kidney Foundation, Maryland (to P.R.). Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; ARTHUR K, 1995, J CHROMATOGR B, V673, P132, DOI 10.1016/0378-4347(95)00255-H; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Dang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089835; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Elliott RA, 2011, J UROLOGY, V186, P2455, DOI 10.1016/j.juro.2011.07.083; Endo A, 2010, PEDIATR NEUROL, V42, P287, DOI 10.1016/j.pediatrneurol.2009.12.003; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hofmeister MV, 2012, AM J PHYSIOL-RENAL, V302, pF358, DOI 10.1152/ajprenal.00343.2011; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huling JC, 2012, AM J PHYSIOL-RENAL, V302, pF401, DOI 10.1152/ajprenal.00457.2011; Hummler E, 1999, J STEROID BIOCHEM, V69, P385, DOI 10.1016/S0960-0760(99)00073-4; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Knorr M, 2004, EPILEPSIA, V45, P868, DOI 10.1111/j.0013-9580.2004.05504.x; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Otaki JM, 2004, J NEUROBIOL, V58, P315, DOI 10.1002/neu.10272; Pluznick JL, 2014, CURR OPIN NEPHROL HY, V23, P507, DOI 10.1097/MNH.0000000000000048; Pluznick JL, 2013, AM J PHYSIOL-RENAL, V305, pF439, DOI 10.1152/ajprenal.00252.2013; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2012, CURR OPIN NEPHROL HY, V21, P404, DOI 10.1097/MNH.0b013e328354a6bd; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; Vargas SL, 2009, J AM SOC NEPHROL, V20, P1002, DOI 10.1681/ASN.2008070740; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	52	41	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111053	10.1371/journal.pone.0111053	http://dx.doi.org/10.1371/journal.pone.0111053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340336	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800082
J	Sarfo, FS; Sarfo, MA; Norman, B; Phillips, R; Bedu-Addo, G; Chadwick, D				Sarfo, Fred Stephen; Sarfo, Maame Anima; Norman, Betty; Phillips, Richard; Bedu-Addo, George; Chadwick, David			Risk of Deaths, AIDS-Defining and Non-AIDS Defining Events among Ghanaians on Long-Term Combination Antiretroviral Therapy	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED ADULTS; CD4 CELL COUNTS; IMMUNE RECONSTITUTION; HIV-1-INFECTED PATIENTS; RENAL DYSFUNCTION; TREATMENT PROGRAM; LOW-INCOME; DISEASE; INDIVIDUALS	Combination antiretroviral therapy (cART) has been widely available in Ghana since 2004. The aim of this cohort study was to assess the incidences of death, AIDS-defining events and non-AIDS defining events and associated risk factors amongst patients initiating cART in a large treatment centre. Clinical and laboratory data were extracted from clinic and hospital case notes for patients initiating cART between 2004 and 2010 and clinical events graded according to recognised definitions for AIDS, non-AIDS events (NADE) and death, with additional events not included in such definitions such as malaria also included. The cumulative incidence of events was calculated using Kaplan Meier analysis, and association of risk factors with events by Cox proportional hazards regression. Data were closed for analysis on 31st December, 2011 after a median follow-up of 30 months (range, 0-90 months). Amongst 4,039 patients starting cART at a median CD4 count of 133 cells/mm(3), there were 324 (8%) confirmed deaths, with an event rate of 28.83 (95% CI 25.78-32.15) deaths per 1000-person follow-up years; the commonest established causes were pulmonary TB and gastroenteritis. There were 681 AIDS-defining events (60.60 [56.14-65.33] per 1000 person years) with pulmonary TB and chronic diarrhoea being the most frequent causes. Forty-one NADEs were recorded (3.64 [2.61-4.95] per 1000 person years), of which hepatic and cardiovascular events were most common. Other common events recorded outside these definitions included malaria (746 events) and respiratory tract infections (666 events). Overall 24% of patients were lost-to-follow-up. Alongside expected risk factors, stavudine use was associated with AIDS [adjusted HR of 1.08 (0.90-1.30)] and death (adjusted HR of 1.60 [1.21-2.11]). Whilst frequency of AIDS and deaths in this cohort were similar to those described in other sub-Saharan African cohorts, rates of NADEs were lower and far exceeded by events such as malaria and respiratory tract infections.	[Sarfo, Fred Stephen; Sarfo, Maame Anima; Norman, Betty; Phillips, Richard; Bedu-Addo, George] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Sarfo, Fred Stephen; Phillips, Richard; Bedu-Addo, George] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Chadwick, David] James Cook Univ Hosp, Middlesbrough, Cleveland, England	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; James Cook University Hospital	Sarfo, FS (corresponding author), Komfo Anokye Teaching Hosp, Kumasi, Ghana.	stephensarfo78@gmail.com	Phillips, Richard Odame/ABD-5394-2021	Phillips, Richard Odame/0000-0001-8992-0222	HIV Research Trust, UK; Medical Research Council [MR/J01477X/1] Funding Source: researchfish; MRC [MR/J01477X/1] Funding Source: UKRI	HIV Research Trust, UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for setting up the database was provided by the HIV Research Trust, UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akileswaran C, 2005, CLIN INFECT DIS, V41, P376, DOI 10.1086/431482; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calza L, 2010, AIDS, V24, P789, DOI 10.1097/QAD.0b013e328337afdf; Charalambous S, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000279696.63438.aa; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cooney EL, 2002, CLIN INFECT DIS, V34, P224, DOI 10.1086/323898; Crum-Cianflone N, 2009, AIDS, V23, P41, DOI 10.1097/QAD.0b013e328317cc2d; Currier JS, 2002, JAIDS-J ACQ IMM DEF, V31, pS16, DOI 10.1097/00126334-200209011-00004; Dai Y, 2006, CHINESE MED J-PEKING, V119, P1677, DOI 10.1097/00029330-200610020-00002; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Desclaux A, 2003, AIDS, V17, pS95, DOI 10.1097/00002030-200317003-00013; *DIV AIDS, 2004, DIV AIDS TABL GRAD S; Division of AIDS NIAID, 1994, DIV AIDS TABL GRAD S; Erhabor O, 2006, Niger J Clin Pract, V9, P128; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; Kilaru KR, 2006, HIV MED, V7, P99, DOI 10.1111/j.1468-1293.2006.00347.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lau B, 2006, ARCH INTERN MED, V166, P64, DOI 10.1001/archinte.166.1.64; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lawden C, 2007, J ACQ IMMUN DEF SYND, V44, P262; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Novak RM, 2012, AIDS, V26, P721, DOI 10.1097/QAD.0b013e3283511e91; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Sarfo FS, 2014, J ANTIMICROB CHEMOTH, V69, P254, DOI 10.1093/jac/dkt336; Sarfo FS, 2013, J INFECTION, V67, P43, DOI 10.1016/j.jinf.2013.03.008; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Sow PS, 2007, JAIDS-J ACQ IMM DEF, V44, P262, DOI 10.1097/QAI.0b013e31802bf109; Srasuebkul P, 2007, HIV MED, V8, P46, DOI 10.1111/j.1468-1293.2007.00427.x; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tuboi SH, 2005, JAIDS-J ACQ IMM DEF, V40, P324, DOI 10.1097/01.qai.0000182627.28595.01; Wester CW, 2011, AIDS, V25, P1471, DOI 10.1097/QAD.0b013e328347f9d4; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; WHO, 2010, ANT THER HIV INF AD; Wolbers M, 2007, ANTIVIR THER, V12, P889	54	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111400	10.1371/journal.pone.0111400	http://dx.doi.org/10.1371/journal.pone.0111400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340766	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800106
J	Ali, SE; Thoen, E; Evensen, O; Wiik-Nielsen, J; Gamil, AAA; Skaar, I				Ali, Shimaa E.; Thoen, Even; Evensen, Oystein; Wiik-Nielsen, Jannicke; Gamil, Amr A. A.; Skaar, Ida			Mitochondrial Dysfunction Is Involved in the Toxic Activity of Boric Acid against Saprolegnia	PLOS ONE			English	Article							TETRAZOLIUM FORMAZAN ASSAY; COLLETOTRICHUM-GLOEOSPORIOIDES; VIABILITY; BORATE	There has been a significant increase in the incidence of Saprolegnia infections over the past decades, especially after the banning of malachite green. Very often these infections are associated with high economic losses in salmonid farms and hatcheries. The use of boric acid to control the disease has been investigated recently both under in vitro and in vivo conditions, however its possible mode of action against fish pathogenic Saprolegnia is not known. In this study, we have explored the transformation in Saprolegnia spores/hyphae after exposure to boric acid (1 g/L) over a period 4-24 h post treatment. Using transmission electron microscopy (TEM), early changes in Saprolegnia spores were detected. Mitochondrial degeneration was the most obvious sign observed following 4 h treatment in about 20% of randomly selected spores. We also investigated the effect of the treatment on nuclear division, mitochondrial activity and function using confocal laser scanning microscopy (CLSM). Fluorescence microscopy was also used to test the effect of treatment on mitochondrial membrane potential and formation of reactive oxygen species. Additionally, the viability and proliferation of treated spores that correlated to mitochondrial enzymatic activity were tested using an MTS assay. All obtained data pointed towards changes in the mitochondrial structure, membrane potential and enzymatic activity following treatment. We have found that boric acid has no effect on the integrity of membranes of Saprolegnia spores at concentrations tested. It is therefore likely that mitochondrial dysfunction is involved in the toxic activity of boric acid against Saprolegnia spp.	[Ali, Shimaa E.; Thoen, Even; Wiik-Nielsen, Jannicke; Skaar, Ida] Norwegian Vet Inst, Oslo, Norway; [Thoen, Even; Evensen, Oystein; Gamil, Amr A. A.] Norwegian Univ Life Sci, Oslo, Norway	Norwegian Veterinary Institute; Norwegian University of Life Sciences	Skaar, I (corresponding author), Norwegian Vet Inst, Oslo, Norway.	ida.skaar@vetinst.no	Evensen, Øystein/O-3011-2015; Ali, Shimaa E/HHD-0713-2022	Evensen, Øystein/0000-0002-4856-3043; Gamil, Amr/0000-0001-9920-6487; Ali, Shimaa E/0000-0002-0227-8124	European Commission through the EU [238550]	European Commission through the EU	The work has been funded by the European Commission through the EU Marie Curie ITN project SAPRO (238550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091878; Ali SE, 2013, VET MICROBIOL, V163, P133, DOI 10.1016/j.vetmic.2012.12.012; AlRubeai M, 1997, CYTOTECHNOLOGY, V24, P161, DOI 10.1023/A:1007910920355; Amberg DC, 2006, CSH PROTOC, V2006; BEAKES GW, 1980, CAN J BOT, V58, P195, DOI 10.1139/b80-021; Bruno DW, 1999, FISH DISEASES AND DISORDERS, VOL 3, P599; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P895, DOI 10.1101/pdb.prot5641; Coder DM, 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0902s15, DOI 10.1002/0471142956.CY0902S15]; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Coughlin JR, 1996, J TRACE ELEM EXP MED, V9, P137; De Seta F, 2009, J ANTIMICROB CHEMOTH, V63, P325, DOI 10.1093/jac/dkn486; Eckhert CD, 1998, J NUTR, V128, P2488, DOI 10.1093/jn/128.12.2488; Hardham AR, 2001, MOL CELL BIOL FILAME, P127; HEATH IB, 1980, J CELL BIOL, V84, P531, DOI 10.1083/jcb.84.3.531; Hulvey JP, 2007, MYCOLOGIA, V99, P421, DOI 10.3852/mycologia.99.3.421; Joshi D.C., 2011, JOVE-J VIS EXP, V23, P7588; JOVANOVIC R, 1991, J REPROD MED, V36, P593; KU WW, 1993, REPROD TOXICOL, V7, P321, DOI 10.1016/0890-6238(93)90021-X; Levina NN, 2006, FUNGAL GENET BIOL, V43, P65, DOI 10.1016/j.fgb.2005.06.008; Lopes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072203; Martins VD, 2011, J BIOENERG BIOMEMBR, V43, P81, DOI 10.1007/s10863-011-9331-1; Mucha J, 2009, MYCOL RES, V113, P981, DOI 10.1016/j.mycres.2009.06.002; Ruy F, 2006, J BIOENERG BIOMEMBR, V38, P129, DOI 10.1007/s10863-006-9012-7; Shi XQ, 2011, PLANT DIS, V95, P63, DOI 10.1094/PDIS-06-10-0437; Shi XQ, 2012, POSTHARVEST BIOL TEC, V67, P138, DOI 10.1016/j.postharvbio.2012.01.003; Silverman-Gavrila LB, 2003, MICROBIOL-SGM, V149, P2475, DOI 10.1099/mic.0.26302-0; Smith SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026908; Stueland S, 2005, J FISH DIS, V28, P445, DOI 10.1111/j.1365-2761.2005.00635.x; Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Torto-Alalibo T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-46; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Zuo XM, 2011, MOL PHARMACOL, V80, P476, DOI 10.1124/mol.111.072322	36	11	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110343	10.1371/journal.pone.0110343	http://dx.doi.org/10.1371/journal.pone.0110343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354209	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000345204200022
J	Chen, LM; Du, WJ; Dai, J; Zhang, Q; Si, GX; Yang, H; Ye, EL; Chen, QS; Yu, LC; Zhang, C; Lu, XM				Chen, Liang-Miao; Du, Wen-Jun; Dai, Jie; Zhang, Qian; Si, Guang-Xin; Yang, Hong; Ye, En-Ling; Chen, Qing-Shou; Yu, Le-Chu; Zhang, Chi; Lu, Xue-Mian			Effects of Subclinical Hypothyroidism on Maternal and Perinatal Outcomes during Pregnancy: A Single-Center Cohort Study of a Chinese Population	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; LOW-BIRTH-WEIGHT; THYROID-FUNCTION; PREMATURE RUPTURE; SUBSEQUENT FETAL; HEART-FAILURE; MANAGEMENT; DYSFUNCTION; CHILDREN; HORMONE	Objective: Adverse maternal outcomes and perinatal complications are closely associated with overt maternal hypothyroidism, but whether these complications occur in women with subclinical hypothyroidism (SCH) during pregnancy remains controversial. The aim of this study was to evaluate the effects of SCH on maternal and perinatal outcomes during pregnancy. Methods: A prospective study of data from 8012 pregnant women (371 women with SCH, 7641 euthyroid women) was performed. Maternal serum samples were collected in different trimesters to examine thyroid hormone concentrations. SCH was defined as a thyroid stimulating hormone concentration exceeding the trimester-specific reference value with a normal free thyroxine concentration. The occurrence of maternal outcomes, including gestational hypertension (GH), gestational diabetes mellitus, placenta previa, placental abruption, prelabor rupture of membranes (PROM), and premature delivery; and perinatal outcomes, including intrauterine growth restriction (IUGR), fetal distress, low birth weight (LBW; live birth weight <= 2500 g), stillbirth, and malformation, was recorded. Logistic regression with adjustment for confounding demographic and medical factors was used to determine the risks of adverse outcomes in patients with SCH. Results: Compared with euthyroid status, SCH was associated with higher rates of GH (1.819% vs. 3.504%, P = 0.020; chi(2) = 7.345; odds ratio (OR), 2.243; 95% confidence interval (CI), 1.251-4.024), PROM (4.973% vs. 8.625%, P = 0.002; chi(2) = 72.102; adjusted OR, 6.014; 95% CI, 3.975-9.099), IUGR (1.008% vs. 2.965%, <0.001; chi(2) = 13.272; adjusted OR, 3.336; 95% CI, 1.745-6.377), and LBW (1.885% vs. 4.582%, P<0.001; chi(2) = 13.558; adjusted OR, 2.919; 95% CI, 1.650-5.163). Conclusions: The results of this study indicate that pregnant women with SCH had increased risks of GH and PROM, and their fetuses and infants had increased risks of IUGR and LBW. Thus, routine maternal thyroid function testing is necessary to improve maternal and perinatal outcomes.	[Chen, Liang-Miao; Du, Wen-Jun; Dai, Jie; Zhang, Qian; Si, Guang-Xin; Yang, Hong; Ye, En-Ling; Chen, Qing-Shou; Yu, Le-Chu; Lu, Xue-Mian] Wenzhou Med Univ, Affiliated Hosp 3, Dept Endocrinol, Ruian, Zhejiang, Peoples R China; [Zhang, Chi; Lu, Xue-Mian] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Peoples R China; [Zhang, Chi; Lu, Xue-Mian] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Affiliated Hosp 3, Ruian Ctr, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhang, C (corresponding author), Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Peoples R China.	zhangchi515@126.com; lu89118@medmail.com.cn	Cai, Lu/AAG-9920-2019	Liangmiao, Chen/0000-0002-6687-5825	Medical Science Research Foundation of Zhejiang Province [2009A198]; Third Batch of Science and Technology Project of Ruian city [20093092]; National Science Foundation of China [81000294, 81370917]; Wenzhou Medical University [QTJ13005]	Medical Science Research Foundation of Zhejiang Province; Third Batch of Science and Technology Project of Ruian city; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University	This study was supported in part by Medical Science Research Foundation of Zhejiang Province (2009A198, to XL), the Third Batch of Science and Technology Project of Ruian city (20093092, to XL), Young Scientist Award from National Science Foundation of China (81000294, to CZ), National Science Foundation of China (81370917, to CZ), Research Development Fund of Wenzhou Medical University (QTJ13005, to CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetrics and Gynecology, 2002, Int J Gynaecol Obstet, V79, P171; Ashoor G, 2010, THYROID, V20, P989, DOI 10.1089/thy.2010.0058; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Casey BM, 2007, OBSTET GYNECOL, V109, P1129, DOI 10.1097/01.AOG.0000262054.03531.24; Casey BM, 2006, OBSTET GYNECOL, V107, P337, DOI 10.1097/01.AOG.0000197991.64246.9a; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Danzi S, 2003, CURR HYPERTENS REP, V5, P513, DOI 10.1007/s11906-003-0060-7; Danzi S, 2012, MED CLIN N AM, V96, P257, DOI 10.1016/j.mcna.2012.01.006; DAVIS LE, 1988, OBSTET GYNECOL, V72, P108; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Di Renzo GC, 2006, J PERINAT MED, V34, P359, DOI 10.1515/JPM.2006.073; Fattal-Valevski A, 1999, J CHILD NEUROL, V14, P724, DOI 10.1177/088307389901401107; Fletcher AK, 1998, J HUM HYPERTENS, V12, P79, DOI 10.1038/sj.jhh.1000574; Gartner R, 2009, CURR OPIN OBSTET GYN, V21, P501, DOI 10.1097/GCO.0b013e328332a836; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Goh ECL, 2006, J INTERGENER RELATSH, V4, P7, DOI 10.1300/J194v04n03_02; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Horacek J, 2010, EUR J ENDOCRINOL, V163, P645, DOI 10.1530/EJE-10-0516; Idris I, 2005, CLIN ENDOCRINOL, V63, P560, DOI 10.1111/j.1365-2265.2005.02382.x; Julvez J, 2013, EPIDEMIOLOGY, V24, P150, DOI 10.1097/EDE.0b013e318276ccd3; KJOS SL, 1995, AM J OBSTET GYNECOL, V173, P1532, DOI 10.1016/0002-9378(95)90645-2; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Laurberg P, 2013, CLIN ENDOCRINOL, V79, P297, DOI 10.1111/cen.12232; Lazarus JH, 2011, BRIT MED BULL, V97, P137, DOI 10.1093/bmb/ldq039; Le J, 2003, GYNECOLOGY OBSTET, P92; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; LEUNG AS, 1993, OBSTET GYNECOL, V81, P349; LIPPER E, 1981, PEDIATRICS, V67, P502; Lu XM, 2012, J MED RES, V41, P70; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nelson DB, 2014, AM J PERINAT, V31, P77, DOI 10.1055/s-0033-1334457; North RA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5183; Ohashi M, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/619718; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Oppenheimer L, 2007, J OBSTET GYNAECOL CA, V29, P261, DOI 10.1016/S1701-2163(16)32401-X; Polzin WJ, 1998, CLIN OBSTET GYNECOL, V41, P810, DOI 10.1097/00003081-199812000-00004; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; Qin C, 2012, MATERN CHILD HLTH J, V16, P1484, DOI 10.1007/s10995-011-0913-7; Rashid M, 2007, OBSTET GYNECOL SURV, V62, P680, DOI 10.1097/01.ogx.0000281558.59184.b5; Reid SM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007752.pub2; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Sahay Rakesh Kumar, 2012, Indian J Endocrinol Metab, V16, P364, DOI 10.4103/2230-8210.95667; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Sheffield JS, 2004, AM J OBSTET GYNECOL, V190, P211, DOI 10.1016/S0002-9378(03)00944-X; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Srinivas SK, 2009, J PERINATOL, V29, P680, DOI 10.1038/jp.2009.83; Stagnaro-Green A, 2012, NAT REV ENDOCRINOL, V8, P650, DOI 10.1038/nrendo.2012.171; Su PY, 2011, J CLIN ENDOCR METAB, V96, P3234, DOI 10.1210/jc.2011-0274; Taddei S, 2003, J CLIN ENDOCR METAB, V88, P3731, DOI 10.1210/jc.2003-030039; Tirosh D, 2013, PEERJ, V1, DOI 10.7717/peerj.52; Tudela CM, 2012, OBSTET GYNECOL, V119, P983, DOI 10.1097/AOG.0b013e318250aeeb; Vaidya B, 2007, J CLIN ENDOCR METAB, V92, P203, DOI 10.1210/jc.2006-1748; Velkeniers B, 2013, HUM REPROD UPDATE, V19, P251, DOI 10.1093/humupd/dms052; Wilson Carol, 2012, Nat Rev Endocrinol, V8, P624, DOI 10.1038/nrendo.2012.156; Wilson KL, 2012, OBSTET GYNECOL, V119, P315, DOI 10.1097/AOG.0b013e318240de6a; Woeber KA, 1997, ARCH INTERN MED, V157, P1065, DOI 10.1001/archinte.157.10.1065; Wollmann HA, 1998, HORM RES, V49, P1, DOI 10.1159/000053079	63	77	87	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109364	10.1371/journal.pone.0109364	http://dx.doi.org/10.1371/journal.pone.0109364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353960	gold, Green Published, Green Submitted			2022-12-26	WOS:000345204200010
J	Martinez-Martinez, N; Martinez-Alonso, E; Ballesta, J; Martinez-Menarguez, JA				Martinez-Martinez, Narcisa; Martinez-Alonso, Emma; Ballesta, Jose; Martinez-Menarguez, Jose A.			Phospholipase D2 Is Involved in the Formation of Golgi Tubules and ArfGAP1 Recruitment	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PHOSPHATIDIC-ACID; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; MEMBRANE CURVATURE; RECYCLING PATHWAY; COPI VESICLES; TRANSPORT; COMPLEX; DIACYLGLYCEROL	Lipids and lipid-modifying enzymes play a key role in the biogenesis, maintenance and fission of transport carriers in the secretory and endocytic pathways. In the present study we demonstrate that phosphatidic acid generated by phospholipase D2 (PLD2) is involved in the formation of Golgi tubules. The main evidence to support this is: 1) inhibitors of phosphatidic acid formation and PLD2 depletion inhibit the formation of tubules containing resident enzymes and regulators of intra-Golgi transport in a low temperature (15 degrees C) model of Golgi tubulation but do not affect brefeldin A-induced tubules, 2) inhibition of PLD2 enzymatic activity and PLD2 depletion in cells cultured under physiological conditions (37 degrees C) induce the formation of tubules specifically containing Golgi matrix proteins, and, 3) over-expression of PLD2 induces the formation of a tubular network. In addition, it was found that the generation of this lipid by the isoenzyme is necessary for ArfGAP1 recruitment to Golgi membranes. These results suggest that both proteins are involved in the molecular mechanisms which drive the formation of different types of Golgi tubules.	[Martinez-Martinez, Narcisa; Martinez-Alonso, Emma; Ballesta, Jose; Martinez-Menarguez, Jose A.] Univ Murcia, Dept Cell Biol & Histol, Sch Med, IMIB Arrixaca, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia	Martinez-Menarguez, JA (corresponding author), Univ Murcia, Dept Cell Biol & Histol, Sch Med, IMIB Arrixaca, Murcia, Spain.	jamartin@um.es	ALONSO, EMMA MARTINEZ/L-7468-2014; Martinez-Martinez, Narcisa/I-1778-2015	ALONSO, EMMA MARTINEZ/0000-0002-8121-0442; Martinez-Martinez, Narcisa/0000-0002-8672-184X; ballesta, Jose/0000-0001-7965-5277	Ministerio de Ciencia e Innovacion (Spain) [Consolider COAT CSD2009-00016]; Fundacion Seneca de la Comunidad Autonoma de la Region de Murcia [04542/GERM/06]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca de la Comunidad Autonoma de la Region de Murcia(Fundacion Seneca)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (Spain) (Consolider COAT CSD2009-00016) and Fundacion Seneca de la Comunidad Autonoma de la Region de Murcia (04542/GERM/06) to JAM-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Beznoussenko GV, 2014, ELIFE, V3, DOI 10.7554/eLife.02009; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brown WJ, 2008, TRAFFIC, V9, P786, DOI 10.1111/j.1600-0854.2008.00711.x; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; CHALIFOUR R, 1982, J NEUROCHEM, V39, P299, DOI 10.1111/j.1471-4159.1982.tb03946.x; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; de Figueiredo P, 2000, TRAFFIC, V1, P504, DOI 10.1034/j.1600-0854.2000.010608.x; DECOURCELLES DD, 1985, J BIOL CHEM, V260, P5762; Drecktrah D, 2003, MOL BIOL CELL, V14, P3459, DOI 10.1091/mbc.E02-11-0711; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Gonzalez-Rubio P, 2011, BBA-BIOMEMBRANES, V1808, P2119, DOI 10.1016/j.bbamem.2011.05.006; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Gutierrez-Martinez E, 2013, J CELL SCI, V126, P2641, DOI 10.1242/jcs.117705; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Kim H, 2007, CELL BIOL INT, V31, P148, DOI 10.1016/j.cellbi.2006.09.020; Klumperman J, 1998, J CELL SCI, V111, P3411; Klumperman J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005181; Kolesnikov YS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1, DOI 10.1134/S0006297912010014; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; KOUL O, 1987, ARCH BIOCHEM BIOPHYS, V253, P453, DOI 10.1016/0003-9861(87)90199-8; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Kurooka T, 2011, J BIOL CHEM, V286, P6832, DOI 10.1074/jbc.M110.183772; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Lopez-Andreo MJ, 2003, MOL BIOL CELL, V14, P4885, DOI 10.1091/mbc.E03-05-0295; Martinez-Alonso E, 2005, TRAFFIC, V6, P32, DOI 10.1111/j.1600-0854.2004.00242.x; Martinez-Alonso E, 2007, TRAFFIC, V8, P359, DOI 10.1111/j.1600-0854.2006.00533.x; Martinez-Alonso E, 2013, HISTOCHEM CELL BIOL, V140, P327, DOI 10.1007/s00418-013-1114-9; Martinez-Menarguez JA, 2013, ISRN CELL BIOL, V2013, P1; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; Polishchuk RS, 2009, FEBS LETT, V583, P3847, DOI 10.1016/j.febslet.2009.10.031; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shiba Y, 2012, HISTOL HISTOPATHOL, V27, P1143, DOI 10.14670/HH-27.1143; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	55	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111685	10.1371/journal.pone.0111685	http://dx.doi.org/10.1371/journal.pone.0111685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354038	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200092
J	Warnke, P; Frickmann, H; Ottl, P; Podbielski, A				Warnke, Philipp; Frickmann, Hagen; Ottl, Peter; Podbielski, Andreas			Nasal Screening for MRSA: Different Swabs - Different Results!	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PORT-A-CUL; METHICILLIN-RESISTANT; TRANSPORT-SYSTEMS; ANAEROBIC-BACTERIA; NEISSERIA-GONORRHOEAE; ECONOMIC-IMPACT; FLOCKED SWABS; NOSOCOMIAL INFECTIONS; HOSPITAL ADMISSION	Objectives: Swab-based nasal screening is commonly used to identify asymptomatic carriage of Staphylococcus aureus in patients. Bacterial detection depends on the uptake and release capacities of the swabs and on the swabbing technique itself. This study investigates the performance of different swab-types in nasal MRSA-screening by utilizing a unique artificial nose model to provide realistic and standardized screening conditions. Methods: An anatomically correct artificial nose model was inoculated with a numerically defined mixture of MRSA and Staphylococcus epidermidis bacteria at quantities of 4x10(2) and 8x10(2) colony forming units (CFU), respectively. Five swab-types were tested following a strict protocol. Bacterial recovery was measured for direct plating and after elution into Amies medium by standard viable count techniques. Results: Mean recovered bacteria quantities varied between 209 and 0 CFU for MRSA, and 365 and 0 CFU for S. epidermidis, resulting swab-type-dependent MRSA-screening-sensitivities ranged between 0 and 100%. Swabs with nylon flocked tips or cellular foam tips performed significantly better compared to conventional rayon swabs referring to the recovered bacterial yield (p<0.001). Best results were obtained by using a flocked swab in combination with Amies preservation medium. Within the range of the utilized bacterial concentrations, recovery ratios for the particular swab-types were independent of the bacterial species. Conclusions: This study combines a realistic model of a human nose with standardized laboratory conditions to analyze swab-performance in MRSA-screening situations. Therefore, influences by inter-individual anatomical differences as well as diverse colonization densities in patients could be excluded. Recovery rates vary significantly between different swab-types. The choice of the swab has a great impact on the laboratory result. In fact, the swab-type contributes significantly to true positive or false negative detection of nasal MRSA carriage. These findings should be considered when screening a patient.	[Warnke, Philipp; Frickmann, Hagen; Podbielski, Andreas] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Frickmann, Hagen] German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Ottl, Peter] Rostock Univ Hosp, Dept Prosthodont & Mat Sci, Rostock, Germany	University of Rostock; Bernhard Nocht Institut fur Tropenmedizin; University of Rostock	Warnke, P (corresponding author), Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	philipp.warnke@med.uni-rostock.de						Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; Abu-Diab A, 2008, J CLIN MICROBIOL, V46, P2414, DOI 10.1128/JCM.00369-08; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Barber S, 1998, PATHOLOGY, V30, P179, DOI 10.1080/00313029800169196; Bartolitius L, 2014, EUR J MICROBIOL IMMU, V4, P159, DOI 10.1556/EUJMI-D-14-00020; Bocher S, 2008, J CLIN MICROBIOL, V46, P3136, DOI 10.1128/JCM.00478-08; BROOK I, 1987, J CLIN MICROBIOL, V25, P2020, DOI 10.1128/JCM.25.10.2020-2022.1987; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Chernesky M, 2006, J CLIN MICROBIOL, V44, P1084, DOI 10.1128/JCM.44.3.1084-1086.2006; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Citron DM, 2000, J CLIN MICROBIOL, V38, P892, DOI 10.1128/JCM.38.2.892-894.2000; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; Datta R, 2014, J CLIN MICROBIOL, V52, P312, DOI 10.1128/JCM.01606-13; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Drake C, 2005, J CLIN MICROBIOL, V43, P1301, DOI 10.1128/JCM.43.3.1301-1303.2005; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Farhat SE, 2001, J CLIN MICROBIOL, V39, P2958, DOI 10.1128/JCM.39.8.2958-2960.2001; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gupta K, 2011, INFECT CONT HOSP EP, V32, P791, DOI 10.1086/660362; Herr CEW, 2003, INFECT CONT HOSP EP, V24, P673, DOI 10.1086/502274; Hindiyeh M, 2001, J CLIN MICROBIOL, V39, P377, DOI 10.1128/JCM.39.1.377-380.2001; Hsu LY, 2005, J CLIN MICROBIOL, V43, P2923, DOI 10.1128/JCM.43.6.2923-2925.2005; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Kalmeijer MD, 2000, INFECT CONT HOSP EP, V21, P319, DOI 10.1086/501763; Kim T, 2001, INFECT CONT HOSP EP, V22, P99, DOI 10.1086/501871; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Kopp BJ, 2004, ANN PHARMACOTHER, V38, P1377, DOI 10.1345/aph.1E028; Lee S, 2008, ANN CLIN LAB SCI, V38, P254; Lodise TP, 2005, DIAGN MICR INFEC DIS, V52, P113, DOI 10.1016/j.diagmicrobio.2005.02.007; Melter O., 2006, EURO SURVEILL, V11; Mermel LA, 2010, INFECT CONT HOSP EP, V31, P592, DOI 10.1086/652778; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Morosini MI, 2006, DIAGN MICR INFEC DIS, V56, P19, DOI 10.1016/j.diagmicrobio.2006.02.011; NCCLS (The National Committee for Clinical Laboratory Standards), 2003, M40A NCCLS; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Nys S, 2010, EUR J CLIN MICROBIOL, V29, P453, DOI 10.1007/s10096-010-0883-5; Olsen CC, 1999, J CLIN MICROBIOL, V37, P3583, DOI 10.1128/JCM.37.11.3583-3585.1999; Osterblad M, 2003, J CLIN MICROBIOL, V41, P1894, DOI 10.1128/JCM.41.5.1894-1900.2003; Paule SM, 2009, AM J CLIN PATHOL, V131, P532, DOI 10.1309/AJCP18ONZUTDUGAQ; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Perry JL, 1997, J CLIN MICROBIOL, V35, P1269, DOI 10.1128/JCM.35.5.1269-1271.1997; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Reed SD, 2005, INFECT CONT HOSP EP, V26, P175, DOI 10.1086/502523; Roelofsen E, 1999, J CLIN MICROBIOL, V37, P3041, DOI 10.1128/JCM.37.9.3041-3043.1999; Rossney AS, 2006, EUR J CLIN MICROBIOL, V25, P79, DOI 10.1007/s10096-006-0091-5; ROTH RR, 1989, J AM ACAD DERMATOL, V20, P367, DOI 10.1016/S0190-9622(89)70048-7; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Smismans A, 2009, DIAGN MICR INFEC DIS, V65, P108, DOI 10.1016/j.diagmicrobio.2009.06.015; Smith JMB, 2005, EPIDEMIOL INFECT, V133, P899, DOI 10.1017/S0950268805004024; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; Van Horn KG, 2008, DIAGN MICR INFEC DIS, V62, P471, DOI 10.1016/j.diagmicrobio.2008.08.004; Verhoeven P, 2010, J CLIN MICROBIOL, V48, P4242, DOI 10.1128/JCM.01425-10; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102215; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089667; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; White A, 1963, ANTIMICROB AGENTS CH, V161, P667	70	36	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111627	10.1371/journal.pone.0111627	http://dx.doi.org/10.1371/journal.pone.0111627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353631	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200090
J	Misic, B; Fatima, Z; Askren, MK; Buschkuehl, M; Churchill, N; Cimprich, B; Deldin, PJ; Jaeggi, S; Jung, M; Korostil, M; Kross, E; Krpan, KM; Peltier, S; Reuter-Lorenz, PA; Strother, SC; Jonides, J; McIntosh, AR; Berman, MG				Misic, Bratislav; Fatima, Zainab; Askren, Mary K.; Buschkuehl, Martin; Churchill, Nathan; Cimprich, Bernadine; Deldin, Patricia J.; Jaeggi, Susanne; Jung, Misook; Korostil, Michele; Kross, Ethan; Krpan, Katherine M.; Peltier, Scott; Reuter-Lorenz, Patricia A.; Strother, Stephen C.; Jonides, John; McIntosh, Anthony R.; Berman, Marc G.			The Functional Connectivity Landscape of the Human Brain	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; DEFAULT-MODE NETWORK; COMPONENT ANALYSIS; NEUROANATOMY; VALIDATION; COMPLEXITY; INTERVIEW; SUBJECT; MOTION; ROBUST	Functional brain networks emerge and dissipate over a primarily static anatomical foundation. The dynamic basis of these networks is inter-regional communication involving local and distal regions. It is assumed that inter-regional distances play a pivotal role in modulating network dynamics. Using three different neuroimaging modalities, 6 datasets were evaluated to determine whether experimental manipulations asymmetrically affect functional relationships based on the distance between brain regions in human participants. Contrary to previous assumptions, here we show that short-and long-range connections are equally likely to strengthen or weaken in response to task demands. Additionally, connections between homotopic areas are the most stable and less likely to change compared to any other type of connection. Our results point to a functional connectivity landscape characterized by fluid transitions between local specialization and global integration. This ability to mediate functional properties irrespective of spatial distance may engender a diverse repertoire of cognitive processes when faced with a dynamic environment.	[Misic, Bratislav; Fatima, Zainab; Churchill, Nathan; Korostil, Michele; Strother, Stephen C.; McIntosh, Anthony R.] Rotman Res Inst, Baycrest Ctr, Toronto, ON, Canada; [Askren, Mary K.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Buschkuehl, Martin] MIND Res Inst, Irvine, CA USA; [Cimprich, Bernadine] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Deldin, Patricia J.; Jaeggi, Susanne; Kross, Ethan; Peltier, Scott; Reuter-Lorenz, Patricia A.; Jonides, John] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Jung, Misook] Chungnam Natl Univ, Dept Psychol, Taejon, South Korea; [Krpan, Katherine M.; Berman, Marc G.] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Berman, Marc G.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Toronto; University Toronto Affiliates; Baycrest; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chungnam National University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Chicago	Misic, B (corresponding author), Rotman Res Inst, Baycrest Ctr, Toronto, ON, Canada.	bmisic@research.baycrest.org; bermanm@uchicago.edu	Strother, Stephen C/D-6752-2011; Strother, Stephen/ABF-3371-2021	Strother, Stephen C/0000-0002-3198-217X; Strother, Stephen/0000-0002-3198-217X; , Ethan/0000-0002-8664-2711; McIntosh, Anthony/0000-0002-1784-5662; deldin, patricia/0000-0002-3584-3513; Jung, Mi Sook/0000-0002-5895-8954; Korostil, Michele/0000-0002-5309-4528	Tom and Kitty Stoner Foundation (TKF); National Institutes of Mental Health (NIMH) [MH 60655]; National Institutes of Health (NIH) [NIH-NINR-R01-NRO10939]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060655] Funding Source: NIH RePORTER	Tom and Kitty Stoner Foundation (TKF); National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by 1) Tom and Kitty Stoner Foundation (TKF) Grant to MGB, 2) National Institutes of Mental Health (NIMH) Grant MH 60655 to JJ, and 3) National Institutes of Health (NIH) grant NIH-NINR-R01-NRO10939 to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Allen E. A., 2012, CEREBRAL CORTEX; Askren MK, 2014, BREAST CANC RES TREA; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Berman MG, 2013, HLTH PSYCHOL; Berman MG, 2014, NEUROIMAGE; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Chen KW, 2004, NEUROIMAGE, V22, P134, DOI 10.1016/j.neuroimage.2004.01.002; Churchill NW, 2012, NEUROIMAGE, V59, P1299, DOI 10.1016/j.neuroimage.2011.08.021; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fatima Z, 2013, NEUROIMAGE, V78, P284, DOI 10.1016/j.neuroimage.2013.04.033; Fatima Z, 2011, EXP BRAIN RES, V214, P9, DOI 10.1007/s00221-011-2745-5; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Kovacevic N, 2007, NEUROIMAGE, V35, P1103, DOI 10.1016/j.neuroimage.2007.01.016; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Larsen J, 2002, COMPUT STAT DATA AN, V38, P517, DOI 10.1016/S0167-9473(01)00076-7; Lazar NA, 2001, INT STAT REV, V69, P105, DOI 10.1111/j.1751-5823.2001.tb00482.x; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; McIntosh AR, 2013, ANNU REV PSYCHOL, V64, P499, DOI 10.1146/annurev-psych-113011-143804; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Quraan MA, 2010, NEUROIMAGE, V49, P2387, DOI 10.1016/j.neuroimage.2009.10.012; Riggs L, 2009, NEUROIMAGE, V45, P627, DOI 10.1016/j.neuroimage.2008.11.018; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	54	22	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111007	10.1371/journal.pone.0111007	http://dx.doi.org/10.1371/journal.pone.0111007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350370	Green Published, gold			2022-12-26	WOS:000343943100051
J	Weiss, A; Joerss, H; Brockmeyer, J				Weiss, Andre; Joerss, Hanna; Brockmeyer, Jens			Structural and Functional Characterization of Cleavage and Inactivation of Human Serine Protease Inhibitors by the Bacterial SPATE Protease EspP alpha from Enterohemorrhagic E-coli	PLOS ONE			English	Article							C1 ESTERASE INHIBITOR; SHIGA TOXIN; ALPHA-1-PROTEINASE INHIBITOR; HUMAN ALPHA-1-ANTICHYMOTRYPSIN; PROTEINASE-INHIBITORS; PROTEOLYTIC ACTIVITY; SERRATIA-MARCESCENS; ALZHEIMERS-DISEASE; REACTIVE-SITE; HUMAN-PLASMA	EspP alpha and EspI are serine protease autotransporters found in enterohemorrhagic Escherichia coli. They both belong to the SPATE autotransporter family and are believed to contribute to pathogenicity via proteolytic cleavage and inactivation of different key host proteins during infection. Here, we describe the specific cleavage and functional inactivation of serine protease inhibitors (serpins) by EspP alpha and compare this activity with the related SPATE EspI. Serpins are structurally related proteins that regulate vital protease cascades, such as blood coagulation and inflammatory host response. For the rapid determination of serpin cleavage sites, we applied direct MALDI-TOF-MS or ESI-FTMS analysis of coincubations of serpins and SPATE proteases and confirmed observed cleavage positions using in-gel-digest of SDS-PAGE-separated degradation products. Activities of both serpin and SPATE protease were assessed in a newly developed photometrical assay using chromogenic peptide substrates. EspP alpha cleaved the serpins alpha 1-protease inhibitor (alpha 1-PI), alpha 1-antichymotrypsin, angiotensinogen, and alpha 2-antiplasmin. Serpin cleavage led to loss of inhibitory function as demonstrated for alpha 1-PI while EspPa activity was not affected. Notably, EspP alpha showed pronounced specificity and cleaved procoagulatory serpins such as alpha 2-antiplasmin while the anticoagulatory antithrombin III was not affected. Together with recently published research, this underlines the interference of EspP alpha with hemostasis or inflammatory responses during infection, while the observed interaction of EspI with serpins is likely to be not physiologically relevant. EspP alpha-mediated serpin cleavage occurred always in flexible loops, indicating that this structural motif might be required for substrate recognition.	[Weiss, Andre; Joerss, Hanna; Brockmeyer, Jens] Univ Munster, Inst Food Chem, D-48149 Munster, Germany	University of Munster	Brockmeyer, J (corresponding author), Univ Munster, Inst Food Chem, D-48149 Munster, Germany.	jbrockm@uni-muenster.de			Deutsche Forschungsgemeinschaft (DFG) [BR 4258/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG) (http://dfg.de), grant BR 4258/1-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; AOKI N, 1984, SEMIN THROMB HEMOST, V10, P42, DOI 10.1055/s-2007-1004406; ARAKAWA K, 1968, BIOCHIM BIOPHYS ACTA, V168, P106, DOI 10.1016/0005-2795(68)90239-0; BEATTY K, 1980, J BIOL CHEM, V255, P3931; Bielaszewska M, 2009, J CLIN MICROBIOL, V47, P2061, DOI 10.1128/JCM.00201-09; Brockmeyer J, 2007, APPL ENVIRON MICROB, V73, P6351, DOI 10.1128/AEM.00920-07; Brockmeyer J, 2011, ENVIRON MICROBIOL, V13, P1327, DOI 10.1111/j.1462-2920.2011.02431.x; Brockmeyer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006100; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Burghaus B, 2006, ACTA HAEMATOL-BASEL, V115, P186, DOI 10.1159/000090933; CHANDRA T, 1983, BIOCHEMISTRY-US, V22, P5055, DOI 10.1021/bi00291a001; COLLEN D, 1979, BLOOD, V53, P313; Coughlin PB, 2005, FEBS J, V272, P4852, DOI 10.1111/j.1742-4658.2005.04881.x; dos Santos LF, 2010, J MED MICROBIOL, V59, P634, DOI 10.1099/jmm.0.015263-0; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; Favier R, 2001, BRIT J HAEMATOL, V114, P4, DOI 10.1046/j.1365-2141.2001.02845.x; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HEEB MJ, 1988, J BIOL CHEM, V263, P11613; HOLMES WE, 1987, J BIOL CHEM, V262, P1659; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V155, P591, DOI 10.1016/S0006-291X(88)80535-7; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; JOHNSON D, 1978, J BIOL CHEM, V253, P7142; KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Khan AB, 2009, INT J MED MICROBIOL, V299, P247, DOI 10.1016/j.ijmm.2008.08.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lathem WW, 2004, J EXP MED, V199, P1077, DOI 10.1084/jem.20030255; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Law D, 2000, J APPL MICROBIOL, V88, P729, DOI 10.1046/j.1365-2672.2000.01031.x; Law RHP, 2008, BLOOD, V111, P2049, DOI 10.1182/blood-2007-09-114215; LENTZ KE, 1956, J EXP MED, V104, P183, DOI 10.1084/jem.104.2.183; Lijnen HR, 2001, BBA-PROTEIN STRUCT M, V1547, P206, DOI 10.1016/S0167-4838(01)00186-8; Lijnen HR, 2000, J BIOL CHEM, V275, P37645, DOI 10.1074/jbc.M006475200; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1995, J BIOL CHEM, V270, P16864, DOI 10.1074/jbc.270.28.16864; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; MARSHALL CJ, 1993, PHILOS T ROY SOC B, V342, P101, DOI 10.1098/rstb.1993.0141; MAST AE, 1991, J BIOL CHEM, V266, P15810; Mauray S, 1998, BBA-PROTEIN STRUCT M, V1387, P184, DOI 10.1016/S0167-4838(98)00120-4; MOLLA A, 1989, INFECT IMMUN, V57, P1868, DOI 10.1128/IAI.57.6.1868-1871.1989; MORII M, 1983, J BIOL CHEM, V258, P2749; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; Orth D, 2010, INFECT IMMUN, V78, P4294, DOI 10.1128/IAI.00488-10; Pearce MC, 2010, J MOL BIOL, V403, P459, DOI 10.1016/j.jmb.2010.09.007; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; POULSEN K, 1976, BIOCHIM BIOPHYS ACTA, V452, P533, DOI 10.1016/0005-2744(76)90205-9; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; ROGERS SJ, 1992, J BIOL CHEM, V267, P3613; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHECHTER NM, 1989, J BIOL CHEM, V264, P21308; Schmidt H, 2001, INFECT IMMUN, V69, P6863, DOI 10.1128/IAI.69.11.6863-6873.2001; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; Thelwell C, 2011, VOX SANG, V101, P83, DOI 10.1111/j.1423-0410.2010.01459.x; Toszeghy M, 2012, RES VET SCI, V93, P1142, DOI 10.1016/j.rvsc.2012.05.001; VIRCA GD, 1982, BIOCHIM BIOPHYS ACTA, V704, P267, DOI 10.1016/0167-4838(82)90155-8; Weiss A, 2013, TOXINS, V5, P25, DOI 10.3390/toxins5010025; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	62	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111363	10.1371/journal.pone.0111363	http://dx.doi.org/10.1371/journal.pone.0111363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347319	Green Submitted, Green Published, gold			2022-12-26	WOS:000347994900063
J	Zhang, RC; Zhang, YH; Zhang, J; An, T; Huang, Y; Guo, X; Januzzi, JL; Cappola, TP; Yin, SJ; Wang, YH; Zhou, Q; Zou, CH; Ji, SM; Lv, R				Zhang, Rongcheng; Zhang, Yuhui; Zhang, Jian; An, Tao; Huang, Yan; Guo, Xiao; Januzzi, James L.; Cappola, Thomas P.; Yin, Shijie; Wang, Yunhong; Zhou, Qiong; Zou, Changhong; Ji, Shiming; Lv, Rong			The Prognostic Value of Plasma Soluble ST2 in Hospitalized Chinese Patients with Heart Failure	PLOS ONE			English	Article							FAMILY-MEMBER ST2; NATIONAL REGISTRY ADHERE; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; RISK STRATIFICATION; EJECTION FRACTION; ACUTE DYSPNEA; MORTALITY; EPIDEMIC; OUTCOMES	Background: sST2 has been shown to be a risk predictor in heart failure (HF). Our aim was to explore the characteristics and prognostic value of soluble ST2 (sST2) in hospitalized Chinese patients with HF. Methods and Results: We consecutively enrolled 1528 hospitalized patients with HF. Receiver operating characteristic (ROC) and multivariable Cox proportional hazards analysis were used to assess the prognostic values of sST2. Adverse events were defined as all-cause death and cardiac transplantation. During a median follow-up of 19.1 months, 325 patients experienced adverse events. Compared with patients free of events, sST2 concentrations were significantly higher in patients with events (P<0.001). Univariable and multivariable Cox regression analyses showed sST2 concentrations were significantly associated with adverse events (per 1 log unit, adjusted hazard ratio 1.52, 95% confidence interval: 1.30 to 1.78, P<0.001). An sST2 concentration in the highest quartiles (>55.6 ng/mL) independently predicted events in comparison to the lowest quartile (>= 25.2 ng/mL) when adjusted by multivariable model. In ROC analysis, the area under the curve for sST2 was not different from that for NT-proBNP in short and longer term. Over time, sST2 also improved discrimination and reclassification of risk beyond NT-proBNP. Conclusions: sST2 is a strong independent risk predictor in Chinese patients hospitalized with HF and can significantly provide additional prognostic value to NT-proBNP in risk prediction.	[Zhang, Rongcheng; Zhang, Yuhui; Zhang, Jian; An, Tao; Huang, Yan; Guo, Xiao; Yin, Shijie; Wang, Yunhong; Zhou, Qiong; Zou, Changhong; Ji, Shiming; Lv, Rong] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Heart Failure Ctr Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhang, Rongcheng; Zhang, Yuhui; Zhang, Jian; An, Tao; Huang, Yan; Guo, Xiao; Yin, Shijie; Wang, Yunhong; Zhou, Qiong; Zou, Changhong; Ji, Shiming; Lv, Rong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Januzzi, James L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Cappola, Thomas P.] Univ Penn, Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Massachusetts General Hospital; University of Pennsylvania	Zhang, YH (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Heart Failure Ctr Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	yuhuizhangjoy@163.com; fwzhangjian62@126.com	Januzzi, James/Y-2436-2019		Key Projects in the National Science & Technology Pillar Program of the 12th Five-year Plan Period, Beijing, China [2011BAI11B02]	Key Projects in the National Science & Technology Pillar Program of the 12th Five-year Plan Period, Beijing, China	This study was supported by grants from the Key Projects in the National Science & Technology Pillar Program of the 12th Five-year Plan Period (No. 2011BAI11B02, project for heart failure), Beijing, China. ST2 assays were provided by Critical Diagnostics, and NT-proBNP assays were provided by Alere Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Ambrosy AP, 2012, EUR J HEART FAIL, V14, P302, DOI 10.1093/eurjhf/hfs007; Bayes-Genis A, 2013, J AM COLL CARDIOL; Boisot S, 2008, J CARD FAIL, V14, P732, DOI 10.1016/j.cardfail.2008.06.415; Chinese Society of Cardiology of Chinese Medical Association, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P1076; Chinese Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P195; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Giamouzis G, 2011, J CARD FAIL, V17, P54, DOI 10.1016/j.cardfail.2010.08.010; Januzzi JL, 2007, J AM COLL CARDIOL, V50, P607, DOI 10.1016/j.jacc.2007.05.014; Kociol RD, 2010, AM HEART J, V160, P885, DOI 10.1016/j.ahj.2010.07.020; Ky B, 2011, CIRC-HEART FAIL, V4, P180, DOI 10.1161/CIRCHEARTFAILURE.110.958223; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Manzano-Fernandez S, 2012, CARDIOLOGY, V122, P158, DOI 10.1159/000338800; Manzano-Fernandez S, 2011, AM J CARDIOL, V107, P259, DOI 10.1016/j.amjcard.2010.09.011; Moons KGM, 2012, CLIN CHEM, V58, P1408, DOI 10.1373/clinchem.2012.182550; Mueller T, 2008, CLIN CHEM, V54, P752, DOI 10.1373/clinchem.2007.096560; Pascual-Figal DA, 2011, EUR J HEART FAIL, V13, P718, DOI 10.1093/eurjhf/hfr047; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rehman SU, 2008, J AM COLL CARDIOL, V52, P1458, DOI 10.1016/j.jacc.2008.07.042; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Socrates T, 2010, J INTERN MED, V268, P493, DOI 10.1111/j.1365-2796.2010.02263.x; Wu AH, 2013, AM J CARDIOL, V111, P1192, DOI 10.1016/j.amjcard.2012.12.048	28	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110976	10.1371/journal.pone.0110976	http://dx.doi.org/10.1371/journal.pone.0110976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347817	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900036
J	Chung, SD; Tsai, MC; Liu, SP; Lin, HC; Kang, JH				Chung, Shiu-Dong; Tsai, Ming-Chieh; Liu, Shih-Ping; Lin, Herng-Ching; Kang, Jiunn-Horng			Herpes Zoster Is Associated with Prior Statin Use: A Population-Based Case-Control Study	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; SIMVASTATIN; DISORDERS; ARTHRITIS; THERAPY; COST; RISK	Background: This study investigated the association between statin use and herpes zoster (HZ) occurrence in a population-based case-control study. Methods: Study subjects were retrieved from the Taiwan Longitudinal Health Insurance Database 2000. This study included 47,359 cases with HZ and 142,077 controls. We performed conditional logistic regression analyses to calculate the odds ratio (OR) to present the association between HZ and having previously been prescribed statin. Results: We found that 13.0% of the sampled subjects had used statins, at 15.5% and 12.1% for cases and controls, respectively (p<0.001). A conditional logistic regression analysis suggested that the adjusted OR of being a statin user before the index date for cases was 1.28 (95% confidence interval (CI): 1.24 similar to 1.32) compared to controls. Subjects aged 18 similar to 44 years had the highest adjusted OR for prior statin use among cases compared to controls (OR: 1.69; 95% CI: 1.45 similar to 1.92). Furthermore, we found that the ORs of being a regular and irregular statin user before the index date for cases were 1.32 (95% CI: 1.27 similar to 1.38) and 1.23 (95% CI: 1.181.29), respectively, compared to controls. Conclusions: We concluded that prior statin use was associated with HZ occurrence.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan; [Chung, Shiu-Dong] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Tsai, Ming-Chieh; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp & Coll Med, Dept Urol, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; Cathay General Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Kang, JH (corresponding author), Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	jhk@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				Antoniou T, 2014, CLIN INFECT DIS, V58, P350, DOI 10.1093/cid/cit745; Bongartz T, 2009, NAT REV RHEUMATOL, V5, P361, DOI 10.1038/nrrheum.2009.120; Che H, JOINT BONE IN PRESS; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Hakamada-Taguchi R, 2003, CIRC RES, V93, P948, DOI 10.1161/01.RES.0000101298.76864.14; Kaneider NC, 2001, ATHEROSCLEROSIS, V158, P23, DOI 10.1016/S0021-9150(00)00764-4; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; Mihos CG, 2012, RHEUMATOL INT, V32, P287, DOI 10.1007/s00296-011-2008-6; Mihos CG, 2010, CARDIOL REV, V18, P298, DOI 10.1097/CRD.0b013e3181f52a7f; Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC; Rosenson RS, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(98)05917-0; Schmader K, 2008, J INFECT DIS, V197, pS207, DOI 10.1086/522152; Stein AN, 2009, VACCINE, V27, P520, DOI 10.1016/j.vaccine.2008.11.012; Terao M, 2005, SKIN RES, V4, P335; Weaver BA, 2007, J AM OSTEOPATH ASSOC, V107, pS2; Whitley RJ, 2009, JAMA-J AM MED ASSOC, V301, P774, DOI 10.1001/jama.2009.150; Wolfe F, 2006, RHEUMATOLOGY, V45, P1370, DOI 10.1093/rheumatology/kel328; Yawn BP, 2009, MAYO CLIN PROC, V84, P787, DOI [10.4065/84.9.787, 10.1016/S0025-6196(11)60488-6]; Yende S, 2011, CRIT CARE MED, V39, P1871, DOI 10.1097/CCM.0b013e31821b8290	21	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111268	10.1371/journal.pone.0111268	http://dx.doi.org/10.1371/journal.pone.0111268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343666	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943500090
J	Loh, CCY; Suwanarusk, R; Lee, YQ; Chan, KWK; Choy, KY; Renia, L; Russell, B; Lear, MJ; Nosten, FH; Tan, KSW; Chow, LMC				Loh, Cheryl C. Y.; Suwanarusk, Rossarin; Lee, Yan Quan; Chan, Kitti W. K.; Choy, Kit-Ying; Renia, Laurent; Russell, Bruce; Lear, Martin J.; Nosten, Francois H.; Tan, Kevin S. W.; Chow, Larry M. C.			Characterization of the Commercially-Available Fluorescent Chloroquine-BODIPY Conjugate, LynxTag-CQ(GREEN), as a Marker for Chloroquine Resistance and Uptake in a 96-Well Plate Assay	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; IN-VITRO; DRUG-RESISTANCE; MALARIA; PARASITES; TRANSPORT; REVERSAL; EFFLUX; VERAPAMIL; DERIVATIVES	Chloroquine was a cheap, extremely effective drug against Plasmodium falciparum until resistance arose. One approach to reversing resistance is the inhibition of chloroquine efflux from its site of action, the parasite digestive vacuole. Chloroquine accumulation studies have traditionally relied on radiolabelled chloroquine, which poses several challenges. There is a need for development of a safe and biologically relevant substitute. We report here a commercially-available green fluorescent chloroquine-BODIPY conjugate, LynxTag-CQ(GREEN), as a proxy for chloroquine accumulation. This compound localized to the digestive vacuole of the parasite as observed under confocal microscopy, and inhibited growth of chloroquine-sensitive strain 3D7 more extensively than in the resistant strains 7G8 and K1. Microplate reader measurements indicated suppression of LynxTag-CQ(GREEN) efflux after pretreatment of parasites with known reversal agents. Microsomes carrying either sensitiveor resistant-type PfCRT were assayed for uptake; resistant-type PfCRT exhibited increased accumulation of LynxTag-CQ(GREEN), which was suppressed by pretreatment with known chemosensitizers. Eight laboratory strains and twelve clinical isolates were sequenced for PfCRT and Pgh1 haplotypes previously reported to contribute to drug resistance, and pfmdr1 copy number and chloroquine IC(50)s were determined. These data were compared with LynxTag-CQ(GREEN) uptake/fluorescence by multiple linear regression to identify genetic correlates of uptake. Uptake of the compound correlated with the logIC(50) of chloroquine and, more weakly, a mutation in Pgh1, F1226Y.	[Loh, Cheryl C. Y.; Lee, Yan Quan; Chan, Kitti W. K.; Russell, Bruce; Tan, Kevin S. W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117548, Singapore; [Suwanarusk, Rossarin; Renia, Laurent] Singapore Immunol Network Agcy Sci Technol & Res, Biopolis, Singapore, Singapore; [Lee, Yan Quan; Tan, Kevin S. W.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Choy, Kit-Ying; Chow, Larry M. C.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, State Key Lab Chirosci, Kowloon, Hong Kong, Peoples R China; [Lear, Martin J.] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 980, Japan; [Nosten, Francois H.] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England; [Nosten, Francois H.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Nosten, Francois H.] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford, England	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Hong Kong Polytechnic University; Tohoku University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Tan, KSW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117548, Singapore.	kevin_tan@nuhs.edu.sg; larry.chow@polyu.edu.hk	Lee, Yan Quan/T-1058-2019; Lear, Martin/Y-2724-2019; Lear, Martin/D-3350-2013; Renia, Laurent/E-2117-2011; Russell, Bruce/A-9240-2011; Nosten, Francois/AAC-5509-2019; Suwanarusk, Rossarin/E-2115-2013; Chow, Larry/C-2639-2009	Lee, Yan Quan/0000-0001-7509-7474; Lear, Martin/0000-0003-2556-2029; Lear, Martin/0000-0003-2556-2029; Renia, Laurent/0000-0003-0349-1557; Russell, Bruce/0000-0003-2333-4348; Nosten, Francois/0000-0002-7951-0745; Suwanarusk, Rossarin/0000-0002-7310-245X; Chow, Larry/0000-0002-9222-8322	Wellcome Trust of Great Britain; National Research Foundation [NRF2009NRF-POC002-102]; National Medical Research Council [NMRC/1310/2011, NMRC/EDG/1038/2011]; Agency for Science, Technology and Research (A*STAR, Singapore)	Wellcome Trust of Great Britain(Wellcome Trust); National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agency for Science, Technology and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR))	As part of the Oxford Tropical Medicine Research Program of Wellcome Trust-Mahidol University, Shoklo Malaria Research Unit (SMRU) is funded by the Wellcome Trust of Great Britain. The authors further thank the National Research Foundation (NRF2009NRF-POC002-102), the National Medical Research Council (NMRC/1310/2011; NMRC/EDG/1038/2011), and the Agency for Science, Technology and Research (A*STAR, Singapore) for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adovelande J, 1998, BIOCHEM PHARMACOL, V55, P433, DOI 10.1016/S0006-2952(97)00482-6; Alcantara LM, 2013, EXP PARASITOL, V134, P235, DOI 10.1016/j.exppara.2013.03.022; [Anonymous], 2006, DRUG DISCOV TODAY TH; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; BAYOUMI RAL, 1994, ACTA TROP, V58, P141, DOI 10.1016/0001-706X(94)90053-1; Burgess SJ, 2006, J MED CHEM, V49, P5623, DOI 10.1021/jm060399n; Butler AR, 2010, J ROY COLL PHYS EDIN, V40, P172, DOI 10.4997/JRCPE.2010.216; Cabrera M, 2009, BIOCHEMISTRY-US, V48, P9471, DOI 10.1021/bi901034r; Ch'ng JH, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.97; Ch'ng JH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.2; Ch'ng JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01734; COATNEY GR, 1963, AM J TROP MED HYG, V12, P121, DOI 10.4269/ajtmh.1963.12.121; De DY, 1996, AM J TROP MED HYG, V55, P579, DOI 10.4269/ajtmh.1996.55.579; Egan TJ, 2007, CURR OPIN INFECT DIS, V20, P598, DOI 10.1097/QCO.0b013e3282f1673a; Gildenhuys J, 2013, J AM CHEM SOC, V135, P1037, DOI 10.1021/ja308741e; Hempelmann E, 2007, PARASITOL RES, V100, P671, DOI 10.1007/s00436-006-0313-x; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Kelly JX, 2007, ANTIMICROB AGENTS CH, V51, P4133, DOI 10.1128/AAC.00669-07; Krafts K, 2012, PARASITOL RES, V111, P1, DOI 10.1007/s00436-012-2886-x; KROGSTAD DJ, 1992, BIOCHEM PHARMACOL, V43, P57, DOI 10.1016/0006-2952(92)90661-2; KYLE DE, 1990, T ROY SOC TROP MED H, V84, P474, DOI 10.1016/0035-9203(90)90004-X; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Martin RE, 2012, ANTIMICROB AGENTS CH, V56, P2283, DOI 10.1128/AAC.00166-12; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; MARTINEY JA, 1995, J BIOL CHEM, V270, P22393, DOI 10.1074/jbc.270.38.22393; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mok S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-391; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Oduola AMJ, 1998, AM J TROP MED HYG, V58, P625, DOI 10.4269/ajtmh.1998.58.625; Peyton DH, 2012, CURR TOP MED CHEM, V12, P400; Pradines B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-268; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; Summers RL, 2010, VIRULENCE, V1, P304, DOI 10.4161/viru.1.4.12012; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tan W, 2006, ARCH BIOCHEM BIOPHYS, V452, P119, DOI 10.1016/j.abb.2006.06.017; Tram K, 2009, DYES PIGMENTS, V82, P392, DOI 10.1016/j.dyepig.2009.03.001; Valderramos SG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000887; van Schalkwyk DA, 2001, ANTIMICROB AGENTS CH, V45, P3171, DOI 10.1128/AAC.45.11.3171-3174.2001; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x; Zishiri VK, 2011, EUR J MED CHEM, V46, P1729, DOI 10.1016/j.ejmech.2011.02.026	51	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110800	10.1371/journal.pone.0110800	http://dx.doi.org/10.1371/journal.pone.0110800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343249	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000343943500056
J	Huang, TX; Li, S; Li, GC; Tian, Y; Wang, HY; Shi, LF; Perez-Cordon, G; Mao, L; Wang, X; Wang, JF; Feng, HP				Huang, Tuxiong; Li, Shan; Li, Guangchao; Tian, Yuan; Wang, Haiying; Shi, Lianfa; Perez-Cordon, Gregorio; Mao, Li; Wang, Xiaoning; Wang, Jufang; Feng, Hanping			Utility of Clostridium difficile Toxin B for Inducing Anti-Tumor Immunity	PLOS ONE			English	Article							APOPTOTIC TUMOR-CELLS; DENDRITIC CELLS; CALRETICULIN EXPOSURE; HUMAN MONOCYTES; CANCER; IMMUNOGENICITY; INFECTION; PROTEINS; DEATH; RHO	Clostridium difficile toxin B (TcdB) is a key virulence factor of bacterium and induces intestinal inflammatory disease. Because of its potent cytotoxic and proinflammatory activities, we investigated the utility of TcdB in developing anti-tumor immunity. TcdB induced cell death in mouse colorectal cancer CT26 cells, and the intoxicated cells stimulated the activation of mouse bone marrow-derived dendritic cells and subsequent T cell activation in vitro. Immunization of BALB/c mice with toxin-treated CT26 cells elicited potent anti-tumor immunity that protected mice from a lethal challenge of the same tumor cells and rejected pre-injected tumors. The anti-tumor immunity generated was cell-mediated, long-term, and tumor-specific. Further experiments demonstrated that the intact cell bodies were important for the immunogenicity since lysing the toxin-treated tumor cells reduced their ability to induce antitumor immunity. Finally, we showed that TcdB is able to induce potent anti-tumor immunity in B16-F10 melanoma model. Taken together, these data demonstrate the utility of C. difficile toxin B for developing anti-tumor immunity.	[Huang, Tuxiong; Li, Shan; Li, Guangchao; Tian, Yuan; Wang, Haiying; Wang, Jufang] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Huang, Tuxiong; Li, Shan; Shi, Lianfa; Perez-Cordon, Gregorio; Feng, Hanping] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Mao, Li] Univ Maryland, Sch Dent, Dept Oncol & Diagnost, Baltimore, MD 21201 USA; [Wang, Xiaoning] Gen Hosp Peoples Liberat Army, Inst Life Sci, Beijing, Peoples R China	South China University of Technology; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wang, JF (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	jufwang@scut.edu.cn; hfeng@umaryland.edu	Pérez-Cordon, Gregorio/F-7944-2018	Pérez-Cordon, Gregorio/0000-0002-2295-3852	National Institutes of Health (NIH) [R01AI088748, R01DK084509, R56AI99458, U19AI109776]; Department of Health and Human Services; National High Technology Development Program of China [2007AA021702]; Scientific and Technological Specialized Project for the national New Medicine Formulation from China [2011ZX09506-001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099458, U19AI109776, R01AI088748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084509] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National High Technology Development Program of China; Scientific and Technological Specialized Project for the national New Medicine Formulation from China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by grants R01AI088748, R01DK084509, R56AI99458, and U19AI109776 from National Institutes of Health (NIH) and the Department of Health and Human Services to HF; and grants from the National High Technology Development Program of China (2007AA021702) and the Scientific and Technological Specialized Project for the national New Medicine Formulation (2011ZX09506-001) from China to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesa-Jove D, 2010, J MOL BIOL, V396, P1260, DOI 10.1016/j.jmb.2010.01.012; BEKESI JG, 1971, CANCER RES, V31, P2130; Bobo LD, 2013, INFECT IMMUN, V81, P713, DOI 10.1128/IAI.00186-12; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; BUZZI S, 1974, CANCER RES, V34, P3481; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; Farrow MA, 2013, P NATL ACAD SCI USA, V110, P18674, DOI 10.1073/pnas.1313658110; Feng HP, 2001, BLOOD, V97, P3505, DOI 10.1182/blood.V97.11.3505; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Feng HP, 2005, J IMMUNOL, V175, P421, DOI 10.4049/jimmunol.175.1.421; Feng HP, 2003, BLOOD, V101, P245, DOI 10.1182/blood-2002-05-1580; FLEGEL WA, 1991, INFECT IMMUN, V59, P3659, DOI 10.1128/IAI.59.10.3659-3666.1991; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hippenstiel S, 2002, AM J PHYSIOL-LUNG C, V283, pL830, DOI 10.1152/ajplung.00467.2001; Huelsenbeck J, 2007, INFECT IMMUN, V75, P801, DOI 10.1128/IAI.01705-06; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; KUSHNARYOV VM, 1992, CANCER RES, V52, P5096; Linevsky JK, 1997, AM J PHYSIOL-GASTR L, V273, pG1333, DOI 10.1152/ajpgi.1997.273.6.G1333; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Ng EK, 2003, MEDIAT INFLAMM, V12, P3, DOI 10.1080/0962935031000096917; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pothoulakis C, 1996, EUR J GASTROEN HEPAT, V8, P1041, DOI 10.1097/00042737-199611000-00003; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; REDLICH PN, 1994, J SURG ONCOL, V57, P191; RIHN B, 1985, BIOL CELL, V53, P23, DOI 10.1111/j.1768-322X.1985.tb00351.x; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Steinman RM, 2004, SCIENCE, V305, P197, DOI 10.1126/science.1099688; Sun XM, 2009, MICROB PATHOGENESIS, V46, P298, DOI 10.1016/j.micpath.2009.03.002; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12; WANG M, 1995, J IMMUNOL, V154, P4685; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	42	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110826	10.1371/journal.pone.0110826	http://dx.doi.org/10.1371/journal.pone.0110826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340750	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800060
J	Liu, H; Chen, GD; Pan, YF; Chen, ZX; Jin, W; Sun, C; Chen, C; Dong, XJ; Chen, K; Xu, ZP; Zhang, SC; Yu, YX				Liu, Hui; Chen, Guangdi; Pan, Yifeng; Chen, Zexin; Jin, Wen; Sun, Chuan; Chen, Chunjing; Dong, Xuanjun; Chen, Kun; Xu, Zhengping; Zhang, Shanchun; Yu, Yunxian			Occupational Electromagnetic Field Exposures Associated with Sleep Quality: A Cross-Sectional Study	PLOS ONE			English	Article							PHONE BASE STATIONS; CEREBRAL-BLOOD-FLOW; MAGNETIC-FIELDS; MOBILE PHONES; OF-LIFE; PREVALENCE; SYMPTOMS; EXCRETION; WORKERS; CANCER	Background: Exposure to electromagnetic field (EMF) emitted by mobile phone and other machineries concerns half the world's population and raises the problem of their impact on human health. The present study aims to explore the effects of electromagnetic field exposures on sleep quality and sleep duration among workers from electric power plant. Methods: A cross-sectional study was conducted in an electric power plant of Zhejiang Province, China. A total of 854 participants were included in the final analysis. The detailed information of participants was obtained by trained investigators using a structured questionnaire, which including socio-demographic characteristics, lifestyle variables, sleep variables and electromagnetic exposures. Physical examination and venous blood collection were also carried out for every study subject. Results: After grouping daily occupational electromagnetic exposure into three categories, subjects with long daily exposure time had a significantly higher risk of poor sleep quality in comparison to those with short daily exposure time. The adjusted odds ratios were 1.68 (95%CI: 1.18, 2.39) and 1.57 (95%CI: 1.10, 2.24) across tertiles. Additionally, among the subjects with long-term occupational exposure, the longer daily occupational exposure time apparently increased the risk of poor sleep quality (OR (95%CI): 2.12 (1.23 similar to 3.66)in the second tertile; 1.83 (1.07 similar to 3.15) in the third tertile). There was no significant association of long-term occupational exposure duration, monthly electric fee or years of mobile-phone use with sleep quality or sleep duration. Conclusions: The findings showed that daily occupational EMF exposure was positively associated with poor sleep quality. It implies EMF exposure may damage human sleep quality rather than sleep duration.	[Liu, Hui; Pan, Yifeng; Chen, Zexin; Jin, Wen; Chen, Kun; Zhang, Shanchun; Yu, Yunxian] Zhejiang Univ, Sch Med, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Guangdi; Sun, Chuan; Chen, Chunjing; Xu, Zhengping] Zhejiang Univ, Sch Med, Bioelectromagnet Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Hui; Pan, Yifeng; Chen, Zexin; Jin, Wen; Zhang, Shanchun; Yu, Yunxian] Zhejiang Univ, Sch Med, Sch Publ Hlth, Chron Dis Res Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, Xuanjun] Yiwu Ctr Dis Control & Prevent, Yiwu, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Yu, YX (corresponding author), Zhejiang Univ, Sch Med, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China.	yunxianyu@gmail.com			National Basic Research Program of China (973 Program) [2011CB503706]; National Natural Science Foundation of China [81172624]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by grants from the National Basic Research Program of China (973 Program) (Grant No.: 2011CB503706) and the National Natural Science Foundation of China (Grant No.: 81172624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelin T, 2005, SLEEP DISTURBANCES V, P203; Ahlbom A, 2004, ENVIRON HEALTH PERSP, V112, P1741, DOI 10.1289/ehp.7306; Altpeter ES, 2006, BIOELECTROMAGNETICS, V27, P142, DOI 10.1002/bem.20183; Berg-Beckhoff G, 2009, OCCUP ENVIRON MED, V66, P124, DOI 10.1136/oem.2008.039834; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Burch JB, 1998, SCAND J WORK ENV HEA, V24, P183, DOI 10.5271/sjweh.297; Dean GE, 2013, ONCOL NURS FORUM, V40, P441, DOI 10.1188/13.ONF.441-451; Fogler KA, 2012, EMERG HLTH THREATS J, V5; Frei P, 2009, ENVIRON RES, V109, P779, DOI 10.1016/j.envres.2009.04.015; Fritzer G, 2007, BIOELECTROMAGNETICS, V28, P316, DOI 10.1002/bem.20301; Gami AS, 2004, EUR HEART J, V25, P709, DOI 10.1016/j.ehj.2004.03.008; Genuis SJ, 2008, PUBLIC HEALTH, V122, P113, DOI 10.1016/j.puhe.2007.04.008; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Guo YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071107; Halgamuge MN, 2012, PINEAL MELATONIN LEV; Huber R, 2005, EUR J NEUROSCI, V21, P1000, DOI 10.1111/j.1460-9568.2005.03929.x; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; Hutter HP, 2006, OCCUP ENVIRON MED, V63, P307, DOI 10.1136/oem.2005.020784; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; Liu R, SLEEP MED, V12, P914; Lo CMH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-72; Loughran SP, 2005, NEUROREPORT, V16, P1973, DOI 10.1097/01.wnr.0000186593.79705.3c; Lowden A, 2011, BIOELECTROMAGNETICS, V32, P4, DOI 10.1002/bem.20609; Manabe K, 2000, GERONTOLOGY, V46, P318, DOI 10.1159/000022184; Mohler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037455; Mohler E, 2010, RADIAT RES, V174, P347, DOI 10.1667/RR2153.1; Monterrosa-Castro A, 2012, MENOPAUSE; Pfluger DH, 1996, J PINEAL RES, V21, P91, DOI 10.1111/j.1600-079X.1996.tb00275.x; Reiter Russel J., 1994, Reviews on Environmental Health, V10, P171; Repacholi MH, 2012, BIOELECTROMAGNETICS, V33, P187, DOI 10.1002/bem.20716; Roberts RE, 2012, J AFFECT DISORD; Roosli M, 2010, B WORLD HEALTH ORGAN, V88, P887, DOI 10.2471/BLT.09.071852; Schreier N, 2006, SOZ PRAVENTIV MED, V51, P202, DOI 10.1007/s00038-006-5061-2; Siu YF, 2012, PAIN MED, V13, P1292, DOI 10.1111/j.1526-4637.2012.01473.x; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Thomas S, 2008, BIOELECTROMAGNETICS, V29, P463, DOI 10.1002/bem.20414; Valberg PA, 2007, ENVIRON HEALTH PERSP, V115, P416, DOI 10.1289/ehp.9633; Wang Hui-shan, 2007, Zhonghua Yufang Yixue Zazhi, V41, P204; WILSON BW, 1990, J PINEAL RES, V9, P259, DOI 10.1111/j.1600-079X.1990.tb00901.x; Yu YX, 2007, SLEEP, V30, P1688, DOI 10.1093/sleep/30.12.1688	40	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110825	10.1371/journal.pone.0110825	http://dx.doi.org/10.1371/journal.pone.0110825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340654	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800059
J	Lopez-Carretero, A; Diaz-Castelazo, C; Boege, K; Rico-Gray, V				Lopez-Carretero, Antonio; Diaz-Castelazo, Cecilia; Boege, Karina; Rico-Gray, Victor			Evaluating the Spatio-Temporal Factors that Structure Network Parameters of Plant-Herbivore Interactions	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; FOOD-WEB; SPECIES COMPOSITION; INSECT HERBIVORES; HOST-SPECIFICITY; BETA-DIVERSITY; FOREST; COMMUNITIES; SPECIALIZATION; TREE	Despite the dynamic nature of ecological interactions, most studies on species networks offer static representations of their structure, constraining our understanding of the ecological mechanisms involved in their spatio-temporal stability. This is the first study to evaluate plant-herbivore interaction networks on a small spatio-temporal scale. Specifically, we simultaneously assessed the effect of host plant availability, habitat complexity and seasonality on the structure of plant-herbivore networks in a coastal tropical ecosystem. Our results revealed that changes in the host plant community resulting from seasonality and habitat structure are reflected not only in the herbivore community, but also in the emergent properties (network parameters) of the plant-herbivore interaction network such as connectance, selectiveness and modularity. Habitat conditions and periods that are most stressful favored the presence of less selective and susceptible herbivore species, resulting in increased connectance within networks. In contrast, the high degree of selectivennes (i.e. interaction specialization) and modularity of the networks under less stressful conditions was promoted by the diversification in resource use by herbivores. By analyzing networks at a small spatio-temporal scale we identified the ecological factors structuring this network such as habitat complexity and seasonality. Our research offers new evidence on the role of abiotic and biotic factors in the variation of the properties of species interaction networks.	[Lopez-Carretero, Antonio; Diaz-Castelazo, Cecilia] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Boege, Karina] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Rico-Gray, Victor] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico	Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Veracruzana	Diaz-Castelazo, C (corresponding author), Inst Ecol AC, Xalapa, Veracruz, Mexico.	diazcastelazogm@gmail.com	Díaz Castelazo, Cecilia/Q-8973-2018; Paré, Karina Boege/AAP-9596-2021	Díaz Castelazo, Cecilia/0000-0002-0185-6607; 	CONACYT [106575, 302184]; Instituto de Ecologia A.C. (INECOL); Universidad Veracruzana, CONACYT [I010/152/2014 C-133/2014]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Ecologia A.C. (INECOL); Universidad Veracruzana, CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Research was supported by grant (project) number 106575 from CONACYT to Cecilia Diaz-Castelazo, CONACYT fellowship number 302184 to Antonio Lopez-Carretero, and Universidad Veracruzana, I010/152/2014 C-133/2014 provided by CONACYT. We acknowledge the financial support provided by Instituto de Ecologia A.C. (INECOL) through the Postgraduate Secretary to Antonio Lopez-Carretero. CONACYT URL is http://www.conacyt.gob.mx/Paginas/InicioNueva.aspx, INECOL URL is http://www.inecol.mx/posgrado/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barber NA, 2011, ECOLOGY, V92, P699, DOI 10.1890/10-0125.1; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Basset Y, 1996, ECOLOGY, V77, P1906, DOI 10.2307/2265793; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bezemer TM, 1998, OIKOS, V82, P212, DOI 10.2307/3546961; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Boege K, 2005, OECOLOGIA, V143, P117, DOI 10.1007/s00442-004-1779-9; Brehm G, 2003, DIVERS DISTRIB, V9, P351, DOI 10.1046/j.1472-4642.2003.00023.x; Cagnolo L., 2011, J ANIM ECOL, V12, P1; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; de Ruiter PC, 2005, SCIENCE, V309, P68, DOI 10.1126/science.1096112; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Dupont YL, 2009, J ANIM ECOL, V78, P346, DOI 10.1111/j.1365-2656.2008.01501.x; Fontaine C, 2009, P R SOC B, V276, P3027, DOI 10.1098/rspb.2009.0635; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GASTON KJ, 1988, AM NAT, V132, P662, DOI 10.1086/284881; Heleno R, 2012, ECOL INDIC, V14, P7, DOI 10.1016/j.ecolind.2011.06.032; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Hughes JB, 2000, OECOLOGIA, V123, P375, DOI 10.1007/s004420051024; Janzen Daniel H., 1993, P448; JANZEN DH, 1988, BIOTROPICA, V20, P120, DOI 10.2307/2388184; Jeffries JM, 2006, ECOL APPL, V16, P901, DOI 10.1890/1051-0761(2006)016[0901:FAIOIH]2.0.CO;2; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Kaartinen R, 2011, J ANIM ECOL, V80, P622, DOI 10.1111/j.1365-2656.2011.01811.x; Laliberte E, 2010, ECOLOGY, V91, P1740, DOI 10.1890/09-1328.1; Leps J, 1998, OIKOS, V81, P538, DOI 10.2307/3546774; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Lopez-Carretero A, 2010, COMPOSICION DIVERSID; Marquitti FMD, 2013, ECOGRAPHY; Martinez ML, 1994, SOBREVIVENCIA ESTABL; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; MORENO-CASASOLA P, 1982, Biotica (Mexico), V7, P577; MORENO-CASASOLA P., 2006, ENTORNOS VERACRUZANO, P205; Murakami M, 2008, ECOL RES, V23, P179, DOI 10.1007/s11284-007-0353-4; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2004, ECOL LETT, V7, P1090, DOI 10.1111/j.1461-0248.2004.00666.x; NYLIN S, 1988, OIKOS, V53, P381, DOI 10.2307/3565539; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Perez-Maqueo O, 1995, ANALISIS EFECTO DIST; Poorter L, 2004, PLANT BIOLOGY, V6, P746, DOI 10.1055/s-2004-821269; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; Price PW, 2004, CONSERV BIOL, V18, P1405, DOI 10.1111/j.1523-1739.2004.00547.x; Price PW, 2002, ECOL RES, V17, P241, DOI 10.1046/j.1440-1703.2002.00483.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; RAUSHER MD, 1987, ECOLOGY, V68, P869, DOI 10.2307/1938358; RAUSHER MD, 1983, ANIM BEHAV, V31, P341, DOI 10.1016/S0003-3472(83)80052-9; REDFEARN A, 1988, ECOL MONOGR, V58, P39, DOI 10.2307/1942633; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; RicoGray V, 1996, SOUTHWEST NAT, V41, P434; Sanchez-Galvan IR, 2012, J TROP ECOL, V28, P603, DOI 10.1017/S0266467412000582; Staley JT, 2006, ECOL ENTOMOL, V31, P460, DOI 10.1111/j.1365-2311.2006.00808.x; Thebault E, 2007, OIKOS, V116, P163, DOI 10.1111/j.2006.0030-1299.15007.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson JN, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P7; Travieso-Bello AC, 2006, ENTORNOS VERACRUZANO, P140; Trotter RT, 2008, ECOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-2311.2007.00941.x; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Valladares G, 2012, OIKOS, V121, P299, DOI 10.1111/j.1600-0706.2011.19671.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Villa-Galaviz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053009; Whittaker JB, 2001, J ECOL, V89, P507, DOI 10.1046/j.0022-0477.2001.00582.x	76	38	38	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110430	10.1371/journal.pone.0110430	http://dx.doi.org/10.1371/journal.pone.0110430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340790	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800035
J	Sanchez-Baracaldo, P; Thomas, GH				Sanchez-Baracaldo, Patricia; Thomas, Gavin H.			Adaptation and Convergent Evolution within the Jamesonia-Eriosorus Complex in High-Elevation Biodiverse Andean Hotspots	PLOS ONE			English	Article							RELAXED PHYLOGENETICS; PLANT DIVERSIFICATION; ALTITUDINAL GRADIENT; MOLECULAR PHYLOGENY; ESPELETIA; BIOGEOGRAPHY; TEMPERATURE; RADIATION; RATES; PHOTOSYNTHESIS	The recent uplift of the tropical Andes (since the late Pliocene or early Pleistocene) provided extensive ecological opportunity for evolutionary radiations. We test for phylogenetic and morphological evidence of adaptive radiation and convergent evolution to novel habitats (exposed, high-altitude paramo habitats) in the Andean fern genera Jamesonia and Eriosorus. We construct time-calibrated phylogenies for the Jamesonia-Eriosorus clade. We then use recent phylogenetic comparative methods to test for evolutionary transitions among habitats, associations between habitat and leaf morphology, and ecologically driven variation in the rate of morphological evolution. Paramo species (Jamesonia) display morphological adaptations consistent with convergent evolution in response to the demands of a highly exposed environment but these adaptations are associated with microhabitat use rather than the paramo per se. Species that are associated with exposed microhabitats (including Jamesonia and Eriorsorus) are characterized by many but short pinnae per frond whereas species occupying sheltered microhabitats (primarily Eriosorus) have few but long pinnae per frond. Pinnae length declines more rapidly with altitude in sheltered species. Rates of speciation are significantly higher among paramo than non-paramo lineages supporting the hypothesis of adaptation and divergence in the unique Paramo biodiversity hotspot.	[Sanchez-Baracaldo, Patricia] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Thomas, Gavin H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Bristol; University of Sheffield	Sanchez-Baracaldo, P (corresponding author), Univ Bristol, Sch Geog Sci, Bristol, Avon, England.	p.sanchez-baracaldo@bristol.ac.uk; gavin.thomas@sheffield.ac.uk	Sanchez-Baracaldo, Patricia/A-5309-2017; Thomas, Gavin/AAE-8959-2019	Thomas, Gavin/0000-0002-1982-6051; Sanchez-Baracaldo, Patricia/0000-0002-5216-2664	National Science Foundation [9801245]; Vice Chancellor for Research; Department of Integrative Biology, University of California at Berkeley; Royal Society Dorothy Hodgkin Fellowship and Colciencias, Colombia; NERC [NERC NE/G012938/1]	National Science Foundation(National Science Foundation (NSF)); Vice Chancellor for Research; Department of Integrative Biology, University of California at Berkeley; Royal Society Dorothy Hodgkin Fellowship and Colciencias, Colombia; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a National Science Foundation Doctoral Dissertation Improvement Grant (9801245), the Vice Chancellor for Research Fund Award, and several grants from the Department of Integrative Biology, University of California at Berkeley. PSB has received funding support from the Royal Society Dorothy Hodgkin Fellowship and Colciencias, Colombia. GHT was supported by a NERC Postdoctoral Fellowship NERC NE/G012938/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azocar A, 1980, ESTUDIO VARIABILIDAD; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; BARUCH Z, 1979, ECOLOGY, V60, P85, DOI 10.2307/1936471; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Beck E., 1994, TROPICAL ALPINE ENV, P77; Bell CD, 2005, ORG DIVERS EVOL, V5, P147, DOI 10.1016/j.ode.2004.10.014; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; Cabrera HM, 1996, REV CHIL HIST NAT, V69, P309; Cabrera HM, 1998, OECOLOGIA, V114, P145, DOI 10.1007/s004420050430; Cochran AT, 2014, PHYTOKEYS, V35, P23, DOI 10.3897/phytokeys.35.6886; Cosacov A, 2010, J BIOGEOGR, V37, P1463, DOI 10.1111/j.1365-2699.2010.02307.x; de Lange PJ, 2010, AUST SYST BOT, V23, P309, DOI 10.1071/SB10019; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Hagen Bernhard von, 2001, ORG DIVERS EVOL, V1, P61, DOI [10.1078/1439-6092-00005., DOI 10.1078/1439-6092-00005]; HEDBERG OLOV, 1964, ACTA PHYTOGEOGR SUECICA, V49, P1; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; HOOGHIEMSTRA H, 1989, PALAEOGEOGR PALAEOCL, V72, P11, DOI 10.1016/0031-0182(89)90129-6; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Jabaily RS, 2013, BOT J LINN SOC, V171, P201, DOI 10.1111/j.1095-8339.2012.01307.x; Johnson DM, 2004, TREE PHYSIOL, V24, P377, DOI 10.1093/treephys/24.4.377; Karl R, 2013, ANN BOT-LONDON, V112, P983, DOI 10.1093/aob/mct165; KEELEY JE, 1984, NATURE, V310, P694, DOI 10.1038/310694a0; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Logacheva MD, 2010, MOL PHYLOGENET EVOL, V57, P471, DOI 10.1016/j.ympev.2010.06.001; Luteyn J.L., 1992, PARAMO ANDEAN ECOSYS, P1; Luteyn JL, 1999, NEW YORK BOT GARDEN; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Madrinan Santiago, 2013, Frontiers in Genetics, V4, P192, DOI 10.3389/fgene.2013.00192; MEINZER F, 1985, ECOLOGY, V66, P512, DOI 10.2307/1940399; Meinzer F, 1994, TROPICAL ALPINE ENV, P45; MILLER GA, 1986, OECOLOGIA, V70, P155, DOI 10.1007/BF00377126; MONASTERIO M, 1991, TRENDS ECOL EVOL, V6, P387, DOI 10.1016/0169-5347(91)90159-U; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nuerk Nicolai M., 2013, Frontiers in Genetics, V4, P175, DOI 10.3389/fgene.2013.00175; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pennington RT, 2010, P NATL ACAD SCI USA, V107, P13783, DOI 10.1073/pnas.1001317107; Rada F, 1998, ACTA OECOL, V19, P73, DOI 10.1016/S1146-609X(98)80010-6; Rambaut A, 1996, RAMBAUT SE AL V2 0A1; Rambaut A, 2009, RAMBAUT TRACER V1 4; Rauscher JT, 2002, AM J BOT, V89, P1074, DOI 10.3732/ajb.89.7.1074; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sakai A., 1987, Frost survival of plants. Responses and adaptation to freezing stress.; Sanchez-Baracaldo P, 2004, AM J BOT, V91, P274, DOI 10.3732/ajb.91.2.274; Sarmiento G., 1986, HIGH ALTITUDE TROPIC, V11, P45; Sidlauskas B, 2008, EVOLUTION, V62, P3135, DOI 10.1111/j.1558-5646.2008.00519.x; Sklenar P, 2011, BOT REV, V77, P71, DOI 10.1007/s12229-010-9061-9; SMITH AP, 1980, J ECOL, V68, P63, DOI 10.2307/2259244; SMITH AP, 1987, ANNU REV ECOL SYST, V18, P137, DOI 10.1146/annurev.es.18.110187.001033; Thomas GH, 2006, P ROY SOC B-BIOL SCI, V273, P1619, DOI 10.1098/rspb.2006.3488; Thomas GH, 2012, METHODS ECOL EVOL, V3, P145, DOI 10.1111/j.2041-210X.2011.00132.x; Thomas GH, 2009, EVOLUTION, V63, P2017, DOI 10.1111/j.1558-5646.2009.00694.x; Tropicos.org, 2014, MISS BOT GARD; Tryon AF, 1970, CONTRIB GRAY HERB HA, V200, P54, DOI [10.5962/p.336423, DOI 10.5962/P.336423]; TRYON ALICE F., 1962, CONTRIB GRAY HERBARIUM HARVARD UNIV, V191, P109; Tryon RM, 1982, PTERIDACEAE FERNS AL, P213; Van der Hammen T., 1960, LEI DES GEOL MEDED, V25, P261; VANDERHAMMEN T, 1985, J GEOL SOC LONDON, V142, P483, DOI 10.1144/gsjgs.142.3.0483; Wikstrom N, 1999, PLANT SYST EVOL, V218, P221, DOI 10.1007/BF01089229; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zacharias EH, 2010, SYST BOT, V35, P839, DOI 10.1600/036364410X539907	69	19	19	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110618	10.1371/journal.pone.0110618	http://dx.doi.org/10.1371/journal.pone.0110618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340770	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000343662800043
J	Sicking, I; Edlund, K; Wesbuer, E; Weyer, V; Battista, MJ; Lebrecht, A; Solbach, C; Grinberg, M; Lotz, J; Hoffmann, G; Rahnenfuhrer, J; Hengstler, JG; Schmidt, M				Sicking, Isabel; Edlund, Karolina; Wesbuer, Eva; Weyer, Veronika; Battista, Marco J.; Lebrecht, Antje; Solbach, Christine; Grinberg, Marianna; Lotz, Johannes; Hoffmann, Gerald; Rahnenfuehrer, Joerg; Hengstler, Jan G.; Schmidt, Marcus			Prognostic Influence of Pre-Operative C-Reactive Protein in Node-Negative Breast Cancer Patients	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; SURVIVAL; RISK; RECURRENCE; PREDICTOR; MARKER	The importance of inflammation is increasingly noticed in cancer. The aim of this study was to analyze the prognostic influence of pre-operative serum C-reactive protein (CRP) in a cohort of 148 lymph node-negative breast cancer patients. The prognostic significance of CRP level for disease-free survival (DFS), metastasis-free survival (MFS) and overall survival (OS) was evaluated using univariate and multivariate Cox regression, also including information on age at diagnosis, tumor size, tumor grade, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status, proliferation index (Ki67) and molecular subtype, as well as an assessment of the presence of necrosis and inflammation in the tumor tissue. Univariate analysis showed that CRP, as a continuous variable, was significantly associated with DFS (P = 0.002, hazard ratio [HR] = 1.04, 95% confidence interval [CI] = 1.02-1.07) and OS (P = 0.036, HR = 1.03, 95% CI = 1.00-1.06), whereas a trend was observed for MFS (P = 0.111). In the multivariate analysis, CRP retained its significance for DFS (P = 0.033, HR = 1.01, 95% CI = 1.00-1.07) as well as OS (P = 0.023, HR = 1.03, 95% CI = 1.00-1.06), independent of established prognostic factors. Furthermore, large-scale gene expression analysis by Affymetrix HG-U133A arrays was performed for 72 (48.6%) patients. The correlations between serum CRP and gene expression levels in the corresponding carcinoma of the breast were assessed using Spearman's rank correlation, controlled for false-discovery rate. No significant correlation was observed between CRP level and gene expression indicative of an ongoing local inflammatory process. In summary, pre-operatively elevated CRP levels at the time of diagnosis were associated with shorter DFS and OS independent of established prognostic factors in node-negative breast cancer, supporting a possible link between inflammation and prognosis in breast cancer.	[Sicking, Isabel; Wesbuer, Eva; Battista, Marco J.; Lebrecht, Antje; Solbach, Christine; Hoffmann, Gerald; Schmidt, Marcus] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, D-55122 Mainz, Germany; [Edlund, Karolina; Hengstler, Jan G.] Dortmund Univ Technol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Weyer, Veronika] Johannes Gutenberg Univ Mainz, Inst Med Biometry Epidemiol & Informat, D-55122 Mainz, Germany; [Grinberg, Marianna; Rahnenfuehrer, Joerg] Dortmund Univ Technol, Dept Stat, Dortmund, Germany; [Lotz, Johannes] Johannes Gutenberg Univ Mainz, Inst Clin Chem, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Johannes Gutenberg University of Mainz; Dortmund University of Technology; Johannes Gutenberg University of Mainz	Schmidt, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, D-55122 Mainz, Germany.	marcus.schmidt@unimedizin-mainz.de	Schmidt, Marcus/H-3383-2013; Weyer-Elberich, Veronika/AAB-8993-2020; Solbach, Christine/AAU-7379-2020	Schmidt, Marcus/0000-0003-1365-2414; Hengstler, Jan/0000-0002-1427-5246; Rahnenfuhrer, Jorg/0000-0002-8947-440X	Federal Ministry of Education and Research	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (BMBF, NGFN project Oncoprofile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Murri AM, 2007, BRIT J CANCER, V96, P891, DOI 10.1038/sj.bjc.6603682; Albuquerque K V, 1995, Eur J Surg Oncol, V21, P504, DOI 10.1016/S0748-7983(95)96935-7; Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; ALTMAN DG, 1989, STAT MED, V8, P771, DOI 10.1002/sim.4780080702; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crumley ABC, 2006, BRIT J CANCER, V94, P1568, DOI 10.1038/sj.bjc.6603150; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferro DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020706; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Heys SD, 1998, INT J ONCOL, V13, P589; Laghi L, 2009, LANCET ONCOL, V10, P877, DOI 10.1016/S1470-2045(09)70186-X; McArdle PA, 2006, UROL INT, V77, P127, DOI 10.1159/000093905; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Metze K, 2008, PATHOL RES PRACT, V204, P213, DOI 10.1016/j.prp.2007.12.002; Metze K, 2011, LANCET ONCOL, V12, P1095, DOI 10.1016/S1470-2045(11)70309-6; Metze K, 2011, J AM COLL SURGEONS, V212, P132, DOI 10.1016/j.jamcollsurg.2010.10.004; O'Hanlon DM, 2002, ANTICANCER RES, V22, P1289; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Ravishankaran P, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-18; Reis-Alves SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081048; ROBERTSON JFR, 1991, CANCER IMMUNOL IMMUN, V33, P403, DOI 10.1007/BF01741602; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Schmidt M, 2012, Minerva Ginecol, V64, P53; Schmidt M, 2009, ANN ONCOL, V20, P258, DOI 10.1093/annonc/mdn590; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Scott HR, 2002, BRIT J CANCER, V87, P264, DOI 10.1038/sj.bjc.6600466; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tibau A, 2013, BREAST CANCER RES TR, V141, P485, DOI 10.1007/s10549-013-2694-8; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Yigit E, 2008, EUR J INTERN MED, V19, P602, DOI 10.1016/j.ejim.2007.06.036	38	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111306	10.1371/journal.pone.0111306	http://dx.doi.org/10.1371/journal.pone.0111306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340395	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800101
J	Feinberg, JA; Newman, CE; Watkins-Colwell, GJ; Schlesinger, MD; Zarate, B; Curry, BR; Shaffer, HB; Burger, J				Feinberg, Jeremy A.; Newman, Catherine E.; Watkins-Colwell, Gregory J.; Schlesinger, Matthew D.; Zarate, Brian; Curry, Brian R.; Shaffer, H. Bradley; Burger, Joanna			Cryptic Diversity in Metropolis: Confirmation of a New Leopard Frog Species (Anura: Ranidae) from New York City and Surrounding Atlantic Coast Regions	PLOS ONE			English	Article							RANA-PIPIENS; CONSERVATION; INFERENCE; HYLIDAE; MRBAYES	We describe a new cryptic species of leopard frog from the New York City metropolitan area and surrounding coastal regions. This species is morphologically similar to two largely parapatric eastern congeners, Rana sphenocephala and R. pipiens. We primarily use bioacoustic and molecular data to characterize the new species, but also examine other lines of evidence. This discovery is unexpected in one of the largest and most densely populated urban parts of the world. It also demonstrates that new vertebrate species can still be found periodically even in well-studied locales rarely associated with undocumented biodiversity. The new species typically occurs in expansive open-canopied wetlands interspersed with upland patches, but centuries of loss and impact to these habitats give some cause for conservation concern. Other concerns include regional extirpations, fragmented extant populations, and a restricted overall geographic distribution. We assign a type locality within New York City and report a narrow and largely coastal lowland distribution from central Connecticut to northern New Jersey (based on genetic data) and south to North Carolina (based on call data).	[Feinberg, Jeremy A.; Curry, Brian R.; Burger, Joanna] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Newman, Catherine E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Newman, Catherine E.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Watkins-Colwell, Gregory J.] Yale Peabody Museum Nat Hist, Div Vertebrate Zool, New Haven, CT USA; [Schlesinger, Matthew D.] SUNY Albany, Coll Environm Sci & Forestry, New York Nat Heritage Program, Albany, NY 12222 USA; [Zarate, Brian] New Jersey Div Fish & Wildlife, Endangered & Nongame Species Program, Clinton, NJ USA; [Shaffer, H. Bradley] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Shaffer, H. Bradley] Univ Calif Los Angeles, Inst Environm & Sustainabil, La Kretz Ctr Calif Conservat Sci, Los Angeles, CA USA; [Burger, Joanna] Rutgers State Univ, Cell Biol & Neurosci & Environm & Occupat Hlth Sc, Piscataway, NJ USA	Rutgers State University New Brunswick; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) College of Environmental Science & Forestry; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rutgers State University New Brunswick	Feinberg, JA (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	jeremy.feinberg@rutgers.edu		Newman, Catherine/0000-0002-1862-7245; Watkins-Colwell, Greg/0000-0002-7789-9806	Rutgers Graduate School of New Brunswick Bevier Dissertation Fellowship; New Jersey Department of Environmental Protection Conserve Wildlife Matching Grant; NIH NIEHS Center [P30ES005022]; Hudson River Foundation; Rutgers Graduate Program in Ecology and Evolution, Brookhaven National Laboratory; Foundation for Ecological Research in the Northeast; Tiko Fund; NSF [DEB-1146033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; Direct For Biological Sciences [1257648] Funding Source: National Science Foundation	Rutgers Graduate School of New Brunswick Bevier Dissertation Fellowship; New Jersey Department of Environmental Protection Conserve Wildlife Matching Grant; NIH NIEHS Center; Hudson River Foundation; Rutgers Graduate Program in Ecology and Evolution, Brookhaven National Laboratory; Foundation for Ecological Research in the Northeast; Tiko Fund; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support for field work and analysis was primarily provided by a Rutgers Graduate School of New Brunswick Bevier Dissertation Fellowship and a New Jersey Department of Environmental Protection Conserve Wildlife Matching Grant to JAF, an NIH NIEHS Center grant P30ES005022 to JB, and a Hudson River Foundation grant to JB and JAF. Partial support was also provided by the Rutgers Graduate Program in Ecology and Evolution, Brookhaven National Laboratory, the Foundation for Ecological Research in the Northeast, and the Tiko Fund. Funding for genetics laboratory work for the holotype, performed at the Louisiana State University Museum of Natural Science, was provided by NSF DEB-1146033 (to Christopher C. Austin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; Barbour T., 1923, CHECK LIST N AM AMPH; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boulenger GA, 1920, P AM ACAD ARTS SCI, V55, P411; Bragg Arthur N., 1941, GREAT BASIN NAT, V2, P109; Bridges AS, 2000, COPEIA, P587, DOI 10.1643/0045-8511(2000)000[0587:TVIACB]2.0.CO;2; Brown L.E, 1977, Bulletin of Zoological Nomenclature, V33, P195; BROWN LE, 1973, AM ZOOL, V13, P73; Burger J, 2014, ECOHEALTH, V11, P154, DOI 10.1007/s10393-014-0913-3; BURT CHARLES E., 1938, TRANS KANSAS ACAD SCI, V41, P331; Charif RA, 2010, RAVEN PRO V 1 4 US M; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Conant R., 1991, FIELD GUIDE REPTILES; Conant R., 1979, PINE BARRENS ECOSYST, P467; Cope E.D., 1889, B US NATL MUSEUM, V34, P1, DOI DOI 10.5962/BHL.TITLE; Daudin FM, 1802, HIST NATURELLE RAINE; Dickerson MC, 1906, FROG BOOK N AM TOADS, DOI [10.5962/bhl.title.1542, DOI 10.5962/BHL.TITLE.1542]; ESRI,, 2010, ARCGIS DESKT REL 10; Florida R, 2008, CAMB J REG ECON SOC, V1, P459, DOI 10.1093/cjres/rsn018; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR, 2013, AMPHIBIAN SPECIES WO; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gerhardt H. Carl, 1995, Amphibian Biology, V2, P603; Grant R., 1941, Copeia, V1941, P151, DOI 10.2307/1437739; Harlan R, 1826, AM J SCI ARTS, V10, P53; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; HILLIS DM, 1988, ANNU REV ECOL SYST, V19, P39; Hinckley M. H., 1882, Proceedings of the Boston Society, Vxxi, P307; Holbrook J.E., 1836, N AM HERPETOLOGY; Holmes SJ, 1916, BIOL FROG, DOI [10.5962/bhl.title.30369, DOI 10.5962/BHL.TITLE.30369]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulse A.C., 2001, AMPHIBIANS REPTILES; JOHNSON C, 1966, TEX J SCI, V18, P361; Kauffeld C. F., 1937, Herpetologica Chicago, V1, P84; Kauffeld CF, 1936, HERPETOLOGICA, V1, P11; Kellogg R., 1932, US Nat Mus Washington Bull, V160, P1; Kiviat E., 2011, FROG CALL SURVEYS UR; KLEMENS M W, 1987, Northeastern Environmental Science, V6, P99; Klemens M. W., 1993, BULLETIN, V112, P1; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lannoo MJ., 2005, AMPHIBIAN DECLINES C, DOI [10.1525/california/9780520235922.001.0001., DOI 10.1525/CALIFORNIA/9780520235922.001.0001, 10.1525/california/9780520235922.001.0001]; LATHAM R, 1971, Engelhardtia, V4, P58; Lavilla EO, 2010, ZOOTAXA, P1; Lemmon EM, 2008, ZOOTAXA, P1; Mathewson R, 1955, P STATEN ISLAND I AR, V17, P28; McCoy CJ, 1982, CARNEGIE MUS NAT HIS, V6, P1; MOORE JA, 1949, EVOLUTION, V3, P1, DOI 10.2307/2405448; MOORE JA, 1975, AM ZOOL, V15, P837; Moore JA, 1944, B AM MUS NAT HIST, V82, P346; Napoli MF, 2005, HERPETOLOGICA, V61, P63, DOI 10.1655/03-41; Netting MG, 1933, P PENN ACAD SCI, V7, P100; Newman CE, 2012, MOL PHYLOGENET EVOL, V63, P445, DOI 10.1016/j.ympev.2012.01.021; Overton F, 1914, BROOKLYN MUS Q, V1, P30; Overton F, 1914, MUS BROOKLYN I ARTS, V2, P21; PACE A. E., 1974, MISC PUBL MUS ZOOL, P1; Penna M, 2011, ETHOLOGY, V117, P63, DOI 10.1111/j.1439-0310.2010.01847.x; PLATZ JE, 1972, COPEIA, P232; PORTER K. R., 1941, BIOL BULL, V80, P238, DOI 10.2307/1537601; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RORABAUGH JC, 2005, AMPHIBIAN DECLINES C, P00570; RUIBAL RODOLFO, 1957, COPEIA, V1957, P212, DOI 10.2307/1439360; Savage J.M., 2002, AMPHIBIANS REPTILES; SCHLAUCH F C, 1971, Engelhardtia, V4, P47; Schlauch F.C, 1978, PITCH PINE NAT, V4, P5; Schmidt K.P., 1953, CHECK LIST N AM AMPH, V6th; Schreber H., 1782, NATURFORSCHER HALLE, V18, P182; SHAFFER LL, 1991, PENNSYLVANIA AMPHIBI; Sherwood WJ, 1898, P LINN SOC NY, V10, P9; Shiels AL, 1999, PENNSYLVANIA ANGLER, V1999, P58; Smith Hobart M., 1995, Herpetological Review, V26, P14; SMITH PHILIP W., 1961, ILLINOIS NAT HIST SURV BULL, V28, P1; Stanaka W, 1933, P PENN ACAD SCI, V7, P96; Stejneger LH, 1939, CHECK LIST N AM AMPH, DOI [10.4159/harvard.9780674592728, DOI 10.4159/HARVARD.9780674592728]; STEJNEGER LH, 1933, CHECK LIST N AM AMPH; Surface HA, 1913, ZOOL B PENN DEP AGRI, V3, P66; Trapido H., 1938, Copeia Ann Arbor, P117; Villani R, 1997, LONG ISLAND NATUTAL; Wells K.D., 2010, ECOLOGY BEHAV AMPHIB, DOI DOI 10.7208/CHICAGO/9780226893334.001.0001.; Wollerman L, 1999, ANIM BEHAV, V57, P529, DOI 10.1006/anbe.1998.1013; Wright A, 1949, HDB FROGS TOADS US C; Wright AH, 1933, HDB FROGS TOADS US C, DOI [10.5962/bhl.title.6753, DOI 10.5962/BHL.TITLE.6753]	83	31	32	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e108213	10.1371/journal.pone.0108213	http://dx.doi.org/10.1371/journal.pone.0108213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354068	Green Submitted, gold, Green Published			2022-12-26	WOS:000345204200004
J	Hamon, R; Homan, CC; Tran, HB; Mukaro, VR; Lester, SE; Roscioli, E; Bosco, MD; Murgia, CM; Ackland, ML; Jersmann, HP; Lang, C; Zalewski, PD; Hodge, SJ				Hamon, Rhys; Homan, Claire C.; Tran, Hai B.; Mukaro, Violet R.; Lester, Susan E.; Roscioli, Eugene; Bosco, Mariea D.; Murgia, Chiara M.; Ackland, Margaret Leigh; Jersmann, Hubertus P.; Lang, Carol; Zalewski, Peter D.; Hodge, Sandra J.			Zinc and Zinc Transporters in Macrophages and Their Roles in Efferocytosis in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ALVEOLAR MACROPHAGES; EXPRESSION; LUNG; HOMEOSTASIS; DEFICIENCY; RECEPTOR; ACTIVATION; CELLS; PHAGOCYTOSIS	Our previous studies have shown that nutritional zinc restriction exacerbates airway inflammation accompanied by an increase in caspase-3 activation and an accumulation of apoptotic epithelial cells in the bronchioles of the mice. Normally, apoptotic cells are rapidly cleared by macrophage efferocytosis, limiting any secondary necrosis and inflammation. We therefore hypothesized that zinc deficiency is not only pro-apoptotic but also impairs macrophage efferocytosis. Impaired efferocytic clearance of apoptotic epithelial cells by alveolar macrophages occurs in chronic obstructive pulmonary disease (COPD), cigarette-smoking and other lung inflammatory diseases. We now show that zinc is a factor in impaired macrophage efferocytosis in COPD. Concentrations of zinc were significantly reduced in the supernatant of bronchoalveolar lavage fluid of patients with COPD who were current smokers, compared to healthy controls, smokers or COPD patients not actively smoking. Lavage zinc was positively correlated with AM efferocytosis and there was decreased efferocytosis in macrophages depleted of Zn in vitro by treatment with the membrane-permeable zinc chelator TPEN. Organ and cell Zn homeostasis are mediated by two families of membrane ZIP and ZnT proteins. Macrophages of mice null for ZIP1 had significantly lower intracellular zinc and efferocytosis capability, suggesting ZIP1 may play an important role. We investigated further using the human THP-1 derived macrophage cell line, with and without zinc chelation by TPEN to mimic zinc deficiency. There was no change in ZIP1 mRNA levels by TPEN but a significant 3-fold increase in expression of another influx transporter ZIP2, consistent with a role for ZIP2 in maintaining macrophage Zn levels. Both ZIP1 and ZIP2 proteins were localized to the plasma membrane and cytoplasm in normal human lung alveolar macrophages. We propose that zinc homeostasis in macrophages involves the coordinated action of ZIP1 and ZIP2 transporters responding differently to zinc deficiency signals and that these play important roles in macrophage efferocytosis.	[Hamon, Rhys; Homan, Claire C.; Tran, Hai B.; Bosco, Mariea D.; Lang, Carol; Zalewski, Peter D.; Hodge, Sandra J.] Univ Adelaide, Queen Elizabeth Hosp, Discipline Med, Woodville, SA 5011, Australia; [Tran, Hai B.; Mukaro, Violet R.; Jersmann, Hubertus P.; Hodge, Sandra J.] Royal Adelaide Hosp, Dept Thorac Med, Lung Res Lab, Hanson Inst, Adelaide, SA 5000, Australia; [Lester, Susan E.] Queen Elizabeth Hosp, Rheumatol Unit, Woodville, SA 5011, Australia; [Roscioli, Eugene] Univ Adelaide, Queen Elizabeth Hosp, Discipline Surg, Woodville, SA 5011, Australia; [Murgia, Chiara M.] CRA NUT, Rome, Italy; [Ackland, Margaret Leigh] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Melbourne, Vic, Australia	University of Adelaide; Hanson Institute; Royal Adelaide Hospital; University of Adelaide; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Deakin University	Zalewski, PD (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Discipline Med, Woodville, SA 5011, Australia.	peter.zalewski@adelaide.edu.au	Zalewski, Peter/ABF-1742-2020; Homan, Claire C/P-9469-2018; Ackland, M Leigh/L-5086-2018; Jersmann, Hubertus/ABC-5287-2020; Murgia, Chiara/Y-6102-2018	Ackland, M Leigh/0000-0002-7474-6556; Jersmann, Hubertus/0000-0003-1763-2736; Homan, Claire/0000-0003-2847-8586; Mukaro, Violet/0000-0002-3968-6551; Hamon, Rhys/0000-0002-5474-8490; Roscioli, Eugene/0000-0002-3201-3899	National Health and Medical Research Council (NHMRC) [627223]; National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) Grant # 627223 to PDZ, and National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bao SY, 2006, AM J PHYSIOL-LUNG C, V290, pL433, DOI 10.1152/ajplung.00341.2005; Cordts F, 2011, LIFE SCI, V89, P806, DOI 10.1016/j.lfs.2011.08.018; de los Monteros MTLE, 2000, REV CLIN ESP, V200, P649; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Dufner-Beattie J, 2006, GENESIS, V44, P239, DOI 10.1002/dvg.20211; Grasseschi RM, 2003, CHEST, V124, P1924, DOI 10.1378/chest.124.5.1924; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2012, RESPIROLOGY, V17, P802, DOI 10.1111/j.1440-1843.2012.02135.x; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hodge S, 2010, AM J RESP CELL MOL, V42, P235, DOI 10.1165/rcmb.2008-0486OC; Jayaram L, 2011, RESPIROLOGY, V16, P459, DOI 10.1111/j.1440-1843.2011.01932.x; Joshi PC, 2008, AM J RESP CELL MOL, V39, P218, DOI 10.1165/rcmb.2007-0344OC; Joshi PC, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-36; Joshi PC, 2009, AM J RESP CELL MOL, V41, P207, DOI 10.1165/rcmb.2008-0209OC; Kirkil G, 2008, RESP MED, V102, P840, DOI 10.1016/j.rmed.2008.01.010; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Lang CJ, 2011, BIOMETALS, V24, P23, DOI 10.1007/s10534-010-9370-9; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lin YS, 2013, J TOXICOL ENV HEAL A, V76, P1, DOI 10.1080/15287394.2012.722185; Lin YS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-53; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Lundahl J, 1996, EUR RESPIR J, V9, P1188, DOI 10.1183/09031936.96.09061188; Mehta AJ, 2013, AM J RESP CRIT CARE, V188, P716, DOI 10.1164/rccm.201301-0061OC; Mehta AJ, 2011, ALCOHOL CLIN EXP RES, V35, P1519, DOI 10.1111/j.1530-0277.2011.01488.x; Michalczyk AA, 2013, GENES NUTR, V8, P475, DOI 10.1007/s12263-013-0332-z; MIURA Y, 1957, CR SOC BIOL, V151, P1460; Murgia C, 2006, CURR DRUG TARGETS, V7, P607, DOI 10.2174/138945006776818683; Murgia C, 2011, NUTRIENTS, V3, P910, DOI 10.3390/nu3110910; Napolitano JR, 2012, AM J PHYSIOL-LUNG C, V302, pL909, DOI 10.1152/ajplung.00351.2011; Prasad AS, 2007, J NUTR, V137, P1345, DOI 10.1093/jn/137.5.1345; Rink L, 2007, TRENDS IMMUNOL, V28, P1, DOI 10.1016/j.it.2006.11.005; SCRUTTON MC, 1971, P NATL ACAD SCI USA, V68, P2497, DOI 10.1073/pnas.68.10.2497; Soriano C, 2012, LUNG CANCER, V77, P38, DOI 10.1016/j.lungcan.2012.01.017; Tanrikulu AC, 2011, BIOL TRACE ELEM RES, V143, P659, DOI 10.1007/s12011-010-8897-5; Thambiayya K, 2012, AM J PHYSIOL-LUNG C, V302, pL1287, DOI 10.1152/ajplung.00385.2011; Tone K, 1991, Kitasato Arch Exp Med, V64, P263; Tran Hai B, 2012, J Allergy (Cairo), V2012, P819176, DOI 10.1155/2012/819176; Truong-Tran AQ, 2001, BIOMETALS, V14, P315, DOI 10.1023/A:1012993017026; Truong-Tran AQ, 2002, AM J RESP CELL MOL, V27, P286, DOI 10.1165/rcmb.2001-0014OC; Vachon E, 2007, BLOOD, V110, P4492, DOI 10.1182/blood-2007-02-076539; WIRTH JJ, 1989, IMMUNOLOGY, V68, P114; Zalewski P, 2006, BIOTECHNIQUES, V40, P509, DOI 10.2144/06404RR02	46	41	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110056	10.1371/journal.pone.0110056	http://dx.doi.org/10.1371/journal.pone.0110056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350745	Green Published, gold			2022-12-26	WOS:000343943100019
J	Nguyen, PTM; Falsetta, ML; Hwang, G; Gonzalez-Begne, M; Koo, H				Phuong Thi Mai Nguyen; Falsetta, Megan L.; Hwang, Geelsu; Gonzalez-Begne, Mireya; Koo, Hyun			alpha-Mangostin Disrupts the Development of Streptococcus mutans Biofilms and Facilitates Its Mechanical Removal	PLOS ONE			English	Article							PROTEIN DOCKING; DENTAL-CARIES; ORAL STREPTOCOCCI; IN-VIVO; POLYSACCHARIDE PRODUCTION; EXOPOLYSACCHARIDE MATRIX; GRAPHICS PROCESSORS; ALKALI PRODUCTION; TT-FARNESOL; GLUCOSYLTRANSFERASES	alpha-Mangostin (alpha MG) has been reported to be an effective antimicrobial agent against planktonic cells of Streptococcus mutans, a biofilm-forming and acid-producing cariogenic organism. However, its anti-biofilm activity remains to be determined. We examined whether alpha MG, a xanthone purified from Garcinia mangostana L grown in Vietnam, disrupts the development, acidogenicity, and/or the mechanical stability of S. mutans biofilms. Treatment regimens simulating those experienced clinically (twice-daily, 60 s exposure each) were used to assess the bioactivity of alpha MG using a saliva-coated hydroxyapatite (sHA) biofilm model. Topical applications of early-formed biofilms with alpha MG (150 mu M) effectively reduced further biomass accumulation and disrupted the 3D architecture of S. mutans biofilms. Biofilms treated with alpha MG had lower amounts of extracellular insoluble and intracellular iodophilic polysaccharides (30-45%) than those treated with vehicle control (P<0.05), while the number of viable bacterial counts was unaffected. Furthermore, alpha MG treatments significantly compromised the mechanical stability of the biofilm, facilitating its removal from the sHA surface when subjected to a constant shear stress of 0.809 N/m(2) (. 3-fold biofilm detachment from sHA vs. vehicle-treated biofilms; P<0.05). Moreover, acid production by S. mutans biofilms was disrupted following alpha MG treatments (vs. vehicle-control, P<0.05). The activity of enzymes associated with glucan synthesis, acid production, and acid tolerance (glucosyltransferases B and C, phosphotransferase-PTS system, and F1F0-ATPase) were significantly inhibited by alpha MG. The expression of manL, encoding a key component of the mannose PTS, and gtfB were slightly repressed by alpha MG treatment (P<0.05), while the expression of atpD (encoding F-ATPase) and gtfC genes was unaffected. Hence, this study reveals that brief exposures to alpha MG can disrupt the development and structural integrity of S. mutans biofilms, at least in part via inhibition of key enzymatic systems associated with exopolysaccharide synthesis and acidogenicity. alpha MG could be an effective anti-virulence additive for the control and/or removal of cariogenic biofilms.	[Phuong Thi Mai Nguyen] Vietnam Acad Sci & Technol, Inst Biotechnol, Hanoi, Vietnam; [Falsetta, Megan L.; Gonzalez-Begne, Mireya; Koo, Hyun] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Hwang, Geelsu; Koo, Hyun] Univ Penn, Sch Dent Med, Dept Orthodont, Levy Ctr Oral Hlth,Biofilm Res Labs, Philadelphia, PA 19104 USA	Vietnam Academy of Science & Technology (VAST); University of Rochester; University of Pennsylvania	Nguyen, PTM (corresponding author), Vietnam Acad Sci & Technol, Inst Biotechnol, Hanoi, Vietnam.	phuong_nguyen_99@yahoo.com; koohy@dental.upenn.edu	Falsetta, Megan L./AAE-1586-2020; Hwang, Geelsu/F-9484-2011	Hwang, Geelsu/0000-0001-7277-5639	National Foundation for Science and Technology Development (Nafosted) [106.05-2011.44]; Vietnam Education Foundation (VEF); National Institutes of Health (NIH) [DE018023]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018023] Funding Source: NIH RePORTER	National Foundation for Science and Technology Development (Nafosted)(National Foundation for Science & Technology Development (NAFOSTED)); Vietnam Education Foundation (VEF); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Foundation for Science and Technology Development (Nafosted) grant (106.05-2011.44) to PTMN (http://www.nafosted.gov.vn); Vietnam Education Foundation (VEF) research scholar grant (VEF 2012) to PTMN (https://home.vef.gov); and National Institutes of Health (NIH) grant (DE018023) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Burne R A, 2009, Adv Dent Res, V21, P17, DOI 10.1177/0895937409335593; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cense AW, 2006, J MICROBIOL METH, V67, P463, DOI 10.1016/j.mimet.2006.04.023; Colby SM, 1997, J APPL MICROBIOL, V83, pS80, DOI 10.1046/j.1365-2672.83.s1.9.x; Cross SE, 2007, MICROBIOL-SGM, V153, P3124, DOI 10.1099/mic.0.2007/007625-0; Cury JA, 2007, ANAL BIOCHEM, V365, P208, DOI 10.1016/j.ab.2007.03.021; Dye Bruce A, 2007, Vital Health Stat 11, P1; Ee GCL, 2006, NAT PROD RES, V20, P1067, DOI 10.1080/14786410500463114; Ee GCL, 2008, J ASIAN NAT PROD RES, V10, P481, DOI 10.1080/10286020801948490; Falsetta ML, 2012, ANTIMICROB AGENTS CH, V56, P6201, DOI 10.1128/AAC.01381-12; Flemmig TF, 2011, PERIODONTOL 2000, V55, P9, DOI 10.1111/j.1600-0757.2010.00383.x; Gundampati R. K., 2013, American Journal of Biochemistry and Biotechnology, V9, P318; Guo LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057182; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hamilton I R, 1990, J Dent Res, V69 Spec No, P660; Hamilton IR, 1976, SPECIAL SUPPLEMENT M, V3, P683; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hope CK, 2004, ANTIMICROB AGENTS CH, V48, P1461, DOI 10.1128/AAC.48.5.1461-1468.2004; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Jones WL, 2011, BIOFOULING, V27, P207, DOI 10.1080/08927014.2011.554977; Jung HA, 2006, J AGR FOOD CHEM, V54, P2077, DOI 10.1021/jf052649z; Kaomongkolgit Ruchadaporn, 2009, J Oral Sci, V51, P401; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klein MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013478; Koo H, 2006, CARIES RES, V40, P20, DOI 10.1159/000088901; Koo H, 2005, J DENT RES, V84, P1016, DOI 10.1177/154405910508401109; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Koo H, 2000, CARIES RES, V34, P418, DOI 10.1159/000016617; Korstgens V, 2001, J MICROBIOL METH, V46, P9, DOI 10.1016/S0167-7012(01)00248-2; Kosem N, 2013, J NAT MED-TOKYO, V67, P255, DOI 10.1007/s11418-012-0673-8; Kreth J, 2008, ORAL MICROBIOL IMMUN, V23, P213, DOI 10.1111/j.1399-302X.2007.00413.x; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JA, 2013, MICROBIOL-SGM, V159, P436, DOI 10.1099/mic.0.066134-0; Li YH, 2001, MICROBIOL-SGM, V147, P2841, DOI 10.1099/00221287-147-10-2841; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1967, ARCH ORAL BIOL, V12, P189, DOI 10.1016/0003-9969(67)90037-4; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Marsh PD, 2012, BRIT DENT J, V212, P601, DOI 10.1038/sj.bdj.2012.524; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; MOOSER G, 1991, J BIOL CHEM, V266, P8916; Nguyen PTM, 2011, CAN J MICROBIOL, V57, P217, DOI 10.1139/W10-122; Nyvad B, 2013, CARIES RES, V47, P89, DOI 10.1159/000345367; Obolskiy D, 2009, PHYTOTHER RES, V23, P1047, DOI 10.1002/ptr.2730; Phan TN, 2004, ORAL MICROBIOL IMMUN, V19, P31, DOI 10.1046/j.0902-0055.2003.00109.x; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; Simoes M, 2004, INT C BIOF 2014 STRU, P171; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; Tanzer JM, 1976, SPEDIAL S MICROBIOLO, V3, P596; Venkatraman V, 2012, PROTEINS, V80, P2262, DOI 10.1002/prot.24115; Venkitaraman AR, 1995, J DENT RES, V74, P1695, DOI 10.1177/00220345950740101101; Vinogradov A., 2004, BIOFILMS, V1, P49, DOI DOI 10.1017/S1479050503001078; Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502; Waters MS, 2014, ACS APPL MATER INTER, V6, P327, DOI 10.1021/am404344h; Xiao J, 2010, J APPL MICROBIOL, V108, P2103, DOI 10.1111/j.1365-2672.2009.04616.x; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x	69	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111312	10.1371/journal.pone.0111312	http://dx.doi.org/10.1371/journal.pone.0111312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350668	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943100063
J	Wang, XM; Hou, XQ; Zhang, YQ; Li, Y				Wang, Xu-Mei; Hou, Xiao-Qi; Zhang, Yu-Qu; Li, Yan			Morphological Variation in Leaf Dissection of Rheum palmatum Complex (Polygonaceae)	PLOS ONE			English	Article							PHYLOGENY; SEQUENCES; EVOLUTION; RHUBARB	Aims: Rheum palmatum complex comprises all taxa within section Palmata in the genus Rheum, including R. officinale, R. palmatum, R. tanguticum, R. tanguticum var. liupanshanense and R. laciniatum. The identification of the taxa in section Palmata is based primarily on the degree of leaf blade dissection and the shape of the lobes; however, difficulties in species identification may arise from their significant variation. The aim of this study is to analyze the patterns of variation in leaf blade characteristics within and among populations through population-based sampling covering the entire distribution range of R. palmatum complex. Methods: Samples were taken from 2340 leaves from 780 individuals and 44 populations representing the four species, and the degree of leaf blade dissection and the shape of the lobe were measured to yield a set of quantitative data. Furthermore, those data were statistically analyzed. Important Findings: The statistical analysis showed that the degree of leaf blade dissection is continuous from lobed to parted, and the shape of the lobe is also continuous from broadly triangular to lanceolate both within and between populations. We suggested that taxa in section Palmata should be considered as one species. Based on the research on the R. palmatum complex, we considered that the quantitative characteristics were greatly influenced by the environment. Therefore, it is not reliable to delimitate the species according to the continuously quantitative vegetative characteristics.	[Wang, Xu-Mei; Li, Yan] Xi An Jiao Tong Univ, Sch Pharm, Xian 710049, Peoples R China; [Hou, Xiao-Qi] Guiyang Bot Garden Med Plants, Guiyang Museum Med Resources, Guiyang, Peoples R China; [Zhang, Yu-Qu] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Sch Pharm, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022; li, yong/HDN-3885-2022		National Natural Science Foundation of China [81001602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao BJ., 2003, FLORA CHINA, V5, P341; Chang CS, 2004, ACTA PHYTOTAXON SIN, V42, P222; Chen JY, 2008, J SYST EVOL, V46, P93, DOI 10.3724/SP.J.1002.2008.06177; Cui Da-fang, 2010, Journal of Plant Resources and Environment, V19, P1; Davis PH, 1963, PRINCIPLES ANGIOSPER; Gallego MT, 2004, BOT J LINN SOC, V145, P219, DOI 10.1111/j.1095-8339.2003.00271.x; Ge S., 1998, ACTA PHYTOTAXONOMICA, V36, P481; Ge S, 1994, ACTA PHYTOTAXONOMICA, V32, P489; Ge S, 2010, J SYST EVOL, V48, P445, DOI 10.1111/j.1759-6831.2010.00104.x; GOTTLIEB LD, 1984, AM NAT, V123, P681, DOI 10.1086/284231; Hsu PS, 1983, B BOT RES, V3, P9; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Li SY, 2000, ACTA BOT BOREALI-OCC, V20, P268; Northwest Institute of Botany of the Chinese Academy of Sciences, 1976, FLOR TSINL, V1, P139; [史刚荣 Shi Gangrong], 2003, [植物研究, Bulletin of Botanical Research], V23, P220; Sun ZY, 1999, B BOT RES, V19, P143; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wei XM, 2008, J SYST EVOL, V46, P919, DOI 10.3724/SP.J.1002.2008.08046; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yang HaiJun, 2011, Pratacultural Science, V28, P207; Yang Li-Juan, 2008, Wuhan Zhiwuxue Yanjiu, V26, P589; Yu YF, 1999, PLANTS, V1999, P3; Zhang FM, 2003, ACTA PHYTOTAXON SIN, V41, P220; Zhang K, 2009, J HANGZHOU NORMAL U, V8, P214; Zhao YZ, 1998, ACTA PHYTOTAXON SIN, V36, P193; 葛颂, 1995, 植物分类学报, V33, P433	30	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110760	10.1371/journal.pone.0110760	http://dx.doi.org/10.1371/journal.pone.0110760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25349989	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100039
J	Batista, AB; Oliveira, JTA; Gifoni, JM; Pereira, ML; Almeida, MGG; Gomes, VM; Da Cunha, M; Ribeiro, SFF; Dias, GB; Beltramini, LM; Lopes, JLS; Grangeiro, TB; Vasconcelos, IM				Batista, Adelina B.; Oliveira, Jose T. A.; Gifoni, Juliana M.; Pereira, Mirella L.; Almeida, Marina G. G.; Gomes, Valdirene M.; Da Cunha, Maura; Ribeiro, Suzanna F. F.; Dias, Germana B.; Beltramini, Leila M.; Lopes, Jose Luiz S.; Grangeiro, Thalles B.; Vasconcelos, Ilka M.			New Insights into the Structure and Mode of Action of Mo-CBP3, an Antifungal Chitin-Binding Protein of Moringa oleifera Seeds	PLOS ONE			English	Article							PLASMA-MEMBRANE; 2S ALBUMIN; PLANT; DEFENSIN; PEPTIDE; APOPTOSIS; ASSAY	Mo-CBP3 is a chitin-binding protein purified from Moringa oleifera Lam. seeds that displays inhibitory activity against phytopathogenic fungi. This study investigated the structural properties and the antifungal mode of action of this protein. To this end, circular dichroism spectroscopy, antifungal assays, measurements of the production of reactive oxygen species and microscopic analyses were utilized. Mo-CBP3 is composed of 30.3% alpha-helices, 16.3% beta-sheets, 22.3% turns and 30.4% unordered forms. The Mo-CBP3 structure is highly stable and retains its antifungal activity regardless of temperature and pH. Fusarium solani was used as a model organism for studying the mechanisms by which this protein acts as an antifungal agent. Mo-CBP3 significantly inhibited spore germination and mycelial growth at 0.05 mg.mL(-1). Mo-CBP3 has both fungistatic and fungicidal effects, depending on the concentration used. Binding of Mo-CBP3 to the fungal cell surface is achieved, at least in part, via electrostatic interactions, as salt was able to reduce its inhibitory effect. Mo-CBP3 induced the production of ROS and caused disorganization of both the cytoplasm and the plasma membrane in F. solani cells. Based on its high stability and specific toxicity, with broad-spectrum efficacy against important phytopathogenic fungi at low inhibitory concentrations but not to human cells, Mo-CBP3 has great potential for the development of new antifungal drugs or transgenic crops with enhanced resistance to phytopathogens.	[Batista, Adelina B.; Oliveira, Jose T. A.; Gifoni, Juliana M.; Pereira, Mirella L.; Almeida, Marina G. G.; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil; [Gomes, Valdirene M.; Da Cunha, Maura; Ribeiro, Suzanna F. F.; Dias, Germana B.] State Univ North Fluminense, Biosci & Biotecnol Ctr, Rio De Janeiro, Brazil; [Beltramini, Leila M.; Lopes, Jose Luiz S.] Univ Sao Paulo, Phys Inst Sao Carlos, Sao Carlos, SP, Brazil; [Grangeiro, Thalles B.] Univ Fed Ceara, Dept Biol, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Universidade de Sao Paulo; Universidade Federal do Ceara	Vasconcelos, IM (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil.	imvasco@ufc.br	Grangeiro, Thalles Barbosa/E-9606-2010; Beltramini, Leila M/I-5523-2012; Da Cunha, Maura/L-1412-2014; Lopes, Jose Luiz S/AAC-2917-2021; Lopes, Jose L S/D-3213-2012; Gomes, Valdirene/G-1805-2015	Grangeiro, Thalles Barbosa/0000-0001-8276-3092; Beltramini, Leila M/0000-0001-5741-8238; Lopes, Jose L S/0000-0003-1281-0521; Gomes, Valdirene/0000-0003-4145-428X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (www.capes.gov.br), and Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP (www.funcap.ce.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2007, J MOL MICROB BIOTECH, V13, P243, DOI 10.1159/000104753; Agizzio AP, 2006, PLANT SCI, V171, P515, DOI 10.1016/j.plantsci.2006.06.001; Asensio JL, 2000, CHEM BIOL, V7, P529, DOI 10.1016/S1074-5521(00)00136-8; BEINTEMA JJ, 1994, FEBS LETT, V350, P159, DOI 10.1016/0014-5793(94)00753-5; BIGNAMI GS, 1993, TOXICON, V31, P817, DOI 10.1016/0041-0101(93)90389-Z; Bindschedler LV, 2006, FEBS LETT, V580, P1541, DOI 10.1016/j.febslet.2006.01.079; Borges AF, 2013, PLANT PHYSIOL BIOCH, V68, P71, DOI 10.1016/j.plaphy.2013.03.024; Bormann C, 1999, J BACTERIOL, V181, P7421, DOI 10.1128/JB.181.24.7421-7429.1999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; Brul S, 1997, J MICROBIOL METH, V28, P169, DOI 10.1016/S0167-7012(97)00975-5; Carvalho AD, 2011, CURR PHARM DESIGN, V17, P4270, DOI 10.2174/138161211798999447; Choi H, 2012, BBA-BIOMEMBRANES, V1818, P1648, DOI 10.1016/j.bbamem.2012.02.026; Duan XH, 2013, PLANT PHYSIOL BIOCH, V66, P84, DOI 10.1016/j.plaphy.2013.01.015; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; Gifoni JM, 2012, BIOPOLYMERS, V98, P406, DOI 10.1002/bip.22068; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Ji C, 1996, PHYSIOL MOL PLANT P, V49, P257, DOI 10.1006/pmpp.1996.0053; KOK LT, 1972, COMP BIOCHEM PHYSIOL, V42, P245, DOI 10.1016/0305-0491(72)90271-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JK, 2012, INT J MOL SCI, V13, P4021, DOI 10.3390/ijms13044021; Lindquist W, 1953, J I BREWING, V59, P59; Mello EO, 2011, CURR MICROBIOL, V62, P1209, DOI 10.1007/s00284-010-9847-3; Mendieta JR, 2006, MICROBIOL-SGM, V152, P2039, DOI 10.1099/mic.0.28816-0; Morais JKS, 2010, J AGR FOOD CHEM, V58, P10356, DOI 10.1021/jf101688k; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Prasad BD, 2008, PLANT SCI, V175, P364, DOI 10.1016/j.plantsci.2008.05.015; Qi GF, 2010, PEPTIDES, V31, P1978, DOI 10.1016/j.peptides.2010.08.003; Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x; Riaz M, 2012, MOLECULES, V17, P14275, DOI 10.3390/molecules171214275; Richards Andrea, 2010, Fungal Biology Reviews, V24, P93, DOI 10.1016/j.fbr.2010.04.002; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; de Freitas CDT, 2011, BBA-BIOMEMBRANES, V1808, P2501, DOI 10.1016/j.bbamem.2011.07.014; Theis T, 2003, ANTIMICROB AGENTS CH, V47, P588, DOI 10.1128/AAC.47.2.588-593.2003; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Trindade MB, 2006, BBA-PROTEINS PROTEOM, V1764, P146, DOI 10.1016/j.bbapap.2005.09.011; Wong JH, 2012, FOOD CHEM, V135, P408, DOI 10.1016/j.foodchem.2012.04.119; Yao Q, 2010, PROCESS BIOCHEM, V45, P1477, DOI 10.1016/j.procbio.2010.05.026; Zottich U, 2011, BBA-GEN SUBJECTS, V1810, P375, DOI 10.1016/j.bbagen.2010.12.002	41	28	30	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111427	10.1371/journal.pone.0111427	http://dx.doi.org/10.1371/journal.pone.0111427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347074	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900069
J	Yan, ZH; Zhang, HJ; Maher, C; Arteaga-Solis, E; Champagne, FA; Wu, LC; McDonald, JD; Yan, BZ; Schwartz, GJ; Miller, RL				Yan, Zhonghai; Zhang, Hanjie; Maher, Christina; Arteaga-Solis, Emilio; Champagne, Frances A.; Wu, Licheng; McDonald, Jacob D.; Yan, Beizhan; Schwartz, Gary J.; Miller, Rachel L.			Prenatal Polycyclic Aromatic Hydrocarbon, Adiposity, Peroxisome Proliferator-Activated Receptor (PPAR) gamma Methylation in Offspring, Grand-Offspring Mice	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; DNA METHYLATION; TRANSPLACENTAL EXPOSURE; ENDOCRINE DISRUPTORS; LIPID-ACCUMULATION; CHILDHOOD OBESITY; MATERNAL EXPOSURE; PHYSICAL-ACTIVITY; COX-2 EXPRESSION; GENE-EXPRESSION	Rationale: Greater levels of prenatal exposure to polycyclic aromatic hydrocarbon (PAH) have been associated with childhood obesity in epidemiological studies. However, the underlying mechanisms are unclear. Objectives: We hypothesized that prenatal PAH over-exposure during gestation would lead to weight gain and increased fat mass in offspring and grand-offspring mice. Further, we hypothesized that altered adipose gene expression and DNA methylation in genes important to adipocyte differentiation would be affected. Materials and Methods: Pregnant dams were exposed to a nebulized PAH mixture versus negative control aerosol 5 days a week, for 3 weeks. Body weight was recorded from postnatal day (PND) 21 through PND60. Body composition, adipose cell size, gene expression of peroxisome proliferator-activated receptor (PPAR) gamma, CCAAT/enhancer-binding proteins (C/EBP) alpha, cyclooxygenase (Cox)-2, fatty acid synthase (FAS) and adiponectin, and DNA methylation of PPAR gamma, were assayed in both the offspring and grand-offspring adipose tissue. Findings: Offspring of dams exposed to greater PAH during gestation had increased weight, fat mass, as well as higher gene expression of PPAR gamma, C/EBP alpha, Cox2, FAS and adiponectin and lower DNA methylation of PPAR gamma. Similar differences in phenotype and DNA methylation extended through the grand-offspring mice. Conclusions: Greater prenatal PAH exposure was associated with increased weight, fat mass, adipose gene expression and epigenetic changes in progeny.	[Yan, Zhonghai; Zhang, Hanjie; Maher, Christina; Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY 10027 USA; [Arteaga-Solis, Emilio] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Pediat Pulm, New York, NY USA; [Champagne, Frances A.] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Wu, Licheng; Schwartz, Gary J.] Albert Einstein Coll Med, Diabet Res Ctr, Dept Med, New York, NY USA; [Wu, Licheng; Schwartz, Gary J.] Albert Einstein Coll Med, Diabet Res Ctr, Dept Neurosci, New York, NY USA; [McDonald, Jacob D.] Lovelace Resp Res Inst, Dept Toxicol, Albuquerque, NM USA; [Yan, Beizhan] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Miller, Rachel L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Pediat Allergy Immunol & Rheumatol, New York, NY USA	Columbia University; Columbia University; Columbia University; Yeshiva University; Yeshiva University; Lovelace Respiratory Research Institute; Columbia University; Columbia University; Columbia University	Miller, RL (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY 10027 USA.	rlm14@cumc.columbia.edu	; Champagne, Frances Anne/Q-1220-2018	Zhang, Hanjie/0000-0002-0015-5614; Champagne, Frances Anne/0000-0002-3922-084X	United States Environmental Protection Agency (US EPA) [RD-83214101]; National Institute for Environmental Health Sciences (NIEHS) [5P01ES09600, P50ES015905, P01 ES009089]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009600, P50ES015905, P30ES009089] Funding Source: NIH RePORTER	United States Environmental Protection Agency (US EPA)(United States Environmental Protection Agency); National Institute for Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by a United States Environmental Protection Agency (US EPA) grant RD-83214101(RLM, FAC) and National Institute for Environmental Health Sciences (NIEHS) grants 5P01ES09600 (RLM, FAC), P50ES015905 (RLM, JDM) and P01 ES009089 (RLM). Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the United States EPA. Further, the United States EPA does not endorse the purchase of any commercial products or services mentioned in the publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EK, 2008, TOXICOL LETT, V176, P178, DOI 10.1016/j.toxlet.2007.11.005; Almeda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074476; Arshad SH, 2012, J ALLERGY CLIN IMMUN, V130, P427, DOI 10.1016/j.jaci.2012.03.042; Bai N, 2012, INHAL TOXICOL, V24, P518, DOI 10.3109/08958378.2012.696221; Billiard SM, 2002, COMP BIOCHEM PHYS B, V133, P55, DOI 10.1016/S1096-4959(02)00105-7; Blouet C, 2012, CELL METAB, V16, P579, DOI 10.1016/j.cmet.2012.10.003; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bourez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031834; Centers for Disease Control, 2004, SAS PROGR CDC GROWTH; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Choi H, 2008, ENVIRON HEALTH PERSP, V116, P658, DOI 10.1289/ehp.10958; Choi SS, 2014, J BIOL CHEM, V289, P26618, DOI 10.1074/jbc.M114.566794; Chou WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072511; Chu S, 2013, J CHEM, V2013, P1; DiVall SA, 2013, CURR OPIN ENDOCRINOL, V20, P50, DOI 10.1097/MED.0b013e32835b7ee6; Dunbar JC, 2001, SCI TOTAL ENVIRON, V279, P1, DOI 10.1016/S0048-9697(01)00686-6; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Ghoshal S, 2011, J BIOL CHEM, V286, P889, DOI 10.1074/jbc.M110.139139; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Hamada K, 2007, J TOXICOL ENV HEAL A, V70, P688, DOI 10.1080/15287390600974692; Hossain MG, 2010, J BIOSCI BIOENG, V109, P297, DOI 10.1016/j.jbiosc.2009.09.003; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Jin D, 2014, CYTOKINE, V69, P196, DOI 10.1016/j.cyto.2014.06.005; JOHNSON PR, 1972, J LIPID RES, V13, P2; Kap M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027704; Kim JH, 2005, TOXICOL SCI, V85, P585, DOI 10.1093/toxsci/kfi118; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Komatsu M, 2010, GENES CELLS, V15, P91, DOI 10.1111/j.1365-2443.2009.01368.x; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kumazawa M, 2007, J LIPID RES, V48, P2039, DOI 10.1194/jlr.M700222-JLR200; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Li J, 2012, J HEPATOLOGY, V56; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Marcelin G, 2012, J LIPID RES, V53, P964, DOI 10.1194/jlr.M022467; Masuyama H, 2012, ENDOCRINOLOGY, V153, P2823, DOI 10.1210/en.2011-2161; Miller LL, 2014, CHEST, V145, P1213, DOI 10.1378/chest.13-1371; Miller RL, 2004, CHEST, V126, P1071, DOI 10.1378/chest.126.4.1071; Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206, DOI 10.14310/horm.2002.1271; Niedzwiecki M, 2012, ALLERGY, V67, P904, DOI 10.1111/j.1398-9995.2012.02841.x; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patel MM, 2009, CURR OPIN PEDIATR, V21, P235, DOI 10.1097/MOP.0b013e3283267726; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Perera FP, 2005, NEUROTOXICOLOGY, V26, P573, DOI 10.1016/j.neuro.2004.07.007; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Rosa MJ, 2011, RESP MED, V105, P869, DOI 10.1016/j.rmed.2010.11.022; Rosen ED, 2000, GENE DEV, V14, P1293; Rundle A, 2012, AM J EPIDEMIOL, V175, P1163, DOI 10.1093/aje/kwr455; Sadagurski M, 2014, AM J PHYSIOL-ENDOC M, V306, pE1305, DOI 10.1152/ajpendo.00031.2014; Sallis JF, 2009, MILBANK Q, V87, P123, DOI 10.1111/j.1468-0009.2009.00550.x; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2006, FUTURE CHILD, V16, P89, DOI 10.1353/foc.2006.0009; Sato M, 2008, BRIT J NUTR, V99, P1013, DOI 10.1017/S0007114507839006; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Schneider JE, 2014, HORM BEHAV, V66, P104, DOI 10.1016/j.yhbeh.2014.03.011; Scinicariello F, 2014, ENVIRON HEALTH PERSP, V122, P299, DOI 10.1289/ehp.1307234; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Sievers CK, 2013, TOXICOL SCI, V132, P359, DOI 10.1093/toxsci/kfs287; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Stillerman KP, 2008, REPROD SCI, V15, P631, DOI 10.1177/1933719108322436; Tang WY, 2012, ENVIRON HEALTH PERSP, V120, P1195, DOI 10.1289/ehp.1103744; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trombino AF, 2000, BREAST CANCER RES TR, V63, P117, DOI 10.1023/A:1006443104670; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Wu GY, 2013, PPAR RES, V2013, DOI 10.1155/2013/701017; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350; Yan BZ, 2005, ENVIRON SCI TECHNOL, V39, P7012, DOI 10.1021/es0506105	83	47	48	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110706	10.1371/journal.pone.0110706	http://dx.doi.org/10.1371/journal.pone.0110706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347678	Green Published, gold			2022-12-26	WOS:000347994900026
J	Itakura, S; Hama, S; Ohgita, T; Kogure, K				Itakura, Shoko; Hama, Susumu; Ohgita, Takashi; Kogure, Kentaro			Development of Nanoparticles Incorporating a Novel Liposomal Membrane Destabilization Peptide for Efficient Release of Cargos into Cancer Cells	PLOS ONE			English	Article							PH-SENSITIVE LIPOSOMES; GAMMA-SECRETASE; SOLID TUMORS; THERAPY; DELIVERY; IMPROVEMENT; INHIBITION; EXPRESSION; BIOLOGY; DRUGS	In anti-cancer therapy mediated by a nanoparticle-based drug delivery system (DDS), overall efficacy depends on the release efficiency of cargos from the nanoparticles in the cancer cells as well as the specificity of delivery to tumor tissue. However, conventional liposome-based DDS have no mechanism for specifically releasing the encapsulated cargos inside the cancer cells. To overcome this barrier, we developed nanoparticles containing a novel liposomal membrane destabilization peptide (LMDP) that can destabilize membranes by cleavage with intramembranous proteases on/in cancer cells. Calcein encapsulated in liposomes modified with LMDP (LMDP-lipo) was effectively released in the presence of a membrane fraction containing an LMDP-cleavable protease. The release was inhibited by a protease inhibitor, suggesting that LMD-Plipo could effectively release its cargo into cells in response to a cancer-specific protease. Moreover, when LMDP-lipo contained fusogenic lipids, the release of cargo was accelerated, suggesting that the fusion of LMDP-lipo with cellular membranes was the initial step in the intracellular delivery. Time-lapse microscopic observations showed that the release of cargo from LMDP-lipo occurred immediately after association of LMDP-lipo with target cells. Consequently, LMDP-lipo could be a useful nanoparticle capable of effective release of cargos specifically into targeted cancer cells.	[Itakura, Shoko; Hama, Susumu; Ohgita, Takashi; Kogure, Kentaro] Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 607, Japan	Kyoto Pharmaceutical University	Kogure, K (corresponding author), Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 607, Japan.	kogure@mb.kyoto-phu.ac.jp		Hama, Susumu/0000-0002-2989-6168	JSPS KAKENHI [25860030, 26-9314]; Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Grants-in-Aid for Scientific Research [14J09314] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Numbers 25860030, 26-9314, and by the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Lila AS, 2010, PHARM RES-DORDR, V27, P1171, DOI 10.1007/s11095-010-0110-1; Banerjee J, 2009, BIOCONJUGATE CHEM, V20, P1332, DOI 10.1021/bc9000646; Biswas S, NAT CHEM, V5, P613; Biswas S, 2013, EUR J PHARM BIOPHARM, V84, P517, DOI 10.1016/j.ejpb.2012.12.021; Bulic B, 2011, CURR NEUROPHARMACOL, V9, P598, DOI 10.2174/157015911798376352; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Carvalho FLF, 2014, PROSTATE, V74, P933, DOI 10.1002/pros.22811; Chen YQ, 2011, CANCER BIOL THER, V11, P14, DOI 10.4161/cbt.11.1.13730; Cho S, 2011, P NATL ACAD SCI USA, V108, P20778, DOI 10.1073/pnas.1019452108; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Gomi M., 2004, CHEM BIO INFORMATICS, V4, P142, DOI DOI 10.1273/CBIJ.4.142; Hatakeyama H, 2007, GENE THER, V14, P68, DOI 10.1038/sj.gt.3302843; Hayashi I, 2012, ONCOGENE, V31, P787, DOI 10.1038/onc.2011.265; Huang L, 2014, ADV DRUG DELIV REV, V66, P110; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Lehtinen J, 2008, J CONTROL RELEASE, V131, P145, DOI 10.1016/j.jconrel.2008.07.018; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Maraver A, 2012, CANCER CELL, V22, P222, DOI 10.1016/j.ccr.2012.06.014; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; Momekova D, 2007, EUR J PHARM SCI, V32, P308, DOI 10.1016/j.ejps.2007.08.009; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Peppicelli S, 2014, CANCER METAST REV, V33, P823, DOI 10.1007/s10555-014-9506-4; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Sandin P, 2012, ACS NANO, V6, P1513, DOI 10.1021/nn204448x; Schwendener RA, 2007, ADV EXP MED BIOL, V620, P117; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Toita R, 2009, J CONTROL RELEASE, V139, P133, DOI 10.1016/j.jconrel.2009.06.011; Tomiyama T, 2010, J CONTROL RELEASE, V148, P101, DOI 10.1016/j.jconrel.2010.08.017; Vanic Z, 2012, J LIPOSOME RES, V22, P148, DOI 10.3109/08982104.2011.633267; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wu XL, 2010, BIOCONJUGATE CHEM, V21, P208, DOI 10.1021/bc9005283; Yingyuad Peerada, 2014, J RNAi Gene Silencing, V10, P490	35	5	5	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111181	10.1371/journal.pone.0111181	http://dx.doi.org/10.1371/journal.pone.0111181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343714	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500085
J	Gafford, G; Jasnow, AM; Ressler, KJ				Gafford, Georgette; Jasnow, Aaron M.; Ressler, Kerry J.			Grin1 Receptor Deletion within CRF Neurons Enhances Fear Memory	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CORTICOTROPIN-RELEASING-FACTOR; DEPENDENT SYNAPTIC PLASTICITY; D-ASPARTATE RECEPTOR; RAT CENTRAL NUCLEUS; LATERAL AMYGDALA; STRIA TERMINALIS; CONDITIONED FEAR; BINDING PROTEIN; NERVOUS-SYSTEM	Corticotropin releasing factor (CRF) dysregulation is implicated in mood and anxiety disorders such as posttraumatic stress disorder (PTSD). CRF is expressed in areas engaged in fear and anxiety processing including the central amygdala (CeA). Complicating our ability to study the contribution of CRF-containing neurons to fear and anxiety behavior is the wide variety of cell types in which CRF is expressed. To manipulate specific subpopulations of CRF containing neurons, our lab has developed a mouse with a Cre recombinase gene driven by a CRF promoter (CRFp3.0Cre) (Martin et al., 2010). In these studies, mice that have the gene that encodes NR1 (Grin1) flanked by loxP sites (floxed) were crossed with our previously developed CRFp3.0Cre mouse to selectively disrupt Grin1 within CRF containing neurons (Cre+/(fGrin1+)). We find that disruption of Grin1 in CRF neurons did not affect baseline levels of anxiety, locomotion, pain sensitivity or exploration of a novel object. However, baseline expression of Grin1 was decreased in Cre+/(fGrin1+) mice as measured by RTPCR. Cre+/(fGrin1+) mice showed enhanced auditory fear acquisition and retention without showing any significant effect on fear extinction. We measured Gria1, the gene that encodes AMPAR1 and the CREB activator Creb1 in the amygdala of Cre+/(fGrin1+) mice after fear conditioning. Both Gria1 and Creb1 were enhanced in the amygdala after training. To determine if the Grin1-expressing CRF neurons within the CeA are responsible for the enhancement of fear memory in adults, we infused a lentivirus with Cre driven by a CRF promoter (LV pCRF-Cre/(fGrin1+)) into the CeA of floxed Grin1 mice. Cre driven deletion of Grin1 specifically within CRF expressing cells in the CeA also resulted in enhanced fear memory acquisition and retention. Altogether, these findings suggest that selective disruption of Grin1 within CeA CRF neurons strongly enhances fear memory.	[Gafford, Georgette; Ressler, Kerry J.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Jasnow, Aaron M.] Kent State Univ, Dept Psychol Sci, Kent, OH 44242 USA	Emory University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Ressler, KJ (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	kressle@emory.edu	Ressler, Kerry J/N-8741-2018	Ressler, Kerry J/0000-0002-5158-1103	Howard Hughes Medical Institute; NIH/National Center for Research Resources [P51RR000165]; Office of Research Infrastructure Programs [OD P51OD011132]; NIH [R01-MH096764, MH088467, MH090785]; Burroughs Wellcome Fund; Viral Vector Core of the Emory Neuroscience NINDS Core Facilities grant [P30NS055077]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096764, F32MH090785, RC1MH088467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Viral Vector Core of the Emory Neuroscience NINDS Core Facilities grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was supported by Howard Hughes Medical Institute KJR, the NIH/National Center for Research Resources base grant P51RR000165 to Yerkes National Primate Research Center KJR and is currently supported by the Office of Research Infrastructure Programs/OD P51OD011132 to Yerkes National Primate Research Center. Other support for this project comes from NIH R01-MH096764 KJR, NIH MH088467 KJR, Burroughs Wellcome Fund and NIH MH090785 GMG, This research project was also supported in part by the Viral Vector Core of the Emory Neuroscience NINDS Core Facilities grant, P30NS055077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinfiresoye L, 2013, PSYCHOPHARMACOLOGY, V230, P291, DOI 10.1007/s00213-013-3153-2; Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Beckerman MA, 2013, EXP NEUROL, V239, P120, DOI 10.1016/j.expneurol.2012.10.009; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; Chhatwal JP, 2007, GENE THER, V14, P575, DOI 10.1038/sj.gt.3302898; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Day HEW, 1999, J COMP NEUROL, V413, P113; Duvarci S, 2011, J NEUROSCI, V31, P289, DOI 10.1523/JNEUROSCI.4985-10.2011; Dykman RA, 1997, INTEGR PHYS BEH SCI, V32, P9, DOI 10.1007/BF02688609; Gafford GM, 2012, P NATL ACAD SCI USA, V109, P16330, DOI 10.1073/pnas.1119261109; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Hand GA, 2002, BRAIN RES, V949, P122, DOI 10.1016/S0006-8993(02)02972-4; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heldt SA, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.022.2009; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Jasnow AM, 2013, J NEUROSCI, V33, P10396, DOI 10.1523/JNEUROSCI.5539-12.2013; Jasnow Aaron M., 2009, V515, P199, DOI 10.1007/978-1-59745-559-6_13; Josselyn SA, 2005, CURR DRUG TARGETS CN, V4, P481; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Machado-Vieira R, 2009, CURR PHARM DESIGN, V15, P1595, DOI 10.2174/138161209788168010; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Makino S, 1999, BRAIN RES, V850, P136, DOI 10.1016/S0006-8993(99)02114-9; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Martin EI, 2010, BIOL PSYCHIAT, V67, P1212, DOI 10.1016/j.biopsych.2010.01.026; Merali Z, 2008, EUR J NEUROSCI, V28, P165, DOI 10.1111/j.1460-9568.2008.06281.x; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Orr SP, 1998, J TRAUMA STRESS, V11, P155, DOI 10.1023/A:1024421502881; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Paxinos GFKBJ, 2004, MOUSE BRAIN STEREOTA; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; PETRALIA RS, 1994, J NEUROSCI, V14, P667; PITMAN RK, 1988, PSYCHIAT ANN, V18, P182, DOI 10.3928/0048-5713-19880301-11; Pitts MW, 2011, NEUROBIOL LEARN MEM, V95, P86, DOI 10.1016/j.nlm.2010.11.006; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rao VR, 2007, TRENDS NEUROSCI, V30, P284, DOI 10.1016/j.tins.2007.03.012; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; SAKURADA K, 1993, J BIOL CHEM, V268, P410; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; SATO K, 1995, NEUROSCIENCE, V64, P459, DOI 10.1016/0306-4522(94)00335-3; Sautter FJ, 2003, BIOL PSYCHIAT, V54, P1382, DOI 10.1016/S0006-3223(03)00571-7; Siegmund A, 2007, PHYSIOL BEHAV, V90, P103, DOI 10.1016/j.physbeh.2006.08.032; Skorzewska A, 2009, NEUROPHARMACOLOGY, V57, P148, DOI 10.1016/j.neuropharm.2009.04.016; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Tian XJ, 2006, J BIOL CHEM, V281, P7578, DOI 10.1074/jbc.M512060200; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zimmerman JM, 2010, EUR J NEUROSCI, V31, P1664, DOI 10.1111/j.1460-9568.2010.07223.x	53	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111009	10.1371/journal.pone.0111009	http://dx.doi.org/10.1371/journal.pone.0111009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340785	Green Submitted, gold, Green Published			2022-12-26	WOS:000343662800078
J	Mpanya, A; Boelaert, M; Baloji, S; Matangila, J; Lubanza, S; Bottieau, E; Chappuis, F; Lutumba, P; Hendrickx, D				Mpanya, Alain; Boelaert, Marleen; Baloji, Sylvain; Matangila, Junior; Lubanza, Symphorien; Bottieau, Emmanuel; Chappuis, Francois; Lutumba, Pascal; Hendrickx, David			Diagnostic Work-Up of Neurological Syndromes in a Rural African Setting: Knowledge, Attitudes and Practices of Health Care Providers	PLOS ONE			English	Article							SLEEPING SICKNESS; TRYPANOSOMIASIS; DISEASE	Background: Neurological disorders of infectious origin are common in rural sub-Saharan Africa and usually have serious consequences. Unfortunately, these syndromes are often poorly documented for lack of diagnostic tools. Clinical management of these diseases is a major challenge in under-equipped rural health centers and hospitals. We documented health care provider knowledge, attitudes and practices related to this syndrome in two rural health zones in Bandundu Province, Democratic Republic of Congo. Methods: We used a qualitative research approach combining observation, in-depth interviews and focus group discussions. We observed 20 patient-provider contacts related to a neurological syndrome, conducted 12 individual interviews and 4 focus group discussions with care providers. All interviews were audiotaped and the transcripts were analyzed with the software ATLAS. ti. Results: Care providers in this region usually limit their diagnostic work-up to clinical examination primarily because of the financial hurdles in this entirely out-of-pocket payment system. The patients prefer to purchase drugs rather than diagnostic tests. Moreover the general lack of diagnostic tools and the representation of the clinician as a "diviner'' do not enhance any use of laboratory or other diagnostic methods. Conclusion: Innovation in diagnostic technology for neurological disorders is badly needed in Central-Africa, but its uptake in clinical practice will only be a success if tools are simple, affordable and embedded in a patient-centered approach.	[Mpanya, Alain] Programme Natl Lutte Trypanosomiase Humaine Afric, Div Rech, Kinshasa, DEM REP CONGO; [Mpanya, Alain; Boelaert, Marleen; Hendrickx, David] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Baloji, Sylvain] Univ Pedagog Natl, Kinshasa, DEM REP CONGO; [Matangila, Junior; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Lubanza, Symphorien] Univ Kinshasa, Dept Anthropol, Kinshasa, DEM REP CONGO; [Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Lutumba, Pascal] Inst Natl Rech Biomed, Dept Epidemiol, Kinshasa, DEM REP CONGO; [Hendrickx, David] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Institute of Tropical Medicine (ITM); Universite de Kinshasa; Universite de Kinshasa; Institute of Tropical Medicine (ITM); University of Geneva; Institute Nacional de Recherche Biomedical; Telethon Kids Institute; University of Western Australia	Mpanya, A (corresponding author), Programme Natl Lutte Trypanosomiase Humaine Afric, Div Rech, Kinshasa, DEM REP CONGO.	mpanya_alain@yahoo.fr	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Chappuis, Francois/0000-0003-0442-7610	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme [260260]	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme	This work is part of the NIDIAG network research partnership supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (Grant agreement no. 260260, http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birbeck GL, 2001, TROP DOCT, V31, P82, DOI 10.1177/004947550103100209; Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Boelaert M, 2010, ANN TROP MED PARASIT, V104, P535, DOI 10.1179/136485910X12786389891641; Bower JH, 2007, NEUROLOGY, V68, P338, DOI 10.1212/01.wnl.0000252801.61190.e8; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Cohen DB, 2010, TROP MED INT HEALTH, V15, P910, DOI 10.1111/j.1365-3156.2010.02565.x; Glaser B, 1992, BASICS GROUNDED THEO, P129; Gouteux J P, 1985, Med Trop (Mars), V45, P259; Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x; Husserl Edmund, 1989, IDEAS PERTAINING PUR; KWASA TOO, 1992, E AFR MED J, V69, P236; LEYGUES M, 1989, SOC SCI MED, V28, P1255, DOI 10.1016/0277-9536(89)90344-4; Lorent N, 2008, INT J TUBERC LUNG D, V12, P392; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Matovu E, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/340538; Mitashi P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002504; Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919; Mpanya A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001467; Palmer JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002003; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Saldana J, 2013, CODING MANUAL QUALIT; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; WHO, 2013, WHO TECH REP SER, V984, P1; Winkler AS, 2009, TROP DOCT, V39, P102, DOI 10.1258/td.2008.080144; World Health Organization, 2012, GLOB REP RES INF DIS; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110167	10.1371/journal.pone.0110167	http://dx.doi.org/10.1371/journal.pone.0110167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340726	Green Published, gold			2022-12-26	WOS:000343662800023
J	Deutzmann, A; Ganz, M; Schonenberger, F; Vervoorts, J; Kappes, F; Ferrando-May, E				Deutzmann, A.; Ganz, M.; Schoenenberger, F.; Vervoorts, J.; Kappes, F.; Ferrando-May, E.			The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress	ONCOGENE			English	Article							DAMAGE RESPONSE; PROTEIN DEK; PROTOONCOGENE; PATHWAY; FORKS; POLY(ADP-RIBOSE); CHEMORESISTANCE; APOPTOSIS; RESTART; MITOSIS	DNA replication stress is a major source of DNA strand breaks and genomic instability, and a hallmark of precancerous lesions. In these hyperproliferative tissues, activation of the DNA damage response results in apoptosis or senescence preventing or delaying their development to full malignancy. In cells, in which this antitumor barrier is disabled by mutations ( for example, in p53), viability and further uncontrolled proliferation depend on factors that help to cope with replication-associated DNA damage. Replication problems preferentially arise in chromatin regions harboring complex DNA structures. DEK is a unique chromatin architectural factor which binds to non-B-form DNA structures, such as cruciform DNA or four-way junctions. It regulates DNA topology and chromatin organization, and is essential for the maintenance of heterochromatin integrity. Since its isolation as part of an oncogenic fusion in a subtype of AML, DEK has been consistently associated with tumor progression and chemoresistance. How DEK promotes cancer, however, is poorly understood. Here we show that DEK facilitates cellular proliferation under conditions of DNA replication stress by promoting replication fork progression. DEK also protects from the transmission of DNA damage to the daughter cell generation. We propose that DEK counteracts replication stress and ensures proliferative advantage by resolving problematic DNA and/or chromatin structures at the replication fork.	[Deutzmann, A.; Ganz, M.; Schoenenberger, F.; Ferrando-May, E.] Univ Konstanz, Dept Biol, Bioimaging Ctr, D-78464 Constance, Germany; [Vervoorts, J.; Kappes, F.] Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Sch Med, Aachen, Germany	University of Konstanz; RWTH Aachen University	Ferrando-May, E (corresponding author), Univ Konstanz, Dept Biol, Bioimaging Ctr, POB 604,Univ Str 10, D-78464 Constance, Germany.	elisa.may@uni-konstanz.de	Ferdinand, Kappes/H-4445-2014	Ferdinand, Kappes/0000-0002-0369-0065; Vervoorts, Jorg/0000-0002-3251-6496; Deutzmann, Anja/0000-0002-3271-1427	German Research Foundation (DFG) [SFB 969, RTG 1331]; DFG [KA 2799/1]; START program of the Faculty of Medicine, RWTH Aachen	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); START program of the Faculty of Medicine, RWTH Aachen	We thank G Marra for U2-OS cells, Y Marquardt for NHD fibroblasts, J Schmidt for ImageJ Macro programming, D Hermann, K Weidele and F Teusel for technical assistance; S Burger and the FlowKon facility for support in flow cytometry and M Lopes, C Lukas, A Burkle and B Luscher for fruitful discussions. This work was supported by the German Research Foundation (DFG) through funds of the SFB 969, and of the RTG 1331. Work in the laboratory of FK is supported by a DFG grant (KA 2799/1) and by the START program of the Faculty of Medicine, RWTH Aachen.	Alexiadis V, 2000, GENE DEV, V14, P1308; Bartek J, 2012, NAT STRUCT MOL BIOL, V19, P5, DOI 10.1038/nsmb.2220; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; Fahrer J, 2010, BIOCHEMISTRY-US, V49, P7119, DOI 10.1021/bi1004365; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07; Kappes F, 2011, GENE DEV, V25, P673, DOI 10.1101/gad.2036411; Kappes F, 2011, HUM PATHOL, V42, P932, DOI 10.1016/j.humpath.2010.10.022; Kavanaugh GM, 2011, NUCLEIC ACIDS RES, V39, P7465, DOI 10.1093/nar/gkr454; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mor-Vaknin N, 2006, MOL CELL BIOL, V26, P9484, DOI 10.1128/MCB.01030-06; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Renaud E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053693; Riveiro-Falkenbach E, 2010, CLIN CANCER RES, V16, P2932, DOI 10.1158/1078-0432.CCR-09-2330; Saha AK, 2013, P NATL ACAD SCI USA, V110, P6847, DOI 10.1073/pnas.1220751110; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Sirbu BM, 2013, J BIOL CHEM, V288, P31458, DOI 10.1074/jbc.M113.511337; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Waldmann T, 2003, NUCLEIC ACIDS RES, V31, P7003, DOI 10.1093/nar/gkg864; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Wilhelm T, 2014, P NATL ACAD SCI USA, V111, P763, DOI 10.1073/pnas.1311520111; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Wise-Draper TM, 2009, AM J PATHOL, V174, P71, DOI 10.2353/ajpath.2009.080330	39	22	22	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4270	4277		10.1038/onc.2014.346	http://dx.doi.org/10.1038/onc.2014.346			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25347734	Green Submitted			2022-12-26	WOS:000359199800013
J	Meniel, V; Megges, M; Young, MA; Cole, A; Sansom, OJ; Clarke, AR				Meniel, V.; Megges, M.; Young, M. A.; Cole, A.; Sansom, O. J.; Clarke, A. R.			Apc and p53 interaction in DNA damage and genomic instability in hepatocytes	ONCOGENE			English	Article							POLYPOSIS-COLI PROTEIN; HEPATOCELLULAR-CARCINOMA; CHROMOSOMAL INSTABILITY; MUTATIONS; PREDISPOSES; DEFICIENCY; ANEUPLOIDY; APOPTOSIS; PATHWAYS; GENETICS	Disruption of Apc (adenomatous polyposis coli) within hepatocytes activates Wnt signalling, perturbs differentiation and ultimately leads to neoplasia. Apc negatively regulates Wnt signalling but is also involved in organizing the cytoskeleton and may have a role in chromosome segregation. In vitro studies have implicated Apc in the control of genomic stability. However, the relevance of this data has been questioned in vivo as Apc is lost earlier than the onset of genomic instability. Here we analyse the relationship between immediate loss of Apc and the acquisition of genomic instability in hepatocytes. We used Cre-lox technology to inactivate Apc and in combination with p53 in vivo, to define the consequences of gene loss on cell cycle regulation, proliferation, death and aneuploidy. We show that, although Apc loss leads to increased proliferation, it also leads to increased apoptosis, the accumulation of p53, p21 and markers of double-strand breaks and DNA repair. Flow cytometry revealed an increased 4N DNA content, consistent with a G2 arrest. Levels of anaphase bridges were also elevated, implicating failed chromosome segregation. This was accompanied by an increase in centrosome number, which demonstrates a role for Apc in maintaining euploidy. To address the role of p53 in these processes, we analysed combined loss of Apc and p53, which led to a further increase in proliferation, cell death, DNA damages and repair and a bypass of G2 arrest than was observed with Apc loss. However, we observed only a marginal effect on anaphase bridges and centrosome number, which could be due to increased cell death. Our data therefore establishes, in an in vivo setting, that APC loss leads to a DNA damage signature and genomic instability in the liver and that additional loss of p53 leads to an increase in the DNA damage signal but not to an immediate increase in the genomic instability phenotype.	[Meniel, V.; Young, M. A.; Clarke, A. R.] Cardiff Univ, European Canc Stem Cell Res Inst, Cardiff CF24 4HQ, S Glam, Wales; [Megges, M.] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Cole, A.; Sansom, O. J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Cardiff University; Max Planck Society; Beatson Institute	Meniel, V (corresponding author), Cardiff Univ, European Canc Stem Cell Res Inst, Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales.	Menielvs@cf.ac.uk		Sansom, Owen J./0000-0001-9540-3010; Clarke, Alan/0000-0002-4281-426X; Young, Maddy/0000-0002-1487-0694	Cancer research UK [RCBMA7613]; Cancer Research UK [12481, 15937] Funding Source: researchfish	Cancer research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank Mark Bishop (genotyping) and Derek Scarborough (histology). This work was financially supported by Cancer research UK RCBMA7613.	Guerrero AA, 2010, P NATL ACAD SCI USA, V107, P4159, DOI 10.1073/pnas.0912143106; Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Bree RT, 2004, DNA REPAIR, V3, P989, DOI 10.1016/j.dnarep.2004.03.016; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; CLARKE AR, 1995, ONCOGENE, V11, P1913; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feng GJ, 2012, GASTROENTEROLOGY, V143, P1650, DOI 10.1053/j.gastro.2012.08.047; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Gougelet A, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/816125; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hadjihannas MV, 2006, CELL CYCLE, V5, P2077, DOI 10.4161/cc.5.18.3282; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026799; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Nasser M, 2008, J CELL BIOL, V181, P719; Pineau P, 2008, MUTAT RES-GEN TOX EN, V653, P6, DOI 10.1016/j.mrgentox.2008.01.012; Prost S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e80; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Reed KR, 2008, P NATL ACAD SCI USA, V105, P18919, DOI 10.1073/pnas.0805778105; Sansom OJ, 2005, ONCOGENE, V24, P8205, DOI 10.1038/sj.onc.1208956; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shih IM, 2001, CANCER RES, V61, P818; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; Vaziri C, 1997, J BIOL CHEM, V272, P2762, DOI 10.1074/jbc.272.5.2762; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002	42	14	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	31					4118	4129		10.1038/onc.2014.342	http://dx.doi.org/10.1038/onc.2014.342			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN9PE	25347740	Green Accepted			2022-12-26	WOS:000358780500010
J	Fu, CL; Odegaard, JI; Hsieh, MH				Fu, Chi-Ling; Odegaard, Justin I.; Hsieh, Michael H.			Macrophages are required for host survival in experimental urogenital schistosomiasis	FASEB JOURNAL			English	Article						clodronate	CLODRONATE-CONTAINING LIPOSOMES; LIPID MEDIATORS; DEPLETION; MECHANISMS; EXPRESSION; RESOLUTION; FIBROSIS; INJURY; CELLS	Urogenital schistosomiasis, Schistosoma haematobium worm infection, afflicts millions of people with egg-triggered, fibrotic bladder granulomata. Despite the significant global impact of urogenital schistosomiasis, the mechanisms of bladder granulomogenesis and fibrosis are ill defined due to the prior lack of tractable animal models. We combined a mouse model of urogenital schistosomiasis with macrophage-depleting liposomal clodronate (LC) to define how macrophages mediate bladder granulomogenesis and fibrosis. Mice were injected with eggs purified from infected hamsters or vehicle prepared from uninfected hamster tissues (xenoantigen and injection trauma control). Empty liposomes were controls for LC: 1) LC treatment resulted in fewer bladder egg granuloma-infiltrating macrophages, eosinophils, and T and B cells, lower bladder and serum levels of eotaxin, and higher bladder concentrations of IL-1 alpha and chemokines (in a time-dependent fashion), confirming that macrophages orchestrate leukocyte infiltration of the egg-exposed bladder; 2) macrophage-depleted mice exhibited greater weight loss and bladder hemorrhage postegg injection; 3) early LC treatment postegg injection resulted in profound decreases in bladder fibrosis, suggesting differing roles for macrophages in fibrosis over time; and 4) LC treatment also led to egg dose-dependent mortality, indicating that macrophages prevent death from urogenital schistosomiasis. Thus, macrophages are a potential therapeutic target for preventing or treating the bladder sequelae of urogenital schistosomiasis.	[Fu, Chi-Ling] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Odegaard, Justin I.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Hsieh, Michael H.] Biomed Res Inst, Rockville, MD 20852 USA; [Hsieh, Michael H.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Hsieh, Michael H.] George Washington Univ, Washington, DC USA	Stanford University; University of California System; University of California San Francisco; Children's National Health System; George Washington University	Hsieh, MH (corresponding author), 12111 Parklawn Dr,Room 206, Rockville, MD 20852 USA.	mhsieh@afbr-bri.com			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK087895] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK087895, DK087895] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barrera P, 2000, ARTHRITIS RHEUM-US, V43, P1951, DOI 10.1002/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K; Barron L, 2011, AM J PHYSIOL-GASTR L, V300, pG723, DOI 10.1152/ajpgi.00414.2010; Botros SS, 2008, J PARASITOL, V94, P386, DOI 10.1645/GE-1270.1; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Carlos CP, 2010, TRANSPLANTATION, V89, P1362, DOI 10.1097/TP.0b013e3181da0587; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Danenberg HD, 2002, CIRCULATION, V106, P599, DOI 10.1161/01.CIR.0000023532.98469.48; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fu CL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002605; Fu CL, 2011, JOVE-J VIS EXP, DOI 10.3791/2523; Gommet C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001421; GuhaSarkar S, 2010, J CONTROL RELEASE, V148, P147, DOI 10.1016/j.jconrel.2010.08.031; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Katzav A, 2013, IMMUNOL RES, V56, P334, DOI 10.1007/s12026-013-8406-y; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Leicester KL, 2004, LIVER INT, V24, P446, DOI 10.1111/j.1478-3231.2004.0943.x; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Ray D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001912; Schleicher Ulrike, 2009, V531, P203, DOI 10.1007/978-1-59745-396-7_14; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yang DM, 2009, J PHARMACOL EXP THER, V330, P613, DOI 10.1124/jpet.109.152447	26	17	17	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					193	207		10.1096/fj.14-259572	http://dx.doi.org/10.1096/fj.14-259572			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25351984	Green Published			2022-12-26	WOS:000347378600019
J	Essig, A; Hofmann, D; Munch, D; Gayathri, S; Kunzler, M; Kallio, PT; Sahl, HG; Wider, G; Schneider, T; Aebi, M				Essig, Andreas; Hofmann, Daniela; Muench, Daniela; Gayathri, Savitha; Kuenzler, Markus; Kallio, Pauli T.; Sahl, Hans-Georg; Wider, Gerhard; Schneider, Tanja; Aebi, Markus			Copsin, a Novel Peptide-based Fungal Antibiotic Interfering with the Peptidoglycan Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Antibiotics; Antimicrobial Peptide (AMP); Fungi; Lipid II; Bacterial-Fungal Interaction (BFI); Fungal Secretome	CELL-WALL BIOSYNTHESIS; PRECURSOR LIPID II; PROTEIN STRUCTURES; PICHIA-PASTORIS; DEFENSIN; FOOD; VANCOMYCIN; EXPRESSION; PLECTASIN; BINDING	Background: Secreted antibacterial substances of fungi provide a rich source for new antibiotics. Results: Copsin is a novel fungal antimicrobial peptide that binds in a unique manner to the cell wall precursor lipid II. Conclusion: As part of the defense strategy of a mushroom, copsin kills bacteria by inhibiting the cell wall synthesis. Significance: Copsin provides a novel highly stabilized scaffold for antibiotics. Fungi and bacteria compete with an arsenal of secreted molecules for their ecological niche. This repertoire represents a rich and inexhaustible source for antibiotics and fungicides. Antimicrobial peptides are an emerging class of fungal defense molecules that are promising candidates for pharmaceutical applications. Based on a co-cultivation system, we studied the interaction of the coprophilous basidiomycete Coprinopsis cinerea with different bacterial species and identified a novel defensin, copsin. The polypeptide was recombinantly produced in Pichia pastoris, and the three-dimensional structure was solved by NMR. The cysteine stabilized /-fold with a unique disulfide connectivity, and an N-terminal pyroglutamate rendered copsin extremely stable against high temperatures and protease digestion. Copsin was bactericidal against a diversity of Gram-positive bacteria, including human pathogens such as Enterococcus faecium and Listeria monocytogenes. Characterization of the antibacterial activity revealed that copsin bound specifically to the peptidoglycan precursor lipid II and therefore interfered with the cell wall biosynthesis. In particular, and unlike lantibiotics and other defensins, the third position of the lipid II pentapeptide is essential for effective copsin binding. The unique structural properties of copsin make it a possible scaffold for new antibiotics.	[Essig, Andreas; Gayathri, Savitha; Kuenzler, Markus; Kallio, Pauli T.; Aebi, Markus] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Hofmann, Daniela; Wider, Gerhard] ETH, Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Muench, Daniela; Sahl, Hans-Georg; Schneider, Tanja] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53115 Bonn, Germany; [Schneider, Tanja] Partner Site Bonn Cologne, German Ctr Infect Res, D-53115 Bonn, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bonn; German Center for Infection Research	Aebi, M (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Schneider, Tanja/L-8049-2013	Kunzler, Markus/0000-0003-1275-0629; Schneider, Tanja/0000-0001-7269-4716; Rausch, Daniela/0000-0003-3211-5745; Hofmann, Daniela/0000-0001-7073-0744; Wider, Gerhard/0000-0001-9366-7645	ETH Zurich	ETH Zurich(ETH Zurich)	This work was supported by the ETH Zurich.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; ARTHUR M, 1993, ANTIMICROB AGENTS CH, V37, P1563, DOI 10.1128/AAC.37.8.1563; BLOMBERG F, 1977, J AM CHEM SOC, V99, P8149, DOI 10.1021/ja00467a005; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Brotz H, 1997, EUR J BIOCHEM, V246, P193, DOI 10.1111/j.1432-1033.1997.t01-1-00193.x; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; de Kruijff B, 2008, PROSTAG LEUKOTR ESS, V79, P117, DOI 10.1016/j.plefa.2008.09.020; Dingley AJ, 2008, NAT PROTOC, V3, P242, DOI 10.1038/nprot.2007.497; Dix N. J., 1995, FUNGAL ECOL, P203; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HEITZ A, 1989, BIOCHEMISTRY-US, V28, P2392, DOI 10.1021/bi00432a009; KLAUS W, 1993, J MOL BIOL, V232, P897, DOI 10.1006/jmbi.1993.1438; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Motyl M., 2005, CURR PROTOC PHARM, V31, p13A, DOI [10.1002/0471141755.ph13a03s31, DOI 10.1002/0471141755.PH13A03S31]; Muller A, 2012, MICROB DRUG RESIST, V18, P261, DOI 10.1089/mdr.2011.0242; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nagorska K, 2007, ACTA BIOCHIM POL, V54, P495; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sambrook J., 2001, MOL CLONING; Scherlach K, 2013, ANNU REV MICROBIOL, V67, P375, DOI 10.1146/annurev-micro-092412-155702; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schneider T, 2010, INT J MED MICROBIOL, V300, P161, DOI 10.1016/j.ijmm.2009.10.005; SHELDRICK GM, 1978, NATURE, V271, P223, DOI 10.1038/271223a0; Sugiki T, 2012, METHODS MOL BIOL, V831, P19, DOI 10.1007/978-1-61779-480-3_2; van Scholl L, 2006, NEW PHYTOL, V170, P153, DOI 10.1111/j.1469-8137.2006.01649.x; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	49	94	101	0	59	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34953	34964		10.1074/jbc.M114.599878	http://dx.doi.org/10.1074/jbc.M114.599878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342741	Green Published, hybrid			2022-12-26	WOS:000346260800044
J	Edwards, DJ; Streich, FC; Ronchi, VP; Todaro, DR; Haas, AL				Edwards, Daniel J.; Streich, Frederick C., Jr.; Ronchi, Virginia P.; Todaro, Dustin R.; Haas, Arthur L.			Convergent Evolution in the Assembly of Polyubiquitin Degradation Signals by the Shigella flexneri IpaH9.8 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; E3 Ubiquitin Ligase; Enzyme Mechanism; Polyubiquitin Chain; Protein Degradation; Virulence Factor; IpaH; Ubc5; Conjugation; Oligomer	E3 UBIQUITIN LIGASES; III SECRETION; MULTIUBIQUITIN CHAIN; PROTEIN; MECHANISM; INVASION; CELLS; VIRULENCE; EFFECTORS; REVEALS	Background: IpaH bacterial ubiquitin ligases show no homology with eukaryotic ligases, and their mechanism is speculative. Results: IpaH9.8 functions as a cooperative allosteric dimer with two Ubc5 approximate to ubiquitin binding sites per subunit. Conclusion: Kinetic parallels between IpaH and eukaryotic HECT ligases suggest convergent catalytic cycle evolution. Significance: These are the first mechanistic details of the IpaH enzyme catalytic mechanism. The human pathogen Shigella flexneri subverts host function and defenses by deploying a cohort of effector proteins via a type III secretion system. The IpaH family of 10 such effectors mimics ubiquitin ligases but bears no sequence or structural homology to their eukaryotic counterpoints. Using rates of I-125-polyubiquitin chain formation as a functional read out, IpaH9.8 displays V-type positive cooperativity with respect to varying concentrations of its Ubc5B approximate to I-125-ubiquitin thioester co-substrate in the nanomolar range ([S](1/2) = 140 +/- 32 nm; n = 1.8 +/- 0.1) and cooperative substrate inhibition at micromolar concentrations ([S](1/2) = 740 +/- 240 nm; n = 1.7 +/- 0.2), requiring ordered binding to two functionally distinct sites per subunit. The isosteric substrate analog Ubc5BC85S-ubiquitin oxyester acts as a competitive inhibitor of wild-type Ubc5B approximate to I-125-ubiquitin thioester (K-i = 117 +/- 29 nm), whereas a Ubc5BC85A product analog shows noncompetitive inhibition (K-i = 2.2 +/- 0.5 m), consistent with the two-site model. Re-evaluation of a related IpaH3 crystal structure (PDB entry 3CVR) identifies a symmetric dimer consistent with the observed cooperativity. Genetic disruption of the predicted IpaH9.8 dimer interface reduces the solution molecular weight and significantly ablates the k(cat) but not [S](1/2) for polyubiquitin chain formation. Other studies demonstrate that cooperativity requires the N-terminal leucine-rich repeat-targeting domain and is transduced through Phe(395). Additionally, these mechanistic features are conserved in a distantly related SspH2 Salmonella enterica ligase. Kinetic parallels between IpaH9.8 and the recently revised mechanism for E6AP/UBE3A (Ronchi, V. P., Klein, J. M., and Haas, A. L. (2013) E6AP/UBE3A ubiquitin ligase harbors two E2 approximate to ubiquitin binding sites. J. Biol. Chem. 288, 10349-10360) suggest convergent evolution of the catalytic mechanisms for prokaryotic and eukaryotic ligases.	[Edwards, Daniel J.; Streich, Frederick C., Jr.; Ronchi, Virginia P.; Todaro, Dustin R.; Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu		Streich Jr, Frederick/0000-0002-7549-424X	National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034009 (to A. L. H.).	Ashida H, 2007, MOL MICROBIOL, V63, P680, DOI 10.1111/j.1365-2958.2006.05547.x; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chou YC, 2012, J BIOL CHEM, V287, P268, DOI 10.1074/jbc.M111.316265; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; Grau-Bove X, 2013, GENOME BIOL EVOL, V5, P833, DOI 10.1093/gbe/evt052; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lee H, 2005, EPIDEMIOL INFECT, V133, P469, DOI 10.1017/S0950268804003590; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; PERDOMO JJ, 1994, J CLIN INVEST, V93, P633, DOI 10.1172/JCI117015; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Sack RB, 1997, CLIN INFECT DIS, V24, pS102, DOI 10.1093/clinids/24.Supplement_1.S102; Sansonetti PJ, 2001, FEMS MICROBIOL REV, V25, P3, DOI 10.1111/j.1574-6976.2001.tb00569.x; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Seyedarabi A, 2010, FEBS LETT, V584, P4163, DOI 10.1016/j.febslet.2010.09.006; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Stoll KE, 2011, J BIOL CHEM, V286, P15165, DOI 10.1074/jbc.M110.203968; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Sur D, 2004, INDIAN J MED RES, V120, P454; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Townes JM, 2010, CLIN INFECT DIS, V50, P247, DOI 10.1086/649540; Wang F, 2013, CELL MICROBIOL, V15, P474, DOI 10.1111/cmi.12052; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wu B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000960; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	55	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34114	34128		10.1074/jbc.M114.609164	http://dx.doi.org/10.1074/jbc.M114.609164			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342744	Green Published, hybrid			2022-12-26	WOS:000346077600036
J	de Boer, CG; Hughes, TR				de Boer, Carl G.; Hughes, Timothy R.			Poly-dA:dT Tracts Form an In Vivo Nucleosomal Turnstile	PLOS ONE			English	Article							EUKARYOTIC GENOME; DNA-SEQUENCE; YEAST; ORGANIZATION; RESOLUTION; OCCUPANCY; REGIONS	Nucleosomes regulate many DNA-dependent processes by controlling the accessibility of DNA, and DNA sequences such as the poly-dA:dT element are known to affect nucleosome binding. We demonstrate that poly-dA: dT tracts form an asymmetric barrier to nucleosome movement in vivo, mediated by ATP-dependent chromatin remodelers. We theorize that nucleosome transit over poly-A elements is more energetically favourable in one direction, leading to an asymmetric arrangement of nucleosomes around these sequences. We demonstrate that different arrangements of poly-A and poly-T tracts result in very different outcomes for nucleosome occupancy in yeast, mouse, and human, and show that yeast takes advantage of this phenomenon in its promoter architecture.	[de Boer, Carl G.; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hughes, Timothy R.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	University of Toronto; University of Toronto	Hughes, TR (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	t.hughes@utoronto.ca		de Boer, Carl/0000-0001-8935-5921	Canadian Institutes of Health Research [MOP-111007]; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) to TRH (MOP-111007) and by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) award to CGD (PGS D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogaard KR, 2012, METHOD ENZYMOL, V513, P315, DOI 10.1016/B978-0-12-391938-0.00014-8; Hampson S, 2002, BIOINFORMATICS, V18, P513, DOI 10.1093/bioinformatics/18.4.513; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Rippe K, 2007, P NATL ACAD SCI USA, V104, P15635, DOI 10.1073/pnas.0702430104; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; van Vugt JJFA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006345; Wu R, 2010, GENOME RES, V20, P473, DOI 10.1101/gr.103226.109; Yigit E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt081; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	12	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110479	10.1371/journal.pone.0110479	http://dx.doi.org/10.1371/journal.pone.0110479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353956	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200028
J	Lovejoy, AF; Riordan, DP; Brown, PO				Lovejoy, Alexander F.; Riordan, Daniel P.; Brown, Patrick O.			Transcriptome-Wide Mapping of Pseudouridines: Pseudouridine Synthases Modify Specific mRNAs in S. cerevisiae	PLOS ONE			English	Article							RIBOSOMAL-RNA; NUCLEOTIDE RESOLUTION; SUBSTRATE-SPECIFICITY; NONCODING RNA; IN-VIVO; METHYLATION; YEAST; RESIDUES; REVEALS; GENE	We developed a novel technique, called pseudouridine site identification sequencing (PSI-seq), for the transcriptome-wide mapping of pseudouridylation sites with single-base resolution from cellular RNAs based on the induced termination of reverse transcription specifically at pseudouridines following CMCT treatment. PSI-seq analysis of RNA samples from S. cerevisiae correctly detected all of the 43 known pseudouridines in yeast 18S and 25S ribosomal RNA with high specificity. Moreover, application of PSI-seq to the yeast transcriptome revealed the presence of site-specific pseudouridylation within dozens of mRNAs, including RPL11a, TEF1, and other genes implicated in translation. To identify the mechanisms responsible for mRNA pseudouridylation, we genetically deleted candidate pseudouridine synthase (Pus) enzymes and reconstituted their activities in vitro. These experiments demonstrated that the Pus1 enzyme was necessary and sufficient for pseudouridylation of RPL11a mRNA, whereas Pus4 modified TEF1 mRNA, and Pus6 pseudouridylated KAR2 mRNA. Finally, we determined that modification of RPL11a at Psi -68 was observed in RNA from the related yeast S. mikitae, and psi -239 in TEF1 mRNA was maintained in S. mikitae as well as S. pombe, indicating that these pseudouridylations are ancient, evolutionarily conserved RNA modifications. This work establishes that site-specific pseudouridylation of eukaryotic mRNAs is a genetically programmed RNA modification that naturally occurs in multiple yeast transcripts via distinct mechanisms, suggesting that mRNA pseudouridylation may provide an important novel regulatory function. The approach and strategies that we report here should be generally applicable to the discovery of pseudouridylation, or other RNA modifications, in diverse biological contexts.	[Lovejoy, Alexander F.; Riordan, Daniel P.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Lovejoy, Alexander F.; Riordan, Daniel P.; Brown, Patrick O.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Riordan, Daniel P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Lovejoy, AF (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	lovejoy@stanford.edu; driordan@stanford.edu			Howard Hughes Medical Institute; National Institutes of Health [NIH RO1 CA77097]; Cellular, Biochemical, and Molecular Sciences Predoctoral Research Training Grant from the National Institutes of Health; Stanford Graduate Fellowship; Stanford Genome Training Program from the National Human Genome Research Institute [T32 HG00044]; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular, Biochemical, and Molecular Sciences Predoctoral Research Training Grant from the National Institutes of Health; Stanford Graduate Fellowship(Stanford University); Stanford Genome Training Program from the National Human Genome Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported mainly by the Howard Hughes Medical Institute and by a grant from the National Institutes of Health to POB (NIH RO1 CA77097). POB is an investigator for the Howard Hughes Medical Institute. AFL was partially supported by a Cellular, Biochemical, and Molecular Sciences Predoctoral Research Training Grant from the National Institutes of Health. DPR was partially supported by a Stanford Graduate Fellowship. DPR was also partially supported by the Stanford Genome Training Program (Grant Number T32 HG00044 from the National Human Genome Research Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MZ, 2009, EUKARYOT CELL, V8, P398, DOI 10.1128/EC.00329-08; BAKIN A, 1995, NUCLEIC ACIDS RES, V23, P3290, DOI 10.1093/nar/23.16.3290; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Baudin-Baillieu A, 2009, NUCLEIC ACIDS RES, V37, P7665, DOI 10.1093/nar/gkp816; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Charette M, 2000, IUBMB LIFE, V49, P341; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; DAVIS FF, 1957, J BIOL CHEM, V227, P907; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002; Grosjean H, 2005, TOP CURR GENET, V12, P1, DOI 10.1007/b106848; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; HO NWY, 1971, BIOCHEMISTRY-US, V10, P3651; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6; Kladwang W, 2010, BIOCHEMISTRY-US, V49, P7414, DOI 10.1021/bi101123g; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Massenet S, 1999, MOL CELL BIOL, V19, P2142; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; ROTTMAN FM, 1994, BIOCHIMIE, V76, P1109, DOI 10.1016/0300-9084(94)90038-8; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Tuck MT, 1999, INT J BIOCHEM CELL B, V31, P837, DOI 10.1016/S1357-2725(99)00041-2; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316; Yi CQ, 2011, ACCOUNTS CHEM RES, V44, P1380, DOI 10.1021/ar200057m; Yoon S, 2011, BIOINFORMATICS, V27, P1798, DOI 10.1093/bioinformatics/btr277; Yu AT, 2011, PROTEIN CELL, V2, P712, DOI 10.1007/s13238-011-1087-1; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	43	220	231	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110799	10.1371/journal.pone.0110799	http://dx.doi.org/10.1371/journal.pone.0110799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353621	Green Submitted, Green Published, gold			2022-12-26	WOS:000345204200036
J	Pappas, JJ; Petropoulos, S; Suderman, M; Iqbal, M; Moisiadis, V; Turecki, G; Matthews, SG; Szyf, M				Pappas, Jane J.; Petropoulos, Sophie; Suderman, Matthew; Iqbal, Majid; Moisiadis, Vasilis; Turecki, Gustavo; Matthews, Stephen G.; Szyf, Moshe			The Multidrug Resistance 1 Gene Abcb1 in Brain and Placenta: Comparative Analysis in Human and Guinea Pig	PLOS ONE			English	Article							P-GLYCOPROTEIN; MESSENGER-RNA; PHOSPHOGLYCOPROTEIN ABCB1; FETAL PROTECTION; PROGESTERONE; PRESCRIPTION; GESTATION; REGION; TISSUE; CELLS	The Multidrug Resistance 1 (MDR1; alternatively ABCB1) gene product P-glycoprotein (P-gp), an ATP binding cassette transporter, extrudes multiple endogenous and exogenous substrates from the cell, playing an important role in normal physiology and xenobiotic distribution and bioavailability. To date, the predominant animal models used to investigate the role of P-gp have been the mouse and rat, which have two distinct genes, Abcb1a and Abcb1b. In contrast, the human has a single gene, ABCB1, for which only a single isoform has been validated. We and others have previously shown important differences between Abcb1a and Abcb1b, limiting the extrapolation from rodent findings to the human. Since the guinea pig has a relatively long gestation, hemomonochorial placentation and neuroanatomically mature offspring, it is more similar to the human, and may provide a more comparable model for investigating the regulation of P-gp in the brain and placenta, however, to date, the Abcb1 gene in the guinea pig remains to be characterized. The placenta and fetal brain are barrier sites that express P-gp and that play a critical role of protection of the fetus and the fetal brain from maternally administered drugs and other xenobiotics. Using RNA sequencing (RNA-seq), reverse transcription-polymerase chain reaction (RT-PCR) and quantitative PCR (QPCR) to sequence the expressed isoforms of guinea pig Abcb1, we demonstrate that like the human, the guinea pig genome contains one gene for Abcb1 but that it is expressed as at least three different isoforms via alternative splicing and alternate exon usage. Further, we demonstrate that these isoforms are more closely related to human than to rat or mouse isoforms. This striking, overall similarity and evolutionary relatedness between guinea pig Abcb1 and human ABCB1 indicate that the guinea pig represents a relevant animal model for investigating the function and regulation of P-gp in the placenta and brain.	[Pappas, Jane J.; Petropoulos, Sophie; Suderman, Matthew; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Pappas, Jane J.; Iqbal, Majid; Moisiadis, Vasilis; Matthews, Stephen G.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Suderman, Matthew] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Suderman, Matthew] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Med, Toronto, ON, Canada	McGill University; University of Toronto; McGill University; McGill University; McGill University; McGill University; McGill University; University of Toronto; University of Toronto	Matthews, SG (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	Stephen.Matthews@utoronto.ca	Petropoulos, Sophie/D-6861-2016; Turecki, Gustavo/K-5100-2015; Petropoulos, Sophie/M-3090-2017; Matthews, Stephen/R-5147-2019; Matthews, Stephen G/N-7555-2018	Petropoulos, Sophie/0000-0003-2293-8238; Matthews, Stephen/0000-0002-9654-9940; Matthews, Stephen G/0000-0002-9654-9940; Turecki, Gustavo/0000-0003-4075-2736; Suderman, Matthew/0000-0002-2715-9930	Canadian Institutes of Health Research: [FRN-57746, FRN-84220]; GlaxoSmithKline	Canadian Institutes of Health Research:(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline(GlaxoSmithKline)	This work was supported by the Canadian Institutes of Health Research: (FRN-57746 and FRN-84220 to SGM and MS). This work was also supported by funding from GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; CROOP JM, 1989, MOL CELL BIOL, V9, P1346, DOI 10.1128/MCB.9.3.1346; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; Dean F, 1999, BRAIN RES, V846, P253, DOI 10.1016/S0006-8993(99)02064-8; DEAN M, 2002, HUMAN ATP BINDING CA; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Feinmesser RL, 1996, ONCOGENE, V12, P2725; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Glover DD, 2003, AM J OBSTET GYNECOL, V188, P1039, DOI 10.1067/mob.2003.223; Gow JM, 2008, DRUG METAB DISPOS, V36, P10, DOI 10.1124/dmd.107.017087; Haimov-Kochman R, 2006, CLIN CHEM, V52, P159, DOI 10.1373/clinchem.2005.059758; Hembury A, 2008, CELL MOL NEUROBIOL, V28, P915, DOI 10.1007/s10571-008-9277-y; Ikemura K, 2013, MOL PHARMACOL, V83, P399, DOI 10.1124/mol.112.081844; Iqbal M, 2012, PLACENTA, V33, P137, DOI 10.1016/j.placenta.2012.01.008; Iqbal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043022; Kalabis GM, 2005, BIOL REPROD, V73, P591, DOI 10.1095/biolreprod.105.042242; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Petropoulos S, 2007, REPROD SCI, V14, P321, DOI 10.1177/1933719107303856; Petropoulos S, 2010, BRAIN RES, V1357, P9, DOI 10.1016/j.brainres.2010.08.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIEKARZ RL, 1993, J BIOL CHEM, V268, P7613; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Prokipcak RD, 1999, BIOCHEM BIOPH RES CO, V261, P627, DOI 10.1006/bbrc.1999.1101; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Shang Y, 2013, ONCOGENE; Smit JW, 1999, J CLIN INVEST, V104, P1441, DOI 10.1172/JCI7963; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082062; Yang T, 2013, EXP BIOL MED, V238, P1024, DOI 10.1177/1535370213497321	29	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111135	10.1371/journal.pone.0111135	http://dx.doi.org/10.1371/journal.pone.0111135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353162	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200061
J	Jezzini, SH; Reyes-Colon, D; Sosa, MA				Jezzini, Sami H.; Reyes-Colon, Dalynes; Sosa, Maria A.			Characterization of a Prawn OA/TA Receptor in Xenopus Oocytes Suggests Functional Selectivity between Octopamine and Tyramine	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AGONISTIC BEHAVIOR; BIOGENIC-AMINES; ION CHANNELS; CL-CURRENTS; DROSOPHILA; CLONING; EXPRESSION; ACTIVATION; SEROTONIN	Here we report the characterization of an octopamine/tyramine (OA/TA or TyrR1) receptor (OA/TA(Mac)) cloned from the freshwater prawn, Macrobrachium rosenbergii, an animal used in the study of agonistic social behavior. The invertebrate OA/TA receptors are seven trans-membrane domain G-protein coupled receptors that are related to vertebrate adrenergic receptors. Behavioral studies in arthropods indicate that octopaminergic signaling systems modulate fight or flight behaviors with octopamine and/or tyramine functioning in a similar way to the adrenalins in vertebrate systems. Despite the importance of octopamine signaling in behavioral studies of decapod crustaceans there are no functional data available for any of their octopamine or tyramine receptors. We expressed OA/TA(Mac) in Xenopus oocytes where agonist-evoked transmembrane currents were used as readouts of receptor activity. The currents were most effectively evoked by tyramine but were also evoked by octopamine and dopamine. They were effectively blocked by yohimbine. The electrophysiological approach we used enabled the continuous observation of complex dynamics over time. Using voltage steps, we were able to simultaneously resolve two types of endogenous currents that are affected over different time scales. At higher concentrations we observe that octopamine and tyramine can produce different and opposing effects on both of these currents, presumably through the activity of the single expressed receptor type. The pharmacological profile and apparent functional-selectivity are consistent with properties first observed in the OA/TA receptor from the insect Drosophila melanogaster. As the first functional data reported for any crustacean OA/TA receptor, these results suggest that functional-selectivity between tyramine and octopamine is a feature of this receptor type that may be conserved among arthropods.	[Jezzini, Sami H.; Reyes-Colon, Dalynes; Sosa, Maria A.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Jezzini, Sami H.; Reyes-Colon, Dalynes; Sosa, Maria A.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA; [Reyes-Colon, Dalynes] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Sosa, MA (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.	maria.sosa@upr.edu			National Institutes of Health [MBRS-SCORE S06GM008224, RCMI G12RR03051, MBRS-RISE R25-GM061838]; National Institute of Mental Health [MRISP MH48190]; National Science Foundation [DBI 0115825]; University of Puerto Rico Medical Sciences Campus School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008224, R25GM061838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH048190] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); University of Puerto Rico Medical Sciences Campus School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Supported by National Institutes of Health MBRS-SCORE S06GM008224 (MAS), National Institute of Mental Health MRISP MH48190 (MAS), National Institutes of Health RCMI G12RR03051 (Infrastructure Support to the Institute of Neurobiology), National Science Foundation DBI 0115825 (Infrastructure Support to the Institute of Neurobiology), National Institutes of Health MBRS-RISE R25-GM061838 (DRC), University of Puerto Rico Medical Sciences Campus School of Medicine (SHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, J EXP BIOL, V198, P1691; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; ARAKAWA S, 1990, NEURON, V4, P343, DOI 10.1016/0896-6273(90)90047-J; Bacon JP, 1995, J NEUROPHYSIOL, V74, P2739, DOI 10.1152/jn.1995.74.6.2739; Baier A, 2002, J EXP BIOL, V205, P1233; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Bayliss A, 2013, J NEUROCHEM, V125, P37, DOI 10.1111/jnc.12158; BEAR CE, 1991, J BIOL CHEM, V266, P19142; Beggs KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026809; Bischof LJ, 2004, INSECT BIOCHEM MOLEC, V34, P511, DOI 10.1016/j.ibmb.2004.02.003; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; BREEN CA, 1983, NATURE, V303, P716, DOI 10.1038/303716a0; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Callamaras N, 2000, AM J PHYSIOL-CELL PH, V278, pC667, DOI 10.1152/ajpcell.2000.278.4.C667; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V338, P1189, DOI 10.1016/j.bbrc.2005.10.058; Chang DJ, 2000, P NATL ACAD SCI USA, V97, P1829, DOI 10.1073/pnas.97.4.1829; Diedenhofen B., 2013, COCOR COMP CORRELATI; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Feng GP, 1996, J NEUROSCI, V16, P3925; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fort TJ, 2004, J NEUROPHYSIOL, V92, P3455, DOI 10.1152/jn.00550.2004; Goudeau H, 1998, DEV BIOL, V193, P225, DOI 10.1006/dbio.1997.8799; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Hansen KB, 2009, METHODS MOL BIOL, V552, P343, DOI 10.1007/978-1-60327-317-6_25; Hartzell HC, 1996, J GEN PHYSIOL, V108, P157, DOI 10.1085/jgp.108.3.157; Hoff M, 2011, FASEB J, V25, P2484, DOI 10.1096/fj.11-180703; Homberg U, 2013, J COMP NEUROL, V521, P2025, DOI 10.1002/cne.23269; Huang J, 2012, BRAIN BEHAV IMMUN, V26, P942, DOI 10.1016/j.bbi.2012.04.007; Huang J, 2009, INSECT BIOCHEM MOLEC, V39, P842, DOI 10.1016/j.ibmb.2009.10.001; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kuruma A, 2000, AM J PHYSIOL-CELL PH, V279, pC1401, DOI 10.1152/ajpcell.2000.279.5.C1401; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Lange AB, 2009, GEN COMP ENDOCR, V162, P18, DOI 10.1016/j.ygcen.2008.05.021; Lind U, 2010, MOL PHARMACOL, V78, P237, DOI 10.1124/mol.110.063594; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Martinez-Torres A, 2006, P NATL ACAD SCI USA, V103, P5120, DOI 10.1073/pnas.0600739103; Nagaya Y, 2002, NEUROSCI LETT, V329, P324, DOI 10.1016/S0304-3940(02)00596-7; Oginsky MF, 2010, J COMP NEUROL, V518, P255, DOI 10.1002/cne.22225; Ohta H, 2003, INSECT MOL BIOL, V12, P217, DOI 10.1046/j.1365-2583.2003.00404.x; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Pfluger HJ, 2005, ARTHROPOD STRUCT DEV, V34, P379, DOI 10.1016/j.asd.2005.04.004; Reale V, 1997, BRAIN RES, V769, P309, DOI 10.1016/S0006-8993(97)00723-3; Rex E, 2002, J NEUROCHEM, V82, P1352, DOI 10.1046/j.1471-4159.2002.01065.x; Reyes-Colon D, 2010, BRAIN RES, V1348, P42, DOI 10.1016/j.brainres.2010.06.021; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; Roeder T, 2003, ARCH INSECT BIOCHEM, V54, P1, DOI 10.1002/arch.10102; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rudling JE, 2000, BRIT J PHARMACOL, V131, P933, DOI 10.1038/sj.bjp.0703644; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; SAUDOU F, 1990, EMBO J, V9, P3611, DOI 10.1002/j.1460-2075.1990.tb07572.x; Scimemi A, 2009, MOL NEUROBIOL, V40, P289, DOI 10.1007/s12035-009-8087-7; Selcho M, 2014, J COMP NEUROL, V522, P3485, DOI 10.1002/cne.23616; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Shih TM, 1998, METHOD ENZYMOL, V293, P529; Sneddon LU, 2000, J EXP BIOL, V203, P537; Sosa MA, 2002, CRUSTACEAN NERVOUS SYSTEM, P143; Stoffolano JG, 2007, J INSECT PHYSIOL, V53, P1293, DOI 10.1016/j.jinsphys.2007.07.002; Tierney AJ, 2003, MICROSC RES TECHNIQ, V60, P325, DOI 10.1002/jemt.10271; Tierney AJ, 2001, J COMP PHYSIOL A, V187, P757; Tinikul Y, 2009, TISSUE CELL, V41, P430, DOI 10.1016/j.tice.2009.05.001; TZOUNOPOULOS T, 1995, BIOPHYS J, V69, P904, DOI 10.1016/S0006-3495(95)79964-7; UEZONO Y, 1993, RECEPTOR CHANNEL, V1, P233; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vazquez-Acevedo N, 2009, J COMP NEUROL, V513, P399, DOI 10.1002/cne.21979; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Verlinden H, 2010, J INSECT PHYSIOL, V56, P868, DOI 10.1016/j.jinsphys.2010.03.003; Vierk R, 2009, J COMP PHYSIOL A, V195, P265, DOI 10.1007/s00359-008-0404-5; WOODWARD RM, 1992, P NATL ACAD SCI USA, V89, P4708, DOI 10.1073/pnas.89.10.4708	75	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111314	10.1371/journal.pone.0111314	http://dx.doi.org/10.1371/journal.pone.0111314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350749	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100064
J	Orton, E; Kendrick, D; West, J; Tata, LJ				Orton, Elizabeth; Kendrick, Denise; West, Joe; Tata, Laila J.			Persistence of Health Inequalities in Childhood Injury in the UK; A Population-Based Cohort Study of Children under 5	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; NEIGHBORHOOD VARIATIONS; UNITED-STATES; SOCIAL-CLASS; EPIDEMIOLOGY; FRACTURES; ACCIDENTS; RATES; AREAS; RISK	Background: Injury is a significant cause of childhood death and can result in substantial long-term disability. Injuries are more common in children from socio-economically deprived families, contributing to health inequalities between the most and least affluent. However, little is known about how the relationship between injuries and deprivation has changed over time in the UK. Methods: We conducted a cohort study of all children under 5 registered in one of 495 UK general practices that contributed medical data to The Health Improvement Network database between 1990-2009. We estimated the incidence of fractures, burns and poisonings by age, sex, socio-economic group and calendar period and adjusted incidence rate ratios (IRR) comparing the least and most socio-economically deprived areas over time. Estimates of the UK annual burden of injuries and the excess burden attributable to deprivation were derived from incidence rates. Results: The cohort of 979,383 children experienced 20,804 fractures, 15,880 burns and 10,155 poisonings, equating to an incidence of 75.8/10,000 person-years (95% confidence interval 74.8-76.9) for fractures, 57.9 (57.0-58.9) for burns and 37.3 (35.6-38.0) for poisonings. Incidence rates decreased over time for burns and poisonings and increased for fractures (p, 0.001 test for trend for each injury). They were significantly higher in more deprived households (IRR test for trend p, 0.001 for each injury type) and these gradients persisted over time. We estimate that 865 fractures, 3,763 burns and 3,043 poisonings could be prevented each year in the UK if incidence rates could be reduced to those of the most affluent areas. Conclusions: The incidence of burns and poisonings declined between 1990 and 2009 but increased for fractures. Despite these changes, strong socio-economic inequalities persisted resulting in an estimated 9,000 additional medically-attended injuries per year in under-5s.	[Orton, Elizabeth; Kendrick, Denise] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [West, Joe; Tata, Laila J.] Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Orton, E (corresponding author), Univ Nottingham, Div Primary Care, Univ Pk, Nottingham NG7 2RD, England.	elizabeth.orton@nottingham.ac.uk	West, Joe/I-6637-2012; Orton, Elizabeth/AAI-1377-2021; West, Joe/M-3867-2019; Tata, Laila/J-5227-2012	West, Joe/0000-0002-1135-9356; Orton, Elizabeth/0000-0002-2531-8846; West, Joe/0000-0002-1135-9356; Tata, Laila/0000-0002-6404-8658; Kendrick, Denise/0000-0003-3603-6542				Alaghehbandan R, 2012, BURNS, V38, P136, DOI 10.1016/j.burns.2011.06.010; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bourke Alison, 2004, Inform Prim Care, V12, P171; BROWN GW, 1978, LANCET, V1, P378; Centre. HaSCI, 2012, ATTR DAT SET GP REG; Cooper C, 2004, J BONE MINER RES, V19, P1976, DOI 10.1359/JBMR.040902; Do, 2012, CROWN COPYRIGHT; Franklin RL, 2008, PEDIATRICS, V122, P1244, DOI 10.1542/peds.2007-3551; Haynes R, 2008, HEALTH PLACE, V14, P693, DOI 10.1016/j.healthplace.2007.11.001; Herrett EL, 2011, BRIT J GEN PRACT, V61, P438, DOI 10.3399/bjgp11X583092; Hippisley-Cox J, 2002, BRIT MED J, V324, P1132, DOI 10.1136/bmj.324.7346.1132; Kendrick D, 2001, PUBLIC HEALTH, V115, P103, DOI 10.1016/S0033-3506(01)00427-9; Kendrick D, 2009, HEALTH EDUC RES, V24, P32, DOI 10.1093/her/cym083; Lyons RA, 2000, BRIT MED J, V320, P149, DOI 10.1136/bmj.320.7228.149; MacInnes K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-120; Mayranpaa MK, 2010, J BONE MINER RES, V25, P2476, DOI 10.1002/jbmr.155; Mayranpaa MK, 2010, J BONE MINER RES, V26, P439; Mulvaney C, 2009, J PUBLIC HEALTH-UK, V31, P154, DOI 10.1093/pubmed/fdn103; NICE, 2010, STRAT PREV UN INJ UN, pPH 29; Pomerantz WJ, 2001, J URBAN HEALTH, V78, P141, DOI 10.1093/jurban/78.1.141; Reading R, 2008, SOC SCI MED, V67, P915, DOI 10.1016/j.socscimed.2008.05.018; Region WHOE, 2010, 5 MIN C ENV HLTH PAR; Rennie L, 2007, INJURY, V38, P913, DOI 10.1016/j.injury.2007.01.036; Roberts I, 1996, BRIT MED J, V313, P784; ROBERTS I, 1992, J PAEDIATR CHILD H, V28, P438, DOI 10.1111/j.1440-1754.1992.tb02713.x; Stark AD, 2002, BRIT MED J, V324, P457, DOI 10.1136/bmj.324.7335.457; Statistics, OFN ALL REL POP EST; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; Townsend PP., 1988, HLTH DEPRIVATION INE; Vloemans AFPM, 2011, BURNS, V37, P1161, DOI 10.1016/j.burns.2011.05.001; Xiang YX, 2012, AM J EMERG MED, V30, P293, DOI 10.1016/j.ajem.2010.11.031	31	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111631	10.1371/journal.pone.0111631	http://dx.doi.org/10.1371/journal.pone.0111631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347771	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000347994900083
J	Pandey, V; Sultan, M; Kashofer, K; Ralser, M; Amstislavskiy, V; Starmann, J; Osprian, I; Grimm, C; Hache, H; Yaspo, ML; Sultmann, H; Trauner, M; Denk, H; Zatloukal, K; Lehrach, H; Wierling, C				Pandey, Vikash; Sultan, Marc; Kashofer, Karl; Ralser, Meryem; Amstislavskiy, Vyacheslav; Starmann, Julia; Osprian, Ingrid; Grimm, Christina; Hache, Hendrik; Yaspo, Marie-Laure; Sueltmann, Holger; Trauner, Michael; Denk, Helmut; Zatloukal, Kurt; Lehrach, Hans; Wierling, Christoph			Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; DIFFERENTIAL EXPRESSION; MOLECULAR-MECHANISMS; METABOLISM; DISEASE; ACID; 5-LIPOXYGENASE; ALPHA; PROSTAGLANDINS; INACTIVATION	Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging from mild steatosis characterized by an abnormal retention of lipids within liver cells to steatohepatitis (NASH) showing fat accumulation, inflammation, ballooning and degradation of hepatocytes, and fibrosis. Ultimately, steatohepatitis can result in liver cirrhosis and hepatocellular carcinoma. Methodology and Results: In this study we have analyzed three different mouse strains, A/J, C57BL/6J, and PWD/PhJ, that show different degrees of steatohepatitis when administered a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) containing diet. RNA-Seq gene expression analysis, protein analysis and metabolic profiling were applied to identify differentially expressed genes/proteins and perturbed metabolite levels of mouse liver samples upon DDC-treatment. Pathway analysis revealed alteration of arachidonic acid (AA) and S-adenosylmethionine (SAMe) metabolism upon other pathways. To understand metabolic changes of arachidonic acid metabolism in the light of disease expression profiles a kinetic model of this pathway was developed and optimized according to metabolite levels. Subsequently, the model was used to study in silico effects of potential drug targets for steatohepatitis. Conclusions: We identified AA/eicosanoid metabolism as highly perturbed in DDC-induced mice using a combination of an experimental and in silico approach. Our analysis of the AA/eicosanoid metabolic pathway suggests that 5-hydroxyeicosatetraenoic acid (5-HETE), 15-hydroxyeicosatetraenoic acid (15-HETE) and prostaglandin D2 (PGD2) are perturbed in DDC mice. We further demonstrate that a dynamic model can be used for qualitative prediction of metabolic changes based on transcriptomics data in a disease-related context. Furthermore, SAMe metabolism was identified as being perturbed due to DDC treatment. Several genes as well as some metabolites of this module show differences between A/J and C57BL/6J on the one hand and PWD/PhJ on the other.	[Pandey, Vikash; Sultan, Marc; Ralser, Meryem; Amstislavskiy, Vyacheslav; Hache, Hendrik; Yaspo, Marie-Laure; Lehrach, Hans; Wierling, Christoph] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Kashofer, Karl; Denk, Helmut; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Starmann, Julia; Sueltmann, Holger] German Canc Res Ctr, Heidelberg, Germany; [Osprian, Ingrid] BIOCRATES Life Sci AG, Innsbruck, Austria; [Osprian, Ingrid] LKH Wagna, Dept Internal Med, Wagna, Austria; [Grimm, Christina] Charite, D-13353 Berlin, Germany; [Yaspo, Marie-Laure; Lehrach, Hans] Dahlem Ctr Genome Res & Med Syst Biol, Berlin, Germany; [Trauner, Michael] Med Univ Vienna, Dept Med, Div Gastroenterol & Hepatol, Hans Popper Lab Mol Hepatol, Vienna, Austria	Max Planck Society; Medical University of Graz; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Vienna	Wierling, C (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 73, D-14195 Berlin, Germany.	wierling@molgen.mpg.de	Grimm, Christina/Z-6172-2019	Grimm, Christina/0000-0002-4676-8870; Trauner, Michael/0000-0002-1275-6425; Wierling, Christoph/0000-0002-8856-8412	Austrian Nationalstiftung; Austria Wirtschaftsservice GmbH; Max Planck Society	Austrian Nationalstiftung; Austria Wirtschaftsservice GmbH; Max Planck Society(Max Planck Society)	This work was funded by a grant of the Austrian Nationalstiftung and the Austria Wirtschaftsservice GmbH in the framework of the IMGuS research program (Institute for Medical Genome Research and Systems Biology, Vienna) and by the Max Planck Society. Co-author Ingrid Osprian was employed by BIOCRATES Life Sciences AG during the runtime of the IMGuS project where she did the metabolic analysis presented in this manuscript. BIOCRATES Life Sciences AG provided support in the form of salary for author Ingrid Osprian, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	AHARONY D, 1987, PROSTAGLANDINS, V33, P85, DOI 10.1016/0090-6980(87)90307-8; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Anfuso CD, 2007, J LIPID RES, V48, P782, DOI 10.1194/jlr.M600489-JLR200; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Brase JC, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-36; Broekman F, 2011, WORLD J CLIN ONCOL, V2, P80, DOI 10.5306/wjco.v2.i2.80; Brunt EM, 2004, HUM PATHOL, V35, P1070, DOI 10.1016/j.humpath.2004.04.017; Cano A, 2011, HEPATOLOGY, V54, P1975, DOI 10.1002/hep.24607; Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Denk H, 2000, J HEPATOL, V32, P689, DOI 10.1016/S0168-8278(00)80233-0; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; Geddis MS, 2004, CELL MOTIL CYTOSKEL, V57, P53, DOI 10.1002/cm.10156; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Giannitrapani L, 2009, ANN NY ACAD SCI, V1155, P293, DOI 10.1111/j.1749-6632.2009.03698.x; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; HAYAISHI O, 1991, FASEB J, V5, P2575, DOI 10.1096/fasebj.5.11.1907936; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hoppe A, 2012, METABOLITES, V2, P614, DOI 10.3390/metabo2030614; Ishihara K, 2012, FASEB J, V26, P4111, DOI 10.1096/fj.12-205625; Jauhiainen A, 2012, BIOSTAT OXF ENGL; Juni P, 2002, BRIT MED J, V324, P1287, DOI 10.1136/bmj.324.7349.1287; Kalhan SC, 2011, CLIN SCI, V121, P179, DOI 10.1042/CS20110060; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Klipp Edda, 2009, SYSTEMS BIOL TXB; LEPLEY RA, 1994, J BIOL CHEM, V269, P2627; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Loebke C, 2007, PROTEOMICS, V7, P558, DOI 10.1002/pmic.200600757; Mahipal SVK, 2007, BIOCHEM PHARMACOL, V74, P202, DOI 10.1016/j.bcp.2007.04.005; Mannsperger HA, 2010, BIOINFORMATICS, V26, P2202, DOI 10.1093/bioinformatics/btq347; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Martinez-Clemente M, 2010, HEPATOLOGY, V51, P817, DOI 10.1002/hep.23463; Mato JM, 2013, ANN HEPATOL, V12, P183, DOI 10.1016/S1665-2681(19)31355-9; Miller SB, 2006, SEMIN ARTHRITIS RHEU, V36, P37, DOI 10.1016/j.semarthrit.2006.03.005; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Perrone MG, 2010, CURR MED CHEM, V17, P3769; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Titos E, 2005, J LEUKOCYTE BIOL, V78, P871, DOI 10.1189/jlb.1204747; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Ulbrich H, 2005, BIOCHEM PHARMACOL, V70, P30, DOI 10.1016/j.bcp.2005.03.031; Unterwurzacher I, 2008, CLIN CHEM LAB MED, V46, P1589, DOI 10.1515/CCLM.2008.323; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wierling Christoph, 2007, Briefings in Functional Genomics & Proteomics, V6, P240, DOI 10.1093/bfgp/elm027; Yang K, 2007, PLOS COMPUT BIOL, V3, P523, DOI 10.1371/journal.pcbi.0030055; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	53	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111006	10.1371/journal.pone.0111006	http://dx.doi.org/10.1371/journal.pone.0111006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347188	gold, Green Submitted, Green Published			2022-12-26	WOS:000347994900038
J	Scholten, DJ; Timmer, CM; Peacock, JD; Pelle, DW; Williams, BO; Steensma, MR				Scholten, Donald J., II; Timmer, Christine M.; Peacock, Jacqueline D.; Pelle, Dominic W.; Williams, Bart O.; Steensma, Matthew R.			Down Regulation of Wnt Signaling Mitigates Hypoxia-Induced Chemoresistance in Human Osteosarcoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; BETA-CATENIN; TUMOR HYPOXIA; CANCER; PATHWAY; HIF-1; METASTASIS; EXPRESSION; OVEREXPRESSION; ANGIOGENESIS	Osteosarcoma (OS) is the most common type of solid bone cancer and remains the second leading cause of cancer-related death for children and young adults. Hypoxia is an element intrinsic to most solid-tumor microenvironments, including that of OS, and is associated with resistance to therapy, poor survival, and a malignant phenotype. Cells respond to hypoxia through alterations in gene expression, mediated most notably through the hypoxia-inducible factor (HIF) class of transcription factors. Here we investigate hypoxia-induced changes in the Wnt/beta-catenin signaling pathway, a key signaling cascade involved in OS pathogenesis. We show that hypoxia results in increased expression and signaling activation of HIF proteins in human osteosarcoma cells. Wnt/beta-catenin signaling is down-regulated by hypoxia in human OS cells, as demonstrated by decreased active beta-catenin protein levels and axin2 mRNA expression (p<0.05). This down-regulation appears to rely on both HIF-independent and HIF-dependent mechanisms, with HIF-1 alpha standing out as an important regulator. Finally, we show that hypoxia results in resistance of human OS cells to doxorubicin-mediated toxicity (6-13 fold increase, p<0.01). These hypoxic OS cells can be sensitized to doxorubicin treatment by further inhibition of the Wnt/bcatenin signaling pathway (p<0.05). These data support the conclusion that Wnt/b-catenin signaling is down-regulated in human OS cells under hypoxia and that this signaling alteration may represent a viable target to combat chemoresistant OS subpopulations in a hypoxic niche.	[Scholten, Donald J., II; Timmer, Christine M.; Pelle, Dominic W.; Steensma, Matthew R.] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA; [Scholten, Donald J., II; Peacock, Jacqueline D.; Pelle, Dominic W.; Williams, Bart O.; Steensma, Matthew R.] Van Andel Res Inst, Grand Rapids, MI USA; [Pelle, Dominic W.; Steensma, Matthew R.] Spectrum Hlth Syst, Helen DeVos Childens Hosp, Grand Rapids, MI USA	Michigan State University; Michigan State University College of Human Medicine; Van Andel Institute	Steensma, MR (corresponding author), Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA.	matt.steensma@vai.org	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301	Van Andel Research Institute and Spectrum Health	Van Andel Research Institute and Spectrum Health	The authors thank the Van Andel Research Institute and Spectrum Health for financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065304; Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Anninga JK, 2011, EUR J CANCER, V47, P2431, DOI 10.1016/j.ejca.2011.05.030; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bielack S, 2009, ANN ONCOL, V20, P137, DOI 10.1093/annonc/mdp154; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Cai Y, 2014, J CELL BIOCHEM, V115, P625, DOI 10.1002/jcb.24708; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065940; Chen DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052948; Chen D, 2013, TUMOR BIOL, V34, P1895, DOI 10.1007/s13277-013-0733-z; Deng ZM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/496193; Du XL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-450; El Naggar A, 2012, PEDIATR BLOOD CANCER, V59, P1215, DOI 10.1002/pbc.24191; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Flores RJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-50; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Knowles HJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-372; Kuijjer ML, 2013, INT J CANCER, V133, P2512, DOI 10.1002/ijc.28124; Kumar N, 2009, NUCLEIC ACIDS RES, V37, P3321, DOI 10.1093/nar/gkp196; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lin Carol H., 2013, Sarcoma, V2013, P147541, DOI 10.1155/2013/147541; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ma YM, 2013, BIOCHEM BIOPH RES CO, V431, P274, DOI 10.1016/j.bbrc.2012.12.118; Martin SK, 2011, LEUKEMIA, V25, P1533, DOI 10.1038/leu.2011.122; Mazumdar J, 2009, J CELL MOL MED, V13, P4319, DOI 10.1111/j.1582-4934.2009.00963.x; Michaylira CZ, 2006, CANCER BIOL THER, V5, P476, DOI 10.4161/cbt.5.5.2749; Mizukami Y, 2007, CLIN CANCER RES, V13, P5670, DOI 10.1158/1078-0432.CCR-07-0111; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; RCore Team, 2020, R LANG ENV STAT COMP; Rubin EM, 2010, MOL CANCER THER, V9, P731, DOI 10.1158/1535-7163.MCT-09-0147; Siclari VA, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-78; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; Turner DC, 2014, CLIN CANCER RES, V20, P2783, DOI 10.1158/1078-0432.CCR-13-2364; Vacchelli E, 2014, ONCOIMMUNOLOGY, V3, DOI [10.4161/onci.27048, 10.4161/onci.27878]; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang DP, 2011, CANCER SCI, V102, P1322, DOI 10.1111/j.1349-7006.2011.01950.x; Wilson-Edell KA, 2014, BREAST CANCER RES TR, V144, P287, DOI 10.1007/s10549-014-2877-y; Yang QC, 2007, JPN J CLIN ONCOL, V37, P127, DOI 10.1093/jjco/hyl137	54	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111431	10.1371/journal.pone.0111431	http://dx.doi.org/10.1371/journal.pone.0111431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347326	gold, Green Submitted, Green Published			2022-12-26	WOS:000347994900071
J	Tan, YW; Pan, TL; Ye, Y; Ge, GH; Chen, L; Wen, DF; Zou, SQ				Tan, Youwen; Pan, Tengli; Ye, Yun; Ge, Guohong; Chen, Li; Wen, Danfeng; Zou, Shengqiang			Serum MicroRNAs as Potential Biomarkers of Primary Biliary Cirrhosis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; RT-PCR; EXPRESSION; MIR-122; CANCER; INJURY; IDENTIFICATION; HEPATITIS	Background: Circulating microRNAs (miRNAs), which are extremely stable and protected from RNAse-mediated degradation in body fluids, have emerged as candidate biomarkers for many diseases. The present study aimed to identify a serum microRNA (miRNA) expression profile that could serve as a novel diagnostic biomarker for primary biliary cirrhosis (PBC). Methods: Serum miRNA expression was investigated using four cohorts comprising 380 participants (healthy controls and patients with PBC) recruited between August 2010 and June 2013. miRNA expression was initially analyzed by Illumina sequencing using serum samples pooled from 3 patients and 3 controls. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was then used to evaluate the expression of selected miRNAs in a screening set (n = 40). A logistic regression model was then constructed using a training cohort (n = 192) and validated using another cohort (n = 142). The area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. Results: We identified a miRNA panel (hsa-miR-122-5p, hsa-miR-141-3p, and hsa-miR-26b-5p) with a high diagnostic accuracy for PBC (AUC = 0.905, 95% confidence interval (CI) = 0.857 to 0.953; sensitivity = 80.5%, specificity = 88.3%). There was a significant difference between AUC values of the miRNA panel and those of alkaline phosphatase (ALP) (AUC = 0.537, difference between areas = 0.314, 95% CI = 0.195 to 0.434, P < 0.001), and those of antinuclear antibody (ANA) (AUC = 0.739, difference between areas = 0.112, 95% CI = 0.012 to 0.213, P = 0.0282). Conclusion: We identified a serum microRNA panel with considerable clinical value in PBC diagnosis. The results indicate that the miRNA panel is a more sensitive and specific biomarker for PBC than ALP and ANA.	[Tan, Youwen; Ye, Yun; Ge, Guohong; Chen, Li; Wen, Danfeng; Zou, Shengqiang] Jiangsu Univ, Hosp Zhenjiang 3, Dept Hepatosis, Zhenjiang, Peoples R China; [Pan, Tengli] Peoples Hosp Bozhou, Dept Infect, Bozhou, Peoples R China	Jiangsu University	Tan, YW (corresponding author), Jiangsu Univ, Hosp Zhenjiang 3, Dept Hepatosis, Zhenjiang, Peoples R China.	tyw915@sina.com; 1210xyz@163.com			Natural Science Foundation of Jiangsu Province, China [BK2011151]; Medical Project of Health Department, Jiangsu Province [H201248]; Social Development Project of Zhenjiang City [SH201346]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Medical Project of Health Department, Jiangsu Province; Social Development Project of Zhenjiang City	This work was supported by the Natural Science Foundation of Jiangsu Province, China (BK2011151) (http://www.jstd.gov.cn/), Medical Project of Health Department, Jiangsu Province (H201248) (http://www.jswst.gov.cn/), and the Social Development Project of Zhenjiang City (SH201346) (http://kjj.zhenjiang.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bala S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-151; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Blanco-Calvo M, 2012, SENSORS-BASEL, V12, P9349, DOI 10.3390/s120709349; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; Chen YP, 2013, LIVER INT, V33, P1257, DOI 10.1111/liv.12196; Corpechot C, 2007, HEPATOLOGY, V46, P963, DOI 10.1002/hep.21871; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Ge Yan, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P908, DOI 10.3969/j.issn.1672-7347.2011.09.017; Gershwin ME, 2008, HEPATOLOGY, V47, P737, DOI 10.1002/hep.22042; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Gougelet A, 2013, M S-MED SCI, V29, P861, DOI 10.1051/medsci/20132910013; He Y, 2012, CELL SIGNAL, V24, P2268, DOI 10.1016/j.cellsig.2012.07.023; Hirschfield GM, 2009, HEPATOLOGY, V50, P1347, DOI 10.1002/hep.23252; Hsu Shu-Hao, 2013, Curr Pathobiol Rep, V1, P53; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Iino I, 2013, CANCER SCI, V104, P624, DOI 10.1111/cas.12122; Koutsaki M, 2014, CANCER LETT, V351, P173, DOI 10.1016/j.canlet.2014.05.022; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Lewis PJS, 2012, CLIN PHARMACOL THER, V92, P291, DOI 10.1038/clpt.2012.101; Li G, 2014, POSTGRAD MED J, V90, P106, DOI 10.1136/postgradmedj-2013-131883; Li ZJ, 2014, CELL SIGNAL, V26, P141, DOI 10.1016/j.cellsig.2013.09.018; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin JJ, 2014, CURR OPIN GASTROENTE; Mei Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046890; Munoz-Garrido P, 2012, WORLD J GASTROENTERO, V18, P6189, DOI 10.3748/wjg.v18.i43.6189; Ninomiya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066086; Oertelt S, 2007, HEPATOLOGY, V45, P659, DOI 10.1002/hep.21583; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Papaconstantinou I, 2012, EUR J GASTROEN HEPAT, V24, P223, DOI 10.1097/MEG.0b013e3283505063; Pares Albert, 2008, Gastroenterol Hepatol, V31, P500; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Qin BD, 2013, J GASTROEN HEPATOL, V28, P543, DOI 10.1111/jgh.12040; Qiu WM, 2014, BBA-MOL CELL RES, V1843, P2114, DOI 10.1016/j.bbamcr.2014.06.004; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Steer CJ, 2012, LIVER TRANSPLANT, V18, P265, DOI 10.1002/lt.23377; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Yan S, 2013, TOXICOL LETT; Zhang H, 2012, WORLD J GASTROENTERO, V18, P5188, DOI 10.3748/wjg.v18.i37.5188; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	46	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111424	10.1371/journal.pone.0111424	http://dx.doi.org/10.1371/journal.pone.0111424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347847	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900068
J	Terryn, S; Francart, A; Lamoral, S; Hultberg, A; Rommelaere, H; Wittelsberger, A; Callewaert, F; Stohr, T; Meerschaert, K; Ottevaere, I; Stortelers, C; Vanlandschoot, P; Kalai, M; Van Gucht, S				Terryn, Sanne; Francart, Aurelie; Lamoral, Sophie; Hultberg, Anna; Rommelaere, Heidi; Wittelsberger, Angela; Callewaert, Filip; Stohr, Thomas; Meerschaert, Kris; Ottevaere, Ingrid; Stortelers, Catelijne; Vanlandschoot, Peter; Kalai, Michael; Van Gucht, Steven			Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice	PLOS ONE			English	Article							DOMAIN ANTIBODY FRAGMENTS; CENTRAL-NERVOUS-SYSTEM; MONOCLONAL-ANTIBODIES; CVS STRAIN; INFECTION; IMMUNIZATION; MECHANISMS; PREVENTION; NANOBODIES; IMMUNITY	Rabies virus causes lethal brain infection in about 61000 people per year. Each year, tens of thousands of people receive anti-rabies prophylaxis with plasma-derived immunoglobulins and vaccine soon after exposure. Anti-rabies immunoglobulins are however expensive and have limited availability. VHH are the smallest antigen-binding functional fragments of camelid heavy chain antibodies, also called Nanobodies. The therapeutic potential of anti-rabies VHH was examined in a mouse model using intranasal challenge with a lethal dose of rabies virus. Anti-rabies VHH were administered directly into the brain or systemically, by intraperitoneal injection, 24 hours after virus challenge. Anti-rabies VHH were able to significantly prolong survival or even completely rescue mice from disease. The therapeutic effect depended on the dose, affinity and brain and plasma half-life of the VHH construct. Increasing the affinity by combining two VHH with a glycine-serine linker into bivalent or biparatopic constructs, increased the neutralizing potency to the picomolar range. Upon direct intracerebral administration, a dose as low as 33 mu g of the biparatopic Rab-E8/H7 was still able to establish an anti-rabies effect. The effect of systemic treatment was significantly improved by increasing the half-life of Rab-E8/H7 through linkage with a third VHH targeted against albumin. Intraperitoneal treatment with 1.5 mg (2505 IU, 1 ml) of anti-albumin Rab-E8/H7 prolonged the median survival time from 9 to 15 days and completely rescued 43% of mice. For comparison, intraperitoneal treatment with the highest available dose of human anti-rabies immunoglobulins (65 mg, 111 IU, 1 ml) only prolonged survival by 2 days, without rescue. Overall, the therapeutic benefit seemed well correlated with the time of brain exposure and the plasma half-life of the used VHH construct. These results, together with the ease-of-production and superior thermal stability, render anti-rabies VHH into valuable candidates for development of alternative post exposure treatment drugs against rabies.	[Terryn, Sanne; Francart, Aurelie; Lamoral, Sophie; Kalai, Michael; Van Gucht, Steven] Sci Inst Publ Hlth WIV ISP, Natl Reference Ctr Rabies, Brussels, Belgium; [Terryn, Sanne; Van Gucht, Steven] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Merelbeke, Belgium; [Hultberg, Anna; Rommelaere, Heidi; Wittelsberger, Angela; Callewaert, Filip; Stohr, Thomas; Meerschaert, Kris; Ottevaere, Ingrid; Stortelers, Catelijne; Vanlandschoot, Peter] Ablynx NV, Ghent, Belgium	Ghent University	Van Gucht, S (corresponding author), Sci Inst Publ Hlth WIV ISP, Natl Reference Ctr Rabies, Brussels, Belgium.	Steven.VanGucht@wiv-isp.be			Research Foundation Flanders (FWO Vlaanderen) [G.0657.08]; Interuniversity Attraction Poles Programme - Belgian Science Policy Office (BELSPO) [IUAP P7/32]; WIV-ISP; Belgian Ministry of Social Affairs through Health Insurance System	Research Foundation Flanders (FWO Vlaanderen)(FWO); Interuniversity Attraction Poles Programme - Belgian Science Policy Office (BELSPO); WIV-ISP; Belgian Ministry of Social Affairs through Health Insurance System	This work was supported by funds from the Research Foundation Flanders (FWO Vlaanderen, www.fwo.be), grant number G.0657.08, and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (BELSPO, www.belspo.be), grant number IUAP P7/32. Sanne Terryn received a fellowship from the WIV-ISP. The National Reference Centre of Rabies is partially supported by the Belgian Ministry of Social Affairs through a fund from the Health Insurance System (https://nrchm.wiv-isp.be/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTIC L, 1993, BRAIN RES, V619, P146, DOI 10.1016/0006-8993(93)91606-S; Boruah BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071383; Both L, 2012, LANCET INFECT DIS, V12, P397, DOI 10.1016/S1473-3099(11)70340-1; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Chennareddy Chakravarthy, 2005, THESIS; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; DIETZSCHOLD B, 1992, P NATL ACAD SCI USA, V89, P7252, DOI 10.1073/pnas.89.15.7252; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; Gage GJ, 2012, WHOLE ANIMAL PERFUSI, pe3564; Hanlon CA, 2001, VACCINE, V19, P2273, DOI 10.1016/S0264-410X(00)00516-8; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2009, VACCINE, V27, P1904, DOI 10.1016/j.vaccine.2009.01.110; Harmsen MM, 2005, VACCINE, V23, P4926, DOI 10.1016/j.vaccine.2005.05.017; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Ibanez LI, 2011, J INFECT DIS, V203, P1063, DOI 10.1093/infdis/jiq168; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Lang J, 1998, ACTA TROP, V70, P317, DOI 10.1016/S0001-706X(98)00038-2; Law M, 2008, CURR OPIN IMMUNOL, V20, P486, DOI 10.1016/j.coi.2008.06.005; Lewis P, 2000, MUSCLE NERVE, V23, P720, DOI 10.1002/(SICI)1097-4598(200005)23:5<720::AID-MUS9>3.0.CO;2-5; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Pepinsky RB, 2011, J PHARMACOL EXP THER, V339, P519, DOI 10.1124/jpet.111.183483; Prosniak M, 2003, J INFECT DIS, V188, P53, DOI 10.1086/375247; Roovers RC, 2011, INT J CANCER, V129, P2013, DOI 10.1002/ijc.26145; Rosseels V, 2011, J VIROL METHODS, V173, P127, DOI 10.1016/j.jviromet.2011.01.019; Rossenu R, 2012, CLIN PHARM DRUG DEV, V1; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Schepens B, 2011, J INFECT DIS, V204, P1692, DOI 10.1093/infdis/jir622; SCHUMACHER CL, 1989, J CLIN INVEST, V84, P971, DOI 10.1172/JCI114260; Shah DK, 2013, BIOANALYSIS, V5, P989, DOI [10.4155/bio.13.78, 10.4155/BIO.13.78]; Suin V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/256175; Tuffereau C, 2007, J VIROL, V81, P13622, DOI 10.1128/JVI.02368-06; Vega CG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003334; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; WHO, 2007, 4950 WHO, V49, P425	38	25	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109367	10.1371/journal.pone.0109367	http://dx.doi.org/10.1371/journal.pone.0109367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347556	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900009
J	van Kampen, E; Beaslas, O; Hildebrand, RB; Lammers, B; Van Berkel, TJC; Olkkonen, VM; Van Eck, M				van Kampen, Erik; Beaslas, Olivier; Hildebrand, Reeni B.; Lammers, Bart; Van Berkel, Theo J. C.; Olkkonen, Vesa M.; Van Eck, Miranda			Orp8 Deficiency in Bone Marrow-Derived Cells Reduces Atherosclerotic Lesion Progression in LDL Receptor Knockout Mice	PLOS ONE			English	Article							CHOLESTEROL EFFLUX; EXPRESSION; MACROPHAGES; ABCA1; INFLAMMATION; LIPOPROTEINS; METABOLISM; ACTIVATION; PHENOTYPE; RISK	Introduction: Oxysterol binding protein Related Proteins (ORPs) mediate intracellular lipid transport and homeostatic regulation. ORP8 downregulates ABCA1 expression in macrophages and cellular cholesterol efflux to apolipoprotein A-I. In line, ORP8 knockout mice display increased amounts of HDL cholesterol in blood. However, the role of macrophage ORP8 in atherosclerotic lesion development is unknown. Methods and Results: LDL receptor knockout (KO) mice were transplanted with bone marrow (BM) from ORP8 KO mice and C57Bl/6 wild type mice. Subsequently, the animals were challenged with a high fat/high cholesterol Western-type diet to induce atherosclerosis. After 9 weeks of Western-Type diet feeding, serum levels of VLDL cholesterol were increased by 50% in ORP8 KO BM recipients compared to the wild-type recipients. However, no differences were observed in HDL cholesterol. Despite the increase in VLDL cholesterol, lesions in mice transplanted with ORP8 KO bone marrow were 20% smaller compared to WT transplanted controls. In addition, ORP8 KO transplanted mice displayed a modest increase in the percentage of macrophages in the lesion as compared to the wild-type transplanted group. ORP8 deficient macrophages displayed decreased production of pro-inflammatory factors IL-6 and TNF alpha, decreased expression of differentiation markers and showed a reduced capacity to form foam cells in the peritoneal cavity. Conclusions: Deletion of ORP8 in bone marrow-derived cells, including macrophages, reduces lesion progression after 9 weeks of WTD challenge, despite increased amounts of circulating pro-atherogenic VLDL. Reduced macrophage foam cell formation and lower macrophage inflammatory potential are plausible mechanisms contributing to the observed reduction in atherosclerosis.	[van Kampen, Erik; Hildebrand, Reeni B.; Lammers, Bart; Van Berkel, Theo J. C.; Van Eck, Miranda] Leiden Acad Ctr Drug Res, Div Biopharmaceut, Cluster BioTherapeut, Leiden, Netherlands; [Beaslas, Olivier; Olkkonen, Vesa M.] Minerva Fdn, Dept Lipid Signalling & Homeostasis, Helsinki, Finland		van Kampen, E (corresponding author), Leiden Acad Ctr Drug Res, Div Biopharmaceut, Cluster BioTherapeut, Leiden, Netherlands.	e.van.kampen.3@lacdr.leidenuniv.nl	Van Berkel, Theo/ABD-7677-2021	van Eck, Miranda/0000-0003-3936-3194; Olkkonen, Vesa/0000-0001-5553-7997	Netherlands Heart Foundation [2009B075, 2007T056]; Netherlands Organization for Scientific Research [91813603]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Academy of Finland [121457]; Novo Nordisk Fonden [NNF11OC1014724] Funding Source: researchfish	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Academy of Finland(Academy of Finland); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by The Netherlands Heart Foundation (Grant 2009B075 (EvK)), www.hartstichting.nl; The Netherlands Organization for Scientific Research (VICI Grant 91813603 (MVE)), www.nwo.nl/; the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, the Magnus Ehrnrooth Foundation, and the Academy of Finland (grant 121457 to VMO), www.sigridjuselius.fi/foundation, www.sydantutkimussaatio.fi, pro.tsv.fi/magnusehrnrooth, www.aka.fi. MVE is an Established Investigator of the Netherlands Heart Foundation (Grant 2007T056), www.hartstichting.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaslas O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058856; Beaslas O, 2012, EXP CELL RES, V318, P1933, DOI 10.1016/j.yexcr.2012.05.026; Cho KY, 2013, J STROKE CEREBROVASC, V22, P910, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.020; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dion S, 2011, INT J PARASITOL, V41, P685, DOI 10.1016/j.ijpara.2011.01.008; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Haghpassand M, 2001, J CLIN INVEST, V108, P1315, DOI 10.1172/JCI200112810; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Lehto M, 2008, J CELL SCI, V121, P695, DOI 10.1242/jcs.016964; Lemaire-Ewing S, 2005, CELL BIOL TOXICOL, V21, P97, DOI 10.1007/s10565-005-0141-2; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; MAHLEY RW, 1985, ANN NY ACAD SCI, V454, P209, DOI 10.1111/j.1749-6632.1985.tb11860.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Olkkonen VM, 2006, BIOCHEM SOC T, V34, P389, DOI 10.1042/BST0340389; Patel PJ, 2013, EUROPEAN J HEART FAI; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Shibata N, 2010, CIRC J, V74, P2045, DOI 10.1253/circj.CJ-10-0860; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Tall AR, 2003, ARTERIOSCL THROM VAS, V23, P710, DOI 10.1161/01.ATV.0000068683.51375.59; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yan D, 2007, ARTERIOSCL THROM VAS, V27, P1618, DOI 10.1161/ATVBAHA.107.144121; Zhou TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021078	35	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109024	10.1371/journal.pone.0109024	http://dx.doi.org/10.1371/journal.pone.0109024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347070	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900005
J	Chao, LL; Liu, LL; Ho, TY; Shih, CM				Chao, Li-Lian; Liu, Li-Ling; Ho, Tsung-Yu; Shih, Chien-Ming			First Detection and Molecular Identification of Borrelia garinii Spirochete from Ixodes ovatus Tick Ectoparasitized on Stray Cat in Taiwan	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; FRAGMENT-LENGTH-POLYMORPHISM; MULTILOCUS SEQUENCE-ANALYSIS; LYME-DISEASE SPIROCHETE; GENOSPECIES IDENTIFICATION; GENOMIC GROUPS; KINMEN ISLAND; SP NOV.; RODENTS; ACARI	Borrelia garinii spirochete was detected for the first time in Ixodes ovatus tick ectoparasitized on stray cat in Taiwan. The genetic identity of this detected spirochete was determined by analyzing the gene sequence amplified by genospecies-specific polymerase chain reaction assays based on the 5S-23S intergenic spacer amplicon (rrf-rrl) and outer surface protein A (ospA) genes of B. burgdorferi sensu lato. Phylogenetic relationships were analyzed by comparing the sequences of rrf-rrl and ospA genes obtained from 27 strains of Borrelia spirochetes representing six genospecies of Borrelia. Seven major clades can be easily distinguished by neighbour-joining analysis and were congruent by maximum-parsimony method. Phylogenetic analysis based on rrf-rrl gene revealed that this detected spirochete (strain IO-TP-TW) was genetically affiliated to the same clade with a high homogeneous sequences (96.7 to 98.1% similarity) within the genospecies of B. garinii and can be discriminated from other genospecies of Borrelia spirochetes. Interspecies analysis based on the genetic distance values indicates a lower level (<0.022) of genetic divergence (GD) within the genospecies of B. garinii, and strain IO-TP-TW was genetically more distant (>0.113) to the strains identified in I. ovatus collected from Japan and China. Intraspecies analysis also reveals a higher homogeneity (GD<0.005) between tick (strain IO-TP-TW) and human (strain Bg-PP-TW1) isolates of B. garinii in Taiwan. This study provides the first evidence of B. garinii isolated and identified in an I. ovatus tick in Asia, and the higher homogeneity of B. garinii between tick and human strain may imply the risk of human infection by I. ovatus bite.	[Chao, Li-Lian; Liu, Li-Ling; Ho, Tsung-Yu; Shih, Chien-Ming] Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Dept Parasitol & Trop Med, Taipei, Taiwan; [Shih, Chien-Ming] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Shih, Chien-Ming] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan	National Defense Medical Center; Kaohsiung Medical University; Kaohsiung Medical University	Shih, CM (corresponding author), Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Dept Parasitol & Trop Med, Taipei, Taiwan.	cmshih@kmu.edu.tw		Shih, Chien-Ming/0000-0003-4399-3295	National Science Council, Taipei [NSC99-2314-B-760-001-MY2]; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China [KMU-TP103E17]	National Science Council, Taipei(Ministry of Science and Technology, Taiwan); Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China	This work was supported by grants from the National Science Council, Taipei (NSC99-2314-B-760-001-MY2) and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung (KMU-TP103E17), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI CX, 1988, ANN NY ACAD SCI, V539, P302; BARANTON G, 1992, INT J SYST BACTERIOL, V42, P378, DOI 10.1099/00207713-42-3-378; BERGSTROM S, 1989, MOL MICROBIOL, V3, P479, DOI 10.1111/j.1365-2958.1989.tb00194.x; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; CAPORALE DA, 1994, MOL BIOL EVOL, V11, P51; Chao LL, 2013, INT J INFECT DIS, V17, pE1141, DOI 10.1016/j.ijid.2013.08.004; Chao LL, 2013, TICKS TICK-BORNE DIS, V4, P246, DOI 10.1016/j.ttbdis.2012.11.002; Chao LL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-167; Chao LL, 2011, INT J INFECT DIS, V15, pE182, DOI 10.1016/j.ijid.2010.11.002; Chao LL, 2009, EXP APPL ACAROL, V48, P329, DOI 10.1007/s10493-009-9244-4; Chao LL, 2009, AM J TROP MED HYG, V80, P389, DOI 10.4269/ajtmh.2009.80.389; Chao LL, 2002, AM J TROP MED HYG, V67, P504, DOI 10.4269/ajtmh.2002.67.504; Chen HC, 2004, J RHEUMATOL, V31, P811; Chen Z, 2010, EXP APPL ACAROL, V51, P393, DOI 10.1007/s10493-010-9335-2; Chu C, 2008, J MED MICROBIOL, V57, P980, DOI 10.1099/jmm.0.47663-0; Chu CY, 2008, J CLIN MICROBIOL, V46, P3130, DOI 10.1128/JCM.01195-08; Clark K, 2005, APPL ENVIRON MICROB, V71, P2616, DOI 10.1128/AEM.71.5.2616-2625.2005; DEMAERSCHALCK I, 1995, J CLIN MICROBIOL, V33, P602, DOI 10.1128/JCM.33.3.602-608.1995; Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739; Felsenstein J, 1985, EVOLUTION, V52, P1119; FUKUNAGA M, 1992, BIOCHEM BIOPH RES CO, V183, P952, DOI 10.1016/S0006-291X(05)80282-7; Fukunaga M, 1996, INT J SYST BACTERIOL, V46, P898, DOI 10.1099/00207713-46-4-898; Hao Q, 2011, J CLIN MICROBIOL, V49, P647, DOI 10.1128/JCM.00725-10; JOBE DA, 1993, J CLIN MICROBIOL, V31, P1896, DOI 10.1128/JCM.31.7.1896-1898.1993; JONSSON M, 1992, INFECT IMMUN, V60, P1845, DOI 10.1128/IAI.60.5.1845-1853.1992; KAWABATA H, 1993, MICROBIOL IMMUNOL, V37, P843, DOI 10.1111/j.1348-0421.1993.tb01714.x; KAWABATA M, 1987, J INFECT DIS, V156, P854, DOI 10.1093/infdis/156.5.854; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; MARCONI RT, 1992, J CLIN MICROBIOL, V30, P628, DOI 10.1128/JCM.30.3.628-632.1992; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Masuzawa T, 2001, INT J SYST EVOL MICR, V51, P1817, DOI 10.1099/00207713-51-5-1817; Mathiesen DA, 1997, J INFECT DIS, V175, P98, DOI 10.1093/infdis/175.1.98; MATUSCHKA FR, 1990, J MED ENTOMOL, V27, P385, DOI 10.1093/jmedent/27.3.385; MAUPIN GO, 1994, J INFECT DIS, V170, P636, DOI 10.1093/infdis/170.3.636; Miyamoto K., 1991, Japanese Journal of Sanitary Zoology, V42, P267; MIYAMOTO K, 1992, J MED ENTOMOL, V29, P216, DOI 10.1093/jmedent/29.2.216; NAKAO M, 1994, J MED ENTOMOL, V31, P467, DOI 10.1093/jmedent/31.3.467; NAKAO M, 1992, AM J TROP MED HYG, V47, P505, DOI 10.4269/ajtmh.1992.47.505; PARK KH, 1993, J CLIN MICROBIOL, V31, P1831, DOI 10.1128/JCM.31.7.1831-1837.1993; POSTIC D, 1993, RES MICROBIOL, V144, P467, DOI 10.1016/0923-2508(93)90054-6; Postic D, 1998, J CLIN MICROBIOL, V36, P3497, DOI 10.1128/JCM.36.12.3497-3504.1998; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Richter D, 2006, INT J SYST EVOL MICR, V56, P873, DOI 10.1099/ijs.0.64050-0; RIJPKEMA SGT, 1995, J CLIN MICROBIOL, V33, P3091, DOI 10.1128/JCM.33.12.3091-3095.1995; Robbins RG, 2005, P ENTOMOL SOC WASH, V107, P245; SCHWARTZ JJ, 1992, J BACTERIOL, V174, P3757, DOI 10.1128/JB.174.11.3757-3765.1992; Shih CM, 2002, AM J TROP MED HYG, V66, P611, DOI 10.4269/ajtmh.2002.66.611; Shih CM, 1998, J CLIN MICROBIOL, V36, P3127, DOI 10.1128/JCM.36.11.3127-3132.1998; Shih CM, 1998, J CLIN MICROBIOL, V36, P807, DOI 10.1128/JCM.36.3.807-808.1998; Shih CM, 1998, AM J TROP MED HYG, V59, P687, DOI 10.4269/ajtmh.1998.59.687; Spielman A., 1988, MBL (Marine Biology Laboratory) Lectures in Biology, V9, P147; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang GQ, 1999, CLIN MICROBIOL REV, V12, P633, DOI 10.1128/CMR.12.4.633; WILSON N, 1970, Oriental Insects, V4, P37; Zhang Z F, 1997, Zhonghua Liu Xing Bing Xue Za Zhi, V18, P8; ZUMSTEIN G, 1992, MED MICROBIOL IMMUN, V181, P57, DOI 10.1007/BF00189424	59	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110599	10.1371/journal.pone.0110599	http://dx.doi.org/10.1371/journal.pone.0110599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343260	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943500038
J	Chen, Y; Xin, XX; Zhang, HY; Xu, JF; Gao, Y; Tan, AH; Yang, XB; Qin, X; Hu, YL; Mo, ZN				Chen, Yang; Xin, Xianxiang; Zhang, Haiying; Xu, Jianfeng; Gao, Yong; Tan, Aihua; Yang, Xiaobo; Qin, Xue; Hu, Yanling; Mo, Zengnan			Immunization Associated with Erectile Dysfunction Based on Cross-Sectional and Genetic Analyses	PLOS ONE			English	Article							C-REACTIVE PROTEIN; METABOLIC SYNDROME; RISK-FACTORS; MEN; INFLAMMATION; RECEPTOR; HEALTH; CELLS; CD40; EPIDEMIOLOGY	Erectile dysfunction (ED) is a global disease affecting a large number of people. Some studies have found a relationship between low-grade inflammation and ED. We hypothesized that the immune system might play a key role in the outcome of ED. Five immune agents (C3, C4, IgA, IgM, and IgG) were collected based on the Fangchenggang Area Male Health and Examination Survey (FAMHES), using methods of a traditional cross-sectional analysis. Our results repeated the significant association between ED and metabolic syndrome, obesity, and so forth. However, there seemed to be no positive relation between the tested indexes and ED risk in the baseline analysis (C3: P = 0.737; C4: P = 0.274; IgA: P = 0.943; IgG: P = 0.069; IgM: P = 0.985). Then, after adjusting for age and multivariate covariates, a potentially significant association between ED and IgG was discovered (P = 0.025 and P = 0.034, respectively). Meanwhile, in order to describe the development of ED on a gene level, SNP-set kernel-machine association test (SKAT) was applied with the known humoral immune genes involved. The outcomes suggested that PTAFR (binary P value: 0.0096; continuous P value: 0.00869), IL27 (0.0029; 0.1954), CD37 (0.0248; 0.5196), CD40 (0.7146; 0.0413), IL7R (0.1223; 0.0222), PSMB9 (0.1237; 0.0212), and CXCR3 (0.0849; 0.0478) might be key genes in ED, especially IL27, when we restricted the family-wise error rate (FWER) to 0.5. Our study shows that IgG and seven genes (PTAFR, CD37, CD40, IL7R, PSMB9, CXCR3, and especially IL27) might be key factors in the pathogenesis of ED, which could pave the way for future gene and immune therapies.	[Chen, Yang; Zhang, Haiying; Gao, Yong; Tan, Aihua; Yang, Xiaobo; Qin, Xue; Hu, Yanling; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Chen, Yang; Gao, Yong; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Zhang, Haiying; Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China; [Xin, Xianxiang; Hu, Yanling] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi Zhuang, Peoples R China; [Xu, Jianfeng] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, Fudan Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Gen, Winston Salem, NC USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Fudan University; Fudan University; Fudan University; Wake Forest University; Wake Forest Baptist Medical Center	Hu, YL (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China.	yangchen91316@yeah.net; zengnanmo@hotmail.com	Yang, Xiaobo/G-3854-2016	mo, zengnan/0000-0002-3047-3138	National Natural Science Foundation of China [81472414, 81272853, 81370857, 81260130, 81060234, 30945204]; University Talents Highland Innovation Team of Guangxi [2012012D003, GJR201147-09]; Key Program [2012012D003, GJR201147-09]; Chairman Science and Technology Fund [1116-03, GKG1298003-07-01]; Tackle Program of Guangxi [1116-03, GKG1298003-07-01]; Guangxi Natural Science Foundation [2012GXNSFDA053016, 2012GXNSFAA053152]; Guangxi Graduate Education Innovation Program [2010105981002M175, 2011105981002M202]; Guangxi Medical University Future Scholar Training Program [02304001012]; Guangxi Provincial Department of Finance and Education [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Talents Highland Innovation Team of Guangxi; Key Program; Chairman Science and Technology Fund; Tackle Program of Guangxi; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Graduate Education Innovation Program; Guangxi Medical University Future Scholar Training Program; Guangxi Provincial Department of Finance and Education	This study was supported by grants from the National Natural Science Foundation of China (81472414, 81272853, 81370857, 81260130, 81060234, 30945204), Key Program and University Talents Highland Innovation Team of Guangxi (2012012D003, GJR201147-09), Chairman Science and Technology Fund and Tackle Program of Guangxi (1116-03, GKG1298003-07-01), Guangxi Natural Science Foundation (2012GXNSFDA053016), Guangxi Graduate Education Innovation Program (2010105981002M175 and 2011105981002M202), Guangxi Natural Science Foundation (2012GXNSFAA053152), Guangxi Medical University Future Scholar Training Program (02304001012) and Guangxi Provincial Department of Finance and Education (2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 1993, Int J Impot Res, V5, P181; Rosainz MDA, 2011, J SEX MED, V8, P2017, DOI 10.1111/j.1743-6109.2011.02277.x; Aytac IA, 1999, BJU INT, V84, P50; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Blans MCA, 2006, EUR J CLIN INVEST, V36, P497, DOI 10.1111/j.1365-2362.2006.01653.x; Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; Cander S, 2014, METAB SYNDR RELAT D, V12, P324, DOI 10.1089/met.2013.0150; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen Y, 2012, IMMUNOGENETICS, V64, P747, DOI 10.1007/s00251-012-0636-y; Dunsmuir WD, 1996, DIABETIC MED, V13, P700, DOI 10.1002/(SICI)1096-9136(199608)13:8<700::AID-DIA174>3.0.CO;2-8; Ettala OO, 2014, J SEX MED; Feeley RJ, 2009, THESCIENTIFICWORLDJO, V9, P676, DOI 10.1100/tsw.2009.79; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Glina S, 2013, J SEX MED, V10, P115, DOI 10.1111/j.1743-6109.2012.02816.x; Guo CA, 2013, AM J PHYSIOL-ENDOC M, V304, pE951, DOI 10.1152/ajpendo.00514.2012; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Honda Z, 2002, J BIOCHEM, V131, P773, DOI 10.1093/oxfordjournals.jbchem.a003164; Huber AK, 2012, J IMMUNOL, V189, P3043, DOI 10.4049/jimmunol.1200311; Koga MM, 2013, PROSTAG LEUKOTR ESS, V89, P319, DOI 10.1016/j.plefa.2013.09.003; Kumar J, 2013, J SEX MED, V10, P1372, DOI 10.1111/jsm.12041; Kupelian V, 2010, PREV MED, V50, P19, DOI 10.1016/j.ypmed.2009.11.006; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Liao MZ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034085, 10.1371/journal.pone.0039234]; Lu Z, 2012, PROSTATE, V72, P193, DOI 10.1002/pros.21421; LUGG JA, 1995, J ANDROL, V16, P2; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Nehra A, 2013, J UROLOGY, V189, P2031, DOI 10.1016/j.juro.2012.12.107; Nicolosi A, 2005, BJU INT, V95, P609, DOI 10.1111/j.1464-410X.2005.05348.x; Nicolosi A, 2003, UROLOGY, V61, P201, DOI 10.1016/S0090-4295(02)02102-7; Ortutay C, 2006, CELL IMMUNOL, V244, P87, DOI 10.1016/j.cellimm.2007.01.012; Pasceri V, 2000, CIRCULATION, V102, P2165; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P2884, DOI 10.1002/art.30493; Pinnock CB, 1999, MED J AUSTRALIA, V171, P353, DOI 10.5694/j.1326-5377.1999.tb123691.x; Predescu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075846; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rendell MS, 1999, JAMA-J AM MED ASSOC, V281, P421, DOI 10.1001/jama.281.5.421; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Shah J, 2002, BJU INT, V90, P433, DOI 10.1046/j.1464-410X.2002.02911.x; Shi M-D, 2014, Int J Impot Res, V26, P235, DOI 10.1038/ijir.2014.26; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Stephen J, 2013, J IMMUNOL, V191, P5677, DOI 10.4049/jimmunol.1301250; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Thorve VS, 2011, J DIABETES COMPLICAT, V25, P129, DOI 10.1016/j.jdiacomp.2010.03.003; van Spriel AB, 2004, J IMMUNOL, V172, P2953, DOI 10.4049/jimmunol.172.5.2953; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Weinberg AE, 2013, J SEX MED, V10, P3102, DOI 10.1111/jsm.12318; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yin GN, 2013, J SEX MED, V10, P1488, DOI 10.1111/jsm.12129; Yu Liang, 2013, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V30, P222, DOI 10.3760/cma.j.issn.1003-9406.2013.04.023; Zhang XY, 2013, J IMMUNOL, V190, P6015, DOI 10.4049/jimmunol.1203366; Zwaka TP, 2001, CIRCULATION, V103, P1194	57	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111269	10.1371/journal.pone.0111269	http://dx.doi.org/10.1371/journal.pone.0111269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343742	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943500091
J	Grasis, JA; Lachnit, T; Anton-Erxleben, F; Lim, YW; Schmieder, R; Fraune, S; Franzenburg, S; Insua, S; Machado, G; Haynes, M; Little, M; Kimble, R; Rosenstiel, P; Rohwer, FL; Bosch, TCG				Grasis, Juris A.; Lachnit, Tim; Anton-Erxleben, Friederike; Lim, Yan Wei; Schmieder, Robert; Fraune, Sebastian; Franzenburg, Soeren; Insua, Santiago; Machado, GloriaMay; Haynes, Matthew; Little, Mark; Kimble, Robert; Rosenstiel, Philip; Rohwer, Forest L.; Bosch, Thomas C. G.			Species-Specific Viromes in the Ancestral Holobiont Hydra	PLOS ONE			English	Article							COMPARATIVE METAGENOMICS; VIRAL METAGENOMES; INNATE IMMUNITY; METAZOAN HYDRA; HUMAN GUT; VIRUSES; EVOLUTION; MICROBIOTA; COMMUNITIES; MAINTENANCE	Recent evidence showing host specificity of colonizing bacteria supports the view that multicellular organisms are holobionts comprised of the macroscopic host in synergistic interdependence with a heterogeneous and host-specific microbial community. Whereas host-bacteria interactions have been extensively investigated, comparatively little is known about host-virus interactions and viral contribution to the holobiont. We sought to determine the viral communities associating with different Hydra species, whether these viral communities were altered with environmental stress, and whether these viruses affect the Hydra-associated holobiont. Here we show that each species of Hydra harbors a diverse host-associated virome. Primary viral families associated with Hydra are Myoviridae, Siphoviridae, Inoviridae, and Herpesviridae. Most Hydra-associated viruses are bacteriophages, a reflection of their involvement in the holobiont. Changes in environmental conditions alter the associated virome, increase viral diversity, and affect the metabolism of the holobiont. The specificity and dynamics of the virome point to potential viral involvement in regulating microbial associations in the Hydra holobiont. While viruses are generally regarded as pathogenic agents, our study suggests an evolutionary conserved ability of viruses to function as holobiont regulators and, therefore, constitutes an emerging paradigm shift in host-microbe interactions.	[Grasis, Juris A.; Lim, Yan Wei; Schmieder, Robert; Haynes, Matthew; Little, Mark; Kimble, Robert; Rohwer, Forest L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Grasis, Juris A.; Lachnit, Tim; Anton-Erxleben, Friederike; Fraune, Sebastian; Franzenburg, Soeren; Insua, Santiago; Bosch, Thomas C. G.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Machado, GloriaMay; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	California State University System; San Diego State University; University of Kiel; University of Kiel	Grasis, JA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	jagrasis@gmail.com	Lachnit, Tim/H-9537-2017; Bosch, Thomas C. G./D-5218-2011; Rosenstiel, Philip/A-5137-2009; Rohwer, Forest/AAC-5315-2019; Grasis, Juris A./K-2568-2012; Fraune, Sebastian/B-7970-2010	Rosenstiel, Philip/0000-0002-9692-8828; Grasis, Juris A./0000-0002-3945-0135; Fraune, Sebastian/0000-0002-6940-9571; Insua, Santiago/0000-0002-9247-243X; Little, Mark/0000-0002-6783-8452; Rohwer, Forest/0000-0003-1548-5429; Lachnit, Tim/0000-0002-2880-5930	National Institutes of Health (NIH) [1R21AI094534, 1F32AI098518]; Deutsche Forschungsgemeinschaft (DFG) [BO 848/17-1]; DFG Excellence Initiative [BO 848/17-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI098418, R21AI094534] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Excellence Initiative(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants 1R21AI094534 and 1F32AI098518 from the National Institutes of Health (NIH), by grant BO 848/17-1 from the Deutsche Forschungsgemeinschaft (DFG), and the DFG Excellence Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Bevins CL, 2011, CELL MOL LIFE SCI, V68, P3675, DOI 10.1007/s00018-011-0830-3; Bosch TCG, 2013, ANNU REV MICROBIOL, V67, P499, DOI 10.1146/annurev-micro-092412-155626; Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dutilh BE, 2012, BIOINFORMATICS, V28, P3225, DOI 10.1093/bioinformatics/bts613; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Foret S, 2010, TRENDS GENET, V26, P154, DOI 10.1016/j.tig.2010.01.003; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Franzenburg S, 2013, ISME J, V7, P781, DOI 10.1038/ismej.2012.156; Franzenburg S, 2012, P NATL ACAD SCI USA, V109, P19374, DOI 10.1073/pnas.1213110109; Fraune S, 2009, MICROBE, V4, P457; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Fraune S, 2009, ENVIRON MICROBIOL, V11, P2361, DOI 10.1111/j.1462-2920.2009.01963.x; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; MARGULIS L, 1991, SYMBIOSIS, V11, P1; Marine R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-3; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Roossinck MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/nrmicro2491; Roux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033641; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Thurber RLV, 2011, J EXP MAR BIOL ECOL, V408, P102, DOI 10.1016/j.jembe.2011.07.030; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Unckless RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026564; VANETTEN JL, 1982, P NATL ACAD SCI-BIOL, V79, P3867; VANETTEN JL, 1981, VIROLOGY, V113, P704, DOI 10.1016/0042-6822(81)90199-9; Wichman HA, 2005, GENETICS, V170, P19, DOI 10.1534/genetics.104.034488; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	54	35	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109952	10.1371/journal.pone.0109952	http://dx.doi.org/10.1371/journal.pone.0109952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343582	Green Published, gold			2022-12-26	WOS:000343943500024
J	Jeon, HG; Ju, HU; Kim, GY; Jeong, J; Kim, MH; Jun, JB				Jeon, Hong Gil; Ju, Hyeong Uk; Kim, Gyu Yeol; Jeong, Joseph; Kim, Min-Ho; Jun, Jae-Bum			Bacteriology and Changes in Antibiotic Susceptibility in Adults with Community-Acquired Perforated Appendicitis	PLOS ONE			English	Article							PEDIATRIC COMPLICATED APPENDICITIS; INTRAABDOMINAL INFECTIONS; INTRAOPERATIVE CULTURE; CHILDREN; EPIDEMIOLOGY; MANAGEMENT; RESISTANCE; SMART	This study evaluated bacterial etiology and antibiotic susceptibility in patients diagnosed with community-acquired perforated appendicitis over a 12-year-period. We retrospectively reviewed records of adult patients diagnosed with perforated appendicitis at an 800-bed teaching hospital between January 2000 and December 2011. In total, 415 culture-positive perforated appendicitis cases were analyzed. Escherichia coli was the most common pathogen (277/415, 66.7%), followed by Streptococcus species (61/415, 14.7%). The susceptibility of E. coli to ampicillin, piperacillin/tazobactam, ceftriaxone, cefepime, amikacin, gentamicin, and imipenem was 35.1%, 97.1%, 97.0%, 98.2%, 98.9%, 81.8%, and 100%, respectively. The overall susceptibility of E. coli to quinolones (ciprofloxacin or levofloxacin) was 78.7%. During the study period, univariate logistic regression analysis showed a significant decrease in E. coli susceptibility to quinolones (OR = 0.91, 95% CI 0.84-0.99, P = 0.040). We therefore do not recommend quinolones as empirical therapy for community-acquired perforated appendicitis.	[Jeon, Hong Gil; Ju, Hyeong Uk; Jun, Jae-Bum] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Internal Med, Ulsan 680749, South Korea; [Kim, Gyu Yeol] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Surg, Ulsan 680749, South Korea; [Jeong, Joseph] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Lab Med, Ulsan 680749, South Korea; [Kim, Min-Ho] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Biomed Res Ctr, Ulsan 680749, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Jun, JB (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Internal Med, Ulsan 680749, South Korea.	uvgotletter@hanmail.net		Kim, Min-ho/0000-0003-4909-2308				Andersen BR, 2001, COCHRANE DB SYST REV; BENNION RS, 1990, ANN SURG, V211, P165, DOI 10.1097/00000658-199002000-00008; BERNE TV, 1982, AM J SURG, V144, P8, DOI 10.1016/0002-9610(82)90594-3; Bochicchio Grant V, 2006, Surg Infect (Larchmt), V7, P537, DOI 10.1089/sur.2006.7.537; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Chan KWE, 2010, PEDIATR SURG INT, V26, P157, DOI 10.1007/s00383-009-2540-6; Chen CY, 2012, SURG INFECT, V13, P383, DOI 10.1089/sur.2011.135; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Fallon SC, 2013, J SURG RES, V185, P273, DOI 10.1016/j.jss.2013.05.088; Foo FJ, 2008, SURG-J R COLL SURG E, V6, P278, DOI 10.1016/S1479-666X(08)80051-0; Guillet-Caruba C, 2011, DIAGN MICR INFEC DIS, V69, P376, DOI 10.1016/j.diagmicrobio.2010.11.003; Kokoska ER, 1999, J PEDIATR SURG, V34, P749, DOI 10.1016/S0022-3468(99)90368-8; LAU WY, 1984, ANN SURG, V200, P576, DOI 10.1097/00000658-198411000-00003; Lau YJ, 2012, J MICROBIOL IMMUNOL, V45, P1, DOI 10.1016/j.jmii.2011.11.010; Lee S, 2014, KOREAN J INTERN MED, V29, P49, DOI 10.3904/kjim.2014.29.1.49; Lob SH, 2013, SURG INFECT, V14, P203, DOI 10.1089/sur.2012.034; Montravers P, 2009, J ANTIMICROB CHEMOTH, V63, P785, DOI 10.1093/jac/dkp005; Paterson DL, 2005, J ANTIMICROB CHEMOTH, V55, P965, DOI 10.1093/jac/dki117; SCHMIT PJ, 1994, J AM COLL SURGEONS, V179, P721; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; WAN YL, 1981, AM J SURG, V142, P393, DOI 10.1016/0002-9610(81)90358-5; Wojcik-Stojek Barbara, 2000, Acta Microbiologica Polonica, V49, P171; YELLIN AE, 1985, SURG GYNECOL OBSTET, V161, P303; 박상원, 2005, Infection and Chemotherapy, V37, P255	24	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111144	10.1371/journal.pone.0111144	http://dx.doi.org/10.1371/journal.pone.0111144			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343342	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943500081
J	Kunasegaran, K; Ho, V; Chang, THT; De Silva, D; Bakker, ML; Christoffels, VM; Pietersen, AM				Kunasegaran, Kamini; Ho, Victor; Chang, Ted H-. T.; De Silva, Duvini; Bakker, Martijn L.; Christoffels, Vincent M.; Pietersen, Alexandra M.			Transcriptional Repressor Tbx3 Is Required for the Hormone-Sensing Cell Lineage in Mammary Epithelium	PLOS ONE			English	Article							BREAST-CANCER; GLAND DEVELOPMENT; STEM-CELLS; DOWNSTREAM TARGET; GENE; MOUSE; EXPRESSION; ESTROGEN; MORPHOGENESIS; PATHWAY	The transcriptional repressor Tbx3 is involved in lineage specification in several tissues during embryonic development. Germ-line mutations in the Tbx3 gene give rise to Ulnar-Mammary Syndrome (comprising reduced breast development) and Tbx3 is required for mammary epithelial cell identity in the embryo. Notably Tbx3 has been implicated in breast cancer, which develops in adult mammary epithelium, but the role of Tbx3 in distinct cell types of the adult mammary gland has not yet been characterized. Using a fluorescent reporter knock-in mouse, we show that in adult virgin mice Tbx3 is highly expressed in luminal cells that express hormone receptors, and not in luminal cells of the alveolar lineage (cells primed for milk production). Flow cytometry identified Tbx3 expression already in progenitor cells of the hormone-sensing lineage and co-immunofluorescence confirmed a strict correlation between estrogen receptor (ER) and Tbx3 expression in situ. Using in vivo reconstitution assays we demonstrate that Tbx3 is functionally relevant for this lineage because knockdown of Tbx3 in primary mammary epithelial cells prevented the formation of ER+ cells, but not luminal ER-or basal cells. Interestingly, genes that are repressed by Tbx3 in other cell types, such as E-cadherin, are not repressed in hormone-sensing cells, highlighting that transcriptional targets of Tbx3 are cell type specific. In summary, we provide the first analysis of Tbx3 expression in the adult mammary gland at a single cell level and show that Tbx3 is important for the generation of hormone-sensing cells.	[Kunasegaran, Kamini; Ho, Victor; Chang, Ted H-. T.; De Silva, Duvini; Pietersen, Alexandra M.] Natl Canc Ctr, Dept Cellular & Mol Res, Singapore, Singapore; [Kunasegaran, Kamini; Ho, Victor; Chang, Ted H-. T.; De Silva, Duvini; Pietersen, Alexandra M.] Duke NUS Grad Med Sch Singapore, Program Canc & Stem Cell Biol, Singapore, Singapore; [Bakker, Martijn L.; Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Ctr Heart Failure Res, NL-1105 AZ Amsterdam, Netherlands; [Pietersen, Alexandra M.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; University of Amsterdam; Academic Medical Center Amsterdam; National University of Singapore	Pietersen, AM (corresponding author), Natl Canc Ctr, Dept Cellular & Mol Res, Singapore, Singapore.	apietersen@gmail.com	Ho, Victor/F-3298-2015	Ho, Victor/0000-0001-8167-5242	Agency for Science, Technology and Research Singapore [SSCC10/022]	Agency for Science, Technology and Research Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by the Agency for Science, Technology and Research Singapore (www.a-star.edu.sg); grant number SSCC10/022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Chang THT, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3593; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Douglas NC, 2013, J MAMMARY GLAND BIOL, V18, P143, DOI 10.1007/s10911-013-9282-8; Eblaghie MC, 2004, J ANAT, V205, P1, DOI 10.1111/j.0021-8782.2004.00309.x; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ewan KBR, 2005, AM J PATHOL, V167, P409, DOI 10.1016/S0002-9440(10)62985-9; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Ho V, 2013, BIOTECHNIQUES, V54, P208, DOI 10.2144/000114019; Hoogaars WMH, 2008, PIGM CELL MELANOMA R, V21, P379, DOI 10.1111/j.1755-148X.2008.00461.x; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; Li J, 2013, MOL BIOL CELL, V24, P3569, DOI 10.1091/mbc.E13-05-0273; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051283; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Lu JA, 2010, BBA-REV CANCER, V1806, P268, DOI 10.1016/j.bbcan.2010.07.001; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Ludtke THW, 2009, HEPATOLOGY, V49, P969, DOI 10.1002/hep.22700; Mastroianni M, 2010, CANCER LETT, V289, P23, DOI 10.1016/j.canlet.2009.07.012; Meier-Abt F, 2014, TRENDS MOL MED, V20, P143, DOI 10.1016/j.molmed.2013.11.002; Michalak EM, 2013, STEM CELLS, V31, P1910, DOI 10.1002/stem.1437; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Peres Jade, 2010, Genes Cancer, V1, P272, DOI 10.1177/1947601910365160; Propper AY, 2013, J MAMMARY GLAND BIOL, V18, P93, DOI 10.1007/s10911-013-9298-0; Regan JL, 2012, ONCOGENE, V31, P869, DOI 10.1038/onc.2011.289; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Sale S, 2013, NAT CELL BIOL, V15, P451, DOI 10.1038/ncb2725; Santagata S, 2014, J CLIN INVEST, V124, P859, DOI 10.1172/JCI70941; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Smalley MJ, 2010, METHODS MOL BIOL, V633, P139, DOI 10.1007/978-1-59745-019-5_11; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tarulli GA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3381; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Washkowitz AJ, 2012, WIRES SYST BIOL MED, V4, P273, DOI 10.1002/wsbm.1162; Yarosh W, 2008, CANCER RES, V68, P693, DOI 10.1158/0008-5472.CAN-07-5012	49	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110191	10.1371/journal.pone.0110191	http://dx.doi.org/10.1371/journal.pone.0110191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343378	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943500027
J	Lai, PC; Chiu, LY; Srivastava, P; Trento, C; Dazzi, F; Petretto, E; Cook, HT; Behmoaras, J				Lai, Ping-Chin; Chiu, Ling-Yin; Srivastava, Prashant; Trento, Cristina; Dazzi, Francesco; Petretto, Enrico; Cook, H. Terence; Behmoaras, Jacques			Unique Regulatory Properties of Mesangial Cells Are Genetically Determined in the Rat	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; EXPERIMENTAL GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; MACROPHAGE ACTIVATION; RENAL-FAILURE; T-CELLS; PROLIFERATION; DISEASE; SUSCEPTIBILITY	Mesangial cells are glomerular cells of stromal origin. During immune complex mediated crescentic glomerulonephritis (Crgn), infiltrating and proliferating pro-inflammatory macrophages lead to crescent formation. Here we have hypothesised that mesangial cells, given their mesenchymal stromal origin, show similar immunomodulatory properties as mesenchymal stem cells (MSCs), by regulating macrophage function associated with glomerular crescent formation. We show that rat mesangial cells suppress conA-stimulated splenocyte proliferation in vitro, as previously shown for MSCs. We then investigated mesangial cell-macrophage interaction by using mesangial cells isolated from nephrotoxic nephritis (NTN)-susceptible Wistar Kyoto (WKY) and NTN-resistant Lewis (LEW) rats. We first determined the mesangial cell transcriptome in WKY and LEW rats and showed that this is under marked genetic control. Supernatant transfer results show that WKY mesangial cells shift bone marrow derived macrophage (BMDM) phenotype to M1 or M2 according to the genetic background (WKY or LEW) of the BMDMs. Interestingly, these effects were different when compared to those of MSCs suggesting that mesangial cells can have unique immunomodulatory effects in the kidney. These results demonstrate the importance of the genetic background in the immunosuppressive effects of cells of stromal origin and specifically of mesangial cell-macrophage interactions in the pathophysiology of crescentic glomerulonephritis.	[Lai, Ping-Chin; Chiu, Ling-Yin] Chang Gung Univ, Chang Gung Mem Hosp, Sch Med, Kidney Inst,Dept Nephrol, Taipei, Taiwan; [Chiu, Ling-Yin; Cook, H. Terence; Behmoaras, Jacques] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, CCIR, London, England; [Srivastava, Prashant; Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England; [Trento, Cristina; Dazzi, Francesco] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Chang Gung Memorial Hospital; Chang Gung University; Imperial College London; Imperial College London; Imperial College London	Behmoaras, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, CCIR, London, England.	Jacquesb@imperial.ac.uk	Dazzi, Francesco/ABD-6171-2021	Dazzi, Francesco/0000-0003-2407-236X	Wellcome Trust [WT092523MA]; National Science Council (Taiwan) [NSC 102-2314-B-182A-021]; Kidney Research UK [RP9/13]; Kidney Research UK [RP9/2013] Funding Source: researchfish; Medical Research Council [MC_U120097112] Funding Source: researchfish; MRC [MC_U120097112] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Kidney Research UK(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust (WT092523MA) (www.wellcome.ac.uk); National Science Council (Taiwan, NSC 102-2314-B-182A-021) (www.taiwan.gov.tw); and Kidney Research UK RP9/13 (www.kidneyresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Behmoaras J, 2008, NAT GENET, V40, P553, DOI 10.1038/ng.137; Behmoaras J, 2010, J AM SOC NEPHROL, V21, P1136, DOI 10.1681/ASN.2009090968; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chavele KM, 2010, J CLIN INVEST, V120, P1469, DOI 10.1172/JCI41560; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dazzi F, 2012, IMMUNOLOGY, V137, P206, DOI 10.1111/j.1365-2567.2012.03621.x; Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; Hayakawa K, 2006, J IMMUNOL, V176, P2529, DOI 10.4049/jimmunol.176.4.2529; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isome M, 2004, NEPHROL DIAL TRANSPL, V19, P2997, DOI 10.1093/ndt/gfh558; JOHNSON RJ, 1992, J EXP MED, V175, P1413, DOI 10.1084/jem.175.5.1413; Kang H, 2014, CELL REP, V8, P1210, DOI 10.1016/j.celrep.2014.07.032; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kluth DC, 2004, KIDNEY INT, V66, P542, DOI 10.1111/j.1523-1755.2004.00773.x; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Maratou K, 2011, GENES IMMUN, V12, P78, DOI 10.1038/gene.2010.61; Min DQ, 2009, AM J PHYSIOL-RENAL, V297, pF1229, DOI 10.1152/ajprenal.00074.2009; Morigi M, 2013, NEPHROL DIAL TRANSPL, V28, P788, DOI 10.1093/ndt/gfs556; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Reinders ME, 2013, CURRENT PHARM DESIGN; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Smith J, 2007, J AM SOC NEPHROL, V18, P1816, DOI 10.1681/ASN.2006070733; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Tam FWK, 1999, NEPHROL DIAL TRANSPL, V14, P1658, DOI 10.1093/ndt/14.7.1658; Tesch GH, 1997, AM J PATHOL, V151, P141	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111452	10.1371/journal.pone.0111452	http://dx.doi.org/10.1371/journal.pone.0111452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343449	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500100
J	Wacker, I; Behrens, J				Wacker, Ingrid; Behrens, juergen			Activin B Antagonizes RhoA Signaling to Stimulate Mesenchymal Morphology and Invasiveness of Clear Cell Renal Cell Carcinomas	PLOS ONE			English	Article							LINDAU TUMOR-SUPPRESSOR; BINDING PROTEIN RHO; EPITHELIAL-CELLS; DOWN-REGULATION; TGF-BETA; CANCER; ACTIVATION; EXPRESSION; ADHESION; KINASE	Activin B belongs to the TGF beta family of growth factors and is upregulated in clear cell renal cell carcinoma cells by hypoxia inducible factors. Expression of Activin B is required for tumor growth in vivo and tumor cell invasion in vitro. Here we show that activation of RhoA signaling counteracts Activin B mediated disassembly of actin stress fibers, mesenchymal cell morphology and invasiveness, whereas inhibition of RhoA rescues these effects in Activin B knockdown cells. Conversely, Activin B inhibits RhoA signaling suggesting that there is an antagonistic connection between both pathways. In addition we found that Rac1 plays an opposite role to RhoA, i.e. activation of Rac1 initiates loss of actin stress fibers, promotes a mesenchymal cell morphology and induces invasion in Activin B knockown cells, whereas inhibition of Rac1 abolishes these Activin B effects. Collectively, our data provide evidence that reduction of RhoA signaling by Activin B together with persistent Rac1 activity is a prerequisite for inducing an invasive phenotype in clear cell renal cell carcinoma.	[Wacker, Ingrid; Behrens, juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de			Deutsche Krebshilfe [109995]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe (www.krebshilfe.de) Grant 109995 to: IW and JB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Antsiferova M, 2012, J CELL SCI, V125, P3929, DOI 10.1242/jcs.094789; Antsiferova M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1585; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Fincham VJ, 1999, J CELL SCI, V112, P947; GLUCK U, 1994, J CELL SCI, V107, P1773; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Leto G, 2006, CLIN EXP METASTAS, V23, P117, DOI 10.1007/s10585-006-9010-5; Mukerji SS, 2009, J NEUROCHEM, V111, P1138, DOI 10.1111/j.1471-4159.2009.06406.x; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pawlak G, 2002, MOL BIOL CELL, V13, P336, DOI 10.1091/mbc.01-02-0302; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sadok A., 2014, SMALL GTPASES, V5; Safina AF, 2009, CELL CYCLE, V8, P284, DOI 10.4161/cc.8.2.7590; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Tomizawa M, 2013, J CELL BIOCHEM, V114, P584, DOI 10.1002/jcb.24395; Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107; von Thun A, 2013, MOL CELL BIOL, V33, P4526, DOI 10.1128/MCB.00585-13; Wacker I, 2009, MOL CELL BIOL, V29, P1707, DOI 10.1128/MCB.01184-07; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088489; Zhang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025143; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	45	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111276	10.1371/journal.pone.0111276	http://dx.doi.org/10.1371/journal.pone.0111276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343250	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943500092
J	Alves, JP; Nunes, RB; Stefani, GP; Dal Lago, P				Alves, Jadson P.; Nunes, Ramiro B.; Stefani, Giuseppe P.; Dal Lago, Pedro			Resistance Training Improves Hemodynamic Function, Collagen Deposition and Inflammatory Profiles: Experimental Model of Heart Failure	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOCARDIAL-INFARCTION; EXTRACELLULAR-MATRIX; VENTRICULAR-FUNCTION; EXERCISE; RATS; STRENGTH; CARDIOMYOPATHY; ASSOCIATION; DYSFUNCTION	The role of resistance training on collagen deposition, the inflammatory profile and muscle weakness in heart failure remains unclear. Therefore, this study evaluated the influence of a resistance training program on hemodynamic function, maximum strength gain, collagen deposition and inflammatory profile in chronic heart failure rats. Thirty-two male Wistar rats submitted to myocardial infarction by coronary artery ligation or sham surgery were assigned into four groups: sedentary sham (S-Sham, n = 8); trained sham (T-Sham, n = 8); sedentary chronic heart failure (S-CHF, n = 8) and trained chronic heart failure (T-CHF, n = 8). The maximum strength capacity was evaluated by the one maximum repetition test. Trained groups were submitted to an 8-week resistance training program (4 days/week, 4 sets of 10-12 repetitions/session, at 65% to 75% of one maximum repetition). After 8 weeks of the resistance training program, the T-CHF group showed lower left ventricular end diastolic pressure (P<0.001), higher left ventricular systolic pressure (P<0.05), higher systolic blood pressure (P<0.05), an improvement in the maximal positive derivative of ventricular pressure (P<0.05) and maximal negative derivative of ventricular pressure (P<0.05) when compared to the S-CHF group; no differences were observed when compared to Sham groups. In addition, resistance training was able to reduce myocardial hypertrophy (P<0.05), left ventricular total collagen volume fraction (P<0.01), IL-6 (P<0.05), and TNF-alpha/IL-10 ratio (P<0.05), as well as increasing IL-10 (P<0.05) in chronic heart failure rats when compared to the S-CHF group. Eight weeks of resistance training promotes an improvement of cardiac function, strength gain, collagen deposition and inflammatory profile in chronic heart failure rats.	[Alves, Jadson P.; Nunes, Ramiro B.; Stefani, Giuseppe P.; Dal Lago, Pedro] Univ Fed Ciencias Saude Porto Alegre, Physiol Lab, Porto Alegre, RS, Brazil; [Dal Lago, Pedro] Univ Fed Ciencias Saude Porto Alegre, Dept Phys Therapy, Porto Alegre, RS, Brazil	Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Ciencias da Saude de Porto Alegre	Dal Lago, P (corresponding author), Univ Fed Ciencias Saude Porto Alegre, Physiol Lab, Porto Alegre, RS, Brazil.	pdallago@ufcspa.edu.br	Dal Lago, Pedro/AAM-9136-2020; Stefani, Giuseppe Potrick/D-4561-2014; Dal Lago, Pedro/K-4414-2013; Alves, Jadson/R-1882-2016	Dal Lago, Pedro/0000-0001-9907-7689; Stefani, Giuseppe Potrick/0000-0001-5492-4530; Dal Lago, Pedro/0000-0001-9907-7689; Alves, Jadson/0000-0002-4131-6058	CAPES, Brasilia, Brazil; CNPq, Brasilia, Brazil; PROAP/UFCSPA, Porto Alegre, Brazil	CAPES, Brasilia, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROAP/UFCSPA, Porto Alegre, Brazil	This work was supported by grants from the following: CAPES and CNPq, Brasilia, Brazil, and PROAP/UFCSPA, Porto Alegre, Brazil (http://www.capes.gov.br/; http://www.ufcspa.edu.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos S, 2002, J AM COLL CARDIOL, V39, P653, DOI 10.1016/S0735-1097(01)01795-8; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Barauna VG, 2007, CLIN MED RES, V5, P114, DOI 10.3121/cmr.2007.707; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Cheetham C, 2002, J APPL PHYSIOL, V93, P175, DOI 10.1152/japplphysiol.01240.2001; de Cassia Cypriano Ervati Pinter R, 2008, EUROPEAN J APPL PHYS, V103, P605; de Leon EB, 2011, ACTA PHYSIOL, V201, P265, DOI 10.1111/j.1748-1716.2010.02176.x; Emter CA, 2010, AM J PHYSIOL-HEART C, V299, pH1348, DOI 10.1152/ajpheart.00578.2010; Francis J, 2001, AM J PHYSIOL-REG I, V281, pR1734, DOI 10.1152/ajpregu.2001.281.5.R1734; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Georgiadou Panagiota, 2012, Curr Heart Fail Rep, V9, P128, DOI 10.1007/s11897-012-0090-z; Gielen S, 2003, J AM COLL CARDIOL, V42, P861, DOI 10.1016/S0735-1097(03)00848-9; Goswami B, 2009, CLIN CHIM ACTA, V408, P14, DOI 10.1016/j.cca.2009.06.029; Gurtl B, 2009, INT J EXP PATHOL, V90, P338, DOI 10.1111/j.1365-2613.2009.00647.x; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Hulsmann M, 2004, EUR J HEART FAIL, V6, P101, DOI 10.1016/j.ejheart.2003.07.008; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001; Jaenisch RB, 2011, J APPL PHYSL; Jankowska EA, 2008, INT J CARDIOL, V130, P36, DOI 10.1016/j.ijcard.2007.07.158; Jannig PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085820; Krisan AD, 2004, J APPL PHYSIOL, V96, P1691, DOI 10.1152/japplphysiol.01054.2003; Kwan G, 2012, CIRCULATION, V125, pE369, DOI 10.1161/CIRCULATIONAHA.112.093310; Levinger I, 2005, INT J CARDIOL, V105, P159, DOI 10.1016/j.ijcard.2004.11.022; LINDPAINTNER K, 1993, J MOL CELL CARDIOL, V25, P133, DOI 10.1006/jmcc.1993.1017; Lunde PK, 2001, ACTA PHYSIOL SCAND, V171, P277, DOI 10.1046/j.1365-201x.2001.00830.x; Matsubara LS, 2000, AM J PHYSIOL-HEART C, V279, pH1534, DOI 10.1152/ajpheart.2000.279.4.H1534; MCKELVIE RS, 1995, AM J CARDIOL, V76, P977, DOI 10.1016/S0002-9149(99)80277-X; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; Mihl C, 2008, NETH HEART J, V16, P129, DOI 10.1007/BF03086131; Musch TI, 2002, J APPL PHYSIOL, V92, P2326, DOI 10.1152/japplphysiol.00686.2001; Nunes RB, 2008, J APPL PHYSIOL, V104, P1641, DOI 10.1152/japplphysiol.00062.2008; Palevo G, 2009, J CARDIOPULM REHABIL, V29, P294, DOI 10.1097/HCR.0b013e3181ac784b; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pfeifer PC, 2001, MED SCI SPORT EXER, V33, P542; Piepoli MF, 2001, ACTA PHYSIOL SCAND, V171, P295, DOI 10.1046/j.1365-201x.2001.00831.x; Savage PA, 2011, MED SCI SPORT EXER, V43, P1379, DOI 10.1249/MSS.0b013e31820eeea1; Smart NA, 2013, INT J CARDIOL, V166, P352, DOI 10.1016/j.ijcard.2011.10.075; Vanzelli AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062452; Weber KT, 2008, J AM COLL CARDIOL, V52, P2029, DOI 10.1016/j.jacc.2008.09.012; WHITTAKER P, 1991, CIRCULATION, V84, P2123, DOI 10.1161/01.CIR.84.5.2123; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Xu XH, 2008, J MOL CELL CARDIOL, V44, P114, DOI 10.1016/j.yjmcc.2007.10.004; Yengo CM, 2012, MED SCI SPORT EXER, V44, P1005, DOI 10.1249/MSS.0b013e318244bc8a; Yu CM, 1996, EUR HEART J, V17, P1694	47	33	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110317	10.1371/journal.pone.0110317	http://dx.doi.org/10.1371/journal.pone.0110317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340545	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800030
J	Russo, D; Di Febbraro, M; Rebelo, H; Mucedda, M; Cistrone, L; Agnelli, P; De Pasquale, PP; Martinoli, A; Scaravelli, D; Spilinga, C; Bosso, L				Russo, Danilo; Di Febbraro, Mirko; Rebelo, Hugo; Mucedda, Mauro; Cistrone, Luca; Agnelli, Paolo; De Pasquale, Pier Paolo; Martinoli, Adriano; Scaravelli, Dino; Spilinga, Cristiano; Bosso, Luciano			What Story Does Geographic Separation of Insular Bats Tell? A Case Study on Sardinian Rhinolophids	PLOS ONE			English	Article							MEDITERRANEAN HORSESHOE BAT; MYOTIS-MYOTIS CHIROPTERA; CHARACTER DISPLACEMENT; HABITAT SELECTION; DISTRIBUTION MODELS; COMMUNITY STRUCTURE; ECHOLOCATION CALLS; MEHELYI CHIROPTERA; EURYALE CHIROPTERA; PREY SELECTION	Competition may lead to changes in a species' environmental niche in areas of sympatry and shifts in the niche of weaker competitors to occupy areas where stronger ones are rarer. Although mainland Mediterranean (Rhinolophus euryale) and Mehely's (R. mehelyi) horseshoe bats mitigate competition by habitat partitioning, this may not be true on resource-limited systems such as islands. We hypothesize that Sardinian R. euryale (SAR) have a distinct ecological niche suited to persist in the south of Sardinia where R. mehelyi is rarer. Assuming that SAR originated from other Italian populations (PES) -mostly allopatric with R. mehelyi -once on Sardinia the former may have undergone niche displacement driven by R. mehelyi. Alternatively, its niche could have been inherited from a Maghrebian source population. We: a) generated Maxent Species Distribution Models (SDM) for Sardinian populations; b) calibrated a model with PES occurrences and projected it to Sardinia to see whether PES niche would increase R. euryale's sympatry with R. mehelyi; and c) tested for niche similarity between R. mehelyi and PES, PES and SAR, and R. mehelyi and SAR. Finally we predicted R. euryale's range in Northern Africa both in the present and during the Last Glacial Maximum (LGM) by calibrating SDMs respectively with SAR and PES occurrences and projecting them to the Maghreb. R. mehelyi and PES showed niche similarity potentially leading to competition. According to PES' niche, R. euryale would show a larger sympatry with R. mehelyi on Sardinia than according to SAR niche. Such niches have null similarity. The current and LGM Maghrebian ranges of R. euryale were predicted to be wide according to SAR's niche, negligible according to PES' niche. SAR's niche allows R. euryale to persist where R. mehelyi is rarer and competition probably mild. Possible explanations may be competition-driven niche displacement or Maghrebian origin.	[Russo, Danilo; Bosso, Luciano] Univ Naples Federico II, Dipartimento Agr, Wildlife Res Unit, Naples, Italy; [Russo, Danilo; Rebelo, Hugo] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Di Febbraro, Mirko] Univ Molise, EnvixLab, Dipartimento Biosci & Terr, Pesche, Italy; [Rebelo, Hugo] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Mucedda, Mauro] Ctr Studio & Protez Pipistrelli Sardegna, Sassari, Italy; [Cistrone, Luca] Forestry & Conservat, Cassino, Frosinone, Italy; [Agnelli, Paolo] Univ Florence, Museo Storia Nat, Sez Zool La Specola, Florence, Italy; [De Pasquale, Pier Paolo] Wildlife Consulting, Bari, Italy; [Martinoli, Adriano] Univ Insubria, Dipartimento Sci Teor & Applicate, Guido Tosi Res Grp, Unita Anal & Gest Risorse Ambientali, Varese, Italy; [Scaravelli, Dino] Univ Bologna, Dipartimento Sci Med Vet, Bologna, Italy; [Spilinga, Cristiano] Studio Naturalist Hyla Snc, Perugia, Italy	University of Naples Federico II; University of Bristol; University of Molise; Universidade do Porto; University of Florence; University of Insubria; University of Bologna	Russo, D (corresponding author), Univ Naples Federico II, Dipartimento Agr, Wildlife Res Unit, Naples, Italy.	danrusso@unina.it	Di Febbraro, Mirko/GQA-4462-2022; Di Febbraro, Mirko/I-3167-2019; Rebelo, Hugo/C-9005-2009; Martinoli, Adriano/L-4924-2016	Rebelo, Hugo/0000-0002-7118-4068; Martinoli, Adriano/0000-0003-0298-0869; Russo, Danilo/0000-0002-1934-7130; Bosso, Luciano/0000-0002-9472-3802; AGNELLI, PAOLO/0000-0002-0004-8325; Di Febbraro, Mirko/0000-0001-8898-7046	Italian Ministry of the Environment and the Protection of Land and Sea, CIG [464598541B]; Programme Investigador FCT [IF/00497/2013]	Italian Ministry of the Environment and the Protection of Land and Sea, CIG; Programme Investigador FCT	DR and LB were funded by Italian Ministry of the Environment and the Protection of Land and Sea, CIG nr.464598541B (www.minambiente.it).HR was funded by the Programme Investigador FCT, IF/00497/2013 (www.fct.pt).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2008, COPEIA, P689, DOI 10.1643/CG-07-217; Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x; Biollaz F, 2010, J BIOGEOGR, V37, P1557, DOI 10.1111/j.1365-2699.2010.02282.x; BOGDANOWICZ W, 1983, ACTA THERIOL, V28, P357, DOI 10.4098/AT.arch.83-31; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; CastilloRivera M, 1996, J FISH BIOL, V49, P1102; Cox C.B., 2010, BIOGEOGRAPHY ECOLOGI; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Di Febbraro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066559; Dietz C, 2006, J MAMMAL, V87, P1241, DOI 10.1644/05-MAMM-A-299R2.1; Dondini G, 2014, HYSTRIX, V25, P59, DOI 10.4404/hystrix-25.1-9248; Dragu A, 2011, ACTA THERIOL, V56, P383, DOI 10.1007/s13364-011-0043-z; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flaquer Carles, 2010, Galemys, V22, P29; Garcia-Mudarra JL, 2009, BIOL J LINN SOC, V96, P434, DOI 10.1111/j.1095-8312.2008.01128.x; Goiti U, 2004, MAMMALIA, V68, P397, DOI 10.1515/mamm.2004.039; Goldberg EE, 2006, EVOLUTION, V60, P1344, DOI 10.1111/j.0014-3820.2006.tb01214.x; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Guillen A, 2003, HORSESHOE BATS WORLD, P7; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Hutson AM, 2008, IUCN 2013 IUCN RED L; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Keith DA, 2014, DIVERS DISTRIB, V20, P440, DOI 10.1111/ddi.12173; KIEFER A., 2007, THESIS GUTENBERG U M; Kingston T, 2000, OECOLOGIA, V124, P332, DOI 10.1007/PL00008866; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kronfeld-Schor N, 1999, OECOLOGIA, V121, P123, DOI 10.1007/s004420050913; Krzanowski A., 1967, Acta Zoologica Cracoviensia, V12, P281; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; McNab Brian K., 2009, P153; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Peers MJL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2495; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Puechmaille SJ, 2014, MAMMALIA, V78, P251, DOI 10.1515/mammalia-2013-0040; Rodder D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072855; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Rombaut Dominique, 2002, Arvicola, V14, P18; Ruedi M, 2008, MOL ECOL, V17, P1801, DOI 10.1111/j.1365-294X.2008.03702.x; Russo D, 2005, J ZOOL, V266, P327, DOI 10.1017/S0952836905006990; Russo D, 2001, MAMMALIA, V65, P429, DOI 10.1515/mamm.2001.65.4.429; Russo D, 2002, BIOL CONSERV, V107, P71, DOI 10.1016/S0006-3207(02)00047-2; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Russo D, 2009, J BIOGEOGR, V36, P2212, DOI 10.1111/j.1365-2699.2009.02158.x; Salsamendi E, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-30; Salsamendi E, 2008, ACTA CHIROPTEROL, V10, P279, DOI 10.3161/150811008X414854; Schuchmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012842; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; SPENCER LM, 1995, J MAMMAL, V76, P448, DOI 10.2307/1382355; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stadelmann B, 2004, J MAMMAL, V85, P133, DOI 10.1644/1545-1542(2004)085<0133:MSOTFB>2.0.CO;2; Theodoridis S, 2013, J BIOGEOGR, V40, P1278, DOI 10.1111/jbi.12085; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Veith M, 2011, ACTA CHIROPTEROL, V13, P89, DOI 10.3161/150811011X578642; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Zhou ZM, 2009, J MAMMAL, V90, P57, DOI 10.1644/08-MAMM-A-048.1	73	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110894	10.1371/journal.pone.0110894	http://dx.doi.org/10.1371/journal.pone.0110894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340737	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800068
J	Bellner, L; Marrazzo, G; van Rooijen, N; Dunn, MW; Abraham, NG; Schwartzman, ML				Bellner, Lars; Marrazzo, Giuseppina; van Rooijen, Nico; Dunn, Michael W.; Abraham, Nader G.; Schwartzman, Michal L.			Heme oxygenase-2 deletion impairs macrophage function: implication in wound healing	FASEB JOURNAL			English	Article						inflammation; bone marrow transfer; clodronate liposomes	CORNEAL NEOVASCULARIZATION; INFLAMMATION; MICE; ACTIVATION; RESOLUTION; REPAIR; INTERLEUKIN-10; MECHANISMS; DEPLETION; SYSTEM	Heme oxygenase (HO)-2 deficiency impairs wound healing and exacerbates inflammation following injury. We examine the impact of HO-2 deficiency on macrophage function and the contribution of macrophage HO-2 to inflammatory and repair responses to injury. Corneal epithelial debridement was performed in control and macrophage-depleted HO-2(-/-) and wild-type (WT) mice and in bone marrow chimeras. Peritoneal macrophages were collected for determination of phagocytic activity and classically activated macrophage (M1)-alternatively activated macrophage (M2) polarization. Depletion of macrophages delayed corneal healing (13.2%) and increased neutrophil infiltration (54.1%) by day 4 in WT mice, whereas in HO-2(-/-) mice, it did not worsen the already impaired wound healing and exacerbated inflammation. HO-2(-/-) macrophages displayed an altered M1 phenotype with no significant expression of M2 or M2-like activated cells and a 31.3% reduction in phagocytic capacity that was restored by inducing HO-1 activity or supplementing biliverdin. Macrophage depletion had no effect, whereas adoptive transfer of WT bone marrow improved wound healing (34% on day 4) but did not resolve the exaggerated inflammatory response in HO-2(-/-) mice. These findings indicate that HO-2-deficient macrophages are dysfunctional and that macrophage HO-2 is required for proper macrophage function but is insufficient to correct the impaired healing of the HO-2(-/-) cornea, suggesting that corneal epithelial expression of HO-2 is a key to resolution and repair in wound healing.	[Bellner, Lars; Marrazzo, Giuseppina; Abraham, Nader G.; Schwartzman, Michal L.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Dunn, Michael W.; Schwartzman, Michal L.] New York Med Coll, Dept Ophthalmol, Valhalla, NY 10595 USA; [Abraham, Nader G.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Fac Med, Dept Mol Cell Biol, Amsterdam, Netherlands	New York Medical College; New York Medical College; New York Medical College; Vrije Universiteit Amsterdam	Bellner, L (corresponding author), New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA.	lars_bellner@nymc.edu	Van Rooijen, Nico/Z-1578-2019		NATIONAL EYE INSTITUTE [R01EY006513] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY06513, R01 EY006513] Funding Source: Medline; NHLBI NIH HHS [P01 HL034300] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; Bellner L, 2008, EXP EYE RES, V87, P268, DOI 10.1016/j.exer.2008.06.007; Bellner L, 2011, MOL VIS, V17, P1144; Bellner L, 2011, INVEST OPHTH VIS SCI, V52, P3246, DOI 10.1167/iovs.10-6219; Bellner L, 2009, J PHARMACOL EXP THER, V331, P925, DOI 10.1124/jpet.109.158352; Brogliato AR, 2012, SHOCK, V38, P620, DOI 10.1097/SHK.0b013e318272ff8a; Chiang N, 2013, J IMMUNOL, V190, P6378, DOI 10.4049/jimmunol.1202969; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; GALLILY R, 1964, P NATL ACAD SCI USA, V51, P1158, DOI 10.1073/pnas.51.6.1158; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Hull TD, 2014, ANTIOXID REDOX SIGN, V20, P1770, DOI 10.1089/ars.2013.5673; Ito Y, 1996, AM J PHYSIOL-HEART C, V270, pH81, DOI 10.1152/ajpheart.1996.270.1.H81; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Li SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061799; Lu PR, 2009, CORNEA, V28, P562, DOI 10.1097/ICO.0b013e3181930bcd; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Marrazzo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021180; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; ODLAND G, 1968, J CELL BIOL, V39, P135, DOI 10.1083/jcb.39.1.135; Patil K, 2008, INVEST OPHTH VIS SCI, V49, P3379, DOI 10.1167/iovs.07-1515; POSS KD, 1995, NEURON, V15, P867, DOI 10.1016/0896-6273(95)90177-9; Rogers B, 2003, FREE RADICAL BIO MED, V35, P872, DOI 10.1016/S0891-5849(03)00431-3; ROSS R, 1968, J CELL BIOL, V39, P152, DOI 10.1083/jcb.39.1.152; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Seta F, 2006, AM J PATHOL, V169, P1612, DOI 10.2353/ajpath.2006.060555; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sivak JM, 2011, J BIOL CHEM, V286, P44965, DOI 10.1074/jbc.M111.294967; Slegers TPAM, 2003, CURR EYE RES, V26, P73, DOI 10.1076/ceyr.26.2.73.14510; Slegers TPAM, 2000, INVEST OPHTH VIS SCI, V41, P2239; Uderhardt S, 2012, J MOL MED, V90, P1247, DOI 10.1007/s00109-012-0954-4; vanRooijen N, 1997, J LEUKOCYTE BIOL, V62, P702, DOI 10.1002/jlb.62.6.702; Wagener FADTG, 2003, BLOOD, V102, P521, DOI 10.1182/blood-2002-07-2248; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Weng YH, 2003, J BIOL CHEM, V278, P50999, DOI 10.1074/jbc.M307644200; Willoughby DA, 2000, INT J IMMUNOPHARMACO, V22, P1131, DOI 10.1016/S0192-0561(00)00064-3; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144	42	23	24	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					105	115		10.1096/fj.14-256503	http://dx.doi.org/10.1096/fj.14-256503			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25342128	Green Published			2022-12-26	WOS:000347378600011
J	Boccalini, G; Sassoli, C; Formigli, L; Bani, D; Nistri, S				Boccalini, Giulia; Sassoli, Chiara; Formigli, Lucia; Bani, Daniele; Nistri, Silvia			Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway	FASEB JOURNAL			English	Article						H9c2; cardiomyocytes; RXFP1; DAPT; oxidative injury	NITRIC-OXIDE; MYOCARDIAL-INFARCTION; ACTIVATION; EXPRESSION; RECEPTOR; HEART; REPERFUSION; APOPTOSIS; ISCHEMIA; CARDIOPROTECTION	In animal models, the cardiotropic hormone relaxin has been shown to protect the heart against ischemia and reperfusion-induced damage, acting by multiple mechanisms that primarily involve the coronary vessels. This in vitro study evaluates whether relaxin also has a direct protective action on cardiac muscle cells. H9c2 rat cardiomyoblasts and primary mouse cardiomyocytes were subjected to hypoxia and reoxygenation. In some experiments, relaxin was added preventatively before hypoxia; in others, at reoxygenation. To elucidate itsmechanisms of action, we focused on Notch-1, which is involved in heart pre-and postconditioning to ischemia. Inactivated RLX was used as negative control. Relaxin (17 nmol/L, EC50 4.7 nmol/L), added 24 h before hypoxia or at reoxygenation, protected against cardiomyocyte injury. In fact, relaxin significantly increased cell viability (assayed by trypan blue and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide), decreased apoptosis (assayed by TUNEL and bax/bcl-2 ratio), and reduced nitroxidative damage (assayed by nitrotyrosine expression and 8-hydroxy-deoxyguanosine levels). These effects were partly attributable to the ability of relaxin to upregulate Notch-1 signaling; indeed, blockade of Notch-1 activation with the specific inhibitor DAPT reduced relaxin-induced cardioprotection during hypoxia and reoxygenation. This study adds new mechanistic insights on the cardioprotective role of relaxin on ischemic and oxidative damage.	[Boccalini, Giulia; Sassoli, Chiara; Formigli, Lucia; Bani, Daniele; Nistri, Silvia] Univ Florence, Dept Expt & Clin Med, Sect Anat & Histol, Res Unit Histol & Embryol, I-50139 Florence, Italy	University of Florence	Nistri, S (corresponding author), Univ Florence, Dept Expt & Clin Med, Sect Anat & Histol, Res Unit Histol & Embryol, Viale G Pieraccini 6, I-50139 Florence, Italy.	silvia.nistri@unifi.it	SASSOLI, CHIARA/AAC-4023-2019	SASSOLI, CHIARA/0000-0002-1337-0938				Baccari MC, 2008, CURR PROTEIN PEPT SC, V9, P638, DOI 10.2174/138920308786733921; Bani D, 1997, GEN PHARMACOL-VASC S, V28, P13, DOI 10.1016/S0306-3623(96)00171-1; Bani D, 1998, AM J PATHOL, V152, P1367; Bani D, 2007, REGUL PEPTIDES, V144, P10, DOI 10.1016/j.regpep.2007.05.004; BANISACCHI T, 1995, BRIT J PHARMACOL, V116, P1589, DOI 10.1111/j.1476-5381.1995.tb16377.x; Bonacchi M, 2009, J CELL MOL MED, V13, P3437, DOI 10.1111/j.1582-4934.2008.00503.x; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Brou C, 2009, EXP CELL RES, V315, P1549, DOI 10.1016/j.yexcr.2008.09.010; BULLESBACH EE, 1988, INT J PEPT PROT RES, V32, P361; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Croquelois A, 2008, J EXP MED, V205, P3173, DOI 10.1084/jem.20081427; Cuzzocrea S, 2001, BRIT J PHARMACOL, V132, P19, DOI 10.1038/sj.bjp.0703775; Della-Morte D, 2012, PHARMACOGENOMICS, V13, P1741, DOI [10.2217/PGS.12.157, 10.2217/pgs.12.157]; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Dschietzig T., 2002, CELL MOL LIFE SCI, V59, P1; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Fernandez JW, 2010, FEBS LETT, V584, P4259, DOI 10.1016/j.febslet.2010.09.022; Formigli L, 2007, J CELL MOL MED, V11, P1087, DOI 10.1111/j.1582-4934.2007.00111.x; Formigli L, 2009, J MOL CELL CARDIOL, V47, P335, DOI 10.1016/j.yjmcc.2009.05.008; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Kompa AR, 2002, BRIT J PHARMACOL, V137, P710, DOI 10.1038/sj.bjp.0704922; Kratsios P, 2010, CIRC RES, V106, P559, DOI 10.1161/CIRCRESAHA.109.203034; Lekgabe ED, 2005, HYPERTENSION, V46, P412, DOI 10.1161/01.HYP.0000171930.00697.2f; Masini E, 1997, ENDOCRINOLOGY, V138, P4713, DOI 10.1210/en.138.11.4713; Masini E, 2004, ENDOCRINOLOGY, V145, P1106, DOI 10.1210/en.2003-0833; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; McGuane JT, 2011, ENDOCRINOLOGY, V152, P2786, DOI 10.1210/en.2010-1126; Moore XL, 2007, ENDOCRINOLOGY, V148, P1582, DOI 10.1210/en.2006-1324; Moore XL, 2014, CARDIOVASC DRUG THER, V28, P221, DOI 10.1007/s10557-014-6525-x; Nemir M, 2008, J MOL CELL CARDIOL, V45, P495, DOI 10.1016/j.yjmcc.2008.02.273; Niessen K, 2007, AM J PHYSIOL-CELL PH, V293, pC1, DOI 10.1152/ajpcell.00415.2006; Nistri S, 2005, CURR NEUROVASC RES, V2, P225, DOI 10.2174/1567202054368362; Nistri S, 2003, FASEB J, V17, P2109, DOI 10.1096/fj.03-0216fje; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Nistri S, 2012, J CELL MOL MED, V16, P507, DOI 10.1111/j.1582-4934.2011.01328.x; Palejwala S, 2001, ENDOCRINOLOGY, V142, P3405, DOI 10.1210/en.142.8.3405; Pei HF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0373-x; Perna AM, 2005, FASEB J, V19, P1525, DOI 10.1096/fj.04-3664fje; Prasanna N, 2014, J BIOCHEM MOL TOXIC, V28, P174, DOI 10.1002/jbt.21550; Rakhit RD, 2001, BIOCHEM BIOPH RES CO, V286, P995, DOI 10.1006/bbrc.2001.5477; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Sassoli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063896; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Simpson P. J., 1988, P UPJ S HALL KAL MI, P63; TAYLOR MJ, 1994, J ENDOCRINOL, V143, pR5, DOI 10.1677/joe.0.143R005; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Unemori EN, 2000, WOUND REPAIR REGEN, V8, P361, DOI 10.1111/j.1524-475X.2000.00361.x; Yu BT, 2014, HEART LUNG CIRC, V23, P152, DOI 10.1016/j.hlc.2013.07.004; Zhang ZL, 2012, MOL CELL BIOCHEM, V365, P243, DOI 10.1007/s11010-012-1265-3; Zhou XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-251	57	58	62	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					239	249		10.1096/fj.14-254854	http://dx.doi.org/10.1096/fj.14-254854			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25342127	Green Submitted			2022-12-26	WOS:000347378600023
J	Mazzone, A; Gibbons, SJ; Bernard, CE; Nowsheen, S; Middha, S; Almada, LL; Ordog, T; Kendrick, ML; Lombardo, KR; Shen, KR; Galietta, LJV; Fernandez-Zapico, ME; Farrugia, G				Mazzone, Amelia; Gibbons, Simon J.; Bernard, Cheryl E.; Nowsheen, Somaira; Middha, Sumit; Almada, Luciana L.; Ordog, Tamas; Kendrick, Michael L.; Lombardo, KMarie Reid; Shen, K. Robert; Galietta, Luis J. V.; Fernandez-Zapico, Martin E.; Farrugia, Gianrico			Identification and characterization of a novel promoter for the human ANO1 gene regulated by the transcription factor signal transducer and activator of transcription 6 (STAT6)	FASEB JOURNAL			English	Article						TMEM16A; calcium-activated chloride channels; alternative splicing	CA2+-ACTIVATED CL-CHANNEL; INTERSTITIAL-CELLS; CHLORIDE CHANNELS; FUNCTIONAL-CHARACTERIZATION; CPG ISLANDS; TMEM16A; EXPRESSION; CAJAL; INTERLEUKIN-4; PROLIFERATION	Anoctamin-1 (Ano1) is a widely expressed protein responsible for endogenous Ca2+-activated Cl- currents. Ano1 is overexpressed in cancer. Differential expression of transcriptional variants is also found in other diseases. However, the mechanisms underlying regulation of Ano1 are unknown. This study identifies the Ano1 promoter and defines a mechanism for regulating its expression. Next-generation RNA sequencing (RNA-seq) analysis in human gastric muscle found a new exon upstream of the reported exon 1 and identified a promoter proximal to this new exon. Reporter assays in human embryonic kidney 293 cells showed a 6.7 +/- 2.1 fold increase in activity over empty vector. Treatment with a known regulator of Ano1 expression, IL-4, increased promoter activity by 1.6 +/- 0.02-fold over untreated cells. The promoter region contained putative binding sites for multiple transcription factors including signal transducer and activator of transcription 6 (STAT6), a downstream effector of IL-4. Chromatin immuno-precipitation (ChIP) experiments on T84 cells, which endogenously express Ano1, showed a 2.1 +/- 0.12-fold increase in binding of STAT6 to P0 after IL-4 treatment. These results were confirmed by mutagenesis, expression, and RNA interference techniques. This work allows deeper understanding of the regulation of Ano1 in physiology and as a potential therapeutic target in a variety of diseases	[Mazzone, Amelia; Gibbons, Simon J.; Bernard, Cheryl E.; Ordog, Tamas; Farrugia, Gianrico] Mayo Clin, Enter NeuroSci Program, Rochester, MN 55905 USA; [Nowsheen, Somaira] Mayo Clin, Mayo Med Sch, Rochester, MN 55905 USA; [Middha, Sumit] Mayo Clin, Rochester, MN 55905 USA; [Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Dept Oncol, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Kendrick, Michael L.; Lombardo, KMarie Reid; Shen, K. Robert] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Galietta, Luis J. V.] Ist Giannina Gaslini, UOC Genet Med, I-16148 Genoa, Italy	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Genoa; IRCCS Istituto Giannina Gaslini	Farrugia, G (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	farrugia.gianrico@mayo.edu	Galietta, Luis JV/HCG-8692-2022	Harrington, Jon/0000-0003-1293-5201; Galietta, Luis/0000-0001-8686-3461; MAZZONE, Amelia/0000-0001-6236-6962; Gibbons, Simon/0000-0001-5311-5993; Middha, Sumit/0000-0003-4135-6268	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057061, P30DK084567] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK57061, R01 DK057061, P30 DK084567] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bergeron C, 2003, CLIN EXP ALLERGY, V33, P1389, DOI 10.1046/j.1365-2222.2003.01785.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Buchholz B, 2014, KIDNEY INT, V85, P1058, DOI 10.1038/ki.2013.418; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Davis AJ, 2010, AM J PHYSIOL-CELL PH, V299, pC948, DOI 10.1152/ajpcell.00018.2010; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dutta AK, 2011, J BIOL CHEM, V286, P766, DOI 10.1074/jbc.M110.164970; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Farlow A, 2012, MOL BIOL EVOL, V29, P21, DOI 10.1093/molbev/msr201; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Kalay E, 2007, J MOL MED, V85, P397, DOI 10.1007/s00109-006-0136-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Mazzone A, 2011, J BIOL CHEM, V286, P13393, DOI 10.1074/jbc.M110.196089; McDonald C, 2004, J INTERF CYTOK RES, V24, P729, DOI 10.1089/1079990042722909; Mercer AJ, 2011, J NEUROPHYSIOL, V105, P321, DOI 10.1152/jn.00332.2010; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; O'Driscoll KE, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-35; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Ruffin M, 2013, BBA-MOL BASIS DIS, V1832, P2340, DOI 10.1016/j.bbadis.2013.09.012; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Simon S, 2013, CANCER RES, V73, P3661, DOI 10.1158/0008-5472.CAN-12-3839; Sondo E, 2014, BBA-BIOMEMBRANES, V1838, P89, DOI 10.1016/j.bbamem.2013.08.010; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Travagli J, 2004, J BIOL CHEM, V279, P35183, DOI 10.1074/jbc.M403223200; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang YP, 2013, ACTA PHARMACOL SIN, V34, P17, DOI 10.1038/aps.2012.140; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	53	35	37	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					152	163		10.1096/fj.14-258541	http://dx.doi.org/10.1096/fj.14-258541			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25351986	Green Published			2022-12-26	WOS:000347378600015
J	Rovira, X; Malhaire, F; Scholler, P; Rodrigo, J; Gonzalez-Bulnes, P; Llebaria, A; Pin, JP; Giraldo, J; Goudet, C				Rovira, Xavier; Malhaire, Fanny; Scholler, Pauline; Rodrigo, Jordi; Gonzalez-Bulnes, Patricia; Llebaria, Amadeu; Pin, Jean-Philippe; Giraldo, Jesus; Goudet, Cyril			Overlapping binding sites drive allosteric agonism and positive cooperativity in type 4 metabotropic glutamate receptors	FASEB JOURNAL			English	Article						allostery; sodium	RESOLUTION CRYSTAL-STRUCTURE; GROUP-III; LIGAND-BINDING; PHARMACOLOGICAL CHARACTERIZATION; HEPTAHELICAL DOMAIN; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; CLASS-A; MODULATOR; DISCOVERY	Type 4 metabotropic glutamate (mGlu(4)) receptors are emerging targets for the treatment of various disorders. Accordingly, numerous mGlu(4)-positive allosteric modulators (PAMs) have been identified, some of which also display agonist activity. To identify the structural bases for their allosteric action, we explored the relationship between the binding pockets of mGlu4 PAMs with different chemical scaffolds and their functional properties. By use of innovative mGlu4 biosensors and second-messenger assays, we show that all PAMs enhance agonist action on the receptor through different degrees of allosteric agonism and positive cooperativity. For example, whereas VU0155041 and VU0415374 display equivalent efficacies [log(tau(B)) = 1.15 +/- 0.38 and 1.25 +/- 0.44, respectively], they increase the ability of L-AP4 to stabilize the active conformation of the receptor by 4 and 39 times, respectively. Modeling and docking studies identify 2 overlapping binding pockets as follows: a first site homologous to the pocket of natural agonists of class A GPCRs linked to allosteric agonism and a second one pointing toward a site topographically homologous to the Na+ binding pocket of class A GPCRs, occupied by PAMs exhibiting the strongest cooperativity. These results reveal that intrinsic efficacy and cooperativity of mGlu4 PAMs are correlated with their binding mode, and vice versa, integrating structural and functional knowledge from different GPCR classes.	[Rovira, Xavier; Malhaire, Fanny; Scholler, Pauline; Pin, Jean-Philippe; Goudet, Cyril] Univ Montpellier, Inst Genom Fonct, CNRS UMR 5203, F-34094 Montpellier 5, France; [Rovira, Xavier; Malhaire, Fanny; Scholler, Pauline; Pin, Jean-Philippe; Goudet, Cyril] INSERM, U661, Montpellier, France; [Rodrigo, Jordi] Univ Paris 11, Fac Pharm, Chim Therapeut Lab, LabEx LERMIT,BioCIS UMR CNRS 8076, Paris, France; [Gonzalez-Bulnes, Patricia; Llebaria, Amadeu] Inst Adv Chem Catalonia IQAC CSIC, Dept Biomed Chem, Med Chem Lab, Barcelona, Spain; [Giraldo, Jesus] Univ Autonoma Barcelona, Inst Neurociencies, Lab Mol Neuropharmacol & Bioinformat, Bellaterra, Spain; [Giraldo, Jesus] Univ Autonoma Barcelona, Unitat Bioestadist, Bellaterra, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Autonomous University of Barcelona; Autonomous University of Barcelona	Goudet, C (corresponding author), Univ Montpellier, INSERM U661, CNRS UMR 5203, Inst Genom Fonct, 141 Rue Cardonille, F-34094 Montpellier 5, France.	jesus.giraldo@uab.es; cyril.goudet@igf.cnrs.fr	Goudet, Cyril/AAE-3415-2020; Llebaria, Amadeu/C-4287-2015; Rovira, Xavier/M-4669-2015; Giraldo, Jesus/F-9881-2011	Goudet, Cyril/0000-0002-8255-3535; Llebaria, Amadeu/0000-0002-8200-4827; Rovira, Xavier/0000-0002-9764-9927; Pin, Jean-Philippe/0000-0002-1423-345X; Giraldo, Jesus/0000-0001-7082-4695; MALHAIRE, Fanny/0000-0001-5930-9879				Abitbol K, 2008, J NEUROCHEM, V105, P2069, DOI 10.1111/j.1471-4159.2008.05290.x; Amalric M, 2013, NEUROPHARMACOLOGY, V66, P53, DOI 10.1016/j.neuropharm.2012.05.026; Becker JAJ, 2014, NEUROPSYCHOPHARMACOL, V39, P2049, DOI 10.1038/npp.2014.59; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bruno A, 2009, J CHEM INF MODEL, V49, P1602, DOI 10.1021/ci900067g; Celanire S, 2012, EXPERT OPIN DRUG DIS, V7, P261, DOI 10.1517/17460441.2012.660914; Chen Y, 2008, MOL PHARMACOL, V73, P909, DOI 10.1124/mol.107.040097; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Christov C, 2011, CHEMMEDCHEM, V6, P131, DOI 10.1002/cmdc.201000378; COSTA T, 1990, MOL PHARMACOL, V37, P383; Dalton JAR, 2014, J CHEM INF MODEL, V54, P1476, DOI 10.1021/ci500127c; de Graaf C, 2008, J MED CHEM, V51, P4978, DOI 10.1021/jm800710x; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Engers D. W., 2010, PROBE REPORTS NIH MO; Engers DW, 2011, J MED CHEM, V54, P1106, DOI 10.1021/jm101271s; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Flor PJ, 2012, BIOCHEM PHARMACOL, V84, P414, DOI 10.1016/j.bcp.2012.04.013; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Goudet C, 2012, FASEB J, V26, P1682, DOI 10.1096/fj.11-195941; Gregory KJ, 2012, MOL PHARMACOL, V82, P860, DOI 10.1124/mol.112.080531; Hammond AS, 2010, ACS CHEM NEUROSCI, V1, P702, DOI 10.1021/cn100051m; Hampson DR, 1999, J BIOL CHEM, V274, P33488, DOI 10.1074/jbc.274.47.33488; Hermans E, 1999, BRIT J PHARMACOL, V126, P873, DOI 10.1038/sj.bjp.0702359; Hong SP, 2011, J MED CHEM, V54, P5070, DOI 10.1021/jm200290z; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Le Poul E, 2012, J PHARMACOL EXP THER, V343, P167, DOI 10.1124/jpet.112.196063; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lundstrom L, 2011, BRIT J PHARMACOL, V164, P521, DOI 10.1111/j.1476-5381.2011.01409.x; Maj M, 2003, NEUROPHARMACOLOGY, V45, P895, DOI 10.1016/S0028-3908(03)00271-5; Marino MJ, 2003, P NATL ACAD SCI USA, V100, P13668, DOI 10.1073/pnas.1835724100; McDonald J, 2003, BRIT J PHARMACOL, V140, P61, DOI 10.1038/sj.bjp.0705401; Molck C, 2014, NEUROCHEM RES, V39, P1862, DOI 10.1007/s11064-014-1248-8; Molck C, 2012, MOL PHARMACOL, V82, P929, DOI 10.1124/mol.112.078808; Muhlemann A, 2006, EUR J PHARMACOL, V529, P95, DOI 10.1016/j.ejphar.2005.11.008; NEVE KA, 1991, MOL PHARMACOL, V39, P733; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Niswender CM, 2008, MOL PHARMACOL, V74, P1345, DOI 10.1124/mol.108.049551; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Noetzel MJ, 2013, MOL PHARMACOL, V83, P835, DOI 10.1124/mol.112.082891; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rook JM, 2013, BIOL PSYCHIAT, V73, P501, DOI 10.1016/j.biopsych.2012.09.012; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaffhauser H, 2003, MOL PHARMACOL, V64, P798, DOI 10.1124/mol.64.4.798; Selent J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000884; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vilar B, 2013, J NEUROSCI, V33, P18951, DOI 10.1523/JNEUROSCI.1221-13.2013; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williams R, 2010, ACS CHEM NEUROSCI, V1, P411, DOI 10.1021/cn9000318; Williams R, 2009, BIOORG MED CHEM LETT, V19, P4967, DOI 10.1016/j.bmcl.2009.07.072; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	70	43	43	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					116	130		10.1096/fj.14-257287	http://dx.doi.org/10.1096/fj.14-257287			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25342125				2022-12-26	WOS:000347378600012
J	Jolly, L; Stavrou, A; Vanderstoken, G; Meliopoulos, VA; Habgood, A; Tatler, AL; Porte, J; Knox, A; Weinreb, P; Violette, S; Hussell, T; Kolb, M; Stampfli, MR; Schultz-Cherry, S; Jenkins, G				Jolly, Lisa; Stavrou, Anastasios; Vanderstoken, Gilles; Meliopoulos, Victoria A.; Habgood, Anthony; Tatler, Amanda L.; Porte, Joanne; Knox, Alan; Weinreb, Paul; Violette, Shelia; Hussell, Tracy; Kolb, Martin; Stampfli, Martin R.; Schultz-Cherry, Stacey; Jenkins, Gisli			Influenza Promotes Collagen Deposition via alpha v beta 6 Integrin-mediated Transforming Growth Factor beta Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Influenza; Integrin; Pulmonary Fibrosis; Toll-like Receptor (TLR)	IDIOPATHIC PULMONARY-FIBROSIS; EPSTEIN-BARR-VIRUS; VIRAL GLYCOPROTEINS GHGL; LUNG EPITHELIAL-CELLS; MOUTH-DISEASE-VIRUS; NF-KAPPA-B; TGF-BETA; LATENT TGF-BETA-1; GENE-EXPRESSION; RNA VIRUSES	Influenza infection exacerbates chronic pulmonary diseases, including idiopathic pulmonary fibrosis. A central pathway in the pathogenesis of idiopathic pulmonary fibrosis is epithelial injury leading to activation of transforming growth factor (TGF). The mechanism and functional consequences of influenza-induced activation of epithelial TGF are unclear. Influenza stimulates toll-like receptor 3 (TLR3), which can increase RhoA activity, a key event prior to activation of TGF by the v6 integrin. We hypothesized that influenza would stimulate TLR3 leading to activation of latent TGF via v6 integrin in epithelial cells. Using H1152 (IC50 6.1 m) to inhibit Rho kinase and 6.3G9 to inhibit v6 integrins, we demonstrate their involvement in influenza (A/PR/8/34 H1N1) and poly(I:C)-induced TGF activation. We confirm the involvement of TLR3 in this process using chloroquine (IC50 11.9 m) and a dominant negative TLR3 construct (pZERO-hTLR3). Examination of lungs from influenza-infected mice revealed augmented levels of collagen deposition, phosphorylated Smad2/3, v6 integrin, and apoptotic cells. Finally, we demonstrate that v6 integrin-mediated TGF activity following influenza infection promotes epithelial cell death in vitro and enhanced collagen deposition in vivo and that this response is diminished in Smad3 knock-out mice. These data show that H1N1 and poly(I:C) can induce v6 integrin-dependent TGF activity in epithelial cells via stimulation of TLR3 and suggest a novel mechanism by which influenza infection may promote collagen deposition in fibrotic lung disease.	[Jolly, Lisa; Stavrou, Anastasios; Habgood, Anthony; Tatler, Amanda L.; Porte, Joanne; Knox, Alan; Jenkins, Gisli] Univ Nottingham, Univ Nottingham Hosp, Nottingham Resp Res Unit, Nottingham NG5 1PB, England; [Meliopoulos, Victoria A.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Weinreb, Paul; Violette, Shelia] Biogen Idec Inc, Cambridge, MA 02142 USA; [Vanderstoken, Gilles; Kolb, Martin; Stampfli, Martin R.] McMaster Univ, St Josephs Hlth Care, McMaster Immunol Res Ctr, Hamilton, ON L8S 4L8, Canada; [Vanderstoken, Gilles; Kolb, Martin; Stampfli, Martin R.] McMaster Univ, St Josephs Hlth Care, Firestone Inst, Hamilton, ON L8S 4L8, Canada; [Hussell, Tracy] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England	University of Nottingham; St Jude Children's Research Hospital; Biogen; McMaster University; McMaster University; University of Manchester	Jenkins, G (corresponding author), Univ Nottingham, Univ Nottingham Hosp, Nottingham Resp Res Unit, Clin Sci Bldg,City Hosp Campus, Nottingham NG5 1PB, England.	gisli.jenkins@nottingham.ac.uk	tatler, amanda/I-2620-2019; Schultz-Cherry, Stacey/N-2506-2018; Jenkins, Gisli/R-8143-2017; Hussell, Tracy/O-4630-2014	tatler, amanda/0000-0002-4644-4614; Jenkins, Gisli/0000-0002-7929-2119; Stampfli, Martin/0000-0003-4918-5889; Hussell, Tracy/0000-0001-7186-6141; Knox, Alan/0000-0002-5906-4143; Weinreb, Paul/0000-0002-0802-0052	National Institutes of Health from NIAID [HHSN266200700005C]; Asthma United Kingdom [07-026, 10-020]; American Lebanese Syrian Associated Charities; Medical Research Council [G0802752] Funding Source: researchfish; Asthma UK [07/026, 10/020] Funding Source: researchfish; MRC [G0802752] Funding Source: UKRI	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Asthma United Kingdom; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN266200700005C from NIAID. This work was also supported by Asthma United Kingdom Grants 07-026 and 10-020 and the American Lebanese Syrian Associated Charities (to S. S. C.). Dr. Gisli Jenkins has acted as a consultant for GlaxoSmithKline, Boehringer Ingelheim, Intermune, Medimmune, and Biogen Idec and has research contracts with GlaxoSmithKline, Novartis, and Biogen Idec. Drs. Paul Weinreb and Shelia Violette are employees and shareholders of Biogen Idec.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Berryman S, 2005, J VIROL, V79, P8519, DOI 10.1128/JVI.79.13.8519-8534.2005; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Brownh PD, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037500; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Chesnokova LS, 2011, J VIROL, V85, P13214, DOI 10.1128/JVI.05580-11; Chesnokova LS, 2009, P NATL ACAD SCI USA, V106, P20464, DOI 10.1073/pnas.0907508106; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fujino N, 2013, J INFECT DIS, V207, P692, DOI 10.1093/infdis/jis739; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Hagimoto N, 1997, AM J RESP CELL MOL, V16, P91, DOI 10.1165/ajrcmb.16.1.8998084; Hagimoto N, 1997, AM J RESP CELL MOL, V17, P272, DOI 10.1165/ajrcmb.17.3.2893; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Haidari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021444; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Hutt-Fletcher LM, 2010, VIRULENCE, V1, P395, DOI 10.4161/viru.1.5.12546; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; John AE, 2013, J NUCL MED, V54, P2146, DOI 10.2967/jnumed.113.120592; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KIRK JME, 1986, CLIN SCI, V70, P39, DOI 10.1042/cs0700039; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Kovner AV, 2012, B EXP BIOL MED+, V153, P229, DOI 10.1007/s10517-012-1683-y; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; Kuwano Kazuyoshi, 2001, Current Molecular Medicine (Hilversum), V1, P551, DOI 10.2174/1566524013363401; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li P, 2012, BRIT J RADIOL, V85, P729, DOI 10.1259/bjr/85580974; Lin CB, 2001, VIROLOGY, V287, P202, DOI 10.1006/viro.2001.1010; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Luckhardt TR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-18; Manukyan M, 2009, J IMMUNOL, V182, P3522, DOI 10.4049/jimmunol.0802280; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; MIYAZONO K, 1989, NATURE, V338, P158, DOI 10.1038/338158a0; Monaghan P, 2005, J GEN VIROL, V86, P2769, DOI 10.1099/vir.0.81172-0; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Neubauer K, 1999, J HEPATOL, V31, P692, DOI 10.1016/S0168-8278(99)80350-X; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Qiao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-107; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; REDLICH CA, 1995, AM J RESP CELL MOL, V12, P287, DOI 10.1165/ajrcmb.12.3.7873195; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996; Seitsonen J, 2010, J VIROL, V84, P8509, DOI 10.1128/JVI.02176-09; SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Singh V, 2012, LUNG INDIA, V29, P277, DOI 10.4103/0970-2113.99118; SPECKS U, 1995, AM J RESP CRIT CARE, V151, P1956, DOI 10.1164/ajrccm.151.6.7767545; SUBBARAO EK, 1992, J CLIN MICROBIOL, V30, P996, DOI 10.1128/JCM.30.4.996-999.1992; Tatler AL, 2008, BIOCHEM BIOPH RES CO, V370, P239, DOI 10.1016/j.bbrc.2008.03.064; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Williams AE, 2005, MICROBES INFECT, V7, P365, DOI 10.1016/j.micinf.2004.11.012; Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044	69	42	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35246	35263		10.1074/jbc.M114.582262	http://dx.doi.org/10.1074/jbc.M114.582262			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25339175	hybrid, Green Published			2022-12-26	WOS:000346660200018
J	Kitamura, C; Guellai, B; Kim, J				Kitamura, Christine; Guellai, Bahia; Kim, Jeesun			Motherese by Eye and Ear: Infants Perceive Visual Prosody in Point-Line Displays of Talking Heads	PLOS ONE			English	Article							SPEECH-PERCEPTION; BIOLOGICAL MOTION; DIRECTED SPEECH; INTERMODAL REPRESENTATION; EXPRESSIVE BEHAVIORS; PHONETIC INFORMATION; PREFERENCE; SYNCHRONY; VOICE; ATTRIBUTES	Infant-directed (ID) speech provides exaggerated auditory and visual prosodic cues. Here we investigated if infants were sensitive to the match between the auditory and visual correlates of ID speech prosody. We presented 8-month-old infants with two silent line-joined point-light displays of faces speaking different ID sentences, and a single vocal-only sentence matched to one of the displays. Infants looked longer to the matched than mismatched visual signal when full-spectrum speech was presented; and when the vocal signals contained speech low-pass filtered at 400 Hz. When the visual display was separated into rigid (head only) and non-rigid (face only) motion, the infants looked longer to the visual match in the rigid condition; and to the visual mismatch in the non-rigid condition. Overall, the results suggest 8-month-olds can extract information about the prosodic structure of speech from voice and head kinematics, and are sensitive to their match; and that they are less sensitive to the match between lip and voice information in connected speech.	[Kitamura, Christine] Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia; [Kitamura, Christine; Kim, Jeesun] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia; [Guellai, Bahia] Univ Paris Ouest Nanterre La Def, Lab Ethol, Paris, France	Western Sydney University; Western Sydney University; Universite Paris Nanterre	Kitamura, C (corresponding author), Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia.	c.kitamura@uws.edu.au		Kim, Jeesun/0000-0003-2651-1020	Australian Research Council (ARC) [ARC DP120104298, ARC DP0666857]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by the Australian Research Council (ARC): ARC DP120104298 [CK JK] and ARC DP0666857 [JK]. http://www.arc.gov.au/ncgp/default.htm. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aldridge MA, 1999, DEVELOPMENTAL SCI, V2, P42, DOI 10.1111/1467-7687.00052; Arterberry ME, 2002, COGNITION, V86, P1, DOI 10.1016/S0010-0277(02)00108-7; Bardi L, 2011, DEVELOPMENTAL SCI, V14, P353, DOI 10.1111/j.1467-7687.2010.00985.x; BERTONCINI J, 1981, INFANT BEHAV DEV, V4, P247, DOI 10.1016/S0163-6383(81)80027-6; Bidet-Ildei C, 2014, DEV PSYCHOL, V50, P113, DOI 10.1037/a0032956; BIJELJACBABIC R, 1993, DEV PSYCHOL, V29, P711, DOI 10.1037/0012-1649.29.4.711; Blossom M., 2006, 30 ANN BOST U C LANG; Chong SCF, 2003, INFANT CHILD DEV, V12, P211, DOI 10.1002/icd.286; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; CUTLER A, 1993, J PHONETICS, V21, P103, DOI 10.1016/S0095-4470(19)31323-3; Cvejic E, 2010, SPEECH COMMUN, V52, P555, DOI 10.1016/j.specom.2010.02.006; Davis C, 2004, Q J EXP PSYCHOL-A, V57, P1103, DOI 10.1080/02724980343000701; Davis C, 2006, COGNITION, V100, pB21, DOI 10.1016/j.cognition.2005.09.002; Desjardins RN, 2004, DEV PSYCHOBIOL, V45, P187, DOI 10.1002/dev.20033; DODD B, 1979, COGNITIVE PSYCHOL, V11, P478, DOI 10.1016/0010-0285(79)90021-5; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; GOLINKOFF RM, 1987, J CHILD LANG, V14, P23, DOI 10.1017/S030500090001271X; Grant KW, 2004, SPEECH COMMUN, V44, P43, DOI 10.1016/j.specom.2004.06.004; Green JR, 2010, J SPEECH LANG HEAR R, V53, P1529, DOI 10.1044/1092-4388(2010/09-0005); Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Karzon R, 1985, J EXPT CHILD PSYCHOL, V39; Kemler Nelson DG, 1989, J CHILD LANGUAGE, V16; Kim J, 2012, P INT, P1119; Kitamura C, 2003, INFANCY, V4, P85, DOI 10.1207/S15327078IN0401_5; Kitamura C, 2002, INFANT BEHAV DEV, V24, P372; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; KUHL PK, 1991, J EXP PSYCHOL HUMAN, V17, P829, DOI 10.1037/0096-1523.17.3.829; KUHL PK, 1984, INFANT BEHAV DEV, V7, P361, DOI 10.1016/S0163-6383(84)80050-8; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Lewkowicz DJ, 2010, DEV PSYCHOL, V46, P66, DOI 10.1037/a0015579; Lewkowicz DJ, 2000, CHILD DEV, V71, P1241, DOI 10.1111/1467-8624.00226; Lewkowicz DJ, 2000, PSYCHOL BULL, V126, P281, DOI 10.1037/0033-2909.126.2.281; Measurements IsoS, 1969, IEEE REC PRACT SPEEC, P227; MOON C, 1992, J CHILD LANG, V19, P1, DOI 10.1017/S030500090001360X; Munhall KG, 1998, BEHAV BRAIN SCI, V21, P524, DOI 10.1017/S0140525X98391268; Munhall KG, 2004, PSYCHOL SCI, V15, P133, DOI 10.1111/j.0963-7214.2004.01502010.x; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; SOKEN NH, 1992, CHILD DEV, V63, P787; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Swerts M, 2008, J PHONETICS, V36, P219, DOI 10.1016/j.wocn.2007.05.001; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; Vignali G., 2005, P CROSS MODAL PROCES, P59; WalkerAndrews AS, 1997, PSYCHOL BULL, V121, P437, DOI 10.1037/0033-2909.121.3.437	47	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111467	10.1371/journal.pone.0111467	http://dx.doi.org/10.1371/journal.pone.0111467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353978	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200083
J	Al Dera, H; Callaghan, BP; Brock, JA				Al Dera, Hussain; Callaghan, Brid P.; Brock, James A.			Modified Cytoplasmic Ca2+ Sequestration Contributes to Spinal Cord Injury-Induced Augmentation of Nerve-Evoked Contractions in the Rat Tail Artery	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NORADRENALINE RELEASE; NEUROVASCULAR TRANSMISSION; SYMPATHETIC ACTIVITY; CALCIUM-CHANNELS; RESPONSES; CALMODULIN; MODULATION; EXPRESSION; RYANODINE	In rat tail artery (RTA), spinal cord injury (SCI) increases nerve-evoked contractions and the contribution of L-type Ca2+ channels to these responses. In RTAs from unoperated rats, these channels play a minor role in contractions and Bay K8644 (L-type channel agonist) mimics the effects of SCI. Here we investigated the mechanisms underlying the facilitatory actions of SCI and Bay K8644 on nerve-evoked contractions of RTAs and the hypothesis that Ca2+ entering via L-type Ca2+ channels is rapidly sequestered by the sarcoplasmic reticulum (SR) limiting its role in contraction. In situ electrochemical detection of noradrenaline was used to assess if Bay K8644 increased noradrenaline release. Perforated patch recordings were used to assess if SCI changed the Ca2+ current recorded in RTA myocytes. Wire myography was used to assess if SCI modified the effects of Bay K8644 and of interrupting SR Ca2+ uptake on nerve-evoked contractions. Bay K8644 did not change noradrenaline-induced oxidation currents. Neither the size nor gating of Ca2+ currents differed between myocytes from sham-operated (control) and SCI rats. Bay K8644 increased nerve-evoked contractions in RTAs from both control and SCI rats, but the magnitude of this effect was reduced by SCI. By contrast, depleting SR Ca2+ stores with ryanodine or cyclopiazonic acid selectively increased nerve-evoked contractions in control RTAs. Cyclopiazonic acid also selectively increased the blockade of these responses by nifedipine (L-type channel blocker) in control RTAs, whereas ryanodine increased the blockade produced by nifedipine in both groups of RTAs. These findings suggest that Ca2+ entering via L-type channels is normally rapidly sequestered limiting its access to the contractile mechanism. Furthermore, the findings suggest SCI reduces the role of this mechanism.	[Al Dera, Hussain; Callaghan, Brid P.; Brock, James A.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Al Dera, Hussain] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia	University of Melbourne; King Saud Bin Abdulaziz University for Health Sciences	Brock, JA (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia.	j.brock@unimelb.edu.au	Callaghan, Brid/N-1764-2019; alDera, Hussain/GVU-0786-2022; Brock, James A/A-2929-2012	Callaghan, Brid/0000-0001-7251-8851; Brock, James/0000-0002-1381-1983	National Health and Medical Research Council of Australia [ID GNT1024485]; Transport Accident Commission (Victoria); King Saud Bin Abdulaziz University for Health Sciences, College of Medicine (Riyadh, Saudi Arabia)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Transport Accident Commission (Victoria); King Saud Bin Abdulaziz University for Health Sciences, College of Medicine (Riyadh, Saudi Arabia)	This work was supported by grants from the National Health and Medical Research Council of Australia (Grant ID GNT1024485) and the Transport Accident Commission (Victoria). H. Al Dera was supported by a postgraduate award from King Saud Bin Abdulaziz University for Health Sciences, College of Medicine (Riyadh, Saudi Arabia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dera H, 2012, AM J PHYSIOL-HEART C, V302, pH752, DOI 10.1152/ajpheart.00745.2011; BAO JX, 1993, N-S ARCH PHARMACOL, V347, P601, DOI 10.1007/BF00166943; Brock JA, 2006, AM J PHYSIOL-HEART C, V290, pH398, DOI 10.1152/ajpheart.00712.2005; Brock JA, 2004, BRIT J PHARMACOL, V142, P267, DOI 10.1038/sj.bjp.0705779; Brock JA, 1999, BRIT J PHARMACOL, V126, P11, DOI 10.1038/sj.bjp.0702256; BULTMANN R, 1993, BRIT J PHARMACOL, V108, P1062; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Davies PJ, 1996, J PHYSIOL-LONDON, V495, P353, DOI 10.1113/jphysiol.1996.sp021599; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Garcha RS, 1997, BRIT J PHARMACOL, V122, P142, DOI 10.1038/sj.bjp.0701337; Laporte R, 2004, PHARMACOL REV, V56, P439, DOI 10.1124/pr.56.4.1; Maiorov DN, 1997, AM J PHYSIOL-HEART C, V272, pH625, DOI 10.1152/ajpheart.1997.272.2.H625; Martinez-Pinna J, 2002, BRAIN RES, V951, P227, DOI 10.1016/S0006-8993(02)03165-7; Mathias C. J., 1999, AUTONOMIC FAILURE TX, P494; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nomura Y, 2000, JPN J PHARMACOL, V83, P335, DOI 10.1254/jjp.83.335; ORALLO F, 1992, GEN PHARMACOL, V23, P257, DOI 10.1016/0306-3623(92)90021-B; PAN M, 1988, J CARDIOVASC PHARM, V11, P127; Petkov GV, 2001, ACTA PHYSIOL SCAND, V173, P257, DOI 10.1046/j.1365-201X.2001.00907.x; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Quintas LEM, 2005, EUR J PHARMACOL, V525, P54, DOI 10.1016/j.ejphar.2005.10.006; Rathner JA, 1998, J AUTONOM NERV SYST, V69, P127, DOI 10.1016/S0165-1838(98)00014-9; Rummery NM, 2010, J NEUROTRAUM, V27, P2077, DOI 10.1089/neu.2010.1468; SCHULTE L, 1994, AM J PHYSIOL, V267, pC617, DOI 10.1152/ajpcell.1994.267.2.C617; Smith JE, 1998, J AUTONOM NERV SYST, V68, P109, DOI 10.1016/S0165-1838(97)00124-0; Somogyi GT, 1997, J PHYSIOL-LONDON, V499, P645, DOI 10.1113/jphysiol.1997.sp021957; Thakali KM, 2010, CIRC RES, V106, P739, DOI 10.1161/CIRCRESAHA.109.206763; Tripovic D, 2010, BRIT J PHARMACOL, V159, P142, DOI 10.1111/j.1476-5381.2009.00520.x; Tsai H, 1998, NEUROBIOL AGING, V19, P89, DOI 10.1016/S0197-4580(98)00008-6; VANBREEMEN C, 1995, TRENDS PHARMACOL SCI, V16, P98, DOI 10.1016/S0165-6147(00)88990-7; WALLIN BG, 1984, BRAIN, V107, P183, DOI 10.1093/brain/107.1.183; WANG R, 1989, AM J PHYSIOL, V256, pH1361, DOI 10.1152/ajpheart.1989.256.5.H1361; Weaver LC, 2006, PROG BRAIN RES, V152, P245, DOI 10.1016/S0079-6123(05)52016-8; Wilkinson MF, 1996, FASEB J, V10, P785, DOI 10.1096/fasebj.10.7.8635696; Yeoh M, 2004, J PHYSIOL-LONDON, V561, P583, DOI 10.1113/jphysiol.2004.074948; Yeoh M, 2004, J PHYSIOL-LONDON, V556, P545, DOI 10.1113/jphysiol.2003.056424	36	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111804	10.1371/journal.pone.0111804	http://dx.doi.org/10.1371/journal.pone.0111804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350563	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100080
J	Liu, Y; Jiang, YG				Liu, Yu; Jiang, Yu-Gang			Podocalyxin Promotes Glioblastoma Multiforme Cell Invasion and Proliferation via beta-Catenin Signaling	PLOS ONE			English	Article							PROSTATE-CANCER; MALIGNANT GLIOMAS; POOR-PROGNOSIS; P38 MAPK; ACTIVATION; PROTEIN; OVEREXPRESSION; SURVIVAL; PATHWAY; BREAST	Both podocalyxin (PODX) and beta-catenin (beta-cat) signaling reportedly play important roles in glioblastoma multiforme (GBM) progression. In this study, we for the first time explored crosstalk between PODX and beta-cat signaling in GBM cells, and assessed its impact on GBM cell invasion and proliferation. Stable overexpression of PODX in LN-229 and U-118 MG human GBM cells increased the soluble/intracellular beta-cat level, TOPflash luciferase reporter activity, the mRNA levels of beta-cat signaling target genes, matrix metalloproteinase 9 (MMP9) expression/activity, and cell invasion and proliferation, which was abolished by selective p38 mitogen-activated protein kinase (MAPK) inhibitor PD169316 and selective beta-cat signaling inhibitor CCT031374. On the other hand, stable knockdown of PODX in LN-229 and U-118 MG cells decreased the soluble beta-cat level, TOPflash luciferase reporter activity, the mRNA levels of beta-cat signaling target genes, MMP9 expression/activity, and cell invasion and proliferation, which was completely reversed by overexpression of a constitutively active beta-cat mutant. In addition, overexpression of PODX induced p38 MAPK activity and inactivating phosphorylation of glycogen synthase kinase-3 beta (GSK-3 beta) at serine 389 in LN-229 and U-118 MG cells, which was abolished by PD169316, but not CCT031374; knockdown of PODX decreased p38 MAPK activity and inactivating phosphorylation of GSK-3 beta at serine 389 in both cell lines, which was not significantly affected by overexpression of constitutively active beta-cat. In conclusion, this study indicates that PODX promotes GBM cell invasion and proliferation by elevating the soluble beta-cat level/beta-cat signaling through the p38 MAPK/GSK-3 beta pathway. Uncovering the PODX/beta-cat signaling axis adds new insights not only into the biological functions of PODX and beta-cat, but also into the molecular mechanisms underlying GBM progression.	[Liu, Yu; Jiang, Yu-Gang] Cent S Univ, Xiangya Hosp 2, Dept Neurosurg, Changsha, Hunan, Peoples R China	Central South University	Jiang, YG (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Neurosurg, Changsha, Hunan, Peoples R China.	13707315567@139.com			Hunan Provincial Natural Science Foundation, Hunan, China [14A2256]	Hunan Provincial Natural Science Foundation, Hunan, China	This work was supported by Hunan Provincial Natural Science Foundation (grants #14A2256), Hunan, China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Cheng BQ, 2014, GENET MOL RES, V13, P5115, DOI 10.4238/2014.July.7.4; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Fu YX, 2003, BIOCHEM BIOPH RES CO, V310, P391, DOI 10.1016/j.bbrc.2003.09.021; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Kaprio T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-493; Kaur N, 2013, MOL CELL NEUROSCI, V54, P44, DOI 10.1016/j.mcn.2013.01.001; Larsson A, 2011, BRIT J CANCER, V105, P666, DOI 10.1038/bjc.2011.295; Lee WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068030; Li Y, 2012, MOL MED REP, V5, P1391, DOI 10.3892/mmr.2012.842; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Pifer MA, 2014, AM J SPORT MED, V42, P1211, DOI 10.1177/0363546514524710; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Spolidoro M, 2012, CEREB CORTEX, V22, P725, DOI 10.1093/cercor/bhr158; Sun P, 2006, MOL PHARMACOL, V69, P520, DOI 10.1124/mol.105.019620; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Von Schulz-Hausmann SA, 2014, ANTICANCER RES, V34, P4101; Wang X, 2004, MOL PSYCHIATR, V9, P65, DOI 10.1038/sj.mp.4001339; Wang Z, 2014, CARCINOGENESIS; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu H, 2013, EXP THER MED, V5, P1025, DOI 10.3892/etm.2013.957; Yasuoka H, 2012, J CLIN PATHOL, V65, P399, DOI 10.1136/jclinpath-2011-200359; Zhang D, 2011, J BIOL CHEM, V286, P44913, DOI 10.1074/jbc.M111.310052; Zhang ZY, 2014, EUR J NEUROSCI, V40, P2859, DOI 10.1111/ejn.12655	30	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111343	10.1371/journal.pone.0111343	http://dx.doi.org/10.1371/journal.pone.0111343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25349993	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100066
J	Yeh, JJ; Chen, HJ; Li, TC; Wong, YS; Tang, HC; Yeh, TC; Kao, CH				Yeh, Jun-Jun; Chen, Hsuan-Ju; Li, Tsai-Chung; Wong, Yi-Sin; Tang, Hsien-Chin; Yeh, Ting-Chun; Kao, Chia-Hung			Association between Sjogren's Syndrome and Respiratory Failure: Put Airway, Interstitia, and Vessels Close Together: A National Cohort Study	PLOS ONE			English	Article							CONNECTIVE-TISSUE DISEASE; PULMONARY INVOLVEMENT; LUNG-DISEASE; MANIFESTATIONS; HYPERTENSION; ALVEOLITIS; ABNORMALITIES; REAPPRAISAL; POPULATION; DIAGNOSIS	Objectives: Few studies have evaluated the association between Sjogren's syndrome (SS) and respiratory failure (RF). Thus, we conducted a retrospective national cohort study to investigate whether Sjogren's syndrome (SS) increases the risk of respiratory failure (RF). Methods: The cohort consisted of 4954 newly diagnosed patients with SS but without a previous diagnosis of RF, and 19816 patients as the comparison cohort from the catastrophic illnesses registry, obtained from the 2000-2005 period. All of the study participants were followed from the index date to December 31, 2011. We analyzed the association between the risk of RF and SS by using a Cox proportional hazards regression model, controlling for sex, age, and comorbidities. Results: The overall incidence rate of RF showed a 3.21-fold increase in the SS cohort compared with the comparison cohort. The adjusted HR of RF was 3.04 for the SS cohort compared with the comparison cohort, after we adjusted for sex, age, and comorbidities. The HRs of RF for patients with primary SS and secondary SS compared with the comparison cohort were 2.99 and 3.93, respectively (P for trend,. 001). The HRs of RF increased as the severity of SS increased, from 2.34 for those with no inpatient care experience to 5.15 for those with inpatient care experience (P for trend, <.001). Conclusion: This study indicates that clinical physicians should not only consider secondary SS but also primary SS as a critical factor that increases the risk of RF.	[Yeh, Jun-Jun; Wong, Yi-Sin; Tang, Hsien-Chin; Yeh, Ting-Chun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Family Med & Pulm Med, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Management, Grad Inst Biostat, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw	Li, Tsai-Chung/P-2052-2015	Li, Tsai-Chung/0000-0002-3346-7462	China Medical University Hospital [DMR-102-014, DMR-102-023]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; Taiwan Ministry Health and Welfare Cancer Research Center for Excellence [MOHW103-TD-B-111-03]; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) [NSC101-2911-I-002-303]	China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Taiwan Ministry Health and Welfare Cancer Research Center for Excellence; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE)	This study was supported by study projects DMR-102-014 and DMR-102-023 in China Medical University Hospital, the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), the Taiwan Ministry Health and Welfare Cancer Research Center for Excellence (MOHW103-TD-B-111-03), and the International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) (NSC101-2911-I-002-303). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Afessa B, 2004, CHEST, V126, P1905, DOI 10.1378/chest.126.6.1905; Asherson RA, 2007, CLIN REV ALLERG IMMU, V32, P153, DOI 10.1007/s12016-007-0012-0; Booth CM, 2011, CURR ONCOL, V18, P105; Burgel PR, 2013, EUR RESPIR REV, V22, P131, DOI 10.1183/09059180.00001313; Chiorini JA, 2009, J AUTOIMMUN, V33, P190, DOI 10.1016/j.jaut.2009.09.009; Chung WS, 2014, J RHEUMATOL, V41, P909, DOI 10.3899/jrheum.131345; Chung WS, 2014, EUR RESPIR J, V43, P801, DOI 10.1183/09031936.00043313; CONSTANTOPOULOS SH, 1985, CHEST, V88, P226, DOI 10.1378/chest.88.2.226; DALAVANGA YA, 1991, CHEST, V99, P1394, DOI 10.1378/chest.99.6.1394; Deheinzelin D, 1996, AM J RESP CRIT CARE, V154, P794, DOI 10.1164/ajrccm.154.3.8810621; Enomoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073774; Fernandez-Perez ER, 2008, CHEST, V133, P1113, DOI 10.1378/chest.07-1481; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; FRANKLIN DJ, 1986, OTOLARYNG HEAD NECK, V94, P230, DOI 10.1177/019459988609400217; Fukumura A, 2001, Ryumachi, V41, P37; Gomes Pde S, 2012, J ORAL MAXILLOFAC RE, V3, pe3; Gunning JE, 2003, SURGERY, V21, P72; HUMBERT P, 1988, ANN MED INTERNE, V139, P159; Ismael S, 2014, RESP CARE, V59, pE156, DOI 10.4187/respcare.02929; Ito I, 2005, AM J RESP CRIT CARE, V171, P632, DOI 10.1164/rccm.200403-417OC; Juarez M, 2014, ARTHRIT CARE RES, V66, P757, DOI 10.1002/acr.22227; Kikuchi A, 1996, J Obstet Gynaecol Res, V22, P421; Kokosi M, 2010, CLIN CHEST MED, V31, P489, DOI 10.1016/j.ccm.2010.05.007; Konstantinides SV, 2014, EUR RESPIR J, V43, P694, DOI 10.1183/09031936.00009414; Launay D, 2007, MEDICINE, V86, P299, DOI 10.1097/MD.0b013e3181579781; LEWANDOWSKI K, 1995, AM J RESP CRIT CARE, V151, P1121; Meiners PM, 2014, ANN RHEUM DIS, V73, P1393, DOI 10.1136/annrheumdis-2013-204653; Moerman RV, 2013, DRUG AGING, V30, P137, DOI 10.1007/s40266-013-0050-7; Naffaa Mohammad, 2013, Isr Med Assoc J, V15, P195; Nannini C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003569; NEWBALL HH, 1977, AM REV RESPIR DIS, V115, P295; PAPATHANASIOU MP, 1986, CHEST, V90, P370, DOI 10.1378/chest.90.3.370; Papiris SA, 1999, ANN RHEUM DIS, V58, P61, DOI 10.1136/ard.58.1.61; Papiris SA, 2007, RESP MED, V101, P84, DOI 10.1016/j.rmed.2006.04.005; Perez-De-Lis M, 2010, LUPUS, V19, P941, DOI 10.1177/0961203310367504; Pirildar T, 2010, RHEUMATOL INT, V30, P599, DOI 10.1007/s00296-009-1023-3; Roussos C, 2003, Eur Respir J Suppl, V47, p3s; Salaffi F, 1998, BRIT J RHEUMATOL, V37, P263; Sarkar Pralay K, 2009, Indian J Chest Dis Allied Sci, V51, P93; SEGAL I, 1981, THORAX, V36, P286, DOI 10.1136/thx.36.4.286; STRIMLAN CV, 1976, CHEST, V70, P354, DOI 10.1378/chest.70.3.354; Thomas E, 1998, BRIT J RHEUMATOL, V37, P1069; Tuder RM, 1998, CHEST, V114, p1S, DOI 10.1378/chest.114.1_Supplement.1S-a; Usuba FS, 2014, CLINICS, V69, P158, DOI 10.6061/clinics/2014(03)02; Vij R, 2013, CHEST, V143, P814, DOI 10.1378/chest.12-0741; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; VITALI C, 1985, ANN RHEUM DIS, V44, P455, DOI 10.1136/ard.44.7.455; WALLAERT B, 1986, AM REV RESPIR DIS, V133, P574; Wright SA, 2003, RHEUMATOLOGY, V42, P697, DOI 10.1093/rheumatology/keg149; Yazisiz V, 2010, RHEUMATOL INT, V30, P1317, DOI 10.1007/s00296-009-1152-8	50	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110783	10.1371/journal.pone.0110783	http://dx.doi.org/10.1371/journal.pone.0110783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350278	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100041
J	Zhou, JH; Ding, YZ; He, Y; Chu, YF; Zhao, P; Ma, LY; Wang, XJ; Li, XR; Liu, YS				Zhou, Jian-hua; Ding, Yao-zhong; He, Ying; Chu, Yue-feng; Zhao, Ping; Ma, Li-ya; Wang, Xin-jun; Li, Xue-rui; Liu, Yong-sheng			The Effect of Multiple Evolutionary Selections on Synonymous Codon Usage of Genes in the Mycoplasma bovis Genome	PLOS ONE			English	Article							MICROCOCCUS-LUTEUS; TRANSFER-RNAS; G+C CONTENT; SEQUENCE; BIAS; BACTERIUM; ADAPTATION; PATTERNS; DISEASE; HOST	Mycoplasma bovis is a major pathogen causing arthritis, respiratory disease and mastitis in cattle. A better understanding of its genetic features and evolution might represent evidences of surviving host environments. In this study, multiple factors influencing synonymous codon usage patterns in M. bovis (three strains' genomes) were analyzed. The overall nucleotide content of genes in the M. bovis genome is AT-rich. Although the G and C contents at the third codon position of genes in the leading strand differ from those in the lagging strand (p<0.05), the 59 synonymous codon usage patterns of genes in the leading strand are highly similar to those in the lagging strand. The over-represented codons and the under-represented codons were identified. A comparison of the synonymous codon usage pattern of M. bovis and cattle (susceptible host) indicated the independent formation of synonymous codon usage of M. bovis. Principal component analysis revealed that (i) strand-specific mutational bias fails to affect the synonymous codon usage pattern in the leading and lagging strands, (ii) mutation pressure from nucleotide content plays a role in shaping the overall codon usage, and (iii) the major trend of synonymous codon usage has a significant correlation with the gene expression level that is estimated by the codon adaptation index. The plot of the effective number of codons against the G+C content at the third codon position also reveals that mutation pressure undoubtedly contributes to the synonymous codon usage pattern of M. bovis. Additionally, the formation of the overall codon usage is determined by certain evolutionary selections for gene function classification (30S protein, 50S protein, transposase, membrane protein, and lipoprotein) and translation elongation region of genes in M. bovis. The information could be helpful in further investigations of evolutionary mechanisms of the Mycoplasma family and heterologous expression of its functionally important proteins.	[Zhou, Jian-hua; Ding, Yao-zhong; He, Ying; Chu, Yue-feng; Zhao, Ping; Ma, Li-ya; Wang, Xin-jun; Li, Xue-rui; Liu, Yong-sheng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Li, XR (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	liuyongsheng@caas.cn; lixuerui@caas.cn	Chu, Yuefeng/K-9892-2019		National Natural Science Foundation of China [31302100, 31172335, 31072143]; Bacterial Disease in Grazing animal Team	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bacterial Disease in Grazing animal Team	This study was supported by National Natural Science Foundation of China (No. 31302100, No. 31172335 and No. 31072143), in addition, this study was also supported by Bacterial Disease in Grazing animal Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1995, BIOCHEM CELL BIOL, V73, P775, DOI 10.1139/o95-086; ANDERSSON SGE, 1991, MOL BIOL EVOL, V8, P530; ARBER W, 1993, GENE, V135, P49, DOI 10.1016/0378-1119(93)90048-8; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Feng C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-732; GONZALEZ YRC, 1995, VET MICROBIOL, V47, P183, DOI 10.1016/0378-1135(95)00058-I; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; KANO A, 1991, J MOL BIOL, V221, P387, DOI 10.1016/0022-2836(91)80061-X; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lafay B, 1999, NUCLEIC ACIDS RES, V27, P1642, DOI 10.1093/nar/27.7.1642; Li WC, 2007, ANTON LEEUW INT J G, V92, P417, DOI 10.1007/s10482-007-9170-6; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; Lithwick G, 2003, GENOME RES, V13, P2665, DOI 10.1101/gr.1485203; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x; McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nayak KC, 2013, GENE, V513, P163, DOI 10.1016/j.gene.2012.10.024; Nicholas RAJ, 2003, RES VET SCI, V74, P105, DOI 10.1016/S0034-5288(02)00155-8; OBA T, 1991, P NATL ACAD SCI USA, V88, P921, DOI 10.1073/pnas.88.3.921; OHAMA T, 1990, NUCLEIC ACIDS RES, V18, P1565, DOI 10.1093/nar/18.6.1565; Ohno H, 2001, GENE, V276, P107, DOI 10.1016/S0378-1119(01)00670-9; Qi JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038239; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Wise KS, 2011, INFECT IMMUN, V79, P982, DOI 10.1128/IAI.00726-10; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-43; Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077239; Zhou JH, 2013, VIRUS RES, V176, P298, DOI 10.1016/j.virusres.2013.06.006; Zhou JH, 2013, VIRUS GENES, V46, P271, DOI 10.1007/s11262-012-0847-1; Zhou T, 2006, GENE, V368, P117, DOI 10.1016/j.gene.2005.10.035	43	17	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e108949	10.1371/journal.pone.0108949	http://dx.doi.org/10.1371/journal.pone.0108949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350396	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943100007
J	Chiang, HH; Tseng, FY; Wang, CY; Chen, CL; Chen, YC; See, TT; Chen, HF				Chiang, Hou-Hsien; Tseng, Fen-Yu; Wang, Chih-Yuan; Chen, Chi-Ling; Chen, Yi-Chun; See, Ting-Ting; Chen, Hua-Fen			All-Cause Mortality in Patients with Type 2 Diabetes in Association with Achieved Hemoglobin A(1c), Systolic Blood Pressure, and Low-Density Lipoprotein Cholesterol Levels	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR OUTCOMES; GLUCOSE CONTROL; RISK-FACTOR; MYOCARDIAL-INFARCTION; PEOPLE; COMPLICATIONS; DEATH; SIMVASTATIN; REDUCTION	Background: To identify the ranges of hemoglobin A(1c) (HbA1c), systolic blood pressure (SBP), and low-density lipoprotein cholesterol (LDL-C) levels which are associated with the lowest all-cause mortality. Methods: A retrospective cohort of 12,643 type 2 diabetic patients (aged >= 18 years) were generated from 2002 to 2010, in Far-Eastern Memorial Hospital, New Taipei city, Taiwan. Patients were identified to include any outpatient diabetes diagnosis (ICD-9: 250), and drug prescriptions that included any oral hypoglycemic agents or insulin prescribed during the 6 months following their first outpatient visit for diabetes. HbA1c, SBP, and LDL-C levels were assessed by the mean value of all available data, from index date to death or censor date. Deaths were ascertained by matching patient records with the Taiwan National Register of Deaths. Results: Our results showed general U-shaped associations, where the lowest hazard ratios occurred at HbA1c 7.0-8.0%, SBP 130-140 mmHg, and LDL-C 100-130 mg/dL. The risk of mortality gradually increases if the patient's mean HbA1c, SBP, or LDL-C during the follow-up period was higher or lower than these ranges. In comparison to the whole population, the adjusted hazard ratio (95% CI) for patients with HbA1c 7.0-8.0%, SBP 130-140 mmHg, and LDL-C 100-130 mg/dL were 0.69 (0.62-0.77), 0.80 (0.72-0.90), and 0.68 (0.61-0.75), respectively. Conclusions: In our type 2 diabetic cohort, the patients with HbA1c 7.0-8.0%, SBP 130-140 mmHg, or LDL-C 100-130 mg/dL had the lowest all-cause mortality. Additional research is needed to confirm these associations and to further investigate their detailed mechanisms.	[Chiang, Hou-Hsien; See, Ting-Ting; Chen, Hua-Fen] Far Eastern Mem Hosp, Dept Internal Med, Sect Endocrinol & Metab, New Taipei City, Taiwan; [Tseng, Fen-Yu; Wang, Chih-Yuan] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei 10764, Taiwan; [Chen, Chi-Ling; Chen, Yi-Chun] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	See, TT (corresponding author), Far Eastern Mem Hosp, Dept Internal Med, Sect Endocrinol & Metab, New Taipei City, Taiwan.	ting2see@gmail.com		Chiang, Hou-Hsien/0000-0002-4801-0262; WANG, CHIH-YUAN/0000-0002-6742-3935; Tseng, Fen-Yu/0000-0003-1571-5255	Section of Endocrinology & Metabolism, Department of Internal Medicine, Far-Eastern Memorial Hospital	Section of Endocrinology & Metabolism, Department of Internal Medicine, Far-Eastern Memorial Hospital	This research was supported by the funds of Section of Endocrinology & Metabolism, Department of Internal Medicine, Far-Eastern Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chen HF, 2011, DIABETES CARE, V34, P1177, DOI 10.2337/dc10-2006; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Colayco DC, 2011, DIABETES CARE, V34, P77, DOI 10.2337/dc10-1318; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Eeg-Olofsson K, 2010, J INTERN MED, V268, P471, DOI 10.1111/j.1365-2796.2010.02265.x; Epstein AE, 2013, J AM COLL CARDIOL, V62, P2000, DOI 10.1016/j.jacc.2013.05.086; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hayes AJ, 2011, DIABETIC MED, V28, P428, DOI 10.1111/j.1464-5491.2010.03189.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2011, DIABETES CARE, V34, P1329, DOI 10.2337/dc10-2377; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kennedy BS, 2002, NEUROEPIDEMIOLOGY, V21, P131, DOI 10.1159/000054810; Li HY, 2012, J FORMOS MED ASSOC, V111, P645, DOI 10.1016/j.jfma.2012.09.013; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Schupf N, 2005, J AM GERIATR SOC, V53, P219, DOI 10.1111/j.1532-5415.2005.53106.x; Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.1151; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tikhonoff V, 2005, J AM GERIATR SOC, V53, P2159, DOI 10.1111/j.1532-5415.2005.00492.x; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vamos EP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5567; Wright RJ, 2010, DIABETES CARE, V33, P1591, DOI 10.2337/dc10-0013; Wu MY, 2012, AM J KIDNEY DIS, V60, P548, DOI 10.1053/j.ajkd.2012.03.018; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	43	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109501	10.1371/journal.pone.0109501	http://dx.doi.org/10.1371/journal.pone.0109501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347712	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900010
J	Li, CG; Zhang, E; Sun, Y; Lee, PS; Zhan, YZ; Guo, YN; Osorio, JC; Rosas, IO; Xu, KF; Kwiatkowski, DJ; Yu, JJ				Li, Chenggang; Zhang, Erik; Sun, Yang; Lee, Po-Shun; Zhan, Yongzhong; Guo, Yanan; Osorio, Juan C.; Rosas, Ivan O.; Xu, Kai-Feng; Kwiatkowski, David J.; Yu, Jane J.			Rapamycin-Insensitive Up-Regulation of Adipocyte Phospholipase A2 in Tuberous Sclerosis and Lymphangioleiomyomatosis	PLOS ONE			English	Article							REPRODUCTIVE-TRACT LEIOMYOMATA; TUMOR-SUPPRESSOR TSC2; MAMMALIAN TARGET; TSC1-TSC2 COMPLEX; SMOOTH-MUSCLE; RODENT MODEL; CELL-GROWTH; GENE; ANGIOMYOLIPOMA; ACTIVATION	Tuberous sclerosis syndrome (TSC) is an autosomal dominant tumor suppressor gene syndrome affecting multiple organs, including renal angiomyolipomas and pulmonary lymphangioleiomyomatosis (LAM). LAM is a female-predominant interstitial lung disease characterized by the progressive cyst formation and respiratory failure, which is also seen in sporadic patients without TSC. Mutations in TSC1 or TSC2 cause TSC, result in hyperactivation of mammalian target of rapamycin (mTOR), and are also seen in LAM cells in sporadic LAM. We recently reported that prostaglandin biosynthesis and cyclooxygenase-2 were deregulated in TSC and LAM. Phospholipase A2 (PLA2) is the rate-limiting enzyme that catalyzes the conversion of plasma membrane phospholipids into prostaglandins. In this study, we identified upregulation of adipocyte AdPLA2 (PLA2G16) in LAM nodule cells using publicly available expression data. We showed that the levels of AdPLA2 transcript and protein were higher in LAM lungs compared with control lungs. We then showed that TSC2 negatively regulates the expression of AdPLA2, and loss of TSC2 is associated with elevated production of prostaglandin E-2 (PGE(2)) and prostacyclin (PGI(2)) in cell culture models. Mouse model studies also showed increased expression of AdPLA2 in xenograft tumors, estrogen-induced lung metastatic lesions of Tsc2 null leiomyoma-derived cells, and spontaneous renal cystadenomas from Tsc2(+/-) mice. Importantly, rapamycin treatment did not affect the expression of AdPLA2 and the production of PGE(2) by TSC2-deficient mouse embryonic fibroblast (Tsc2(-/-) MEFs), rat uterine leiomyoma-derived ELT3 cells, and LAM patient-associated renal angiomyolipoma-derived "mesenchymal'' cells. Furthermore, methyl arachidonyl fluorophosphate (MAFP), a potent irreversible PLA2 inhibitor, selectively suppressed the growth and induced apoptosis of TSC2-deficient LAM patient-derived cells relative to TSC2-addback cells. Our findings suggest that AdPLA2 plays an important role in promoting tumorigenesis and disease progression by modulating the production of prostaglandins and may serve as a potential therapeutic target in TSC and LAM.	[Li, Chenggang; Zhang, Erik; Sun, Yang; Lee, Po-Shun; Guo, Yanan; Osorio, Juan C.; Rosas, Ivan O.; Kwiatkowski, David J.; Yu, Jane J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02163 USA; [Zhan, Yongzhong; Xu, Kai-Feng] Peking Union Med Coll, Beijing 100021, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yu, JJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02163 USA.	jyu13@rics.bwh.harvard.edu	, 孙阳/B-2495-2016; Xu, Kai-Feng/AAO-2445-2020	, 孙阳/0000-0002-1463-689X; Osorio, Juan C/0000-0001-8090-1551	National Cancer Institute [PO1CA120964]; National Heart, Lung and blood Institute [HL098216]; Department of Defense [W81XWH-12-1-0442]; LAM Foundation [LAM00101F01-14]; Biomedical Research Institute (BRI); NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098331] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Defense(United States Department of Defense); LAM Foundation; Biomedical Research Institute (BRI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the following: The National Cancer Institute PO1 (PO1CA120964, http://www.cancer.gov/) to DJK; The National Heart, Lung and blood Institute (HL098216, https://www.nhlbi.nih.gov/) and Department of Defense Exploratory Idea Development Award (W81XWH-12-1-0442, http://www. defense.gov/) to JJY; The LAM Foundation Fellowship Award (LAM00101F01-14, http://www.thelamfoundation.org/) and Biomedical Research Institute (BRI) -BWH Micro Grants (http://www.brighamandwomens.org/research/microgrants/default.aspx) to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2013, CAN MED ASSOC J, V185, pE763, DOI 10.1503/cmaj.122072; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Barnes EA, 2010, AM J PATHOL, V177, P1765, DOI 10.2353/ajpath.2010.090233; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Duffy K, 2002, MODERN PATHOL, V15, P205, DOI 10.1038/modpathol.3880517; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; El-Hashemite N, 2003, CANCER RES, V63, P5173; EVERITT JI, 1995, AM J PATHOL, V146, P1556; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P473, DOI 10.1165/rcmb.2005-0374OC; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; HOWE SR, 1995, ENDOCRINOLOGY, V136, P4996, DOI 10.1210/en.136.11.4996; HOWE SR, 1995, AM J PATHOL, V146, P1568; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; HUANG Z, 1994, ANAL BIOCHEM, V222, P110, DOI 10.1006/abio.1994.1461; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Karbowniczek M, 2004, J BIOL CHEM, V279, P29930, DOI 10.1074/jbc.M402591200; Karbowniczek M, 2003, AM J PATHOL, V162, P491, DOI 10.1016/S0002-9440(10)63843-6; Karbowniczek M, 2006, J BIOL CHEM, V281, P25447, DOI 10.1074/jbc.M605273200; Karbowniczek M, 2010, J CLIN INVEST, V120, P93, DOI 10.1172/JCI40221; Kenerson HL, 2002, CANCER RES, V62, P5645; Krymskaya Vera P, 2008, Proc Am Thorac Soc, V5, P119, DOI 10.1513/pats.200705-061VS; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lee PS, 2010, AM J RESP CELL MOL, V42, P227, DOI 10.1165/rcmb.2009-0050OC; Li CG, 2014, J EXP MED, V211, P15, DOI 10.1084/jem.20131080; Liu Y, 2013, CANCER DISCOV, V3, P870, DOI 10.1158/2159-8290.CD-13-0015; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Matsumoto Y, 1999, AM J RESP CELL MOL, V21, P327, DOI 10.1165/ajrcmb.21.3.3693; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Muller R, 2004, J CANCER RES CLIN, V130, P429, DOI 10.1007/s00432-004-0570-y; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Pacheco-Rodriguez G, 2007, CANCER RES, V67, P10573, DOI 10.1158/0008-5472.CAN-07-1356; Pacheco-Rodriguez G, 2009, J IMMUNOL, V182, P1270, DOI 10.4049/jimmunol.182.3.1270; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Plank TL, 1998, CANCER RES, V58, P4766; Prevost N, 2009, BLOOD, V113, P447, DOI 10.1182/blood-2008-06-162032; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Young LR, 2013, LANCET RESP MED, V1, P445, DOI 10.1016/S2213-2600(13)70090-0; Young LR, 2010, CHEST, V138, P674, DOI 10.1378/chest.10-0573; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Yu JJ, 2009, P NATL ACAD SCI USA, V106, P2635, DOI 10.1073/pnas.0810790106; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhe XN, 2004, J HISTOCHEM CYTOCHEM, V52, P1537, DOI 10.1369/jhc.4A6438.2004	54	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e104809	10.1371/journal.pone.0104809	http://dx.doi.org/10.1371/journal.pone.0104809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347447	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900001
J	Choi, ES; Kim, MK; Song, MK; Kim, JM; Kim, ES; Chung, WJ; Park, KS; Cho, KB; Hwang, JS; Jang, BK				Choi, Eun Sung; Kim, Mi Kyung; Song, Min Kyung; Kim, Jeong Min; Kim, Eun Soo; Chung, Woo Jin; Park, Kyung Sik; Cho, Kwang Bum; Hwang, Jae Seok; Jang, Byoung Kuk			Association between Serum Irisin Levels and Non-Alcoholic Fatty Liver Disease in Health Screen Examinees	PLOS ONE			English	Article							EXERCISE	Irisin is a recently found myokine that aids obesity control and improves glucose homeostasis by acting on white adipose tissue cells and increases total energy consumption. The aim of this study was to evaluate serum irisin levels in patients with non-alcoholic fatty liver disease (NAFLD) and to compare these levels with those of normal controls. Among 595 health screen examinees who had visited our institute between January 2013 to March 2013, 355 patients (84 NAFLD patients and 271 normal controls) were enrolled depending on whether they gave written informed consents and their history of alcohol intake, blood tests, and abdominal ultrasonographic findings. Age; sex; laboratory test parameters; homeostasis model assessment-insulin resistance; and levels of leptin, adiponectin, and irisin were assessed. Serum irisin levels (ng/ml) were significantly higher in the NAFLD group than in normal controls (63.4 +/- 32.6 vs. 43.0 +/- 29.7, p<0.001) and higher in the mild fatty liver group than in the moderate-to-severe fatty liver group (68.3 +/- 38.2 vs. 56.6 +/- 21.2, p<0.001). Additionally, serum irisin levels were not different between the non-obese and obese groups (48.4 +/- 34.2 vs. 45.8 +/- 22.9, p = 0.492); however, the levels were significantly lowest in normal controls and highest in the mild fatty liver group in the non-obese (44.9 +/- 31.7 vs. 73.1 +/- 48.5 vs 59.7 +/- 18.0, p<0.001) and obese groups (35.0 +/- 17.0 vs. 62.9 +/- 21.2 vs. 54.6 +/- 23.3, p<0.001). Serum irisin levels were significantly higher in NAFLD patients, which is not consistent with the results of previously published studies. Therefore, more studies are needed to confirm the role of irisin in NAFLD.	[Choi, Eun Sung; Kim, Mi Kyung; Kim, Jeong Min; Kim, Eun Soo; Chung, Woo Jin; Park, Kyung Sik; Cho, Kwang Bum; Hwang, Jae Seok; Jang, Byoung Kuk] Keimyung Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Song, Min Kyung] Keimyung Univ, Grad Sch, Dept Food Sci & Nutr, Taegu, South Korea; [Jang, Byoung Kuk] Keimyung Univ, Inst Canc Res, Taegu, South Korea	Keimyung University; Keimyung University; Keimyung University	Jang, BK (corresponding author), Keimyung Univ, Sch Med, Dept Internal Med, Taegu, South Korea.	jangha106@dsmc.or.kr		Jang, Byoung Kuk/0000-0002-8950-0866	Keimyung University Dongsan Medical Center	Keimyung University Dongsan Medical Center	This work was supported by the research promoting grant from the Keimyung University Dongsan Medical Center in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bostrom PA, 2014, METABOLISM, V63, P178, DOI 10.1016/j.metabol.2013.11.009; Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Polyzos SA, 2014, METABOLISM, V63, P207, DOI 10.1016/j.metabol.2013.09.013; Polyzos SA, 2013, METABOLISM, V62, P1037, DOI 10.1016/j.metabol.2013.04.008; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Sahini N, 2014, PROG LIPID RES, V54, P86, DOI 10.1016/j.plipres.2014.02.002; Sanchis-Gomar F, 2014, HORMONE METABOLIC RE; Sanchis-Gomar F, 2014, ENDOCRINE; Zhang HJ, 2013, J HEPATOL, V59, P557, DOI 10.1016/j.jhep.2013.04.030	17	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110680	10.1371/journal.pone.0110680	http://dx.doi.org/10.1371/journal.pone.0110680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343462	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500046
J	Magee, AF; May, MR; Moore, BR				Magee, Andrew F.; May, Michael R.; Moore, Brian R.			The Dawn of Open Access to Phylogenetic Data	PLOS ONE			English	Article							INFORMATION; AVAILABILITY; REUSE; TREE; NEED	The scientific enterprise depends critically on the preservation of and open access to published data. This basic tenet applies acutely to phylogenies (estimates of evolutionary relationships among species). Increasingly, phylogenies are estimated from increasingly large, genome-scale datasets using increasingly complex statistical methods that require increasing levels of expertise and computational investment. Moreover, the resulting phylogenetic data provide an explicit historical perspective that critically informs research in a vast and growing number of scientific disciplines. One such use is the study of changes in rates of lineage diversification (speciation - extinction) through time. As part of a meta-analysis in this area, we sought to collect phylogenetic data (comprising nucleotide sequence alignment and tree files) from 217 studies published in 46 journals over a 13-year period. We document our attempts to procure those data (from online archives and by direct request to corresponding authors), and report results of analyses (using Bayesian logistic regression) to assess the impact of various factors on the success of our efforts. Overall, complete phylogenetic data for similar to 60% of these studies are effectively lost to science. Our study indicates that phylogenetic data are more likely to be deposited in online archives and/or shared upon request when: (1) the publishing journal has a strong data-sharing policy; (2) the publishing journal has a higher impact factor, and; (3) the data are requested from faculty rather than students. Importantly, our survey spans recent policy initiatives and infrastructural changes; our analyses indicate that the positive impact of these community initiatives has been both dramatic and immediate. Although the results of our study indicate that the situation is dire, our findings also reveal tremendous recent progress in the sharing and preservation of phylogenetic data.	[Magee, Andrew F.; May, Michael R.; Moore, Brian R.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Moore, BR (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	brianmoore@ucdavis.edu			NSF grants [DEB-0842181, DEB-0919529]; NSF grant [DBI-1356737]	NSF grants(National Science Foundation (NSF)); NSF grant(National Science Foundation (NSF))	This research was supported by NSF grants DEB-0842181 and DEB-0919529 awarded to BRM (http://www.nsf.gov/div/index.jsp?div=DEB) and by NSF grant DBI-1356737 awarded to BRM (http://www.nsf.gov/div/index.jsp?div=DBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; [Anonymous], 2006, NATURE, V444, P653, DOI 10.1038/444653b; [Anonymous], 2007, TREE LIFE WEB PROJEC; Blackburne BP, 2013, MOL BIOL EVOL, V30, P642, DOI 10.1093/molbev/mss256; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; CECI SJ, 1983, AM PSYCHOL, V38, P414, DOI 10.1037/0003-066X.38.4.414; Cranston K, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.bf01eff4a6b60ca4825c69293dc59645; Donoghue MJ, 2000, ANN MO BOT GARD, V87, P110, DOI 10.2307/2666212; Drew BT, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001636; Drew BT, 2013, NATURE, V493, P305, DOI 10.1038/493305f; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Evangelou E, 2005, FASEB J, V19, P1943, DOI 10.1096/fj.05-4784lsf; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Hughes J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-178; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Leebens-Mack J, 2006, OMICS, V10, P231, DOI 10.1089/omi.2006.10.231; Moore AJ, 2010, J EVOLUTION BIOL, V23, P659, DOI 10.1111/j.1420-9101.2010.01937.x; Morrison DA, 2009, SYST BIOL, V58, P150, DOI 10.1093/sysbio/syp009; Noor MAF, 2006, PLOS BIOL, V4, P1113, DOI 10.1371/journal.pbio.0040228; Notredame C, 2007, PLOS COMPUT BIOL, V3, P1405, DOI 10.1371/journal.pcbi.0030123; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Piwowar HA, 2011, P AM SOC INFORM SCI, V48, P1, DOI DOI 10.1002/MEET.2011.14504801337; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Piwowar HA, 2013, PEERJ, V1, DOI 10.7717/peerj.175; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Piwowar HA, 2010, J BIOMED DISCOV COLL, V5, P7; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Polson NG, 2012, ARXIV E PRINTS; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Core Team, 2021, R LANGUAGE ENV STAT; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rausher MD, 2010, EVOLUTION, V64, P603, DOI 10.1111/j.1558-5646.2009.00940.x; Rieseberg L, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04450.x; Roche DG, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001779; Sanderson Michael J., 1994, American Journal of Botany, V81, P183; SANDERSON MJ, 1993, SYST BIOL, V42, P562, DOI 10.2307/2992488; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Stoltzfus Arlin, 2012, BMC Res Notes, V5, P574, DOI 10.1186/1756-0500-5-574; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Uyenoyama MK, 2010, MOL BIOL EVOL, V27, P742; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Vines TH, 2013, FASEB J, V27, P1304, DOI 10.1096/fj.12-218164; Vision TJ, 2010, BIOSCIENCE, V60, P330, DOI 10.1525/bio.2010.60.5.2; Whitlock MC, 2011, TRENDS ECOL EVOL, V26, P61, DOI 10.1016/j.tree.2010.11.006; Whitlock MC, 2010, AM NAT, V175, pE45, DOI 10.1086/650340; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	52	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110268	10.1371/journal.pone.0110268	http://dx.doi.org/10.1371/journal.pone.0110268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343725	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500031
J	Mehan, WA; Gonzalez, RG; Buchbinder, BR; Chen, JW; Copen, WA; Gupta, R; Hirsch, JA; Hunter, GJ; Hunter, S; Johnson, JM; Kelly, HR; Larvie, M; Lev, MH; Pomerantz, SR; Rapalino, O; Rincon, S; Romero, JM; Schaefer, PW; Shah, V				Mehan, William A., Jr.; Gonzalez, R. Gilberto; Buchbinder, Bradley R.; Chen, John W.; Copen, William A.; Gupta, Rajiv; Hirsch, Joshua A.; Hunter, George J.; Hunter, Scott; Johnson, Jason M.; Kelly, Hillary R.; Larvie, Mykol; Lev, Michael H.; Pomerantz, Stuart R.; Rapalino, Otto; Rincon, Sandra; Romero, Javier M.; Schaefer, Pamela W.; Shah, Vinil			Optimal Brain MRI Protocol for New Neurological Complaint	PLOS ONE			English	Article							ATTENUATED INVERSION-RECOVERY; GRADIENT-ECHO MR; SPIN-ECHO; INTRACRANIAL HEMORRHAGE; MULTIPLE-SCLEROSIS; PLANAR SEQUENCES; THIN-SECTION; FLAIR; LESIONS; IMAGES	Background/Purpose: Patients with neurologic complaints are imaged with MRI protocols that may include many pulse sequences. It has not been documented which sequences are essential. We assessed the diagnostic accuracy of a limited number of sequences in patients with new neurologic complaints. Methods: 996 consecutive brain MRI studies from patients with new neurological complaints were divided into 2 groups. In group 1, reviewers used a 3-sequence set that included sagittal T1-weighted, axial T2-weighted fluid-attenuated inversion recovery, and axial diffusion-weighted images. Subsequently, another group of studies were reviewed using axial susceptibility-weighted images in addition to the 3 sequences. The reference standard was the study's official report. Discrepancies between the limited sequence review and the reference standard including Level I findings (that may require immediate change in patient management) were identified. Results: There were 84 major findings in 497 studies in group 1 with 21 not identified in the limited sequence evaluations: 12 enhancing lesions and 3 vascular abnormalities identified on MR angiography. The 3-sequence set did not reveal microhemorrhagic foci in 15 of 19 studies. There were 117 major findings in 499 studies in group 2 with 19 not identified on the 4-sequence set: 17 enhancing lesions and 2 vascular lesions identified on angiography. All 87 Level I findings were identified using limited sequence (56 acute infarcts, 16 hemorrhages, and 15 mass lesions). Conclusion: A 4-pulse sequence brain MRI study is sufficient to evaluate patients with a new neurological complaint except when contrast or angiography is indicated.	[Mehan, William A., Jr.; Gonzalez, R. Gilberto; Buchbinder, Bradley R.; Chen, John W.; Copen, William A.; Gupta, Rajiv; Hirsch, Joshua A.; Hunter, George J.; Hunter, Scott; Johnson, Jason M.; Kelly, Hillary R.; Larvie, Mykol; Lev, Michael H.; Pomerantz, Stuart R.; Rapalino, Otto; Rincon, Sandra; Romero, Javier M.; Schaefer, Pamela W.; Shah, Vinil] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroradiol Div, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Gonzalez, RG (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroradiol Div, Boston, MA 02115 USA.	rggonzalez@mgh.harvard.edu	Hunter, Scott J./AAB-8814-2020; Schaefer, Pamela/AAA-1323-2019	johnson, jason/0000-0001-7724-5784; Kelly, Hillary/0000-0002-6655-8723; Rapalino, Otto/0000-0002-5038-4183; Romero, Javier/0000-0001-5749-3000				Aprile I, 1999, AM J NEURORADIOL, V20, P1259; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; Bakshi R, 1999, AM J NEURORADIOL, V20, P629; BrantZawadzki M, 1996, STROKE, V27, P1187, DOI 10.1161/01.STR.27.7.1187; Casey SO, 2000, AM J NEURORADIOL, V21, P1199; Chan S, 1996, AM J NEURORADIOL, V17, P1821; Demaerel P, 1998, NEURORADIOLOGY, V40, P355, DOI 10.1007/s002340050598; Essig M, 2000, INVEST RADIOL, V35, P689, DOI 10.1097/00004424-200011000-00007; HASHEMI RH, 1995, RADIOLOGY, V196, P505, DOI 10.1148/radiology.196.2.7617868; Herskovits EH, 2001, AM J ROENTGENOL, V176, P1313, DOI 10.2214/ajr.176.5.1761313; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Lam WWM, 2003, J NEUROIMAGING, V13, P99, DOI 10.1177/1051228403251083; Lin DDM, 2001, AM J NEURORADIOL, V22, P1275; Maeda M, 2001, AM J NEURORADIOL, V22, P632; Maubon AJ, 1998, RADIOLOGY, V208, P671, DOI 10.1148/radiology.208.3.9722844; Meiners LC, 1999, INVEST RADIOL, V34, P134, DOI 10.1097/00004424-199902000-00006; Noguchi K, 1997, RADIOLOGY, V203, P257, DOI 10.1148/radiology.203.1.9122404; Palmer S, 1999, RADIOLOGY, V210, P149, DOI 10.1148/radiology.210.1.r99ja38149; Saleh A, 2004, BRIT J RADIOL, V77, P183, DOI 10.1259/bjr/62546157; Taillibert S, 1999, EUR NEUROL, V41, P64, DOI 10.1159/000008005; Thurnher MM, 1997, AM J NEURORADIOL, V18, P1601; Tsushima Y, 2003, AM J NEURORADIOL, V24, P88	23	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110803	10.1371/journal.pone.0110803	http://dx.doi.org/10.1371/journal.pone.0110803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343371	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500057
J	Cheong, HT; Ng, KT; Ong, LY; Chook, JB; Chan, KG; Takebe, Y; Kamarulzaman, A; Tee, KK				Cheong, Hui Ting; Ng, Kim Tien; Ong, Lai Yee; Chook, Jack Bee; Chan, Kok Gan; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng			Cross-Border Sexual Transmission of the Newly Emerging HIV-1 Clade CRF51_01B	PLOS ONE			English	Article							KUALA-LUMPUR; RECOMBINANT FORMS; RISK BEHAVIOR; TYPE-1; IDENTIFICATION; SINGAPORE; TRAVELERS; PREVALENCE; DIVERSITY; EMERGENCE	A novel HIV-1 recombinant clade (CRF51_01B) was recently identified among men who have sex with men (MSM) in Singapore. As cases of sexually transmitted HIV-1 infection increase concurrently in two socioeconomically intimate countries such as Malaysia and Singapore, cross transmission of HIV-1 between said countries is highly probable. In order to investigate the timeline for the emergence of HIV-1 CRF51_01B in Singapore and its possible introduction into Malaysia, 595 HIV-positive subjects recruited in Kuala Lumpur from 2008 to 2012 were screened. Phylogenetic relationship of 485 amplified polymerase gene sequences was determined through neighbour-joining method. Next, near-full length sequences were amplified for genomic sequences inferred to be CRF51_01B and subjected to further analysis implemented through Bayesian Markov chain Monte Carlo (MCMC) sampling and maximum likelihood methods. Based on the near full length genomes, two isolates formed a phylogenetic cluster with CRF51_01B sequences of Singapore origin, sharing identical recombination structure. Spatial and temporal information from Bayesian MCMC coalescent and maximum likelihood analysis of the protease, gp120 and gp41 genes suggest that Singapore is probably the country of origin of CRF51_01B (as early as in the mid-1990s) and featured a Malaysian who acquired the infection through heterosexual contact as host for its ancestral lineages. CRF51_01B then spread rapidly among the MSM in Singapore and Malaysia. Although the importation of CRF51_01B from Singapore to Malaysia is supported by coalescence analysis, the narrow timeframe of the transmission event indicates a closely linked epidemic. Discrepancies in the estimated divergence times suggest that CRF51_01B may have arisen through multiple recombination events from more than one parental lineage. We report the cross transmission of a novel CRF51_01B lineage between countries that involved different sexual risk groups. Understanding the cross-border transmission of HIV-1 involving sexual networks is crucial for effective intervention strategies in the region.	[Cheong, Hui Ting; Ng, Kim Tien; Ong, Lai Yee; Chook, Jack Bee; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Chan, Kok Gan] Univ Malaya, Inst Biol Sci, Div Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan	Universiti Malaya; Universiti Malaya; National Institute of Infectious Diseases (NIID)	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Tee, Kok Keng/A-8148-2008; Ng, Kim Tien/K-7667-2013; Chan, Kok Gan/B-8347-2010; KAMARULZAMAN, ADEEBA/B-5216-2010	Tee, Kok Keng/0000-0002-7923-5448; Ng, Kim Tien/0000-0002-4097-9984; Chan, Kok Gan/0000-0002-1883-1115; 	Ministry of Education, Malaysia: High Impact Research [E-000001-20001]; High Impact Research [H-500001-00-A000011-000001, H-500001-00-A000012-000001]	Ministry of Education, Malaysia: High Impact Research; High Impact Research	This work was supported in part by grants from the Ministry of Education, Malaysia: High Impact Research E-000001-20001 to AK, and High Impact Research H-500001-00-A000011-000001 and H-500001-00-A000012-000001 to KKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah ASM, 2004, CLIN INFECT DIS, V39, P533, DOI 10.1086/422721; Abubakar YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080487; Ansart S, 2009, J TRAVEL MED, V16, P79, DOI 10.1111/j.1708-8305.2008.00279.x; Charpentier C, 2006, J VIROL, V80, P2472, DOI 10.1128/JVI.80.5.2472-2482.2006; Chow WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085250; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Deng XT, 2008, ALGORITHMICA, V52, P1, DOI 10.1007/s00453-007-9001-1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Hamlyn E, 2007, OCCUP MED-OXFORD, V57, P313, DOI 10.1093/occmed/kqm044; HAWKES S, 1994, AIDS, V8, P247, DOI 10.1097/00002030-199402000-00013; Kalish ML, 2002, VIROLOGY, V304, P311, DOI 10.1006/viro.2002.1691; Kanter J, 2011, INT J STD AIDS, V22, P30, DOI 10.1258/ijsa.2010.010277; Ng KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080884; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Malaysia - Department of Statistics, 2012, TOUR SAT ACC 2000 20; Malaysian Ministry of Health, 2012, GLOB AIDS RESP COUNT; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Ng OT, 2012, AIDS RES HUM RETROV, V28, P527, DOI [10.1089/aid.2011.0177, 10.1089/AID.2011.0177]; Ong LY, 2014, J MED VIROL, V86, P38, DOI 10.1002/jmv.23772; Ng OT, 2011, AIDS RES HUM RETROV, V27, P1135, DOI [10.1089/aid.2010.0364, 10.1089/AID.2010.0364]; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Philpott S, 2005, J VIROL, V79, P353, DOI 10.1128/JVI.79.1.353-363.2005; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schierup MH, 2000, GENETICS, V156, P879; Shriner D, 2004, GENETICS, V156, P879; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Singapore Ministry of Health, 2012, HIV STAT UPD HIV AID; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2005, AIDS, V19, P119, DOI 10.1097/00002030-200501280-00003; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2008, AIDS, V22, P156, DOI 10.1097/QAD.0b013e3282f2d77a; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Worobey M, 2001, MOL BIOL EVOL, V18, P1425, DOI 10.1093/oxfordjournals.molbev.a003928; Zhao J, 2014, JAIDS-J ACQ IMM DEF, V66, pE65, DOI 10.1097/QAI.0000000000000144	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111236	10.1371/journal.pone.0111236	http://dx.doi.org/10.1371/journal.pone.0111236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340817	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800098
J	Cockerham, LR; Siliciano, JD; Sinclair, E; O'Doherty, U; Palmer, S; Yukl, SA; Strain, MC; Chomont, N; Hecht, FM; Siliciano, RF; Richman, DD; Deeks, SG				Cockerham, Leslie R.; Siliciano, Janet D.; Sinclair, Elizabeth; O'Doherty, Una; Palmer, Sarah; Yukl, Steven A.; Strain, Matt C.; Chomont, Nicolas; Hecht, Frederick M.; Siliciano, Robert F.; Richman, Douglas D.; Deeks, Steven G.			CD4(+) and CD8(+) T Cell Activation Are Associated with HIV DNA in Resting CD4(+) T Cells	PLOS ONE			English	Article							SUPPRESSIVE ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; VIRAL PERSISTENCE; INFECTED PATIENTS; RESERVOIR; SIZE; REPLICATION; INTEGRATION; LYMPHOCYTES; EXPRESSION	The association between the host immune environment and the size of the HIV reservoir during effective antiretroviral therapy is not clear. Progress has also been limited by the lack of a well-accepted assay for quantifying HIV during therapy. We examined the association between multiple measurements of HIV and T cell activation (as defined by markers including CD38, HLA-DR, CCR5 and PD-1) in 30 antiretroviral-treated HIV-infected adults. We found a consistent association between the frequency of CD4(+) and CD8(+) T cells expressing HLA-DR and the frequency of resting CD4(+) T cells containing HIV DNA. This study highlights the need to further examine this relationship and to better characterize the biology of markers commonly used in HIV studies. These results may also have implications for reactivation strategies.	[Cockerham, Leslie R.; Hecht, Frederick M.; Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Sinclair, Elizabeth] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [O'Doherty, Una] Univ Penn, Philadelphia, PA 19104 USA; [Palmer, Sarah] Westmead Millennium Inst Med Res, Westmead, NSW, Australia; [Palmer, Sarah] Univ Sydney, Sydney, NSW 2006, Australia; [Palmer, Sarah] Karolinska Inst, Stockholm, Sweden; [Yukl, Steven A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Strain, Matt C.; Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Richman, Douglas D.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Chomont, Nicolas] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Johns Hopkins University; University of California System; University of California San Francisco; University of Pennsylvania; University of Sydney; Karolinska Institutet; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Vaccine & Gene Therapy Institute of Florida; Howard Hughes Medical Institute; Johns Hopkins University	Cockerham, LR (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	leslie.cockerham@ucsf.edu	Chomont, Nicolas/ABG-2545-2020	Chomont, Nicolas/0000-0001-9747-5018; Deeks, Steven/0000-0001-6371-747X; Hecht, Frederick/0000-0002-5782-1171	ARCHE Collaborative Research Grant from the Foundation for AIDS Research [amFAR 108165-50-RGRL]; Martin Delaney CARE and DARE Collaboratories (NIH) [AI096113, 1U19AI096109]; NIH [43222]; Howard Hughes Medical Institute; Department of Veterans Affairs; James Pendleton Charitable Trust; National Institutes of Health [AI080193, AI74621, AI69432-S]; CFAR [AI306214]; Department of Veterans Affairs (VA Career Development Award) [1 IK2 CX000520-01]; NIAID [RO1AIO87145, K24AIO69994]; UCSF/Gladstone CFAR [P30 AIO27763]; UCSF Clinical and Translational Research Institute Clinical Research Center [UL 1 RR024131]; Center for AIDS Prevention Studies [P30 MH62246]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087145, U01AI069432, P01AI080193, P30AI027763, U19AI096113, P30AI045008, U19AI096109, P01AI074621, K24AI069994, P30AI036214, UM1AI069432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000520] Funding Source: NIH RePORTER	ARCHE Collaborative Research Grant from the Foundation for AIDS Research; Martin Delaney CARE and DARE Collaboratories (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Veterans Affairs(US Department of Veterans Affairs); James Pendleton Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFAR; Department of Veterans Affairs (VA Career Development Award)(US Department of Veterans Affairs); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCSF/Gladstone CFAR; UCSF Clinical and Translational Research Institute Clinical Research Center; Center for AIDS Prevention Studies; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by an ARCHE Collaborative Research Grant from the Foundation for AIDS Research (amFAR 108165-50-RGRL), by the Martin Delaney CARE and DARE Collaboratories (NIH grants AI096113 and 1U19AI096109), and by NIH grant 43222 (RFS), and by the Howard Hughes Medical Institute (RFS). For MCS and DDR, this work was supported by the Department of Veterans Affairs, the James Pendleton Charitable Trust, National Institutes of Health (AI080193, AI74621, AI69432-S), and CFAR grant AI306214. For SAY, this work was supported by the Department of Veterans Affairs (VA Career Development Award 1 IK2 CX000520-01). The UCSF SCOPE cohort was supported in part by the NIAID (RO1AIO87145, K24AIO69994), the UCSF/Gladstone CFAR (P30 AIO27763), the UCSF Clinical and Translational Research Institute Clinical Research Center (UL 1 RR024131) and the Center for AIDS Prevention Studies (P30 MH62246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hunt PW, 2011, CLIN INFECT DIS, V52, P681, DOI 10.1093/cid/ciq202; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Persaud D, 2011, AIDS, V25, P2227, DOI 10.1097/QAD.0b013e32834cdaba; Poizot-Martin I, 2013, J CLIN VIROL, V57, P351, DOI 10.1016/j.jcv.2013.04.007; PRINCE HE, 1992, CELL IMMUNOL, V145, P254, DOI 10.1016/0008-8749(92)90329-N; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shacklett Barbara L., 2009, V485, P347, DOI 10.1007/978-1-59745-170-3_23; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Steel A, 2007, ANTIVIR THER, V12, P971; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Trautmann L, 2012, BLOOD, V120, P3466, DOI 10.1182/blood-2012-04-422550; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; Yu JJQ, 2008, VIROLOGY, V379, P78, DOI 10.1016/j.virol.2008.05.030; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722	39	79	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110731	10.1371/journal.pone.0110731	http://dx.doi.org/10.1371/journal.pone.0110731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340755	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800051
J	Matsuo, R; Morihara, H; Mohri, T; Murasawa, S; Takewaki, K; Nakayama, H; Maeda, M; Fujio, Y				Matsuo, Reo; Morihara, Hirofumi; Mohri, Tomomi; Murasawa, Shiho; Takewaki, Kana; Nakayama, Hiroyuki; Maeda, Makiko; Fujio, Yasushi			The Inhibition of N-Glycosylation of Glycoprotein 130 Molecule Abolishes STAT3 Activation by IL-6 Family Cytokines in Cultured Cardiac Myocytes	PLOS ONE			English	Article							SIGNAL; GP130; IDENTIFICATION; EXPRESSION; RECEPTOR; TARGET	Interleukin-6 (IL-6) family cytokines play important roles in cardioprotection against pathological stresses. IL-6 cytokines bind to their specific receptors and activate glycoprotein 130 (gp130), a common receptor, followed by further activation of STAT3 and extracellular signal-regulated kinase (ERK)1/2 through janus kinases (JAKs); however the importance of glycosylation of gp130 remains to be elucidated in cardiac myocytes. In this study, we examined the biological significance of gp130 glycosylation using tunicamycin (Tm), an inhibitor of enzyme involved in N-linked glycosylation. In cardiomyocytes, the treatment with Tm completely replaced the glycosylated form of gp130 with its unglycosylated one. Tm treatment inhibited leukemia inhibitory factor (LIF)-mediated activation of STAT3 and ERK1/2. Similarly, IL-11 failed to activate STAT3 and ERK1/2 in the presence of Tm. Interestingly, Tm inhibited the activation of JAKs 1 and 2, without influencing the expression of suppressor of cytokine signalings (SOCSs) and protein-tyrosine phosphatase 1B (PTP1B), which are endogenous inhibitors of JAKs. To exclude the possibility that Tm blocks LIF and IL-11 signals by inhibiting the glycosylation of their specific receptors, we investigated whether the stimulation with IL-6 plus soluble IL-6 receptor (sIL-6R) could transduce their signals in Tm-treated cardiomyocytes and found that this stimulation was unable to activate the downstream signals. Collectively, these findings indicate that glycosylation of gp130 is essential for signal transduction of IL-6 family cytokines in cardiomyocytes.	[Matsuo, Reo; Morihara, Hirofumi; Mohri, Tomomi; Murasawa, Shiho; Takewaki, Kana; Nakayama, Hiroyuki; Maeda, Makiko; Fujio, Yasushi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Osaka University	Maeda, M (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan.	makikom@phs.osaka-u.ac.jp; fujio@phs.osaka-u.ac.jp	Fujio, Yasushi/H-3421-2017	Fujio, Yasushi/0000-0003-0828-2930	Japan society for the promotion of science; MEXT/JSPS KAKENHI [23390057, 26293054, 25860061, 22590160]	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid for scientific research from the Japan society for the promotion of science; YF, HN, MM. This study was supported by MEXT/JSPS KAKENHI Grant Numbers 23390057, 26293054, 25860061 and 22590160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; DORNER AJ, 1990, J BIOL CHEM, V265, P22029; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Fukuda S, 2010, DIABETES OBES METAB, V12, P299, DOI 10.1111/j.1463-1326.2009.01162.x; Funamoto M, 2003, J BIOL CHEM, V7, P10561; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Iwakura I, 2001, J MOL CELL CARDIOL, V51, P207; Kimura R, 2007, CYTOKINE, V38, P107, DOI 10.1016/j.cyto.2007.05.011; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Kunisada K, 1996, CIRCULATION, V94, P2626, DOI 10.1161/01.CIR.94.10.2626; Moritz RL, 2001, J BIOL CHEM, V276, P8244, DOI 10.1074/jbc.M009979200; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Waetzig GH, 2010, J BIOL CHEM, V285, P1781, DOI 10.1074/jbc.M109.075952; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; Yanagisawa M, 2009, BIOCHEM BIOPH RES CO, V386, P101, DOI 10.1016/j.bbrc.2009.05.132	19	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111097	10.1371/journal.pone.0111097	http://dx.doi.org/10.1371/journal.pone.0111097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340554	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800085
J	Phillips, O; Squitieri, F; Sanchez-Castaneda, C; Elifani, F; Caltagirone, C; Sabatini, U; Di Paola, M				Phillips, Owen; Squitieri, Ferdinando; Sanchez-Castaneda, Cristina; Elifani, Francesca; Caltagirone, Carlo; Sabatini, Umberto; Di Paola, Margherita			Deep White Matter in Huntington's Disease	PLOS ONE			English	Article							CORPUS-CALLOSUM; LONGITUDINAL FASCICLE; MAGNETIC-RESONANCE; HUMAN BRAIN; LIFE-SPAN; IN-VIVO; MRI; MYELIN; PATHOGENESIS; CONNECTIONS	White matter (WM) abnormalities have already been shown in presymptomatic (Pre-HD) and symptomatic HD subjects using Magnetic Resonance Imaging (MRI). In the present study, we examined the microstructure of the long-range large deep WM tracts by applying two different MRI approaches: Diffusion Tensor Imaging (DTI) -based tractography, and T2*weighted (iron sensitive) imaging. We collected Pre-HD subjects (n = 25), HD patients (n = 25) and healthy control subjects (n = 50). Results revealed increased axial (AD) and radial diffusivity (RD) and iron levels in Pre-HD subjects compared to controls. Fractional anisotropy decreased between the Pre-HD and HD phase and AD/RD increased and although impairment was pervasive in HD, degeneration occurred in a pattern in Pre-HD. Furthermore, iron levels dropped for HD patients. As increased iron levels are associated with remyelination, the data suggests that Pre-HD subjects attempt to repair damaged deep WM years before symptoms occur but this process fails with disease progression.	[Phillips, Owen; Caltagirone, Carlo; Di Paola, Margherita] IRCCS Santa Lucia Fdn, Clin & Behav Neurol Dept, Rome, Italy; [Squitieri, Ferdinando; Elifani, Francesca] IRCSS Neuromed, Pozzilli, Italy; [Sanchez-Castaneda, Cristina; Sabatini, Umberto] IRCCS Santa Lucia Fdn, Dept Radiol, Rome, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	IRCCS Santa Lucia; IRCCS Neuromed; IRCCS Santa Lucia; University of Rome Tor Vergata	Squitieri, F (corresponding author), IRCSS Neuromed, Pozzilli, Italy.	ferdinando.squitieri@lirh.it; m.dipaola@hsantalucia.it	Sabatini, Umberto/K-4659-2016; Sanchez-Castañeda, Cristina/J-2303-2015; Elifani, Francesca/AAE-2509-2020; phillips, owen/J-3651-2017; Squitieri, Ferdinando/N-1852-2019	Sabatini, Umberto/0000-0001-5321-8626; Sanchez-Castañeda, Cristina/0000-0002-6827-9146; Elifani, Francesca/0000-0002-0824-9543; phillips, owen/0000-0002-5391-707X; Squitieri, Ferdinando/0000-0002-7397-1727	Italian Ministry of Health [204/GR-2009-1606835]; European Commission: Marie Curie Fellowship; Italian Ministry of Health (Ricerca Corrente); European Huntington's Disease Network; Italian League for Huntington and related diseases onlus	Italian Ministry of Health(Ministry of Health, Italy); European Commission: Marie Curie Fellowship; Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); European Huntington's Disease Network; Italian League for Huntington and related diseases onlus	This work was supported by the Italian Ministry of Health grant 204/GR-2009-1606835. Also, support was provided by the European Commission: Marie Curie Fellowship for career development to CS (FP7-PEOPLE-2011-IEF). The authors are grateful for the support they received from the Italian Ministry of Health (Ricerca Corrente), European Huntington's Disease Network for the Registry Study, by the "Italian League for Huntington and related diseases onlus (www.lirh.it)" to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to all patients for contributing to the work.	Aylward EH, 1998, NEUROLOGY, V50, P252, DOI 10.1212/WNL.50.1.252; Bartzokis G, 2007, NEUROCHEM RES, V32, P1655, DOI 10.1007/s11064-007-9352-7; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; Bartzokis G, 2012, NEUROPHARMACOLOGY, V62, P2137, DOI 10.1016/j.neuropharm.2012.01.015; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Bohanna I, 2011, BRAIN IMAGING BEHAV, V5, P171, DOI 10.1007/s11682-011-9121-8; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Cherubini A, 2009, MAGN RESON MED, V61, P1066, DOI 10.1002/mrm.21978; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Di Paola M, 2014, HUM BRAIN MAPP, V35, P3143, DOI 10.1002/hbm.22391; Di Paola M, 2012, CEREB CORTEX, V22, P2858, DOI 10.1093/cercor/bhr360; Di Paola M, 2010, NEUROIMAGE, V49, P141, DOI 10.1016/j.neuroimage.2009.07.050; Dick A. S., 2013, NEUROSCIENTIST; Dumas EM, 2012, HUM BRAIN MAPP, V33, P203, DOI 10.1002/hbm.21205; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Esmaeilzadeh M, 2011, CNS NEUROSCI THER, V17, P368, DOI 10.1111/j.1755-5949.2010.00157.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomez-Tortosa E, 2001, ANN NEUROL, V49, P29, DOI 10.1002/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Hasan KM, 2007, NEUROREPORT, V18, P1735, DOI 10.1097/WNR.0b013e3282f0d40c; Jones DK, 2012, NEUROIMAGE; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Makris N, 2013, BRAIN STRUCT FUNCT, V218, P951, DOI 10.1007/s00429-012-0441-2; Marrakchi-Kacem L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053135; Matsui J.T., 2013, HUM BRAIN MAPP; Muthusami P, 2013, J MAGN RESON IMAGING; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; Nopoulos PC, 2010, NEUROBIOL DIS, V40, P544, DOI 10.1016/j.nbd.2010.07.014; Novak MJ, 2013, CORTEX; Paulsen JS, 2006, BIOL PSYCHIAT, V59, P57, DOI 10.1016/j.biopsych.2005.06.003; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Peran P, 2007, J MAGN RESON IMAGING, V26, P1413, DOI 10.1002/jmri.21204; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Phillips O, 2014, CEREB CORTEX; Phillips O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073280; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Phillips OR, 2011, BIOL PSYCHIAT, V70, P680, DOI 10.1016/j.biopsych.2011.03.039; Ravera S, 2009, INT J BIOCHEM CELL B, V41, P1581, DOI 10.1016/j.biocel.2009.01.009; Rosas HD, 2010, NEUROIMAGE, V49, P2995, DOI 10.1016/j.neuroimage.2009.10.015; Schmahmann J. D., 2006, FIBER PATHWAYS BRAIN, V18; Schmierer K, 2008, MAGN RESON MED, V59, P268, DOI 10.1002/mrm.21487; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; Squitieri F, 2009, CNS NEUROSCI THER, V15, P1, DOI 10.1111/j.1755-5949.2008.00068.x; Takahashi M, 2000, RADIOLOGY, V216, P881, DOI 10.1148/radiology.216.3.r00se41881; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Xiang ZM, 2011, J NEUROSCI, V31, P9544, DOI 10.1523/JNEUROSCI.1291-11.2011; Zoppelt D, 2003, NEUROPSYCHOLOGIA, V41, P1160, DOI 10.1016/S0028-3932(03)00019-8	51	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109676	10.1371/journal.pone.0109676	http://dx.doi.org/10.1371/journal.pone.0109676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340651	gold, Green Submitted, Green Published			2022-12-26	WOS:000343662800014
J	Van den Heuvel, F				Van den Heuvel, Frank			A Closed Parameterization of DNA-Damage by Charged Particles, as a Function of Energy - A Geometrical Approach	PLOS ONE			English	Article							MONTE-CARLO-SIMULATION; PROTON-BEAM; ELECTRONS; SOLIDS; MODEL	Purpose: To present a closed formalism calculating charged particle radiation damage induced in DNA. The formalism is valid for all types of charged particles and due to its closed nature is suited to provide fast conversion of dose to DNA-damage. Methods: The induction of double strand breaks in DNA-strings residing in irradiated cells is quantified using a single particle model. This leads to a proposal to use the cumulative Cauchy distribution to express the mix of high and low LET type damage probability generated by a single particle. A microscopic phenomenological Monte Carlo code is used to fit the parameters of the model as a function of kinetic energy related to the damage to a DNA molecule embedded in a cell. The model is applied for four particles: electrons, protons, alpha-particles, and carbon ions. A geometric interpretation of this observation using the impact ionization mean free path as a quantifier, allows extension of the model to very low energies. Results: The mathematical expression describes the model adequately using a chi-square test (chi(2)/NDF<1). This applies to all particle types with an almost perfect fit for protons, while the other particles seem to result in some discrepancies at very low energies. The implementation calculating a strict version of the RBE based on complex damage alone is corroborated by experimental data from the measured RBE. The geometric interpretation generates a unique dimensionless parameter k for each type of charged particle. In addition, it predicts a distribution of DNA damage which is different from the current models.	[Van den Heuvel, Frank] Univ Oxford, Dept Oncol, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England; [Van den Heuvel, Frank] Univ Leuven, Dept Oncol, Lab Expt Radiotherapy, Leuven, Belgium	University of Oxford; KU Leuven	Van den Heuvel, F (corresponding author), Univ Oxford, Dept Oncol, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England.	frank.vandenheuvel@oncology.ox.ac.uk	Van den Heuvel, Frank/CAE-9338-2022; Van den Heuvel, Frank/GOK-2337-2022	Van den Heuvel, Frank/0000-0001-9904-502X; Van den Heuvel, Frank/0000-0001-9904-502X				[Anonymous], CR ACAD SCI PARIS; BARKAS WH, 1963, PHYS REV LETT, V11, P26, DOI 10.1103/PhysRevLett.11.26; Bethe H, 1930, ANN PHYS, V5; Breit G, 1959, HDB PHYS, VXLI/1; BRENNER DJ, 1992, INT J RADIAT BIOL, V61, P737, DOI 10.1080/09553009214551591; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chaudhary P, 2014, INT J RADIAT ONCOL, V90, P27, DOI 10.1016/j.ijrobp.2014.05.010; Cucinotta FA, 2000, RADIAT RES, V153, P459, DOI 10.1667/0033-7587(2000)153[0459:MFRDOF]2.0.CO;2; Goitein M, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-0-387-72645-8; Hall E.J, 1978, RADIOBIOLOGY RADIOLO, V1st; Hsiao Y, 2008, PHYS MED BIOL, V53, P233, DOI 10.1088/0031-9155/53/1/016; ICRU International Commission on Radiation Units and Measurements, 1970, 16 ICRU; ICRU International Commission on Radiation Units and Measurements, 1983, 36 ICRU; ICRU International Commission on Radiation Units and Measurements, 1971, 19 ICRU; Katz R, 2003, RADIAT RES, V160, P724, DOI 10.1667/RR3088; Kavanagh JN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01770; Kramer M, 2006, PHYS MED BIOL, V51, P1959, DOI 10.1088/0031-9155/51/8/001; Nikjoo H, 1997, INT J RADIAT BIOL, V71, P467, DOI 10.1080/095530097143798; Paganetti H, 2002, INT J RADIAT ONCOL, V53, P407, DOI 10.1016/S0360-3016(02)02754-2; Paganetti H, 2001, INT J RADIAT BIOL, V77, P911, DOI 10.1080/0953000110066059; Powell C. J., 2010, NIST ELECT INELASTIC; Sato T, 2009, RADIAT RES, V171, P107, DOI 10.1667/RR1510.1; Semenenko VA, 2006, PHYS MED BIOL, V51, P1693, DOI 10.1088/0031-9155/51/7/004; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Stewart RD, 2011, RADIAT RES, V176, P587, DOI 10.1667/RR2663.1; Tanuma S, 2005, SURF INTERFACE ANAL, V37, P1, DOI 10.1002/sia.1997; Van den Heuvel F, 2010, PHYS MED BIOL, V55, P4509, DOI 10.1088/0031-9155/55/16/S06; WARD JF, 1985, RADIAT RES, V104, pS103, DOI 10.2307/3576637; Waters LS, 2007, AIP CONF PROC, V896, P81, DOI 10.1063/1.2720459; Zhen-Yu T, 2010, CHINESE PHYS LETT, V27; Ziaja B, 2006, J APPL PHYS, V99, DOI 10.1063/1.2161821	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110333	10.1371/journal.pone.0110333	http://dx.doi.org/10.1371/journal.pone.0110333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340636	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800031
J	Xiang, Z; Wang, S; Xiang, Y				Xiang, Zheng; Wang, Sen; Xiang, Yao			Up-Regulated MicroRNA499a by Hepatitis B Virus Induced Hepatocellular Carcinogenesis via Targeting MAPK6	PLOS ONE			English	Article							KINASES; ASSOCIATIONS; ACTIVATION; CARCINOMA; MIR-499; RISK; ERK3	Emerging evidence showed miR499a could not only function as an oncogene but also as a tumor suppressor in various types of cancer, such as melanoma. However, whether miR499a was involved in hepatocarcinogenesis remains unknown. We previously reported that miR499a was up-regulated in HBV-mediated hepatocellular carcinoma (HCC). In this study, we found that HBV could induce the expression of miR499a by promoting its promoter activity. In addition, we reported that miR499a increased cell proliferation and cell migration of HCC cells. MAPK6 was further identified as a target of miR499a, which could also be down-regulated by HBV. Moreover, we demonstrated that MAPK6 could rescue the cell growth induced by miR499a and HBV. These findings indicated that miR499a might play an oncogene role by targeting MAPK6 in the development and progression of HBV-related HCC.	[Xiang, Zheng; Xiang, Yao] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing, Peoples R China; [Xiang, Zheng; Xiang, Yao] Chongqing Med Univ, Dept Gen Surg, Chongqing Key Lab, Chongqing, Peoples R China; [Wang, Sen] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xiang, Z (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing, Peoples R China.	13330209937@163.com			Natural Science Foundation Project of CQ CSTC [cstc2012gg-yyjs0644]	Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by Natural Science Foundation Project of CQ CSTC (cstc2012gg-yyjs0644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuthnot P, 2001, INT J EXP PATHOL, V82, P77, DOI 10.1111/j.1365-2613.2001.iep178.x; BEASLEY RP, 1981, LANCET, V2, P1129; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Du W, 2014, ASIAN PAC J CANCER P, V15, P1047, DOI 10.7314/APJCP.2014.15.2.1047; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Kostenko Sergiy, 2012, J Mol Signal, V7, P9, DOI 10.1186/1750-2187-7-9; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai CL, 2008, NEW ENGL J MED, V359, P2488, DOI 10.1056/NEJMe0808185; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li M, 2014, ONCOL REP, V31, P1961, DOI 10.3892/or.2014.3029; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074504; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Olivieri F, 2014, INT J CARDIOL, V172, pE276, DOI 10.1016/j.ijcard.2013.12.203; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Wang ZX, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/719202; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243	24	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111410	10.1371/journal.pone.0111410	http://dx.doi.org/10.1371/journal.pone.0111410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340781	gold, Green Submitted, Green Published			2022-12-26	WOS:000343662800107
J	Komatsu, Y; Christian, SL; Ho, N; Pongnopparat, T; Licursi, M; Hirasawa, K				Komatsu, Y.; Christian, S. L.; Ho, N.; Pongnopparat, T.; Licursi, M.; Hirasawa, K.			Oncogenic Ras inhibits IRF1 to promote viral oncolysis	ONCOGENE			English	Article							INTERFERON-ALPHA RESISTANCE; TRANSCRIPTION FACTOR; MESSENGER-RNA; ANTIVIRAL RESPONSE; SIGNALING PATHWAY; CANCER-THERAPY; CONSTITUTIVE EXPRESSION; INDUCIBLE GENES; MEASLES-VIRUS; IFN-BETA	Oncolytic viruses exploit common molecular changes in cancer cells, which are not present in normal cells, to target and kill cancer cells. Ras transformation and defects in type I interferon (IFN)-mediated antiviral responses are known to be the major mechanisms underlying viral oncolysis. Previously, we demonstrated that oncogenic RAS/Mitogen-activated protein kinase kinase (Ras/MEK) activation suppresses the transcription of many IFN-inducible genes in human cancer cells, suggesting that Ras transformation underlies type I IFN defects in cancer cells. Here, we investigated how Ras/MEK downregulates IFN-induced transcription. By conducting promoter deletion analysis of IFN-inducible genes, namely guanylate-binding protein 2 and IFN gamma inducible protein 47 (Ifi47), we identified the IFN regulatory factor 1 (IRF1) binding site as the promoter region responsible for the regulation of transcription by MEK. MEK inhibition promoted transcription of the IFN-inducible genes in wild type mouse embryonic fibroblasts (MEFs), but not in IRF1(-/-) MEFs, showing that IRF1 is involved in MEK-mediated downregulation of IFN-inducible genes. Furthermore, IRF1 protein expression was lower in RasV12 cells compared with vector control NIH3T3 cells, but was restored to equivalent levels by inhibition of MEK. Similarly, the restoration of IRF1 expression by MEK inhibition was observed in human cancer cells. IRF1 re-expression in human cancer cells caused cells to become resistant to infection by the oncolytic vesicular stomatitis virus strain. Together, this work demonstrates that Ras/MEK activation in cancer cells downregulates transcription of IFN-inducible genes by targeting IRF1 expression, resulting in increased susceptibility to viral oncolysis.	[Komatsu, Y.; Ho, N.; Pongnopparat, T.; Licursi, M.; Hirasawa, K.] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF A1B 3V6, Canada; [Christian, S. L.] Mem Univ Newfoundland, Fac Med, Dept Biochem, St John, NF A1B 3V6, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Hirasawa, K (corresponding author), Mem Univ Newfoundland, Fac Med, Div Biomed Sci, 300 Prince Philip Dr, St John, NF A1B 3V6, Canada.	kensuke@mun.ca		Christian, Sherri/0000-0002-4289-4386	Canadian Institutes for Health Research (CIHR); Regional Development Corporation of Newfoundland and Labrador (RDC); Canadian Breast Cancer Foundation (CBCF); Beatrice Hunter Cancer Research Institute; Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Regional Development Corporation of Newfoundland and Labrador (RDC); Canadian Breast Cancer Foundation (CBCF); Beatrice Hunter Cancer Research Institute; Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	This work was supported by grants (to KH) from the Canadian Institutes for Health Research (CIHR), the Regional Development Corporation of Newfoundland and Labrador (RDC) and Canadian Breast Cancer Foundation (CBCF). SLC was supported by a post-doctoral award from CIHR and RDC and a separate trainee award from the Beatrice Hunter Cancer Research Institute with funds provided by the Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR. Special thanks to Dr John Bell (Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada) for VSV and VSVM51R, and Nebiur E A for graphic design. We thank Susan Wakeham and Rahul-dev Kalsi for technical support.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Battcock SA, 2006, J VIROL, V80, P4422, DOI 10.1128/JVI.80.9.4422-4430.2006; Bell J, 2010, MOL THER, V18, P233, DOI 10.1038/mt.2009.314; Bergmann M, 2001, CANCER RES, V61, P8188; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Cascallo M, 2003, CANCER RES, V63, P5544; Christian SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044267; Christian SL, 2009, J VIROL, V83, P6717, DOI 10.1128/JVI.02213-08; Doherty GM, 2001, ANN SURG, V233, P623, DOI 10.1097/00000658-200105000-00005; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farassati F, 2001, NAT CELL BIOL, V3, P745, DOI 10.1038/35087061; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Goetz C, 2010, MOL THER, V18, P1937, DOI 10.1038/mt.2010.145; GOLDSTEIN D, 1986, CANCER RES, V46, P4315; Iankov I, 2014, MOL THER, V22, pS12; Kanazawa N, 2004, J VIROL, V78, P9713, DOI 10.1128/JVI.78.18.9713-9720.2004; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; Kurokawa C, 2014, MOL THER, V22, pS248; Landolfo S, 2000, Hematol J, V1, P7, DOI 10.1038/sj.thj.6200004; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058489; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Moriyama Y, 2001, CLIN CANCER RES, V7, P1293; Nguyen TLA, 2008, P NATL ACAD SCI USA, V105, P14981, DOI 10.1073/pnas.0803988105; Norman KL, 2005, DRUG DISCOV TODAY, V10, P847, DOI 10.1016/S1359-6446(05)03483-5; Noser JA, 2007, MOL THER, V15, P1531, DOI 10.1038/sj.mt.6300193; Phillips A, 2008, ONCOGENE, V27, P1645, DOI 10.1038/sj.onc.1210785; PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Puhlmann J, 2010, ONCOGENE, V29, P2205, DOI 10.1038/onc.2009.507; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Shang D, 2007, CANCER SCI, V98, P1259, DOI 10.1111/j.1349-7006.2007.00526.x; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Sun WH, 1998, BLOOD, V91, P570, DOI 10.1182/blood.V91.2.570.570_570_576; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156	50	24	24	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	30					3985	3993		10.1038/onc.2014.331	http://dx.doi.org/10.1038/onc.2014.331			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN6KR	25347735				2022-12-26	WOS:000358544200011
J	Lacek, K; Urbanowicz, RA; Troise, F; De Lorenzo, C; Severino, V; Di Maro, A; Tarr, AW; Ferrara, F; Ploss, A; Temperton, N; Ball, JK; Nicosia, A; Cortese, R; Pessi, A				Lacek, Krzysztof; Urbanowicz, Richard A.; Troise, Fulvia; De Lorenzo, Claudia; Severino, Valeria; Di Maro, Antimo; Tarr, Alexander W.; Ferrara, Francesca; Ploss, Alexander; Temperton, Nigel; Ball, Jonathan K.; Nicosia, Alfredo; Cortese, Riccardo; Pessi, Antonello			Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Cholesterol; Human Immunodeficiency Virus (HIV); Lipid Raft; Membrane Fusion; Molecular Evolution; Viral Immunology; Virus Entry	IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; SITE-SPECIFIC CONJUGATION; MEMBRANE-PROXIMAL REGION; INFLUENZA HEMAGGLUTININ; FUSION PORE; NEUTRALIZING ANTIBODIES; ENTRY INHIBITORS; GP41 EPITOPE; LIPID RAFTS	Background: Some HIV-neutralizing antibodies have an antigen-binding site with dual specificity, for the plasma membrane and a viral epitope. Results: We engineered membrane affinity outside the antigen-binding site by conjugating cholesterol, with concomitantly increased antiviral potency. Conclusion: A natural mechanism dependent on affinity maturation is mimicked by conjugation of a lipid. Significance: This is a general strategy to boost the potency of antiviral antibodies. The broadly neutralizing antibodies HIV 2F5 and 4E10, which bind to overlapping epitopes in the membrane-proximal external region of the fusion protein gp41, have been proposed to use a two-step mechanism for neutralization; first, they bind and preconcentrate at the viral membrane through their long, hydrophobic CDRH3 loops, and second, they form a high affinity complex with the protein epitope. Accordingly, mutagenesis of the CDRH3 can abolish their neutralizing activity, with no change in the affinity for the peptide epitope. We show here that we can mimic this mechanism by conjugating a cholesterol group outside of the paratope of an antibody. Cholesterol-conjugated antibodies bind to lipid raft domains on the membrane, and because of this enrichment, they show increased antiviral potency. In particular, we find that cholesterol conjugation (i) rescues the antiviral activity of CDRH3-mutated 2F5, (ii) increases the antiviral activity of WT 2F5, (iii) potentiates the non-membrane-binding HIV antibody D5 10-100-fold (depending on the virus strain), and (iv) increases synergy between 2F5 and D5. Conjugation can be made at several positions, including variable and constant domains. Cholesterol conjugation therefore appears to be a general strategy to boost the potency of antiviral antibodies, and, because membrane affinity is engineered outside of the antibody paratope, it can complement affinity maturation strategies.	[Lacek, Krzysztof; Troise, Fulvia; De Lorenzo, Claudia; Nicosia, Alfredo; Cortese, Riccardo; Pessi, Antonello] Ceinge Biotecnol Avanzate SCRL, I-80145 Naples, NA, Italy; [Lacek, Krzysztof] Univ Gdansk, Lab Virus Mol Biol, PL-80822 Gdansk, Poland; [Urbanowicz, Richard A.; Tarr, Alexander W.; Ball, Jonathan K.] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2UH, England; [Urbanowicz, Richard A.; Tarr, Alexander W.; Ball, Jonathan K.] Univ Nottingham, Queens Med Ctr, Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham NG7 2UH, England; [De Lorenzo, Claudia; Nicosia, Alfredo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, NA, Italy; [Severino, Valeria; Di Maro, Antimo] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, I-81100 Caserta, CE, Italy; [Ferrara, Francesca; Temperton, Nigel] Univ Kent, Sch Pharm, Infect Dis & Allergy Grp, Viral Pseudotype Unit, Chatham ME4 4TB, Kent, England; [Ploss, Alexander] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Pessi, Antonello] JV Bio, I-80145 Naples, NA, Italy	CEINGE Biotecnologie Avanzate; Fahrenheit Universities; University of Gdansk; University of Nottingham; University of Nottingham; University of Naples Federico II; Universita della Campania Vanvitelli; University of Kent; Princeton University	Pessi, A (corresponding author), JV Bio, Via Gaetano Salvatore 486, I-80145 Naples, NA, Italy.	a.pessi@jvbio.com	Tarr, Alexander W/B-7953-2008; Temperton, Nigel James/M-1164-2019; Ferrara, Francesca/I-3686-2014; Ploss, Alexander/ABG-2330-2020; Urbanowicz, Richard Antoni/M-3354-2019; Ball, Jonathan/HGU-3130-2022; Temperton, Nigel James/K-5158-2013	Tarr, Alexander W/0000-0003-1009-0823; Temperton, Nigel James/0000-0002-7978-3815; Ferrara, Francesca/0000-0002-4973-1520; Ploss, Alexander/0000-0001-9322-7252; Urbanowicz, Richard Antoni/0000-0002-2461-4993; Temperton, Nigel James/0000-0002-7978-3815; De Lorenzo, Claudia/0000-0002-6195-5631; ball, jonathan/0000-0001-5773-8733	National Science Centre [UMO-2012/04/A/NZ1/00056]; Ministry of Science and Higher Education [0330/IP1/2013/72]; Medical Research Council [G0801169]; MRC [G0801169] Funding Source: UKRI	National Science Centre(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Science Centre Grant UMO-2012/04/A/NZ1/00056 and Ministry of Science and Higher Education Grant 0330/IP1/2013/72 (to K. L.) and by Medical Research Council Grant G0801169 (to J. K. B. and R. A. U.).	Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Ashkenazi A, 2012, FASEB J, V26, P4628, DOI 10.1096/fj.12-215111; Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; Bentz J, 2000, BIOPHYS J, V78, P227, DOI 10.1016/S0006-3495(00)76587-8; Brown RJP, 2011, J VIROL, V85, P6024, DOI 10.1128/JVI.00131-11; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Francis JN, 2012, BIOCONJUGATE CHEM, V23, P1252, DOI 10.1021/bc300076f; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; He Y, 2007, PROTEINS, V69, P75, DOI 10.1002/prot.21478; Hrin R, 2008, AIDS RES HUM RETROV, V24, P1537, DOI 10.1089/aid.2008.0129; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Junutula JR, 2008, J IMMUNOL METHODS, V332, P41, DOI 10.1016/j.jim.2007.12.011; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lee KK, 2011, J BIOL CHEM, V286, P42141, DOI 10.1074/jbc.M111.254243; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Montgomery DL, 2009, MABS, V1, P462, DOI 10.4161/mabs.1.5.9214; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Ono A, 2005, ADV VIRUS RES, V64, P311, DOI 10.1016/S0065-3527(05)64010-9; Persic L, 1997, GENE, V187, P9, DOI 10.1016/S0378-1119(96)00628-2; Pessi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036833; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Santoprete A, 2011, J PEPT SCI, V17, P270, DOI 10.1002/psc.1328; SHARPLES.NE, 1966, BIOCHEMISTRY-US, V5, P2963, DOI 10.1021/bi00873a028; Stimmel JB, 2000, J BIOL CHEM, V275, P30445, DOI 10.1074/jbc.M001672200; Teruya K, 2010, PROTEIN J, V29, P493, DOI 10.1007/s10930-010-9278-9; Voynov V, 2010, BIOCONJUGATE CHEM, V21, P385, DOI 10.1021/bc900509s; Welsch JC, 2013, J VIROL, V87, P13785, DOI 10.1128/JVI.02436-13; Xu HY, 2010, J VIROL, V84, P1076, DOI 10.1128/JVI.02113-09; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zolot RS, 2013, NAT REV DRUG DISCOV, V12, P259, DOI 10.1038/nrd3980	53	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					35015	35028		10.1074/jbc.M114.591826	http://dx.doi.org/10.1074/jbc.M114.591826			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342747	hybrid, Green Published			2022-12-26	WOS:000346260800049
J	Wu, MV; Bikopoulos, G; Hung, S; Ceddia, RB				Wu, Michelle V.; Bikopoulos, George; Hung, Steven; Ceddia, Rolando B.			Thermogenic Capacity Is Antagonistically Regulated in Classical Brown and White Subcutaneous Fat Depots by High Fat Diet and Endurance Training in Rats IMPACT ON WHOLE-BODY ENERGY EXPENDITURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue Metabolism; AMP-activated Kinase (AMPK); Exercise; Obesity; Peroxisome Proliferator-activated Receptor Coactivator 1-(PGC-1a) (PPARGC1A); UCP-1; FNDC5; Irisin; Brown Adipocytes; ATGL	NERVOUS-SYSTEM ACTIVITY; MESSENGER-RNA EXPRESSION; ADIPOSE-TISSUE; SKELETAL-MUSCLE; COLD-EXPOSURE; EXHAUSTIVE EXERCISE; GENE-EXPRESSION; IRISIN; ADIPOCYTES; OBESITY	Background: Brown adipose tissue (BAT) is important for cold- and diet-induced thermogenesis. Results: Obesity and chronic exercise antagonistically regulate thermogenic capacity of BAT and subcutaneous white fat (SC WAT). Conclusion: Endurance exercise reduces thermogenic capacity in classical BAT while increasing it in the SC WAT. Significance: Browning of the SC WAT may be potentially used to treat obesity. This study investigated the regulation of thermogenic capacity in classical brown adipose tissue (BAT) and subcutaneous inguinal (SC Ing) white adipose tissue (WAT) and how it affects whole-body energy expenditure in sedentary and endurance-trained rats fed ad libitum either low fat or high fat (HF) diets. Analysis of tissue mass, PGC-1 and UCP-1 content, the presence of multilocular adipocytes, and palmitate oxidation revealed that a HF diet increased the thermogenic capacity of the interscapular and aortic brown adipose tissues, whereas exercise markedly suppressed it. Conversely, exercise induced browning of the SC Ing WAT. This effect was attenuated by a HF diet. Endurance training neither affected skeletal muscle FNDC5 content nor circulating irisin, but it increased FNDC5 content in SC Ing WAT. This suggests that locally produced FNDC5 rather than circulating irisin mediated the exercise-induced browning effect on this fat tissue. Importantly, despite reducing the thermogenic capacity of classical BAT, exercise increased whole-body energy expenditure during the dark cycle. Therefore, browning of subcutaneous WAT likely exerted a compensatory effect and raised whole-body energy expenditure in endurance-trained rats. Based on these novel findings, we propose that exercise-induced browning of the subcutaneous WAT provides an alternative mechanism that reduces thermogenic capacity in core areas and increases it in peripheral body regions. This could allow the organism to adjust its metabolic rate to accommodate diet-induced thermogenesis while simultaneously coping with the stress of chronically increased heat production through exercise.	[Wu, Michelle V.; Bikopoulos, George; Hung, Steven; Ceddia, Rolando B.] York Univ, Sch Kinesiol & Hlth Sci, Muscle Hlth Res Ctr, N York, ON M3J 1P3, Canada	York University - Canada	Ceddia, RB (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Muscle Hlth Res Ctr, 4700 Keele St, N York, ON M3J 1P3, Canada.	roceddia@yorku.ca			Natural Sciences and Engineering Research Council of Canada [311818-2011]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 311818-2011 (to R. B. C.).	Araujo RL, 2010, ENDOCRINOLOGY, V151, P3460, DOI 10.1210/en.2010-0026; ARNOLD J, 1987, J PHYSIOL-LONDON, V390, P45, DOI 10.1113/jphysiol.1987.sp016685; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brenmoehl J, 2014, INT J BIOL SCI, V10, P338, DOI 10.7150/ijbs.7972; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gaidhu MP, 2011, J LIPID RES, V52, P1702, DOI 10.1194/jlr.M015354; GOHIL K, 1984, BIOSCIENCE REP, V4, P987, DOI 10.1007/BF01116898; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; LANDSBERG L, 1981, LIFE SCI, V28, P1801, DOI 10.1016/0024-3205(81)90352-0; LARUEACHAGIOTIS C, 1995, PHYSIOL BEHAV, V57, P1013, DOI 10.1016/0031-9384(94)00005-P; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; PERONNET F, 1981, J APPL PHYSIOL, V51, P812, DOI 10.1152/jappl.1981.51.4.812; Pescatello LS, 2014, AM COLL SPORTS MED G, P162; RAPPAPORT EB, 1982, METABOLISM, V31, P143, DOI 10.1016/0026-0495(82)90126-3; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; SCHWARTZ JH, 1983, J CLIN INVEST, V72, P361, DOI 10.1172/JCI110976; Terblanche SE, 2001, COMP BIOCHEM PHYS A, V128, P889, DOI 10.1016/S1095-6433(00)00344-5; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitzel KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062190; Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022; WINDER WW, 1978, J APPL PHYSIOL, V45, P370, DOI 10.1152/jappl.1978.45.3.370; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; YAMASHITA H, 1993, INT J BIOMETEOROL, V37, P61, DOI 10.1007/BF01212769; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541; YOUNG JB, 1983, AM J PHYSIOL, V245, pE148, DOI 10.1152/ajpendo.1983.245.2.E148; Zhang YY, 2014, J BIOL CHEM, V289, P22063, DOI 10.1074/jbc.M114.559104	45	120	127	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34129	34140		10.1074/jbc.M114.591008	http://dx.doi.org/10.1074/jbc.M114.591008			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25344623	hybrid, Green Published			2022-12-26	WOS:000346077600037
J	Koo, HK; Park, JH; Park, HK; Jung, H; Lee, SS				Koo, Hyeon-Kyoung; Park, Joo-Hyun; Park, Hye Kyeong; Jung, Hoon; Lee, Sung-Soon			Conflicting Role of Sarcopenia and Obesity in Male Patients with Chronic Obstructive Pulmonary Disease: Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							BODY-MASS INDEX; PROGNOSTIC VALUE; COPD; PREVALENCE; DYSPNEA	Objective: To determine the impact of sarcopenia and obesity on pulmonary function and quality of life (QOL) in chronic obstructive pulmonary disease (COPD) patients. Research Design and Methods: Data were obtained from the Korea National Health and Nutrition Examination Survey, including data from health interviews, health examinations, nutritional questionnaires, and laboratory findings. Laboratory data included pulmonary function assessment and dual energy X-ray absorptiometry results. Sarcopenia was measured by dual energy X-ray absorptiometry, and obesity was defined by body mass index. Male COPD patients were then classified into 4 groups according to the presence of sarcopenia and obesity. Results: In male patients with COPD, the prevalence of sarcopenia was found to be 29.3%, and that of sarcopenic obesity was 14.2%. Furthermore, 22.5% of the patients observed in this study had impaired QOL. Following multivariable statistical analysis, both sarcopenia and obesity were independent risk factors for worsening lung function. Adjusted values of forced vital capacity and forced expiratory volume in 1 second were the lowest in the sarcopenic obesity group. Sarcopenia was also associated with more subjective activity limitation and poorer QOL; however obesity was related to less subjective limitation and better QOL after multivariable analysis. Adjusted value of QOL was the lowest in sarcopenic subjects without obesity, and the highest in obese subject without sarcopenia. Conclusions: Both sarcopenia and obesity were found to be associated with worsening lung function in male COPD patients. However, obesity was positively correlated with improved QOL while sarcopenia was negatively correlated with QQL.	[Koo, Hyeon-Kyoung; Park, Joo-Hyun; Park, Hye Kyeong; Jung, Hoon; Lee, Sung-Soon] Inje Univ, Coll Med, Ilsan Paik Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Goyang, South Korea	Inje University	Lee, SS (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Goyang, South Korea.	LeeSS@paik.ac.kr						[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Chin SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060119; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Ferrer M, 1997, ANN INTERN MED, V127, P1072, DOI 10.7326/0003-4819-127-12-199712150-00003; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Ischaki E, 2007, CHEST, V132, P164, DOI 10.1378/chest.06-2789; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kim JH, 2010, ANN GERIATR MED RES, V14, P121, DOI 10.4235/jkgs.2010.14.3.121; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Miravitlles M, 2005, RESP MED, V99, P985, DOI 10.1016/j.rmed.2005.01.012; Prescott E, 2002, EUR RESPIR J, V20, P539, DOI 10.1183/09031936.02.00532002; Roisin RR, 2011, GLOBAL STRATEGY DIAG; SAHEBJAMI H, 1993, AM J MED, V94, P469, DOI 10.1016/0002-9343(93)90080-9; Wilke S, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-98; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wust Rob C I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P289	23	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110448	10.1371/journal.pone.0110448	http://dx.doi.org/10.1371/journal.pone.0110448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353344	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200026
J	Nilsson, OB; Neimert-Andersson, T; Bronge, M; Grundstrom, J; Sarma, R; Uchtenhagen, H; Kikhney, A; Sandalova, T; Holmgren, E; Svergun, D; Achour, A; van Hage, M; Gronlund, H				Nilsson, Ola B.; Neimert-Andersson, Theresa; Bronge, Mattias; Grundstrom, Jeanette; Sarma, Ranjana; Uchtenhagen, Hannes; Kikhney, Alexey; Sandalova, Tatyana; Holmgren, Erik; Svergun, Dmitri; Achour, Adnane; van Hage, Marianne; Gronlund, Hans			Designing a Multimer Allergen for Diagnosis and Immunotherapy of Dog Allergic Patients	PLOS ONE			English	Article							CARBOHYDRATE-BASED PARTICLES; IMMUNOLOGICAL CHARACTERIZATION; LIPOCALIN ALLERGEN; CROSS-REACTIVITY; CAT; SCATTERING; ASTHMA; DANDER; INFLAMMATION; PROTEINS	Background: Dog dander extract used for diagnosis and allergen-specific immunotherapy is often of variable and of poor quality. Objective: To assemble four well-established dog allergen components into one recombinant folded protein for improved diagnosis and vaccination of allergy to dog. Methods: A linked molecule, comprising the four dog lipocalin allergens Can f 1, Can f 2, Can f 4 and Can f 6 was constructed. The tetrameric protein was structurally characterized by small angle X-ray scattering, and compared with each single recombinant lipocalin allergen or an equimolar mix of the four allergens by analytical size exclusion chromatography, circular dichroism, allergen-specific IgE in serum by ELISA and allergen-dependent capacity to activate basophils. The immunogenicity of the fusion protein was evaluated in immunized mice by assessing splenocyte proliferation and antibody production. Results: The linked tetrameric construct was produced as a soluble fusion protein, with the specific folds of the four individual allergens conserved. This multi-allergen molecule was significantly more efficient (p < 0.001) than each single recombinant allergen in binding to dog-specific IgE, and the epitope spectrum was unaffected compared to an equimolar mix of the four allergens. Basophil degranulation revealed that the biologic activity of the linked molecule was retained. Immunization of mice with the linked construct induced comparable allergen-specific IgG responses with blocking capacity towards all included allergens and generated comparably low T-cell responses. Conclusion: We provide the first evidence for a linked recombinant molecule covering the major dog allergens for potential use in diagnostics and allergy vaccination of dog allergic patients.	[Nilsson, Ola B.; Grundstrom, Jeanette; Holmgren, Erik; van Hage, Marianne] Karolinska Inst, Clin Immunol & Allergy Unit, Dept Med, Stockholm, Sweden; [Nilsson, Ola B.] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [Neimert-Andersson, Theresa; Bronge, Mattias; Holmgren, Erik; Gronlund, Hans] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design Unit, Stockholm, Sweden; [Sarma, Ranjana; Uchtenhagen, Hannes; Sandalova, Tatyana; Achour, Adnane] Karolinska Inst, Dept Med Solna, Sci Life Lab, Stockholm, Sweden; [Kikhney, Alexey; Svergun, Dmitri] DESY, European Mol Biol Lab EMBL Hamburg Outstn, Hamburg, Germany	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska Institutet; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Gronlund, H (corresponding author), Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design Unit, Stockholm, Sweden.	hans.gronlund@ki.se	van Hage, Marianne/A-9678-2017	van Hage, Marianne/0000-0003-3091-1596; Bronge, Mattias/0000-0002-1258-3982; Sandalova, Tatyana/0000-0002-7694-6420; Holmgren, Erik/0000-0002-2656-1864; Svergun, Dmitri/0000-0003-0830-5696; Gronlund, Hans/0000-0003-4882-7624; Achour, Adnane/0000-0003-0432-710X	Erling-Persson Family Foundation; Swedish Asthma and Allergy Association's Research Foundation; Cancer and Allergy Foundation; Konsul Th C Bergh Foundation; Hesselman Foundation; Swedish Research Council; Swedish Heart-Lung Foundation; Stockholm County Council; Centre for Allergy Research; European Commission (the 7th Framework Program) BioStruct-X project [283570]; Karolinska Institutet	Erling-Persson Family Foundation; Swedish Asthma and Allergy Association's Research Foundation; Cancer and Allergy Foundation; Konsul Th C Bergh Foundation; Hesselman Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Centre for Allergy Research; European Commission (the 7th Framework Program) BioStruct-X project; Karolinska Institutet(Karolinska Institutet)	This research was funded by grants from the Erling-Persson Family Foundation, the Swedish Asthma and Allergy Association's Research Foundation, the Cancer and Allergy Foundation, the Konsul Th C Bergh Foundation, the Hesselman Foundation, the Swedish Research Council, the Swedish Heart-Lung Foundation, the Stockholm County Council, the Centre for Allergy Research, the European Commission (the 7th Framework Program) BioStruct-X project (contract number 283570) and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse R, 2011, ALLERGY, V66, P28, DOI 10.1111/j.1398-9995.2011.02628.x; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Blanchet CE, 2012, J APPL CRYSTALLOGR, V45, P489, DOI 10.1107/S0021889812013490; Burks AW, 2013, J ALLERGY CLIN IMMUN, V131, P1288, DOI 10.1016/j.jaci.2013.01.049; Curin M, 2011, INT ARCH ALLERGY IMM, V154, P258, DOI 10.1159/000321113; Flower DR, 1996, BIOCHEM J, V318, P1; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Gronlund H, 2008, CLIN EXP ALLERGY, V38, P1275, DOI 10.1111/j.1365-2222.2008.03003.x; Gronlund H, 2002, IMMUNOLOGY, V107, P523, DOI 10.1046/j.1365-2567.2002.01535.x; HEDLIN G, 1991, J ALLERGY CLIN IMMUN, V87, P955, DOI 10.1016/0091-6749(91)90417-M; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Konieczny A, 1997, IMMUNOLOGY, V92, P577, DOI 10.1046/j.1365-2567.1997.00386.x; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Ling M, 2010, ALLERGY ASTHMA PROC, V31, P385, DOI 10.2500/aap.2010.31.3390; Linhart B, 2012, CURR OPIN IMMUNOL, V24, P354, DOI 10.1016/j.coi.2012.03.006; Madhurantakam C, 2010, J MOL BIOL, V401, P68, DOI 10.1016/j.jmb.2010.05.043; Mattsson L, 2010, CLIN EXP ALLERGY, V40, P1276, DOI 10.1111/j.1365-2222.2010.03533.x; Neimert-Andersson T, 2008, ALLERGY, V63, P518, DOI 10.1111/j.1398-9995.2008.01644.x; Nilsson OB, 2012, ALLERGY, V67, P751, DOI 10.1111/j.1398-9995.2012.02826.x; Nilsson OB, 2014, METHODS, V66, P86, DOI 10.1016/j.ymeth.2013.09.002; Nilsson OB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024558; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Saarelainen S, 2008, CLIN EXP ALLERGY, V38, P374, DOI 10.1111/j.1365-2222.2007.02895.x; Saarne T, 2005, CLIN EXP ALLERGY, V35, P657, DOI 10.1111/j.1365-2222.2005.02234.x; Senti G, 2012, J ALLERGY CLIN IMMUN, V129, P1290, DOI 10.1016/j.jaci.2012.02.026; Smith W, 2004, CLIN EXP ALLERGY, V34, P1732, DOI 10.1111/j.1365-2222.2004.02090.x; SPITZAUER S, 1994, J ALLERGY CLIN IMMUN, V93, P614, DOI 10.1016/S0091-6749(94)70073-7; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Valenta R, 1999, CLIN EXP ALLERGY, V29, P896; Valenta R, 2011, ALLERGY; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; Winther L, 2006, CLIN EXP ALLERGY, V36, P254, DOI 10.1111/j.1365-2222.2006.02340.x	34	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111041	10.1371/journal.pone.0111041	http://dx.doi.org/10.1371/journal.pone.0111041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353166	gold, Green Published			2022-12-26	WOS:000345204200052
J	Shah, S; McArthur, E; Farag, A; Nartey, M; Fleet, JL; Knoll, GA; Kim, SJ; Garg, AX; Jain, AK				Shah, Sachin; McArthur, Eric; Farag, Alexandra; Nartey, Michael; Fleet, Jamie L.; Knoll, Greg A.; Kim, S. Joseph; Garg, Amit X.; Jain, Arsh K.			Risk of Hospitalization for Community Acquired Pneumonia with Renin-Angiotensin Blockade in Elderly Patients: A Population-Based Study	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; RECEPTOR BLOCKERS; ACE-INHIBITOR; COUGH; METAANALYSIS; MORTALITY; REFLEX	Objective: To characterize the 90-day risk of hospitalization with pneumonia among patients treated with different antihypertensive drug classes. Design: Population based cohort study using five linked databases. Participants: Individuals over the age of 65 who filled a new outpatient prescription for one of four anti-hypertensive medications: ACE inhibitors (n = 86 775), ARBs (n = 33 953), calcium channel blockers (CCB, n = 34 240), beta blockers (BB, n = 35 331) and thiazide diuretics (n = 64 186). Primary Outcome: Hospitalization with pneumonia within 90 days of a qualifying prescription. We adjusted for ten a priori selected covariates, including age, sex, diabetes and number of visits to a family doctor. Results: Baseline characteristics of the groups were relatively well matched, except for age, sex, diabetes and frequency of family doctor visits. 128 of the 86 775 patients (0.15%) initiated on an ACE inhibitor and 43 of the 33953 patients (0.13%) of patients initiated on an ARB were hospitalized with pneumonia in the subsequent 90 days. 135 of 64 186 patients (0.21%) initiated on a thiazide, 112 of 35 331 patients (.32%) initiated on a BB, and 89 of 34 240 (0.26%) patients initiated on a CCB achieved the primary outcome. Compared to calcium channel blockers, ACE inhibitors (adjusted OR 0.61, 95% CI 0.46 to 0.81) and ARBs (adjusted OR 0.52, 95% CI 0.36 to 0.76) were associated with a lower risk of pneumonia. No benefit was seen with thiazides (adjusted OR 0.87, 95% CI 0.66 to 1.14) or beta blockers (adjusted OR 1.21, 95% CI 0.91 to 1.60). Conclusion: Initiating medications that block the renin angiotensin system, compared to other anti-hypertensive medications, is associated with a small absolute reduction in the 90 day risk of hospitalization with pneumonia.	[Shah, Sachin; Farag, Alexandra; Nartey, Michael; Fleet, Jamie L.; Garg, Amit X.; Jain, Arsh K.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [Garg, Amit X.; Jain, Arsh K.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [McArthur, Eric; Garg, Amit X.; Jain, Arsh K.] Inst Clin Evaluat Sci, London, ON, Canada; [Knoll, Greg A.] Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Div Nephrol, Ottawa, ON, Canada; [Kim, S. Joseph] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Div Nephrol, Toronto, ON M5G 1L7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Jain, AK (corresponding author), Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada.	arsh.jain@lhsc.on.ca	Jain, Arsh/G-3308-2011; Fleet, Jamie L/GYJ-7373-2022; Garg, Amit X/G-3295-2011	Knoll, Greg/0000-0001-5442-9310; Fleet, Jamie/0000-0002-9468-0697	Ontario Ministry of Health and Long-term Care; Academic Medical Organization of Southwestern Ontario	Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario	This project was conducted at the Institute for Clinical Evaluative Sciences (ICES) Western Site. ICES is funded by an annual grant from the Ontario Ministry of Health and Long-term Care. ICES@Western is funded by an operating grant from the Academic Medical Organization of Southwestern Ontario. Dr. Jain receives unrestricted grant support from the Academic Medical Organization of Southwestern Ontario. The opinions, results and conclusions reported in this paper are those of the authors and are independent of the funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 1999, EUR RESPIR J, V13, P349, DOI 10.1183/09031936.99.13234999; Arai T, 2001, CHEST, V119, P660, DOI 10.1378/chest.119.2.660; Asadi L, 2012, CLIN INFECT DIS, V55, P371, DOI 10.1093/cid/cis414; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Caldeira D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4260; Etminan M, 2006, PHARMACOTHERAPY, V26, P479, DOI 10.1592/phco.26.4.479; Fox AJ, 1996, NAT MED, V2, P814, DOI 10.1038/nm0796-814; Gonzalez NC, 2007, AM J PHYSIOL-HEART C, V292, pH2285, DOI 10.1152/ajpheart.00981.2006; Hagiwara S, 2009, CRIT CARE MED, V37, P626, DOI 10.1097/CCM.0b013e3181958d91; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; Joffe MM, 1998, STAT MED, V17, P2233, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2233::AID-SIM922>3.0.CO;2-0; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Marrie TJ, 2000, CLIN INFECT DIS, V31, P1066, DOI 10.1086/318124; MORICE AH, 1987, LANCET, V2, P1116; Mukamal KJ, 2010, J HYPERTENS, V28, P401, DOI 10.1097/HJH.0b013e3283330948; Nahmod KA, 2013, CLIN INFECT DIS, V56, P1193, DOI 10.1093/cid/cit007; Nakayama K, 1998, CHEST, V113, P1425, DOI 10.1378/chest.113.5.1425; Ohkubo T, 2004, AM J RESP CRIT CARE, V169, P1041, DOI 10.1164/rccm.200309-1219OC; Okaishi K, 1999, AM J HYPERTENS, V12, P778, DOI 10.1016/S0895-7061(99)00035-7; Sekizawa K, 1998, LANCET, V352, P1069, DOI 10.1016/S0140-6736(05)60114-6; Tomaki M, 1996, THORAX, V51, P199, DOI 10.1136/thx.51.2.199; Vinogradova Y, 2009, BRIT J GEN PRACT, V59, P742, DOI 10.3399/bjgp09X472629; Yusuf S, 2000, NEW ENGL J MED, V342, P145	25	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110165	10.1371/journal.pone.0110165	http://dx.doi.org/10.1371/journal.pone.0110165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353172	gold, Green Published, Green Submitted			2022-12-26	WOS:000345204200016
J	Varanda, CMR; Machado, M; Martel, P; Nolasco, G; Clara, MIE; Felix, MR				Varanda, Carla M. R.; Machado, Marco; Martel, Paulo; Nolasco, Gustavo; Clara, Maria I. E.; Felix, Maria R.			Genetic Diversity of the Coat Protein of Olive Mild Mosaic Virus (OMMV) and Tobacco Necrosis Virus D (TNV-D) Isolates and Its Structural Implications	PLOS ONE			English	Article							CITRUS-TRISTEZA-VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; COMPLETE GENOME SEQUENCE; PHYLOGENETIC ANALYSIS; CAPSID PROTEINS; AMINO-ACIDS; VARIABILITY; POPULATIONS; TRANSMISSION; GRAPEFRUIT	The genetic variability among 13 isolates of Olive mild mosaic virus (OMMV) and of 11 isolates of Tobacco necrosis virus D (TNV-D) recovered from Olea europaea L. samples from various sites in Portugal, was assessed through the analysis of the coat protein (CP) gene sequences. This gene was amplified through reverse transcriptase polymerase chain reaction (RTPCR), cloned, and 5 clone sequences of each virus isolate, were analysed and compared, including sequences from OMMV and TNV-D isolates originally recovered from different hosts and countries and available in the GenBank, totalling 131 sequences. The encoded CP sequences consisted of 269 amino acids (aa) in OMMV and 268 in TNV-D. Comparison of the CP genomic and amino acid sequences of the isolates showed a very low variability among OMMV isolates, 0.005 and 0.007, respectively, as well as among TNV-D isolates, 0.006 and 0.008. The maximum nucleotide distances of OMMV and TNV-D sequences within isolates were also low, 0.013 and 0.031, respectively, and close to that found between isolates, 0.018 and 0.034, respectively. In some cases, less variability was found in clone sequences between isolates than in clone sequences within isolates, as also shown through phylogenetic analysis. CP aa sequence identities among OMMV and TNV-D isolates ranged from 84.3% to 85.8%. Comparison between the CP genomic sequences of the two viruses, showed a relatively low variability, 0.199, and a maximum nucleotide distance between isolates of 0.411. Analysis of comparative models of OMMV and TNV-D CPs, showed that naturally occurring substitutions in their respective sequences do not seem to cause significant alterations in the virion structure. This is consistent with a high selective pressure to preserve the structure of viral capsid proteins.	[Varanda, Carla M. R.; Machado, Marco; Clara, Maria I. E.; Felix, Maria R.] Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, Lab Virol Vegetal, Evora, Portugal; [Martel, Paulo] Univ Algarve, Fac Ciencias & Tecnol, Dept Ciencias Biol & Bioengn, Faro, Portugal; [Nolasco, Gustavo] Univ Algarve, Lab Virol Vegetal, Faro, Portugal	University of Evora; Universidade do Algarve; Universidade do Algarve	Varanda, CMR (corresponding author), Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, Lab Virol Vegetal, Evora, Portugal.	carlavaranda@uevora.pt	Varanda, Carla Marisa Reis/W-2502-2018; Felix, Maria/L-1118-2016; Martel, Paulo J/AFV-2568-2022	Varanda, Carla Marisa Reis/0000-0002-6915-1793; Felix, Maria/0000-0003-3870-5033; Martel, Paulo J/0000-0001-8237-1267	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/76194/2011]; FEDER; Programa Operacional Regional do Alentejo (InAlentejo) Operation [ALENT-07-0262-FEDER-001871]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); Programa Operacional Regional do Alentejo (InAlentejo) Operation	Carla Marisa R. Varanda is the recipient of a Post doctoral fellowship from Fundacao para a Ciencia e a Tecnologia (FCT), SFRH/BPD/76194/2011. This work has been supported by FEDER and National funds, through the Programa Operacional Regional do Alentejo (InAlentejo) Operation ALENT-07-0262-FEDER-001871/Laboratorio de Biotecnologia Aplicada e Tecnologias Agro-Ambientais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayllon MA, 2006, VIRUS GENES, V32, P119, DOI 10.1007/s11262-005-6866-4; Boulila M, 2011, GENET MOL BIOL, V34, P647, DOI 10.1590/S1415-47572011005000046; Callaway A, 2001, ANNU REV PHYTOPATHOL, V39, P419, DOI 10.1146/annurev.phyto.39.1.419; Canizares MC, 2001, ARCH VIROL, V146, P2039, DOI 10.1007/s007050170051; Cardoso JMS, 2005, ARCH VIROL, V150, P815, DOI 10.1007/s00705-004-0453-1; Cardoso JMS, 2004, ARCH VIROL, V149, P1129, DOI 10.1007/s00705-003-0258-7; Cardoso JMS, 2009, ARCH VIROL, V154, P1169, DOI 10.1007/s00705-009-0414-9; Castano A, 2011, VIRUS RES, V155, P274, DOI 10.1016/j.virusres.2010.10.022; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; COUTTS RHA, 1991, J GEN VIROL, V72, P1521, DOI 10.1099/0022-1317-72-7-1521; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; DOLJA VV, 1991, J GEN VIROL, V72, P1481, DOI 10.1099/0022-1317-72-7-1481; Felix MR, 2005, VIRUS RES, V108, P195, DOI 10.1016/j.virusres.2004.09.007; Fraile A, 1996, VIROLOGY, V223, P148, DOI 10.1006/viro.1996.0463; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Gratsia ME, 2012, PLANT DIS, V96, P1230, DOI 10.1094/PDIS-03-12-0273-PDN; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hull R., 2014, PLANT VIROLOGY; Kakani K, 2001, J VIROL, V75, P5576, DOI 10.1128/JVI.75.12.5576-5583.2001; KASSANIS B, 1949, ANN APPL BIOL, V36, P14, DOI 10.1111/j.1744-7348.1949.tb06396.x; King A. M. Q, 2012, VIRUS TAXONOMY; Lin HX, 2003, J GEN VIROL, V84, P249, DOI 10.1099/vir.0.18673-0; Lommel S, 2008, DESK ENCY PLANT FUNG; Manrubia SC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188102; Matos LA, 2013, PLANT DIS, V97, P339, DOI 10.1094/PDIS-05-12-0421-RE; MEULEWAETER F, 1990, VIROLOGY, V177, P699, DOI 10.1016/0042-6822(90)90536-Z; Molnar A, 1997, J GEN VIROL, V78, P1235, DOI 10.1099/0022-1317-78-6-1235; Moreno P, 2008, MOL PLANT PATHOL, V9, P251, DOI 10.1111/J.1364-3703.2007.00455.X; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pantaleo V, 2006, ARCH VIROL, V151, P1973, DOI 10.1007/s00705-006-0767-2; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Powell CA, 2003, PLANT DIS, V87, P1116, DOI 10.1094/PDIS.2003.87.9.1116; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Rico P, 2006, J VIROL, V80, P8124, DOI 10.1128/JVI.00603-06; Rubio L, 2001, J VIROL, V75, P8054, DOI 10.1128/JVI.75.17.8054-8062.2001; Rubio L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00151; Saeki K, 2001, BIOSCI BIOTECH BIOCH, V65, P719, DOI 10.1271/bbb.65.719; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambade A, 2002, PLANT PATHOL, V51, P257, DOI 10.1046/j.1365-3059.2002.00720.x; Scott KA, 2013, ARCH VIROL, V158, P27, DOI 10.1007/s00705-012-1450-4; Sit TL, 2001, J VIROL, V75, P9538, DOI 10.1128/JVI.75.19.9538-9542.2001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Varanda CMR, 2014, ARCH VIROL, V159, P1351, DOI 10.1007/s00705-013-1953-7; Varanda C, 2011, J GEN VIROL, V92, P2209, DOI 10.1099/vir.0.032284-0; Varanda C, 2010, EUR J PLANT PATHOL, V127, P161, DOI 10.1007/s10658-010-9593-1; Varanda CMR, 2011, EUR J PLANT PATHOL, V130, P165, DOI 10.1007/s10658-011-9742-1; Vives MC, 2002, J GEN VIROL, V83, P2587, DOI 10.1099/0022-1317-83-10-2587	47	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110941	10.1371/journal.pone.0110941	http://dx.doi.org/10.1371/journal.pone.0110941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350108	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100049
J	Coutinho-Abreu, IV; Forster, L; Guda, T; Ray, A				Coutinho-Abreu, Iliano V.; Forster, Lisa; Guda, Tom; Ray, Anandasankar			Odorants for Surveillance and Control of the Asian Citrus Psyllid (Diaphorina citri)	PLOS ONE			English	Article							TRIOZA-APICALIS HOMOPTERA; DISEASE; HEMIPTERA; VOLATILES; KUWAYAMA; NEURONS; CO2	Background: The Asian Citrus Psyllid (ACP), Diaphorina citri, can transmit the bacterium Candidatus Liberibacter while feeding on citrus flush shoots. This bacterium causes Huanglongbing (HLB), a major disease of citrus cultivation worldwide necessitating the development of new tools for ACP surveillance and control. The olfactory system of ACP is sensitive to variety of odorants released by citrus plants and offers an opportunity to develop new attractants and repellents. Results: In this study, we performed single-unit electrophysiology to identify odorants that are strong activators, inhibitors, and prolonged activators of ACP odorant receptor neurons (ORNs). We identified a suite of odorants that activated the ORNs with high specificity and sensitivity, which may be useful in eliciting behavior such as attraction. In separate experiments, we also identified odorants that evoked prolonged ORN responses and antagonistic odorants able to suppress neuronal responses to activators, both of which can be useful in lowering attraction to hosts. In field trials, we tested the electrophysiologically identified activating odorants and identified a 3-odor blend that enhances trap catches by similar to 230%. Conclusion: These findings provide a set of odorants that can be used to develop affordable and safe odor-based surveillance and masking strategies for this dangerous pest insect.	[Coutinho-Abreu, Iliano V.; Forster, Lisa; Guda, Tom; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Ray, Anandasankar] Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ray, A (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	anand.ray@ucr.edu	Coutinho-Abreu, Iliano/AAQ-5754-2020	Coutinho-Abreu, Iliano/0000-0002-1389-1071; Ray, Anandasankar/0000-0003-4133-2581	Citrus Research Board [5500-186]	Citrus Research Board	This study was supported by funding from the Citrus Research Board (#5500-186) to Anandasankar Ray. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bove JM, 2006, J PLANT PATHOL, V88, P7; CHAPMAN RF, 1982, ADV INSECT PHYSIOL, V16, P247, DOI 10.1016/S0065-2806(08)60155-1; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Coutinho-Abreu IV, 2014, CHEM SENSES, V39, P539, DOI 10.1093/chemse/bju023; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; HODKINSON ID, 1974, B ENTOMOL RES, V64, P325, DOI 10.1017/S0007485300031217; Kristoffersen L, 2008, CHEM SENSES, V33, P759, DOI 10.1093/chemse/bjn034; Kristoffersen L, 2008, CHEM SENSES, V33, P771, DOI 10.1093/chemse/bjn044; Kristoffersen L, 2006, ARTHROPOD STRUCT DEV, V35, P85, DOI 10.1016/j.asd.2006.04.001; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Mann RS, 2011, B ENTOMOL RES, V101, P89, DOI 10.1017/S0007485310000222; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Onagbola EO, 2011, J APPL ENTOMOL, V135, P404, DOI 10.1111/j.1439-0418.2010.01565.x; Onagbola EO, 2008, MICRON, V39, P1184, DOI 10.1016/j.micron.2008.05.002; Park KC, 2002, J INSECT PHYSIOL, V48, P527, DOI 10.1016/S0022-1910(02)00082-3; Patti JM, 2010, ENVIRON ENTOMOL, V39, P618, DOI 10.1603/EN09216; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Tiwari S, 2010, J ECON ENTOMOL, V103, P1972, DOI 10.1603/EC10149; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Valterova I, 1997, BIOCHEM SYST ECOL, V25, P477, DOI 10.1016/S0305-1978(97)00028-8; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Wenninger EJ, 2007, FLA ENTOMOL, V90, P715, DOI 10.1653/0015-4040(2007)90[715:DTOMAA]2.0.CO;2; Yasuda K, 2005, JPN J APPL ENTOMOL Z, V49, P146, DOI 10.1303/jjaez.2005.146	29	28	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109236	10.1371/journal.pone.0109236	http://dx.doi.org/10.1371/journal.pone.0109236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347318	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900007
J	Lesaint, F; Sigaud, O; Khamassi, M				Lesaint, Florian; Sigaud, Olivier; Khamassi, Mehdi			Accounting for Negative Automaintenance in Pigeons: A Dual Learning Systems Approach and Factored Representations	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; CENTRAL AMYGDALA; REWARD; DOPAMINE; CUE; UNCERTAINTY; MISBEHAVIOR; ACTIVATION; ADDICTION; TRACKING	Animals, including Humans, are prone to develop persistent maladaptive and suboptimal behaviours. Some of these behaviours have been suggested to arise from interactions between brain systems of Pavlovian conditioning, the acquisition of responses to initially neutral stimuli previously paired with rewards, and instrumental conditioning, the acquisition of active behaviours leading to rewards. However the mechanics of these systems and their interactions are still unclear. While extensively studied independently, few models have been developed to account for these interactions. On some experiment, pigeons have been observed to display a maladaptive behaviour that some suggest to involve conflicts between Pavlovian and instrumental conditioning. In a procedure referred as negative automaintenance, a key light is paired with the subsequent delivery of food, however any peck towards the key light results in the omission of the reward. Studies showed that in such procedure some pigeons persisted in pecking to a substantial level despite its negative consequence, while others learned to refrain from pecking and maximized their cumulative rewards. Furthermore, the pigeons that were unable to refrain from pecking could nevertheless shift their pecks towards a harmless alternative key light. We confronted a computational model that combines dual-learning systems and factored representations, recently developed to account for sign-tracking and goal-tracking behaviours in rats, to these negative automaintenance experimental data. We show that it can explain the variability of the observed behaviours and the capacity of alternative key lights to distract pigeons from their detrimental behaviours. These results confirm the proposed model as an interesting tool to reproduce experiments that could involve interactions between Pavlovian and instrumental conditioning. The model allows us to draw predictions that may be experimentally verified, which could help further investigate the neural mechanisms underlying theses interactions.	[Lesaint, Florian; Sigaud, Olivier; Khamassi, Mehdi] Univ Paris 06, Sorbonne Univ, Inst Syst Intelligents & Robot, UMR 7222, Paris, France; [Lesaint, Florian; Sigaud, Olivier; Khamassi, Mehdi] CNRS, UMR 7222, Inst Syst Intelligents & Robot, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lesaint, F (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Syst Intelligents & Robot, UMR 7222, Paris, France.	lesaint@isir.upmc.fr	Khamassi, Mehdi/B-2425-2012	Khamassi, Mehdi/0000-0002-2515-1046	L'Agence Nationale de la Recherche, France [ANR-11-BSV4-006 "LU2" (Learning Under Uncertainty)]	L'Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was supported by Grant ANR-11-BSV4-006 "LU2" (Learning Under Uncertainty) from L'Agence Nationale de la Recherche, France (FL, OS, MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOY LB, 1981, LEARN MOTIV, V12, P109, DOI 10.1016/0023-9690(81)90027-8; Balkenius C, 1999, AUTON ROBOT, V7, P41, DOI 10.1023/A:1008965713435; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Beierholm UR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000903; Bellman R., 1957, DYNAMIC PROGRAMMING; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Boakes RA, 1977, OPERANT PAVLOVIAN IN, V1st, P35; Boutilier C, 2000, ARTIF INTELL, V121, P49, DOI 10.1016/S0004-3702(00)00033-3; BRELAND K, 1961, AM PSYCHOL, V16, P681, DOI 10.1037/h0040090; BROWN PL, 1968, J EXP ANAL BEHAV, V11, P1, DOI 10.1901/jeab.1968.11-1; Clark JJ, 2012, CURR OPIN NEUROBIOL, V22, P1054, DOI 10.1016/j.conb.2012.06.004; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Daw ND, 2011, DECISION MAKING AFFE, V23; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P, 2014, COGN AFFECT BEHAV NE, P1; Dayan P, 2006, NEURAL NETWORKS, V19, P1153, DOI 10.1016/j.neunet.2006.03.002; Degris T., 2006, 23 INT C MACH LEARN, P257; DEICH JD, 1977, J EXP ANAL BEHAV, V27, P399, DOI 10.1901/jeab.1977.27-399; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; DiFeliceantonio AG, 2012, BEHAV BRAIN RES, V230, P399, DOI 10.1016/j.bbr.2012.02.032; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Elfwing S, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00003; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fitzpatrick CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075042; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; GAMZU E, 1974, J EXP ANAL BEHAV, V21, P361, DOI 10.1901/jeab.1974.21-361; Gargiulo PA, 2005, PHARMACOL BIOCHEM BE, V81, P732, DOI 10.1016/j.pbb.2005.05.009; Gershman SJ, 2012, LEARN BEHAV, V40, P255, DOI 10.3758/s13420-012-0080-8; Geurts DEM, 2013, J COGNITIVE NEUROSCI, V25, P1428, DOI 10.1162/jocn_a_00425; GORMEZANO I, 1972, PSYCHON SCI, V29, P276; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; GRIFFIN RW, 1973, B PSYCHONOMIC SOC, V2, P402; Guitart-Masip M, 2014, TRENDS COGN SCI, V18, P194, DOI 10.1016/j.tics.2014.01.003; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; HERSHBERGER WA, 1986, ANIM LEARN BEHAV, V14, P443, DOI 10.3758/BF03200092; Huys QJM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002028; Kamin L.J., 1967, PUNISHMENT AVERSIVE, P279; Keramati M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002055; Khamassi M, 2006, LECT NOTES COMPUT SC, V4095, P394; Killeen PR, 2003, J EXP PSYCHOL-ANIM B, V29, P49, DOI 10.1037//0097-7403.29.1.49; Lattal KM, 1998, ANIM LEARN BEHAV, V26, P351, DOI 10.3758/BF03199227; Lesaint F, 2014, J PHYSL PAR IN PRESS; Lesaint F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003466; LOCURTO C, 1976, J EXP ANAL BEHAV, V26, P451, DOI 10.1901/jeab.1976.26-451; LOCURTO CM, 1978, B PSYCHONOMIC SOC, V12, P11; Mahler SV, 2009, J NEUROSCI, V29, P6500, DOI 10.1523/JNEUROSCI.3875-08.2009; Meyer PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098163; Meyer PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038987; Miyata H, 2008, ANIM COGN, V11, P505, DOI 10.1007/s10071-008-0141-8; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; Niv Y, 2009, J MATH PSYCHOL, V53, P139, DOI 10.1016/j.jmp.2008.12.005; OCONNELL MF, 1979, J EXP ANAL BEHAV, V31, P31, DOI 10.1901/jeab.1979.31-31; Pezzulo G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00092; POLING A, 1978, J EXP ANAL BEHAV, V30, P37, DOI 10.1901/jeab.1978.30-37; Prevost C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002918; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Sanabria F, 2006, J EXP ANAL BEHAV, V86, P1, DOI 10.1901/jeab.2006.36-05; Schmajuk NA, 1996, J EXP PSYCHOL ANIM B, V22, P321, DOI 10.1037/0097-7403.22.3.321; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Stout SC, 2007, PSYCHOL REV, V114, P759, DOI 10.1037/0033-295X.114.3.759; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Vigorito CM, 2008, YAL WORKSH AD LEARN; Williams DR, 1969, J EXP ANAL BEHAV; WOODARD WT, 1974, J EXP ANAL BEHAV, V22, P47, DOI 10.1901/jeab.1974.22-47; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x	71	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111050	10.1371/journal.pone.0111050	http://dx.doi.org/10.1371/journal.pone.0111050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347531	Green Submitted, gold, Green Published			2022-12-26	WOS:000347994900041
J	Yamamoto, R; Okada, Y; Hirose, J; Koshika, T; Kawato, Y; Maeda, M; Saito, R; Hattori, K; Harada, H; Nagasaka, Y; Morokata, T				Yamamoto, Rie; Okada, Youhei; Hirose, Jun; Koshika, Tadatsura; Kawato, Yuka; Maeda, Masashi; Saito, Rika; Hattori, Kazuyuki; Harada, Hironori; Nagasaka, Yasuhisa; Morokata, Tatsuaki			ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile	PLOS ONE			English	Article							RELAPSING MULTIPLE-SCLEROSIS; FINGOLIMOD FTY720; LYMPHOCYTE EGRESS; ORAL FINGOLIMOD; SPHINGOSINE-1-PHOSPHATE RECEPTOR; AIRWAY HYPERREACTIVITY; HEART-RATE; ORGANS; DEMYELINATION; TRAFFICKING	Sphingosine-1-phosphate (S1P) is a biologically active sphingolipid that acts through the members of a family of five G protein-coupled receptors (S1P(1)-S1P(5)). S1P(1) is a major regulator of lymphocyte trafficking, and fingolimod, whose active metabolite fingolimod phosphate acts as a nonselective S1P receptor agonist, exerts its immunomodulatory effect, at least in part, by regulating the lymphocyte trafficking by inducing down regulation of lymphocyte S1P(1). Here, we detail the pharmacological profile of 5-{5-[3-(trifluoromethyl)-4-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy} phenyl]-1,2,4-oxadiazol-3-yl}-1Hbenzimidazole (ASP4058), a novel next-generation S1P receptor agonist selective for S1P(1) and S1P(5). ASP4058 preferentially activates S1P(1) and S1P(5) compared with S1P(2), (3), (4) in GTP gamma S binding assays in vitro. Oral administration of ASP4058 reduced the number of peripheral lymphocytes and inhibited the development of experimental autoimmune encephalomyelitis (EAE) in Lewis rats. Further, ASP4058 prevented relapse of disease in a mouse model of relapsing-remitting EAE. Although these immunomodulatory effects were comparable to those of fingolimod, ASP4058 showed a wider safety margin than fingolimod for bradycardia and bronchoconstriction in rodents. These observations suggest that ASP4058 represents a new therapeutic option for treating multiple sclerosis that is safer than nonselective S1P receptor agonists such as fingolimod.	[Yamamoto, Rie; Okada, Youhei; Hirose, Jun; Koshika, Tadatsura; Kawato, Yuka; Maeda, Masashi; Hattori, Kazuyuki; Harada, Hironori; Nagasaka, Yasuhisa; Morokata, Tatsuaki] Astellas Pharma Inc, Tsukuba Res Ctr, Drug Discovery Res, Ibaraki, Japan; [Saito, Rika] Astellas Pharma Inc, Kashima R&D Ctr, Drug Discovery Res, Osaka, Japan	Astellas Pharmaceuticals; Astellas Pharmaceuticals	Morokata, T (corresponding author), Astellas Pharma Inc, Tsukuba Res Ctr, Drug Discovery Res, Ibaraki, Japan.	tatsuaki.morokata@astellas.com			Astellas Pharma Inc.	Astellas Pharma Inc.(Astellas Pharmaceuticals)	All of the research was funded by Astellas Pharma Inc. The funder did have a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript as the authors are employed by the funder.	Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chun J, 2011, DISCOV MED, V12, P213; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; DiMarco JP, 2010, MULT SCLER, V16, pS290; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Hemmer B, 2006, NAT CLIN PRACT NEURO, V2, P201, DOI 10.1038/ncpneuro0154; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kennedy PC, 2011, J PHARMACOL EXP THER, V338, P879, DOI 10.1124/jpet.111.181552; Kume H, 2007, J PHARMACOL EXP THER, V320, P766, DOI 10.1124/jpet.106.110718; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Miron VE, 2008, AM J PATHOL, V173, P1143, DOI 10.2353/ajpath.2008.080478; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Rosenfeldt HM, 2003, FASEB J, V17, P1789, DOI 10.1096/fj.02-0836com; Roviezzo F, 2010, AM J RESP CELL MOL, V42, P572, DOI 10.1165/rcmb.2009-0108OC; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Trifilieff A, 2012, J PHARMACOL EXP THER, V342, P399, DOI 10.1124/jpet.112.191585; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	34	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110819	10.1371/journal.pone.0110819	http://dx.doi.org/10.1371/journal.pone.0110819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347187	Green Submitted, Green Published, gold			2022-12-26	WOS:000347994900030
J	Chung, YA; Burkle, LA; Knight, TM				Chung, Y. Anny; Burkle, Laura A.; Knight, Tiffany M.			Minimal Effects of an Invasive Flowering Shrub on the Pollinator Community of Native Forbs	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; FLORAL CHARACTERS; PLANT FITNESS; ALIEN PLANTS; VISITATION; DENSITY; SUCCESS; SPECIALIZATION; METAANALYSIS; INTEGRATION	Biological invasions can strongly influence species interactions such as pollination. Most of the documented effects of exotic plant species on plant-pollinator interactions have been observational studies using single pairs of native and exotic plants, and have focused on dominant exotic plant species. We know little about how exotic plants alter interactions in entire communities of plants and pollinators, especially at low to medium invader densities. In this study, we began to address these gaps by experimentally removing the flowers of a showy invasive shrub, Rosa multiflora, and evaluating its effects on the frequency, richness, and composition of bee visitors to co-flowering native plants. We found that while R. multiflora increased plot-level richness of bee visitors to co-flowering native plant species at some sites, its presence had no significant effects on bee visitation rate, visitor richness, bee community composition, or abundance overall. In addition, we found that compared to co-flowering natives, R. multiflora was a generalist plant that primarily received visits from generalist bee species shared with native plant species. Our results suggest that exotic plants such as R. multiflora may facilitate native plant pollination in a community context by attracting a more diverse assemblage of pollinators, but have limited and idiosyncratic effects on the resident plant-pollinator network in general.	[Chung, Y. Anny; Burkle, Laura A.; Knight, Tiffany M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Chung, Y. Anny] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Burkle, Laura A.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	Washington University (WUSTL); University of New Mexico; Montana State University System; Montana State University Bozeman	Chung, YA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	yyachung@unm.edu		Chung, Yan Yi/0000-0001-5207-2872	National Science Foundation [DEB-934376]; Washington University	National Science Foundation(National Science Foundation (NSF)); Washington University	This research was supported by the National Science Foundation (grant DEB-934376) awarded to LAB and TMK (www.nsf.gov), and fellowships at Washington University awarded to YAC (Howard Hughes Summer Undergraduate Research Fellowship, Tyson Research Center Fellowship, and Lennette Undergraduate Research Fellowship, www.wustl.edu). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; ASCHER JS, 2012, DISCOVER LIFE BEE SP; Ashworth L, 2004, J ECOL, V92, P717, DOI 10.1111/j.0022-0477.2004.00910.x; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Brown BJ, 2002, ECOLOGY, V83, P2328, DOI 10.1890/0012-9658(2002)083[2328:CFPBAI]2.0.CO;2; Burkle LA, 2009, PLANT ECOL, V203, P83, DOI 10.1007/s11258-008-9512-0; Campbell C, 2011, P NATL ACAD SCI USA, V108, P197, DOI 10.1073/pnas.1008204108; Carvalheiro LG, 2010, ECOLOGY, V91, P1063, DOI 10.1890/08-2092.1; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Chrobock T, 2013, BIOL INVASIONS, V15, P2577, DOI 10.1007/s10530-013-0474-3; Essenberg CJ, 2012, AM NAT, V180, P153, DOI 10.1086/666610; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Gibson MR, 2013, BIOL CONSERV, V157, P196, DOI 10.1016/j.biocon.2012.07.011; Gilbert B, 2005, ECOLOGY, V86, P1848, DOI 10.1890/04-09997; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Jesse LC, 2006, WEED BIOL MANAG, V6, P235, DOI 10.1111/j.1445-6664.2006.00221.x; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; KLINKHAMER PGL, 1990, OIKOS, V57, P399, DOI 10.2307/3565970; Kunin W, 1996, THEOR POPUL BIOL, V49, P232, DOI 10.1006/tpbi.1996.0013; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Lortie CJ, 2007, J ECOL, V95, P468, DOI 10.1111/j.1365-2745.2007.01231.x; Mack RN, 2000, ECOLOGICAL APPL, V10, P489; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Moragues E, 2005, BIOL CONSERV, V122, P611, DOI 10.1016/j.biocon.2004.09.015; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Munger G. T., 2002, FIRE EFFECTS INFORM; Munoz AA, 2008, J ECOL, V96, P459, DOI 10.1111/j.1365-2745.2008.01361.x; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Proctor M., 1996, NATURAL HIST POLLINA; Pysek P, 2011, ECOL MONOGR, V81, P277, DOI 10.1890/10-0630.1; Robertson C., 1929, FLOWERS INSECTS LIST; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; STEAVENSON HA, 1946, J WILDLIFE MANAGE, V10, P227, DOI 10.2307/3795837; Strauss SY, 1997, ECOLOGY, V78, P1640, DOI 10.1890/0012-9658(1997)078[1640:FCLHPA]2.0.CO;2; USDA NRCS, 2013, PLANTS DAT; Vanparys V, 2008, ACTA OECOL, V34, P361, DOI 10.1016/j.actao.2008.06.008; Vila M, 2009, P ROY SOC B-BIOL SCI, V276, P3887, DOI 10.1098/rspb.2009.1076; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Waser NM., 2006, PLANT POLLINATOR INT; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769	52	10	10	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109088	10.1371/journal.pone.0109088	http://dx.doi.org/10.1371/journal.pone.0109088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343718	Green Published, gold			2022-12-26	WOS:000343943500007
J	Colman, R; Whittingham, H; Tomlinson, G; Granton, J				Colman, Rebecca; Whittingham, Heather; Tomlinson, George; Granton, John			Utility of the Physical Examination in Detecting Pulmonary Hypertension. A Mixed Methods Study	PLOS ONE			English	Article							SECOND HEART SOUND; PHONOCARDIOGRAPHIC SIGNS; ARTERIAL-HYPERTENSION; DIAGNOSIS; GUIDELINES	Introduction: Patients with pulmonary hypertension (PH) often present with a variety of physical findings reflecting a volume or pressure overloaded right ventricle (RV). However, there is no consensus regarding the diagnostic utility of the physical examination in PH. Methods: We conducted a systematic review of publications that evaluated the clinical examination and diagnosis of PH using MEDLINE (1946-2013) and EMBASE (1947-2013). We also prospectively evaluated the diagnostic utility of the physical examination findings. Patients who underwent right cardiac catheterization for any reason were recruited. After informed consent, participants were examined by 6 physicians (3 "specialists'' and 3 "generalists'') who were unaware of the results of the patient's hemodynamics. Each examiner independently assessed patients for the presence of a RV lift, loud P2, jugular venous distension (JVD), tricuspid insufficiency murmur and right-sided 4th heart sound at rest and during a slow inspiration. A global rating (scale of 1-5) of the likelihood that the patient had pulmonary hypertension was provided by each examiner. Results: 31 articles that assessed the physical examination in PH were included in the final analysis. There was heterogeneity amongst the studies and many did not include control data. The sign most associated with PH in the literature was a loud pulmonic component of the second heart sound (P2). In our prospective study physical examination was performed on 52 subjects (25 met criteria for PH; mPAP >= 25 mmHg). The physical sign with the highest likelihood ratio (LR) was a loud P2 on inspiration with a LR +ve 1.9, 95% CrI [1.2, 3.1] when data from all examiners was analyzed together. Results from the specialist examiners had higher diagnostic utility; a loud P2 on inspiration was associated with a positive LR of 3.2, 95% CrI [1.5, 6.2] and a right sided S4 on inspiration had a LR +ve 4.7, 95% CI [1.0, 15.6]. No aspect of the physical exam, could consistently rule out PH (negative LRs 0.7-1.3). Conclusions: The presence of a loud P2 or audible right-sided 4th heart sound are associated with PH. However the physical examination is unreliable for determining the presence of PH.	[Colman, Rebecca; Granton, John] Univ Toronto, Toronto Gen Hosp, Div Respirol, Pulm Hypertens Program, Toronto, ON M5G 1L7, Canada; [Whittingham, Heather] McMaster Univ, Hamilton Gen Hosp, Dept Crit Care Med, Hamilton, ON, Canada; [Tomlinson, George] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Tomlinson, George] Univ Toronto, Fac Med, Univ Hlth Network, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Granton, J (corresponding author), Univ Toronto, Toronto Gen Hosp, Div Respirol, Pulm Hypertens Program, Toronto, ON M5G 1L7, Canada.	John.granton@uhn.ca	Tomlinson, George/L-5432-2016	Tomlinson, George/0000-0002-9328-6399	Toronto General Hospital Foundation	Toronto General Hospital Foundation	This study was funded through the Toronto General Hospital Foundation. The funder had no role in the design, execution or interpretation of the study results.	BLEIFER S, 1960, AM J CARDIOL, V5, P191, DOI 10.1016/0002-9149(60)90198-3; Chan W, 2013, BMJ OPEN, V3; CRAIGE E, 1960, AM HEART J, V60, P51, DOI 10.1016/0002-8703(60)90058-2; Dennis A, 2010, COMPUT BIOL MED, V40, P758, DOI 10.1016/j.compbiomed.2010.07.003; Gaine S, 2000, JAMA-J AM MED ASSOC, V284, P3160, DOI 10.1001/jama.284.24.3160; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Goryanina NK, 1964, TERAPEVTICHESKII ARC, V36, P85; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRIS A, 1970, AM HEART J, V79, P145, DOI 10.1016/0002-8703(70)90302-9; HARRIS A, 1968, BRIT HEART J, V30, P739; Javed F., 2007, Journal of Medical Engineering & Technology, V31, P341, DOI 10.1080/03091900600887876; KARNEGIS JN, 1964, AM J CARDIOL, V14, P75, DOI 10.1016/0002-9149(64)90109-2; LEATHAM A, 1956, BRIT HEART J, V18, P193; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Nigam V, 2006, PHYSIOL MEAS, V27, P553, DOI 10.1088/0967-3334/27/7/001; Pilatis ND, 2000, LIVER TRANSPLANT, V6, P85, DOI 10.1016/S1527-6465(00)80038-6; Plummer M, 2013, PLUMMER MARTYN RIAGS; SHAVER JA, 1974, CIRCULATION, V49, P316, DOI 10.1161/01.CIR.49.2.316; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Slodki S J, 1965, Chic Med Sch Q, V25, P108; STEIN P D, 1980, Henry Ford Hospital Medical Journal, V28, P205; Sung L, 2005, J CLIN EPIDEMIOL, V58, P261, DOI 10.1016/j.jclinepi.2004.08.010; SUTTON G, 1968, BRIT HEART J, V30, P743; UNGERER RG, 1983, AM J MED, V75, P65, DOI 10.1016/0002-9343(83)91169-5; WOOD P, 1952, BRIT MED BULL, V8, P348, DOI 10.1093/oxfordjournals.bmb.a074201; Xu J, 2002, HEART, V88, P76, DOI 10.1136/heart.88.1.76	28	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e108499	10.1371/journal.pone.0108499	http://dx.doi.org/10.1371/journal.pone.0108499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343585	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500006
J	Huang, GH; Yao, WQ; Yu, W; Mao, LL; Sun, HB; Yao, W; Tian, J; Wang, L; Bo, ZJ; Zhu, Z; Zhang, Y; Zhao, Z; Xu, WB				Huang, Guohong; Yao, Wenqing; Yu, Wei; Mao, Lingling; Sun, Haibo; Yao, Wei; Tian, Jiang; Wang, Ling; Bo, Zhijian; Zhu, Zhen; Zhang, Yan; Zhao, Zhuo; Xu, Wenbo			Outbreak of Epidemic Keratoconjunctivitis Caused by Human Adenovirus Type 56, China, 2012	PLOS ONE			English	Article							NOSOCOMIAL OUTBREAK; CONJUNCTIVITIS; INFECTIONS; JAPAN; CARE	HAdV-56 is a new recombinant type isolated from epidemic keratoconjunctivitis (EKC) patients and has been sporadically isolated in Japan several times. Here, an outbreak of EKC in the city of Dalian, China involving a large number of workers in two factories was reported; this was the first outbreak of EKC associated with HAdV-56 worldwide.	[Huang, Guohong; Zhu, Zhen; Zhang, Yan; Xu, Wenbo] Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Yao, Wenqing; Yu, Wei; Mao, Lingling; Sun, Haibo; Tian, Jiang; Wang, Ling; Zhao, Zhuo] Liaoning Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China; [Yao, Wei; Bo, Zhijian] Dalian Ctr Dis Control & Prevent, Dalian, Liaoning Provin, Peoples R China; [Huang, Guohong] Peoples Hosp Xinjiang Uygur Autonomous Reg, Clin Lab, Urumqi, Xinjiang Uygur, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhao, Z (corresponding author), Liaoning Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China.	zhaozhuo699@163.com; wenbo_xu1@aliyun.com			National Basic Research Program of China (973 Program) [2011CB504902]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Technologies R&D Program of National Ministry of Science	This study was supported by National Basic Research Program of China (973 Program): (Grant No. 2011CB504902); Key Technologies R&D Program of National Ministry of Science (Grant No. 2013ZX10004-202; 2012ZX10004201-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI K, 1982, BRIT J OPHTHALMOL, V66, P776, DOI 10.1136/bjo.66.12.776; AOKI K, 1986, JPN J OPHTHALMOL, V30, P158; Aoki Koki, 2002, International Ophthalmology Clinics, V42, P49; FORD E, 1987, EPIDEMIOL REV, V9, P244, DOI 10.1093/oxfordjournals.epirev.a036304; Hamada N, 2008, J HOSP INFECT, V68, P262, DOI 10.1016/j.jhin.2007.12.012; Hiroi S, 2012, JPN J INFECT DIS, V65, P273, DOI 10.7883/yoken.65.273; Ishiko H, 2008, J CLIN MICROBIOL, V46, P2002, DOI 10.1128/JCM.01835-07; Kaneko H, 2011, J GEN VIROL, V92, P1251, DOI 10.1099/vir.0.030361-0; Kaneko H, 2011, J CLIN MICROBIOL, V49, P484, DOI 10.1128/JCM.01044-10; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Nakamura M, 2012, J MED VIROL, V84, P81, DOI 10.1002/jmv.22252; PACINI DL, 1987, J INFECT DIS, V156, P920, DOI 10.1093/infdis/156.6.920; Percivalle E, 2003, J CLIN VIROL, V28, P257, DOI 10.1016/S1386-6532(03)00011-8; Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020; Sambursky Robert P, 2007, Optometry, V78, P236, DOI 10.1016/j.optm.2006.11.012; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; Weitgasser U, 2002, OPHTHALMOLOGICA, V216, P329, DOI 10.1159/000066175; WOLD WSM, 2007, FIELD VIROLOGY, P02395	18	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110781	10.1371/journal.pone.0110781	http://dx.doi.org/10.1371/journal.pone.0110781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343525	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500054
J	Nozaki, K; Kagamu, H; Shoji, S; Igarashi, N; Ohtsubo, A; Okajima, M; Miura, S; Watanabe, S; Yoshizawa, H; Narita, I				Nozaki, Koichiro; Kagamu, Hiroshi; Shoji, Satoshi; Igarashi, Natsue; Ohtsubo, Aya; Okajima, Masaaki; Miura, Satoru; Watanabe, Satoshi; Yoshizawa, Hirohisa; Narita, Ichiei			DDX3X Induces Primary EGFR-TKI Resistance Based on Intratumor Heterogeneity in Lung Cancer Cells Harboring EGFR-Activating Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; STEM-CELLS; MESENCHYMAL TRANSITION; PROSTATE-CANCER; RNA HELICASE; GEFITINIB; MEDULLOBLASTOMA; DIFFERENTIATION; PROGRESSION; PROTEINS	The specific mechanisms how lung cancer cells harboring epidermal growth factor receptor (EGFR) activating mutations can survive treatment with EGFR-tyrosine kinase inhibitors (TKIs) until they eventually acquire treatment-resistance genetic mutations are unclear. The phenotypic diversity of cancer cells caused by genetic or epigenetic alterations (intratumor heterogeneity) confers treatment failure and may foster tumor evolution through Darwinian selection. Recently, we found DDX3X as the protein that was preferentially expressed in murine melanoma with cancer stem cell (CSC)-like phenotypes by proteome analysis. In this study, we transfected PC9, human lung cancer cells harboring EGFR exon19 deletion, with cDNA encoding DDX3X and found that DDX3X, an ATP-dependent RNA helicase, induced CSC-like phenotypes and the epithelial-mesenchymal transition (EMT) accompanied with loss of sensitivity to EGFR-TKI. DDX3X expression was associated with upregulation of Sox2 and increase of cancer cells exhibiting CSC-like phenotypes, such as anchorage-independent proliferation, strong expression of CD44, and aldehyde dehydrogenase (ALDH). The EMT with switching from E-cadherin to N-cadherin was also facilitated by DDX3X. Either ligand-independent or ligand-induced EGFR phosphorylation was inhibited in lung cancer cells that strongly expressed DDX3X. Lack of EGFR signal addiction resulted in resistance to EGFR-TKI. Moreover, we found a small nonadherent subpopulation that strongly expressed DDX3X accompanied by the same stem cell-like properties and the EMT in parental PC9 cells. The unique subpopulation lacked EGFR signaling and was highly resistant to EGFR-TKI. In conclusion, our data indicate that DDX3X may play a critical role for inducing phenotypic diversity, and that treatment targeting DDX3X may overcome primary resistance to EGFR-TKI resulting from intratumor heterogeneity.	[Nozaki, Koichiro; Kagamu, Hiroshi; Shoji, Satoshi; Igarashi, Natsue; Ohtsubo, Aya; Okajima, Masaaki; Miura, Satoru; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat & Dev, Div Resp Med, Niigata, Japan; [Watanabe, Satoshi; Yoshizawa, Hirohisa] Niigata Univ, Med & Dent Hosp, Biosci Med Res Ctr, Niigata, Japan	Niigata University; Niigata University	Kagamu, H (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat & Dev, Div Resp Med, Niigata, Japan.	hkagamu@med.niigata-u.ac.jp	Narita, Ichiei/G-5204-2017	Narita, Ichiei/0000-0001-7692-3096	Ministry of Education, Science, and Culture of Japan [20590915, 23591141, 24591157, 26293196]; Otsuka Pharmaceutical Co., Ltd.	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (#20590915, #23591141, #24591157, #26293196), and by research funding from Otsuka Pharmaceutical Co., Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; Ambrus AM, 2009, CELL CYCLE, V8, P3500, DOI 10.4161/cc.8.21.9887; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Chen YR, 2006, ONCOGENE, V25, P1205, DOI 10.1038/sj.onc.1209159; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Koshio J, 2013, CANC IMMUNOLOGY IMMU; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Miyabayashi T, 2011, CANC IMMUNOLOGY IMMU; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Rosinski KV, 2008, BLOOD, V111, P4817, DOI 10.1182/blood-2007-06-096313; Shah GV, 2009, J BIOL CHEM, V284, P1018, DOI 10.1074/jbc.M807823200; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Singh SK, 2003, CANCER RES, V63, P5821; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Sun M, 2011, BIOCH BIOPHYS ACTA; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tomita K, 2000, CANCER RES, V60, P3650; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455	36	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111019	10.1371/journal.pone.0111019	http://dx.doi.org/10.1371/journal.pone.0111019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343452	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500076
J	Safari, D; Kurniati, N; Waslia, L; Khoeri, MM; Putri, T; Bogaert, D; Trzcinski, K				Safari, Dodi; Kurniati, Nia; Waslia, Lia; Khoeri, Miftahuddin Majid; Putri, Tiara; Bogaert, Debby; Trzcinski, Krzysztof			Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Strains Carried by Children Infected with Human Immunodeficiency Virus	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; DISEASE; COLONIZATION; RESISTANCE; REPLACEMENT; PREVALENCE; TRENDS; IMPACT; COHORT	Background: We studied the serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates carried by children infected with HIV in Jakarta, Indonesia. Methods: Nasopharyngeal swabs were collected from 90 HIV infected children aged 4 to 144 months. S. pneumoniae was identified by conventional and molecular methods. Serotyping was performed with sequential multiplex PCR and antibiotic susceptibility with the disk diffusion method. Results: We identified S. pneumoniae carriage in 41 children (46%). Serotype 19F was most common among 42 cultured strains (19%) followed by 19A and 6A/B (10% each), and 23F (7%). Most isolates were susceptible to chloramphenicol (86%), followed by clindamycin (79%), erythromycin (76%), tetracycline (43%), and sulphamethoxazole/trimethoprim (41%). Resistance to penicillin was most common with only 33% of strains being susceptible. Strains of serotypes targeted by the 13-valent pneumococcal conjugate polysaccharide vaccine (PCV13) were more likely to be multidrug resistant (13 of 25 or 52%) compared to non-PCV13 serotype isolates (3 of 17 or 18%; Fisher exact test p = 0.05). Conclusion: Our study provides insight into the epidemiology of pneumococcal carriage in young HIV patients in Indonesia. These findings may facilitate potential preventive strategies that target invasive pneumococcal disease in Indonesia.	[Safari, Dodi; Khoeri, Miftahuddin Majid] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Kurniati, Nia] Univ Indonesia, Dr Cipto Mangunkusumo Hospital, Fac Med, Dept Child Hlth, Jakarta, Indonesia; [Waslia, Lia] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Putri, Tiara] Gajah Mada Univ, Fac Biol, Yogyakarta, Indonesia; [Bogaert, Debby; Trzcinski, Krzysztof] Wilhelminas Children Hosp, Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands	Eijkman Institute; University of Indonesia; Eijkman Institute; Gadjah Mada University; Utrecht University; Utrecht University Medical Center	Safari, D (corresponding author), Eijkman Inst Mol Biol, Jakarta, Indonesia.	safari@eijkman.go.id	Trzcinski, Krzysztof/I-8840-2019	Trzcinski, Krzysztof/0000-0002-5433-8846; Khoeri, Miftahuddin Majid/0000-0002-8862-6707; Bogaert, Debby/0000-0003-2651-7000	International Society of Infectious Disease (ISID)	International Society of Infectious Disease (ISID)	This study was supported by a small grant from International Society of Infectious Disease (ISID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Anthony L, 2012, INT J INFECT DIS, V16, pE753, DOI 10.1016/j.ijid.2012.05.1037; Auranen K, 2013, VACCINE, V32, P153, DOI 10.1016/j.vaccine.2013.08.061; Bliss SJ, 2008, LANCET INFECT DIS, V8, P67, DOI 10.1016/S1473-3099(07)70242-6; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Cardoso Viviane C., 2006, J. Pediatr. (Rio J.), V82, P51, DOI 10.2223/JPED.1437; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUS S; Dagan R, 2009, CLIN MICROBIOL INFEC, V15, P16, DOI 10.1111/j.1469-0691.2009.02726.x; Farida H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087431; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Le CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019547; Leibovitz E, 1999, Int J Infect Dis, V3, P211, DOI 10.1016/S1201-9712(99)90027-9; Link-Gelles R, 2013, J INFECT DIS, V208, P1266, DOI 10.1093/infdis/jit315; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Morrison KE, 2000, J CLIN MICROBIOL, V38, P434; Mwenya DM, 2010, ANTIMICROB AGENTS CH, V54, P3756, DOI 10.1128/AAC.01409-09; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Polack FP, 2000, PEDIATR INFECT DIS J, V19, P608, DOI 10.1097/00006454-200007000-00005; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Shiri T, 2013, AM J EPIDEMIOL, V178, P1629, DOI 10.1093/aje/kwt200; Soewignjo S, 2001, CLIN INFECT DIS, V32, P1039, DOI 10.1086/319605; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Valente C, 2013, PEDIATR INFECT DIS J, V32, P703, DOI 10.1097/INF.0b013e31828692be; van der Linden M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-70; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	35	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110526	10.1371/journal.pone.0110526	http://dx.doi.org/10.1371/journal.pone.0110526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343448	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500034
J	Heimerl, S; Fischer, M; Baessler, A; Liebisch, G; Sigruener, A; Wallner, S; Schmitz, G				Heimerl, Susanne; Fischer, Marcus; Baessler, Andrea; Liebisch, Gerhard; Sigruener, Alexander; Wallner, Stefan; Schmitz, Gerd			Alterations of Plasma Lysophosphatidylcholine Species in Obesity and Weight Loss	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; ESI-MS/MS; CHOLESTEROL; LIPIDOMICS; CERAMIDE; SEPSIS; ETHER	Background: Obesity and related diseases of the metabolic syndrome contribute to the major health problems in industrialized countries. Alterations in the metabolism of lipid classes and lipid species may significantly be involved in these metabolic overload diseases. However, little is known about specific lipid species in this syndrome and existing data are contradictive. Methods: In this study, we quantified plasma lipid species by electrospray ionization tandem mass spectrometry (ESI-MS/MS) in obese subjects before and after 3 month weight loss as well as in a control group. Results: The comparison of obese subjects with control subjects before weight loss revealed significantly lower lysophosphatidylcholine (LPC) concentrations in obesity. LPC concentrations did not significantly increase during the observed period in the weight loss group. Analysis of LPC species revealed a decrease of most species in obesity and negative correlations with C-reactive protein (CRP) and body mass index (BMI). Correlating BMI ratio before and after weight loss with the ratio of total LPC and individual LPC species revealed significant negative relationships of LPC ratios with BMI ratio. Conclusions: Our findings contribute to the contradictive discussion of the role of LPC in obesity and related chronic inflammation strongly supporting pre-existing data in the literature that show a decrease of LPC species in plasma of obese and a potentially anti-inflammatory role in these subjects.	[Heimerl, Susanne; Liebisch, Gerhard; Sigruener, Alexander; Wallner, Stefan; Schmitz, Gerd] Univ Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany; [Fischer, Marcus; Baessler, Andrea] Univ Med Ctr, Clin Internal Med 2, Regensburg, Germany	University of Regensburg; University of Regensburg	Schmitz, G (corresponding author), Univ Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany.	gerd.schmitz@klinik.uni-regensburg.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Schmitz, Gerd/0000-0002-1325-1007	German Competence Network of Obesity - Federal Ministry of Education and Research [01GI1320]	German Competence Network of Obesity - Federal Ministry of Education and Research	This study was supported by the German Competence Network of Obesity funded by the Federal Ministry of Education and Research (01GI1320 to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends J, 2007, LIPIDS HLTH DIS, V6, P17, DOI [10.1186/1476-511X-6-17, DOI 10.1186/1476-511X-6-17]; Baessler A, 2012, EUR J HEART FAIL, V14, P1240, DOI 10.1093/eurjhf/hfs116; Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kita T, 1999, DIABETES RES CLIN PR, V45, P123, DOI 10.1016/S0168-8227(99)00041-8; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2002, CLIN CHEM, V48, P2217; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Nestel PJ, 2014, AM J CLIN NUTR, V99, P46, DOI 10.3945/ajcn.113.071712; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Rosenson RS, 2012, EUR HEART J, V33, P2899, DOI 10.1093/eurheartj/ehs148; Scherer M, 2010, ANAL CHEM, V82, P8794, DOI 10.1021/ac1021826; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Schwenk RW, 2013, MOL METAB, V2, P337, DOI 10.1016/j.molmet.2013.09.002; SEKAS G, 1985, J LAB CLIN MED, V105, P190; Sigruener A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085724; Strack C, 2012, J ATHEROSCLER THROMB, V19, P539, DOI 10.5551/jat.10918; SUBBAIAH PV, 1992, BIOCHIM BIOPHYS ACTA, V1128, P83, DOI 10.1016/0005-2760(92)90261-S; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wong G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076577; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989	34	80	81	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111348	10.1371/journal.pone.0111348	http://dx.doi.org/10.1371/journal.pone.0111348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340546	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800103
J	House, JS; Li, HL; DeGraff, LM; Flake, G; Zeldin, DC; London, SJ				House, John S.; Li, Huiling; DeGraff, Laura M.; Flake, Gordon; Zeldin, Darryl C.; London, Stephanie J.			Genetic variation in HTR4 and lung function: GWAS follow-up in mouse	FASEB JOURNAL			English	Article						pulmonary function; airway hyperresponsiveness; mouse models	GENOME-WIDE ASSOCIATION; OBSTRUCTIVE PULMONARY-DISEASE; SEROTONIN 5-HT4 RECEPTORS; AIRWAY HYPERRESPONSIVENESS; ASTHMA; EXPRESSION; KNOCK; IDENTIFICATION; HIPPOCAMPUS; VARIANTS	Human genome-wide association studies (GWASs) have identified numerous associations between single nucleotide polymorphisms (SNPs) and pulmonary function. Proving that there is a causal relationship between GWAS SNPs, many of which are noncoding and without known functional impact, and these traits has been elusive. Furthermore, noncoding GWAS-identified SNPs may exert trans-regulatory effects rather than impact the proximal gene. Noncoding variants in 5-hydroxytryptamine (serotonin) receptor 4 (HTR4) are associated with pulmonary function in human GWASs. To gain insight into whether this association is causal, we tested whether Htr4-null mice have altered pulmonary function. We found that HTR4-deficient mice have 12% higher baseline lung resistance and also increased methacholine-induced airway hyper responsiveness (AHR) as measured by lung resistance (27%), tissue resistance (48%), and tissue elastance (30%). Furthermore, Htr4-null mice were more sensitiveto serotonin-induced AHR. In models of exposure to bacterial lipopolysaccharide, bleomycin, and allergic airway inflammation induced by house dust mites, pulmonary function and cytokine profiles in Htr4-null mice differed little from their wild-type controls. The findings of altered baseline lung function and increased AHR in Htr4-null mice support a causal relationship between genetic variation in HTR4 and pulmonary function identified in human GWAS.	[House, John S.; Li, Huiling; DeGraff, Laura M.; Zeldin, Darryl C.; London, Stephanie J.] NIEHS, Div Intramural Res, US Natl Inst Hlth, Res Triangle Pk, NC 27709 USA; [Flake, Gordon] US Natl Inst Environm Hlth Sci, Div Natl Toxicol Program, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	London, SJ (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,POB 12233,MD A3-05, Res Triangle Pk, NC 27709 USA.	london2@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018; House, John S/A-1933-2013; London, Stephanie/C-3734-2019	Zeldin, Darryl C/0000-0002-2087-7307; House, John S/0000-0002-8447-7871; London, Stephanie/0000-0003-4911-5290	Intramural NIH HHS [Z01 ES025045, Z01 ES043012] Funding Source: Medline; NIBIB NIH HHS [P41 EB015897] Funding Source: Medline; PHS HHS [Z01 025043] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025043, ZIAES043012, ZICES102425, Z01ES043012, ZICES102546, Z01ES025045, ZIAES025045] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABRAMOWSKI D, 1995, J NEUROCHEM, V65, P782; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Azim S, 2012, BRAIN RES BULL, V87, P250, DOI 10.1016/j.brainresbull.2011.10.016; Bayer H, 2007, AM J RESP CELL MOL, V36, P85, DOI 10.1165/rcmb.2006-0151OC; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bockaert J, 2004, CNS NEUROL DISORD-DR, V3, P39, DOI 10.2174/1568007043482615; BUCKNER CK, 1991, J PHARMACOL EXP THER, V257, P26; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Compan V, 1996, EUR J NEUROSCI, V8, P2591, DOI 10.1111/j.1460-9568.1996.tb01553.x; Compan Valerie, 2004, Journal de la Societe de Biologie, V198, P37; Conductier G, 2006, EUR J NEUROSCI, V24, P1053, DOI 10.1111/j.1460-9568.2006.04943.x; COOPER DM, 1974, AM REV RESPIR DIS, V110, P708; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; DeMeo DL, 2003, SEMIN RESP CRIT CARE, V24, P151, DOI 10.1055/s-2003-39014; Dupont LL, 2014, PULM PHARMACOL THER, V28, P60, DOI 10.1016/j.pupt.2013.10.003; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Hegde SS, 1996, FASEB J, V10, P1398, DOI 10.1096/fasebj.10.12.8903510; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Hodge E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-77; Hospers JJ, 2000, LANCET, V356, P1313, DOI 10.1016/S0140-6736(00)02815-4; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Jean A, 2007, P NATL ACAD SCI USA, V104, P16335, DOI 10.1073/pnas.0701471104; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Kim DK, 2012, AM J RESP CRIT CARE, V186, P1238, DOI 10.1164/rccm.201206-1013OC; Kim TH, 2011, RESPIROLOGY, V16, P630, DOI 10.1111/j.1440-1843.2011.01963.x; Li XN, 2013, J ALLERGY CLIN IMMUN, V132, P313, DOI 10.1016/j.jaci.2013.01.051; Loth DW, 2014, NAT GENET, V46, P669, DOI 10.1038/ng.3011; Manzke T, 2003, SCIENCE, V301, P226, DOI 10.1126/science.1084674; MARTIN TR, 1994, J PHARMACOL EXP THER, V268, P104; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; REYNOLDS GP, 1995, BRIT J PHARMACOL, V114, P993, DOI 10.1111/j.1476-5381.1995.tb13303.x; RIJCKEN B, 1995, AM J RESP CRIT CARE, V151, P1377, DOI 10.1164/ajrccm.151.5.7735588; RYBICKI BA, 1990, J CLIN EPIDEMIOL, V43, P667, DOI 10.1016/0895-4356(90)90037-P; Segu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009529; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Vestbo J, 1998, THORAX, V53, pS15, DOI 10.1136/thx.53.2008.S15; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429	54	13	13	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					323	335		10.1096/fj.14-253898	http://dx.doi.org/10.1096/fj.14-253898			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25342126	Green Published			2022-12-26	WOS:000347378600030
J	Park, SY; Waheed, AA; Zhang, ZR; Freed, EO; Bonifacino, JS				Park, Sang Yoon; Waheed, Abdul A.; Zhang, Zai-Rong; Freed, Eric O.; Bonifacino, Juan S.			HIV-1 Vpu Accessory Protein Induces Caspase-mediated Cleavage of IRF3 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Cellular Immune Response; Human Immunodeficiency Virus (HIV); Innate Immunity; Vpu; Interferon Regulatory Factor 3	VIRUS TYPE-1 NEF; BETA-TRCP; ANTIVIRAL RESPONSE; DENDRITIC CELLS; RESTRICTS HIV-1; DOWN-REGULATION; IMMUNODEFICIENCY; APOPTOSIS; DEGRADATION; EXPRESSION	Vpu is an accessory protein encoded by HIV-1 that interferes with multiple host-cell functions. Herein we report that expression of Vpu by transfection into 293T cells causes partial proteolytic cleavage of interferon regulatory factor 3 (IRF3), a key transcription factor in the innate anti-viral response. Vpu-induced IRF3 cleavage is mediated by caspases and occurs mainly at Asp-121. Cleavage produces a C-terminal fragment of approximate to 37 kDa that comprises the IRF dimerization and transactivation domains but lacks the DNA-binding domain. A similar cleavage is observed upon infection of the Jurkat T-cell line with vesicular stomatitis virus G glycoprotein (VSV-G)-pseudotyped HIV-1. Two other HIV-1 accessory proteins, Vif and Vpr, also contribute to the induction of IRF3 cleavage in both the transfection and the infection systems. The C-terminal IRF3 fragment interferes with the transcriptional activity of full-length IRF3. Cleavage of IRF3 under all of these conditions correlates with cleavage of poly(ADP-ribose) polymerase, an indicator of apoptosis. We conclude that Vpu contributes to the attenuation of the anti-viral response by partial inactivation of IRF3 while host cells undergo apoptosis.	[Park, Sang Yoon; Zhang, Zai-Rong; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Waheed, Abdul A.; Freed, Eric O.] NCI, HIV Drug Resistance Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bonifacino, JS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	bonifacinoj@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370; ZHANG, ZAIRONG/0000-0001-9768-0548	NICHD; NCI; Intramural AIDS Targeted Antiviral Program (IATAP), National Institutes of Health; National Institutes of Health [IATAP-ZIA HD008909, NICHD DIR-ZIA HD001607]; NATIONAL CANCER INSTITUTE [ZIABC010776] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program (IATAP), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Intramural Programs of the NICHD and NCI and the Intramural AIDS Targeted Antiviral Program (IATAP), National Institutes of Health, and by National Institutes of Health Grants IATAP-ZIA HD008909 and NICHD DIR-ZIA HD001607 (to J. S. B.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Akari H, 2001, J EXP MED, V194, P1299, DOI 10.1084/jem.194.9.1299; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Best SM, 2004, VIROLOGY, V320, P191, DOI 10.1016/j.virol.2003.11.025; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; Casella CR, 1999, J VIROL, V73, P92, DOI 10.1128/JVI.73.1.92-100.1999; Chaipan C, 2013, J VIROL, V87, P444, DOI 10.1128/JVI.00676-12; Doehle BP, 2012, J VIROL, V86, P8367, DOI 10.1128/JVI.00423-12; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Garcia S, 1997, IMMUNOL LETT, V57, P53, DOI 10.1016/S0165-2478(97)00070-9; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Harman AN, 2011, BLOOD, V118, P298, DOI 10.1182/blood-2010-07-297721; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hotter D, 2013, J VIROL, V87, P7160, DOI 10.1128/JVI.00526-13; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Li Y, 2011, BBA-GENE REGUL MECH, V1809, P166, DOI 10.1016/j.bbagrm.2011.01.006; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Moll M, 2010, BLOOD, V116, P1876, DOI 10.1182/blood-2009-09-243667; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Sastry KJ, 1996, ONCOGENE, V13, P487; Schaeffer E, 2001, J VIROL, V75, P2993, DOI 10.1128/JVI.75.6.2993-3000.2001; Sears N, 2011, J BIOL CHEM, V286, P33037, DOI 10.1074/jbc.M111.257022; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160; Zhang ZR, 2013, CELL, V154, P609, DOI 10.1016/j.cell.2013.06.038	43	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35102	35110		10.1074/jbc.M114.597062	http://dx.doi.org/10.1074/jbc.M114.597062			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352594	hybrid, Green Published			2022-12-26	WOS:000346660200005
J	Sanchez-Sanchez, J; Garcia-Unanue, J; Jimenez-Reyes, P; Gallardo, A; Burillo, P; Felipe, JL; Gallardo, L				Sanchez-Sanchez, Javier; Garcia-Unanue, Jorge; Jimenez-Reyes, Pedro; Gallardo, Ana; Burillo, Pablo; Luis Felipe, Jose; Gallardo, Leonor			Influence of the Mechanical Properties of Third-Generation Artificial Turf Systems on Soccer Players' Physiological and Physical Performance and Their Perceptions	PLOS ONE			English	Article							REPEATED SPRINT ABILITY; NATURAL GRASS; PLAYING SURFACE; INTERMITTENT EXERCISE; ROTATIONAL TRACTION; FOOTBALL PLAYERS; SYNTHETIC TURF; ELITE FOOTBALL; RESPONSES; SAND	The aim of this research was to evaluate the influence of the mechanical properties of artificial turf systems on soccer players' performance. A battery of perceptive physiological and physical tests were developed on four different structural systems of artificial turf (System 1: Compacted gravel sub-base without elastic layer; System 2: Compacted gravel sub-base with elastic layer; System 3: Asphalt sub-base without elastic layer; System 4: Asphalt sub-base with elastic layer). The sample was composed of 18 soccer players (22.44 +/- 1.72 years) who typically train and compete on artificial turf. The artificial turf system with less rotational traction (S3) showed higher total time in the Repeated Sprint Ability test in comparison to the systems with intermediate values (49.46 +/- 1.75 s vs 47.55 +/- 1.82 s (S1) and 47.85 +/- 1.59 s (S2); p < 0.001). The performance in jumping tests (countermovement jump and squat jump) and ball kicking to goal decreased after the RSA test in all surfaces assessed (p < 0.05), since the artificial turf system did not affect performance deterioration (p > 0.05). The physiological load was similar in all four artificial turf systems. However, players felt more comfortable on the harder and more rigid system (S4; visual analogue scale = 70.83 +/- 14.28) than on the softer artificial turf system (S2; visual analogue scale = 54.24 +/- 19.63). The lineal regression analysis revealed a significant influence of the mechanical properties of the surface of 16.5%, 15.8% and 7.1% on the mean time of the sprint, the best sprint time and the maximum mean speed in the RSA test respectively. Results suggest a mechanical heterogeneity between the systems of artificial turf which generate differences in the physical performance and in the soccer players' perceptions.	[Sanchez-Sanchez, Javier; Jimenez-Reyes, Pedro; Gallardo, Ana] Univ Catolica San Antonio, UCAM, Sch Sport Sci, Murcia, Spain; [Sanchez-Sanchez, Javier; Garcia-Unanue, Jorge; Burillo, Pablo; Luis Felipe, Jose; Gallardo, Leonor] Univ Castilla La Mancha, IGOID Res Grp, Toledo, Spain; [Burillo, Pablo] Camilo Jose Cela Univ, Sport Sci Inst, Madrid, Spain; [Luis Felipe, Jose] European Univ, Sch Sport Sci, Madrid, Spain	Universidad Catolica de Murcia; Universidad de Castilla-La Mancha; Camilo Jose Cela University	Sanchez-Sanchez, J (corresponding author), Univ Catolica San Antonio, UCAM, Sch Sport Sci, Murcia, Spain.	jssanchez@ucam.edu	Garcia-Unanue, Jorge/AAY-6231-2020; Felipe, Jose Luis/M-1442-2015; Felipe, José Luis/U-1062-2017; García-Unanue, Jorge/F-6674-2016; Jimenez-Reyes, Pedro/P-1075-2016; Guerrero, Ana Maria Gallardo/K-3103-2017	Garcia-Unanue, Jorge/0000-0002-1741-5566; Felipe, José Luis/0000-0002-2029-1277; García-Unanue, Jorge/0000-0002-1741-5566; Jimenez-Reyes, Pedro/0000-0002-8156-243X; Gallardo Guerrero, Ana Maria/0000-0001-8803-9820; Gallardo Guerrero, Leonor/0000-0002-6296-6121; Sanchez-Sanchez, Javier/0000-0003-0017-0184				Alcantara E, 2009, P I MECH ENG P-J SPO, V223, P1, DOI 10.1243/17543371JSET27; Allgeuer T., 2008, SPORT TECHNOL, V1, P29; Andersson H, 2008, J SPORT SCI, V26, P113, DOI 10.1080/02640410701422076; [Anonymous], 2010, SPORTS TECHNOLOGY; Bishop D, 2003, J SPORT MED PHYS FIT, V43, P418; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Bravo DF, 2008, INT J SPORTS MED, V29, P668, DOI 10.1055/s-2007-989371; Brito J, 2012, HUM MOVEMENT SCI, V31, P946, DOI 10.1016/j.humov.2011.08.011; Buchheit M, 2010, EUR J APPL PHYSIOL, V110, P1007, DOI 10.1007/s00421-010-1587-3; Burillo P., 2012, SCI RES ESSAYS, V7, P2457, DOI DOI 10.5897/SRE11.1454; Burillo P, 2014, EUR J SPORT SCI, V14, pS437, DOI 10.1080/17461391.2012.713005; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Castagna C, 2008, J STRENGTH COND RES, V22, P923, DOI 10.1519/JSC.0b013e31816a4281; Chamari K, 2008, J STRENGTH COND RES, V22, P944, DOI 10.1519/JSC.0b013e31816a57c6; Chaouachi A, 2010, J STRENGTH COND RES, V24, P2663, DOI [10.1519/JSC.0b013e3181e347f4, 10.1519/JSC.0b013e3181d65071]; Comite Europeen de Normalisation, 2014, 1533012014 EN; De Clercq D, 2014, FOOTWEAR SCI, V6, P81, DOI 10.1080/19424280.2014.895056; Di Michele R, 2009, J STRENGTH COND RES, V23, P939, DOI 10.1519/JSC.0b013e3181a07b6e; Dixon SJ., 2003, SPORTS ENG, V6, P1, DOI [10.1007/BF02844155, DOI 10.1007/BF02844155]; Dragoo JL, 2010, SPORTS MED, V40, P981, DOI 10.2165/11535910-000000000-00000; Ekstrand J, 2006, BRIT J SPORT MED, V40, P975, DOI 10.1136/bjsm.2006.027623; Ekstrand J, 2011, SCAND J MED SCI SPOR, V21, P824, DOI 10.1111/j.1600-0838.2010.01118.x; FIFA, 2012, FIFA HDB REQ; FIFA, 2012, FIFA HDB TEST METH; Figueiredo AJ, 2009, J SPORT SCI, V27, P883, DOI 10.1080/02640410902946469; Fitzsimons M., 1993, AUST J SCI MED SPORT, V25, P82; Ford KR, 2006, J SCI MED SPORT, V9, P433, DOI 10.1016/j.jsams.2006.03.019; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Gains GL, 2010, J STRENGTH COND RES, V24, P2613, DOI 10.1519/JSC.0b013e3181eccdf8; Giatsis George, 2004, Sports Biomech, V3, P145, DOI 10.1080/14763140408522835; Goedecke JH, 2013, NUTRIENTS, V5, P5193, DOI 10.3390/nu5125193; Greig M, 2007, BRIT J SPORT MED, V41, P908, DOI 10.1136/bjsm.2006.030387; Hardin EC, 2004, MED SCI SPORT EXER, V36, P838, DOI 10.1249/01.MSS.0000126605.65966.40; Hennig EM, 2014, FOOTWEAR SCI, V6, P119, DOI 10.1080/19424280.2013.873486; Hughes MG, 2013, J SPORT SCI, V31, P878, DOI 10.1080/02640414.2012.757340; Ivarez JC, 2009, J SCI MED SPORT, V13, P232; Kalapotharakos VI, 2006, J SPORT MED PHYS FIT, V46, P515; Kanaras V, 2014, AM J SPORT SCI, V2, P1; Kerdok AE, 2002, J APPL PHYSIOL, V92, P469, DOI 10.1152/japplphysiol.01164.2000; Krustrup P, 2001, J SPORT SCI, V19, P881, DOI 10.1080/026404101753113831; Kuhlman S, 2010, P I MECH ENG P-J SPO, V224, P155, DOI 10.1243/17543371JSET56; Lara AJ, 2006, J SPORT MED PHYS FIT, V46, P419; Lejeune TM, 1998, J EXP BIOL, V201, P2071; Livesay GA, 2006, AM J SPORT MED, V34, P415, DOI 10.1177/0363546505284182; Luo G, 2011, FOOTWEAR SCI, V3, P127, DOI 10.1080/19424280.2011.639807; McGhie D, 2013, AM J SPORT MED, V41, P177, DOI 10.1177/0363546512464697; Mohr M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039202; Muller C, 2010, SPORT BIOMECH, V9, P193, DOI 10.1080/14763141.2010.511679; Naunheim R, 2004, J TRAUMA, V57, P1311, DOI 10.1097/01.TA.0000136154.36483.98; Nedelec M, 2013, J SPORT SCI, V31, P529, DOI 10.1080/02640414.2012.738923; Oliver JL, 2009, J SCI MED SPORT, V12, P20, DOI 10.1016/j.jsams.2007.10.010; Perez Soriano P, 2009, J HUM SPORT EXERC, V4, P78; Pinnington HC, 2005, EUR J APPL PHYSIOL, V94, P242, DOI 10.1007/s00421-005-1323-6; Pinnington HC, 2001, J SCI MED SPORT, V4, P416, DOI 10.1016/S1440-2440(01)80051-7; Potthast W, 2010, SPORT TECHNOL, V3, P5; Potthast W, 2010, FOOTWEAR SCI, V2, P29, DOI 10.1080/19424280903535447; Poulos CCN, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-11; Pyne DB, 2008, J STRENGTH COND RES, V22, P1633, DOI 10.1519/JSC.0b013e318181fe7a; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Rebelo A, 2013, INT J SPORTS MED, V34, P312, DOI 10.1055/s-0032-1323729; Sanchez-Sanchez J, 2014, P I MECH ENG P-J SPO; Schrier NM, 2014, FOOTWEAR SCI, V6, P69, DOI 10.1080/19424280.2014.886302; Spencer M, 2006, J SCI MED SPORT, V9, P181, DOI 10.1016/j.jsams.2005.05.001; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Villwock MR, 2009, P I MECH ENG P-J SPO, V223, P11, DOI 10.1243/17543371JSET26; Villwock MR, 2009, AM J SPORT MED, V37, P518, DOI 10.1177/0363546508328108; Zanetti EM, 2009, APPL ERGON, V40, P485, DOI 10.1016/j.apergo.2008.09.007	68	33	33	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111368	10.1371/journal.pone.0111368	http://dx.doi.org/10.1371/journal.pone.0111368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354188	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200075
J	Juhas, M; Evans, LDB; Frost, J; Davenport, PW; Yarkoni, O; Fraser, GM; Ajioka, JW				Juhas, Mario; Evans, Lewis D. B.; Frost, Joe; Davenport, Peter W.; Yarkoni, Orr; Fraser, Gillian M.; Ajioka, James W.			Escherichia coli Flagellar Genes as Target Sites for Integration and Expression of Genetic Circuits	PLOS ONE			English	Article							DNA; PROTEIN; PCR; CHROMOSOME; SEQUENCES; RESOURCE; SYSTEMS; CLONING; GENOME; TOOL	E. coli is a model platform for engineering microbes, so genetic circuit design and analysis will be greatly facilitated by simple and effective approaches to introduce genetic constructs into the E. coli chromosome at well-characterised loci. We combined the Red recombinase system of bacteriophage lambda and Isothermal Gibson Assembly for rapid integration of novel DNA constructs into the E. coli chromosome. We identified the flagellar region as a promising region for integration and expression of genetic circuits. We characterised integration and expression at four candidate loci, fliD, fliS, fliT, and fliY, of the E. coli flagellar region 3a. The integration efficiency and expression from the four integrations varied considerably. Integration into fliD and fliS significantly decreased motility, while integration into fliT and fliY had only a minor effect on the motility. None of the integrations had negative effects on the growth of the bacteria. Overall, we found that fliT was the most suitable integration site.	[Juhas, Mario; Evans, Lewis D. B.; Frost, Joe; Davenport, Peter W.; Yarkoni, Orr; Fraser, Gillian M.; Ajioka, James W.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Juhas, M (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mj417@cam.ac.uk	Fraser, Gillian/I-1846-2013	Fraser, Gillian/0000-0002-4874-8734; Frost, Joe/0000-0002-5946-6062; Evans, Lewis/0000-0001-7279-7651	UK Engineering and Physical Sciences Research Council; Welcome Trust	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Welcome Trust(Wellcome Trust)	This work was supported by grants from the UK Engineering and Physical Sciences Research Council and the Welcome Trust to JWA and GMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Chen XZ, 2013, BIOTECHNOL ADV, V31, P1200, DOI 10.1016/j.biotechadv.2013.02.009; Cunningham DS, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-27; Das B, 2010, P NATL ACAD SCI USA, V107, P4377, DOI 10.1073/pnas.0910212107; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fraser GM, 1999, MOL MICROBIOL, V32, P569, DOI 10.1046/j.1365-2958.1999.01372.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Ikeda T, 1996, J MOL BIOL, V259, P679, DOI 10.1006/jmbi.1996.0349; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Juhas M, 2013, BIOTECHNOL J; Juhas M, 2014, MICROBIOLOGY; Juhas M, 2012, TRENDS BIOTECHNOL, V30, P601, DOI 10.1016/j.tibtech.2012.08.002; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Marcellin E, 2010, METAB ENG, V12, P62, DOI 10.1016/j.ymben.2009.09.001; Merryman C, 2012, METAB ENG, V14, P196, DOI 10.1016/j.ymben.2012.02.005; MIESCHENDAHL M, 1985, J BACTERIOL, V164, P1366, DOI 10.1128/JB.164.3.1366-1369.1985; Miller E M, 1995, Methods Mol Biol, V47, P105; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Ozin AJ, 2003, FEMS MICROBIOL LETT, V219, P219, DOI 10.1016/S0378-1097(02)01208-9; Park SJ, 2012, APPL MICROBIOL BIOT, V93, P273, DOI 10.1007/s00253-011-3530-x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Sabri S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-60; St-Pierre F, 2013, ACS SYNTH BIOL, V2, P537, DOI 10.1021/sb400021j; Ublinskaya AA, 2012, J MICROBIOL METH, V89, P167, DOI 10.1016/j.mimet.2012.03.013; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]	36	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111451	10.1371/journal.pone.0111451	http://dx.doi.org/10.1371/journal.pone.0111451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350000	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943100075
J	Lau, K; Lai, KP; Bao, JYJ; Zhang, N; Tse, A; Tong, A; Li, JW; Lok, S; Kong, RYC; Lui, WY; Wong, A; Wu, RSS				Lau, Karen; Lai, Keng Po; Bao, Jessie Yun Juan; Zhang, Na; Tse, Anna; Tong, Amy; Li, Jing Woei; Lok, Si; Kong, Richard Yuen Chong; Lui, Wing Yee; Wong, Alice; Wu, Rudolf Shiu Sun			Identification and Expression Profiling of MicroRNAs in the Brain, Liver and Gonads of Marine Medaka (Oryzias melastigma) and in Response to Hypoxia	PLOS ONE			English	Article							MOLECULAR RESPONSES; GENE-EXPRESSION; LET-7 FAMILY; CANCER; CELLS; ZEBRAFISH; RNAS; DIFFERENTIATION; DISCOVERY; LATIPES	The marine medaka (Oryzias melastigma) has been increasingly used as a fish model for detecting environmental stresses and chemical contaminants in the marine environment. Recent mammalian studies have shown that environmental stresses can alter the expression profiles of microRNAs (miRNAs), leading to transgenerational effects. Here, we use high-throughput Illumina RNA sequencing (RNA-Seq) for miRNA transcriptome analysis of brain, liver, and gonads from sexually mature male and female marine medaka. A total of 128,883,806 filtered sequence reads were generated from six small RNA libraries, identifying a total of 2,125,663 non-redundant sequences. These sequences were aligned and annotated to known animal miRNAs (miRBase) using the BLAST method. A total of 223 distinct miRNA types were identified, with the greatest number expressed in brain tissue. Our data suggested that 55 miRNA types from 34 families are common to all tested tissues, while some of the miRNAs are tissue-enriched or sex-enriched. Quantitative real-time PCR analysis further demonstrated that let-7a, miR-122, and miR-9-3p were downregulated in hypoxic female medaka, while miR-2184 was specifically upregulated in the testis of hypoxic male fish. This is the first study to identify miRNAs in O. melastigma using small RNA deep sequencing technology. Because miRNA expression is highly conserved between marine medaka and other vertebrates, marine medaka may serve as a good model for studies on the functional roles of miRNAs in hypoxia stress response and signaling in marine fish.	[Lau, Karen; Lai, Keng Po; Tse, Anna; Lui, Wing Yee; Wong, Alice; Wu, Rudolf Shiu Sun] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Lau, Karen; Lai, Keng Po; Tse, Anna; Kong, Richard Yuen Chong; Wu, Rudolf Shiu Sun] State Key Lab Marine Pollut, Hong Kong, Hong Kong, Peoples R China; [Bao, Jessie Yun Juan; Zhang, Na; Tong, Amy; Lok, Si] Univ Hong Kong, Hong Kong Jockey Club Bldg Interdisciplinary Res, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Li, Jing Woei] Chinese Univ Hong Kong, Hong Kong Bioinformat Ctr, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Lau, K (corresponding author), Univ Hong Kong, Sch Biol Sci, Kadoorie Biol Sci Bldg, Hong Kong, Hong Kong, Peoples R China.	karenytlau@hotmail.com; rudolfwu@hku.hk	; Lui, Wing Yee/A-2743-2010	LAI, Keng Po/0000-0001-8135-6030; Li, Jing Woei/0000-0001-6167-7689; Lui, Wing Yee/0000-0002-3096-1158; KONG, Yuen Chong Richard/0000-0002-4636-5756				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bannister SC, 2011, BIOL REPROD, V85, P22, DOI 10.1095/biolreprod.110.088476; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brevik A., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/407431; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chen Z, 2013, J CLIN INVEST, V123, P1057, DOI 10.1172/JCI65344; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Dunaeva TY, 2008, B EXP BIOL MED+, V146, P385, DOI 10.1007/s10517-009-0316-6; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kawahara H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00030; Kissling GE, 2006, TOXICOL SCI, V92, P143, DOI 10.1093/toxsci/kfj181; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kong RYC, 2008, AQUAT TOXICOL, V86, P131, DOI 10.1016/j.aquatox.2007.10.011; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kure EH, 2013, AQUAT TOXICOL, V138, P98, DOI 10.1016/j.aquatox.2013.04.004; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li SC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S8; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lind GE, 2006, J PATHOL, V210, P441, DOI 10.1002/path.2064; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Shan FB, 2014, J CELL PHYSIOL, V229, P1511, DOI 10.1002/jcp.24593; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908	50	50	52	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110698	10.1371/journal.pone.0110698	http://dx.doi.org/10.1371/journal.pone.0110698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350659	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100036
J	Kockx, M; Karunakaran, D; Traini, M; Xue, J; Huang, KY; Nawara, D; Gaus, K; Jessup, W; Robinson, PJ; Kritharides, L				Kockx, Maaike; Karunakaran, Denuja; Traini, Mathew; Xue, Jing; Huang, Kuan Yen; Nawara, Diana; Gaus, Katharina; Jessup, Wendy; Robinson, Phillip J.; Kritharides, Leonard			Pharmacological Inhibition of Dynamin II Reduces Constitutive Protein Secretion from Primary Human Macrophages	PLOS ONE			English	Article							APOLIPOPROTEIN-E SECRETION; TRANS-GOLGI NETWORK; CELL BIOLOGY; ENDOCYTOSIS; ATHEROSCLEROSIS; VESICLES; ISOFORMS; IDENTIFICATION; MICROTUBULES; FIBRONECTIN	Dynamins are fission proteins that mediate endocytic and exocytic membrane events and are pharmacological therapeutic targets. These studies investigate whether dynamin II regulates constitutive protein secretion and show for the first time that pharmacological inhibition of dynamin decreases secretion of apolipoprotein E (apoE) and several other proteins constitutively secreted from primary human macrophages. Inhibitors that target recruitment of dynamin to membranes (MiTMABs) or directly target the GTPase domain (Dyngo or Dynole series), dose- and time-dependently reduced the secretion of apoE. SiRNA oligo's targeting all isoforms of dynamin II confirmed the involvement of dynamin II in apoE secretion. Inhibition of secretion was not mediated via effects on mRNA or protein synthesis. 2D-gel electrophoresis showed that inhibition occurred after apoE was processed and glycosylated in the Golgi and live cell imaging showed that inhibited secretion was associated with reduced post-Golgi movement of apoE-GFP-containing vesicles. The effect was not restricted to macrophages, and was not mediated by the effects of the inhibitors on microtubules. Inhibition of dynamin also altered the constitutive secretion of other proteins, decreasing the secretion of fibronectin, matrix metalloproteinase 9, Chitinase-3-like protein 1 and lysozyme but unexpectedly increasing the secretion of the inflammatory mediator cyclophilin A. We conclude that pharmacological inhibitors of dynamin II modulate the constitutive secretion of macrophage apoE as a class effect, and that their capacity to modulate protein secretion may affect a range of biological processes.	[Kockx, Maaike; Traini, Mathew; Nawara, Diana; Jessup, Wendy] Univ Sydney, ANZAC Res Inst, Atherosclerosis Lab, Sydney, NSW 2006, Australia; [Karunakaran, Denuja; Huang, Kuan Yen; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Karunakaran, Denuja] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Xue, Jing; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia; [Kritharides, Leonard] Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW 2006, Australia; [Kritharides, Leonard] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW 2006, Australia	University of Sydney; ANZAC Research Institute; University of New South Wales Sydney; University of Ottawa; University of Ottawa Heart Institute; Children's Medical Research Institute - Australia; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute	Kritharides, L (corresponding author), Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW 2006, Australia.	leonard.kritharides@sydney.edu.au	Xue, Jingling/AAE-1991-2020; Kritharides, Leonard/AAQ-2720-2020; Ekanayake, Kanchana/P-8817-2016; Karunakaran, Denuja/G-2275-2010; Research Institute, ANZAC/CAE-9030-2022; Robinson, Phillip J/G-4008-2011	Xue, Jingling/0000-0003-0380-3506; Karunakaran, Denuja/0000-0002-4789-8634; Robinson, Phillip J/0000-0002-7878-0313; Traini, Mathew/0000-0002-9423-5294; Gaus, Katharina/0000-0002-8009-9658	National Health and Medical Research Council [482820, APP1011457]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council (482820 for LK and WJ and APP1011457 for PJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; BALCH WE, 1986, J BIOL CHEM, V261, P4690; Berbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; DECURTIS I, 1989, CELL, V58, P719, DOI 10.1016/0092-8674(89)90106-2; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Hill TA, 2004, BIOORG MED CHEM LETT, V14, P3275, DOI 10.1016/j.bmcl.2004.03.096; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Huang ZH, 2013, J LIPID RES, V54, P202, DOI 10.1194/jlr.M031906; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Karunakaran D, 2013, J BIOL CHEM, V288, P5186, DOI 10.1074/jbc.M112.428961; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Kockx M, 2008, ARTERIOSCL THROM VAS, V28, P1060, DOI 10.1161/ATVBAHA.108.164350; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; Kockx M, 2012, BIOCHEM J, V447, P51, DOI 10.1042/BJ20111891; Kockx M, 2009, J BIOL CHEM, V284, P24144, DOI 10.1074/jbc.M109.032615; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Liu HX, 2006, AM J PATHOL, V169, P303, DOI 10.2353/ajpath.2006.050885; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Ly S, 2013, J BIOL CHEM, V288, P11628, DOI 10.1074/jbc.M112.411900; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Nigro P, 2011, J EXP MED, V208, P53, DOI 10.1084/jem.20101174; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Sadowski L, 2013, TRAFFIC; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; TAKEMURA R, 1984, AM J PHYSIOL, V246, pC1, DOI 10.1152/ajpcell.1984.246.1.C1; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111186	10.1371/journal.pone.0111186	http://dx.doi.org/10.1371/journal.pone.0111186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347775	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900051
J	Sahagun-Ruiz, A; Martinez, APG; Breda, LCD; Fraga, TR; Valencia, MMC; Barbosa, AS; Isaac, L				Sahagun-Ruiz, Alfredo; Granados Martinez, Adriana Patricia; Dantas Breda, Leandro Carvalho; Fraga, Tatiana Rodrigues; Castiblanco Valencia, Monica Marcela; Barbosa, Angela Silva; Isaac, Lourdes			Pasteurella pneumotropica Evades the Human Complement System by Acquisition of the Complement Regulators Factor H and C4BP	PLOS ONE			English	Article							C4B-BINDING PROTEIN CONTRIBUTES; BORRELIA-BURGDORFERI; IMMUNE EVASION; MULTOCIDA; BINDING; PATHOGENESIS; ACTIVATION; STRATEGIES; VIRULENCE	Pasteurella pneumotropica is an opportunist Gram negative bacterium responsible for rodent pasteurellosis that affects upper respiratory, reproductive and digestive tracts of mammals. In animal care facilities the presence of P. pneumotropica causes severe to lethal infection in immunodeficient mice, being also a potential source for human contamination. Indeed, occupational exposure is one of the main causes of human infection by P. pneumotropica. The clinical presentation of the disease includes subcutaneous abscesses, respiratory tract colonization and systemic infections. Given the ability of P. pneumotropica to fully disseminate in the organism, it is quite relevant to study the role of the complement system to control the infection as well as the possible evasion mechanisms involved in bacterial survival. Here, we show for the first time that P. pneumotropica is able to survive the bactericidal activity of the human complement system. We observed that host regulatory complement C4BP and Factor H bind to the surface of P. pneumotropica, controlling the activation pathways regulating the formation and maintenance of C3-convertases. These results show that P. pneumotropica has evolved mechanisms to evade the human complement system that may increase the efficiency by which this pathogen is able to gain access to and colonize inner tissues where it may cause severe infections.	[Sahagun-Ruiz, Alfredo] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Dept Microbiol & Inmunol, Mexico City 04510, DF, Mexico; [Granados Martinez, Adriana Patricia; Dantas Breda, Leandro Carvalho; Fraga, Tatiana Rodrigues; Castiblanco Valencia, Monica Marcela; Isaac, Lourdes] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Barbosa, Angela Silva] Inst Butantan, Bacteriol Lab, Sao Paulo, Brazil	Universidad Nacional Autonoma de Mexico; Universidade de Sao Paulo; Instituto Butantan	Isaac, L (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.	louisaac@icb.usp.br	Barbosa, Angela S/I-3518-2013; Sahagún-Ruiz, Alfredo/AAE-2549-2020; Breda, Leandro C D/C-1552-2018; Breda, Leandro/A-8458-2015; FRAGA, TATIANA RODRIGUES/ABD-8152-2020; Isaac, Lourdes/I-7186-2012	Barbosa, Angela S/0000-0002-6458-9489; Breda, Leandro C D/0000-0001-9556-1676; Breda, Leandro/0000-0001-9556-1676; Sahagun-Ruiz, Alfredo/0000-0002-9737-1945; Rodrigues Fraga, Tatiana/0000-0002-5896-5994; Isaac, Lourdes/0000-0002-7746-8942	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50043-0]; Programa de Apoyos para la Superacion del Personal Academico (PASPA-DGAPA) from Universidad Nacional Autonoma de Mexico (UNAM)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa de Apoyos para la Superacion del Personal Academico (PASPA-DGAPA) from Universidad Nacional Autonoma de Mexico (UNAM)	Funding provided by Grant #2010/50043-0, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). A.S.R. was supported by a fellowship from the Programa de Apoyos para la Superacion del Personal Academico (PASPA-DGAPA) from Universidad Nacional Autonoma de Mexico (UNAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Barbosa AS, 2010, INFECT IMMUN, V78, P3207, DOI 10.1128/IAI.00279-10; Barbosa AS, 2009, INFECT IMMUN, V77, P1137, DOI 10.1128/IAI.01310-08; BARNUM SR, 1991, IMMUNOL RES, V10, P28, DOI 10.1007/BF02918165; BLAU KA, 1987, CAN J VET RES, V51, P157; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Botto M., 2000, COMPLEMENT FACTS BOO, P88; Boyce JD, 2000, INFECT IMMUN, V68, P3463, DOI 10.1128/IAI.68.6.3463-3468.2000; Campos A, 2000, PEDIATR NEPHROL, V15, P31, DOI 10.1007/s004670000432; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; CUADRADOGOMEZ JM, 1995, CLIN INFECT DIS, V21, P445, DOI 10.1093/clinids/21.2.445; Dan Maria, 2005, Rev Med Chir Soc Med Nat Iasi, V109, P743; de Paula PF, 2003, SCAND J IMMUNOL, V58, P572, DOI 10.1046/j.1365-3083.2003.01326.x; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Frebourg NB, 2002, J CLIN MICROBIOL, V40, P687, DOI 10.1128/JCM.40.2.687-689.2002; GADBERRY JL, 1984, J CLIN MICROBIOL, V19, P926, DOI 10.1128/JCM.19.6.926-927.1984; GIGLI I, 1985, J IMMUNOL, V135, P440; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Guillard T, 2010, DIAGN MICR INFEC DIS, V68, P190, DOI 10.1016/j.diagmicrobio.2010.06.004; Hallstrom T, 2008, J IMMUNOL, V181, P537, DOI 10.4049/jimmunol.181.1.537; Hallstrom T, 2007, J IMMUNOL, V178, P6359, DOI 10.4049/jimmunol.178.10.6359; Harper M, 2006, FEMS MICROBIOL LETT, V265, P1, DOI 10.1111/j.1574-6968.2006.00442.x; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; JAWETZ E, 1950, J INFECT DIS, V86, P172, DOI 10.1093/infdis/86.2.172; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; MINTON EJ, 1990, POSTGRAD MED J, V66, P125, DOI 10.1136/pgmj.66.772.125; MISASI R, 1989, EUR J IMMUNOL, V19, P1765, DOI 10.1002/eji.1830190936; Pasteur Louis, 1880, COMPTES RENDUS ACAD, V91, P673; Potempa M, 2008, J IMMUNOL, V181, P5537, DOI 10.4049/jimmunol.181.8.5537; Reid KBM, 1988, FRONTIERS MOL BIOL, P189; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Tatum FM, 2009, MICROB PATHOGENESIS, V46, P337, DOI 10.1016/j.micpath.2009.04.003; Tirmizi A, 2012, INT J CARDIOL, V161, pE44, DOI 10.1016/j.ijcard.2012.04.007; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WARD GE, 1978, J CLIN MICROBIOL, V8, P177; WEBER DJ, 1984, MEDICINE, V63, P133, DOI 10.1097/00005792-198405000-00001; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111194	10.1371/journal.pone.0111194	http://dx.doi.org/10.1371/journal.pone.0111194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347183	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900054
J	Connolly, F; Rae, MT; Butler, M; Klibanov, AL; Sboros, V; McNeilly, AS; Duncan, WC				Connolly, Fiona; Rae, Michael T.; Butler, Mairead; Klibanov, Alexander L.; Sboros, Vassilis; McNeilly, Alan S.; Duncan, W. Colin			The Local Effects of Ovarian Diathermy in an Ovine Model of Polycystic Ovary Syndrome	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STROMAL BLOOD-FLOW; PRENATAL TESTOSTERONE EXCESS; INSULIN-SENSITIZING DRUGS; CORPUS-LUTEUM; CLOMIPHENE CITRATE; SYNDROME PCOS; ANDROGEN PRODUCTION; FOLLICULAR-GROWTH; INFERTILE WOMEN	In order to develop a medical alternative to surgical ovarian diathermy (OD) in polycystic ovary syndrome (PCOS) more mechanistic information is required about OD. We therefore studied the cellular, molecular and vascular effects of diathermy on the ovary using an established ovine model of PCOS. Pregnant sheep were treated twice weekly with testosterone propionate (100 mg) from day 30-100 gestation. Their female offspring (n = 12) were studied during their second breeding season when the PCOS-like phenotype, with anovulation, is fully manifest. In one group (n = 4) one ovary underwent diathermy and it was collected and compared to the contralateral ovary after 24 hours. In another group a treatment PCOS cohort underwent diathermy (n = 4) and the ovaries were collected and compared to the control PCOS cohort (n = 4) after 5 weeks. Ovarian vascular indices were measured using contrast-enhanced ultrasound and colour Doppler before, immediately after, 24 hours and five weeks after diathermy. Antral follicles were assessed by immunohistochemistry and ovarian stromal gene expression by quantitative RT-PCR 24 hours and 5 weeks after diathermy. Diathermy increased follicular atresia (P<0.05) and reduced antral follicle numbers after 5 weeks (P<0.05). There was an increase in stromal CCL2 expression 24 hours after diathermy (P<0.01) but no alteration in inflammatory indices at 5 weeks. Immediately after diathermy there was increased microbubble transit time in the ovarian microvasculature (P = 0.05) but this was not seen at 24 hours. However 24 hours after diathermy there was a reduction in the stromal Doppler blood flow signal (P<0.05) and an increased ovarian resistance index (P<0.05) both of which persisted at 5 weeks (P<0.01; P<0.05). In the ovine model of PCOS, OD causes a sustained reduction in ovarian stromal blood flow with an increased ovarian artery resistance index associated with atresia of antral follicles.	[Connolly, Fiona; McNeilly, Alan S.; Duncan, W. Colin] Univ Edinburgh, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland; [Rae, Michael T.] Edinburgh Napier Univ, Sch Hlth Life & Social Sci, Edinburgh, Midlothian, Scotland; [Butler, Mairead; Sboros, Vassilis] Heriot Watt Univ, Inst Biophys Biochem & Bioengn, Edinburgh, Midlothian, Scotland; [Klibanov, Alexander L.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	University of Edinburgh; Edinburgh Napier University; Heriot Watt University; University of Virginia	Duncan, WC (corresponding author), Univ Edinburgh, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland.	W.C.Duncan@ed.ac.uk		Sboros, Vassilis/0000-0002-9133-7252	Medical Research Council [G0901807]; Scottish Funding Council; MRC [G0800896, G0500717, G1002033, G0901807] Funding Source: UKRI; Medical Research Council [G1002033, G0500717] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Medical Research Council (G0901807) and WCD was supported by a Senior Clinical Fellowship from the Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich D, 2012, ENDOCRINOLOGY, V153, P3446, DOI 10.1210/en.2012-1105; Agrawal R, 1998, HUM REPROD, V13, P651, DOI 10.1093/humrep/13.3.651; Aleem FA, 1996, FERTIL STERIL, V65, P510, DOI 10.1016/S0015-0282(16)58145-X; Amer S, 2011, ACTA OBSTET GYN SCAN, V90, P338, DOI 10.1111/j.1600-0412.2010.01061.x; Amer SAKS, 2003, FERTIL STERIL, V79, P1211, DOI 10.1016/S0015-0282(02)04960-9; Amer SAKS, 2002, HUM REPROD, V17, P2851, DOI 10.1093/humrep/17.11.2851; Amin AF, 2003, FERTIL STERIL, V79, P938, DOI 10.1016/S0015-0282(02)04849-5; Anderson RA, 1998, CLIN ENDOCRINOL, V48, P577, DOI 10.1046/j.1365-2265.1998.00442.x; Averkiou M, 2010, ULTRASOUND MED BIOL, V36, P68, DOI 10.1016/j.ultrasmedbio.2009.07.005; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; BATTAGLIA C, 1995, AM J OBSTET GYNECOL, V172, P108, DOI 10.1016/0002-9378(95)90094-2; Birch RA, 2003, ENDOCRINOLOGY, V144, P1426, DOI 10.1210/en.2002-220965; BRANNSTROM M, 1993, ENDOCRINOLOGY, V132, P399, DOI 10.1210/en.132.1.399; Connolly F, 2013, ENDOCRINOLOGY, V154, P1921, DOI 10.1210/en.2012-2153; Dale PO, 2004, GYNECOL ENDOCRINOL, V19, P182, DOI 10.1080/09513590400012093; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dunaif A, 2008, NAT CLIN PRACT ENDOC, V4, P272, DOI 10.1038/ncpendmet0787; Duncan W. C., 2009, Animal Reproduction, V6, P34; Duncan WC, 2013, REPROD FERT DEVELOP, V25, P362, DOI 10.1071/RD12112; Duncan WC, 1998, HUM REPROD, V13, P2435, DOI 10.1093/humrep/13.9.2435; Duncan WC, 1994, CONT REV OBSTET GYNE, V6, P154; El Behery MM, 2011, INT J GYNECOL OBSTET, V112, P119, DOI 10.1016/j.ijgo.2010.08.018; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Fraser Hamish M., 2005, Angiogenesis, V8, P101, DOI 10.1007/s10456-005-9004-y; Fraser HM, 2009, REPROD FERT DEVELOP, V21, P277; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; GJONNAESS H, 1994, ACTA OBSTET GYN SCAN, V73, P407, DOI 10.3109/00016349409006253; GONEN Y, 1990, HUM REPROD, V5, P670, DOI 10.1093/oxfordjournals.humrep.a137165; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Hogg K, 2012, ENDOCRINOLOGY, V153, P450, DOI 10.1210/en.2011-1607; Hogg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024877; Homburg R, 2005, HUM REPROD, V20, P2043, DOI 10.1093/humrep/dei042; Homburg R, 2012, HUM REPROD, V27, P468, DOI 10.1093/humrep/der401; Homburg R, 1998, J ENDOCRINOL INVEST, V21, P552, DOI 10.1007/BF03350780; KECKSTEIN J, 1989, BAILLIERE CLIN OB GY, V3, P563, DOI 10.1016/S0950-3552(89)80009-4; Klibanov AL, 2004, INVEST RADIOL, V39, P187, DOI 10.1097/01.rli.0000115926.96796.75; Li HWR, 2010, HUM FERTIL, V13, P35, DOI 10.3109/14647270903490765; Liguori G, 1996, GYNECOL ENDOCRINOL, V10, P257, DOI 10.3109/09513599609012317; Lopez E, 2004, REPROD BIOMED ONLINE, V9, P382, DOI 10.1016/S1472-6483(10)61273-4; Manikkam M, 2006, ENDOCRINOLOGY, V147, P1997, DOI 10.1210/en.2005-1338; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nieuwenhuis-Ruifrok AE, 2009, HUM REPROD UPDATE, V15, P57, DOI 10.1093/humupd/dmn043; Ozkan S, 2007, J CLIN ULTRASOUND, V35, P305, DOI 10.1002/jcu.20358; Padmanabhan V, 2006, MOL CELL ENDOCRINOL, V246, P165, DOI 10.1016/j.mce.2005.11.016; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Padmanabhan V, 2013, MOL CELL ENDOCRINOL, V373, P8, DOI 10.1016/j.mce.2012.10.005; Palomba S, 2010, HUM REPROD, V25, P1005, DOI 10.1093/humrep/dep466; Pate JL, 2010, AM J REPROD IMMUNOL, V64, P275, DOI 10.1111/j.1600-0897.2010.00906.x; Peluffo MC, 2009, MOL REPROD DEV, V76, P367, DOI 10.1002/mrd.20970; Rae M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056263; Recabarren SE, 2005, AM J PHYSIOL-ENDOC M, V289, pE801, DOI 10.1152/ajpendo.00107.2005; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Sboros V, 2011, ULTRASOUND MED BIOL, V37, P59, DOI 10.1016/j.ultrasmedbio.2010.10.013; Schmidt J, 2014, MOL HUM REPROD, V20, P49, DOI 10.1093/molehr/gat051; Strouthos C, 2010, IEEE T ULTRASON FERR, V57, P1296, DOI 10.1109/TUFFC.2010.1550; Sunj M, 2013, HUM REPROD, V28, P2417, DOI 10.1093/humrep/det273; Takayama K, 1996, HUM REPROD, V11, P1387; Tan Seang Lin, 2002, Reprod Biomed Online, V4 Suppl 1, P18; TOZAWA H, 1995, HUM REPROD, V10, P544, DOI 10.1093/oxfordjournals.humrep.a135986; Tulandi T, 2000, FERTIL STERIL, V74, P585, DOI 10.1016/S0015-0282(00)00684-1; Tulandi T, 1997, INT J FERTIL WOMEN M, V42, P436; Veiga-Lopez A, 2008, BIOL REPROD, V78, P636, DOI 10.1095/biolreprod.107.065904; Veiga-Lopez A, 2010, ENDOCRINOLOGY, V151, P4007, DOI 10.1210/en.2010-0124; Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081; Wulff C, 2002, ENDOCRINOLOGY, V143, P2797, DOI 10.1210/en.143.7.2797; Yoshioka S, 2012, MOL REPROD DEV, V79, P689, DOI 10.1002/mrd.22075; ZAIDI J, 1995, HUM REPROD, V10, P1992, DOI 10.1093/oxfordjournals.humrep.a136222	68	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111280	10.1371/journal.pone.0111280	http://dx.doi.org/10.1371/journal.pone.0111280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343339	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500093
J	Katsura, M; Hirose, S; Sasaki, H; Mori, H; Kunimatsu, A; Ohtomo, K; Jimura, K; Konishi, S				Katsura, Masaki; Hirose, Satoshi; Sasaki, Hiroki; Mori, Harushi; Kunimatsu, Akira; Ohtomo, Kuni; Jimura, Koji; Konishi, Seiki			Decreased Fronto-Temporal Interaction during Fixation after Memory Retrieval	PLOS ONE			English	Article							VENTROLATERAL PREFRONTAL CORTEX; TEMPORAL CONTEXT MEMORY; AGE-RELATED DIFFERENCES; BRAINS DEFAULT NETWORK; FALSE DISCOVERY RATE; EVENT-RELATED FMRI; LONG-TERM-MEMORY; FUNCTIONAL CONNECTIVITY; UNWANTED MEMORIES; DECLARATIVE MEMORY	Previous studies have revealed top-down control during memory retrieval from the prefrontal cortex to the temporal cortex. In the present functional MRI study, we investigated whether the fronto-temporal functional interaction occurs even during fixation periods after memory retrieval trials. During recency judgments, subjects judged the temporal order of two items in a study list. The task used in the present study consisted of memory trials of recency judgments and non-memory trials of counting dots, and post-trial fixation periods. By comparing the brain activity during the fixation periods after the memory trials with that during the fixation periods after the non-memory trials, we detected heightened brain activity in the lateral prefrontal cortex, the lateral temporal cortex and the hippocampus. Functional interactions during the fixation periods after the memory vs. non-memory trials as examined using a psychophysiological interaction revealed a decreased interaction from the lateral prefrontal cortex to the lateral temporal cortex, but not to the hippocampus. The functional interaction between the same frontal and temporal regions was also present during the memory trials. A trial-based functional connectivity analysis further revealed that the fronto-temporal interaction was positive and decreased during the fixation periods after the memory trials, relative to the fixation periods after the non-memory trials. These results suggest that the fronto-temporal interaction existed during the post-trial fixation periods, which had been present during the memory trials and temporally extended into the fixation periods.	[Katsura, Masaki; Sasaki, Hiroki; Mori, Harushi; Kunimatsu, Akira; Ohtomo, Kuni] Univ Tokyo, Sch Med, Dept Radiol, Tokyo 113, Japan; [Hirose, Satoshi; Jimura, Koji; Konishi, Seiki] Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan; [Hirose, Satoshi; Jimura, Koji; Konishi, Seiki] Juntendo Univ, Sch Med, Dept Physiol, Tokyo 113, Japan; [Jimura, Koji] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan	University of Tokyo; University of Tokyo; Juntendo University; Tokyo Institute of Technology	Konishi, S (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan.	skonishi@juntendo.ac.jp	Kunimatsu, Akira/AAC-8617-2019; MORI, Harushi/AAA-2669-2022	Kunimatsu, Akira/0000-0002-7141-2585; MORI, Harushi/0000-0003-1370-5272	Uehara Memorial Foundation;  [22300134]	Uehara Memorial Foundation(Uehara Memorial Foundation); 	Funding was provided by the Uehara Memorial Foundation and a Grant-in-Aid for Scientific Research B (22300134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Badre David, 2002, Behav Cogn Neurosci Rev, V1, P206, DOI 10.1177/1534582302001003002; Benoit RG, 2012, NEURON, V76, P450, DOI 10.1016/j.neuron.2012.07.025; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Buckner RL, 2003, J NEUROSCI, V23, P3999; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2008, CURR DIR PSYCHOL SCI, V17, P112, DOI 10.1111/j.1467-8721.2008.00559.x; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Duarte A, 2005, J NEUROSCI, V25, P8333, DOI 10.1523/JNEUROSCI.1392-05.2005; Dudukovic NM, 2007, NEUROPSYCHOLOGIA, V45, P2608, DOI 10.1016/j.neuropsychologia.2007.02.025; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fujii T, 2004, NEUROIMAGE, V21, P1596, DOI 10.1016/j.neuroimage.2004.01.005; Gagnepain P, 2014, P NATL ACAD SCI USA, V111, pE1310, DOI 10.1073/pnas.1311468111; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greve A, 2010, J NEUROSCI, V30, P7099, DOI 10.1523/JNEUROSCI.0345-10.2010; Grove KL, 2009, J COGNITIVE NEUROSCI, V21, P461, DOI 10.1162/jocn.2009.21040; Hayama H, 2009, FUNCTIONAL SIGNIFICA; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Hayama HR, 2009, NEUROPSYCHOLOGIA, V47, P2409, DOI 10.1016/j.neuropsychologia.2009.04.010; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; Hintzman DL, 2003, MEM COGNITION, V31, P26, DOI 10.3758/BF03196079; Hintzman DL, 2001, J EXP PSYCHOL LEARN, V27, P1347, DOI 10.1037//0278-7393.27.6.1347; Hirose S, 2013, CEREB CORTEX, V23, P2863, DOI 10.1093/cercor/bhs268; Hirose S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071210; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Jimura K, 2009, EUR J NEUROSCI, V29, P1915, DOI 10.1111/j.1460-9568.2009.06731.x; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; Kimura HM, 2010, NEUROIMAGE, V49, P3474, DOI 10.1016/j.neuroimage.2009.11.003; Konishi S, 2006, CEREB CORTEX, V16, P469, DOI 10.1093/cercor/bhi126; Konishi S, 2002, J NEUROSCI, V22, P9549; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Levy BJ, 2008, ACTA PSYCHOL, V127, P623, DOI 10.1016/j.actpsy.2007.12.004; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Naya Y, 2003, J NEUROSCI, V23, P2861; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P299, DOI 10.1098/rspb.1991.0158; Rajah MN, 2008, BRAIN RES, V1199, P111, DOI 10.1016/j.brainres.2007.12.051; Rajah MN, 2011, J NEUROSCI, V31, P17941, DOI 10.1523/JNEUROSCI.1690-11.2011; Rajah MN, 2011, NEUROIMAGE, V54, P1549, DOI 10.1016/j.neuroimage.2010.09.001; Rajah MN, 2006, NEUROPSYCHOLOGIA, V44, P350, DOI 10.1016/j.neuropsychologia.2005.06.003; Ranganath C, 2007, NEUROIMAGE, V35, P1663, DOI 10.1016/j.neuroimage.2007.01.020; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rugg MD, 2003, NEUROPSYCHOLOGIA, V41, P40, DOI 10.1016/S0028-3932(02)00129-X; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Schott BH, 2011, P NATL ACAD SCI USA, V108, P5408, DOI 10.1073/pnas.1013287108; Snodgrass JS, 1980, J EXP PSYCHOL HUM LE, V9, P164; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Spreng RN, 2012, CEREB CORTEX, V22, P2610, DOI 10.1093/cercor/bhr339; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; St Jacques P, 2008, J COGNITIVE NEUROSCI, V20, P1327, DOI 10.1162/jocn.2008.20091; Suzuki M, 2002, NEUROIMAGE, V17, P1790, DOI 10.1006/nimg.2002.1303; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Tsukiura T, 2006, NEUROIMAGE, V30, P617, DOI 10.1016/j.neuroimage.2005.09.043; Tsukiura T, 2002, J COGNITIVE NEUROSCI, V14, P922, DOI 10.1162/089892902760191144; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Watanabe T, 2012, J NEUROSCI, V32, P9659, DOI 10.1523/JNEUROSCI.5553-11.2012; Werkle-Bergner M, 2005, COGNITIVE BRAIN RES, V24, P599, DOI 10.1016/j.cogbrainres.2005.03.011; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yamashita K, 2009, J NEUROSCI, V29, P10335, DOI 10.1523/JNEUROSCI.1328-09.2009; Zorrilla LTE, 1996, NEUROREPORT, V7, P2803	82	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110798	10.1371/journal.pone.0110798	http://dx.doi.org/10.1371/journal.pone.0110798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340398	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800056
J	Mittal, N; Malpani, S; Dyson, M; Ono, M; Coon, JS; Kim, JJ; Schink, JC; Bulun, SE; Pavone, ME				Mittal, Navdha; Malpani, Saurabh; Dyson, Matthew; Ono, Masanori; Coon, John S.; Kim, Julie J.; Schink, Julian C.; Bulun, Serdar E.; Pavone, Mary Ellen			Fenretinide: A Novel Treatment for Endometrial Cancer	PLOS ONE			English	Article							TRANS-RETINOIC ACID; CARCINOMA-CELL-LINES; BREAST-CANCER; HUMAN HEAD; PHASE-II; APOPTOSIS; TRIAL; N-(4-HYDROXYPHENYL)RETINAMIDE; EXPRESSION; SURVIVAL	Resistance to progestin treatment is a major hurdle in the treatment of advanced and reoccurring endometrial cancer. Fenretinide is a synthetic retinoid that has been evaluated in clinical trials as a cancer therapeutic and chemo-preventive agent. Fenretinide has been established to be cytotoxic to many kinds of cancer cells. In the present study, we demonstrate that fenretinide decreased cell viability and induced apoptosis in Ishikawa cells, which are an endometrial cancer cell line, in dose dependent manner in-vitro. This effect was found to be independent of retinoic acid nuclear receptor signaling pathway. Further, we have shown that this induction of apoptosis by fenretinide may be caused by increased retinol uptake via STRA6. Silencing of STRA6 was shown to decrease apoptosis which was inhibited by knockdown of STRA6 expression in Ishikawa cells. Results of an in-vivo study demonstrated that intraperitoneal injections of fenretinide in endometrial cancer tumors (created using Ishikawa cells) in mice inhibited tumor growth effectively. Immunohistochemistry of mice tumors showed a decrease in Ki67 expression and an increase in cleaved caspase-3 staining after fenretinide treatment when compared to vehicle treated mice. Collectively, our results are the first to establish the efficacy of fenretinide as an antitumor agent for endometrial cancer both in-vitro and in-vivo, providing a valuable rationale for initiating more preclinical studies and clinical trials using fenretinide for the treatment of endometrial cancer.	[Mittal, Navdha; Malpani, Saurabh; Dyson, Matthew; Ono, Masanori; Coon, John S.; Kim, Julie J.; Bulun, Serdar E.; Pavone, Mary Ellen] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Chicago, IL 60611 USA; [Bulun, Serdar E.; Pavone, Mary Ellen] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chicago, IL 60611 USA; [Schink, Julian C.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Chicago, IL 60611 USA; [Schink, Julian C.] Spectrum Hlth Med Grp, Dept Obstet & Gynecol, Grand Rapids, MI USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Spectrum Health Medical Group	Pavone, ME (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Chicago, IL 60611 USA.	mpavone@nmff.org	; Ono, Masanori/F-7443-2019	Kim, J Julie/0000-0001-9834-8213; Dyson, Matthew/0000-0003-3596-5753; Ono, Masanori/0000-0001-9249-6813	Reproductive Biology Division, NU; ASRM Career Development Award; Center Support Grant [NCI CA060553]; NCI CCSG [P30 CA060553];  [K12HD050121]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD050121] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA155513] Funding Source: NIH RePORTER	Reproductive Biology Division, NU; ASRM Career Development Award; Center Support Grant; NCI CCSG; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies were supported by generous funds from John and Diane O'Donnell (to division of Gynecology Oncology, NU) and Reproductive Biology Division, NU. Studies were also supported by K12HD050121 and the ASRM Career Development Award which were awarded to Mary Ellen Pavone. Center Support Grant (NCI CA060553) was used for embedding, sectioning and staining of tumor tissues. NU Cell Imaging Facility was generously supported by NCI CCSG P30 CA060553 which was awarded to the Robert H Lurie Comprehensive Cancer Center.	Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bonanni B, 2009, RECENT RES CANCER, V181, P77; Carrera S, 2013, CELL DEATH DIFFER, V20, P910, DOI 10.1038/cdd.2013.14; Cazzaniga M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/172897; Cheng YH, 2008, J CLIN ENDOCR METAB, V93, P1915, DOI 10.1210/jc.2007-1536; Cheng YH, 2011, J MOL ENDOCRINOL, V46, P139, DOI 10.1530/JME-10-0064; Chiesa F, 2005, INT J CANCER, V115, P625, DOI 10.1002/ijc.20923; Children's Oncology G, 2006, J CLIN ONCOL, V24, P3423; Choi Y, 2003, INT J CANCER, V107, P145, DOI 10.1002/ijc.11354; Cooper JP, 2011, BRIT J PHARMACOL, V163, P1263, DOI 10.1111/j.1476-5381.2011.01310.x; DELIA D, 1993, CANCER RES, V53, P6036; Deng L, 2003, J CLIN ENDOCR METAB, V88, P2157, DOI 10.1210/jc.2002-021844; Di CH, 2005, CANCER RES, V65, P919; Formelli F, 2000, EUR J CANCER, V36, P2411, DOI 10.1016/S0959-8049(00)00335-X; Garaventa A, 2003, CLIN CANCER RES, V9, P2032; Holmes WF, 2004, J CELL PHYSIOL, V199, P317, DOI 10.1002/jcp.10338; Howlader N, 2012, AM J EPIDEMIOL, V176, P347, DOI 10.1093/aje/kwr512; Hu Y, 2013, BIOCHEM PHARMACOL, V85, P1007, DOI 10.1016/j.bcp.2013.01.023; Invitrogen, 2012, PRESTOBLUE CELL VIAB; KALEMKERIAN GP, 1995, J NATL CANCER I, V87, P1674, DOI 10.1093/jnci/87.22.1674; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JJ, 2013, HORM CANCER-US, V4, P358, DOI 10.1007/s12672-013-0157-7; MARIOTTI A, 1994, J NATL CANCER I, V86, P1245, DOI 10.1093/jnci/86.16.1245; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; O'Donnell PH, 2002, LEUKEMIA, V16, P902, DOI 10.1038/sj.leu.2402485; Oridate N, 1996, CLIN CANCER RES, V2, P855; Pant A, 2012, INHIBITION AKT ORALL; Pant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041593; Pavone ME, 2010, J CLIN ENDOCR METAB, V95, pE300, DOI 10.1210/jc.2010-0459; Puduvalli VK, 2004, J CLIN ONCOL, V22, P4282, DOI 10.1200/JCO.2004.09.096; Ray M, 2009, SEMIN ONCOL, V36, P145, DOI 10.1053/j.seminoncol.2008.12.006; Reynolds CP FT, 2007, HIGH PLASMA LEVELS F; Sabichi AL, 2008, CLIN CANCER RES, V14, P224, DOI 10.1158/1078-0432.CCR-07-0733; Society AC, 2013, CANC FACTS FIG 2013; Ulukaya E, 2003, CELL DEATH DIFFER, V10, P856, DOI 10.1038/sj.cdd.4401242; Vaishampayan U, 2005, INVEST NEW DRUG, V23, P179, DOI 10.1007/s10637-005-5864-7; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Zhao SJ, 2013, ONCOL LETT, V5, P139, DOI 10.3892/ol.2012.975	42	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110410	10.1371/journal.pone.0110410	http://dx.doi.org/10.1371/journal.pone.0110410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340777	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800034
J	Moore, LS; Wei, W; Stolovicki, E; Benbenishty, T; Wilkening, S; Steinmetz, LM; Braun, E; David, L				Moore, Lindsay S.; Wei, Wu; Stolovicki, Elad; Benbenishty, Tamar; Wilkening, Stefan; Steinmetz, Lars M.; Braun, Erez; David, Lior			Induced Mutations in Yeast Cell Populations Adapting to an Unforeseen Challenge	PLOS ONE			English	Article							GENE-REGULATION; EVOLUTION; HYPERMUTATION; ADAPTATION; RATES	The modern evolutionary synthesis assumes that mutations occur at random, independently of the environment in which they confer an advantage. However, there are indications that cells facing challenging conditions can adapt rapidly, utilizing processes beyond selection of pre-existing genetic variation. Here, we show that a strong regulatory challenge can induce mutations in many independent yeast cells, in the absence of general mutagenesis. Whole genome sequencing of cell lineages reveals a repertoire of independent mutations within a single lineage that arose only after the cells were exposed to the challenging environment, while other cells in the same lineage adapted without any mutation in their genomes. Thus, our experiments uncovered multiple alternative routes for heritable adaptation that were all induced in the same lineage during a short time period. Our results demonstrate the existence of adaptation mechanisms beyond random mutation, suggesting a tight connection between physiological and genetic processes.	[Moore, Lindsay S.; Stolovicki, Elad; Braun, Erez] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Moore, Lindsay S.; Stolovicki, Elad; Braun, Erez] Technion Israel Inst Technol, Network Biol Res Labs, IL-32000 Haifa, Israel; [Wei, Wu; Steinmetz, Lars M.] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Benbenishty, Tamar; David, Lior] Hebrew Univ Jerusalem, Dept Anim Sci, IL-76100 Rehovot, Israel; [Wilkening, Stefan; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, D-69012 Heidelberg, Germany	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Stanford University; Hebrew University of Jerusalem; European Molecular Biology Laboratory (EMBL)	David, L (corresponding author), Hebrew Univ Jerusalem, Dept Anim Sci, IL-76100 Rehovot, Israel.	lior.david@mail.huji.ac.il	David, Lior/G-8754-2012; Wei, Wu/AAC-8285-2020; Stolovicki, Elad/AAT-1742-2021	Wei, Wu/0000-0001-5643-8739; Steinmetz, Lars/0000-0002-3962-2865; David, Lior/0000-0002-6555-0594	Aly Kaufman postdoctoral Fellowship; Israeli Science Foundation [95/08, 496/10]; National Institutes of Health; European Research Council under the European Union's Seventh Framework Programme (FP7/ERC) [AdG-294542]	Aly Kaufman postdoctoral Fellowship; Israeli Science Foundation(Israel Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council under the European Union's Seventh Framework Programme (FP7/ERC)(European Research Council (ERC))	LSM was supported by the Aly Kaufman postdoctoral Fellowship. This study was funded by the Israeli Science Foundation grants FIRST program 95/08 to EB and LD and 496/10 to EB. Funding for this research was obtained also from the National Institutes of Health and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. AdG-294542 to LMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EVOLUTION MODERN SYN; David L, 2013, MOL BIOL EVOL, V30, P1514, DOI 10.1093/molbev/mst071; David L, 2010, HFSP J, V4, P131, DOI 10.2976/1.3353782; Hall BG, 1998, GENETICA, V102-3, P109, DOI 10.1023/A:1017015815643; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Kondrashov FA, 2010, PHILOS T R SOC B, V365, P1169, DOI 10.1098/rstb.2009.0286; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luria SE, 1943, GENETICS, V28, P491; Martincorena I, 2013, BIOESSAYS, V35, P123, DOI 10.1002/bies.201200150; Ram Y, 2012, EVOLUTION, V66, P2315, DOI 10.1111/j.1558-5646.2012.01576.x; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; Sniegowski PD, 2006, CURR BIOL, V16, pR831, DOI 10.1016/j.cub.2006.08.080; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Stern S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100147; Stolovicki E, 2006, GENETICS, V173, P75, DOI 10.1534/genetics.106.055442; Stolovicki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020530; Wilkening S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-90; Zeyl C, 2004, RES MICROBIOL, V155, P217, DOI 10.1016/j.resmic.2003.12.006	22	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111133	10.1371/journal.pone.0111133	http://dx.doi.org/10.1371/journal.pone.0111133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340744	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800087
J	Rodriguez, M; Delibes, M; Fedriani, JM				Rodriguez, Marta; Delibes, Miguel; Fedriani, Jose Ma			Hierarchical Levels of Seed Predation Variation by Introduced Beetles on an Endemic Mediterranean Palm	PLOS ONE			English	Article							CHAMAEROPS-HUMILIS; BRUCHID BEETLES; COLEOPTERA; DISPERSAL; FRUITS	Seed predators can limit plant recruitment and thus profoundly impinge the dynamics of plant populations, especially when diverse seed predators (e.g., native and introduced) attack particular plant populations. Surprisingly, however, we know little concerning the potential hierarchy of spatial scales (e.g., region, population, patch) and coupled ecological correlates governing variation in the overall impact that native and introduced seed predators have on plant populations. We investigated several spatial scales and ecological correlates of pre-dispersal seed predation by invasive borer beetles in Chamaerops humilis (Arecaceae), a charismatic endemic palm of the Mediteranean basin. To this end, we considered 13 palm populations (115 palms) within four geographical regions of the Iberian Peninsula. The observed interregional differences in percentages of seed predation by invasive beetles were not significant likely because of considerable variation among populations within regions. Among population variation in seed predation was largely related to level of human impact. In general, levels of seed predation were several folds higher in human-altered populations than in natural populations. Within populations, seed predation declined significantly with the increase in amount of persisting fruit pulp, which acted as a barrier against seed predators. Our results revealed that a native species (a palm) is affected by the introduction of related species because of the concurrent introduction of seed predators that feed on both the introduced and native palms. We also show how the impact of invasive seed predators on plants can vary across a hierarchy of levels ranging from variation among individuals within local populations to large scale regional divergences.	[Rodriguez, Marta; Delibes, Miguel; Fedriani, Jose Ma] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Fedriani, Jose Ma] Helmholtz Ctr Environm Res GmbH UFZ, Dept Ecol Modelling, Leipzig, Germany; [Fedriani, Jose Ma] Univ Lisbon, Inst Super Agron, Ctr Appl Ecol Prof Baeta Neves, P-1699 Lisbon, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Universidade de Lisboa	Fedriani, JM (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	fedriani@ebd.csic.es	Fedriani, Jose/R-1328-2018; Delibes, Miguel/K-2744-2014	Fedriani, Jose/0000-0002-1581-2621; Delibes, Miguel/0000-0002-3569-567X	Spanish Ministerio de Medio Ambiente (National Park Service) [070/2009]; Ministerio de Educacion y Ciencia [CGL2007-63488/BOS, CGL2010-21926/BOS]; Marie Curie Intraeuropean fellowship [FP7-PEOPLE-2011-IEF-298137]	Spanish Ministerio de Medio Ambiente (National Park Service); Ministerio de Educacion y Ciencia(Spanish Government); Marie Curie Intraeuropean fellowship(European Commission)	The Spanish Ministerio de Medio Ambiente (National Park Service, grant 070/2009) and Ministerio de Educacion y Ciencia (CGL2007-63488/BOS and CGL2010-21926/BOS) supported this study. JMF was funded by a Marie Curie Intraeuropean fellowship (FP7-PEOPLE-2011-IEF-298137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain R, 2010, BIORISK, V4; ANDERSEN AN, 1988, OIKOS, V52, P337, DOI 10.2307/3565207; [Anonymous], 2006, SAS MIXED MODELS; Anstett MC, 1999, ACTA OECOL, V20, P551, DOI 10.1016/S1146-609X(00)86622-9; Bernabo E., 1991, Bollettino della Societa Entomologica Italiana, V122, P185; Blumberg D, 2008, PHYTOPARASITICA, V36, P411, DOI 10.1007/BF03020290; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Delobel A, 1995, AMAZONIANA, V13, P209; Delobel B, 2006, OECOLOGIA, V149, P428, DOI 10.1007/s00442-006-0461-9; Fedriani JM, 2006, FUNCT ECOL, V20, P1070, DOI 10.1111/j.1365-2435.2006.01199.x; Fedriani JM, 2004, OIKOS, V105, P181, DOI 10.1111/j.0030-1299.2004.12782.x; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Fedriani JM, 2013, J ECOL, V101, P1581, DOI 10.1111/1365-2745.12146; Fedriani JM, 2011, ECOLOGY, V92, P304, DOI 10.1890/09-2194.1; FORGET PM, 1994, BIOTROPICA, V26, P420, DOI 10.2307/2389236; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Gomez Vives S., 2004, Boletin de Sanidad Vegetal Plagas, V30, P497; Herrera C.M., 2009, MULTIPLICITY UNITY P; HERRERA CM, 1989, OIKOS, V54, P185, DOI 10.2307/3565264; HERRERA J, 1989, Principes, V33, P27; Holzman JP, 2009, J EVOLUTION BIOL, V22, P1076, DOI 10.1111/j.1420-9101.2009.01722.x; Hulme Philip E., 2002, P132; JANZEN D, 1972, ECOLOGY, V53, P350, DOI 10.2307/1934092; Janzen DH, 1982, BRENESIA, V20, P165; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Kirkendall LR, 2010, ZOOKEYS, P227, DOI 10.3897/zookeys.56.529; Lombardero M. J., 1994, Boletin de la Asociacion Espanola de Entomologia, V18, P181; Medail F, 1996, CR ACAD SCI III-VIE, V319, P139; Merlo M. E., 1993, Principes, V37, P151; Moore D, 2001, INSECTS ON PALMS, P233, DOI 10.1079/9780851993263.0233; Nunez MA, 2008, BIOL INVASIONS, V10, P1389, DOI 10.1007/s10530-007-9214-x; Palacios J., 1973, Miscelanea Zoologica, V3, P69; Rodriguez A, 2013, NEW PHYTOL, V197, P36, DOI 10.1111/j.1469-8137.2012.04382.x; Rose KE, 2005, ECOLOGY, V86, P453, DOI 10.1890/03-0697; Sauvard Daniel, 2010, BioRisk, V4, P219; Shiels AB, 2011, BIOL INVASIONS, V13, P781, DOI 10.1007/s10530-010-9868-7; Silvius KM, 2002, J ECOL, V90, P1024, DOI 10.1046/j.1365-2745.2002.00728.x; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Valladares F, 2004, ECOLOGIA BOSQUE MEDI, P163; Vila M, 2008, INVASIONES BIOL COLE; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Whitehead PF, 2000, ANZ SCHADL-J PEST SC, V73, P17; Wotton DM, 2011, P ROY SOC B-BIOL SCI, V278, P3345, DOI 10.1098/rspb.2011.0185; Zorzenon FJ, 1995, REV AGR PIRACICABA, P7017	46	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109867	10.1371/journal.pone.0109867	http://dx.doi.org/10.1371/journal.pone.0109867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340462	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800020
J	Defamie, V; Sanchez, O; Murthy, A; Khokha, R				Defamie, V.; Sanchez, O.; Murthy, A.; Khokha, R.			TIMP3 controls cell fate to confer hepatocellular carcinoma resistance	ONCOGENE			English	Article							NECROSIS-FACTOR-ALPHA; COMPENSATORY PROLIFERATION; TISSUE INHIBITOR; TUMOR-FORMATION; LIVER; INFLAMMATION; P53; SUPPRESSOR; EXPRESSION; PROMOTER	Inflammation enables human cancers and is a critical promoter of hepatocellular carcinoma (HCC). TIMP3 (Tissue inhibitor of metalloproteinase 3), a natural metalloproteinase inhibitor, controls cytokine and growth factor bioavailability to keep inflammation in check and regulate cell survival in the liver. TIMP3 is also found silenced in human cancers. We therefore tested whether Timp3 affects HCC predisposition. Remarkably, genetic loss of Timp3 protected from carcinogen-induced HCC through the immediate engagement of several tumor suppressor pathways, while tumor necrosis factor (TNF) signaling was dispensable for this protection. All wild-type mice developed HCC by 12 months, whereas HCC incidence was reduced to 33% at 12 months and 57% at 15 months in Timp3 null mice. Upon acute carcinogen treatment the deficient livers exhibited greater cytokine expression, but lower cell death and higher hepatocyte senescence. We found that precocious activation of p53, p38 and Notch preceded senescence and hepatic cell differentiation, and these events were conserved throughout tumorigenesis. Timp3-deficient mouse embryo fibroblasts also responded to carcinogen by favoring senescence over apoptosis. We conclude that Timp3 status determines p53, p38 and Notch coactivation to instruct hepatic cell fate and transformation and uncover mechanisms that are protective even within a proinflammatory microenvironment.	[Defamie, V.; Murthy, A.; Khokha, R.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 1A1, Canada; [Sanchez, O.] Univ Ontario, Inst Technol, Oshawa, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Ontario Tech University	Khokha, R (corresponding author), TMDT Res, MARS Med Discovery Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.	rkhokha@uhnres.utoronto.ca		Defamie, Virginie/0000-0002-6405-0539; Khokha, Rama/0000-0002-6028-1524	Canadian Institutes of Health Research; Helena H Lam and Fondation pour la Recherche Medicale fellowships	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Helena H Lam and Fondation pour la Recherche Medicale fellowships	We would like to thank Dr Paul Waterhouse and Dr Razqallah Hakem for their constructive criticism of the manuscript. This work was supported by grants from the Canadian Institutes of Health Research to RK. VD was supported by the Helena H Lam and Fondation pour la Recherche Medicale fellowships.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Bachman KE, 1999, CANCER RES, V59, P798; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2004, NAT GENET, V36, P934, DOI 10.1038/ng0904-934; Boggs K, 2009, CELL BIOL INT, V33, P318, DOI 10.1016/j.cellbi.2008.12.005; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Catasus L, 2013, HISTOPATHOLOGY, V62, P632, DOI 10.1111/his.12047; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Dolado Ignacio, 2008, V20, P99, DOI 10.1007/4735_2007_0245; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425; Jeliazkova P, 2013, HEPATOLOGY, V57, P2469, DOI 10.1002/hep.26254; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Masson D, 2010, EUR J CANCER, V46, P1430, DOI 10.1016/j.ejca.2010.01.009; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Nakamura M, 2005, LAB INVEST, V85, P165, DOI 10.1038/labinvest.3700223; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Poehlmann A, 2010, PATHOL RES PRACT, V206, P591, DOI 10.1016/j.prp.2010.06.006; Qi RZ, 2003, CANCER RES, V63, P8323; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Sun Hong, 2007, V383, P311, DOI 10.1007/978-1-59745-335-6_20; Tchorz JS, 2009, HEPATOLOGY, V50, P871, DOI 10.1002/hep.23048; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zochbauer-Muller S, 2001, CANCER RES, V61, P249; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	58	19	20	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	31					4098	4108		10.1038/onc.2014.339	http://dx.doi.org/10.1038/onc.2014.339			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN9PE	25347747				2022-12-26	WOS:000358780500008
J	Rajapaksa, G; Nikolos, F; Bado, I; Clarke, R; Gustafsson, JA; Thomas, C				Rajapaksa, G.; Nikolos, F.; Bado, I.; Clarke, R.; Gustafsson, J-A; Thomas, C.			ER beta decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway	ONCOGENE			English	Article							UNFOLDED PROTEIN RESPONSE; ESTROGEN-RECEPTOR-BETA; ENDOPLASMIC-RETICULUM STRESS; BOX BINDING PROTEIN-1; GENE-EXPRESSION; KAPPA-B; PROMOTES; XBP-1; BORTEZOMIB; AUTOPHAGY	Unfolded protein response (UPR) is an adaptive reaction that allows cancer cells to survive endoplasmic reticulum (EnR) stress that is often induced in the tumor microenvironment because of inadequate vascularization. Previous studies report an association between activation of the UPR and reduced sensitivity to antiestrogens and chemotherapeutics in estrogen receptor alpha (ER alpha)-positive and triple-negative breast cancers, respectively. ER alpha has been shown to regulate the expression of a key mediator of the EnR stress response, the X-box-binding protein-1 (XBP-1). Although network prediction models have associated ER beta with the EnR stress response, its role as regulator of the UPR has not been experimentally tested. Here, upregulation of wild-type ER beta (ER beta 1) or treatment with ER beta agonists enhanced apoptosis in breast cancer cells in the presence of pharmacological inducers of EnR stress. Targeting the BCL-2 to the EnR of the ER beta 1-expressing cells prevented the apoptosis induced by EnR stress but not by non-EnR stress apoptotic stimuli indicating that ER beta 1 promotes EnR stress-regulated apoptosis. Downregulation of inositol-requiring kinase 1 alpha (IRE1 alpha) and decreased splicing of XBP-1 were associated with the decreased survival of the EnR-stressed ER beta 1-expressing cells. ER beta 1 was found to repress the IRE1 pathway of the UPR by inducing degradation of IRE1 alpha. These results suggest that the ability of ER beta 1 to target the UPR may offer alternative treatment strategies for breast cancer.	[Rajapaksa, G.; Nikolos, F.; Bado, I.; Gustafsson, J-A; Thomas, C.] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA; [Clarke, R.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA	University of Houston System; University of Houston; Georgetown University	Thomas, C (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, 3605 Cullen Blvd, Houston, TX 77204 USA.	chthomas@uh.edu	Bado, Igor/AAY-1214-2021; Clarke, Robert/A-6485-2008; Nikolos, Fotis/AGF-3489-2022	Bado, Igor/0000-0001-8855-4750; Clarke, Robert/0000-0002-9278-0854; Nikolos, Fotis/0000-0002-8622-0017	Swedish Cancer Society; Robert A Welch Foundation [E-0004]; Emerging Technology Fund of Texas [300-9-1958];  [U54-CA149147]; NATIONAL CANCER INSTITUTE [U54CA149147] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Robert A Welch Foundation(The Welch Foundation); Emerging Technology Fund of Texas; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C Koumenis for the Bcl-2 expression vector and Anders Strom for the ER beta 2 expression lentivirus. We also thank Efrocini Cuko for technical assistance with confocal microscopy. This study was supported by grants from the Swedish Cancer Society, the Robert A Welch Foundation (E-0004), the Emerging Technology Fund of Texas under Agreement 300-9-1958 and the U54-CA149147.	BUTLER WB, 1992, CANCER RES, V52, P6164; BUTLER WB, 1986, CANCER RES, V46, P6339; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Cheng L, 2012, J CLIN INVEST, V122, P2857, DOI 10.1172/JCI62676; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Clarke Robert, 2011, Horm Mol Biol Clin Investig, V5, P35, DOI 10.1515/HMBCI.2010.073; Cook KL, 2012, CANCER RES, V72, P3337, DOI 10.1158/0008-5472.CAN-12-0269; Crawford AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008604; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies MPA, 2008, INT J CANCER, V123, P85, DOI 10.1002/ijc.23479; Davis AM, 2008, J MOL ENDOCRINOL, V41, P205, DOI 10.1677/JME-08-0029; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; GADBOIS DM, 1992, BIOCHEM BIOPH RES CO, V184, P80, DOI 10.1016/0006-291X(92)91160-R; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Gomez BP, 2007, FASEB J, V21, P4013, DOI 10.1096/fj.06-7990com; Gu ZP, 2002, CANCER RES, V62, P3428; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Hodges-Gallagher L, 2008, BREAST CANCER RES TR, V109, P241, DOI 10.1007/s10549-007-9640-6; Honma N, 2008, J CLIN ONCOL, V26, P3727, DOI 10.1200/JCO.2007.14.2968; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jones MD, 2010, CLIN CANCER RES, V16, P4978, DOI 10.1158/1078-0432.CCR-09-3293; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee E, 2011, INT J CANCER, V128, P726, DOI 10.1002/ijc.25370; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Nakajima Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001551; Nikolos F, 2014, MOL CANCER RES, V12, P843, DOI 10.1158/1541-7786.MCR-13-0663; Rodriguez DA, 2012, EMBO J, V31, P2322, DOI 10.1038/emboj.2012.84; Sengupta S, 2010, HORM MOL BIOL CLIN I, V2, P235, DOI 10.1515/HMBCI.2010.025; Shaaban AM, 2008, CLIN CANCER RES, V14, P5228, DOI 10.1158/1078-0432.CCR-07-4528; Shajahan AN, 2012, J BIOL CHEM, V287, P17682, DOI 10.1074/jbc.M111.304022; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Thomas C, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3358; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Thomas CG, 2011, BREAST CANCER RES TR, V127, P417, DOI 10.1007/s10549-010-1011-z; Thomas CG, 2009, J BIOL CHEM, V284, P6282, DOI 10.1074/jbc.M806189200; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang CH, 2006, ANN ONCOL, V17, P813, DOI 10.1093/annonc/mdj131; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhang B, 2009, BIOINFORMATICS, V25, P526, DOI 10.1093/bioinformatics/btn660; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	50	34	35	1	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	31					4130	4141		10.1038/onc.2014.343	http://dx.doi.org/10.1038/onc.2014.343			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN9PE	25347741				2022-12-26	WOS:000358780500011
J	Gilbert, M; Miquelle, DG; Goodrich, JM; Reeve, R; Cleaveland, S; Matthews, L; Joly, DO				Gilbert, Martin; Miquelle, Dale G.; Goodrich, John M.; Reeve, Richard; Cleaveland, Sarah; Matthews, Louise; Joly, Damien O.			Estimating the Potential Impact of Canine Distemper Virus on the Amur Tiger Population (Panthera tigris altaica) in Russia	PLOS ONE			English	Article							FAR-EAST; VIABILITY ANALYSIS; SIBERIAN TIGER; LIONS; CARNIVORES; INFECTION; EPIDEMIC; PERSISTENCE; PREVALENCE; DISEASE	Lethal infections with canine distemper virus (CDV) have recently been diagnosed in Amur tigers (Panthera tigris altaica), but long-term implications for the population are unknown. This study evaluates the potential impact of CDV on a key tiger population in Sikhote-Alin Biosphere Zapovednik (SABZ), and assesses how CDV might influence the extinction potential of other tiger populations of varying sizes. An individual-based stochastic, SIRD (susceptible-infected-recovered/dead) model was used to simulate infection through predation of infected domestic dogs, and/or wild carnivores, and direct tiger-to-tiger transmission. CDV prevalence and effective contact based on published and observed data was used to define plausible low-and high-risk infection scenarios. CDV infection increased the 50-year extinction probability of tigers in SABZ by 6.3% to 55.8% compared to a control population, depending on risk scenario. The most significant factors influencing model outcome were virus prevalence in the reservoir population(s) and its effective contact rate with tigers. Adjustment of the mortality rate had a proportional impact, while inclusion of epizootic infection waves had negligible additional impact. Small populations were found to be disproportionately vulnerable to extinction through CDV infection. The 50-year extinction risk in populations consisting of 25 individuals was 1.65 times greater when CDV was present than that of control populations. The effects of density dependence do not protect an endangered population from the impacts of a multi-host pathogen, such as CDV, where they coexist with an abundant reservoir presenting a persistent threat. Awareness of CDV is a critical component of a successful tiger conservation management policy.	[Gilbert, Martin; Miquelle, Dale G.; Joly, Damien O.] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Gilbert, Martin; Reeve, Richard; Cleaveland, Sarah; Matthews, Louise] Univ Glasgow, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Goodrich, John M.] Panthera, New York, NY USA; [Joly, Damien O.] Metabiota, San Francisco, CA USA	Wildlife Conservation Society; University of Glasgow	Gilbert, M (corresponding author), Wildlife Conservat Soc, Bronx, NY 10460 USA.	mgilbert@wcs.org	Matthews, Louise/E-2913-2013; Reeve, Richard/K-9918-2015	Matthews, Louise/0000-0003-4420-8367; Reeve, Richard/0000-0003-2589-8091; Gilbert, Martin/0000-0002-9930-4383; Cleaveland, Sarah/0000-0002-0456-0959	Morris Animal Foundation; Zoo Boise; Biotechnology and Biological Sciences Research Council [BBSRC DTG - BB/F016786/1]; Biological Sciences Research Council through their Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute	Morris Animal Foundation; Zoo Boise; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biological Sciences Research Council through their Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank all institutions who generously supported this work including the Morris Animal Foundation http://www.morrisanimalfoundation.org/ (MG, DGM, LM, SC), Zoo Boise http://www.zooboise.org/ (MG, DGM), and the Biotechnology and Biological Sciences Research Council http://www.bbsrc.com/home/home.aspx (MG, LM, SM) directly through a doctoral training grant (BBSRC DTG - BB/F016786/1), and through their Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2010, COMP IMMUNOL MICROB, V33, P249, DOI 10.1016/j.cimid.2008.10.005; Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1; APPEL MJ, 1987, VIRUS INFECT CARNIVO, P00133; APPEL MJG, 1994, J VET DIAGN INVEST, V6, P277, DOI 10.1177/104063879400600301; BLYTHE LL, 1983, J AM VET MED ASSOC, V183, P1159; Carroll C, 2006, J APPL ECOL, V43, P1056, DOI 10.1111/j.1365-2664.2006.01237.x; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Chundawat RS, 2011, IUCN RED LIST THREAT; Craft ME, 2009, P ROY SOC B-BIOL SCI, V276, P1777, DOI 10.1098/rspb.2008.1636; Creel S, 2002, INFECT DIS AFRICAN W, P269; Daoust PY, 2009, J WILDLIFE DIS, V45, P611, DOI 10.7589/0090-3558-45.3.611; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; FANSHAWE J H, 1991, Oryx, V25, P137; Frolich K, 2000, VET MICROBIOL, V74, P283, DOI 10.1016/S0378-1135(00)00192-9; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; Goodrich JM, 2012, J WILDLIFE DIS, V48, P186, DOI 10.7589/0090-3558-48.1.186; Goodrich JM, 2010, J MAMMAL, V91, P737, DOI 10.1644/09-MAMM-A-293.1; Greene C.E., 2006, INFECT DIS DOG CAT, P25; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Haydon DT, 2002, CONSERV BIOL, V16, P1372, DOI 10.1046/j.1523-1739.2002.00559.x; KENNEY JS, 1995, CONSERV BIOL, V9, P1127, DOI 10.1046/j.1523-1739.1995.9051116.x-i1; Kerley LL, 2003, J MAMMAL, V84, P288, DOI 10.1644/1545-1542(2003)084<0288:RPOWFA>2.0.CO;2; Konjevic D, 2011, ACTA VET BRNO, V80, P47, DOI 10.2754/avb201180010047; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Meli ML, 2010, VET MICROBIOL, V146, P132, DOI 10.1016/j.vetmic.2010.04.024; Miller C., 2012, AMUR TIGER PREDATION; Miquelle D, 2005, CONSERV BIOL SER, V9, P305; Miquelle Dale G., 1996, Journal of Wildlife Research, V1, P138; Miquelle Dale G., 2010, P325; Mochizuki M, 2008, J VET MED SCI, V70, P563, DOI 10.1292/jvms.70.563; Munson L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002545; Myers DL, 1997, CLIN DIAGN LAB IMMUN, V4, P180, DOI 10.1128/CDLI.4.2.180-184.1997; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; Pavlacik L, 2007, VET MED-CZECH, V52, P69, DOI 10.17221/2057-VETMED; Posuwan N, 2010, ASIAN BIOMED, V4, P563, DOI 10.2478/abm-2010-0071; Quigley KS, 2010, J WILDLIFE DIS, V46, P1252, DOI 10.7589/0090-3558-46.4.1252; Ranganathan J, 2008, BIOL CONSERV, V141, P67, DOI 10.1016/j.biocon.2007.09.003; RAUTENBACH GH, 1991, J S AFR VET ASSOC, V62, P158; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Roscoe E, 1993, J WILDLIFE DIS, V29, P390; Sanderson E., 2006, SETTING PRIORITIES C; Seimon TA, 2013, MBIO, V4, DOI 10.1128/mBio.00410-13; Smirnov Evgeny N., 1999, P61; Sunquist M, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P19, DOI 10.1016/B978-0-8155-1570-8.00002-5; Timm SF, 2009, J WILDLIFE DIS, V45, P333, DOI 10.7589/0090-3558-45.2.333; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; WILLIAMS ES, 1988, J WILDLIFE DIS, V24, P385, DOI 10.7589/0090-3558-24.3.385	48	37	43	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110811	10.1371/journal.pone.0110811	http://dx.doi.org/10.1371/journal.pone.0110811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354196	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000345204200040
J	Lucas, AR; Verma, RK; Dai, EB; Liu, LY; Chen, H; Kesavalu, S; Rivera, M; Velsko, I; Ambadapadi, S; Chukkapalli, S; Kesavalu, L				Lucas, Alexandra R.; Verma, Raj K.; Dai, Erbin; Liu, Liying; Chen, Hao; Kesavalu, Sheela; Rivera, Mercedes; Velsko, Irina; Ambadapadi, Sriram; Chukkapalli, Sasanka; Kesavalu, Lakshmyya			Myxomavirus Anti-Inflammatory Chemokine Binding Protein Reduces the Increased Plaque Growth Induced by Chronic Porphyromonas gingivalis Oral Infection after Balloon Angioplasty Aortic Injury in Mice	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; SERINE PROTEINASE; PERIODONTAL-DISEASE; VIRAL SERPIN; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS; VIRUS; INFLAMMATION; MODEL; M-T7	Thrombotic occlusion of inflammatory plaque in coronary arteries causes myocardial infarction. Treatment with emergent balloon angioplasty (BA) and stent implant improves survival, but restenosis (regrowth) can occur. Periodontal bacteremia is closely associated with inflammation and native arterial atherosclerosis, with potential to increase restenosis. Two virus-derived anti-inflammatory proteins, M-T7 and Serp-1, reduce inflammation and plaque growth after BA and transplant in animal models through separate pathways. M-T7 is a broad spectrum C, CC and CXC chemokine-binding protein. Serp-1 is a serine protease inhibitor (serpin) inhibiting thrombotic and thrombolytic pathways. Serp-1 also reduces arterial inflammation and improves survival in a mouse herpes virus (MHV68) model of lethal vasculitis. In addition, Serp-1 demonstrated safety and efficacy in patients with unstable coronary disease and stent implant, reducing markers of myocardial damage. We investigate here the effects of Porphyromonas gingivalis, a periodontal pathogen, on restenosis after BA and the effects of blocking chemokine and protease pathways with M-T7 and Serp-1. ApoE(-/-) mice had aortic BA and oral P. gingivalis infection. Arterial plaque growth was examined at 24 weeks with and without anti-inflammatory protein treatment. Dental plaques from mice infected with P. gingivalis tested positive for infection. Neither Serp-1 nor M-T7 treatment reduced infection, but IgG antibody levels in mice treated with Serp-1 and M-T7 were reduced. P. gingivalis significantly increased monocyte invasion and arterial plaque growth after BA (P < 0.025). Monocyte invasion and plaque growth were blocked by M-T7 treatment (P < 0.023), whereas Serp-1 produced only a trend toward reductions. Both proteins modified expression of TLR4 and MyD88. In conclusion, aortic plaque growth in ApoE(-/-) mice increased after angioplasty in mice with chronic oral P. gingivalis infection. Blockade of chemokines, but not serine proteases significantly reduced arterial plaque growth, suggesting a central role for chemokine-mediated inflammation after BA in P. gingivalis infected mice.	[Lucas, Alexandra R.; Dai, Erbin; Liu, Liying; Chen, Hao; Ambadapadi, Sriram] Univ Florida, Coll Med, Dept Med, Div Cardiovasc Med, Gainesville, FL 32611 USA; [Lucas, Alexandra R.; Dai, Erbin; Liu, Liying; Chen, Hao; Ambadapadi, Sriram] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Div Cardiovasc Med, Gainesville, FL USA; [Verma, Raj K.; Kesavalu, Sheela; Rivera, Mercedes; Velsko, Irina; Chukkapalli, Sasanka; Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lucas, AR (corresponding author), Univ Florida, Coll Med, Dept Med, Div Cardiovasc Med, Gainesville, FL 32611 USA.	alexandra.lucas@medicine.ufl.edu; kesavalu@dental.ufl.edu		Ambadapadi, Sriram/0000-0001-6542-4259	USPHS from National Institute of Dental, Craniofacial Research (NIH/NIDCR) [U24 DE016509]; NIH [R01DE015720-01, DE020820-01, 1RC1HL100202-01]; University of Florida Research Opportunity seed fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015720, U24DE016509] Funding Source: NIH RePORTER	USPHS from National Institute of Dental, Craniofacial Research (NIH/NIDCR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Research Opportunity seed fund(University of Florida); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by USPHS research grant U24 DE016509 from National Institute of Dental, Craniofacial Research (NIH/NIDCR), NIH grants R01DE015720-01, DE020820-01, and 1RC1HL100202-01, and the University of Florida Research Opportunity seed fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Bartee MY, 2014, CYTOKINE, V65, P79, DOI 10.1016/j.cyto.2013.10.005; Bartee MY, 2009, METHOD ENZYMOL, V460, P209, DOI 10.1016/S0076-6879(09)05210-0; Bot I, 2003, CIRC RES, V93, P464, DOI 10.1161/01.RES.0000090993.01633.D4; Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115; Chen H, 2013, ANTIMICROB AGENTS CH, V57, P4114, DOI 10.1128/AAC.02594-12; Chen H, 2011, METHOD ENZYMOL, V499, P301, DOI 10.1016/B978-0-12-386471-0.00015-8; Dai E, 2003, J BIOL CHEM, V278, P18563, DOI 10.1074/jbc.M209683200; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; Dai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010510; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Hamalainen M, 2013, BASIC CLIN PHARMACOL, V112, P296, DOI 10.1111/bcpt.12056; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Jalandhara NB, 2009, AM J THER, V16, P257, DOI [10.1097/MJT.0b013e3181788cdf, 10.1097/MJT.0b013e31804c7238]; Jiang J, 2007, TRANSPLANTATION, V84, P1158, DOI 10.1097/01.tp.0000286099.50532.b0; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kesavalu L, 2012, J DENT RES, V91, P255, DOI 10.1177/0022034511435101; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kobayashi N, 2012, J VASC RES, V49, P417, DOI 10.1159/000339583; Liu D, 2004, TRANSPLANTATION, V77, P1652, DOI 10.1097/01.TP.0000131173.52424.84; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Lucas A, 1996, CIRCULATION, V94, P2890, DOI 10.1161/01.CIR.94.11.2890; Lucas A, 2009, ADV EXP MED BIOL, V666, P132; MACEN JL, 1993, VIROLOGY, V195, P348, DOI 10.1006/viro.1993.1385; Madan M, 2008, ATHEROSCLEROSIS, V197, P504, DOI 10.1016/j.atherosclerosis.2007.02.023; Madan M, 2007, ATHEROSCLEROSIS, V190, P62, DOI 10.1016/j.atherosclerosis.2006.02.026; Mustapha IZ, 2007, J PERIODONTOL, V78, P2289, DOI 10.1902/jop.2007.070140; Paquette DW, 2007, PERIODONTOL 2000, V44, P113, DOI 10.1111/j.1600-0757.2006.00196.x; Petrov L, 2005, J VASC RES, V42, P292, DOI 10.1159/000085905; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Scott NA, 2006, ADV DRUG DELIVER REV, V58, P358, DOI 10.1016/j.addr.2006.01.015; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; TURNER PC, 1995, J VIROL, V69, P5978, DOI 10.1128/JVI.69.10.5978-5987.1995; UPTON C, 1990, VIROLOGY, V179, P618, DOI 10.1016/0042-6822(90)90129-F; Velsko IM, 2014, PLOS ONE, V9; Viswanathan K, 2009, J LEUKOCYTE BIOL, V85, P418, DOI 10.1189/jlb.0808506; Yuan HP, 2013, P NATL ACAD SCI USA, V110, pE5059, DOI 10.1073/pnas.1320862110; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	42	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111353	10.1371/journal.pone.0111353	http://dx.doi.org/10.1371/journal.pone.0111353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354050	gold, Green Published, Green Submitted			2022-12-26	WOS:000345204200074
J	Manvati, S; Mangalhara, KC; Kalaiarasan, P; Srivastava, N; Kumar, B; Bamezai, RNK				Manvati, Siddharth; Mangalhara, Kailash Chandra; Kalaiarasan, P.; Srivastava, Niloo; Kumar, Bhupender; Bamezai, R. N. K.			MiR-101 Induces Senescence and Prevents Apoptosis in the Background of DNA Damage in MCF7 Cells	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; CELLULAR SENESCENCE; IONIZING-RADIATION; BREAST-CANCER; FIBROBLASTS; EXPRESSION; REPRESSION; MICRORNAS; STABILITY; PATHWAY	Moderately increased DNA damage due to the exogenous miR-101 (4 fold) over-expression in MCF7 cells was substantiated by an increase in the number of gamma-H2AX foci, correlating with a simple-to-do Halo-assay. miR-101 induced mild/moderate DNA damage favoured senescence rather than apoptosis. An experimental support emanated from the induced mild/moderate DNA damage with 1 mu M/5 mu M etoposide in MCF7 cells, which resulted in an endogenous miR-101 over-expression (10/4 fold, respectively), followed by senescence. On the other hand, the severe DNA damage induced with 10 mu M etoposide, resulted in a low (<1 fold) endogenous expression of miR-101 and an elevated percentage of apoptotic cells. Using bioinformatics tools along with in-vitro and in-vivo validations, miR-101 was found to target and downregulate the mRNA expression of UBE2N and SMARCA4, involved in DNA damage repair (DDR) pathways. Recovery of the expression of the two novel targets in anti-miR-101 transfection validated the results. We conclude that a threshold range of over-expressed miR-101, capable of inducing mild/moderate DNA damage, is sensed by cells to become senescent. The observation derives further support from in-silico protein-protein network analysis where the two novel targets showed their involvement in senescence pathway.	[Manvati, Siddharth; Kalaiarasan, P.] Shri Mata Vaishno Devi Univ, Sch Biotechnol, Kakrayal, Jammu & Kashmir, India; [Mangalhara, Kailash Chandra; Srivastava, Niloo; Kumar, Bhupender; Bamezai, R. N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India	Shri Mata Vaishno Devi University; Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	bamezai@hotmail.com	Kumar, Bhupender/GLR-8413-2022	Kumar, Bhupender/0000-0003-3887-5040	Jammu and Kashmir, Department of Science and Technology, Govt of India, through Shri Mata Vaishnov Devi University	Jammu and Kashmir, Department of Science and Technology, Govt of India, through Shri Mata Vaishnov Devi University	The study was funded by Jammu and Kashmir, Department of Science and Technology, Govt of India, through Shri Mata Vaishnov Devi University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio N, 2013, CELL MOL LIFE SCI, V70, P1637, DOI 10.1007/s00018-012-1224-x; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen SS, 2011, INT J RADIAT ONCOL, V81, P1524, DOI 10.1016/j.ijrobp.2011.05.031; Collard TJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.142; Das S, 2008, CELL CYCLE, V7, P154, DOI 10.4161/cc.7.2.5236; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Galaz-Leiva S, 2012, BIOTECH HISTOCHEM, V87, P208, DOI 10.3109/10520295.2011.604163; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Greussing R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-224; Hibio N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00996; Hogstrand K, 1999, MUTAT RES-FUND MOL M, V423, P155, DOI 10.1016/S0027-5107(98)00239-5; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kim KS, 2013, INT J RAD BIOL; Li Z, 2013, TOXICOL SCI; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mok MTS, 2012, RADIOTHER ONCOL, V103, P415, DOI 10.1016/j.radonc.2012.04.009; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Sandberg AA, 2010, CANCER GENET CYTOGEN, V203, P102, DOI 10.1016/j.cancergencyto.2010.10.004; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Strillacci A, 2009, EXP CELL RES, V315, P1439, DOI 10.1016/j.yexcr.2008.12.010; Sun Yang, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P460, DOI 10.3760/cma.j.issn.0529-5807.2013.07.007; Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667; Van Oorschot B, 2013, CELL MOL BIOL LETT; Xiaoping L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.197; Zhao LY, 2012, INT J BIOCHEM CELL B, V44, P2051, DOI 10.1016/j.biocel.2012.08.005	36	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111177	10.1371/journal.pone.0111177	http://dx.doi.org/10.1371/journal.pone.0111177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353636	Green Submitted, Green Published, gold			2022-12-26	WOS:000345204200063
J	Pinhasi, R; Meshveliani, T; Matskevich, Z; Bar-Oz, G; Weissbrod, L; Miller, CE; Wilkinson, K; Lordkipanidze, D; Jakeli, N; Kvavadze, E; Higham, TFG; Belfer-Cohen, A				Pinhasi, Ron; Meshveliani, Tengiz; Matskevich, Zinovi; Bar-Oz, Guy; Weissbrod, Lior; Miller, Christopher E.; Wilkinson, Keith; Lordkipanidze, David; Jakeli, Nino; Kvavadze, Eliso; Higham, Thomas F. G.; Belfer-Cohen, Anna			Satsurblia: New Insights of Human Response and Survival across the Last Glacial Maximum in the Southern Caucasus	PLOS ONE			English	Article							UPPER PALEOLITHIC CAVE; SEQUENCE; MIDDLE; ZOOARCHAEOLOGY; DZUDZUANA; TAPHONOMY; HOVK-1; DEMISE; SITE	The region of western Georgia (Imereti) has been a major geographic corridor for human migrations during the Middle and Upper Palaeolithic (MP/UP). Knowledge of the MP and UP in this region, however, stems mostly from a small number of recent excavations at the sites of Ortvale Klde, Dzudzuana, Bondi, and Kotias Klde. These provide an absolute chronology for the Late MP and MP-UP transition, but only a partial perspective on the nature and timing of UP occupations, and limited data on how human groups in this region responded to the harsh climatic oscillations between 37,000-11,500 years before present. Here we report new UP archaeological sequences from fieldwork in Satsurblia cavein the same region. A series of living surfaces with combustion features, faunal remains, stone and bone tools, and ornaments provide new information about human occupations in this region (a) prior to the Last Glacial Maximum (LGM) at 25.5-24.4 ka cal. BP and (b) after the LGM at 17.9-16.2 ka cal. BP. The latter provides new evidence in the southern Caucasus for human occupation immediately after the LGM. The results of the campaigns in Satsurblia and Dzudzuana suggest that at present the most plausible scenario is one of a hiatus in the occupation of this region during the LGM (between 24.4-17.9 ka cal. BP). Analysis of the living surfaces at Satsurblia offers information about human activities such as the production and utilisation of lithics and bone tools, butchering, cooking and consumption of meat and wild cereals, the utilisation of fibers, and the use of certain woods. Microfaunal and palynological analyses point to fluctuations in the climate with consequent shifts in vegetation and the faunal spectrum not only before and after the LGM, but also during the two millennia following the end of the LGM.	[Pinhasi, Ron] Univ Coll Dublin, Earth Inst, Dublin 2, Ireland; [Pinhasi, Ron] Univ Coll Dublin, Sch Archaeol, Dublin 2, Ireland; [Meshveliani, Tengiz; Lordkipanidze, David; Jakeli, Nino] Georgian State Museum, Dept Prehist, Tbilisi, Georgia; [Matskevich, Zinovi] Israel Antiqu Author, Jerusalem, Israel; [Bar-Oz, Guy; Weissbrod, Lior] Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel; [Miller, Christopher E.] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany; [Miller, Christopher E.] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany; [Wilkinson, Keith] Univ Winchester, Dept Archaeol, Winchester, Hants, England; [Kvavadze, Eliso] Natl Museum Georgia, Inst Paleobiol, Tbilisi, Georgia; [Higham, Thomas F. G.] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Res Lab Archaeol & Hist Art, Oxford, England; [Belfer-Cohen, Anna] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	University College Dublin; University College Dublin; University of Haifa; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Winchester; University of Oxford; Hebrew University of Jerusalem	Pinhasi, R (corresponding author), Univ Coll Dublin, Earth Inst, Dublin 2, Ireland.	ron.pinhasi@ucd.ie; Anna.Belfer-Cohen@mail.huji.ac.il	Lordkipanidze, David/AAH-6472-2020; Higham, Tom/Y-2707-2019; Weissbrod, Lior/I-8735-2019; Pinhasi, Ron/AAT-1531-2020; BarOz, Guy/ABF-6518-2020	Higham, Tom/0000-0002-5949-598X; Weissbrod, Lior/0000-0003-3401-8180; Pinhasi, Ron/0000-0003-1629-8131; BarOz, Guy/0000-0002-1009-5619	National Geographic-Global Exploration Fund [GEFNE78-13]; European Research Council Starter [ERC-2010-StG 263441]	National Geographic-Global Exploration Fund(National Geographic Society); European Research Council Starter	National Geographic-Global Exploration Fund funded this research from April 2013 to February 2014 (grant- GEFNE78-13). Additional support was receieved from European Research Council Starter (grant- ERC-2010-StG 263441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DS, 2008, J HUM EVOL, V55, P817, DOI 10.1016/j.jhevol.2008.08.010; Adler DS, 2006, CURR ANTHROPOL, V47, P89, DOI 10.1086/432455; Amorosi T., 1989, BRIT ARCHAEOLOGICAL; Bader N. O., 1984, PALEOLIT SSSR, P272; Bar-Oz G, 2008, INT J OSTEOARCHAEOL, V18, P131, DOI 10.1002/oa.926; Bar-Oz G, 2009, ARCHAEOL ETHNOL ANTH, V37, P15, DOI 10.1016/j.aeae.2009.05.002; Bar-Oz Guy, 2005, Journal of Taphonomy, V3, P185; Bar-Oz G, 2012, J ARCHAEOL SCI, V39, P2452, DOI 10.1016/j.jas.2012.02.014; Bar-Yosef O, 2011, ANTIQUITY, V85, P331, DOI 10.1017/S0003598X0006779X; Baryshnikov Gennady F., 2002, Russian Journal of Theriology, V1, P61; Cuenca-Bescos G, 2009, J ARCHAEOL SCI, V36, P947, DOI 10.1016/j.jas.2008.09.025; Gabunia M, 2003, DZIEBANI, V12, P5; Gamble C, 2005, CAMB ARCHAEOL J, V15, P193, DOI 10.1017/S0959774305000107; Golovanova LV, 2014, QUATERN INT, V337, P189, DOI 10.1016/j.quaint.2012.04.034; Grigolia GK, 1977, CENTRALURI KOLHETIS; Gromov IM, 1980, KUDARO PALEOLITHIC C, P79; HEPTNER VG, 1989, MAMMALS SOVIET UNION, V1; Kalandadze A.N., 1978, CAVES GEORGIA, P116; Kalandadze KS, 2004, TSKALTUBO EXPEDITION; Kandel AW, 2011, ARAMAZD, V2, P7; Krystufek B, 2008, IUCN RED LIST THREAT; KURTEN BJORN, 1958, ACTA ZOOL FENNICA, V95, P1; Kvavadze E, 2011, P NAT PREH SECT GEOR, P85; Kvavadze E, 2011, C VIEW MOUSNT BERN S; Liubin VP, 1966, ISTOKOV DREVNIKH KUL, V126, P155; Lopez-Garcia JM, 2014, PALAEOGEOGR PALAEOCL, V409, P169, DOI 10.1016/j.palaeo.2014.05.017; Meshveliani T, 2004, EARLY UPPER PALEOLITHIC BEYOND WESTERN EUROPE, P129; Meshveliani T., 2007, PALEORIENT, V33, P47, DOI [10.3406/paleo.2007.5220, DOI 10.3406/PALEO.2007.5220]; Montoya C, 2013, J HUM EVOL, V65, P621, DOI 10.1016/j.jhevol.2013.07.011; Nioradze MG, 2000, ANTHROPOLOGIE, V104, P265; Payne S., 1988, ARCHAEOZOOLOGIA, V2, P27; Pinhasi R, 2012, J HUM EVOL, V63, P770, DOI 10.1016/j.jhevol.2012.08.004; Pinhasi R, 2011, QUATERNARY SCI REV, V30, P3846, DOI 10.1016/j.quascirev.2011.09.020; Smith A. T, 2008, IUCN RED LIST THREAT; Soffer O, 1990, HIGH LATITUDES, V1; Stiner MC, 1998, J HUM EVOL, V34, P303, DOI 10.1006/jhev.1997.0198; Tsytsulina K., 2008, IUCN RED LIST THREAT; Tushabramishvili D., 1960, PALEOLITHIC REMAINS; Tushabramishvili N, 2012, J HUM EVOL, V62, P179, DOI 10.1016/j.jhevol.2011.11.001; VERESHCHAGIN N. K., 1958, ZOOL ZHUR, V37, P1874; Vereshchagin NK, 1967, MAMMALS CAUCASUS HIS; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Yigit Nuri, 2006, Turkish Journal of Zoology, V30, P291; Zamiatnin SN, 1957, COLLECTION PAPERS AN, V17, P432	44	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111271	10.1371/journal.pone.0111271	http://dx.doi.org/10.1371/journal.pone.0111271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354048	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200065
J	Gibbs, JP; Hunter, EA; Shoemaker, KT; Tapia, WH; Cayot, LJ				Gibbs, James P.; Hunter, Elizabeth A.; Shoemaker, Kevin T.; Tapia, Washington H.; Cayot, Linda J.			Demographic Outcomes and Ecosystem Implications of Giant Tortoise Reintroduction to Espanola Island, Galapagos	PLOS ONE			English	Article							SURVIVAL RATES; CONSERVATION; TRANSLOCATION; RESTORATION; YELLOWSTONE; TOOL; REPATRIATION; POPULATIONS; LANDSCAPE; ENGINEERS	Restoration of extirpated species via captive breeding has typically relied on population viability as the primary criterion for evaluating success. This criterion is inadequate when species reintroduction is undertaken to restore ecological functions and interactions. Herein we report on the demographic and ecological outcomes of a five-decade-long population restoration program for a critically endangered species of "ecosystem engineer'': the endemic Espanola giant Galapagos tortoise (Chelonoidis hoodensis). Our analysis of complementary datasets on tortoise demography and movement, tortoise-plant interactions and Espanola Island's vegetation history indicated that the repatriated tortoise population is secure from a strictly demographic perspective: about half of tortoises released on the island since 1975 were still alive in 2007, in situ reproduction is now significant, and future extinction risk is low with or without continued repatriation. Declining survival rates, somatic growth rates, and body condition of repatriates suggests, however, that resources for continued population growth are increasingly limited. Soil stable carbon isotope analyses indicated a pronounced shift toward woody plants in the recent history of the island's plant community, likely a legacy of changes in competitive relations between woody and herbaceous plants induced by now-eradicated feral goats and prolonged absence of tortoises. Woody plants are of concern because they block tortoise movement and hinder recruitment of cactus-a critical resource for tortoises. Tortoises restrict themselves to remnant cactus patches and areas of low woody plant density in the center of the island despite an apparent capacity to colonize a far greater range, likely because of a lack of cactus elsewhere on the island. We conclude that ecosystem-level criteria for success of species reintroduction efforts take much longer to achieve than population-level criteria; moreover, reinstatement of endangered species as fully functioning ecosystem engineers may often require large-scale habitat restoration efforts in concert with population restoration.	[Gibbs, James P.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Hunter, Elizabeth A.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Shoemaker, Kevin T.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Tapia, Washington H.] Galapagos Natl Pk Serv, Dept Appl Res, Puerto Ayora, Galapagos, Ecuador; [Cayot, Linda J.] Galapagos Conservancy, Fairfax, VA USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gibbs, JP (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.	jpgibbs@esf.edu		Tapia, Washington/0000-0002-5222-1804; Hunter, Elizabeth/0000-0003-4710-167X	Galapagos Conservancy; Galapagos National Park Service; Prometeo Program of Ecuador's National Secretariat for Higher Education, Science, Technology and Innovation; U.S. National Science Foundation [DEB 1258062]; Direct For Biological Sciences [1258062, 1146198] Funding Source: National Science Foundation	Galapagos Conservancy; Galapagos National Park Service; Prometeo Program of Ecuador's National Secretariat for Higher Education, Science, Technology and Innovation; U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The 2010 field surveys of tortoise-plant interactions as well as this synthesis of the accumulated information was funded by the Galapagos Conservancy in collaboration with the Galapagos National Park Service, the Prometeo Program of Ecuador's National Secretariat for Higher Education, Science, Technology and Innovation, and U.S. National Science Foundation grant DEB 1258062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson David J., 2002, Marine Ornithology, V30, P63; Anderson DJ, 2008, ALBATROSS THEIR WORL; ARCHER S, 1995, ECOSCIENCE, V2, P83, DOI 10.1080/11956860.1995.11682272; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Armstrong DP, 2005, J ANIM ECOL, V74, P160, DOI 10.1111/j.1365-2656.2004.00908.x; Asner GP, 2012, ECOL LETT, V15, P1211, DOI 10.1111/j.1461-0248.2012.01842.x; Bai E, 2012, ORG GEOCHEM, V42, P1512, DOI 10.1016/j.orggeochem.2010.11.004; Beyer HL, 2007, ECOL APPL, V17, P1563, DOI 10.1890/06-1254.1; Blake S, 2013, J ANIM ECOL, V82, P310, DOI 10.1111/1365-2656.12020; Bolker B, 2008, ECOLOGICAL MODELS DA; Bourn D, 1999, P ROY SOC B-BIOL SCI, V266, P1091, DOI 10.1098/rspb.1999.0748; Browning DM, 2011, ECOL APPL, V21, P1629, DOI 10.1890/10-0542.1; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cayot L. J., 1987, ECOLOGY GIANT TORTOI; Cayot Linda J., 2008, Galapagos Research, V65, P39; Chiari Y, 2011, J MORPHOL, V272, P379, DOI 10.1002/jmor.10923; Chiari Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006272; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; Crawley M.J., 2007, R BOOK; Cromsigt JPGM, 2014, J ECOL, V102, P1365; Cruz Márquez, 2003, Ecol. apl., V2, P21; Davidson AD, 2014, J WILDLIFE IN PRESS; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DODD CK, 1991, HERPETOLOGICA, V47, P336; Douglas HD, 1998, CONDOR, V100, P737, DOI 10.2307/1369757; Field KJ, 2007, BIOL CONSERV, V136, P232, DOI 10.1016/j.biocon.2006.11.022; Froyd CA, 2014, ECOL LETT, V17, P144, DOI 10.1111/ele.12203; Gibbs JP, 2008, RESTOR ECOL, V16, P88, DOI 10.1111/j.1526-100X.2007.00265.x; Gibbs James P., 2010, Galapagos Research, V67, P18; Gibbs JP, 2010, BIOTROPICA, V42, P208, DOI 10.1111/j.1744-7429.2009.00552.x; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Griffiths CJ, 2011, CURR BIOL, V21, P762, DOI 10.1016/j.cub.2011.03.042; HAMANN O, 1993, BIODIVERS CONSERV, V2, P138, DOI 10.1007/BF00056130; Hansen DM, 2010, ECOGRAPHY, V33, P272, DOI 10.1111/j.1600-0587.2010.06305.x; Hicks DJ, 1996, HASELTONIA, P89; Hicks DJ, 2000, BIOTROPICA, V32, P235, DOI 10.1111/j.1744-7429.2000.tb00466.x; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; Hunter EA, 2014, RESTOR ECOL, V22, P248, DOI 10.1111/rec.12055; Johnson BE, 2007, CONSERV BIOL, V21, P515, DOI 10.1111/j.1523-1739.2006.00610.x; Liu MaoXiu, 2014, Advanced Science, Engineering and Medicine (ASEM), V6, P236; MARQUEZ C, 1991, Noticias de Galapagos, P17; Marquez C., 1999, CRIANZA TORTUGAS GIG; Márquez Cruz, 2004, Ecol. apl., V3, P98; Milinkovitch MC, 2004, P ROY SOC B-BIOL SCI, V271, P341, DOI 10.1098/rspb.2003.2607; Mueller-Dombois D., 1974, AIMS METHODS VEGETAT; Nicoll MAC, 2003, J ANIM ECOL, V72, P917, DOI 10.1046/j.1365-2656.2003.00768.x; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Pike DA, 2008, ECOLOGY, V89, P607, DOI 10.1890/06-2162.1; R Development Core Team, 2012, R LANG ENV STAT COMP; RACINE C H, 1974, Biotropica, V6, P175, DOI 10.2307/2989650; Reinert HK, 1999, J HERPETOL, V33, P45, DOI 10.2307/1565542; Ripple WJ, 2007, BIOL CONSERV, V138, P514, DOI 10.1016/j.biocon.2007.05.006; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Schadt S, 2002, J APPL ECOL, V39, P189, DOI 10.1046/j.1365-2664.2002.00700.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Shoemaker KT, 2014, CONSERVATION BIOL; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; SWINGLAND IR, 1979, PHILOS T ROY SOC B, V286, P177, DOI 10.1098/rstb.1979.0025; Tortoise & Freshwater Turtle Specialist Group, 1996, IUCN 2013 IUCN RED L; Trueman M, 2013, LANDSCAPE ECOL, V28, P519, DOI 10.1007/s10980-013-9854-4; Truett Joe, 2009, Ecological Restoration, V27, P144, DOI 10.3368/er.27.2.144; Tuberville TD, 2008, BIOL CONSERV, V141, P2690, DOI 10.1016/j.biocon.2008.08.004; WALKER BH, 1981, J ECOL, V69, P473, DOI 10.2307/2259679; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Yott A, 2010, RESTORATION ECOLOGY, V19, P70	68	41	41	0	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110742	10.1371/journal.pone.0110742	http://dx.doi.org/10.1371/journal.pone.0110742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350744	Green Published, gold			2022-12-26	WOS:000343943100037
J	Hraiech, S; Hiblot, J; Lafleur, J; Lepidi, H; Papazian, L; Rolain, JM; Raoult, D; Elias, M; Silby, MW; Bzdrenga, J; Bregeon, F; Chabriere, E				Hraiech, Sami; Hiblot, Julien; Lafleur, John; Lepidi, Hubert; Papazian, Laurent; Rolain, Jean-Marc; Raoult, Didier; Elias, Mikael; Silby, Mark W.; Bzdrenga, Janek; Bregeon, Fabienne; Chabriere, Eric			Inhaled Lactonase Reduces Pseudomonas aeruginosa Quorum Sensing and Mortality in Rat Pneumonia	PLOS ONE			English	Article							ANTIBACTERIAL EFFICACY; BIOFILM FORMATION; VIRULENCE; MODEL; INHIBITORS; INFECTION; EXPRESSION; MOLECULE; AUTOINDUCTION; ENZYME	Rationale: The effectiveness of antibiotic molecules in treating Pseudomonas aeruginosa pneumonia is reduced as a result of the dissemination of bacterial resistance. The existence of bacterial communication systems, such as quorum sensing, has provided new opportunities of treatment. Lactonases efficiently quench acyl-homoserine lactone-based bacterial quorum sensing, implicating these enzymes as potential new anti-Pseudomonas drugs that might be evaluated in pneumonia. Objectives: The aim of the present study was to evaluate the ability of a lactonase called SsoPox-I to reduce the mortality of a rat P. aeruginosa pneumonia. Methods: To assess SsoPox-I-mediated quorum quenching, we first measured the activity of the virulence gene lasB, the synthesis of pyocianin, the proteolytic activity of a bacterial suspension and the formation of biofilm of a PAO1 strain grown in the presence of lactonase. In an acute lethal model of P. aeruginosa pneumonia in rats, we evaluated the effects of an early or deferred intra-tracheal treatment with SsoPox-I on the mortality, lung bacterial count and lung damage. Measurements and Primary Results: SsoPox-I decreased PAO1 lasB virulence gene activity, pyocianin synthesis, proteolytic activity and biofilm formation. The early use of SsoPox-I reduced the mortality of rats with acute pneumonia from 75% to 20%. Histological lung damage was significantly reduced but the lung bacterial count was not modified by the treatment. A delayed treatment was associated with a non-significant reduction of mortality. Conclusion: These results demonstrate the protective effects of lactonase SsoPox-I in P. aeruginosa pneumonia and open the way for a future therapeutic use.	[Hraiech, Sami; Hiblot, Julien; Lepidi, Hubert; Papazian, Laurent; Rolain, Jean-Marc; Raoult, Didier; Bzdrenga, Janek; Bregeon, Fabienne; Chabriere, Eric] Aix Marseille Univ, IFR48, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS IRD 6236, Marseille, France; [Hraiech, Sami; Papazian, Laurent] CHU Nord, APHM, Reanimat Detresses Respiratoires & Infect Severe, Marseille, France; [Lafleur, John; Silby, Mark W.] Univ Massachusetts, Dept Biol, Dartmouth, MA USA; [Lafleur, John] Alpert Sch Med, Dept Emergency Med, Providence, RI USA; [Elias, Mikael] Weizmann Inst Sci Biol Chem, Rehovot, Israel	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Massachusetts System; University Massachusetts Dartmouth	Bregeon, F (corresponding author), Aix Marseille Univ, IFR48, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS IRD 6236, Marseille, France.	Fabienne.bregeon@ap-hm.fr; Eric.chabriere@univ-amu.fr	Elias, Mikael/AAH-9385-2021; Rolain, Jean-Marc/Y-3788-2019; RAOULT, Didier/A-8434-2008; Hiblot, Julien/AAA-4452-2020	Elias, Mikael/0000-0003-0406-7539; Rolain, Jean-Marc/0000-0002-2402-4467; RAOULT, Didier/0000-0002-0633-5974; Hiblot, Julien/0000-0002-7883-8079; Silby, Mark/0000-0002-3092-8008; Bzdrenga, Janek/0000-0003-3705-3459	Aix Marseille University (AMU)	Aix Marseille University (AMU)	This study was funded by Aix Marseille University (AMU) and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014; Agodi A, 2007, INTENS CARE MED, V33, P1155, DOI 10.1007/s00134-007-0671-6; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Bakker-Woudenberg IAJM, 2002, ANTIMICROB AGENTS CH, V46, P2575, DOI 10.1128/AAC.46.8.2575-2581.2002; Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051; Bjarnsholt T, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001420; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Galloway WRJD, 2012, TRENDS MICROBIOL, V20, P449, DOI 10.1016/j.tim.2012.06.003; Garcia-Quintanilla M, 2013, TRENDS MICROBIOL, V21, P157, DOI 10.1016/j.tim.2012.12.002; Grabiner MA, 2014, J IMMUNOL, V193, P1459, DOI 10.4049/jimmunol.1303437; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hiblot J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075272; Hiblot J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00779; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hraiech S, 2013, ANTIMICROB AGENTS CH, V57, P5120, DOI 10.1128/AAC.00700-13; Hraiech S, 2012, J ANTIMICROB CHEMOTH, V67, P2452, DOI 10.1093/jac/dks230; Ilangovan A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003508; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Lesprit P, 2003, AM J RESP CRIT CARE, V167, P1478, DOI 10.1164/rccm.200207-736BC; Marquette CH, 1999, CHEST, V115, P200, DOI 10.1378/chest.115.1.200; Migiyama Y, 2013, ANTIMICROB AGENTS CH, V57, P3653, DOI 10.1128/AAC.00456-13; Ng FSW, 2011, APPL ENVIRON MICROB, V77, P1181, DOI 10.1128/AEM.01642-10; Nicodeme M, 2005, J APPL MICROBIOL, V99, P641, DOI 10.1111/j.1365-2672.2005.02634.x; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Papaioannou E, 2009, ANTIMICROB AGENTS CH, V53, P4891, DOI 10.1128/AAC.00380-09; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Pearson JP, 2000, INFECT IMMUN, V68, P4331, DOI 10.1128/IAI.68.7.4331-4334.2000; Pei RT, 2014, APPL ENVIRON MICROB, V80, P5340, DOI 10.1128/AEM.01434-14; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Rasmussen TB, 2005, MICROBIOL-SGM, V151, P1325, DOI 10.1099/mic.0.27715-0; Rezaiguia S, 1997, J CLIN INVEST, V99, P325, DOI 10.1172/JCI119161; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; SEED PC, 1995, J BACTERIOL, V177, P654, DOI 10.1128/jb.177.3.654-659.1995; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Stanton TB, 2013, TRENDS MICROBIOL, V21, P111, DOI 10.1016/j.tim.2012.11.002; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07; van Delden C, 2012, INTENS CARE MED, V38, P1118, DOI 10.1007/s00134-012-2559-3; Wagner VE, 2006, TRENDS MICROBIOL, V14, P55, DOI 10.1016/j.tim.2005.12.002; Wagner VE, 2004, VACCINE, V22, pS15, DOI 10.1016/j.vaccine.2004.08.011; Wen J, 2014, INFLAMMATION, V37, P933, DOI 10.1007/s10753-014-9813-5; Wilkins MR, 1999, METH MOL B, V112, P531; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005	53	63	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e107125	10.1371/journal.pone.0107125	http://dx.doi.org/10.1371/journal.pone.0107125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350373	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100006
J	Gordon, DS; Madden, JR; Lea, SEG				Gordon, David S.; Madden, Joah R.; Lea, Stephen E. G.			Both Loved and Feared: Third Party Punishers Are Viewed as Formidable and Likeable, but These Reputational Benefits May Only Be Open to Dominant Individuals	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; INDIRECT RECIPROCITY; COOPERATION; EVOLUTION; RETALIATION; GENEROSITY; DETERRENCE; LEADERSHIP; THREATS; POWER	Third party punishment can be evolutionarily stable if there is heterogeneity in the cost of punishment or if punishers receive a reputational benefit from their actions. A dominant position might allow some individuals to punish at a lower cost than others and by doing so access these reputational benefits. Three vignette-based studies measured participants' judgements of a third party punisher in comparison to those exhibiting other aggressive/dominant behaviours (Study 1), when there was variation in the success of punishment (Study 2), and variation in the status of the punisher and the type of punishment used (Study 3). Third party punishers were judged to be more likeable than (but equally dominant as) those who engaged in other types of dominant behaviour (Study 1), were judged to be equally likeable and dominant whether their intervention succeeded or failed (Study 2), and participants believed that only a dominant punisher could intervene successfully (regardless of whether punishment was violent or non-violent) and that subordinate punishers would face a higher risk of retaliation (Study 3). The results suggest that dominance can dramatically reduce the cost of punishment, and that while individuals can gain a great deal of reputational benefit from engaging in third party punishment, these benefits are only open to dominant individuals. Taking the status of punishers into account may therefore help explain the evolution of third party punishment.	[Gordon, David S.; Madden, Joah R.; Lea, Stephen E. G.] Univ Exeter, Sch Psychol, Exeter, Devon, England	University of Exeter	Gordon, DS (corresponding author), Univ Exeter, Sch Psychol, Exeter, Devon, England.	dsg204@exeter.ac.uk	Lea, Stephen/B-4811-2009	Lea, Stephen/0000-0002-8498-4187; Gordon, David/0000-0003-0807-834X; Madden, Joah/0000-0002-0691-0967	School of Psychology, University of Exeter	School of Psychology, University of Exeter	Funding for this project was provided internally by the School of Psychology, University of Exeter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2008, PERS SOC PSYCHOL B, V34, P90, DOI 10.1177/0146167207307489; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Barclay P, 2006, EVOL HUM BEHAV, V27, P325, DOI 10.1016/j.evolhumbehav.2006.01.003; Barclay P, 2013, EVOL HUM BEHAV, V34, P164, DOI 10.1016/j.evolhumbehav.2013.02.002; Barclay P, 2010, BRIT J PSYCHOL, V101, P123, DOI 10.1348/000712609X435733; Barr Abigail, 2001, SOCIAL DILEMMAS SHAM; Bazzan ALC, 2010, ADV COMPLEX SYST, V13, P755, DOI 10.1142/S0219525910002815; Benard S, 2013, SOC SCI RES, V42, P230, DOI 10.1016/j.ssresearch.2012.09.004; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Brosnan SF, 2011, J EC BEHAV ORG; BUSS DM, 1981, J PERS SOC PSYCHOL, V40, P147, DOI 10.1037/0022-3514.40.1.147; Cant MA, 2009, AM NAT, V173, P759, DOI 10.1086/598489; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Cummins D., 2005, HDB EVOLUTIONARY PSY, P676; Cummins DD, 1996, MIND MACH, V6, P463; Dasgupta P, 2011, J THEORETICAL BIOL; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; de Weerd H, 2011, J THEORETICAL BIOL; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dreber A, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11001221; Eckel CC, 2010, J PUBLIC ECON THEORY, V12, P737, DOI 10.1111/j.1467-9779.2010.01472.x; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fessler DMT, 2014, EVOL HUM BEHAV, V35, P26, DOI 10.1016/j.evolhumbehav.2013.09.003; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; Frank SA, 1996, ANIM BEHAV, V52, P1163, DOI 10.1006/anbe.1996.0263; Fudenberg D, 2010, J PUBLIC ECON, V94, P78, DOI 10.1016/j.jpubeco.2009.10.007; Griskevicius V, 2009, J PERS SOC PSYCHOL, V96, P980, DOI 10.1037/a0013907; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hawley PH, 2008, INT J BEHAV DEV, V32, P76, DOI 10.1177/0165025407084054; Hawley PH, 1999, DEV REV, V19, P97, DOI 10.1006/drev.1998.0470; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hogg MA, 2012, EUR REV SOC PSYCHOL, V23, P258, DOI 10.1080/10463283.2012.741134; HUSTON TL, 1981, SOC PSYCHOL QUART, V44, P14, DOI 10.2307/3033858; Iredale W, 2008, EVOL PSYCHOL-US, V6, P386, DOI 10.1177/147470490800600302; Jennings DJ, 2011, ANIM BEHAV, V81, P1217, DOI 10.1016/j.anbehav.2011.03.007; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; Jones BC, 2011, ANIMAL BEHAV; Kim SH, 1998, PERS SOC PSYCHOL B, V24, P353, DOI 10.1177/0146167298244002; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Levine M, 2011, PSYCHOL SCI; Lewis RJ, 2002, Q REV BIOL, V77, P149, DOI 10.1086/343899; Maner JK, 2010, J PERS SOC PSYCHOL, V99, P482, DOI 10.1037/a0018559; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Mathew S, 2011, P NATL ACAD SCI; McCullough ME, 2013, BEHAV BRAIN SCI, V36, P1, DOI 10.1017/S0140525X11002160; McNamara JM, 2002, PHILOS T R SOC B, V357, P1607, DOI 10.1098/rstb.2002.1069; Melis AP, 2010, PHILOS T R SOC B, V365, P2663, DOI 10.1098/rstb.2010.0157; Nelissen RMA, 2008, EVOL HUM BEHAV, V29, P242, DOI 10.1016/j.evolhumbehav.2008.01.001; Nikiforakis N, 2008, EXP ECON, V11, P358, DOI 10.1007/s10683-007-9171-3; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nikiforakis N, 2010, SOUTH ECON J, V76, P638, DOI 10.4284/sej.2010.76.3.638; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ottone S, 2008, EC B, V3, P1; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Pedersen EJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2723; Platek S. M., 2009, J SOCIAL EVOLUTIONAR, V3, P182, DOI [10.1037/h0099323, DOI 10.1037/H0099323]; Przepiorka W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0247; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Reuben E, 2009, J CONFLICT RESOLUT, V53, P72, DOI 10.1177/0022002708322361; Santos MD, 2010, P ROYAL SOC B, V278, P371, DOI DOI 10.1098/RSPB.2010.1275; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Silk JB, 2002, EVOL ANTHROPOL, V11, P221, DOI 10.1002/evan.10038; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Szamado S, 2011, ANIMAL BEHAV; Tarling R, 2010, BRIT J CRIMINOL, V50, P474, DOI 10.1093/bjc/azq011; Tennie C, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11001336; Tibbetts EA, 2010, CURR BIOL, V20, P1637, DOI 10.1016/j.cub.2010.07.042; Topalli V, 2002, BRIT J CRIMINOL, V42, P337, DOI 10.1093/bjc/42.2.337; Widdig A, 2000, AM J PRIMATOL, V50, P37, DOI 10.1002/(SICI)1098-2345(200001)50:1<37::AID-AJP4>3.3.CO;2-V; Wilson DS, 2003, HUM NATURE-INT BIOS, V14, P277, DOI 10.1007/s12110-003-1007-z; Wong MYL, 2007, P ROY SOC B-BIOL SCI, V274, P1093, DOI 10.1098/rspb.2006.0284	77	18	18	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110045	10.1371/journal.pone.0110045	http://dx.doi.org/10.1371/journal.pone.0110045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347781	Green Published, gold			2022-12-26	WOS:000347994900019
J	Kobayashi, S; Hara, A; Isagawa, T; Manabe, I; Takeda, K; MaruYama, T				Kobayashi, Shuhei; Hara, Akira; Isagawa, Takayuki; Manabe, Ichiro; Takeda, Kiyoshi; MaruYama, Takashi			The Nuclear I kappa B Family Protein I kappa B-NS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model	PLOS ONE			English	Article							REGULATORY T-CELLS; ROR-GAMMA-T; DIFFERENTIATION; TRANSCRIPTION; RECEPTOR; INFLAMMATION; INDUCTION; T(H)17; TH17; BNS	The nuclear I kappa B family protein I kappa B-NS is expressed in T cells and plays an important role in Interferon (IFN)-gamma and Interleukin (IL)-2 production. I kappa B-zeta, the most similar homolog of I kappa B-NS, plays an important role in the generation of T helper (Th)17 cells in cooperation with ROR gamma t, a master regulator of Th17 cells. Thus, I kappa B-zeta deficient mice are resistant to Th17-dependent experimental autoimmune encephalomyelitis (EAE). However, I kappa B-zeta deficient mice develop the autoimmune-like Sjogren syndrome with aging. Here we found that I kappa B-NS-deficient (Nfkbid(-/-)) mice show resistance against developing Th17-dependent EAE. We found that Nfkbid(-/-) T cells have decreased expression of IL-17-related genes and ROR gamma t in response to Transforming Growth Factor (TGF)-beta 1 and IL-6 stimulation. Thus, I kappa B-NS plays a pivotal role in the generation of Th17 cells and in the control of Th17-dependent EAE.	[Kobayashi, Shuhei; MaruYama, Takashi] Tohoku Univ, Lab Cell Recognit & Response, Sendai, Miyagi 980, Japan; [Hara, Akira] Gifu Univ, Grad Sch Med, Dept Pathol, Gifu, Japan; [Isagawa, Takayuki] Tokyo Med & Dent Univ, Dept Genom Pathol, Tokyo, Japan; [Manabe, Ichiro] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Takeda, Kiyoshi] Osaka Univ, Lab Immune Regulat, Osaka, Japan; [MaruYama, Takashi] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Gifu, Japan	Tohoku University; Gifu University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Osaka University; Gifu University	MaruYama, T (corresponding author), Tohoku Univ, Lab Cell Recognit & Response, Sendai, Miyagi 980, Japan.	ta-maru@umin.ac.jp	Manabe, Ichiro/AAE-5105-2021; MaruYama, Takashi/N-5994-2014; Manabe, Ichiro/E-1529-2014; Takeda, Kiyoshi/C-9331-2009	MaruYama, Takashi/0000-0003-0820-3219; Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education [25118702]; Japan Society for the Promotion of Science [24790458]; Takeda Science Foundation; Uehara Memorial Foundation; Novartis Foundation; Sumitomo Foundation	Ministry of Education; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Novartis Foundation(Novartis); Sumitomo Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (25118702) from the Ministry of Education, a Grant-in-Aid for Young Scientists (B) (24790458) from the Japan Society for the Promotion of Science, and by grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Novartis Foundation, and the Sumitomo Foundation to TMY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Arnold CN, 2012, P NATL ACAD SCI USA, V109, P12286, DOI 10.1073/pnas.1209134109; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Fujita S, 2006, BLOOD, V107, P3656, DOI 10.1182/blood-2005-10-4190; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hermann-Kleiter N, 2012, J AUTOIMMUN, V39, P428, DOI 10.1016/j.jaut.2012.07.007; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; Maruyama T, 2011, SEMIN IMMUNOL, V23, P418, DOI 10.1016/j.smim.2011.06.005; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Oukka M, 2007, ANN RHEUM DIS, V66, P87, DOI 10.1136/ard.2007.078527; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Reichert F, 1999, EXP NEUROL, V160, P508, DOI 10.1006/exnr.1999.7229; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Satoh K, 2011, BRAIN RES, V1382, P266, DOI 10.1016/j.brainres.2011.01.049; Schuster M, 2012, IMMUNITY, V37, P998, DOI 10.1016/j.immuni.2012.08.023; Touma M, 2007, J IMMUNOL, V179, P1681, DOI 10.4049/jimmunol.179.3.1681; Veldhoen M, 2006, TRENDS IMMUNOL, V27, P358, DOI 10.1016/j.it.2006.06.001; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	29	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110838	10.1371/journal.pone.0110838	http://dx.doi.org/10.1371/journal.pone.0110838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347393	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900032
J	Nallanchakravarthula, S; Mahmood, S; Alstrom, S; Finlay, RD				Nallanchakravarthula, Srivathsa; Mahmood, Shahid; Alstrom, Sadhna; Finlay, Roger D.			Influence of Soil Type, Cultivar and Verticillium dahliae on the Structure of the Root and Rhizosphere Soil Fungal Microbiome of Strawberry	PLOS ONE			English	Article							ENDOPHYTIC BACTERIAL COMMUNITIES; ARABIDOPSIS-THALIANA; DIVERSITY; RESISTANCE; POPULATIONS; BIOCONTROL; WILT; MANAGEMENT; IMPACT; GENES	Sustainable management of crop productivity and health necessitates improved understanding of the ways in which rhizosphere microbial populations interact with each other, with plant roots and their abiotic environment. In this study we examined the effects of different soils and cultivars, and the presence of a soil-borne fungal pathogen, Verticillium dahliae, on the fungal microbiome of the rhizosphere soil and roots of strawberry plants, using high-throughput pyrosequencing. Fungal communities of the roots of two cultivars, Honeoye and Florence, were statistically distinct from those in the rhizosphere soil of the same plants, with little overlap. Roots of plants growing in two contrasting field soils had high relative abundance of Leptodontidium sp. C2 BESC 319 g whereas rhizosphere soil was characterised by high relative abundance of Trichosporon dulcitum or Cryptococcus terreus, depending upon the soil type. Differences between different cultivars were not as clear. Inoculation with the pathogen V. dahliae had a significant influence on community structure, generally decreasing the number of rhizosphere soil-and root-inhabiting fungi. Leptodontidium sp. C2 BESC 319 g was the dominant fungus responding positively to inoculation with V. dahliae. The results suggest that 1) plant roots select microorganisms from the wider rhizosphere pool, 2) that both rhizosphere soil and root inhabiting fungal communities are influenced by V. dahliae and 3) that soil type has a stronger influence on both of these communities than cultivar.	[Nallanchakravarthula, Srivathsa; Mahmood, Shahid; Alstrom, Sadhna; Finlay, Roger D.] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden	Swedish University of Agricultural Sciences	Nallanchakravarthula, S (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden.	srivathsa.nallan@gmail.com	Finlay, Roger/Q-7796-2019; Finlay, Roger D/B-4731-2009; Mahmood, Shahid/AAK-2276-2020; Nallan, Srivathsa/U-8199-2019	Finlay, Roger/0000-0002-3652-2930; Finlay, Roger D/0000-0002-3652-2930; Mahmood, Shahid/0000-0001-6280-4387; Nallan, Srivathsa/0000-0002-3488-273X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [2007-1689]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This work was funded by Grant No. 2007-1689 to RF from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; An MJ, 2011, CAN J MICROBIOL, V57, P355, DOI [10.1139/w11-015, 10.1139/W11-015]; Andrade-Linares DR, 2011, MYCORRHIZA, V21, P413, DOI 10.1007/s00572-010-0351-1; Andreote FD, 2010, ANTON LEEUW INT J G, V97, P389, DOI 10.1007/s10482-010-9421-9; AZAD HR, 1987, APPL MICROBIOL BIOT, V26, P99, DOI 10.1007/BF00282156; Berg G, 2005, APPL ENVIRON MICROB, V71, P4203, DOI 10.1128/AEM.71.8.4203-4213.2005; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Mestre MC, 2011, FEMS MICROBIOL ECOL, V78, P531, DOI 10.1111/j.1574-6941.2011.01183.x; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Davik J, 2000, ADV STRAWBERRY RES, V19, P13; Favaro LCD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036826; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Edel-Hermann V, 2009, FEMS MICROBIOL ECOL, V68, P37, DOI 10.1111/j.1574-6941.2009.00656.x; El-Deeb HM, 2013, ARCH PHYTOPATHOL PLA, P1; Ellis MA, 2008, VERTICILLIUM WILT ST; Fan L, 2011, BOTANY, V89, P397, DOI [10.1139/B11-028, 10.1139/b11-028]; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Gao GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031806; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Harris DC, 1996, PLANT PATHOL, V45, P106, DOI 10.1046/j.1365-3059.1996.d01-96.x; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Heale JB, 1999, CAN J PLANT PATHOL, V21, P1; Hoitink HAJ, 1999, ANNU REV PHYTOPATHOL, V37, P427, DOI 10.1146/annurev.phyto.37.1.427; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Johansson JF, 2004, FEMS MICROBIOL ECOL, V48, P1, DOI 10.1016/j.femsec.2003.11.012; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kent AD, 2002, ANNU REV MICROBIOL, V56, P211, DOI 10.1146/annurev.micro.56.012302.161120; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Lord Cheryl A S, 1994, FACT SHEET; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Margesin R, 2005, RES MICROBIOL, V156, P68, DOI 10.1016/j.resmic.2004.08.002; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Meszka B, 2009, PHYTOPATHOLOGIA, V52, P21; MIDDELHOVEN WJ, 1992, PLANT SOIL, V145, P37, DOI 10.1007/BF00009539; Morgan JAW, 2005, J EXP BOT, V56, P1729, DOI 10.1093/jxb/eri205; Mousa WK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00065; Norman JR, 1996, PLANT SOIL, V185, P191, DOI 10.1007/BF02257524; Norman JR, 2000, MYCOL RES, V104, P1069, DOI 10.1017/S0953756299002191; Olbricht K, 2008, STRAWBERRY BREEDING, P144; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Raaijmakers JM, 2012, ANNU REV PHYTOPATHOL, V50, P403, DOI 10.1146/annurev-phyto-081211-172908; Rastogi G, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P29, DOI 10.1007/978-1-4419-7931-5_2; Reeve JR, 2010, ISME J, V4, P1099, DOI 10.1038/ismej.2010.42; Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346; Reiter B, 2002, APPL ENVIRON MICROB, V68, P2261, DOI 10.1128/AEM.68.5.2261-2268.2002; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Santos-Gonzalez JC, 2011, MICROB ECOL, V62, P25, DOI 10.1007/s00248-011-9834-7; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Simpson DW, 2002, ACTA HORTIC, P165, DOI 10.17660/ActaHortic.2002.567.29; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Smith KP, 1999, ANNU REV PHYTOPATHOL, V37, P473, DOI 10.1146/annurev.phyto.37.1.473; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Trivedi P, 2012, ISME J, V6, P363, DOI 10.1038/ismej.2011.100; Trivedi P, 2010, APPL ENVIRON MICROB, V76, P3427, DOI 10.1128/AEM.02901-09; Vandemark GEJ, 2010, J PHYTOPATHOL, V158, P117, DOI 10.1111/j.1439-0434.2009.01583.x; Weinert N, 2011, FEMS MICROBIOL ECOL, V75, P497, DOI 10.1111/j.1574-6941.2010.01025.x; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Wissuwa M, 2009, PLANT SOIL, V321, P409, DOI 10.1007/s11104-008-9693-2; Xu LH, 2012, FEMS MICROBIOL ECOL, V82, P736, DOI 10.1111/j.1574-6941.2012.01445.x; Yang CH, 2001, FEMS MICROBIOL ECOL, V35, P129, DOI 10.1111/j.1574-6941.2001.tb00796.x; Yao HY, 2010, FEMS MICROBIOL ECOL, V72, P456, DOI 10.1111/j.1574-6941.2010.00859.x; Yuxiang Wu, 2008, Frontiers of Agriculture in China, V2, P435, DOI 10.1007/s11703-008-0079-2; Zhao Y, 2005, EUR J SOIL BIOL, V41, P21, DOI 10.1016/j.ejsobi.2005.03.002	70	34	34	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111455	10.1371/journal.pone.0111455	http://dx.doi.org/10.1371/journal.pone.0111455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347069	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900077
J	Eisses, JF; Davis, AW; Tosun, AB; Dionise, ZR; Chen, C; Ozolek, JA; Rohde, GK; Husain, SZ				Eisses, John F.; Davis, Amy W.; Tosun, Akif Burak; Dionise, Zachary R.; Chen, Cheng; Ozolek, John A.; Rohde, Gustavo K.; Husain, Sohail Z.			A Computer-Based Automated Algorithm for Assessing Acinar Cell Loss after Experimental Pancreatitis	PLOS ONE			English	Article							ACTIVATION; CHOLECYSTOKININ; SEGMENTATION; MORPHOLOGY	The change in exocrine mass is an important parameter to follow in experimental models of pancreatic injury and regeneration. However, at present, the quantitative assessment of exocrine content by histology is tedious and operator-dependent, requiring manual assessment of acinar area on serial pancreatic sections. In this study, we utilized a novel computer-generated learning algorithm to construct an accurate and rapid method of quantifying acinar content. The algorithm works by learning differences in pixel characteristics from input examples provided by human experts. HE-stained pancreatic sections were obtained in mice recovering from a 2-day, hourly caerulein hyperstimulation model of experimental pancreatitis. For training data, a pathologist carefully outlined discrete regions of acinar and non-acinar tissue in 21 sections at various stages of pancreatic injury and recovery (termed the "ground truth''). After the expert defined the ground truth, the computer was able to develop a prediction rule that was then applied to a unique set of high-resolution images in order to validate the process. For baseline, non-injured pancreatic sections, the software demonstrated close agreement with the ground truth in identifying baseline acinar tissue area with only a difference of 1% 60.05% (p = 0.21). Within regions of injured tissue, the software reported a difference of 2.5% 60.04% in acinar area compared with the pathologist (p = 0.47). Surprisingly, on detailed morphological examination, the discrepancy was primarily because the software outlined acini and excluded inter-acinar and luminal white space with greater precision. The findings suggest that the software will be of great potential benefit to both clinicians and researchers in quantifying pancreatic acinar cell flux in the injured and recovering pancreas.	[Eisses, John F.; Davis, Amy W.; Dionise, Zachary R.; Ozolek, John A.; Husain, Sohail Z.] Univ Pittsburgh, UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Tosun, Akif Burak; Chen, Cheng; Rohde, Gustavo K.] Carnegie Mellon Univ, Ctr Bioimage Informat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Husain, SZ (corresponding author), Univ Pittsburgh, UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA.	sohail.husain@chp.edu		Rohde, Gustavo/0000-0003-1703-9035; Husain, Sohail Z/0000-0003-3012-1308	National Institutes of Health (NIH) Grants [DK083327, DK093491, DK103002]; National Pancreas Foundation Grant; NIH T32 Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK071492, R01DK093491, R01DK103002, R01DK083327, T32DK007017] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Pancreas Foundation Grant; NIH T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants DK083327, DK093491, and DK103002 (to S.Z.H.) and National Pancreas Foundation Grant and an NIH T32 Training Grant (to J.F.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia M, 2005, SCAND J SURG, V94, P97, DOI 10.1177/145749690509400203; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Bhatia M, 2004, AM J PHYSIOL-GASTR L, V286, pG189, DOI 10.1152/ajpgi.00304.2003; Bockman DE, 1997, MICROSC RES TECHNIQ, V37, P509, DOI 10.1002/(SICI)1097-0029(19970601)37:5/6<509::AID-JEMT13>3.3.CO;2-Q; Chen C, 2013, THESIS CARNEGIE MELL, pxvi; Chen C, 2011, INT J BIOMED IMAGING, V2011, DOI 10.1155/2011/606857; Coelho LP, 2009, I S BIOMED IMAGING, P518, DOI 10.1109/ISBI.2009.5193098; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Deng YN, 2001, IEEE T PATTERN ANAL, V23, P800, DOI 10.1109/34.946985; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Gaisano HY, 2009, GASTROENTEROLOGY, V136, P2040, DOI 10.1053/j.gastro.2009.04.023; Giger ML, 2008, MED PHYS, V35, P5799, DOI 10.1118/1.3013555; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Gunduz-Demir C, 2010, MED IMAGE ANAL, V14, P1, DOI 10.1016/j.media.2009.09.001; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Hoque R, 2011, GASTROENTEROLOGY, V141, P358, DOI 10.1053/j.gastro.2011.03.041; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Lerch MM, 1997, GASTROENTEROLOGY, V113, P1355, DOI 10.1053/gast.1997.v113.pm9322531; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; Liu YH, 2014, EXCLI J, V13, P19; Mendez AJ, 1998, MED PHYS, V25, P957, DOI 10.1118/1.598274; Mills SE, 2007, HISTOLOGY PATHOLOGIS; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Naik S, 2008, I S BIOMED IMAGING, P284, DOI 10.1109/ISBI.2008.4540988; Ross M. H., 1985, HISTOLOGY TEXT ATLAS; Rubin R., 2012, RUBINS PATHOLOGY CLI; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Sleisenger M. H., 2010, SLEISENGER FORDTRANS; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Tosun AB, 2011, IEEE T MED IMAGING, V30, P721, DOI 10.1109/TMI.2010.2094200; Veta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070221	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110220	10.1371/journal.pone.0110220	http://dx.doi.org/10.1371/journal.pone.0110220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343460	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000343943500028
J	Shimizu, M; Yasuda, H; Hara, K; Takahashi, K; Nagata, M; Yokono, K				Shimizu, Mami; Yasuda, Hisafumi; Hara, Kenta; Takahashi, Kazuma; Nagata, Masao; Yokono, Koichi			The Dual Role of Scavenger Receptor Class A in Development of Diabetes in Autoimmune NOD Mice	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; IFN-GAMMA; T-CELLS; IL-17 PRODUCTION; INNATE IMMUNITY; DEFICIENT MICE; LIVE CELLS; TNF-ALPHA	Human type 1 diabetes is an autoimmune disease that results from the autoreactive destruction of pancreatic beta cells by T cells. Antigen presenting cells including dendritic cells and macrophages are required to activate and suppress antigen-specific T cells. It has been suggested that antigen uptake from live cells by dendritic cells via scavenger receptor class A (SR-A) may be important. However, the role of SR-A in autoimmune disease is unknown. In this study, SR-A(-/-) nonobese diabetic (NOD) mice showed significant attenuation of insulitis, lower levels of insulin autoantibodies, and suppression of diabetes development compared with NOD mice. We also found that diabetes progression in SR-A(-/-) NOD mice treated with low-dose polyinosinic-polycytidylic acid (poly(I:C)) was significantly accelerated compared with that in disease-resistant NOD mice treated with low-dose poly(I:C). In addition, injection of high-dose poly(I: C) to mimic an acute RNA virus infection significantly accelerated diabetes development in young SR-A 2/2 NOD mice compared with untreated SR-A(-/-) NOD mice. Pathogenic cells including CD4(+) CD25(+) activated T cells were increased more in SR-A(-/-) NOD mice treated with poly(I:C) than in untreated SR-A(-/-) NOD mice. These results suggested that viral infection might accelerate diabetes development even in diabetes-resistant subjects. In conclusion, our studies demonstrated that diabetes progression was suppressed in SR-A(-/-) NOD mice and that acceleration of diabetes development could be induced in young mice by poly(I:C) treatment even in SR-A(-/-) NOD mice. These results suggest that SR-A on antigen presenting cells such as dendritic cells may play an unfavorable role in the steady state and a protective role in a mild infection. Our findings imply that SR-A may be an important target for improving therapeutic strategies for type 1 diabetes.	[Shimizu, Mami; Yasuda, Hisafumi; Hara, Kenta; Yokono, Koichi] Kobe Univ, Grad Sch Med, Dept Gen Internal Med, Chuo Ku, Kobe, Hyogo 657, Japan; [Yasuda, Hisafumi] Kobe Univ, Grad Sch Hlth Sci, Dept Community Hlth Sci, Div Hlth Sci,Suma Ku, Kobe, Hyogo 657, Japan; [Takahashi, Kazuma] Iwate Med Univ, Sch Med, Dept Internal Med, Div Diabet & Metab, Morioka, Iwate 020, Japan; [Nagata, Masao] Kakogawa West City Hosp, Div Internal Med & Diabet, Kakogawa, Hyogo, Japan	Kobe University; Kobe University; Iwate Medical University	Yasuda, H (corresponding author), Kobe Univ, Grad Sch Med, Dept Gen Internal Med, Chuo Ku, Kobe, Hyogo 657, Japan.	yasuda@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23590880]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 23590880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Becker M, 2006, EUR J IMMUNOL, V36, P950, DOI 10.1002/eji.200535660; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Ferber IA, 1996, J IMMUNOL, V156, P5; Fukushima K, 2008, BIOCHEM BIOPH RES CO, V367, P719, DOI 10.1016/j.bbrc.2007.12.191; Grant CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072989; Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6; Haasken S, 2013, J IMMUNOL, V191, P1055, DOI 10.4049/jimmunol.1201680; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Hu CY, 2013, DIABETES, V62, P2849, DOI 10.2337/db12-1175; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; Jain R, 2008, J EXP MED, V205, P207, DOI 10.1084/jem.20071878; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelley JL, 2014, CRIT REV IMMUNOL, V34, P241, DOI 10.1615/CritRevImmunol.2014010267; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Kobayashi H, 2007, J PATHOL, V212, P38, DOI 10.1002/path.2150; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Levy-Barazany H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-120; Liao JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026463; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Marwaha AK, 2010, J IMMUNOL, V185, P3814, DOI 10.4049/jimmunol.1001860; Mori Y, 2009, INT IMMUNOL, V21, P1291, DOI 10.1093/intimm/dxp097; Raycroft MT, 2012, J BIOL CHEM, V287, P5310, DOI 10.1074/jbc.M111.316356; Saeki K, 2009, J IMMUNOL, V182, P5929, DOI 10.4049/jimmunol.0802672; SATOH J, 1989, J CLIN INVEST, V84, P1345, DOI 10.1172/JCI114304; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tada A, 2011, J IMMUNOL, V187, P4947, DOI 10.4049/jimmunol.1000837; Tai NW, 2011, CLIN IMMUNOL, V139, P336, DOI 10.1016/j.clim.2011.03.003; Takemura K, 2010, BIOCHEM BIOPH RES CO, V391, P1675, DOI 10.1016/j.bbrc.2009.12.126; Tatematsu M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2857; Tsujita K, 2007, CIRCULATION, V115, P1904, DOI 10.1161/CIRCULATIONAHA.106.671198; Usui HK, 2007, DIABETES, V56, P363, DOI 10.2337/db06-0359; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wong FS, 2008, ANN NY ACAD SCI, V1150, P146, DOI 10.1196/annals.1447.039; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Zhang J, 2012, J AUTOIMMUN, V38, P20, DOI 10.1016/j.jaut.2011.11.017	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109531	10.1371/journal.pone.0109531	http://dx.doi.org/10.1371/journal.pone.0109531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343451	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943500016
J	Antonio, FJ; de Picoli, S; Teixeira, JJV; Mendes, RD				Antonio, Fernando Jose; de Picoli, Sergio, Jr.; Vieira Teixeira, Jorge Juarez; Mendes, Renio dos Santos			Growth Patterns and Scaling Laws Governing AIDS Epidemic in Brazilian Cities	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; REPRODUCTION NUMBER; HIV; INFECTION; SPREAD; IMPACT; LIFE; MEN	Brazil holds approximately 1/3 of population living infected with AIDS (acquired immunodeficiency syndrome) in Central and South Americas, and it was also the first developing country to implement a large-scale control and intervention program against AIDS epidemic. In this scenario, we investigate the temporal evolution and current status of the AIDS epidemic in Brazil. Specifically, we analyze records of annual absolute frequency of cases for more than 5000 cities for the first 33 years of the infection in Brazil. We found that (i) the annual absolute frequencies exhibit a logistic-type growth with an exponential regime in the first few years of the AIDS spreading; (ii) the actual reproduction number decaying as a power law; (iii) the distribution of the annual absolute frequencies among cities decays with a power law behavior; (iv) the annual absolute frequencies and the number of inhabitants have an allometric relationship; (v) the temporal evolution of the annual absolute frequencies have different profile depending on the average annual absolute frequencies in the cities. These findings yield a general quantitative description of the AIDS infection dynamics in Brazil since the beginning. They also provide clues about the effectiveness of treatment and control programs against the infection, that has had a different impact depending on the number of inhabitants of cities. In this framework, our results give insights into the overall dynamics of AIDS epidemic, which may contribute to select empirically accurate models.	[Antonio, Fernando Jose; de Picoli, Sergio, Jr.; Mendes, Renio dos Santos] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; [Antonio, Fernando Jose; de Picoli, Sergio, Jr.; Mendes, Renio dos Santos] Natl Inst Sci & Technol Complex Syst, Maringa, Parana, Brazil; [Vieira Teixeira, Jorge Juarez] Univ Estadual Maringa, Dept Anal Clin & Biomed, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Antonio, FJ (corresponding author), Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil.	fja@dfi.uem.br	Antonio, Fernando Jose/D-3024-2016	Antonio, Fernando Jose/0000-0001-6931-3046				Acuna-Soto R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023467; Alsallaq RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054575; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Amundsen EJ, 2004, EPIDEMIOL INFECT, V132, P1139, DOI 10.1017/S0950268804002997; BAILEY NTJ, 1988, J ROY STAT SOC A STA, V151, P31, DOI 10.2307/2982180; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; BOR R, 1993, J FAM THER, V15, P187, DOI 10.1111/j.1467-6427.1993.00753.x; Coe JB, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051925; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; Fonseca MGP, 2007, CAD SAUDE PUBLICA, V23, pS333, DOI 10.1590/S0102-311X2007001500002; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Gompertz B, 1825, PHILOS T ROY SOC LON, V115, P513, DOI DOI 10.1098/RSTL.1825.0026; Gran JM, 2008, STAT MED, V27, P4819, DOI 10.1002/sim.3219; Grangeiro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014585; Grangeiro A, 2010, REV SAUDE PUBL, V44, P430, DOI 10.1590/S0034-89102010005000013; Hall HI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012756; Hayes R, 2006, SCIENCE, V311, P620, DOI 10.1126/science.1124072; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Malacarne LC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.017106; Meiners C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023478; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Moura NJ, 2006, PHYSICA A, V367, P441, DOI 10.1016/j.physa.2005.11.038; Murray, 2002, MATH BIOL I INTRO IN; NELDER JA, 1961, BIOMETRICS, V17, P89, DOI 10.2307/2527498; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Ni SJ, 2008, PHYSICA A, V387, P5295, DOI 10.1016/j.physa.2008.05.051; Ni SJ, 2011, PHYSICA A, V390, P4528, DOI 10.1016/j.physa.2011.07.042; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Nishiura H, 2010, INT J ENV RES PUB HE, V7, P291, DOI 10.3390/ijerph7010291; Nunn AS, 2007, PLOS MED, V4, P1804, DOI 10.1371/journal.pmed.0040305; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Quinn TC, 1996, LANCET, V348, P99, DOI 10.1016/S0140-6736(96)01029-X; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS, AH WORLD AIDS DAY 20; Vogl D, 1999, J PAIN SYMPTOM MANAG, V18, P253, DOI 10.1016/S0885-3924(99)00066-4; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wallenstein S, 2004, AM J SURG, V188, p73S, DOI 10.1016/S0002-9610(03)00294-0; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1	45	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111015	10.1371/journal.pone.0111015	http://dx.doi.org/10.1371/journal.pone.0111015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340796	Green Submitted, gold, Green Published			2022-12-26	WOS:000343662800079
J	Chapman, S; Stevens, LJ; Boevink, PC; Engelhardt, S; Alexander, CJ; Harrower, B; Champouret, N; McGeachy, K; Van Weymers, PSM; Chen, XW; Birch, PRJ; Hein, I				Chapman, Sean; Stevens, Laura J.; Boevink, Petra C.; Engelhardt, Stefan; Alexander, Colin J.; Harrower, Brian; Champouret, Nicolas; McGeachy, Kara; Van Weymers, Pauline S. M.; Chen, Xinwei; Birch, Paul R. J.; Hein, Ingo			Detection of the Virulent Form of AVR3a from Phytophthora infestans following Artificial Evolution of Potato Resistance Gene R3a	PLOS ONE			English	Article							LATE BLIGHT RESISTANCE; HYPERSENSITIVE RESPONSE; CELL-DEATH; NUCLEOTIDE-BINDING; EFFECTOR AVR3A; PROTEIN; HOST; TRANSFORMATION; SUPERFAMILY; PERCEPTION	Engineering resistance genes to gain effector recognition is emerging as an important step in attaining broad, durable resistance. We engineered potato resistance gene R3a to gain recognition of the virulent AVR3a(EM) effector form of Phytophthora infestans. Random mutagenesis, gene shuffling and site-directed mutagenesis of R3a were conducted to produce R3a* variants with gain of recognition towards AVR3a(EM). Programmed cell death following gain of recognition was enhanced in iterative rounds of artificial evolution and neared levels observed for recognition of AVR3a(KI) by R3a. We demonstrated that R3a*-mediated recognition responses, like for R3a, are dependent on SGT1 and HSP90. In addition, this gain of response is associated with re-localisation of R3a* variants from the cytoplasm to late endosomes when co-expressed with either AVR3a(KI) or AVR3a(EM) a mechanism that was previously only seen for R3a upon co-infiltration with AVR3a(KI). Similarly, AVR3a(EM) specifically re-localised to the same vesicles upon recognition by R3a* variants, but not with R3a. R3a and R3a* provide resistance to P. infestans isolates expressing AVR3a(KI) but not those homozygous for AVR3a(EM).	[Chapman, Sean; Stevens, Laura J.; Boevink, Petra C.; Harrower, Brian; McGeachy, Kara; Van Weymers, Pauline S. M.; Chen, Xinwei; Birch, Paul R. J.; Hein, Ingo] James Hutton Inst, Dundee, Scotland; [Stevens, Laura J.; Engelhardt, Stefan; Van Weymers, Pauline S. M.; Birch, Paul R. J.] Univ Dundee, James Hutton Inst, Div Plant Sci, Invergowrie Dundee, Scotland; [Stevens, Laura J.; Boevink, Petra C.; Engelhardt, Stefan; Van Weymers, Pauline S. M.; Chen, Xinwei; Birch, Paul R. J.; Hein, Ingo] Dundee Effector Consortium, Invergowrie Dundee, Scotland; [Alexander, Colin J.] Biomath & Stat Scotland, Invergowrie Dundee, Scotland; [Champouret, Nicolas] JR Simplot Co, Simplot Plant Sci, Boise, ID USA	James Hutton Institute; James Hutton Institute; University of Dundee; James Hutton Institute	Hein, I (corresponding author), James Hutton Inst, Dundee, Scotland.	Ingo.Hein@hutton.ac.uk	Alexander, Colin/C-5802-2009; Chapman, Sean N/H-5193-2013; Engelhardt, Stefan/AAA-9329-2019; Boevink, Petra/AAO-6498-2021	Alexander, Colin/0000-0003-4995-1678; Engelhardt, Stefan/0000-0001-5378-8661; Boevink, Petra/0000-0002-7021-9097; Hein, Ingo/0000-0002-0128-2084; Birch, Paul/0000-0002-6559-3746	James Hutton Institute; University of Dundee; U.S. Department of Agriculture through National Institute of Food and Agriculture (NIFA) [2011-68004-30154]; Rural & Environment Science & Analytical Services (RESAS) Division of the Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC) [CRF/2009/SCRI/SOP & BB/H018441/1 (IH), BB/K018299/1]; RESAS; BBSRC [BB/K018299/1, BB/L01050X/1, BB/L008025/1, BB/H018697/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K018299/1, BB/L008025/1, BB/H018697/1, BB/L01050X/1] Funding Source: researchfish	James Hutton Institute; University of Dundee; U.S. Department of Agriculture through National Institute of Food and Agriculture (NIFA); Rural & Environment Science & Analytical Services (RESAS) Division of the Scottish Government; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RESAS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LS is supported by The James Hutton Institute and the University of Dundee through a joint PhD student bursary. PSMVW is supported by the U.S. Department of Agriculture through National Institute of Food and Agriculture (NIFA) project 2011-68004-30154 (http://www.csrees.usda.gov/). NC is employed by J.R. Simplot Company, Simplot Plant Sciences, 5369 West Irving Street, Boise, ID 83706, USA. This work was funded by the Rural & Environment Science & Analytical Services (RESAS) Division of the Scottish Government (http://www.scotland.gov.uk/Topics/Research/About/EBAR/research-providers) and the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/home/home.aspx) through the joint projects CRF/2009/SCRI/SOP & BB/H018441/1 (IH), BB/K018299/1 and RESAS funded work package 6.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bernal AJ, 2005, J BIOL CHEM, V280, P23073, DOI 10.1074/jbc.M500992200; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Cardenas M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-23; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Duan H, 2012, TRANSGENIC RES, V21, P929, DOI 10.1007/s11248-011-9576-9; Engelhardt S, 2012, PLANT CELL, V24, P5142, DOI 10.1105/tpc.112.104992; Segretin ME, 2014, MOL PLANT MICROBE IN, V27, P624, DOI 10.1094/MPMI-02-14-0040-R; Farnham G, 2006, P NATL ACAD SCI USA, V103, P18828, DOI 10.1073/pnas.0605777103; Foster SJ, 2009, MOL PLANT MICROBE IN, V22, P589, DOI 10.1094/MPMI-22-5-0589; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Gilroy EM, 2011, NEW PHYTOL, V190, P653, DOI 10.1111/j.1469-8137.2011.03643.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hein I, 2009, MOL PLANT PATHOL, V10, P547, DOI [10.1111/J.1364-3703.2009.00547.X, 10.1111/j.1364-3703.2009.00547.x]; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Leung DW, 1989, TECHNIQUE, V1, P11; Li GC, 2011, MOL PLANT MICROBE IN, V24, P1132, DOI 10.1094/MPMI-11-10-0276; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Maffei ME, 2012, NAT PROD REP, V29, P1288, DOI 10.1039/c2np20053h; Mcdowell JM, 2006, MOL PLANT PATHOL, V7, P437, DOI 10.1111/j.1364-3703.2006.00342.x; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Ori N, 1997, PLANT CELL, V9, P521, DOI 10.1105/tpc.9.4.521; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rietman H, 2012, MOL PLANT MICROBE IN, V25, P910, DOI 10.1094/MPMI-01-12-0010-R; Saint-Jean B, 2010, PLANT CELL, V22, P2825, DOI 10.1105/tpc.109.072215; Saunders DGO, 2012, PLANT CELL, V24, P3420, DOI 10.1105/tpc.112.099861; Simpson CG, 2014, NEW PHYTOL, V203, P424, DOI 10.1111/nph.12821; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stirnweis D, 2014, MOL PLANT MICROBE IN, V27, P265, DOI 10.1094/MPMI-10-13-0297-FI; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vetukuri RR, 2011, FUNGAL BIOL-UK, V115, P1225, DOI 10.1016/j.funbio.2011.08.007; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; Vleeshouwers VGAA, 2011, ANNU REV PHYTOPATHOL, V49, P507, DOI 10.1146/annurev-phyto-072910-095326; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	48	27	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110158	10.1371/journal.pone.0110158	http://dx.doi.org/10.1371/journal.pone.0110158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340613	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800022
J	Kobayashi, M; Ray, SM; Hanfelt, J; Wang, YF				Kobayashi, Miwako; Ray, Susan M.; Hanfelt, John; Wang, Yun F.			Diagnosis of Tuberculosis by Using a Nucleic Acid Amplification Test in an Urban Population with High HIV Prevalence in the United States	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; COST-EFFECTIVENESS; PULMONARY; INFECTION; RISK; DISEASE	Background: Use of nucleic acid amplification tests (NAAT) for the diagnosis of Mycobacterium tuberculosis (TB) has been recommended on respiratory specimens submitted for acid-fast bacilli (AFB) testing. It also helps distinguish between TB and non-tuberculous mycobacteria (NTM) species in a setting where NTM rates are relatively high. The purposes of this study are to describe the trend and characteristics of all AFB smear-positive respiratory samples that underwent amplified Mycobacterium tuberculosis direct (MTD) testing, a type of NAAT, and to evaluate the clinical utility and necessity of the test for diagnosis of TB in a population with high-HIV prevalence. Methods: Prospective diagnostic testing and retrospective data analyses were conducted on all AFB smear-positive respiratory samples that underwent MTD testing from 2001 to 2011 at Grady Memorial Hospital (GMH), Atlanta, USA. The test performance was compared to culture. Results: A total of 2,240 AFB smear-positive specimens from 1,412 patients were tested and analyzed in the study. The proportion of specimens that were culture-positive for TB was 28.5%. Sensitivity, specificity, positive predictive value, and negative predictive value of the MTD were 99.0%, 98.0%, 95.3% and 99.6%, respectively. A downward trend was observed in the yearly numbers as well as the proportions of MTD-positive specimens during the study period (p<0.01). There were 2,027 (90.5%) specimens from patients with known HIV status, of which 70.6% was HIV positive and the majority of them (81.8%) had CD4 counts of less than 200 cells/mu L. HIV-positives were more likely to have NTM compared to HIV negatives (67.7% vs. 35.4%, p<0.01). Conclusion: Despite the decrease in the incidence of TB, NAAT continues to be an accurate and important diagnostic test in a population with high HIV prevalence, and it differentiates TB and NTM organisms.	[Kobayashi, Miwako; Ray, Susan M.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Wang, Yun F.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Hanfelt, John] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA; [Wang, Yun F.] Grady Mem Hosp, Atlanta, GA USA	Emory University; Emory University; Emory University; Rollins School Public Health	Wang, YF (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	yfwang@emory.edu		Ray, Susan/0000-0002-6327-088X	National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (Award Number UL1TR000454 to co-author JH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The manuscript does not necessarily represent the official views of the National Institutes of Health.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P7; Centers for Disease Control and Prevention, 2011, REP TUB US; Centers for Disease Control and Prevention, 2011, HIV SURV REP; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P593; Dowdy DW, 2003, J CLIN MICROBIOL, V41, P948, DOI 10.1128/JCM.41.3.948-953.2003; Gen Probe Incorporated, 2011, AMPL MYC TUB DIR TES; Georgia Department of Public Health, 2011, 2009 GEORG TUB REP; Guerra RL, 2007, CHEST, V132, P946, DOI 10.1378/chest.06-2959; Hopewell P C, 1989, Semin Respir Infect, V4, P111; Hughes R, 2012, RESP MED, V106, P300, DOI 10.1016/j.rmed.2011.10.005; Jorgensen JH, 1999, J CLIN MICROBIOL, V37, P175, DOI 10.1128/JCM.37.1.175-178.1999; Kambashi B, 2001, INT J TUBERC LUNG D, V5, P364; Lemaitre N, 2004, J CLIN MICROBIOL, V42, P4307, DOI 10.1128/JCM.42.9.4307-4309.2004; Leonard MK, 2006, AM J INFECT CONTROL, V34, P69, DOI 10.1016/j.ajic.2005.09.003; Marks SM, 2013, CLIN INFECT DIS, V57, P532, DOI 10.1093/cid/cit336; NOLTE FS, 1995, MYCOBACTERIUM; Salama C, 2003, CLIN INFECT DIS, V37, pE35, DOI 10.1086/375895; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Syre H, 2009, J CLIN MICROBIOL, V47, P3635, DOI 10.1128/JCM.00411-09; Teo J, 2011, J CLIN MICROBIOL, V49, P3659, DOI 10.1128/JCM.00211-11; Tjhie JHT, 2001, J CLIN MICROBIOL, V39, P2311, DOI 10.1128/JCM.39.6.2311-2312.2001; Wallace JM, 1997, AM J RESP CRIT CARE, V155, P72, DOI 10.1164/ajrccm.155.1.9001292; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; Zaki MES, 2008, ARCH PATHOL LAB MED, V132, P244, DOI 10.1043/1543-2165(2008)132[244:CEOGAM]2.0.CO;2; ZAZA S, 1995, J INFECT DIS, V172, P1542, DOI 10.1093/infdis/172.6.1542	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e107552	10.1371/journal.pone.0107552	http://dx.doi.org/10.1371/journal.pone.0107552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340424	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800002
J	Sadaka, A; Palmer, K; Suzuki, T; Gilmore, MS				Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.			In Vitro and In Vivo Models of Staphylococcus aureus Endophthalmitis Implicate Specific Nutrients in Ocular Infection	PLOS ONE			English	Article							STATIONARY-PHASE; VITREOUS FLUID; SIALIC ACIDS; AMINO-ACIDS; VIRULENCE; CODY; IDENTIFICATION; REGULATOR; ASCORBATE; METABOLISM	Purpose: To define global transcriptional responses of Staphylococcus aureus and its codY mutant (CodY is a transcription regulator of virulence and metabolic genes in response to branched-chain amino acids) when growing in bovine aqueous (AH) and vitreous humor (VH) in vitro, and to investigate the impact of codY deletion on S. aureus virulence in a novel murine anterior chamber (AC) infection model. Methods: For the in vitro model, differential transcriptomic gene expression of S. aureus and its codY mutant grown in chemically defined medium (CDM), AH, and VH was analyzed. Furthermore, the strains were inoculated into the AC of mice. Changes in bacterial growth, electroretinography and inflammation scores were monitored. Results: Bovine AH and VH provide sufficient nutrition for S. aureus growth in vitro. Transcriptome analysis identified 72 unique open reading frames differentially regulated >= 10-fold between CDM, AH, and VH. In the AC model, we found comparable growth of the codY mutant and wild type strains in vivo. Average inflammation scores and retinal function were significantly worse for codY mutant-infected eyes at 24 h post-infection. Conclusion: Our in vitro bovine AH and VH models identified likely nutrient sources for S. aureus in the ocular milieu. The in vivo model suggests that control of branched-chain amino acid availability has therapeutic potential in limiting S. aureus endophthalmitis severity.	[Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA; [Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Sadaka, Ama; Palmer, Kelli; Suzuki, Takashi; Gilmore, Michael S.] Harvard Microbial Sci Initiat, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Gilmore, MS (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA.	michael_gilmore@meei.harvard.edu			NIH/NEI [EY008289]; NIH fellowship [EY020734]; NATIONAL EYE INSTITUTE [F32EY020734, R01EY008289] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project has been funded in part by NIH/NEI grant EY008289. KP was supported by NIH fellowship EY020734. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix I, GENECHIP MAD TO ORD; Andreoli CM, 2009, AM J OPHTHALMOL, V147, P601, DOI 10.1016/j.ajo.2008.10.023; Balzli CL, 2010, INVEST OPHTH VIS SCI, V51, P5114, DOI 10.1167/iovs.10-5179; Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bertram KM, 2008, EYE, V22, P582, DOI 10.1038/sj.eye.6702993; BOOTH MC, 1995, INVEST OPHTH VIS SCI, V36, P1828; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Callegan MC, 2002, CLIN MICROBIOL REV, V15, P111, DOI 10.1128/CMR.15.1.111-124.2002; Campos E, 2007, MICROBIOL-SGM, V153, P3399, DOI 10.1099/mic.0.2007/009613-0; den Hengst CD, 2006, J BACTERIOL, V188, P3280, DOI 10.1128/JB.188.9.3280-3289.2006; DURHAM DG, 1971, CLIN CHEM, V17, P285; Geiger T, 2010, INFECT IMMUN, V78, P1873, DOI 10.1128/IAI.01439-09; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; HADDAD HM, 1962, ARCH OPHTHALMOL-CHIC, V67, P459, DOI 10.1001/archopht.1962.00960020459013; Hanscom T, 1996, ARCH OPHTHALMOL-CHIC, V114, P1029, DOI 10.1001/archopht.1996.01100140233036; JOHNSEN H, 1985, ACTA OPHTHALMOL, V63, P31; Jonas JB, 2000, OPHTHALMOLOGY, V107, P823, DOI 10.1016/S0161-6420(00)00079-8; Kowalski RP, 2008, JPN J OPHTHALMOL, V52, P211, DOI 10.1007/s10384-008-0530-1; Labit CM, 2001, EUR J OPHTHALMOL, V11, P160, DOI 10.1177/112067210101100210; Levdikov VM, 2009, J MOL BIOL, V390, P1007, DOI 10.1016/j.jmb.2009.05.077; Levdikov VM, 2006, J BIOL CHEM, V281, P11366, DOI 10.1074/jbc.M513015200; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Mattis DM, 2013, PROTEIN ENG DES SEL, V26, P133, DOI 10.1093/protein/gzs094; Nakatsukasa M, 2011, AM J OPHTHALMOL, V151, P799, DOI 10.1016/j.ajo.2010.11.003; Olson ME, 2013, J BACTERIOL, V195, P1779, DOI 10.1128/JB.02294-12; ORTWERTH BJ, 1975, EXP EYE RES, V20, P417, DOI 10.1016/0014-4835(75)90084-6; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Preumont A, 2008, J BIOL CHEM, V283, P25238, DOI 10.1074/jbc.M804122200; SLACK FJ, 1995, MOL MICROBIOL, V15, P689, DOI 10.1111/j.1365-2958.1995.tb02378.x; SOCRANSKY SS, 1985, J CLIN MICROBIOL, V22, P303, DOI 10.1128/JCM.22.2.303-305.1985; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Spaulding AR, 2012, VACCINE, V30, P5099, DOI 10.1016/j.vaccine.2012.05.067; Strandberg KL, 2010, J INFECT DIS, V202, P1690, DOI 10.1086/657156; Suzuki T, 2008, J CATARACT REFR SURG, V34, P1776, DOI 10.1016/j.jcrs.2008.06.033; Suzuki T, 2011, INVEST OPHTH VIS SCI, V52, P3187, DOI 10.1167/iovs.10-6558; TSO MOM, 1984, CURR EYE RES, V3, P181, DOI 10.3109/02713688408997200; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; WM H, 1992, ADL PHYSL EYE; Wu PC, 2006, GRAEF ARCH CLIN EXP, V244, P920, DOI 10.1007/s00417-005-0170-9; Wu XG, 2012, J OCUL PHARMACOL TH, V28, P186, DOI 10.1089/jop.2011.0136; Zhang ZG, 2003, J BACTERIOL, V185, P2243, DOI 10.1128/JB.185.7.2243-2250.2003	48	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e0110872	10.1371/journal.pone.0110872	http://dx.doi.org/10.1371/journal.pone.0110872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340474	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800065
J	Weng, SL; Chiu, CM; Lin, FM; Huang, WC; Liang, C; Yang, T; Yang, TL; Liu, CY; Wu, WY; Chang, YA; Chang, TH; Huang, HD				Weng, Shun-Long; Chiu, Chih-Min; Lin, Feng-Mao; Huang, Wei-Chih; Liang, Chao; Yang, Ting; Yang, Tzu-Ling; Liu, Chia-Yu; Wu, Wei-Yun; Chang, Yi-An; Chang, Tzu-Hao; Huang, Hsien-Da			Bacterial Communities in Semen from Men of Infertile Couples: Metagenomic Sequencing Reveals Relationships of Seminal Microbiota to Semen Quality	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MALE GENITAL-TRACT; GARDNERELLA-VAGINALIS; MEDICAL-TREATMENT; ESCHERICHIA-COLI; HUMAN HEALTH; IDENTIFICATION; LACTOBACILLUS; INFECTIONS; BLOOD	Some previous studies have identified bacteria in semen as being a potential factor in male infertility. However, only few types of bacteria were taken into consideration while using PCR-based or culturing methods. Here we present an analysis approach using next-generation sequencing technology and bioinformatics analysis to investigate the associations between bacterial communities and semen quality. Ninety-six semen samples collected were examined for bacterial communities, measuring seven clinical criteria for semen quality (semen volume, sperm concentration, motility, Kruger's strict morphology, antisperm antibody (IgA), Atypical, and leukocytes). Computer-assisted semen analysis (CASA) was also performed. Results showed that the most abundant genera among all samples were Lactobacillus (19.9%), Pseudomonas (9.85%), Prevotella (8.51%) and Gardnerella (4.21%). The proportion of Lactobacillus and Gardnerella was significantly higher in the normal samples, while that of Prevotella was significantly higher in the low quality samples. Unsupervised clustering analysis demonstrated that the seminal bacterial communities were clustered into three main groups: Lactobacillus, Pseudomonas, and Prevotella predominant group. Remarkably, most normal samples (80.6%) were clustered in Lactobacillus predominant group. The analysis results showed seminal bacteria community types were highly associated with semen health. Lactobacillus might not only be a potential probiotic for semen quality maintenance, but also might be helpful in countering the negative influence of Prevotella and Pseudomonas. In this study, we investigated whole seminal bacterial communities and provided the most comprehensive analysis of the association between bacterial community and semen quality. The study significantly contributes to the current understanding of the etiology of male fertility.	[Weng, Shun-Long; Chiu, Chih-Min; Lin, Feng-Mao; Huang, Wei-Chih; Liang, Chao; Yang, Ting; Yang, Tzu-Ling; Liu, Chia-Yu; Wu, Wei-Yun; Chang, Yi-An; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Weng, Shun-Long; Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Weng, Shun-Long] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Weng, Shun-Long] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Chang, Yi-An] Hlth GeneTech Corp, Taoyuan, Taiwan; [Chang, Tzu-Hao] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Huang, Hsien-Da] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Medical College; Taipei Medical University; Kaohsiung Medical University; National Yang Ming Chiao Tung University	Chang, TH (corresponding author), Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan.	kevinchang@tmu.edu.tw; bryan@mail.nctu.edu.tw	Huang, Hsien-Da/AAA-7376-2019; Kuo, Hao-chung/ABF-9568-2020		Ministry of Science and Technology of the Republic of China [NSC 101-2311-B-009-005-MY3, NSC 102-2627-B-009-001, NSC 103-2628-B-009 -001 -MY3, NSC 103-2221-E-038-013-My2]; UST-UCSD International Center of Excellence in Advanced Bio-engineering - Taiwan Ministry of Science and Technology I-RiCE Program [NSC 102-2911-I-009-101]; Veterans General Hospitals and University System of Taiwan (VGHUST) Joint Research Program [VGHUST103-G5-1-2]; MOE ATU	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering - Taiwan Ministry of Science and Technology I-RiCE Program; Veterans General Hospitals and University System of Taiwan (VGHUST) Joint Research Program; MOE ATU(Ministry of Education, Taiwan)	Ministry of Science and Technology of the Republic of China financially supported this research under contract nos. NSC 101-2311-B-009-005-MY3, NSC 102-2627-B-009-001, NSC 103-2628-B-009 -001 -MY3 and NSC 103-2221-E-038-013-My2. This work was supported in part by the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan Ministry of Science and Technology I-RiCE Program under grant nos. NSC 102-2911-I-009-101, and Veterans General Hospitals and University System of Taiwan (VGHUST) Joint Research Program under grant no. VGHUST103-G5-1-2. This work was also partially supported by MOE ATU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2012, LEGAL MED-TOKYO, V14, P160, DOI 10.1016/j.legalmed.2012.01.005; Andrade-Rocha FT, 2009, GYNECOL OBSTET INVES, V68, P134, DOI 10.1159/000228583; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Atassi F, 2006, FEMS IMMUNOL MED MIC, V48, P424, DOI 10.1111/j.1574-695X.2006.00162.x; BARRATT CLR, 1990, HUM REPROD, V5, P639, DOI 10.1093/oxfordjournals.humrep.a137162; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Berktas M, 2008, INT UROL NEPHROL, V40, P383, DOI 10.1007/s11255-007-9289-4; Bukharin O. V., 2000, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P106; Cao Xing-Wu, 2011, Zhonghua Nan Ke Xue, V17, P1059; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carr BR, 2013, SEMIN REPROD MED, V31, P231, DOI 10.1055/s-0033-1345267; CATLIN BW, 1992, CLIN MICROBIOL REV, V5, P213, DOI 10.1128/CMR.5.3.213-237.1992; CLOSE CE, 1990, J UROLOGY, V144, P900, DOI 10.1016/S0022-5347(17)39618-0; Cox MJ, 2013, HUM MOL GENET, V22, pR88, DOI 10.1093/hmg/ddt398; De Francesco MA, 2011, EUR J CONTRACEP REPR, V16, P47, DOI 10.3109/13625187.2010.533219; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2003, BIOINFORMATICS, V19, P1461, DOI 10.1093/bioinformatics/btg200; Dicks LMT, 2000, INT J SYST EVOL MICR, V50, P1253, DOI 10.1099/00207713-50-3-1253; Diemer T, 2003, ANDROLOGIA, V35, P283, DOI 10.1046/j.1439-0272.2003.00556.x; Diemer T, 2003, ANDROLOGIA, V35, P100, DOI 10.1046/j.1439-0272.2003.00523.x; Domes T, 2012, FERTIL STERIL, V97, P1050, DOI 10.1016/j.fertnstert.2012.01.124; Donders G, 2010, OBSTET GYNECOL SURV, V65, P462, DOI 10.1097/OGX.0b013e3181e09621; ELSNER P, 1988, ZBL BAKT-INT J MED M, V269, P56; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Fraczek M, 2007, FERTIL STERIL, V88, P1076, DOI 10.1016/j.fertnstert.2006.12.025; Goldenberger D, 1997, J CLIN MICROBIOL, V35, P2733, DOI 10.1128/JCM.35.11.2733-2739.1997; Gonzalez Pedraza Aviles A, 1999, Rev Latinoam Microbiol, V41, P25; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HARPER JJ, 1982, INT J SYST BACTERIOL, V32, P48, DOI 10.1099/00207713-32-1-48; Hattemer A, 2013, ANTIMICROB AGENTS CH, V57, P3969, DOI 10.1128/AAC.02467-12; Henkel R, 2006, WORLD J UROL, V24, P39, DOI 10.1007/s00345-005-0038-y; Hou DS, 2013, FERTIL STERIL, V100, P1261, DOI 10.1016/j.fertnstert.2013.07.1991; Isaiah IN, 2011, N AM J MED SCI, V3, P562, DOI 10.4297/najms.2011.3559; Ivanov IB, 2009, INT J ANDROL, V32, P462, DOI 10.1111/j.1365-2605.2008.00878.x; Jarvi K, 1994, Can J Urol, V1, P25; Jarvi K, 1996, FERTIL STERIL, V66, P463, DOI 10.1016/S0015-0282(16)58520-3; Jordan JA, 2005, J MOL DIAGN, V7, P575, DOI 10.1016/S1525-1578(10)60590-9; Kaewsrichan J, 2006, FEMS IMMUNOL MED MIC, V48, P75, DOI 10.1111/j.1574-695X.2006.00124.x; Kamischke A, 1999, HUM REPROD, V14, P1; Keck C, 1998, HUM REPROD UPDATE, V4, P891, DOI 10.1093/humupd/4.6.891; Kiessling AA, 2008, FERTIL STERIL, V90, P1744, DOI 10.1016/j.fertnstert.2007.08.083; Kozak M, 2012, COMMUN STAT-THEOR M, V41, P2279, DOI 10.1080/03610926.2011.560741; Lacroix JM, 1996, J MICROBIOL METH, V26, P61, DOI 10.1016/0167-7012(96)00844-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lbadin OKaI I N, 2008, MALAYSIAN J MICROBIO, V4, P65; Liu YM, 2014, INT J INFECT DIS, V23, P105, DOI 10.1016/j.ijid.2014.02.013; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Madupu Ramana, 2013, Science Progress, V96, P153, DOI 10.3184/003685013X13683759820813; Mandar R, 2013, PHARMACOL RES, V69, P32, DOI 10.1016/j.phrs.2012.10.019; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marchandin H, 2005, RES MICROBIOL, V156, P603, DOI 10.1016/j.resmic.2005.01.013; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Moretti E, 2009, J ASSIST REPROD GEN, V26, P47, DOI 10.1007/s10815-008-9283-5; Ochsendorf FR, 2008, ANDROLOGIA, V40, P72, DOI 10.1111/j.1439-0272.2007.00825.x; Osset J, 2001, J INFECT DIS, V183, P485, DOI 10.1086/318070; Pascual LM, 2008, J GEN APPL MICROBIOL, V54, P141, DOI 10.2323/jgam.54.141; Pleckaityte M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-301; Reid G, 2009, CURR OPIN CLIN NUTR, V12, P583, DOI 10.1097/MCO.0b013e328331b611; Rittenberg V, 2010, HUM FERTIL, V13, P208, DOI 10.3109/14647273.2010.534833; Saha Rumpa, 2010, J Indian Med Assoc, V108, P344; Sanocka-Maciejewska D, 2005, J REPROD IMMUNOL, V67, P51, DOI 10.1016/j.jri.2005.06.003; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schulz M, 2010, FERTIL STERIL, V94, P619, DOI 10.1016/j.fertnstert.2009.01.140; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; SMITH SM, 1992, J CLIN MICROBIOL, V30, P1575, DOI 10.1128/JCM.30.6.1575-1577.1992; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Stumpf RM, 2013, AM J PHYS ANTHROPOL, V152, P119, DOI 10.1002/ajpa.22395; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taneja Neelam, 2004, Journal of Communicable Diseases, V36, P27; Tanner MA, 1999, J CLIN MICROBIOL, V37, P1863, DOI 10.1128/JCM.37.6.1863-1870.1999; Virecoulon F, 2005, ANDROLOGIA, V37, P160, DOI 10.1111/j.1439-0272.2005.00673.x; Yang CH, 1996, J FORMOS MED ASSOC, V95, P754	74	123	133	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110152	10.1371/journal.pone.0110152	http://dx.doi.org/10.1371/journal.pone.0110152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340531	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800021
J	Quist, T; Jin, H; Zhu, JF; Smith-Fry, K; Capecchi, MR; Jones, KB				Quist, T.; Jin, H.; Zhu, J-F; Smith-Fry, K.; Capecchi, M. R.; Jones, K. B.			The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse	ONCOGENE			English	Article							CANCER STEM-CELLS; TUMOR HETEROGENEITY; EXPRESSION; PROMOTER; MICE; P53; RB; SARCOMA; TUMORIGENESIS; DISRUPTION	Osteosarcomas remain an enigmatic group of malignancies that share in common the presence of transformed cells producing osteoid matrix, even if these cells comprise a minority of the tumor volume. The differentiation state of osteosarcomas has therefore become a topic of interest and challenge to those who study this disease. In order to test how the cell of origin contributes to the final state of differentiation in the transformed cells, we compared the relative tumorigenicity of Cre-LoxP conditional disruption of the cell cycle checkpoint tumor-suppressor genes Trp53 and Rb1 using Prx1-Cre, Collagen-1a1-Cre and Osteocalcin-Cre to transform undifferentiated mesenchyme, preosteoblasts and mature osteoblasts, respectively. The Prx1 and Col1a1 lineages developed tumors with nearly complete penetrance, as anticipated. Osteosarcomas also developed in 44% of Oc-Cre; Rb1(fl/fl); Trp53(fl/fl) mice. We confirmed using 5-ethynyl-2'-deoxyuridine click chemistry that the Oc-Cre lineage includes very few actively cycling cells. By assessing radiographic mineralization and histological osteoid production, the differentiation state of tumors did not correlate with the differentiation state of the lineage of origin. Some of the osteocalcin-lineage-derived osteosarcomas were among the least osteoblastic. Osteocalcin immunohistochemistry in tumors correlated well with the expression of DNA methyl transferases, suggesting that silencing of these epigenetic regulators may influence the final differentiation state of an osteosarcoma. Transformation of differentiated, minimally proliferative osteoblasts is possible but may require such an epigenetic reprogramming that the tumors no longer resemble their differentiated origins.	[Quist, T.; Jin, H.; Zhu, J-F; Smith-Fry, K.; Jones, K. B.] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA; [Quist, T.; Jin, H.; Zhu, J-F; Smith-Fry, K.; Jones, K. B.] Univ Utah, Ctr Childrens Canc Res, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Capecchi, M. R.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Capecchi, M. R.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Jones, KB (corresponding author), Univ Utah, Dept Orthopaed, Sarcoma Serv, 2000 Circle Hope Dr,Room 4263, Salt Lake City, UT 84112 USA.	kevin.jones@hci.utah.edu			National Cancer Institute (National Institutes of Health, NIH) [K08CA138764]; Damon Runyon Cancer Research Foundation; National Cancer Institute [P30CA042014]; NATIONAL CANCER INSTITUTE [R01CA210165, P30CA042014, K08CA138764] Funding Source: NIH RePORTER	National Cancer Institute (National Institutes of Health, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Thomas Clemens for the Oc-Cre mouse line, Malcolm Logan for Prx1-Cre and Benoit de Crombrugghe for Col1a1-Cre. This work was directly supported by National Cancer Institute (National Institutes of Health, NIH) K08CA138764. KBJ receives additional career development support from the Damon Runyon Cancer Research Foundation. This work was also partly supported by P30CA042014 from the National Cancer Institute.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Damron TA, 2007, CLIN ORTHOP RELAT R, P40, DOI 10.1097/BLO.0b013e318059b8c9; Desandes E, 2007, CANCER TREAT REV, V33, P609, DOI 10.1016/j.ctrv.2006.12.007; Dick JE, 2003, P NATL ACAD SCI USA, V100, P3547, DOI 10.1073/pnas.0830967100; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; Hopyan S, 1999, J ORTHOPAED RES, V17, P633, DOI 10.1002/jor.1100170503; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Lin PP, 2008, CANCER RES, V68, P8968, DOI 10.1158/0008-5472.CAN-08-0573; Lin PP, 2009, CARCINOGENESIS, V30, P1789, DOI 10.1093/carcin/bgp180; LIU F, 1994, DEV BIOL, V166, P220, DOI 10.1006/dbio.1994.1309; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Molyneux SD, 2010, J CLIN INVEST, V120, P3310, DOI 10.1172/JCI42391; Mutsaers AJ, 2014, BONE, V62, P56, DOI 10.1016/j.bone.2014.02.003; OWEN TA, 1990, P NATL ACAD SCI USA, V87, P5129, DOI 10.1073/pnas.87.13.5129; Ragland BD, 2002, LAB INVEST, V82, P365, DOI 10.1038/labinvest.3780431; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; San Martin IA, 2009, J CELL PHYSIOL, V221, P560, DOI 10.1002/jcp.21894; SHARKEY FE, 1983, ARCH PATHOL LAB MED, V107, P411; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; UNNI KK, 1989, SEMIN ROENTGENOL, V24, P143, DOI 10.1016/0037-198X(89)90010-2; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Weiss A, 2007, CANCER, V109, P1627, DOI 10.1002/cncr.22574; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Yeo HJ, 2007, J BIOL CHEM, V282, P35318, DOI 10.1074/jbc.M702435200	36	33	33	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4278	4284		10.1038/onc.2014.354	http://dx.doi.org/10.1038/onc.2014.354			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25347737	Green Accepted			2022-12-26	WOS:000359199800014
J	Kim, HY; Park, JH; Won, HY; Lee, JY; Kong, G				Kim, Hey-Yon; Park, Ji-Hye; Won, Hee-Young; Lee, Jeong-Yeon; Kong, Gu			CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/beta-catenin pathway	FASEB JOURNAL			English	Article						polycomb; self-renewal pathway; p300; acetylation	POLYCOMB GROUP PROTEINS; STEM-CELLS; CHROMOBOX PROTEIN; TUMOR-SUPPRESSOR; CANCER CELLS; SIGNALING PATHWAY; EXPRESSION; GENE; DICKKOPF-1; CARCINOMA	Polycomb protein chromobox homolog 7 (CBX7) is involved in several biologic processes including stem cell regulation and cancer development, but its roles in breast cancer remain unknown. Here, we demonstrate that CBX7 negatively regulates breast tumor initiation. CD44(+)/CD24(-)/ESA(+) breast stem-like cells showed diminished CBX7 expression. Furthermore, small hairpin RNA-mediated CBX7 knockdown in breast epithelial and cancer cells increased the CD44(+)/CD24(-)/ESA(+) cell population and reinforced in vitro self-renewal and in vivo tumor-initiating ability. Similarly, CBX7 overexpression repressed these effects. We also found that CBX7 inhibits the Wnt/b-catenin/T cell factor pathway by enhancing the expression of Dickkopf-1 (DKK-1), a Wnt antagonist. In particular, CBX7 increased DKK-1 transcription by cooperating with p300 acetyltransferase and subsequently enhancing the histone acetylation of the DKK-1 promoter. Furthermore, pharmacologic inhibition of DKK-1 in CBX7-overexpressing cells showed recovery of Wnt signaling and consequent rescue of the CD44(+)/CD24(-)/ESA(+) cell population. Taken together, these findings indicate that CBX7-mediated epigenetic induction of DKK-1 is crucial for the inhibition of breast tumorigenicity, suggesting that CBX7 could be a potential tumor suppressor in human breast cancer.	[Kim, Hey-Yon; Won, Hee-Young; Kong, Gu] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea; [Park, Ji-Hye; Lee, Jeong-Yeon; Kong, Gu] Hanyang Univ, Inst Bioengn & Biopharmaceut Res, Seoul 133791, South Korea	Hanyang University; Hanyang University	Kong, G (corresponding author), Hanyang Univ, Coll Med, Dept Pathol, 17 Haengdang Dong, Seoul 133791, South Korea.	jy2jy2@hanyang.ac.kr; gkong@hanyang.ac.kr						Agur Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024225; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Arima Y, 2012, INT J CANCER, V130, P2568, DOI 10.1002/ijc.26271; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; Dees C, 2014, ANN RHEUM DIS, V73, P1232, DOI 10.1136/annrheumdis-2012-203194; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Forzati F, 2012, CELL CYCLE, V11, P1888, DOI 10.4161/cc.20022; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hinz S, 2008, TUMOR BIOL, V29, P323, DOI 10.1159/000170879; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070077, 10.1371/journal.pone.0075007]; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Jiang Z, 2010, J GASTROENTEROL, V45, P17, DOI 10.1007/s00535-009-0135-6; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Karamitopoulou E, 2010, EUR J CANCER, V46, P1438, DOI 10.1016/j.ejca.2010.01.033; Klauke K, 2013, NAT CELL BIOL, V15, P353, DOI 10.1038/ncb2701; Lamb R, 2013, CELL CYCLE, V12, P2384, DOI 10.4161/cc.25403; Lee JY, 2014, ONCOGENE, V33, P1325, DOI 10.1038/onc.2013.53; Lee JY, 2008, CANCER RES, V68, P4201, DOI 10.1158/0008-5472.CAN-07-2570; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Mansueto Gelsomina, 2010, Genes Cancer, V1, P210, DOI 10.1177/1947601910366860; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Pallante P, 2010, EUR J CANCER, V46, P2304, DOI 10.1016/j.ejca.2010.05.011; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Rawson JB, 2012, NUTR CANCER, V64, P919, DOI 10.1080/01635581.2012.711418; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Vibhakar R, 2007, NEURO-ONCOLOGY, V9, P135, DOI 10.1215/15228517-2006-038; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418; Zhang XW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-114	48	48	51	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					300	313		10.1096/fj.14-253997	http://dx.doi.org/10.1096/fj.14-253997			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25351982				2022-12-26	WOS:000347378600028
J	Kirby, KA; Ong, YT; Hachiya, A; Laughlin, TG; Chiang, LA; Pan, Y; Moran, JL; Marchand, B; Singh, K; Gallazzi, F; Quinn, TP; Yoshimura, K; Murakami, T; Matsushita, S; Sarafianos, SG				Kirby, Karen A.; Ong, Yee Tsuey; Hachiya, Atsuko; Laughlin, Thomas G.; Chiang, Leslie A.; Pan, Yun; Moran, Jennifer L.; Marchand, Bruno; Singh, Kamalendra; Gallazzi, Fabio; Quinn, Thomas P.; Yoshimura, Kazuhisa; Murakami, Toshio; Matsushita, Shuzo; Sarafianos, Stefan G.			Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247	FASEB JOURNAL			English	Article						crystal structure; entry; HIV; single-chain variable fragment	HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; BROAD NEUTRALIZATION; BINDING MODE; V3 PEPTIDES; TYPE-1; ENVELOPE; EPITOPE; SEQUENCE	Humanized monoclonal antibody KD-247 targets the Gly(312)-Pro(313)-Gly(314)-Arg(315) arch of the third hypervariable (V3) loop of the HIV-1 surface glycoprotein. It potently neutralizes many HIV-1 clade B isolates, but not of other clades. To understand the molecular basis of this specificity, we solved a high-resolution (1.55 angstrom) crystal structure of the KD-247 antigen binding fragment and examined the potential interactions with various V3 loop targets. Unlike most antibodies, KD-247 appears to interact with its target primarily through light chain residues. Several of these interactions involve Arg(315) of the V3 loop. To evaluate the role of light chain residues in the recognition of the V3 loop, we generated 20 variants of KD-247 single-chain variable fragments with mutations in the antigen-binding site. Purified proteins were assessed for V3 loop binding using Alpha-Screen technology and for HIV-1 neutralization. Our data revealed that recognition of the clade-specificity defining residue Arg(315) of the V3 loop is based on a network of interactions that involve Tyr(L32), Tyr(L92), and Asn(L27d) that directly interact with Arg(315), thus elucidating the molecular interactions of KD-247 with its V3 loop target.	[Kirby, Karen A.; Ong, Yee Tsuey; Hachiya, Atsuko; Laughlin, Thomas G.; Chiang, Leslie A.; Pan, Yun; Moran, Jennifer L.; Marchand, Bruno; Singh, Kamalendra; Sarafianos, Stefan G.] Univ Missouri, Christopher S Bond Life Sci Ctr, Sch Med, Columbia, MO USA; [Kirby, Karen A.; Ong, Yee Tsuey; Hachiya, Atsuko; Laughlin, Thomas G.; Chiang, Leslie A.; Pan, Yun; Moran, Jennifer L.; Marchand, Bruno; Singh, Kamalendra; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Gallazzi, Fabio] Univ Missouri, Struct Biol Core, Columbia, MO USA; [Quinn, Thomas P.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Yoshimura, Kazuhisa] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Murakami, Toshio] Chemoserotherapeut Res Inst Kaketsuken, Kumamoto, Japan; [Matsushita, Shuzo] Kumamoto Univ, Ctr AIDS Res, Div Clin Retrovirol & Infect Dis, Kumamoto, Japan	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Institute of Infectious Diseases (NIID); Kumamoto University	Sarafianos, SG (corresponding author), 471d Christopher S Bond Life Sci Ctr, 1201 Rollins St, Columbia, MO 65211 USA.	sarafianoss@missouri.edu		Laughlin, Thomas/0000-0001-8943-1330; Kirby, Karen A./0000-0003-2468-4796; Ong, Yee Tsuey/0000-0001-9361-2855; Sarafianos, Stefan G/0000-0002-5840-154X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094715, R01AI076119, R21AI112417, R01AI099284, R01AI100890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103368] Funding Source: NIH RePORTER; Canadian Institutes of Health Research Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI100890, R21 AI094715, AI112417, AI099284, AI094715, R01 AI100890, R01 AI099284, AI076119, R21 AI112417, R01 AI076119, R37 AI076119] Funding Source: Medline; NIGMS NIH HHS [P50 GM103368, GM103368] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Branden C., 1999, INTRO PROTEIN STRUCT; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Eda Y, 2006, J VIROL, V80, P5563, DOI 10.1128/JVI.02095-05; Eda Y, 2006, J VIROL, V80, P5552, DOI 10.1128/JVI.02094-05; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hatada M, 2010, J GEN VIROL, V91, P1335, DOI 10.1099/vir.0.017426-0; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Janes R. W., 2009, ADV BIOMEDICAL SPECT, V1, P183; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kabat EA, 1991, SEQUENCES PROTEINS I; Kessler N, 2003, PROTEIN EXPRES PURIF, V29, P291, DOI 10.1016/S1046-5928(03)00047-0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Le Douce V, 2012, J ANTIMICROB CHEMOTH, V67, P1063, DOI 10.1093/jac/dkr599; Lynch RM, 2009, AIDS RES HUM RETROV, V25, P237, DOI 10.1089/aid.2008.0219; MATSUSHITA S, 1988, J VIROL, V62, P2107, DOI 10.1128/JVI.62.6.2107-2114.1988; Matsushita Shuzo, 2005, Human Antibodies, V14, P81; MATTHEWS BW, 1985, METHOD ENZYMOL, V114, P176; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Murakami T, 2009, AIDS, V23, P1485, DOI 10.1097/QAD.0b013e32832e5331; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ong YT, 2012, CELL MOL BIOL, V58, P71, DOI 10.1170/T923; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; SHAW GM, 1984, SCIENCE, V226, P1165, DOI 10.1126/science.6095449; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stanfield RL, 2003, VIROLOGY, V315, P159, DOI 10.1016/S0042-6822(03)00525-7; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sundberg EJ, 2009, METHODS MOL BIOL, V524, P23, DOI 10.1007/978-1-59745-450-6_2; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yoshimura K, 2006, AIDS, V20, P2065, DOI 10.1097/01.aids.0000247587.31320.fe; Yusim K, 2011, HIV MOL IMMUNOLOGY	72	1	1	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					70	80		10.1096/fj.14-252262	http://dx.doi.org/10.1096/fj.14-252262			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25351987	Green Published			2022-12-26	WOS:000347378600008
J	Raddatz, N; Castillo, JP; Gonzalez, C; Alvarez, O; Latorre, R				Raddatz, Natalia; Castillo, Juan P.; Gonzalez, Carlos; Alvarez, Osvaldo; Latorre, Ramon			Temperature and Voltage Coupling to Channel Opening in Transient Receptor Potential Melastatin 8 (TRPM8)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Calcium Channel; Gating; Ion Channel; Thermodynamics; TRPM8; Allosteric Model; Deactivation Processes; Temperature Coefficient	SHAKER POTASSIUM CHANNELS; SQUID GIANT-AXON; ION CHANNELS; COLD SENSATION; PORE TURRET; SODIUM-CHANNELS; HEAT ACTIVATION; GATING CHARGE; K+ CHANNELS; REVEALS	Expressed in somatosensory neurons of the dorsal root and trigeminal ganglion, the transient receptor potential melastatin 8 (TRPM8) channel is a Ca2+-permeable cation channel activated by cold, voltage, phosphatidylinositol 4,5-bisphosphate, and menthol. Although TRPM8 channel gating has been characterized at the single channel and macroscopic current levels, there is currently no consensus regarding the extent to which temperature and voltage sensors couple to the conduction gate. In this study, we extended the range of voltages where TRPM8-induced ionic currents were measured and made careful measurements of the maximum open probability the channel can attain at different temperatures by means of fluctuation analysis. The first direct measurements of TRPM8 channel temperature-driven conformational rearrangements provided here suggest that temperature alone is able to open the channel and that the opening reaction is voltage-independent. Voltage is a partial activator of TRPM8 channels, because absolute open probability values measured with fully activated voltage sensors are less than 1, and they decrease as temperature rises. By unveiling the fast temperature-dependent deactivation process, we show that TRPM8 channel deactivation is well described by a double exponential time course. The fast and slow deactivation processes are temperature-dependent with enthalpy changes of 27.2 and 30.8 kcal mol(-1). The overall Q(10) for the closing reaction is about 33. A three-tiered allosteric model containing four voltage sensors and four temperature sensors can account for the complex deactivation kinetics and coupling between voltage and temperature sensor activation and channel opening.	[Raddatz, Natalia; Castillo, Juan P.; Gonzalez, Carlos; Alvarez, Osvaldo; Latorre, Ramon] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2366103, Chile; [Alvarez, Osvaldo] Univ Chile, Fac Ciencias, Dept Biol, Santiago 7800003, Chile	Universidad de Valparaiso; Universidad de Chile	Alvarez, O (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2366103, Chile.	oalvarez@uchile.cl; ramon.latorre@uv.cl	Gonzalez, Carlos/V-7628-2019	Raddatz, Natalia/0000-0002-1801-4131	FONDECYT [1110430, 1120802, Anillo ACT-1104]; Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo (Chilean Government)	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo (Chilean Government)	This work was supported by Grants FONDECYT 1110430 (to R. L.) and 1120802 (to C. G.) and Anillo ACT-1104 (to C. G.). The Centro Interdisciplinario de Neurociencia de Valparaiso is a Millennium Institute supported by the Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo (Chilean Government).	Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Ashour SK, 2010, J ADV RES, V1, P341, DOI 10.1016/j.jare.2010.06.004; AZZALINI A, 1985, SCAND J STAT, V12, P171; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chowdhury S, 2014, CELL, V158, P1148, DOI 10.1016/j.cell.2014.07.026; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; CORREA AM, 1992, BIOPHYS J, V61, P1332, DOI 10.1016/S0006-3495(92)81941-0; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; FITZHUGH R, 1983, MATH BIOSCI, V64, P75, DOI 10.1016/0025-5564(83)90028-7; GOLDMAN L, 1991, BIOPHYS J, V60, P519, DOI 10.1016/S0006-3495(91)82080-X; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; HORN R, 1984, BIOPHYS J, V45, P323, DOI 10.1016/S0006-3495(84)84158-2; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jara-Oseguera A, 2013, BIOPHYS J, V104, P2160, DOI 10.1016/j.bpj.2013.03.055; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2013, ACS CHEM NEUROSCI, V4, P238, DOI 10.1021/cn300193h; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nieto-Posadas A, 2011, CURR TOP MED CHEM, V11, P2131, DOI 10.2174/156802611796904870; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Salazar M, 2011, J NEUROSCI, V31, P5554, DOI 10.1523/JNEUROSCI.6775-10.2011; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Sigg D, 1997, J GEN PHYSIOL, V109, P27, DOI 10.1085/jgp.109.1.27; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Stewart AP, 2010, BIOCHEM BIOPH RES CO, V394, P383, DOI 10.1016/j.bbrc.2010.03.027; STUHMER W, 1987, EUR BIOPHYS J BIOPHY, V14, P131, DOI 10.1007/BF00253837; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Voets T, 2012, REV PHYSIOL BIOCH P, V162, P91, DOI 10.1007/112_2011_5; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yao J, 2010, P NATL ACAD SCI USA, V107, pE125, DOI 10.1073/pnas.1008272107; YELLEN G, 1984, J GEN PHYSIOL, V84, P187, DOI 10.1085/jgp.84.2.187; Yudin Y, 2012, MOL CELL ENDOCRINOL, V353, P68, DOI 10.1016/j.mce.2011.10.023; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010	60	40	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35438	35454		10.1074/jbc.M114.612713	http://dx.doi.org/10.1074/jbc.M114.612713			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352597	Green Published, hybrid			2022-12-26	WOS:000346660200034
J	Stanfield, BA; Stahl, J; Chouljenko, VN; Subramanian, R; Charles, AS; Saied, AA; Walker, JD; Kousoulas, KG				Stanfield, Brent A.; Stahl, Jacque; Chouljenko, Vladimir N.; Subramanian, Ramesh; Charles, Anu-Susan; Saied, Ahmad A.; Walker, Jason D.; Kousoulas, Konstantin G.			A Single Intramuscular Vaccination of Mice with the HSV-1 VC2 Virus with Mutations in the Glycoprotein K and the Membrane Protein UL20 Confers Full Protection against Lethal Intravaginal Challenge with Virulent HSV-1 and HSV-2 Strains	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; OCULARLY-INFECTED MICE; T-CELL EPITOPE; GENITAL HERPES; TYPE-2 INFECTION; IMMUNODEFICIENCY-VIRUS; AMINO-TERMINUS; GUINEA-PIGS; HERPES-SIMPLEX-VIRUS-2 INFECTION; REPLICATION-COMPETENT	Herpes Simplex Virus type-1 (HSV-1) and type-2 (HSV-2) establish life-long infections and cause significant orofacial and genital infections in humans. HSV-1 is the leading cause of infectious blindness in the western world. Currently, there are no available vaccines to protect against herpes simplex infections. Recently, we showed that a single intramuscular immunization with an HSV-1(F) mutant virus lacking expression of the viral glycoprotein K (gK), which prevents the virus from entering into distal axons of ganglionic neurons, conferred significant protection against either virulent HSV-1(McKrae) or HSV-2(G) intravaginal challenge in mice. Specifically, 90% of the mice were protected against HSV-1(McKrae) challenge, while 70% of the mice were protected against HSV-2(G) challenge. We constructed the recombinant virus VC2 that contains specific mutations in gK and the membrane protein UL20 preventing virus entry into axonal compartments of neurons, while allowing efficient replication in cell culture, unlike the gK-null virus, which has a major defect in virus replication and spread. Intramuscular injection of mice with 10(7) VC2 plaque forming units did not cause any significant clinical disease in mice. A single intramuscular immunization with the VC2 virus protected 100% of mice against lethal intravaginal challenge with either HSV-1(McKrae) or HSV-2(G) viruses. Importantly, vaccination with VC2 produced robust cross protective humoral and cellular immunity that fully protected vaccinated mice against lethal disease. Quantitative PCR did not detect any viral DNA in ganglionic tissues of vaccinated mice, while unvaccinated mice contained high levels of viral DNA. The VC2 virus may serve as an efficient vaccine against both HSV-1 and HSV-2 infections, as well as a safe vector for the production of vaccines against other viral and bacterial pathogens.	[Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA; Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Kousoulas, KG (corresponding author), Louisiana State Univ, Sch Vet Med, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA.	vtgusk@lsu.edu	Stanfield, Brent/A-3266-2019	Stanfield, Brent/0000-0002-0966-9662; KOUSOULAS, KONSTANTIN/0000-0001-7077-9003	Louisiana Board of Regents Biotechnology Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110760] Funding Source: NIH RePORTER	Louisiana Board of Regents Biotechnology Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Louisiana Board of Regents Biotechnology Initiative grant to KGK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhrameyeva NV, 2011, J VIROL, V85, P5036, DOI 10.1128/JVI.02548-10; Allen SJ, 2014, INVEST OPHTH VIS SCI, V55, P2442, DOI 10.1167/iovs.14-14013; Allen SJ, 2010, VIROLOGY, V399, P11, DOI 10.1016/j.virol.2009.12.011; Anuradha K, 2008, INDIAN J DERMATOL VE, V74, P230; Augustinova H, 2004, J VIROL, V78, P5756, DOI 10.1128/JVI.78.11.5756-5765.2004; Awasthi S, 2014, J INFECT DIS, V209, P813, DOI 10.1093/infdis/jit658; Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; BLANK H, 1973, J INVEST DERMATOL, V61, P223, DOI 10.1111/1523-1747.ep12676442; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brans R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-163; Brans R, 2009, J INVEST DERMATOL, V129, P2470, DOI 10.1038/jid.2009.86; Brittle EE, 2008, J VIROL, V82, P8431, DOI 10.1128/JVI.00551-08; Brown JM, 2007, AIDS, V21, P1515, DOI 10.1097/QAD.0b013e3282004929; Chentoufi AA, 2008, J VIROL, V82, P11792, DOI 10.1128/JVI.00692-08; Chouljenko VN, 2010, J VIROL, V84, P8596, DOI 10.1128/JVI.00298-10; Chouljenko VN, 2009, J VIROL, V83, P12301, DOI 10.1128/JVI.01329-09; Chowdhury S, 2013, J VIROL, V87, P3305, DOI 10.1128/JVI.02982-12; Coleman JL, 2013, HUM VACC IMMUNOTHER, V9, P729, DOI 10.4161/hv.23289; COOK SD, 1991, INVEST OPHTH VIS SCI, V32, P1558; Da Costa XJ, 2001, VIROLOGY, V288, P256, DOI 10.1006/viro.2001.1094; David AT, 2008, CURR EYE RES, V33, P455, DOI 10.1080/02713680802130362; David AT, 2012, MBIO, V3, DOI 10.1128/mBio.00144-12; Dervillez X, 2012, FUTURE VIROL, V7, P371, DOI 10.2217/FVL.12.22; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; Dudek T, 2008, VIROLOGY, V372, P165, DOI 10.1016/j.virol.2007.10.014; Dudley KL, 2000, VIROLOGY, V270, P454, DOI 10.1006/viro.2000.0298; Foster TP, 2008, J VIROL, V82, P6310, DOI 10.1128/JVI.00147-08; Foster TP, 2004, J VIROL, V78, P13262, DOI 10.1128/JVI.78.23.13262-13277.2004; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2009, VACCINE, V27, P940, DOI 10.1016/j.vaccine.2008.11.074; Ghiasi H, 2000, VIRUS RES, V68, P137, DOI 10.1016/S0168-1702(00)00165-9; Gottlieb SL, 2014, VACCINE, V32, P1527, DOI 10.1016/j.vaccine.2013.07.087; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Harrington KJ, 2010, CLIN CANCER RES, V16, P4005, DOI 10.1158/1078-0432.CCR-10-0196; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hofstetter AM, 2014, CURR OPIN INFECT DIS, V27, P75, DOI 10.1097/QCO.0000000000000029; Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022; Iyer AV, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-317; Johnston C, 2014, VACCINE, V32, P1553, DOI 10.1016/j.vaccine.2013.08.066; Kim IJ, 2014, CURR EYE RE IN PRESS; Kim IJ, 2013, J VIROL, V87, P8029, DOI 10.1128/JVI.01181-13; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; KOUSOULAS KG, 1988, VIROLOGY, V166, P423, DOI 10.1016/0042-6822(88)90513-2; Lee HC, 2009, J VIROL, V83, P6115, DOI 10.1128/JVI.00128-09; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Mertz GJ, 2008, J INFECT DIS, V198, P1098, DOI 10.1086/591914; Milligan GN, 1998, J IMMUNOL, V160, P6093; Morrison LA, 2001, J VIROL, V75, P1195, DOI 10.1128/JVI.75.3.1195-1204.2001; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2009, INVEST OPHTH VIS SCI, V50, P2903, DOI 10.1167/iovs.08-2957; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; Murphy CG, 2000, J VIROL, V74, P7745, DOI 10.1128/JVI.74.17.7745-7754.2000; PEREIRA L, 1980, INFECT IMMUN, V29, P724; Prichard MN, 2005, VACCINE, V23, P5424, DOI 10.1016/j.vaccine.2005.02.028; Renzi C, 2003, J INFECT DIS, V187, P19, DOI 10.1086/345867; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Roth K, 2013, MICROB PATHOGENESIS, V58, P45, DOI 10.1016/j.micpath.2012.11.001; Rupp R, 2008, EXPERT OPIN EMERG DR, V13, P41, DOI 10.1517/14728214.13.1.41 ; Saied AA, 2014, CURR EYE RES, V39, P596, DOI 10.3109/02713683.2013.855238; Sartori E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-166; Schiffer JT, 2013, NAT MED, V19, P280, DOI 10.1038/nm.3103; Seppanen M, 2006, J INFECT DIS, V194, P571, DOI 10.1086/506477; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; St Leger AJ, 2011, J NEUROVIROL, V17, P528, DOI 10.1007/s13365-011-0062-1; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; van Lint AL, 2007, VIROLOGY, V368, P227, DOI 10.1016/j.virol.2007.08.030; Wakim LM, 2008, IMMUNOL CELL BIOL, V86, P666, DOI 10.1038/icb.2008.47; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watanabe D, 2007, VIROLOGY, V357, P186, DOI 10.1016/j.virol.2006.08.015; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu XP, 2014, VIRUSES-BASEL, V6, P371, DOI 10.3390/v6020371	77	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109890	10.1371/journal.pone.0109890	http://dx.doi.org/10.1371/journal.pone.0109890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350288	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100014
J	Cohen, OR; Steele, JA; Zhang, QS; Schmidt, DJ; Wang, YK; Hamel, PES; Beamer, G; Xu, BL; Tzipori, S				Cohen, Ocean R.; Steele, Jennifer A.; Zhang, Quanshun; Schmidt, Diane J.; Wang, Yuankai; Hamel, Philip E. S.; Beamer, Gillian; Xu, Bingling; Tzipori, Saul			Systemically Administered IgG Anti-Toxin Antibodies Protect the Colonic Mucosa during Infection with Clostridium difficile in the Piglet Model	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; TOXIN-A; DISEASE	The use of anti-toxin human monoclonal antibodies (HMab) as treatment for C. difficile infection has been investigated in animal models and human clinical trials as an alternative to or in combination with traditional antibiotic therapy. While HMab therapy appears to be a promising option, how systemically administered IgG antibodies protect the colonic mucosa during Clostridium difficile infection is unknown. Using the gnotobiotic piglet model of Clostridium difficile infection, we administered a mixture of anti-TcdA and anti-TcdB HMabs systemically to piglets infected with either pathogenic or nonpathogenic C. difficile strains. The HMabs were present throughout the small and large intestinal tissue of both groups, but significant HMabs were present in the lumen of the large intestines only in the pathogenic strain-infected group. Similarly, HMabs measured in the large intestine over a period of 2-4 days following antibody administration were not significantly different over time in the gut mucosa among the groups, but concentrations in the lumen of the large intestine were again consistently higher in the pathogenic strain-infected group. These results indicate that systemically administered HMab IgG reaches the gut mucosa during the course of CDI, protecting the host against systemic intoxication, and that leakage through the damaged colon likely protects the mucosa from further damage, allowing initiation of repair and recovery.	[Cohen, Ocean R.; Steele, Jennifer A.; Zhang, Quanshun; Schmidt, Diane J.; Wang, Yuankai; Hamel, Philip E. S.; Beamer, Gillian; Xu, Bingling; Tzipori, Saul] Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA		Tzipori, S (corresponding author), Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA.	Saul.Tzipori@tufts.edu			Merck, Inc. award VT ID [40660]; National Institutes of Health [R01-AI-0022748]; Merck, Inc.	Merck, Inc. award VT ID; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck, Inc.(Merck & Company)	The work was supported by the following: Merck, Inc. award VT ID#40660 (ST) and National Institutes of Health award R01-AI-0022748 (ST). Merck, Inc. approved the study design in the award application but had no role in the data collection, analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Bakken JS, 2013, ANAEROBE, V24, P20, DOI 10.1016/j.anaerobe.2013.08.007; Carter GP, 2010, GUT MICROBES, V1, P58, DOI 10.4161/gmic.1.1.10768; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; McCollum DL, 2012, CLIN GASTROENTEROL H, V10, P581, DOI 10.1016/j.cgh.2012.03.008; Mohawk KL, 2010, VACCINE, V28, P4777, DOI 10.1016/j.vaccine.2010.04.099; Rath T, 2013, J CLIN IMMUNOL, V33, pS9, DOI 10.1007/s10875-012-9768-y; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; Steele J, 2012, J INFECT DIS, V205, P384, DOI 10.1093/infdis/jir748; Steele J, 2010, J INFECT DIS, V201, P428, DOI 10.1086/649799; Sun XM, 2010, TOXINS, V2, P1848, DOI 10.3390/toxins2071848; Taylor CP, 2008, VACCINE, V26, P3404, DOI 10.1016/j.vaccine.2008.04.042; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821	17	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111075	10.1371/journal.pone.0111075	http://dx.doi.org/10.1371/journal.pone.0111075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347821	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900044
J	Henderson, LJ; Evans, NP; Heidinger, BJ; Adams, A; Arnold, KE				Henderson, Lindsay J.; Evans, Neil P.; Heidinger, Britt J.; Adams, Aileen; Arnold, Kathryn E.			Maternal Condition but Not Corticosterone Is Linked to Offspring Sex Ratio in a Passerine Bird	PLOS ONE			English	Article							BLUE TITS; PARENTAL CONDITION; FOOD AVAILABILITY; STRESS HORMONES; BODY CONDITION; PARUS-MAJOR; POPULATION; QUALITY; EGGS; SEGREGATION	There is evidence of offspring sex ratio adjustment in a range of species, but the potential mechanisms remain largely unknown. Elevated maternal corticosterone (CORT) is associated with factors that can favour brood sex ratio adjustment, such as reduced maternal condition, food availability and partner attractiveness. Therefore, the steroid hormone has been suggested to play a key role in sex ratio manipulation. However, despite correlative and causal evidence CORT is linked to sex ratio manipulation in some avian species, the timing of adjustment varies between studies. Consequently, whether CORT is consistently involved in sex-ratio adjustment, and how the hormone acts as a mechanism for this adjustment remains unclear. Here we measured maternal baseline CORT and body condition in free-living blue tits (Cyanistes caeruleus) over three years and related these factors to brood sex ratio and nestling quality. In addition, a non-invasive technique was employed to experimentally elevate maternal CORT during egg laying, and its effects upon sex ratio and nestling quality were measured. We found that maternal CORT was not correlated with brood sex ratio, but mothers with elevated CORT fledged lighter offspring. Also, experimental elevation of maternal CORT did not influence brood sex ratio or nestling quality. In one year, mothers in superior body condition produced male biased broods, and maternal condition was positively correlated with both nestling mass and growth rate in all years. Unlike previous studies maternal condition was not correlated with maternal CORT. This study provides evidence that maternal condition is linked to brood sex ratio manipulation in blue tits. However, maternal baseline CORT may not be the mechanistic link between the maternal condition and sex ratio adjustment. Overall, this study serves to highlight the complexity of sex ratio adjustment in birds and the difficulties associated with identifying sex biasing mechanisms.	[Henderson, Lindsay J.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Henderson, Lindsay J.; Evans, Neil P.; Heidinger, Britt J.; Adams, Aileen; Arnold, Kathryn E.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Heidinger, Britt J.] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Arnold, Kathryn E.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	University of California System; University of California Davis; University of Glasgow; North Dakota State University Fargo; University of York - UK	Henderson, LJ (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	lindsayhenderson@hotmail.com	Arnold, Kathryn E/F-8683-2016	Arnold, Kathryn E/0000-0002-6485-6065; Henderson, Lindsay J./0000-0001-7794-3048	Natural Environment Research Council [NE/H526886/1]; Royal Society University Research Fellowship	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society University Research Fellowship(Royal Society of London)	LJH, KEA, and NPE received PhD funding from Natural Environment Research Council (award number NE/H526886/1, http://www.nerc.com/). KEA was also supported by a Royal Society University Research Fellowship (https://royalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam MA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115352; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; Bonier F, 2007, BEHAV ECOL, V18, P1045, DOI 10.1093/beheco/arm075; Buck CL, 2007, GEN COMP ENDOCR, V150, P430, DOI 10.1016/j.ygcen.2006.10.011; Cameron EZ, 2008, P ROY SOC B-BIOL SCI, V275, P323, DOI 10.1098/rspb.2007.1401; Cameron EZ, 2007, BIOL LETTERS, V3, P395, DOI 10.1098/rsbl.2007.0089; Charmantier A, 2004, J AVIAN BIOL, V35, P524, DOI 10.1111/j.0908-8857.2004.03296.x; CHARNOV E L, 1982; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; Criscuolo Francois, 2001, Marine Ornithology, V29, P47; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; Delhey K, 2007, BEHAV ECOL SOCIOBIOL, V61, P853, DOI 10.1007/s00265-006-0314-x; Dreiss A, 2006, BEHAV ECOL, V17, P13, DOI 10.1093/beheco/ari089; Ewen JG, 2004, P ROY SOC B-BIOL SCI, V271, P1277, DOI 10.1098/rspb.2004.2735; Gam AE, 2011, J AVIAN BIOL, V42, P253, DOI 10.1111/j.1600-048X.2010.05251.x; Goerlich VC, 2010, PHYSIOL BIOCHEM ZOOL, V83, P490, DOI 10.1086/651315; Griffith SC, 2003, J EVOLUTION BIOL, V16, P1045, DOI 10.1046/j.1420-9101.2003.00550.x; Griffith SC, 2011, P ROY SOC B-BIOL SCI, V278, P2798, DOI 10.1098/rspb.2010.2672; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GULLBERG A, 1992, HEREDITAS, V117, P103, DOI 10.1111/j.1601-5223.1992.tb00164.x; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Henderson LJ, 2013, BEHAV ECOL, V24, P1299, DOI 10.1093/beheco/art066; Henderson LJ, ARE GLUCOCORTI UNPUB; Hunt S, 1999, ANIM BEHAV, V58, P809, DOI 10.1006/anbe.1999.1214; Jones KS, 2009, AM NAT, V174, P122, DOI 10.1086/599299; Kilner R, 1998, ANIM BEHAV, V56, P155, DOI 10.1006/anbe.1998.0775; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kitaysky AS, 2001, J COMP PHYSIOL B, V171, P701, DOI 10.1007/s003600100230; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Koenig WD, 1996, AUK, V113, P902, DOI 10.2307/4088867; Komdeur J, 2002, PHILOS T R SOC B, V357, P373, DOI 10.1098/rstb.2001.0927; Komdeur J, 2002, P ROY SOC B-BIOL SCI, V269, P1067, DOI 10.1098/rspb.2002.1965; Korpimaki E, 2000, J AVIAN BIOL, V31, P128, DOI 10.1034/j.1600-048X.2000.310204.x; Korsten P, 2006, BEHAV ECOL, V17, P539, DOI 10.1093/beheco/arj061; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Leech DI, 2001, BEHAV ECOL, V12, P674, DOI 10.1093/beheco/12.6.674; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Oddie K, 1998, TRENDS ECOL EVOL, V13, P130, DOI 10.1016/S0169-5347(97)01320-7; OLSEN MW, 1950, J EXP ZOOL, V114, P475, DOI 10.1002/jez.1401140304; Pendlebury CJ, 2005, IBIS, V147, P342, DOI 10.1111/j.1474-919x.2005.00409.x; Perrins C.M., 1979, BRIT TITS; Perrins CM, 1996, IBIS, V138, P2, DOI 10.1111/j.1474-919X.1996.tb04308.x; Pike TW, 2005, ANIM BEHAV, V70, P745, DOI 10.1016/j.anbehav.2004.12.020; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; PIKE TW, 2005, OFFSPRING SEX RATIO, V1, P204; Pinson SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P292, DOI 10.1086/659373; Pryke SR, 2011, BEHAV ECOL, V22, P717, DOI 10.1093/beheco/arr040; Pryke SR, 2014, FUNCTIONAL ECOLOGY; Radford AN, 2000, BEHAV ECOL, V11, P294, DOI 10.1093/beheco/11.3.294; Romanoff A., 1960, THE AVIAN EMBRYO, V1, P429; Rutkowska J, 2008, PHILOS T R SOC B, V363, P1675, DOI 10.1098/rstb.2007.0006; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Schoech SJ, 1997, PHYSIOL ZOOL, V70, P68, DOI 10.1086/639545; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Stauss M, 2005, OIKOS, V109, P367, DOI 10.1111/j.0030-1299.2005.13333.x; Sturkie P.D., 2000, STURKIES AVIAN PHYSL; Svensson L., 1992, IDENTIFICATION GUIDE; Tilgar V, 2010, J ORNITHOL, V151, P61, DOI 10.1007/s10336-009-0426-y; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Whittingham LA, 2005, P ROY SOC B-BIOL SCI, V272, P1775, DOI 10.1098/rspb.2005.3167; Wilkin TA, 2009, CURR BIOL, V19, P1998, DOI 10.1016/j.cub.2009.09.065; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004; WINGFIELD JC, 1976, CONDOR, V78, P570, DOI 10.2307/1367117; WINGFIELD JC, 1978, BIOL REPROD, V19, P1046, DOI 10.1095/biolreprod19.5.1046; Wingfield JC, 2005, J MAMMAL, V86, P248, DOI 10.1644/BHE-004.1; WINGFIELD JC, 1982, CONDOR, V84, P399, DOI 10.2307/1367443	71	15	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110858	10.1371/journal.pone.0110858	http://dx.doi.org/10.1371/journal.pone.0110858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347532	Green Accepted, Green Published, gold			2022-12-26	WOS:000347994900033
J	Tiffin-Richards, FE; Costa, AS; Holschbach, B; Frank, RD; Vassiliadou, A; Kruger, T; Kuckuck, K; Gross, T; Eitner, F; Floege, J; Schulz, JB; Reetz, K				Tiffin-Richards, Frances E.; Costa, Ana S.; Holschbach, Bernhard; Frank, Rolf D.; Vassiliadou, Athina; Krueger, Thilo; Kuckuck, Karl; Gross, Theresa; Eitner, Frank; Floege, Juergen; Schulz, Joerg B.; Reetz, Kathrin			The Montreal Cognitive Assessment (MoCA) - A Sensitive Screening Instrument for Detecting Cognitive Impairment in Chronic Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MINI-MENTAL-STATE; RELIABILITY; DEMENTIA; PERFORMANCE; PREVALENCE; DIALYSIS; VALIDITY; ADULTS; TIME	Background: Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) therapy have an increased risk of developing cognitive impairment and dementia, which are known relevant factors in disease prognosis and therapeutic success, but still lack adequate screening in clinical routine. We evaluated the Montreal Cognitive Assessment (MoCA) for suitability in assessing cognitive performance in HD patients in comparison to the commonly used Mini-Mental State Examination (MMSE) and a detailed neuropsychological test battery, used as gold standard. Methods: 43 HD patients and 42 healthy controls with an average age of 58 years, were assessed with the MoCA, the MMSE and a detailed neuropsychological test battery, covering the domains of memory, attention, language, visuospatial and executive functions. Composite scores were created for comparison of cognitive domains and test results were analyzed using Spearman's correlation and linear regression. Cognitive dysfunction was defined using z-score values and predictive values were calculated. Sensitivity and specificity of the MoCA were determined using receiver operating characteristic (ROC) analysis. Results: HD patients performed worse in all cognitive domains, especially in memory recall and executive functions. The MoCA correlated well with the detailed test battery and identified patients with cognitive impairment with a sensitivity of 76.7% and specificity of 78.6% for a cut-off value of <= 24 out of 30 points. In the detailed assessment executive functions accounted significantly for performance in the MoCA. The MMSE only discriminated weakly between groups. Conclusions: The MoCA represents a suitable cognitive screening tool for hemodialysis patients, demonstrating good sensitivity and specificity levels, and covering executive functions, which appear to play an important role in cognitive performance of HD patients.	[Tiffin-Richards, Frances E.; Costa, Ana S.; Kuckuck, Karl; Schulz, Joerg B.; Reetz, Kathrin] RWTH Aachen Univ Hosp, Dept Neurol, Aachen, Germany; [Tiffin-Richards, Frances E.; Costa, Ana S.; Kuckuck, Karl; Schulz, Joerg B.; Reetz, Kathrin] Julich Aachen Res Alliance JARA, Translat Brain Med, Aachen, Germany; [Tiffin-Richards, Frances E.; Costa, Ana S.; Kuckuck, Karl; Schulz, Joerg B.; Reetz, Kathrin] Julich Aachen Res Alliance JARA, Translat Brain Med, Julich, Germany; [Holschbach, Bernhard] KfH Nephrol Ctr, KfH Curatorship Dialysis & Kidney Transplant EV, Stolberg, Germany; [Frank, Rolf D.] St Antonius Hosp Eschweiler, Dept Internal Med, Eschweiler, Germany; [Vassiliadou, Athina] Dialysis Ctr Aachen, Dialysis Ctr, Aachen, Germany; [Krueger, Thilo; Gross, Theresa; Eitner, Frank; Floege, Juergen] Rhein Westfal TH Aachen, Div Nephrol & Clin Immunol, Aachen, Germany; [Gross, Theresa] Dresden Friedreichstadt Hosp, Dept Internal Med, Dresden, Germany; [Eitner, Frank] Bayer Pharma AG, Wuppertal, Germany; [Reetz, Kathrin] Res Ctr Julich GmbH, Inst Neurosci & Med INM 4, Julich, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Saint Antonius Hospital; RWTH Aachen University; Bayer AG; Bayer Healthcare Pharmaceuticals; Helmholtz Association; Research Center Julich	Reetz, K (corresponding author), RWTH Aachen Univ Hosp, Dept Neurol, Aachen, Germany.	kreetz@ukaachen.de	Schulz, Jörg B/D-9786-2012; Costa, Ana Sofia/O-3913-2017; Reetz, Kathrin/H-9510-2012	Schulz, Jörg B/0000-0002-8903-0593; Costa, Ana Sofia/0000-0002-1999-6616; Reetz, Kathrin/0000-0002-9730-9228	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [SFRH/BD/65743/2009]; Excellence Initiative of the German federal and state governments (DFG) [ZUK32/1]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; POPH - QREN Program	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Excellence Initiative of the German federal and state governments (DFG)(German Research Foundation (DFG)); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; POPH - QREN Program	Ana S. Costa was supported by a PhD fellowship (SFRH/BD/65743/2009) from Fundacao para a Ciencia e Tecnologia (FCT, Portugal) and financed by the POPH - QREN Program. Kathrin Reetz was funded by the Excellence Initiative of the German federal and state governments (DFG ZUK32/1). Jorg B. Schulz was in part funded by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 2002, VALIEDIRUNG NEUROPSY; Agganis BT, 2010, AM J KIDNEY DIS, V56, P704, DOI 10.1053/j.ajkd.2010.04.018; Ahmed S, 2011, NEUROCASE; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Beddhu S, 2000, AM J MED, V108, P609, DOI 10.1016/S0002-9343(00)00371-5; Bossola M, 2011, J PSYCHOSOM RES, V71, P50, DOI 10.1016/j.jpsychores.2011.01.001; Bossola Maurizio, 2009, Blood Purif, V28, P245, DOI 10.1159/000231985; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Buumler G., 1985, FARBE WORT INTERFERE; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa AS, 2012, DEMENT GERIATR COGN, V33, P379, DOI 10.1159/000340006; Costa AS, 2014, AM J KIDNEY DIS, pS0272; Elias MF, 2009, NEPHROL DIAL TRANSPL, V24, P2446, DOI 10.1093/ndt/gfp107; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freitas S, 2011, ALZ DIS ASSOC DIS, V00, P1; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; Griva K, 2010, AM J KIDNEY DIS, V56, P693, DOI 10.1053/j.ajkd.2010.07.003; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Herrmann-Lingen C., 1995, HOSP ANXIETY DEPRESS; Ingram F, 1997, NEUROPSY NEUROPSY BE, V10, P144; Johns M, 1991, SLEEP; Kessler J, 2000, MINIMENTALSTATUSTEST; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Lessig S, 2012, MOVEMENT DISORD, V27, P1125, DOI 10.1002/mds.25070; Luis CA, 2009, INT J GERIATR PSYCHI; Madero M, SEMIN DIAL, V21, P29; McLennan SN, 2011, J GERIATR PSYCH NEUR, V24, P33, DOI 10.1177/0891988710390813; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Murray AM, 2010, AM J KIDNEY DIS, V56, P615, DOI 10.1053/j.ajkd.2010.08.003; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niemann H., 2008, CALIFORNIA VERBAL LE; Pereira Arema A, 2007, Hemodial Int, V11, P309, DOI 10.1111/j.1542-4758.2007.00185.x; Perk J, 2012, EUR HEART J, V33, P2126, DOI 10.1093/eurheartj/ehs254; Post JB, 2010, NEPHRON CLIN PRACT, V116, pC247, DOI 10.1159/000317206; Radbruch L, 2003, J PAIN SYMPTOM MANAG, V25, P449, DOI 10.1016/S0885-3924(03)00073-3; Sanchez-Roman S, 2011, J INT NEUROPSYCH SOC, V17, P80, DOI 10.1017/S1355617710001219; Sarnak MJ, 2013, NEUROLOGY, V80, P471, DOI 10.1212/WNL.0b013e31827f0f7f; Sehgal AR, 1997, AM J KIDNEY DIS, V30, P41, DOI 10.1016/S0272-6386(97)90563-1; Sorensen EP, 2012, AM J KIDNEY DIS, P1; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Tholen S, 2014, DEMENT GERIATR COGN, V38, P31, DOI 10.1159/000357803; Von Aste M, 2006, WECHSLER INTELLIGENZ; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024; Wang F, 2010, AM J NEPHROL, V32, P117, DOI 10.1159/000315618; Warrington E, 1992, TESTBATTERIE VISUELL; Watnick S, 2003, AM J KIDNEY DIS, V41, P105, DOI 10.1053/ajkd.2003.50029; Williams MA, 2004, AM J KIDNEY DIS, V43, P705, DOI 10.1053/j.ajkd.2003.12.031; Wong A, 2009, DEMENT GERIATR COGN, V28, P81, DOI 10.1159/000232589; Yaffe K, 2010, J AM GERIATR SOC, V58, P338, DOI 10.1111/j.1532-5415.2009.02670.x; Zadikoff C, 2008, MOVEMENT DISORD, V23, P297, DOI 10.1002/mds.21837; Zhao J, 2012, METAB BRAIN DIS, V27, P17, DOI 10.1007/s11011-011-9275-5; Zimmermann P, 2012, TESTBATTERIE AUFMERK	54	102	110	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e106700	10.1371/journal.pone.0106700	http://dx.doi.org/10.1371/journal.pone.0106700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347578	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900002
J	De Vuyst, H; Mugo, NR; Franceschi, S; McKenzie, K; Tenet, V; Njoroge, J; Rana, FS; Sakr, SR; Snijders, PJF; Chung, MH				De Vuyst, Hugo; Mugo, Nelly R.; Franceschi, Silvia; McKenzie, Kevin; Tenet, Vanessa; Njoroge, Julia; Rana, Farzana S.; Sakr, Samah R.; Snijders, Peter J. F.; Chung, Michael H.			Residual Disease and HPV Persistence after Cryotherapy for Cervical Intraepithelial Neoplasia Grade 2/3 in HIV-Positive Women in Kenya	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS; HIGH-RISK; INFECTED WOMEN; FOLLOW-UP; RESIDUAL/RECURRENT DISEASE; ANTIRETROVIRAL THERAPY; RECURRENCE; CYTOLOGY; DYSPLASIA	Objective: To assess residual cervical intraepithelial neoplasia (CIN) 2/3 disease and clearance of high-risk (hr) human papillomavirus (HPV) infections at 6 months after cryotherapy among HIV-positive women. Design: Follow-up study. Methods: 79 HIV-positive women received cryotherapy for CIN2/3 in Nairobi, Kenya, and underwent conventional cytology 6 months later. Biopsies were performed on high grade cytological lesions and hrHPV was assessed before (cervical cells and biopsy) and after cryotherapy (cells). Results: At 6 months after cryotherapy CIN2/3 had been eliminated in 61 women (77.2%; 95% Confidence Interval, (CI): 66.4-85.9). 18 women (22.8%) had residual CIN2/3, and all these women had hrHPV at baseline. CD4 count and duration of combination antiretroviral therapy (cART) were not associated with residual CIN2/3. CIN3 instead of CIN2 was the only significant risk factor for residual disease (odds ratio, OR vs CIN2 = 4.3; 95% CI: 1.2-15.0) among hrHPV-positive women after adjustment for age and HPV16 infection. Persistence of hrHPV types previously detected in biopsies was found in 77.5% of women and was associated with residual CIN2/3 (OR = 8.1, 95% CI: 0.9-70). The sensitivity, specificity, and negative predictive value of hrHPV test in detecting residual CIN2/3 were 0.94, 0.36, and 0.96 respectively. Conclusions: Nearly one quarter of HIV-positive women had residual CIN2/3 disease at 6 months after cryotherapy, and the majority had persistent hrHPV. CD4 count and cART use were not associated with residual disease or hrHPV persistence. The value of hrHPV testing in the detection of residual CIN2/3 was hampered by a low specificity.	[De Vuyst, Hugo; Franceschi, Silvia; Tenet, Vanessa] Int Agcy Res Canc, F-69372 Lyon, France; [Mugo, Nelly R.] Kenyatta Natl Hosp, Dept Obstet & Gynecol, Nairobi, Kenya; [McKenzie, Kevin; Njoroge, Julia; Chung, Michael H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Rana, Farzana S.] Aga Khan Univ Hosp, Nairobi, Kenya; [Sakr, Samah R.] Coptic Hosp, Coptic Hope Ctr, Nairobi, Kenya; [Snijders, Peter J. F.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Chung, Michael H.] Univ Washington, Dept Med, Seattle, WA USA; [Chung, Michael H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	World Health Organization; International Agency for Research on Cancer (IARC); Kenyatta National Hospital; University of Washington; University of Washington Seattle; Vrije Universiteit Amsterdam; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	De Vuyst, H (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	devuysth@iarc.fr	franceschi, silvia/M-2452-2014	franceschi, silvia/0000-0003-4181-8071	Washington Global Health Alliance; National Institutes of Health [5K23AI065222-04]; Fondation de France [00016673]; Bill & Melinda Gates Foundation [35537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065222] Funding Source: NIH RePORTER	Washington Global Health Alliance; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation de France(Fondation de France); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Washington Global Health Alliance, the National Institutes of Health (grant number 5K23AI065222-04), the Fondation de France (grant number 00016673), and the Bill & Melinda Gates Foundation (grant number 35537). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso I, 2006, GYNECOL ONCOL, V103, P631, DOI 10.1016/j.ygyno.2006.04.016; Bais AG, 2009, INT J CANCER, V124, P889, DOI 10.1002/ijc.23824; Cejtin HE, 2011, J LOW GENIT TRACT DI, V15, P37, DOI 10.1097/LGT.0b013e3181eb3115; Chirenje Z M, 2003, J Low Genit Tract Dis, V7, P16, DOI 10.1097/00128360-200301000-00005; Chung MH, 2013, AIDS, V27, P2909, DOI 10.1097/01.aids.0000432472.92120.1b; Chung MH, 2011, AIDS, V25, P1915, DOI 10.1097/QAD.0b013e32834a3654; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; De Vuyst H, 2013, INT J CANCER, V133, P1441, DOI 10.1002/ijc.28131; Elfgren K, 2002, OBSTET GYNECOL, V100, P965, DOI 10.1016/S0029-7844(02)02280-9; Foulot H, 2008, EUR J OBSTET GYN R B, V141, P153, DOI 10.1016/j.ejogrb.2008.07.015; Fruchter RG, 1996, OBSTET GYNECOL, V87, P338, DOI 10.1016/0029-7844(95)00408-4; Gilles C, 2005, GYNECOL ONCOL, V96, P112, DOI 10.1016/j.ygyno.2004.10.003; Gingelmaier A, 2007, ANTICANCER RES, V27, P1795; Heard I, 2005, JAIDS-J ACQ IMM DEF, V39, P412, DOI 10.1097/01.qai.0000167157.83098.60; Holcomb K, 1999, GYNECOL ONCOL, V74, P428, DOI 10.1006/gyno.1999.5479; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Jones J, 2011, J CLIN VIROL, V52, P88, DOI 10.1016/j.jcv.2011.06.021; Kitchener HC, 2008, BJOG-INT J OBSTET GY, V115, P1001, DOI 10.1111/j.1471-0528.2008.01748.x; Kocken M, 2012, BRIT J CANCER, V106, P817, DOI 10.1038/bjc.2012.5; Kocken M, 2012, GYNECOL ONCOL, V125, P500, DOI 10.1016/j.ygyno.2012.01.015; Kocken M, 2011, LANCET ONCOL, V12, P441, DOI 10.1016/S1470-2045(11)70078-X; Kreimer AR, 2006, CANCER EPIDEM BIOMAR, V15, P908, DOI 10.1158/1055-9965.EPI-05-0845; Lehtovirta P, 2008, INT J STD AIDS, V19, P37, DOI 10.1258/ijsa.2007.005672; LUFF RD, 1992, AM J CLIN PATHOL, V98, P152, DOI 10.1093/ajcp/98.2.152; Martin-Hirsch PPL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001421.pub3; Massad L Stewart, 2007, J Low Genit Tract Dis, V11, P90, DOI 10.1097/01.lgt.0000245038.06977.a7; Nene BM, 2008, INT J GYNECOL OBSTET, V103, P232, DOI 10.1016/j.ijgo.2008.07.016; Nobbenhuis MAE, 2001, BRIT J CANCER, V84, P796, DOI 10.1054/bjoc.2000.1689; Ojoo S, 2007, KENYA NATL CLIN MANU; Quint W, 2012, J PATHOL, V227, P62, DOI 10.1002/path.3970; Reimers LL, 2010, GYNECOL ONCOL, V119, P92, DOI 10.1016/j.ygyno.2010.06.012; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Sankaranarayanan R, 2007, BRIT J CANCER, V96, P738, DOI 10.1038/sj.bjc.6603633; Santesso N, 2012, INT J GYNECOL OBSTET, V118, P97, DOI 10.1016/j.ijgo.2012.01.029; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Sellors J. W., 2003, COLPOSCOPY TREATMENT; Strander B, 2007, EUR J CANCER, V43, P1849, DOI 10.1016/j.ejca.2007.05.016; Tate DR, 2002, AM J OBSTET GYNECOL, V186, P880, DOI 10.1067/mob.2002.123607; Tebeu PM, 2006, INT J STD AIDS, V17, P507, DOI 10.1258/095646206778145703; Valasoulis G, 2011, GYNECOL ONCOL, V121, P43, DOI 10.1016/j.ygyno.2010.12.003; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; van der Marel J, 2012, INT J CANCER, V131, pE946, DOI 10.1002/ijc.27532; Zielinski GD, 2003, GYNECOL ONCOL, V91, P67, DOI 10.1016/S0090-8258(03)00415-3	45	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111037	10.1371/journal.pone.0111037	http://dx.doi.org/10.1371/journal.pone.0111037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343563	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500078
J	Izawa, K; Okada, M; Sumitomo, K; Nakagawa, N; Aizawa, Y; Kawabe, J; Kikuchi, K; Hasebe, N				Izawa, Kazuma; Okada, Motoi; Sumitomo, Kazuhiro; Nakagawa, Naoki; Aizawa, Yoshiaki; Kawabe, Junichi; Kikuchi, Kenjiro; Hasebe, Naoyuki			Impaired Glutathione Redox System Paradoxically Suppresses Angiotensin II-Induced Vascular Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-C; E-DEFICIENT MICE; OXIDATIVE STRESS; NITRIC-OXIDE; ENDOTHELIAL-CELLS; APOPTOSIS; ATHEROSCLEROSIS; RAT; PROLIFERATION	Background: Angiotensin II (AII) plays a central role in vascular remodeling via oxidative stress. However, the interaction between AII and reduced glutathione (GSH) redox status in cardiovascular remodeling remains unknown. Methods: In vivo: The cuff-induced vascular injury model was applied to Sprague Dawley rats. Then we administered saline or a GSH inhibitor, buthionine sulfoximine (BSO, 30 mmol/L in drinking water) for a week, subsequently administered 4 more weeks by osmotic pump with saline or AII (200 ng/kg/minute) to the rats. In vitro: Incorporation of bromodeoxyuridine (BrdU) was measured to determine DNA synthesis in cultured rat vascular smooth muscle cells (VSMCs). Results: BSO reduced whole blood GSH levels. Systolic blood pressure was increased up to 215 +/- 4 mmHg by AII at 4 weeks (p<0.01), which was not affected by BSO. Superoxide production in vascular wall was increased by AII and BSO alone, and was markedly enhanced by AII+BSO. The left ventricular weight to body weight ratio was significantly increased in AII and AII+BSO as compared to controls (2.52 +/- 0.08, 2.50 +/- 0.09 and 2.10 +/- 0.07 mg/g respectively, p<0.05). Surprisingly, the co-treatment of BSO totally abolished these morphological changes. Although the vascular circumferential wall stress was well compensated in AII, significantly increased in AII+BSO. The anti-single-stranded DNA staining revealed increasing apoptotic cells in the neointima of injured arteries in BSO groups. BrdU incorporation in cultured VSMCs with AII was increased dose-dependently. Furthermore it was totally abolished by BSO and was reversed by GSH monoethyl ester. Conclusions: We demonstrated that a vast oxidative stress in impaired GSH redox system totally abolished AII-induced vascular, not cardiac remodeling via enhancement of apoptosis in the neointima and suppression of cell growth in the media. The drastic suppression of remodeling may result in fragile vasculature intolerable to mechanical stress by AII.	[Izawa, Kazuma; Okada, Motoi; Sumitomo, Kazuhiro; Nakagawa, Naoki; Aizawa, Yoshiaki; Kawabe, Junichi; Kikuchi, Kenjiro; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan	Asahikawa Medical College	Hasebe, N (corresponding author), Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan.	haselove@asahikawa-med.ac.jp	Okada, Motoi/CAF-5178-2022	Okada, Motoi/0000-0003-3779-6703	Kaken [16590655]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS)	Kaken(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from Kaken (Grant-in-Aid for Scientific Research C 16590655). KAKEN is the database which is established and provided by the National Institute of Informatics (NII) with support of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2001, CIRCULATION, V104, P455, DOI 10.1161/hc3001.092040; Akishita M, 1997, ATHEROSCLEROSIS, V130, P1, DOI 10.1016/S0021-9150(96)06023-6; Bhunia AK, 1997, J BIOL CHEM, V272, P15642, DOI 10.1074/jbc.272.25.15642; Bishop SP, 1996, J MOL CELL CARDIOL, V28, P141, DOI 10.1006/jmcc.1996.0014; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Chen ZP, 2001, ARTERIOSCL THROM VAS, V21, P759, DOI 10.1161/01.ATV.21.5.759; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; Domenicotti C, 2000, FREE RADICAL BIO MED, V29, P1280, DOI 10.1016/S0891-5849(00)00429-9; Ejiri J, 2003, CARDIOVASC RES, V59, P988, DOI 10.1016/S0008-6363(03)00523-6; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 1998, J LAB CLIN MED, V132, P9, DOI 10.1016/S0022-2143(98)90019-1; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Halliwell B, 1989, FREE RADICAL BIO MED, P87; Hermann C, 1997, ARTERIOSCL THROM VAS, V17, P3588, DOI 10.1161/01.ATV.17.12.3588; Hiraku Y, 2002, BBA-GEN SUBJECTS, V1570, P47, DOI 10.1016/S0304-4165(02)00152-6; HIROSUMI J, 1987, ATHEROSCLEROSIS, V64, P243, DOI 10.1016/0021-9150(87)90252-8; Huth F, 1975, Curr Top Pathol, V60, P1; KAWABE J, 1992, BIOCHIM BIOPHYS ACTA, V1175, P81, DOI 10.1016/0167-4889(92)90012-Z; Kawarada Y, 1998, J BIOCHEM-TOKYO, V123, P492; Liao SX, 2001, J VASC SURG, V33, P1057, DOI 10.1067/mva.2001.112810; MADAMANCHI NR, 2005, ARTERIOSCLER THROMB, V25, P1; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Nishimoto M, 2002, LIFE SCI, V71, P2195, DOI 10.1016/S0024-3205(02)01998-7; Ogihara T, 2004, DIABETOLOGIA, V47, P794, DOI 10.1007/s00125-004-1391-x; Okada M, 2004, CIRCULATION, V109, P1763, DOI 10.1161/01.CIR.0000124226.88860.55; Ono Y, 1999, HYPERTENSION, V34, P609, DOI 10.1161/01.HYP.34.4.609; Pollman MJ, 1996, CIRC RES, V79, P748, DOI 10.1161/01.RES.79.4.748; PORRECA E, 1993, ATHEROSCLEROSIS, V100, P141, DOI 10.1016/0021-9150(93)90200-E; PURI PL, 1995, J BIOL CHEM, V270, P22129, DOI 10.1074/jbc.270.38.22129; Rosenblat M, 2002, ATHEROSCLEROSIS, V163, P17, DOI 10.1016/S0021-9150(01)00744-4; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Schmidt-Ott KM, 2000, REGUL PEPTIDES, V93, P65, DOI 10.1016/S0167-0115(00)00178-6; Sharpe PC, 1998, DIABETOLOGIA, V41, P1210, DOI 10.1007/s001250051054; Sugiyama S, 2004, ARTERIOSCL THROM VAS, V24, P1309, DOI 10.1161/01.ATV.0000131784.50633.4f; Suzuki J, 2002, CIRCULATION, V106, P847, DOI 10.1161/01.CIR.0000024103.04821.86; SZEJDA P, 1984, J IMMUNOL, V133, P3303; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Touyz RM, 1999, J HYPERTENS, V17, P907, DOI 10.1097/00004872-199917070-00006; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142; Yamakawa T, 2000, HYPERTENSION, V35, P313, DOI 10.1161/01.HYP.35.1.313; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e108115	10.1371/journal.pone.0108115	http://dx.doi.org/10.1371/journal.pone.0108115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343455	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500004
J	Pak, Y; Pastan, I; Kreitman, RJ; Lee, B				Pak, Youngshang; Pastan, Ira; Kreitman, Robert J.; Lee, Byungkook			Effect of Antigen Shedding on Targeted Delivery of Immunotoxins in Solid Tumors from a Mathematical Model	PLOS ONE			English	Article							RECOMBINANT IMMUNOTOXIN; ANTITUMOR-ACTIVITY; ANIMAL TOXICITY; CANCER; CELL; MESOTHELIN; THERAPY; PENETRATION; BINDING; IMMUNOTHERAPY	Most cancer-specific antigens used as targets of antibody-drug conjugates and immunotoxins are shed from the cell surface (Zhang & Pastan (2008) Clin. Cancer Res. 14: 7981-7986), although at widely varying rates and by different mechanisms (Dello Sbarba & Rovida (2002) Biol. Chem. 383: 69-83). Why many cancer-specific antigens are shed and how the shedding affects delivery efficiency of antibody-based protein drugs are poorly understood questions at present. Before a detailed numerical study, it was assumed that antigen shedding would reduce the efficacy of antibody-drug conjugates and immunotoxins. However, our previous study using a comprehensive mathematical model showed that antigen shedding can significantly improve the efficacy of the mesothelin-binding immunotoxin, SS1P (anti-mesothelin-Fv-PE38), and suggested that receptor shedding can be a general mechanism for enhancing the effect of inter-cellular signaling molecules. Here, we improved this model and applied it to both SS1P and another recombinant immunotoxin, LMB-2, which targets CD25. We show that the effect of antigen shedding is influenced by a number of factors including the number of antigen molecules on the cell surface and the endocytosis rate. The high shedding rate of mesothelin is beneficial for SS1P, for which the antigen is large in number and endocytosed rapidly. On the other hand, the slow shedding of CD25 is beneficial for LMB-2, for which the antigen is small in number and endocytosed slowly.	[Pak, Youngshang] Pusan Natl Univ, Dept Chem, Pusan, South Korea; [Pak, Youngshang] Pusan Natl Univ, Inst Funct Mat, Pusan, South Korea; [Pak, Youngshang; Pastan, Ira; Kreitman, Robert J.; Lee, Byungkook] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Pusan National University; Pusan National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pak, Y (corresponding author), Pusan Natl Univ, Dept Chem, Pusan, South Korea.	ypak@pusan.ac.kr; bk@nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270	NCI; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011233] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an appointment to the ORISE Research Participation Program at NCI. This program is administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US department of Energy and the National Cancer Institute. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen KC, 2008, ANN BIOMED ENG, V36, P486, DOI 10.1007/s10439-007-9425-4; Dello Sbarba P, 2002, BIOL CHEM, V383, P69; Dosio F, 2014, RECENT PAT ANTI-CANC, V9, P35; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; FUJIMORI K, 1990, J NUCL MED, V31, P1191; GREENE WC, 1986, ANN INTERN MED, V105, P560, DOI 10.7326/0003-4819-105-4-560; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; HONDA M, 1990, J IMMUNOL, V145, P4131; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; Junghans RP, 1996, J EXP MED, V183, P1587, DOI 10.1084/jem.183.4.1587; Kobayashi H, 2000, J NUCL MED, V41, P755; Kreitman RJ, 1998, CANCER RES, V58, P968; KREITMAN RJ, 1994, BLOOD, V83, P426; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; LAUK S, 1989, CANCER RES, V49, P4557; Michaelis L, 1913, BIOCHEM Z, V49, P333; Onda M, 2001, CANCER RES, V61, P5070; Pak Y, 2012, CANCER RES, V72, P3143, DOI 10.1158/0008-5472.CAN-11-3925; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Reiter Y, 1996, NAT BIOTECHNOL, V14, P1239, DOI 10.1038/nbt1096-1239; Rippe B, 1985, Microvasc Res, V30, P246, DOI 10.1016/0026-2862(85)90055-X; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Singh R, 2012, CLIN CANCER RES, V18, P152, DOI 10.1158/1078-0432.CCR-11-1839; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Tsutsumi Y, 2000, P NATL ACAD SCI USA, V97, P8548, DOI 10.1073/pnas.140210597; Zhang YJ, 2008, CLIN CANCER RES, V14, P7981, DOI 10.1158/1078-0432.CCR-08-0324; Zhang YJ, 2007, P NATL ACAD SCI USA, V104, P17099, DOI 10.1073/pnas.0708101104; Zhang YJ, 2011, CANCER RES, V71, P5915, DOI 10.1158/0008-5472.CAN-11-0466; Zhang YJ, 2010, CANCER RES, V70, P1082, DOI 10.1158/0008-5472.CAN-09-2405	35	9	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110716	10.1371/journal.pone.0110716	http://dx.doi.org/10.1371/journal.pone.0110716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343405	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943500051
J	West, JA; Olsen, SL; Mitchell, JM; Priddle, RE; Luke, JM; Akefeldt, SO; Henter, JI; Turville, C; Kannourakis, G				West, Jennifer A.; Olsen, Sharon L.; Mitchell, Jenee M.; Priddle, Ross E.; Luke, Jennifer M.; Akefeldt, Selma Olsson; Henter, Jan-Inge; Turville, Christopher; Kannourakis, George			Polyclonal T-Cells Express CD1a in Langerhans Cell Histiocytosis (LCH) Lesions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENE-EXPRESSION; DENDRITIC CELLS; DIFFERENTIATION; CYTOKINES; PROTEIN; INTERLEUKIN-3; LYMPHOCYTES; THYMOCYTES; MATURATION	Langerhans cell histiocytosis (LCH) is a complex and poorly understood disorder that has characteristics of both inflammatory and neoplastic disease. By using eight-colour flow cytometry, we have identified a previously unreported population of CD1a(+)/CD3(+) T-cells in LCH lesions. The expression of CD1a is regarded as a hallmark of this disease; however, it has always been presumed that it was only expressed by pathogenic Langerhans cells (LCs). We have now detected CD1a expression by a range of T-cell subsets within all of the LCH lesions that were examined, establishing that CD1a expression in these lesions is no longer restricted to pathogenic LCs. The presence of CD1a(+) T-cells in all of the LCH lesions that we have studied to date warrants further investigation into their biological function to determine whether these cells are important in the pathogenesis of LCH.	[West, Jennifer A.; Olsen, Sharon L.; Mitchell, Jenee M.; Priddle, Ross E.; Luke, Jennifer M.; Kannourakis, George] Fiona Elsey Canc Res Inst, Ballarat, Vic, Australia; [West, Jennifer A.; Olsen, Sharon L.; Mitchell, Jenee M.; Priddle, Ross E.; Kannourakis, George] Federat Univ, Sch Hlth Sci, Mt Helen, Vic, Australia; [Akefeldt, Selma Olsson; Henter, Jan-Inge] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Turville, Christopher] Federat Univ, Sch Sci Informat Technol & Engn, Mt Helen, Vic, Australia	Federation University Australia; Karolinska Institutet; Karolinska University Hospital; Federation University Australia	Kannourakis, G (corresponding author), Fiona Elsey Canc Res Inst, Ballarat, Vic, Australia.	George@fecri.org.au		, Jenee/0000-0002-1834-3699; Turville, Chris/0000-0001-9855-9838; Henter, Jan-Inge/0000-0002-0629-2126	Board of the Fiona Elsey Cancer Research Institute; Histiocytosis Association of America (HAA); Swedish Children's Cancer Foundation; Swedish Research Council; Stockholm County Council (ALF project)	Board of the Fiona Elsey Cancer Research Institute; Histiocytosis Association of America (HAA); Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF project)(Stockholm County Council)	This work was supported by the Board of the Fiona Elsey Cancer Research Institute, the Histiocytosis Association of America (HAA), the Swedish Children's Cancer Foundation, the Swedish Research Council and the Stockholm County Council (ALF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen HN, 2003, J MOL DIAGN, V5, P34, DOI 10.1016/S1525-1578(10)60449-7; Allen CE, 2007, DRUG TODAY, V43, P627, DOI 10.1358/dot.2007.43.9.1088823; Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Allen CE, 2009, NAT MED, V15, P483, DOI 10.1038/nm0509-483; [Anonymous], 1987, Lancet, V1, P208; Arico M, 1998, HEMATOL ONCOL CLIN N, V12, P247, DOI 10.1016/S0889-8588(05)70508-6; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Bechan GI, 2006, INT REV CYTOL, V254, P1, DOI 10.1016/S0074-7696(06)54001-X; Caux C, 1996, BLOOD, V87, P2376, DOI 10.1182/blood.V87.6.2376.bloodjournal8762376; Christie LJ, 2006, HUM PATHOL, V37, P32, DOI 10.1016/j.humpath.2005.08.024; CHU T, 1994, BRIT J CANCER, V70, pS4; Cortelazzo S, 2011, CRIT REV ONCOL HEMAT, V79, P330, DOI 10.1016/j.critrevonc.2010.12.003; Coury F, 2008, NAT MED, V14, P81, DOI 10.1038/nm1694; Coventry B, 2004, TRENDS IMMUNOL, V25, P242, DOI 10.1016/j.it.2004.03.002; Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; Crawford J M, 1989, Reg Immunol, V2, P91; da Costa CET, 2009, GENE CHROMOSOME CANC, V48, P239, DOI 10.1002/gcc.20634; De Filippi P, 2006, BRIT J HAEMATOL, V132, P784, DOI 10.1111/j.1365-2141.2005.05922.x; de Graaf JH, 1995, HISTIOCYTOSES CHILDH; Degar BA, 2009, DIS MODEL MECH, V2, P436, DOI 10.1242/dmm.004010; deGraaf JH, 1996, J PATHOL, V180, P400, DOI 10.1002/(SICI)1096-9896(199612)180:4<400::AID-PATH701>3.0.CO;2-W; Egeler RM, 2010, IMMUNOL REV, V234, P213, DOI 10.1111/j.0105-2896.2009.00883.x; Egeler RM, 1999, BLOOD, V94, P4195; FITHIAN E, 1981, P NATL ACAD SCI-BIOL, V78, P2541, DOI 10.1073/pnas.78.4.2541; Geissmann F, 2001, BLOOD, V97, P1241, DOI 10.1182/blood.V97.5.1241; Gogolak P, 2007, BLOOD, V109, P643, DOI 10.1182/blood-2006-04-016840; Gong L, 2010, J INT MED RES, V38, P1099, DOI 10.1177/147323001003800338; Han X, 2007, AM J CLIN PATHOL, V127, P528, DOI 10.1309/2QE3A6EKQ8UUDYRC; KANNOURAKIS G, 1994, BRIT J CANCER, V70, pS37; Kim WY, 2010, HUM PATHOL, V41, P129, DOI 10.1016/j.humpath.2009.05.014; Kohler T, 2000, STEM CELLS, V18, P139, DOI 10.1634/stemcells.18-2-139; Malpas JS, 1998, HEMATOL ONCOL CLIN N, V12, P259, DOI 10.1016/S0889-8588(05)70509-8; McClain Kenneth L, 2004, Hematology Am Soc Hematol Educ Program, P283; McClory S, 2012, J CLIN INVEST, V122, P1403, DOI 10.1172/JCI46125; Minkov M, 2007, PEDIATR BLOOD CANCER, V49, P694, DOI 10.1002/pbc.21227; Mittal A, 2003, PHOTOCHEM PHOTOBIOL, V77, P259, DOI 10.1562/0031-8655(2003)077<0259:CCATMS>2.0.CO;2; Mollah ZUA, 2003, J INVEST DERMATOL, V121, P1397, DOI 10.1111/j.1523-1747.2003.12641.x; NEZELOF C, 1973, BIOMEDICINE, V18, P365; Nezelof C, 2004, PEDIATR BLOOD CANCER, V42, P398, DOI 10.1002/pbc.10463; Peters TL, 2011, MOL THER, V19, P1433, DOI 10.1038/mt.2011.106; Pigozzi B, 2006, ONCOL REP, V15, P347; Res P, 1997, J EXP MED, V185, P141, DOI 10.1084/jem.185.1.141; Sahm F, 2012, BLOOD, V120, pE28, DOI 10.1182/blood-2012-06-429597; SALAMONE MD, 1992, IMMUNOL LETT, V33, P61, DOI 10.1016/0165-2478(92)90094-5; Satter EK, 2008, PEDIATR DERMATOL, V25, P291, DOI 10.1111/j.1525-1470.2008.00669.x; Schmitz L, 1998, HEMATOL ONCOL CLIN N, V12, P221, DOI 10.1016/S0889-8588(05)70507-4; Senechal B, 2007, PLOS MED, V4, P1374, DOI 10.1371/journal.pmed.0040253; SOTZIK F, 1993, IMMUNOL LETT, V36, P101, DOI 10.1016/0165-2478(93)90073-B; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; SUMMERS KL, 1994, CLIN EXP IMMUNOL, V97, P39; Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.0.CO;2-Q; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WILLMAN CL, 1994, NEW ENGL J MED, V331, P154, DOI 10.1056/NEJM199407213310303; YU RC, 1994, LANCET, V343, P767, DOI 10.1016/S0140-6736(94)91842-2	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109586	10.1371/journal.pone.0109586	http://dx.doi.org/10.1371/journal.pone.0109586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343480	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500017
J	Holzinger, A; Kaplan, F; Blaas, K; Zechmann, B; Komsic-Buchmann, K; Becker, B				Holzinger, Andreas; Kaplan, Franziska; Blaas, Kathrin; Zechmann, Bernd; Komsic-Buchmann, Karin; Becker, Burkhard			Transcriptomics of Desiccation Tolerance in the Streptophyte Green Alga Klebsormidium Reveal a Land Plant-Like Defense Reaction	PLOS ONE			English	Article							ANTIOXIDANTS; DEHYDRATION; TEMPERATURE; CULTURE; LICHEN; STRESS; ORIGIN; RNA; ULTRASTRUCTURE; CHAROPHYCEAE	Water loss has significant effects on physiological performance and survival rates of algae. However, despite the prominent presence of aeroterrestrial algae in terrestrial habitats, hardly anything is known about the molecular events that allow aeroterrestrial algae to survive harsh environmental conditions. We analyzed the transcriptome and physiology of a strain of the alpine aeroterrestrial alga Klebsormidium crenulatum under control and strong desiccation-stress conditions. Principal Findings: For comparison we first established a reference transcriptome. The high-coverage reference transcriptome includes about 24,183 sequences (1.5 million reads, 636 million bases). The reference transcriptome encodes for all major pathways (energy, carbohydrates, lipids, amino acids, sugars), nearly all deduced pathways are complete or missing only a few transcripts. Upon strong desiccation, more than 7000 transcripts showed changes in their expression levels. Most of the highest up-regulated transcripts do not show similarity to known viridiplant proteins, suggesting the existence of some genus-or species-specific responses to desiccation. In addition, we observed the up-regulation of many transcripts involved in desiccation tolerance in plants (e.g. proteins similar to those that are abundant in late embryogenesis (LEA), or proteins involved in early response to desiccation ERD), and enzymes involved in the biosynthesis of the raffinose family of oligosaccharides (RFO) known to act as osmolytes). Major physiological shifts are the up-regulation of transcripts for photosynthesis, energy production, and reactive oxygen species (ROS) metabolism, which is supported by elevated cellular glutathione content as revealed by immunoelectron microscopy as well as an increase in total antiradical power. However, the effective quantum yield of Photosystem II and CO2 fixation decreased sharply under the applied desiccation stress. In contrast, transcripts for cell integrative functions such as cell division, DNA replication, cofactor biosynthesis, and amino acid biosynthesis were down-regulated. Significance: This is the first study investigating the desiccation transcriptome of a streptophyte green alga. Our results indicate that the cellular response is similar to embryophytes, suggesting that embryophytes inherited a basic cellular desiccation tolerance from their streptophyte predecessors.	[Holzinger, Andreas; Kaplan, Franziska; Blaas, Kathrin] Univ Innsbruck, A-6020 Innsbruck, Austria; [Zechmann, Bernd] Baylor Univ, Ctr Microscopy & Imaging, Waco, TX 76798 USA; [Komsic-Buchmann, Karin; Becker, Burkhard] Univ Cologne, Bioctr, Inst Bot, D-50931 Cologne, Germany	University of Innsbruck; Baylor University; University of Cologne	Holzinger, A (corresponding author), Univ Innsbruck, A-6020 Innsbruck, Austria.	Andreas.Holzinger@uibk.ac.at	Holzinger, Andreas/A-6396-2008; Holzinger, Andreas/E-9530-2010; Holzinger, Andreas/Z-2659-2019; Becker, Burkhard/I-4022-2012	Holzinger, Andreas/0000-0002-7745-3978; Holzinger, Andreas/0000-0002-6786-5194; Holzinger, Andreas/0000-0002-7745-3978; Zechmann, Bernd/0000-0002-7702-2588; Becker, Burkhard/0000-0002-7965-1396	FWF [P24242-B16]; Austrian Science Fund (FWF) [P 22988, P 24242] Funding Source: researchfish	FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by FWF grant P24242-B16 (http://www.fwf.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-109; Agrawal SC, 2012, FOLIA MICROBIOL, V57, P387, DOI 10.1007/s12223-012-0147-0; AGRAWAL SB, 1992, ENVIRON EXP BOT, V32, P137, DOI 10.1016/0098-8472(92)90038-4; Ahmad P., 2012, ENV ADAPTATIONS STRE, P297, DOI DOI 10.1007/978-1-4614-0815-4_14; Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; Becker B, 2013, TRENDS PLANT SCI, V18, P180, DOI 10.1016/j.tplants.2012.09.010; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; BERTSCH A, 1966, PLANTA, V70, P46, DOI 10.1007/BF00539910; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; BOROWITZKA MA, 1991, J APPL PHYCOL, V3, P295, DOI 10.1007/BF02392882; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078471; Cruces E, 2012, PHOTOCHEM PHOTOBIOL, V88, P58, DOI 10.1111/j.1751-1097.2011.01013.x; Deng YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039704; Dinakar C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00482; Dinakar C, 2012, PLANT SCI, V182, P29, DOI 10.1016/j.plantsci.2011.01.018; Djilianov DL, 2013, J PLANT GROWTH REGUL, V32, P564, DOI 10.1007/s00344-013-9323-y; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ElSayed AI, 2014, PLANT BIOLOGY, V16, P1, DOI 10.1111/plb.12053; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Gasulla F, 2009, PLANTA, V231, P195, DOI 10.1007/s00425-009-1019-y; Gasulla F, 2013, PLANT CELL ENVIRON, V36, P1363, DOI 10.1111/pce.12065; Gray DW, 2007, PLANT CELL ENVIRON, V30, P1240, DOI 10.1111/j.1365-3040.2007.01704.x; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Haubner N, 2006, MICROB ECOL, V51, P285, DOI 10.1007/s00248-006-9016-1; Heinrich S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044342; Holzinger A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00327; Holzinger A, 2011, J PHYCOL, V47, P591, DOI 10.1111/j.1529-8817.2011.00980.x; Holzinger A, 2011, PHYCOL RES, V59, P221, DOI 10.1111/j.1440-1835.2011.00620.x; Kaplan F, 2012, PROTOPLASMA, V249, P789, DOI 10.1007/s00709-011-0324-z; Karsten U, 2014, J PHYCOL, V50, P804, DOI 10.1111/jpy.12210; Karsten Ulf, 2013, Algological Studies, V142, P45, DOI 10.1127/1864-1318/2013/0102; Karsten U, 2012, MICROB ECOL, V63, P51, DOI 10.1007/s00248-011-9924-6; Karsten U, 2010, J PHYCOL, V46, P1187, DOI 10.1111/j.1529-8817.2010.00921.x; Kranner I, 2005, INTEGR COMP BIOL, V45, P734, DOI 10.1093/icb/45.5.734; Kranner I, 2005, P NATL ACAD SCI USA, V102, P3141, DOI 10.1073/pnas.0407716102; LOKHORST GM, 1985, J PHYCOL, V21, P466; Luttge U, 2010, PLANT BIOLOGY, V12, P437, DOI 10.1111/j.1438-8677.2009.00249.x; Lunch CK, 2013, PHOTOSYNTH RES, V115, P139, DOI 10.1007/s11120-013-9846-x; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; MCFADDEN GI, 1986, PHYCOLOGIA, V25, P551, DOI 10.2216/i0031-8884-25-4-551.1; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Nagao M, 2008, PLANT CELL ENVIRON, V31, P872, DOI 10.1111/j.1365-3040.2008.01804.x; Nagao M, 2012, PLANTA, V235, P851, DOI 10.1007/s00425-011-1550-5; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Oliver MJ, 2010, METHODS MOL BIOL, V639, P3, DOI 10.1007/978-1-60761-702-0_1; OLIVER MJ, 1984, PLANT PHYSIOL, V74, P917, DOI 10.1104/pp.74.4.917; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Plank DW, 2012, J AOAC INT, V95, P1562, DOI 10.5740/jaoacint.CS2012_04; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RAPOPORT AI, 1986, MICROBIOLOGY+, V55, P689; Rindi F, 2011, MOL PHYLOGENET EVOL, V58, P218, DOI 10.1016/j.ympev.2010.11.030; Rindi F, 2008, J PHYCOL, V44, P1529, DOI 10.1111/j.1529-8817.2008.00593.x; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Rysanek D, 2015, ENVIRON MICROBIOL, V17, P689, DOI 10.1111/1462-2920.12501; Schreiber U., 1993, Progress in Botany, V54, P151; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shiratake T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079630; Skaloud P, 2013, J EUKARYOT MICROBIOL, V60, P350, DOI 10.1111/jeu.12040; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Timme RE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-96; Turmel M, 2013, GENOME BIOL EVOL, V5, P1817, DOI 10.1093/gbe/evt135; Usadel B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00048; Weissman L, 2005, APPL ENVIRON MICROB, V71, P6508, DOI 10.1128/AEM.71.11.6508-6514.2005; Wieners PC, 2012, PHOTOSYNTH RES, V113, P239, DOI 10.1007/s11120-012-9771-4; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Zechmann B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-54; Zechmann B, 2010, PROTOPLASMA, V246, P15, DOI 10.1007/s00709-010-0111-2; Zhong BJ, 2014, MOL BIOL EVOL, V31, P177, DOI 10.1093/molbev/mst200	73	75	75	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110630	10.1371/journal.pone.0110630	http://dx.doi.org/10.1371/journal.pone.0110630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340847	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800044
J	Shen, SQ; Turro, E; Corbo, JC				Shen, Susan Q.; Turro, Ernest; Corbo, Joseph C.			Hybrid Mice Reveal Parent-of-Origin and Cis- and Trans-Regulatory Effects in the Retina	PLOS ONE			English	Article							GENE-EXPRESSION; HUMAN GENOME; MAMMALIAN RETINA; RNA-SEQ; DIFFERENTIAL EXPRESSION; LABORATORY MOUSE; IMPRINTED GRB10; PHOTORECEPTOR; CRX; MUTATIONS	A fundamental challenge in genomics is to map DNA sequence variants onto changes in gene expression. Gene expression is regulated by cis-regulatory elements (CREs, i. e., enhancers, promoters, and silencers) and the trans factors (e. g., transcription factors) that act upon them. A powerful approach to dissecting cis and trans effects is to compare F1 hybrids with F0 homozygotes. Using this approach and taking advantage of the high frequency of polymorphisms in wild-derived inbred Cast/EiJ mice relative to the reference strain C57BL/6J, we conducted allele-specific mRNA-seq analysis in the adult mouse retina, a disease-relevant neural tissue. We found that cis effects account for the bulk of gene regulatory divergence in the retina. Many CREs contained functional (i. e., activating or silencing) cis-regulatory variants mapping onto altered expression of genes, including genes associated with retinal disease. By comparing our retinal data with previously published liver data, we found that most of the cis effects identified were tissue-specific. Lastly, by comparing reciprocal F1 hybrids, we identified evidence of imprinting in the retina for the first time. Our study provides a framework and resource for mapping cis-regulatory variants onto changes in gene expression, and underscores the importance of studying cis-regulatory variants in the context of retinal disease.	[Shen, Susan Q.; Corbo, Joseph C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Turro, Ernest] Univ Cambridge, Canc Res UK, Cambridge Inst, Cambridge, England; [Turro, Ernest] Univ Cambridge, Natl Hlth Serv Blood & Transplant, Dept Haematol, Cambridge, England	Washington University (WUSTL); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Cambridge	Corbo, JC (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	jcorbo@pathology.wustl.edu		Turro, Ernest/0000-0002-1820-6563; Shen, Susan/0000-0001-5558-294X; Corbo, Joseph/0000-0002-9323-7140	National Institutes of Health [5T32EY013360-14, R01HG006790, R01EY018826]; Cancer Research UK [C14303/ A10825]; Cambridge Biomedical Research Centre; Genome Technology Access Center at Washington University; National Cancer Institute Cancer Center Support Grant [P30 CA91842]; Institute of Clinical and Translational Sciences (ICTS)/Clinical & Translational Science Awards (CTSA) [UL1RR024992]; National Center for Research Resources (NCRR); NATIONAL EYE INSTITUTE [R01EY018826] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006790] Funding Source: NIH RePORTER; Cancer Research UK [19556] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Cambridge Biomedical Research Centre(General Electric); Genome Technology Access Center at Washington University; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute of Clinical and Translational Sciences (ICTS)/Clinical & Translational Science Awards (CTSA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research UK(Cancer Research UK)	This project was supported by the National Institutes of Health (NIH, http://www.nih.gov/) (grant numbers 5T32EY013360-14 to SQS, and R01HG006790 and R01EY018826 to JCC). ET was supported by Cancer Research UK (http://www.cancerresearchuk.org/) grant C14303/ A10825 and the Cambridge Biomedical Research Centre (http://cambridge-brc. org. uk/). The Genome Technology Access Center at Washington University was partially supported by National Cancer Institute (NCI, http://www.cancer.gov/) Cancer Center Support Grant P30 CA91842 to the Siteman Cancer Center and by Institute of Clinical and Translational Sciences (ICTS)/Clinical & Translational Science Awards (CTSA) Grant UL1RR024992 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Chadwick LH, 2006, GENETICS, V173, P2103, DOI 10.1534/genetics.105.054882; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Daiger S. P., 1998, IOVS, V39, pS295; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emerson JJ, 2010, GENOME RES, V20, P826, DOI 10.1101/gr.101576.109; Erceg J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004060; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gaffney DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003501; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Goncalves A, 2012, GENOME RES, V22, P2376, DOI 10.1101/gr.142281.112; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Grubb SC, 2014, NUCLEIC ACIDS RES, V42, pD825, DOI 10.1093/nar/gkt1159; Haider NB, 2008, MAMM GENOME, V19, P145, DOI 10.1007/s00335-008-9092-2; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Jelcick AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021858; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krueger F., TRIM GALORE; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; McManus CJ, 2014, GENOME RES, V24, P422, DOI 10.1101/gr.164996.113; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Mott R, 2014, CELL, V156, P332, DOI 10.1016/j.cell.2013.11.043; Nasonkin IO, 2011, J COMP NEUROL, V519, P1914, DOI 10.1002/cne.22613; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Prickett AR, 2012, MOL GENET GENOMICS, V287, P621, DOI 10.1007/s00438-012-0708-6; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Turro E, 2014, BIOINFORMATICS, V30, P180, DOI 10.1093/bioinformatics/btt624; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Williamson CM BA, 2014, MOUSEBOOK IMPRINTING; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	73	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109382	10.1371/journal.pone.0109382	http://dx.doi.org/10.1371/journal.pone.0109382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340786	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800008
J	Boulton, SJ; Birch-Machin, MA				Boulton, Sarah Jayne; Birch-Machin, Mark A.			Impact of hyperpigmentation on superoxide flux and melanoma cell metabolism at mitochondrial complex II	FASEB JOURNAL			English	Article						bioenergetics; melanin; succinate dehydrogenase; skin; cytoprotection	HEART SUCCINATE-DEHYDROGENASE; OXIDATIVE STRESS; HUMAN SKIN; RESPIRATORY-CHAIN; DNA-DAMAGE; 3-NITROPROPIONIC ACID; FLAVOPROTEIN SUBUNIT; HYDROGEN-PEROXIDE; MELANOSOMAL PH; MELANOGENESIS	Melanogenesis is a highly conserved process of cytophotoprotection from UV radiation present in many species. Although both mitochondrial function and UV radiation insults are well-documented promoters of increased cellular stress, their individual molecular relationships with skin pigmentation have not been clearly resolved. This study provides evidence for a direct relationship between cellular melanin content, superoxide flux, and mitochondrial function at complex II. Direct and significant correlation between increased pigmentation and complex II turnover was observed in genetically different melanoma cell lines of varied basal pigmentation states (P < 0.01). The same trend was also observed when comparing genetically identical cell cultures with increasing levels of induced pigmentation (P < 0.005). The observation of increased steady-state levels of the catalytic complex II succinate dehydrogenase subunit A alongside hyperpigmentation suggested coregulation of activity and pigment production (P < 0.01). The study also presents novel evidence for a relationship between hyperpigmentation and increased superoxide-generating capacity at complex II. By amperometrically monitoring superoxide flux from differently pigmented FM55 melanocytes and their isolated mitochondria, a dynamic and responsive relationship between pigmentation, complex II function, and intracellular superoxide generation was observed (P < 0.005). The data support hyperpigmentation as a protective antioxidant mechanism in response to complex II-mediated reactive oxygen species generation.	[Boulton, Sarah Jayne; Birch-Machin, Mark A.] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Birch-Machin, MA (corresponding author), Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	mark.birch-machin@ncl.ac.uk		Boulton, Sarah Jayne/0000-0002-3867-3644	Department of Health Funding Source: Medline	Department of Health		Ackrell BAC, 2000, FEBS LETT, V466, P1, DOI 10.1016/S0014-5793(99)01749-4; Ancans J, 2000, FEBS LETT, V478, P57, DOI 10.1016/S0014-5793(00)01795-6; Ancans J, 2001, J INVEST DERMATOL, V117, P158, DOI 10.1046/j.0022-202x.2001.01397.x; Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; Anderson AM, 2009, BRIT J DERMATOL, V160, P924; Anderson A, 2014, REDOX BIOL, V2, P1016, DOI 10.1016/j.redox.2014.08.005; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Birch-Machin MA, 2013, BRIT J DERMATOL, V169, P9, DOI 10.1111/bjd.12207; Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x; Birch-Machin MA, 2010, MUTAGENESIS, V25, P101, DOI 10.1093/mutage/gep061; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; BIRCHMACHIN MA, 1992, J BIOL CHEM, V267, P11553; Cashion L., 1991, U.S. patent, Patent No. [US5017478 A, 5017478]; Dayal D, 2009, RADIAT RES, V172, P737, DOI 10.1667/RR1617.1; Denat L, 2014, J INVEST DERMATOL, V134, P1512, DOI 10.1038/jid.2014.65; Dzhandzhugazyan KN, 1998, FEBS LETT, V430, P227, DOI 10.1016/S0014-5793(98)00603-6; Hall A, 2013, ONCOTARGET, V4, P584, DOI 10.18632/oncotarget.965; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Henderson JR, 2009, FREE RADICAL RES, V43, P796, DOI 10.1080/10715760903062895; Hoogduijn MJ, 2004, EXP CELL RES, V294, P60, DOI 10.1016/j.yexcr.2003.11.007; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Jantschitsch C, 2003, PHOTOCH PHOTOBIO SCI, V2, P899, DOI 10.1039/b301253k; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; KIRKIN AF, 1995, CANCER IMMUNOL IMMUN, V41, P71, DOI 10.1007/BF01527402; Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x; Mandavilli BS, 2005, MOL BRAIN RES, V133, P215, DOI 10.1016/j.molbrainres.2004.10.033; Meyskens Frank L. Jr., 2007, V174, P191; Minn Y, 2008, NEUROSCI LETT, V430, P142, DOI 10.1016/j.neulet.2007.10.042; MORRIS AAM, 1994, BBA-BIOENERGETICS, V1185, P125, DOI 10.1016/0005-2728(94)90203-8; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Noonan FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1893; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Swalwell H, 2012, FREE RADICAL BIO MED, V52, P626, DOI 10.1016/j.freeradbiomed.2011.11.019; Tammeveski K, 1998, FREE RADICAL BIO MED, V25, P973, DOI 10.1016/S0891-5849(98)00182-8; Tulah AS, 2013, MITOCHONDRION, V13, P444, DOI 10.1016/j.mito.2012.11.007	36	17	17	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					346	353		10.1096/fj.14-261982	http://dx.doi.org/10.1096/fj.14-261982			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25351989	Green Submitted			2022-12-26	WOS:000347378600032
J	Brett, K; Kordyukova, LV; Serebryakova, MV; Mintaev, RR; Alexeevski, AV; Veit, M				Brett, Katharina; Kordyukova, Larisa V.; Serebryakova, Marina V.; Mintaev, Ramil R.; Alexeevski, Andrei V.; Veit, Michael			Site-specific S-Acylation of Influenza Virus Hemagglutinin THE LOCATION OF THE ACYLATION SITE RELATIVE TO THE MEMBRANE BORDER IS THE DECISIVE FACTOR FOR ATTACHMENT OF STEARATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid; Glycoprotein; Influenza Virus; Mass Spectrometry (MS); Protein Acylation; Protein Palmitoylation; Transmembrane Domain; Hemagglutinin; Palmitate; Stearate	FUSION PORE FORMATION; MULTIPLE SEQUENCE ALIGNMENT; FATTY-ACID SELECTION; CYTOPLASMIC TAIL; MASS-SPECTROMETRY; PROTEIN PALMITOYLATION; LIPID MODIFICATIONS; A HEMAGGLUTININ; INSECT CELLS; RAFTS	Background:S-Acylation of hemagglutinin with stearate and palmitate is essential for influenza virus replication. Results: Mass spectrometry showed that shifting a cysteine from the transmembrane region to a cytoplasmic position eliminates attachment of stearate. Conclusion: The location of the acylation site is the decisive factor for site-specific acylation. Significance: Similar differential acylation might occur in cellular transmembrane proteins. S-Acylation of hemagglutinin (HA), the main glycoprotein of influenza viruses, is an essential modification required for virus replication. Using mass spectrometry, we have previously demonstrated specific attachment of acyl chains to individual acylation sites. Whereas the two cysteines in the cytoplasmic tail of HA contain only palmitate, stearate is exclusively attached to a cysteine positioned at the end of the transmembrane region (TMR). Here we analyzed recombinant viruses containing HA with exchange of conserved amino acids adjacent to acylation sites or with a TMR cysteine shifted to a cytoplasmic location to identify the molecular signal that determines preferential attachment of stearate. We first developed a new protocol for sample preparation that requires less material and might thus also be suitable to analyze cellular proteins. We observed cell type-specific differences in the fatty acid pattern of HA: more stearate was attached if human viruses were grown in mammalian compared with avian cells. No underacylated peptides were detected in the mass spectra, and even mutations that prevented generation of infectious virus particles did not abolish acylation of expressed HA as demonstrated by metabolic labeling experiments with [H-3]palmitate. Exchange of conserved amino acids in the vicinity of an acylation site had a moderate effect on the stearate content. In contrast, shifting the TMR cysteine to a cytoplasmic location virtually eliminated attachment of stearate. Thus, the location of an acylation site relative to the transmembrane span is the main signal for stearate attachment, but the sequence context and the cell type modulate the fatty acid pattern.	[Brett, Katharina; Veit, Michael] Free Univ Berlin, Inst Virol, D-14163 Berlin, Germany; [Kordyukova, Larisa V.; Serebryakova, Marina V.; Mintaev, Ramil R.; Alexeevski, Andrei V.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Serebryakova, Marina V.] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Mintaev, Ramil R.] Russian Acad Med Sci, II Mechnikov Res Inst Vaccines & Sera, Moscow 105064, Russia; [Alexeevski, Andrei V.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow 119234, Russia	Free University of Berlin; Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Medical Sciences; Research Institute of Vaccines and Sera Mechnikov, RAMS; Lomonosov Moscow State University	Veit, M (corresponding author), Free Univ Berlin, Inst Virol, Fachbereich Vet Med, Zentrum Infekt Med Robert von Ostertag Haus, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany.	mveit@zedat.fu-berlin.de	Mintaev, Ramil/AAE-3303-2019; Serebryakova, Marina/E-2986-2012; Kordyukova, Larisa V./D-6547-2012	Serebryakova, Marina/0000-0002-5402-8215; Kordyukova, Larisa V./0000-0002-6089-1103; Mintaev, Ramil/0000-0001-5398-3627; Veit, Michael/0000-0002-7638-1829	Deutsche Forschungsgemeinschaft [Ve 141/10]; Priority Program 1175; Russian Foundation for Basic Research [13-04-00290, 14-04-01693]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Priority Program 1175; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Deutsche Forschungsgemeinschaft Grant Ve 141/10 and Priority Program 1175 and Russian Foundation for Basic Research Grants 13-04-00290 and 14-04-01693.	Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel S, 2010, BIOCHEM J, V425, P567, DOI 10.1042/BJ20091388; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hernandez R., 2010, CURR PROTOC MICROBIO, V4, P41; Hutchinson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5816; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kordyukova LV, 2008, J VIROL, V82, P9288, DOI 10.1128/JVI.00704-08; Kordyukova LV, 2011, BBA-BIOMEMBRANES, V1808, P1843, DOI 10.1016/j.bbamem.2011.03.005; Kordyukova LV, 2010, VIROLOGY, V398, P49, DOI 10.1016/j.virol.2009.11.039; Kordyukova LV, 2004, PROTEIN PEPTIDE LETT, V11, P385, DOI 10.2174/0929866043406850; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; KURODA K, 1991, VIROLOGY, V180, P159, DOI 10.1016/0042-6822(91)90019-8; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Liang XQ, 2002, J BIOL CHEM, V277, P33032, DOI 10.1074/jbc.M204607200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Melikyan GB, 1997, VIROLOGY, V235, P118, DOI 10.1006/viro.1997.8686; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; NAEVE CW, 1990, EMBO J, V9, P3857, DOI 10.1002/j.1460-2075.1990.tb07604.x; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Reverey H, 1996, J BIOL CHEM, V271, P23607, DOI 10.1074/jbc.271.39.23607; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; RODRIGUEZBOULAN E, 1984, J CELL BIOL, V98, P308, DOI 10.1083/jcb.98.1.308; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sakai T, 2002, J VIROL, V76, P4603, DOI 10.1128/JVI.76.9.4603-4611.2002; SCHMIDT MFG, 1984, EMBO J, V3, P2295, DOI 10.1002/j.1460-2075.1984.tb02129.x; Serebryakova MV, 2013, ARCH VIROL, V158, P467, DOI 10.1007/s00705-012-1510-9; Serebryakova MV, 2011, VIRUS RES, V160, P294, DOI 10.1016/j.virusres.2011.07.002; Serebryakova MV, 2006, EUR J MASS SPECTROM, V12, P51, DOI 10.1255/ejms.792; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Simonsen AC, 2003, FEBS LETT, V552, P253, DOI 10.1016/S0014-5793(03)00970-0; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEINHAUER DA, 1991, VIROLOGY, V184, P445, DOI 10.1016/0042-6822(91)90867-B; Sugita Y, 2011, J GEN VIROL, V92, P2485, DOI 10.1099/vir.0.036715-0; Ujike M, 2004, J VIROL, V78, P11536, DOI 10.1128/JVI.78.21.11536-11543.2004; VEIT M, 1991, J VIROL, V65, P2491, DOI 10.1128/JVI.65.5.2491-2500.1991; VEIT M, 1993, FEBS LETT, V336, P243, DOI 10.1016/0014-5793(93)80812-9; VEIT M, 1990, VIROLOGY, V177, P807, DOI 10.1016/0042-6822(90)90554-5; Veit M, 1996, BIOCHEM J, V318, P163, DOI 10.1042/bj3180163; Veit M, 2013, BIOCHEM SOC T, V41, P50, DOI 10.1042/BST20120210; Veit Michael, 2008, V446, P163, DOI 10.1007/978-1-60327-084-7_12; Wagner R, 2005, J VIROL, V79, P6449, DOI 10.1128/JVI.79.10.6449-6458.2005; ZURCHER T, 1994, J VIROL, V68, P5748, DOI 10.1128/JVI.68.9.5748-5754.1994	49	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34978	34989		10.1074/jbc.M114.586180	http://dx.doi.org/10.1074/jbc.M114.586180			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349209	Green Published, hybrid			2022-12-26	WOS:000346260800046
J	Jin, HJ; Kanthasamy, A; Harischandra, DS; Kondru, N; Ghosh, A; Panicker, N; Anantharam, V; Rana, A; Kanthasamy, AG				Jin, Huajun; Kanthasamy, Arthi; Harischandra, Dilshan S.; Kondru, Naveen; Ghosh, Anamitra; Panicker, Nikhil; Anantharam, Vellareddy; Rana, Ajay; Kanthasamy, Anumantha G.			Histone Hyperacetylation Up-regulates Protein Kinase C delta in Dopaminergic Neurons to Induce Cell Death RELEVANCE TO EPIGENETIC MECHANISMS OF NEURODEGENERATION IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Epigenetics; Histone Deacetylase Inhibitor (HDAC Inhibitor); Neurodegeneration; Oxidative Stress; Parkinson Disease; PKC; Histone Acetylation	ALPHA-SYNUCLEIN OLIGOMERS; PKC-DELTA; PROTEOLYTIC ACTIVATION; DEACETYLASE INHIBITOR; OXIDATIVE-STRESS; DIFFERENTIAL ACTIVATION; SODIUM-BUTYRATE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; REPRESS TRANSCRIPTION	Background: Dysregulation of neuronal acetylation homeostasis promotes neurodegeneration. Results: Histone hyperacetylation up-regulates PKC in dopaminergic neurons and augments susceptibility to oxidative damage. Conclusion: Epigenetic regulation of PKC plays a proapoptotic role in neuronal cell death. Significance: The up-regulation of PKC expression by hyperacetylation provides an epigenetic molecular basis of neurodegenerative disease. The oxidative stress-sensitive protein kinase C (PKC) has been implicated in dopaminergic neuronal cell death. However, little is known about the epigenetic mechanisms regulating PKC expression in neurons. Here, we report a novel mechanism by which the PKC gene can be regulated by histone acetylation. Treatment with histone deacetylase (HDAC) inhibitor sodium butyrate (NaBu) induced PKC expression in cultured neurons, brain slices, and animal models. Several other HDAC inhibitors also mimicked NaBu. The chromatin immunoprecipitation analysis revealed that hyperacetylation of histone H4 by NaBu is associated with the PKC promoter. Deletion analysis of the PKC promoter mapped the NaBu-responsive element to an 81-bp minimal promoter region. Detailed mutagenesis studies within this region revealed that four GC boxes conferred hyperacetylation-induced PKC promoter activation. Cotransfection experiments and Sp inhibitor studies demonstrated that Sp1, Sp3, and Sp4 regulated NaBu-induced PKC up-regulation. However, NaBu did not alter the DNA binding activities of Sp proteins or their expression. Interestingly, a one-hybrid analysis revealed that NaBu enhanced transcriptional activity of Sp1/Sp3. Overexpression of the p300/cAMP-response element-binding protein-binding protein (CBP) potentiated the NaBu-mediated transactivation potential of Sp1/Sp3, but expressing several HDACs attenuated this effect, suggesting that p300/CBP and HDACs act as coactivators or corepressors in histone acetylation-induced PKC up-regulation. Finally, using genetic and pharmacological approaches, we showed that NaBu up-regulation of PKC sensitizes neurons to cell death in a human dopaminergic cell model and brain slice cultures. Together, these results indicate that histone acetylation regulates PKC expression to augment nigrostriatal dopaminergic cell death, which could contribute to the progressive neuropathogenesis of Parkinson disease.	[Jin, Huajun; Kanthasamy, Arthi; Harischandra, Dilshan S.; Kondru, Naveen; Ghosh, Anamitra; Panicker, Nikhil; Anantharam, Vellareddy; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neurotoxicol, Ames, IA 50011 USA; [Rana, Ajay] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Rana, Ajay] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA	Iowa State University; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, 2062 Coll Vet Med Bldg, Ames, IA 50011 USA.	akanthas@iastate.edu	Kondru, Naveen/AAM-9444-2021; Kondru, Naveen/AAB-7468-2020; Panicker, Nikhil/A-2770-2019; Rana, Ajay/ABE-3739-2020; Kondru, Naveen/P-9687-2019; Ghosh, Anamitra/C-5118-2015	Kondru, Naveen/0000-0002-1433-6336; Kondru, Naveen/0000-0002-1433-6336; Panicker, Nikhil/0000-0003-1752-4284; Rana, Ajay/0000-0003-0951-2566; Kanthasamy, Anumantha/0000-0002-6454-4264; Kanthasamy, Arthi/0000-0003-4654-9907; Harischandra, Dilshan/0000-0003-3220-8765; Ghosh, Anamitra/0000-0001-9740-2070	National Institutes of Health RO1 [ES10586, NS074443, NS65167, GM055835]; W. Eugene and Linda Lloyd Endowed Chair Professorship; Dean Professorship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074443, R01NS065167] Funding Source: NIH RePORTER	National Institutes of Health RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. Eugene and Linda Lloyd Endowed Chair Professorship; Dean Professorship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants ES10586 and NS074443 (to A. G. K.), NS65167 (to A. K.), and GM055835 (to A. R.). This work was also supported by the W. Eugene and Linda Lloyd Endowed Chair Professorship (to A. G. K.) and the Dean Professorship (to A. K.).	Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Anantharam V, 2004, ANN NY ACAD SCI, V1035, P271, DOI 10.1196/annals.1332.017; Anantharam V, 2002, J NEUROSCI, V22, P1738, DOI 10.1523/JNEUROSCI.22-05-01738.2002; Asaithambi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096947; Azadi S, 2006, MOL CELL NEUROSCI, V31, P759, DOI 10.1016/j.mcn.2006.01.001; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Barrasa JI, 2012, BBA-MOL CELL RES, V1823, P570, DOI 10.1016/j.bbamcr.2011.12.010; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Boutillier AL, 2003, J NEUROCHEM, V84, P814, DOI 10.1046/j.1471-4159.2003.01581.x; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Camarero N, 2003, NUCLEIC ACIDS RES, V31, P1693, DOI 10.1093/nar/gkg262; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Chou CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018087; Chou WH, 2005, TRENDS CARDIOVAS MED, V15, P47, DOI 10.1016/j.tcm.2005.01.003; Chu SJ, 2012, GENE, V508, P1, DOI 10.1016/j.gene.2012.07.022; D'Costa AM, 2006, ONCOGENE, V25, P378, DOI 10.1038/sj.onc.1209065; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; Dietz KC, 2010, PHARMACOL RES, V62, P11, DOI 10.1016/j.phrs.2010.01.011; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Ghosh A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444224; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Goldberg M, 1996, BIOCHEM PHARMACOL, V51, P1089, DOI 10.1016/0006-2952(96)00046-9; Gordon R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-82; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hanrott K, 2008, EUR J NEUROSCI, V27, P1086, DOI 10.1111/j.1460-9568.2008.06097.x; Harischandra DS, 2014, PRION, V8, P142, DOI 10.4161/pri.28369; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jin HJ, 2011, J BIOL CHEM, V286, P19840, DOI 10.1074/jbc.M110.203687; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Kanthasamy AG, 2005, NEUROTOXICOLOGY, V26, P701, DOI 10.1016/j.neuro.2004.07.010; Kanthasamy A, 2012, NEUROTOXICOLOGY, V33, P833, DOI 10.1016/j.neuro.2012.01.011; Kanthasamy A, 2010, NEUROTOXICOLOGY, V31, P555, DOI 10.1016/j.neuro.2009.12.003; Kanthasamy AG, 2006, FREE RADICAL BIO MED, V41, P1578, DOI 10.1016/j.freeradbiomed.2006.08.016; Kaul S, 2003, EUR J NEUROSCI, V18, P1387, DOI 10.1046/j.1460-9568.2003.02864.x; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim JH, 2010, AM J PATHOL, V176, P1517, DOI 10.2353/ajpath.2010.090398; Konduri S, 2009, MOL CANCER THER, V8, P533, DOI 10.1158/1535-7163.MCT-08-0405; Koponen S, 2000, J CEREBR BLOOD F MET, V20, P93, DOI 10.1097/00004647-200001000-00013; Kuehn HS, 2013, BLOOD, V121, P3117, DOI 10.1182/blood-2012-12-469544; Kurkinen KMA, 2000, GENE, V242, P115, DOI 10.1016/S0378-1119(99)00539-9; Latchoumycandane C, 2011, TOXICOL APPL PHARM, V256, P314, DOI 10.1016/j.taap.2011.07.021; Lee HH, 2008, J GEN VIROL, V89, P878, DOI 10.1099/vir.0.83533-0; Leitges M, 2001, J CLIN INVEST, V108, P1505; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Lin KT, 2012, CLIN CANCER RES, V18, P4691, DOI 10.1158/1078-0432.CCR-12-0633; Lin M, 2012, NEUROSCIENCE, V210, P308, DOI 10.1016/j.neuroscience.2012.03.004; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; Markova NG, 2007, J INVEST DERMATOL, V127, P1126, DOI 10.1038/sj.jid.5700684; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; McMillan L, 2003, BRIT J CANCER, V88, P748, DOI 10.1038/sj.bjc.6600793; Miettinen S, 1996, J NEUROSCI, V16, P6236; Min BW, 2008, EXP MOL MED, V40, P699, DOI 10.3858/emm.2008.40.6.699; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; MURATA Y, 1994, J BIOL CHEM, V269, P20674; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Palaniyandi SS, 2009, CARDIOVASC RES, V82, P229, DOI 10.1093/cvr/cvp001; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pirooznia SK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00030; Pirooznia SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041776; Ponassi R, 2006, BIOCHEM PHARMACOL, V72, P1417, DOI 10.1016/j.bcp.2006.07.031; PONGRACZ J, 1995, INT J CANCER, V61, P35, DOI 10.1002/ijc.2910610107; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Ramirez T, 2008, CHROMOSOMA, V117, P147, DOI 10.1007/s00412-007-0133-5; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Salminen A, 1998, MOL BRAIN RES, V61, P203, DOI 10.1016/S0169-328X(98)00210-1; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Schildknecht S, 2009, TOXICOL APPL PHARM, V241, P23, DOI 10.1016/j.taap.2009.07.027; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Shin EJ, 2012, BEHAV BRAIN RES, V232, P98, DOI 10.1016/j.bbr.2012.04.001; Shin EJ, 2011, NEUROCHEM INT, V59, P39, DOI 10.1016/j.neuint.2011.03.022; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Song C, 2011, NEUROTOXICOLOGY, V32, P586, DOI 10.1016/j.neuro.2011.05.018; Song C, 2010, MOL PHARMACOL, V77, P621, DOI 10.1124/mol.109.062174; Sowa Y, 1999, CANCER RES, V59, P4266; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suh KS, 2003, GENOMICS, V82, P57, DOI 10.1016/S0888-7543(03)00072-7; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Valor LM, 2013, CURR PHARM DESIGN, V19, P5051, DOI 10.2174/13816128113199990382; Varga A, 2004, EUR UROL, V46, P462, DOI 10.1016/j.eururo.2004.04.014; Walker GE, 2001, ENDOCRINOLOGY, V142, P3817, DOI 10.1210/en.142.9.3817; Wang Y, 2009, NEUROSCI LETT, V467, P212, DOI 10.1016/j.neulet.2009.10.037; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang YJ, 2004, MOL CELL NEUROSCI, V25, P406, DOI 10.1016/j.mcn.2003.11.011; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007; Zhu WG, 2001, CANCER RES, V61, P1327	120	50	54	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34743	34767		10.1074/jbc.M114.576702	http://dx.doi.org/10.1074/jbc.M114.576702			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342743	Green Published, hybrid			2022-12-26	WOS:000346260800029
J	Yeo, GC; Baldock, C; Wise, SG; Weiss, AS				Yeo, Giselle C.; Baldock, Clair; Wise, Steven G.; Weiss, Anthony S.			A Negatively Charged Residue Stabilizes the Tropoelastin N-terminal Region for Elastic Fiber Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspartate (Aspartic Acid); Elastin; Protein Self-assembly; Small Angle X-ray Scattering; Tertiary Structure; Domain 6; Elastic Fiber Assembly; N-terminal Region; Tropoelastin	RECOMBINANT HUMAN TROPOELASTIN; HUMAN SKIN ELASTIN; SMALL-ANGLE SCATTERING; CROSS-LINKING DOMAIN; LYSYL OXIDASE; IN-VITRO; COACERVATION; ASSOCIATION; PEPTIDES; SEQUENCES	Background: Negative residues are rare in human tropoelastin, and their contributions to protein structure and function are unknown. Results: Mutating aspartate 72 reduces coacervation, cross-linking, and elastogenesis and alters the N-terminal conformation. Conclusion: Aspartate 72 residue stabilizes the N-terminal structure for functional assembly into elastic fibers. Significance: This work provides the first direct evidence of the importance of the tropoelastin N-terminal structure in elastic fiber assembly. Tropoelastin is an extracellular matrix protein that assembles into elastic fibers that provide elasticity and strength to vertebrate tissues. Although the contributions of specific tropoelastin regions during each stage of elastogenesis are still not fully understood, studies predominantly recognize the central hinge/bridge and C-terminal foot as the major participants in tropoelastin assembly, with a number of interactions mediated by the abundant positively charged residues within these regions. However, much less is known about the importance of the rarely occurring negatively charged residues and the N-terminal coil region in tropoelastin assembly. The sole negatively charged residue in the first half of human tropoelastin is aspartate 72. In contrast, the same region comprises 17 positively charged residues. We mutated this aspartate residue to alanine and assessed the elastogenic capacity of this novel construct. We found that D72A tropoelastin has a decreased propensity for initial self-association, and it cross-links aberrantly into denser, less porous hydrogels with reduced swelling properties. Although the mutant can bind cells normally, it does not form elastic fibers with human dermal fibroblasts and forms fewer atypical fibers with human retinal pigmented epithelial cells. This impaired functionality is associated with conformational changes in the N-terminal region. Our results strongly point to the role of the Asp-72 site in stabilizing the N-terminal segment of human tropoelastin and the importance of this region in facilitating elastic fiber assembly.	[Yeo, Giselle C.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Yeo, Giselle C.; Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Baldock, Clair] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Wise, Steven G.] Heart Res Inst, Sydney, NSW 2042, Australia; [Wise, Steven G.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Manchester; University of Sydney; Heart Research Institute; University of Sydney; University of Sydney	Weiss, AS (corresponding author), Univ Sydney, Charles Perkins Ctr, Bldg D17, Sydney, NSW 2006, Australia.	tony.weiss@sydney.edu.au	Wise, Steven G/G-2630-2018; Weiss, Anthony S/GYV-0157-2022; Wise, Steven/AAB-8170-2021; Weiss, Anthony S/F-8103-2010; Wise, Steven/B-1858-2009	Weiss, Anthony S/0000-0002-8106-4836; Yeo, Giselle/0000-0001-6071-8899; Wise, Steven/0000-0001-7964-819X; Baldock, Clair/0000-0003-3497-1959	European Radiation Synchrotron Fund (ESRF) [MX-1483]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014283] Funding Source: NIH RePORTER	European Radiation Synchrotron Fund (ESRF); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the European Radiation Synchrotron Fund (ESRF) for access to beamline BM29 (Midland BAG Proposal MX-1483) and Dr. Benoit Maillot for assistance during data collection.	Akhtart K, 2011, J BIOL CHEM, V286, P13574, DOI 10.1074/jbc.M110.192088; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; BASHIR MM, 1989, J BIOL CHEM, V264, P8887; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345; Bochicchio B, 2011, CHIRALITY, V23, P694, DOI 10.1002/chir.20979; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Dyksterhuis LB, 2007, MATRIX BIOL, V26, P125, DOI 10.1016/j.matbio.2006.10.002; Dyksterhuis LB, 2009, ARCH BIOCHEM BIOPHYS, V487, P79, DOI 10.1016/j.abb.2009.06.001; Getie M, 2005, PROTEINS, V61, P649, DOI 10.1002/prot.20643; GROSSO LE, 1993, BIOCHEMISTRY-US, V32, P13369, DOI 10.1021/bi00211a052; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; Jensen SA, 2000, J BIOL CHEM, V275, P28449, DOI 10.1074/jbc.M004265200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Lee P, 2014, J BIOL CHEM, V289, P1467, DOI 10.1074/jbc.M113.518381; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Megarbane H, 2009, J INVEST DERMATOL, V129, P1650, DOI 10.1038/jid.2008.450; Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200; Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005; Muiznieks LD, 2007, BIOCHEMISTRY-US, V46, P8196, DOI 10.1021/bi700139k; Ostuni A, 2007, BIOPHYS J, V93, P3640, DOI 10.1529/biophysj.107.110809; PasqualiRonchetti I, 1997, MICROSC RES TECHNIQ, V38, P428, DOI 10.1002/(SICI)1097-0029(19970815)38:4<428::AID-JEMT10>3.0.CO;2-L; Piontkivska H, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-31; Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060; Schmelzer CEH, 2005, J CHROMATOGR A, V1083, P120, DOI 10.1016/j.chroma.2005.06.034; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stone PJ, 2001, AM J RESP CELL MOL, V24, P733, DOI 10.1165/ajrcmb.24.6.4304; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Taddese S, 2008, MATRIX BIOL, V27, P420, DOI 10.1016/j.matbio.2008.02.001; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; UITTO J, 1979, J INVEST DERMATOL, V72, P1, DOI 10.1111/1523-1747.ep12530093; Urry DW, 2004, CHEM PHYS LETT, V399, P177, DOI 10.1016/j.cplett.2004.09.137; URRY DW, 1979, BIOCHEM BIOPH RES CO, V90, P194, DOI 10.1016/0006-291X(79)91608-5; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Wang HW, 2008, PROC SPIE, V6860, DOI 10.1117/12.763604; Waterhouse A, 2011, PHARM RES-DORDR, V28, P1415, DOI 10.1007/s11095-010-0327-z; Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006; Wu WJ, 1999, EUR J BIOCHEM, V266, P308, DOI 10.1046/j.1432-1327.1999.00891.x; Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108	47	18	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34815	34826		10.1074/jbc.M114.606772	http://dx.doi.org/10.1074/jbc.M114.606772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342751	Green Published, hybrid			2022-12-26	WOS:000346260800033
J	Sparks, EL; Cebrian, J; Smith, SM				Sparks, Eric L.; Cebrian, Just; Smith, Sara M.			Removal of Fast Flowing Nitrogen from Marshes Restored in Sandy Soils	PLOS ONE			English	Article							FRINGING MARSH; RESTORATION; ECOSYSTEM; NUTRIENT; TRACKING	Groundwater flow rates and nitrate removal capacity from an introduced solution were examined for five marsh restoration designs and unvegetated plots shortly after planting and 1 year post-planting. The restoration site was a sandy beach with a wave-dampening fence 10 m offshore. Simulated groundwater flow into the marsh was introduced at a rate to mimic intense rainfall events. Restoration designs varied in initial planting density and corresponded to 25%, 50%, 75% and 100% of the plot area planted. In general, groundwater flow was slower with increasing planting density and decreased from year 0 to year 1 across all treatments. Nevertheless, removal of nitrate from the introduced solution was similar and low for all restoration designs (3-7%) and similar to the unvegetated plots. We suggest that the low NO3- removal was due to sandy sediments allowing rapid flow of groundwater through the marsh rhizosphere, thereby decreasing the contact time of the NO3- with the marsh biota. Our findings demonstrate that knowledge of the groundwater flow regime for restoration projects is essential when nutrient filtration is a target goal of the project.	[Sparks, Eric L.; Cebrian, Just; Smith, Sara M.] Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Sparks, Eric L.; Cebrian, Just] Univ S Alabama, Mobile, AL 36688 USA	Dauphin Island Sea Lab; University of South Alabama	Sparks, EL (corresponding author), Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA.	esparks4040@gmail.com			Alabama Department of Conservation and Natural Resources, State Lands Division, Coastal Section; National Oceanic and Atmospheric Administration, Office of Ocean and Coastal Resource Management [10NOS4190206]	Alabama Department of Conservation and Natural Resources, State Lands Division, Coastal Section; National Oceanic and Atmospheric Administration, Office of Ocean and Coastal Resource Management(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding for this project provided by the Alabama Department of Conservation and Natural Resources, State Lands Division, Coastal Section, in part, by a grant from the National Oceanic and Atmospheric Administration, Office of Ocean and Coastal Resource Management, Award #10NOS4190206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Chapman MG, 2000, WETLANDS, V19, P28; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Corbett DR, 2000, ESTUAR COAST SHELF S, V51, P227; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dingman S.L., 2008, PHYS HYDROLOGY, V2; Drake DC, 2009, ECOLOGY, V90, P2535, DOI 10.1890/08-1051.1; Ehrenfeld JG, 2000, RESTOR ECOL, V8, P2, DOI 10.1046/j.1526-100x.2000.80002.x; ELEUTERIUS L N, 1976, Chesapeake Science, V17, P289, DOI 10.2307/1350516; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Hamersley MR, 2005, MAR ECOL PROG SER, V299, P123, DOI 10.3354/meps299123; HARRELL J, 1978, J SEDIMENT PETROL, V48, P25; Hilderbrand RH, 2005, ECOL SOC, V10; LaSalle M.W, 1996, WRPRE15 US ARM CORPS; Lewis RR, 1982, CREATION RESTORATION, P153; Maynard DG, 1993, SOIL SAMPLING METHOD, P25; Moeller I, 1996, J COASTAL RES, V12, P1009; Quinn GP, 2003, EXPT DESIGN DATA ANA; Soro, 1992, DETERMINATION HYDRAU; Sparks EL, 2013, ECOL ENG, V53, P250, DOI 10.1016/j.ecoleng.2012.12.053; Stout JP, 1998, MESC CONTRIBUTION; STUMPF RP, 1983, ESTUAR COAST SHELF S, V17, P495, DOI 10.1016/0272-7714(83)90002-1; Tobias CR, 2001, LIMNOL OCEANOGR, V46, P1977, DOI 10.4319/lo.2001.46.8.1977; Tobias CR, 2001, LIMNOL OCEANOGR, V46, P604, DOI 10.4319/lo.2001.46.3.0604; Tobias CR, 2001, MAR ECOL PROG SER, V210, P25, DOI 10.3354/meps210025; Tobias C, 2019, COASTAL WETLANDS: AN INTEGRATED ECOSYSTEM APPROACH, 2ND EDITION, P539, DOI 10.1016/B978-0-444-63893-9.00016-2; Turner R.E., 2002, APPROACHES COASTAL W; TURNER RE, 1990, AM ZOOL, V30, P89; VALIELA I, 1978, LIMNOL OCEANOGR, V23, P798, DOI 10.4319/lo.1978.23.4.0798; VALIELA I, 1990, BIOGEOCHEMISTRY, V10, P177; Valiela I, 2002, ECOSYSTEMS, V5, P92, DOI 10.1007/s10021-001-0058-4; Wilkins S, 2003, RESTOR ECOL, V11, P489, DOI 10.1046/j.1526-100X.2003.rec0244.x; Zedler JB, 1999, RESTOR ECOL, V7, P69, DOI 10.1046/j.1526-100X.1999.07108.x	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111456	10.1371/journal.pone.0111456	http://dx.doi.org/10.1371/journal.pone.0111456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353607	Green Submitted, Green Published, gold			2022-12-26	WOS:000345204200081
J	Hill, AE; Plyler, ZE; Tiwari, H; Patki, A; Tully, JP; McAtee, CW; Moseley, LA; Sorscher, EJ				Hill, Aubrey E.; Plyler, Zackery E.; Tiwari, Hemant; Patki, Amit; Tully, Joel P.; McAtee, Christopher W.; Moseley, Leah A.; Sorscher, Eric J.			Longevity and Plasticity of CFTR Provide an Argument for Noncanonical SNP Organization in Hominid DNA	PLOS ONE			English	Article							HUMAN-Y-CHROMOSOMES; GENOME SEQUENCE VARIATION; MUTATION-RATE EVOLUTION; RECENT COMMON ANCESTRY; CYSTIC-FIBROSIS; NUCLEOTIDE SUBSTITUTION; DROSOPHILA-MELANOGASTER; NONCODING DNA; HUMAN-DISEASE; MOUSE MODEL	Like many other ancient genes, the cystic fibrosis transmembrane conductance regulator (CFTR) has survived for hundreds of millions of years. In this report, we consider whether such prodigious longevity of an individual gene - as opposed to an entire genome or species - should be considered surprising in the face of eons of relentless DNA replication errors, mutagenesis, and other causes of sequence polymorphism. The conventions that modern human SNP patterns result either from purifying selection or random (neutral) drift were not well supported, since extant models account rather poorly for the known plasticity and function (or the established SNP distributions) found in a multitude of genes such as CFTR. Instead, our analysis can be taken as a polemic indicating that SNPs in CFTR and many other mammalian genes may have been generated-and continue to accrue-in a fundamentally more organized manner than would otherwise have been expected. The resulting viewpoint contradicts earlier claims of 'directional' or 'intelligent design-type' SNP formation, and has important implications regarding the pace of DNA adaptation, the genesis of conserved non-coding DNA, and the extent to which eukaryotic SNP formation should be viewed as adaptive.	[Hill, Aubrey E.; Tully, Joel P.] Univ Alabama Birmingham, Dept Comp & Informat Sci, Birmingham, AL 35294 USA; [Plyler, Zackery E.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Tiwari, Hemant; Patki, Amit] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Tully, Joel P.; McAtee, Christopher W.; Moseley, Leah A.; Sorscher, Eric J.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35233 USA; [Sorscher, Eric J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sorscher, EJ (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35233 USA.	sorscher@uab.edu		Sorscher, Eric J./0000-0001-9341-3354	National Institutes of Health [P30DK72482]; Cystic Fibrosis Foundation [R464]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [P30DK72482 to E. S.]; and the Cystic Fibrosis Foundation [R464 to E. S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2013, J INFECT DIS, V208, P780, DOI 10.1093/infdis/jit251; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Berglund J, 2009, PLOS BIOL, V7, P45, DOI 10.1371/journal.pbio.1000026; Blanchette Mathieu, 2008, V422, P171, DOI 10.1007/978-1-59745-581-7_11; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CAIRNS J, 1995, SCIENCE, V269, P288, DOI 10.1126/science.269.5222.288; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Chen IP, 2009, MAR BIOTECHNOL, V11, P141, DOI 10.1007/s10126-008-9129-2; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GABRIEL W, 1993, EVOLUTION, V47, P1744, DOI 10.1111/j.1558-5646.1993.tb01266.x; Goebel T, 2007, SCIENCE, V315, P194, DOI 10.1126/science.1137564; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Gulyas-Kovacs A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036546; Hahn MW, 2008, EVOLUTION, V62, P255, DOI 10.1111/j.1558-5646.2007.00308.x; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Havasi V, 2010, FERTIL STERIL, V94, P2122, DOI 10.1016/j.fertnstert.2009.11.044; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hodgkinson A, 2010, GENOME BIOL EVOL, V2, P547, DOI 10.1093/gbe/evq039; Hodgkinson A, 2009, PLOS BIOL, V7, P226, DOI 10.1371/journal.pbio.1000027; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1979, P NATL ACAD SCI USA, V76, P3440, DOI 10.1073/pnas.76.7.3440; Kondrashov AS, 2008, P NATL ACAD SCI USA, V105, P9133, DOI 10.1073/pnas.0804749105; Koonin EV, 2012, LOGIC CHANCE NATURES; Kreitman M, 1996, BIOESSAYS, V18, P678, DOI 10.1002/bies.950180812; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Laszlo C, 2011, METHODS MOL BIOL, V741, P443, DOI 10.1007/978-1-61779-117-8_28; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; LYNCH M, 1990, EVOLUTION, V44, P1725, DOI 10.1111/j.1558-5646.1990.tb05244.x; Lynch M, 2012, MOL BIOL EVOL, V29, P1353, DOI 10.1093/molbev/msr300; Lynch M, 2010, P NATL ACAD SCI USA, V107, P16577, DOI 10.1073/pnas.1010836107; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McClellan DA, 2004, J THEOR BIOL, V226, P393, DOI 10.1016/j.jtbi.2003.09.019; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Meyer Steven, 2013, DARWINS DOUBT EXPLOS; Mitchell RJ, 1996, CURR OPIN GENET DEV, V6, P737, DOI 10.1016/S0959-437X(96)80029-3; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nachman MW, 2000, GENETICS, V156, P297; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Ostedgaard LS, 2011, P NATL ACAD SCI USA, V108, P2921, DOI 10.1073/pnas.1019752108; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; Plyler ZE, SNP DISTRIB IN PRESS; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Rishishwar L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042336; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SAWYER SA, 1992, GENETICS, V132, P1161; Sayres MAW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004064; Schon I, 2003, P ROY SOC B-BIOL SCI, V270, P827, DOI 10.1098/rspb.2002.2314; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Sung W, 2013, P NATL ACAD SCI USA, V110, pE860, DOI 10.1073/pnas.1220650110; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Tucker AE, 2013, P NATL ACAD SCI USA, V110, P15740, DOI 10.1073/pnas.1313388110; Tuggle KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091253; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Yang ZH, 2000, GENETICS, V155, P431; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588	90	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109186	10.1371/journal.pone.0109186	http://dx.doi.org/10.1371/journal.pone.0109186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350658	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100009
J	Chen, FF; Ren, P; Feng, Y; Liu, HY; Sun, Y; Liu, ZH; Ge, JY; Cui, XL				Chen, Fangfang; Ren, Ping; Feng, Ye; Liu, Haiyan; Sun, Yang; Liu, Zhonghui; Ge, Jingyan; Cui, Xueling			Follistatin Is a Novel Biomarker for Lung Adenocarcinoma in Humans	PLOS ONE			English	Article							CANCER CELL-LINES; ACTIVIN-A; PROSTATE-CANCER; TUMOR-MARKERS; SECRETION; APOPTOSIS; MACROPHAGES; REGULATORS; SURVIVAL; BINDING	Background: Follistatin (FST), a single chain glycoprotein, is originally isolated from follicular fluid of ovary. Previous studies have revealed that serum FST served as a biomarker for pregnancy and ovarian mucinous tumor. However, whether FST can serve as a biomarker for diagnosis in lung adenocarcinoma of humans remains unclear. Methods and Results: The study population consisted of 80 patients with lung adenocarcinoma, 40 patients with ovarian adenocarcinoma and 80 healthy subjects. Serum FST levels in patients and healthy subjects were measured using ELISA. The results showed that the positive ratio of serum FST levels was 51.3% (41/80), which was comparable to the sensitivity of FST in 40 patients with ovarian adenocarcinoma (60%, 24/40) using the 95th confidence interval for the healthy subject group as the cut-off value. FST expressions in lung adenocarcinoma were examined by immunohistochemical staining, we found that lung adenocarcinoma could produce FST and there was positive correlation between the level of FST expression and the differential degree of lung adenocarcinoma. Furthermore, the results showed that primary cultured lung adenocarcinoma cells could secrete FST, while cells derived from non-tumor lung tissues almost did not produce FST. In addition, the results of CCK8 assay and flow cytometry showed that using anti-FST monoclonal antibody to neutralize endogenous FST significantly augmented activin A-induced lung adenocarcinoma cells apoptosis. Conclusions: These data indicate that lung adenocarcinoma cells can secret FST into serum, which may be beneficial to the survival of adenocarcinoma cells by neutralizing activin A action. Thus, FST can serve as a promising biomarker for diagnosis of lung adenocarcinoma and a useful biotherapy target for lung adenocarcinoma.	[Chen, Fangfang; Feng, Ye] Jilin Univ, China Japan Union Hosp, Dept Gastrointestinal Surg, Changchun 130023, Peoples R China; [Ren, Ping] Jilin Univ, Hosp 1, Dept Thorac Surg, Changchun 130023, Peoples R China; [Liu, Haiyan; Sun, Yang; Liu, Zhonghui; Ge, Jingyan; Cui, Xueling] Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Ge, JY (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun 130023, Peoples R China.	gejy@jlu.edu.cn; cxl@jlu.edu.cn	Ge, Jingyan/G-3184-2013		National Natural Science Foundation of China [31101039]; Project of Science and Technology of Jilin Province [20110754, 20130522041JH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology of Jilin Province	This work was supported by the National Natural Science Foundation of China (Grant No. 31101039) and the Project of Science and Technology of Jilin Province (Grant No. 20110754 and No. 20130522041JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Muench GR, 2012, IMMUNOL CELL BIOL, V90, P137, DOI 10.1038/icb.2011.32; Ardizzoni A, 2006, CANCER-AM CANCER SOC, V107, P2842, DOI 10.1002/cncr.22330; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; deWinter JP, 1996, MOL CELL ENDOCRINOL, V116, P105, DOI 10.1016/0303-7207(95)03705-5; Ejaz S, 2011, CANCER-AM CANCER SOC, V117, P4381, DOI 10.1002/cncr.26029; FARRELL WE, 1992, J CLIN INVEST, V90, P705, DOI 10.1172/JCI115941; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Florio P, 2010, REPROD SCI, V17, P320, DOI 10.1177/1933719109353205; Gao XW, 2010, J BIOL CHEM, V285, P36857, DOI 10.1074/jbc.M110.144477; Kim YI, 2009, ONCOL REP, V21, P491, DOI 10.3892/or_00000249; Kojima I, 2001, MOL CELL ENDOCRINOL, V180, P179, DOI 10.1016/S0303-7207(01)00511-1; LambertMesserlian G, 1997, BIOL REPROD, V57, P1211, DOI 10.1095/biolreprod57.5.1211; Li N, 2013, BIOCHEM BIOPH RES CO, V435, P222, DOI 10.1016/j.bbrc.2013.04.077; Licona-Limon P, 2009, BIOCHEM BIOPH RES CO, V381, P229, DOI 10.1016/j.bbrc.2009.02.029; Liu ZH, 1996, ENDOCR J, V43, P321, DOI 10.1507/endocrj.43.321; Maguer-Satta W, 2003, EXP CELL RES, V282, P110, DOI 10.1016/S0014-4827(02)00013-7; Morgillo F, 2011, BRIT J CANCER, V105, P382, DOI 10.1038/bjc.2011.244; NAKAMURA T, 1992, BIOCHIM BIOPHYS ACTA, V1135, P103, DOI 10.1016/0167-4889(92)90173-9; NISHIHARA T, 1993, BIOCHEM BIOPH RES CO, V197, P985, DOI 10.1006/bbrc.1993.2576; Ogino H, 2008, CLIN CANCER RES, V14, P660, DOI 10.1158/1078-0432.CCR-07-1221; Okamura K, 2013, LUNG CANCER, V80, P45, DOI 10.1016/j.lungcan.2013.01.002; Parkin DM, 2010, INT J CANCER, V127, P2918, DOI 10.1002/ijc.25517; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Planque C, 2009, MOL CELL PROTEOMICS, V8, P2746, DOI 10.1074/mcp.M900134-MCP200; Ren P, 2012, J INT MED RES, V40, P877, DOI 10.1177/147323001204000306; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Rodrigues P, 2012, ARQ BRAS ENDOCRINOL, V56, P461, DOI 10.1590/S0004-27302012000700009; Sepporta MV, 2013, TARGET ONCOL, V8, P215, DOI 10.1007/s11523-013-0268-7; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tumminello FM, 2010, CLIN EXP METASTAS, V27, P549, DOI 10.1007/s10585-010-9344-x; VandeVoort CA, 2009, BIOL REPROD, V81, P1139, DOI 10.1095/biolreprod.109.077198; Wakatsuki M, 1996, J CLIN ENDOCR METAB, V81, P630, DOI 10.1210/jc.81.2.630; Wang BD, 2009, TOXICOLOGY, V258, P176, DOI 10.1016/j.tox.2009.01.023; Wang WJ, 2013, ASIAN PAC J CANCER P, V14, P4369, DOI 10.7314/APJCP.2013.14.7.4369; Wang YN, 2009, CELL MOL IMMUNOL, V6, P387, DOI 10.1038/cmi.2009.50; Ying XZ, 2011, BIOL TRACE ELEM RES, V144, P306, DOI 10.1007/s12011-011-9094-x	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111398	10.1371/journal.pone.0111398	http://dx.doi.org/10.1371/journal.pone.0111398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347573	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900065
J	Kohr, MJ; Murphy, E; Steenbergen, C				Kohr, Mark J.; Murphy, Elizabeth; Steenbergen, Charles			Glyceraldehyde-3-Phosphate Dehydrogenase Acts as a Mitochondrial Trans-S-Nitrosylase in the Heart	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CYCLOPHILIN D; CELL-DEATH; PROTEIN; GAPDH; PHOSPHORYLATION; IDENTIFICATION; NITROSATION; MYOCARDIUM; ACTIVATION	Mitochondrial proteins have been shown to be common targets of S-nitrosylation (SNO), but the existence of a mitochondrial source of nitric oxide remains controversial. SNO is a nitric oxide-dependent thiol modification that can regulate protein function. Interestingly, trans-S-nitrosylation represents a potential pathway for the import of SNO into the mitochondria. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which has been shown to act as a nuclear trans-S-nitrosylase, has also been shown to enter mitochondria. However, the function of GAPDH in the mitochondria remains unknown. Therefore, we propose the hypothesis that S-nitrosylated GAPDH (SNO-GAPDH) interacts with mitochondrial proteins as a trans-S-nitrosylase. In accordance with this hypothesis, SNO-GAPDH should be detected in mitochondrial fractions, interact with mitochondrial proteins, and increase mitochondrial SNO levels. Our results demonstrate a four-fold increase in GAPDH levels in the mitochondrial fraction of mouse hearts subjected to ischemic preconditioning, which increases SNO-GAPDH levels. Co-immunoprecipitation studies performed in mouse hearts perfused with the S-nitrosylating agent S-nitrosoglutathione (GSNO), suggest that SNO promotes the interaction of GAPDH with mitochondrial protein targets. The addition of purified SNO-GAPDH to isolated mouse heart mitochondria demonstrated the ability of SNO-GAPDH to enter the mitochondrial matrix, and to increase SNO for many mitochondrial proteins. Further, the overexpression of GAPDH in HepG2 cells increased SNO for a number of different mitochondrial proteins, including heat shock protein 60, voltage-dependent anion channel 1, and acetyl-CoA acetyltransferase, thus supporting the role of GAPDH as a potential mitochondrial trans-S-nitrosylase. In further support of this hypothesis, many of the mitochondrial SNO proteins identified with GAPDH overexpression were no longer detected with GAPDH knock-down or mutation. Therefore, our results suggest that SNO-GAPDH can act as a mitochondrial trans-S-nitrosylase, thereby conferring the transfer of SNO from the cytosol to the mitochondria.	[Kohr, Mark J.; Steenbergen, Charles] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Kohr, Mark J.; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kohr, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	mkohr1@jhmi.edu		Kohr, Mark/0000-0002-6034-5962	American Heart Association [12BGIA11780030]; National Heart, Lung and Blood Institute/National Institutes of Health [1K99HL114721, 5R01HL039752]; National Heart, Lung and Blood Institute/National Institutes of Health Intramural Program [ZO1HL006059, ZO1HL002066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, R01HL039752, Z01HL002066, K99HL114721, R00HL114721, ZIAHL006059] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung and Blood Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung and Blood Institute/National Institutes of Health Intramural Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (12BGIA11780030, MK), National Heart, Lung and Blood Institute/National Institutes of Health grants 1K99HL114721 (MK) and 5R01HL039752 (CS), and the National Heart, Lung and Blood Institute/National Institutes of Health Intramural Program (ZO1HL006059 and ZO1HL002066, EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes PS, 2004, MITOCHONDRION, V3, P187, DOI 10.1016/j.mito.2003.10.001; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Brown GC, 2007, FRONT BIOSCI-LANDMRK, V12, P1024, DOI 10.2741/2122; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kohr MJ, 2014, J MOL CELL CARDIOL, V69, P67, DOI 10.1016/j.yjmcc.2014.01.010; Kohr MJ, 2012, CIRC RES, V111, P1308, DOI 10.1161/CIRCRESAHA.112.271320; Kohr MJ, 2011, AM J PHYSIOL-HEART C, V300, pH1327, DOI 10.1152/ajpheart.00997.2010; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Murphy E, 2014, J MOL CELL IN PRESS; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Nguyen TTM, 2013, CIRC RES, V113, P1308, DOI 10.1161/CIRCRESAHA.113.301867; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Qu J, 2007, NUCLEIC ACIDS RES, V35, P2522, DOI 10.1093/nar/gkl1163; Reiss N, 1996, BIOCHEM MOL BIOL INT, V40, P1191; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Sha YG, 2012, BBA-GEN SUBJECTS, V1820, P701, DOI 10.1016/j.bbagen.2011.05.008; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2012, ANTIOXID REDOX SIGN, V16, P45, DOI 10.1089/ars.2010.3844; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870	31	29	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111448	10.1371/journal.pone.0111448	http://dx.doi.org/10.1371/journal.pone.0111448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347796	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900075
J	Murgan, S; Colabianchi, AMC; Monti, RJ; Lopez, LEB; Aguirre, CE; Stivala, EG; Carrasco, AE; Lopez, SL				Murgan, Sabrina; Castro Colabianchi, Aitana Manuela; Jose Monti, Renato; Boyadjian Lopez, Laura Elena; Aguirre, Cecilia E.; Gonzalez Stivala, Ernesto; Carrasco, Andres E.; Lopez, Silvia L.			FoxA4 Favours Notochord Formation by Inhibiting Contiguous Mesodermal Fates and Restricts Anterior Neural Development in Xenopus Embryos	PLOS ONE			English	Article							FORK-HEAD DOMAIN; FLOOR-PLATE; TRANSCRIPTION FACTORS; SPEMANN ORGANIZER; SONIC HEDGEHOG; CONVERGENT EXTENSION; LAEVIS EMBRYOS; RETINOIC ACID; HOMEOBOX GENE; BETA-CATENIN	In vertebrates, the embryonic dorsal midline is a crucial signalling centre that patterns the surrounding tissues during development. Members of the FoxA subfamily of transcription factors are expressed in the structures that compose this centre. Foxa2 is essential for dorsal midline development in mammals, since knock-out mouse embryos lack a definitive node, notochord and floor plate. The related gene foxA4 is only present in amphibians. Expression begins in the blastula - chordin and - noggin expressing centre (BCNE) and is later restricted to the dorsal midline derivatives of the Spemann's organiser. It was suggested that the early functions of mammalian foxa2 are carried out by foxA4 in frogs, but functional experiments were needed to test this hypothesis. Here, we show that some important dorsal midline functions of mammalian foxa2 are exerted by foxA4 in Xenopus. We provide new evidence that the latter prevents the respecification of dorsal midline precursors towards contiguous fates, inhibiting prechordal and paraxial mesoderm development in favour of the notochord. In addition, we show that foxA4 is required for the correct regionalisation and maintenance of the central nervous system. FoxA4 participates in constraining the prospective rostral forebrain territory during neural specification and is necessary for the correct segregation of the most anterior ectodermal derivatives, such as the cement gland and the pituitary anlagen. Moreover, the early expression of foxA4 in the BCNE (which contains precursors of the whole forebrain and most of the midbrain and hindbrain) is directly required to restrict anterior neural development.	[Murgan, Sabrina; Castro Colabianchi, Aitana Manuela; Jose Monti, Renato; Boyadjian Lopez, Laura Elena; Aguirre, Cecilia E.; Gonzalez Stivala, Ernesto; Carrasco, Andres E.; Lopez, Silvia L.] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia, Lab Embriol Mol Prof Dr Andres E Carrasco, Buenos Aires, DF, Argentina	University of Buenos Aires	Lopez, SL (corresponding author), Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia, Lab Embriol Mol Prof Dr Andres E Carrasco, Buenos Aires, DF, Argentina.	slopez@fmed.uba.ar		Lopez, Silvia/0000-0002-3760-7549	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2005/6123, PIP 2012-2014/20110100508]; Universidad de Buenos Aires [M803/05]; Agencia Nacional de Promocion Cientifica y Tecnologica [BID PICT 2005/32024, BID PICT 2006/767, BID PICT 2011/1559, PME 2006/00319]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2005/6123 and PIP 2012-2014/20110100508), Universidad de Buenos Aires (M803/05), and Agencia Nacional de Promocion Cientifica y Tecnologica (BID PICT 2005/32024, BID PICT 2006/767, BID PICT 2011/1559, and PME 2006/00319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta H, 2011, DEVELOPMENT, V138, P2567, DOI 10.1242/dev.061143; ALTABA ARI, 1992, DEVELOPMENT, V116, P81; ALTABA ARI, 1993, P NATL ACAD SCI USA, V90, P8268, DOI 10.1073/pnas.90.17.8268; ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Artinger M, 1997, MECH DEVELOP, V65, P187, DOI 10.1016/S0925-4773(97)00073-7; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; BLITZ IL, 1995, DEVELOPMENT, V121, P993; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Carron C, 2005, MECH DEVELOP, V122, P1234, DOI 10.1016/j.mod.2005.06.007; Charrier JB, 2005, INT J DEV BIOL, V49, P181, DOI 10.1387/ijdb.041962jc; Charrier JB, 2002, DEVELOPMENT, V129, P4785; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; Dal-Pra S, 2011, DEV BIOL, V350, P484, DOI 10.1016/j.ydbio.2010.12.018; DALE L, 1987, DEVELOPMENT, V99, P527; de-Leon SBT, 2011, DEV BIOL, V357, P21, DOI 10.1016/j.ydbio.2010.11.027; Dickinson A, 2007, SEMIN CELL DEV BIOL, V18, P525, DOI 10.1016/j.semcdb.2007.04.002; DIRKSEN ML, 1992, GENE DEV, V6, P599, DOI 10.1101/gad.6.4.599; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Ermakova GV, 2007, DEV BIOL, V307, P483, DOI 10.1016/j.ydbio.2007.03.524; Ermakova GV, 1999, DEVELOPMENT, V126, P4513; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Franco PG, 1999, DEVELOPMENT, V126, P4257; GODSAVE S, 1994, DEV BIOL, V166, P465, DOI 10.1006/dbio.1994.1330; Hallonet M, 2002, DEV BIOL, V243, P20, DOI 10.1006/dbio.2001.0536; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hogan KA, 2004, CURR TOP DEV BIOL, V62, P55; Holland LZ, 1999, CURR OPIN NEUROBIOL, V9, P596, DOI 10.1016/S0959-4388(99)00003-3; HOPWOOD ND, 1991, DEVELOPMENT, V111, P551; HOPWOOD ND, 1989, EMBO J, V8, P3409, DOI 10.1002/j.1460-2075.1989.tb08505.x; Ishibashi H, 2008, MECH DEVELOP, V125, P58, DOI 10.1016/j.mod.2007.10.005; Kablar B, 1996, MECH DEVELOP, V55, P145, DOI 10.1016/0925-4773(96)00497-2; Kaestner KH, 2000, GENE DEV, V14, P142; Kazanskaya OV, 1997, GENE, V200, P25, DOI 10.1016/S0378-1119(97)00326-0; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kimura-Yoshida C, 2007, P NATL ACAD SCI USA, V104, P5919, DOI 10.1073/pnas.0607779104; Kishi M, 2000, DEVELOPMENT, V127, P791; KNOCHEL S, 1992, MECH DEVELOP, V38, P157, DOI 10.1016/0925-4773(92)90007-7; Kuroda H, 2004, PLOS BIOL, V2, P623, DOI 10.1371/journal.pbio.0020092; Kwan KM, 2003, DEVELOPMENT, V130, P1961, DOI 10.1242/dev.00412; Latimer AJ, 2006, DEV BIOL, V298, P392, DOI 10.1016/j.ydbio.2006.05.039; Latinkic BV, 1999, DEVELOPMENT, V126, P1769; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; LOPEZ SL, 1992, MECH DEVELOP, V36, P153, DOI 10.1016/0925-4773(92)90066-S; Lopez SL, 2005, DEVELOPMENT, V132, P1035, DOI 10.1242/dev.01659; Luu O, 2008, DEV DYNAM, V237, P1307, DOI 10.1002/dvdy.21522; Martynova N, 2004, DEVELOPMENT, V131, P2329, DOI 10.1242/dev.01133; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Monuki ES, 2007, J NEUROPATH EXP NEUR, V66, P566, DOI 10.1097/nen.0b013e3180986e1b; Morgan BA, 1996, P NATL ACAD SCI USA, V93, P2801, DOI 10.1073/pnas.93.7.2801; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Murato Y, 2007, DEV GENES EVOL, V217, P665, DOI 10.1007/s00427-007-0176-x; Nagatomo KI, 2007, DEV DYNAM, V236, P1475, DOI 10.1002/dvdy.21152; NIETO MA, 1991, DEVELOPMENT, P59; Norton WH, 2005, DEVELOPMENT, V132, P645, DOI 10.1242/dev.01611; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Pannese M, 1998, MECH DEVELOP, V73, P73, DOI 10.1016/S0925-4773(98)00034-3; PANNESE M, 1995, DEVELOPMENT, V121, P707; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; Patten I, 2003, DEVELOPMENT, V130, P4809, DOI 10.1242/dev.00694; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Peres JN, 2006, MECH DEVELOP, V123, P321, DOI 10.1016/j.mod.2006.03.001; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pizard A, 2004, CURR PROTOC MOL BIOL, V14, p14.9, DOI 10.1002/0471142727.mb1409-66; Pohl BS, 2005, GENE, V344, P21, DOI 10.1016/j.gene.2004.09.037; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Revinski DR, 2010, DEV BIOL, V339, P477, DOI 10.1016/j.ydbio.2010.01.010; Saka Y, 2000, MECH DEVELOP, V93, P27, DOI 10.1016/S0925-4773(00)00260-4; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; SASAKI H, 1993, DEVELOPMENT, V118, P47; Schafer M, 2005, GENE DEV, V19, P897, DOI 10.1101/gad.336305; Sive H.L., 2000, EARLY DEV XENOPUS LA; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Strahle U, 2004, TRENDS GENET, V20, P155, DOI 10.1016/j.tig.2004.01.002; Tada M, 2000, DEVELOPMENT, V127, P2227; Teillet MA, 1998, P NATL ACAD SCI USA, V95, P11733, DOI 10.1073/pnas.95.20.11733; Theveneau E, 2011, GENESIS, V49, P164, DOI 10.1002/dvg.20700; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wardle FC, 2002, DEVELOPMENT, V129, P4387; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wessely O, 2004, DEV BIOL, V269, P552, DOI 10.1016/j.ydbio.2004.01.018; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Yamaguti M, 2005, DEV DYNAM, V234, P102, DOI 10.1002/dvdy.20523; Yang YP, 2006, DEV BIOL, V296, P458, DOI 10.1016/j.ydbio.2006.06.014; Yusuf F, 2006, ANAT EMBRYOL, V211, pS21, DOI 10.1007/s00429-006-0119-8; ZARAISKY AG, 1995, DEVELOPMENT, V121, P3839; Zhou XL, 2000, MECH DEVELOP, V91, P327, DOI 10.1016/S0925-4773(99)00270-1	98	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110559	10.1371/journal.pone.0110559	http://dx.doi.org/10.1371/journal.pone.0110559			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343614	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943500036
J	Laulund, AS; Nybo, M; Brix, TH; Abrahamsen, B; Jorgensen, HL; Hegedus, L				Laulund, Anne Sofie; Nybo, Mads; Brix, Thomas Heiberg; Abrahamsen, Bo; Jorgensen, Henrik Lovendahl; Hegedus, Laszlo			Duration of Thyroid Dysfunction Correlates with All-Cause Mortality. The OPENTHYRO Register Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POPULATION-BASED REGISTERS; AGED HOSPITALIZED-PATIENTS; FUNCTION TESTS; SUBCLINICAL HYPERTHYROIDISM; CARDIOVASCULAR EVENTS; EXCESS MORTALITY; CANCER-MORTALITY; ELDERLY-PEOPLE; GRAVES-DISEASE	Introduction and Aim: The association between thyroid dysfunction and mortality is controversial. Moreover, the impact of duration of thyroid dysfunction is unclarified. Our aim was to investigate the correlation between biochemically assessed thyroid function as well as dysfunction duration and mortality. Methods: Register-based follow-up study of 239,768 individuals with a serum TSH measurement from hospitals and/or general practice in Funen, Denmark. Measurements were performed at a single laboratory from January 1st 1995 to January 1st 2011. Cox regression was used for mortality analyses and Charlson Comorbidity Index (CCI) was used as comorbidity score. Results: Hazard ratios (HR) with 95% confidence intervals (CI) for mortality with decreased (<0.3 mIU/L) or elevated (>4.0 mIU/L) levels of TSH were 2.22; 2.14-2.30; P<0.0001 and 1.28; 1.22-1.35; P<0.0001, respectively. Adjusting for age, gender, CCI and diagnostic setting attenuated the risk estimates (HR 1.23; 95% CI: 1.19-1.28; P<0.0001, mean follow-up time 7.7 years, and HR 1.07; 95% CI: 1.02-1.13; P = 0.004, mean follow-up time 7.2 years) for decreased and elevated values of TSH, respectively. Mortality risk increased by a factor 1.09; 95% CI: 1.08-1.10; P<0.0001 or by a factor 1.03; 95% CI: 1.02-1.04; P<0.0001 for each six months a patient suffered from decreased or elevated TSH, respectively. Subdividing according to degree of thyroid dysfunction, overt hyperthyroidism (HRovert 1.12; 95% CI: 1.06-1.19; P<0.0001), subclinical hyperthyroidism (HRsubclinical 1.09; 95% CI: 1.02-1.17; P = 0.02) and overt hypothyroidism (HRovert 1.57; 95% CI: 1.34-1.83; P<0.0001), but not subclinical hypothyroidism (HRsubclinical 1.03; 95% CI: 0.97-1.09; P = 0.4) were associated with increased mortality. Conclusions and Relevance: In a large-scale, population-based cohort with long-term follow-up (median 7.4 years), overt and subclinical hyperthyroidism and overt but not subclinical hypothyroidism were associated with increased mortality. Excess mortality with increasing duration of decreased or elevated serum TSH suggests the importance of timely intervention in individuals with thyroid dysfunction.	[Laulund, Anne Sofie; Brix, Thomas Heiberg; Hegedus, Laszlo] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; [Nybo, Mads] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Abrahamsen, Bo] Univ Southern Denmark, Odense Patient Data Explorat Network OPEN, Odense, Denmark; [Abrahamsen, Bo] Inst Clin Res, Odense, Denmark; [Abrahamsen, Bo] Glostrup Cty Hosp, Dept Med M, Res Ctr Ageing & Osteoporosis, Copenhagen, Denmark; [Jorgensen, Henrik Lovendahl] Bispebjerg Hosp, Dept Clin Biochem, DK-2400 Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Hegedus, L (corresponding author), Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark.	laszlo.hegedus@rsyd.dk	Jorgensen, Henrik/ABI-8236-2020; Nybo, Mads/J-6040-2019	Nybo, Mads/0000-0002-3029-2855; Jorgensen, Henrik Lovendahl/0000-0001-6374-761X; Abrahamsen, Bo/0000-0002-2730-6080	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The authors confirm that the study was funded by Novo Nordisk Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizaki M, 2006, CLIN ENDOCRINOL, V65, P369, DOI 10.1111/j.1365-2265.2006.02606.x; Bauer DC, 2007, AM J MED, V120, P343, DOI 10.1016/j.amjmed.2006.04.034; Biondi B, 2002, ANN INTERN MED, V137, P904, DOI 10.7326/0003-4819-137-11-200212030-00011; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627; Brandt F, 2014, EUR J ENDOCRINOL, V170, P341, DOI 10.1530/EJE-13-0708; Brandt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066711; Brandt F, 2013, THYROID, V23, P408, DOI 10.1089/thy.2012.0500; Brandt F, 2012, J CLIN ENDOCR METAB, V97, P4123, DOI 10.1210/jc.2012-2268; Brandt F, 2011, EUR J ENDOCRINOL, V165, P491, DOI 10.1530/EJE-11-0299; Brix TH, 2000, ARCH INTERN MED, V160, P661, DOI 10.1001/archinte.160.5.661; Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coceani M, 2009, CLIN CARDIOL, V32, P380, DOI 10.1002/clc.20574; Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402; Flynn RWV, 2006, J CLIN ENDOCR METAB, V91, P2159, DOI 10.1210/jc.2005-1833; Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103; Franklyn JA, 1999, J ROY COLL PHYS LOND, V33, P564; GOLDMAN MB, 1990, CANCER RES, V50, P2283; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Haentjens P, 2008, EUR J ENDOCRINOL, V159, P329, DOI 10.1530/EJE-08-0110; HALL P, 1993, ACTA ENDOCRINOL-COP, V128, P230, DOI 10.1530/acta.0.1280230; HEGEDUS L, 1988, METABOLISM, V37, P229, DOI 10.1016/0026-0495(88)90100-X; Iglesias P, 2009, CLIN ENDOCRINOL, V70, P961, DOI 10.1111/j.1365-2265.2008.03421.x; Iglesias P, 2013, J CLIN ENDOCR METAB, V98, P4683, DOI 10.1210/jc.2012-3849; Jensen E, 2004, CLIN CHEM LAB MED, V42, P824, DOI 10.1515/CCLM.2004.136; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; LAURBERG P, 1991, J INTERN MED, V229, P415, DOI 10.1111/j.1365-2796.1991.tb00368.x; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; MALDONADO LS, 1992, THYROID, V2, P119, DOI 10.1089/thy.1992.2.119; McGue M, 2010, PERSPECT PSYCHOL SCI, V5, P546, DOI 10.1177/1745691610383511; McQuade C, 2011, THYROID, V21, P837, DOI 10.1089/thy.2010.0298; Metso S, 2007, J CLIN ENDOCR METAB, V92, P2190, DOI 10.1210/jc.2006-2321; Milla CE, 2012, PAEDIATR RESPIR REV, V13, P23, DOI 10.1016/j.prrv.2011.01.004; Mingote E, 2012, HORM-INT J ENDOCRINO, V11, P350, DOI 10.14310/horm.2002.1364; Nyirenda MJ, 2005, THYROID, V15, P718, DOI 10.1089/thy.2005.15.718; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Osman F, 2007, J AM COLL CARDIOL, V49, P71, DOI 10.1016/j.jacc.2006.08.042; Osman Faizel, 2001, Current Opinion in Pharmacology, V1, P626, DOI 10.1016/S1471-4892(01)00107-2; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; PETERSEN K, 1990, ARCH INTERN MED, V150, P2077, DOI 10.1001/archinte.150.10.2077; Radacsi A, 2003, ENDOCRINE, V21, P133, DOI 10.1385/ENDO:21:2:133; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; SLAG MF, 1981, JAMA-J AM MED ASSOC, V245, P43, DOI 10.1001/jama.245.1.43; Solanki A., 2013, INDIAN J ENDOCRINOL, V17, pS167, DOI [DOI 10.4103/2230-8210.119560, 10.4103/2230-8210.119560]; Sortso C, 2011, SCAND J PUBLIC HEALT, V39, P17, DOI 10.1177/1403494811399171; Stoving RK, 2001, INT J EAT DISORDER, V29, P230; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Thvilum M, 2014, THYROID IN PRESS; Thvilum M, 2013, J CLIN ENDOCR METAB, V98, P1069, DOI 10.1210/jc.2012-3375; Thvilum M, 2012, NAT REV ENDOCRINOL, V8, P417, DOI 10.1038/nrendo.2012.29; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P8, DOI 10.1177/1403494811409654; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; van den Beld AW, 2005, J CLIN ENDOCR METAB, V90, P6403, DOI 10.1210/jc.2005-0872; Vanderpump MPJ, 1996, THYROID, V6, P155; Volzke H, 2007, J CLIN ENDOCR METAB, V92, P2421, DOI 10.1210/jc.2007-0179; Yang LB, 2012, EUR J ENDOCRINOL, V167, P75, DOI 10.1530/EJE-12-0015	62	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110437	10.1371/journal.pone.0110437	http://dx.doi.org/10.1371/journal.pone.0110437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340819	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800036
J	Pachulec, E; Siewering, K; Bender, T; Heller, EM; Salgado-Pabon, W; Schmoller, SK; Woodhams, KL; Dillard, JP; van der Does, C				Pachulec, Emilia; Siewering, Katja; Bender, Tobias; Heller, Eva-Maria; Salgado-Pabon, Wilmara; Schmoller, Shelly K.; Woodhams, Katelynn L.; Dillard, Joseph P.; van der Does, Chris			Functional Analysis of the Gonococcal Genetic Island of Neisseria gonorrhoeae	PLOS ONE			English	Article							IV SECRETION SYSTEM; T-PILUS BIOGENESIS; CHROMOSOMAL DNA; SUBSTRATE SELECTION; PROTEIN; MENINGITIDIS; MUTAGENESIS; DIVERSITY; HOMOLOG; VIRB9	Neisseria gonorrhoeae is an obligate human pathogen that is responsible for the sexually-transmitted disease gonorrhea. N. gonorrhoeae encodes a T4SS within the Gonococcal Genetic Island (GGI), which secretes ssDNA directly into the external milieu. Type IV secretion systems (T4SSs) play a role in horizontal gene transfer and delivery of effector molecules into target cells. We demonstrate that GGI-like T4SSs are present in other beta-proteobacteria, as well as in alpha- and gamma-proteobacteria. Sequence comparison of GGI-like T4SSs reveals that the GGI-like T4SSs form a highly conserved unit that can be found located both on chromosomes and on plasmids. To better understand the mechanism of DNA secretion by N. gonorrhoeae, we performed mutagenesis of all genes encoded within the GGI, and studied the effects of these mutations on DNA secretion. We show that genes required for DNA secretion are encoded within the yaa-atlA and parA-parB regions, while genes encoded in the yfeB-exp1 region could be deleted without any effect on DNA secretion. Genes essential for DNA secretion are encoded within at least four different operons.	[Pachulec, Emilia] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Siewering, Katja; Bender, Tobias; Heller, Eva-Maria; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Salgado-Pabon, Wilmara; Schmoller, Shelly K.; Woodhams, Katelynn L.; Dillard, Joseph P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Groningen; Max Planck Society; University of Wisconsin System; University of Wisconsin Madison	van der Does, C (corresponding author), Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany.	does@mpi-marburg.mpg.de	Salgado-Pabon, Wilmara/N-9443-2018	Salgado-Pabon, Wilmara/0000-0003-0854-1568	University of Groningen; Max Planck Institute; US National Institutes of Health [AI047958]; NIH [T32 AI055397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055397, R01AI047958] Funding Source: NIH RePORTER	University of Groningen; Max Planck Institute(Max Planck Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in the van der Does lab was funded by intramural funds of the University of Groningen and the Max Planck Institute. Work in the Dillard lab was supported by US National Institutes of Health grant AI047958 to JPD. WSP was also supported by a traineeship on NIH grant T32 AI055397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmakuri K, 2007, EMBO J, V26, P2540, DOI 10.1038/sj.emboj.7601696; Bhatty M, 2013, RES MICROBIOL, V164, P620, DOI 10.1016/j.resmic.2013.03.012; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; BOYLEVAVRA S, 1995, GENE, V155, P101, DOI 10.1016/0378-1119(94)00890-5; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; Dillard J. P., 2006, CURR PROTOC MICROBIO, V2; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dominguez NM, 2011, J BACTERIOL, V193, P377, DOI 10.1128/JB.00948-10; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Guglielmini J, 2013, MOL BIOL EVOL, V30, P315, DOI 10.1093/molbev/mss221; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; Jain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035285; Jain S, 2011, J BIOL CHEM, V286, P43601, DOI 10.1074/jbc.M111.264028; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Jakubowski SJ, 2003, J BACTERIOL, V185, P2867, DOI 10.1128/JB.185.9.2867-2878.2003; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kohler PL, 2007, J BACTERIOL, V189, P5421, DOI 10.1128/JB.00531-07; Kohler PL, 2013, J BACTERIOL, V195, P1666, DOI 10.1128/JB.02098-12; MORSE SA, 1974, P SOC EXP BIOL MED, V145, P1418; Ramsey ME, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00061; Sagulenko E, 2001, J BACTERIOL, V183, P5813, DOI 10.1128/JB.183.20.5813-5825.2001; Salgado-Pabon W, 1912, J BACTERIOL, V192; Salgado-Pabon W, 2007, MOL MICROBIOL, V66, P930, DOI 10.1111/j.1365-2958.2007.05966.x; Salgado-Pabon W, 2010, J BACTERIOL, V192, P1912, DOI 10.1128/JB.01357-09; Snyder LAS, 2005, MICROBIOL-SGM, V151, P4005, DOI 10.1099/mic.0.27925-0; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x; Waksman G, 2010, TRENDS BIOCHEM SCI, V35, P691, DOI 10.1016/j.tibs.2010.06.002; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; WEISS AA, 1993, P NATL ACAD SCI USA, V90, P2970, DOI 10.1073/pnas.90.7.2970; Woodhams KL, 2012, J BACTERIOL, V194, P2275, DOI 10.1128/JB.00094-12; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207; Zola TA, 2010, INFECT IMMUN, V78, P2429, DOI 10.1128/IAI.00228-10; Zweig MA, 2013, ENV MICROBIOL	39	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109613	10.1371/journal.pone.0109613	http://dx.doi.org/10.1371/journal.pone.0109613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340397	Green Submitted, gold, Green Published			2022-12-26	WOS:000343662800011
J	Padial, AA; Ceschin, F; Declerck, SAJ; De Meester, L; Bonecker, CC; Lansac-Toha, FA; Rodrigues, L; Rodrigues, LC; Train, S; Velho, LFM; Bini, LM				Padial, Andre A.; Ceschin, Fernanda; Declerck, Steven A. J.; De Meester, Luc; Bonecker, Claudia C.; Lansac-Toha, Fabio A.; Rodrigues, Liliana; Rodrigues, Luzia C.; Train, Sueli; Velho, Luiz F. M.; Bini, Luis M.			Dispersal Ability Determines the Role of Environmental, Spatial and Temporal Drivers of Metacommunity Structure	PLOS ONE			English	Article							RELATIVE IMPORTANCE; STREAM NETWORKS; BETA-DIVERSITY; AUTOCORRELATION; LIMITATION; TRAITS; RIVER; COMMUNITIES; ASSEMBLAGES; INCREASES	Recently, community ecologists are focusing on the relative importance of local environmental factors and proxies to dispersal limitation to explain spatial variation in community structure. Albeit less explored, temporal processes may also be important in explaining species composition variation in metacommunities occupying dynamic systems. We aimed to evaluate the relative role of environmental, spatial and temporal variables on the metacommunity structure of different organism groups in the Upper Parana River floodplain (Brazil). We used data on macrophytes, fish, benthic macroinvertebrates, zooplankton, periphyton, and phytoplankton collected in up to 36 habitats during a total of eight sampling campaigns over two years. According to variation partitioning results, the importance of predictors varied among biological groups. Spatial predictors were particularly important for organisms with comparatively lower dispersal ability, such as aquatic macrophytes and fish. On the other hand, environmental predictors were particularly important for organisms with high dispersal ability, such as microalgae, indicating the importance of species sorting processes in shaping the community structure of these organisms. The importance of watercourse distances increased when spatial variables were the main predictors of metacommunity structure. The contribution of temporal predictors was low. Our results emphasize the strength of a trait-based analysis and of better defining spatial variables. More importantly, they supported the view that "all-or- nothing" interpretations on the mechanisms structuring metacommunities are rather the exception than the rule.	[Padial, Andre A.] Univ Fed Parana, Dept Bot, BR-80060000 Curitiba, Parana, Brazil; [Padial, Andre A.; Ceschin, Fernanda] Univ Fed Parana, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil; [Declerck, Steven A. J.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [De Meester, Luc] Univ Leuven, KU Leuven, Lab Aquat Ecol Evolut & Conservat, Leuven, Belgium; [Bonecker, Claudia C.; Lansac-Toha, Fabio A.; Rodrigues, Liliana; Rodrigues, Luzia C.; Train, Sueli; Velho, Luiz F. M.] Univ Estadual Maringa, Nucleo Pesquisa Limnol Ictiol & Aquicultura Nupel, Maringa, Parana, Brazil; [Bini, Luis M.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); KU Leuven; Universidade Estadual de Maringa; Universidade Federal de Goias	Padial, AA (corresponding author), Univ Fed Parana, Dept Bot, BR-80060000 Curitiba, Parana, Brazil.	aapadial@gmail.com	Bonecker, Claudia C/D-5946-2013; Rodrigues, Luzia C/B-7856-2017; Padial, Andre Andrian/H-8977-2012; De Meester, Luc/F-3832-2015; Lansac-Toha, Fábio A/I-3556-2016; Velho, Luiz Felipe Machado/I-9130-2016; Rodrigues, Luzia/AAB-2194-2021; Bini, Luis Mauricio/D-5865-2013; Declerck, Steven/E-4338-2010; KNAW, NIOO-KNAW/A-4320-2012	Bonecker, Claudia C/0000-0003-4338-9012; Rodrigues, Luzia C/0000-0002-0593-0931; Padial, Andre Andrian/0000-0002-8766-5974; De Meester, Luc/0000-0001-5433-6843; Velho, Luiz Felipe Machado/0000-0001-8111-4955; Rodrigues, Luzia/0000-0002-0593-0931; Bini, Luis Mauricio/0000-0003-3398-9399; Declerck, Steven/0000-0001-6179-667X; KNAW, NIOO-KNAW/0000-0002-3835-159X	CNPq; CAPES; KU Leuven [PF/2010/07]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); KU Leuven(KU Leuven)	CNPq (http://www.cnpq.br/) and CAPES (http://www.capes.gov.br/) provided scholarships. KU Leuven (http://www.kuleuven.be/) provided research fund grant PF/2010/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho AA, 2004, REV FISH BIOL FISHER, V14, P11, DOI 10.1007/s11160-004-3551-y; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bellier E, 2013, ECOGRAPHY, V36; Bengtsson J, 1997, OIKOS, V78, P249, DOI 10.2307/3546291; Bini LM, 2014, ECOLOGY, V95, P1569, DOI 10.1890/13-0656.1; Bivand R., 2017, SPDEP SPATIAL DEPEND; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Chang LW, 2013, ECOLOGY, V94, P2145, DOI 10.1890/12-2053.1; Chase JM, 2005, FUNCT ECOL, V19, P182, DOI 10.1111/j.0269-8463.2005.00937.x; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Diniz JAF, 2012, OIKOS, V121, P201, DOI 10.1111/j.1600-0706.2011.19563.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Heino J, 2008, ECOL ENTOMOL, V33, P614, DOI 10.1111/j.1365-2311.2008.01012.x; Heino J, 2013, OECOLOGIA, V171, P971, DOI 10.1007/s00442-012-2451-4; Hubbell Stephen P., 2001, V32, pi; Jellyman PG, 2013, FRESHWATER BIOL, V58, P2614, DOI 10.1111/fwb.12238; Junk WJ, 1989, CANADIAN SPECIAL PUB, V106, P110, DOI DOI 10.1016/J.MATCHEMPHYS.2012.10.032; Landeiro VL, 2011, FRESHWATER BIOL, V56, P1184, DOI 10.1111/j.1365-2427.2010.02563.x; Landeiro VL, 2012, FRESHWATER BIOL, V57, P1554, DOI 10.1111/j.1365-2427.2012.02816.x; Langenheder S, 2012, ISME J, V6, P1107, DOI 10.1038/ismej.2011.177; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2010, ECOLOGY, V91, P262, DOI 10.1890/09-0199.1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Liu J, 2013, J BIOGEOGR, V40, P2238, DOI 10.1111/jbi.12160; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Padial AA, 2012, ECOL INDIC, V13, P55, DOI 10.1016/j.ecolind.2011.05.007; Padial AA, 2009, AQUAT SCI, V71, P389, DOI 10.1007/s00027-009-0109-z; Pavanelli CS., 2007, PEIXES PLANICIE INUN; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Peterson EE, 2006, ENVIRON MONIT ASSESS, V121, P615, DOI 10.1007/s10661-005-9163-8; R Core Team, 2021, R LANGUAGE ENV STAT; Roach KA, 2014, FRESHWATER BIOL, V59, P1278, DOI 10.1111/fwb.12347; Rouquette JR, 2013, DIVERS DISTRIB, V19, P1429, DOI 10.1111/ddi.12120; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Stendera S, 2012, HYDROBIOLOGIA, V696, P1, DOI 10.1007/s10750-012-1183-0; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Thomaz SM, 2004, BIO INL WAT, P75; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vanormelingen P, 2008, FRESHWATER BIOL, V53, P2170, DOI 10.1111/j.1365-2427.2008.02040.x; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Wetzel CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045071	50	184	193	5	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111227	10.1371/journal.pone.0111227	http://dx.doi.org/10.1371/journal.pone.0111227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340577	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800094
J	Poddighe, S; De Rose, F; Marotta, R; Ruffilli, R; Fanti, M; Secci, PP; Mostallino, MC; Setzu, MD; Zuncheddu, MA; Collu, I; Solla, P; Marrosu, F; Kasture, S; Acquas, E; Liscia, A				Poddighe, Simone; De Rose, Francescaelena; Marotta, Roberto; Ruffilli, Roberta; Fanti, Maura; Secci, Pietro Paolo; Mostallino, Maria Cristina; Setzu, Maria Dolores; Zuncheddu, Maria Antonietta; Collu, Ignazio; Solla, Paolo; Marrosu, Francesco; Kasture, Sanjay; Acquas, Elio; Liscia, Anna			Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1(B9) Drosophila melanogaster Genetic Model of Parkinson's Disease (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							ANTIPARKINSON DRUG; DYSFUNCTION; NEURODEGENERATION; PATHOLOGY; DOPAMINE; EXTRACT; FRUIT	The fruit fly Drosophila melanogaster (Dm) mutant for PTEN-induced putative kinase 1 (PINK1(B9)) gene is a powerful tool to investigate physiopathology of Parkinson's disease (PD). Using PINK1(B9) mutant Dm we sought to explore the effects of Mucuna pruriens methanolic extract (Mpe), a L-Dopa-containing herbal remedy of PD. The effects of Mpe on PINK1(B9) mutants, supplied with standard diet to larvae and adults, were assayed on 3-6 (I), 10-15 (II) and 20-25 (III) days old flies. Mpe 0.1% significantly extended lifespan of PINK1(B9) and fully rescued olfactory response to 1-hexanol and improved climbing behavior of PINK1(B9) of all ages; in contrast, L-Dopa (0.01%, percentage at which it is present in Mpe 0.1%) ameliorated climbing of only PINK1(B9) flies of age step II. Transmission electron microscopy analysis of antennal lobes and thoracic ganglia of PINK1(B9) revealed that Mpe restored to wild type (WT) levels both T-bars and damaged mitochondria. Western blot analysis of whole brain showed that Mpe, but not L-Dopa on its own, restored bruchpilot (BRP) and tyrosine hydroxylase (TH) expression to age-matched WT control levels. These results highlight multiple sites of action of Mpe, suggesting that its effects cannot only depend upon its L-Dopa content and support the clinical observation of Mpe as an effective medication with intrinsic ability of delaying the onset of chronic L-Dopa-induced long-term motor complications. Overall, this study strengthens the relevance of using PINK1(B9) Dm as a translational model to study the properties of Mucuna pruriens for PD treatment.	[Poddighe, Simone; Fanti, Maura; Setzu, Maria Dolores] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [De Rose, Francescaelena; Zuncheddu, Maria Antonietta; Collu, Ignazio; Acquas, Elio; Liscia, Anna] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Marotta, Roberto; Ruffilli, Roberta] Ist Italiano Tecnol, Nanochem Dept, Electron Microscopy Lab, Genoa, Italy; [Secci, Pietro Paolo; Mostallino, Maria Cristina] CNR, Inst Neurosci, Cagliari, Italy; [Solla, Paolo; Marrosu, Francesco] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy; [Kasture, Sanjay] Sanjivani Coll Pharmaceut Educ & Res, Ahmednagar, Maharashtra, India; [Acquas, Elio] Univ Cagliari, Ctr Excellence Study Neurobiol Addict, Cagliari, Italy; [Acquas, Elio] Univ Cagliari, Natl Inst Neurosci INN, Cagliari, Italy	University of Cagliari; University of Cagliari; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; University of Cagliari; University of Cagliari	Liscia, A (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.	liscia@unica.it	Marotta, Roberto/B-5382-2014; Solla, Paolo/R-5366-2016; Marotta, Roberto/HGV-1599-2022; Solla, Paolo/GQZ-7556-2022; Solla, Paolo/AAL-9671-2020	Solla, Paolo/0000-0002-2982-0665; Marotta, Roberto/0000-0003-0634-5483; Poddighe, Simone/0000-0002-7244-9240; Liscia, Anna/0000-0002-1629-2090; Acquas, Elio/0000-0002-4783-9319; Setzu, Maria Dolores/0000-0002-6934-4042				Bjorklund A, 2010, PROG BRAIN RES, V184, P3, DOI 10.1016/S0079-6123(10)84001-4; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brooks David J, 2008, Neuropsychiatr Dis Treat, V4, P39; Celotto AM, 2005, MOL INTERV, V5, P292, DOI 10.1124/mi.5.5.9; Chambers RP, 2013, BEHAV BRAIN RES, V253, P95, DOI 10.1016/j.bbr.2013.07.020; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Dhanasekaran M, 2008, PHYTOTHER RES, V22, P6, DOI 10.1002/ptr.2109; Ferraris A, 2009, MOVEMENT DISORD, V24, P2350, DOI 10.1002/mds.22816; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fox SH, 2013, DRUGS, V73, P1405, DOI 10.1007/s40265-013-0105-4; Gil S, 2010, CELL MOL NEUROBIOL, V30, P817, DOI 10.1007/s10571-010-9509-9; Haehner A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/450939; Humphrey DM, 2012, HUM MOL GENET, V21, P2698, DOI 10.1093/hmg/dds096; Kasture S, 2013, ORIENTAL PHARM EXP M, V13, P165, DOI 10.1007/s13596-013-0126-2; Katzenschlager R, 2004, J NEUROL NEUROSUR PS, V75, P1672, DOI 10.1136/jnnp.2003.028761; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Katzenschlager Regina, 2002, J Neurol, V249 Suppl 2, pII19; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Knott A, 2009, ANN NY ACAD SCI, V1147, P283; Lieu CA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/840247; Lieu CA, 2010, PARKINSONISM RELAT D, V16, P458, DOI 10.1016/j.parkreldis.2010.04.015; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Liu ZH, 2011, PHARMACOL RES, V63, P439, DOI 10.1016/j.phrs.2011.01.004; Manyam BV, 2004, PHYTOTHER RES, V18, P706, DOI 10.1002/ptr.1514; Mercuri NB, 2005, TRENDS PHARMACOL SCI, V26, P341, DOI 10.1016/j.tips.2005.05.002; Moisoi N, 2014, NEUROPHARMACOLOGY, V77, P350, DOI 10.1016/j.neuropharm.2013.10.009; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Morelli Micaela, 2009, Handb Exp Pharmacol, P589, DOI 10.1007/978-3-540-89615-9_18; Obata T, 2001, BRAIN RES, V906, P170, DOI 10.1016/S0006-8993(01)02238-7; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poddighe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073156; Porras G, 2014, SCI REP-UK, V4, DOI 10.1038/srep03730; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Tufi R, 2014, NAT CELL BIOL, V16, P157, DOI 10.1038/ncb2901; Wagh DA, 2006, BRUCHPILOT PROTEIN; Wang J, 2011, AM J NEURORADIOL, V32, P677, DOI 10.3174/ajnr.A2350; Yadav SK, 2014, NEUROCHEM INT, V65, P1, DOI 10.1016/j.neuint.2013.12.001; Yadav SK, 2013, NEUROCHEM INT, V62, P1039, DOI 10.1016/j.neuint.2013.03.015; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131	46	26	28	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110802	10.1371/journal.pone.0110802	http://dx.doi.org/10.1371/journal.pone.0110802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340511	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800057
J	Schaarschmidt, J; Huth, S; Meier, R; Paschke, R; Jaeschke, H				Schaarschmidt, Joerg; Huth, Sandra; Meier, Rene; Paschke, Ralf; Jaeschke, Holger			Influence of the Hinge Region and Its Adjacent Domains on Binding and Signaling Patterns of the Thyrotropin and Follitropin Receptor	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; EXTRACELLULAR DOMAIN; TSH RECEPTOR; LIGAND-BINDING; AMINO-ACIDS; ECTODOMAIN; RESIDUES; COMPLEX; MUTAGENESIS; ACTIVATION	Glycoprotein hormone receptors (GPHR) have a large extracellular domain (ECD) divided into the leucine rich repeat (LRR) domain for binding of the glycoprotein hormones and the hinge region (HinR), which connects the LRR domain with the transmembrane domain (TMD). Understanding of the activation mechanism of GPHRs is hindered by the unknown interaction of the ECD with the TMD and the structural changes upon ligand binding responsible for receptor activation. Recently, our group showed that the HinR of the thyrotropin receptor (TSHR) can be replaced by those of the follitropin (FSHR) and lutropin receptor (LHCGR) without effects on surface expression and hTSH signaling. However, differences in binding characteristics for bovine TSH at the various HinRs were obvious. To gain further insights into the interplay between LRR domain, HinR and TMD we generated chimeras between the TSHR and FSHR. Our results obtained by the determination of cell surface expression, ligand binding and G protein activation confirm the similar characteristics of GPHR HinRs but they also demonstrate an involvement of the HinR in ligand selectivity indicated by the observed promiscuity of some chimeras. While the TSHR HinR contributes to specific binding of TSH and its variants, no such contribution is observed for FSH and its analog TR4401 at the HinR of the FSHR. Furthermore, the charge distribution at the poorly characterized LRR domain/HinR transition affected ligand binding and signaling even though this area is not in direct contact with the ligand. In addition our results also demonstrate the importance of the TMD/HinR interface. Especially the combination of the TSHR HinR with the FSHR-TMD resulted in a loss of cell surface expression of the respective chimeras. In conclusion, the HinRs of GPHRs do not only share similar characteristics but also behave as ligand specific structural and functional entities.	[Schaarschmidt, Joerg; Huth, Sandra; Paschke, Ralf; Jaeschke, Holger] Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Endocrinol & Nephrol, D-04109 Leipzig, Germany; [Meier, Rene] Univ Leipzig, Inst Biochem, D-04109 Leipzig, Germany	Leipzig University; Leipzig University	Jaeschke, H (corresponding author), Univ Leipzig, Dept Internal Med Neurol & Dermatol, Div Endocrinol & Nephrol, D-04109 Leipzig, Germany.	holger.jaeschke@medizin.uni-leipzig.de	Schaarschmidt, Joerg/A-9449-2017	Schaarschmidt, Joerg/0000-0002-4389-2366; Meier, Rene/0000-0002-1501-1349	Deutsche Forschungsgemeinschaft (DFG) [Ja 1927/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) Ja 1927/1-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons EJ, 2001, VIROLOGY, V287, P382, DOI 10.1006/viro.2001.1046; Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Angelova K, 2010, J BIOL CHEM, V285, P34813, DOI 10.1074/jbc.M110.148221; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2010, ENDOCRINOLOGY, V151, P1940, DOI 10.1210/en.2009-1430; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Couet J, 1996, J BIOL CHEM, V271, P4545; de Bernard S, 1999, J BIOL CHEM, V274, P101, DOI 10.1074/jbc.274.1.101; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaeschke H, 2011, ENDOCRINOLOGY, V152, P3986, DOI 10.1210/en.2011-1389; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; Krause G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052920; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Miguel RN, 2008, J MOL ENDOCRINOL, V41, P145, DOI 10.1677/JME-08-0040; Montanelli L, 2004, MOL ENDOCRINOL, V18, P2061, DOI 10.1210/me.2004-0036; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2010, METHOD ENZYMOL, V485, P421, DOI [10.1016/S0076-6879(10)85023-2, 10.1016/B978-0-12-381296-4.00023-3]; Mueller S, 2010, TRENDS ENDOCRIN MET, V21, P111, DOI 10.1016/j.tem.2009.09.001; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1990, BIOCHEM BIOPH RES CO, V173, P1150, DOI 10.1016/S0006-291X(05)80906-4; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Quellari M, 2003, EUR J BIOCHEM, V270, P3486, DOI 10.1046/j.1432-1033.2003.03718.x; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Smits G, 2003, NEW ENGL J MED, V349, P760, DOI 10.1056/NEJMoa030064; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Troppmann B, 2013, HUM REPROD UPDATE, V19, P583, DOI 10.1093/humupd/dmt023; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vischer HF, 2006, MOL ENDOCRINOL, V20, P1880, DOI 10.1210/me.2005-0202; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	45	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							111570	10.1371/journal.pone.0111570	http://dx.doi.org/10.1371/journal.pone.0111570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340405	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800110
J	Hu, J; Muller, KA; Furnari, FB; Cavenee, WK; VandenBerg, SR; Gonias, SL				Hu, J.; Muller, K. A.; Furnari, F. B.; Cavenee, W. K.; VandenBerg, S. R.; Gonias, S. L.			Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; UROKINASE PLASMINOGEN-ACTIVATOR; BREAST-CANCER CELLS; SRC-FAMILY KINASES; CONFERS ENHANCED TUMORIGENICITY; TYROSINE KINASE; MUTANT EGFR; PHASE-II; IN-VIVO; C-SRC	In glioblastoma (GBM), the EGF receptor (EGFR) and Src family kinases (SFKs) contribute to an aggressive phenotype. EGFR may be targeted therapeutically; however, resistance to EGFR-targeting drugs such as Erlotinib and Gefitinib develops quickly. In many GBMs, a truncated form of the EGFR (EGFRvIII) is expressed. Although EGFRvIII is constitutively active and promotes cancer progression, its activity is attenuated compared with EGF-ligated wild-type EGFR, suggesting that EGFRvIII may function together with other signaling receptors in cancer cells to induce an aggressive phenotype. In this study, we demonstrate that in EGFRvIII-expressing GBM cells, the urokinase receptor (uPAR) functions as a major activator of SFKs, controlling phosphorylation of downstream targets, such as p130Cas and Tyr-845 in the EGFR in vitro and in vivo. When EGFRvIII expression in GBM cells was neutralized, either genetically or by treating the cells with Gefitinib, paradoxically, the cells demonstrated increased cell migration. The increase in cell migration was explained by a compensatory increase in expression of urokinase-type plasminogen activator, which activates uPAR-dependent cell signaling. GBM cells that were selected for their ability to grow in vivo in the absence of EGFRvIII also demonstrated increased cell migration, due to activation of the uPAR signaling system. The increase in GBM cell migration, induced by genetic or pharmacologic targeting of the EGFR, was blocked by Dasatinib, highlighting the central role of SFKs in uPAR-promoted cell migration. These results suggest that compensatory activation of uPAR-dependent cell signaling, in GBM cells treated with targeted therapeutics, may adversely affect the course of the disease by promoting cell migration, which may be associated with tumor progression.	[Hu, J.; Muller, K. A.; Furnari, F. B.; VandenBerg, S. R.; Gonias, S. L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Furnari, F. B.; Cavenee, W. K.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Cavenee, W. K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Gonias, SL (corresponding author), UCSD, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sgonias@ucsd.edu	Jones, Karra A/GXM-8805-2022	Jones, Karra A/0000-0002-8819-8992; Furnari, Frank/0000-0003-1909-4361	NIH [R01 CA169096, R01 NS080939]; Defeat GBM Research Collaborative; subsidiary of National Brain Tumor Society; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA169096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defeat GBM Research Collaborative; subsidiary of National Brain Tumor Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 CA169096 (to SLG), R01 NS080939 (to FBF) and the Defeat GBM Research Collaborative, a subsidiary of National Brain Tumor Society (to WKC and FBF). WKC is a Fellow of the National Foundation for Cancer Research. We would like to thank Aran Merati and Nancy Du for their technical assistance with some of the experiments.	Ahluwalia MS, 2010, CANCER LETT, V298, P139, DOI 10.1016/j.canlet.2010.08.014; Alfano D, 2005, THROMB HAEMOSTASIS, V93, P205, DOI 10.1160/TH04-09-0592; Alfano D, 2006, J BIOL CHEM, V281, P17758, DOI 10.1074/jbc.M601812200; Alper O, 2005, CURR PHARM DESIGN, V11, P1119, DOI 10.2174/1381612053507576; BesnardGuerin C, 1996, HUM GENET, V97, P163, DOI 10.1007/BF02265259; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; Carriero MV, 2011, CURR DRUG TARGETS, V12, P1761; Carriero MV, 1999, CANCER RES, V59, P5307; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chandrasekar N, 2003, ONCOGENE, V22, P392, DOI 10.1038/sj.onc.1206164; Chumbalkar V, 2011, J PROTEOME RES, V10, P1343, DOI 10.1021/pr101075e; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; Degryse B, 1999, BLOOD, V94, P649, DOI 10.1182/blood.V94.2.649.414k34_649_662; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Eastman BM, 2012, CELL SIGNAL, V24, P1847, DOI 10.1016/j.cellsig.2012.05.011; ELLIS V, 1993, METHOD ENZYMOL, V223, P223; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Franceschi E, 2007, BRIT J CANCER, V96, P1047, DOI 10.1038/sj.bjc.6603669; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huveldt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056505; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jo M, 2007, ONCOGENE, V26, P2585, DOI 10.1038/sj.onc.1210066; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Jo M, 2009, AM J PATHOL, V175, P190, DOI 10.2353/ajpath.2009.081053; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Kubota Y, 2001, EMBO J, V20, P5666, DOI 10.1093/emboj/20.20.5666; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Lu-Emerson C, 2011, J NEURO-ONCOL, V104, P287, DOI 10.1007/s11060-010-0489-x; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Ma Z, 2001, J CELL SCI, V114, P3387; Mazar AP, 2011, CURR PHARM DESIGN, V17, P1970; Montuori N, 2013, THROMB HAEMOSTASIS, V109, P309, DOI 10.1160/TH12-08-0546; Mukasa A, 2010, P NATL ACAD SCI USA, V107, P2616, DOI 10.1073/pnas.0914356107; Nagane M, 1996, CANCER RES, V56, P5079; Nguyen DHD, 2000, J BIOL CHEM, V275, P19382, DOI 10.1074/jbc.M909575199; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Parker JJ, 2013, NEURO-ONCOLOGY, V15, P1048, DOI 10.1093/neuonc/not053; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sato K, 2013, INT J MOL SCI, V14, P10761, DOI 10.3390/ijms140610761; SCHLEGEL J, 1994, J NEURO-ONCOL, V22, P201, DOI 10.1007/BF01052920; SCHLEGEL J, 1994, INT J CANCER, V56, P72; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shi ZG, 2011, MOL CELL BIOCHEM, V357, P151, DOI 10.1007/s11010-011-0885-3; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Stettner AR, 2005, CANCER RES, V65, P5535, DOI 10.1158/0008-5472.CAN-04-3688; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Wykosky J, 2010, CELL CYCLE, V9, P1661, DOI 10.4161/cc.9.9.11592; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yu W, 1997, J CELL BIOL, V137, P767, DOI 10.1083/jcb.137.3.767; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	67	15	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	31					4078	4088		10.1038/onc.2014.336	http://dx.doi.org/10.1038/onc.2014.336			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN9PE	25347738	Green Accepted, Green Submitted			2022-12-26	WOS:000358780500006
J	Zhao, FP; Xu, G; Zhou, YQ; Wang, LY; Xie, JJ; Ren, S; Liu, S; Zhu, Y				Zhao, Fanpeng; Xu, Gang; Zhou, Yaqin; Wang, Lvyin; Xie, Jiajia; Ren, Sheng; Liu, Shi; Zhu, Ying			MicroRNA-26b Inhibits Hepatitis B Virus Transcription and Replication by Targeting the Host Factor CHORDC1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatitis Virus; Host-Pathogen Interaction; Infectious Disease; MicroRNA (miRNA); Viral Transcription; CHORDC1; Hepatitis B Virus; Host Factor; MicroRNA-26b; Viral Infection	GENE-EXPRESSION; CARCINOMA; DISEASE; CANCER; HETEROZYGOSITY; RESISTANCE; INFECTION; APOPTOSIS; SEQUENCE; ENHANCER	Background: Disordered miR-26b expression has been linked to the development of many diseases induced by hepatitis B virus (HBV). Results: miR-26b inhibits HBV replication, and HBV infection suppresses miR-26b expression. Conclusion: miR-26b acts as a host restriction factor to attenuate HBV transcription and replication. Significance: The functional interplay between HBV infection and miR-26b may influence the outcome of viral proliferation and virus-induced diseases. Hepatitis B virus (HBV) causes acute and chronic hepatitis in humans, and HBV infection is a major threat to global health. HBV replication is regulated by a series of host factors, including microRNAs (miRNAs), which are highly conserved small noncoding RNAs that participate in a variety of physiological and pathological processes. Here, we report that a chemically synthesized mimic of miR-26b inhibited HBV antigen expression, transcription, and replication, whereas antisense knockdown of endogenous miR-26b enhanced HBV replication in HepG2 cells. Overexpression and knockdown experiments showed that miR-26b significantly decreased HBV enhancer/promoter activities. We identified the cysteine- and histidine-rich domain containing 1 (CHORDC1) as a novel host factor target of miR-26b. CHORDC1 protein but not mRNA was markedly decreased by miR-26b overexpression via base-pairing with complementary sequences in the 3UTR of its mRNA. Overexpression and knockdown studies showed that CHORDC1 increased viral antigen expression, transcription, and replication by elevating HBV enhancer/promoter activities. Conversely, HBV infection suppressed miR-26b expression and increased CHORDC1 protein levels in human liver cells. Another mature miRNA of the hsa-miR-26 family, miR-26a, had a similar function as miR-26b in targeting CHORDC1 and affecting HBV production. These results suggest that suppression of miR-26b expression up-regulates its target gene CHORDC1, which increases HBV enhancer/promoter activities and promotes viral transcription, gene expression, and replication. Our study could provide new insights into miRNA expression and the persistence of HBV infection.	[Zhao, Fanpeng; Xu, Gang; Zhou, Yaqin; Wang, Lvyin; Xie, Jiajia; Ren, Sheng; Liu, Shi; Zhu, Ying] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Zhu, Y (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	yingzhu@whu.edu.cn	Zhao, Fanpeng/X-9816-2019		Major State Basic Research Development Program of China [2013CB911102]; National Natural Science Foundation of China [81461130019, 81271821]; National Mega Project on Major Infectious Diseases Prevention [2012ZX10004503-004]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Diseases Prevention	This work was supported by Major State Basic Research Development Program of China Grant 2013CB911102, National Natural Science Foundation of China Grants 81461130019 and 81271821, and National Mega Project on Major Infectious Diseases Prevention Grant 2012ZX10004503-004.	Absalon S, 2013, J NEUROSCI, V33, P14645, DOI 10.1523/JNEUROSCI.1327-13.2013; ANTONUCCI TK, 1989, J VIROL, V63, P579, DOI 10.1128/JVI.63.2.579-583.1989; Arora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023802; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Brancaccio M, 2003, FEBS LETT, V551, P47, DOI 10.1016/S0014-5793(03)00892-5; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Doitsh G, 2004, MOL CELL BIOL, V24, P1799, DOI 10.1128/MCB.24.4.1799-1808.2004; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Ferretti R, 2010, DEV CELL, V18, P486, DOI 10.1016/j.devcel.2009.12.020; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Gao J, 2011, ONCOL LETT, V2, P1019, DOI 10.3892/ol.2011.413; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Guo HY, 2011, HEPATOLOGY, V54, P808, DOI 10.1002/hep.24441; Hong TJ, 2013, J BIOL CHEM, V288, P215, DOI 10.1074/jbc.M112.398636; Hoppe-Seyler K, 2012, HEPATOLOGY, V56, P9, DOI 10.1002/hep.25602; Hu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034165; Huang S, 2011, BRIT J CANCER, V104, P235, DOI 10.1038/sj.bjc.6606010; Jackson R. J., 2007, SCI STKE, V2007, pe1; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu SC, 2002, MOL CARCINOGEN, V34, P131, DOI 10.1002/mc.10057; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Michowski W, 2010, BBA-MOL CELL RES, V1803, P1043, DOI 10.1016/j.bbamcr.2010.05.005; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shang LM, 2006, J BIOL CHEM, V281, P1876, DOI 10.1074/jbc.M509901200; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; SU H, 1992, P NATL ACAD SCI USA, V89, P2708, DOI 10.1073/pnas.89.7.2708; Thiagalingam S, 2002, CURR OPIN ONCOL, V14, P65, DOI 10.1097/00001622-200201000-00012; Thirion M, 2013, VIRUSES-BASEL, V5, P2690, DOI 10.3390/v5112690; Verghese ET, 2013, J PATHOL, V231, P388, DOI 10.1002/path.4248; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wang YL, 2013, J BIOL CHEM, V288, P18484, DOI 10.1074/jbc.M113.458158; WILL H, 1987, J VIROL, V61, P904, DOI 10.1128/JVI.61.3.904-911.1987; Wu JC, 2005, FEBS LETT, V579, P421, DOI 10.1016/j.febslet.2004.12.005; Wu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016264; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405; Zhang CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069963; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	46	37	40	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					35029	35041		10.1074/jbc.M114.589978	http://dx.doi.org/10.1074/jbc.M114.589978			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342750	hybrid, Green Published			2022-12-26	WOS:000346260800050
J	Caetano, AL; Marques, CR; Gavina, A; Carvalho, F; Goncalves, F; da Silva, EF; Pereira, R				Caetano, Ana Luisa; Marques, Catarina R.; Gavina, Ana; Carvalho, Fernando; Goncalves, Fernando; da Silva, Eduardo Ferreira; Pereira, Ruth			Contribution for the Derivation of a Soil Screening Value (SSV) for Uranium, Using a Natural Reference Soil	PLOS ONE			English	Article							ECOLOGICAL RISK-ASSESSMENT; ENZYME-ACTIVITIES; FOLSOMIA-CANDIDA; ECOSYSTEM SERVICES; EISENIA-ANDREI; HEAVY-METALS; HERBICIDE PHENMEDIPHAM; CONTAMINATED SOILS; DEPLETED URANIUM; CENTRAL PORTUGAL	In order to regulate the management of contaminated land, many countries have been deriving soil screening values (SSV). However, the ecotoxicological data available for uranium is still insufficient and incapable to generate SSVs for European soils. In this sense, and so as to make up for this shortcoming, a battery of ecotoxicological assays focusing on soil functions and organisms, and a wide range of endpoints was carried out, using a natural soil artificially spiked with uranium. In terrestrial ecotoxicology, it is widely recognized that soils have different properties that can influence the bioavailability and the toxicity of chemicals. In this context, SSVs derived for artificial soils or for other types of natural soils, may lead to unfeasible environmental risk assessment. Hence, the use of natural regional representative soils is of great importance in the derivation of SSVs. A Portuguese natural reference soil PTRS1, from a granitic region, was thereby applied as test substrate. This study allowed the determination of NOEC, LOEC, EC20 and EC50 values for uranium. Dehydrogenase and urease enzymes displayed the lowest values (34.9 and,134.5 mg U Kg, respectively). Eisenia andrei and Enchytraeus crypticus revealed to be more sensitive to uranium than Folsomia candida. EC50 values of 631.00, 518.65 and 851.64 mg U Kg were recorded for the three species, respectively. Concerning plants, only Lactuca sativa was affected by U at concentrations up to 1000 mg U kg(1). The outcomes of the study may in part be constrained by physical and chemical characteristics of soils, hence contributing to the discrepancy between the toxicity data generated in this study and that available in the literature. Following the assessment factor method, a predicted no effect concentration (PNEC) value of 15.5 mg kg(dw)(-1) was obtained for U. This PNEC value is proposed as a SSV for soils similar to the PTRS1.	[Caetano, Ana Luisa; Marques, Catarina R.; Goncalves, Fernando] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Caetano, Ana Luisa; Marques, Catarina R.; Gavina, Ana; Goncalves, Fernando] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Carvalho, Fernando] ITN, Dept Radiol Protect & Nucl Safety, Sacavem, Portugal; [da Silva, Eduardo Ferreira] Univ Aveiro, Dept Geosci, GeoBioTec Res Ctr, P-3800 Aveiro, Portugal; [Pereira, Ruth] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal; [Gavina, Ana; Pereira, Ruth] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4100 Oporto, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Lisboa; Universidade de Aveiro; Universidade do Porto; Universidade do Porto	Caetano, AL (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3800 Aveiro, Portugal.	ana.caetano@ua.pt	Caetano, Ana Luisa/AAI-1543-2020; Pereira, Ruth/AAY-3535-2021; Gonçalves, Fernando J. M./B-8000-2008; da Silva, Eduardo A Ferreira/B-3317-2012; da Silva, Eduardo Ferreira/AAT-5115-2020; Gavina, Ana Catarina Soares/T-8943-2017	Pereira, Ruth/0000-0001-6857-5968; Gonçalves, Fernando J. M./0000-0002-9326-187X; da Silva, Eduardo A Ferreira/0000-0002-3019-8471; da Silva, Eduardo Ferreira/0000-0002-3019-8471; Gavina, Ana Catarina Soares/0000-0001-5085-2197; Carvalho, Fernando da Piedade/0000-0002-6639-6138; Marques, Catarina/0000-0001-6908-8272; Caetano, Ana/0000-0001-7333-6312	Fundacao para a Ciencia e Tecnologia (FCT)	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	ALC was supported by a PhD grant from Fundacao para a Ciencia e Tecnologia (FCT) (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga P, 2008, CHEMOSPHERE, V72, P1774, DOI 10.1016/j.chemosphere.2008.04.042; Alvarenga P, 2012, ENVIRON POLLUT, V161, P50, DOI 10.1016/j.envpol.2011.09.044; Amorim MJB, 2005, CHEMOSPHERE, V61, P1102, DOI 10.1016/j.chemosphere.2005.03.048; Amorim MJB, 2005, ARCH ENVIRON CON TOX, V49, P343, DOI 10.1007/s00244-004-0220-z; Antunes S, 2011, SCI TOTAL ENVIRON, P410; Arogunjo AM, 2009, J ENVIRON RADIOACTIV, V100, P232, DOI 10.1016/j.jenvrad.2008.12.004; ASTDR, 2011, AG TOX SUBST DIS REG; Barrios E, 2007, ECOL ECON, V64, P269, DOI 10.1016/j.ecolecon.2007.03.004; Bednar AJ, 2007, CHEMOSPHERE, V70, P237, DOI 10.1016/j.chemosphere.2007.06.032; BERG P, 1985, BIOL FERT SOILS, V1, P131, DOI 10.1007/BF00301780; Bone J, 2010, ENVIRON INT, V36, P609, DOI 10.1016/j.envint.2010.04.010; Caetano AL, 2012, J ENVIRON MONITOR, V14, P925, DOI 10.1039/c2em10827e; Carlon C., 2007, DERIVATION METHODS S, P306; Carvalho F, 2011, J AM SCI ENV PUBL SC, V7, P547; Carvalho FP, 2007, J ENVIRON RADIOACTIV, V96, P39, DOI 10.1016/j.jenvrad.2007.01.016; Carvalho FP, 2009, B ENVIRON CONTAM TOX, V83, P668, DOI 10.1007/s00128-009-9808-3; Chelinho S, 2011, ENVIRON TOXICOL CHEM, V30, P1050, DOI 10.1002/etc.480; CLAPP J, 2012, OXFAM RES REPORTS, P1; Coppolecchia D, 2011, SOIL BIOL BIOCHEM, V43, P1798, DOI 10.1016/j.soilbio.2010.06.018; Dai J, 2004, APPL SOIL ECOL, V25, P99, DOI 10.1016/j.apsoil.2003.09.003; Domene X, 2011, ENVIRON TOXICOL CHEM, V30, P1497, DOI 10.1002/etc.533; Dominati E, 2010, ECOL ECON, V69, P1858, DOI 10.1016/j.ecolecon.2010.05.002; *FAOUN, 1984, SOILS B, V10, P1; Figueiredo MO, 2011, J GEOCHEM EXPLOR, V109, P134, DOI 10.1016/j.gexplo.2010.09.004; Fishwick S., 2004, SOIL SCREENING VALUE; Gavrilescu M, 2009, J HAZARD MATER, V163, P475, DOI 10.1016/j.jhazmat.2008.07.103; Geng F, 2012, J RADIOANAL NUCL CH, V292, P453, DOI 10.1007/s10967-011-1451-x; Geras'kin SA, 2007, J ENVIRON RADIOACTIV, V94, P151, DOI 10.1016/j.jenvrad.2007.01.003; Giovanetti A, 2010, J ENVIRON RADIOACTIV, V101, P509, DOI 10.1016/j.jenvrad.2010.03.003; Gongalsky KB, 2003, ENVIRON MONIT ASSESS, V89, P197, DOI 10.1023/A:1026031224658; Gopal R, 2008, CHEMOSPHERE, V70, P1539, DOI 10.1016/j.chemosphere.2007.08.043; Gulser F, 2008, ENVIRON MONIT ASSESS, V145, P127, DOI 10.1007/s10661-007-0022-7; Hobbelen PHF, 2006, ENVIRON POLLUT, V144, P639, DOI 10.1016/j.envpol.2006.01.019; Hofman J., 2009, P223, DOI 10.1007/978-0-387-88959-7_24; Hu B, 2013, ENVIRON TOXICOL CHEM, V32, P1109, DOI 10.1002/etc.2152; Hubalek T, 2007, ARCH ENVIRON CON TOX, V52, P1, DOI 10.1007/s00244-006-0030-6; International Organization for Standardization I., 1998, 112682 ISO; Islam E, 2011, INT BIODETER BIODEGR, V65, P1043, DOI 10.1016/j.ibiod.2011.08.005; *ISO, 2005, 112692 ISO; ISO, 1999, 11267 ISO; ISO (International Organization for Standardization), 2008, 175121 ISO; ISO-International Organization for Standardization, 2003, 16387 ISO; Jansch S, 2011, ENVIRON REV, V13, P51; Jensen J, 2006, ECOLOGICAL RISK ASSE; Joner EJ, 2007, ENVIRON TOXICOL CHEM, V26, P1644, DOI 10.1897/06-551R.1; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Kandeler E., 1996, METHODS SOIL BIOL, P146; Kenarova A, 2010, 2 BALK C BIOL, P5; Khan S, 2007, J ENVIRON SCI, V19, P834, DOI 10.1016/S1001-0742(07)60139-9; Kizilkaya R, 2005, APPL SOIL ECOL, V30, P192, DOI 10.1016/j.apsoil.2005.02.009; Kuperman RG, 2006, EUR J SOIL BIOL, V42, pS234, DOI 10.1016/j.ejsobi.2006.07.028; Kuperman RG, 2004, ECOTOX ENVIRON SAFE, V57, P48, DOI 10.1016/j.ecoenv.2003.08.010; Laurette J, 2012, ENVIRON EXP BOT, V77, P87, DOI 10.1016/j.envexpbot.2011.11.005; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Layinka T, 2011, P ENV MANAGEMENT C, P489; Lee SH, 2011, J HAZARD MATER, V188, P44, DOI 10.1016/j.jhazmat.2011.01.046; Lee SH, 2009, J HAZARD MATER, V170, P382, DOI 10.1016/j.jhazmat.2009.04.088; Li LXY, 2009, J HAZARD MATER, V167, P634, DOI 10.1016/j.jhazmat.2009.01.013; Liu XL, 2007, ECOTOX ENVIRON SAFE, V68, P305, DOI 10.1016/j.ecoenv.2006.11.001; Lock K, 2001, ECOTOXICOLOGY, V10, P315, DOI 10.1023/A:1016767519556; Lourenco J, 2011, CHEMOSPHERE, V85, P1630, DOI 10.1016/j.chemosphere.2011.08.027; Lourenco J, 2012, ECOTOX ENVIRON SAFE, V75, P46, DOI 10.1016/j.ecoenv.2011.08.024; Lourenco JI, 2011, J HAZARD MATER, V186, P788, DOI 10.1016/j.jhazmat.2010.11.073; Malyshkina N, 2010, ENVIRON SCI TECHNOL, V44, P9134, DOI 10.1021/es100730q; MAOTDR, 2006, MIN AMB ORD TERR DES; Meyer MC, 1998, J ENVIRON QUAL, V27, P1306, DOI 10.2134/jeq1998.00472425002700060006x; Mitchell N, 2013, J RADIOL PROT, V33, pR17, DOI 10.1088/0952-4746/33/2/R17; Momcilovic M, 2010, RADIAT MEAS, V45, P225; Natal-da-Luz T, 2011, ECOTOX ENVIRON SAFE, V74, P1715, DOI 10.1016/j.ecoenv.2011.05.017; Niemeyer JC, 2010, J SOIL SEDIMENT, V10, P1557, DOI 10.1007/s11368-010-0255-x; O'Halloran K, 2006, HUM ECOL RISK ASSESS, V12, P74, DOI 10.1080/10807030500428603; ohlinger R., 1996, METHODS SOIL BIOL; Papa S, 2010, ENVIRON MONIT ASSESS, V165, P193, DOI 10.1007/s10661-009-0938-1; Patra AC, 2011, J ENVIRON MANAGE, V92, P919, DOI 10.1016/j.jenvman.2010.10.046; Peijnenburg WJGM, 1999, ECOTOX ENVIRON SAFE, V44, P294, DOI 10.1006/eesa.1999.1838; Peijnenburg WJGM, 2003, ECOTOX ENVIRON SAFE, V56, P63, DOI 10.1016/S0147-6513(03)00051-4; Pereira AJSC, 2012, J ENVIRON RADIOACTIV, V112, P96, DOI 10.1016/j.jenvrad.2012.05.022; Pereira R, 2008, SCI TOTAL ENVIRON, V390, P377, DOI 10.1016/j.scitotenv.2007.08.051; Pereira R, 2006, SOIL SEDIMENT CONTAM, V15, P147, DOI 10.1080/15320380500506813; Pereira R, 2014, ENVIRON GEOCHEM HLTH, V36, P285, DOI 10.1007/s10653-013-9563-6; Pereira R, 2009, APPL SOIL ECOL, V42, P209, DOI 10.1016/j.apsoil.2009.04.002; Provoost J, 2008, J SOIL SEDIMENT, V8, P298, DOI 10.1007/s11368-008-0026-0; Rombke J, 2006, ENVIRON TOXICOL CHEM, V25, P776, DOI 10.1897/04-584R.1; Rooney CP, 2007, ENVIRON POLLUT, V145, P596, DOI 10.1016/j.envpol.2006.04.008; Scheele F, 2011, SSRN ELECT J; SCHINNER F, 1990, SOIL BIOL BIOCHEM, V22, P511, DOI 10.1016/0038-0717(90)90187-5; Schinner F., 1996, METHODS SOIL BIOL; Scott-Fordsmand JJ, 1995, 48 DAN ENV PROT AG; Sheppard SC, 2012, B ENVIRON CONTAM TOX, V88, P43, DOI 10.1007/s00128-011-0442-5; SHEPPARD SC, 1992, ARCH ENVIRON CON TOX, V23, P117; Sheppard SC, 2005, J ENVIRON RADIOACTIV, V79, P55, DOI 10.1016/j.jenvrad.2004.05.015; SHEPPARD SC, 1992, ENVIRON TOXIC WATER, V7, P275, DOI 10.1002/tox.2530070307; Sivakumar S, 2012, J HAZARD MATER, V227, P179, DOI 10.1016/j.jhazmat.2012.05.030; Song J, 2006, ENVIRON TOXICOL CHEM, V25, P1663, DOI 10.1897/05-480R2.1; Soudek P, 2011, AGROCHIMICA, V55, P15; Soudek P, 2011, J ENVIRON RADIOACTIV, V102, P598, DOI 10.1016/j.jenvrad.2011.03.008; *SPAC, 2000, HDB REF METH; Stojanovic M, 2009, WATER AIR SOIL POLL, V200, P101, DOI 10.1007/s11270-008-9896-4; TABATABAI MA, 1970, SOIL SCI SOC AM PRO, V34, P225, DOI 10.2136/sssaj1970.03615995003400020016x; Thavamani P, 2012, J ENVIRON MANAGE, V99, P10, DOI 10.1016/j.jenvman.2011.12.030; Tunney H, 2009, J PLANT NUTR SOIL SC, V172, P346, DOI 10.1002/jpln.200800069; Turner BL, 2002, BETA GLUCOSIDASE ACT; USEPA, 2003, US ENV PROT AG GUID; van Gestel CAM, 2012, ZOOKEYS, P275, DOI 10.3897/zookeys.176.2275; van Gestel CAM, 2011, ECOTOX ENVIRON SAFE, V74, P1, DOI 10.1016/j.ecoenv.2010.10.001; VanAssche F, 2002, TEST METHODS DETERMI, P37; Vandenhove H, 2007, ENVIRON POLLUT, V145, P587, DOI 10.1016/j.envpol.2006.04.011; Vandenhove H, 2006, J ENVIRON RADIOACTIV, V88, P118, DOI 10.1016/j.jenvrad.2006.01.008; Viehweger K, 2010, ENVIRON EXP BOT, V69, P39, DOI 10.1016/j.envexpbot.2010.03.001; Wang JH, 2007, ENVIRON GEOCHEM HLTH, V29, P395, DOI 10.1007/s10653-007-9084-2; Wang ME, 2011, ENVIRON SCI POLLUT R, V18, P958, DOI 10.1007/s11356-011-0445-0; Winding A, 2005, ECOTOX ENVIRON SAFE, V62, P230, DOI 10.1016/j.ecoenv.2005.03.026	112	10	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e108041	10.1371/journal.pone.0108041	http://dx.doi.org/10.1371/journal.pone.0108041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353962	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200003
J	Esposito, G; Nakazawa, J; Ogawa, S; Stival, R; Kawashima, A; Putnick, DL; Bornstein, MH				Esposito, Gianluca; Nakazawa, Jun; Ogawa, Shota; Stival, Rita; Kawashima, Akiko; Putnick, Diane L.; Bornstein, Marc H.			Baby, You Light-Up My Face: Culture-General Physiological Responses to Infants and Culture-Specific Cognitive Judgements of Adults	PLOS ONE			English	Article							UNITED-STATES; MOTHER; SKIN; EXPOSURE; CUTENESS; SCHEMA; JAPAN	Infants universally elicit in adults a set of solicitous behaviors that are evolutionarily important for the survival of the species. However, exposure, experience, and prejudice appear to govern adults' social choice and ingroup attitudes towards other adults. In the current study, physiological arousal and behavioral judgments were assessed while adults processed unfamiliar infant and adult faces of ingroup vs. outgroup members in two contrasting cultures, Japan and Italy. Physiological arousal was investigated using the novel technique of infrared thermography and behavioral judgments using ratings. We uncovered a dissociation between physiological and behavioral responses. At the physiological level, both Japanese and Italian adults showed significant activation (increase of facial temperature) for both ingroup and outgroup infant faces. At the behavioral level, both Japanese and Italian adults showed significant preferences for ingroup adults. Arousal responses to infants appear to be mediated by the autonomic nervous system and are not dependent on direct caregiving exposure, but behavioral responses appear to be mediated by higher-order cognitive processing based on social acceptance and cultural exposure.	[Esposito, Gianluca; Stival, Rita] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, TN, Italy; [Esposito, Gianluca] Nanyang Technol Univ, Sch Humanities & Social Sci, Div Psychol, Singapore 639798, Singapore; [Nakazawa, Jun] Chiba Univ, Fac Educ, Dept Dev Sci, Chiba, Japan; [Ogawa, Shota] Tokyo Gakugei Univ, United Grad Sch Educ, Chiba, Japan; [Kawashima, Akiko] Tokyo Univ Social Welf, Sch Social Welf, Tokyo, Japan; [Putnick, Diane L.; Bornstein, Marc H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	University of Trento; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chiba University; Tokyo Gakugei University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Esposito, G (corresponding author), Univ Trento, Dept Psychol & Cognit Sci, Rovereto, TN, Italy.	gianluca.esposito@unitn.it; Marc_H_Bornstein@nih.gov	Esposito, Gianluca/B-1374-2012; Putnick, Diane L/B-1707-2009	Esposito, Gianluca/0000-0002-9442-0254; Putnick, Diane L/0000-0002-6323-749X	Japan Society for the Promotion of Science [JSPS PE09064, 22530694, 24730563, 26285149]; FPR Program (RIKEN Brain Science Institute); National Institutes of Health (NIH), NICHD (USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001119] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FPR Program (RIKEN Brain Science Institute); National Institutes of Health (NIH), NICHD (USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the ST fellowship from Japan Society for the Promotion of Science (JSPS PE09064), Grant-in-aid for Scientific Research from Japan Society for the Promotion of Science (Projects #22530694, #24730563, and #26285149), the FPR Program (RIKEN Brain Science Institute), and the Intramural Research Program of the National Institutes of Health (NIH), NICHD (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe B, 2007, DEV PSYCHOL, V43, P1360, DOI 10.1037/0012-1649.43.6.1360; BORNSTEIN MH, 1989, DEV REV, V9, P171, DOI 10.1016/0273-2297(89)90028-2; BORNSTEIN MH, 1990, INT J BEHAV DEV, V13, P289, DOI 10.1177/016502549001300303; BORNSTEIN MH, 1990, INT J BEHAV DEV, V13, P267, DOI 10.1177/016502549001300302; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Caria A, 2012, NEUROIMAGE, V60, P884, DOI 10.1016/j.neuroimage.2011.12.068; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Chen X., 2012, HDB TEMPERAMENT, P462; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dunham Y, 2013, PSYCHOL SCI, V24, P860, DOI 10.1177/0956797612463081; Esposito G, 2015, EARLY CHILD DEV CARE, V185, P438, DOI 10.1080/03004430.2014.932153; FELDSTEIN S, 1993, INFANT BEHAV DEV, V16, P455, DOI 10.1016/0163-6383(93)80004-R; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Hrdy S., 2009, MOTHERS OTHERS; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Lorenz K, 1971, STUDIES ANIMAL HUMAN, VII; MCCALL RB, 1980, J EXP CHILD PSYCHOL, V29, P189, DOI 10.1016/0022-0965(80)90015-6; MIZUKAMI K, 1990, INFANT BEHAV DEV, V13, P257, DOI 10.1016/0163-6383(90)90034-6; Nakanishi R, 2008, INFANT BEHAV DEV, V31, P137, DOI 10.1016/j.infbeh.2007.09.001; Nhan BR, 2010, IEEE T BIO-MED ENG, V57, P979, DOI 10.1109/TBME.2009.2035926; Ochs E., 1984, CULTURE THEORY ESSAY, P276; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Parsons CE, 2013, SOC NEUROSCI-UK, V8, P268, DOI 10.1080/17470919.2013.795189; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Peer P, 2003, CVL FACE DATABASE; RimmKaufman SE, 1996, MOTIV EMOTION, V20, P63, DOI 10.1007/BF02251007; Sanefuji W, 2007, J ETHOL, V25, P249, DOI 10.1007/s10164-006-0018-8; Senese VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080379; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Solina F, 2003, P MIR INRIA ROCQ FRA; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; Stern D.N., 1985, INTERPERSONAL WORLD; Trevarthen C, 2003, PARENT INFANT PSYCHO, P25; Triandis HC, 1995, INDIVIDUALISM COLLEC; Van Duuren M, 2003, INT J BEHAV DEV, V27, P212, DOI 10.1080/01650250244000218; Williams LM, 2000, NEUROREPORT, V11, P3011, DOI 10.1097/00001756-200009110-00037; Winecoff A, 2013, J NEUROSCI, V33, P11032, DOI 10.1523/JNEUROSCI.4317-12.2013; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042; ZAJONC RB, 1989, PSYCHOL REV, V96, P395, DOI 10.1037/0033-295X.96.3.395; Zajonc RB, 2001, CURR DIR PSYCHOL SCI, V10, P224, DOI 10.1111/1467-8721.00154	46	36	36	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e106705	10.1371/journal.pone.0106705	http://dx.doi.org/10.1371/journal.pone.0106705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353362	Green Published, gold			2022-12-26	WOS:000345204200001
J	Flueckiger, L; Lieb, R; Meyer, AH; Mata, J				Flueckiger, Lavinia; Lieb, Roselind; Meyer, Andrea H.; Mata, Jutta			How Health Behaviors Relate to Academic Performance via Affect: An Intensive Longitudinal Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TASK-PERFORMANCE; AEROBIC EXERCISE; SLEEP QUALITY; INTELLIGENCE; ACHIEVEMENT; BRAIN; MOOD; ADOLESCENTS; PREVALENCE	Objective: This intensive longitudinal study examined how sleep and physical activity relate to university students' affect and academic performance during a stressful examination period. Methods: On 32 consecutive days, 72 first-year students answered online questionnaires on their sleep quality, physical activity, positive and negative affect, learning goal achievement, and examination grades. First-year university students are particularly well-suited to test our hypotheses: They represent a relatively homogeneous population in a natural, but controlled setting, and simultaneously deal with similar stressors, such as examinations. Data were analyzed using multilevel structural equation models. Results: Over the examination period, better average sleep quality but not physical activity predicted better learning goal achievement. Better learning goal achievement was associated with increased probability of passing all examinations. Relations of average sleep quality and average physical activity with learning goal achievement were mediated by experienced positive affect. In terms of day-to-day dynamics, on days with better sleep quality, participants reported better learning goal achievement. Day-to-day physical activity was not related to daily learning goal achievement. Daily positive and negative affect both mediated the effect of day-to-day sleep quality and physical activity on daily learning goal achievement. Conclusion: Health behaviors such as sleep quality and physical activity seem important for both academic performance and affect experience, an indicator of mental health, during a stressful examination period. These results are a first step toward a better understanding of between-and within-person variations in health behaviors, affect, and academic performance, and could inform prevention and intervention programs for university students.	[Flueckiger, Lavinia; Lieb, Roselind; Meyer, Andrea H.; Mata, Jutta] Univ Basel, Dept Psychol, Div Clin Psychol & Epidemiol, Basel, Switzerland; [Mata, Jutta] Max Planck Inst Human Dev, ARC, Berlin, Germany	University of Basel; Max Planck Society	Mata, J (corresponding author), Univ Basel, Dept Psychol, Div Clin Psychol & Epidemiol, Basel, Switzerland.	jutta.mata@unibas.ch	Mata, Jutta/M-5817-2016	Mata, Jutta/0000-0003-2498-5054	Swiss National Science Foundation [140991]; grant for promotion of "Dual Career Couples" (DCC) at Swiss Universities [01/10]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); grant for promotion of "Dual Career Couples" (DCC) at Swiss Universities	This study was supported by a grant of the Swiss National Science Foundation (No. 140991) to Jutta Mata and Roselind Lieb, and a grant for promotion of "Dual Career Couples" (DCC) at Swiss Universities 2008-2011 within the scope of the national program of equality of opportunities awarded to Roselind Lieb (01/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrberg K, 2012, J PSYCHIATR RES, V46, P1618, DOI 10.1016/j.jpsychires.2012.09.008; ALWIN DF, 1975, AM SOCIOL REV, V40, P37, DOI 10.2307/2094445; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bower B, 2010, J SLEEP RES, V19, P323, DOI 10.1111/j.1365-2869.2009.00816.x; Brown GW, 1989, LIFE EVENTS ILLNESS; Bundesamt fur Statistik [Federal agency for statistics], 2012, STUD RETR NACH HOCHS; Bussmann JBJ, 2009, EUR PSYCHOL, V14, P142, DOI 10.1027/1016-9040.14.2.142; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Daniels LM, 2009, J EDUC PSYCHOL, V101, P948, DOI 10.1037/a0016096; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dyson R, 2006, J CLIN PSYCHOL, V62, P1231, DOI 10.1002/jclp.20295; Fedewa AL, 2011, RES Q EXERCISE SPORT, V82, P521; Field T, 2001, ADOLESCENCE, V36, P105; Franzen PL, 2008, J SLEEP RES, V17, P34, DOI 10.1111/j.1365-2869.2008.00635.x; Furnham A, 2002, LEARN INDIVID DIFFER, V14, P47, DOI 10.1016/j.lindif.2003.08.002; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hogan CL, 2013, PSYCHOL AGING, V28, P587, DOI 10.1037/a0032634; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Kantomaa MT, 2010, HEALTH EDUC RES, V25, P368, DOI 10.1093/her/cyp048; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kramer AF, 1999, NATURE, V402, P750; Kristjansson AL, 2010, HEALTH EDUC BEHAV, V37, P51, DOI 10.1177/1090198107313481; KUHL J, 1994, INTERNATIONAL PERSPECTIVES ON PSYCHOLOGICAL SCIENCE, VOL 2: THE STATE OF THE ART, P311; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MacIntosh BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085163; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Mata J, 2012, J ABNORM PSYCHOL, V121, P297, DOI 10.1037/a0023533; Mega C, 2014, J EDUC PSYCHOL, V106, P121, DOI 10.1037/a0033546; Miner AG, 2010, ORGAN BEHAV HUM DEC, V112, P43, DOI 10.1016/j.obhdp.2009.11.009; Morisano D, 2010, J APPL PSYCHOL, V95, P255, DOI 10.1037/a0018478; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; OECD, 2012, ED GLANC 2012 HIGHL; Organisation for Economic Cooperation and Development (OECD), 2010, HIGHL ED GLANC 2010; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Perkins HW, 2002, J STUD ALCOHOL, P91, DOI 10.15288/jsas.2002.s14.91; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Reed J, 2006, PSYCHOL SPORT EXERC, V7, P477, DOI 10.1016/j.psychsport.2005.11.003; Reed J, 2009, PSYCHOL SPORT EXERC, V10, P581, DOI 10.1016/j.psychsport.2009.05.009; Richard EM, 2011, ORGAN BEHAV HUM DEC, V115, P99, DOI 10.1016/j.obhdp.2010.11.008; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Riemann D, 1996, BEHANDLUNG SCHLAFSTO; Robbins SB, 2004, PSYCHOL BULL, V130, P261, DOI 10.1037/0033-2909.130.2.261; Robbins SB, 2009, J APPL PSYCHOL, V94, P1163, DOI 10.1037/a0015738; Roecke C, 2006, THESIS FREIE U BERLI; Schwarz N, 2003, PSYCHOL INQ, V14, P296, DOI 10.1207/S15327965PLI1403&4_20; Seo MG, 2004, ACAD MANAGE REV, V29, P423, DOI 10.2307/20159052; Sonnentag S, 2008, J APPL PSYCHOL, V93, P674, DOI 10.1037/0021-9010.93.3.674; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; TOTTERDELL P, 1994, SLEEP, V17, P466, DOI 10.1093/sleep/17.5.466; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zheng JL, 2002, J COLL STUDENT DEV, V43, P267	65	22	22	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111080	10.1371/journal.pone.0111080	http://dx.doi.org/10.1371/journal.pone.0111080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353638	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000345204200054
J	Hosking, JG; Lam, FCW; Winstanley, CA				Hosking, Jay G.; Lam, Fred C. W.; Winstanley, Catharine A.			Nicotine Increases Impulsivity and Decreases Willingness to Exert Cognitive Effort despite Improving Attention in "Slacker" Rats: Insights into Cholinergic Regulation of Cost/Benefit Decision Making	PLOS ONE			English	Article							REACTION-TIME-TASK; MUSCARINIC ACETYLCHOLINE-RECEPTORS; DOPAMINERGIC MODULATION; SELECTIVE ATTENTION; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; BASAL FOREBRAIN; PARIETAL CORTEX; PERFORMANCE; ENHANCEMENT	Successful decision making in our daily lives requires weighing an option's costs against its associated benefits. The neuromodulator acetylcholine underlies both the etiology and treatment of a number of illnesses in which decision making is perturbed, including Alzheimer's disease, attention-deficit/hyperactivity disorder, and schizophrenia. Nicotine acts on the cholinergic system and has been touted as a cognitive enhancer by both smokers and some researchers for its attention-boosting effects; however, it is unclear whether treatments that have a beneficial effect on attention would also have a beneficial effect on decision making. Here we utilize the rodent Cognitive Effort Task (rCET), wherein animals can choose to allocate greater visuospatial attention for a greater reward, to examine cholinergic contributions to both attentional performance and choice based on attentional demand. Following the establishment of baseline behavior, four drug challenges were administered: nicotine, mecamylamine, scopolamine, and oxotremorine (saline plus three doses for each). As per previous rCET studies, animals were divided by their baseline preferences, with "worker" rats choosing high-effort/high-reward options more than their "slacker" counterparts. Nicotine caused slackers to choose even fewer high-effort trials than at baseline, but had no effect on workers' choice. Despite slackers' decreased willingness to expend effort, nicotine improved their attentional performance on the task. Nicotine also increased measures of motor impulsivity in all animals. In contrast, scopolamine decreased animals' choice of high-effort trials, especially for workers, while oxotremorine decreased motor impulsivity for all animals. In sum, the cholinergic system appears to contribute to decision making, and in part these contributions can be understood as a function of individual differences. While nicotine has been considered as a cognitive enhancer, these data suggest that its modest benefits to attention may be coupled with impulsiveness and decreased willingness to work hard, especially in individuals who are particularly sensitive to effort costs (i.e. slackers).	[Hosking, Jay G.; Lam, Fred C. W.; Winstanley, Catharine A.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Hosking, JG (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jayhosking@psych.ubc.ca	Winstanley, Catharine/K-5003-2015	Winstanley, Catharine/0000-0001-7032-4471	Canadian Natural Sciences and Engineering Council; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research (CIHR) New Investigator Award program; CIHR Doctoral Research Award	Canadian Natural Sciences and Engineering Council; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR) New Investigator Award program(Canadian Institutes of Health Research (CIHR)); CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR))	This work was supported by a discovery grant awarded to CAW from the Canadian Natural Sciences and Engineering Council (http://www.nserc-crsng.gc.ca/index_eng.asp). CAW also receives salary support through the Michael Smith Foundation for Health Research (http://www.msfhr.org/) and the Canadian Institutes of Health Research (CIHR) New Investigator Award program (http://www.cihr-irsc.gc.ca/e/193.html). JGH was supported by a CIHR Doctoral Research Award (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barch DM, 2014, J ABNORM PSYCHOL, V123, P387, DOI 10.1037/a0036299; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; Bracco L, 2014, J ALZHEIMERS DIS, V40, P737, DOI 10.3233/JAD-131154; Bruno JP, 2006, EUR J NEUROSCI, V24, P2749, DOI 10.1111/j.1460-9568.2006.05176.x; Bucci DJ, 1998, J NEUROSCI, V18, P8038; Cardinal R., 2006, ANOVA BEHAV SCI RES, DOI [10.4324/9780203763933, DOI 10.4324/9780203763933]; Cocker PJ, 2012, NEUROPSYCHOPHARMACOL; COUSINS MS, 1994, PSYCHOPHARMACOLOGY, V116, P529, DOI 10.1007/BF02247489; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Fadel JR, 2011, BEHAV BRAIN RES, V221, P527, DOI 10.1016/j.bbr.2010.02.022; Floresco SB, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00062; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Fobbs WC, 2014, PROG MOL BIOL TRANSL, V122, P233, DOI 10.1016/B978-0-12-420170-5.00009-X; Gleichgerrcht E, 2010, NAT REV NEUROL, V6, P611, DOI 10.1038/nrneurol.2010.148; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; Hahn B, 2002, PSYCHOPHARMACOLOGY, V162, P129, DOI 10.1007/s00213-002-1005-6; Hahn B, 2009, CEREB CORTEX, V19, P1990, DOI 10.1093/cercor/bhn226; Harrell PT, 2012, EXP CLIN PSYCHOPHARM, V20, P278, DOI 10.1037/a0028652; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Hosking JG, 2014, NEUROPSYCHOPHARMACOL, V39, P1558, DOI 10.1038/npp.2014.27; JONES DNC, 1995, PSYCHOPHARMACOLOGY, V120, P142, DOI 10.1007/BF02246186; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Kuhl DE, 1996, ANN NEUROL, V40, P399, DOI 10.1002/ana.410400309; Mackowick KM, 2014, PROG NEURO-PSYCHOPH, V52, P79, DOI 10.1016/j.pnpbp.2013.07.010; Mendez IA, 2013, NEUROSCIENCE, V230, P121, DOI 10.1016/j.neuroscience.2012.10.067; Mendez IA, 2012, PSYCHOPHARMACOLOGY, V224, P489, DOI 10.1007/s00213-012-2777-y; Mirza NR, 2000, PSYCHOPHARMACOLOGY, V148, P243, DOI 10.1007/s002130050048; Mirza NR, 1998, PSYCHOPHARMACOLOGY, V138, P266, DOI 10.1007/s002130050671; Mirza NR, 2001, PSYCHOPHARMACOLOGY, V154, P8, DOI 10.1007/s002130000605; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Nunes EJ, 2013, NEUROSCI BIOBEHAV R, V37, P2015, DOI 10.1016/j.neubiorev.2013.04.002; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; Randall PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047934; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Ruotsalainen S, 2000, PSYCHOPHARMACOLOGY, V148, P111, DOI 10.1007/s002130050032; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Shannon HE, 2006, BEHAV PHARMACOL, V17, P71, DOI 10.1097/01.fbp.0000189813.54178.e3; Stolerman IP, 2009, BEHAV PHARMACOL, V20, P742, DOI 10.1097/FBP.0b013e328333b290; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Wilens TE, 2007, BIOCHEM PHARMACOL, V74, P1212, DOI 10.1016/j.bcp.2007.07.002; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Winstanley CA, 2010, BEHAV BRAIN RES, V210, P263, DOI 10.1016/j.bbr.2010.02.044; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243	49	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111580	10.1371/journal.pone.0111580	http://dx.doi.org/10.1371/journal.pone.0111580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353339	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200089
J	Srivastava, G; Mehrotra, RC				Srivastava, Gaurav; Mehrotra, R. C.			Phytogeographical Implication of Bridelia Will. (Phyllanthaceae) Fossil Leaf from the Late Oligocene of India	PLOS ONE			English	Article							MAKUM COALFIELD; CLIMATE; ASSAM; SEDIMENTS; EVOLUTION; GONDWANA; EUPHORBIACEAE; DISPERSAL; PETROLOGY; AFRICA	Background: The family Phyllanthaceae has a predominantly pantropical distribution. Of its several genera, Bridelia Willd. is of a special interest because it has disjunct equally distributed species in Africa and tropical Asia i.e. 18-20 species in Africa-Madagascar (all endemic) and 18 species in tropical Asia (some shared with Australia). On the basis of molecular phylogenetic study on Bridelia, it has been suggested that the genus evolved in Southeast Asia around 33 +/- 5 Ma, while speciation and migration to other parts of the world occurred at 10 +/- 2 Ma. Fossil records of Bridelia are equally important to support the molecular phylogenetic studies and plate tectonic models. Results: We describe a new fossil leaf of Bridelia from the late Oligocene (Chattian, 28.4-23 Ma) sediments of Assam, India. The detailed venation pattern of the fossil suggests its affinities with the extant B. ovata, B. retusa and B. stipularis. Based on the present fossil evidence and the known fossil records of Bridelia from the Tertiary sediments of Nepal and India, we infer that the genus evolved in India during the late Oligocene (Chattian, 28.4-23 Ma) and speciation occurred during the Miocene. The stem lineage of the genus migrated to Africa via "Iranian route'' and again speciosed in Africa-Madagascar during the late Neogene resulting in the emergence of African endemic clades. Similarly, the genus also migrated to Southeast Asia via Myanmar after the complete suturing of Indian and Eurasian plates. The emergence and speciation of the genus in Asia and Africa is the result of climate change during the Cenozoic. Conclusions: On the basis of present and known fossil records of Bridelia, we have concluded that the genus evolved during the late Oligocene in northeast India. During the Neogene, the genus diversified and migrated to Southeast Asia via Myanmar and Africa via "Iranian Route''.	[Srivastava, Gaurav; Mehrotra, R. C.] Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP)	Srivastava, G (corresponding author), Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India.	gaurav_jan10@yahoo.co.in	Srivastava, Gaurav/A-1384-2019	Srivastava, Gaurav/0000-0001-7498-4338				Ahmed M, 1996, INT J COAL GEOL, V30, P319, DOI 10.1016/0166-5162(95)00051-8; Ascherson PFA, 1864, FLORA PROVINZ BRANDE, V1, P59; Awasthi N., 1992, GEOPHYTOLOGY, V22, P193; Awasthi N, 1995, PALEOBOTANIST, V44, P157; AWASTHI N, 1989, PALEOBOTANIST, V37, P147; Bailey IW, 1924, ANN BOT-LONDON, V38, P439, DOI 10.1093/oxfordjournals.aob.a089910; BANDE MB, 1986, REV PALAEOBOT PALYNO, V49, P203, DOI 10.1016/0034-6667(86)90028-X; Bande MB., 1974, GEOPHYTOLOGY, V4, P189; Bibi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016688; Bobe R, 2006, J ARID ENVIRON, V66, P564, DOI 10.1016/j.jaridenv.2006.01.010; Bonnefille R, 2010, GLOBAL PLANET CHANGE, V72, P390, DOI 10.1016/j.gloplacha.2010.01.015; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; Chatterjee S, 1999, P INDIAN NATL SCI A, V65, P397; Chatterjee S, 2013, GONDWANA RES, V23, P238, DOI 10.1016/j.gr.2012.07.001; DILCHER DL, 1974, BOT REV, V40, P1, DOI 10.1007/BF02860067; Dressler S, 1996, BLUMEA, V41, P263; Forster Paul I., 1999, Austrobaileya, V5, P405; Ganju JI, 1986, B OIL NAT GAS COMM, V23, P129; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Gregory M., 2009, IAWA J SUPPL, V6, P220; Griffin DL, 2002, PALAEOGEOGR PALAEOCL, V182, P65, DOI 10.1016/S0031-0182(01)00453-9; GRUASCAVAGNETTO C, 1992, GRANA, V31, P291, DOI 10.1080/00173139209429452; HICKEY LJ, 1973, AM J BOT, V60, P17, DOI 10.2307/2441319; Hooker J.D., 1885, FLORA BRIT INDIA, V4, P644; Jussieu ALD, 1820, PRIROZENOSTI ROSTIN, V225; Kumar M, 2012, PALAEOGEOGR PALAEOCL, V342, P143, DOI 10.1016/j.palaeo.2012.05.001; LAKHANPAL R N, 1970, Taxon, V19, P675, DOI 10.2307/1219280; Li PT, 2008, FLORA CHINA, P172; Li YQ, 2009, SYST BOT, V34, P521, DOI 10.1600/036364409789271263; Madel E, 1962, SENCKENBERG LETH, V43, P283; Martinov II, 1820, TEKHNOBOTANICHESKII, DOI Sanktpeterburgie; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Mehrotra R. C., 1998, Phytomorphology, V48, P91; Mehrotra RC, 2003, GEOBIOS-LYON, V36, P83, DOI 10.1016/S0016-6995(02)00107-9; Mehrotra RC, 2009, PALEOBOTANIST, V58, P1, DOI DOI 10.1016/S0016-6995(02)00107-9; Mishra HK, 1996, INT J COAL GEOL, V30, P65, DOI 10.1016/0166-5162(95)00038-0; Misra BK, 1992, PALEOBOTANIST, V39, P309; Molnar P, 2009, TECTONICS, V28; Muller Argoviensis J, 1864, BOT ZEITUNG, V22, P324; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Pascoe E. H, 1964, MANUAL GEOLOGY INDIA, V1; Pathak NR, 1969, J SEN MEMORIAL VOLUM, P379; Prasad M, 2008, PALAEONTOGR ABT B, V278, P13, DOI 10.1127/palb/278/2008/13; Punyasena SW, 2008, J BIOGEOGR, V35, P117, DOI 10.1111/j.1365-2699.2007.01773.x; Ramanujam CGK., 1960, PALAEONTOGR ABT B, V106, P99; Shukla A, 2013, ALCHERINGA, V37, P1, DOI 10.1080/03115518.2012.688688; Srivastava G.A., 2010, MEMOIR GEOLOGICAL SO, V75, P123; Srivastava G, 2013, J EARTH SYST SCI, V122, P1341, DOI 10.1007/s12040-013-0354-3; Srivastava G, 2013, J EARTH SYST SCI, V122, P283, DOI 10.1007/s12040-013-0277-z; Srivastava G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053177; Srivastava G, 2012, J EARTH SYST SCI, V121, P747, DOI 10.1007/s12040-012-0179-5; Srivastava G, 2012, PALAEOGEOGR PALAEOCL, V342, P130, DOI 10.1016/j.palaeo.2012.05.002; Srivastava G, 2012, CURR SCI INDIA, V102, P398; Srivastava G, 2010, J GEOL SOC INDIA, V75, P820, DOI 10.1007/s12594-010-0069-x; STEENIS C. G. G. J. VAN., 1962, Blumea, V11, P235; Tomlinson P. B., 1990, The structural biology of palms.; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; WHEELER EA, 1987, BOT J LINN SOC, V94, P111; WILLDENOW CL, 1806, SPECIES PLANTARUM, P4; Wolfe J.A., 1993, US GEOLOGICAL SURVEY, V2040, P1, DOI DOI 10.3133/B2040; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	63	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111140	10.1371/journal.pone.0111140	http://dx.doi.org/10.1371/journal.pone.0111140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353345	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200062
J	Calik, MW; Carley, DW				Calik, Michael W.; Carley, David W.			Cannabinoid Type 1 and Type 2 Receptor Antagonists Prevent Attenuation of Serotonin-Induced Reflex Apneas by Dronabinol in Sprague-Dawley Rats	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; CISPLATIN-INDUCED EMESIS; 5-HT3 RECEPTORS; CB1 RECEPTORS; GUINEA-PIG; HYPOGLOSSAL; DELTA(9)-TETRAHYDROCANNABINOL; DELTA-9-TETRAHYDROCANNABINOL; IDENTIFICATION; ONDANSETRON	The prevalence of obstructive sleep apnea (OSA) in Americans is 9% and increasing. Increased afferent vagal activation may predispose to OSA by reducing upper airway muscle activation/patency and disrupting respiratory rhythmogenesis. Vagal afferent neurons are inhibited by cannabinoid type 1 (CB1) or cannabinoid type 2 (CB2) receptors in animal models of vagally-mediated behaviors. Injections of dronabinol, a non-selective CB1/CB2 receptor agonist, into the nodose ganglia reduced serotonin (5-HT)-induced reflex apneas. It is unknown what role CB1 and/or CB2 receptors play in reflex apnea. Here, to determine the independent and combined effects of activating CB1 and/or CB2 receptors on dronabinol's attenuating effect, rats were pre-treated with CB1 (AM251) and/or CB2 (AM630) receptor antagonists. Adult male Sprague-Dawley rats were anesthetized, instrumented with bilateral electrodes to monitor genioglossus electromyogram (EMGgg) and a piezoelectric strain gauge to monitor respiratory pattern. Following intraperitoneal treatment with AM251 and/or AM630, or with vehicle, serotonin was intravenously infused into a femoral vein to induce reflex apnea. After baseline recordings, the nodose ganglia were exposed and 5-HT-induced reflex apneas were again recorded to confirm that the nerves remained functionally intact. Dronabinol was injected into each nodose ganglion and 5-HT infusion was repeated. Prior to dronabinol injection, there were no significant differences in 5-HT-induced reflex apneas or phasic and tonic EMGgg before or after surgery in the CB1, CB 2, combined CB1/CB2 antagonist, and vehicle groups. In the vehicle group, dronabinol injections reduced 5-HT-induced reflex apnea duration. In contrast, dronabinol injections into nodose ganglia of the CB1, CB2, and combined CB1/CB2 groups did not attenuate 5-HT-induced reflex apnea duration. However, the CB1 and CB2 antagonists had no effect on dronabinol's ability to increase phasic EMGgg. These findings underscore the therapeutic potential of dronabinol in the treatment of OSA and implicate participation of both cannabinoid receptors in dronabinol's apnea suppression effect.	[Calik, Michael W.; Carley, David W.] Univ Illinois, Ctr Narcolepsy Sleep & Hlth Res, Chicago, IL 60607 USA; [Calik, Michael W.; Carley, David W.] Univ Illinois, Dept Biobehav Hlth Sci, Chicago, IL USA; [Carley, David W.] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Calik, MW (corresponding author), Univ Illinois, Ctr Narcolepsy Sleep & Hlth Res, Chicago, IL 60607 USA.	mcalik@uic.edu		Calik, Michael/0000-0001-6295-7420	National Institutes of Health [1UM1HL112856]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL112856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health Grant 1UM1HL112856 awarded to DWC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barann M, 2002, BRIT J PHARMACOL, V137, P589, DOI 10.1038/sj.bjp.0704829; Belvisi MG, 2008, BRIT J PHARMACOL, V155, P547, DOI 10.1038/bjp.2008.298; Burdyga G, 2010, AM J PHYSIOL-GASTR L, V299, pG63, DOI 10.1152/ajpgi.00059.2010; Calik MW, 2014, RESP PHYSIOL NEUROBI, V190, P20, DOI 10.1016/j.resp.2013.10.001; Carley DW, 2002, SLEEP, V25, P391; Carley DW, 1999, CHEST, V115, P1397, DOI 10.1378/chest.115.5.1397; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Darmani NA, 2004, EUR J PHARMACOL, V488, P201, DOI 10.1016/j.ejphar.2004.02.018; Darmani NA, 2001, PHARMACOL BIOCHEM BE, V69, P239, DOI 10.1016/S0091-3057(01)00531-7; Doan TN, 1999, J PHYSIOL-LONDON, V514, P125, DOI 10.1111/j.1469-7793.1999.125af.x; Doan TN, 2004, J NEUROSCI, V24, P3335, DOI 10.1523/JNEUROSCI.5156-03.2004; FAN P, 1995, J NEUROPHYSIOL, V73, P907, DOI 10.1152/jn.1995.73.2.907; Fenik P, 2001, SLEEP, V24, P871, DOI 10.1093/sleep/24.8.871; GINZEL KH, 1954, J PHYSIOL-LONDON, V123, P277, DOI 10.1113/jphysiol.1954.sp005050; Glazebrook PA, 2002, J PHYSIOL-LONDON, V541, P467, DOI 10.1113/jphysiol.2001.018333; Haji A, 2000, PHARMACOL THERAPEUT, V86, P277, DOI 10.1016/S0163-7258(00)00059-0; Hermes SM, 2014, J COMP NEUROL, V522, P642, DOI 10.1002/cne.23438; Kaczynska K, 2013, PHYSIOL RES, V62, P227, DOI 10.33549/physiolres.932412; Khlaifia A, 2013, J NEUROSCI, V33, P12627, DOI 10.1523/JNEUROSCI.1028-13.2013; Marchenko V, 2000, BRAIN RES, V857, P99, DOI 10.1016/S0006-8993(99)02377-X; Mason M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003002.pub3; Mukhtarov M, 2005, J PHYSIOL-LONDON, V569, P817, DOI 10.1113/jphysiol.2005.094862; NISHI K, 1975, BRIT J PHARMACOL, V55, P27, DOI 10.1111/j.1476-5381.1975.tb07606.x; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Parhizgar F, 2011, J CLIN SLEEP MED, V7, P401, DOI 10.5664/JCSM.1204; Patel HJ, 2003, BRIT J PHARMACOL, V140, P261, DOI 10.1038/sj.bjp.0705435; Peever JH, 2001, PFLUG ARCH EUR J PHY, V442, P78, DOI 10.1007/s004240000502; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Prasad Bharati, 2013, Front Psychiatry, V4, P1, DOI 10.3389/fpsyt.2013.00001; Prasad B, 2010, SLEEP, V33, P982, DOI 10.1093/sleep/33.7.982; Radulovacki M, 1998, SLEEP, V21, P131, DOI 10.1093/sleep/21.2.131; Ray AP, 2009, BEHAV BRAIN RES, V196, P30, DOI 10.1016/j.bbr.2008.07.028; Rohof WO, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01868.x; Saito Y, 2002, J PHYSIOL-LONDON, V544, P183, DOI 10.1113/jphysiol.2002.022566; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100536; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Tadjalli A, 2010, J NEUROSCI, V30, P16886, DOI 10.1523/JNEUROSCI.3394-10.2010; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Veasey SC, 2001, SLEEP, V24, P155, DOI 10.1093/sleep/24.2.155; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Yang KHS, 2010, NEUROSCIENCE, V171, P40, DOI 10.1016/j.neuroscience.2010.08.044; YOSHIOKA M, 1992, J PHARMACOL EXP THER, V260, P917; Zhuo H, 1997, PROG NEUROBIOL, V52, P79, DOI 10.1016/S0301-0082(97)00003-8	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111412	10.1371/journal.pone.0111412	http://dx.doi.org/10.1371/journal.pone.0111412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350456	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100070
J	Chien, LC; Lien, YJ; Yang, CH; Yu, HL				Chien, Lung-Chang; Lien, Yi-Jen; Yang, Chiang-Hsin; Yu, Hwa-Lung			Acute Increase of Children's Conjunctivitis Clinic Visits by Asian Dust Storms Exposure - A Spatiotemporal Study in Taipei, Taiwan	PLOS ONE			English	Article							LUNG-FUNCTION GROWTH; BAYESIAN P-SPLINES; AIR-POLLUTION; HOSPITAL ADMISSIONS; RESPIRATORY SYMPTOMS; PULMONARY-FUNCTION; EMERGENCY VISITS; EVENTS; HEALTH; ASTHMA	Adverse health impacts of Asian dust storms (ADS) have been widely investigated and discussed in respiratory disease, but no study has examined the association between ADS events and their impact on eye diseases, especially in children. The impact of ADS events on the incidence of children's conjunctivitis is examined by analyzing the data from children's clinic visits registered in the 41 districts of Taipei area in Taiwan during the period 2002-2007. The structural additive regression modeling approach was used to assess the association between ADS events and clinic visits for conjunctivitis in children with consideration of day-of-the-week effects, temperature, and air quality levels. This study identifies an acute increase in the relative rate for children's conjunctivitis clinic visits during ADS periods with 1.48% (95% CI = 0.79, 2.17) for preschool children (aged <6 years old) and 9.48% (95% CI = 9.03, 9.93) for schoolchildren (aged >= 6 years old), respectively. The relative rates during post-ADS periods were still statistically significant, but much lower than those during ADS periods. The spatial analysis presents geographic heterogeneity of children's conjunctivitis clinic visits where higher relative rates were more likely observed in the most populated districts Compared to previous ADS studies related to respiratory diseases, our results reveals significantly acute impacts on children's conjunctivitis during ADS periods, and much influence on schoolchildren. Vulnerable areas were also identified in high density population.	[Chien, Lung-Chang] Univ Texas San Antonio, Sch Publ Hlth, Div Biostat, San Antonio, TX USA; [Lien, Yi-Jen; Yu, Hwa-Lung] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Yang, Chiang-Hsin] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan	University of Texas System; University of Texas at San Antonio (UTSA); National Taiwan University; National Taipei University of Nursing & Health Science (NTUNHS)	Yu, HL (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	hlyu@ntu.edu.tw		Yu, Hwa Lung/0000-0001-9558-2100	National Science Council of Taiwan [NSC101-2628-E-002-017-MY3, NSC101-2628-E-002-003]; Environmental Protection Department of the New Taipei City Government (Taiwan)	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Environmental Protection Department of the New Taipei City Government (Taiwan)	This research and data collection was supported by funds from the National Science Council of Taiwan (NSC101-2628-E-002-017-MY3 and NSC101-2628-E-002-003) and the Environmental Protection Department of the New Taipei City Government (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1974, AUTOMATIC CONTROL IE, V19, P716, DOI [DOI 10.1109/TAC.1974.1100705, 10.1109/tac.1974.1100705]; [Anonymous], 2012, BAYESX SOFTWARE BAYE; Belitz C, 2008, COMPUT STAT DATA AN, V53, P61, DOI 10.1016/j.csda.2008.05.032; Boezen HM, 1999, LANCET, V353, P874, DOI 10.1016/S0140-6736(98)06311-9; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P809, DOI 10.1136/bjo.87.7.809; Brezger A, 2008, STAT MODEL, V8, P141, DOI 10.1177/1471082X0800800202; Cakmak S, 2002, LANCET, V359, P947, DOI 10.1016/S0140-6736(02)08045-5; Chan CC, 2008, ENVIRON RES, V106, P393, DOI 10.1016/j.envres.2007.09.006; Chen PS, 2010, ENVIRON HEALTH PERSP, V118, P1211, DOI 10.1289/ehp.0901782; Chen YS, 2004, ENVIRON RES, V95, P151, DOI 10.1016/j.envres.2003.08.008; Cheng MF, 2008, J TOXICOL ENV HEAL A, V71, P1295, DOI 10.1080/15287390802114808; Chien L-C, 2012, ENVIRON HEALTH PERSP, V7; Chiu HF, 2008, INHAL TOXICOL, V20, P777, DOI 10.1080/08958370802005308 ; DASSEN W, 1986, JAPCA J AIR WASTE MA, V36, P1223, DOI 10.1080/00022470.1986.10466168; DOCKERY DW, 1982, JAPCA J AIR WASTE MA, V32, P937, DOI 10.1080/00022470.1982.10465494; Ezzati M, 2000, ENVIRON HEALTH PERSP, V108, P833, DOI 10.2307/3434990; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Fromont A, 2010, BRAIN, V133, P1889, DOI 10.1093/brain/awq134; Horak F, 2002, EUR RESPIR J, V19, P838, DOI 10.1183/09031936.02.00512001; Jedrychowski W, 1999, ENVIRON HEALTH PERSP, V107, P669, DOI 10.2307/3434460; Kindermann R, 1980, MARKOV RANDOM FIELDS, Vix; Kuo HW, 2010, BUILD ENVIRON, V45, P610, DOI 10.1016/j.buildenv.2009.07.017; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Lee EC, 2008, EPIDEMIOLOGY, V19, pS145; Lee H., 2003, WATER AIR SOIL POLL, V3, P231, DOI DOI 10.1023/A:1023254910362; Liu Z, 2009, ACUTE CONJUNCTIVITIS, P443; Ma CJ, 2001, ATMOS ENVIRON, V35, P2707, DOI 10.1016/S1352-2310(00)00410-6; McConnell R, 1999, ENVIRON HEALTH PERSP, V107, P757, DOI 10.2307/3434662; Middleton N, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-39; NCU, 2005, TAIW WIND QUER SYST; Novaes P, 2007, ENVIRON HEALTH PERSP, V115, P1753, DOI 10.1289/ehp.10363; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; Schwartz J, 2004, PEDIATRICS, V113, P1037; Stoss M, 2000, J ALTERN COMPLEM MED, V6, P499, DOI 10.1089/acm.2000.6.499; Tam WWS, 2011, RESPIROLOGY; Tuominen ISJ, 2003, INVEST OPHTH VIS SCI, V44, P2545, DOI 10.1167/iovs.02-1260; [TWDOH Department of Health EY], 2012, REGULATIONS GOVERNIN; TWEPA, 2011, AS DUST STORM MON NE; van der Zee SC, 1999, OCCUP ENVIRON MED, V56, P802, DOI 10.1136/oem.56.12.802; Yang CY, 2006, J TOXICOL ENV HEAL A, V69, P1673, DOI 10.1080/15287390600630096; Yang CY, 2009, J TOXICOL ENV HEAL A, V72, P324, DOI 10.1080/15287390802529880; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254; Yu HL, 2013, ENVIRON INT, V54, P35, DOI 10.1016/j.envint.2013.01.004; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041317	44	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109175	10.1371/journal.pone.0109175	http://dx.doi.org/10.1371/journal.pone.0109175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347189	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900006
J	Choi, AR; Shi, LC; Brown, LS; Jung, KH				Choi, Ah Reum; Shi, Lichi; Brown, Leonid S.; Jung, Kwang-Hwan			Cyanobacterial Light-Driven Proton Pump, Gloeobacter Rhodopsin: Complementarity between Rhodopsin-Based Energy Production and Photosynthesis	PLOS ONE			English	Article							ANABAENA SENSORY RHODOPSIN; PHOTOCHEMICAL-REACTION CYCLE; VIOLACEUS PCC-7421; SEQUENCE-ANALYSIS; LACKS THYLAKOIDS; PURPLE MEMBRANE; PROTEORHODOPSIN; BACTERIORHODOPSIN; BINDING; PROTEIN	A homologue of type I rhodopsin was found in the unicellular Gloeobacter violaceus PCC7421, which is believed to be primitive because of the lack of thylakoids and peculiar morphology of phycobilisomes. The Gloeobacter rhodopsin (GR) gene encodes a polypeptide of 298 amino acids. This gene is localized alone in the genome unlike cyanobacterium Anabaena opsin, which is clustered together with 14 kDa transducer gene. Amino acid sequence comparison of GR with other type I rhodopsin shows several conserved residues important for retinal binding and H+ pumping. In this study, the gene was expressed in Escherichia coli and bound all-trans retinal to form a pigment (lambda max = 544 nm at pH 7). The pK(a) of proton acceptor (Asp121) for the Schiff base, is approximately 5.9, so GR can translocate H+ under physiological conditions (pH 7.4). In order to prove the functional activity in the cell, pumping activity was measured in the sphaeroplast membranes of E. coli and one of Gloeobacter whole cell. The efficient proton pumping and rapid photocycle of GR strongly suggests that Gloeobacter rhodopsin functions as a proton pumping in its natural environment, probably compensating the shortage of energy generated by chlorophyll-based photosynthesis without thylakoids.	[Choi, Ah Reum; Jung, Kwang-Hwan] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Choi, Ah Reum; Jung, Kwang-Hwan] Sogang Univ, Inst Biol Interfaces, Seoul, South Korea; [Shi, Lichi; Brown, Leonid S.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada	Sogang University; Sogang University; University of Guelph	Jung, KH (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	kjung@sogang.ac.kr	Brown, Leonid/X-7445-2019; Brown, Leonid/A-1050-2008	Brown, Leonid/0000-0002-5614-8317; Brown, Leonid/0000-0002-5614-8317	Research Foundation of Korea [2011-0012320, 2011-220-C00057]; National Nuclear R&D Program - Ministry of Science ICT & future planning [2012055325]; NSERC; PREA;  [NRF-2013R1A1A064883]	Research Foundation of Korea(National Research Foundation of Korea); National Nuclear R&D Program - Ministry of Science ICT & future planning; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); PREA; 	This work was supported by grants from the Research Foundation of Korea (2011-0012320 and 2011-220-C00057) and National Nuclear R&D Program funded by the Ministry of Science ICT & future planning (2012055325) to K.H. Jung, and grants from NSERC and PREA to L.S. Brown. A. R. Choi was supported by NRF-2013R1A1A064883. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashov SP, 2010, BIOCHEMISTRY-US, V49, P9792, DOI 10.1021/bi1014166; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X; BRYANT DA, 1981, ARCH MICROBIOL, V129, P190, DOI 10.1007/BF00425249; Chizhov I, 1996, BIOPHYS J, V71, P2329, DOI 10.1016/S0006-3495(96)79475-4; Choi AR, 2007, J MICROBIOL BIOTECHN, V17, P138; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; FISCHER U, 1979, BIOPHYS J, V28, P211, DOI 10.1016/S0006-3495(79)85172-3; Friedrich T, 2002, J MOL BIOL, V321, P821, DOI 10.1016/S0022-2836(02)00696-4; GUGLIELMI G, 1981, ARCH MICROBIOL, V129, P181, DOI 10.1007/BF00425248; Hashimoto K, 2010, BIOCHEMISTRY-US, V49, P3343, DOI 10.1021/bi100184k; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Honda D, 1999, J MOL EVOL, V48, P723, DOI 10.1007/PL00006517; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Jung JY, 2008, FEBS LETT, V582, P1679, DOI 10.1016/j.febslet.2008.04.025; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Jung KH, 2007, PHOTOCHEM PHOTOBIOL, V83, P63, DOI 10.1562/2006-03-20-IR-853; Kelemen L, 1999, BIOPHYS J, V76, P1951, DOI 10.1016/S0006-3495(99)77354-6; Kim SY, 2008, BBA-BIOENERGETICS, V1777, P504, DOI 10.1016/j.bbabio.2008.03.010; KOENIG F, 1995, PHYSIOL PLANTARUM, V94, P621; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Mimuro M, 2002, PLANT CELL PHYSIOL, V43, P587, DOI 10.1093/pcp/pcf070; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; MOWERY PC, 1979, BIOCHEMISTRY-US, V18, P4100, DOI 10.1021/bi00586a007; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Nelissen B, 1996, J MOL EVOL, V42, P194, DOI 10.1007/BF02198845; NELISSEN B, 1995, MOL BIOL EVOL, V12, P1166; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OTTOLENGHI M, 1989, J MEMBRANE BIOL, V112, P193, DOI 10.1007/BF01870951; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; Samuilov VD, 2001, BIOCHEMISTRY-MOSCOW+, V66, P640, DOI 10.1023/A:1010207314408; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Shi LC, 2006, J MOL BIOL, V358, P686, DOI 10.1016/j.jmb.2006.02.036; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sineshchevkov OA, 2005, J BIOL CHEM, V280, P14663, DOI 10.1074/jbc.m501416200; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; SPUDICH JL, 1980, J BIOL CHEM, V255, P5501; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Vogt A, 2013, BIOPHYS J, V105, P2055, DOI 10.1016/j.bpj.2013.08.031; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; XIE AH, 1987, BIOPHYS J, V51, P627, DOI 10.1016/S0006-3495(87)83387-8; Yamada M, 2005, J BACTERIOL, V187, P1702, DOI 10.1128/JB.187.5.1702-1709.2005	51	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110643	10.1371/journal.pone.0110643	http://dx.doi.org/10.1371/journal.pone.0110643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347537	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900025
J	Xu, J; Xu, L; Wang, YX; You, QS; Jonas, JB; Bin Wei, W				Xu, Jie; Xu, Liang; Wang, Ya Xing; You, Qi Sheng; Jonas, Jost B.; Bin Wei, Wen			Ten-Year Cumulative Incidence of Diabetic Retinopathy. The Beijing Eye Study 2001/2011	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; RETINAL VESSEL DIAMETER; AXIAL LENGTH; VISION LOSS; PROGRESSION; POPULATION; PREVALENCE; RISK; ARTERIAL; CHINA	Objective: To assess the cumulative 10-year incidence of diabetic retinopathy (DR) and its associated factors in a population living in Greater Beijing. Methods: The population-based longitudinal Beijing Eye Study, which included 4439 subjects (age in 2001: 40+years) in 2001, was repeated in 2011 with 2695 subjects participating (66.4% of the survivors). The study participants underwent a detailed ophthalmic examination. Fundus photographs were examined for the new development of DR. Results: After excluding individuals with DR at baseline (n = 87) or no sufficient fundus photographs in 2011 (n = 6), the study included 2602 subjects with a mean age of 64.6 +/- 9.7 years (median: 64.0 years; range: 50 to 93 years). In the 10-year period, 109 subjects (39 men) developed new DR with an incidence of 4.2% (95% confidence interval (CI): 3.45,5.03). In multiple logistic regression analysis, incident DR was significantly associated with higher HbA1c value (P < 0.001; Odds Ratio (OR): 1.73; 95% Confidence Interval (CI): 1.35,2.21), longer duration of diabetes mellitus (P < 0.001; OR: 1.16; 95% CI: 1.10,1.22), higher serum concentration of creatinine (P = 0.02; OR: 1.01; 95% CI: 1.002,1.022), lower educational level (P = 0.049; OR: 0.74; 95% CI: 0.55,0.99), higher estimated cerebrospinal fluid pressure (P = 0.038; OR: 1.10; 95% CI: 1.01,1.22), and shorter axial length (P < 0.001; OR: 0.48; 95% CI: 0.33,0.71). Conclusions: The cumulative 10-year incidence (mean: 4.2%) of DR in a North Chinese population was significantly associated with a higher HbA1c value, longer known duration of diabetes mellitus, higher estimated CSFP and shorter axial length (P, 0.001). Shorter axial length (or hyperopia) and, potentially, higher CSFP may be additional risk factors to be taken into account when counseling and treating patients with diabetes mellitus.	[Xu, Jie; Xu, Liang; Wang, Ya Xing; You, Qi Sheng; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Bin Wei, Wen] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Bin Wei, W (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	wenbing_wei@yahoo.com.cn	xu, jie/GQR-1913-2022; Dagdelen, Selcuk/A-9432-2017; wang, YA XING/K-9671-2016; Xu, Jie/AIE-0524-2022; You, Qisheng/AAG-7153-2020	xu, jie/0000-0002-2039-7055; Dagdelen, Selcuk/0000-0002-0513-1750; wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	Supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Cikamatana L, 2007, EYE, V21, P465, DOI 10.1038/sj.eye.6702771; DWYER MS, 1985, DIABETES CARE, V8, P316, DOI 10.2337/diacare.8.4.316; Grauslund J, 2009, DIABETOLOGIA, V52, P1829, DOI 10.1007/s00125-009-1450-4; HAYREH SS, 1971, BRIT J OPHTHALMOL, V55, P649, DOI 10.1136/bjo.55.10.649; Henricsson M, 2003, DIABETES CARE, V26, P349, DOI 10.2337/diacare.26.2.349; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jonas JB, 2014, AM J HYPERTENS, V27, P1170, DOI 10.1093/ajh/hpu037; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096273; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Jonas JB, 2013, DIABETES CARE, V36, pE69, DOI 10.2337/dc12-2377; Jonas JB, 2010, OPHTHALMOLOGY, V117, P2234, DOI 10.1016/j.ophtha.2009.12.006; Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; Klein R, 2012, ARCH OPHTHALMOL-CHIC, V130, P749, DOI 10.1001/archophthalmol.2011.2560; Klein R, 2009, OPHTHALMOLOGY, V116, P497, DOI 10.1016/j.ophtha.2008.10.016; Leske MC, 2003, OPHTHALMOLOGY, V110, P941, DOI 10.1016/S0161-6420(03)00086-1; Lim LS, 2010, OPHTHALMOLOGY, V117, P524, DOI 10.1016/j.ophtha.2009.07.044; Man REK, 2012, OPHTHALMOLOGY, V119, P1754, DOI 10.1016/j.ophtha.2012.03.021; Mirshahi A, 2014, OPHTHALMOLOGY, V121, P2047, DOI 10.1016/j.ophtha.2014.04.017; Pan CW, 2013, OPHTHALMOLOGY, V120, P2058, DOI 10.1016/j.ophtha.2013.03.028; Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Rogers SL, 2008, DIABETES CARE, V31, P761, DOI 10.2337/dc07-1622; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Stodtmeister R, 2013, INVEST OPHTH VIS SCI, V54, P4698, DOI 10.1167/iovs.12-10607; Tapp RJ, 2008, DIABETES CARE, V31, P1349, DOI 10.2337/dc07-1707; Tapp RJ, 2006, DIABETES RES CLIN PR, V73, P298, DOI 10.1016/j.diabres.2006.02.009; Varma R, 2010, AM J OPHTHALMOL, V149, P752, DOI 10.1016/j.ajo.2009.11.014; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wong TY, 2007, AM J OPHTHALMOL, V143, P970, DOI 10.1016/j.ajo.2007.02.020; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P49, DOI 10.1007/s00417-009-1204-5; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	39	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111320	10.1371/journal.pone.0111320	http://dx.doi.org/10.1371/journal.pone.0111320			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347072	Green Submitted, Green Published, gold			2022-12-26	WOS:000347994900061
J	Dong, B; Zhou, HL; Han, CH; Yao, JF; Xu, LM; Zhang, M; Fu, YW; Xia, Q				Dong, Biao; Zhou, Honglan; Han, Conghui; Yao, Jufang; Xu, Longmei; Zhang, Ming; Fu, Yaowen; Xia, Qiang			Ischemia/Reperfusion-Induced CHOP Expression Promotes Apoptosis and Impairs Renal Function Recovery: The Role of Acidosis and GPR4	PLOS ONE			English	Article							REPERFUSION INJURY; PH SENSOR; ISCHEMIA; PROTECTS; PATHWAY; DEATH; MICE	Endoplasmic reticulum (ER) stress-induced apoptosis is implicated in a wide range of diseases, including ischemia/reperfusion injury (IRI). As a common feature of ER stress, the role of CCAT/enhancer-binding protein homologous protein (CHOP) in renal IRI has not been thoroughly investigated. We found that IR led to renal CHOP expression, accompanied by apoptosis induction. Renal IRI was markedly alleviated in CHOP-/- mice. Observations from bone marrow chimeras showed that this was based on CHOP inactivation in renal parenchymal cells rather than inflammatory cells. In vivo and in vitro studies demonstrated that IRI induced CHOP expression in both endothelial and epithelial cells, which was responsible for apoptosis induction. These results were reinforced by the observation that CHOP knockout led to improvement of the postischemic microcirculatory recovery. In vitro studies revealed hypoxia-induced acidosis to be a major inducer of CHOP in endothelial cells, and neutralizing acidosis not only diminished CHOP protein, but also reduced apoptosis. Finally, knockdown of a proton-sensing G protein-coupled receptor GPR4 markedly reduced CHOP expression and endothelial cell apoptosis after hypoxia exposure. These results highlight the importance of hypoxia-acidosis in ER stress signaling regulation in ischemic kidneys and suggest that GPR4 inhibitors or agents targeting CHOP expression may be promising in the treatment of renal IRI.	[Dong, Biao; Zhang, Ming; Xia, Qiang] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Transplantat & Hepat Surg, Shanghai 200030, Peoples R China; [Dong, Biao; Zhou, Honglan; Fu, Yaowen] Jilin Univ, Hosp 1, Dept Urol, Changchun 130023, Peoples R China; [Dong, Biao; Zhou, Honglan; Fu, Yaowen] Xuzhou Cent Hosp, Xuzhou Med Coll, Affiliated Sch Clin Med, Dept Urol, Xuzhou, Peoples R China; [Yao, Jufang] Shanghai Jiao Tong Univ, Renji Hosp, Anim Facil, Shanghai 200030, Peoples R China; [Xu, Longmei] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Cent Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Jilin University; Xuzhou Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fu, YW (corresponding author), Jilin Univ, Hosp 1, Dept Urol, Changchun 130023, Peoples R China.	fuyaowenjdyy@163.com; xiaqiang@shsmu.edu.cn			National Natural Science Foundation of China [81270558, 81470895]; Shanghai Municipal Commission of Health and Family Planning [XBR2011029, 2013ZYJB0001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	This work was supported by grants from the National Natural Science Foundation of China (grant number: 81270558) to QX and (grant number: 81470895) to MZ, and grants from the Shanghai Municipal Commission of Health and Family Planning (XBR2011029, 2013ZYJB0001) to QX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blohmke CJ, 2012, J IMMUNOL, V189, P5467, DOI 10.4049/jimmunol.1103661; BONVENTRE JV, 1988, ANNU REV MED, V39, P531, DOI 10.1146/annurev.med.39.1.531; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040801; DeZwaan-McCabe D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003937; Dong LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061991; Engel T, 2013, BRAIN, V136, P577, DOI 10.1093/brain/aws337; Esposito V, 2013, AM J PHYSIOL-RENAL, V304, pF440, DOI 10.1152/ajprenal.00487.2011; Halterman MW, 2010, J BIOL CHEM, V285, P21329, DOI 10.1074/jbc.M109.095299; He K, 2014, KIDNEY INT, V85, P276, DOI 10.1038/ki.2013.342; Liu J, 2012, TRANSPLANTATION, V94, P211, DOI 10.1097/TP.0b013e318259d38e; Lozon TI, 2011, AM J PHYSIOL-LUNG C, V300, pL422, DOI 10.1152/ajplung.00166.2010; Malhi H, 2013, J BIOL CHEM, V288, P18624, DOI 10.1074/jbc.M112.442954; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Sun XM, 2010, J AM SOC NEPHROL, V21, P1745, DOI 10.1681/ASN.2009050477; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Yang JR, 2014, AM J PHYSIOL-RENAL, V306, pF75, DOI 10.1152/ajprenal.00117.2013; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029876	21	38	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110944	10.1371/journal.pone.0110944	http://dx.doi.org/10.1371/journal.pone.0110944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343248	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943500068
J	Feng, L; Chen, Z; Ma, H; Chen, X; Li, Y; Wang, YY; Xiang, Y				Feng, Lin; Chen, Zhu; Ma, Hui; Chen, Xue; Li, Yuan; Wang, Yiyi; Xiang, Yan			The IQD Gene Family in Soybean: Structure, Phylogeny, Evolution and Expression	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; CALCIUM; CALMODULIN; PROTEIN; POPULUS; DUPLICATION; SEQUENCE; SENSORS	Members of the plant-specific IQ67-domain (IQD) protein family are involved in plant development and the basal defense response. Although systematic characterization of this family has been carried out in Arabidopsis, tomato (Solanum lycopersicum), Brachypodium distachyon and rice (Oryza sativa), systematic analysis and expression profiling of this gene family in soybean (Glycine max) have not previously been reported. In this study, we identified and structurally characterized IQD genes in the soybean genome. A complete set of 67 soybean IQD genes (GmIQD1-67) was identified using Blast search tools, and the genes were clustered into four subfamilies (IQD I-IV) based on phylogeny. These soybean IQD genes are distributed unevenly across all 20 chromosomes, with 30 segmental duplication events, suggesting that segmental duplication has played a major role in the expansion of the soybean IQD gene family. Analysis of the Ka/Ks ratios showed that the duplicated genes of the GmIQD family primarily underwent purifying selection. Microsynteny was detected in most pairs: genes in clade 1-3 might be present in genome regions that were inverted, expanded or contracted after the divergence; most gene pairs in clade 4 showed high conservation with little rearrangement among these gene-residing regions. Of the soybean IQD genes examined, six were most highly expressed in young leaves, six in flowers, one in roots and two in nodules. Our qRT-PCR analysis of 24 soybean IQD III genes confirmed that these genes are regulated by MeJA stress. Our findings present a comprehensive overview of the soybean IQD gene family and provide insights into the evolution of this family. In addition, this work lays a solid foundation for further experiments aimed at determining the biological functions of soybean IQD genes in growth and development.	[Feng, Lin; Chen, Zhu; Ma, Hui; Chen, Xue; Li, Yuan; Wang, Yiyi; Xiang, Yan] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Lab Modern Biotechnol, Hefei, Peoples R China; [Xiang, Yan] Anhui Agr Univ, Key Lab Crop Biol, Hefei, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Xiang, Y (corresponding author), Anhui Agr Univ, Sch Forestry & Landscape Architecture, Lab Modern Biotechnol, Hefei, Peoples R China.	xiangyanahau@sina.com	wang, yiyi/GWZ-5830-2022		National Natural Science Foundation of China [31370561]; Specialized research Fund for the Doctoral Program of Higher Education [20133418110005]; Anhui Provincial Natural Science Foundation [1308085MC36]; Anhui Agricultural University disciplinary construction Foundation [XKTS2013001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Agricultural University disciplinary construction Foundation	This work was supported by grants from the National Natural Science Foundation of China (No. 31370561), Specialized research Fund for the Doctoral Program of Higher Education(No. 20133418110005), Anhui Provincial Natural Science Foundation (No. 1308085MC36) and Anhui Agricultural University disciplinary construction Foundation(No. XKTS2013001) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-72; Abel S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24369; Ali GS, 2003, PLANT MOL BIOL, V51, P803, DOI 10.1023/A:1023001403794; Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batistic O, 2004, PLANTA, V219, P915, DOI 10.1007/s00425-004-1333-3; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Boonburapong B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-4; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Bryfczynski S, 2009, ITICSE 2009: PROCEEDING OF THE 2009 ACM SIGSE ANNUAL CONFERENCE ON INNOVATION AND TECHNOLOGY IN COMPUTER SCIENCE EDUCATION, P389, DOI 10.1145/1595496.1563031; Burstenbinder K, 2013, J BIOL CHEM, V288, P1871, DOI 10.1074/jbc.M112.396200; Cannon SB, 2003, MOL GENET GENOMICS, V270, P347, DOI 10.1007/s00438-003-0928-x; Cannon SB, 2012, BREEDING SCI, V61; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Cheng Q, 2006, PLANT SCI, V170, P1027, DOI 10.1016/j.plantsci.2005.12.012; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dittmar K, 2011, EVOLUTION GENE DUPLI; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Du JC, 2012, PLANT CELL, V24, P21, DOI [10.1105/tpc.111.092759, 10.1105/tpc.112.103630]; Du LQ, 2009, NATURE, V457, P1154, DOI 10.1038/nature07612; Evans NH, 2001, CURR OPIN PLANT BIOL, V4, P415, DOI 10.1016/S1369-5266(00)00194-1; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Filiz E, 2013, PLANT OMICS, V6, P425; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer C, 2013, PLANT CELL PHYSIOL, V54, P573, DOI 10.1093/pcp/pct021; Gao F, 2012, PLANT J, V70, P1056, DOI 10.1111/j.1365-313X.2012.04969.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hajduch M, 2005, PLANT PHYSIOL, V137, P1397, DOI 10.1104/pp.104.056614; Harada A, 2009, PLANT CELL PHYSIOL, V50, P360, DOI 10.1093/pcp/pcn203; Harper JF, 2001, TRENDS PLANT SCI, V6, P395, DOI 10.1016/S1360-1385(01)02023-4; Helfer S, 2014, NEW PHYTOL, V201, P770, DOI 10.1111/nph.12570; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; HU W-z, 2012, SCI TECHNOLOGY FOOD, V16; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Hyun TK, 2013, IND CROP PROD, V49, P864, DOI 10.1016/j.indcrop.2013.06.046; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kamenetzky L, 2010, PLANT PHYSIOL, V152, P1772, DOI 10.1104/pp.109.150532; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Ng CKY, 2001, NEW PHYTOL, V151, P109, DOI 10.1046/j.1469-8137.2001.00152.x; Ohno S., 1970, EVOLUTION GENE DUPLI; Pauly N, 2000, NATURE, V405, P754, DOI 10.1038/35015671; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Perochon A, 2011, BIOCHIMIE, V93, P2048, DOI 10.1016/j.biochi.2011.07.012; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Reddy ASN, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-7-research0024; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Silva DCG, 2008, THEOR APPL GENET, V117, P57, DOI 10.1007/s00122-008-0752-0; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Soto-Valdez H, 2012, FABRICATION PROPERTI, P206; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Team RC, 2012, R LANG ENV STAT COMP; Tian CG, 2014, CHINESE B BOT, V48, P447; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wei HY, 2008, PROG BIOCHEM BIOPHYS, V35, P703; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Wu S, 2011, PLANT PHYSIOL, V157, P1175, DOI 10.1104/pp.111.181065; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Xiong TC, 2004, PLANT J, V40, P12, DOI 10.1111/j.1365-313X.2004.02184.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoo JH, 2005, J BIOL CHEM, V280, P3697, DOI 10.1074/jbc.M408237200; Yu YH, 2007, PLANT GROWTH REGUL, V52, P101, DOI 10.1007/s10725-007-9165-3; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang CX, 2011, PLANT PHYSIOL BIOCH, V49, P1306, DOI 10.1016/j.plaphy.2011.08.010; Zhang HC, 2008, PLANT GROWTH REGUL, V56, P129, DOI 10.1007/s10725-008-9293-4; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	95	63	68	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110896	10.1371/journal.pone.0110896	http://dx.doi.org/10.1371/journal.pone.0110896			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343341	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500063
J	Gas-Pascual, E; Berna, A; Bach, TJ; Schaller, H				Gas-Pascual, Elisabet; Berna, Anne; Bach, Thomas J.; Schaller, Hubert			Plant Oxidosqualene Metabolism: Cycloartenol Synthase-Dependent Sterol Biosynthesis in Nicotiana benthamiana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; LANOSTEROL SYNTHASE; DIRECTED EVOLUTION; TRITERPENE; YEAST; PHYTOSTEROLS; PATHWAYS; CYCLASES; LEAVES	The plant sterol pathway exhibits a major biosynthetic difference as compared with that of metazoans. The committed sterol precursor is the pentacyclic cycloartenol (9 beta, 19-cyclolanost-24-en-3 beta-ol) and not lanosterol (lanosta-8,24-dien-3 beta-ol), as it was shown in the late sixties. However, plant genome mining over the last years revealed the general presence of lanosterol synthases encoding sequences (LAS1) in the oxidosqualene cyclase repertoire, in addition to cycloartenol synthases (CAS1) and to non-steroidal triterpene synthases that contribute to the metabolic diversity of C30H50O compounds on earth. Furthermore, plant LAS1 proteins have been unambiguously identified by peptidic signatures and by their capacity to complement the yeast lanosterol synthase deficiency. A dual pathway for the synthesis of sterols through lanosterol and cycloartenol was reported in the model Arabidopsis thaliana, though the contribution of a lanosterol pathway to the production of 24-alkyl-Delta(5) -sterols was quite marginal (Ohyama et al. (2009) PNAS 106, 725). To investigate further the physiological relevance of CAS1 and LAS1 genes in plants, we have silenced their expression in Nicotiana benthamiana. We used virus induced gene silencing (VIGS) based on gene specific sequences from a Nicotiana tabacum CAS1 or derived from the solgenomics initiative (http://solgenomics.net/) to challenge the respective roles of CAS1 and LAS1. In this report, we show a CAS1-specific functional sterol pathway in engineered yeast, and a strict dependence on CAS1 of tobacco sterol biosynthesis.	[Schaller, Hubert] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Univ Strasbourg, Inst Bot, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schaller, H (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	hubert.schaller@ibmp-cnrs.unistra.fr		Schaller, Hubert/0000-0002-4099-4447; Gas-Pascual, Elisabet/0000-0002-2643-6916	Centre National de la Recherche Scientifique; Universite de Strasbourg; Agence Nationale de la Recherche [BIOSIS ANR-06-BLAN-0291-02, TERPENE ANR-05-BLAN-0217-01, TERPENE ANR-05-BLAN-0217-02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique, the Universite de Strasbourg, and the Agence Nationale de la Recherche (grant BIOSIS ANR-06-BLAN-0291-02 to TJB and TERPENE ANR-05-BLAN-0217-01 and 02 to HS and TJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiychuk E, 2008, P NATL ACAD SCI USA, V105, P3163, DOI 10.1073/pnas.0712190105; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; BENVENISTE P, 1966, PHYTOCHEMISTRY, V5, P45, DOI 10.1016/S0031-9422(00)85080-3; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; BLADOCHA M, 1983, PLANT PHYSIOL, V71, P756, DOI 10.1104/pp.71.4.756; Burger C, 2003, J EXP BOT, V54, P1675, DOI 10.1093/jxb/erg184; Buschhaus C, 2012, PLANT PHYSIOL, V160, P1120, DOI 10.1104/pp.112.198473; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; Cornforth JW, 2002, BIOCHEM BIOPH RES CO, V292, P1129, DOI 10.1006/bbrc.2001.2006; Darnet S, 2003, BBA-MOL CELL BIOL L, V1633, P106, DOI 10.1016/S1388-1981(03)00093-3; Gachotte D, 1999, P NATL ACAD SCI USA, V96, P12655, DOI 10.1073/pnas.96.22.12655; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Guhling O, 2005, J CHEM ECOL, V31, P2323, DOI 10.1007/s10886-005-7104-1; Hayward A, 2011, METHODS MOL BIOL, V678, P55, DOI 10.1007/978-1-60761-682-5_5; HEINTZ R, 1974, J BIOL CHEM, V249, P4267; Heupel RC, 1986, METABOLISM STRUCTURE; HEWLINS MJE, 1969, EUR J BIOCHEM, V8, P184, DOI 10.1111/j.1432-1033.1969.tb00513.x; Itkin M, 2013, SCIENCE, V341, P175, DOI 10.1126/science.1240230; Ito R, 2011, ORG LETT, V13, P2678, DOI 10.1021/ol200777d; Kolesnikova M, 2009, THESIS RICE U HOUSTO; Kolesnikova MD, 2006, ARCH BIOCHEM BIOPHYS, V447, P87, DOI 10.1016/j.abb.2005.12.010; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Lovato MA, 2000, J BIOL CHEM, V275, P13394, DOI 10.1074/jbc.275.18.13394; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Meyer MM, 2002, ORG LETT, V4, P1395, DOI 10.1021/ol0257225; Milla P, 2002, LIPIDS, V37, P1171, DOI 10.1007/s11745-002-1017-9; Nes WD, 2011, CHEM REV, V111, P6423, DOI 10.1021/cr200021m; NES WD, 1993, ARCH BIOCHEM BIOPHYS, V300, P724, DOI 10.1006/abbi.1993.1100; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Ohyama K, 2009, P NATL ACAD SCI USA, V106, P725, DOI 10.1073/pnas.0807675106; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; PONSINET G, 1967, PHYTOCHEMISTRY, V6, P1235, DOI 10.1016/S0031-9422(00)86086-0; Racolta S, 2012, PROTEINS, V80, P2009, DOI 10.1002/prot.24089; RAEDERSTORFF D, 1987, EUR J BIOCHEM, V164, P427, DOI 10.1111/j.1432-1033.1987.tb11075.x; Rahier A., 1989, ANAL STEROLS OTHER B, P223, DOI [10.1016/B978-0-12-515445-1.50016-1, DOI 10.1016/B978-0-12-515445-1.50016-1]; Vicente MRS, 2013, PLANTA, V237, P121, DOI 10.1007/s00425-012-1758-z; Sainsbury F, 2012, METHOD ENZYMOL, V517, P185, DOI 10.1016/B978-0-12-404634-4.00009-7; Sawai S, 2006, PLANT CELL PHYSIOL, V47, P673, DOI 10.1093/pcp/pcj032; SCHALLER H, 1991, PHYTOCHEMISTRY, V30, P2547, DOI 10.1016/0031-9422(91)85097-J; Schaller H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P755; Segura MJR, 2002, ORG LETT, V4, P4459, DOI 10.1021/ol0269897; Venkatramesh M, 1995, ARCH BIOCHEM BIOPHYS, V324, P189, DOI 10.1006/abbi.1995.9912; Voutquenne-Nazabadioko L, 2013, PHYTOCHEMISTRY, V90, P114, DOI 10.1016/j.phytochem.2013.03.001; Wang KR, 2012, PLANT PHYSIOL, V158, P1789, DOI 10.1104/pp.111.189217; Wang ZH, 2011, PLANT PHYSIOL, V155, P540, DOI 10.1104/pp.110.162883; Wu TK, 2008, CHEM REC, V8, P302, DOI 10.1002/tcr.20157; Xu R, 2004, PHYTOCHEMISTRY, V65, P261, DOI 10.1016/j.phytochem.2003.11.014	48	39	43	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109156	10.1371/journal.pone.0109156	http://dx.doi.org/10.1371/journal.pone.0109156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343375	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943500009
J	Gounarides, J; Cobb, JS; Zhou, J; Cook, F; Yang, XM; Yin, H; Meredith, E; Rao, C; Huang, Q; Xu, YY; Anderson, K; De Erkenez, A; Liao, SM; Crowley, M; Buchanan, N; Poor, S; Qiu, YB; Fassbender, E; Shen, SY; Woolfenden, A; Jensen, A; Cepeda, R; Etemad-Gilbertson, B; Giza, S; Mogi, M; Jaffee, B; Azarian, S				Gounarides, John; Cobb, Jennifer S.; Zhou, Jing; Cook, Frank; Yang, Xuemei; Yin, Hong; Meredith, Erik; Rao, Chang; Huang, Qian; Xu, YongYao; Anderson, Karen; De Erkenez, Andrea; Liao, Sha-Mei; Crowley, Maura; Buchanan, Natasha; Poor, Stephen; Qiu, Yubin; Fassbender, Elizabeth; Shen, Siyuan; Woolfenden, Amber; Jensen, Amy; Cepeda, Rosemarie; Etemad-Gilbertson, Bijan; Giza, Shelby; Mogi, Muneto; Jaffee, Bruce; Azarian, Sassan			Lack of Involvement of CEP Adducts in TLR Activation and in Angiogenesis	PLOS ONE			English	Article							MACULAR DEGENERATION; NEOVASCULARIZATION; INFLAMMATION; BIOMARKERS; COMPLEX; DAMAGE; CRB1	Proteins that are post-translationally adducted with 2-(omega-carboxyethyl) pyrrole (CEP) have been proposed to play a pathogenic role in age-related macular degeneration, by inducing angiogenesis in a Toll Like Receptor 2 (TLR2)-dependent manner. We have investigated the involvement of CEP adducts in angiogenesis and TLR activation, to assess the therapeutic potential of inhibiting CEP adducts and TLR2 for ocular angiogenesis. As tool reagents, several CEP-adducted proteins and peptides were synthetically generated by published methodology and adduction was confirmed by NMR and LC-MS/MS analyses. Structural studies showed significant changes in secondary structure in CEP-adducted proteins but not the untreated proteins. Similar structural changes were also observed in the treated unadducted proteins, which were treated by the same adduction method except for one critical step required to form the CEP group. Thus some structural changes were unrelated to CEP groups and were artificially induced by the synthesis method. In biological studies, the CEP-adducted proteins and peptides failed to activate TLR2 in cell-based assays and in an in vivo TLR2-mediated retinal leukocyte infiltration model. Neither CEP adducts nor TLR agonists were able to induce angiogenesis in a tube formation assay. In vivo, treatment of animals with CEP-adducted protein had no effect on laser-induced choroidal neovascularization. Furthermore, in vivo inactivation of TLR2 by deficiency in Myeloid Differentiation factor 88 (Myd88) had no effect on abrasion-induced corneal neovascularization. Thus the CEP-TLR2 axis, which is implicated in other wound angiogenesis models, does not appear to play a pathological role in a corneal wound angiogenesis model. Collectively, our data do not support the mechanism of action of CEP adducts in TLR2-mediated angiogenesis proposed by others.	[Gounarides, John; Cobb, Jennifer S.; Zhou, Jing; Cook, Frank; Yang, Xuemei; Yin, Hong; Meredith, Erik; Rao, Chang; Huang, Qian; Xu, YongYao; Anderson, Karen; De Erkenez, Andrea; Liao, Sha-Mei; Crowley, Maura; Buchanan, Natasha; Poor, Stephen; Qiu, Yubin; Fassbender, Elizabeth; Shen, Siyuan; Woolfenden, Amber; Jensen, Amy; Cepeda, Rosemarie; Etemad-Gilbertson, Bijan; Giza, Shelby; Mogi, Muneto; Jaffee, Bruce; Azarian, Sassan] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Novartis	Azarian, S (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	Sassan.Azarian@novartis.com		Giza, Shelby/0000-0002-0772-8200	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This study was funded by the Novartis Institutes for Biomedical Research. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed N, 2002, BIOCHEM J, V364, P1; Alves CH, 2014, PROG RETIN EYE RES, V40, P35, DOI 10.1016/j.preteyeres.2014.01.001; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cruz-Guilloty F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088201; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Gu J, 2009, THESIS CASE W RESERV; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Jang G-F, 2012, INVEST OPHTHALMOL, V53, P6478; Kuno Noriyuki, 2011, Curr Mol Pharmacol, V4, P196; Lu L, 2009, BIOORGAN MED CHEM, V17, P7548, DOI 10.1016/j.bmc.2009.09.009; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Nguyen DH, 2013, DISCOV MED, V15, P343; Organisciak DT, 2013, MOL VIS, V19, P1433; Renganathan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076325; Saeed AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106421; Salomon RG, 2011, CHEM RES TOXICOL, V24, P1803, DOI 10.1021/tx200206v; Sivak JM, 2011, J BIOL CHEM, V286, P44965, DOI 10.1074/jbc.M111.294967; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111472	10.1371/journal.pone.0111472	http://dx.doi.org/10.1371/journal.pone.0111472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343517	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943500102
J	Wang, GQ; MacRaild, CA; Mohanty, B; Mobli, M; Cowieson, NP; Anders, RF; Simpson, JS; McGowan, S; Norton, RS; Scanlon, MJ				Wang, Geqing; MacRaild, Christopher A.; Mohanty, Biswaranjan; Mobli, Mehdi; Cowieson, Nathan P.; Anders, Robin F.; Simpson, Jamie S.; McGowan, Sheena; Norton, Raymond S.; Scanlon, Martin J.			Molecular Insights into the Interaction between Plasmodium falciparum Apical Membrane Antigen 1 and an Invasion-Inhibitory Peptide	PLOS ONE			English	Article							HOST-CELL INVASION; MALARIA PARASITE INVASION; DRUGGABLE HOT-SPOTS; NMR CHEMICAL-SHIFTS; ERYTHROCYTE INVASION; BINDING; AMA1; NONPEPTIDE; PROTEINS; ANTIBODY	Apical membrane antigen 1 (AMA1) of the human malaria parasite Plasmodium falciparum has been implicated in invasion of the host erythrocyte. It interacts with malarial rhoptry neck (RON) proteins in the moving junction that forms between the host cell and the invading parasite. Agents that block this interaction inhibit invasion and may serve as promising leads for anti-malarial drug development. The invasion-inhibitory peptide R1 binds to a hydrophobic cleft on AMA1, which is an attractive target site for small molecules that block parasite invasion. In this work, truncation and mutational analyses show that Phe5-Phe9, Phe12 and Arg15 in R1 are the most important residues for high affinity binding to AMA1. These residues interact with two well-defined binding hot spots on AMA1. Computational solvent mapping reveals that one of these hot spots is suitable for small molecule targeting. We also confirm that R1 in solution binds to AMA1 with 1:1 stoichiometry and adopts a secondary structure consistent with the major form of R1 observed in the crystal structure of the complex. Our results provide a basis for designing high affinity inhibitors of the AMA1-RON2 interaction.	[Wang, Geqing; MacRaild, Christopher A.; Mohanty, Biswaranjan; Simpson, Jamie S.; Norton, Raymond S.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Mohanty, Biswaranjan; Scanlon, Martin J.] Monash Univ, Australian Res Council Ctr Excellence Coherent Xr, Parkville, Vic, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia; [Cowieson, Nathan P.] Australian Synchrotron, Clayton, Vic, Australia; [Anders, Robin F.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia; [McGowan, Sheena] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University; University of Queensland; La Trobe University; Monash University	Norton, RS (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	ray.norton@monash.edu; martin.scanlon@monash.edu	McGowan, Sheena/C-4797-2014; Simpson, Jamie/ABC-7083-2020; Simpson, Jamie S/A-1700-2012; Mobli, Mehdi/O-7244-2014; Mohanty, Biswaranjan/E-2080-2018	McGowan, Sheena/0000-0001-6863-1106; Simpson, Jamie/0000-0002-8894-422X; Simpson, Jamie S/0000-0002-8894-422X; Mobli, Mehdi/0000-0003-2420-4262; Mohanty, Biswaranjan/0000-0002-6921-343X; Wang, Geqing/0000-0002-9419-8657; Norton, Raymond/0000-0001-8893-0584; Anders, Robin/0000-0002-0693-4547; MacRaild, Christopher/0000-0002-3694-3989; Scanlon, Martin/0000-0002-9230-7506	National Health and Medical Research Council of Australia [1025150]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The work was funded in part by a grant from the National Health and Medical Research Council of Australia (1025150). RSN is a research fellow of the National Health and Medical Research Council (1059060) (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bargieri DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3552; Blackburn BK, 1997, J MED CHEM, V40, P717, DOI 10.1021/jm960652r; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Damour D, 1996, BIOORG MED CHEM LETT, V6, P1667, DOI 10.1016/0960-894X(96)00289-2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Harris KS, 2009, J BIOL CHEM, V284, P9361, DOI 10.1074/jbc.M808762200; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; HIRSCHMANN R, 1993, J AM CHEM SOC, V115, P12550, DOI 10.1021/ja00079a039; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; Keller R., 2004, COMPUTER AIDED RESON, V1; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; Lee EF, 2011, BIOPOLYMERS, V95, P354, DOI 10.1002/bip.21582; Li F, 2002, J BIOL CHEM, V277, P50303, DOI 10.1074/jbc.M207985200; Lim SS, 2013, AUST J CHEM, V66, P1530, DOI 10.1071/CH13266; MacRaild CA, 2011, CURR TOP MED CHEM, V11, P2039; MCDOWELL RS, 1994, J AM CHEM SOC, V116, P5069, DOI 10.1021/ja00091a007; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Mobli M, 2007, NAT METHODS, V4, P467, DOI 10.1038/nmeth0607-467; Mobli M, 2010, J MAGN RESON, V204, P160, DOI 10.1016/j.jmr.2010.02.012; Ono K, 2014, ANGEW CHEM INT EDIT, V53, P2597, DOI 10.1002/anie.201310749; Polley SD, 2003, GENETICS, V165, P555; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tonkin ML, 2013, PROTEIN SCI, V22, P114, DOI 10.1002/pro.2193; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Yap A, 2014, CELL MICROBIOL, DOI [10.1111/cmi.122287, DOI 10.1111/CMI.122287]	54	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109674	10.1371/journal.pone.0109674	http://dx.doi.org/10.1371/journal.pone.0109674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343578	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500019
J	Xu, Y; Hua, J; Ni, ZH; Chen, QL; Fan, YB; Ananiadou, S; Chang, EIC; Tsujii, J				Xu, Yan; Hua, Ji; Ni, Zhaoheng; Chen, Qinlang; Fan, Yubo; Ananiadou, Sophia; Chang, Eric I-Chao; Tsujii, Junichi			Anatomical Entity Recognition with a Hierarchical Framework Augmented by External Resources	PLOS ONE			English	Article							CLINICAL DOCUMENTS; FOUNDATIONAL MODEL; ONTOLOGY; TEXT	References to anatomical entities in medical records consist not only of explicit references to anatomical locations, but also other diverse types of expressions, such as specific diseases, clinical tests, clinical treatments, which constitute implicit references to anatomical entities. In order to identify these implicit anatomical entities, we propose a hierarchical framework, in which two layers of named entity recognizers (NERs) work in a cooperative manner. Each of the NERs is implemented using the Conditional Random Fields (CRF) model, which use a range of external resources to generate features. We constructed a dictionary of anatomical entity expressions by exploiting four existing resources, i.e., UMLS, MeSH, RadLex and BodyPart3D, and supplemented information from two external knowledge bases, i.e., Wikipedia and WordNet, to improve inference of anatomical entities from implicit expressions. Experiments conducted on 300 discharge summaries showed a micro-averaged performance of 0.8509 Precision, 0.7796 Recall and 0.8137 F1 for explicit anatomical entity recognition, and 0.8695 Precision, 0.6893 Recall and 0.7690 F1 for implicit anatomical entity recognition. The use of the hierarchical framework, which combines the recognition of named entities of various types (diseases, clinical tests, treatments) with information embedded in external knowledge bases, resulted in a 5.08% increment in F1. The resources constructed for this research will be made publicly available.	[Xu, Yan; Hua, Ji; Ni, Zhaoheng; Chen, Qinlang; Fan, Yubo] Beihang Univ, State Key Lab Software Dev Environm, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing 100191, Peoples R China; [Chang, Eric I-Chao; Tsujii, Junichi] Microsoft Res Asia, Beijing, Peoples R China; [Ananiadou, Sophia] Univ Manchester, Natl Ctr Text Min, Sch Comp Sci, Manchester, Lancs, England	Beihang University; Microsoft; Microsoft Research Asia; University of Manchester	Chang, EIC (corresponding author), Microsoft Res Asia, Beijing, Peoples R China.	eric.chang@microsoft.com; jtsujii@microsoft.com			Microsoft Research Asia (MSR Asia); MSRA eHealth grant; National Science Foundation of China [61073077]; State Key Laboratory of Software Development Environment in Beihang University in China [SKLSDE-2011ZX-13]; Medical Research Council [MR/L01078X/1]; Defense Advanced Research Projects Agency [DARPA-BAA-14-14]; MRC [MR/L01078X/1] Funding Source: UKRI	Microsoft Research Asia (MSR Asia)(Microsoft); MSRA eHealth grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Software Development Environment in Beihang University in China; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Microsoft Research Asia (MSR Asia). The work was also supported by MSRA eHealth grant, Grant 61073077 from National Science Foundation of China and Grant SKLSDE-2011ZX-13 from State Key Laboratory of Software Development Environment in Beihang University in China. This work has been funded by the Medical Research Council (Supporting Evidence-based Public Health Interventions using Text Mining [Grant MR/L01078X/1]) and by the Defense Advanced Research Projects Agency (Big Mechanism [Grant DARPA-BAA-14-14]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiadou S, 2014, BRIEFINGS F IN PRESS; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Cucerzan Silviu, 2007, P 2007 JOINT C EMPIR; FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; HRIPCSAK G, 1995, ANN INTERN MED, V122, P681, DOI 10.7326/0003-4819-122-9-199505010-00007; Hripcsak G, 2002, RADIOLOGY, V224, P157, DOI 10.1148/radiol.2241011118; Jin-Dong K, 2004, P JNLPABA 2004; John L, 2001, P 18 INT C MACH LEAR; Junichi K, 2007, P 2007 JOINT C EMP M, P698; Li X, 2009, P 32 ACM SPEC INT GR; Martin G, 2010, BIONLP, P72; Meystre S, 2006, J BIOMED INFORM, V39, P589, DOI 10.1016/j.jbi.2005.11.004; Meystre Stephane M, 2005, AMIA Annu Symp Proc, P525; MX Zuo, 2009, HUMAN ANATOMY PHYSL; Naderi N, 2011, BIOINFORMATICS, V27, P2721, DOI 10.1093/bioinformatics/btr452; Powers D.M.W., 2011, J MACH LEARN TECHNOL, V2, P3763; Pyysalo S, 2014, BIOINFORMATICS, V30, P868, DOI 10.1093/bioinformatics/btt580; Rink B, 2011, J AM MED INFORM ASSN, V18, P594, DOI 10.1136/amiajnl-2011-000153; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Rosse C., 2007, COMPUT BIOL SER, V6, P59; SAGER N, 1994, J AM MED INFORM ASSN, V1, P142, DOI 10.1136/jamia.1994.95236145; Schwartz A.S., 2003, PACIFIC S BIOCOMPUTI, V8, P451; Spyns P, 1996, METHOD INFORM MED, V35, P285; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Xu Y, 2012, J AM MED INFORM ASSN, V19, P897, DOI 10.1136/amiajnl-2011-000734; Yan X, 2012, BIOMED INFORM INSIGH, V5, P31	27	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e108396	10.1371/journal.pone.0108396	http://dx.doi.org/10.1371/journal.pone.0108396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343498	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943500005
J	Diaz, N; Ribas, L; Piferrer, F				Diaz, Noelia; Ribas, Laia; Piferrer, Francesc			Effects of Changes in Food Supply at the Time of Sex Differentiation on the Gonadal Transcriptome of Juvenile Fish. Implications for Natural and Farmed Populations	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; DICENTRARCHUS-LABRAX L.; COD GADUS-MORHUA; GENE-EXPRESSION; ATLANTIC COD; BASS; GROWTH; TEMPERATURE; ENERGY; BIOINFORMATICS	Background: Food supply is a major factor influencing growth rates in animals. This has important implications for both natural and farmed fish populations, since food restriction may difficult reproduction. However, a study on the effects of food supply on the development of juvenile gonads has never been transcriptionally described in fish. Methods and Findings: This study investigated the consequences of growth on gonadal transcriptome of European sea bass in: 1) 4-month-old sexually undifferentiated fish, comparing the gonads of fish with the highest vs. the lowest growth, to explore a possible link between transcriptome and future sex, and 2) testis from 11-month-old juveniles where growth had been manipulated through changes in food supply. The four groups used were: i) sustained fast growth, ii) sustained slow growth, iii) accelerated growth, iv) decelerated growth. The transcriptome of undifferentiated gonads was not drastically affected by initial natural differences in growth. Further, changes in the expression of genes associated with protein turnover were seen, favoring catabolism in slow-growing fish and anabolism in fast-growing fish. Moreover, while fast-growing fish took energy from glucose, as deduced from the pathways affected and the analysis of protein-protein interactions examined, in slow-growing fish lipid metabolism and gluconeogenesis was favored. Interestingly, the highest transcriptomic differences were found when forcing initially fast-growing fish to decelerate their growth, while accelerating growth of initially slow-growing fish resulted in full transcriptomic convergence with sustained fast-growing fish. Conclusions: Food availability during sex differentiation shapes the juvenile testis transcriptome, as evidenced by adaptations to different energy balances. Remarkably, this occurs in absence of major histological changes in the testis. Thus, fish are able to recover transcriptionally their testes if they are provided with enough food supply during sex differentiation; however, an initial fast growth does not represent any advantage in terms of transcriptional fitness if later food becomes scarce.	[Diaz, Noelia; Ribas, Laia; Piferrer, Francesc] CSIC, Inst Ciencias Mar, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Piferrer, F (corresponding author), CSIC, Inst Ciencias Mar, Barcelona, Spain.	piferrer@icm.csic.es	Piferrer, Francesc/A-5634-2012; Ribas, Laia/E-1466-2013; Díaz, Noelia/AAZ-6001-2020	Piferrer, Francesc/0000-0003-0903-4736; Ribas, Laia/0000-0001-5538-6236; Díaz, Noelia/0000-0002-0319-3448	Spanish Ministry of Science [AGL2010-15939, CDS2007-0002]; Government of Spain [BES-2007-14273]; Epigen-Aqua project; Aquagenomics postdoctoral contract	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of Spain(Spanish Government); Epigen-Aqua project; Aquagenomics postdoctoral contract	Research was supported by the Spanish Ministry of Science projects "Epigen-Aqua'' (AGL2010-15939) and "Aquagenomics'' (CDS2007-0002) to FP. ND was supported by a scholarship from the Government of Spain (BES-2007-14273) and then by a contract by the Epigen-Aqua project. LR was supported by an Aquagenomics postdoctoral contract and Epigen-Aqua project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SM, 1982, T AM FISH SOC, V111, P549, DOI 10.1577/1548-8659(1982)111<549:EPILBU>2.0.CO;2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blazquez M, 1995, AQUACULTURE, V135, P329, DOI 10.1016/0044-8486(95)01030-0; Blazquez M, 1999, J FISH BIOL, V55, P916, DOI 10.1111/j.1095-8649.1999.tb00730.x; Blazquez M, 2009, J EXP ZOOL PART B, V312B, P686, DOI 10.1002/jez.b.21286; Bolstad B, 2001, PROBE LEVEL QU UNPUB; Boshra H, 2004, J IMMUNOL, V173, P349, DOI 10.4049/jimmunol.173.1.349; Bozinovic G, 2011, ENVIRON TOXICOL CHEM, V30, P283, DOI 10.1002/etc.403; Calduch-Giner JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-470; Campos C, 2010, J EXP BIOL, V213, P200, DOI 10.1242/jeb.033126; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Castellano JM, 2009, PEPTIDES, V30, P139, DOI 10.1016/j.peptides.2008.06.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Diaz N, 2013, AQUACULTURE, V408, P191, DOI 10.1016/j.aquaculture.2013.05.032; Dobly A, 2004, COMP BIOCHEM PHYS A, V137, P75, DOI 10.1016/j.cbpb.2003.09.002; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gabillard JC, 2006, J ENDOCRINOL, V191, P15, DOI 10.1677/joe.1.06869; Geay F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-522; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Houlihan DF, 1995, PROTEIN SYNTHESIS FI; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Kjaer MA, 2009, AQUACULTURE, V288, P325, DOI 10.1016/j.aquaculture.2008.12.022; KJESBU OS, 1994, J FISH BIOL, V45, P719, DOI 10.1006/jfbi.1994.1172; Koumoundouros G, 2002, J EXP ZOOL, V292, P573, DOI 10.1002/jez.10095; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin P, 2007, NATURWISSENSCHAFTEN, V94, P843, DOI 10.1007/s00114-007-0260-0; Martin SAM, 2002, PFLUG ARCH EUR J PHY, V445, P257, DOI 10.1007/s00424-002-0916-8; Martin SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-418; Moretti A, 1999, MANUAL HATCHERY PROD; Morgan MJ, 2013, FISH RES, V138, P42, DOI 10.1016/j.fishres.2012.02.019; Mylonas CC, 2005, J FISH BIOL, V67, P652, DOI 10.1111/j.0022-1112.2005.00766.x; Navarro-Martin L, 2009, AQUACULTURE, V296, P347, DOI 10.1016/j.aquaculture.2009.07.022; Overturf K, 2010, AQUACULTURE, V307, P111, DOI 10.1016/j.aquaculture.2010.06.010; Palstra AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053171; Papadaki M, 2005, J FISH BIOL, V66, P938, DOI 10.1111/j.0022-1112.2005.00639.x; Ravi P, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-5; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; ROBLIN C, 1983, REPROD NUTR DEV, V23, P115, DOI 10.1051/rnd:19830110; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; Saillant E, 2003, J ZOOL, V260, P53, DOI 10.1017/S0952836903003467; Saillant E, 2003, AQUACULTURE, V221, P183, DOI 10.1016/S0044-8486(02)00539-2; Salas-Leiton E, 2010, FISH SHELLFISH IMMUN, V28, P296, DOI 10.1016/j.fsi.2009.11.006; Salem M, 2006, COMP BIOCHEM PHYS D, V1, P227, DOI 10.1016/j.cbd.2005.12.003; Schiller V, 2013, REPROD TOXICOL, V42, P210, DOI 10.1016/j.reprotox.2013.09.003; Schiller V, 2013, COMP BIOCHEM PHYS C, V157, P41, DOI 10.1016/j.cbpc.2012.09.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068452; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Tanaka K, 1998, GENES CELLS, V3, P499, DOI 10.1046/j.1365-2443.1998.00207.x; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Vandeputte M, 2007, GENETICS, V176, P1049, DOI 10.1534/genetics.107.072140; Volkoff H, 2009, COMP BIOCHEM PHYS A, V153, P8, DOI 10.1016/j.cbpa.2008.12.001; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Yoneda M, 2005, J FISH BIOL, V67, P1225, DOI 10.1111/j.1095-8649.2005.00819.x	64	7	7	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111304	10.1371/journal.pone.0111304	http://dx.doi.org/10.1371/journal.pone.0111304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340342	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800100
J	Fumagalli, M; Rossiello, F; Mondello, C; di Fagagna, FD				Fumagalli, Marzia; Rossiello, Francesca; Mondello, Chiara; di Fagagna, Fabrizio d'Adda			Stable Cellular Senescence Is Associated with Persistent DDR Activation	PLOS ONE			English	Article							DNA-DAMAGE-RESPONSE; ONCOGENE-INDUCED SENESCENCE; STRESS-INDUCED SENESCENCE; HEMATOPOIETIC STEM-CELLS; HUMAN FIBROBLASTS; PREMATURE SENESCENCE; TRIGGERS SENESCENCE; AGING PRIMATES; P53; P16(INK4A)	The DNA damage response (DDR) is activated upon DNA damage generation to promote DNA repair and inhibit cell cycle progression in the presence of a lesion. Cellular senescence is a permanent cell cycle arrest characterized by persistent DDR activation. However, some reports suggest that DDR activation is a feature only of early cellular senescence that is then lost with time. This challenges the hypothesis that cellular senescence is caused by persistent DDR activation. To address this issue, we studied DDR activation dynamics in senescent cells. Here we show that normal human fibroblasts retain DDR markers months after replicative senescence establishment. Consistently, human fibroblasts from healthy aged donors display markers of DDR activation even three years in culture after entry into replicative cellular senescence. However, by extending our analyses to different human cell strains, we also observed an apparent DDR loss with time following entry into cellular senescence. This though correlates with the inability of these cell strains to survive in culture upon replicative or irradiation-induced cellular senescence. We propose a model to reconcile these results. Cell strains not suffering the prolonged in vitro culture stress retain robust DDR activation that persists for years, indicating that under physiological conditions persistent DDR is causally involved in senescence establishment and maintenance. However, cell strains unable to maintain cell viability in vitro, due to their inability to cope with prolonged cell culture-associated stress, show an only-apparent reduction in DDR foci which is in fact due to selective loss of the most damaged cells.	[Fumagalli, Marzia; Rossiello, Francesca; di Fagagna, Fabrizio d'Adda] FIRC Inst Mol Oncol Fdn, IFOM Fdn, Milan, Italy; [Mondello, Chiara; di Fagagna, Fabrizio d'Adda] CNR, Ist Genet Mol, I-27100 Pavia, Italy	IFOM - FIRC Institute of Molecular Oncology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	di Fagagna, FD (corresponding author), FIRC Inst Mol Oncol Fdn, IFOM Fdn, Milan, Italy.	fabrizio.dadda@ifom.eu	d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Rossiello, Francesca/AAA-8160-2022; Mondello, Chiara/B-8305-2015	d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; Rossiello, Francesca/0000-0002-6240-9907; Mondello, Chiara/0000-0002-8379-9246; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185	FIRC (Fondazione Italiana per la Ricerca sul Cancro) [12476]; AIRC (Associazione Italiana per la Ricerca sul Cancro) [8866]; HFSP (Human Frontier Science Program) [RGP 0014/2012]; AICR (Association for International Cancer Research) [14-1331]; FP7 PEOPLE ITN (CodeAge) [GA 316354]; Telethon [GGP12059]; Italian Ministry of Education, Universities, and Research (MIUR) [2010M4NEFY_006]; EPIGEN Project; European Research Council [322726]; Fondazione Cariplo [2011-0370]	FIRC (Fondazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); HFSP (Human Frontier Science Program)(Human Frontier Science Program); AICR (Association for International Cancer Research); FP7 PEOPLE ITN (CodeAge); Telethon(Fondazione Telethon); Italian Ministry of Education, Universities, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); EPIGEN Project; European Research Council(European Research Council (ERC)European Commission); Fondazione Cariplo(Fondazione Cariplo)	F.R. is supported by FIRC (Fondazione Italiana per la Ricerca sul Cancro, code 12476, http://www.fondazionefirc.it); F.d'A.d.F. laboratory is supported by AIRC (Associazione Italiana per la Ricerca sul Cancro, grant number 8866, http://www.airc.it); HFSP (Human Frontier Science Program, contract number: RGP 0014/2012, http://www.hfsp.org); AICR (Association for International Cancer Research, 14-1331, http://www.aicr.org.uk); FP7 PEOPLE 2012 ITN (CodeAge, GA 316354, http://itn-codeage.uni-koeln.de); Telethon (GGP12059, http://www.telethon.it); PRIN 2010-2011, the Italian Ministry of Education, Universities, and Research (MIUR, 2010M4NEFY_006, http://prin.miur.it); EPIGEN Project (http://www.epigen.it); and European Research Council advanced grant (322726, http://erc.europa.eu). C.M. laboratory is supported by Fondazione Cariplo (grant n. 2011-0370, http://www.fondazionecariplo.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Britt-Compton B, 2009, BIOGERONTOLOGY, V10, P683, DOI 10.1007/s10522-009-9216-4; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen JH, 2006, FEBS LETT, V580, P6669, DOI 10.1016/j.febslet.2006.11.023; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; de Magalhaes JP, 2002, FEBS LETT, V523, P157, DOI 10.1016/S0014-5793(02)02973-3; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Drayton S, 2002, CURR OPIN GENET DEV, V12, P98, DOI 10.1016/S0959-437X(01)00271-4; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Falcone G, 2013, AGING CELL, V12, P312, DOI 10.1111/acel.12034; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Herbert BS, 2002, ONCOGENE, V21, P7897, DOI 10.1038/sj.onc.1205902; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Johnson DG, 2006, CURR MOL MED, V6, P731; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06; Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Milyavsky M, 2003, CANCER RES, V63, P7147; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Mondello C, 2003, BIOCHEM BIOPH RES CO, V308, P914, DOI 10.1016/S0006-291X(03)01484-0; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Suram A, 2012, EMBO J; Suzuki M, 2006, BIOCHEM BIOPH RES CO, V340, P145, DOI 10.1016/j.bbrc.2005.11.167; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; te Poele RH, 2002, CANCER RES, V62, P1876; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Zdanov S, 2006, FEBS LETT, V580, P6455, DOI 10.1016/j.febslet.2006.10.064; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	58	78	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110969	10.1371/journal.pone.0110969	http://dx.doi.org/10.1371/journal.pone.0110969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340529	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800075
J	Gonzalo, S; Llaneza, V; Pulido-Reyes, G; Fernandez-Pinas, F; Bonzongo, JC; Leganes, F; Rosal, R; Garcia-Calvo, E; Rodea-Palomares, I				Gonzalo, Soledad; Llaneza, Veronica; Pulido-Reyes, Gerardo; Fernandez-Pinas, Francisca; Bonzongo, Jean Claude; Leganes, Francisco; Rosal, Roberto; Garcia-Calvo, Eloy; Rodea-Palomares, Ismael			A Colloidal Singularity Reveals the Crucial Role of Colloidal Stability for Nanomaterials In-Vitro Toxicity Testing: nZVI-Microalgae Colloidal System as a Case Study	PLOS ONE			English	Article							SILVER NANOPARTICLES SNPS; VALENT IRON NANOPARTICLES; OXIDE NANOPARTICLES; BIOPHYSICOCHEMICAL INTERACTIONS; SILICA NANOPARTICLES; DNA FRAGMENTATION; ECOTOXICITY; CELL; CYTOTOXICITY; COAGULATION	Aggregation raises attention in Nanotoxicology due to its methodological implications. Aggregation is a physical symptom of a more general physicochemical condition of colloidal particles, namely, colloidal stability. Colloidal stability is a global indicator of the tendency of a system to reduce its net surface energy, which may be achieved by homo-aggregation or hetero-aggregation, including location at bio-interfaces. However, the role of colloidal stability as a driver of ENM bioactivity has received little consideration thus far. In the present work, which focuses on the toxicity of nanoscaled Fe nanoparticles (nZVI) towards a model microalga, we demonstrate that colloidal stability is a fundamental driver of ENM bioactivity, comprehensively accounting for otherwise inexplicable differential biological effects. The present work throws light on basic aspects of Nanotoxicology, and reveals a key factor which may reconcile contradictory results on the influence of aggregation in bioactivity of ENMs.	[Gonzalo, Soledad; Pulido-Reyes, Gerardo; Rosal, Roberto; Garcia-Calvo, Eloy] Univ Alcala de Henares, Dept Ingn Quim, Madrid, Spain; [Llaneza, Veronica; Bonzongo, Jean Claude] Univ Florida, Dept Environm Engn Sci, Gainesville, FL 32611 USA; [Pulido-Reyes, Gerardo; Fernandez-Pinas, Francisca; Leganes, Francisco; Rodea-Palomares, Ismael] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain; [Rosal, Roberto; Garcia-Calvo, Eloy] Inst Madrileno Estudios Avanzados IMDEA Agua, Madrid, Spain	Universidad de Alcala; State University System of Florida; University of Florida; Autonomous University of Madrid	Rodea-Palomares, I (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain.	ismael.rodea@uam.es	Fernandez-Piñas, Francisca/L-2450-2013; Bonzongo, Jean-Claude J/K-8271-2015; Rosal, Roberto/N-1231-2014; Calvo, Eloy García/K-3627-2017; Pulido-Reyes, Gerardo/AAA-4125-2022	Fernandez-Piñas, Francisca/0000-0002-7444-7601; Rosal, Roberto/0000-0003-0816-8775; Calvo, Eloy García/0000-0001-8795-3880; Pulido-Reyes, Gerardo/0000-0003-0853-9951; Rodea Palomares, Ismael Martin/0000-0002-4630-7345; BONZONGO, Jean-Claude/0000-0001-8431-7723	Comunidad de Madrid (Microambiente-CM) [S-0505/AMB/0321, S-2009/AMB/1511]; Spanish Ministry of Science and Innovation sub-program BOS [CGL2010-15675, CTM2008-04239/TECNO]; Spanish Ministry of Economy and Competitiveness (MINECO) [CTM2013-45775-C2-1-R, CTM2013-45775-C2-2-R]; US-National Science Foundation [CBET-0853347]	Comunidad de Madrid (Microambiente-CM)(Comunidad de Madrid); Spanish Ministry of Science and Innovation sub-program BOS(Ministry of Science and Innovation, Spain (MICINN)); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); US-National Science Foundation(National Science Foundation (NSF))	This research was supported by the Comunidad de Madrid grants S-0505/AMB/0321 and S-2009/AMB/1511 (Microambiente-CM). The Spanish Ministry of Science and Innovation grants CGL2010-15675 sub-program BOS, and the CTM2008-04239/TECNO, and the Spanish Ministry of Economy and Competitiveness (MINECO) grants CTM2013-45775-C2-1-R, CTM2013-45775-C2-2-R and the US-National Science Foundation, grant number CBET-0853347.	[Anonymous], 2012, NAT NANOTECHNOL, V7, P545, DOI 10.1038/nnano.2012.150; [Anonymous], 1998, ORGANIC STRUCTURE AN; Auffan M, 2008, ENVIRON SCI TECHNOL, V42, P6730, DOI 10.1021/es800086f; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Duan JM, 2003, ADV COLLOID INTERFAC, V100, P475, DOI 10.1016/S0001-8686(02)00067-2; Garside P, 2003, STUD CONSERV, V48, P269, DOI 10.1179/sic.2003.48.4.269; Gilbert B, 2009, J COLLOID INTERF SCI, V339, P285, DOI 10.1016/j.jcis.2009.07.058; Gong N, 2011, CHEMOSPHERE, V83, P510, DOI 10.1016/j.chemosphere.2010.12.059; Gregory J., 2006, PARTICLES WATER PROP; Grieger KD, 2010, J CONTAM HYDROL, V118, P165, DOI 10.1016/j.jconhyd.2010.07.011; Hadjoudja S, 2010, J COLLOID INTERF SCI, V342, P293, DOI 10.1016/j.jcis.2009.10.078; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; Hartmann NB, 2013, NANOTOXICOLOGY, V7, P1082, DOI 10.3109/17435390.2012.710657; Henderson RK, 2010, WATER RES, V44, P3617, DOI 10.1016/j.watres.2010.04.016; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Jiang W, 2010, LANGMUIR, V26, P18071, DOI 10.1021/la103738e; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Keller AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043983; Khan SS, 2011, J HAZARD MATER, V192, P299, DOI 10.1016/j.jhazmat.2011.05.024; Khan SS, 2011, COLLOID SURFACE B, V87, P129, DOI 10.1016/j.colsurfb.2011.05.012; Lee C, 2008, ENVIRON SCI TECHNOL, V42, P4927, DOI 10.1021/es800408u; Li HC, 2009, ECOTOX ENVIRON SAFE, V72, P684, DOI 10.1016/j.ecoenv.2008.09.027; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Lin DH, 2012, WATER RES, V46, P4477, DOI 10.1016/j.watres.2012.05.035; Long ZF, 2012, ENVIRON SCI TECHNOL, V46, P8458, DOI 10.1021/es301802g; Lugo-Lugo V, 2012, J ENVIRON MANAGE, V112, P120, DOI 10.1016/j.jenvman.2012.07.009; Ma S, 2013, ENVIRON SCI-PROC IMP, V15, P145, DOI 10.1039/c2em30637a; Mace C, 2006, REMEDIATION, V16, P23, DOI 10.1002/rem.20079; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel A, 2013, ACCOUNTS CHEM RES, V46, P605, DOI 10.1021/ar400005v; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; OECD, 2006, 201 OECD TG; Pakrashi S, 2013, AQUAT TOXICOL, V132, P34, DOI 10.1016/j.aquatox.2013.01.018; Phenrat T, 2009, ENVIRON SCI TECHNOL, V43, P195, DOI 10.1021/es801955n; Phenrat T, 2007, ENVIRON SCI TECHNOL, V41, P284, DOI [10.1021/es061349a, 10.1021/es0614349a]; Pitre D, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-8; Rabolli V, 2011, TOXICOL LETT, V206, P197, DOI 10.1016/j.toxlet.2011.07.013; Rodea-Palomares I, 2012, AQUAT TOXICOL, V122, P133, DOI 10.1016/j.aquatox.2012.06.005; Rodea-Palomares I, 2011, TOXICOL SCI, V119, P135, DOI 10.1093/toxsci/kfq311; Rosicka D, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9753-4; Sadiq IM, 2011, ECOTOX ENVIRON SAFE, V74, P1180, DOI 10.1016/j.ecoenv.2011.03.006; Schrand AM, 2010, NAT PROTOC, V5, P744, DOI 10.1038/nprot.2010.2; Schrurs F, 2012, NAT NANOTECHNOL, V7, P546, DOI 10.1038/nnano.2012.148; Sevcu A, 2011, MICROBES ENVIRON, V26, P271, DOI 10.1264/jsme2.ME11126; Stone V, 2006, NAT NANOTECHNOL, V1, P23, DOI 10.1038/nnano.2006.69; Sun YP, 2006, ADV COLLOID INTERFAC, V120, P47, DOI 10.1016/j.cis.2006.03.001; Thomas CR, 2011, ACS NANO, V5, P13, DOI 10.1021/nn1034857; Van Hoecke K, 2008, ENVIRON TOXICOL CHEM, V27, P1948, DOI 10.1897/07-634.1; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; von Moos N, 2014, NANOTOXICOLOGY, V8, P605, DOI 10.3109/17435390.2013.809810; Westerhoff P, 2013, ACCOUNTS CHEM RES, V46, P844, DOI 10.1021/ar300030n; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zheng RK, 2006, ADV MATER, V18, P2418, DOI 10.1002/adma.200600788; Zhu MT, 2013, ACCOUNTS CHEM RES, V46, P622, DOI 10.1021/ar300031y	56	23	24	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109645	10.1371/journal.pone.0109645	http://dx.doi.org/10.1371/journal.pone.0109645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340509	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800012
J	Horm, SV; Mardy, S; Rith, S; Ly, S; Heng, S; Vong, S; Kitsutani, P; Ieng, V; Tarantola, A; Ly, S; Sar, B; Chea, N; Sokhal, B; Barr, I; Kelso, A; Horwood, PF; Timmermans, A; Hurt, A; Lon, C; Saunders, D; Ung, SA; Asgari, N; Roces, MC; Touch, S; Komadina, N; Buchy, P				Horm, Srey Viseth; Mardy, Sek; Rith, Sareth; Ly, Sovann; Heng, Seng; Vong, Sirenda; Kitsutani, Paul; Ieng, Vannra; Tarantola, Arnaud; Ly, Sowath; Sar, Borann; Chea, Nora; Sokhal, Buth; Barr, Ian; Kelso, Anne; Horwood, Paul F.; Timmermans, Ans; Hurt, Aeron; Lon, Chanthap; Saunders, David; Ung, Sam An; Asgari, Nima; Roces, Maria Concepcion; Touch, Sok; Komadina, Naomi; Buchy, Philippe			Epidemiological and Virological Characteristics of Influenza Viruses Circulating in Cambodia from 2009 to 2011	PLOS ONE			English	Article							ADAMANTANE RESISTANCE; SEASONAL INFLUENZA; ANTIVIRAL RESISTANCE; SURVEILLANCE; REASSORTMENT; MORTALITY; TAIWAN; HEMAGGLUTININ; INFECTIONS; EPIDEMICS	Background: The Cambodian National Influenza Center (NIC) monitored and characterized circulating influenza strains from 2009 to 2011. Methodology/Principal Findings: Sentinel and study sites collected nasopharyngeal specimens for diagnostic detection, virus isolation, antigenic characterization, sequencing and antiviral susceptibility analysis from patients who fulfilled case definitions for influenza-like illness, acute lower respiratory infections and event-based surveillance. Each year in Cambodia, influenza viruses were detected mainly from June to November, during the rainy season. Antigenic analysis show that A/H1N1pdm09 isolates belonged to the A/California/7/2009-like group. Circulating A/H3N2 strains were A/Brisbane/10/2007-like in 2009 before drifting to A/Perth/16/2009-like in 2010 and 2011. The Cambodian influenza B isolates from 2009 to 2011 all belonged to the B/Victoria lineage represented by the vaccine strains B/Brisbane/60/2008 and B/Malaysia/2506/2004. Sequences of the M2 gene obtained from representative 2009-2011 A/H3N2 and A/H1N1pdm09 strains all contained the S31N mutation associated with adamantanes resistance except for one A/H1N1pdm09 strain isolated in 2011 that lacked this mutation. No reduction in the susceptibility to neuraminidase inhibitors was observed among the influenza viruses circulating from 2009 to 2011. Phylogenetic analysis revealed that A/H3N2 strains clustered each year to a distinct group while most A/H1N1pdm09 isolates belonged to the S203T clade. Conclusions/Significance: In Cambodia, from 2009 to 2011, influenza activity occurred throughout the year with peak seasonality during the rainy season from June to November. Seasonal influenza epidemics were due to multiple genetically distinct viruses, even though all of the isolates were antigenically similar to the reference vaccine strains. The drug susceptibility profile of Cambodian influenza strains revealed that neuraminidase inhibitors would be the drug of choice for influenza treatment and chemoprophylaxis in Cambodia, as adamantanes are no longer expected to be effective.	[Horm, Srey Viseth; Mardy, Sek; Rith, Sareth; Vong, Sirenda; Tarantola, Arnaud; Ly, Sowath; Horwood, Paul F.; Buchy, Philippe] Reseau Int Inst Pasteur, Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Mardy, Sek; Ieng, Vannra; Asgari, Nima; Roces, Maria Concepcion] WHO, Phnom Penh, Cambodia; [Ly, Sovann; Heng, Seng; Touch, Sok] Minist Hlth, Dept Communicable Dis Control, Phnom Penh, Cambodia; [Kitsutani, Paul] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA; [Sar, Borann; Chea, Nora] Ctr Dis Control & Prevent, Cambodia Off, Phnom Penh, Cambodia; [Sokhal, Buth; Ung, Sam An] Natl Inst Publ Hlth, Phnom Penh, Cambodia; [Barr, Ian; Kelso, Anne; Hurt, Aeron; Komadina, Naomi] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia; [Timmermans, Ans; Lon, Chanthap; Saunders, David] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; World Health Organization; Centers for Disease Control & Prevention - USA; World Health Organization; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Buchy, P (corresponding author), Reseau Int Inst Pasteur, Inst Pasteur Cambodge, Phnom Penh, Cambodia.	buchyphilippe@hotmail.com	Tarantola, Arnaud/D-2149-2015	Tarantola, Arnaud/0000-0002-6946-7958; Horwood, Paul/0000-0001-9622-0742; Kelso, Anne/0000-0002-3166-3267; Barr, Ian/0000-0002-7351-418X; Hurt, Aeron/0000-0003-1826-4314; BUCHY, Philippe/0000-0003-1372-3008	World Health Organization office in Cambodia; French Agency for Development (SISEA project); Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services	World Health Organization office in Cambodia; French Agency for Development (SISEA project); Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services	The study was funded by the World Health Organization office in Cambodia, the French Agency for Development (SISEA project) and by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P61; [Anonymous], 2012, PLOS ONE, V7; [Anonymous], 2013, WPSAR, V4, DOI 10.5365; Barr IG, 2008, ANTIVIR RES, V80, P200, DOI 10.1016/j.antiviral.2008.06.008; Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; CDC, 2011, INFL ANT MED SUMM CL; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Fourment M, 2010, J CLIN MICROBIOL, V48, P295, DOI 10.1128/JCM.01687-09; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Nguyen HLK, 2007, J INFECTION, V55, P58, DOI 10.1016/j.jinf.2006.12.001; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Hurt AC, 2008, COMMUN DIS INTELL, V32, P57; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ilyushina NA, 2005, VIROLOGY, V341, P102, DOI 10.1016/j.virol.2005.07.003; Jian JW, 2008, J CLIN MICROBIOL, V46, P1426, DOI 10.1128/JCM.01560-07; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leang SK, 2013, ANTIVIR RES, V97, P206, DOI 10.1016/j.antiviral.2012.12.016; Mardy S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-168; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; National Institute of Statistics, 2002, GEN POP CENS CAMB 19; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; Pariani E, 2009, J Prev Med Hyg, V50, P113; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; RAO BL, 1993, B WORLD HEALTH ORGAN, V71, P177; Shek LP, 2003, PAEDIATR RESPIR REV, V4, P104; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; Tsai HP, 2006, J CLIN MICROBIOL, V44, P2705, DOI 10.1128/JCM.02694-05; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2007, REC LAB PROC DET AV; WHO, 2009, CDC PROT REALT RT PC; WHO, 2008, GUID EST EV BAS SURV; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P61; World Health Organization, 2010, GLOB INFL PROGR INFL; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P301	58	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110713	10.1371/journal.pone.0110713	http://dx.doi.org/10.1371/journal.pone.0110713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340711	Green Published, gold, Green Accepted			2022-12-26	WOS:000343662800050
J	Kranitz, ML; Biffin, E; Clark, A; Hollingsworth, ML; Ruhsam, M; Gardner, MF; Thomas, P; Mill, RR; Ennos, RA; Gaudeul, M; Lowe, AJ; Hollingsworth, PM				Kranitz, Mai Lan; Biffin, Edward; Clark, Alexandra; Hollingsworth, Michelle L.; Ruhsam, Markus; Gardner, Martin F.; Thomas, Philip; Mill, Robert R.; Ennos, Richard A.; Gaudeul, Myriam; Lowe, Andrew J.; Hollingsworth, Peter M.			Evolutionary Diversification of New Caledonian Araucaria	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; AGATHIS ARAUCARIACEAE; FAMILY ARAUCARIACEAE; DIVERGENCE TIMES; CHLOROPLAST DNA; NEW-ZEALAND; SP NOV.; CONIFER; MACROFOSSILS; PLANTS	New Caledonia is a global biodiversity hotspot. Hypotheses for its biotic richness suggest either that the island is a 'museum' for an old Gondwana biota or alternatively it has developed following relatively recent long distance dispersal and in situ radiation. The conifer genus Araucaria (Araucariaceae) comprises 19 species globally with 13 endemic to this island. With a typically Gondwanan distribution, Araucaria is particularly well suited to testing alternative biogeographic hypotheses concerning the origins of New Caledonian biota. We derived phylogenetic estimates using 11 plastid and rDNA ITS2 sequence data for a complete sampling of Araucaria (including multiple accessions of each of the 13 New Caledonian Araucaria species). In addition, we developed a dataset comprising 4 plastid regions for a wider taxon sample to facilitate fossil based molecular dating. Following statistical analyses to identify a credible and internally consistent set of fossil constraints, divergence times estimated using a Bayesian relaxed clock approach were contrasted with geological scenarios to explore the biogeographic history of Araucaria. The phylogenetic data resolve relationships within Araucariaceae and among the main lineages in Araucaria, but provide limited resolution within the monophyletic New Caledonian species group. Divergence time estimates suggest a Late Cretaceous-Cenozoic radiation of extant Araucaria and a Neogene radiation of the New Caledonian lineage. A molecular timescale for the evolution of Araucariaceae supports a relatively recent radiation, and suggests that earlier (pre-Cenozoic) fossil types assigned to Araucaria may have affinities elsewhere in Araucariaceae. While additional data will be required to adequately resolve relationships among the New Caledonian species, their recent origin is consistent with overwater dispersal following Eocene emersion of New Caledonia but is too old to support a single dispersal from Australia to Norfolk Island for the radiation of the Pacific Araucaria sect. Eutacta clade.	[Kranitz, Mai Lan; Clark, Alexandra; Hollingsworth, Michelle L.; Ruhsam, Markus; Gardner, Martin F.; Thomas, Philip; Mill, Robert R.; Hollingsworth, Peter M.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Ennos, Richard A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Gaudeul, Myriam] Museum Natl Hist Nat, Inst Syst, CNRS, UMR MNHN UPMC EPHE 7205, F-75231 Paris, France; [Biffin, Edward; Lowe, Andrew J.] Univ Adelaide, Sch Earth & Environm Sci, Inst Environm, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Adelaide	Biffin, E (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Inst Environm, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia.	ed.biffin@adelaide.edu.au	Ruhsam, Markus/B-3608-2010; Ruhsam, Markus/N-6820-2019	Ruhsam, Markus/0000-0002-8457-345X; Lowe, Andrew/0000-0003-1139-2516; Hollingsworth, Peter/0000-0003-0602-0654; Hart, Michelle/0000-0001-9503-7786	Darwin Trust of Edinburgh; ANR project BIONEOCAL; PPF MNHN 'Structure et evolution des ecosystemes'; Australian Research Council through a Super Science Fellowship [FS1102 00051]; Discovery Grant [DP0665859]; Scottish Government's Rural and Environment Science and Analytical Services Division	Darwin Trust of Edinburgh; ANR project BIONEOCAL(French National Research Agency (ANR)); PPF MNHN 'Structure et evolution des ecosystemes'; Australian Research Council through a Super Science Fellowship(Australian Research Council); Discovery Grant; Scottish Government's Rural and Environment Science and Analytical Services Division	This work was supported by funds from the Darwin Trust of Edinburgh and the ANR project BIONEOCAL, the PPF MNHN 'Structure et evolution des ecosystemes' led by P. Grandcolas. The work of AJL and EB was supported by the Australian Research Council through a Super Science Fellowship (FS1102 00051) and Discovery Grant (DP0665859) awarded to AJL. The Royal Botanic Garden Edinburgh is supported by the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Axsmith BJ, 1998, AM J BOT, V85, P704, DOI 10.2307/2446541; Axsmith BJ, 2008, PALAEONTOL ELECTRON, V11; Biffin E, 2010, SYST BIOL, V59, P594, DOI 10.1093/sysbio/syq030; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Cantrill DJ, 2006, INT J PLANT SCI, V167, P1259, DOI 10.1086/507608; CANTRILL DJ, 1992, INT J PLANT SCI, V153, P622, DOI 10.1086/297084; Chambers TC, 1998, INT J PLANT SCI, V159, P160, DOI 10.1086/297534; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Del Fueyo GM, 2002, CRETACEOUS RES, V23, P265, DOI 10.1006/cres.2002.1001; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Dettmann ME, 2012, ALCHERINGA, V36, P217, DOI 10.1080/03115518.2012.622155; Dornburg A, 2011, SYST BIOL, V60, P519, DOI 10.1093/sysbio/syr019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Escapa I, 2008, REV PALAEOBOT PALYNO, V151, P110, DOI 10.1016/j.revpalbo.2008.03.002; Escapa IH, 2013, INT J PLANT SCI, V174, P1153, DOI 10.1086/672369; Francis J. E., 2008, ANTARCTICA KEYSTONE, P19, DOI [10.3133/of2007-1047, DOI 10.3133/OF2007-1047]; Gaudeul M, 2012, AM J BOT, V99, P68, DOI 10.3732/ajb.1100321; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Grivet D, 2001, MOL ECOL NOTES, V1, P345, DOI 10.1046/j.1471-8278.2001.00107.x; Hall R, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P35; Hamilton MB, 1999, MOL ECOL, V8, P521; Heads M, 2008, J BIOGEOGR, V35, P2153, DOI 10.1111/j.1365-2699.2008.01977.x; Heads M, 2010, J BIOGEOGR, V37, P1179, DOI 10.1111/j.1365-2699.2010.02311.x; HILL R S, 1991, Australian Systematic Botany, V4, P449, DOI 10.1071/SB9910449; Hill RS, 2008, AUST SYST BOT, V21, P162, DOI 10.1071/SB08006; Hill RS, 1999, AUST J BOT, V47, P639, DOI 10.1071/BT98093; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kershaw P, 2001, ANNU REV ECOL SYST, V32, P397, DOI 10.1146/annurev.ecolsys.32.081501.114059; Knapp M, 2007, SYST BIOL, V56, P862, DOI 10.1080/10635150701636412; Kunzmann L, 2007, ZOOL ANZ, V246, P257, DOI 10.1016/j.jcz.2007.08.001; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Lee DE, 2007, NEW ZEAL J BOT, V45, P565, DOI 10.1080/00288250709509739; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Liu N, 2009, CHINESE SCI BULL, V54, P2648, DOI 10.1007/s11434-009-0373-2; Macphailm M, 2014, ALCHERINGA, V38, P135, DOI 10.1080/03115518.2014.843145; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; McLean D, 2013, REV PALAEOBOT PALYNO, V190, P1, DOI 10.1016/j.revpalbo.2012.11.005; McLoughlin S, 2008, AM J BOT, V95, P465, DOI 10.3732/ajb.95.4.465; Meffre S, 2006, ASEG 18 GEOPH C MELB, V2006, P1, DOI DOI 10.1071/ASEG2006AB111; Miller CN, 1999, BOT REV, V65, P239, DOI 10.1007/BF02857631; Morat P., 1993, BIODIVERSITY LETT, V1, P72, DOI DOI 10.2307/2999750; Murienne J, 2009, J BIOGEOGR, V36, P1433, DOI 10.1111/j.1365-2699.2009.02143.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OHSAWA T, 1995, J PLANT RES, V108, P25, DOI 10.1007/BF02344302; Pelletier B, 2006, DOCUMENTS SCI TECHNI, VII; Pillon Y, 2012, BOT J LINN SOC, V170, P288, DOI 10.1111/j.1095-8339.2012.01274.x; Pole M, 2008, ALCHERINGA, V32, P405, DOI 10.1080/03115510802417935; Pole M, 2009, CRETACEOUS RES, V30, P917, DOI 10.1016/j.cretres.2009.02.007; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruane S, 2011, J EVOLUTION BIOL, V24, P274, DOI 10.1111/j.1420-9101.2010.02164.x; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Sinclair WT, 2002, PLANT SYST EVOL, V233, P79, DOI 10.1007/s00606-002-0199-8; STOCKEY RA, 1982, REV PALAEOBOT PALYNO, V37, P133, DOI 10.1016/0034-6667(82)90041-0; Stockler K, 2002, SYST BIOL, V51, P827, DOI 10.1080/10635150290102474; van der Ham RWJM, 2010, PALAEOGEOGR PALAEOCL, V291, P469, DOI 10.1016/j.palaeo.2010.03.017; van Waveren IM, 2008, NETH J GEOSCI, V87, P339, DOI 10.1017/S0016774600023398; VEEVERS JJ, 1991, AUST J EARTH SCI, V38, P373, DOI 10.1080/08120099108727979; Zwickl D. J, 2006, GENETIC ALGORITHM AP	67	31	33	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110308	10.1371/journal.pone.0110308	http://dx.doi.org/10.1371/journal.pone.0110308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340350	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800028
J	Wei, J; Freytag, M; Schober, Y; Nockher, WA; Mautner, VF; Friedrich, RE; Manley, PW; Kluwe, L; Kurtz, A				Wei, Jiang; Freytag, Marcus; Schober, Yvonne; Nockher, Wolfgang A.; Mautner, Victor F.; Friedrich, Reinhard E.; Manley, Paul W.; Kluwe, Lan; Kurtz, Andreas			Nilotinib Is More Potent than Imatinib for Treating Plexiform Neurofibroma In Vitro and In Vivo	PLOS ONE			English	Article							KINASE INHIBITOR NILOTINIB; CHRONIC MYELOID-LEUKEMIA; TUMORS; TYPE-1; PATHOGENESIS; CELLS	In Plexiform neurofibromas (PNFs) are benign nerve sheath tumors mostly associated with neurofibromatosis type 1. They often extend through multiple layers of tissue and therefore cannot be treated satisfactorily by surgery. Nilotinib is a tyrosine kinase inhibitor used to treat leukemia, with advantages over the prototype imatinib in terms of potency and selectivity towards BCR-ABL, and the DDR, PDGFR, and KIT receptor kinases. In this study, we compared efficacies of the two drugs on cultured cells of PNF in vitro and on xenografted tumor fragments on sciatic nerve of athymic nude mice. Xenografts were monitored weekly using a high resolution ultrasound measurement. Treatment with nilotinib at a daily dose of 100 mg/kg for four weeks led to a reduction of the graft sizes(std) by 68(+/- 7)% in the 8 treated mice, significantly more than the 33(+/- 8)% reduction in the 8 untreated mice (P<0.05) and the 47(+/- 15)% in the 7 mice treated with imatinib (P<0.05). The peak plasma nilotinib concentration 6.6(+/- 1.1) mu M is within the pharmacological range of clinical application. Imatinib, but not nilotinib significantly hindered body weight increase of the mice and elevated cytotoxicity of mouse spleen cells (P<0.05). Our results suggest that nilotinib may be more potent than imatinib for treating PNFs and may also be better tolerated. Imatinib seems to have some off-target effect in elevating immunity.	[Wei, Jiang; Mautner, Victor F.; Kluwe, Lan] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Lab Tumor Genet, Hamburg, Germany; [Freytag, Marcus; Friedrich, Reinhard E.; Kluwe, Lan] Univ Med Ctr Hamburg Eppendorf, Dept Maxillofacial Surg, Hamburg, Germany; [Schober, Yvonne; Nockher, Wolfgang A.] Univ Marburg, Inst Lab Med & Pathobiochem, Marburg, Germany; [Manley, Paul W.] Novartis Inst Biomed Res, Basel, Switzerland; [Kurtz, Andreas] Charite, Berlin Brandenburg Ctr Regenerat Med, D-13353 Berlin, Germany; [Kurtz, Andreas] Seoul Natl Univ, Coll Vet Med, Seoul, South Korea; [Kurtz, Andreas] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philipps University Marburg; Novartis; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Seoul National University (SNU); Seoul National University (SNU)	Kurtz, A (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Med, D-13353 Berlin, Germany.	andreas.kurt@charite.de	manley, paul william/GVT-9482-2022	Kurtz, Andreas/0000-0003-3301-6546; Manley, Paul William/0000-0002-9722-7863	Novartis Pharmaceuticals AG of Switzerland	Novartis Pharmaceuticals AG of Switzerland	The study was funded by Novartis Pharmaceuticals AG of Switzerland. Novartis provided support in the form of salary for author Paul W. Manley, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions'' section.	Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Borrego-Diaz E, 2012, J NEURO-ONCOL, V108, P423, DOI 10.1007/s11060-012-0852-1; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Demestre M, 2010, J NEURO-ONCOL, V98, P11, DOI 10.1007/s11060-009-0049-4; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Gambacorti-Passerini CB, 2002, BLOOD CELL MOL DIS, V28, P361, DOI 10.1006/bcmd.2002.0526; Gleiss J, 2013, IN VIVO, V27, P723; Gotze L, 2012, CLIN CHIM ACTA, V413, P143, DOI 10.1016/j.cca.2011.09.012; Cunha KSG, 2008, CLINICS, V63, P39, DOI 10.1590/S1807-59322008000100008; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Jiang W, 2014, J NEURO-ONCOL, V116, P231, DOI 10.1007/s11060-013-1295-z; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kitamura M, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-2; Larson RA, 2012, LEUKEMIA, V26, P2197, DOI 10.1038/leu.2012.134; Laycock-van Spyk Sebastian, 2011, Human Genomics, V5, P623; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Oates EC, 2013, AM J MED GENET A, V161A, P659, DOI 10.1002/ajmg.a.35840; Plotkin SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035711; Rastogi MV, 2012, PEDIATR BLOOD CANCER, V59, P840, DOI 10.1002/pbc.24121; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Spyra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021099; Tanaka C, 2010, CLIN PHARMACOL THER, V87, P197, DOI 10.1038/clpt.2009.208; Ward BA, 2005, PEDIATR NEUROL, V32, P221, DOI 10.1016/j.pediatrneurol.2004.11.002	23	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e107760	10.1371/journal.pone.0107760	http://dx.doi.org/10.1371/journal.pone.0107760			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340526	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800003
J	Sangrar, W; Shi, C; Mullins, G; LeBrun, D; Ingalls, B; Greer, PA				Sangrar, W.; Shi, C.; Mullins, G.; LeBrun, D.; Ingalls, B.; Greer, P. A.			Amplified Ras-MAPK signal states correlate with accelerated EGFR internalization, cytostasis and delayed HER2 tumor onset in Fer-deficient model systems	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE FER; HUMAN-BREAST-CANCER; CELL-ADHESION; CORTACTIN PHOSPHORYLATION; MEMBRANE INVAGINATION; MEDIATED ENDOCYTOSIS; RECEPTOR ENDOCYTOSIS; ERBB RECEPTORS; NEU ONCOGENE	The non-receptor tyrosine kinase Fer belongs to a distinct subfamily of F-BAR domain containing kinases implicated in vesicular trafficking and signaling downstream of adhesion and growth factor receptors. Targeted inactivation of the fer gene in a transgenic mouse model of HER2(+), breast cancer was associated with delayed tumor onset and reduced proliferative rates in tumor cells. Fer deficiency was associated with increased rates of epidermal growth factor (EGF)-induced epidermal growth factor receptor (EGFR) internalization and amplified Ras-Raf-Mek-Erk (Ras-MAPK) signaling in primary mammary tumor epithelial cells, as well as increased cytotoxic and anti-proliferative sensitivity to the dual EGFR/HER2 inhibitor Lapatinib (LPN). These observations suggest a model in which accelerated ligand-induced EGFR internalization in Fer-deficient cells hypersensitizes the Ras-MAPK pathway to EGF, resulting in MAPK signal amplification to levels that induce cytostasis, rather than proliferation. Thus, Ras-MAPK cytostatic signaling delays HER2 tumor initiation and increases LPN cytotoxicity in Fer-deficient model systems. Taken together, these data suggest that targeting Fer alone, or in combination with LPN, may be of therapeutic benefit in HER2(+) breast cancer.	[Sangrar, W.; Shi, C.; Mullins, G.; LeBrun, D.; Greer, P. A.] Queens Canc Res Inst, Div Canc Biol & Genet, Kingston, ON, Canada; [Sangrar, W.; Mullins, G.; LeBrun, D.; Greer, P. A.] Queens Univ, Queens Canc Res Inst, Dept Pathol & Mol Med, Kingston, ON, Canada; [Sangrar, W.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Ingalls, B.] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada	McMaster University; Queens University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Waterloo	Sangrar, W (corresponding author), Queens Univ, Queens Canc Res Inst, Dept Pathol & Mol Med, Botterell Hall,Room A309, Kingston, ON K7L 3N6, Canada.	ws4@queensu.ca; greerp@queensu.ca			Canadian Breast Cancer Foundation; Canadian Institutes for Health Research; Canadian Cancer Society Research Institute	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	We are grateful to Lee Boudreau, Christine Hall and Yan Gao for technical assistance. This work was funded by operating grants from the Canadian Breast Cancer Foundation, the Canadian Institutes for Health Research, and the Canadian Cancer Society Research Institute to PAG.	Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Craig AWB, 1999, J BIOL CHEM, V274, P19934, DOI 10.1074/jbc.274.28.19934; Craig AWB, 2001, MOL CELL BIOL, V21, P603, DOI 10.1128/MCB.21.2.603-613.2001; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; de Wit R, 2000, J BIOMOL SCREEN, V5, P133, DOI 10.1177/108705710000500305; Disanza A, 2009, MOL ONCOL, V3, P280, DOI 10.1016/j.molonc.2009.05.008; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; IMAI Y, 1982, CANCER RES, V42, P4394; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Ivanova IA, 2013, ONCOGENE, V32, P5582, DOI 10.1038/onc.2013.277; Iwanishi M, 2000, J BIOL CHEM, V275, P38995, DOI 10.1074/jbc.M006665200; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; KAWAMOTO T, 1984, J BIOL CHEM, V259, P7761; KIM L, 1995, MOL CELL BIOL, V15, P4553; Kogata N, 2003, MOL BIOL CELL, V14, P3553, DOI 10.1091/mbc.E03-02-0080; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; Laurent CE, 2004, MOL CELL BIOL, V24, P9351, DOI 10.1128/MCB.24.21.9351-9358.2004; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Milde-Langosch K, 2005, BRIT J CANCER, V92, P2206, DOI 10.1038/sj.bjc.6602655; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; PHONPHOK Y, 1991, FEBS LETT, V281, P188, DOI 10.1016/0014-5793(91)80390-O; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Sangrar W, 2005, CANCER RES, V65, P3518, DOI 10.1158/0008-5472.CAN-04-3468; Sangrar W, 2009, POMBE CDC15 HOMOLOGY, P78; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Schmidt-Glenewinkel H, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-32; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zhang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-78	53	16	18	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	31					4109	4117		10.1038/onc.2014.340	http://dx.doi.org/10.1038/onc.2014.340			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN9PE	25347743				2022-12-26	WOS:000358780500009
J	Wang, J; Vodovotz, Y; Fan, LY; Li, YH; Liu, Z; Namas, R; Barclay, D; Zamora, R; Billiar, TR; Wilson, MA; Fan, J; Jiang, Y				Wang, Juan; Vodovotz, Yoram; Fan, Liyan; Li, Yuehua; Liu, Zheng; Namas, Rami; Barclay, Derek; Zamora, Ruben; Billiar, Timothy R.; Wilson, Mark A.; Fan, Jie; Jiang, Yong			Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages	FASEB JOURNAL			English	Article						IFN regulatory factor 3; myeloid-related protein; Toll-like receptor 4	NF-KAPPA-B; INDUCIBLE PROTEIN-10 PRODUCTION; DOUBLE-STRANDED-RNA; REGULATORY T-CELLS; IFN-GAMMA; NEUTROPHIL MIGRATION; RESPONSE ELEMENT; CXC CHEMOKINE; HIGH-AFFINITY; S100 FAMILY	Trauma/hemorrhagic shock is associated with morbidity and mortality due to dysregulated inflammation, which is driven in part by monocytes/macrophages stimulated by injury-induced release of damage-associated molecular pattern (DAMP) molecules. MRP8/MRP14 is an endogenous DAMP involved in various inflammatory diseases, though its mechanism of action is unclear. Circulating MRP8/MRP14 levels in human blunt trauma nonsurvivors were significantly lower than those of survivors (P < 0.001). Human monocytic THP-1 cells stimulated with MRP8/MRP14 expressed the chemokine IFN-gamma inducible protein 10 (IP-10)/CXCL10. Circulating IP-10 levels in human blunt trauma patients were correlated positively with MRP8/MRP14 levels (r = 0.396, P < 0.001), and were significantly lower in trauma nonsurvivors than in survivors (P < 0.001). We therefore sought to determine the mechanisms by which MRP8/MRP14 stimulates IP-10 in monocytes/macrophages, and found that induction of IP-10 by MRP8/MRP14 required Toll-like receptor 4 and TRIF but not MyD88. Full induction of IP-10 by MRP8/MRP14 required synergy between the transcription factors NF-kappa B and IFN regulatory factor 3 (IRF3). The receptor for IP-10 is CXCR3, and MRP8/MRP14-induced chemotaxis of CXCR3(+) cells was dependent on the production of IP-10 in monocytes/macrophages. Furthermore, in vivo study with a mouse trauma/hemorrhagic shock model showed that administration of neutralizing antibody against MRP8 prevented activation of NF-kB and IRF3 as well as IP-10 production. Thus, the current study identified a novel signaling mechanism that controls IP-10 expression in monocytes/macrophages by MRP8/MRP14, which may play an important role in injury-induced inflammation.	[Wang, Juan; Liu, Zheng; Fan, Jie; Jiang, Yong] Southern Med Univ, State Key Lab Organ Failure Res, Key Lab Transcript & Prote, Minist Educ China,Key Lab Prote Guangdong Prov, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Juan; Vodovotz, Yoram; Li, Yuehua; Namas, Rami; Barclay, Derek; Zamora, Ruben; Billiar, Timothy R.; Wilson, Mark A.; Fan, Jie] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Wilson, Mark A.; Fan, Jie] Vet Affairs Pittsburgh Healthcare Syst, Res & Dev, Pittsburgh, PA USA; [Fan, Liyan] Univ Pittsburgh, Sch Arts & Sci, Pittsburgh, PA USA; [Vodovotz, Yoram; Billiar, Timothy R.; Fan, Jie] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Ministry of Education, China; Southern Medical University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jiang, Y (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China.	jif7@pitt.edu; jiang48231@163.com	LI, Yue/GRS-8071-2022; Namas, Rami/AAD-5796-2020; Namas, Rami/GZK-4999-2022; Namas, Rami/AAD-5793-2020	Namas, Rami/0000-0002-8582-5321; Namas, Rami/0000-0002-8582-5321	NHLBI NIH HHS [R01 HL079669, R01-HL-079669] Funding Source: Medline; NIGMS NIH HHS [P50 GM053789, P50-GM-53789] Funding Source: Medline; BLRD VA [I01 BX002729] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002729] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BLRD VA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)		Agostini C, 2000, AM J RESP CRIT CARE, V162, P1466, DOI 10.1164/ajrccm.162.4.2003130; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baker HN, 2012, JOVE-J VIS EXP, DOI 10.3791/4084; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Blackwell SE, 2003, J IMMUNOL, V170, P4061, DOI 10.4049/jimmunol.170.8.4061; Chen X, 2013, BIOCHEM BIOPH RES CO, V433, P532, DOI 10.1016/j.bbrc.2013.03.024; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Davis Beckley K, 2013, Methods Mol Biol, V1031, P27, DOI 10.1007/978-1-62703-481-4_3; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gopal R, 2013, AM J RESP CRIT CARE, V188, P1137, DOI 10.1164/rccm.201304-0803OC; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Herzig DS, 2012, AM J RESP CRIT CARE, V185, P291, DOI 10.1164/rccm.201108-1560OC; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoerning A, 2011, EUR J IMMUNOL, V41, P2291, DOI 10.1002/eji.201041095; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; Kim S, 2013, MOL MED, V19, P88, DOI 10.2119/molmed.2012.00306; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Liu YJ, 2009, J IMMUNOL, V182, P572, DOI 10.4049/jimmunol.182.1.572; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Majumder S, 1998, J IMMUNOL, V161, P4736; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; Menzel CL, 2011, MOL MED, V17, P1031, DOI 10.2119/molmed.2011.00015; Minino AM, 2011, NCHS DATA BRIEF, V2013, P1; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Namas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008406; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; OHMORI Y, 1995, J IMMUNOL, V154, P5235; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Rammes A, 1997, J BIOL CHEM, V272, P9496; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; Suga H, 2013, J IMMUNOL, V190, P6059, DOI 10.4049/jimmunol.1201606; Takeuchi O, 2012, NAT IMMUNOL, V13, P634, DOI 10.1038/ni.2346; Ukena SN, 2011, BLOOD, V118, pE82, DOI 10.1182/blood-2011-05-352708; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vollmer J, 2004, J ENDOTOXIN RES, V10, P431, DOI 10.1179/096805104225006534; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zaaqoq AM, 2014, CRIT CARE MED, V42, P1487, DOI 10.1097/CCM.0000000000000248; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	60	38	44	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					250	262		10.1096/fj.14-255992	http://dx.doi.org/10.1096/fj.14-255992			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25342131	Green Published			2022-12-26	WOS:000347378600024
J	Dong, XH; Wu, DT; Jia, CF; Ruan, Y; Feng, XC; Wang, GX; Liu, J; Shen, Y; Li, H; Li, LX				Dong, Xuehong; Wu, Dingting; Jia, Chengfang; Ruan, Yu; Feng, Xiaocheng; Wang, Guoxing; Liu, Jun; Shen, Yi; Li, Hong; Li, Lianxi			Low Ankle-Brachial Index Is Associated with Early-Stage Chronic Kidney Disease in Type 2 Diabetic Patients Independent of Albuminuria	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PERIPHERAL ARTERIAL-DISEASE; RISK-FACTORS; CARDIOVASCULAR MORTALITY; RENAL-INSUFFICIENCY; CHINESE; POPULATION; PREVALENCE; ATHEROSCLEROSIS; NEPHROPATHY	Aims: The role of low ankle-brachial index (ABI) in early-stage chronic kidney disease (CKD) is not fully known. This study was designed to investigate the prevalence of low ABI in early-stage CKD defined as an estimated glomerular filtration rate (eGFR) between 60-89 ml/min/1.73 m(2) of type 2 diabetic patients without albuminuria and to determine the association between the low ABI and mildly decreased eGFR. Methods: The cross-sectional study enrolled 448 type 2 diabetic patients with normoalbuminuria. The patients were stratified into two groups according to the CKD-EPI eGFR level: the normal group with eGFR level >= 90 mL/min/1.73 m(2) and the lower group with eGFR of 60-89. ABI was categorized as normal (1.0-1.39), low-normal (0.9-0.99), and low (<0.9). Both stepwise forward multiple linear regression and binary logistic regression analyses were performed to examine the association between ABI categories and eGFR levels and to assess the relation of low ABI and early-stage CKD. Results: The prevalence of low ABI in early-stage CKD of type 2 diabetic patients without albuminuria was 39.5%. Low ABI was associated with an approximate 3-fold greater risk of early-stage CKD in bivariate logistic regression analysis, and remained significantly associated with a 2.2 fold risk (95% confidence interval: 1.188-4.077; P = 0.012) after adjusting traditional chronic kidney disease risk factors. Conclusions: There was a high prevalence of low ABI in early-stage CKD patients of type 2 diabetes with normoalbuminuria and a close relation between low ABI and early-stage CKD, suggesting that we should pay much more attention to the patients who have only mildly decreased eGFR and normoalbuminuria but have already had a low ABI in clinic work and consider the preventive therapy in early stage.	[Dong, Xuehong; Wu, Dingting; Jia, Chengfang; Ruan, Yu; Feng, Xiaocheng; Wang, Guoxing; Liu, Jun; Li, Hong] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, Xuehong; Wu, Dingting; Jia, Chengfang; Ruan, Yu; Feng, Xiaocheng; Wang, Guoxing; Liu, Jun; Li, Hong] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Metab, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Yi] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Lianxi] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Shanghai Jiao Tong University	Li, H (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China.	lihongheyi@126.com; lilx@sjtu.edu.cn			National Natural Science Foundation of China [30900703, 81170759]; Ministry of Education of China [200803351042]; Zhejiang Project of Science and Technology [2009A11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Zhejiang Project of Science and Technology	This research was supported by the National Natural Science Foundation of China for young scientists (30900703), the Doctoral Fund of Ministry of Education of China (200803351042), the Zhejiang Project of Science and Technology (2009A11), and the National Natural Science Foundation of China (81170759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse AD, 2014, DIABETES CARE; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; ANDERSON S, 1986, AM J MED, V80, P435, DOI 10.1016/0002-9343(86)90718-7; [Anonymous], 1992, MUSCLE NERVE, V15, P229; Banerjee S, 2014, AM J CARDIOL; Bi YF, 2014, JAMA-J AM MED ASSOC, V311, P200, DOI 10.1001/jama.2013.283143; Clase CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013291.78621.26; de Vinuesa SG, 2005, KIDNEY INT, V67, pS44, DOI 10.1111/j.1523-1755.2005.09310.x; Dong X, 2007, DIABETIC MED, V24, P1482, DOI 10.1111/j.1464-5491.2007.02275.x; Dwyer JP, 2012, CARDIORENAL MED, V2, P1, DOI 10.1159/000333249; Ekinci EI, 2013, DIABETES CARE, V36, P3620, DOI 10.2337/dc12-2572; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foster MC, 2013, AM J KIDNEY DIS, V61, P204, DOI 10.1053/j.ajkd.2012.07.009; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Guerrero A, 2006, NEPHROL DIAL TRANSPL, V21, P3525, DOI 10.1093/ndt/gfl470; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Jia WP, 2009, NEPHROL DIAL TRANSPL, V24, P3724, DOI 10.1093/ndt/gfp349; Karalliedde J, 2010, J AM SOC NEPHROL, V21, P2020, DOI 10.1681/ASN.2010030250; Kesteloot H, 1996, J HUM HYPERTENS, V10, P245; Kshirsagar AV, 2004, RENAL FAILURE, V26, P433, DOI 10.1081/JDI-120039828; Lee AJ, 2004, CIRCULATION, V110, P3075, DOI 10.1161/01.CIR.0000143102.38256.DE; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lou QL, 2012, DIABETES METAB J, V36, P433, DOI 10.4093/dmj.2012.36.6.433; MacIsaac R, 2004, DIABETES CARE, V27, P195, DOI 10.2337/diacare.27.1.195; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Murgatroyd H, 2004, BRIT J OPHTHALMOL, V88, P920, DOI 10.1136/bjo.2003.026385; O'Hare AM, 2005, ARCH INTERN MED, V165, P1481, DOI 10.1001/archinte.165.13.1481; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; Scanlon PH, 2005, DIABETES CARE, V28, P2448, DOI 10.2337/diacare.28.10.2448; Thomas MC, 2009, DIABETES CARE, V32, P1497, DOI 10.2337/dc08-2186; Turner ST, 2011, J HYPERTENS, V29, P1796, DOI 10.1097/HJH.0b013e328349052b; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Xu BH, 2014, ATHEROSCLEROSIS, V232, P285, DOI 10.1016/j.atherosclerosis.2013.11.046; Yamashita T, 2013, J ATHEROSCLER THROMB, V20, P790	38	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109641	10.1371/journal.pone.0109641	http://dx.doi.org/10.1371/journal.pone.0109641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354133	gold, Green Published, Green Submitted			2022-12-26	WOS:000345204200012
J	Ehlers, I; Betson, TR; Vetter, W; Schleucher, J				Ehlers, Ina; Betson, Tatiana R.; Vetter, Walter; Schleucher, Jurgen			Elucidating Turnover Pathways of Bioactive Small Molecules by Isotopomer Analysis: The Persistent Organic Pollutant DDT	PLOS ONE			English	Article							HYDROGEN; RATIOS; DISTRIBUTIONS; DEGRADATION; RESIDUES	The persistent organic pollutant DDT (1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane) is still indispensable in the fight against malaria, although DDT and related compounds pose toxicological hazards. Technical DDT contains the dichloro congener DDD (1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethyl] benzene) as by-product, but DDD is also formed by reductive degradation of DDT in the environment. To differentiate between DDD formation pathways, we applied deuterium NMR spectroscopy to measure intramolecular deuterium distributions (H-2 isotopomer abundances) of DDT and DDD. DDD formed in the technical DDT synthesis was strongly deuterium-enriched at one intramolecular position, which we traced back to H-2/H-1 fractionation of a chlorination step in the technical synthesis. In contrast, DDD formed by reductive degradation was strongly depleted at the same position, which was due to the incorporation of 2 H-depleted hydride equivalents during reductive degradation. Thus, intramolecular isotope distributions give mechanistic information on reaction pathways, and explain a puzzling difference in the whole-molecule H-2/H-1 ratio between DDT and DDD. In general, our results highlight that intramolecular isotope distributions are essential to interpret whole-molecule isotope ratios. Intramolecular isotope information allows distinguishing pathways of DDD formation, which is important to identify polluters or to assess DDT turnover in the environment. Because intramolecular isotope data directly reflect isotope fractionation of individual chemical reactions, they are broadly applicable to elucidate transformation pathways of small bioactive molecules in chemistry, physiology and environmental science.	[Ehlers, Ina; Betson, Tatiana R.; Schleucher, Jurgen] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Vetter, Walter] Univ Hohenheim, Dept Food Chem, Stuttgart, Germany	Umea University; University Hohenheim	Schleucher, J (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	jurgen.schleucher@chem.umu.se			Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [216-2008-764]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This work was funded by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; JS; grant 216-2008-764 (http://www.formas.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aislabie JM, 1997, NEW ZEAL J AGR RES, V40, P269, DOI 10.1080/00288233.1997.9513247; Armbruster W, 2006, ANAL BIOANAL CHEM, V384, P237, DOI 10.1007/s00216-005-0160-0; Betson TR, 2006, ANAL CHEM, V78, P8406, DOI 10.1021/ac061050a; Elsner M, 2010, J ENVIRON MONITOR, V12, P2005, DOI 10.1039/c0em00277a; Eskenazi B, 2009, ENVIRON HEALTH PERSP, V117, P1359, DOI 10.1289/ehp.11748; Fenner K, 2013, SCIENCE, V341, P752, DOI 10.1126/science.1236281; FISHBEIN L, 1974, J CHROMATOGR, V98, P177, DOI 10.1016/S0021-9673(00)84785-8; Guillette LJ, 1996, GEN COMP ENDOCR, V101, P32, DOI 10.1006/gcen.1996.0005; Kovacs H, 2005, PROG NUCL MAG RES SP, V46, P131, DOI 10.1016/j.pnmrs.2005.03.001; Kuder T, 2013, ENVIRON SCI TECHNOL, V47, P1461, DOI 10.1021/es303476v; Lesot P, 2009, PROG NUCL MAG RES SP, V55, P128, DOI 10.1016/j.pnmrs.2009.01.001; Lind PM, 2014, ENVIRON RES, V129, P27, DOI 10.1016/j.envres.2013.12.003; LUO YH, 1991, PLANT CELL PHYSIOL, V32, P897; Markai S, 2002, CHEMBIOCHEM, V3, P212, DOI 10.1002/1439-7633(20020301)3:2/3<212::AID-CBIC212>3.0.CO;2-R; MARTIN GJ, 1982, ANAL CHEM, V54, P2380, DOI 10.1021/ac00250a057; Melander L., 1980, REACTION RATES ISOTO; Remaud GS, 1997, J AGR FOOD CHEM, V45, P859, DOI 10.1021/jf960518f; Richardson JR, 2014, JAMA NEUROL, V71, P284, DOI 10.1001/jamaneurol.2013.6030; Sayles GD, 1997, ENVIRON SCI TECHNOL, V31, P3448, DOI 10.1021/es9701669; Schleucher J, 1999, PLANT CELL ENVIRON, V22, P525, DOI 10.1046/j.1365-3040.1999.00440.x; Schmidt Hanns-Ludwig, 2003, Phytochemistry Reviews, V2, P61, DOI 10.1023/B:PHYT.0000004185.92648.ae; Schmidt HL, 2003, NATURWISSENSCHAFTEN, V90, P537, DOI 10.1007/s00114-003-0485-5; Sheng JJ, 2013, ENVIRON SCI TECHNOL, V47, P3199, DOI 10.1021/es305201s; Shouakar-Stash O, 2013, RAPID COMMUN MASS SP, V27, P1335, DOI 10.1002/rcm.6578; SLADEN WJL, 1966, NATURE, V210, P670, DOI 10.1038/210670a0; Turusov V, 2002, ENVIRON HEALTH PERSP, V110, P125, DOI 10.1289/ehp.02110125; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176; Walter S, 2012, BIOGEOSCIENCES, V9, P4115, DOI 10.5194/bg-9-4115-2012; WIBERG KB, 1955, CHEM REV, V55, P713, DOI 10.1021/cr50004a004; Wolfsberg M., 2010, ISOTOPE EFFECTS CHEM; World Health Organization, 2013, US DDT MAL VECT CONT	31	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110648	10.1371/journal.pone.0110648	http://dx.doi.org/10.1371/journal.pone.0110648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350380	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100033
J	Liu, ZJ; Hu, XM; Huang, CC; Zheng, K; Takebayashi, H; Cao, C; Qiu, MS				Liu, Zijing; Hu, Xuemei; Huang, Chengcheng; Zheng, Kang; Takebayashi, Hirohide; Cao, Cheng; Qiu, Mengsheng			Olig3 Is Not Involved in the Ventral Patterning of Spinal Cord	PLOS ONE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; OLIGODENDROCYTE DIFFERENTIATION; NEURONAL IDENTITY; NEURAL-TUBE; SPECIFICATION; NKX2.2; INTERNEURONS; IDENTIFICATION; EXPRESSION; FAMILY	At embryonic stages, Olig3 is initially expressed in the dorsal-most region of the spinal cord, but later in the ventral marginal zone as well. Previous studies indicated that Olig3 controlled the patterning of dorsal spinal cord and loss of Olig3 function led to the re-specification of dI2 and dI3 neurons into dI4 interneurons. However, the role of Olig3 in regulating the development of ventral spinal cord has remained unknown. BrdU labeling demonstrated that ventral Olig3 was expressed in the post-mitotic neurons and Olig3+ cells seen at late embryonic stages were born at the earlier stage but remained in the marginal zone throughout embryogenesis. Loss-of-function and gain-of-function experiment indicated that Nkx2.2 regulated the expression of Olig3 in V3 interneurons. However, Olig3 mutation didn't apparently affect the generation and migration of ventral neurons. These findings suggest that Olig3 plays different roles in regulating the development of dorsal and ventral spinal cord.	[Liu, Zijing; Hu, Xuemei; Qiu, Mengsheng] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Liu, Zijing; Huang, Chengcheng; Cao, Cheng] Beijing Inst Biotechnol, Beijing, Peoples R China; [Zheng, Kang; Qiu, Mengsheng] Hangzhou Normal Univ, Inst Dev & Regenerat Biol, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou, Zhejiang, Peoples R China; [Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan	University of Louisville; Hangzhou Normal University; Niigata University	Liu, ZJ (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	zijingsy@yahoo.com; m0qiu001@yahoo.com	huang, chengcheng/GRX-5340-2022; Cao, Cheng/GNP-6156-2022; Takebayashi, Hirohide/AAO-1693-2020	Liu, Zijing/0000-0001-7790-0590	Natural Science Foundation of China [31371102]; National Key Basic Research Program of China [2012CB910402, 2013CB531300]; National Institutes of Health [R01 NS37717]; Kentucky Spinal Cord and Head Injury Trust (KSHIRT)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Trust (KSHIRT)	ZL was supported by Natural Science Foundation of China (31371102); MQ was supported by National Key Basic Research Program of China (2012CB910402; 2013CB531300), National Institutes of Health (R01 NS37717) and Kentucky Spinal Cord and Head Injury Trust (KSHIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Borowska J, 2013, J NEUROSCI, V33, P18553, DOI 10.1523/JNEUROSCI.2005-13.2013; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Ding L, 2005, DEV DYNAM, V234, P622, DOI 10.1002/dvdy.20545; Francius C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070325; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Holz A, 2010, DEVELOPMENT, V137, P4249, DOI 10.1242/dev.053819; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Liu Z, 2008, J NEUROSCI, V28, P10124, DOI 10.1523/JNEUROSCI.3769-08.2008; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Matise MP, 2013, WIRES DEV BIOL, V2, P419, DOI 10.1002/wdev.83; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Qi YC, 2001, DEVELOPMENT, V128, P2723; Storm R, 2009, DEVELOPMENT, V136, P295, DOI 10.1242/dev.027193; Sussel L, 1998, DEVELOPMENT, V125, P2213; Takebayashi H, 2002, MECH DEVELOP, V113, P169, DOI 10.1016/S0925-4773(02)00021-7; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111076	10.1371/journal.pone.0111076	http://dx.doi.org/10.1371/journal.pone.0111076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350849	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100056
J	Rohailla, S; Clarizia, N; Sourour, M; Sourour, W; Gelber, N; Wei, C; Li, J; Redington, AN				Rohailla, Sagar; Clarizia, Nadia; Sourour, Michel; Sourour, Wesam; Gelber, Nitai; Wei, Can; Li, Jing; Redington, Andrew N.			Acute, Delayed and Chronic Remote Ischemic Conditioning Is Associated with Downregulation of mTOR and Enhanced Autophagy Signaling	PLOS ONE			English	Article							REPERFUSION INJURY; PRECONDITIONING PROVIDES; LATE-PHASE; MECHANISMS; HEART; PROTECTION; CARDIOPROTECTION; DISEASE; KINASE; ROLES	Background: Remote ischemic conditioning (RIC), induced by brief periods of limb ischemia has been shown to decrease acute myocardial injury and chronic responses after acute coronary syndromes. While several signaling pathways have been implicated, our understanding of the cardioprotection and its underlying mediators and mechanisms remains incomplete. In this study we examine the effect of RIC on pro-autophagy signaling as a possible mechanism of benefit. Methods and Results: We examined the role of autophagy in the acute/first window (15 minutes after RIC), delayed/second window (24 hours after RIC) and chronic (24 hours after 9 days of repeated RIC) phases of cardioprotection. C57BL/6 mice (N = 69) were allocated to each treatment phase and further stratified to receive RIC, induced by four cycles of 5 minutes of limb ischemia followed by 5 minutes of reperfusion, or control treatment consisting solely of handling without transient ischemia. The groups included, group 1 (1W control), group 2 (1W RIC), group 3 (2W control), group 4 (2W RIC), group 5 (3W control) and group 6 (3W RIC). Hearts were isolated for assessment of cardiac function and infarct size after global ischemia using a Langendorff preparation. Infarct size was reduced in all three phases of cardioprotection, in association with improvements in post- ischemic left ventricular end diastolic pressure (LVEDP) and developed pressure (LVDP) (P, 0.05). The pattern of autophagy signaling varied; 1W RIC increased AMPK levels and decreased the activation of mammalian target of rapamycin (mTOR), whereas chronic RIC was associated with persistent mTOR suppression and increased levels of autophagosome proteins, LC3II/I and Atg5. Conclusions: Cardioprotection following transient ischemia exists in both the acute and delayed/chronic phases of conditioning. RIC induces pro-autophagy signaling but the pattern of responses varies depending on the phase, with the most complete portfolio of responses observed when RIC is administered chronically.	[Rohailla, Sagar; Clarizia, Nadia; Sourour, Michel; Sourour, Wesam; Gelber, Nitai; Wei, Can; Li, Jing; Redington, Andrew N.] Univ Toronto, Hosp Sick Children, Labatt Family Heart Ctr, Div Cardiol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Redington, AN (corresponding author), Univ Toronto, Hosp Sick Children, Labatt Family Heart Ctr, Div Cardiol, Toronto, ON M5S 1A1, Canada.	andrew.redington@sickkids.ca						Bolli R, 2000, CIRC RES, V87, P972, DOI 10.1161/01.RES.87.11.972; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Depre C, 2010, AM J PHYSIOL-HEART C, V299, pH752, DOI 10.1152/ajpheart.00147.2010; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Gedik N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096567; Gottlieb RA, 2013, HEART FAIL REV, V18, P575, DOI 10.1007/s10741-012-9367-2; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hahn CD, 2011, STROKE, V42, P2960, DOI 10.1161/STROKEAHA.111.622340; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hassouna A, 2004, AM J PHYSIOL-CELL PH, V287, pC1418, DOI 10.1152/ajpcell.00144.2004; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hougaard KD, 2014, STROKE, V45, P159, DOI 10.1161/STROKEAHA.113.001346; Jenkins DP, 1997, HEART, V77, P314, DOI 10.1136/hrt.77.4.314; Joo JD, 2006, J AM SOC NEPHROL, V17, P3115, DOI 10.1681/ASN.2006050424; Kanamori H, 2011, CARDIOVASC RES, V91, P330, DOI 10.1093/cvr/cvr073; Khan SA, 2006, J MOL CELL CARDIOL, V41, P256, DOI 10.1016/j.yjmcc.2006.04.014; Li J, 2011, CLIN SCI, V120, P451, DOI 10.1042/CS20100466; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mehrjerdi FZ, 2013, BRAIN RES, V1526, P94, DOI 10.1016/j.brainres.2013.06.018; Meng R, 2012, NEUROLOGY, V79, P1853, DOI 10.1212/WNL.0b013e318271f76a; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; Przyklenk K, 2011, AUTOPHAGY, V7, P432, DOI 10.4161/auto.7.4.14395; Reid EA, 2005, AM J PHYSIOL-HEART C, V288, pH2253, DOI 10.1152/ajpheart.01009.2004; Romanque P, 2010, TRANSPL P, V42, P1569, DOI 10.1016/j.transproceed.2009.11.052; Shen YT, 2008, CIRCULATION, V118, P1961, DOI 10.1161/CIRCULATIONAHA.108.788240; Shimizu M, 2010, J SURG RES, V158, P155, DOI 10.1016/j.jss.2008.08.010; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Wei M, 2011, CIRC RES, V108, P1220, DOI 10.1161/CIRCRESAHA.110.236190; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yan WJ, 2013, ACTA PHARMACOL SIN, V34, P636, DOI 10.1038/aps.2013.18; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhou CH, 2014, J CARDIOVASC PHARM T, V19, P558, DOI 10.1177/1074248414524479; Zhou WW, 2010, PEDIATR CARDIOL, V31, P22, DOI 10.1007/s00246-009-9536-9	39	42	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111291	10.1371/journal.pone.0111291	http://dx.doi.org/10.1371/journal.pone.0111291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347774	gold, Green Submitted, Green Published			2022-12-26	WOS:000347994900059
J	Sandor, B; Nagy, A; Toth, A; Rabai, M; Mezey, B; Csatho, A; Czuriga, I; Toth, K; Szabados, E				Sandor, Barbara; Nagy, Alexandra; Toth, Andras; Rabai, Miklos; Mezey, Bela; Csatho, Arpad; Czuriga, Istvan; Toth, Kalman; Szabados, Eszter			Effects of Moderate Aerobic Exercise Training on Hemorheological and Laboratory Parameters in Ischemic Heart Disease Patients	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; BLOOD-CELL AGGREGATION; CARDIAC REHABILITATION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; PHYSICAL-ACTIVITY; ESC GUIDELINES; RISK	Background and Design: In this study we set out to determine the effects of long-term physical training on hemorheological, laboratory parameters, exercise tolerability, psychological factors in cardiac patients participating in an ambulatory rehabilitation program. Methods: Before physical training, patients were examined by echocardiography, tested on treadmill by the Bruce protocol, and blood was drawn for laboratory tests. The enrolled 79 ischemic heart disease patients joined a 24-week cardiac rehabilitation training program. Blood was drawn to measure hematocrit (Hct), plasma and whole blood viscosity (PV, WBV), red blood cell (RBC) aggregation and deformability. Hemorheological, clinical chemistry and psychological measurements were repeated 12 and 24 weeks later, and a treadmill test was performed at the end of the program. Results: After 12 weeks Hct, PV, WBV and RBC aggregation were significantly decreased, RBC deformability exhibited a significant increase (p < 0.05). Laboratory parameters (triglyceride, uric acid, hsCRP and fibrinogen) were significantly decreased (p < 0.05). After 24 weeks the significant results were still observed. By the end of the study, IL-6 and TNF-alpha levels displayed decreasing trends (p < 0.06). There was a significant improvement in MET (p < 0.001), and the BMI decrease was also significant (p < 0.05). The vital exhaustion parameters measured on the fatigue impact scale indicated a significant improvement in two areas of the daily activities (p < 0.05). Conclusions: Regular physical training improved the exercise tolerability of patients with ischemic heart disease. Previous publications have demonstrated that decreases in Hct and PV may reduce cardiovascular risk, while a decrease in RBC aggregation and an increase in deformability improve the capillary flow. Positive changes in laboratory parameters and body weight may indicate better oxidative and inflammatory circumstances and an improved metabolic state. The psychological findings point to an improvement in the quality of life.	[Sandor, Barbara; Toth, Andras; Rabai, Miklos; Mezey, Bela; Czuriga, Istvan; Toth, Kalman; Szabados, Eszter] Univ Pecs, Sch Med, Dept Med 1, Pecs, Hungary; [Nagy, Alexandra; Csatho, Arpad] Univ Pecs, Sch Med, Dept Behav Sci, Pecs, Hungary	University of Pecs; University of Pecs	Szabados, E (corresponding author), Univ Pecs, Sch Med, Dept Med 1, Pecs, Hungary.	szabados.eszter@pte.hu	Csatho, Arpad/ABG-4329-2021; Csatho, Arpad/GNM-7312-2022	Csatho, Arpad/0000-0002-0284-654X				Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Baskurt OK, 2007, BIOMED HEALTH RES, V69, P170; Baskurt OK, 2013, CLIN HEMORHEOL MICRO, V54, P99, DOI 10.3233/CH-2012-1616; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; BAUERSACHS RM, 1989, CLIN HEMORHEOL, V9, P1; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Brun JF, 1998, CLIN HEMORHEOL MICRO, V19, P89; Bruna JF, 2013, CLIN HEMORHEOL MICRO, V55, P15, DOI 10.3233/CH-131686; Cakir-Atabek H, 2009, CLIN HEMORHEOL MICRO, V41, P251, DOI 10.3233/CH-2009-1176; CARTER C, 1983, AM HEART J, V105, P674, DOI 10.1016/0002-8703(83)90493-3; Church TS, 2002, AM HEART J, V143, P349, DOI 10.1067/mhj.2002.119758; Connes P, 2004, CLIN HEMORHEOL MICRO, V31, P311; Connes P, 2007, CLIN HEMORHEOL MICRO, V36, P319; Connes P, 2013, CLIN HEMORHEOL MICRO, V53, P187, DOI 10.3233/CH-2012-1643; Connes P, 2010, SCAND J MED SCI SPOR, V20, P48, DOI 10.1111/j.1600-0838.2010.01208.x; Cossette S, 2001, PSYCHOSOM MED, V63, P257, DOI 10.1097/00006842-200103000-00009; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dobbe JGG, 2002, CYTOMETRY, V50, P313, DOI 10.1002/cyto.10171; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Ekman Inger, 2002, Eur J Cardiovasc Nurs, V1, P77, DOI 10.1016/S1474-5151(01)00016-0; ERNST E, 1987, EUR HEART J, V8, P59, DOI 10.1093/eurheartj/8.suppl_G.59; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194; HUME R, 1966, J CLIN PATHOL, V19, P389, DOI 10.1136/jcp.19.4.389; Hunt SA, 2005, CIRCULATION, V112, P1825, DOI 10.1016/j.jacc.2005.08.023; KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9; Kesmarky G, 2001, CLIN HEMORHEOL MICRO, V24, P33; Kilic-Toprak E, 2012, MED SCI MONITOR, V18, pCR351, DOI 10.12659/MSM.882878; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee KW, 2005, HEART, V91, P1413, DOI 10.1136/hrt.2004.050005; LEVINE GN, 1995, AM J CARDIOL, V76, P80, DOI 10.1016/S0002-9149(99)80808-X; LOWE GDO, 1988, CLIN HEMORHEOL, V8, P517; Lowe G, 2011, MOD INSIGHTS DIS MOL, P235; Marton Z, 2003, CLIN HEMORHEOL MICRO, V29, P81; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Piepoli MF, 2010, EUR HEART J, V31, P1967, DOI 10.1093/eurheartj/ehq236; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Simmonds MJ, 2012, CLIN HEMORHEOL MICRO, V51, P87, DOI 10.3233/CH-2011-1514; Smith MM, 2015, CLIN HEMORHEOL MICRO, V60, P347, DOI 10.3233/CH-131708; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Toth K, 2007, BIOMED HEALTH RES, V69, P392; Tripette J, 2011, CLIN HEMORHEOL MICRO, V47, P261, DOI 10.3233/CH-2011-1388; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Waltz X, 2015, CLIN HEMORHEOL MICRO, V59, P37, DOI 10.3233/CH-131742; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; Yalcin O, 2003, J APPL PHYSIOL, V94, P997, DOI 10.1152/japplphysiol.00368.2002; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; ZIJLSTRA WG, 1958, ACTA PHYSIOL PHARM N, V7, P153	58	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110751	10.1371/journal.pone.0110751	http://dx.doi.org/10.1371/journal.pone.0110751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347067	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900029
J	Tano, K; Yasuda, S; Kuroda, T; Saito, H; Umezawa, A; Sato, Y				Tano, Keiko; Yasuda, Satoshi; Kuroda, Takuya; Saito, Hirohisa; Umezawa, Akihiro; Sato, Yoji			A Novel In Vitro Method for Detecting Undifferentiated Human Pluripotent Stem Cells as Impurities in Cell Therapy Products Using a Highly Efficient Culture System	PLOS ONE			English	Article							HUMAN FIBROBLASTS; IPS CELLS; INDUCTION; SURVIVAL	Innovative applications of cell therapy products (CTPs) derived from human pluripotent stem cells (hPSCs) in regenerative medicine are currently being developed. The presence of residual undifferentiated hPSCs in CTPs is a quality concern associated with tumorigencity. However, no simple in vitro method for direct detection of undifferentiated hPSCs that contaminate CTPs has been developed. Here, we show a novel approach for direct and sensitive detection of a trace amount of undifferentiated human induced pluripotent stem cells (hiPSCs) using a highly efficient amplification method in combination with laminin-521 and Essential 8 medium. Essential 8 medium better facilitated the growth of hiPSCs dissociated into single cells on laminin-521 than in mTeSR1 medium. hiPSCs cultured on laminin-521 in Essential 8 medium were maintained in an undifferentiated state and they maintained the ability to differentiate into various cell types. Essential 8 medium allowed robust hiPSC proliferation plated on laminin-521 at low cell density, whereas mTeSR1 did not enhance the cell growth. The highly efficient culture system using laminin-521 and Essential 8 medium detected hiPSCs spiked into primary human mesenchymal stem cells (hMSCs) or human neurons at the ratio of 0.001%-0.01% as formed colonies. Moreover, this assay method was demonstrated to detect residual undifferentiated hiPSCs in cell preparations during the process of hMSC differentiation from hiPSCs. These results indicate that our highly efficient amplification system using a combination of laminin-521 and Essential 8 medium is able to detect a trace amount of undifferentiated hPSCs contained as impurities in CTPs and would contribute to quality assessment of hPSC-derived CTPs during the manufacturing process.	[Tano, Keiko; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Tano, Keiko; Yasuda, Satoshi; Kuroda, Takuya; Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo, Japan; [Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Sato, Yoji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Qual Assurance Sci Pharmaceut, Nagoya, Aichi, Japan; [Sato, Yoji] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Cellular & Gene Therapy Prod, Osaka, Japan; [Sato, Yoji] Kyushu Univ, Graduated Sch Pharmaceut Sci, Dept Translat Pharmaceut Sci, Fukuoka 812, Japan	National Center for Child Health & Development - Japan; National Institute of Health Sciences - Japan; National Center for Child Health & Development - Japan; Nagoya City University; Osaka University; Kyushu University	Sato, Y (corresponding author), Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo, Japan.	yoji@nihs.go.jp		YASUDA, Satoshi/0000-0002-1011-0815; Saito, Hirohisa/0000-0002-6630-8337	Japanese Ministry of Health, Labour and Welfare and Marketing Authorization Facilitation Program for Innovative Therapeutic Products [H23-SAISEI-IPPAN-004, H23-SAISEI-IPPAN-005, H24-IYAKU-SHITEI-027, H25-JITSUYOKA(SAISEI)-IPPAN-008]	Japanese Ministry of Health, Labour and Welfare and Marketing Authorization Facilitation Program for Innovative Therapeutic Products	This work was supported by Research Grants from the Japanese Ministry of Health, Labour and Welfare (H23-SAISEI-IPPAN-004, H23-SAISEI-IPPAN-005, H24-IYAKU-SHITEI-027, H25-JITSUYOKA(SAISEI)-IPPAN-008, and Marketing Authorization Facilitation Program for Innovative Therapeutic Products), http://www.mhlw.go.jp/english/policy/other/research-projects/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003685; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022; Food and Drug Administration, 2008, CELL TISS GEN THER A; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Jung YJ, 2012, STEM CELLS, V30, P42, DOI 10.1002/stem.727; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kanemura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02334; Kimbrel EA, 2014, STEM CELLS DEV, V23, P1611, DOI 10.1089/scd.2013.0554; Kuroda T, 2013, BIOL PHARM BULL, V36, P189, DOI 10.1248/bpb.b12-00970; Kuroda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037342; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107	19	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110496	10.1371/journal.pone.0110496	http://dx.doi.org/10.1371/journal.pone.0110496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347300	gold, Green Submitted, Green Published			2022-12-26	WOS:000347994900023
J	Wada, K; Matsushima, Y; Tada, T; Hasegawa, S; Obara, Y; Yoshizawa, Y; Takahashi, G; Hiai, H; Shimanuki, M; Suzuki, S; Saitou, J; Yamamoto, N; Ichikawa, M; Watanabe, K; Kikkawa, Y				Wada, Kenta; Matsushima, Yoshibumi; Tada, Tomoki; Hasegawa, Sayaka; Obara, Yo; Yoshizawa, Yasuhiro; Takahashi, Gou; Hiai, Hiroshi; Shimanuki, Midori; Suzuki, Sari; Saitou, Junichi; Yamamoto, Naoki; Ichikawa, Masumi; Watanabe, Kei; Kikkawa, Yoshiaki			Expression of Truncated PITX3 in the Developing Lens Leads to Microphthalmia and Aphakia in Mice	PLOS ONE			English	Article							HOMEOBOX GENE; CRYSTALLIN; MUTATIONS; DELETION; ANOPHTHALMIA; FAMILY; REGION; PAX6	Microphthalmia is a severe ocular disorder, and this condition is typically caused by mutations in transcription factors that are involved in eye development. Mice carrying mutations in these transcription factors would be useful tools for defining the mechanisms underlying developmental eye disorders. We discovered a new spontaneous recessive microphthalmos mouse mutant in the Japanese wild-derived inbred strain KOR1/Stm. The homozygous mutant mice were histologically characterized as microphthalmic by the absence of crystallin in the lens, a condition referred to as aphakia. By positional cloning, we identified the nonsense mutation c.444C>A outside the genomic region that encodes the homeodomain of the paired-like homeodomain transcription factor 3 gene (Pitx3) as the mutation responsible for the microphthalmia and aphakia. We examined Pitx3 mRNA expression of mutant mice during embryonic stages using RT-PCR and found that the expression levels are higher than in wild-type mice. Pitx3 over-expression in the lens during developmental stages was also confirmed at the protein level in the microphthalmos mutants via immunohistochemical analyses. Although lens fiber differentiation was not observed in the mutants, strong PITX3 protein signals were observed in the lens vesicles of the mutant lens. Thus, we speculated that abnormal PITX3, which lacks the C-terminus (including the OAR domain) as a result of the nonsense mutation, is expressed in mutant lenses. We showed that the expression of the downstream genes Foxe3, Prox1, and Mip was altered because of the Pitx3 mutation, with large reductions in the lens vesicles in the mutants. Similar profiles were observed by immunohistochemical analysis of these proteins. The expression profiles of crystallins were also altered in the mutants. Therefore, we speculated that the microphthalmos/aphakia in this mutant is caused by the expression of truncated PITX3, resulting in the abnormal expression of downstream targets and lens fiber proteins.	[Wada, Kenta; Tada, Tomoki; Hasegawa, Sayaka; Yoshizawa, Yasuhiro; Takahashi, Gou; Suzuki, Sari] Tokyo Univ Agr, Dept Bioprod, Abashiri, Japan; [Wada, Kenta; Matsushima, Yoshibumi; Obara, Yo; Suzuki, Sari; Saitou, Junichi; Watanabe, Kei; Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan; [Matsushima, Yoshibumi] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan; [Obara, Yo; Saitou, Junichi; Watanabe, Kei] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Hiai, Hiroshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Shimanuki, Midori; Ichikawa, Masumi] Tokyo Metropolitan Inst Med Sci, Basic Res Ctr, Tokyo 113, Japan; [Yamamoto, Naoki] Fujita Hlth Univ, Inst Joint Res, Toyoake, Aichi, Japan	Tokyo University of Agriculture; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Kyoto University; Tokyo Metropolitan Institute of Medical Science; Fujita Health University	Kikkawa, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan.	kikkawa-ys@igakuken.or.jp	Kikkawa, Yoshiaki/AAI-7229-2020; Yamamoto, Naoki/L-2603-2019	Takahashi, Gou/0000-0003-2277-7657; Kikkawa, Yoshiaki/0000-0001-8859-4998	Japan Society for the Promotion of Science [24700437]; Tokyo Metropolitan Institute of Medical Science; Tokyo University of Agriculture	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Metropolitan Institute of Medical Science; Tokyo University of Agriculture	This work was supported by a Grant-in-Aid of Scientific Research (Young Scientists (B), no. 24700437) from the Japan Society for the Promotion of Science. This study was also supported by Tokyo Metropolitan Institute of Medical Science, and Tokyo University of Agriculture. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2013, INT J DEV BIOL, V57, P741, DOI 10.1387/ijdb.130193jg; Aldahmesh MA, 2011, GENET MED, V13, P978, DOI 10.1097/GIM.0b013e31822623d5; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Brouwer A, 2003, MECH DEVELOP, V120, P241, DOI 10.1016/S0925-4773(02)00416-1; Burgess D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-13; Carmona FD, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-44; Chepelinsky Ana B, 2009, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-540-79885-9_14; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Grimm C, 1998, DEV GENET, V23, P299, DOI 10.1002/(SICI)1520-6408(1998)23:4&lt;299::AID-DVG5&gt;3.0.CO;2-G; Ho HY, 2009, MECH DEVELOP, V126, P18, DOI 10.1016/j.mod.2008.10.007; Matsushima Y, 2012, EXP ANIM TOKYO, V61, P25, DOI 10.1538/expanim.61.25; Medina-Martinez O, 2009, DEV DYNAM, V238, P2193, DOI 10.1002/dvdy.21924; Miyasaka Y, 2013, EXP ANIM TOKYO, V62, P333, DOI 10.1538/expanim.62.333; Morishita H, 2013, J BIOL CHEM, V288, P11436, DOI 10.1074/jbc.M112.437103; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Ravenscroft G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028699; Rieger DK, 2001, GENOMICS, V72, P61, DOI 10.1006/geno.2000.6464; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; Rosemann M, 2010, MAMM GENOME, V21, P13, DOI 10.1007/s00335-009-9235-0; Sakazume S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-84; Semina EV, 2000, HUM MOL GENET, V9, P1575, DOI 10.1093/hmg/9.11.1575; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Varadaraj K, 2007, DEV DYNAM, V236, P1319, DOI 10.1002/dvdy.21125; VARNUM DS, 1968, J HERED, V59, P147, DOI 10.1093/oxfordjournals.jhered.a107667; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; Wada K, 2011, MAMM GENOME, V22, P693, DOI 10.1007/s00335-011-9358-y; Watanabe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050737; Wistow G, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-26; Yan XH, 2014, HUM MOL GENET, V23, P5597, DOI 10.1093/hmg/ddu274	35	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111432	10.1371/journal.pone.0111432	http://dx.doi.org/10.1371/journal.pone.0111432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347445	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900072
J	Xiong, X; Mei, WJ; Xie, YY; Liu, JS; Lu, MM; Peng, XQ; Yang, CY; Zhang, X; Xie, MY; Luo, RN; Yuan, XN; Huang, L; Wu, L; Qin, J; Peng, Y; Jia, XJ; Hu, GY; Tang, DM; Tao, LJ				Xiong, Xuan; Mei, Wenjuan; Xie, Yanyun; Liu, Jishi; Lu, Miaomiao; Peng, Xiongqun; Yang, Congyin; Zhang, Xin; Xie, Mingyan; Luo, Renna; Yuan, Xiangning; Huang, Ling; Wu, Lin; Qin, Jiao; Peng, Yu; Jia, Xiujie; Hu, Gaoyun; Tang, Damu; Tao, Lijian			Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways	PLOS ONE			English	Article							MESANGIAL CELLS; KIDNEY-DISEASE; EXPRESSION; MODEL; FIBROSIS; PIRFENIDONE; PREVENTION; OXIDASE	Diabetic nephropathy (DN) remains the leading cause of end-stage renal disease (ESRD), a situation that is in part attributable to the lack of effective treatments. Fluorofenidone is a newly developed reagent with anti-fibrotic activity. While fluorofenidone was previously demonstrated to possess renoprotection from DN pathogenesis in db/db mice, the protective process and its underlying mechanisms have not been well studied. To characterize fluorofenidone-derived renoprotection, we treated 5, 8, or 12-week old db/db mice with daily doses of placebo, fluorofenidone, or losartan until 24 weeks of age; the time at which diabetes and DN were fully developed in placebo-treated animals. In comparison to db/db mice receiving fluorofenidone at 12-weeks old, those treated at 5-weeks had less glomerular expansion and better preservation of renal functions, judged by serum creatinine levels, albumin to creatinine ratio, and urinary albumin excretion (mg/24 hours). These benefits of early treatment were associated with significant reductions of multiple DN-promoting events, such as decreased expression of TGF-beta 1 and the p22(phox) subunit of NADPH oxidase as well as downregulated activation of protein kinase C-zeta (zeta), ERK and AKT. This improvement in renoprotection following early interventions is not a unique property of DN pathogenesis, as losartan does not apparently offer the same benefits and is not more renoprotective than fluorofenidone. Additionally, the enhanced renoprotection provided by fluorofenidone did not affect the diabetic process, as it did not alter serum levels of glycated serum proteins, glucose, triglyceride or cholesterol. Collectively, we provide evidence that fluorofenidone offers improved renoprotection at early stages of DN pathogenesis.	[Xiong, Xuan; Mei, Wenjuan; Xie, Yanyun; Lu, Miaomiao; Luo, Renna; Yuan, Xiangning; Huang, Ling; Wu, Lin; Qin, Jiao; Peng, Yu; Tao, Lijian] Cent S Univ, Xiangya Hosp, Div Nephrol, Changsha, Hunan, Peoples R China; [Xie, Yanyun; Tang, Damu] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [Liu, Jishi] Third Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Peng, Xiongqun; Yang, Congyin; Zhang, Xin; Xie, Mingyan] Xiangya Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Jia, Xiujie] Second Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China; [Hu, Gaoyun] Cent S Univ, Sch Pharmaceut Sci, Dept Med Chem, Chem Sect, Changsha, Hunan, Peoples R China; [Tao, Lijian] Cent S Univ, State Key Lab Med Genet China, Changsha, Hunan, Peoples R China	Central South University; McMaster University; Central South University; Central South University; Central South University; Central South University	Tang, DM (corresponding author), McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada.	damut@mcmaster.ca; taolj@mail.csu.edu.cn	TAO, Li/HIR-4254-2022; Tang, Damu/AAQ-1786-2021	Tang, Damu/0000-0002-3282-9521	NSFC [81061120524]; CIHR [CC1-10961]	NSFC(National Natural Science Foundation of China (NSFC)); CIHR(Canadian Institutes of Health Research (CIHR))	This research was supported by a NSFC grant (81061120524) to LT and a CIHR grant (CC1-10961) to DT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaad KO, 2007, J CLIN PATHOL, V60, P18, DOI 10.1136/jcp.2005.035592; Balakumar P, 2009, J CARDIOVASC PHARM, V54, P129, DOI 10.1097/FJC.0b013e3181ad2190; Chiarelli F, 2009, HORM METAB RES, V41, P585, DOI 10.1055/s-0029-1220752; Cohen MP, 2001, METABOLISM, V50, P1435, DOI 10.1053/meta.2001.28074; Danesh FR, 2002, P NATL ACAD SCI USA, V99, P8301, DOI 10.1073/pnas.122228799; Forbes JM, 2003, FASEB J, V17, P1762, DOI 10.1096/fj.02-1102fje; Fujita H, 2004, AM J PHYSIOL-RENAL, V286, pF120, DOI 10.1152/ajprenal.00351.2002; GARTNER K, 1978, DIABETOLOGIA, V15, P59, DOI 10.1007/BF01219330; Gilbert RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047160; Ha TS, 2010, J MOL MED, V88, P391, DOI 10.1007/s00109-009-0575-8; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Joo JD, 2007, AM J PHYSIOL-RENAL, V293, pF1847, DOI 10.1152/ajprenal.00336.2007; Kwon DS, 2006, EUR J CELL BIOL, V85, P1189, DOI 10.1016/j.ejcb.2006.06.001; Leiter LA, 2005, DIABETES RES CLIN PR, V68, pS3, DOI 10.1016/j.diabres.2005.03.015; Levin A, 2011, J AM SOC NEPHROL, V22, P992, DOI 10.1681/ASN.2011040402; Lewis Edmund J, 2003, Clin Exp Nephrol, V7, P1, DOI 10.1007/s101570300000; Lin X, 2013, CURR MED CHEM, V20, P3774, DOI 10.2174/09298673113209990183; Ma KL, 2014, INT J BIOL SCI, V10, P149, DOI 10.7150/ijbs.7875; Nicholas SB, 2010, KIDNEY INT, V77, P588, DOI 10.1038/ki.2009.518; Pan D, 2014, FOOD CHEM TOXICOL, V63, P111, DOI 10.1016/j.fct.2013.10.046; PARVING HH, 2004, DIABETIC NEPHROPATHY, P1777; Peng ZZ, 2009, NEPHROLOGY, V14, P565, DOI 10.1111/j.1440-1797.2009.01129.x; Pichaiwong W, 2013, J AM SOC NEPHROL, V24, P1088, DOI 10.1681/ASN.2012050445; Quaggin SE, 2007, J AM SOC NEPHROL, V18, P364, DOI 10.1681/ASN.2006121396; RamachandraRao SP, 2009, J AM SOC NEPHROL, V20, P1765, DOI 10.1681/ASN.2008090931; Reeves WB, 2000, P NATL ACAD SCI USA, V97, P7667, DOI 10.1073/pnas.97.14.7667; Remuzzi G, 2004, J AM SOC NEPHROL, V15, P3117, DOI 10.1097/01.ASN.0000146423.71226.0C; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Shimizu F, 2011, DIABETOLOGIA, V54, P1517, DOI 10.1007/s00125-011-2107-7; Stitt-Cavanagh E, 2009, THESCIENTIFICWORLDJO, V9, P1127, DOI 10.1100/tsw.2009.133; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Tanios BY, 2012, NEPHRON EXTRA, V2, P278, DOI 10.1159/000343312; Taye A, 2013, N-S ARCH PHARMACOL, V386, P1071, DOI 10.1007/s00210-013-0904-x; Wang L, 2009, PHARMAZIE, V64, P680, DOI 10.1691/ph.2009.9525; Wang LH, 2011, PHARMACOLOGY, V88, P88, DOI 10.1159/000329419; Wu DC, 2009, J AM SOC NEPHROL, V20, P554, DOI 10.1681/ASN.2008040445; Xia L, 2007, AM J PHYSIOL-ENDOC M, V293, pE1280, DOI 10.1152/ajpendo.00223.2007; Xia L, 2008, AM J PHYSIOL-RENAL, V295, pF1705, DOI 10.1152/ajprenal.00043.2008; Zeng R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076836; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	42	10	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111242	10.1371/journal.pone.0111242	http://dx.doi.org/10.1371/journal.pone.0111242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347392	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900056
J	Harriague, AC; Bavestrello, G; Bo, M; Borghini, M; Castellano, M; Majorana, M; Massa, F; Montella, A; Povero, P; Misic, C				Harriague, Anabella Covazzi; Bavestrello, Giorgio; Bo, Marzia; Borghini, Mireno; Castellano, Michela; Majorana, Margherita; Massa, Francesco; Montella, Alessandro; Povero, Paolo; Misic, Cristina			Linking Environmental Forcing and Trophic Supply to Benthic Communities in the Vercelli Seamount Area (Tyrrhenian Sea)	PLOS ONE			English	Article							ORGANIC-MATTER; BACTERIAL PRODUCTION; FLUXES; WATER; SIZE; ASSEMBLAGES; EXTRACTION; DIVERSITY; DYNAMICS; ECOLOGY	Seamounts and their influence on the surrounding environment are currently being extensively debated but, surprisingly, scant information is available for the Mediterranean area. Furthermore, although the deep Tyrrhenian Sea is characterised by a complex bottom morphology and peculiar hydrodynamic features, which would suggest a variable influence on the benthic domain, few studies have been carried out there, especially for soft-bottom macrofaunal assemblages. In order to fill this gap, the structure of the meio-and macrofaunal assemblages of the Vercelli Seamount and the surrounding deep area (northern Tyrrhenian Sea - western Mediterranean) were studied in relation to environmental features. Sediment was collected with a box-corer from the seamount summit and flanks and at two far-field sites in spring 2009, in order to analyse the metazoan communities, the sediment texture and the sedimentary organic matter. At the summit station, the heterogeneity of the habitat, the shallowness of the site and the higher trophic supply (water column phytopigments and macroalgal detritus, for instance) supported a very rich macrofaunal community, with high abundance, biomass and diversity. In fact, its trophic features resembled those observed in coastal environments next to seagrass meadows. At the flank and far-field stations, sediment heterogeneity and depth especially influenced the meiofaunal distribution. From a trophic point of view, the low content of the valuable sedimentary proteins that was found confirmed the general oligotrophy of the Tyrrhenian Sea, and exerted a limiting influence on the abundance and biomass of the assemblages. In this scenario, the rather refractory sedimentary carbohydrates became a food source for metazoans, which increased their abundance and biomass at the stations where the hydrolytic-enzyme-mediated turnover of carbohydrates was faster, highlighting high lability.	[Harriague, Anabella Covazzi; Bavestrello, Giorgio; Bo, Marzia; Castellano, Michela; Majorana, Margherita; Massa, Francesco; Montella, Alessandro; Povero, Paolo; Misic, Cristina] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita DiSTAV, I-16126 Genoa, Italy; [Borghini, Mireno] CNR, Inst Marine Sci, CNR ISMAR, Sect La Spezia, Pozzuolo Di Lerici, Italy	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Harriague, AC (corresponding author), Univ Genoa, Dipartimento Sci Terra Ambiente & Vita DiSTAV, I-16126 Genoa, Italy.	anabella7@hotmail.com	CNR, Ismar/P-1247-2014	CNR, Ismar/0000-0001-5351-1486; Castellano, Michela/0000-0001-6101-0112; COVAZZI HARRIAGUE, Sandra Anabella/0000-0003-0378-5395; MISIC, CRISTINA/0000-0002-2577-1800; Bo, Marzia/0000-0001-8400-6722; Massa, Francesco/0000-0001-9632-4939	Italian Ministry of Research and Instruction	Italian Ministry of Research and Instruction	This work was undertaken within the PRIN (Progetti di Rilevante Interesse Nazionale) project "Tyrrhenian Seamount Ecosystems: An Integrated Study (TySEc)'', financed by the Italian Ministry of Research and Instruction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTALE V, 1994, J GEOPHYS RES-OCEANS, V99, P14127, DOI 10.1029/94JC00284; Bhaskar PV, 2008, ESTUAR COAST SHELF S, V80, P413, DOI 10.1016/j.ecss.2008.09.005; Bianchi A, 2002, OCEANOL ACTA, V25, P315, DOI 10.1016/S0399-1784(02)01205-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Bongiorni L, 2013, DEEP-SEA RES PT II, V98, P75, DOI 10.1016/j.dsr2.2013.08.006; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; Buchanan J. B., 1971, P30; Caruso G, 2005, MAR FRESHWATER RES, V56, P173, DOI 10.1071/MF04049; Christiansen B, 2009, DEEP-SEA RES PT II, V56, P2579, DOI 10.1016/j.dsr2.2008.12.021; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; Danovaro R, 2010, METHODS STUDY DEEP S, P420; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Danovaro R, 2009, DEEP-SEA RES PT II, V56, P738, DOI 10.1016/j.dsr2.2008.10.011; DOWER J, 1992, DEEP-SEA RES, V39, P1139, DOI 10.1016/0198-0149(92)90061-W; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Fonseca G, 2009, POLAR BIOL, V32, P1345, DOI 10.1007/s00300-009-0631-4; Gad G, 2004, ARCH FISH MAR RES, V51, P43; Galil Bella, 1998, Senckenbergiana Maritima, V28, P111; Galil Bella S., 1994, Senckenbergiana Maritima, V25, P41; George KH, 2004, ORG DIVERS EVOL, V4, P241, DOI 10.1016/j.ode.2004.02.003; Gooday AJ, 2002, J OCEANOGR, V58, P305, DOI 10.1023/A:1015865826379; Hansen H.P., 1983, METHODS SEAWATER ANA, V2nd ed., P347; Harriague AC, 2006, ESTUAR COAST SHELF S, V70, P251, DOI 10.1016/j.ecss.2005.10.017; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Heinz P, 2004, MAR BIOL, V144, P985, DOI 10.1007/s00227-003-1257-7; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Krivosheya V. G., 1983, Oceanology, V23, P166; Leduc D, 2012, DEEP-SEA RES PT I, V63, P164, DOI 10.1016/j.dsr.2011.10.009; MARSH JB, 1966, J LIPID RES, V7, P574; Misic C, 2012, DEEP-SEA RES PT I, V67, P1, DOI 10.1016/j.dsr.2012.04.012; Moen J, 1984, SR75; Mudryk ZJ, 2004, ESTUAR COAST SHELF S, V59, P59, DOI 10.1016/j.ecss.2003.08.001; Nair R, 1994, P 10 S IT ASS LIMN O, P65; Piepenburg D, 2004, ARCH FISH MAR RES, V51, P55; Psarra S, 2000, PROG OCEANOGR, V46, P187, DOI 10.1016/S0079-6611(00)00018-5; Pusceddu A, 2010, DEEP-SEA RES PT I, V57, P441, DOI 10.1016/j.dsr.2009.11.008; Pusceddu A, 2009, DEEP-SEA RES PT II, V56, P755, DOI 10.1016/j.dsr2.2008.10.012; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Rossi S, 2003, ESTUAR COAST SHELF S, V58, P423, DOI 10.1016/S0272-7714(03)00108-2; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; Sinsabaugh RL, 1997, LIMNOL OCEANOGR, V42, P29, DOI 10.4319/lo.1997.42.1.0029; Speicher EA, 2006, DEEP-SEA RES PT I, V53, P1810, DOI 10.1016/j.dsr.2006.08.005; Tamburini C, 2002, DEEP-SEA RES PT II, V49, P2109, DOI 10.1016/S0967-0645(02)00030-9; Tselepides A, 2000, PROG OCEANOGR, V46, P401, DOI 10.1016/S0079-6611(00)00027-6; Vakondios N, 2014, WATER RES, V63, P62, DOI 10.1016/j.watres.2014.06.011; Vetrano A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005680; Wezel F.C., 1985, GEOLOGICAL EVOLUTION, P153; Wit R De, 1998, 3 MTP 2 WORKSH VAR M, P207; Zeppilli D, 2013, DEEP-SEA RES PT II, V98, P87, DOI 10.1016/j.dsr2.2013.08.009; ZOBRIST EC, 1992, MAR ECOL PROG SER, V88, P1, DOI 10.3354/meps088001	56	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110880	10.1371/journal.pone.0110880	http://dx.doi.org/10.1371/journal.pone.0110880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343621	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500061
J	Jackson, SR; Berrien-Elliott, M; Yuan, JY; Hsueh, EC; Teague, RM				Jackson, Stephanie R.; Berrien-Elliott, Melissa; Yuan, Jinyun; Hsueh, Eddy C.; Teague, Ryan M.			Neuropilin-1 Expression Is Induced on Tolerant Self-Reactive CD8(+) T Cells but Is Dispensable for the Tolerant Phenotype	PLOS ONE			English	Article							REGULATORY T; MEMBRANE-PROTEIN; DENDRITIC CELLS; RECEPTOR; PD-1; IMMUNOTHERAPY; VEGF; COMBINATION; DISRUPTION; INITIATION	Establishing peripheral CD8(+) T cell tolerance is vital to avoid immune mediated destruction of healthy self-tissues. However, it also poses a major impediment to tumor immunity since tumors are derived from self-tissue and often induce T cell tolerance and dysfunction. Thus, understanding the mechanisms that regulate T cell tolerance versus immunity has important implications for human health. Signals received from the tissue environment largely dictate whether responding T cells become activated or tolerant. For example, induced expression and subsequent ligation of negative regulatory receptors on the surface of self-reactive CD8(+) T cells are integral in the induction of tolerance. We utilized a murine model of T cell tolerance to more completely define the molecules involved in this process. We discovered that, in addition to other known regulatory receptors, tolerant self-reactive CD8(+) T cells distinctly expressed the surface receptor neuropilin-1 (Nrp1). Nrp1 was highly induced in response to self-antigen, but only modestly when the same antigen was encountered under immune conditions, suggesting a possible mechanistic link to T cell tolerance. We also observed a similar Nrp1 expression profile on human tumor infiltrating CD4(+) and CD8(+) T cells. Despite high expression on tolerant CD8(+) T cells, our studies revealed that Nrp1 had no detectable role in the tolerant phenotype. Specifically, Nrp1-deficient T cells displayed the same functional defects as wild-type self-reactive T cells, lacking in vivo cytolytic potential, IFN gamma production, and antitumor responses. While reporting mostly negative data, our findings have therapeutic implications, as Nrp1 is now being targeted for human cancer therapy in clinical trials, but the precise molecular pathways and immune cells being engaged during treatment remain incompletely defined.	[Jackson, Stephanie R.; Berrien-Elliott, Melissa; Yuan, Jinyun; Teague, Ryan M.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Hsueh, Eddy C.] St Louis Univ, Sch Med, Dept Surg, St Louis, MO 63103 USA; [Hsueh, Eddy C.; Teague, Ryan M.] St Louis Univ, Ctr Canc, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; Saint Louis University	Teague, RM (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	rteague@slu.edu		Teague, Ryan/0000-0002-8426-2870; Jackson Cullison, Stephanie/0000-0002-5833-122X; Berrien-Elliott, Melissa/0000-0002-7319-9159	National Institute of Allergy and Infectious Disease/National Institutes of Health [R01AI087764]; Cancer Research Institute Investigator Award; National Cancer Institute/National Institutes of Health fellowship [F30CA180375]; NATIONAL CANCER INSTITUTE [F30CA180375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087764] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research Institute Investigator Award; National Cancer Institute/National Institutes of Health fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Disease/National Institutes of Health (R01AI087764) to RMT, by a Cancer Research Institute Investigator Award to RMT, and by a National Cancer Institute/National Institutes of Health fellowship (F30CA180375) to SRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia A, 2008, IMMUNOLOGY, V123, P129, DOI 10.1111/j.1365-2567.2007.02737.x; Battaglia A, 2009, CANCER IMMUNOL IMMUN, V58, P1363, DOI 10.1007/s00262-008-0646-7; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Berrien-Elliott MM, 2013, CANCER RES, V73, P605, DOI 10.1158/0008-5472.CAN-12-2179; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Bottcher JP, 2013, CELL REP, V3, P779, DOI 10.1016/j.celrep.2013.02.008; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Carrer A, 2012, CANCER RES, V72, P6371, DOI 10.1158/0008-5472.CAN-12-0762; Catalano A, 2010, J IMMUNOL, V185, P6373, DOI 10.4049/jimmunol.0903527; Chaudhary B, 2014, CANCER IMMUNOL IMMUN, V63, P81, DOI 10.1007/s00262-013-1500-0; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Fuh G, 2000, J BIOL CHEM, V275, P26690; Fujisawa H, 1995, DEV NEUROSCI-BASEL, V17, P343, DOI 10.1159/000111304; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Jackson SR, 2014, IMMUNOTHERAPY; Jackson SR, 2014, J LEUKOC BIOL; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ohlen C, 2001, J IMMUNOL, V166, P2863, DOI 10.4049/jimmunol.166.4.2863; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Patnaik A, 2014, CANCER CHEMOTH PHARM, V73, P951, DOI 10.1007/s00280-014-2426-8; Piechnik A, 2013, INT J CANCER, V133, P1489, DOI 10.1002/ijc.28135; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Solomon BD, 2011, P NATL ACAD SCI USA, V108, P2040, DOI 10.1073/pnas.1008721108; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Weekes CD, 2014, INVEST NEW DRUGS; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	45	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110707	10.1371/journal.pone.0110707	http://dx.doi.org/10.1371/journal.pone.0110707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343644	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943500049
J	Vivot, K; Langlois, A; Bietiger, W; Dal, S; Seyfritz, E; Pinget, M; Jeandidier, N; Maillard, E; Gies, JP; Sigrist, S				Vivot, Kevin; Langlois, Allan; Bietiger, William; Dal, Stephanie; Seyfritz, Elodie; Pinget, Michel; Jeandidier, Nathalie; Maillard, Elisa; Gies, Jean-Pierre; Sigrist, Severine			Pro-Inflammatory and Pro-Oxidant Status of Pancreatic Islet In Vitro Is Controlled by TLR-4 and HO-1 Pathways	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; EARLY GRAFT FAILURE; GENE-EXPRESSION; CARBON-MONOXIDE; TRANSPLANTED ISLETS; SIGNALING PATHWAYS; ALLOGENEIC ISLETS; CELL-DEATH; LANGERHANS; RAT	Since their isolation until implantation, pancreatic islets suffer a major stress leading to the activation of inflammatory reactions. The maintenance of controlled inflammation is essential to preserve survival and function of the graft. Identification and targeting of pathway(s) implicated in post-transplant detrimental inflammatory events, is mandatory to improve islet transplantation success. We sought to characterize the expression of the pro-inflammatory and pro-oxidant mediators during islet culture with a focus on Heme oxygenase (HO-1) and Toll-like receptors-4 signaling pathways. Rat pancreatic islets were isolated and pro-inflammatory and pro-oxidant status were evaluated after 0, 12, 24 and 48 hours of culture through TLR-4, HO-1 and cyclooxygenase-2 (COX-2) expression, CCL-2 and IL-6 secretion, ROS (Reactive Oxygen Species) production (Dihydroethidine staining, DHE) and macrophages migration. To identify the therapeutic target, TLR4 inhibition (CLI-095) and HO-1 activation (cobalt protoporphyrin, CoPP) was performed. Activation of NFkB signaling pathway was also investigated. After isolation and during culture, pancreatic islet exhibited a proinflammatory and prooxidant status (increase levels of TLR-4, COX-2, CCL-2, IL-6, and ROS). Activation of HO-1 or inhibition of TLR-4 decreased inflammatory status and oxidative stress of islets. Moreover, the overexpression of HO-1 induced NF kappa B phosphorylation while the inhibition of TLR-4 had no effect NF kappa B activation. Finally, inhibition of pro-inflammatory pathway induced a reduction of macrophages migration. These data demonstrated that the TLR-4 signaling pathway is implicated in early inflammatory events leading to a pro-inflammatory and pro-oxidant status of islets in vitro. Moreover, these results provide the mechanism whereby the benefits of HO-1 target in TLR-4 signaling pathway. HO-1 could be then an interesting target to protect islets before transplantation.	[Vivot, Kevin; Langlois, Allan; Bietiger, William; Dal, Stephanie; Seyfritz, Elodie; Pinget, Michel; Jeandidier, Nathalie; Maillard, Elisa; Sigrist, Severine] Univ Strasbourg, Ctr Europeen Etude Diabete, DIATHEC, EA 7294, Strasbourg, France; [Pinget, Michel; Jeandidier, Nathalie] HUS, Pole NUDE, Strasbourg, France; Univ Strasbourg, Fac Pharm, CNRS, UMR 7034, Illkirch Graffenstaden, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sigrist, S (corresponding author), Univ Strasbourg, Ctr Europeen Etude Diabete, DIATHEC, EA 7294, Strasbourg, France.	s.sigrist@ceed-diabete.org	Vivot, Kevin/P-8329-2016	Vivot, Kevin/0000-0003-4617-0016	ASDIA (Assistance Service DIAbete); REUNICA Group; foundation "Vaincre le Diabete"	ASDIA (Assistance Service DIAbete); REUNICA Group; foundation "Vaincre le Diabete"	This work was supported by ASDIA (Assistance Service DIAbete), the REUNICA Group and the foundation "Vaincre le Diabete". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2008, TRANSPLANTATION, V86, P1, DOI 10.1097/TP.0b013e31817c11e6; Arita S, 2002, TRANSPLANTATION, V73, P7, DOI 10.1097/00007890-200201150-00003; Armann B, 2007, AM J TRANSPLANT, V7, P38, DOI 10.1111/j.1600-6143.2006.01577.x; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316; BURKART V, 1993, CLIN EXP IMMUNOL, V93, P273; Chen X, 2010, J SURG RES, V164, P336, DOI 10.1016/j.jss.2009.08.016; Cowley MJ, 2012, CELL TRANSPLANT, V21, P2063, DOI 10.3727/096368911X627372; Dal-Ros S, 2010, GASTROENTEROLOGY, V138, P1574, DOI 10.1053/j.gastro.2009.10.040; Danner S, 2008, TRANSPL P, V40, P470, DOI 10.1016/j.transproceed.2008.01.002; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Forman K, 2011, J GERONTOL A-BIOL, V66, P823, DOI 10.1093/gerona/glr083; Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; Gysemans C, 2003, DIABETOLOGIA, V46, P1115, DOI 10.1007/s00125-003-1154-0; HAKIM J, 1993, CR SOC BIOL, V187, P286; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; Hildebrand D, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-22; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Itoh T, 2011, ISLETS, V3, P376, DOI 10.4161/isl.3.6.18159; Johansson U, 2003, BIOCHEM BIOPH RES CO, V308, P474, DOI 10.1016/S0006-291X(03)01392-5; Juang JH, 2010, TRANSPL P, V42, P4221, DOI 10.1016/j.transproceed.2010.09.086; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kruger B, 2010, EUR J IMMUNOL, V40, P2914, DOI 10.1002/eji.201040601; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; McCall M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007823; Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639; Moberg L, 2005, CLIN EXP IMMUNOL, V142, P125, DOI 10.1111/j.1365-2249.2005.02883.x; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393; Pepper Andrew R, 2013, World J Transplant, V3, P48, DOI 10.5500/wjt.v3.i4.48; Persaud SJ, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.2007.S190; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Remy S, 2009, J IMMUNOL, V182, P1877, DOI 10.4049/jimmunol.0802436; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Ryan EA, 2006, DIABETES OBES METAB, V8, P1, DOI 10.1111/j.1463-1326.2004.00460.x; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Ryan EA, 2001, J INVEST MED, V49, P559, DOI 10.2310/6650.2001.33719; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; SEIBERT K, 1994, RECEPTOR, V4, P17; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Shapiro AMJ, 2008, NAT CLIN PRACT NEPHR, V4, P662, DOI 10.1038/ncpneph0964; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shen XD, 2005, AM J TRANSPLANT, V5, P1793, DOI 10.1111/j.1600-6143.2005.00932.x; Sigrist S, 2005, TRANSPL P, V37, P3516, DOI 10.1016/j.transproceed.2005.09.048; Sigrist S, 2004, IMMUNOLOGY, V111, P416, DOI 10.1111/j.1365-2567.2004.01828.x; Sklavos MM, 2010, DIABETES, V59, P1731, DOI 10.2337/db09-0588; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Vivot K, 2011, TRANSPL P, V43, P3201, DOI 10.1016/j.transproceed.2011.09.096; Wang HJ, 2006, ENDOCRINOLOGY, V147, P762, DOI 10.1210/en.2005-0632; Wang HJ, 2005, DIABETES, V54, P1400, DOI 10.2337/diabetes.54.5.1400; Wang HJ, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/141898; WELSH N, 1995, MOL MED, V1, P806, DOI 10.1007/BF03401895; Wen L, 2004, J IMMUNOL, V172, P3173, DOI 10.4049/jimmunol.172.5.3173; XENOS ES, 1994, TRANSPLANTATION, V57, P1208, DOI 10.1097/00007890-199404270-00012; Ye J, 1998, ENDOCRINOLOGY, V139, P4155, DOI 10.1210/en.139.10.4155; Yin D, 2006, AM J TRANSPLANT, V6, P60, DOI 10.1111/j.1600-6143.2005.01157.x; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang YC, 2003, DIABETES, V52, P708, DOI 10.2337/diabetes.52.3.708; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	74	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e107656	10.1371/journal.pone.0107656	http://dx.doi.org/10.1371/journal.pone.0107656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343247	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500002
J	Baier, PC; Brzozka, MM; Shahmoradi, A; Reinecke, L; Kroos, C; Wichert, SP; Oster, H; Wehr, MC; Taneja, R; Hirrlinger, J; Rossner, MJ				Baier, Paul C.; Brzozka, Magdalena M.; Shahmoradi, Ali; Reinecke, Lisa; Kroos, Christina; Wichert, Sven P.; Oster, Henrik; Wehr, Michael C.; Taneja, Reshma; Hirrlinger, Johannes; Rossner, Moritz J.			Mice Lacking the Circadian Modulators SHARP1 and SHARP2 Display Altered Sleep and Mixed State Endophenotypes of Psychiatric Disorders	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; BIPOLAR-I DISORDER; PREPULSE INHIBITION; FUNCTIONAL-ANALYSIS; STRAIN DIFFERENCES; GENE-EXPRESSION; MOOD DISORDERS; PHASE SYNDROME; ANIMAL-MODELS; CLOCK GENES	Increasing evidence suggests that clock genes may be implicated in a spectrum of psychiatric diseases, including sleep and mood related disorders as well as schizophrenia. The bHLH transcription factors SHARP1/DEC2/BHLHE41 and SHARP2/DEC1/ BHLHE40 are modulators of the circadian system and SHARP1/DEC2/BHLHE40 has been shown to regulate homeostatic sleep drive in humans. In this study, we characterized Sharp1 and Sharp2 double mutant mice (S1/2(-/-)) using online EEG recordings in living animals, behavioral assays and global gene expression profiling. EEG recordings revealed attenuated sleep/wake amplitudes and alterations of theta oscillations. Increased sleep in the dark phase is paralleled by reduced voluntary activity and cortical gene expression signatures reveal associations with psychiatric diseases. S1/2(-/-) mice display alterations in novelty induced activity, anxiety and curiosity. Moreover, mutant mice exhibit impaired working memory and deficits in prepulse inhibition resembling symptoms of psychiatric diseases. Network modeling indicates a connection between neural plasticity and clock genes, particularly for SHARP1 and PER1. Our findings support the hypothesis that abnormal sleep and certain (endo) phenotypes of psychiatric diseases may be caused by common mechanisms involving components of the molecular clock including SHARP1 and SHARP2.	[Baier, Paul C.] Univ Kiel, Dept Neurol, Kiel, Germany; [Baier, Paul C.] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Brzozka, Magdalena M.; Wichert, Sven P.; Wehr, Michael C.; Rossner, Moritz J.] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Shahmoradi, Ali; Reinecke, Lisa; Kroos, Christina; Hirrlinger, Johannes; Rossner, Moritz J.] Max Planck Inst Expt Med, Res Grp Gene Express, D-37075 Gottingen, Germany; [Oster, Henrik] Max Planck Inst Biophys Chem, Circadian Rhythms Grp, D-37077 Gottingen, Germany; [Oster, Henrik] Med Univ Lubeck, Dept Med 1, D-23538 Lubeck, Germany; [Taneja, Reshma] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Hirrlinger, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany	University of Kiel; University of Gottingen; University of Munich; Max Planck Society; Max Planck Society; University of Lubeck; National University of Singapore; Leipzig University	Rossner, MJ (corresponding author), Univ Munich, Dept Psychiat, D-80539 Munich, Germany.	Moritz.Rossner@med.uni-muenchen.de	Brzózka, Magdalena Marta/ABH-2260-2021; Hirrlinger, Johannes/F-5984-2010; Wehr, Michael/J-7989-2019; Taneja, Reshma/F-9658-2014	Wehr, Michael/0000-0003-1770-8323; Taneja, Reshma/0000-0002-2151-2094; Reshma, Taneja/0000-0001-6214-6177; Brzozka, Magdalena M./0000-0001-8633-2855	Deutsche Forschungsgemeinschaft (CMPB); Klinische Forschergruppe [(KFO: RO 4076/1-1) 241]	Deutsche Forschungsgemeinschaft (CMPB)(German Research Foundation (DFG)); Klinische Forschergruppe	H. Oster is a Lichtenberg Fellow of the Volkswagen Foundation. This work was supported by the Deutsche Forschungsgemeinschaft (CMPB and grant Klinische Forschergruppe (KFO: RO 4076/1-1) 241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Badcock JC, 2005, CORTEX, V41, P753, DOI 10.1016/S0010-9452(08)70294-6; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Barnett JH, 2009, NEUROSCIENCE, V164, P331, DOI 10.1016/j.neuroscience.2009.03.080; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Benedetti F, 2011, NEUROPSYCHOBIOLOGY, V64, P141, DOI 10.1159/000328947; Bilkei-Gorzo A, 2004, PSYCHOPHARMACOLOGY, V176, P343, DOI 10.1007/s00213-004-1904-9; Bilkei-Gorzo A, 2010, BRIT J PHARMACOL, V160, P1443, DOI 10.1111/j.1476-5381.2010.00757.x; Bode B, 2011, J BIOL RHYTHM, V26, P530, DOI 10.1177/0748730411419782; Bode B, 2011, CHRONOBIOL INT, V28, P737, DOI 10.3109/07420528.2011.607374; Bodenmann S, 2012, BRIT J PHARMACOL, V165, P1904, DOI 10.1111/j.1476-5381.2011.01689.x; Boison D, 2012, NEUROPHARMACOLOGY, V62, P1527, DOI 10.1016/j.neuropharm.2011.01.048; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brzozka MM, 2013, BEHAV BRAIN RES, V237, P348, DOI 10.1016/j.bbr.2012.10.001; Brzozka MM, 2010, BIOL PSYCHIAT, V68, P33, DOI 10.1016/j.biopsych.2010.03.015; Casamassima F, 2010, AM J MED GENET B, V153B, P1373, DOI 10.1002/ajmg.b.31122; Castner SA, 2004, PSYCHOPHARMACOLOGY, V174, P111, DOI 10.1007/s00213-003-1710-9; Chen JF, 2000, NEUROSCIENCE, V97, P195, DOI 10.1016/S0306-4522(99)00604-1; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Colgin LL, 2011, CURR OPIN NEUROBIOL, V21, P467, DOI 10.1016/j.conb.2011.04.006; Coogan AN, 2011, WORLD J BIOL PSYCHIA, V12, P40, DOI 10.3109/15622975.2011.598389; Dao DT, 2010, BIOL PSYCHIAT, V68, P801, DOI 10.1016/j.biopsych.2010.06.019; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Duncan GE, 2006, PSYCHOPHARMACOLOGY, V184, P190, DOI 10.1007/s00213-005-0214-1; Dzirasa K, 2011, J NEUROSCI, V31, P6449, DOI 10.1523/JNEUROSCI.6144-10.2011; Einat H, 2007, NEUROSCI BIOBEHAV R, V31, P850, DOI 10.1016/j.neubiorev.2006.12.001; Fledrich R, 2012, BRAIN, V135, P72, DOI 10.1093/brain/awr322; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Franken P, 2000, J NEUROSCI, V20, P617, DOI 10.1523/JNEUROSCI.20-02-00617.2000; Glahn DC, 2006, BIPOLAR DISORD, V8, P117, DOI 10.1111/j.1399-5618.2006.00296.x; Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Leussis MP, 2013, BIOL PSYCHIAT, V73, P683, DOI 10.1016/j.biopsych.2012.10.016; Mabrouk OS, 2011, J NEUROCHEM, V118, P24, DOI 10.1111/j.1471-4159.2011.07293.x; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; McOmish CE, 2008, MOL PSYCHIATR, V13, P661, DOI 10.1038/sj.mp.4002046; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Naylor E, 2000, J NEUROSCI, V20, P8138; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nicholas B, 2007, MOL PSYCHIATR, V12, P581, DOI 10.1038/sj.mp.4001953; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Nievergelt CM, 2005, PSYCHIAT GENET, V15, P45, DOI 10.1097/00041444-200503000-00008; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Nikonova EV, 2010, SLEEP, V33, P889, DOI 10.1093/sleep/33.7.889; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Porcelli S, 2012, EUR NEUROPSYCHOPHARM, V22, P165, DOI 10.1016/j.euroneuro.2011.08.005; Postuma RB, 2012, NEUROBIOL DIS, V46, P553, DOI 10.1016/j.nbd.2011.10.003; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Scharf MT, 2008, PROG NEUROBIOL, V86, P264, DOI 10.1016/j.pneurobio.2008.08.003; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Swerdlow NR, 2005, PHARMACOL BIOCHEM BE, V80, P203, DOI 10.1016/j.pbb.2004.11.002; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; TRULLAS R, 1993, PSYCHOPHARMACOLOGY, V111, P323, DOI 10.1007/BF02244948; Vollenweider FX, 2006, BIOL PSYCHIAT, V60, P597, DOI 10.1016/j.biopsych.2006.03.058; Weber M, 2008, BEHAV PHARMACOL, V19, P786, DOI 10.1097/FBP.0b013e32831c3b2b; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Wu JC, 2009, BIOL PSYCHIAT, V66, P298, DOI 10.1016/j.biopsych.2009.02.018; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Young JW, 2010, PHARMACOL BIOCHEM BE, V96, P7, DOI 10.1016/j.pbb.2010.03.014; Zhu B, 2012, NEUROBIOL DIS, V48, P348, DOI 10.1016/j.nbd.2012.06.022; Zou YF, 2012, J AFFECT DISORDERS, V136, P229, DOI 10.1016/j.jad.2010.11.012	88	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110310	10.1371/journal.pone.0110310	http://dx.doi.org/10.1371/journal.pone.0110310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340473	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800029
J	Cai, QZ; Zhao, A; Yin, YT; Ma, LS; Jiao, ZZ; Zhi, HL; Lai, SH; Cheng, S; Yang, HM; Lu, YX; Siminovitch, KA; Gao, JM				Cai, Qinzhen; Zhao, Ai; Yin, Yuting; Ma, Lisha; Jiao, Zhenzhen; Zhi, Huilin; Lai, Shouhua; Cheng, Sha; Yang, Hongmei; Lu, Yinxiang; Siminovitch, Katherine A.; Gao, Jimin			Efficient Production of sTNFRII-gAD Fusion Protein in Large Quantity by Use of the Modified CHO-S Cell Expression System	PLOS ONE			English	Article							HAMSTER OVARY CELLS; LOW CULTURE TEMPERATURE; BATCH CULTURES; RECEPTORS; AGENTS; METABOLISM; ADIPOSE; GAMMA	TNF alpha is one of the initial and important mediators to activate downstream signaling pathways by binding to trimerized TNF alpha receptors (TNFR), and thus is an ideal drug target for cancer therapy. Taking advantage of intrinsic homotimerization of the globular domain of adiponectin (gAD), we have developed a novel TNF alpha antagonist, the trimerized fusion protein named sTNFRII-gAD. However, our previously-used CHO expression system yielded less than 10 mg/L of sTNFRII-gAD. To produce large quantities of sTNFRII-gAD efficiently, we used a modified CHO-S cell expression system, which is based on a pMH3 vector with non-coding GC-rich DNA fragments for high-level gene expression. We obtained stable clones that produced 75 mg/L of sTNFRII-gAD in the 96-well plate, adapted the clones to 40 ml suspension serum-free batch culture, then optimized the culturing conditions to scale up the fed-batch culture in a 3 L shake-flask and finally in a 5 L AP30 bioreactor. We achieved a final yield of 52 mg/L of sTNFRII-gAD. The trimerized sTNFRII-gAD exhibited the higher affinity to TNF alpha with a dissociation constant (Kd) of 5.63 nM than the dimerized sTNFRII-Fc with a Kd of 13.4 nM, and further displayed the higher TNF alpha-neutralizing activity than sTNFRII-Fc (p<0.05) in a L929 cytotoxicity assay. Therefore, the strategy employed in this study may provide an efficient avenue for large-scale production of other recombinant proteins by use of the modified CHO-S cell expression system.	[Cai, Qinzhen; Zhao, Ai; Yin, Yuting; Ma, Lisha; Jiao, Zhenzhen; Zhi, Huilin; Lai, Shouhua; Cheng, Sha; Yang, Hongmei; Lu, Yinxiang; Gao, Jimin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China; [Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Immunol, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Mol Genet, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Toronto Gen Res Inst, Toronto, ON, Canada	Wenzhou Medical University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Lu, YX (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China.	18905856000@189.com; ksimin@mshri.on.ca; jimingao@yahoo.com	Siminovitch, Katherine/K-1475-2013		National Major Specific Project for Innovation of New Pharmaceuticals [2009ZX09103-649]; Chinese National 863 plan [2012AA02A407]; Scientific Research Fund of Ministry of Public Health [201231029]; Zhejiang Provincial Major Research Program [2010C13007]; Key Science and Technology Innovation Team of Zhejiang Province; Natural Science Foundation of Zhejiang Province [Y2110580, LY12C07001, LY13H100003, LZ14H260001]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Science & Technology Innovation Program for College/University Students in Zhejiang Province [2012R413039, 2012R413041]; Wenzhou Municipal Research Program [Y20100183, Y20100274]	National Major Specific Project for Innovation of New Pharmaceuticals; Chinese National 863 plan; Scientific Research Fund of Ministry of Public Health; Zhejiang Provincial Major Research Program; Key Science and Technology Innovation Team of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Science & Technology Innovation Program for College/University Students in Zhejiang Province; Wenzhou Municipal Research Program	The authors would like to thank Dr. Mizhou Hui at AmProtein China, Hangzhou for his technical support. This work was sponsored partly by National Major Specific Project for Innovation of New Pharmaceuticals (2009ZX09103-649), Chinese National 863 plan (2012AA02A407), The Scientific Research Fund of Ministry of Public Health (201231029), Zhejiang Provincial Major Research Program (2010C13007), Key Science and Technology Innovation Team of Zhejiang Province, the Natural Science Foundation of Zhejiang Province (Y2110580, LY12C07001, LY13H100003, LZ14H260001), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents, Science & Technology Innovation Program for College/University Students in Zhejiang Province (2012R413039, 2012R413041), and Wenzhou Municipal Research Program (Y20100183, Y20100274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2007, EPIGENETICS-US, V2, P227, DOI 10.4161/epi.2.4.5231; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Chen Suyun, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P207; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Fernandez-Botran R, 2000, EXPERT OPIN INV DRUG, V9, P497, DOI 10.1517/13543784.9.3.497; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Furukawa K, 1999, CYTOTECHNOLOGY, V31, P85, DOI 10.1023/A:1008059803038; Gambhir A, 1999, J BIOSCI BIOENG, V87, P805, DOI 10.1016/S1389-1723(99)80157-1; Heiker JT, 2010, BIOL CHEM, V391, P1005, DOI 10.1515/BC.2010.104; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Huang SS, 2013, ACTA CARDIOL SIN, V29, P115; Jia Q, 2010, SCI CHINA LIFE SCI, V53, P94, DOI 10.1007/s11427-010-0003-x; Kim NS, 1998, BIOTECHNOL BIOENG, V60, P679, DOI 10.1002/(SICI)1097-0290(19981220)60:6<679::AID-BIT5>3.0.CO;2-Q; Lai TF, 2013, PHARMACEUTICALS, V6, P579, DOI 10.3390/ph6050579; Landry Y, 2008, FUND CLIN PHARMACOL, V22, P1, DOI 10.1111/j.1472-8206.2007.00548.x; Li F, 2006, BIOTECHNOL PROGR, V22, P696, DOI 10.1021/bp0504041; Luo MS, 2012, INT IMMUNOPHARMACOL, V13, P88, DOI 10.1016/j.intimp.2012.03.013; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maranga L, 2006, BIOTECHNOL BIOENG, V94, P139, DOI 10.1002/bit.20890; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Moore A, 1997, CYTOTECHNOLOGY, V23, P47, DOI 10.1023/A:1007919921991; REUVENY S, 1993, APPL MICROBIOL BIOT, V38, P619, DOI 10.1007/BF00182800; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Toussirot E, 2004, EXPERT OPIN PHARMACO, V5, P581, DOI 10.1517/14656566.5.3.581; Wlaschin KF, 2006, ADV BIOCHEM ENG BIOT, V101, P43, DOI 10.1007/10_015; Xie LZ, 1996, BIOTECHNOL BIOENG, V51, P725, DOI 10.1002/(SICI)1097-0290(19960920)51:6<725::AID-BIT12>3.0.CO;2-C; Yoon SK, 2004, BIOTECHNOL PROGR, V20, P1683, DOI 10.1021/bp049847f; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566	29	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111229	10.1371/journal.pone.0111229	http://dx.doi.org/10.1371/journal.pone.0111229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340707	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800095
J	da Silva, MDS; Paula, TD; Moreira, BC; Carolino, M; Cruz, C; Bazzolli, DMS; Silva, CC; Kasuya, MCM				Soares da Silva, Marliane de Cassia; Paula, Thiago de Almeida; Moreira, Bruno Coutinho; Carolino, Manuela; Cruz, Cristina; Bazzolli, Denise Mara Soares; Silva, Cynthia Canedo; Megumi Kasuya, Maria Catarina			Nitrogen-Fixing Bacteria in Eucalyptus globulus Plantations	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; DIAZOTROPHIC BACTERIA; COMMUNITY STRUCTURE; DIVERSITY; SOIL; MICROORGANISMS; BIODIVERSITY; RHIZOSPHERE; WASTELANDS; DGGE	Eucalypt cultivation is an important economic activity worldwide. In Portugal, Eucalyptus globulus plantations account for one-third of the total forested area. The nutritional requirements of this crop have been well studied, and nitrogen (N) is one of the most important elements required for vegetal growth. N dynamics in soils are influenced by microorganisms, such as diazotrophic bacteria (DB) that are responsible for biological nitrogen fixation (BNF), so the aim of this study was to evaluate and identity the main groups of DB in E. globulus plantations. Samples of soil and root systems were collected in winter and summer from three different Portuguese regions (Penafiel, Gaviao and Odemira). We observed that DB communities were affected by season, N fertilization and moisture. Furthermore Bradyrhizobium and Burkholderia were the most prevalent genera in these three regions. This is the first study describing the dynamic of these bacteria in E. globulus plantations, and these data will likely contribute to a better understanding of the nutritional requirements of eucalypt cultivation and associated organic matter turnover.	[Soares da Silva, Marliane de Cassia; Paula, Thiago de Almeida; Moreira, Bruno Coutinho; Bazzolli, Denise Mara Soares; Silva, Cynthia Canedo; Megumi Kasuya, Maria Catarina] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Carolino, Manuela; Cruz, Cristina] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Campo Grande, Portugal	Universidade Federal de Vicosa; Universidade de Lisboa	Kasuya, MCM (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mkasuya@ufv.br	Cruz, Cristina/H-7026-2019; Cruz, Cristina/F-2643-2011; Moreira, Bruno C/H-8516-2018; de Cássia S da Silva, Marliane/G-4068-2012; Kasuya, Maria Catarina Megumi/E-1123-2013; Bazzolli, Denise Mara Soares/AAR-7924-2021; Carolino, Manuela/K-7876-2017	Cruz, Cristina/0000-0003-3100-463X; de Cássia S da Silva, Marliane/0000-0003-4678-7876; Kasuya, Maria Catarina Megumi/0000-0002-9539-9370; Bazzolli, Denise Mara Soares/0000-0002-0371-6966; Moreira, Bruno Coutinho/0000-0002-6290-9282; Carolino, Manuela/0000-0001-8237-6834	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAF, 2010, AN EST ABRAF 2010 AN; [Anonymous], [No title captured]; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Castro-Gonzalez R, 2011, PLANT SOIL, V345, P155, DOI 10.1007/s11104-011-0768-0; Coelho MRR, 2009, APPL SOIL ECOL, V42, P48, DOI 10.1016/j.apsoil.2009.01.010; Coelho MRR, 2008, FEMS MICROBIOL LETT, V279, P15, DOI 10.1111/j.1574-6968.2007.00975.x; Costa R, 2006, SOIL BIOL BIOCHEM, V38, P2434, DOI 10.1016/j.soilbio.2006.03.003; da Silva K, 2012, SYST APPL MICROBIOL, V35, P253, DOI 10.1016/j.syapm.2012.04.001; Direito I. C. N., 2002, Revista Universidade Rural. Serie Ciencias da Vida, V22, P123; DOBEREINER J, 1988, PLANT SOIL, V110, P207, DOI 10.1007/BF02226800; Estrada-De los Santos P, 2001, APPL ENVIRON MICROB, V67, P2790, DOI 10.1128/AEM.67.6.2790-2798.2001; GAMA-RODRIGUES E. F. D., 2005, REV BRAS CIENC SOLO, V29, P893; Gobert A, 2008, MYCORRHIZA, P209, DOI DOI 10.1007/978-3-540-78826-3_11; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Hong YY, 2012, MICROBIOL RES, V167, P596, DOI 10.1016/j.micres.2012.05.003; James EK, 2000, FIELD CROP RES, V65, P197, DOI 10.1016/S0378-4290(99)00087-8; Kahindi JHP, 1997, APPL SOIL ECOL, V6, P55, DOI 10.1016/S0929-1393(96)00151-5; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Kozdroj J, 2000, SOIL BIOL BIOCHEM, V32, P1405, DOI 10.1016/S0038-0717(00)00058-4; Mulvaney R. L., 1996, Methods of soil analysis. Part 3 - chemical methods., P1123; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; OBANDO CASTELLANOS DOLLY MELISSA, 2010, Acta biol.Colomb., V15, P107; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rosado AS, 1998, APPL ENVIRON MICROB, V64, P2770; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Schulte EE, 1987, WINCONSIN PROCEDURES; Silva TF, 2011, REV BRAS CIENC SOLO, V35, P359, DOI 10.1590/S0100-06832011000200007; Smerthurst P, 2004, FOREST ECOL MANAG, V193, P63; Smith H, 1996, FOREST ECOL MANAG, V89, P189, DOI 10.1016/S0378-1127(96)03847-9; UEDA T, 1995, J BACTERIOL, V177, P1414, DOI 10.1128/jb.177.5.1414-1417.1995; Vitousek PM, 2002, AMBIO, V31, P97, DOI 10.1639/0044-7447(2002)031[0097:NAN]2.0.CO;2; Wartiainen I, 2008, APPL SOIL ECOL, V39, P65, DOI 10.1016/j.apsoil.2007.11.008; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zhan J, 2012, MICROBIOL RES, V167, P157, DOI 10.1016/j.micres.2011.05.006; Zhan J, 2011, J ENVIRON SCI-CHINA, V23, P476, DOI 10.1016/S1001-0742(10)60433-0	37	7	7	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111313	10.1371/journal.pone.0111313	http://dx.doi.org/10.1371/journal.pone.0111313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340502	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800102
J	Zeraik, ML; Petronio, MS; Coelho, D; Regasini, LO; Silva, DHS; da Fonseca, LM; Machado, SAS; Bolzani, VS; Ximenes, VF				Zeraik, Maria Luiza; Petronio, Maicon S.; Coelho, Dyovani; Regasini, Luis Octavio; Silva, Dulce H. S.; da Fonseca, Luiz Marcos; Machado, Sergio A. S.; Bolzani, Vanderlan S.; Ximenes, Valdecir F.			Improvement of Pro-Oxidant Capacity of Protocatechuic Acid by Esterification	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; NADPH OXIDASE; GALLIC ACID; HORSERADISH-PEROXIDASE; HYDROXYCINNAMIC ACIDS; PHENOXYL RADICALS; CARCINOMA-CELLS; FATTY-ACID; OXIDATION; CURCUMIN	Pro-oxidant effects of phenolic compounds are usually correlated to the one-electron redox potential of the phenoxyl radicals. Here we demonstrated that, besides their oxidizability, hydrophobicity can also be a decisive factor. We found that esterification of protocatechuic acid (P0) provoked a profound influence in its pro-oxidant capacity. The esters bearing alkyl chains containing two (P2), four (P4) and seven (P7) carbons, but not the acid precursor (P0), were able to exacerbate the oxidation of trolox, alpha-tocopherol and rifampicin. This effect was also dependent on the catechol moiety, since neither gallic acid nor butyl gallate showed any pro-oxidant effects. A comparison was also made with apocynin, which is well-characterized regarding its pro-oxidant properties. P7 was more efficient than apocynin regarding co-oxidation of trolox. However, P7 was not able to co-oxidize glutathione and NADH, which are targets of the apocynin radical. A correlation was found between pro-oxidant capacity and the stability of the radicals, as suggested by the intensity of the peak current in the differential pulse voltammetry experiments. In conclusion, taking into account that hydroquinone and related moieties are frequently found in biomolecules and quinone-based chemotherapeutics, our demonstration that esters of protocatechuic acid are specific and potent co-catalysts in their oxidations may be very relevant as a pathway to exacerbate redox cycling reactions, which are usually involved in their biological and pharmacological mechanisms of action.	[Zeraik, Maria Luiza; Ximenes, Valdecir F.] Sao Paulo State Univ, UNESP, Fac Sci, Dept Chem, Sao Paulo, Brazil; [Zeraik, Maria Luiza; Regasini, Luis Octavio; Silva, Dulce H. S.; Bolzani, Vanderlan S.] Sao Paulo State Univ, UNESP, Nuclei Bioassays Ecophysiol & Biosynth Nat Prod N, Dept Organ Chem,Inst Chem, Sao Paulo, Brazil; [Petronio, Maicon S.; da Fonseca, Luiz Marcos] Sao Paulo State Univ, UNESP, Sch Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil; [Coelho, Dyovani; Machado, Sergio A. S.] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Carlos, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo	Ximenes, VF (corresponding author), Sao Paulo State Univ, UNESP, Fac Sci, Dept Chem, Sao Paulo, Brazil.	vfximenes@fc.unesp.br	Bolzani, Vanderlan S/C-2111-2012; Regasini, Luis O/B-1985-2012; Zeraik, Maria Luiza/I-8072-2014; Silva, Dulce H S/F-2626-2012; Ximenes, Valdecir/A-5323-2008; SILVA, DULCE/AAZ-5978-2020; Petrônio, Maicon Segalla/B-8581-2015; Coelho, Dyovani/G-8293-2016; Machado, Sergio/M-9384-2013; Zeraik, Maria Luiza/AAB-8302-2020; Bolzani, Vanderlan/C-2111-2012	Bolzani, Vanderlan S/0000-0003-0615-8776; Zeraik, Maria Luiza/0000-0002-0559-8502; Silva, Dulce H S/0000-0002-1516-7765; Ximenes, Valdecir/0000-0003-2636-3080; SILVA, DULCE/0000-0002-1516-7765; Coelho, Dyovani/0000-0002-1652-7144; Machado, Sergio/0000-0001-8946-8467; Zeraik, Maria Luiza/0000-0002-0559-8502; Bolzani, Vanderlan/0000-0001-7019-5825	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2013/08784-0, 010/52327-5, 2011/03017-6, 2013/07600-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors gratefully acknowledge financial support from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grants #2013/08784-0, #010/52327-5, #2011/03017-6 and #2013/07600-3; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IK, 2013, J EXP ZOOL PART A, V319A, P328, DOI 10.1002/jez.1797; Cavaliere V, 2014, TARGET ONCOL, V9, P25, DOI 10.1007/s11523-013-0256-y; Chan T, 1999, CHEM-BIOL INTERACT, V122, P15, DOI 10.1016/S0009-2797(99)00103-9; de Faria CMQG, 2012, CURR MED CHEM, V19, P4885; Delicado EN, 1997, BBA-GEN SUBJECTS, V1335, P127, DOI 10.1016/S0304-4165(96)00130-4; dos Santos FJN, 2005, BIOL PHARM BULL, V28, P1822; Du Q, 2013, ONCOL REP, V29, P1851, DOI 10.3892/or.2013.2310; Fan GJ, 2009, CHEM-EUR J, V15, P12889, DOI 10.1002/chem.200901627; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Galato D, 2001, REDOX REP, V6, P243, DOI 10.1179/135100001101536391; Gandhy SU, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-564; Gaspar A, 2009, EUR J MED CHEM, V44, P2092, DOI 10.1016/j.ejmech.2008.10.027; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Gilloteaux J, 2010, ULTRASTRUCT PATHOL, V34, P140, DOI 10.3109/01913121003662304; Castor LRG, 2010, FREE RADICAL BIO MED, V48, P1636, DOI 10.1016/j.freeradbiomed.2010.03.010; Gunckel S, 1998, CHEM-BIOL INTERACT, V114, P45, DOI 10.1016/S0009-2797(98)00041-6; Kagan VE, 2001, CANCER RES, V61, P7777; Kapiotis S, 1997, ARTERIOSCL THROM VAS, V17, P2855, DOI 10.1161/01.ATV.17.11.2855; Lende Amol B., 2011, Inflammopharmacology, V19, P255, DOI 10.1007/s10787-011-0086-4; Ligeret H, 2004, FREE RADICAL BIO MED, V36, P919, DOI 10.1016/j.freeradbiomed.2003.12.018; Locatelli C, 2008, BIOORGAN MED CHEM, V16, P3791, DOI 10.1016/j.bmc.2008.01.049; Martins-Maciel ER, 2013, TOXICOL LETT, V217, P82, DOI 10.1016/j.toxlet.2012.11.021; Martins LAM, 2014, CELL BIOCHEM BIOPHYS, V68, P247, DOI 10.1007/s12013-013-9703-8; Metzler M, 2013, BIOFACTORS, V39, P14, DOI 10.1002/biof.1042; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Park WH, 2013, ONCOL REP, V30, P513, DOI 10.3892/or.2013.2447; Petronio MS, 2013, MOLECULES, V18, P2821, DOI 10.3390/molecules18032821; Porter NA, 2013, J ORG CHEM, V78, P3511, DOI 10.1021/jo4001433; Putchala MC, 2013, ARCH ORAL BIOL, V58, P563, DOI 10.1016/j.archoralbio.2013.01.016; Reis B, 2010, J AGR FOOD CHEM, V58, P6986, DOI 10.1021/jf100569j; Russell LH, 2012, ANTICANCER RES, V32, P1595; Saito S, 2006, HELV CHIM ACTA, V89, P1395, DOI 10.1002/hlca.200690139; Senejoux F, 2013, FUND CLIN PHARMACOL, V27, P262, DOI 10.1111/j.1472-8206.2011.01025.x; Simic A, 2007, MOLECULES, V12, P2327, DOI 10.3390/12102327; Simonyi Agnes, 2012, Front Biosci (Elite Ed), V4, P2183; Sukalovic VHT, 2008, J PLANT RES, V121, P115, DOI 10.1007/s10265-007-0124-x; Tafazoli S, 2005, CHEM RES TOXICOL, V18, P1567, DOI 10.1021/tx0500575; THOMAS MJ, 1989, J AM CHEM SOC, V111, P3315, DOI 10.1021/ja00191a031; Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Ximenes VF, 2007, ARCH BIOCHEM BIOPHYS, V457, P134, DOI 10.1016/j.abb.2006.11.010; Ximenes VF, 2010, J AGR FOOD CHEM, V58, P5355, DOI 10.1021/jf100233y; Ximenes VF, 2009, BBA-GEN SUBJECTS, V1790, P787, DOI 10.1016/j.bbagen.2009.03.021; Zeraik ML, 2012, CURR MED CHEM, V19, P5405, DOI 10.2174/092986712803833344; Zou LN, 2012, ANALYST, V137, P414, DOI 10.1039/c1an15720e	45	26	28	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110277	10.1371/journal.pone.0110277	http://dx.doi.org/10.1371/journal.pone.0110277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340774	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800025
J	Berkut, AA; Peigneur, S; Myshkin, MY; Paramonov, AS; Lyukmanova, EN; Arseniev, AS; Grishin, EV; Tytgat, J; Shenkarev, ZO; Vassilevski, AA				Berkut, Antonina A.; Peigneur, Steve; Myshkin, Mikhail Yu.; Paramonov, Alexander S.; Lyukmanova, Ekaterina N.; Arseniev, Alexander S.; Grishin, Eugene V.; Tytgat, Jan; Shenkarev, Zakhar O.; Vassilevski, Alexander A.			Structure of Membrane-active Toxin from Crab Spider Heriaeus melloteei Suggests Parallel Evolution of Sodium Channel Gating Modifiers in Araneomorphae and Mygalomorphae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Ion Channel; Neurotoxin; Nuclear Magnetic Resonance (NMR); Sodium Channel; Toxin; Channel Activation; Gating Modifiers; Inhibitor Cystine Knot; Spider Toxins	JINGZHAOTOXIN-III BETA-TRTX-CJ1-ALPHA; SCORPION ALPHA-TOXINS; VOLTAGE-SENSOR; HUWENTOXIN-IV; TARANTULA TOXINS; ION-CHANNEL; DOMAIN-II; FUNCTIONAL-CHARACTERIZATION; POTASSIUM CHANNEL; MOLECULAR-BASIS	Background: Several toxins from mygalomorph spiders are known to inhibit sodium channel activation. Results: Hm-3 toxin from the araneomorph spider Heriaeus melloteei inhibits mammalian and insect sodium channel activation and possesses membrane activity. Conclusion: Hm-3 binds to sodium channel voltage sensors through membrane access. Significance: The first sodium channel activation inhibitor from Araneomorphae points to parallel evolution of H. melloteei and its distant mygalomorph relatives. We present a structural and functional study of a sodium channel activation inhibitor from crab spider venom. Hm-3 is an insecticidal peptide toxin consisting of 35 amino acid residues from the spider Heriaeus melloteei (Thomisidae). We produced Hm-3 recombinantly in Escherichia coli and determined its structure by NMR spectroscopy. Typical for spider toxins, Hm-3 was found to adopt the so-called inhibitor cystine knot or knottin fold stabilized by three disulfide bonds. Its molecule is amphiphilic with a hydrophobic ridge on the surface enriched in aromatic residues and surrounded by positive charges. Correspondingly, Hm-3 binds to both neutral and negatively charged lipid vesicles. Electrophysiological studies showed that at a concentration of 1 m Hm-3 effectively inhibited a number of mammalian and insect sodium channels. Importantly, Hm-3 shifted the dependence of channel activation to more positive voltages. Moreover, the inhibition was voltage-dependent, and strong depolarizing prepulses attenuated Hm-3 activity. The toxin is therefore concluded to represent the first sodium channel gating modifier from an araneomorph spider and features a membrane access mechanism of action. Its amino acid sequence and position of the hydrophobic cluster are notably different from other known gating modifiers from spider venom, all of which are described from mygalomorph species. We hypothesize parallel evolution of inhibitor cystine knot toxins from Araneomorphae and Mygalomorphae suborders.	[Berkut, Antonina A.; Myshkin, Mikhail Yu.; Paramonov, Alexander S.; Lyukmanova, Ekaterina N.; Arseniev, Alexander S.; Grishin, Eugene V.; Shenkarev, Zakhar O.; Vassilevski, Alexander A.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Berkut, Antonina A.; Myshkin, Mikhail Yu.; Arseniev, Alexander S.] State Univ, Moscow Inst Phys & Technol, Moscow 117303, Russia; [Peigneur, Steve; Tytgat, Jan] Univ Leuven, B-3000 Leuven, Belgium	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; KU Leuven	Vassilevski, AA (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia.	avas@ibch.ru	Vassilevski, Alexander/S-3824-2016; Shenkarev, Zakhar O./P-1808-2015; Berkut, Antonina/AAE-4247-2019; Lyukmanova, Ekaterina/F-2340-2014	Vassilevski, Alexander/0000-0002-1359-0076; Shenkarev, Zakhar O./0000-0003-1383-3522; Lyukmanova, Ekaterina/0000-0002-9728-9407; Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702	Russian Foundation for Basic Research [12-04-01712]; Molecular and Cell Biology Program of the Russian Academy of Sciences; Russian Federation [1924.2014.4]; Russian Science Foundation [14-14-01180]; Fonds Wetenschappelijk Onderzoek Vlaanderen [G.0433.12, G.A071.10N, G.0257.08]; Inter-University Attraction Poles Program from Belgian State, Belgian Science Policy [IUAP 7/10]; KU Leuven Grant [OT/12/081]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cell Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF)); Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); Inter-University Attraction Poles Program from Belgian State, Belgian Science Policy; KU Leuven Grant	This work was supported in part by Russian Foundation for Basic Research Grant 12-04-01712, the Molecular and Cell Biology Program of the Russian Academy of Sciences, and Grant 1924.2014.4 from the President of Russian Federation.; Supported by Russian Science Foundation Grant 14-14-01180 to perform large scale production of Hm-3 and physiological studies.; Supported by Fonds Wetenschappelijk Onderzoek Vlaanderen Grants G.0433.12, G.A071.10N, and G.0257.08; Inter-University Attraction Poles Program Grant IUAP 7/10 from Belgian State, Belgian Science Policy; and KU Leuven Grant OT/12/081.	Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Billen B, 2008, TOXICON, V52, P309, DOI 10.1016/j.toxicon.2008.05.018; Billen B, 2010, J BIOL CHEM, V285, P18545, DOI 10.1074/jbc.M110.125211; Bladen C, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-36; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2007, TOXICON, V49, P142, DOI 10.1016/j.toxicon.2006.09.023; CATTERALL WA, 1977, J BIOL CHEM, V252, P8660; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Corzo G, 2005, BIOCHEMISTRY-US, V44, P1542, DOI 10.1021/bi048434k; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; de Lima ME, 2002, J INSECT PHYSIOL, V48, P53, DOI 10.1016/S0022-1910(01)00143-3; Delaglio F, 2001, J MAGN RESON, V149, P276, DOI 10.1006/jmre.2001.2297; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Estrada G, 2007, NAT PROD REP, V24, P145, DOI 10.1039/b603083c; French RJ, 2010, MAR DRUGS, V8, P2153, DOI 10.3390/md8072153; GRISHIN EV, 1986, BIOORG KHIM+, V12, P1121; Grishin EV, 1998, TOXICON, V36, P1693, DOI 10.1016/S0041-0101(98)00162-7; Gui JH, 2014, CURR BIOL, V24, P473, DOI 10.1016/j.cub.2014.01.013; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Kuhn-Nentwig L, 2003, CELL MOL LIFE SCI, V60, P2651, DOI 10.1007/s00018-003-3106-8; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Liao Z, 2007, TOXICON, V50, P135, DOI 10.1016/j.toxicon.2007.03.006; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Little MJ, 1998, FEBS LETT, V439, P246, DOI 10.1016/S0014-5793(98)01378-7; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Moran Y, 2009, TOXICON, V54, P1089, DOI 10.1016/j.toxicon.2009.02.028; Nikolsky AS, 2009, BIOCHEM MOSC SUPPL S, V3, P245, DOI 10.1134/S1990747809030027; Escalona MP, 2013, FRONT BIOSCI-LANDMRK, V18, P572, DOI 10.2741/4121; Peigneur S, 2011, BIOCHEM PHARMACOL, V82, P81, DOI 10.1016/j.bcp.2011.03.023; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Redaelli E, 2010, J BIOL CHEM, V285, P4130, DOI 10.1074/jbc.M109.054718; Rong MQ, 2011, FASEB J, V25, P3177, DOI 10.1096/fj.10-178848; Schroeder FC, 2008, P NATL ACAD SCI USA, V105, P14283, DOI 10.1073/pnas.0806840105; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; Silva AO, 2012, BIOCHIMIE, V94, P2756, DOI 10.1016/j.biochi.2012.08.016; SKINNER WS, 1989, J BIOL CHEM, V264, P2150; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Tao H, 2013, BIOCHEMISTRY-US, V52, P7439, DOI 10.1021/bi4006418; Trachsel C, 2012, FEBS J, V279, P2683, DOI 10.1111/j.1742-4658.2012.08650.x; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Xiao YC, 2004, J BIOL CHEM, V279, P26220, DOI 10.1074/jbc.M401387200; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332	57	10	11	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					492	504		10.1074/jbc.M114.595678	http://dx.doi.org/10.1074/jbc.M114.595678			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25352595	hybrid, Green Published			2022-12-26	WOS:000347231200043
J	Alcarraz-Vizan, G; Casini, P; Cadavez, L; Visa, M; Montane, J; Servitja, JM; Novials, A				Alcarraz-Vizan, Gema; Casini, Paola; Cadavez, Lisa; Visa, Montse; Montane, Joel; Servitja, Joan-Marc; Novials, Anna			Inhibition of BACE2 counteracts hIAPP-induced insulin secretory defects in pancreatic beta-cells	FASEB JOURNAL			English	Article						amylin; BACE activity; secretase; type 2 diabetes	ISLET-AMYLOID-POLYPEPTIDE; ENDOPLASMIC-RETICULUM STRESS; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; HUMAN-IAPP; DIABETES-MELLITUS; PATHWAY; PATHOGENESIS; BRAIN; OLIGOMERS	BACE2 (beta-site APP-cleaving enzyme 2) is a protease localized in the brain, where it appears to play a role in the development of Alzheimer disease (AD). It is also found in the pancreas, although its biologic function is not fully known. Amyloidogenic diseases, including AD and type 2 diabetes mellitus (T2D), share the accumulation of abnormally folded and insoluble proteins that interfere with cell function. Islet amyloid polypeptide (IAPP) deposits are a key pathogenic feature of T2D. Within this context, we found by global gene expression profiling that BACE2 was up-regulated in the rat pancreatic beta-cell line INS1E stably transfected with human IAPP gene (hIAPP-INS1E). Glucose-stimulated insulin secretion (GSIS) in hIAPP-INS1E cells was 30% lower than in INS1E cells. Additionally, INS1E cells transfected with a transient overexpression of BACE2 showed a 60% decrease in proliferation, a 3-fold increase in reactive oxygen species production, and a 25% reduction in GSIS compared to control cells. Remarkably, silencing of endogenous BACE2 in hIAPP-INS1E cells resulted in a significant improvement in GSIS (3-fold increase vs. untransfected cells), revealing the significant role of BACE2 expression in beta-cell function. Thus, BACE2 inhibition may be useful to recover insulin secretion in hIAPP-INS1E defective cells and may be proposed as a therapeutic target for T2D.	[Alcarraz-Vizan, Gema; Casini, Paola; Cadavez, Lisa; Visa, Montse; Montane, Joel; Servitja, Joan-Marc; Novials, Anna] Spanish Biomed Res Ctr Diabet & Associated Metab, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Novials, A (corresponding author), IDIBAPS, Diabet & Obes Res Lab, C Rossello 149-153,5th Floor, Barcelona 08036, Spain.	anovials@clinic.ub.es	Visa, Montse/AAQ-8529-2021; Montane, Joel/ABE-6021-2021	Montane, Joel/0000-0001-9531-9580; SERVITJA, JOAN-MARC/0000-0002-1241-8004; Alcarraz-Vizan, Gema/0000-0002-2429-0597; Novials, Anna/0000-0003-0465-2949				Abdul-Hay SO, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-46; Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Altirriba J, 2010, DIABETOLOGIA, V53, P1406, DOI 10.1007/s00125-010-1728-6; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Casas S, 2010, AM J PHYSIOL-ENDOC M, V299, pE1087, DOI 10.1152/ajpendo.00420.2010; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Clark A, 1996, BIOCHEM SOC T, V24, P594, DOI 10.1042/bst0240594; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Gilbert EJ, 2013, EXPERT OPIN THER PAT, V23, P1069, DOI 10.1517/13543776.2013.818134; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Holler CJ, 2012, AM J PATHOL, V180, P337, DOI 10.1016/j.ajpath.2011.09.034; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jonsson A, 2009, DIABETES, V58, P2409, DOI 10.2337/db09-0246; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Lahiri DK, 2006, J MOL NEUROSCI, V29, P65, DOI 10.1385/JMN:29:1:65; Liu X, 2013, EUR J NEUROSCI, V37, P1970, DOI 10.1111/ejn.12204; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Moreno-Asso A, 2013, DIABETOLOGIA, V56, P1761, DOI 10.1007/s00125-013-2930-0; NOVIALS A, 1993, DIABETES, V42, P1514, DOI 10.2337/diabetes.42.10.1514; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Saunders A.J, 1999, SCIENCE, V286, P1255, DOI DOI 10.1126/SCIENCE.286.5443.1255A; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Soty M, 2011, J BIOL CHEM, V286, P40857, DOI 10.1074/jbc.M111.232801; Southan Christopher, 2013, Frontiers in Genetics, V4, P293, DOI 10.3389/fgene.2013.00293; Southan C, 2013, EXPERT OPIN THER PAT, V23, P649, DOI 10.1517/13543776.2013.780032; Stutzer I, 2012, DIABETOLOGIA, V55, P1877, DOI 10.1007/s00125-012-2531-3; Stutzer I, 2013, J BIOL CHEM, V288, P10536, DOI 10.1074/jbc.M112.444703; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Sun XL, 2012, J NEUROCHEM, V120, P62, DOI 10.1111/j.1471-4159.2011.07515.x; Sun XL, 2005, FASEB J, V19, P739, DOI 10.1096/fj.04-3426com; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Westermark Per, 2005, Curr Diab Rep, V5, P184, DOI 10.1007/s11892-005-0007-2; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200	48	14	14	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					95	104		10.1096/fj.14-255489	http://dx.doi.org/10.1096/fj.14-255489			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25342134				2022-12-26	WOS:000347378600010
J	Myeong, J; Kwak, M; Hong, C; Jeon, JH; So, I				Myeong, Jongyun; Kwak, Misun; Hong, Chansik; Jeon, Ju-Hong; So, Insuk			Identification of a Membrane-targeting Domain of the Transient Receptor Potential Canonical (TRPC)4 Channel Unrelated to Its Formation of a Tetrameric Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence Resonance Energy Transfer (FRET); Ion Channel; Membrane Trafficking; Phosphatidylinositol; Transient Receptor Potential Channels (TRP Channels)	SURFACE EXPRESSION; PLASMA-MEMBRANE; ACIDIC SEQUENCE; ENERGY-TRANSFER; PROTEIN; ACTIVATION; TRPC4; SUBUNIT; CALMODULIN; LOCALIZATION	Background: Functional TRPC4/5 channels make tetrameric structures in the plasma membrane. Results: The 21-30 motif of TRPC4/5 regulates the membrane expression of the channels by interacting with PI(4,5)P-2. Conclusion: The 21-30 motif of TRPC4/5 has an essential role in the membrane expression that does not involve the tetrameric structure. Significance: Our findings indicate the membrane expression regulating domain of TRP channels. Canonical transient receptor potential (TRPC) channels are Ca2+-permeable nonselective cation channels that are activated by a wide variety of stimuli, including G protein-coupled receptors (GPCRs). The TRPC4 channel is expressed in a punctate distribution in the membrane. To identify the regulating region of the channel trafficking to the membrane, we generated deletion mutants of the TRPC4 channel. We determined that when either region that was downstream of the 20 amino acids of the N terminus or the 700-730 amino acids was deleted, the mutants were retained in the endoplasmic reticulum. By coexpression of the wild-type TRPC4 with deletion mutants, we found that the 23-29 amino acids of the N terminus regulate a membrane trafficking. Additionally, by the fluorescence resonance energy transfer (FRET) method, we found that the regions downstream of the 99 amino acid region of the N terminus and upstream of the 730 amino acid region in the C terminus produce assembly of the TRPC4 tetramers. We inferred the candidate proteins that regulate or interact with the 23-29 domain of TRPC4.	[Myeong, Jongyun; Kwak, Misun; Hong, Chansik; Jeon, Ju-Hong; So, Insuk] Seoul Natl Univ, Dept Physiol, Coll Med, Seoul 110799, South Korea	Seoul National University (SNU)	So, I (corresponding author), Seoul Natl Univ, Grad Sch, Coll Med, Dept Physiol, Biomed Sci Bldg 101,103 Daehakro, Seoul 110799, South Korea.	insuk@snu.ac.kr		Hong, Chansik/0000-0001-9684-4651; Jeon, Ju-Hong/0000-0002-5603-2955	National Research Foundation of Korea - Ministry of Science, ICT (Information & Communication Technology) and Future Planning (MSIP) of the Korean government [2010-0019472, 2012R1A2A1A01003073]; graduate program of BK21; MSIP	National Research Foundation of Korea - Ministry of Science, ICT (Information & Communication Technology) and Future Planning (MSIP) of the Korean government; graduate program of BK21; MSIP	This study was supported by grants obtained from the National Research Foundation of Korea, which is funded by the Ministry of Science, ICT (Information & Communication Technology) and Future Planning (MSIP) of the Korean government (2010-0019472 and 2012R1A2A1A01003073) (to I. S.).; Supported by the graduate program of BK21 and by grants from the MSIP.	Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; de Groot T, 2011, J BIOL CHEM, V286, P32132, DOI 10.1074/jbc.M111.226878; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; EPE B, 1983, P NATL ACAD SCI-BIOL, V80, P2579, DOI 10.1073/pnas.80.9.2579; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Errasti-Murugarren E, 2010, MOL PHARMACOL, V78, P795, DOI 10.1124/mol.110.065920; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hong C., 2014, PFLUGERS ARCH; Jeon JP, 2012, J BIOL CHEM, V287, P17029, DOI 10.1074/jbc.M111.326553; Jikim M, 2008, BIOCHEM BIOPH RES CO, V365, P239, DOI 10.1016/j.bbrc.2007.10.154; Kim H, 2013, PFLUG ARCH EUR J PHY, V465, P1011, DOI 10.1007/s00424-013-1236-x; Kim H, 2012, CHANNELS, V6, P333, DOI 10.4161/chan.21198; Kim MT, 2006, AM J PHYSIOL-CELL PH, V290, pC1031, DOI 10.1152/ajpcell.00602.2004; Lemmon MA, 2005, CELL, V120, P574, DOI 10.1016/j.cell.2005.02.023; Lepage PK, 2006, J BIOL CHEM, V281, P30356, DOI 10.1074/jbc.M603930200; Lepage PK, 2009, CELL CALCIUM, V45, P251, DOI 10.1016/j.ceca.2008.11.002; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mery L, 2002, J CELL SCI, V115, P3497; Miehe S, 2010, J BIOL CHEM, V285, P12426, DOI 10.1074/jbc.M109.068304; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Murakami M, 2005, J BIOL CHEM, V280, P5626, DOI 10.1074/jbc.M411496200; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 2002, P NATL ACAD SCI USA, V99, P6755, DOI 10.1073/pnas.092150699; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Patterson G, 2001, J CELL SCI, V114, P837; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V453, P753, DOI 10.1007/s00424-006-0153-7; Schindl R, 2008, CELL CALCIUM, V43, P260, DOI 10.1016/j.ceca.2007.05.015; So Insuk, 2003, Journal of Smooth Muscle Research, V39, P231, DOI 10.1540/jsmr.39.231; Song XY, 2005, GLIA, V49, P418, DOI 10.1002/glia.20128; Tourkina Elena, 2012, Open Rheumatol J, V6, P116, DOI 10.2174/1874312901206010116; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Yan HD, 2003, BRIT J PHARMACOL, V139, P605, DOI 10.1038/sj.bjp.0705289; Zhang S, 2004, AM J PHYSIOL-CELL PH, V287, pC1192, DOI 10.1152/ajpcell.00158.2004; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	55	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34990	35002		10.1074/jbc.M114.584649	http://dx.doi.org/10.1074/jbc.M114.584649			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349210	Green Published, hybrid			2022-12-26	WOS:000346260800047
J	Miyata, Y; Shibata, T; Aoshima, M; Tsubata, T; Nishida, E				Miyata, Yoshihiko; Shibata, Takeshi; Aoshima, Masato; Tsubata, Takuichi; Nishida, Eisuke			The Molecular Chaperone TRiC/CCT Binds to the Trp-Asp 40 (WD40) Repeat Protein WDR68 and Promotes Its Folding, Protein Kinase DYRK1A Binding, and Nuclear Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-DIMER; DOWN-SYNDROME; EUKARYOTIC CHAPERONIN; CRYSTAL-STRUCTURE; POSTTRANSLATIONAL MODIFICATIONS; DUAL-SPECIFICITY; COMPLEX; FAMILY; HSP90; PHOSPHORYLATION	Trp-Asp (WD) repeat protein 68 (WDR68) is an evolutionarily conserved WD40 repeat protein that binds to several proteins, including dual specificity tyrosine phosphorylation-regulated protein kinase (DYRK1A), MAPK/ERK kinase kinase 1 (MEKK1), and Cullin4-damage-specific DNA-binding protein 1 (CUL4-DDB1). WDR68 affects multiple and diverse physiological functions, such as controlling anthocyanin synthesis in plants, tissue growth in insects, and craniofacial development in vertebrates. However, the biochemical basis and the regulatory mechanism of WDR68 activity remain largely unknown. To better understand the cellular function of WDR68, here we have isolated and identified cellular WDR68 binding partners using a phosphoproteomic approach. More than 200 cellular proteins with wide varieties of biochemical functions were identified as WDR68-binding protein candidates. Eight T-complex protein 1 (TCP1) subunits comprising the molecular chaperone TCP1 ring complex/chaperonin-containing TCP1 (TRiC/CCT) were identified as major WDR68-binding proteins, and phosphorylation sites in both WDR68 and TRiC/CCT were identified. Co-immunoprecipitation experiments confirmed the binding between TRiC/CCT and WDR68. Computer-aided structural analysis suggested that WDR68 forms a seven-bladed beta-propeller ring. Experiments with a series of deletion mutants in combination with the structural modeling showed that three of the seven beta-propeller blades of WDR68 are essential and sufficient for TRiC/CCT binding. Knockdown of cellular TRiC/CCT by siRNA caused an abnormal WDR68 structure and led to reduction of its DYRK1A-binding activity. Concomitantly, nuclear accumulation of WDR68 was suppressed by the knockdown of TRiC/CCT, and WDR68 formed cellular aggregates when overexpressed in the TRiC/CCT-deficient cells. Altogether, our results demonstrate that the molecular chaperone TRiC/CCT is essential for correct protein folding, DYRK1A binding, and nuclear accumulation of WDR68.	[Miyata, Yoshihiko; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Shibata, Takeshi; Aoshima, Masato; Tsubata, Takuichi] KK AB Sciex Japan, Tokyo 1400001, Japan	Kyoto University	Miyata, Y (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	ymiyata@lif.kyoto-u.ac.jp	Miyata, Y/X-7111-2019		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25440046] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Cloutier P, 2013, BBA-GENE REGUL MECH, V1829, P443, DOI 10.1016/j.bbagrm.2013.02.010; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; Degoutin JL, 2013, NAT CELL BIOL, V15, P1176, DOI 10.1038/ncb2829; deVetten N, 1997, GENE DEV, V11, P1422, DOI 10.1101/gad.11.11.1422; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2003, J NEURAL TRANSM-SUPP, P129; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Miyata Y, 1997, P NATL ACAD SCI USA, V94, P14500, DOI 10.1073/pnas.94.26.14500; Miyata Y, 2000, ONCOGENE, V19, P1477, DOI 10.1038/sj.onc.1203475; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Miyata Y, 2001, J BIOL CHEM, V276, P21841, DOI 10.1074/jbc.M010944200; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Miyata Y, 2011, BBA-MOL CELL RES, V1813, P1728, DOI 10.1016/j.bbamcr.2011.06.023; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Morita K, 2006, J DERMATOL SCI, V44, P11, DOI 10.1016/j.jdermsci.2006.06.001; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nissen RM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-28; Pan DQ, 2013, NAT STRUCT MOL BIOL, V20, P987, DOI 10.1038/nsmb.2618; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Park KI, 2012, J PLANT PHYSIOL, V169, P523, DOI 10.1016/j.jplph.2011.12.001; Ritterhoff S, 2010, EMBO J, V29, P3750, DOI 10.1038/emboj.2010.251; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054363; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Wu JF, 2008, PLANT PHYSIOL, V148, P948, DOI 10.1104/pp.108.124917; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yi CL, 2006, INT J BIOCHEM CELL B, V38, P1076, DOI 10.1016/j.biocel.2005.12.019; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009	65	27	27	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33320	33332		10.1074/jbc.M114.586115	http://dx.doi.org/10.1074/jbc.M114.586115			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25342745	Green Published, hybrid			2022-12-26	WOS:000345636600023
J	Fan, M; Stuart-Fox, D; Cadena, V				Fan, Marie; Stuart-Fox, Devi; Cadena, Viviana			Cyclic Colour Change in the Bearded Dragon Pogona vitticeps under Different Photoperiods	PLOS ONE			English	Article							ELICITING PIGMENT DISPERSION; FIDDLER-CRAB; CIRCADIAN-RHYTHM; UCA-PUGILATOR; RELATIVE EFFECTIVENESS; ANOLIS-CAROLINENSIS; VISIBLE LIGHT; TIDAL RHYTHMS; TEMPERATURE; MELANOPHORES	The ability to change colour rapidly is widespread among ectotherms and has various functions including camouflage, communication and thermoregulation. The process of colour change can occur as an aperiodic event or be rhythmic, induced by cyclic environmental factors or regulated by internal oscillators. Despite the importance of colour change in reptile ecology, few studies have investigated the occurrence of a circadian rhythm in lizard pigmentation. Additionally, although colour change also entails changes in near-infrared reflectance, which may affect thermoregulation, little research has examined this part of the spectrum. We tested whether the bearded dragon lizard, Pogona vitticeps, displays an endogenous circadian rhythm in pigmentation changes that could be entrained by light/dark (LD) cycles and how light affected the relative change in reflectance in both ultraviolet-visible and near-infrared spectra. We subjected 11 lizards to four photoperiodic regimens:LD 12:12; LD 6:18; LD 18:6 and DD; and measured their dorsal skin reflectance at 3-hour intervals for 72 hours after a habituation period. A proportion of lizards displayed a significant rhythm under constant darkness, with maximum reflectance occurring in the subjective night. This endogenous rhythm synchronised to the different artificial LD cycles, with maximum reflectance occurring during dark phases, but did not vary in amplitude. In addition, the total ultraviolet-visible reflectance in relation to the total near-infrared reflectance was significantly higher during dark phases than during light phases. We conclude that P. vitticeps exhibits a circadian pigmentation rhythm of constant amplitude, regulated by internal oscillators and that can be entrained by light/dark cycles.	[Fan, Marie] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, England; [Fan, Marie; Stuart-Fox, Devi; Cadena, Viviana] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia	University of Exeter; University of Melbourne	Fan, M (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, England.	mf330@exeter.ac.uk		Stuart-Fox, Devi/0000-0003-3362-1412	Australian Research Council [DP120100105]	Australian Research Council(Australian Research Council)	DSF received funding from the Australian Research Council (http://www.arc.gov.au/) (Grant Number: DP120100105). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Bagnara JT., 2006, PIGMENTARY SYSTEM PH, P11, DOI [10.1002/9780470987100.ch2, DOI 10.1002/9780470987100.CH2]; Bagnara JT, 1973, CHROMATOPHORES COLOR; BARNWELL FH, 1963, BIOL BULL, V125, P399, DOI 10.2307/1539355; Bertolucci C, 2004, CHRONOBIOL INT, V21, P501, DOI 10.1081/CBI-120039813; Binkley S, 1987, PINEAL RES REV, P133; BROWN FA, 1948, PHYSIOL ZOOL, V21, P371, DOI 10.1086/physzool.21.4.30152016; Cadena V, 2009, PHYSIOL BIOCHEM ZOOL, V82, P203, DOI 10.1086/597483; Campbell SS, 2001, CHRONOBIOL INT, V18, P137, DOI 10.1081/CBI-100103183; CASWELL HH, 1950, COPEIA, P87, DOI 10.2307/1438950; Chatfield C, 1980, ANAL TIME SERIES INT; Christian KA, 1996, AUST J ZOOL, V44, P59, DOI 10.1071/ZO9960059; Clusella-Trullas S, 2008, FUNCT ECOL, V22, P232, DOI 10.1111/j.1365-2435.2007.01377.x; COOHILL TP, 1970, PHYSIOL ZOOL, V43, P232, DOI 10.1086/physzool.43.3.30155532; COOHILL TP, 1975, PHYSIOL ZOOL, V48, P57, DOI 10.1086/physzool.48.1.30155638; Cooper WE, 1992, BIOL REPTILIA HORMON, V18, P298; Darnell MZ, 2012, J EXP MAR BIOL ECOL, V426, P39, DOI 10.1016/j.jembe.2012.05.014; de Velasco JB, 2008, J COMP PHYSIOL B, V178, P867, DOI 10.1007/s00360-008-0274-8; Detto T, 2006, P ROY SOC B-BIOL SCI, V273, P1661, DOI 10.1098/rspb.2006.3503; Dowse Harold B, 2007, Methods Mol Biol, V362, P29; Filadelfi AMC, 2005, COMP BIOCHEM PHYS A, V142, P370, DOI 10.1016/j.cbpa.2005.09.001; FINGERMAN M, 1955, BIOL BULL, V109, P255, DOI 10.2307/1538725; Foa A, 2006, CHRONOBIOL INT, V23, P317, DOI 10.1080/07420520500521954; Garcia TS, 2004, ECOL APPL, V14, P1055, DOI 10.1890/02-5288; Granato FC, 2004, COMP BIOCHEM PHYS A, V138, P313, DOI 10.1016/j.cbpb.2004.04.009; Hanlon RT, 1999, BIOL J LINN SOC, V66, P1; HINTON HE, 1972, NATURE, V238, P160, DOI 10.1038/238160a0; HOROWITZ SB, 1958, J CELL COMPAR PHYSL, V51, P341, DOI 10.1002/jcp.1030510304; KAVALIERS M, 1980, CAN J ZOOL, V58, P456, DOI 10.1139/z80-060; KING RB, 1994, COPEIA, P422; Kodric-Brown A, 1998, AM ZOOL, V38, P70; LERNER AB, 1956, RECENT PROG HORM RES, V12, P303; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Melville J, 2001, AUSTRAL ECOL, V26, P660, DOI 10.1046/j.1442-9993.2001.01152.x; MENAKER M, 1983, P NATL ACAD SCI-BIOL, V80, P6119, DOI 10.1073/pnas.80.19.6119; MINUTINI L, 1995, J COMP PHYSIOL A, V176, P281; Morgan E, 2004, BIOL RHYTHM RES, V35, P3, DOI 10.1080/09291010412331313205; Oshima N, 2001, PIGM CELL RES, V14, P312, DOI 10.1034/j.1600-0749.2001.140502.x; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; PORTER WP, 1969, SCIENCE, V163, P482, DOI 10.1126/science.163.3866.482; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; THURMAN CL, 1988, COMP BIOCHEM PHYS C, V91, P171, DOI 10.1016/0742-8413(88)90184-3; UNDERWOOD H, 1985, J COMP PHYSIOL A, V157, P57, DOI 10.1007/BF00611095; UNDERWOOD H, 1987, Journal of Biological Rhythms, V2, P179, DOI 10.1177/074873048700200302; WILKENS JL, 1965, BIOL BULL, V128, P133, DOI 10.2307/1539396	45	26	26	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111504	10.1371/journal.pone.0111504	http://dx.doi.org/10.1371/journal.pone.0111504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354192	Green Published, gold			2022-12-26	WOS:000345204200085
J	Ryan, CP; Anderson, WG; Berkvens, CN; Hare, JF				Ryan, Calen P.; Anderson, W. Gary; Berkvens, Charlene N.; Hare, James F.			Maternal Gestational Cortisol and Testosterone Are Associated with Trade-Offs in Offspring Sex and Number in a Free-Living Rodent (Urocitellus richardsonii)	PLOS ONE			English	Article							GROUND-SQUIRRELS; POTENTIAL MECHANISMS; RATIO; STRESS; ALLOCATION; SUPPORT; GLUCOCORTICOIDS; VERTEBRATES; BONFERRONI; ADJUSTMENT	The adaptive manipulation of offspring sex and number has been of considerable interest to ecologists and evolutionary biologists. The physiological mechanisms that translate maternal condition and environmental cues into adaptive responses in offspring sex and number, however, remain obscure. In mammals, research into the mechanisms responsible for adaptive sex allocation has focused on two major endocrine axes: the hypothalamic pituitary adrenal (HPA) axis and glucocorticoids, and the hypothalamic pituitary gonadal (HPG) axis and sex steroids, particularly testosterone. While stress-induced activation of the HPA axis provides an intuitive model for sex ratio and litter size adjustment, plasma glucocorticoids exist in both bound and free fractions, and may be acting indirectly, for example by affecting plasma glucose levels. Furthermore, in female mammals, activation of the HPA axis stimulates the secretion of adrenal testosterone in addition to glucocorticoids (GCs). To begin to untangle these physiological mechanisms influencing offspring sex and number, we simultaneously examined fecal glucocorticoid metabolites, free and bound plasma cortisol, free testosterone, and plasma glucose concentration during both gestation and lactation in a free-living rodent (Urocitellus richardsonii). We also collected data on offspring sex and litter size from focal females and from a larger study population. Consistent with previous work in this population, we found evidence for a trade-off between offspring sex and number, as well as positive and negative correlations between glucocorticoids and sex ratio and litter size, respectively, during gestation (but not lactation). We also observed a negative relationship between testosterone and litter size during gestation (but not lactation), but no effect of glucose on either sex ratio or litter size. Our findings highlight the importance of binding proteins, cross-talk between endocrine systems, and temporal windows in the regulation of trade-offs in offspring sex and number.	[Ryan, Calen P.; Anderson, W. Gary; Hare, James F.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Berkvens, Charlene N.] Assiniboine Pk Zoo, Winnipeg, MB, Canada	University of Manitoba	Ryan, CP (corresponding author), Northwestern Univ, Dept Anthropol, Lab Human Biol Res, Evanston, IL 60208 USA.	calen.p.ryan@gmail.com			Natural Sciences and Engineering Research Council of Canada [154271, 311909]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (JFH-#154271; WGA-#311909). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banszegi O, 2012, PHYSIOL BEHAV, V105, P1226, DOI 10.1016/j.physbeh.2012.01.002; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; Boonstra R, 2001, CAN J ZOOL, V79, P49, DOI 10.1139/cjz-79-1-49; Breuner CW, 2013, FUNCT ECOL, V27, P24, DOI 10.1111/1365-2435.12016; Cameron EZ, 2008, P ROY SOC B-BIOL SCI, V275, P323, DOI 10.1098/rspb.2007.1401; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; CHARNOV E L, 1982; Christiansen K., 1998, TESTOSTERONE, P107, DOI DOI 10.1017/CBO9780511545221.005; Cizza G, 2012, J CLIN ENDOCR METAB, V97, P77, DOI 10.1210/jc.2011-3090; CLARK MM, 1993, DEV PSYCHOBIOL, V26, P25, DOI 10.1002/dev.420260103; Clary D, 2014, ETHOLOGY, V120, P1101, DOI 10.1111/eth.12283; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; Dickenson H, 2012, GLUCOCORTICOIDS NEW; Diez C, 2009, J EXP ZOOL PART A, V311A, P448, DOI 10.1002/jez.540; Drea CM, 2011, HORM BEHAV, V59, P417, DOI 10.1016/j.yhbeh.2010.09.011; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; French JA, 2010, GEN COMP ENDOCR, V165, P309, DOI 10.1016/j.ygcen.2009.07.015; Garcia-Herreros M, 2010, REPROD FERT DEVELOP, V22, P533, DOI 10.1071/RD09157; Gedir JV, 2014, OECOLOGIA, V174, P1225, DOI 10.1007/s00442-013-2861-y; Gotz AA, 2008, PHYSIOL BEHAV, V93, P1055, DOI 10.1016/j.physbeh.2008.01.009; Good TC, 2005, PHYSIOL BEHAV, V86, P96, DOI 10.1016/j.physbeh.2005.06.030; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Grant VJ, 2007, J THEOR BIOL, V246, P708, DOI 10.1016/j.jtbi.2007.02.005; Grant VJ, 2011, ANIM BEHAV, V82, P893, DOI 10.1016/j.anbehav.2011.07.029; Grant VJ, 2005, J EXP ZOOL PART A, V303A, P1120, DOI 10.1002/jez.a.233; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; Hardy ICW, 1997, APPL ANIM BEHAV SCI, V51, P217, DOI 10.1016/S0168-1591(96)01106-9; Hare JF, 2014, CURR ZOOL, V60, P591, DOI 10.1093/czoolo/60.5.591; Helle S, 2008, ANIM BEHAV, V75, P1031, DOI 10.1016/j.anbehav.2007.08.015; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; HOUTSMULLER EJ, 1995, PHYSIOL BEHAV, V57, P495, DOI 10.1016/0031-9384(94)00291-C; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; Krackow S, 2002, ETHOLOGY, V108, P1041, DOI 10.1046/j.1439-0310.2002.00843.x; KRACKOW S, 1995, BIOL REV, V70, P225, DOI 10.1111/j.1469-185X.1995.tb01066.x; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Michael AE, 2008, HUM REPROD UPDATE, V14, P497, DOI 10.1093/humupd/dmn021; MICHENER G R, 1985, Mammalian Species, P1, DOI 10.2307/3503990; MICHENER GR, 1980, J MAMMAL, V61, P531, DOI 10.2307/1379847; MICHENER GR, 1979, CAN J ZOOL, V57, P125, DOI 10.1139/z79-010; MICHENER GR, 1985, J MAMMAL, V66, P280, DOI 10.2307/1381240; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Navara KJ, 2010, J COMP PHYSIOL B, V180, P785, DOI 10.1007/s00360-010-0483-9; Szenczi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074066; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; Powell LH, 2002, PSYCHOSOM MED, V64, P502, DOI 10.1097/00006842-200205000-00015; PRATT NC, 1989, J REPROD FERTIL, V87, P763, DOI 10.1530/jrf.0.0870763; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Ryan CP, 2012, BEHAV ECOL, V23, P160, DOI 10.1093/beheco/arr169; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sathishkumar K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-110; Schoech SJ, 2013, FUNCT ECOL, V27, P1100, DOI 10.1111/1365-2435.12142; Schwanz LE, 2014, BEHAV ECOL SOCIOBIOL, V68, P1085, DOI 10.1007/s00265-014-1720-0; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Sun M, 2012, AM J PHYSIOL-ENDOC M, V303, pE1373, DOI 10.1152/ajpendo.00421.2012; Thogerson CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067867; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x	61	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111052	10.1371/journal.pone.0111052	http://dx.doi.org/10.1371/journal.pone.0111052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353347	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200053
J	Miar, Y; Plastow, G; Bruce, H; Moore, S; Manafiazar, G; Kemp, R; Charagu, P; Huisman, A; van Haandel, B; Zhang, CY; McKay, R; Wang, ZQ				Miar, Younes; Plastow, Graham; Bruce, Heather; Moore, Stephen; Manafiazar, Ghader; Kemp, Robert; Charagu, Patrick; Huisman, Abe; van Haandel, Benny; Zhang, Chunyan; McKay, Robert; Wang, Zhiquan			Genetic and Phenotypic Correlations between Performance Traits with Meat Quality and Carcass Characteristics in Commercial Crossbred Pigs	PLOS ONE			English	Article							INDIVIDUAL BIRTH-WEIGHT; RESIDUAL FEED-INTAKE; LARGE WHITE-PIGS; PIGLET SURVIVAL; OUTDOOR CONDITIONS; INTRAMUSCULAR FAT; PORK QUALITY; DUROC PIGS; PARAMETERS; SELECTION	Genetic correlations between performance traits with meat quality and carcass traits were estimated on 6,408 commercial crossbred pigs with performance traits recorded in production systems with 2,100 of them having meat quality and carcass measurements. Significant fixed effects (company, sex and batch), covariates (birth weight, cold carcass weight, and age), random effects (additive, litter and maternal) were fitted in the statistical models. A series of pairwise bivariate analyses were implemented in ASREML to estimate heritability, phenotypic, and genetic correlations between performance traits (n = 9) with meat quality (n = 25) and carcass (n = 19) traits. The animals had a pedigree compromised of 9,439 animals over 15 generations. Performance traits had low-to-moderate heritabilities (+/- SE), ranged from 0.07 +/- 0.13 to 0.45 +/- 0.07 for weaning weight, and ultrasound backfat depth, respectively. Genetic correlations between performance and carcass traits were moderate to high. The results indicate that: (a) selection for birth weight may increase drip loss, lightness of longissimus dorsi, and gluteus medius muscles but may reduce fat depth; (b) selection for nursery weight can be valuable for increasing both quantity and quality traits; (c) selection for increased daily gain may increase the carcass weight and most of the primal cuts. These findings suggest that deterioration of pork quality may have occurred over many generations through the selection for less backfat thickness, and feed efficiency, but selection for growth had no adverse effects on pork quality. Low-to-moderate heritabilities for performance traits indicate that they could be improved using traditional selection or genomic selection. The estimated genetic parameters for performance, carcass and meat quality traits may be incorporated into the breeding programs that emphasize product quality in these Canadian swine populations.	[Miar, Younes; Plastow, Graham; Bruce, Heather; Moore, Stephen; Manafiazar, Ghader; Zhang, Chunyan; Wang, Zhiquan] Univ Alberta, Livestock Gentec Ctr, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Kemp, Robert] Genesus Genet, Oakville, MB, Canada; [Charagu, Patrick; van Haandel, Benny] Hypor Inc, Regina, SK, Canada; [Huisman, Abe] Hendrix Genet, Res & Technol Ctr, Boxmeer, Netherlands; [Moore, Stephen] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [McKay, Robert] McKay GENSTAT Consultants Inc, Brandon, MB, Canada	University of Alberta; University of Queensland	Wang, ZQ (corresponding author), Univ Alberta, Livestock Gentec Ctr, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	Zhiquan@ualberta.ca		Miar, Younes/0000-0001-9933-5414; Bruce, Heather/0000-0002-8522-813X; Plastow, Graham/0000-0002-3774-3110	Natural Sciences and Engineering Research Council of Canada (NSERC); Hypor Inc.; Genesus Genetics	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hypor Inc.; Genesus Genetics	The authors acknowledge the financial support from Natural Sciences and Engineering Research Council of Canada (NSERC): www.nserc-crsng.gc.ca; Hypor Inc.: http://www.hypor.com/; and Genesus Genetics: http://www.genesus.com/. The authors would like to extend thanks to the companies for providing the possibility and the facilities to collect the data. Except for the role of the industry staff in preparation of the manuscript as co-authors the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango J, 2006, LIVEST SCI, V101, P208, DOI 10.1016/j.livprodsci.2005.11.011; Cai W, 2008, J ANIM SCI, V86, P287, DOI 10.2527/jas.2007-0396; CAMERON ND, 1988, ANIM PROD, V46, P87, DOI 10.1017/S0003356100003147; CAMERON ND, 1990, LIVEST PROD SCI, V26, P119, DOI 10.1016/0301-6226(90)90061-A; Cassady JP, 2002, J ANIM SCI, V80, P2286; Ciobanu DC, 2011, GENETICS OF THE PIG, 2ND EDITION, P355, DOI 10.1079/9781845937560.0355; Clutter AC, 1998, GENETICS OF THE PIG, P427; Clutter AC, 2011, GENETICS OF THE PIG, 2ND EDITION, P325, DOI 10.1079/9781845937560.0325; DEVRIES AG, 1994, LIVEST PROD SCI, V40, P277, DOI 10.1016/0301-6226(94)90095-7; Dransfield E, 2005, MEAT SCI, V69, P61, DOI 10.1016/j.meatsci.2004.06.006; Ducos A, 1994, MISE POINT BIBLIO TE, V17, P35; Fix JS, 2010, LIVEST SCI, V127, P51, DOI 10.1016/j.livsci.2009.08.007; Gibson JP, 1998, P 6 WORLD C GENETICS, V23, P499; Gilbert H, 2007, J ANIM SCI, V85, P3182, DOI 10.2527/jas.2006-590; Gilmour AR, 2009, ASREML USER GUIDE RE; Hermesch S, 2000, LIVEST PROD SCI, V65, P249, DOI 10.1016/S0301-6226(00)00151-2; Hoque MA, 2007, J ANIM SCI, V85, P1873, DOI 10.2527/jas.2006-730; Jiang YZ, 2012, GENET MOL RES, V11, P4447, DOI 10.4238/2012.September.19.6; Kaufmann D, 2000, J ANIM BREED GENET, V117, P121, DOI 10.1111/j.1439-0388.2000x.00238.x; Knol EF, 2002, LIVEST PROD SCI, V78, P47, DOI 10.1016/S0301-6226(02)00184-7; Koots K.R., 1994, P 5 WORLD C GEN APPL, V18, P353; Latorre MA, 2008, LIVEST SCI, V115, P258, DOI 10.1016/j.livsci.2007.08.013; Lo LL, 1992, J ANIMAL SCI, V70, P2357; Maignel L., 2010, P 9 WORLD C GEN APPL; Miar Y, 2014, J ANIM SCI, V92, P2869, DOI 10.2527/jas.2014-7685; Miar Y, 2014, CAN J ANIM SCI, V94, P273, DOI [10.4141/CJAS2013-115, 10.4141/cjas2013-115]; National Swine Improvement Federation, 1997, GUID UN SWIN IMPR PR; Newcom DW, 2002, J ANIM SCI, V80, P3099; Olfert E.D, 1993, GUIDE CARE USE EXPT, V1; Rehfeldt C, 2008, MEAT SCI, V78, P170, DOI 10.1016/j.meatsci.2007.05.029; Roehe R, 2010, J ANIM SCI, V88, P1276, DOI 10.2527/jas.2009-2287; Roehe R, 2009, LIVEST SCI, V121, P173, DOI 10.1016/j.livsci.2008.06.010; Roehe R, 1999, J ANIM SCI, V77, P330; Schwab CR, 2009, J ANIM SCI, V87, P2774, DOI 10.2527/jas.2008-1335; Sonesson AK, 1998, LIVEST PROD SCI, V57, P23, DOI 10.1016/S0301-6226(98)00163-8; Stewart T., 1991, GENETICS SWINE, P77; Suzuki K, 2005, J ANIM SCI, V83, P2058; van Wijk HJ, 2005, J ANIM SCI, V83, P324	38	38	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110105	10.1371/journal.pone.0110105	http://dx.doi.org/10.1371/journal.pone.0110105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350845	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943100020
J	Bozza, G; Capitani, M; Montanari, P; Benucci, B; Biancucci, M; Nardi-Dei, V; Caproni, E; Barrile, R; Picciani, B; Savino, S; Arico, B; Rappuoli, R; Pizza, M; Luini, A; Sallese, M; Merola, M				Bozza, Giuseppe; Capitani, Mirco; Montanari, Paolo; Benucci, Barbara; Biancucci, Marco; Nardi-Dei, Vincenzo; Caproni, Elena; Barrile, Riccardo; Picciani, Benedetta; Savino, Silvana; Arico, Beatrice; Rappuoli, Rino; Pizza, Mariagrazia; Luini, Alberto; Sallese, Michele; Merola, Marcello			Role of ARF6, Rab11 and External Hsp90 in the Trafficking and Recycling of Recombinant-Soluble Neisseria meningitidis Adhesin A (rNadA) in Human Epithelial Cells	PLOS ONE			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; TRIMERIC AUTOTRANSPORTER ADHESINS; CAVEOLAE-MEDIATED ENDOCYTOSIS; PROTEIN-KINASE-C; MORAXELLA-CATARRHALIS; MOLECULAR CHAPERONE; NADA; ACTIVATION; MECHANISMS; BARTONELLA	Neisseria meningitidis adhesin A (NadA) is a meningococcus surface protein thought to assist in the adhesion of the bacterium to host cells. We have previously shown that NadA also promotes bacterial internalization in a heterologous expression system. Here we have used the soluble recombinant NadA (rNadA) lacking the membrane anchor region to characterize its internalization route in Chang epithelial cells. Added to the culture medium, rNadA internalizes through a PI3K-dependent endocytosis process not mediated by the canonical clathrin or caveolin scaffolds, but instead follows an ARF6-regulated recycling pathway previously described for MHC-I. The intracellular pool of rNadA reaches a steady state level within one hour of incubation and colocalizes in endocytic vesicles with MHC-I and with the extracellularly labeled chaperone Hsp90. Treatment with membrane permeated and impermeable Hsp90 inhibitors 17-AAG and FITC-GA respectively, lead to intracellular accumulation of rNadA, strongly suggesting that the extracellular secreted pool of the chaperone is involved in rNadA intracellular trafficking. A significant number of intracellular vesicles containing rNadA recruit Rab11, a small GTPase associated to recycling endosomes, but do not contain transferrin receptor (TfR). Interestingly, cell treatment with Hsp90 inhibitors, including the membrane-impermeable FITC-GA, abolished Rab11-rNadA colocalization but do not interfere with Rab11-TfR colocalization. Collectively, these results are consistent with a model whereby rNadA internalizes into human epithelial cells hijacking the recycling endosome pathway and recycle back to the surface of the cell via an ARF6-dependent, Rab11 associated and Hsp90-regulated mechanism. The present study addresses for the first time a meningoccoccal adhesin mechanism of endocytosis and suggests a possible entry pathway engaged by N. meningitidis in primary infection of human epithelial cells.	[Bozza, Giuseppe; Montanari, Paolo; Benucci, Barbara; Biancucci, Marco; Nardi-Dei, Vincenzo; Caproni, Elena; Barrile, Riccardo; Savino, Silvana; Arico, Beatrice; Rappuoli, Rino; Pizza, Mariagrazia; Merola, Marcello] Novartis Vaccines, Siena, Italy; [Capitani, Mirco; Picciani, Benedetta; Sallese, Michele] Fdn Mario Negri Sud, Unit Genom Approaches Membrane Traff, Santa Maria Imbaro, CH, Italy; [Luini, Alberto] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Merola, Marcello] Univ Naples Federico II, Dept Biol, Naples, Italy	Novartis; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Naples Federico II	Sallese, M (corresponding author), Fdn Mario Negri Sud, Unit Genom Approaches Membrane Traff, Santa Maria Imbaro, CH, Italy.	sallese@negrisud.it; marcello.merola@novartis.com	Sallese, Michele/J-5347-2016; Luini, Alberto/L-1372-2013	Sallese, Michele/0000-0002-2555-3571; Luini, Alberto/0000-0002-8729-2549; Picciani, Benedetta/0000-0002-4023-5547	Novartis Vaccines	Novartis Vaccines	This work is entirely funded by Novartis Vaccines; no external entities have contributed to cover project expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Binder RJ, 2004, TISSUE ANTIGENS, V64, P442, DOI 10.1111/j.1399-0039.2004.00299.x; BIRKNESS KA, 1995, INFECT IMMUN, V63, P402, DOI 10.1128/IAI.63.2.402-409.1995; Bowe F, 2004, INFECT IMMUN, V72, P4052, DOI 10.1128/IAI.72.7.4052-4060.2004; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Carbonnelle E, 2009, VACCINE, V27, pB78, DOI 10.1016/j.vaccine.2009.04.069; Cecchini P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025089; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Cortese K, 2013, MOL BIOL CELL, V24, P129, DOI 10.1091/mbc.E12-04-0282; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Delom Frederic, 2011, Int J Cell Biol, V2011, P246954, DOI 10.1155/2011/246954; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Franzoso S, 2008, J LEUKOCYTE BIOL, V83, P1100, DOI 10.1189/jlb.1207810; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Kobayashi Hotaka, 2013, Commun Integr Biol, V6, pe25036, DOI 10.4161/cib.25036; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Laarmann S, 2002, MOL MICROBIOL, V46, P731, DOI 10.1046/j.1365-2958.2002.03189.x; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li W, 2012, BBA-MOL CELL RES, V1823, P730, DOI 10.1016/j.bbamcr.2011.09.009; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; Lyskowski A, 2011, ADV EXP MED BIOL, V715, P143, DOI 10.1007/978-94-007-0940-9_9; Magagnoli C, 2009, VACCINE, V27, P2156, DOI 10.1016/j.vaccine.2009.01.099; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mazzon C, 2007, J IMMUNOL, V179, P3904, DOI 10.4049/jimmunol.179.6.3904; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMichael JC, 1998, INFECT IMMUN, V66, P4374; Montanari P, 2012, CELL MICROBIOL, V14, P368, DOI 10.1111/j.1462-5822.2011.01722.x; Nagele V, 2011, J BIOL CHEM, V286, P20536, DOI 10.1074/jbc.M110.188326; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; O'Rourke F, 2011, ADV EXP MED BIOL, V715, P51, DOI 10.1007/978-94-007-0940-9_4; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Serruto D, 2009, CELL MICROBIOL, V11, P1044, DOI 10.1111/j.1462-5822.2009.01306.x; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; STEPHENS DS, 1983, J INFECT DIS, V148, P369, DOI 10.1093/infdis/148.3.369; Surana NK, 2004, J BIOL CHEM, V279, P14679, DOI 10.1074/jbc.M311496200; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Yang W, 2004, BIOCHEM J, V382, P199, DOI 10.1042/BJ20040623; YANG YX, 1993, INFECT IMMUN, V61, P3907, DOI 10.1128/IAI.61.9.3907-3913.1993; Zagorac GB, 2012, J CELL PHYSIOL, V227, P2953, DOI 10.1002/jcp.23042; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101; Zhao XH, 2001, J CELL SCI, V114, P353	80	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110047	10.1371/journal.pone.0110047	http://dx.doi.org/10.1371/journal.pone.0110047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347845	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900020
J	Salanki, R; Hos, C; Orgovan, N; Peter, B; Sandor, N; Bajtay, Z; Erdei, A; Horvath, R; Szabo, B				Salanki, Rita; Hos, Csaba; Orgovan, Norbert; Peter, Beatrix; Sandor, Noemi; Bajtay, Zsuzsa; Erdei, Anna; Horvath, Robert; Szabo, Balint			Single Cell Adhesion Assay Using Computer Controlled Micropipette	PLOS ONE			English	Article							FLUID SLIP; SURFACE; DEPENDENCE; INTEGRINS; FORCE; SERUM; FLOW; STRENGTH; AVIDITY; DESIGN	Cell adhesion is a fundamental phenomenon vital for all multicellular organisms. Recognition of and adhesion to specific macromolecules is a crucial task of leukocytes to initiate the immune response. To gain statistically reliable information of cell adhesion, large numbers of cells should be measured. However, direct measurement of the adhesion force of single cells is still challenging and today's techniques typically have an extremely low throughput (5-10 cells per day). Here, we introduce a computer controlled micropipette mounted onto a normal inverted microscope for probing single cell interactions with specific macromolecules. We calculated the estimated hydrodynamic lifting force acting on target cells by the numerical simulation of the flow at the micropipette tip. The adhesion force of surface attached cells could be accurately probed by repeating the pick-up process with increasing vacuum applied in the pipette positioned above the cell under investigation. Using the introduced methodology hundreds of cells adhered to specific macromolecules were measured one by one in a relatively short period of time (similar to 30 min). We blocked nonspecific cell adhesion by the protein non-adhesive PLL-g-PEG polymer. We found that human primary monocytes are less adherent to fibrinogen than their in vitro differentiated descendants: macrophages and dendritic cells, the latter producing the highest average adhesion force. Validation of the here introduced method was achieved by the hydrostatic step-pressure micropipette manipulation technique. Additionally the result was reinforced in standard microfluidic shear stress channels. Nevertheless, automated micropipette gave higher sensitivity and less side-effect than the shear stress channel. Using our technique, the probed single cells can be easily picked up and further investigated by other techniques; a definite advantage of the computer controlled micropipette. Our experiments revealed the existence of a sub-population of strongly fibrinogen adherent cells appearing in macrophages and highly represented in dendritic cells, but not observed in monocytes.	[Salanki, Rita; Peter, Beatrix] Univ Pannonia, Doctoral Sch Mol & Nanotechnol, Veszprem, Hungary; [Salanki, Rita; Orgovan, Norbert; Peter, Beatrix; Horvath, Robert; Szabo, Balint] Res Ctr Nat Sci, Inst Tech Phys & Mat Sci, Nanobiosensor Grp, Budapest, Hungary; [Salanki, Rita; Orgovan, Norbert; Szabo, Balint] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Hos, Csaba] Budapest Univ Technol & Econ, Dept Hydrodynam Syst, Budapest, Hungary; [Sandor, Noemi; Erdei, Anna] Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, Budapest, Hungary; [Bajtay, Zsuzsa; Erdei, Anna] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Szabo, Balint] CellSorter Co Innovat, Budapest, Hungary	University of Pannonia; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Budapest University of Technology & Economics; Eotvos Lorand University; Eotvos Lorand University	Szabo, B (corresponding author), Res Ctr Nat Sci, Inst Tech Phys & Mat Sci, Nanobiosensor Grp, Budapest, Hungary.	balintszabo1@gmail.com	Horvath, Robert/C-4602-2008; Sándor, Noémi/AAG-1715-2021; Erdei, Anna/AAN-5988-2020; bajtay, zsuzsa/AAI-1267-2020; Hos, Csaba/E-7089-2013; Hos, Csaba/J-5881-2019; Horvath, Robert/AAW-9031-2020	Horvath, Robert/0000-0001-8617-2302; Hos, Csaba/0000-0002-1930-515X; Hos, Csaba/0000-0002-0233-9759; Horvath, Robert/0000-0001-8617-2302; Erdei, Anna/0000-0002-3622-6680	Lendulet Program of the Hungarian Academy of Sciences; project Social Renewal Operational Programme [4.2.2/B-10/1-2010-0025]; Hungarian Scientific Research Fund: Funding Basic Research in Hungary, Hungarian national research grant [K104838]; Bolyai Scholarship of the Hungarian Academy of Sciences	Lendulet Program of the Hungarian Academy of Sciences; project Social Renewal Operational Programme; Hungarian Scientific Research Fund: Funding Basic Research in Hungary, Hungarian national research grant; Bolyai Scholarship of the Hungarian Academy of Sciences	This work was supported by the Lendulet Program of the Hungarian Academy of Sciences for R. H. (http://mta.hu/english/); the project Social Renewal Operational Programme-4.2.2/B-10/1-2010-0025 for R. S.; The Hungarian Scientific Research Fund: Funding Basic Research in Hungary K104838 Hungarian national research grant for Z.B. (http://www.otka.hu/en); and Bolyai Scholarship of the Hungarian Academy of Sciences for B. S. (http://mta.hu/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1994, MOL BIOL CELL, P966; Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x; [Anonymous], 2012, ANSYS CFX 14 0 THEOR; Christ KV, 2010, J ADHES SCI TECHNOL, V24, P2027, DOI 10.1163/016942410X507911; Cottier K, 2008, APPL PHYS B-LASERS O, V91, P319, DOI 10.1007/s00340-008-2994-6; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Faraasen S, 2003, PHARMACEUT RES, V20, P237, DOI 10.1023/A:1022366921298; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2; Gupta R, 2013, HOUILLE BLANCHE, P60, DOI 10.1051/lhb/2013017; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+; KAPLANSKI G, 1993, BIOPHYS J, V64, P1922, DOI 10.1016/S0006-3495(93)81563-7; Karimi S, 2014, J NON-NEWTON FLUID, V207, P42, DOI 10.1016/j.jnnfm.2014.03.007; Kazemzadeh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073002; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; KLEBE RJ, 1974, NATURE, V250, P248, DOI 10.1038/250248a0; Kornyei Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01088; Lauga E, 2005, MICROFLUIDICS NO SLI, P2; Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h; Mohanty S, 2008, LECT NOTES ENG COMP, P68; Neto C, 2005, REP PROG PHYS, V68, P2859, DOI 10.1088/0034-4885/68/12/R05; Ogaki R, 2012, BIOMACROMOLECULES, V13, P3668, DOI 10.1021/bm301125g; Orgovan N, 2014, ADV COLLOID INTERFAC, V211, P1, DOI 10.1016/j.cis.2014.03.011; Orgovan N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04034; Orgovan N, 2014, BIOSENS BIOELECTRON, V54, P339, DOI 10.1016/j.bios.2013.10.076; Park H, 2014, INT J HEAT MASS TRAN, V73, P511, DOI 10.1016/j.ijheatmasstransfer.2014.02.038; Potthoff E, 2014, NANO LETT, V14, P1069, DOI 10.1021/nl4047398; Potthoff E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052712; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Ramsden JJ, 2009, J RECEPT SIG TRANSD, V29, P211, DOI 10.1080/10799890903064119; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471; Salanki R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893922; Sandor N, 2013, IMMUNOBIOLOGY, V218, P652, DOI 10.1016/j.imbio.2012.07.031; Sandor N, 2009, MOL IMMUNOL, V47, P438, DOI 10.1016/j.molimm.2009.08.025; Schurpf T, 2011, EMBO J; Shao JY, 2004, FRONT BIOSCI-LANDMRK, V9, P2183, DOI 10.2741/1386; SUNG KLP, 1986, SCIENCE, V234, P1405, DOI 10.1126/science.3491426; Toth E, 2013, BIOMED CIRC SYST C, P266, DOI 10.1109/BioCAS.2013.6679690; Tretheway DC, 2004, PHYS FLUIDS, V16, P1509, DOI 10.1063/1.1669400; USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Voronov RS, 2008, IND ENG CHEM RES, V47, P2455, DOI 10.1021/ie0712941; Wei D, 2014, J WIND ENG IND AEROD, V126, P118, DOI 10.1016/j.jweia.2014.01.008; Xu JL, 2007, INT J HEAT MASS TRAN, V50, P2571, DOI 10.1016/j.ijheatmasstransfer.2006.11.031; Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052; Zhu Y, 2001, PHYS REV LETT, V87; Zhu YX, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.106102	53	27	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111450	10.1371/journal.pone.0111450	http://dx.doi.org/10.1371/journal.pone.0111450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343359	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000343943500099
J	Siragam, V; Cui, XZ; Masse, S; Ackerley, C; Aafaqi, S; Strandberg, L; Tropak, M; Fridman, MD; Nanthakumar, K; Liu, J; Su, B; Wang, C; Liu, XR; Yan, YQ; Mendlowitz, A; Hamilton, RM				Siragam, Vinayakumar; Cui, Xuezhi; Masse, Stephane; Ackerley, Cameron; Aafaqi, Shabana; Strandberg, Linn; Tropak, Michael; Fridman, Michael D.; Nanthakumar, Kumaraswamy; Liu, Jun; Su, Bin; Wang, Caroline; Liu, Xiaoru; Yan, Yuqing; Mendlowitz, Ariel; Hamilton, Robert M.			TMEM43 Mutation p.S358L Alters Intercalated Disc Protein Expression and Reduces Conduction Velocity in Arrhythmogenic Right Ventricular Cardiomyopathy	PLOS ONE			English	Article							LUMINAL CA2+ ACTIVATION; INNER NUCLEAR-MEMBRANE; SUDDEN-DEATH; CONNEXIN PHOSPHORYLATION; RYANODINE RECEPTOR; JUNCTIONAL COMMUNICATION; HL-1 CARDIOMYOCYTES; ACTIN CYTOSKELETON; CARDIAC MYOCYTES; TIGHT JUNCTION	Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a myocardial disease characterized by fibro-fatty replacement of myocardium in the right ventricular free wall and frequently results in life-threatening ventricular arrhythmias and sudden cardiac death. A heterozygous missense mutation in the transmembrane protein 43 (TMEM43) gene, p. S358L, has been genetically identified to cause autosomal dominant ARVC type 5 in a founder population from the island of Newfoundland, Canada. Little is known about the function of the TMEM43 protein or how it leads to the pathogenesis of ARVC. We sought to determine the distribution of TMEM43 and the effect of the p. S358L mutation on the expression and distribution of various intercalated (IC) disc proteins as well as functional effects on IC disc gap junction dye transfer and conduction velocity in cell culture. Through Western blot analysis, transmission electron microscopy (TEM), immunofluorescence (IF), and electrophysiological analysis, our results showed that the stable expression of p. S358L mutation in the HL-1 cardiac cell line resulted in decreased Zonula Occludens (ZO-1) expression and the loss of ZO-1 localization to cell-cell junctions. Junctional Plakoglobin (JUP) and a-catenin proteins were redistributed to the cytoplasm with decreased localization to cell-cell junctions. Connexin-43 (Cx43) phosphorylation was altered, and there was reduced gap junction dye transfer and conduction velocity in mutant TMEM43-transfected cells. These observations suggest that expression of the p. S358L mutant of TMEM43 found in ARVC type 5 may affect localization of proteins involved in conduction, alter gap junction function and reduce conduction velocity in cardiac tissue.	[Siragam, Vinayakumar; Cui, Xuezhi; Aafaqi, Shabana; Strandberg, Linn; Tropak, Michael; Fridman, Michael D.; Su, Bin; Wang, Caroline; Liu, Xiaoru; Yan, Yuqing; Mendlowitz, Ariel; Hamilton, Robert M.] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Siragam, Vinayakumar; Cui, Xuezhi; Ackerley, Cameron; Aafaqi, Shabana; Strandberg, Linn; Tropak, Michael; Fridman, Michael D.; Su, Bin; Wang, Caroline; Liu, Xiaoru; Yan, Yuqing; Mendlowitz, Ariel; Hamilton, Robert M.] Res Inst, Toronto, ON, Canada; [Masse, Stephane; Nanthakumar, Kumaraswamy] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Ackerley, Cameron] Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; [Liu, Jun; Su, Bin] Univ Toronto, Dept Mech & Ind Engn, Adv Micro & Nanosyst Lab, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Hamilton, RM (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	robert.hamilton@sickkids.ca	Liu, Jun/K-2919-2019; , Nanthakumar/AAA-9943-2020	Liu, Jun/0000-0002-5815-2483; Sun, Yu/0000-0001-7895-0741	Heart and Stroke Foundation of Canada [NA 6379]; CIHR Emerging Team Grant in ARVC; Caitlin Elizabeth Morris Fund of the Hospital for Sick Children Foundation; Alex Corrance Memorial Fund	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); CIHR Emerging Team Grant in ARVC; Caitlin Elizabeth Morris Fund of the Hospital for Sick Children Foundation; Alex Corrance Memorial Fund	This work was supported by the Heart and Stroke Foundation of Canada (#NA 6379), a CIHR Emerging Team Grant in ARVC, the Caitlin Elizabeth Morris Fund of the Hospital for Sick Children Foundation and the Alex Corrance Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; Asimaki A, 2007, AM J HUM GENET, V81, P964, DOI 10.1086/521633; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Baskin B, 2013, HUMAN GENETICS; Beffagna G, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-65; Bengtsson L, 2008, J CELL SCI, V121, P536, DOI 10.1242/jcs.019281; Cerrone M., 2013, HEART RHYTHM, V10, P1743, DOI [10.1016/j.hrthm.2013.09.019, DOI 10.1016/J.HRTHM.2013.09.019]; Christensen AH, 2011, CLIN GENET, V80, P256, DOI 10.1111/j.1399-0004.2011.01623.x; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Coonar AS, 1998, CIRCULATION, V97, P2049, DOI 10.1161/01.CIR.97.20.2049; DAVIS LM, 1995, J CARDIOVASC ELECTR, V6, P103, DOI 10.1111/j.1540-8167.1995.tb00762.x; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; Fidler LM, 2009, J CELL MOL MED, V13, P4219, DOI 10.1111/j.1582-4934.2008.00438.x; Franke WW, 2014, CELL TISSUE RES, V357, P159, DOI 10.1007/s00441-014-1865-1; George CH, 2006, CIRC RES, V98, P88, DOI 10.1161/01.RES.0000199296.70534.7c; George CH, 2003, CIRC RES, V93, P531, DOI 10.1161/01.RES.0000091335.07574.86; George CH, 2007, CIRC RES, V100, P874, DOI 10.1161/01.RES.0000260804.77807.cf; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Gizurarson S, 2012, CELL PHYSIOL BIOCHEM, V30, P477, DOI 10.1159/000339029; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Kim JC, 2010, PROG BIOPHYS MOL BIO, V103, P59, DOI 10.1016/j.pbiomolbio.2010.02.002; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Meinke P, 2011, BIOCHEM SOC T, V39, P1693, DOI 10.1042/BST20110658; Merner ND, 2008, AM J HUM GENET, V82, P809, DOI 10.1016/j.ajhg.2008.01.010; Milting H, 2014, EUR HEART J; Moreno AP, 2007, PROG BIOPHYS MOL BIO, V94, P107, DOI 10.1016/j.pbiomolbio.2007.03.004; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Oxford EM, 2007, CIRC RES, V101, P703, DOI 10.1161/CIRCRESAHA.107.154252; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Pilmer CM, 2013, HEART RHYTHM, V10, P517, DOI 10.1016/j.hrthm.2012.12.003; Pilmer CM, 2013, HEART RHYTHM; Platonov PG, 2011, J ELECTROCARDIOL, V44, P237, DOI 10.1016/j.jelectrocard.2010.08.008; Rajkumar R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-21; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Saffitz JE, 2000, AM J PHYSIOL-HEART C, V278, pH1662, DOI 10.1152/ajpheart.2000.278.5.H1662; Saffitz JE, 1999, CARDIOVASC RES, V42, P309, DOI 10.1016/S0008-6363(99)00023-1; Saffitz JE, 2009, HEART RHYTHM, V6, pS62, DOI 10.1016/j.hrthm.2009.03.003; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smyth JW, 2012, CIRC RES, V110, P978, DOI 10.1161/CIRCRESAHA.111.257964; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122; Tabib A, 2003, CIRCULATION, V108, P3000, DOI 10.1161/01.CIR.0000108396.65446.21; Takemura N, 2008, J CARDIOL, V51, P205, DOI 10.1016/j.jjcc.2008.03.003; Tandri H, 2008, J CARDIOVASC ELECTR, V19, P1212, DOI 10.1111/j.1540-8167.2008.01207.x; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Umapathy K, 2008, HEART RHYTHM, V5, P1029, DOI 10.1016/j.hrthm.2008.03.022; Vanpoucke G, 2004, NUCLEIC ACIDS RES, V32, P4155, DOI 10.1093/nar/gkh727; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wu JC, 2003, J CELL BIOCHEM, V88, P823, DOI 10.1002/jcb.10390	66	27	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109128	10.1371/journal.pone.0109128	http://dx.doi.org/10.1371/journal.pone.0109128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343256	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500008
J	Sun, DJY; Li, SX; Zhang, XT; Fernandez, C; Chen, W; Srinivasan, SR; Berenson, GS				Sun, Dianjianyi; Li, Shengxu; Zhang, Xiaotao; Fernandez, Camilo; Chen, Wei; Srinivasan, Sathanur R.; Berenson, Gerald S.			Uric Acid Is Associated with Metabolic Syndrome in Children and Adults in a Community: The Bogalusa Heart Study	PLOS ONE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; CELL-PROLIFERATION; INSULIN-RESISTANCE; YOUNG ADULTHOOD; SYNDROME-X; RISK; ADOLESCENTS; CHILDHOOD	Background: Elevated serum uric acid (UA) is commonly found in subjects with metabolic syndrome (MetS). This study examined the association of UA with levels of individual MetS components and the degree of their clustering patterns in both children and adults. Methods: The study sample consisted of 2614 children aged 4-18 years and 2447 adults aged 19-54 years. MetS components included body mass index (BMI), mean arterial pressure (MAP), triglycerides to high-density lipoprotein cholesterol ratio (TG/HDLC), and homeostasis model assessment of insulin resistance (HOMA). Observed/expected (O/E) ratio and intra-class correlation coefficient (ICC) were used as a measure of the degree of clustering of categorical and continuous MetS variables, respectively. Results: UA was positively and significantly associated only with BMI in children but with all four components in adults. The odds ratio for MetS associated with 1 mg/dL increase of UA was 1.74 (p<0.001) in children and 1.92 (p<0.001) in adults. O/E ratios showed a significant, increasing trend with increasing UA quartiles in both children and adults for 3- and 4-variable clusters with p-values for trend <0.001, except for BMI-MAP-TG/HDLC and MAP-TG/HDLC-HOMA clusters in children and MAP-TG/HDLC-HOMA cluster in adults. ICCs of 3 and 4 components increased with increasing UA quartiles in children and adults. Conclusions: These results indicate that UA may play a role in the development of MetS in both pediatric and adult populations alike, which may aid in the identification and treatment of high risk individuals for MetS and related clinical disorders in early life.	[Sun, Dianjianyi] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Sun, Dianjianyi; Li, Shengxu; Zhang, Xiaotao; Fernandez, Camilo; Chen, Wei; Srinivasan, Sathanur R.; Berenson, Gerald S.] Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA	Peking University; Tulane University	Berenson, GS (corresponding author), Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA.	berenson@tulane.edu	Zhang, Xiaotao/K-1581-2019	Zhang, Xiaotao/0000-0002-3968-5030; Sun, Dianjianyi/0000-0003-3651-6693	National Institute of Environmental Health Science [5R01ES021724]; National Institute on Aging [2R01AG016592]; American Heart Association [13SDG14650068]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants 5R01ES021724 from National Institute of Environmental Health Science, 2R01AG016592 from the National Institute on Aging and 13SDG14650068 from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; Alvarez-Lario B, 2011, QJM-INT J MED, V104, P1015, DOI 10.1093/qjmed/hcr159; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; BAO WH, 1994, ARCH INTERN MED, V154, P1842; Berenson GS., 1980, CARDIOVASCULAR RISK; Borges RL, 2010, CURR HYPERTENS REP, V12, P113, DOI 10.1007/s11906-010-0098-2; Chen W, 2000, DIABETES, V49, P1042, DOI 10.2337/diabetes.49.6.1042; Chen W, 2007, AM J EPIDEMIOL, V166, P527, DOI 10.1093/aje/kwm105; Chen W, 2011, EVOLUTION OF CARDIO-METABOLIC RISK FROM BIRTH TO MIDDLE AGE: THE BOGALUSA HEART STUDY, P35, DOI 10.1007/978-94-007-1451-9_4; Chiou WK, 2010, J EPIDEMIOL, V20, P219, DOI 10.2188/jea.JE20090078; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Cohen E, 2012, ISR MED ASSOC J, V14, P676; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Ford ES, 2008, J PEDIATR-US, V152, P160, DOI 10.1016/j.jpeds.2007.07.056; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; GINSBERG MH, 1977, J CLIN INVEST, V60, P999, DOI 10.1172/JCI108880; Girillo P, 2006, J AM SOC NEPHROL, V17, pS165, DOI 10.1681/ASN.2006080909; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Ishiro M, 2013, ANN NUTR METAB, V62, P169, DOI 10.1159/000346227; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Koga M, 2009, ACTA DIABETOL, V46, P141, DOI 10.1007/s00592-008-0072-5; Kuzuya M, 2002, J GERONTOL A-BIOL, V57, pM660, DOI 10.1093/gerona/57.10.M660; LEE J, 1995, AM J EPIDEMIOL, V142, P288, DOI 10.1093/oxfordjournals.aje.a117634; MACLACHLAN MJ, 1967, AM J MED, V42, P38, DOI 10.1016/0002-9343(67)90005-8; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Osgood K, 2013, METAB SYNDR RELAT D, V11, P157, DOI 10.1089/met.2012.0151; ROSNER B, 2000, FUNDAMENTALS BIOSTAT, P211; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Wang JY, 2012, J PEDIATR-US, V161, P753, DOI 10.1016/j.jpeds.2012.03.036; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; Yoo TW, 2005, CIRC J, V69, P928, DOI 10.1253/circj.69.928	44	35	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e89696	10.1371/journal.pone.0089696	http://dx.doi.org/10.1371/journal.pone.0089696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343690	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943500001
J	Tittarelli, E; Mistchenko, AS; Barrero, PR				Tittarelli, Estefania; Mistchenko, Alicia S.; Barrero, Paola R.			Dengue Virus 1 in Buenos Aires from 1999 to 2010: Towards Local Spread	PLOS ONE			English	Article							POPULATION-DYNAMICS; ARGENTINA; INFERENCE; AMERICA; TYPE-3; MODELS; GENOME; BRAZIL	Dengue virus (DENV) is a public health problem representing the most important arthropod-borne viral disease in humans. In Argentina, Northern provinces have reported autochthonous cases since 1997, though these outbreaks have originated in bordering countries, where co-circulation of more than one serotype has been reported. In the last decade, imported dengue cases have been reported in Buenos Aires, the urban area of Argentina with the highest population density. In 2009, a dengue outbreak affected Buenos Aires and, for the first time, local transmission was detected. All cases of this outbreak were caused by DENV-1. In this report, we present the full-length sequences of 27 DENV-1 isolates, corresponding to imported cases of 1999-2000, as well as local and imported cases of the 2009 and 2010 outbreaks. We analyzed their phylogenetic and phylodynamic relationships and their global and local spread. Additionally, we characterized their genomic and phenotypic features. All cases belonged to DENV-1 genotype V. The most recent ancestor for this genotype was dated similar to 1934, whereas that for the 2009 outbreak was dated similar to 2007. The mean rates of nucleotide substitution were 4.98E-4 and 8.53E-4 subs./site/yr, respectively. We inferred an introduction from Paraguay in 1999-2000 and mainly from Venezuela during 2009-2010. Overall, the number of synonymous substitutions per synonymous site significantly exceeded the number of non-synonymous substitutions per site and 12 positively selected sites were detected. These analyses could contribute to a better understanding regarding spread and evolution of this pathogen in the Southern Cone of South America.	[Tittarelli, Estefania; Mistchenko, Alicia S.; Barrero, Paola R.] Hosp Ninos Dr Ricardo Gutierrez, Virol Lab, Buenos Aires, DF, Argentina; [Tittarelli, Estefania; Barrero, Paola R.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Mistchenko, Alicia S.] Comis Invest Cient Prov Buenos Aires, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision de Investigaciones Cientificas	Tittarelli, E (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Virol Lab, Buenos Aires, DF, Argentina.	estefaniatittarelli@conicet.gov.ar			ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina [PICT2244/10]	ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina(ANPCyT)	This work was supported by ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina (grant PICT2244/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Barrero PR, 2004, VIRUS RES, V101, P135, DOI 10.1016/j.virusres.2003.12.033; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Di Rienzo J.A., INFOSTAT, VVersion 2020; Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770; Ding XX, 2011, CLIN VACCINE IMMUNOL, V18, P430, DOI 10.1128/CVI.00462-10; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludert JE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-51; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Resch W, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-65; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Roca Y, 2009, VECTOR-BORNE ZOONOT, V9, P337, DOI 10.1089/vbz.2008.0187; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Barrero PR, 2008, VIRUS RES, V135, P83, DOI 10.1016/j.virusres.2008.02.013; Seijo A, 2001, MEDICINA-BUENOS AIRE, V61, P137; Seijo A, 2009, MEDICINA-BUENOS AIRE, V69, P593; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	37	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111017	10.1371/journal.pone.0111017	http://dx.doi.org/10.1371/journal.pone.0111017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343372	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500075
J	Venugopalan, A; Ghorpade, RP; Chopra, A				Venugopalan, Anuradha; Ghorpade, Ravi P.; Chopra, Arvind			Cytokines in Acute Chikungunya	PLOS ONE			English	Article							VIRUS-INFECTION; INNATE IMMUNITY; EPIDEMIC; CHEMOKINES; DISEASE; PHASE; CELLS	Introduction: Acute chikungunya (CHIKV) is predominantly an acute onset of excruciatingly painful, self-limiting musculoskeletal (MSK) arbovirus illness and this was further reported by us during the 2006 Indian epidemic [Chopra et al. Epidemiol Infect 2012]. Selected serum cytokines profile in subjects within one month of onset of illness is being presented. Methods: Out of 509 clinical CHIKV cases (43% population) identified during a rural population survey, 225 subjects consented blood investigations. 132 examined within 30 days of febrile onset are the study cohort. Anti-CHIKV IgM and IgG antibodies tested by immunochromatography and indirect immunofluorescence respectively. Interferons (IFN)-alpha, -beta and -gamma, Interferon Gamma-Induced Protein-10 (CXCL-10/IP-10), Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 beta (IL-1 beta), Interleukin-6 (IL-6), Interleukin-13 (IL-13), Monocyte Chemoattractant Protein-1 (MCP-1), Interleukin-4 (IL-4) and Interleukin-10 (IL-10) performed by ELISA. Samples collected from neighboring community a year prior to the epidemic used as healthy controls. Results: Seropositivity for anti-CHIKV IgM and IgG was 65% and 52% respectively. IFN-alpha, IFN-beta, IFN-gamma, CXCL10/IP-10 and IL-1 beta showed intense response in early acute phase. Cytokines (particularly TNF-alpha, MCP-1, IL-4, IL-6 and IL-10) was maximum in extended symptomatic phase and remained elevated in recovered subjects. Higher (p<0.05) IFN and IL-4 seen in patients seropositive for anti-CHIKV IgG. Elderly cases (>= 65 years) showed elevated cytokines (except IFN) and anti-CHIKV antibodies near similar to younger subjects. Significant correlations (p<0.05) found between cytokines and clinical features (fatigue, low back ache, myalgia) and anti-CHIKV antibodies. Conclusion: An intense cytokine milieu was evident in the early and immediate persistent symptomatic phase and in recovered subjects. Early persistent IgM and lower IgG to anti-CHKV and intense Th2 cytokine phenotype seem to be associated with delay in resolution of MSK symptoms. Intriguingly, maximum TNF-alpha, IL-6 and IL-13 with low anti-CHIKV IgM response found in subjects recovered from CHIKV within one month of illness.	[Venugopalan, Anuradha; Ghorpade, Ravi P.; Chopra, Arvind] Ctr Rheumat Dis, Pune, Maharashtra, India		Venugopalan, A (corresponding author), Ctr Rheumat Dis, Pune, Maharashtra, India.	venugopalan_anuradha@hotmail.com			Indian Council of Medical Research (Government of India) [5/8/7/20/2006-ECD-I]; Arthritis Research Care Foundation (CRD, Pune)	Indian Council of Medical Research (Government of India)(Indian Council of Medical Research (ICMR)); Arthritis Research Care Foundation (CRD, Pune)	This project was funded by Indian Council of Medical Research (Government of India, 5/8/7/20/2006-ECD-I) and Arthritis Research Care Foundation (CRD, Pune). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2007, P NATL ACAD SCI USA, V104, P2827, DOI 10.1073/pnas.0700021104; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; BRIGHTON SW, 1983, S AFR MED J, V63, P313; Broom AK, 2003, MANSONS TROPICAL DIS, P737; Chaaitanya IK, 2011, VIRAL IMMUNOL, V24, P265, DOI 10.1089/vim.2010.0123; Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300; Chopra A., 2009, INDIAN J RHEUMATOL, V4, P119, DOI [10.1016/S0973-3698(10)60192-6, DOI 10.1016/S0973-3698(10)60192-6]; Chopra A, 2011, INDIAN J RHEUMATOL, V6, P5; Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753; Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446; El-Gabalawy HS, 2012, ARTHRITIS RHEUM-US, V64, P1720, DOI 10.1002/art.34449; GIFFORD GE, 1963, NATURE, V200, P50, DOI 10.1038/200050a0; Hapuarachchi H. A. C., 2008, CEYLON MEDICAL JOURNAL, V53, P104; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Kalantri SP, 2006, NATL MED J INDIA, V19, P315; Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003; Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Morceau F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/405016; Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261; Noridah O, 2007, Med J Malaysia, V62, P323; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005; Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	35	55	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111305	10.1371/journal.pone.0111305	http://dx.doi.org/10.1371/journal.pone.0111305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343623	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500097
J	Freeman, A; Bridge, JA; Maruthayanar, P; Overgaard, NH; Jung, JW; Simpson, F; Prow, TW; Soyer, HP; Frazer, IH; Freeman, M; Wells, JW				Freeman, Andrew; Bridge, Jennifer A.; Maruthayanar, Pirashanthini; Overgaard, Nana H.; Jung, Ji-Won; Simpson, Fiona; Prow, Tarl W.; Soyer, H. Peter; Frazer, Ian H.; Freeman, Michael; Wells, James W.			Comparative Immune Phenotypic Analysis of Cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in Immune-Competent Individuals: Proportional Representation of CD8(+) T-Cells but Not FoxP3(+) Regulatory T-Cells Is Associated with Disease Stage	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; INVARIANT NKT CELLS; SKIN-CANCER; ACTINIC KERATOSES; MAST-CELLS; PROGRESSION; IMIQUIMOD; TUMORS; EXPRESSION; REGRESSION	Squamous Cell Carcinoma (SCC) is a type of non-melanoma skin cancer prevalent in immune-suppressed transplant recipients and older individuals with a history of chronic sun-exposure. SCC itself is believed to be a late-stage manifestation that can develop from premalignant lesions including Intraepidermal Carcinoma (IEC). Notably, while SCC regression is rare, IEC typically regresses in response to immune modifying topical treatments, however the underlying immunological reasons for these differential responses remain unclear. This study aimed to define whether IEC and SCC are associated with distinct immune profiles. We investigated the immune cell infiltrate of photo-damaged skin, IEC, and SCC tissue using 10-colour flow cytometry following fresh lesion digest. We found that IEC lesions contain higher percentages of CD3(+) T-cells than photo-damaged skin, however, the abundance of CD3(-)CD56(+) Natural Killer (NK) cells, CD11c(+)HLA-DR+ conventional Dendritic Cells (cDC), BDCA-2(+)HLA-DR+ plasmacytoid DC (pDC), FoxP3(+) Regulatory T-cells (T-reg), V alpha 24(+)V beta 11(+) invariant NKT-cells, and gamma delta Tcells did not alter with disease stage. Within the total T-cell population, high percentages of CD4(+) T-cells were associated with SCC, yet CD8(+) T-cells were less abundant in SCC compared with IEC. Our study demonstrates that while IEC lesions contain a higher proportion of T-cells than SCC lesions in general, SCC lesions specifically display a lower abundance of CD8(+) T-cells than IEC. We propose that differences in CD8(+) T-cell abundance contribute critically to the different capacity of SCC and IEC to regress in response to immune modifying topical treatments. Our study also suggests that a high ratio of CD4(+) T-cells to CD8(+) T-cells may be a immunological diagnostic indicator of late-stage SCC development in immune-competent patients.	[Freeman, Andrew; Freeman, Michael] Pindara Private Hosp, Skin Ctr, Gold Coast, Australia; [Freeman, Andrew; Prow, Tarl W.; Soyer, H. Peter; Freeman, Michael] Univ Queensland, Sch Med, Dermatol Res Ctr, Translat Res Inst, Brisbane, Qld, Australia; [Bridge, Jennifer A.; Maruthayanar, Pirashanthini; Overgaard, Nana H.; Jung, Ji-Won; Simpson, Fiona; Frazer, Ian H.; Wells, James W.] Univ Queensland, Translat Res Inst, Univ Queensland Diamantina Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Wells, JW (corresponding author), Univ Queensland, Translat Res Inst, Univ Queensland Diamantina Inst, Brisbane, Qld, Australia.	j.wells3@uq.edu.au	Simpson, Fiona/J-2721-2012; Overgaard, Nana/A-3733-2016; Overgaard, Nana Haahr/P-2923-2019; Wells, James W./C-7480-2011; Simpson, Fiona/ABE-1276-2020; Soyer, H. Peter/W-3791-2017; Prow, Tarl/AAB-8359-2019; Soyer, H. Peter/E-6000-2010; Frazer, Ian/A-1137-2007	Simpson, Fiona/0000-0002-0271-781X; Overgaard, Nana/0000-0001-6916-9566; Overgaard, Nana Haahr/0000-0001-6916-9566; Wells, James W./0000-0002-9618-6940; Simpson, Fiona/0000-0002-0271-781X; Soyer, H. Peter/0000-0002-4770-561X; Prow, Tarl/0000-0003-2892-6238; Soyer, H. Peter/0000-0002-4770-561X; Frazer, Ian/0000-0002-8002-4680	University of Queensland New Staff Research Start-Up Fund; Perpetual Trustees Fellowship; Cancer Council Queensland project grant	University of Queensland New Staff Research Start-Up Fund(University of Queensland); Perpetual Trustees Fellowship; Cancer Council Queensland project grant(Cancer Council Queensland)	This work was supported by The University of Queensland New Staff Research Start-Up Fund (J.W.W), a Perpetual Trustees Fellowship (J.W.W) and a Cancer Council Queensland project grant (J.W.W and I.H.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkilic-Materna M, 2011, ACTA DERM-VENEREOL, V91, P432, DOI 10.2340/00015555-1099; Anwar J, 2004, CLIN DERMATOL, V22, P189, DOI 10.1016/j.clindermatol.2003.12.006; Beham A, 1998, Adv Anat Pathol, V5, P269, DOI 10.1097/00125480-199809000-00001; Berhane T, 2002, BRIT J DERMATOL, V146, P810, DOI 10.1046/j.1365-2133.2002.04720.x; Bier H, 1998, CANCER IMMUNOL IMMUN, V46, P167, DOI 10.1007/s002620050475; Bluth MJ, 2009, J INVEST DERMATOL, V129, P2451, DOI 10.1038/jid.2009.96; Carroll RP, 2010, J AM SOC NEPHROL, V21, P713, DOI 10.1681/ASN.2009060669; Chu PG, 2001, HISTOPATHOLOGY, V39, P9, DOI 10.1046/j.1365-2559.2001.01105.x; Clark RA, 2008, J EXP MED, V205, P2221, DOI 10.1084/jem.20071190; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; DODSON JM, 1991, ARCH DERMATOL, V127, P1029, DOI 10.1001/archderm.127.7.1029; Fukunaga A, 2010, J IMMUNOL, V185, P4633, DOI 10.4049/jimmunol.1000246; Parizi ACG, 2010, AN BRAS DERMATOL, V85, P811, DOI 10.1590/S0365-05962010000600006; HALLIDAY GM, 1995, WORLD J SURG, V19, P352, DOI 10.1007/BF00299157; Hanke CW, 2011, J DRUGS DERMATOL, V10, P165; Harnden P, 1997, J CLIN PATHOL, V50, P1032, DOI 10.1136/jcp.50.12.1032; Hope CM, 2014, KIDNEY INT; Hussein MR, 2005, CANCER BIOL THER, V4, P819, DOI 10.4161/cbt.4.8.1864; Jang TJ, 2008, YONSEI MED J, V49, P942, DOI 10.3349/ymj.2008.49.6.942; Junankar SR, 2006, J INVEST DERM SYMP P, V11, P36, DOI 10.1038/sj.jidsymp.5650024; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Kosmidis M, 2010, J IMMUNOTHER, V33, P538, DOI 10.1097/CJI.0b013e3181cc2615; Love WE, 2009, ARCH DERMATOL, V145, P1431, DOI 10.1001/archdermatol.2009.291; MARKS R, 1986, BRIT J DERMATOL, V115, P649, DOI 10.1111/j.1365-2133.1986.tb06644.x; Mattarollo SR, 2011, J IMMUNOL, V187, P1601, DOI 10.4049/jimmunol.1100756; Mattarollo SR, 2010, J IMMUNOL, V184, P1242, DOI 10.4049/jimmunol.0902191; Moodycliffe AM, 2000, NAT IMMUNOL, V1, P521, DOI 10.1038/82782; Muhleisen B, 2009, HISTOPATHOLOGY, V55, P67, DOI 10.1111/j.1365-2559.2009.03324.x; PATEL A, 1995, J DERMATOL SCI, V9, P12, DOI 10.1016/0923-1811(94)00344-E; Peguillet I, 2014, CANCER RES, V74, P2204, DOI 10.1158/0008-5472.CAN-13-2269; Sarchio SNE, 2014, J INVEST DERMATOL, V134, P1091, DOI 10.1038/jid.2013.424; SMOLLE J, 1987, BRIT J DERMATOL, V116, P823, DOI 10.1111/j.1365-2133.1987.tb04901.x; Ulrich C, 2003, BRIT J DERMATOL, V149, P40, DOI 10.1046/j.0366-077X.2003.05633.x; Ulrich C, 2010, EUR J DERMATOL, V20, P482, DOI 10.1684/ejd.2010.1010; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; Zhang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062154; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	38	30	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110928	10.1371/journal.pone.0110928	http://dx.doi.org/10.1371/journal.pone.0110928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340823	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800072
J	Kivuyo, HS; Mbazi, PH; Kisika, DS; Munga, S; Rumisha, SF; Urasa, FM; Kweka, EJ				Kivuyo, Happiness S.; Mbazi, Paschal H.; Kisika, Denis S.; Munga, Stephen; Rumisha, Susan F.; Urasa, Felister M.; Kweka, Eliningaya J.			Performance of Five Food Regimes on Anopheles gambiae Senso Stricto Larval Rearing to Adult Emergence in Insectary	PLOS ONE			English	Article							MALARIA VECTOR MOSQUITOS; WESTERN KENYA; QUADRIMACULATUS DIPTERA; LABORATORY CONDITIONS; HABITAT PRODUCTIVITY; DEVELOPMENT RATES; AEDES-AEGYPTI; MICHIGAN POND; MAIZE POLLEN; CULICIDAE	Background: Rearing of Anopheles gambiae s.s mosquitoes in insectary with quality cheap food sources is of paramount importance for better and healthy colony. This study evaluated larval survival and the development rate of aquatic stages of An. gambiae s.s under five food regimes; tetramin fish food (a standard insectary larval food), maize pollen, Cerelac, green filamentous algae and dry powdered filamentous algae. Methods: Food materials were obtained from different sources, cerelac was made locally, fresh filamentous algae was taken from water bodies, dry filamentous algae was ground to powder after it was dried under shade, and maize pollen was collected from the flowering maize. Each food source type was used to feed three densities of mosquito larvae 20, 60, and 100 in six replicates each. Larval age structure was monitored daily until pupation and subsequently adult emergence. Tetramin was used and taken as a standard food source for An. gambiae s.s. larvae feeding in Insectary. Results: Larval survivorship using maize pollen and Tetramin fish food was statistically insignificant (P = 0.564). However when compared to other food regime survivorship was significantly different with Tetramin fish food performing better than cerelac (P<0.001), dry algae (P<0.001) and fresh algae (P<0.001). The pupation rates and sex ratio of emerging adults had significant differences among the food regimes. Conclusion: The findings of this study have shown that maize pollen had closely similar nutritional value for larval survivorship to tetramin fish food, a standard larvae food in insectary. Further studies are required to assess the effect of food sources on various life traits of the emerged adults.	[Kivuyo, Happiness S.; Mbazi, Paschal H.; Kisika, Denis S.; Urasa, Felister M.] Univ Dar Es Salaam, Coll Nat & Appl Sci, Dept Zool & Wildlife Conservat, Dar Es Salaam, Tanzania; [Munga, Stephen] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Rumisha, Susan F.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Kweka, Eliningaya J.] Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, Arusha, Tanzania; [Kweka, Eliningaya J.] Catholic Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, Mwanza, Tanzania	University of Dar es Salaam; Kenya Medical Research Institute; National Institute of Medical Research	Kweka, EJ (corresponding author), Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, Arusha, Tanzania.	pat.kweka@gmail.com		Kweka, Eliningaya/0000-0002-8891-758X				Araujo MD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-261; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; DADD RH, 1978, ANN ENTOMOL SOC AM, V71, P794, DOI 10.1093/aesa/71.5.794; Das S., 2007, J VIS EXP, V221; Fish D., 2008, VECTOR BORNE DIS UND; Frouz J, 2009, AQUAT ECOL, V43, P487, DOI 10.1007/s10452-008-9178-7; Garros C, 2008, MOL ECOL RESOUR, V8, P512, DOI 10.1111/j.1471-8286.2007.02013.x; Gilbreath TM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-353; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Gouagna LC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-96; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; KARANJA DMS, 1994, ACTA TROP, V56, P365, DOI 10.1016/0001-706X(94)90107-4; Kebede A, 2005, AM J TROP MED HYG, V73, P676, DOI 10.4269/ajtmh.2005.73.676; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Kweka EJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-33; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-110; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; MCCRAE AWR, 1984, ANN TROP MED PARASIT, V78, P307, DOI 10.1080/00034983.1984.11811821; MCCRAE AWR, 1983, ANN TROP MED PARASIT, V77, P615, DOI 10.1080/00034983.1983.11811761; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Moribayashi Atsuko, 2004, Medical Entomology and Zoology, V55, P59; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Ng'habi KR, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-49; Schneider JR, 2004, J MED ENTOMOL, V41, P634, DOI 10.1603/0022-2585-41.4.634; Shawa ST, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-299; Takken W, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-345; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Vrzal EM, 2010, J INSECT PHYSIOL, V56, P1659, DOI 10.1016/j.jinsphys.2010.06.011; Wallace JR, 2004, J MED ENTOMOL, V41, P853, DOI 10.1603/0022-2585-41.5.853; Wallace JR, 1999, ENVIRON ENTOMOL, V28, P233, DOI 10.1093/ee/28.2.233; Yang GJ, 2008, ECOL APPL, V18, P2028, DOI 10.1890/07-1209.1; Ye-Ebiyo Y, 2003, J MED ENTOMOL, V40, P860, DOI 10.1603/0022-2585-40.6.860; Ye-Ebiyo Y, 2003, AM J TROP MED HYG, V68, P748, DOI 10.4269/ajtmh.2003.68.748; Ye-Ebiyo Y, 2000, AM J TROP MED HYG, V63, P90, DOI 10.4269/ajtmh.2000.63.90	35	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110671	10.1371/journal.pone.0110671	http://dx.doi.org/10.1371/journal.pone.0110671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340408	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800047
J	Lu, ZY; Wang, Y; Chen, F; Tong, HM; Reddy, MVVVS; Luo, L; Seshadrinathan, S; Zhang, L; Holthauzen, LMF; Craig, AM; Ren, G; Rudenko, G				Lu, Zhuoyang; Wang, Yun; Chen, Fang; Tong, Huimin; Reddy, M. V. V. V. Sekhar; Luo, Lin; Seshadrinathan, Suchithra; Zhang, Lei; Holthauzen, Luis Marcelo F.; Craig, Ann Marie; Ren, Gang; Rudenko, Gabby			Calsyntenin-3 Molecular Architecture and Interaction with Neurexin 1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Surface Receptor; Protein-Protein Interaction; Single-particle Analysis; Synapse; Calsyntenins; Neurexins; Neuropsychiatric Disorders; Synaptic Organizers	ELECTRON-MICROSCOPY; SYNAPTIC ADHESION; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; LIGAND-BINDING; BETA; VISUALIZATION; NEUROLIGIN; DIMERIZATION; PROMOTES	Background: Calsyntenin-3 (Cstn3) promotes synapse development, controversially interacting with neurexin 1 (n1). Results: Cstn3 binds n1 directly, and its structure adopts multiple forms. Conclusion: Cstn3 interacts with n1 via a novel mechanism and can produce distinct trans-synaptic bridges with n1. Significance: A complex portfolio of molecular interactions between proteins implicated in autism spectrum disorder and schizophrenia guide synapse development. Calsyntenin 3 (Cstn3 or Clstn3), a recently identified synaptic organizer, promotes the development of synapses. Cstn3 localizes to the postsynaptic membrane and triggers presynaptic differentiation. Calsyntenin members play an evolutionarily conserved role in memory and learning. Cstn3 was recently shown in cell-based assays to interact with neurexin 1 (n1), a synaptic organizer that is implicated in neuropsychiatric disease. Interaction would permit Cstn3 and n1 to form a trans-synaptic complex and promote synaptic differentiation. However, it is contentious whether Cstn3 binds n1 directly. To understand the structure and function of Cstn3, we determined its architecture by electron microscopy and delineated the interaction between Cstn3 and n1 biochemically and biophysically. We show that Cstn3 ectodomains form monomers as well as tetramers that are stabilized by disulfide bonds and Ca2+, and both are probably flexible in solution. We show further that the extracellular domains of Cstn3 and n1 interact directly and that both Cstn3 monomers and tetramers bind n1 with nanomolar affinity. The interaction is promoted by Ca2+ and requires minimally the LNS domain of Cstn3. Furthermore, Cstn3 uses a fundamentally different mechanism to bind n1 compared with other neurexin partners, such as the synaptic organizer neuroligin 2, because Cstn3 does not strictly require the sixth LNS domain of n1. Our structural data suggest how Cstn3 as a synaptic organizer on the postsynaptic membrane, particularly in tetrameric form, may assemble radially symmetric trans-synaptic bridges with the presynaptic synaptic organizer n1 to recruit and spatially organize proteins into networks essential for synaptic function.	[Reddy, M. V. V. V. Sekhar; Seshadrinathan, Suchithra; Rudenko, Gabby] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Holthauzen, Luis Marcelo F.; Rudenko, Gabby] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Lu, Zhuoyang; Tong, Huimin; Zhang, Lei; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Lu, Zhuoyang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China; [Lu, Zhuoyang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Luo, Lin; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Wang, Yun; Chen, Fang] Univ Michigan, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Xi'an Jiaotong University; Xi'an Jiaotong University; University of British Columbia; University of Michigan System; University of Michigan	Ren, G (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry Rm 2220,1 Cyclotron Rd,MS 67R2206, Berkeley, CA 94720 USA.	gren@lbl.gov	Rudenko, Gabrielle (Gabby)/O-7938-2018; M, Sekharreddy/C-9428-2014; Craig, Ann Marie/M-2054-2014; Ren, Gang/B-1567-2012; Reddy, M. V. V. V. Sekhar/I-1093-2019; Zhang, Lei/G-6427-2012	Rudenko, Gabrielle (Gabby)/0000-0002-7372-0530; Ren, Gang/0000-0002-8036-2321; Zhang, Lei/0000-0002-4880-824X; manukonda, veera/0000-0002-9917-8778	National Institutes of Health, NIMH [R01MH077303, R01MH070860]; Sealy Center for Structural Biology and Molecular Biophysics (UTMB); Brain and Behavior Research Foundation; United States Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860, R01MH077303] Funding Source: NIH RePORTER	National Institutes of Health, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sealy Center for Structural Biology and Molecular Biophysics (UTMB); Brain and Behavior Research Foundation; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health, NIMH, Grants R01MH077303 and R01MH070860. This work was also supported by the Sealy Center for Structural Biology and Molecular Biophysics (UTMB) and the Brain and Behavior Research Foundation. Work at the Molecular Foundry was supported by the United States Department of Energy under Contract DE-AC02-05CH11231.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Bena F, 2013, AM J MED GENET B, V162B, P388, DOI 10.1002/ajmg.b.32148; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Boucard AA, 2012, J BIOL CHEM, V287, P9399, DOI 10.1074/jbc.M111.318659; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grimm S, 2011, FREE RADICAL RES, V45, P73, DOI 10.3109/10715762.2010.512040; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lee SJ, 2012, J NEUROSCI, V32, P4688, DOI 10.1523/JNEUROSCI.5584-11.2012; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makagiansar IT, 2002, J BIOL CHEM, V277, P16002, DOI 10.1074/jbc.M200916200; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pettem KL, 2013, NEURON, V80, P113, DOI 10.1016/j.neuron.2013.07.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poulopoulos A, 2012, BIOCHEM J, V446, P321, DOI 10.1042/BJ20120808; Rames M, 2014, JOVE-J VIS EXP, DOI 10.3791/51087; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sheckler LR, 2006, J BIOL CHEM, V281, P22896, DOI 10.1074/jbc.M603464200; Shen KC, 2008, STRUCTURE, V16, P422, DOI 10.1016/j.str.2008.01.005; Shipman SL, 2012, P NATL ACAD SCI USA, V109, P19432, DOI 10.1073/pnas.1217633109; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Steuble M, 2012, BIOL OPEN, V1, P761, DOI 10.1242/bio.20121578; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Um JW, 2014, CELL REP, V6, P1096, DOI 10.1016/j.celrep.2014.02.010; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030249, 10.1371/journal.pone.0030592]; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493	48	36	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34530	34542		10.1074/jbc.M114.606806	http://dx.doi.org/10.1074/jbc.M114.606806			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25352602	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000346260800013
J	Fahrner, M; Muik, M; Schindl, R; Butorac, C; Stathopulos, P; Zheng, L; Jardin, I; Ikura, M; Romanin, C				Fahrner, Marc; Muik, Martin; Schindl, Rainer; Butorac, Carmen; Stathopulos, Peter; Zheng, Le; Jardin, Isaac; Ikura, Mitsuhiko; Romanin, Christoph			A Coiled-coil Clamp Controls Both Conformation and Clustering of Stromal Interaction Molecule 1 (STIM1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; ACTIVATES CRAC CHANNELS; PLASMA-MEMBRANE; CA2+ SENSOR; MECHANISTIC INSIGHTS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; ORAI CHANNELS; SAM DOMAIN; STORE	Store-operated Ca2+ entry, essential for the adaptive immunity, is initiated by the endoplasmic reticulum (ER) Ca2+ sensor STIM1. Ca2+ entry occurs through the plasma membrane resident Ca2+ channel Orai1 that directly interacts with the C-terminal STIM1 domain, named SOAR/CAD. Depletion of the ER Ca2+ store controls this STIM1/Orai1 interaction via transition to an extended STIM1 C-terminal conformation, exposure of the SOAR/CAD domain, and STIM1/Orai1 co-clustering. Here we developed a novel approach termed FRET-derived Interaction in a Restricted Environment (FIRE) in an attempt to dissect the interplay of coiled-coil (CC) interactions in controlling STIM1 quiescent as well as active conformation and cluster formation. We present evidence of a sequential activation mechanism in the STIM1 cytosolic domains where the interaction between CC1 and CC3 segment regulates both SOAR/CAD exposure and CC3-mediated higher-order oligomerization as well as cluster formation. These dual levels of STIM1 auto-inhibition provide efficient control over the coupling to and activation of Orai1 channels.	[Fahrner, Marc; Muik, Martin; Schindl, Rainer; Butorac, Carmen; Jardin, Isaac; Romanin, Christoph] Johannes Kepler Univ Linz, Inst Biophys, Life Sci Ctr JKU, A-4020 Linz, Austria; [Stathopulos, Peter] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Zheng, Le; Ikura, Mitsuhiko] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Zheng, Le; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	Johannes Kepler University Linz; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Romanin, C (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Life Sci Ctr JKU, Gruberstr 40, A-4020 Linz, Austria.	christoph.romanin@jku.at	Schindl, Rainer/V-4205-2019; Fahrner, Marc/AAI-7927-2021; Hoeglinger, Carmen/AAF-9364-2021; Romanin, Christoph/D-5399-2009; Jardin, Isaac/E-8310-2016; Schindl, Rainer/E-3959-2013	Romanin, Christoph/0000-0003-3756-4136; Jardin, Isaac/0000-0003-4575-8264; Schindl, Rainer/0000-0003-0896-8887; Ikura, Mitsuhiko/0000-0002-9524-1303; Fahrner, Marc/0000-0002-2689-0158; Hoglinger, Carmen/0000-0002-2754-592X; Stathopulos, Peter B./0000-0002-0536-6656	Austrian Science Fund (FWF) [P26067, M01506000, P25172, P27263]; Canadian Institutes for Health Research; Heart and Stroke Foundation of Canada; Austrian Science Fund (FWF) [M 1506, P 25172, P 27263] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF Project P26067, to R. S.; FWF Project M01506000, to I. J.; and FWF Project P25172 and P27263, to C. R.) and grant support by the Canadian Institutes for Health Research and Heart and Stroke Foundation of Canada (to M. I.).	Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Engh A, 2012, FRONT BIOSCI-LANDMRK, V17, P1613, DOI 10.2741/4007; Fahrner M, 2013, CHANNELS, V7, P330, DOI 10.4161/chan.26742; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Furukawa Y, 2014, J MOL BIOL, V426, P2082, DOI 10.1016/j.jmb.2014.03.006; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Misceo D, 2014, HUM MUTAT, V35, P556, DOI 10.1002/humu.22544; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2012, CELL MOL LIFE SCI, V69, P4163, DOI 10.1007/s00018-012-1072-8; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Nesin V, 2014, P NATL ACAD SCI USA, V111, P4197, DOI 10.1073/pnas.1312520111; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yu F, 2013, J CELL SCI, V126, P2401, DOI 10.1242/jcs.117200; Yu JW, 2013, BIOCHEM J, V454, P401, DOI 10.1042/BJ20130292; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhang W, 2011, CIRC RES, V109, P534, DOI 10.1161/CIRCRESAHA.111.246777; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; Zheng L, 2011, P NATL ACAD SCI USA, V108, P1337, DOI 10.1073/pnas.1015125108; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	48	88	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33231	33244		10.1074/jbc.M114.610022	http://dx.doi.org/10.1074/jbc.M114.610022			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25342749	hybrid, Green Published			2022-12-26	WOS:000345636600016
J	Bosiger, YJ; McCormick, MI				Bosiger, Yoland J.; McCormick, Mark I.			Temporal Links in Daily Activity Patterns between Coral Reef Predators and Their Prey	PLOS ONE			English	Article							ANTIPREDATOR RESPONSE; FEEDING-BEHAVIOR; ACTIVITY RHYTHMS; GAME-THEORY; FISH; RISK; DIEL; ABUNDANCE; COMPETITION; SERRANIDAE	Few studies have documented the activity patterns of both predators and their common prey over 24 h diel cycles. This study documents the temporal periodicity of two common resident predators of juvenile reef fishes, Cephalopholis cyanostigma (rockcod) and Pseudochromis fuscus (dottyback) and compares these to the activity and foraging pattern of a common prey species, juvenile Pomacentrus moluccensis (lemon damselfish). Detailed observations of activity in the field and using 24 h infrared video in the laboratory revealed that the two predators had very different activity patterns. C. cyanostigma was active over the whole 24 h period, with a peak in feeding strikes at dusk and increased activity at both dawn and dusk, while P. fuscus was not active at night and had its highest strike rates at midday. The activity and foraging pattern of P. moluccensis directly opposes that of C. cyanostigma with individuals reducing strike rate and intraspecific aggression at both dawn and dusk, and reducing distance from shelter and boldness at dusk only. Juveniles examined were just outside the size-selection window of P. fuscus. We suggest that the relatively predictable diel behaviour of coral reef predators results from physiological factors such as visual sensory abilities, circadian rhythmicity, variation in hunting profitability, and predation risk at different times of the day. Our study suggests that the diel periodicity of P. moluccensis behaviour may represent a response to increased predation risk at times when both the ability to efficiently capture food and visually detect predators is reduced.	[McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	McCormick, MI (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	mark.mccormick@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	Australian Research Council [DP0985015]	Australian Research Council(Australian Research Council)	This research was funded through an Australian Research Council Discovery grant to MIM (DP0985015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi J, 2013, MAR ECOL PROG SER, V486, P223, DOI 10.3354/meps10399; Ali MA, 1992, RHYTHMS FISHES; ALLDREDGE AL, 1977, MAR BIOL, V41, P317, DOI 10.1007/BF00389098; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Beukers-Stewart BD, 2011, CORAL REEFS, V30, P855, DOI 10.1007/s00338-011-0792-9; Beukers-Stewart BD, 2004, J EXP MAR BIOL ECOL, V299, P155, DOI 10.1016/j.jembe.2003.08.015; Booth DJ, 2004, OECOLOGIA, V140, P289, DOI 10.1007/s00442-004-1608-1; Bosiger YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034535; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; CLARK CW, 1988, AM NAT, V131, P271, DOI 10.1086/284789; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Colmenero AI, 2010, MAR ECOL PROG SER, V416, P255, DOI 10.3354/meps08766; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Danilowicz BS, 1999, MAR BIOL, V133, P337, DOI 10.1007/s002270050472; DOMM SB, 1973, PAC SCI, V27, P128; FEENER DH, 1988, BEHAV ECOL SOCIOBIOL, V22, P421, DOI 10.1007/BF00294980; Feeney WE, 2012, CORAL REEFS, V31, P909, DOI 10.1007/s00338-012-0894-z; Ferrari MCO, 2008, BEHAV ECOL, V19, P980, DOI 10.1093/beheco/arn056; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Ferrari MCO, 2009, ANIM BEHAV, V78, P11, DOI 10.1016/j.anbehav.2009.03.016; Fox RJ, 2011, FUNCT ECOL, V25, P1096, DOI 10.1111/j.1365-2435.2011.01874.x; Gibran FZ, 2007, NEOTROP ICHTHYOL, V5, P387, DOI 10.1590/S1679-62252007000300018; GLADSTONE W, 1988, ENVIRON BIOL FISH, V21, P207, DOI 10.1007/BF00004864; Green SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI 10.3354/meps09208; Guthrie D.M., 1993, Fish and Fisheries Series, V7, P89; HARMELINVIVIEN ML, 1976, MAR BIOL, V37, P329, DOI 10.1007/BF00387488; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479, DOI DOI 10.1007/978-94-011-1578-0; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; HELFMAN GS, 1981, CAN J FISH AQUAT SCI, V38, P1405, DOI 10.1139/f81-187; Hobson E.S., 1991, P69; Hobson E. S., 1965, Copeia, V1965, P291, DOI 10.2307/1440790; HOBSON ES, 1975, AM SCI, V63, P382; HOBSON ES, 1972, FISH BULL NATL OC AT, V70, P715; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Holmes TH, 2012, CORAL REEFS, V31, P1113, DOI 10.1007/s00338-012-0934-8; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; HUGIE DM, 1994, J FISH BIOL, V45, P151, DOI 10.1111/j.1095-8649.1994.tb01090.x; Kavanau JL, 1998, BRAIN RES BULL, V46, P269, DOI 10.1016/S0361-9230(98)00018-5; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lonnstedt OM, 2011, CORAL REEFS, V30, P805, DOI 10.1007/s00338-011-0768-9; Lonnstedt OM, 2013, ECOL EVOL, V3, P38, DOI 10.1002/ece3.388; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Martin JM, 1994, THESIS J COOK U; McCormick MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep03280; McCormick MI, 2013, ECOL EVOL, V3, P4221, DOI 10.1002/ece3.793; McCormick MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042590; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; McCormick MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007096; McFarland W.N., 1991, P16; Melinski M, 1990, BEHAV TELEOST FISHES, P285; Metcalfe NB, 1999, J ANIM ECOL, V68, P371, DOI 10.1046/j.1365-2656.1999.00289.x; Metcalfe NB, 1998, P ROY SOC B-BIOL SCI, V265, P1503, DOI 10.1098/rspb.1998.0464; Meyer CG, 2007, MAR BIOL, V151, P2133, DOI 10.1007/s00227-007-0647-7; Mitchell MD, 2013, BEHAV ECOL SOCIOBIOL, V67, P1123, DOI 10.1007/s00265-013-1537-2; Mitchell MD, 2011, ANIM COGN, V14, P707, DOI 10.1007/s10071-011-0405-6; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; MUNZ FW, 1973, VISION RES, V13, P1829, DOI 10.1016/0042-6989(73)90060-6; PITCHER TJ, 1986, J FISH BIOL, V29, P59, DOI 10.1111/j.1095-8649.1986.tb04999.x; POTTS GW, 1990, LIGHT AND LIFE IN THE SEA, P221; Quinn GP, 2003, EXPT DESIGN DATA ANA; Randall JE, 1997, FISHES GREAT BARRER; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; Rickel S, 2005, ANIM BEHAV, V70, P133, DOI 10.1016/j.anbehav.2004.10.014; RIECHERT SE, 1983, ANNU REV ECOL SYST, V14, P377, DOI 10.1146/annurev.es.14.110183.002113; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; Roth TC, 2007, AM NAT, V169, P264, DOI 10.1086/510605; SHPIGEL M, 1989, ENVIRON BIOL FISH, V24, P67, DOI 10.1007/BF00001611; Sih A, 2000, TRENDS ECOL EVOL, V15, P3, DOI 10.1016/S0169-5347(99)01766-8; Smith R. Jan F., 1997, P163; Stephens D.W., 1986, pi; Stephens David W., 1993, P195; Stewart BD, 2000, MAR ECOL PROG SER, V197, P259, DOI 10.3354/meps197259; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; Stier AC, 2014, CORAL REEFS, V33, P181, DOI 10.1007/s00338-013-1077-2; Sullivan AM, 2005, CHEM SIGNAL, V10, P349, DOI 10.1007/0-387-25160-X_40; SWEATMAN HPA, 1984, COPEIA, P187; Tessmar-Raible K, 2011, BIOESSAYS, V33, P165, DOI 10.1002/bies.201000096; Vail AL, 2011, BIOL LETTERS, V7, P921, DOI 10.1098/rsbl.2011.0380; WOLFE JL, 1989, ANIM BEHAV, V37, P410, DOI 10.1016/0003-3472(89)90088-2; WURTSBAUGH W, 1985, LIMNOL OCEANOGR, V30, P565, DOI 10.4319/lo.1985.30.3.0565; Yahel R, 2005, LIMNOL OCEANOGR, V50, P930, DOI 10.4319/lo.2005.50.3.0930; Zeller DC, 1997, MAR ECOL PROG SER, V154, P65, DOI 10.3354/meps154065	86	17	17	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111723	10.1371/journal.pone.0111723	http://dx.doi.org/10.1371/journal.pone.0111723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354096	Green Published, gold, Green Accepted			2022-12-26	WOS:000345204200093
J	Ibanez, F; Hancock, J; Tamborindeguy, C				Ibanez, Freddy; Hancock, Joseph; Tamborindeguy, Cecilia			Identification and Expression Analysis of Aquaporins in the Potato Psyllid, Bactericera cockerelli	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEINS; FUNCTIONAL-CHARACTERIZATION; WATER CHANNEL; PEA APHID; MOLECULAR CHARACTERIZATION; GUT SUCRASE; INSECT	Aquaporin (AQPs) proteins transport water and uncharged low molecular-weight solutes across biological membranes. Six to 8 AQP genes have been identified in many insect species, but presently only three aquaporins have been characterized in phloem feeding insects. The objective of this study was to identify candidate AQPs in the potato psyllid, Bactericera cockerelli. Herein, we identified four candidate aquaporin cDNAs in B. cockerelli transcriptome. Phylogenetic analysis showed that candidate BcAQP2-like had high similarity to PRIP aquaporins; while candidates BcAQP4-like, BcAQP5-like and BcAQP9-like clustered within clade B. In particular, candidates BcAQP4-like and BcAQP5-like clustered with functionally validated insect aquaglyceroporin proteins. Expression analyses using RT-qPCR showed that all candidates were expressed in all life stages and tissues. Candidates BcAQP4-like and BcAQP5-like were highly expressed in bacteriocytes, while BcAQP9-like appeared to be expressed at high levels in whole body but not in the assayed tissues. This study is the first global attempt to identify putative aquaporins in a phloem feeding insect.	[Ibanez, Freddy; Hancock, Joseph; Tamborindeguy, Cecilia] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Tamborindeguy, C (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ctamborindeguy@ag.tamu.edu			NIFA-AFRI [2012-67013-19431]; Texas AM University; Texas A&M Agrilife Research start-up funds; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	NIFA-AFRI; Texas AM University; Texas A&M Agrilife Research start-up funds; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	Funding for this work was provided by NIFA-AFRI grant 2012-67013-19431, Texas A&M University and Texas A&M Agrilife Research start-up funds. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	AGRE P, 1987, J BIOL CHEM, V262, P17497; Agre P, 2009, J VIS EXP; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Ashford DA, 2000, J INSECT PHYSIOL, V46, P335, DOI 10.1016/S0022-1910(99)00186-9; Azuma M, 2012, J INSECT PHYSIOL, V58, P523, DOI 10.1016/j.jinsphys.2012.01.007; Bienert GP, 2008, TRENDS BIOCHEM SCI, V33, P20, DOI 10.1016/j.tibs.2007.10.004; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Cicero JM, 2009, ANN ENTOMOL SOC AM, V102, P650, DOI 10.1603/008.102.0410; CROSSLIN JM, 2010, PLANT HLTH PROGR, DOI DOI 10.1094/PHP-2010-0317-1001-RV; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Fabrick JA, 2014, INSECT BIOCHEM MOLEC, V45, P125, DOI 10.1016/j.ibmb.2013.12.002; Goto SG, 2011, J INSECT PHYSIOL, V57, P1106, DOI 10.1016/j.jinsphys.2011.03.023; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Herraiz A, 2011, J EXP BIOL, V214, P3630, DOI 10.1242/jeb.057406; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Karley AJ, 2005, J INSECT PHYSIOL, V51, P1313, DOI 10.1016/j.jinsphys.2005.08.001; Kataoka N, 2009, INSECT MOL BIOL, V18, P303, DOI 10.1111/j.1365-2583.2009.00871.x; Kaufmann N, 2005, AM J PHYSIOL-CELL PH, V289, pC397, DOI 10.1152/ajpcell.00612.2004; Kikawada T, 2008, BBA-BIOMEMBRANES, V1778, P514, DOI 10.1016/j.bbamem.2007.11.009; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Mathew LG, 2011, INSECT BIOCHEM MOLEC, V41, P178, DOI 10.1016/j.ibmb.2010.12.002; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P307, DOI 10.1016/j.ibmb.2006.12.005; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Salvucci ME, 1997, J INSECT PHYSIOL, V43, P457, DOI 10.1016/S0022-1910(96)00124-2; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Staniscuaski F, 2013, J INSECT PHYSIOL, V59, P1140, DOI 10.1016/j.jinsphys.2013.08.013; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wallace IS, 2012, BBA-BIOMEMBRANES, V1818, P627, DOI 10.1016/j.bbamem.2011.11.032; Yakata K, 2007, BBA-BIOMEMBRANES, V1768, P688, DOI 10.1016/j.bbamem.2006.11.005	41	20	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111745	10.1371/journal.pone.0111745	http://dx.doi.org/10.1371/journal.pone.0111745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354208	gold, Green Published, Green Submitted			2022-12-26	WOS:000345204200094
J	Zhao, LQ; Qu, L; Zhou, J; Sun, ZD; Zou, H; Chen, YY; Marks, JD; Zhou, Y				Zhao, Lequn; Qu, Liang; Zhou, Jing; Sun, Zhengda; Zou, Hao; Chen, Yunn-Yi; Marks, James D.; Zhou, Yu			High Throughput Identification of Monoclonal Antibodies to Membrane Bound and Secreted Proteins Using Yeast and Phage Display	PLOS ONE			English	Article							NEUROTOXIN TYPE-A; BREAST-CANCER; SURFACE DISPLAY; SACCHAROMYCES-CEREVISIAE; RECEPTOR ANTIBODIES; EXPRESSION SYSTEMS; CD44 ISOFORMS; AFFINITY; CELLS; LIBRARIES	Antibodies are ubiquitous and essential reagents for biomedical research. Uses of antibodies include quantifying proteins, identifying the temporal and spatial pattern of expression in cells and tissue, and determining how proteins function under normal or pathological conditions. Specific antibodies are only available for a small portion of the proteome, limiting study of those proteins for which antibodies do not exist. The technologies to generate target-specific antibodies need to be improved to obtain high quality antibodies to the proteome at reasonable cost. Here we show that renewable, validated, and standardized monoclonal antibodies can be generated at high throughput, without the need for antigen production or animal immunizations. In this study, 60 protein domains from 24 selected secreted proteins were expressed on the surface of yeast and used for selection of phage antibodies, over 400 monoclonal antibodies were identified within 3 weeks. A subset of these antibodies was validated for binding to cancer cells that overexpress the target protein by flow cytometry or immunohistochemistry. This approach will be applicable to many of the membrane-bound and the secreted proteins, 20-40% of the proteome, accelerating the timeline for Ab generation while reducing the cost.	[Zhao, Lequn; Qu, Liang; Zhou, Jing; Sun, Zhengda; Zou, Hao; Marks, James D.; Zhou, Yu] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marks, JD (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	marksj@anesthesia.ucsf.edu; zhoue@anesthesia.ucsf.edu			NCI of the National Institutes of Health [P50 CA58207]; NATIONAL CANCER INSTITUTE [P50CA058207] Funding Source: NIH RePORTER	NCI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by NCI of the National Institutes of Health under award number P50 CA58207. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggen DH, 2010, PROTEIN ENG DES SEL; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; [Anonymous], 2008, CURRENT PROTOCOLS MO; Baggetta R, 2010, EUR J IMMUNOL, V40, P2182, DOI 10.1002/eji.200939995; Benedict CA, 1997, J IMMUNOL METHODS, V201, P223, DOI 10.1016/S0022-1759(96)00227-X; Berner HS, 2001, BREAST CANCER RES TR, V65, P23, DOI 10.1023/A:1006417412046; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Cho EY, 2006, PATHOL INT, V56, P62, DOI 10.1111/j.1440-1827.2006.01925.x; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Dimitrov Dimiter S., 2009, V525, P1, DOI 10.1007/978-1-59745-554-1_1; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Gerngross TU, 2004, NAT BIOTECHNOL, V22, P1409, DOI 10.1038/nbt1028; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goding JW, 1983, MONOCLONAL ANTIBODIE; Grimsey NL, 2008, J NEUROSCI METH, V171, P78, DOI 10.1016/j.jneumeth.2008.02.014; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Huie MA, 2001, P NATL ACAD SCI USA, V98, P2682, DOI 10.1073/pnas.051631798; Isserlin R, 2007, PROTEOM CLIN APPL, V1, P1156, DOI 10.1002/prca.200700146; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Klee EW, 2008, ZEBRAFISH, V5, P131, DOI 10.1089/zeb.2008.0529; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Merritt WM, 2007, DIS MARKERS, V23, P419, DOI 10.1155/2007/257602; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen UB, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-24; O'Connell D, 2002, J MOL BIOL, V321, P49, DOI 10.1016/S0022-2836(02)00561-2; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Piatesi A, 2006, PROTEIN EXPRES PURIF, V48, P232, DOI 10.1016/j.pep.2006.01.026; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Pozner-Moulis S, 2007, LAB INVEST, V87, P251, DOI 10.1038/labinvest.3700515; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Reichert JM, 2009, MABS, V1, P387, DOI 10.4161/mabs.1.4.9031; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; ROBINSON AS, 1994, BIO-TECHNOL, V12, P381, DOI 10.1038/nbt0494-381; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Shiozaki M, 2011, ONCOL LETT, V2, P429, DOI 10.3892/ol.2011.264; Spellman PT, 2006, TRANSCRIPTION PROFIL; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Watanabe O, 2005, J EXP CLIN CANC RES, V24, P75; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071048; Zavrides HN, 2005, FOLIA HISTOCHEM CYTO, V43, P31; Zhou Y, 2012, MOL CANCER THER, V11, P1467, DOI 10.1158/1535-7163.MCT-11-1038; Zhou Y, 2010, J MOL BIOL, V404, P88, DOI 10.1016/j.jmb.2010.09.006	57	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111339	10.1371/journal.pone.0111339	http://dx.doi.org/10.1371/journal.pone.0111339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353955	Green Submitted, Green Published, gold			2022-12-26	WOS:000345204200073
J	Ankarfeldt, MZ; Larsen, SC; Angquist, L; Husemoen, LLN; Roswall, N; Overvad, K; Jakobsen, MU; Halkjaer, J; Tjonneland, A; Linneberg, A; Toft, U; Hansen, T; Pedersen, O; Heitmann, BL; Astrup, A; Sorensen, TIA				Ankarfeldt, Mikkel Z.; Larsen, Sofus C.; Angquist, Lars; Husemoen, Lise Lotte N.; Roswall, Nina; Overvad, Kim; Jakobsen, Marianne Uhre; Halkjaer, Jytte; Tjonneland, Anne; Linneberg, Allan; Toft, Ulla; Hansen, Torben; Pedersen, Oluf; Heitmann, Berit L.; Astrup, Arne; Sorensen, Thorkild I. A.			Interaction between Genetic Predisposition to Adiposity and Dietary Protein in Relation to Subsequent Change in Body Weight and Waist Circumference	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; GLYCEMIC INDEX; CONFER RISK; MASS INDEX; VARIANTS; LOCI; MEN; METAANALYSIS	Background: Genetic predisposition to adiposity may interact with dietary protein in relation to changes of anthropometry. Objective: To investigate the interaction between genetic predisposition to higher body mass index (BMI), waist circumference (WC) or waist-hip ratio adjusted for BMI (WHRBMI) and dietary protein in relation to subsequent change in body weight (DBW) or change in WC (DWC). Design: Three different Danish cohorts were used. In total 7,054 individuals constituted the study population with information on diet, 50 single-nucleotide polymorphisms (SNPs) associated with BMI, WC or WHRBMI, as well as potential confounders. Mean follow-up time was similar to 5 years. Four genetic predisposition-scores were based on the SNPs; a complete-score including all selected adiposity-associated SNPs, and three scores including BMI, WC or WHRBMI associated polymorphisms, respectively. The association between protein intake and Delta BW or Delta WC were examined and interactions between SNP-score and protein were investigated. Analyses were based on linear regressions using macronutrient substitution models and meta-analyses. Results: When protein replaced carbohydrate, meta-analyses showed no associations with Delta BW (41.0 gram/y/5 energy% protein, [95% CI: 232.3; 114.3]) or Delta WC (<-0.1 mm/y/5 energy % protein, [-1.1; 1.1]). Similarly, there were no interactions for any SNP-scores and protein for either Delta BW (complete SNP-score: 1.8 gram/y/5 energy% protein/risk allele, [-7.0; 10.6]) or Delta WC (complete SNP-score: <0.1 mm/y/5 energy% protein/risk allele, [-0.1; 0.1]). Similar results were seen when protein replaced fat. Conclusion: This study indicates that the genetic predisposition to general and abdominal adiposity, assessed by gene-scores, does not seem to modulate the influence of dietary protein on Delta BW or Delta WC.	[Ankarfeldt, Mikkel Z.; Larsen, Sofus C.; Angquist, Lars; Heitmann, Berit L.; Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Ankarfeldt, Mikkel Z.; Larsen, Sofus C.] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark; [Husemoen, Lise Lotte N.; Linneberg, Allan; Toft, Ulla] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Roswall, Nina; Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Overvad, Kim; Jakobsen, Marianne Uhre] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res,Sect Metab Genet, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Astrup, Arne] Univ Copenhagen, NEXS, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; Danish Cancer Society; Aarhus University; Aalborg University; Aalborg University Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Southern Denmark; University of Sydney; University of Copenhagen	Ankarfeldt, MZ (corresponding author), Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark.	mikkelza@gmail.com	Toft, Ulla/AAH-2589-2020; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Jakobsen, Marianne Uhre/I-8550-2018; Larsen, Sofus Christian/AAO-5894-2020; Roswall, Nina/AAJ-6700-2020; Astrup, Arne/B-1407-2015	Toft, Ulla/0000-0001-7770-8419; Pedersen, Oluf/0000-0002-3321-3972; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Larsen, Sofus Christian/0000-0002-0838-9378; Roswall, Nina/0000-0003-3071-1658; Overvad, Kim/0000-0001-6429-7921; Hansen, Torben/0000-0001-8748-3831; Tjonneland, Anne/0000-0003-4385-2097; Linneberg, Allan/0000-0002-0994-0184; Astrup, Arne/0000-0001-8968-8996; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Angquist, Lars/0000-0002-9516-4424	Danish Council for Strategic Research [09-067111]; Danish Medical Research Council; Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk; Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus foundation; Ib Henriksen foundation; Becket foundation	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk(Novo Nordisk); Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus foundation; Ib Henriksen foundation; Becket foundation	This work is carried out as a part of the research program of Gene-Diet Interactions in Obesity (GENDINOB). GENDINOB is supported by the Danish Council for Strategic Research (Grant 09-067111). Data collection in the INTER99 study was supported economically by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County, The Danish Heart Foundation, The Danish Pharmaceutical Association, Augustinus foundation, Ib Henriksen foundation and Becket foundation. The support by Novo Nordisk and The Danish Pharmaceutical Association were unconditional grants. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Adegboye ARA, 2010, J NUTR, V140, P1864, DOI 10.3945/jn.109.117770; Aller EE, 2014, INT J OBES LOND; Ankarfeldt MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101134; Ankarfeldt MZ, 2014, INT J OBES IN PRESS; Bender AM, 2012, EUROPEAN J PREVENTIV; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bigaard J, 2005, J NUTR, V135, P2263; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017436; Due A, 2004, INT J OBESITY, V28, P1283, DOI 10.1038/sj.ijo.0802767; Fisher E, 2012, AM J CLIN NUTR, V95, P1468, DOI 10.3945/ajcn.111.014670; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Halkjaer J, 2011, INT J OBESITY, V35, P1104, DOI 10.1038/ijo.2010.254; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heitmann BL, 2009, OBESITY, V17, P136, DOI 10.1038/oby.2008.479; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Larsen LH, 2012, AM J CLIN NUTR, V95, P1254, DOI 10.3945/ajcn.111.016543; Larsen SC, 2014, AM J CLIN NUTR; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; MOLLER A, 1996, LEVNEDSMIDDELTABELLE; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sterne JACe, 2009, MET STAT UPD COLL ST; Stocks T, 2013, HUM HERED, V75, P213, DOI 10.1159/000353591; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Toft U, 2008, EUR J CLIN NUTR, V62, P1038, DOI 10.1038/sj.ejcn.1602815; Vergnaud AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057300; Vimaleswaran KS, 2012, OBESITY, V20, P1669, DOI 10.1038/oby.2012.49; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110890	10.1371/journal.pone.0110890	http://dx.doi.org/10.1371/journal.pone.0110890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350854	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943100047
J	Loomis, WP; Johnson, ML; Brasfield, A; Blanc, MP; Yi, J; Miller, SI; Cookson, BT; Hajjar, AM				Loomis, Wendy P.; Johnson, Matthew L.; Brasfield, Alicia; Blanc, Marie-Pierre; Yi, Jaehun; Miller, Samuel I.; Cookson, Brad T.; Hajjar, Adeline M.			Temporal and Anatomical Host Resistance to Chronic Salmonella Infection Is Quantitatively Dictated by Nramp1 and Influenced by Host Genetic Background	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MESENTERIC LYMPH-NODES; NATURAL-RESISTANCE; INTRACELLULAR PARASITES; SEQUENCE-ANALYSIS; MOUSE STRAINS; MICE; MACROPHAGES; DISEASE; DISSEMINATION	The lysosomal membrane transporter, Nramp1, plays a key role in innate immunity and resistance to infection with intracellular pathogens such as non-typhoidal Salmonella (NTS). NTS-susceptible C57BL/6 (B6) mice, which express the mutant Nramp1(D169) allele, are unable to control acute infection with Salmonella enterica serovar Typhimurium following intraperitoneal or oral inoculation. Introducing functional Nramp1(G169) into the B6 host background, either by constructing a congenic strain carrying Nramp1(G169) from resistant A/J mice (Nramp-Cg) or overexpressing Nramp1(G169) from a transgene (Nramp-Tg), conferred equivalent protection against acute Salmonella infection. In contrast, the contributions of Nramp1 for controlling chronic infection are more complex, involving temporal and anatomical differences in Nramp1-dependent host responses. Nramp-Cg, Nramp-Tg and NTS-resistant 129x1/SvJ mice survived oral Salmonella infection equally well for the first 2-3 weeks, providing evidence that Nramp1 contributes to the initial control of NTS bacteremia preceding establishment of chronic Salmonella infection. By day 30, increased host Nramp1 expression (Tg>Cg) provided greater protection as indicated by decreased splenic bacterial colonization (Tg<Cg). However, despite controlling bacterial growth within MLN as effectively as 129x1/SvJ mice, Nramp-Cg and Nramp-Tg mice eventually succumbed to infection. These data indicate: 1) discrete, anatomically localized host resistance is conferred by Nramp1 expression in NTS-susceptible mice, 2) restriction of systemic bacterial growth in the spleens of NTS-susceptible mice is enhanced by Nramp1 expression and dose-dependent, and 3) host genes other than Nramp1 also contribute to the ability of NTS-resistant 129x1/SvJ mice to control bacterial replication during chronic infection.	[Loomis, Wendy P.; Johnson, Matthew L.; Cookson, Brad T.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Brasfield, Alicia; Yi, Jaehun; Hajjar, Adeline M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Blanc, Marie-Pierre; Miller, Samuel I.; Cookson, Brad T.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hajjar, AM (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	hajjar@uw.edu		Hajjar, Adeline/0000-0002-4838-8070	National Institute of Allergy and Infectious Diseases (NIAID) [U54 AI057141, U19 AI 090882]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090882, U54AI057141] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) under U54 AI057141 (SIM as PI, with core to AMH) and U19 AI 090882 (SIM as PI, with project to BTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrego A, 2006, MICROBES INFECT, V8, P2766, DOI 10.1016/j.micinf.2006.08.005; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; Brown D. E., 2013, VET PATHOL; Caron J, 2005, GENES IMMUN, V6, P500, DOI 10.1038/sj.gene.6364234; Crome SQ, 2013, TRENDS IMMUNOL, V34, P342, DOI 10.1016/j.it.2013.03.002; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Griffin AJ, 2011, INFECT IMMUN, V79, P1479, DOI 10.1128/IAI.01033-10; Hajjar AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002963; Johanns TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001043; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Mastroeni P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001840; McCoy MW, 2012, INFECT IMMUN, V80, P3642, DOI 10.1128/IAI.00656-12; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Melles DC, 2004, NETH J MED, V62, P45; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Nakanaga K, 1999, J VET MED SCI, V61, P717, DOI 10.1292/jvms.61.717; NAUCIEL C, 1988, INFECT IMMUN, V56, P2407, DOI 10.1128/IAI.56.9.2407-2411.1988; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; PLANT J, 1974, NATURE, V248, P345, DOI 10.1038/248345a0; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; Sancho-Shimizu V, 2007, GENETICS, V177, P1125, DOI 10.1534/genetics.107.075523; Trezena AG, 2002, MICROBES INFECT, V4, P1409, DOI 10.1016/S1286-4579(02)00023-0; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Vidal SM, 1996, J IMMUNOL, V157, P3559; Voedisch S, 2009, INFECT IMMUN, V77, P3170, DOI 10.1128/IAI.00272-09; Watson KG, 2010, CELL MICROBIOL, V12, P1389, DOI 10.1111/j.1462-5822.2010.01511.x; Workman MR, 1996, BRIT MED J, V312, P1359, DOI 10.1136/bmj.312.7042.1359c; Yang IV, 2009, GENETICS, V183, P1535, DOI 10.1534/genetics.109.107540; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004	34	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111763	10.1371/journal.pone.0111763	http://dx.doi.org/10.1371/journal.pone.0111763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350459	Green Published, gold			2022-12-26	WOS:000343943100079
J	Saxena, N; Kumar, V				Saxena, Nehul; Kumar, Vijay			The HBx Oncoprotein of Hepatitis B Virus Deregulates the Cell Cycle by Promoting the Intracellular Accumulation and Re-Compartmentalization of the Cellular Deubiquitinase USP37	PLOS ONE			English	Article							TRCP UBIQUITIN LIGASE; X-PROTEIN; BETA-CATENIN; DEPENDENT PROTEOLYSIS; DEGRADATION; EXPRESSION; TRANSACTIVATION; DESTRUCTION; CHECKPOINT; COMPLEX	The HBx oncoprotein of hepatitis B Virus has been accredited as one of the protagonists in driving hepatocarcinogenesis. HBx exerts its influence over the cell cycle progression by potentiating the activity of cyclin A/E CDK2 complex, the Cyclin A partner of which is a well-known target of cellular deubiquitinase USP37. In the present study, we observed the intracellular accumulation of cyclin A and USP37 proteins under the HBx microenvironment. Flow cytometry analysis of the HBx-expressing cells showed deregulation of cell cycle apparently due to the enhanced gene expression and stabilization of USP37 protein and deubiquitination of Cyclin A by USP37. Our co-immunoprecipitation and confocal microscopic studies suggested a direct interaction between USP37 and HBx. This interaction promoted the translocation of USP37 outside the nucleus and prevented its association and ubiquitination by E3 ubiquitin ligases - APC/CDH1 and SCF/beta-TrCP. Thus, HBx seems to control the cell cycle progression via the cyclin A-CDK2 complex by regulating the intracellular distribution and stability of deubiquitinase USP37.	[Saxena, Nehul; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Marg, New Delhi, India.	vijay@icgeb.res.in			Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR12658/BRB/10/712/2009]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grant no. BT/PR12658/BRB/10/712/2009 of the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India (to VK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja R, 2014, CURR SCI IN PRESS; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Chae S, 2013, CARCINOGENESIS, V34, P1680, DOI 10.1093/carcin/bgt105; Da Silva-Ferrada E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025397; Das CM, 2013, ONCOGENE, V32, P1691, DOI 10.1038/onc.2012.182; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; Forgues M, 2001, J BIOL CHEM, V276, P22797, DOI 10.1074/jbc.M101259200; Fukushima H, 2013, CELL REP, V4, P803, DOI 10.1016/j.celrep.2013.07.031; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hung L, 2004, FEBS LETT, V560, P210, DOI 10.1016/S0014-5793(04)00113-9; Jacobs HW, 2001, EMBO J, V20, P2376, DOI 10.1093/emboj/20.10.2376; Jung JK, 2007, J GEN VIROL, V88, P2144, DOI 10.1099/vir.0.82836-0; Kapoor NR, 2012, P NATL A SCI INDIA B, V82, P31, DOI 10.1007/s40011-011-0003-z; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kumar V, 1996, P NATL ACAD SCI USA, V93, P5647, DOI 10.1073/pnas.93.11.5647; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Pandey V, 2012, J BIOL CHEM, V287, P20545, DOI 10.1074/jbc.M112.359760; Saxena N, 2013, VIROL DISCOV, V1, P5, DOI DOI 10.7243/2052-6202-1-5; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Sidhu K, 2014, MASS SPECTR IN PRESS; Studach L, 2010, J BIOL CHEM, V285, P30282, DOI 10.1074/jbc.M109.093963; Tanno H, 2014, J BIOL CHEM, V289, P2415, DOI 10.1074/jbc.M113.528372; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Yang WC, 2013, ONCOGENE, V32, P5167, DOI 10.1038/onc.2012.537; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526; Zhao YH, 2013, HUM PATHOL, V44, P365, DOI 10.1016/j.humpath.2012.03.030; Zhou Y, 2003, BIOCHEM J, V374, P349, DOI 10.1042/BJ20030600	43	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111256	10.1371/journal.pone.0111256	http://dx.doi.org/10.1371/journal.pone.0111256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347529	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900057
J	Ammar, ED; Richardson, ML; Abdo, Z; Hall, DG; Shatters, RG				Ammar, El-Desouky; Richardson, Matthew L.; Abdo, Zaid; Hall, David G.; Shatters, Robert G., Jr.			Differences in Stylet Sheath Occurrence and the Fibrous Ring (Sclerenchyma) between xCitroncirus Plants Relatively Resistant or Susceptible to Adults of the Asian Citrus Psyllid Diaphorina citri (Hemiptera: Liviidae)	PLOS ONE			English	Article							FEEDING-BEHAVIOR; DISEASE; APHIDIDAE	The Asian citrus psyllid (ACP, Diaphorina citri, Hemiptera: Liviidae), is the principal vector of the phloem-limited bacteria strongly associated with huanglongbing (HLB), the world's most serious disease of citrus. Host plant resistance may provide an environmentally safe and sustainable method of controlling ACP and/or HLB. Two xCitroncirus accessions (hybrids of Poncirus trifoliata and Citrus spp.), that are relatively resistant (UN-3881) or relatively susceptible (Troyer-1459) to ACP adults with regard to adult longevity, were compared in relation to ACP feeding behavior and some structural features of the leaf midrib. The settling (putative feeding/probing) sites of ACP adults on various parts of the leaf were not influenced primarily by plant accession. However, fewer ACP stylet sheaths were found in the midrib and fewer stylet sheath termini reached the vascular bundle (phloem and/or xylem) in UN-3881 compared to Troyer-1459 plants. Furthermore, in midribs of UN-3881 leaves the fibrous ring (sclerenchyma) around the phloem was significantly wider (thicker) compared to that in midribs of Troyer-1459 leaves. Our data indicate that feeding and/or probing by ACP adults into the vascular bundle is less frequent in the more resistant (UN-3881) than in the more susceptible (Troyer-1459) accessions. Our results also suggest that the thickness of the fibrous ring may be a barrier to stylet penetration into the vascular bundle, which is important for successful ACP feeding on the phloem and for transmitting HLB-associated bacteria. These results may help in the development of citrus plants resistant to ACP, which in turn could halt or slow the spread of the HLB-associated bacteria by this vector.	[Ammar, El-Desouky; Richardson, Matthew L.; Hall, David G.; Shatters, Robert G., Jr.] USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA; [Abdo, Zaid] USDA ARS, South Atlantic Area, Athens, GA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Ammar, ED (corresponding author), USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA.	desoukyammar@gmail.com	Abdo, Zaid/E-5176-2017	Abdo, Zaid/0000-0002-8272-7734; Shatters, Robert/0000-0002-3903-772X	USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was funded by USDA-ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059914; Ammar ED, 2012, ANN ENTOMOL SOC AM, V105, P731, DOI 10.1603/AN12056; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Chandran P, 2013, J ECON ENTOMOL, V106, P2234, DOI 10.1603/EC13126; Civolani S, 2013, J APPL ENTOMOL, V137, P365, DOI 10.1111/jen.12003; Crompton DS, 2010, J ECON ENTOMOL, V103, P648, DOI 10.1603/EC09370; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2007, J ECON ENTOMOL, V100, P847, DOI 10.1603/0022-0493(2007)100[847:EOAPFO]2.0.CO;2; Hall DG, 2013, HORTSCIENCE, V48, P330, DOI 10.21273/HORTSCI.48.3.330; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hewer A, 2011, J EXP BIOL, V214, P3868, DOI 10.1242/jeb.060913; Lei H, 1999, ENTOMOL EXP APPL, V92, P299, DOI 10.1023/A:1003806417443; MESFIN T, 1995, B ENTOMOL RES, V85, P387, DOI 10.1017/S0007485300036129; Morgan JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062444; R Core Team, 2021, R LANGUAGE ENV STAT; Rangasamy M, 2009, J ECON ENTOMOL, V102, P432, DOI 10.1603/029.102.0156; Richardson M. L., 2013, Crop Science, V53, P183, DOI 10.2135/cropsci2012.02.0091; Richardson ML, 2011, HORTSCIENCE, V46, P1260, DOI 10.21273/HORTSCI.46.9.1260; Richter S, 2011, PLANTA, V233, P763, DOI 10.1007/s00425-010-1338-z; Ripley B. D, 2002, MODERN APPL STAT S, P4, DOI DOI 10.1007/978-0-387-21706-2; Schliephake E, 2013, ENTOMOL EXP APPL, V146, P347, DOI 10.1111/eea.12033; Smith CM, 2012, ANNU REV ENTOMOL, V57, P309, DOI 10.1146/annurev-ento-120710-100642; Stover E, 2010, PROC FL STATE HORTIC, V123, P115; Westbrook CJ, 2011, HORTSCIENCE, V46, P997, DOI 10.21273/HORTSCI.46.7.997; Will T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046903	31	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110919	10.1371/journal.pone.0110919	http://dx.doi.org/10.1371/journal.pone.0110919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343712	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943500067
J	Tomassini, A; Solomon, JA; Morgan, MJ				Tomassini, Alessandro; Solomon, Joshua Adam; Morgan, Michael John			Which Way Is Down? Positional Distortion in the Tilt Illusion	PLOS ONE			English	Article							INDUCED EYE TORSION; VISUAL-CORTEX; HEAD TILT; ORIENTATION; PERCEPTION; ADAPTATION; BODY; CONTRAST; NEURONS; FRAME	Contextual information can have a huge impact on our sensory experience. The tilt illusion is a classic example of contextual influence exerted by an oriented surround on a target's perceived orientation. Traditionally, the tilt illusion has been described as the outcome of inhibition between cortical neurons with adjacent receptive fields and a similar preference for orientation. An alternative explanation is that tilted contexts could produce a re-calibration of the subjective frame of reference. Although the distinction is subtle, only the latter model makes clear predictions for unoriented stimuli. In the present study, we tested one such prediction by asking four naive subjects to estimate three positions (4, 6, and 8 o'clock) on an imaginary clock face within a tilted surround. To indicate their estimates, they used either an unoriented dot or a line segment, with one endpoint at fixation in the middle of the surround. The surround's tilt was randomly chosen from a set of orientations (+/- 75 degrees, +/- 65 degrees, +/- 55 degrees, +/- 45 degrees, +/- 35 degrees, +/- 25 degrees, +/- 15 degrees, +/- 5 degrees with respect to vertical) across trials. Our results showed systematic biases consistent with the tilt illusion in both conditions. Biases were largest when observers attempted to estimate the 4 and 8 o'clock positions, but there was no significant difference between data gathered with the dot and data gathered with the line segment. A control experiment confirmed that biases were better accounted for by a local coordinate shift than to torsional eye movements induced by the tilted context. This finding supports the idea that tilted contexts distort perceived positions as well as perceived orientations and cannot be readily explained by lateral interactions between orientation selective cells in V1.	[Tomassini, Alessandro] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Tomassini, Alessandro; Solomon, Joshua Adam; Morgan, Michael John] City Univ London, Appl Vis Res Ctr, Optometry Div, London EC1V 0HB, England; [Morgan, Michael John] Max Planck Inst Neurol Res, D-50931 Cologne, Germany	University of London; University College London; City University London; Max Planck Society	Tomassini, A (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	a.tomassini@ucl.ac.uk		Tomassini, Alessandro/0000-0001-5645-6910	EPSRC [EP/E064604]; Engineering and Physical Sciences Research Council [EP/E064604/1] Funding Source: researchfish; EPSRC [EP/E064604/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC with the grant number EP/E064604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson E. H., 2000, NEW COGNITIVE NEUROS; ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; ANDREWS DP, 1964, Q J EXP PSYCHOL, V16, P104, DOI 10.1080/17470216408416355; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; ASCH SE, 1948, J EXP PSYCHOL, V38, P325, DOI 10.1037/h0057855; Aubert H., 1861, ARCH PATHOL ANAT PH, V20, P381, DOI [10.1007/BF02355256, DOI 10.1007/BF02355256]; Barlow H.B., 1961, SENSORY COMMUNICATIO, V1; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V210, P727, DOI 10.1113/jphysiol.1970.sp009238; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUCHANANSMITH HM, 1993, PERCEPTION, V22, P1389, DOI 10.1068/p221389; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; Clifford C.W.G., 2005, FITTING MIND WORLD A; Clifford CWG, 1996, VISION RES, V36, P2595, DOI 10.1016/0042-6989(95)00301-0; CRONE RA, 1975, A GRAEF ARCH KLIN EX, V196, P1, DOI 10.1007/BF00410021; Daddaoua N, 2008, J VISION, V8, DOI 10.1167/8.3.19; DAY RH, 1969, PSYCHOL BULL, V71, P33, DOI 10.1037/h0026872; Dichgans J, 1974, PSYCHOPHYSICS VISUAL; DILORENZO JR, 1982, J EXP PSYCHOL HUMAN, V8, P536, DOI 10.1037/0096-1523.8.4.536; EBBINGHAUS H, 1897, Z PSYCHOL, V13, P401; EBENHOLTZ SM, 1977, PERCEPT PSYCHOPHYS, V22, P491, DOI 10.3758/BF03199516; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GOODENOUGH DR, 1979, VISION RES, V19, P1177, DOI 10.1016/0042-6989(79)90015-4; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HENN V, 1974, BRAIN RES, V71, P144, DOI 10.1016/0006-8993(74)90198-X; Hering E., 1878, LEHRE LICHTSINN; HORN G, 1969, NATURE, V221, P186, DOI 10.1038/221186a0; HOWARD IP, 1964, VISION RES, V4, P433, DOI 10.1016/0042-6989(64)90015-X; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Lewis RF, 2005, ANN NY ACAD SCI, V1039, P294, DOI 10.1196/annals.1325.028; Lipshits M, 1999, NEUROREPORT, V10, P1085, DOI 10.1097/00001756-199904060-00033; Luyat M, 2001, PERCEPT PSYCHOPHYS, V63, P541, DOI 10.3758/BF03194419; Luyat M, 2005, NEUROSCI LETT, V385, P215, DOI 10.1016/j.neulet.2005.05.044; Luyat M, 2002, J EXP PSYCHOL HUMAN, V28, P1002, DOI 10.1037//0096-1523.28.4.1002; MACH E., 1865, SB AKAD WISS WIEN MN, V52, P303; Milner D, 2003, TRENDS COGN SCI, V7, P10, DOI 10.1016/S1364-6613(02)00004-9; Muller GE, 1916, Z SINNESPHYSIOL, V49; OTOOLE B, 1977, VISION RES, V17, P367, DOI 10.1016/0042-6989(77)90025-6; PARKER DE, 1983, PERCEPT PSYCHOPHYS, V33, P139, DOI 10.3758/BF03202831; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Purves D, 2011, P NATL ACAD SCI USA, V108, P15588, DOI 10.1073/pnas.1012178108; Sauvan XM, 1999, VIS COGN, V6, P43, DOI 10.1080/713756803; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Trousselard M, 2003, PERCEPT PSYCHOPHYS, V65, P1179, DOI 10.3758/BF03194843; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; Watson AB, 1997, SPATIAL VISION, V10, P447, DOI 10.1163/156856897X00384; WENDEROTH P, 1988, VISION RES, V28, P301, DOI 10.1016/0042-6989(88)90158-7	51	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110729	10.1371/journal.pone.0110729	http://dx.doi.org/10.1371/journal.pone.0110729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343463	Green Published, Green Accepted, gold			2022-12-26	WOS:000343943500052
J	Sumrall, ET; Gallo, EB; Aboderin, AO; Lamikanra, A; Okeke, IN				Sumrall, Eric T.; Gallo, Elizabeth B.; Aboderin, Aaron Oladipo; Lamikanra, Adebayo; Okeke, Iruka N.			Dissemination of the Transmissible Quinolone-Resistance Gene qnrS1 by IncX Plasmids in Nigeria	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; REFERENCE STRAIN; GENOME SEQUENCE; IDENTIFICATION; TOPOISOMERASES	The plasmid-encoded quinolone resistance gene qnrS1 was recently found to be commonly associated with ciprofloxacin resistance in Nigeria. We mapped the qnrS1 gene from an Escherichia coli isolate obtained in Nigeria to a 43.5 Kb IncX2 plasmid. The plasmid, pEBG1, was sufficient to confer ciprofloxacin non-susceptibility, as well as tetracycline and trimethoprim resistance, on E. coli K-12. Deletion analysis confirmed that qnrS1 accounted for all the ciprofloxacin non-suceptibility conferred by pEBG1 and tetracycline and trimethoprim resistance could be attributed to tetAR and dfrA14 genes respectively. While it contained a complete IncX conjugation system, pEBG1 was not self-transmissible likely due to an IS3 element inserted between the pilX5 and pilX6 genes. The plasmid was however efficiently mobilizable. pEBG1 was most similar to another qnrS1-bearing IncX2 plasmid from Nigeria, but both plasmids acquired qnrS1 independently and differ in their content of other resistance genes. Screening qnrS1-positive isolates from other individuals in Nigeria revealed that they carried neither pEBG1 nor pNGX2-QnrS1 but that IncX plasmids were prevalent. This study demonstrates that the IncX backbone is a flexible platform that has contributed to qnrS1 dissemination in Nigeria.	[Sumrall, Eric T.; Gallo, Elizabeth B.; Okeke, Iruka N.] Haverford Coll, Dept Biol, Haverford, PA 19041 USA; [Aboderin, Aaron Oladipo] Obafemi Awolowo Univ, Dept Med Microbiol & Parasitol, Ife, Osun State, Nigeria; [Lamikanra, Adebayo] Obafemi Awolowo Univ, Dept Pharmaceut, Ife, Osun State, Nigeria	Haverford College; Obafemi Awolowo University; Obafemi Awolowo University	Okeke, IN (corresponding author), Haverford Coll, Dept Biol, Haverford, PA 19041 USA.	iokeke@haverford.edu	Okeke, Iruka N/N-1595-2019; Aboderin, Aaron/V-8025-2019	Okeke, Iruka N/0000-0002-1694-7587; Aboderin, Aaron/0000-0002-4280-2218; Sumrall, Eric/0000-0001-9181-6918	Society-in-Science, ETHZ, Zurich; Haverford College	Society-in-Science, ETHZ, Zurich(ETH Zurich); Haverford College	This work was supported by a Branco Weiss Fellowship to INO from the Society-in-Science, ETHZ, Zurich and intramural funding from Haverford College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; APPLEYARD RK, 1954, GENETICS, V39, P440; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Carattoli A, 2010, J ANTIMICROB CHEMOTH, V65, P2070, DOI 10.1093/jac/dkq269; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chah KF, 2010, J BASIC MICROB, V50, pS18, DOI 10.1002/jobm.200900325; Clinical and Laboratory Standards (CLSI), 2009, METHODS DILUTION ANT, Veighth; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Du XX, 2013, J MED MICROBIOL, V62, P1332, DOI 10.1099/jmm.0.057091-0; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Gay K, 2006, CLIN INFECT DIS, V43, P297, DOI 10.1086/505397; Grudniak AM, 2007, CURR MICROBIOL, V55, P549, DOI 10.1007/s00284-007-9032-5; Gunell M, 2009, ANTIMICROB AGENTS CH, V53, P3832, DOI 10.1128/AAC.00121-09; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hata M, 2005, ANTIMICROB AGENTS CH, V49, P801, DOI 10.1128/AAC.49.2.801-803.2005; Huang SY, 2012, FOODBORNE PATHOG DIS, V9, P896, DOI 10.1089/fpd.2012.1131; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Jun L, 2002, PLASMID, V48, P24, DOI 10.1016/S0147-619X(02)00007-0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kehrenberg C, 2007, J ANTIMICROB CHEMOTH, V60, P903, DOI 10.1093/jac/dkm283; Labar AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038142; Lamikanra A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-312; Le TMV, 2011, ANTIMICROB AGENTS CH, V55, P1798, DOI 10.1128/AAC.01200-10; Lescat M, 2009, ANTIMICROB AGENTS CH, V53, P2283, DOI 10.1128/AAC.00123-09; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; MOLLET B, 1983, NUCLEIC ACIDS RES, V11, P6319, DOI 10.1093/nar/11.18.6319; NCCLS, 2003, M2A8 NCCLS; Nunez B, 1997, MOL MICROBIOL, V24, P1157, DOI 10.1046/j.1365-2958.1997.4111778.x; Nwaneshiudu AI, 2007, J BACTERIOL, V189, P6074, DOI 10.1128/JB.00349-07; OBRIEN TF, 1995, EMERG INFECT DIS, V1, P66, DOI 10.3201/eid0102.950209; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P5933, DOI 10.1128/AAC.00639-11; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J., 2001, MOL CLONING LAB MANU; Sandegren L, 2012, J ANTIMICROB CHEMOTH, V67, P74, DOI 10.1093/jac/dkr405; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; SIMONSEN CC, 1983, J BACTERIOL, V155, P1001, DOI 10.1128/JB.155.3.1001-1008.1983; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Usongo V, 2013, J BACTERIOL, V195, P1758, DOI 10.1128/JB.02001-12; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wu JJ, 2007, ANTIMICROB AGENTS CH, V51, P1223, DOI 10.1128/AAC.01195-06; Yi H, 2012, J BACTERIOL, V194, P3742, DOI 10.1128/JB.00641-12	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110279	10.1371/journal.pone.0110279	http://dx.doi.org/10.1371/journal.pone.0110279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340787	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800026
J	Rout, AK; Strub, MP; Piszczek, G; Tjandra, N				Rout, Ashok K.; Strub, Marie-Paule; Piszczek, Grzegorz; Tjandra, Nico			Structure of Transmembrane Domain of Lysosome-associated Membrane Protein Type 2a (LAMP-2A) Reveals Key Features for Substrate Specificity in Chaperone-mediated Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Chaperone; Nuclear Magnetic Resonance (NMR); Protein Structure; Transport; CMA; DPC; LAMP-2; Micelles	TRIPLE-RESONANCE NMR; CYTOSOLIC PROTEINS; ALPHA-SYNUCLEIN; RAT-LIVER; BACKBONE DYNAMICS; RIBONUCLEASE-A; MUTANT UCH-L1; DISEASE; DEGRADATION; MACROAUTOPHAGY	Chaperone-mediated autophagy (CMA) is a highly regulated cellular process that mediates the degradation of a selective subset of cytosolic proteins in lysosomes. Increasing CMA activity is one way for a cell to respond to stress, and it leads to enhanced turnover of non-critical cytosolic proteins into sources of energy or clearance of unwanted or damaged proteins from the cytosol. The lysosome-associated membrane protein type 2a (LAMP-2A) together with a complex of chaperones and co-chaperones are key regulators of CMA. LAMP-2A is a transmembrane protein component for protein translocation to the lysosome. Here we present a study of the structure and dynamics of the transmembrane domain of human LAMP-2A in n-dodecylphosphocholine micelles by nuclear magnetic resonance (NMR). We showed that LAMP-2A exists as a homotrimer in which the membrane-spanning helices wrap around each other to form a parallel coiled coil conformation, whereas its cytosolic tail is flexible and exposed to the cytosol. This cytosolic tail of LAMP-2A interacts with chaperone Hsc70 and a CMA substrate RNase A with comparable affinity but not with Hsp40 and RNase S peptide. Because the substrates and the chaperone complex can bind at the same time, thus creating a bimodal interaction, we propose that substrate recognition by chaperones and targeting to the lysosomal membrane by LAMP-2A are coupled. This can increase substrate affinity and specificity as well as prevent substrate aggregation, assist in the unfolding of the substrate, and promote the formation of the higher order complex of LAMP-2A required for translocation.	[Rout, Ashok K.; Strub, Marie-Paule; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] NHLBI, Biophys Core, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tjandra, N (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov	Piszczek, Grzegorz/GYU-2029-2022	Rout, Ashok Kumar/0000-0003-1448-300X	Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048, ZICHL000338] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NHLBI.	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Agarraberes FA, 2001, BBA-BIOMEMBRANES, V1513, P1, DOI 10.1016/S0304-4157(01)00005-3; Akasaki K, 1998, BIOCHEM MOL BIOL INT, V46, P197; BACKER JM, 1983, P NATL ACAD SCI-BIOL, V80, P2166, DOI 10.1073/pnas.80.8.2166; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; Cuervo AM, 1998, J MOL MED-JMM, V76, P6, DOI 10.1007/s109-1998-8099-y; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2000, J CELL SCI, V113, P4441; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dice J. F., 2000, LYSOSOMAL PATHWAYS P; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Dice JF, 2010, AUTOPHAGY, V6, P320, DOI 10.4161/auto.6.3.11263; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; DICE JF, 1990, CRIT REV THER DRUG, V7, P211; Ellis RJ, 2003, NATURE, V421, P801, DOI 10.1038/421801a; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FLEMING KG, 2008, CURR PROTOC PROTEIN, pCH7; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOUGH NR, 1995, DNA CELL BIOL, V14, P863, DOI 10.1089/dna.1995.14.863; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; HATEM CL, 1995, J CELL SCI, V108, P2093; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kaushik S, 2012, PHARMACOL RES, V66, P484, DOI 10.1016/j.phrs.2012.10.002; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kaushik S, 2011, J CELL SCI, V124, P495, DOI 10.1242/jcs.073874; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Keller RLJ, 2004, COMPUTER AIDED NMR R; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2009, AUTOPHAGY, V5, P1079, DOI 10.4161/auto.5.8.9476; Kluger R, 2004, BIOORG CHEM, V32, P451, DOI 10.1016/j.bioorg.2004.08.002; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; KONECKI DS, 1994, BIOCHEM BIOPH RES CO, V205, P1, DOI 10.1006/bbrc.1994.2620; Lustig A, 2000, BBA-BIOMEMBRANES, V1464, P199, DOI 10.1016/S0005-2736(99)00254-0; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Proenca CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068357; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Roche J, 2014, P NATL ACAD SCI USA, V111, P3425, DOI 10.1073/pnas.1401397111; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; TERLECKY SR, 1993, J BIOL CHEM, V268, P23490; TERLECKY SR, 1992, J BIOL CHEM, V267, P9202; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xilouri M, 2008, AUTOPHAGY, V4, P917, DOI 10.4161/auto.6685; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	81	50	52	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35111	35123		10.1074/jbc.M114.609446	http://dx.doi.org/10.1074/jbc.M114.609446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25342746	Green Published, hybrid			2022-12-26	WOS:000346660200006
J	Zhang, XL; Hoey, R; Koide, A; Dolios, G; Paduch, M; Nguyen, P; Wu, XZ; Li, YM; Wagner, SL; Wang, R; Koide, S; Sisodia, SS				Zhang, Xulun; Hoey, Robert; Koide, Akiko; Dolios, Georgia; Paduch, Marcin; Phuong Nguyen; Wu, Xianzhong; Li, Yueming; Wagner, Steven L.; Wang, Rong; Koide, Shohei; Sisodia, Sangram S.			A Synthetic Antibody Fragment Targeting Nicastrin Affects Assembly and Trafficking of gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid Precursor Protein (APP); Cancer; -Secretase; Notch Receptor; Synthetic Antibody	CARBOXYL-TERMINAL FRAGMENT; AMYLOID BETA-PROTEIN; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; INTRACELLULAR DOMAIN; PRESENILIN/GAMMA-SECRETASE; TRANSMEMBRANE ASPARTATES; NOTCH; COMPLEX; ENDOPROTEOLYSIS	Background: -Secretase is critical in Notch signaling and Alzheimer disease. Results: Coexpression of a nicastrin antibody affects maturation and trafficking of -secretase and alters Notch and APP processing. Conclusion: Nicastrin is a feasible target for modulating the targeting and substrate specificity of -secretase. Significance: Modulation of -secretase through nicastrin may be of therapeutic value in cancer and Alzheimer disease. The -secretase complex, composed of presenilin, nicastrin (NCT), anterior pharynx-defective 1 (APH-1), and presenilin enhancer 2 (PEN-2), is assembled in a highly regulated manner and catalyzes the intramembranous proteolysis of many type I membrane proteins, including Notch and amyloid precursor protein. The Notch family of receptors plays important roles in cell fate specification during development and in adult tissues, and aberrant hyperactive Notch signaling causes some forms of cancer. -Secretase-mediated processing of Notch at the cell surface results in the generation of the Notch intracellular domain, which associates with several transcriptional coactivators involved in nuclear signaling events. On the other hand, -secretase-mediated processing of amyloid precursor protein leads to the production of amyloid (A) peptides that play an important role in the pathogenesis of Alzheimer disease. We used a phage display approach to identify synthetic antibodies that specifically target NCT and expressed them in the single-chain variable fragment (scFv) format in mammalian cells. We show that expression of a NCT-specific scFv clone, G9, in HEK293 cells decreased the production of the Notch intracellular domain but not the production of amyloid peptides that occurs in endosomal and recycling compartments. Biochemical studies revealed that scFvG9 impairs the maturation of NCT by associating with immature forms of NCT and, consequently, prevents its association with the other components of the -secretase complex, leading to degradation of these molecules. The reduced cell surface levels of mature -secretase complexes, in turn, compromise the intramembranous processing of Notch.	[Zhang, Xulun; Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Hoey, Robert; Koide, Akiko; Paduch, Marcin; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Dolios, Georgia; Wang, Rong] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Phuong Nguyen; Wagner, Steven L.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Wu, Xianzhong; Li, Yueming] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	University of Chicago; University of Chicago; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; Memorial Sloan Kettering Cancer Center	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol, 947 E 58th St,MC0928, Chicago, IL 60637 USA.	ssisodia@bsd.uchicago.edu	LI, Yue/GRS-8071-2022	Koide, Shohei/0000-0001-5473-4358	National Institutes of Health [P30 NS061777, S10 RR022415, U01 NS074501, R01AG026660, U54-GM087519, R01-GM072688]; Adler Foundation; Edward H. Levy Fund; Alzheimer's Association; American Health Assistance Foundation; Cure Alzheimer's Fund; University of Chicago Comprehensive Cancer Center; Eisai Research Labs Inc.; AZ Therapies Inc.; Jannsen Pharmaceutica NV; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777, U01NS074501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adler Foundation; Edward H. Levy Fund; Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation(BrightFocus Foundation); Cure Alzheimer's Fund; University of Chicago Comprehensive Cancer Center; Eisai Research Labs Inc.; AZ Therapies Inc.; Jannsen Pharmaceutica NV; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 NS061777 and S10 RR022415 (to R. W.), U01 NS074501 (to S. L. W.), R01AG026660 (to Y. L.), and U54-GM087519 and R01-GM072688 (to S. K.). This work was also supported by the Adler Foundation, by the Edward H. Levy Fund, by the Alzheimer's Association, by the American Health Assistance Foundation, and by the Cure Alzheimer's Fund (to S. S. S.), and by the University of Chicago Comprehensive Cancer Center (to S. K.). S. S. S. is a paid consultant of Eisai Research Labs Inc., AZ Therapies Inc., and Jannsen Pharmaceutica NV but is not a shareholder in any company that is a maker or owner of an FDA-regulated drug or device.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Crump CJ, 2013, BIOCHEMISTRY-US, V52, P3197, DOI 10.1021/bi400377p; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Filipovic A, 2011, BREAST CANCER RES TR, V125, P43, DOI 10.1007/s10549-010-0823-1; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hayashi I, 2012, ONCOGENE, V31, P787, DOI 10.1038/onc.2011.265; Hayashi I, 2009, J BIOL CHEM, V284, P27838, DOI 10.1074/jbc.M109.055061; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kulic L, 2000, P NATL ACAD SCI USA, V97, P5913, DOI 10.1073/pnas.100049897; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Martys-Zage JL, 2000, J MOL NEUROSCI, V15, P189, DOI 10.1385/JMN:15:3:189; Miller KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043746; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xie T, 2014, P NATL ACAD SCI USA, V111, P13349, DOI 10.1073/pnas.1414837111; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P8534, DOI 10.1073/pnas.1202691109	50	4	5	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34851	34861		10.1074/jbc.M114.609636	http://dx.doi.org/10.1074/jbc.M114.609636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25352592	hybrid, Green Published			2022-12-26	WOS:000346260800036
J	Allievi, MC; Palomino, MM; Acosta, MP; Lanati, L; Ruzal, SM; Sanchez-Rivas, C				Claudia Allievi, Mariana; Mercedes Palomino, Maria; Prado Acosta, Mariano; Lanati, Leonardo; Monica Ruzal, Sandra; Sanchez-Rivas, Carmen			Contribution of S-Layer Proteins to the Mosquitocidal Activity of Lysinibacillus sphaericus	PLOS ONE			English	Article							THURINGIENSIS SUBSP MEDELLIN; SYNERGIZE BACILLUS-SPHAERICUS; AEDES-AEGYPTI; GENE; EXPRESSION; STRAINS; CHITINASES; VIRULENCE; TOXICITY; TOXIN	Lysinibacillus sphaericus strains belonging the antigenic group H5a5b produce spores with larvicidal activity against larvae of Culex mosquitoes. C7, a new isolated strain, which presents similar biochemical characteristics and Bin toxins in their spores as the reference strain 2362, was, however, more active against larvae of Culex mosquitoes. The contribution of the surface layer protein (S-layer) to this behaviour was envisaged since this envelope protein has been implicated in the pathogenicity of several bacilli, and we had previously reported its association to spores. Microscopic observation by immunofluorescence detection with anti S-layer antibody in the spores confirms their attachment. S-layers and BinA and BinB toxins formed high molecular weight multimers in spores as shown by SDS-PAGE and western blot detection. Purified S-layer from both L. sphaericus C7 and 2362 strain cultures was by itself toxic against Culex sp larvae, however, that from C7 strain was also toxic against Aedes aegypti. Synergistic effect between purified S-layer and spore-crystal preparations was observed against Culex sp. and Aedes aegypti larvae. This effect was more evident with the C7 strain. In silico analyses of the S-layer sequence suggest the presence of chitin-binding and hemolytic domains. Both biochemical characteristics were detected for both Slayers strains that must justify their contribution to pathogenicity.	[Claudia Allievi, Mariana; Mercedes Palomino, Maria; Prado Acosta, Mariano; Lanati, Leonardo; Monica Ruzal, Sandra; Sanchez-Rivas, Carmen] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, IQUIBICEN CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires	Ruzal, SM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, IQUIBICEN CONICET, Buenos Aires, DF, Argentina.	sandra@qb.fcen.uba.ar		Palomino, Mercedes/0000-0003-1988-7388; Ruzal, Sandra/0000-0001-6388-7567; Allievi, Mariana Claudia/0000-0002-8782-2810	Consejo Nacional de Investigaciones Cientificas y Tecnicas [CONICET PIP0229]; Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT PICT-2012-0789]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	Support was provided by Consejo Nacional de Investigaciones Cientificas y Tecnicas CONICET PIP0229 and Agencia Nacional de Promocion Cientifica y Tecnologica ANPCyT PICT-2012-0789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2007, INT J SYST EVOL MICR, V57, P1117, DOI 10.1099/ijs.0.63867-0; Alice AF, 2003, MICROBIOL-SGM, V149, P1687, DOI 10.1099/mic.0.26231-0; Alice AF, 2002, APPL ENVIRON MICROB, V68, P6410, DOI 10.1128/aem.68.12.6410-6415.2002; Allievi MC, 2011, J MICROBIOL BIOTECHN, V21, P147, DOI 10.4014/jmb.1009.09046; Allievi MC, 2012, THESIS U BUENOS AIRE; Balomenou S, 2013, MOL MICROBIOL, V87, P867, DOI 10.1111/mmi.12137; Balzarini M., 2008, INFOSTAT MANUAL USUA; Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008; Cai YJ, 2007, APPL ENVIRON MICROB, V73, P7744, DOI 10.1128/AEM.01510-07; Charles JF, 1996, ANNU REV ENTOMOL, V41, P451, DOI 10.1146/annurev.en.41.010196.002315; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Fischer S, 2004, J VECTOR ECOL, V29, P365; Forsberg LS, 2012, GLYCOBIOLOGY, V22, P1103, DOI 10.1093/glycob/cws080; Forsberg LS, 2011, GLYCOBIOLOGY, V21, P934, DOI 10.1093/glycob/cwr026; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Gomez-Ramirez M, 2001, CHITIN ENZYMOLOGY, P273; Guo G, 2008, FEMS MICROBIOL LETT, V282, P1, DOI 10.1111/j.1574-6968.2008.01087.x; Hu XM, 2008, BIOSCI BIOTECH BIOCH, V72, P1257, DOI 10.1271/bbb.70747; Hu XM, 2008, J BACTERIOL, V190, P2892, DOI 10.1128/JB.01652-07; Itoh T, 2013, APPL ENVIRON MICROB, V79, P7482, DOI 10.1128/AEM.02483-13; Janesch B, 2013, J BACTERIOL, V195, P565, DOI 10.1128/JB.01487-12; Kailas L, 2011, P NATL ACAD SCI USA, V108, P16014, DOI 10.1073/pnas.1109419108; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; KRYCH VK, 1980, INT J SYST BACTERIOL, V30, P476, DOI 10.1099/00207713-30-2-476; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; LEWIS LO, 1987, J BACTERIOL, V169, P72, DOI 10.1128/jb.169.1.72-79.1987; Lopez-Diaz JA, 2013, ENVIRON MICROBIOL, V15, P3030, DOI 10.1111/1462-2920.12263; Lozano LC, 2011, BIOTECHNOL LETT, V33, P2037, DOI 10.1007/s10529-011-0666-9; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; MYERS PS, 1980, APPL ENVIRON MICROB, V39, P1205, DOI 10.1128/AEM.39.6.1205-1211.1980; Pena G, 2006, APPL ENVIRON MICROB, V72, P353, DOI 10.1128/AEM.72.1.353-360.2006; Pollmann K, 2006, BIOTECHNOL ADV, V24, P58, DOI 10.1016/j.biotechadv.2005.06.002; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Rippere KE, 1997, INT J SYST BACTERIOL, V47, P214, DOI 10.1099/00207713-47-1-214; Rodenburg CM, 2014, J STRUCT BIOL, V186, P181, DOI 10.1016/j.jsb.2014.02.018; Rodriguez-Almazan C, 2011, BIOCHEMISTRY-US, V50, P388, DOI 10.1021/bi101239r; RUSSELL BL, 1989, APPL ENVIRON MICROB, V55, P294, DOI 10.1128/AEM.55.2.294-297.1989; Sampson MN, 1998, MICROBIOL-SGM, V144, P2189, DOI 10.1099/00221287-144-8-2189; Smith AW, 2005, J INVERTEBR PATHOL, V88, P27, DOI 10.1016/j.jip.2004.10.005; THANABALU T, 1991, J BACTERIOL, V173, P2776, DOI 10.1128/JB.173.9.2776-2785.1991; Thiery I, 1998, APPL ENVIRON MICROB, V64, P3910; Thiery I, 1997, APPL ENVIRON MICROB, V63, P468, DOI 10.1128/AEM.63.2.468-473.1997; TRAVERS RS, 1987, APPL ENVIRON MICROB, V53, P1263, DOI 10.1128/AEM.53.6.1263-1266.1987; van Frankenhuyzen K, 2013, J INVERTEBR PATHOL, V114, P76, DOI 10.1016/j.jip.2013.05.010; Wang YT, 2013, J BACTERIOL, V195, P596, DOI 10.1128/JB.02005-12; Wirth MC, 2007, APPL ENVIRON MICROB, V73, P6066, DOI 10.1128/AEM.00654-07; Wirth MC, 2001, APPL ENVIRON MICROB, V67, P3280, DOI 10.1128/AEM.67.7.3280-3284.2001; Yang YK, 2007, APPL ENVIRON MICROB, V73, P218, DOI 10.1128/AEM.01100-06; Yousten A A, 1984, Adv Biotechnol Processes, V3, P315; YOUSTEN AA, 1982, APPL ENVIRON MICROB, V44, P1449, DOI 10.1128/AEM.44.6.1449-1455.1982; Zhou Z, 2011, BMB REP, V44, P323, DOI 10.5483/BMBRep.2011.44.5.323	51	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111114	10.1371/journal.pone.0111114	http://dx.doi.org/10.1371/journal.pone.0111114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354162	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200057
J	Clarke, RH; Moosa, S; Anzivino, M; Wang, Y; Floyd, DH; Purow, BW; Lee, KS				Clarke, Ryon H.; Moosa, Shayan; Anzivino, Matthew; Wang, Yi; Floyd, Desiree Hunt; Purow, Benjamin W.; Lee, Kevin S.			Sustained Radiosensitization of Hypoxic Glioma Cells after Oxygen Pretreatment in an Animal Model of Glioblastoma and In Vitro Models of Tumor Hypoxia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HIGH-GRADE GLIOMAS; BRAIN-TUMORS; INDUCIBLE FACTORS; INTRACRANIAL GLIOBLASTOMA; HYPERBARIC OXYGENATION; IMPLANTABLE RESONATORS; IONIZING-RADIATION; MALIGNANT GLIOMAS; EPR OXIMETRY	Glioblastoma multiforme (GBM) is the most common and lethal form of brain cancer and these tumors are highly resistant to chemo-and radiotherapy. Radioresistance is thought to result from a paucity of molecular oxygen in hypoxic tumor regions, resulting in reduced DNA damage and enhanced cellular defense mechanisms. Efforts to counteract tumor hypoxia during radiotherapy are limited by an attendant increase in the sensitivity of healthy brain tissue to radiation. However, the presence of heightened levels of molecular oxygen during radiotherapy, while conventionally deemed critical for adjuvant oxygen therapy to sensitize hypoxic tumor tissue, might not actually be necessary. We evaluated the concept that pre-treating tumor tissue by transiently elevating tissue oxygenation prior to radiation exposure could increase the efficacy of radiotherapy, even when radiotherapy is administered after the return of tumor tissue oxygen to hypoxic baseline levels. Using nude mice bearing intracranial U87-luciferase xenografts, and in vitro models of tumor hypoxia, the efficacy of oxygen pretreatment for producing radiosensitization was tested. Oxygen-induced radiosensitization of tumor tissue was observed in GBM xenografts, as seen by suppression of tumor growth and increased survival. Additionally, rodent and human glioma cells, and human glioma stem cells, exhibited prolonged enhanced vulnerability to radiation after oxygen pretreatment in vitro, even when radiation was delivered under hypoxic conditions. Over-expression of HIF-1 alpha reduced this radiosensitization, indicating that this effect is mediated, in part, via a change in HIF-1-dependent mechanisms. Importantly, an identical duration of transient hyperoxic exposure does not sensitize normal human astrocytes to radiation in vitro. Taken together, these results indicate that briefly pre-treating tumors with elevated levels of oxygen prior to radiotherapy may represent a means for selectively targeting radiation-resistant hypoxic cancer cells, and could serve as a safe and effective adjuvant to radiation therapy for patients with GBM.	[Clarke, Ryon H.; Anzivino, Matthew; Wang, Yi; Lee, Kevin S.] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA; [Clarke, Ryon H.; Moosa, Shayan; Anzivino, Matthew; Wang, Yi; Floyd, Desiree Hunt; Purow, Benjamin W.; Lee, Kevin S.] Univ Virginia Hlth Syst, Sch Med, Charlottesville, VA USA; [Floyd, Desiree Hunt; Purow, Benjamin W.] Univ Virginia Hlth Syst, Dept Neurol, Div Neurooncol, Charlottesville, VA USA; [Floyd, Desiree Hunt; Purow, Benjamin W.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [Floyd, Desiree Hunt; Purow, Benjamin W.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Lee, Kevin S.] Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Lee, KS (corresponding author), Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA.	ksl3h@virginia.edu			Pre-doctoral Research Neuroscience Training Grant [T32 6M008328]; Chester Research Fund [138857101DR0280240455]	Pre-doctoral Research Neuroscience Training Grant; Chester Research Fund	This study was supported by the Pre-doctoral Research Neuroscience Training Grant (T32 6M008328) and the Chester Research Fund (138857101DR0280240455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005365; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Beppu T, 2002, J NEURO-ONCOL, V58, P47, DOI 10.1023/A:1015832726054; Bernhardt WM, 2007, METHOD ENZYMOL, V435, P221, DOI 10.1016/S0076-6879(07)35012-X; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; CHAPMAN JD, 1979, NEW ENGL J MED, V301, P1429, DOI 10.1056/NEJM197912273012606; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; Chou CW, 2012, NEURO-ONCOLOGY, V14, P1227, DOI 10.1093/neuonc/nos195; COLEMAN CN, 1990, CRIT REV ONCOL HEMAT, V10, P225, DOI 10.1016/1040-8428(90)90033-O; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Dong Z, 2001, J BIOL CHEM, V276, P18702, DOI 10.1074/jbc.M011774200; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; FULTON DS, 1984, INT J RADIAT ONCOL, V10, P1709, DOI 10.1016/0360-3016(84)90533-9; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Grosu AL, 2005, INT J RADIAT ONCOL, V63, P511, DOI 10.1016/j.ijrobp.2005.01.056; Grosu AL, 2005, STRAHLENTHER ONKOL, V181, P483, DOI 10.1007/s00066-005-1422-7; Hadjipanayis CG, 2008, MOL THER, V16, P1783, DOI 10.1038/mt.2008.185; Hamza MA, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0379-z; Hou HG, 2012, J MAGN RESON, V214, P22, DOI 10.1016/j.jmr.2011.09.043; Hou HG, 2011, ADV EXP MED BIOL, V701, P61, DOI 10.1007/978-1-4419-7756-4_9; Hsieh CH, 2010, ONCOL REP, V24, P1629, DOI 10.3892/or_00001027; Huang LE, 2013, SCIENCE, V339, P1285, DOI 10.1126/science.1236966; Jackson CM, 2014, CLIN CANC RES; Kaanders JHAM, 2002, LANCET ONCOL, V3, P728, DOI 10.1016/S1470-2045(02)00929-4; Kanu OO, 2009, EXPERT OPIN THER TAR, V13, P701, DOI [10.1517/14728220902942348 , 10.1517/14728220902942348]; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Knisely JPS, 2002, NEUROIMAG CLIN N AM, V12, P525, DOI 10.1016/S1052-5149(02)00032-1; Kohshi K, 1999, BRIT J CANCER, V80, P236, DOI 10.1038/sj.bjc.6690345; Kohshi K, 2007, J NEURO-ONCOL, V82, P297, DOI 10.1007/s11060-006-9283-1; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lanvin O, 2013, EUR J CANCER, V49, P2884, DOI 10.1016/j.ejca.2013.05.003; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu WW, 2012, NEUROL RES, V34, P415, DOI 10.1179/1743132812Y.0000000034; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lund EL, 2000, CLIN CANCER RES, V6, P971; Luo Z, 2014, NEUROPHARMACOLOGY; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; McGee MC, 2010, INT J RADIAT ONCOL, V76, P1537, DOI 10.1016/j.ijrobp.2009.12.010; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Overgaard J, 2011, RADIOTHER ONCOL, V100, P22, DOI 10.1016/j.radonc.2011.03.004; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Radaelli E, 2009, HISTOL HISTOPATHOL, V24, P879, DOI 10.14670/HH-24.879; RAMPLING R, 1994, INT J RADIAT ONCOL, V29, P427, DOI 10.1016/0360-3016(94)90432-4; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Seshadri M, 2009, J CEREBR BLOOD F MET, V29, P1373, DOI 10.1038/jcbfm.2009.68; Shrieve DC, 2006, NEUROSURG CLIN N AM, V17, P67, DOI 10.1016/j.nec.2006.02.003; STEWART FA, 1989, INT J RADIAT ONCOL, V16, P1195, DOI 10.1016/0360-3016(89)90282-4; Strofer M, 2011, CELL PHYSIOL BIOCHEM, V28, P805, DOI 10.1159/000335794; Whitfield GA, 2014, CLIN ONCOL R COLL RA; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W	58	24	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111199	10.1371/journal.pone.0111199	http://dx.doi.org/10.1371/journal.pone.0111199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350400	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100061
J	Kankova, S; Prochazkova, L; Flegr, J; Calda, P; Springer, D; Potlukova, E				Kankova, Sarka; Prochazkova, Lucie; Flegr, Jaroslav; Calda, Pavel; Springer, Drahomira; Potlukova, Eliska			Effects of Latent Toxoplasmosis on Autoimmune Thyroid Diseases in Pregnancy	PLOS ONE			English	Article							CELL-MEDIATED-IMMUNITY; HASHIMOTOS-THYROIDITIS; MURINE TOXOPLASMOSIS; GONDII INFECTION; HUMANS; INDUCTION; MODEL; MICROCHIMERISM; TESTOSTERONE; AUTOANTIGENS	Background: Toxoplasmosis, one of the most common zoonotic diseases worldwide, can induce various hormonal and behavioural alterations in infected hosts, and its most common form, latent toxoplasmosis, influences the course of pregnancy. Autoimmune thyroid diseases (AITD) belong to the well-defined risk factors for adverse pregnancy outcomes. The aim of this study was to investigate whether there is a link between latent toxoplasmosis and maternal AITD in pregnancy. Methods: Cross-sectional study in 1248 consecutive pregnant women in the 9-12 th gestational weeks. Serum thyroid-stimulating hormone (TSH), thyroperoxidase antibodies (TPOAb), and free thyroxine (FT4) were assessed by chemiluminescence; the Toxoplasma status was detected by the complement fixation test (CFT) and anti-Toxoplasma IgG enzyme-linked immunosorbent assay (ELISA). Results: Overall, 22.5% of the women were positive for latent toxoplasmosis and 14.7% were screened positive for AITD. Women with latent toxoplasmosis had more often highly elevated TPOAb than the Toxoplasma-negative ones (p = 0.004), and latent toxoplasmosis was associated with decrease in serum TSH levels (p = 0.049). Moreover, we found a positive correlation between FT4 and the index of positivity for anti-Toxoplasma IgG antibodies (p = 0.033), which was even stronger in the TPOAb-positive Toxoplasma-positive women, (p = 0.014), as well as a positive correlation between FT4 and log(2) CFT (p = 0.009). Conclusions: Latent toxoplasmosis was associated with a mild increase in thyroid hormone production in pregnancy. The observed Toxoplasma-associated changes in the parameters of AITD are mild and do not seem to be clinically relevant; however, they could provide new clues to the complex pathogenesis of autoimmune thyroid diseases.	[Kankova, Sarka; Prochazkova, Lucie; Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic; [Calda, Pavel] Charles Univ Prague, Gen Univ Hosp, Dept Obstet & Gynaecol, Prague, Czech Republic; [Calda, Pavel; Springer, Drahomira; Potlukova, Eliska] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Springer, Drahomira] Charles Univ Prague, Gen Univ Hosp, Inst Clin Biochem & Lab Diagnost, Prague, Czech Republic; [Potlukova, Eliska] Charles Univ Prague, Gen Univ Hosp, Dept Med 3, Prague, Czech Republic	Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; General University Hospital Prague	Kankova, S (corresponding author), Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic.	kankova.sarka@gmail.com	Springer, Drahomira/J-2474-2017; Šárka, Kaňková/F-8514-2019; Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021; Calda, Pavel/C-9171-2017	Springer, Drahomira/0000-0003-4756-0585; Šárka, Kaňková/0000-0002-3087-7538; Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Calda, Pavel/0000-0002-2903-5026; Potlukova, Eliska/0000-0003-4790-8860	Charles University [UNCE 204004, PRVOUK 25]; Ministry of Health of the Czech Republic [RVO-VFN64165]	Charles University; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The research was supported by project UNCE 204004 of the Charles University, the grant PRVOUK 25 of the Charles University, and research grant No. RVO-VFN64165 from the Ministry of Health of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; Benvenga S, 2006, THYROID, V16, P225, DOI 10.1089/thy.2006.16.225; Benvenga S, 2004, THYROID, V14, P964, DOI 10.1089/thy.2004.14.964; CDC, 2013, TOX EP RISK FACT; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793; Flegr J, 1996, PARASITOLOGY, V113, P49, DOI 10.1017/S0031182000066269; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 2014, NEUROENDOCRINOL LETT, V35, P20; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Flegr J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-274; Fugazzola L, 2012, J CLIN ENDOCR METAB, V97, P1452, DOI 10.1210/jc.2011-3160; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; GAZZINELLI RT, 1993, INFECT AGENT DIS, V2, P139; GLINOER D, 1990, J CLIN ENDOCR METAB, V71, P276, DOI 10.1210/jcem-71-2-276; Groer MW, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.004; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kankova S, 2010, PARASITOL RES, V107, P1421, DOI 10.1007/s00436-010-2013-9; Kolbekova P, 2007, CLIN MICROBIOL INFEC, V13, P1012, DOI 10.1111/j.1469-0691.2007.01771.x; Limanova Zdenka, 2011, Cas Lek Cesk, V150, P389; Lindova J, 2006, INT J PARASITOL, V36, P1485, DOI 10.1016/j.ijpara.2006.07.008; Morohoshi K, 2011, DISCOV MED, V12, P505; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; Potlukova E, 2012, J CLIN ENDOCR METAB, V97, P1945, DOI 10.1210/jc.2011-3275; Prandota J, 2012, NEUROINFLAMMATION PA, P447; Ronet C, 2005, J IMMUNOL, V175, P899, DOI 10.4049/jimmunol.175.2.899; Shapira Y, 2012, J AUTOIMMUN, V39, P112, DOI 10.1016/j.jaut.2012.01.001; Shapira Y, 2012, CLIN REV ALLERG IMMU, V42, P154, DOI 10.1007/s12016-010-8241-z; Solerte SB, 2005, EUR J ENDOCRINOL, V152, P703, DOI 10.1530/eje.1.01906; Springer D, 2009, EUR J ENDOCRINOL, V160, P791, DOI 10.1530/EJE-08-0890; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Stahl W, 1998, PARASITOLOGY, V117, P217, DOI 10.1017/S003118209800300X; Stahl W, 1998, PARASITOLOGY, V117, P223, DOI 10.1017/S0031182098003035; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tozzoli R, 2008, AUTOIMMUN REV, V8, P112, DOI 10.1016/j.autrev.2008.07.013; Wasserman EE, 2009, AUTOIMMUNITY, V42, P439, DOI 10.1080/08916930902787716; Wolf A, 1939, AM J PATHOL, V15, P657	39	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110878	10.1371/journal.pone.0110878	http://dx.doi.org/10.1371/journal.pone.0110878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350671	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100045
J	Lizama, LEC; Pijnappels, M; Faber, GH; Reeves, PN; Verschueren, SM; van Dieen, JH				Lizama, L. Eduardo Cofre; Pijnappels, Mirjam; Faber, Gert H.; Reeves, Peter N.; Verschueren, Sabine M.; van Dieen, Jaap H.			Age Effects on Mediolateral Balance Control	PLOS ONE			English	Article							SENSORIMOTOR INTEGRATION; POSTURAL ORIENTATION; MUSCLE MASS; FALL-RISK; STABILITY; HIP; VARIABILITY; DEMANDS; DECLINE; PEOPLE	Background: Age-related balance impairments, particularly in mediolateral direction (ML) may cause falls. Sufficiently sensitive and reliable ML balance tests are, however, lacking. This study is aimed to determine (1) the effect of age on and (2) the reliability of ML balance performance using Center of Mass (CoM) tracking. Methods: Balance performance of 19 young (26 +/- 3 years) and 19 older (72 +/- 5 years) adults on ML-CoM tracking tasks was compared. Subjects tracked predictable and unpredictable target displacements at increasing frequencies with their CoM by shifting their weight sideward. Phase-shift (response delay) and gain (amplitude difference) between the CoM and target in the frequency domain were used to quantify performance. Thirteen older and all young adults were reassessed to determine reliability of balance performance measures. In addition, all older adults performed a series of clinical balance tests and conventional posturography was done in a sub-sample. Results: Phase-shift and gain dropped below pre-determined thresholds (-90 degrees and 0.5) at lower frequencies in the older adults and were even lower below these frequencies than in young adults. Performance measures showed good to excellent reliability in both groups. All clinical scores were close to the maximum and no age effect was found using posturography. ML balance performance measures exhibited small but systematic between-session differences indicative of learning. Conclusions: The ability to accurately perform ML-CoM tracking deteriorates with age. ML-CoM tracking tasks form a reliable tool to assess ML balance in young and older adults and are more sensitive to age-related impairment than posturography and clinical tests.	[Lizama, L. Eduardo Cofre; Pijnappels, Mirjam; Faber, Gert H.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Reeves, Peter N.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Verschueren, Sabine M.] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Rehabil Sci, Leuven, Belgium	Vrije Universiteit Amsterdam; Michigan State University; Michigan State University College of Osteopathic Medicine; KU Leuven	van Dieen, JH (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	j.van.dieen@vu.nl	Lizama, L. Eduardo Cofré/AAW-8548-2020; Verschueren, Sabine/K-4213-2015; van Dieen, Jaap/B-3937-2013	Verschueren, Sabine/0000-0003-2592-494X; van Dieen, Jaap/0000-0002-7719-5585; Pijnappels, Mirjam/0000-0001-8416-2602; Faber, Gert/0000-0003-3596-0389; Cofre Lizama, L. Eduardo/0000-0002-3490-4521	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program [2011-0015]; TOP-NIG from the Dutch Organization for Scientific Research (NWO) [91209021]	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program; TOP-NIG from the Dutch Organization for Scientific Research (NWO)	This research was funded by the European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program (2011-0015). Experimental set-up was supported by MOTEK Medical BV, Amsterdam, The Netherlands. Mirjam Pijnappels was financially supported by a TOP-NIG grant (#91209021) from the Dutch Organization for Scientific Research (NWO). The European Union as well as The Dutch Organization for Scientific Research (NWO) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baloh RW, 2003, ARCH NEUROL-CHICAGO, V60, P835, DOI 10.1001/archneur.60.6.835; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Bingham JT, 2011, J NEUROPHYSIOL, V106, P437, DOI 10.1152/jn.00010.2011; Brauer SG, 2000, J GERONTOL A-BIOL, V55, pM469, DOI 10.1093/gerona/55.8.M469; Cenciarini M, 2010, IEEE T BIO-MED ENG, V57, P267, DOI 10.1109/TBME.2009.2031874; Chang SHJ, 2005, ARCH PHYS MED REHAB, V86, P1843, DOI 10.1016/j.apmr.2005.03.006; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Close JCT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5153; Cofre Lizama LE, CAN VISUAL FEE UNPUB; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Dionyssiotis Y, 2012, INT J GEN MED, V5, P805, DOI 10.2147/IJGM.S32651; Egerton T, 2010, HUM MOVEMENT SCI, V29, P1011, DOI 10.1016/j.humov.2010.06.001; Franchignoni F, 2010, J REHABIL MED, V42, P323, DOI 10.2340/16501977-0537; Freiherr J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00863; Goodworth AD, 2009, J NEUROPHYSIOL, V102, P496, DOI 10.1152/jn.00118.2009; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; HARADA N, 1995, PHYS THER, V75, P462, DOI 10.1093/ptj/75.6.462; Hay L, 1996, EXP BRAIN RES, V108, P129; Marjorie JH, 2008, ARCH PHYS MED REHAB, V89, P1708, DOI 10.1016/j.apmr.2008.01.023; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Hortobagyi T, 2006, EXERC SPORT SCI REV, V34, P29, DOI 10.1097/00003677-200601000-00007; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Lizama LEC, 2013, J BIOMECH, V46, P2831, DOI 10.1016/j.jbiomech.2013.08.018; Mak MKY, 2013, J REHABIL MED, V45, P565, DOI 10.2340/16501977-1144; Maki BE, 2007, J NEURAL TRANSM, V114, P1279, DOI 10.1007/s00702-007-0764-y; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maki BE, 2011, J SAFETY RES, V42, P473, DOI 10.1016/j.jsr.2011.02.002; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Narici MV, 2008, DISABIL REHABIL, V30, P1548, DOI 10.1080/09638280701831058; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Orr R, 2010, EUR J PHYS REHAB MED, V46, P183; Pardasaney PK, 2012, PHYS THER, V92, P388, DOI 10.2522/ptj.20100398; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Sparto PJ, 2014, GAIT POSTURE, V39, P799, DOI 10.1016/j.gaitpost.2013.10.021; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Thorbahn LDB, 1996, PHYS THER, V76, P576, DOI 10.1093/ptj/76.6.576; Tiedemann A, 2010, J GERONTOL A-BIOL, V65, P893, DOI 10.1093/gerona/glq067; TOPPER AK, 1993, J AM GERIATR SOC, V41, P479, DOI 10.1111/j.1532-5415.1993.tb01881.x; Tucker MG, 2009, CLIN BIOMECH, V24, P597, DOI 10.1016/j.clinbiomech.2009.06.002; van Emmerik REA, 2002, EXERC SPORT SCI REV, V30, P177, DOI 10.1097/00003677-200210000-00007; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Wingert JR, 2014, ARCH PHYS MED REHAB, V95, P253, DOI 10.1016/j.apmr.2013.08.012; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; World Health Organization, 2007, GLOB REP FALLS PREV; Young WR, 2012, GAIT POSTURE, V36, P477, DOI 10.1016/j.gaitpost.2012.04.009	50	31	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110757	10.1371/journal.pone.0110757	http://dx.doi.org/10.1371/journal.pone.0110757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350846	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100038
J	Mendes, CS; Rajendren, SV; Bartos, I; Marka, S; Mann, RS				Mendes, Cesar S.; Rajendren, Soumya V.; Bartos, Imre; Marka, Szabolcs; Mann, Richard S.			Kinematic Responses to Changes in Walking Orientation and Gravitational Load in Drosophila melanogaster	PLOS ONE			English	Article							TIBIAL CAMPANIFORM SENSILLA; FREELY STANDING COCKROACHES; SPIKING LOCAL INTERNEURONS; FEMORAL CHORDOTONAL ORGAN; INTER-LEG COORDINATION; BODY LOAD; STICK INSECT; GENETIC MANIPULATION; HEXAPEDAL RUNNERS; SENSORY SIGNALS	Walking behavior is context-dependent, resulting from the integration of internal and external influences by specialized motor and pre-motor centers. Neuronal programs must be sufficiently flexible to the locomotive challenges inherent in different environments. Although insect studies have contributed substantially to the identification of the components and rules that determine locomotion, we still lack an understanding of how multi-jointed walking insects respond to changes in walking orientation and direction and strength of the gravitational force. In order to answer these questions we measured with high temporal and spatial resolution the kinematic properties of untethered Drosophila during inverted and vertical walking. In addition, we also examined the kinematic responses to increases in gravitational load. We find that animals are capable of shifting their step, spatial and inter-leg parameters in order to cope with more challenging walking conditions. For example, flies walking in an inverted orientation decreased the duration of their swing phase leading to increased contact with the substrate and, as a result, greater stability. We also find that when flies carry additional weight, thereby increasing their gravitational load, some changes in step parameters vary over time, providing evidence for adaptation. However, above a threshold that is between 1 and 2 times their body weight flies display locomotion parameters that suggest they are no longer capable of walking in a coordinated manner. Finally, we find that functional chordotonal organs are required for flies to cope with additional weight, as animals deficient in these proprioceptors display increased sensitivity to load bearing as well as other locomotive defects.	[Mendes, Cesar S.; Rajendren, Soumya V.; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Rajendren, Soumya V.] Columbia Univ, Neurosci & Behav Barnard Coll, New York, NY USA; [Bartos, Imre; Marka, Szabolcs] Columbia Univ, Dept Phys, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Mendes, CS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	cesar2001@gmail.com; rsm10@columbia.edu	Bartos, Imre/AAD-6024-2019; Bartos, Imre/A-2592-2017; Marka, Szabolcs/ABE-7493-2021	S. Mendes, Cesar/0000-0001-6974-9042	National Institutes of Health; Ellison Foundation [-NIH/5 R01 NS070644-03 (GG005430/5-38621), PG005402]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for CSM and RSM: National Institutes of Health (http://www.nih.gov/), -NIH/5 R01 NS070644-03 (GG005430/5-38621) Ellison Foundation (http://www.ellisonfoundation.org/), PG005402. Funding for SVR: Barnard College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay T, 2001, J NEUROPHYSIOL, V85, P594, DOI 10.1152/jn.2001.85.2.594; Akay T, 2007, J NEUROSCI, V27, P3285, DOI 10.1523/JNEUROSCI.5202-06.2007; Akay T, 2006, J NEUROPHYSIOL, V96, P3532, DOI 10.1152/jn.00625.2006; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; BASSLER U, 1977, J COMP PHYSIOL, V121, P99; Bender JA, 2011, J EXP BIOL, V214, P2057, DOI 10.1242/jeb.056481; Bender JA, 2009, CURR BIOL, V19, pR186, DOI 10.1016/j.cub.2008.12.024; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; BURROWS M, 1987, J NEUROSCI, V7, P1064; BURROWS M, 1985, J NEUROPHYSIOL, V54, P463, DOI 10.1152/jn.1985.54.3.463; Burrows M., 1996, NEUROBIOLOGY INSECT; Burrows M, 1988, J COMP PHYSL A; BUSCHGES A, 1994, J EXP BIOL, V189, P285; Buschges A, 2008, SENSES COMPREHENSIVE, P355; Chang YH, 2000, J EXP BIOL, V203, P229; CRUSE H, 1984, J COMP PHYSIOL, V154, P695, DOI 10.1007/BF01350223; Cruse H, 1998, NEURAL NETWORKS, V11, P1435, DOI 10.1016/S0893-6080(98)00067-7; Cruse H, 1976, FUNCTION LEGS FREE W, P235; Cruse H, 2007, PHILOS T R SOC A, V365, P221, DOI 10.1098/rsta.2006.1913; Davis KG, 2000, CLIN BIOMECH, V15, P703, DOI 10.1016/S0268-0033(00)00035-8; Dietz V, 1998, MOVEMENT DISORD, V13, P255, DOI 10.1002/mds.870130210; DUCH C, 1995, J EXP BIOL, V198, P1963; Durr V, 2004, ARTHROPOD STRUCT DEV, V33, P237, DOI 10.1016/j.asd.2004.05.004; FULL RJ, 1991, J EXP BIOL, V156, P215; FULL RJ, 1990, J EXP BIOL, V149, P307; FULL RJ, 1991, J EXP BIOL, V158, P369; Full RJ, 1999, J EXP BIOL, V202, P3325; Gorb SN, 2001, NATURWISSENSCHAFTEN, V88, P530, DOI 10.1007/s00114-001-0274-y; Grabowska M, 2012, J EXP BIOL, V215, P4255, DOI 10.1242/jeb.073643; GRAHAM D, 1985, ADV INSECT PHYSIOL, V18, P31; GUTHRIE DM, 1967, J INSECT PHYSIOL, V13, P1637, DOI 10.1016/0022-1910(67)90159-X; Hess D, 1997, J NEUROBIOL, V33, P891; HOFMANN T, 1985, J EXP BIOL, V114, P207; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Jamon M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00011; Jindrich DL, 1999, J EXP BIOL, V202, P1603; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KAPLAN WD, 1974, GENETICS, V77, P721; Keller BR, 2007, J COMP PHYSIOL A, V193, P881, DOI 10.1007/s00359-007-0241-y; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; KOTO M, 1981, BRAIN RES, V221, P213, DOI 10.1016/0006-8993(81)90772-1; Kram R, 1996, J EXP BIOL, V199, P609; LARSEN GS, 1995, J COMP PHYSIOL A, V176, P229, DOI 10.1007/BF00239925; Lipp A, 2005, J EXP BIOL, V208, P707, DOI 10.1242/jeb.01434; MATHESON T, 1995, J EXP BIOL, V198, P1673; Matsuo E, 2013, J COMP PHYSIOL A, V199, P253, DOI 10.1007/s00359-013-0806-x; Mendes CS, 2013, ELIFE, V2, DOI 10.7554/eLife.00231; Moll K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052816; Muir G, 1999, J NEUROTRAUM, V16, P705, DOI 10.1089/neu.1999.16.705; Niederegger S, 2003, J INSECT PHYSIOL, V49, P611, DOI 10.1016/S0022-1910(03)00048-9; Noah JA, 2004, J COMP PHYSIOL A, V190, P201, DOI 10.1007/s00359-003-0487-y; Noah JA, 2001, J COMP PHYSIOL A, V187, P769, DOI 10.1007/s00359-001-0247-9; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Pringle JWS, 1938, J EXP BIOL, V15, P114; Quimby LA, 2006, J COMP PHYSIOL A, V192, P247, DOI 10.1007/s00359-005-0062-9; Ridgel AL, 2001, J COMP PHYSIOL A, V187, P405, DOI 10.1007/s003590100213; Rossignol S, 2004, CAN J PHYSIOL PHARM, V82, P617, DOI 10.1139/Y04-068; Seidl T, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-8; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; SONG SM, 1989, MATH BIOSCI, V97, P199, DOI 10.1016/0025-5564(89)90005-9; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TING LH, 1994, J EXP BIOL, V197, P251; Triphan T, 2010, CURR BIOL, V20, P663, DOI 10.1016/j.cub.2010.02.055; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Wosnitza A, 2013, J EXP BIOL, V216, P480, DOI 10.1242/jeb.078139; Zill S, 2004, ARTHROPOD STRUCT DEV, V33, P273, DOI 10.1016/j.asd.2004.05.005; ZILL SN, 1981, J EXP BIOL, V94, P43	73	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109204	10.1371/journal.pone.0109204	http://dx.doi.org/10.1371/journal.pone.0109204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350743	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100010
J	Risco, D; Serrano, E; Fernandez-Llario, P; Cuesta, JM; Goncalves, P; Garcia-Jimenez, WL; Martinez, R; Cerrato, R; Velarde, R; Gomez, L; Segales, J; de Mendoza, JH				Risco, David; Serrano, Emmanuel; Fernandez-Llario, Pedro; Cuesta, Jesus M.; Goncalves, Pilar; Garcia-Jimenez, Waldo L.; Martinez, Remigio; Cerrato, Rosario; Velarde, Roser; Gomez, Luis; Segales, Joaquim; Hermoso de Mendoza, Javier			Severity of Bovine Tuberculosis Is Associated with Co-Infection with Common Pathogens in Wild Boar	PLOS ONE			English	Article							CIRCOVIRUS TYPE-2 INFECTIONS; SUS-SCROFA; MYCOBACTERIUM-TUBERCULOSIS; SPECIES COOCCURRENCE; PREVALENCE; IDENTIFICATION; CONSEQUENCES; ANTIBODIES; PARASITES; INVASION	Co-infections with parasites or viruses drive tuberculosis dynamics in humans, but little is known about their effects in other non-human hosts. This work aims to investigate the relationship between Mycobacterium bovis infection and other pathogens in wild boar (Sus scrofa), a recognized reservoir of bovine tuberculosis (bTB) in Mediterranean ecosystems. For this purpose, it has been assessed whether contacts with common concomitant pathogens are associated with the development of severe bTB lesions in 165 wild boar from mid-western Spain. The presence of bTB lesions affecting only one anatomic location (cervical lymph nodes), or more severe patterns affecting more than one location (mainly cervical lymph nodes and lungs), was assessed in infected animals. In addition, the existence of contacts with other pathogens such as porcine circovirus type 2 (PCV2), Aujeszky's disease virus (ADV), swine influenza virus, porcine reproductive and respiratory syndrome virus, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, Haemophilus parasuis and Metastrongylus spp, was evaluated by means of serological, microbiological and parasitological techniques. The existence of contacts with a structured community of pathogens in wild boar infected by M. bovis was statistically investigated by null models. Association between this community of pathogens and bTB severity was examined using a Partial Least Squares regression approach. Results showed that adult wild boar infected by M. bovis had contacted with some specific, non-random pathogen combinations. Contact with PCV2, ADV and infection by Metastrongylus spp, was positively correlated to tuberculosis severity. Therefore, measures against these concomitant pathogens such as vaccination or deworming, might be useful in tuberculosis control programmes in the wild boar. However, given the unexpected consequences of altering any community of organisms, further research should evaluate the impact of such measures under controlled conditions. Furthermore, more research including other important pathogens, such as gastro-intestinal nematodes, will be necessary to complete this picture.	[Risco, David; Fernandez-Llario, Pedro; Cuesta, Jesus M.; Goncalves, Pilar; Garcia-Jimenez, Waldo L.; Martinez, Remigio; Cerrato, Rosario; Gomez, Luis; Hermoso de Mendoza, Javier] Univ Extremadura, Fac Vet, Red Grp Invest Recursos Faunist, Caceres, Spain; [Serrano, Emmanuel] Univ Aveiro, Ctr Environm & Marine Studies CESAM, Dept Biol, P-3800 Aveiro, Portugal; [Serrano, Emmanuel; Velarde, Roser] Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Bellaterra, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Inst Recerca & Tecnol Agroalimentaries, Ctr Recerca Sanitat Anim CReSA, Bellaterra, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain	Universidad de Extremadura; Universidade de Aveiro; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona	Risco, D (corresponding author), Univ Extremadura, Fac Vet, Red Grp Invest Recursos Faunist, Caceres, Spain.	driscope@gmail.com	Velarde, Roser/M-1614-2014; Segalés, Joaquim/A-4933-2011; Hermoso-de-Mendoza, Javier/N-7808-2013; Segalés, Joaquim/AAB-4815-2020; Pérez, Remigio Martínez/A-2414-2009; SERRANO-FERRON, Emmanuel/J-4489-2013	Velarde, Roser/0000-0003-3332-6405; Segalés, Joaquim/0000-0002-1539-7261; Hermoso-de-Mendoza, Javier/0000-0002-5574-4432; Segalés, Joaquim/0000-0002-1539-7261; Pérez, Remigio Martínez/0000-0002-5908-9447; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804	Ministerio de Ciencia e Innovacion (Gobierno de Espana) [PS0900513]; Junta de Extremadura [PDT09A046, GRU10142]; Ministerio de Ciencia e Innovacion; Fundacao para a Ciencia ea Tecnologia, Portugal [SFRH/BPD/96637/2013]	Ministerio de Ciencia e Innovacion (Gobierno de Espana)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Extremadura; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacao para a Ciencia ea Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This study was supported by Ministerio de Ciencia e Innovacion (Gobierno de Espana) PS0900513 and Junta de Extremadura (PDT09A046 and GRU10142). D. Risco has a Formacion Profesorado Universitario (FPU) grant from the Ministerio de Ciencia e Innovacion (https://sede.educacion.gob.es). E. Serrano was supported by the postdoctoral program (SFRH/BPD/96637/2013) of the Fundacao para a Ciencia ea Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2007, ENCY MEASUREMENT STA, P741; Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Black Thomas C., 1946, SOUTHERN MED JOUR, V39, P881, DOI 10.1097/00007611-194611000-00007; BOITANI L, 1992, ONGULES / UNGULATES 91, P419; Bollo E, 2000, J VET MED B, V47, P337, DOI 10.1046/j.1439-0450.2000.00354.x; Bordes Frederic, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7346; Borkow G, 2004, CLIN MICROBIOL REV, V17, P1012, DOI 10.1128/CMR.17.4.1012-1030.2004; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Calero-Bernal R, 2013, J WILDLIFE DIS, V49, P1019, DOI 10.7589/2013-01-024; Cho WS, 2003, LETT APPL MICROBIOL, V37, P56, DOI 10.1046/j.1472-765X.2003.01347.x; CORNER LA, 1988, VET MICROBIOL, V18, P127, DOI 10.1016/0378-1135(88)90058-2; COUSINS DV, 1991, VET MICROBIOL, V27, P187, DOI 10.1016/0378-1135(91)90010-D; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Elias D, 2005, CLIN EXP IMMUNOL, V139, P398, DOI 10.1111/j.1365-2249.2004.02719.x; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Ezenwa VO, 2010, AM NAT, V176, P613, DOI 10.1086/656496; Fenton A, 2013, PARASITOLOGY, V140, P1119, DOI 10.1017/S0031182013000590; Fitzgerald SD, 2013, VET PATHOL, V50, P488, DOI 10.1177/0300985812467472; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gortazar C, 2013, EPIDEMIOL INFECT, V141, P1339, DOI 10.1017/S0950268813000599; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gotelli NJ, 2002, ECOL LETT, V5, P86, DOI 10.1046/j.1461-0248.2002.00288.x; Gottschalk M, 2006, DIS SWINE, P563; Graham AL, 2007, TRENDS PARASITOL, V23, P284, DOI 10.1016/j.pt.2007.04.005; Haenlein M., 2004, UNDERSTANDING STAT, V3, P283, DOI [10.1207/s15328031us0304_4, DOI 10.1207/S15328031US0304_4]; Hammer R, 2012, J WILDLIFE DIS, V48, P87, DOI 10.7589/0090-3558-48.1.87; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lass S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0588; Li XX, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-79; Garcia-Gonzalez AM, 2013, J WILDLIFE DIS, V49, P157, DOI 10.7589/2011-07-217; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Menin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053884; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Navarro-Gonzalez N, 2013, VET PARASITOL, V196, P114, DOI 10.1016/j.vetpar.2013.02.019; Oliveira S, 2001, J VET DIAGN INVEST, V13, P495, DOI 10.1177/104063870101300607; Olsen CW, 2006, DIS SWINE, V9, P469; Pathak AK, 2012, INT J PARASITOL, V42, P647, DOI 10.1016/j.ijpara.2012.04.011; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Pejsak ZK, 2006, DIS SWINE, P419; Perez JM, 2006, BIODIVERS CONSERV, V15, P2033, DOI 10.1007/s10531-005-0773-9; Rafi W, 2012, CURR OPIN HIV AIDS, V7, P239, DOI 10.1097/COH.0b013e3283524dc5; Rapp-Gabrielson VJ, 2006, DIS SWINE, P681; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Risco D, 2013, TRANSBOUND EMERG DIS, V60, P121, DOI 10.1111/tbed.12112; Risco D, 2013, T EMERG DIS IN PRESS; Roic B, 2012, J WILDLIFE DIS, V48, P131, DOI 10.7589/0090-3558-48.1.131; SANCHEZ G, 2010, PLSPM PARTIAL LEAST; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Segales J, 2006, DIS SWINE, P299; Serrano E, 2014, EPIDEMIOL INFECT, V142, P1533, DOI 10.1017/S0950268813002100; Serrano E, 2014, EPIDEMIOL INFECT, V142, P530, DOI 10.1017/S0950268813001295; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Stukelj M, 2014, SLOV VET RES, V51, P21; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; Team RDC, 2014, R LANG ENV STAT COMP; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Thacker EL, 2006, DIS SWINE, P701; Thakar J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002345; Yacob HT, 2006, VET PARASITOL, V137, P184, DOI 10.1016/j.vetpar.2006.01.020; Zimmerman J., 2006, DIS SWINE, P387	67	34	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110123	10.1371/journal.pone.0110123	http://dx.doi.org/10.1371/journal.pone.0110123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350002	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943100021
J	Wilton, CM; Puckett, EE; Beringer, J; Gardner, B; Eggert, LS; Belant, JL				Wilton, Clay M.; Puckett, Emily E.; Beringer, Jeff; Gardner, Beth; Eggert, Lori S.; Belant, Jerrold L.			Trap Array Configuration Influences Estimates and Precision of Black Bear Density and Abundance	PLOS ONE			English	Article							ESTIMATING POPULATION-SIZE; MARK-RECAPTURE; GENETIC-STRUCTURE; URSUS-AMERICANUS; NATIONAL-PARK; CAMERA-TRAPS; DNA DATA; CAPTURE; MODELS; HABITAT	Spatial capture-recapture (SCR) models have advanced our ability to estimate population density for wide ranging animals by explicitly incorporating individual movement. Though these models are more robust to various spatial sampling designs, few studies have empirically tested different large-scale trap configurations using SCR models. We investigated how extent of trap coverage and trap spacing affects precision and accuracy of SCR parameters, implementing models using the R package secr. We tested two trapping scenarios, one spatially extensive and one intensive, using black bear (Ursus americanus) DNA data from hair snare arrays in south-central Missouri, USA. We also examined the influence that adding a second, lower barbed-wire strand to snares had on quantity and spatial distribution of detections. We simulated trapping data to test bias in density estimates of each configuration under a range of density and detection parameter values. Field data showed that using multiple arrays with intensive snare coverage produced more detections of more individuals than extensive coverage. Consequently, density and detection parameters were more precise for the intensive design. Density was estimated as 1.7 bears per 100 km(2) and was 5.5 times greater than that under extensive sampling. Abundance was 279 (95% CI = 193-406) bears in the 16,812 km(2) study area. Excluding detections from the lower strand resulted in the loss of 35 detections, 14 unique bears, and the largest recorded movement between snares. All simulations showed low bias for density under both configurations. Results demonstrated that in low density populations with non-uniform distribution of population density, optimizing the tradeoff among snare spacing, coverage, and sample size is of critical importance to estimating parameters with high precision and accuracy. With limited resources, allocating available traps to multiple arrays with intensive trap spacing increased the amount of information needed to inform parameters with high precision.	[Wilton, Clay M.; Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Puckett, Emily E.; Eggert, Lori S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Beringer, Jeff] Missouri Dept Conservat, Columbia, MO USA; [Gardner, Beth] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA	Mississippi State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of North Carolina; North Carolina State University	Wilton, CM (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	cwilton@cfr.msstate.edu	Belant, Jerrold/HDM-7749-2022	Puckett, Emily/0000-0002-9325-4629	Missouri Department of Conservation; U.S. Fish and Wildlife Service Federal Aid in Wildlife Restoration; Department of Wildlife, Fisheries, and Aquaculture at Mississippi State University; Forest and Wildlife Research Center at Mississippi State University; Safari Club International Foundation	Missouri Department of Conservation; U.S. Fish and Wildlife Service Federal Aid in Wildlife Restoration; Department of Wildlife, Fisheries, and Aquaculture at Mississippi State University; Forest and Wildlife Research Center at Mississippi State University; Safari Club International Foundation	Funding was provided by the Missouri Department of Conservation; U.S. Fish and Wildlife Service Federal Aid in Wildlife Restoration; Department of Wildlife, Fisheries, and Aquaculture and Forest and Wildlife Research Center at Mississippi State University; and Safari Club International Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps CD, 2004, J WILDLIFE MANAGE, V68, P138, DOI 10.2193/0022-541X(2004)068[0138:EGBDAA]2.0.CO;2; Baldwin RA, 2012, EUR J WILDLIFE RES, V58, P557, DOI 10.1007/s10344-011-0605-z; Bales SL, 2005, WILDLIFE SOC B, V33, P1342, DOI 10.2193/0091-7648(2005)33[1342:DOARPO]2.0.CO;2; Belant JL, 2005, URSUS, V16, P85, DOI 10.2192/1537-6176(2005)016[0085:ABBPSA]2.0.CO;2; BONDRUPNIELSEN S, 1983, CAN J ZOOL, V61, P2361, DOI 10.1139/z83-313; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Boulanger J, 2004, J WILDLIFE MANAGE, V68, P457, DOI 10.2193/0022-541X(2004)068[0457:SDABID]2.0.CO;2; Boulanger J, 2001, CAN J ZOOL, V79, P642, DOI 10.1139/cjz-79-4-642; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carmichael LE, 2005, J MAMMAL, V86, P160, DOI 10.1644/1545-1542(2005)086<0160:GOPPBI>2.0.CO;2; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; Drewry JM, 2013, J WILDLIFE MANAGE, V77, P153, DOI 10.1002/jwmg.443; Ebert C, 2010, WILDLIFE BIOL, V16, P225, DOI 10.2981/09-108; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Efford M. G., 2012, DENSITY 5 0 SOFTWARE; Efford M. G., 2013, SECR SPATIALLY EXPLI; Efford MG, 2005, WILDLIFE SOC B, V33, P731, DOI 10.2193/0091-7648(2005)33[731:AFTOTM]2.0.CO;2; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Eggert LS, 2005, METHOD ENZYMOL, V395, P73, DOI 10.1016/S0076-6879(05)95006-4; Frary VJ, 2011, WILDLIFE BIOL, V17, P404, DOI 10.2981/09-103; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gardner B, 2009, ECOLOGY, V90, P1106, DOI 10.1890/07-2112.1; Garshelis DL, 2006, URSUS, V17, P109, DOI 10.2192/1537-6176(2006)17[109:OTAONG]2.0.CO;2; Garshelis DL, 2006, URSUS, V17, P1, DOI 10.2192/1537-6176(2006)17[1:SAPEOA]2.0.CO;2; Gross M, 2008, WILDLIFE CONSERVATIO; Howe EJ, 2013, POPUL ECOL, V55, P595, DOI 10.1007/s10144-013-0389-y; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P97, DOI 10.1007/978-4-431-99495-4_7; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kery M, 2011, CONSERV BIOL, V25, P356, DOI 10.1111/j.1523-1739.2010.01616.x; Lofroth EC, 2007, J WILDLIFE MANAGE, V71, P2159, DOI 10.2193/2007-094; MASTER LL, 1991, CONSERV BIOL, V5, P559, DOI 10.1111/j.1523-1739.1991.tb00370.x; Missouri Spatial Data Information Service, 2005, MSDIS DAT THEM LIST; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; Neel MC, 2012, BIOSCIENCE, V62, P646, DOI 10.1525/bio.2012.62.7.7; Ngoprasert D, 2012, URSUS, V23, P117, DOI 10.2192/URSUS-D-11-00009.1; Nigh T.A., 2002, ATLAS MISSOURI ECORE; Noyce KV, 2011, BEHAV ECOL SOCIOBIOL, V65, P823, DOI 10.1007/s00265-010-1086-x; Noyce KV, 2001, URSUS-SERIES, V12, P211; O'Brien TG, 2011, ECOL APPL, V21, P2908, DOI 10.1890/10-2284.1; OTIS DL, 1978, WILDLIFE MONOGR, P1; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; Peacock E, 2011, J WILDLIFE MANAGE, V75, P1513, DOI 10.1002/jwmg.171; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Puckett EE, 2014, MOL ECOL, V23, P2414, DOI 10.1111/mec.12748; R Core Team, 2021, R LANGUAGE ENV STAT; RAEKER G., 2010, MISSOURIS FOREST RES; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P163, DOI 10.1007/978-4-431-99495-4_10; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Russell RE, 2012, J WILDLIFE MANAGE, V76, P1551, DOI 10.1002/jwmg.412; Sanderlin JS, 2009, MOL ECOL RESOUR, V9, P288, DOI 10.1111/j.1755-0998.2008.02234.x; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Settlage KE, 2008, J WILDLIFE MANAGE, V72, P1035, DOI 10.2193/2006-472; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025; Sunarto, 2013, ORYX, V47, P211, DOI 10.1017/S0030605311001530; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; TURNER MG, 1995, ECOL APPL, V5, P12, DOI 10.2307/1942046; United States Geological Survey, 2009, SCI YOUR BACK MISS; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Wegge P, 2004, ANIM CONSERV, V7, P251, DOI 10.1017/S1367943004001441; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilton CM, 2014, URSUS, V25, P53, DOI 10.2192/URSUS-D-13-00017.1; Woods JG, 1999, WILDLIFE SOC B, V27, P616	76	46	46	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111257	10.1371/journal.pone.0111257	http://dx.doi.org/10.1371/journal.pone.0111257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350557	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100062
J	Nie, XH; Pan, ZM; Zhang, DS; Zhou, H; Chen, M; Zhang, WN				Nie, Xinhua; Pan, Zhongming; Zhang, Dasha; Zhou, Han; Chen, Min; Zhang, Wenna			Energy Detection Based on Undecimated Discrete Wavelet Transform and Its Application in Magnetic Anomaly Detection	PLOS ONE			English	Article								Magnetic anomaly detection (MAD) is a passive approach for detection of a ferromagnetic target, and its performance is often limited by external noises. In consideration of one major noise source is the fractal noise (or called 1/f noise) with a power spectral density of 1/f(a) (0<a<2), which is non-stationary, self-similarity and long-range correlation. Meanwhile the orthonormal wavelet decomposition can play the role of a Karhunen-Loeve-type expansion to the 1/f-type signal by its decorrelation abilities, an effective energy detection method based on undecimated discrete wavelet transform (UDWT) is proposed in this paper. Firstly, the foundations of magnetic anomaly detection and UDWT are introduced in brief, while a possible detection system based on giant magneto-impedance (GMI) magnetic sensor is also given out. Then our proposed energy detection based on UDWT is described in detail, and the probabilities of false alarm and detection for given the detection threshold in theory are presented. It is noticeable that no a priori assumptions regarding the ferromagnetic target or the magnetic noise probability are necessary for our method, and different from the discrete wavelet transform (DWT), the UDWT is shift invariant. Finally, some simulations are performed and the results show that the detection performance of our proposed detector is better than that of the conventional energy detector even utilized in the Gaussian white noise, especially when the spectral parameter alpha is less than 1.0. In addition, a real-world experiment was done to demonstrate the advantages of the proposed method.	[Nie, Xinhua; Pan, Zhongming; Zhang, Dasha; Zhou, Han; Chen, Min; Zhang, Wenna] Natl Univ Def Technol, Coll Mechatron Engn & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Pan, ZM (corresponding author), Natl Univ Def Technol, Coll Mechatron Engn & Automat, Changsha, Hunan, Peoples R China.	chungmingpan@163.com			National Natural Science Foundation of China [91320202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China, NO. 91320202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A., 2005, FDN ANALOG DIGITAL E, V1st; [Anonymous], 1999, WAVELET TOUR SIGNAL, DOI DOI 10.1016/B978-012466606-1/50016-7; Bahoura M, 2012, CIRC SYST SIGNAL PR, V31, P987, DOI 10.1007/s00034-011-9355-0; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; DAUBECHIES I, 1998, COMMUN PURE APPL MAT, V41, P909; Emanuele VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048103; FLANDRIN P, 1992, IEEE T INFORM THEORY, V38, P910, DOI 10.1109/18.119751; Ginzburg B, 2002, SENSOR ACTUAT A-PHYS, V102, P67, DOI 10.1016/S0924-4247(02)00351-5; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; He D, 2013, CIRC SYST SIGNAL PR, V32, P1891, DOI 10.1007/s00034-013-9552-0; He YZ, 2010, NDT&E INT, V43, P409, DOI 10.1016/j.ndteint.2010.03.007; Hirchoren GA, 1998, IEEE T SIGNAL PROCES, V46, P1624, DOI 10.1109/78.678478; Ji RR, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2168752.2168758; Kay, 1998, FUNDAMENTALS STAT SI; Kim WH, 1999, EL CIRC SYST C BRAT, P251; Meng XD, 2013, CIRC SYST SIGNAL PR, V32, P2003, DOI 10.1007/s00034-013-9549-8; Nie Xinhua, 2014, Journal of National University of Defense Technology, V36, P181; Nimgaonkar S, 2013, CIRC SYST SIGNAL PR, V32, P2581, DOI 10.1007/s00034-013-9621-4; Phan MH, 2008, PROG MATER SCI, V53, P323, DOI 10.1016/j.pmatsci.2007.05.003; Sheinker A, 2007, SENSOR ACTUAT A-PHYS, V138, P105, DOI 10.1016/j.sna.2007.04.018; Sheinker A, 2012, IEEE T GEOSCI REMOTE, V50, P1095, DOI 10.1109/TGRS.2011.2164086; Sheinker A, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/4/045205; Uchiyama T, 2012, IEEE T MAGN, V48, P3833, DOI 10.1109/TMAG.2012.2198627; WORNELL GW, 1993, P IEEE, V81, P1428, DOI 10.1109/5.241506; WORNELL GW, 1990, IEEE T INFORM THEORY, V36, P859, DOI 10.1109/18.53745; Yu GL, 2011, IEEE SENS J, V11, DOI 10.1109/JSEN.2011.2134084; Zhang L, 2013, T I MEAS CONTROL, V35, P625, DOI 10.1177/0142331212463026; Zhao W, 2012, J MAGN MAGN MATER, V324, P3073, DOI 10.1016/j.jmmm.2012.05.004	29	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110829	10.1371/journal.pone.0110829	http://dx.doi.org/10.1371/journal.pone.0110829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343484	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500059
J	Vetter, BN; Orlowski, V; Fransen, K; Niederhauser, C; Aubert, V; Brandenberger, M; Ciardo, D; Dollenmaier, G; Klimkait, T; Regenass, S; Schmid, P; Schottstedt, V; Suter-Riniker, F; Yerly, S; Shah, C; Boni, J; Schupbach, J				Vetter, Beatrice N.; Orlowski, Vanessa; Fransen, Katrien; Niederhauser, Christoph; Aubert, Vincent; Brandenberger, Marcel; Ciardo, Diana; Dollenmaier, Guenter; Klimkait, Thomas; Regenass, Stephan; Schmid, Patrick; Schottstedt, Volkmar; Suter-Riniker, Franziska; Yerly, Sabine; Shah, Cyril; Boeni, Juerg; Schuepbach, Joerg			Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests	PLOS ONE			English	Article							HEAT-DENATURED PLASMA; AG/AB COMBO ASSAY; ANTIRETROVIRAL THERAPY; SENSITIVE DETECTION; TYPE-1 INFECTION; SCREENING ASSAYS; ANTIBODY; RNA; TRANSMISSION; SEROCONVERSION	Background: Detection of HIV-1 p24 antigen permits early identification of primary HIV infection and timely intervention to limit further spread of the infection. Principally, HIV screening should equally detect all viral variants, but reagents for a standardised test evaluation are limited. Therefore, we aimed to create an inexhaustible panel of diverse HIV-1 p24 antigens. Methods: We generated a panel of 43 recombinantly expressed virus-like particles (VLPs), containing the structural Gag proteins of HIV-1 subtypes A-H and circulating recombinant forms (CRF) CRF01_AE, CRF02_AG, CRF12_BF, CRF20_BG and group O. Eleven 4th generation antigen/antibody tests and five antigen-only tests were evaluated for their ability to detect VLPs diluted in human plasma to p24 concentrations equivalent to 50, 10 and 2 IU/ml of the WHO p24 standard. Three tests were also evaluated for their ability to detect p24 after heat-denaturation for immune-complex disruption, a pre-requisite for ultrasensitive p24 detection. Results: Our VLP panel exhibited an average intra-clade p24 diversity of 6.7%. Among the 4th generation tests, the Abbott Architect and Siemens Enzygnost Integral 4 had the highest sensitivity of 97.7% and 93%, respectively. Alere Determine Combo and BioRad Access were least sensitive with 10.1% and 40.3%, respectively. Antigen-only tests were slightly more sensitive than combination tests. Almost all tests detected the WHO HIV-1 p24 standard at a concentration of 2 IU/ml, but their ability to detect this input for different subtypes varied greatly. Heat-treatment lowered overall detectability of HIV-1 p24 in two of the three tests, but only few VLPs had a more than 3-fold loss in p24 detection. Conclusions: The HIV-1 Gag subtype panel has a broad diversity and proved useful for a standardised evaluation of the detection limit and breadth of subtype detection of p24 antigen-detecting tests. Several tests exhibited problems, particularly with non-B subtypes.	[Vetter, Beatrice N.; Orlowski, Vanessa; Shah, Cyril; Boeni, Juerg; Schuepbach, Joerg] Univ Zurich, Inst Med Virol, SNCR, Zurich, Switzerland; [Fransen, Katrien] Inst Trop Med, B-2000 Antwerp, Belgium; [Niederhauser, Christoph] BSDSRK, Swiss Red Cross Bern, Blood Transfus Serv, Bern, Switzerland; [Aubert, Vincent] CHU Vaudois, Univ Hosp, Serv Immunol & Allergy, Lausanne, Switzerland; [Brandenberger, Marcel] Labor Synlab Luzern, Luzern, Switzerland; [Ciardo, Diana] Viollier AG, Allschwil, Switzerland; [Dollenmaier, Guenter] ZLMSG, Ctr Lab Med, St Gallen, Switzerland; [Klimkait, Thomas] Univ Basel, Dept Biomed, Basel, Switzerland; [Regenass, Stephan] Univ Hosp, Clin Immunol, Zurich, Switzerland; [Schmid, Patrick] KSSG, Cantonal Hosp St Gallen, Dept Infect Dis, St Gallen, Switzerland; [Schottstedt, Volkmar] DRK, German Red Cross Blood Transfus Serv West, Hagen, Germany; [Suter-Riniker, Franziska] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Yerly, Sabine] HUG, Univ Hosp, Geneva, Switzerland	University of Zurich; Institute of Tropical Medicine (ITM); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Bern; University of Geneva	Vetter, BN (corresponding author), Univ Zurich, Inst Med Virol, SNCR, Zurich, Switzerland.	vetter.beatrice@virology.uzh.ch	Boeni, Juerg/B-8386-2015; Schüpbach, Jörg/G-4209-2016	Schüpbach, Jörg/0000-0002-8074-5891; Klimkait, Thomas/0000-0003-4945-6511	Merck Sharp Dohme; Gilead	Merck Sharp Dohme(Merck & Company); Gilead(Gilead Sciences)	The authors have read the journal's policy and one author of this manuscript has the following competing interests: SY has received educational grants from Merck Sharp & Dohme and Gilead. The following authors were associated with private companies when this work was done: MB with Labor Synlab Luzern and DC with Viollier AG. Both companies are commercial diagnostic laboratories. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; BESNIER JM, 1990, LANCET, V335, P798, DOI 10.1016/0140-6736(90)90920-Z; Boni J, 1997, AIDS, V11, pF47, DOI 10.1097/00002030-199706000-00001; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Brennan CA, 2013, J CLIN VIROL, V57, P169, DOI 10.1016/j.jcv.2013.01.017; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Brinkhof MWG, 2006, JAIDS-J ACQ IMM DEF, V41, P557, DOI 10.1097/01.qai.0000209824.77784.2c; Busch Michael P., 1997, American Journal of Medicine, V102, P117, DOI 10.1016/S0002-9343(97)00077-6; BUSCH MP, 1995, TRANSFUSION, V35, P91, DOI 10.1046/j.1537-2995.1995.35295125745.x; Christiansen CB, 1996, VOX SANG, V70, P144, DOI 10.1111/j.1423-0410.1996.tb01312.x; Conway DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094062; Eshleman SH, 2009, JAIDS-J ACQ IMM DEF, V52, P121, DOI 10.1097/QAI.0b013e3181ab61e1; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fiscus SA, 2007, J CLIN MICROBIOL, V45, P2274, DOI 10.1128/JCM.00813-07; Foley B., 2013, HIV SEQUENCE COMPEND; George E, 2007, J CLIN MICROBIOL, V45, P3416, DOI 10.1128/JCM.01314-07; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holmes H, 2008, J VIROL METHODS, V154, P86, DOI 10.1016/j.jviromet.2008.08.014; Kilembe W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037154; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Ly TD, 2007, J VIROL METHODS, V143, P86, DOI 10.1016/j.jviromet.2007.02.013; Ly TD, 2012, J CLIN VIROL, V55, P121, DOI 10.1016/j.jcv.2012.06.012; Miedouge M, 2011, J CLIN VIROL, V50, P57, DOI 10.1016/j.jcv.2010.09.003; Muhlbacher A, 2013, MED MICROBIOL IMMUN, V202, P77, DOI 10.1007/s00430-012-0250-5; Pandori MW, 2009, J CLIN MICROBIOL, V47, P2639, DOI 10.1128/JCM.00119-09; RITTER J, 1990, VOX SANG, V59, P244, DOI 10.1111/j.1423-0410.1990.tb00246.x; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Schupbach J, 2006, J MED VIROL, V78, P1003, DOI 10.1002/jmv.20655; SCHUPBACH J, 1994, J INFECT DIS, V170, P318, DOI 10.1093/infdis/170.2.318; Schupbach J, 2005, JAIDS-J ACQ IMM DEF, V40, P250, DOI 10.1097/01.qai.0000181281.75670.56; SCHUPBACH J, 1993, J VIROL METHODS, V43, P247, DOI 10.1016/0166-0934(93)90080-B; Schupbach J, 1996, AIDS, V10, P1085; Schupbach Jorg, 2002, AIDS Reviews, V4, P83; Song EY, 2012, J MED VIROL, V84, P1884, DOI 10.1002/jmv.23423; Tao CM, 2013, J CLIN VIROL, V58, P221, DOI 10.1016/j.jcv.2013.05.012; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Torrecilla E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088099; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weber B, 1998, J CLIN MICROBIOL, V36, P2235, DOI 10.1128/JCM.36.8.2235-2239.1998; World Health Organization, 2010, WHO REC DIAGN HIV IN; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111552	10.1371/journal.pone.0111552	http://dx.doi.org/10.1371/journal.pone.0111552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343245	gold, Green Accepted, Green Published			2022-12-26	WOS:000343943500104
J	Zeng, W; Zeng, A; Liu, H; Shang, MS; Zhang, YC				Zeng, Wei; Zeng, An; Liu, Hao; Shang, Ming-Sheng; Zhang, Yi-Cheng			Similarity from Multi-Dimensional Scaling: Solving the Accuracy and Diversity Dilemma in Information Filtering	PLOS ONE			English	Article							RECOMMENDATION	Recommender systems are designed to assist individual users to navigate through the rapidly growing amount of information. One of the most successful recommendation techniques is the collaborative filtering, which has been extensively investigated and has already found wide applications in e-commerce. One of challenges in this algorithm is how to accurately quantify the similarities of user pairs and item pairs. In this paper, we employ the multidimensional scaling (MDS) method to measure the similarities between nodes in user-item bipartite networks. The MDS method can extract the essential similarity information from the networks by smoothing out noise, which provides a graphical display of the structure of the networks. With the similarity measured from MDS, we find that the item-based collaborative filtering algorithm can outperform the diffusion-based recommendation algorithms. Moreover, we show that this method tends to recommend unpopular items and increase the global diversification of the networks in long term.	[Zeng, Wei; Shang, Ming-Sheng; Zhang, Yi-Cheng] Univ Elect Sci & Technol China, Web Sci Ctr, Sch Comp Sci & Engn, Chengdu 610054, Peoples R China; [Zeng, Wei; Shang, Ming-Sheng] State Key Lab Networking & Switching Technol, Beijing, Peoples R China; [Zeng, Wei; Zeng, An; Liu, Hao; Zhang, Yi-Cheng] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Zhang, Yi-Cheng] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Zeng, An] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	University of Electronic Science & Technology of China; Beijing University of Posts & Telecommunications; University of Fribourg; Hangzhou Normal University; Beijing Normal University	Zeng, A (corresponding author), Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland.	an.zeng@unifr.ch; shang.mingsheng@gmail.com	Zeng, Wei/O-4804-2017		National Natural Science Foundation of China [61370150, 91324002]; Open Foundation of State Key Laboratory of Networking and Switching Technology [SKLNST-2013-1-18]; Program of Outstanding Ph.D. Candidate in Academic Research by UESTC [YBXSZC20131029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of State Key Laboratory of Networking and Switching Technology; Program of Outstanding Ph.D. Candidate in Academic Research by UESTC	This work is supported by the National Natural Science Foundation of China (Grant Nos. 61370150 and 91324002) and the Open Foundation of State Key Laboratory of Networking and Switching Technology (SKLNST-2013-1-18). W.Z. acknowledges support from the Program of Outstanding Ph.D. Candidate in Academic Research by UESTC (YBXSZC20131029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Becavin C, 2011, BIOINFORMATICS, V27, P1413, DOI 10.1093/bioinformatics/btr143; Berry MW, 1995, SIAM REV, V37, P573, DOI 10.1137/1037127; Breese J. S., 1998, Uncertainty in Artificial Intelligence. Proceedings of the Fourteenth Conference (1998), P43; Cremonesi P., 2010, RECSYS, P39, DOI [10.1145/1864708.1864721, DOI 10.1145/1864708.1864721]; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Jamali Mohsen, 2010, P 4 ACM C REC SYST, P135, DOI DOI 10.1145/1864708.1864736; Kinoshita K, 2009, BIOINFORMATICS, V25, P2677, DOI 10.1093/bioinformatics/btp442; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Koren Yehuda, 2008, KDD, P426, DOI DOI 10.1145/1401890.1401944; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Lu L, 2011, PHYSICA A, V390; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Maslov S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248701; Qiu T, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/58003; Sarwar B., 2001, PROC 10 INT WORLD WI, P285, DOI 10.1145/371920.372071; Schafer J. B., 1999, P 1 ACM C EL COMM, P158, DOI DOI 10.1145/336992.337035; Shang MS, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/68008; Wang J., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P501, DOI 10.1145/1148170.1148257; Zeng A, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18005; Zeng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079354; Zeng W, 2010, INT J MOD PHYS C, V21, P1217, DOI 10.1142/S0129183110015786; Zhang FG, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/58005; Zhang YC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154301; Zhao DD, 2013, CHINESE PHYS LETT, V30, DOI 10.1088/0256-307X/30/11/118901; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	37	6	6	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111005	10.1371/journal.pone.0111005	http://dx.doi.org/10.1371/journal.pone.0111005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343243	Green Published, gold			2022-12-26	WOS:000343943500074
J	Choi, M; Wang, SE; Ko, SY; Kang, HJ; Chae, SY; Lee, SH; Kim, YS; Duman, RS; Son, H				Choi, Miyeon; Wang, Sung Eun; Ko, Seung Yeon; Kang, Hyo Jung; Chae, Seung Yeun; Lee, Seung Hoon; Kim, Yong-Seok; Duman, Ronald S.; Son, Hyeon			Overexpression of Human GATA-1 and GATA-2 Interferes with Spine Formation and Produces Depressive Behavior in Rats	PLOS ONE			English	Article							ANTIDEPRESSANT ACTIONS; TRANSCRIPTION FACTORS; DENDRITIC SPINES; GENE; EXPRESSION; PROMOTER; BRAIN; IDENTIFICATION; PLASTICITY; REGULATOR	Functional consequences to which vertebrate GATA transcription factors contribute in the adult brain remain largely an open question. The present study examines how human GATA-1 and GATA-2 (hGATA-1 and hGATA-2) are linked to neuronal differentiation and depressive behaviors in rats. We investigated the effects of adeno-associated viral expression of hGATA-1 and hGATA-2 (AAV-hGATA1 and AAV-hGATA2) in the dentate gyrus (DG) of the dorsal hippocampus on dendrite branching and spine number. We also examined the influence of AAV-hGATA1 and AAV-hGATA2 infusions into the dorsal hippocampus on rodent behavior in models of depression. Viral expression of hGATA-1 and hGATA-2 cDNA in rat hippocampal neurons impaired dendritic outgrowth and spine formation. Moreover, viral-mediated expression of hGATA-1 and hGATA-2 in the dorsal hippocampus caused depressive-like deficits in the forced swim test and learned helplessness models of depression, and decreased the expression of several synapse-related genes as well as spine number in hippocampal neurons. Conversely, shRNA knockdown of GATA-2 increased synapse-related gene expression, spine number, and dendrite branching. The results demonstrate that hGATA-1 and hGATA-2 expression in hippocampus is sufficient to cause depressive like behaviors that are associated with reduction in spine synapse density and expression of synapserelated genes.	[Choi, Miyeon; Kim, Yong-Seok; Son, Hyeon] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea; [Wang, Sung Eun; Ko, Seung Yeon; Chae, Seung Yeun; Lee, Seung Hoon; Kim, Yong-Seok; Son, Hyeon] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Kang, Hyo Jung] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Duman, Ronald S.] Yale Univ, Sch Med, Dept Psychiat, Lab Mol Psychiat,Ctr Genes & Behav, New Haven, CT USA; [Duman, Ronald S.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Duman, Ronald S.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	Hanyang University; Hanyang University; Chung Ang University; Yale University; Yale University; Yale University	Son, H (corresponding author), Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea.	hyeonson@hanyang.ac.kr	Kim, Yongseok/P-7501-2015	Kim, Yongseok/0000-0001-5062-7408; Wang, Sung Eun/0000-0002-0526-588X	National Research Foundation grant of Korea - Korea government [2011-0028317]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105910, R01MH093897] Funding Source: NIH RePORTER	National Research Foundation grant of Korea - Korea government; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Research Foundation grant of Korea (No. 2011-0028317) funded by Korea government awarded to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; Begley CG, 1999, BLOOD, V93, P2760; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Eyre H, 2012, PSYCHONEUROENDOCRINO, V37, P1397, DOI 10.1016/j.psyneuen.2012.03.019; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; GONG QH, 1991, MOL CELL BIOL, V11, P2558, DOI 10.1128/MCB.11.5.2558; Gumina RJ, 1997, BLOOD, V89, P1260, DOI 10.1182/blood.V89.4.1260; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kim JS, 2004, J NEUROCHEM, V89, P324, DOI 10.1046/j.1471-4159.2004.02329.x; Kumari J, 2009, MOL IMMUNOL, V46, P3099, DOI 10.1016/j.molimm.2009.06.008; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MELIA KR, 1994, J NEUROSCI, V14, P5929; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Morceau F, 2004, ANN NY ACAD SCI, V1030, P537, DOI 10.1196/annals.1329.064; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; Santarelli L, 2001, P NATL ACAD SCI USA, V98, P1912, DOI 10.1073/pnas.041596398; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; SHOLL DA, 1953, J ANAT, V87, P387; Son H, 2012, P NATL ACAD SCI USA, V109, P11378, DOI 10.1073/pnas.1201191109; Wallach I, 2009, PEDIATR RES, V65, P619, DOI 10.1203/PDR.0b013e31819ea3b8; Zhou YH, 2000, DEVELOPMENT, V127, P3829	37	13	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109253	10.1371/journal.pone.0109253	http://dx.doi.org/10.1371/journal.pone.0109253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340772	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800007
J	Perlikowski, D; Wisniewska, H; Goral, T; Kwiatek, M; Majka, M; Kosmala, A				Perlikowski, Dawid; Wisniewska, Halina; Goral, Tomasz; Kwiatek, Michal; Majka, Maciej; Kosmala, Arkadiusz			Identification of Kernel Proteins Associated with the Resistance to Fusarium Head Blight in Winter Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							ALPHA-AMYLASE ACTIVITY; DEOXYNIVALENOL ACCUMULATION; INFECTION; GRAIN; GRAMINEARUM; TRICHOTHECENES; CONTAMINATION; GENOTYPE; PROTEOME; CULMORUM	Numerous potential components involved in the resistance to Fusarium head blight (FHB) in cereals have been indicated, however, our knowledge regarding this process is still limited and further work is required. Two winter wheat (Triticum aestivum L.) lines differing in their levels of resistance to FHB were analyzed to identify the most crucial proteins associated with resistance in this species. The presented work involved analysis of protein abundance in the kernel bulks of more resistant and more susceptible wheat lines using two-dimensional gel electrophoresis and mass spectrometry identification of proteins, which were differentially accumulated between the analyzed lines, after inoculation with F. culmorum under field conditions. All the obtained two-dimensional patterns were demonstrated to be well-resolved protein maps of kernel proteomes. Although, 11 proteins were shown to have significantly different abundance between these two groups of plants, only two are likely to be crucial and have a potential role in resistance to FHB. Monomeric alpha-amylase and dimeric alpha-amylase inhibitors, both highly accumulated in the more resistant line, after inoculation and in the control conditions. Fusarium pathogens can use hydrolytic enzymes, including amylases to colonize kernels and acquire nitrogen and carbon from the endosperm and we suggest that the inhibition of pathogen amylase activity could be one of the most crucial mechanisms to prevent infection progress in the analyzed wheat line with a higher resistance. Alpha-amylase activity assays confirmed this suggestion as it revealed the highest level of enzyme activity, after F. culmorum infection, in the line more susceptible to FHB.	[Perlikowski, Dawid; Wisniewska, Halina; Kwiatek, Michal; Majka, Maciej; Kosmala, Arkadiusz] Polish Acad Sci, Inst Plant Genet, Poznan, Poland; [Goral, Tomasz] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Radzikow, Blonie, Poland	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Institute of Plant Breeding & Acclimatization	Kosmala, A (corresponding author), Polish Acad Sci, Inst Plant Genet, Poznan, Poland.	akos@igr.poznan.pl	Góral, Tomasz/I-4887-2019; Perlikowski, Dawid/ABA-1345-2020; Majka, Maciej/ABG-2805-2020; Kwiatek, Michał T./ABG-5673-2020; Kosmala, Arkadiusz/R-6737-2019	Góral, Tomasz/0000-0001-9130-6109; Perlikowski, Dawid/0000-0001-5532-5118; Majka, Maciej/0000-0002-5039-9465; Kwiatek, Michał T./0000-0001-9442-3124; Kosmala, Arkadiusz/0000-0002-1760-1334	Polish Ministry of Agriculture and Rural Development [HOR hn-078/PB/18/14 no. 6]	Polish Ministry of Agriculture and Rural Development	The study was supported by the Polish Ministry of Agriculture and Rural Development (HOR hn-078/PB/18/14 no. 6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottalico A, 2002, EUR J PLANT PATHOL, V108, P611, DOI 10.1023/A:1020635214971; Bottalico A., 1998, MYCOTOXINS AGR FOOD, P65; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Champeil A, 2004, PLANT SCI, V166, P1389, DOI 10.1016/j.plantsci.2004.02.004; Chelkowski J, 2001, OCCURRENCE TOXIGENIC, P111; Comeau A, 2008, CEREAL RES COMMUN, V36, P91; Cowger C, 2010, PHYTOPATHOLOGY, V100, P719, DOI 10.1094/PHYTO-100-7-0719; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Edwards SG, 2004, TOXICOL LETT, V153, P29, DOI 10.1016/j.toxlet.2004.04.022; Eggert K, 2011, PLANT PATHOL, V60, P918, DOI 10.1111/j.1365-3059.2011.02442.x; Eggert K, 2011, PROTEOMICS, V11, P972, DOI 10.1002/pmic.201000322; Foroud NA, 2009, INT J MOL SCI, V10, P147, DOI 10.3390/ijms10010147; Golinski P, 2010, FOOD ADDIT CONTAM A, V27, P1015, DOI 10.1080/19440041003702208; Gottwald S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-369; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jackowiak H, 2005, INT J FOOD MICROBIOL, V98, P113, DOI 10.1016/j.ijfoodmicro.2004.05.014; Kiecana I, 2004, AGRONOMIJAS VESTIS L, V7, P165; Kosmala A, 2012, J EXP BOT, V63, P6161, DOI 10.1093/jxb/ers265; Langevin F, 2004, EUR J PLANT PATHOL, V110, P735, DOI 10.1023/B:EJPP.0000041568.31778.ad; Lunn GD, 2001, J CEREAL SCI, V33, P313, DOI 10.1006/jcrs.2001.0369; Mardi M, 2006, PLANT BREEDING, V125, P313, DOI 10.1111/j.1439-0523.2006.01228.x; Mares D, 2008, J CEREAL SCI, V47, P6, DOI 10.1016/j.jcs.2007.01.005; Masojc P, 2013, J APPL GENET, V54, P11, DOI 10.1007/s13353-012-0127-8; Masojc P, 2012, MOL BREEDING, V30, P1355, DOI 10.1007/s11032-012-9721-z; McCleary BV, 2002, J AOAC INT, V85, P1096; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Miedaner T, 2001, PLANT BREEDING, V120, P97, DOI 10.1046/j.1439-0523.2001.00580.x; Mielniczuk E, 2004, BIOLOGIA, V59, P809; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Packa D, 2013, EJPAU, V16, p#06; Packa D., 2008, SEED SCI BIOTECHNOL, V2, P27; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Perlikowski D, 2014, PLANT BIOLOGY, V16, P385, DOI 10.1111/plb.12074; Pirgozliev SR, 2003, EUR J PLANT PATHOL, V109, P731, DOI 10.1023/A:1026034509247; Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; SNIJDERS CHA, 1990, PHYTOPATHOLOGY, V80, P566, DOI 10.1094/Phyto-80-566; Svensson B, 2004, BBA-PROTEINS PROTEOM, V1696, P145, DOI 10.1016/j.bbapap.2003.07.004; Thitisaksakul M, 2012, J CEREAL SCI, V56, P67, DOI 10.1016/j.jcs.2012.04.002; Veronese P, 2003, PLANT PHYSIOL, V131, P1580, DOI 10.1104/pp.102.013417; Wang JH, 2005, J AGR FOOD CHEM, V53, P5818, DOI 10.1021/jf050525g; Wisniewska H, 2004, J PHYTOPATHOL, V152, P613, DOI 10.1111/j.1439-0434.2004.00904.x; Xu XM, 2007, PLANT PATHOL, V56, P943, DOI 10.1111/j.1365-3059.2007.01650.x; Yang F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00037; Yang F, 2010, PROTEOMICS, V10, P3748, DOI 10.1002/pmic.201000243; Yang F, 2010, J PROTEOMICS, V73, P743, DOI 10.1016/j.jprot.2009.10.010; Zhang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082079; Zhou WC, 2005, GENOME, V48, P770, DOI 10.1139/g05-041; Zhou WC, 2006, PROTEOMICS, V6, P4599, DOI 10.1002/pmic.200600052	50	14	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110822	10.1371/journal.pone.0110822	http://dx.doi.org/10.1371/journal.pone.0110822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340555	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800058
J	Zhou, ZW; Zhang, BC; Guo, K; Li, W; Zhang, R; Zhang, PP; Li, YG				Zhou, Zhi-Wen; Zhang, Bu-Chun; Guo, Kai; Li, Wei; Zhang, Rui; Zhang, Peng-Pai; Li, Yi-Gang			Acute Impact of Pacing at Different Cardiac Sites on Left Ventricular Rotation and Twist in Dogs	PLOS ONE			English	Article							HEART-FAILURE; RESYNCHRONIZATION THERAPY; TISSUE-DOPPLER; SYNCHRONY; DYSSYNCHRONY; ACTIVATION; DURATION; TORSION; MODEL; APEX	Objectives: We evaluated the acute impact of different cardiac pacing sites on two-dimensional speckle-tracking echocardiography (STE) derived left ventricular (LV) rotation and twist in healthy dogs. Methods: Twelve dogs were used in this study. The steerable pacing electrodes were positioned into right heart through the superior or inferior vena cava, into LV through aorta across the aortic valve. The steerable pacing electrodes were positioned individually in the right atrium (RA), right ventricular apex (RVA), RV outflow tract (RVOT), His bundle (HB), LV apex (LVA) and LV high septum (LVS), individual pacing mode was applied at 10 minutes interval for at least 5 minutes from each position under fluoroscopy and ultrasound guidance and at stabilized hemodynamic conditions. LV short-axis images at the apical and basal levels were obtained during sinus rhythm and pacing. Offline STE analysis was performed. Rotation, twist, time to peak rotation (TPR), time to peak twist (TPT), and apical-basal rotation delay (rotational synchronization index, RSI) values were compared at various conditions. LV pressure was monitored simultaneously. Results: Anesthetic death occurred in 1 dog, and another dog was excluded because of bad imaging quality. Data from 10 dogs were analyzed. RVA, RVOT, HB, LVA, LVS, RARV (RA+RVA) pacing resulted in significantly reduced apical and basal rotation and twist, significantly prolonged apical TPR, TPT and RSI compared to pre-pacing and RA pacing (all P<0.05). The apical and basal rotation and twist values were significantly higher during HB pacing than during pacing at ventricular sites (all P<0.05, except basal rotation at RVA pacing). The apical TPR during HB pacing was significantly shorter than during RVOT and RVA pacing (both P<0.05). The LV end systolic pressure (LVESP) was significantly lower during ventricular pacing than during pre-pacing and RA pacing. Conclusions: Our results show that RA and HB pacing results in less acute reduction on LV twist, rotation and LVESP compared to ventricular pacing.	[Zhou, Zhi-Wen; Guo, Kai; Li, Wei; Zhang, Rui; Zhang, Peng-Pai; Li, Yi-Gang] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Zhou, Zhi-Wen] Shanghai Xuhui Cent Hosp, Dept Cardiol, Shanghai, Peoples R China; [Zhang, Bu-Chun] Xuzhou Med Coll, Affiliated Hosp, Dept Cardiol, Xuzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Xuzhou Medical University	Li, YG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	drliyigang@outlook.com			China Postdoctoral Science Foundation [2012M511114]; National Natural Science Foundation of China [81070154, 81270258]; Shanghai Committee of Science and Technology [11JC1408200]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by China Postdoctoral Science Foundation (NO: 2012M511114), the National Natural Science Foundation of China (No: 81070154 and 81270258), and the Shanghai Committee of Science and Technology (NO: 11JC1408200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen AE, 2008, EUROPACE, V10, P127, DOI 10.1093/europace/eum279; Barba-Pichardo R, 2008, REV ESP CARDIOL, V61, P1096; Barba-Pichardo R, 2013, EUROPACE, V15, P83, DOI 10.1093/europace/eus228; Barba-Pichardo R, 2010, EUROPACE, V12, P527, DOI 10.1093/europace/euq038; Burns AT, 2008, HEART, V94, P978, DOI 10.1136/hrt.2007.120410; Burns AT, 2009, JACC-CARDIOVASC IMAG, V2, P709, DOI 10.1016/j.jcmg.2009.01.015; Burns KV, 2011, J CARD FAIL, V17, P495, DOI 10.1016/j.cardfail.2011.02.011; Catanzariti D, 2013, EUROPACE, V15, P546, DOI 10.1093/europace/eus313; Delgado V, 2009, CIRC-ARRHYTHMIA ELEC, V2, P135, DOI 10.1161/CIRCEP.108.814608; Deshmukh PM, 2004, PACE, V27, P862, DOI 10.1111/j.1540-8159.2004.00548.x; Domenichini G, 2012, EUR J INTERN MED, V23, P621, DOI 10.1016/j.ejim.2012.03.012; Friedberg MK, 2006, AM J CARDIOL, V97, P101, DOI 10.1016/j.amjcard.2005.07.127; Hara M, 2011, ECHOCARDIOGR-J CARD, V28, P69, DOI 10.1111/j.1540-8175.2010.01257.x; Hu K, 1998, CARDIOVASC RES, V39, P401, DOI 10.1016/S0008-6363(98)00090-X; Hu K, 2013, EUR HEART J-CARD IMG, V14, P205, DOI 10.1093/ehjci/jes240; Ji L, 2010, ECHOCARDIOGR-J CARD, V27, P1219, DOI 10.1111/j.1540-8175.2010.01221.x; Johnson L, 2007, AM J PHYSIOL-HEART C, V293, pH3046, DOI 10.1152/ajpheart.00728.2007; Kavanagh KM, 2008, CARDIOVASC RES, V77, P81, DOI 10.1093/cvr/cvm036; Kim WJ, 2009, CIRC-CARDIOVASC IMAG, V2, P123, DOI 10.1161/CIRCIMAGING.108.794719; Manolis AS, 2006, PACE, V29, P298, DOI 10.1111/j.1540-8159.2006.00338.x; Matsuoka K, 2009, J AM SOC ECHOCARDIOG, V22, P914, DOI 10.1016/j.echo.2009.05.001; Neilan TG, 2008, AM J PHYSIOL-HEART C, V294, pH2106, DOI 10.1152/ajpheart.01128.2007; Nielsen JC, 2011, EUR HEART J, V32, P686, DOI 10.1093/eurheartj/ehr022; Occhetta Eraldo, 2007, Indian Pacing Electrophysiol J, V7, P110; Padeletti L, 2007, AM J CARDIOL, V100, P1556, DOI 10.1016/j.amjcard.2007.06.055; Peschar M, 2003, J AM COLL CARDIOL, V41, P1218, DOI 10.1016/S0735-1097(03)00091-3; Poerner TC, 2007, ULTRASOUND MED BIOL, V33, P699, DOI 10.1016/j.ultrasmedbio.2006.11.014; RADEMAKERS FE, 1992, CIRCULATION, V85, P1572, DOI 10.1161/01.CIR.85.4.1572; Russel IK, 2009, JACC-CARDIOVASC IMAG, V2, P648, DOI 10.1016/j.jcmg.2009.03.001; Sade LE, 2008, AM J CARDIOL, V101, P1163, DOI 10.1016/j.amjcard.2007.11.069; Simantirakis EN, 2009, EUROPACE, V11, P77, DOI 10.1093/europace/eup277; Smith JJ, 1990, CIRCULATORY PHYSL ES, P40; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Takeuchi M, 2007, EUR HEART J, V28, P2756, DOI 10.1093/eurheartj/ehm440; Tanabe M, 2008, J AM SOC ECHOCARDIOG, V21, P1382, DOI 10.1016/j.echo.2008.09.012; van Deursen C, 2009, CIRC-ARRHYTHMIA ELEC, V2, P580, DOI 10.1161/CIRCEP.108.846022; Vanerio G, 2008, J INTERV CARD ELECTR, V21, P195, DOI 10.1007/s10840-008-9238-x; Varma N, 2012, J ELECTROCARDIOL, V45, P660, DOI 10.1016/j.jelectrocard.2012.07.003; Yoon HJ, 2009, ECHOCARDIOGR-J CARD, V26, P665, DOI 10.1111/j.1540-8175.2008.00855.x	39	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111231	10.1371/journal.pone.0111231	http://dx.doi.org/10.1371/journal.pone.0111231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340769	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800096
J	Moreno, KX; Satapati, S; DeBerardinis, RJ; Burgess, SC; Malloy, CR; Merritt, ME				Moreno, Karlos X.; Satapati, Santhosh; DeBerardinis, Ralph J.; Burgess, Shawn C.; Malloy, Craig R.; Merritt, Matthew E.			Real-time Detection of Hepatic Gluconeogenic and Glycogenolytic States Using Hyperpolarized [2-C-13]Dihydroxyacetone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; GLUCOSE-PRODUCTION; C-13 NMR; PYRUVATE-CARBOXYLASE; INTEGRATED H-2; FUTILE CYCLES; IN-VIVO; METABOLISM; FLUX; PATHWAYS	Glycogenolysis and gluconeogenesis are sensitive to nutritional state, and the net direction of flux is controlled by multiple enzymatic steps. This delicate balance in the liver is disrupted by a variety of pathological states including cancer and diabetes mellitus. Hyperpolarized carbon-13 magnetic resonance is a new metabolic imaging technique that can probe intermediary metabolism nondestructively. There are currently no methods to rapidly distinguish livers in a gluconeogenic from glycogenolytic state. Here we use the gluconeogenic precursor dihydroxyacetone (DHA) to deliver hyperpolarized carbon-13 to the perfused mouse liver. DHA enters gluconeogenesis at the level of the trioses. Perfusion conditions were designed to establish either a gluconeogenic or a glycogenolytic state. Unexpectedly, we found that [2-C-13]DHA was metabolized within a few seconds to the common intermediates and end products of both glycolysis and gluconeogenesis under both conditions, including [2,5-C-13]glucose, [2-C-13]glycerol 3-phosphate, [2-C-13]phosphoenolpyruvate (PEP), [2-C-13]pyruvate, [2-C-13]alanine, and [2-C-13]lactate. [2-C-13]Phosphoenolpyruvate, a key branch point in gluconeogenesis and glycolysis, was monitored in functioning tissue for the first time. Observation of [2-C-13]PEP was not anticipated as the free energy difference between PEP and pyruvate is large. Pyruvate kinase is the only regulatory step of the common glycolytic-gluconeogenic pathway that appears to exert significant control over the kinetics of any metabolites of DHA. A ratio of glycolytic to gluconeogenic products distinguished the gluconeogenic from glycogenolytic state in these functioning livers.	[Moreno, Karlos X.; Satapati, Santhosh; Burgess, Shawn C.; Malloy, Craig R.; Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Burgess, Shawn C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Malloy, Craig R.; Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Malloy, Craig R.] Vet Affairs North Texas Healthcare Syst, Lancaster, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Merritt, ME (corresponding author), Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	matthew.merritt@utsouthwestern.edu		Malloy, Craig/0000-0001-5077-0642; Merritt, Matthew/0000-0003-4617-9651	National Institutes of Health [P41 EB015908, R01 DK058398, R01 CA157996, R21 EB016197, R37 HL34557]; Robert A. Welch Foundation [I-1733, I-1804-01]; Damon Runyon Cancer Research Foundation; Cancer Prevention Research Institute of Texas (CPRIT) Grant [RP-101243]; NATIONAL CANCER INSTITUTE [R01CA157996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034557, R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908, R21EB016197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, R01DK078184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Damon Runyon Cancer Research Foundation; Cancer Prevention Research Institute of Texas (CPRIT) Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P41 EB015908 (to K. X. M., C. R. M., and M. E. M.), R01 DK058398 (to S. S. and S. C. B.), R01 CA157996 (to R. J. D.), and R21 EB016197 and R37 HL34557 (to M. E. M.). This work was also supported by Robert A. Welch Foundation Grants I-1733 (to R. J. D.) and I-1804-01 (to S. C. B.) and the Damon Runyon Cancer Research Foundation (to R. J. D.), and Cancer Prevention Research Institute of Texas (CPRIT) Grant RP-101243 (to M. E. M.).	Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bergmeyer H. U., 1984, METHOD ENZYMAT AN, V6, P1198; Burgess SC, 2005, AM J PHYSIOL-ENDOC M, V289, pE53, DOI 10.1152/ajpendo.00601.2004; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Burgess SC, 2003, ANAL BIOCHEM, V318, P321, DOI 10.1016/S0003-2697(03)00158-1; Burgess SC, 2003, ANAL BIOCHEM, V312, P228, DOI 10.1016/S0003-2697(02)00465-7; Harris T, 2013, NMR BIOMED, V26, P1831, DOI 10.1002/nbm.3024; Hausler N, 2006, BIOCHEM J, V394, P465, DOI 10.1042/BJ20051174; HEMS R, 1966, BIOCHEM J, V101, P284, DOI 10.1042/bj1010284; Hue L, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P247; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jones JG, 2001, AM J PHYSIOL-ENDOC M, V281, pE848, DOI 10.1152/ajpendo.2001.281.4.E848; Jones JG, 1997, FEBS LETT, V412, P131, DOI 10.1016/S0014-5793(97)00764-3; LANDAU BR, 1995, J CLIN INVEST, V95, P172, DOI 10.1172/JCI117635; Larson PEZ, 2011, MAGN RESON MED, V65, P610, DOI 10.1002/mrm.22650; Lau AZ, 2010, MAGN RESON MED, V64, P1323, DOI 10.1002/mrm.22525; Lee P, 2013, HEPATOLOGY, V57, P515, DOI 10.1002/hep.26028; Merritt ME, 2011, P NATL ACAD SCI USA, V108, P19084, DOI 10.1073/pnas.1111247108; NEESE RA, 1995, J BIOL CHEM, V270, P14452, DOI 10.1074/jbc.270.24.14452; Patyal BR, 1997, J MAGN RESON, V126, P58, DOI 10.1006/jmre.1997.1159; Petersen KF, 1996, AM J PHYSIOL-ENDOC M, V270, pE186, DOI 10.1152/ajpendo.1996.270.1.E186; Phillips JW, 2002, EUR J BIOCHEM, V269, P792, DOI 10.1046/j.0014-2956.2001.02687.x; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Qian H, 2006, IEE P SYST BIOL, V153, P192, DOI 10.1049/ip-syb:20050086; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Tayek JA, 1996, AM J PHYSIOL-ENDOC M, V270, pE709, DOI 10.1152/ajpendo.1996.270.4.E709; Yang CD, 2014, J BIOL CHEM, V289, P6212, DOI 10.1074/jbc.M113.543637	29	45	45	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35859	35867		10.1074/jbc.M114.613265	http://dx.doi.org/10.1074/jbc.M114.613265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25352600	Green Published, hybrid			2022-12-26	WOS:000346897900018
J	Boesler, B; Meier, D; Forstner, KU; Friedrich, M; Hammann, C; Sharma, CM; Nellen, W				Boesler, Benjamin; Meier, Doreen; Foerstner, Konrad U.; Friedrich, Michael; Hammann, Christian; Sharma, Cynthia M.; Nellen, Wolfgang			Argonaute Proteins Affect siRNA Levels and Accumulation of a Novel Extrachromosomal DNA from the Dictyostelium Retrotransposon DIRS-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; Gene Silencing; RNA Interference (RNAi); Small Interfering RNA (siRNA); Transposable Element (TE)	SELECTABLE MARKER; RNA INTERFERENCE; GENE-EXPRESSION; HEAT-SHOCK; C-ELEGANS; DISCOIDEUM; METHYLATION; AMPLIFICATION; ARABIDOPSIS; SEQUENCE	The retrotransposon DIRS-1 is the most abundant retroelement in Dictyostelium discoideum and constitutes the pericentromeric heterochromatin of the six chromosomes in D. discoideum. The vast majority of cellular siRNAs is derived from DIRS-1, suggesting that the element is controlled by RNAi-related mechanisms. We investigated the role of two of the five Argonaute proteins of D. discoideum, AgnA and AgnB, in DIRS-1 silencing. Deletion of agnA resulted in the accumulation of DIRS-1 transcripts, the expression of DIRS-1-encoded proteins, and the loss of most DIRS-1-derived secondary siRNAs. Simultaneously, extrachromosomal single-stranded DIRS-1 DNA accumulated in the cytoplasm of agnA- strains. These DNA molecules appear to be products of reverse transcription and thus could represent intermediate structures before transposition. We further show that transitivity of endogenous siRNAs is impaired in agnA- strains. The deletion of agnB alone had no strong effect on DIRS-1 transposon regulation. However, in agnA-/agnB- double mutant strains strongly reduced accumulation of extrachromosomal DNA compared with the single agnA- strains was observed.	[Boesler, Benjamin; Meier, Doreen; Friedrich, Michael; Nellen, Wolfgang] Univ Kassel, FB10, Dept Genet, D-34132 Kassel, Germany; [Foerstner, Konrad U.; Sharma, Cynthia M.] Univ Wurzburg, Res Ctr Infect Dis ZINF, D-97080 Wurzburg, Germany; [Hammann, Christian] Jacobs Univ Bremen, Mol Life Sci Res Ctr, Sch Sci & Engn, Ribogenet Biochem Lab, DE-28759 Bremen, Germany	Universitat Kassel; University of Wurzburg; Jacobs University	Nellen, W (corresponding author), Univ Kassel, FB10, Dept Genet, Heinrich Plett Str 40, D-34132 Kassel, Germany.	nellen@uni-kassel.de	Sharma, Cynthia/D-2869-2013; Förstner, Konrad U./B-1531-2010; Hammann, Christian/AAE-7325-2020	Förstner, Konrad U./0000-0002-1481-2996; Sharma, Cynthia Mira/0000-0002-2321-9705	Deutsche Forschungsgemeinschaft [NE285/10-1, HA3459/7]; Land Hessen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Land Hessen	This work was supported by Deutsche Forschungsgemeinschaft Grants NE285/10-1 (to W. N.) and HA3459/7 (to C. H.).; Supported by a stipend from the Land Hessen. Both are joint first authors.	Bouttier M, 2012, NUCLEIC ACIDS RES, V40, P775, DOI 10.1093/nar/gkr762; CAPPELLO J, 1985, CELL, V43, P105, DOI 10.1016/0092-8674(85)90016-9; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; CHUNG S, 1983, NUCLEIC ACIDS RES, V11, P4835, DOI 10.1093/nar/11.14.4835; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN SM, 1984, MOL CELL BIOL, V4, P2332, DOI 10.1128/MCB.4.11.2332; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; Dubin M, 2010, NUCLEIC ACIDS RES, V38, P7526, DOI 10.1093/nar/gkq664; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Glockner G, 2001, GENOME RES, V11, P585, DOI 10.1101/gr.GR-1622RR; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Maida Y, 2011, BIOL CHEM, V392, P299, DOI 10.1515/BC.2011.035; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Muller S, 2013, NUCLEIC ACIDS RES, V41, P8615, DOI 10.1093/nar/gkt634; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Parrish S, 2001, RNA, V7, P1397; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piednoel M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-621; Poulter RTM, 2005, CYTOGENET GENOME RES, V110, P575, DOI 10.1159/000084991; ROSEN E, 1983, CELL, V35, P243, DOI 10.1016/0092-8674(83)90227-1; Rot G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-265; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; WALLRAFF E, 1986, EMBO J, V5, P61, DOI 10.1002/j.1460-2075.1986.tb04178.x; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wiegand S, 2014, NUCLEIC ACIDS RES, V42, P3330, DOI 10.1093/nar/gkt1337; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; ZUKER C, 1983, CELL, V34, P997, DOI 10.1016/0092-8674(83)90557-3	51	8	9	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35124	35138		10.1074/jbc.M114.612663	http://dx.doi.org/10.1074/jbc.M114.612663			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352599	Green Published, hybrid			2022-12-26	WOS:000346660200007
J	Choi, BH; Chattopadhaya, S; Thanh, LN; Feng, L; Nguyen, QT; Lim, CB; Harikishore, A; Nanga, RPR; Bharatham, N; Zhao, Y; Liu, XW; Yoon, HS				Choi, Bo-Hwa; Chattopadhaya, Souvik; Le Nguyen Thanh; Feng, Lin; Quoc Toan Nguyen; Lim, Chuan Bian; Harikishore, Amaravadhi; Nanga, Ravi Prakash Reddy; Bharatham, Nagakumar; Zhao, Yan; Liu, Xuewei; Yoon, Ho Sup			Suprafenacine, an Indazole-Hydrazide Agent, Targets Cancer Cells Through Microtubule Destabilization	PLOS ONE			English	Article							BCL2 PHOSPHORYLATION; SIGNALING PATHWAY; BREAST-CANCER; BAD COUPLES; IN-VIVO; DEATH; ACTIVATION; SURVIVAL; BINDING; RESISTANT	Microtubules are a highly validated target in cancer therapy. However, the clinical development of tubulin binding agents (TBA) has been hampered by toxicity and chemoresistance issues and has necessitated the search for new TBAs. Here, we report the identification of a novel cell permeable, tubulin-destabilizing molecule - 4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid [1p-tolyl-meth-(E)-ylidene]-hydrazide (termed as Suprafenacine, SRF). SRF, identified by in silico screening of annotated chemical libraries, was shown to bind microtubules at the colchicine-binding site and inhibit polymerization. This led to G(2)/M cell cycle arrest and cell death via a mitochondria-mediated apoptotic pathway. Cell death was preceded by loss of mitochondrial membrane potential, JNK - mediated phosphorylation of Bcl-2 and Bad, and activation of caspase-3. Intriguingly, SRF was found to selectively inhibit cancer cell proliferation and was effective against drug-resistant cancer cells by virtue of its ability to bypass the multidrug resistance transporter P-glycoprotein. Taken together, our results suggest that SRF has potential as a chemotherapeutic agent for cancer treatment and provides an alternate scaffold for the development of improved anti-cancer agents.	[Choi, Bo-Hwa; Chattopadhaya, Souvik; Feng, Lin; Quoc Toan Nguyen; Lim, Chuan Bian; Harikishore, Amaravadhi; Nanga, Ravi Prakash Reddy; Bharatham, Nagakumar; Zhao, Yan; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore; [Le Nguyen Thanh; Liu, Xuewei] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 639798, Singapore; [Yoon, Ho Sup] Kyung Hee Univ, Coll Life Sci, Dept Genet Engn, Yongin, Gyeonggi Do, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Kyung Hee University	Yoon, HS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore.	hsyoon@ntu.edu.sg	Le, Thanh/AAW-5776-2021; Zhao, Yan/A-2197-2011; Le, Thanh/GRY-4094-2022; Amaravadhi, Harikishore/E-9294-2016; Yoon, Ho Sup/A-2193-2011	Le, Thanh/0000-0002-8375-4187; Amaravadhi, Harikishore/0000-0001-6552-1534; Yoon, Ho Sup/0000-0002-8243-3904; Nguyen, Toan/0000-0002-8015-6130	Ministry of Health Singapore [NMRC1177/2008]	Ministry of Health Singapore(Ministry of Health-Singapore)	This work was supported by Ministry of Health Singapore Grant NMRC1177/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Aneja R, 2006, CANCER RES, V66, P3782, DOI 10.1158/0008-5472.CAN-05-2962; Argyriou AA, 2008, CRIT REV ONCOL HEMAT, V66, P218, DOI 10.1016/j.critrevonc.2008.01.008; Bacher G, 2001, CANCER RES, V61, P392; Basu A, 1998, INT J ONCOL, V13, P659; BATES SE, 1989, MOL CELL BIOL, V9, P4337, DOI 10.1128/MCB.9.10.4337; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Dimitroulis J, 2005, ONCOL REP, V13, P923; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Haldar S, 1998, CANCER RES, V58, P1609; Haldar S, 1997, CANCER RES, V57, P229; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Liou JP, 2007, J PHARMACOL EXP THER, V323, P398, DOI 10.1124/jpet.107.126680; Luduena RF, 1998, INT REV CYTOL, V178, P207; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Okano J, 2001, J BIOL CHEM, V276, P19555, DOI 10.1074/jbc.M011164200; Pajk B, 2008, BREAST, V17, P180, DOI 10.1016/j.breast.2007.09.002; Poommipanit PB, 1999, J BIOL CHEM, V274, P1033, DOI 10.1074/jbc.274.2.1033; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Watanabe T, 1997, J NATL CANCER I, V89, P512, DOI 10.1093/jnci/89.7.512; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; WU L, 1992, CANCER RES, V52, P3029; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	50	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110955	10.1371/journal.pone.0110955	http://dx.doi.org/10.1371/journal.pone.0110955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354194	gold, Green Submitted, Green Published			2022-12-26	WOS:000345204200049
J	Ferrario, V; Siragusa, L; Ebert, C; Baroni, M; Foscato, M; Cruciani, G; Gardossi, L				Ferrario, Valerio; Siragusa, Lydia; Ebert, Cynthia; Baroni, Massimo; Foscato, Marco; Cruciani, Gabriele; Gardossi, Lucia			BioGPS Descriptors for Rational Engineering of Enzyme Promiscuity and Structure Based Bioinformatic Analysis	PLOS ONE			English	Article							COMPUTATIONAL DESIGN; BINDING-SITES; PROTEINS; AMIDASE; GROMACS	A new bioinformatic methodology was developed founded on the Unsupervised Pattern Cognition Analysis of GRID-based BioGPS descriptors (Global Positioning System in Biological Space). The procedure relies entirely on three-dimensional structure analysis of enzymes and does not stem from sequence or structure alignment. The BioGPS descriptors account for chemical, geometrical and physical-chemical features of enzymes and are able to describe comprehensively the active site of enzymes in terms of "pre-organized environment'' able to stabilize the transition state of a given reaction. The efficiency of this new bioinformatic strategy was demonstrated by the consistent clustering of four different Ser hydrolases classes, which are characterized by the same active site organization but able to catalyze different reactions. The method was validated by considering, as a case study, the engineering of amidase activity into the scaffold of a lipase. The BioGPS tool predicted correctly the properties of lipase variants, as demonstrated by the projection of mutants inside the BioGPS "roadmap''.	[Ferrario, Valerio; Ebert, Cynthia; Foscato, Marco; Gardossi, Lucia] Univ Trieste, Dipartimento Sci Chim & Farmaceut, Lab Appl & Computat Biocatalysis, Trieste, TS, Italy; [Siragusa, Lydia; Cruciani, Gabriele] Univ Perugia, Dipartimento Chim Biol & Biotecnol, Lab Chemometr & Mol Modeling, I-06100 Perugia, PG, Italy; [Baroni, Massimo] Mol Discovery Ltd, London, Middx, England	University of Trieste; University of Perugia	Gardossi, L (corresponding author), Univ Trieste, Dipartimento Sci Chim & Farmaceut, Lab Appl & Computat Biocatalysis, Trieste, TS, Italy.	gardossi@units.it	Cruciani, Gabriele/E-5927-2014; Ferrario, Valerio VF/F-3846-2012; CRUCIANI, Gabriele/AAH-4627-2019; Ferrario, Valerio/AAN-8963-2020	Cruciani, Gabriele/0000-0002-4162-8692; Ferrario, Valerio VF/0000-0002-4233-4805; CRUCIANI, Gabriele/0000-0002-4162-8692; Ferrario, Valerio/0000-0002-4233-4805; Siragusa, Lydia/0000-0003-4596-7242; Foscato, Marco/0000-0001-7762-6931	European Community [227279]; Molecular Discovery Ltd	European Community(European Commission); Molecular Discovery Ltd	This work has received funding from the European Community's Seventh Framework Programme under the FP7-KBBE-2008-2B grant agreement nu 227279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Moreover: MB is an employee of Molecular Discovery Ltd. Molecular Discovery Ltd provided support in the form of salary for author MB but Molecular Discovery Ltd. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], PYMOL MOL GRAPH SYST; Baroni M, 2007, J CHEM INF MODEL, V47, P279, DOI 10.1021/ci600253e; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Besenmatter W, 2004, METHOD ENZYMOL, V388, P91; Boas FE, 2007, CURR OPIN STRUC BIOL, V17, P199, DOI 10.1016/j.sbi.2007.03.006; Bommarius AS, 2011, CURR OPIN CHEM BIOL, V15, P194, DOI 10.1016/j.cbpa.2010.11.011; Boutros PC, 2005, BRIEF BIOINFORM, V6, P331, DOI 10.1093/bib/6.4.331; Braiuca P, 2006, ADV SYNTH CATAL, V348, P773, DOI 10.1002/adsc.200505346; Brincat JP, 2011, J MED CHEM, V54, P354, DOI 10.1021/jm1011963; Carboni C, 2006, TETRAHEDRON-ASYMMETR, V17, P245, DOI 10.1016/j.tetasy.2005.12.023; Cross S, 2012, J CHEM INF MODEL, V52, P2587, DOI 10.1021/ci300153d; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferrario V, 2014, J MOL CATAL B-ENZYM, V101, P7, DOI 10.1016/j.molcatb.2013.12.004; Ferrario V, 2011, ADV SYNTH CATAL, V353, P2466, DOI 10.1002/adsc.201100397; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; GHOSH D, 1995, STRUCTURE, V3, P279, DOI 10.1016/S0969-2126(01)00158-7; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Hediger MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049849; Henrich S, 2010, J MOL RECOGNIT, V23, P209, DOI 10.1002/jmr.984; Ho BK, 2005, PROTEIN SCI, V14, P1011, DOI 10.1110/ps.041156905; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Khoury GA, 2009, PROTEIN SCI, V18, P2125, DOI 10.1002/pro.227; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Ouzounis CA, 2003, BIOINFORMATICS, V19, P2176, DOI 10.1093/bioinformatics/btg309; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Sciabola S, 2010, J CHEM INF MODEL, V50, P155, DOI 10.1021/ci9003317; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Suplatov DA, 2012, PROTEIN ENG DES SEL, V25, P689, DOI 10.1093/protein/gzs068; Suplatov D, 2014, J BIOMOL STRUCT DYN, V32, P75, DOI 10.1080/07391102.2012.750249; Syren PO, 2012, CHEMBIOCHEM, V13, P645, DOI 10.1002/cbic.201100779; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004	43	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109354	10.1371/journal.pone.0109354	http://dx.doi.org/10.1371/journal.pone.0109354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353170	Green Submitted, gold, Green Published			2022-12-26	WOS:000345204200007
J	Li, C; Zhang, YY; Frieler, RA; Zheng, XJ; Zhang, WC; Sun, XN; Yang, QZ; Ma, SM; Huang, BZ; Berger, S; Wang, W; Wu, Y; Yu, Y; Duan, SZ; Mortensen, RM				Li, Chao; Zhang, Yu Yao; Frieler, Ryan A.; Zheng, Xiao Jun; Zhang, Wu Chang; Sun, Xue Nan; Yang, Qing Zhen; Ma, Shu Min; Huang, Baozhuan; Berger, Stefan; Wang, Wang; Wu, Yong; Yu, Ying; Duan, Sheng Zhong; Mortensen, Richard M.			Myeloid Mineralocorticoid Receptor Deficiency Inhibits Aortic Constriction-Induced Cardiac Hypertrophy in Mice	PLOS ONE			English	Article							SELECTIVE ALDOSTERONE BLOCKER; HEART-FAILURE; OXIDATIVE STRESS; NADPH OXIDASE; MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD; BLOOD-PRESSURE; INFLAMMATION; ATHEROSCLEROSIS; DYSFUNCTION	Mineralocorticoid receptor (MR) blockade has been shown to suppress cardiac hypertrophy and remodeling in animal models of pressure overload (POL). This study aims to determine whether MR deficiency in myeloid cells modulates aortic constriction-induced cardiovascular injuries. Myeloid MR knockout (MMRKO) mice and littermate control mice were subjected to abdominal aortic constriction (AAC) or sham operation. We found that AAC-induced cardiac hypertrophy and fibrosis were significantly attenuated in MMRKO mice. Expression of genes important in generating reactive oxygen species was decreased in MMRKO mice, while that of manganese superoxide dismutase increased. Furthermore, expression of genes important in cardiac metabolism was increased in MMRKO hearts. Macrophage infiltration in the heart was inhibited and expression of inflammatory genes was decreased in MMRKO mice. In addition, aortic fibrosis and inflammation were attenuated in MMRKO mice. Taken together, our data indicated that MR deficiency in myeloid cells effectively attenuated aortic constriction-induced cardiac hypertrophy and fibrosis, as well as aortic fibrosis and inflammation.	[Li, Chao; Zhang, Yu Yao; Zheng, Xiao Jun; Zhang, Wu Chang; Sun, Xue Nan; Yang, Qing Zhen; Ma, Shu Min; Yu, Ying; Duan, Sheng Zhong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Zhang, Yu Yao; Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Frieler, Ryan A.; Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Huang, Baozhuan] Xuhui Cent Hosp, Dept Nephrol, Shanghai, Peoples R China; [Berger, Stefan] German Canc Res Ctr, Div Mol Biol Cell 1, Heidelberg, Germany; [Wang, Wang] Univ Washington, Mitochondria & Metab Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Wu, Yong] Charles R Drew Univ Med & Sci, Dept Internal Med, Div Canc Res & Training, Los Angeles, CA 90059 USA; [Wu, Yong] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Helmholtz Association; German Cancer Research Center (DKFZ); University of Washington; University of Washington Seattle; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan	Duan, SZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	szduan@sibs.ac.cn; rmort@umich.edu	wang, wang/GWQ-7272-2022	Frieler, Ryan/0000-0003-2780-3244; Wang, Wang/0000-0001-9093-412X	One Hundred Talents Program of the Chinese Academy of Sciences [2012OHTP06]; Ministry of Science and Technology of China (973 Program) [2012CB524900]; National Natural Science Foundation of China [31371153, 91339110, 31171133]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-08]; Xuhui Central Hospital, Shanghai, China [CRC2011003]; NIH [R01HL083201]; American Diabetes Association [1-08-RA-137]; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083201, R01HL112610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077780] Funding Source: NIH RePORTER	One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Xuhui Central Hospital, Shanghai, China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the One Hundred Talents Program of the Chinese Academy of Sciences (2012OHTP06), the Ministry of Science and Technology of China (973 Program 2012CB524900), the National Natural Science Foundation of China (31371153, 91339110, 31171133), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-08), and Xuhui Central Hospital, Shanghai, China (CRC2011003) (to S.Z. Duan), as well as grants from the National Heart, Lung, and Blood Institute, NIH (R01HL083201) and American Diabetes Association (1-08-RA-137) (to R. M. Mortensen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahokas RA, 2003, CIRC RES, V93, pE124, DOI 10.1161/01.RES.0000102404.81461.25; Ardehali H, 2012, EUR J HEART FAIL, V14, P120, DOI 10.1093/eurjhf/hfr173; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bienvenu LA, 2012, ENDOCRINOLOGY, V153, P3416, DOI 10.1210/en.2011-2098; Cat AND, 2012, CURR OPIN NEPHROL HY, V21, P147, DOI 10.1097/MNH.0b013e32834fb25b; Duan SZ, 2007, PHYSIOL MEAS, V28, P1329, DOI 10.1088/0967-3334/28/11/001; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Kalogeropoulos AP, 2012, HEART FAIL CLIN, V8, P113, DOI 10.1016/j.hfc.2011.08.002; Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D; Keidar S, 2003, J CARDIOVASC PHARM, V41, P955, DOI 10.1097/00005344-200306000-00019; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Kuster GM, 2005, CIRCULATION, V111, P420, DOI 10.1161/01.CIR.0000153800.09920.40; Kuwahara F, 2004, HYPERTENSION, V43, P739, DOI 10.1161/01.HYP.0000118584.33350.7d; Lother A, 2011, HYPERTENSION, V57, P746, DOI 10.1161/HYPERTENSIONAHA.110.163287; Maejima Y, 2011, J MOL CELL CARDIOL, V50, P408, DOI 10.1016/j.yjmcc.2010.12.018; McCurley A, 2012, NAT MED, V18, P1429, DOI 10.1038/nm.2891; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Nagata K, 2006, HYPERTENSION, V47, P656, DOI 10.1161/01.HYP.0000203772.78696.67; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pruthi D, 2014, ARTERIOSCL THROM VAS, V34, P355, DOI 10.1161/ATVBAHA.113.302854; Rickard AJ, 2014, HYPERTENSION; Rickard AJ, 2009, HYPERTENSION, V54, P537, DOI 10.1161/HYPERTENSIONAHA.109.131110; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Schafer N, 2013, EUR HEART J, V34, P3515, DOI 10.1093/eurheartj/eht095; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Whaley-Connell A, 2010, PROG CARDIOVASC DIS, V52, P401, DOI 10.1016/j.pcad.2009.12.004; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	35	41	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110950	10.1371/journal.pone.0110950	http://dx.doi.org/10.1371/journal.pone.0110950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354087	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200048
J	Maliti, D; Ranson, H; Magesa, S; Kisinza, W; Mcha, J; Haji, K; Killeen, G; Weetman, D				Maliti, Deodatus; Ranson, Hilary; Magesa, Stephen; Kisinza, William; Mcha, Juma; Haji, Khamis; Killeen, Gerald; Weetman, David			Islands and Stepping-Stones: Comparative Population Structure of Anopheles gambiae sensu stricto and Anopheles arabiensis in Tanzania and Implications for the Spread of Insecticide Resistance	PLOS ONE			English	Article							TREATED BED NETS; MALARIA VECTOR; GENETIC DIFFERENTIATION; MOLECULAR-FORMS; LYMPHATIC FILARIASIS; DIPTERA-CULICIDAE; FIELD-EVALUATION; WESTERN KENYA; RIFT-VALLEY; TRANSMISSION	Population genetic structures of the two major malaria vectors Anopheles gambiae s.s. and An. arabiensis, differ markedly across Sub-Saharan Africa, which could reflect differences in historical demographies or in contemporary gene flow. Elucidation of the degree and cause of population structure is important for predicting the spread of genetic traits such as insecticide resistance genes or artificially engineered genes. Here the population genetics of An. gambiae s.s. and An. arabiensis in the central, eastern and island regions of Tanzania were compared. Microsatellite markers were screened in 33 collections of female An. gambiae s.l., originating from 22 geographical locations, four of which were sampled in two or three years between 2008 and 2010. An. gambiae were sampled from six sites, An. arabiensis from 14 sites, and both species from two sites, with an additional colonised insectary sample of each species. Frequencies of the knock-down resistance (kdr) alleles 1014S and 1014F were also determined. An. gambiae exhibited relatively high genetic differentiation (average pairwise F-ST = 0.131), significant even between nearby samples, but without clear geographical patterning. In contrast, An. arabiensis exhibited limited differentiation (average F-ST = 0.015), but strong isolation-by-distance (Mantel test r = 0.46, p = 0.0008). Most time-series samples of An. arabiensis were homogeneous, suggesting general temporal stability of the genetic structure. An. gambiae populations from Dar es Salaam and Bagamoyo were found to have high frequencies of kdr 1014S (around 70%), with almost 50% homozygote but was at much lower frequency on Unguja Island, with no. An. gambiae population genetic differentiation was consistent with an island model of genetic structuring with highly restricted gene flow, contrary to An. arabiensis which was consistent with a stepping-stone model of extensive, but geographically-restricted gene flow.	[Maliti, Deodatus; Killeen, Gerald] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Morogoro, Tanzania; [Maliti, Deodatus] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Ranson, Hilary; Killeen, Gerald; Weetman, David] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Mcha, Juma; Haji, Khamis] Zanzibar Malaria Eliminat Programme, Unguja, Zanzibar, Tanzania; [Magesa, Stephen] RTI Int, Global Hlth Div, Dar Es Salaam, Tanzania; [Kisinza, William] Natl Inst Med Res, Amani Res Ctr, Muheza, Tanga, Tanzania	Ifakara Health Institute; University of Glasgow; Liverpool School of Tropical Medicine; University of Liverpool; Research Triangle Institute; National Institute of Medical Research	Maliti, D (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Morogoro, Tanzania.	dmaliti@ihi.or.tz	Weetman, David/M-1261-2014	Weetman, David/0000-0002-5820-1388; Ranson, Hilary/0000-0003-2332-8247	Wellcome Trust through the Wellcome Trust Masters of Science Fellowship Programme [08703/Z/08/Z]; Bill and Melinda Gates Foundation through the Malaria Transmission Consortium [45114]	Wellcome Trust through the Wellcome Trust Masters of Science Fellowship Programme; Bill and Melinda Gates Foundation through the Malaria Transmission Consortium	The authors thank the Wellcome Trust for funding this work through the Wellcome Trust Masters of Science Fellowship Programme (award number 08703/Z/08/Z). The authors thank the Bill and Melinda Gates Foundation through the Malaria Transmission Consortium (award number 45114) for supporting the initial processes of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelmaali SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080549; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Balding D, 2001, HDB STAT GENETICS; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Cartaxo MFS, 2011, T ROY SOC TROP MED H, V105, P491, DOI 10.1016/j.trstmh.2011.05.004; Coetzee M, 2013, ANNU REV ENTOMOL, V58, P393, DOI 10.1146/annurev-ento-120811-153628; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Cornuet JM, 1996, GENETICS, V144, P2001; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Czeher C, 2010, J MED ENTOMOL, V47, P355, DOI 10.1603/ME09173; Derua YA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-188; Dia I, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-61; Donnelly MJ, 1999, HEREDITY, V83, P408, DOI 10.1038/sj.hdy.6885930; Donnelly MJ, 2000, INSECT MOL BIOL, V9, P357, DOI 10.1046/j.1365-2583.2000.00197.x; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Duchemin JB, 2001, MED VET ENTOMOL, V15, P50, DOI 10.1046/j.1365-2915.2001.00276.x; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Faye O, 1997, J MED ENTOMOL, V34, P285, DOI 10.1093/jmedent/34.3.285; Felsenstein J, 2008, PHYLIP PHYLOGENY INF; Gillies MT, 1987, ANOPHELINAE AFRICA S, V55; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Govella NJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-124; Hanfling B, 2006, GENETICS, V173, P1487, DOI 10.1534/genetics.105.054296; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Hood GM, 2008, POPTOOLS VERS 2 5 9; Hutchison WD, 1999, EVOLUTION, V53; Jones CM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-343; Kabula B, 2013, MED VET ENTOMOL; Kabula B, 2014, TROP MED INT HEALTH, V19, P331, DOI 10.1111/tmi.12248; Kamau L, 1998, AM J TROP MED HYG, V58, P64, DOI 10.4269/ajtmh.1998.58.64; Kamau L, 1999, INSECT MOL BIOL, V8, P287, DOI 10.1046/j.1365-2583.1999.820287.x; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024323; Kayondo JK, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-59; Kent RJ, 2007, AM J TROP MED HYG, V77, P316, DOI 10.4269/ajtmh.2007.77.316; Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lunde TM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-78; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Matowo NS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-137; Mawejje HD, 2013, MED VET ENTOMOL, V27, P276, DOI 10.1111/j.1365-2915.2012.01055.x; Midega JT, 2010, ACTA TROP, V114, P103, DOI 10.1016/j.actatropica.2010.01.011; Moreno M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-137; Mutuku FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-356; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Ng'habi KR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-289; Nyanjom SRG, 2003, J HERED, V94, P457, DOI 10.1093/jhered/esg100; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-17; Onyabe DY, 2001, MOL ECOL, V10, P2577, DOI 10.1046/j.0962-1083.2001.01387.x; Pinto J, EVOLUTIONARY APPL, V6, P910; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rambaut A, 2008, FIGTREE 1 3 1; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; ROMANS P, 1991, J MED ENTOMOL, V28, P147, DOI 10.1093/jmedent/28.1.147; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Russell TL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-24; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Simard F, 2000, INSECT MOL BIOL, V9, P467, DOI 10.1046/j.1365-2583.2000.00210.x; Simard F, 1999, AM J TROP MED HYG, V60, P1000, DOI 10.4269/ajtmh.1999.60.1000; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Temu EA, 2005, AM J TROP MED HYG, V73, P726, DOI 10.4269/ajtmh.2005.73.726; Tripet F, 2005, GENETICS, V169, P313, DOI 10.1534/genetics.104.026534; van den Broek IVF, 1999, J INSECT PHYSIOL, V45, P1001, DOI 10.1016/S0022-1910(99)00081-5; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Witzig C, 2013, PARASITOLOGY, V140, P1468, DOI 10.1017/S0031182013000024; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; World Health Organization, 2012, WHO MAL REP; World Health Organization, 2012, WHO GLOB MAL PROGR G; Yawson AE, 2007, GENETICS, V175, P751, DOI 10.1534/genetics.106.065888; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738; Zheng LB, 1996, GENETICS, V143, P941	91	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110910	10.1371/journal.pone.0110910	http://dx.doi.org/10.1371/journal.pone.0110910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353688	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000345204200046
J	Martin-Fernandez, B; de las Heras, N; Valero-Munoz, M; Ballesteros, S; Yao, YZ; Stanton, PG; Fuller, PJ; Lahera, V				Martin-Fernandez, Beatriz; de las Heras, Natalia; Valero-Munoz, Maria; Ballesteros, Sandra; Yao, Yi-Zhou; Stanton, Peter G.; Fuller, Peter J.; Lahera, Vicente			Beneficial Effects of Proanthocyanidins in the Cardiac Alterations Induced by Aldosterone in Rat Heart through Mineralocorticoid Receptor Blockade	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ANGIOTENSIN-II; POSSIBLE INVOLVEMENT; DIETARY-SODIUM; PROTEIN-KINASE; EXPRESSION; PROCYANIDINS; INFLAMMATION; FIBROSIS; FAILURE	Aldosterone administration in rats results in several cardiac alterations. Previous studies have demonstrated that proanthocyanidins, phenolic bioactive compounds, have cardioprotective effects. We studied the potential beneficial effects of the proanthocyanidin-rich almond skin extract (PASE) on the cardiac alterations induced by aldosterone-salt treatment, their effects in mineralocorticoid receptor activity and we sought to confirm proanthocyanidins as the specific component of the extract involved in the beneficial cardiac effects. Male Wistar rats received aldosterone (1 mg/Kg/day) + 1% NaCl for 3 weeks. Half of the animals in each group were simultaneously treated with either PASE (100 mg/Kg/day) or spironolactone (200 mg/Kg/day). The ability of PASE to act as an antagonist of the mineralocorticoid receptor was examined using a transactivation assay. High performance liquid chromatography was used to identify and to isolate proanthocyanidins. Hypertension and diastolic dysfunction induced by aldosterone were abolished by treatment with PASE. Expression of the aldosterone mediator SGK-1, together with fibrotic, inflammatory and oxidative mediators were increased by aldosteronesalt treatment; these were reduced by PASE. Aldosterone-salt induced transcriptional activity of the mineralocorticoid receptor was reduced by PASE. HPLC confirmed proanthocyanidins as the compound responsible for the beneficial effects of PASE. The effects of PASE were comparable to those seen with the mineralocorticoid antagonist, spironolactone. The observed responses in the aldosterone-salt treated rats together with the antagonism of transactivation at the mineralocorticoid receptor by PASE provides evidence that the beneficial effect of this proanthocyanidin-rich almond skin extract is via as a mineralocorticoid receptor antagonist with proanthocyanidins identified as the compounds responsible for the beneficial effects of PASE.	[Martin-Fernandez, Beatriz; de las Heras, Natalia; Valero-Munoz, Maria; Ballesteros, Sandra; Lahera, Vicente] Univ Complutense, Sch Med, Dept Physiol, E-28040 Madrid, Spain; [Martin-Fernandez, Beatriz; Yao, Yi-Zhou; Stanton, Peter G.; Fuller, Peter J.] Prince Henrys Inst Med Res, Clayton, Vic, Australia	Complutense University of Madrid; Prince Henry's Institute of Medical Research	Lahera, V (corresponding author), Univ Complutense, Sch Med, Dept Physiol, E-28040 Madrid, Spain.	vlahera@med.ucm.es	Martín Fernández, Beatriz/ABG-8713-2021	Martin-Fernandez, Beatriz/0000-0002-1904-6194; Lahera, Vicente/0000-0002-9688-4503; Fuller, Peter/0000-0002-0948-2072; DE LAS HERAS, NATALIA/0000-0002-2960-6175	VI Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de Espana [SAF2011-30396]; National Health and Medical Research Council of Australia [1002559, 1002575]; Victorian Government's Operational Infrastructure Program	VI Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de Espana; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Program	This work was supported by grants from VI Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de Espana (SAF2011-30396) and the National Health and Medical Research Council of Australia through a Fellowship (#1002559) and Project Grant (#1002575) support to PJF. Prince Henry's Institute is supported by the Victorian Government's Operational Infrastructure Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman L, 2014, MOL NUTR FOOD RES, V58, P1708, DOI 10.1002/mnfr.201300559; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Barreiros ALBS, 2000, PHYTOCHEMISTRY, V55, P805, DOI 10.1016/S0031-9422(00)00297-1; Bauersachs J, 2008, PHARMACOL REP, V60, P119; Belleville J, 2002, NUTRITION, V18, P173, DOI 10.1016/S0899-9007(01)00721-3; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; BRILLA CG, 1992, J LAB CLIN MED, V120, P893; BRILLA CG, 1990, CIRC RES, V67, P1355, DOI 10.1161/01.RES.67.6.1355; Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727; Chanet A, 2013, BRIT J NUTR, V110, P587, DOI 10.1017/S0007114512005454; Coban D, 2012, MOL NUTR FOOD RES, V56, P1270, DOI 10.1002/mnfr.201100818; Dietz JD, 2008, HYPERTENSION, V51, P742, DOI 10.1161/HYPERTENSIONAHA.107.103580; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Fraga CG, 2011, FREE RADICAL BIO MED, V51, P813, DOI 10.1016/j.freeradbiomed.2011.06.002; Funder JW, 2007, AM J CARDIOVASC DRUG, V7, P151, DOI 10.2165/00129784-200707030-00001; Garcia-Conesa MT, 2009, MOL NUTR FOOD RES, V53, P266, DOI 10.1002/mnfr.200800134; Goto T, 2012, BRIT J NUTR, V107, P769, DOI 10.1017/S0007114511003758; Guler A, 2011, MED SCI MONITOR, V17, pBR326, DOI 10.12659/MSM.882042; Hamalainen M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/45673; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Kwak CJ, 2009, J HYPERTENS, V27, P92, DOI 10.1097/HJH.0b013e3283186994; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mano A, 2004, CIRCULATION, V110, P317, DOI 10.1161/01.CIR.0000135599.33787.CA; Martin-Fernandez B, 2011, J CARDIOVASC PHARM, V57, P114, DOI 10.1097/FJC.0b013e31820088ca; Martin-Fernandez B, 2009, EXP PHYSIOL, V94, P675, DOI 10.1113/expphysiol.2009.047688; Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Milenkovic D, 2013, FREE RADICAL BIO MED, V64, P40, DOI 10.1016/j.freeradbiomed.2013.05.046; Mill JG, 2003, CLIN EXP PHARMACOL P, V30, P739, DOI 10.1046/j.1440-1681.2003.03906.x; Monagas M, 2007, J AGR FOOD CHEM, V55, P8498, DOI 10.1021/jf071780z; Murphy KJ, 2003, AM J CLIN NUTR, V77, P1466, DOI 10.1093/ajcn/77.6.1466; Nishiyama A, 2004, HYPERTENSION, V43, P841, DOI 10.1161/01.HYP.0000118519.66430.22; Nocun M, 2008, BIOMED PHARMACOTHER, V62, P168, DOI 10.1016/j.biopha.2007.07.002; Palfi A, 2009, J NUTR BIOCHEM, V20, P418, DOI 10.1016/j.jnutbio.2008.04.009; Pitt B, 2005, J AM COLL CARDIOL, V46, P425, DOI 10.1016/j.jacc.2005.04.038; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Ricchiuti V, 2011, J ENDOCRINOL, V211, P47, DOI 10.1530/JOE-10-0458; Rocha R, 2000, ENDOCRINOLOGY, V141, P3871, DOI 10.1210/en.141.10.3871; Rocha R, 2002, ENDOCRINOLOGY, V143, P4828, DOI 10.1210/en.2002-220120; Rogerson FM, 1999, J BIOL CHEM, V274, P36305, DOI 10.1074/jbc.274.51.36305; Rogerson FM, 2007, MOL ENDOCRINOL, V21, P817, DOI 10.1210/me.2006-0246; Rossi GP, 2005, TRENDS ENDOCRIN MET, V16, P104, DOI 10.1016/j.tem.2005.02.010; Sano T, 2005, THROMB RES, V115, P115, DOI 10.1016/j.thromres.2004.07.015; Satoh M, 2002, CLIN SCI, V102, P381, DOI 10.1042/CS20010219; Schafer A, 2006, BIOMED PHARMACOTHER, V60, P5, DOI 10.1016/j.biopha.2005.08.006; Schafer A, 2003, THROMB HAEMOSTASIS, V89, P1024, DOI 10.1055/s-0037-1613404; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; SCOTT BC, 1993, FREE RADICAL RES COM, V19, P241, DOI 10.3109/10715769309056512; Sheng R, 2007, ACTA PHARMACOL SIN, V28, P191, DOI 10.1111/j.1745-7254.2007.00495.x; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Spiller GA, 2003, J AM COLL NUTR, V22, P195, DOI 10.1080/07315724.2003.10719293; Spiller GA, 1998, J AM COLL NUTR, V17, P285, DOI 10.1080/07315724.1998.10718761; Struthers AD, 2004, CARDIOVASC RES, V61, P663, DOI 10.1016/j.cardiores.2003.11.037; Struthers AD, 2004, EUR J HEART FAIL, V6, P539, DOI 10.1016/j.ejheart.2004.04.013; Sun Y, 1997, CARDIOVASC RES, V35, P138, DOI 10.1016/S0008-6363(97)00097-7; SWEDBERG K, 1990, CIRCULATION, V82, P1730, DOI 10.1161/01.CIR.82.5.1730; Takeda Y, 2000, ENDOCRINOLOGY, V141, P1901, DOI 10.1210/en.141.5.1901; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; Toufektsian MC, 2008, J NUTR, V138, P747, DOI 10.1093/jn/138.4.747; Wilke A, 1996, BASIC RES CARDIOL, V91, P79, DOI 10.1007/BF00795367; Young M, 2004, ENDOCRINOLOGY, V145, P3153, DOI 10.1210/en.2004-0005; Young MJ, 1996, STEROIDS, V61, P233, DOI 10.1016/0039-128X(96)00020-7; Zhao XH, 2006, PHYSIOL MEAS, V27, pN27, DOI 10.1088/0967-3334/27/6/N01	67	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111104	10.1371/journal.pone.0111104	http://dx.doi.org/10.1371/journal.pone.0111104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353961	Green Submitted, gold, Green Published			2022-12-26	WOS:000345204200055
J	van Bommel, L; Johnson, CN				van Bommel, Linda; Johnson, Chris N.			Where Do Livestock Guardian Dogs Go? Movement Patterns of Free-Ranging Maremma Sheepdogs	PLOS ONE			English	Article							HOME-RANGE; ESTIMATORS; AUSTRALIA; BEHAVIOR; LOSSES	In many parts of the world, livestock guardian dogs (LGDs) are a relatively new and increasingly popular method for controlling the impact of wild predators on livestock. On large grazing properties in Australia, LGDs are often allowed to range freely over large areas, with minimal supervision by their owners. How they behave in this situation is mostly unknown. We fitted free-ranging Maremma sheepdogs with GPS tracking collars on three properties in Victoria, Australia; on two properties, four sheep were also fitted with GPS collars. We investigated how much time the Maremmas spent with their livestock, how far they moved outside the ranges of their stock, and tested whether they use their ranges sequentially, which is an effective way of maintaining a presence over a large area. The 95% kernel isopleth of the Maremmas ranged between 31 and 1161 ha, the 50% kernel isopleth ranged between 4 and 252 ha. Maremmas spent on average 90% of their time in sheep paddocks. Movements away from sheep occurred mostly at night, and were characterised by high-speed travel on relatively straight paths, similar to the change in activity at the edge of their range. Maremmas used different parts of their range sequentially, similar to sheep, and had a distinct early morning and late afternoon peak in activity. Our results show that while free-ranging LGDs spend the majority of their time with livestock, movements away from stock do occur. These movements could be important in allowing the dogs to maintain large territories, and could increase the effectiveness of livestock protection. Allowing LGDs to range freely can therefore be a useful management decision, but property size has to be large enough to accommodate the large areas that the dogs use.	[van Bommel, Linda; Johnson, Chris N.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [van Bommel, Linda] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	University of Tasmania; Australian National University	van Bommel, L (corresponding author), Univ Tasmania, Sch Zool, Hobart, Tas, Australia.	linda.vanbommel@anu.edu.au	Johnson, Christopher/J-7894-2014	Johnson, Christopher/0000-0002-9719-3771	Hermon Slade Foundation; Australian Research Council; Australian Postgraduate Award	Hermon Slade Foundation; Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	The research was funded by the Hermon Slade Foundation and the Australian Research Council. Linda van Bommel was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLES ED, 1969, J WILDLIFE MANAGE, V33, P145, DOI 10.2307/3799662; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; BLACK HL, 1985, J RANGE MANAGE, V38, P11, DOI 10.2307/3899323; BOWNS JE, 1971, J RANGE MANAGE, V24, P105, DOI 10.2307/3896515; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Coppinger L, 2007, LIVESTOCK HANDLING AND TRANSPORT, 3RD EDITION, P199, DOI 10.1079/9781845932190.0199; Coppinger R., 1983, P 1 E WILDL DAM CONT, P129; Coppinger R., 2001, DOGS NEW UNDERSTANDI; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Demma DJ, 2009, J WILDLIFE MANAGE, V73, P380, DOI 10.2193/2008-114; ESRI, 2011, ARCGIS DESKT REL 10; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Fleming P. J. S., 1989, Australian Rangeland Journal, V11, P61; Gehring Thomas M., 2011, Human-Wildlife Interactions, V5, P106; Gehring TM, 2010, WILDLIFE RES, V37, P715, DOI 10.1071/WR10023; Gingold G, 2009, ANIM CONSERV, V12, P155, DOI 10.1111/j.1469-1795.2009.00235.x; GREEN JS, 1983, APPL ANIM ETHOL, V11, P141, DOI 10.1016/0304-3762(83)90123-2; GREENSITE J, 1990, NATO ADV SCI I B-PHY, V224, P233; Hansen I, 1999, J RANGE MANAGE, V52, P312, DOI 10.2307/4003539; Hansen I, 2002, ACTA AGR SCAND A-AN, V52, P43, DOI 10.1080/09064700252806416; Jacques CN, 2009, J MAMMAL, V90, P433, DOI 10.1644/07-MAMM-A-395.1; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; LINHART SB, 1979, J RANGE MANAGE, V32, P238, DOI 10.2307/3897131; Marker LL, 2005, RANGELAND ECOL MANAG, V58, P329, DOI 10.2111/1551-5028(2005)058[0329:PEOLDP]2.0.CO;2; MCGREW JC, 1982, J RANGE MANAGE, V35, P693, DOI 10.2307/3898240; Otstavel Teet, 2009, Estonian Journal of Ecology, V58, P216, DOI 10.3176/eco.2009.3.06; PHILLIPS M, 1991, WILDLIFE RES, V18, P677, DOI 10.1071/WR9910677; R Core Team, 2018, R LANG ENV STAT COMP; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; REYNOLDS TD, 1990, J WILDLIFE MANAGE, V54, P316, DOI 10.2307/3809049; Rigg R., 2001, LIVESTOCK GUARDING D; Rigg R, 2011, ORYX, V45, P272, DOI 10.1017/S0030605310000074; Sims DE, 2004, LIVESTOCK PROTECTION; Squires V. R., 1974, Applied Animal Ethology, V1, P17, DOI 10.1016/0304-3762(74)90004-2; THOMSON PC, 1992, WILDLIFE RES, V19, P519, DOI 10.1071/WR9920519; Turchin Peter, 1998; van Bommel L, 2014, MOVEMENTS FREE RANGI, DOI [10.5441/001/1.pv048q7v, DOI 10.5441/001/1.PV048Q7V]; van Bommel L., 2010, GUARDIAN DOGS BEST P; van Bommel L, 2012, WILDLIFE RES, V39, P220, DOI 10.1071/WR11135; WARREN JT, 1991, J RANGE MANAGE, V44, P2, DOI 10.2307/4002628; White G.C., 1990, ANAL WILDLIFE RADIO; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	43	30	30	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111444	10.1371/journal.pone.0111444	http://dx.doi.org/10.1371/journal.pone.0111444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353319	gold, Green Published, Green Submitted			2022-12-26	WOS:000345204200080
J	Antonini, V; Perez-Barzaga, V; Bampi, S; Penton, D; Martinez, D; Serra, MD; Tejuca, M				Antonini, Valeria; Perez-Barzaga, Victor; Bampi, Silvia; Penton, David; Martinez, Diana; Serra, Mauro Dalla; Tejuca, Mayra			Functional Characterization of Sticholysin I and W111C Mutant Reveals the Sequence of the Actinoporin's Pore Assembly	PLOS ONE			English	Article							CYTOLYSIN EQUINATOXIN-II; SEA-ANEMONE; FORMING TOXIN; MODEL MEMBRANES; PROTEIN; MECHANISM; CONSTRUCTION; INSIGHTS; CRYSTAL; BINDING	The use of pore-forming toxins in the construction of immunotoxins against tumour cells is an alternative for cancer therapy. In this protein family one of the most potent toxins are the actinoporins, cytolysins from sea anemones. We work on the construction of tumour proteinase-activated immunotoxins using sticholysin I (StI), an actinoporin isolated from the sea anemone Stichodactyla helianthus. To accomplish this objective, recombinant StI (StIr) with a mutation in the membrane binding region has been employed. In this work, it was evaluated the impact of mutating tryptophan 111 to cysteine on the toxin pore forming capability. StI W111C is still able to permeabilize erythrocytes and liposomes, but at ten-fold higher concentration than StI. This is due to its lower affinity for the membrane, which corroborates the importance of residue 111 for the binding of actinoporins to the lipid bilayer. In agreement, other functional characteristics not directly associated to the binding, are essentially the same for both variants, that is, pores have oligomeric structures with similar radii, conductance, cation-selectivity, and instantaneous current-voltage behavior. In addition, this work provides experimental evidence sustaining the toroidal protein-lipid actinoporins lytic structures, since the toxins provoke the trans-bilayer movement (flip-flop) of a pyrene-labeled analogue of phosphatidylcholine in liposomes, indicating the existence of continuity between the outer and the inner membrane leaflet. Finally, our planar lipid membranes results have also contributed to a better understanding of the actinoporin's pore assembly mechanism. After the toxin binding and the N-terminal insertion in the lipid membrane, the pore assembly occurs by passing through different transient sub-conductance states. These states, usually 3 or 4, are due to the successive incorporation of N-terminal a-helices and lipid heads to the growing pores until a stable toroidal oligomeric structure is formed, which is mainly tetrameric.	[Antonini, Valeria; Bampi, Silvia; Serra, Mauro Dalla] Inst Biophys & Bruno Kessler Fdn, Natl Res Council Italy, Trento, Italy; [Perez-Barzaga, Victor; Penton, David; Martinez, Diana; Tejuca, Mayra] Univ Havana, Fac Biol, Ctr Prot Studies, Vedado, Ciudad de La Ha, Cuba	Consiglio Nazionale delle Ricerche (CNR); Fondazione Bruno Kessler; Universidad de la Habana	Serra, MD (corresponding author), Inst Biophys & Bruno Kessler Fdn, Natl Res Council Italy, Trento, Italy.	mauro.dallaserra@cnr.it; mayra@cepes.uh.cu	Serra, Mauro Dalla/A-6218-2010; Penton, David/L-2597-2016; Serra, Mauro Dalla/AAK-9299-2021	Serra, Mauro Dalla/0000-0003-1048-2739; Serra, Mauro Dalla/0000-0003-1048-2739				Alegre-Cebollada J, 2008, J MOL BIOL, V382, P920, DOI 10.1016/j.jmb.2008.07.053; Anderluh G, 2005, J MOL BIOL, V347, P27, DOI 10.1016/j.jmb.2004.12.058; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Anderluh G, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P141; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; Burks RL, 2002, J CHEM ECOL, V28, P1901, DOI 10.1023/A:1020785525081; Carneiro CMM, 1997, FEBS LETT, V416, P187, DOI 10.1016/S0014-5793(97)01198-8; Castrillo I, 2010, PROTEINS, V78, P1959, DOI 10.1002/prot.22712; Dalla Serra M, 2000, METH MOL B, V145, P171; Dalla Serra M, 2011, ELS; De los Rios V, 1998, EUR J BIOCHEM, V252, P284, DOI 10.1046/j.1432-1327.1998.2520284.x; Epand RM, 1998, BBA-REV BIOMEMBRANES, V1376, P353, DOI 10.1016/S0304-4157(98)00015-X; Fradin C, 2009, HANDB MOD BIOPHYS, V2, P223, DOI 10.1007/978-1-60761-314-5_9; Garcia-Linares S, 2013, ARCH BIOCHEM BIOPHYS, V532, P39, DOI 10.1016/j.abb.2013.01.005; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; GINSBURG H, 1987, J MEMBRANE BIOL, V96, P1, DOI 10.1007/BF01869329; Gutierrez-Aguirre I, 2004, BIOCHEM J, V384, P421, DOI 10.1042/BJ20040601; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Kristan K, 2007, FEBS J, V274, P539, DOI 10.1111/j.1742-4658.2006.05608.x; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; KUGA S, 1981, J CHROMATOGR, V206, P449, DOI 10.1016/S0021-9673(00)88914-1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Muller P, 2000, CHEM PHYS LIPIDS, V106, P89, DOI 10.1016/S0009-3084(00)00134-1; Pazos F, 2006, TOXICON, V48, P1083, DOI 10.1016/j.toxicon.2006.09.004; PEDERZOLLI C, 1995, BIOCONJUGATE CHEM, V6, P166, DOI 10.1021/bc00032a003; Penton D, 2011, PROTEIN ENG DES SEL, V24, P485, DOI 10.1093/protein/gzr002; RENKIN EM, 1954, J GEN PHYSIOL, V38, P225; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Sher D, 2005, TOXICON, V45, P865, DOI 10.1016/j.toxicon.2005.02.004; Stoddart D, 2014, P NATL ACAD SCI USA, V111, P2425, DOI 10.1073/pnas.1312976111; Tejuca M, 2004, INT IMMUNOPHARMACOL, V4, P731, DOI 10.1016/j.intimp.2004.02.010; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; Tosatto L, 2012, BBA-BIOMEMBRANES, V1818, P2876, DOI 10.1016/j.bbamem.2012.07.007; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3	48	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110824	10.1371/journal.pone.0110824	http://dx.doi.org/10.1371/journal.pone.0110824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350457	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100043
J	Chen, Q; Zhang, WQ; Ran, H; Feng, LZ; Yan, H; Mu, XY; Han, YY; Liu, W; Xia, GL; Wang, C				Chen, Qian; Zhang, Wenqiang; Ran, Hao; Feng, Lizhao; Yan, Hao; Mu, Xinyi; Han, Yingying; Liu, Wei; Xia, Guoliang; Wang, Chao			PKC delta and theta Possibly Mediate FSH-Induced Mouse Oocyte Maturation via NOX-ROS-TACE Cascade Signaling Pathway	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; NADPH OXIDASE; MEIOTIC MATURATION; HUMAN NEUTROPHILS; FACTOR RECEPTOR; MESSENGER-RNA; CUMULUS CELLS; IN-VITRO	In mammals, gonadotropins stimulate oocyte maturation via the epidermal growth factor (EGF) network, and the protein kinase C (PKC) signaling pathway mediates this process. Tumor necrosis factor-alpha converting enzyme (TACE) is an important protein responding to PKC activation. However, the detailed signaling cascade between PKC and TACE in follicle-stimulating hormone (FSH)-induced oocyte maturation in vitro remains unclear. In this study, we found that rottlerin (mallotoxin, MTX), the inhibitor of PKC delta and h, blocked FSH-induced maturation of mouse cumulus-oocyte complexes (COCs) in vitro. We further clarified the relationship between two molecules downstream of PKC delta and theta and TACE in COCs: nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and its products, reactive oxygen species (ROS). We proved that the respective inhibitors of NOX, ROS and TACE could block FSH-stimulated oocyte maturation dose-dependently, but these inhibitory effects could be reversed partially by amphiregulin (Areg), an EGF family member. Notably, inhibition of PKC delta and theta prevented FSH-induced translocation of two cytosolic components of NOX, p47(phox) and p67(phox), to the plasma membrane in cumulus cells. Moreover, FSH-induced TACE activity in cumulus cells was decreased markedly by inhibition of NOX and ROS. In conclusion, PKC delta and theta possibly mediate FSH-induced meiotic resumption in mouse COCs via NOX-ROS-TACE signaling pathway.	[Chen, Qian; Zhang, Wenqiang; Ran, Hao; Feng, Lizhao; Yan, Hao; Liu, Wei; Xia, Guoliang; Wang, Chao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Mu, Xinyi] Chongqing Med Univ, Dept Histol & Embryol, Chongqing, Peoples R China; [Han, Yingying] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China	China Agricultural University; Chongqing Medical University; Beijing Forestry University	Wang, C (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	wangcam@126.com		Feng, Lizhao/0000-0002-9843-3941; Yan, Hao/0000-0003-1468-6165	National Basic Research Program of China [2013CB945500]; National Natural Science Foundation of China [C120102]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB945500) and National Natural Science Foundation of China (C120102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; Aroca P, 2000, FEBS LETT, V483, P27, DOI 10.1016/S0014-5793(00)02075-5; Ashkenazi H, 2005, ENDOCRINOLOGY, V146, P77, DOI 10.1210/en.2004-0588; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blondin P, 1997, J ANDROL, V18, P454; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Chen XF, 2008, J ENDOCRINOL, V197, P409, DOI 10.1677/JOE-07-0592; DOWNS SM, 1988, J EXP ZOOL, V245, P86, DOI 10.1002/jez.1402450113; Downs SM, 2008, MOL REPROD DEV, V75, P105, DOI 10.1002/mrd.20781; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; HANSEL W, 1991, J REPROD FERTIL, P77; Jain S, 2000, LIFE SCI, V66, P1139, DOI 10.1016/S0024-3205(00)00417-3; JONES SA, 1995, J AM SOC NEPHROL, V5, P1483; Kawashima I, 2008, REPRODUCTION, V136, P9, DOI 10.1530/REP-08-0074; Liu L, 2013, REPROD FERT DEVELOP, V25, P463, DOI 10.1071/RD12310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mesquita FS, 2010, BIOL REPROD, V82, P341, DOI 10.1095/biolreprod.108.075887; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Park JW, 1996, BIOCHEM BIOPH RES CO, V220, P31, DOI 10.1006/bbrc.1996.0351; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; SHIMAMOTO T, 1993, ENDOCRINOLOGY, V133, P2127, DOI 10.1210/en.133.5.2127; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Takami M, 2000, AM J PHYSIOL-CELL PH, V278, pC646, DOI 10.1152/ajpcell.2000.278.4.C646; Viveiros MM, 2003, BIOL REPROD, V69, P1494, DOI 10.1095/biolreprod.103.019018; Wang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045043; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Yamashita Y, 2007, ENDOCRINOLOGY, V148, P6164, DOI 10.1210/en.2007-0195; Yamashita Y, 2014, ENDOCRINOLOGY, V155, P1080, DOI 10.1210/en.2013-1655; Yamashita Y, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-20; Yamashita Y, 2010, J REPROD DEVELOP, V56, P315, DOI 10.1262/jrd.09-199H; Zhang ZL, 2001, FASEB J, V15, P303	36	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111423	10.1371/journal.pone.0111423	http://dx.doi.org/10.1371/journal.pone.0111423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350560	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100071
J	Hoang, DT; Matsunari, H; Nagaya, M; Nagashima, H; Millis, JM; Witkowski, P; Periwal, V; Hara, M; Jo, J				Hoang, Danh-Tai; Matsunari, Hitomi; Nagaya, Masaki; Nagashima, Hiroshi; Millis, J. Michael; Witkowski, Piotr; Periwal, Vipul; Hara, Manami; Jo, Junghyo			A Conserved Rule for Pancreatic Islet Organization	PLOS ONE			English	Article							CELL-ADHESION; CONFOCAL MICROSCOPY; INSULIN-SECRETION; BETA-CELLS; ARCHITECTURE; LANGERHANS; AGGREGATION; ORGANOGENESIS; MORPHOGENESIS; MICROANATOMY	Morphogenesis, spontaneous formation of organism structure, is essential for life. In the pancreas, endocrine alpha, beta, and delta cells are clustered to form islets of Langerhans, the critical micro-organ for glucose homeostasis. The spatial organization of endocrine cells in islets looks different between species. Based on the three-dimensional positions of individual cells in islets, we computationally inferred the relative attractions between cell types, and found that the attractions between homotypic cells were slightly, but significantly, stronger than the attractions between heterotypic cells commonly in mouse, pig, and human islets. The difference between alpha - beta cell attraction and beta - beta cell attraction was minimal in human islets, maximizing the plasticity of islet structures. Our result suggests that although the cellular composition and attractions of pancreatic endocrine cells are quantitatively different between species, the physical mechanism of islet morphogenesis may be evolutionarily conserved.	[Hoang, Danh-Tai; Jo, Junghyo] Asia Pacific Ctr Theoret Phys, Pohang, South Korea; [Matsunari, Hitomi; Nagaya, Masaki; Nagashima, Hiroshi] Meiji Univ, Int Inst Bioresource Res, Kanagawa, Japan; [Millis, J. Michael; Witkowski, Piotr] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Periwal, Vipul] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA; [Hara, Manami] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Jo, Junghyo] POSTECH, Dept Phys, Pohang, South Korea	Asia Pacific Center for Theoretical Physics; Meiji University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Chicago; Pohang University of Science & Technology (POSTECH)	Hara, M (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mhara@uchicago.edu; jojunghyo@apctp.org	Hara, Masayuki/AAH-4361-2019; Jo, Junghyo/D-4889-2011; Millis, Michael/K-5346-2019	Nagashima, Hiroshi/0000-0001-9940-8783; Hoang, Danh-Tai/0000-0003-2640-4196	Basic Science Research Program through the National Foundation of Korea - Ministry of Science, ICT & Future Planning [2013R1A1A1006655]; Max Planck Society; Korea Ministry of Education, Science and Technology; Gyeongsangbuk-Do and Pohang City; Intramural Research Program of the NIH; National Institute of Diabetes and Digestive and Kidney Diseases;  [DK-020595];  [DK-072473];  [AG-042151]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075038, P60DK020595, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042151] Funding Source: NIH RePORTER	Basic Science Research Program through the National Foundation of Korea - Ministry of Science, ICT & Future Planning; Max Planck Society(Max Planck SocietyFoundation CELLEX); Korea Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Gyeongsangbuk-Do and Pohang City; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by Basic Science Research Program through the National Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (No. 2013R1A1A1006655) and by the Max Planck Society, the Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J.J.), the Intramural Research Program of the NIH, the National Institute of Diabetes and Digestive and Kidney Diseases (V. P.), and DK-020595 to the University of Chicago Diabetes Research and Training Center (Animal Models Core), DK-072473, AG-042151, and a gift from the Kovler Family Foundation (M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2008, DIABETES, V57, P2899, DOI 10.2337/db07-1842; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; BRELJE TC, 1989, DIABETES, V38, P808, DOI 10.2337/diabetes.38.6.808; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; BRITT LD, 1981, DIABETES, V30, P580, DOI 10.2337/diabetes.30.7.580; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Charollais A, 2000, J CLIN INVEST, V106, P235, DOI 10.1172/JCI9398; CIRULLI V, 1994, J CELL SCI, V107, P1429; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; ERLANDSEN SL, 1976, J HISTOCHEM CYTOCHEM, V24, P883, DOI 10.1177/24.7.60437; GRUBE D, 1983, BIOMED RES-TOKYO, V4, P25; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783; HALBAN PA, 1988, ENDOCRINOLOGY, V123, P113, DOI 10.1210/endo-123-1-113; Hoang DT, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062725; Hong H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032711; Hopcroft DW, 1985, IN VITRO CELL DEV, V2, P421; Jamal AM, 2005, CELL DEATH DIFFER, V12, P702, DOI 10.1038/sj.cdd.4401617; Jia D, 2007, DEV DYNAM, V236, P2039, DOI 10.1002/dvdy.21207; Jo J, 2009, J THEOR BIOL, V257, P312, DOI 10.1016/j.jtbi.2008.12.005; Kelly C, 2011, ISLETS, V3, P41, DOI 10.4161/isl.3.2.14805; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; KUO CY, 1992, PANCREAS, V7, P320, DOI 10.1097/00006676-199205000-00008; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; ORCI L, 1976, METABOLISM, V25, P1303, DOI 10.1016/S0026-0495(76)80129-1; ROUILLER DG, 1990, EXP CELL RES, V191, P305, DOI 10.1016/0014-4827(90)90019-7; ROUILLER DG, 1991, DEV BIOL, V148, P233, DOI 10.1016/0012-1606(91)90332-W; Sivia DS, 2006, DATA ANLYSIS BAYESIA; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815	36	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110384	10.1371/journal.pone.0110384	http://dx.doi.org/10.1371/journal.pone.0110384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350558	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943100026
J	Israely, T; Melamed, S; Achdout, H; Erez, N; Politi, B; Waner, T; Lustig, S; Paran, N				Israely, Tomer; Melamed, Sharon; Achdout, Hagit; Erez, Noam; Politi, Boaz; Waner, Trevor; Lustig, Shlomo; Paran, Nir			TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ADAPTIVE IMMUNE-RESPONSE; VIRUS-INFECTION; INTERFERON-GAMMA; MONKEYPOX VIRUS; RECOGNITION RECEPTORS; POXVIRUS INFECTION; ECTROMELIA-VIRUS; INNATE IMMUNITY; PROTECTS MICE	Eradication of smallpox and discontinuation of the vaccination campaign resulted in an increase in the percentage of unvaccinated individuals, highlighting the need for postexposure efficient countermeasures in case of accidental or deliberate viral release. Intranasal infection of mice with ectromelia virus (ECTV), a model for human smallpox, is curable by vaccination with a high vaccine dose given up to 3 days postexposure. To further extend this protective window and to reduce morbidity, mice were vaccinated postexposure with Vaccinia-Lister, the conventional smallpox vaccine or Modified Vaccinia Ankara, a highly attenuated vaccine in conjunction with TLR3 or TLR9 agonists. We show that co-administration of the TLR3 agonist poly(I:C) even 5 days postexposure conferred protection, avoiding the need to increase the vaccination dose. Efficacious treatments prevented death, ameliorated disease symptoms, reduced viral load and maintained tissue integrity of target organs. Protection was associated with significant elevation of serum IFN alpha and anti-vaccinia IgM antibodies, modulation of IFN gamma response, and balanced activation of NK and T cells. TLR9 agonists (CpG ODNs) were less protective than the TLR3 agonist poly(I:C). We show that activation of type 1 IFN by poly(I:C) and protection is achievable even without co-vaccination, requiring sufficient amount of the viral antigens of the infective agent or the vaccine. This study demonstrated the therapeutic potential of postexposure immune modulation by TLR activation, allowing to alleviate the disease symptoms and to further extend the protective window of postexposure vaccination.	[Israely, Tomer; Melamed, Sharon; Achdout, Hagit; Erez, Noam; Politi, Boaz; Waner, Trevor; Lustig, Shlomo; Paran, Nir] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Paran, N (corresponding author), Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel.	nirp@iibr.gov.il	Erez, Noam/AAW-4953-2021; Paran, Nir/AAC-1036-2020	Erez, Noam/0000-0001-5241-8028	Israel Institute for Biological Research	Israel Institute for Biological Research	This work was supported by internal institute (Israel Institute for Biological Research) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Buchman GW, 2010, VACCINE, V28, P6627, DOI 10.1016/j.vaccine.2010.07.030; Coban C, 2010, EXPERT REV VACCINES, V9, P775, DOI 10.1586/ERV.10.60; Cross J, 1821, HIST VARIOLOUS EPIDE; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Earl PL, 2012, J VIROL, V86, P9105, DOI 10.1128/JVI.00162-12; Esteban David, 2012, Methods Mol Biol, V890, P177, DOI 10.1007/978-1-61779-876-4_11; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; FENNER F, 1982, REV INFECT DIS, V4, P916; Fogg CN, 2007, VACCINE, V25, P2787, DOI 10.1016/j.vaccine.2006.12.037; Golden JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042353; Goulding J, 2012, J IMMUNOL, V189, P2432, DOI 10.4049/jimmunol.1200799; Hanagata N, 2012, INT J NANOMED, V7, P2181, DOI 10.2147/IJN.S30197; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; Holechek SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077879; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Israely T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-119; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; JURADO A, 1989, EXPERIENTIA, V45, P521, DOI 10.1007/BF01990501; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KNOPF HLS, 1971, INVEST OPHTH VISUAL, V10, P750; Kremer M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002557; Kundi M, 2007, EXPERT REV VACCINES, V6, P133, DOI 10.1586/14760584.6.2.133; Lau YF, 2009, VACCINE, V27, P1354, DOI 10.1016/j.vaccine.2008.12.048; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; LEVY HB, 1978, J INFECT DIS, V137, P78, DOI 10.1093/infdis/137.1.78; Liu G, 2004, FEMS IMMUNOL MED MIC, V40, P201, DOI 10.1016/S0928-8244(03)00358-4; Lustig S, 2009, VACCINE, V27, P1691, DOI 10.1016/j.vaccine.2009.01.038; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mortimer PP, 2003, CLIN INFECT DIS, V36, P622, DOI 10.1086/374054; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Paran N, 2009, J INFECT DIS, V199, P39, DOI 10.1086/595565; Paran N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-229; Parker S, 2008, ANTIVIR RES, V77, P39, DOI 10.1016/j.antiviral.2007.08.003; Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P689, DOI 10.1128/AAC.00879-06; RAMSHAW I, 1992, IMMUNOL REV, V127, P157, DOI 10.1111/j.1600-065X.1992.tb01413.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; REYNOLDS DS, 1987, J IMMUNOL, V139, P767; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Sasai M, 2013, INT REV IMMUNOL, V32, P116, DOI 10.3109/08830185.2013.774391; Skountzou I, 2010, VACCINE, V28, P4103, DOI 10.1016/j.vaccine.2009.07.058; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Stabenow J, 2010, J VIROL, V84, P3909, DOI 10.1128/JVI.02012-09; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Tatematsu M, 2014, BIOCHEM J, V458, P195, DOI 10.1042/BJ20131492; Taylor DN, 2011, VACCINE, V29, P4897, DOI 10.1016/j.vaccine.2011.05.001; Tougan T, 2013, HUM VACCIN IMMUNOTHE, V9; Vilaysane A, 2009, SEMIN IMMUNOL, V21, P208, DOI 10.1016/j.smim.2009.05.006; Volz A, 2014, J VIROL; Walsh KB, 2014, J VIROL; Xiao YH, 2007, VACCINE, V25, P1214, DOI 10.1016/j.vaccine.2006.10.009; Xiao YH, 2013, VACCINE, V31, P319, DOI 10.1016/j.vaccine.2012.11.007; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854; Xu RH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002475; Zhang SY, 2013, CURR OPIN IMMUNOL, V25, P19, DOI 10.1016/j.coi.2012.11.001	58	10	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110545	10.1371/journal.pone.0110545	http://dx.doi.org/10.1371/journal.pone.0110545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350003	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943100030
J	Li, ZL; Yu, JH; Liu, L; Wei, ZH; Ehrlich, ES; Liu, GC; Li, JL; Liu, X; Wang, H; Yu, XF; Zhang, WY				Li, Zhaolong; Yu, Jinghua; Liu, Li; Wei, Zhenhong; Ehrlich, Elana S.; Liu, Guanchen; Li, Jingliang; Liu, Xin; Wang, Hong; Yu, Xiao-fang; Zhang, Wenyan			Coxsackievirus A16 Infection Induces Neural Cell and Non-Neural Cell Apoptosis In Vitro	PLOS ONE			English	Article							MOUTH-DISEASE; ENTEROVIRUS 71; HAND; FOOT; TAIWAN; EPIDEMIOLOGY; CHILDREN; MALAYSIA; FAS; SINGAPORE	Coxsackievirus A16 (CA16) is one of the main causative pathogens of hand, foot and mouth disease (HFMD). Viral replication typically results in host cell apoptosis. Although CA16 infection has been reported to induce apoptosis in the human rhabdomyosarcoma (RD) cell line, it remains unclear whether CA16 induces apoptosis in diverse cell types, especially neural cells which have important clinical significance. In the current study, CA16 infection was found to induce similar apoptotic responses in both neural cells and non-neural cells in vitro, including nuclear fragmentation, DNA fragmentation and phosphatidylserine translocation. CA16 generally is not known to lead to serious neurological symptoms in vivo. In order to further clarify the correlation between clinical symptoms and cell apoptosis, two CA16 strains from patients with different clinical features were investigated. The results showed that both CA16 strains with or without neurological symptoms in infected patients led to neural and muscle cell apoptosis. Furthermore, mechanistic studies showed that CA16 infection induced apoptosis through the same mechanism in both neural and non-neural cells, namely via activation of both the mitochondrial (intrinsic) pathway-related caspase 9 protein and the Fas death receptor (extrinsic) pathway-related caspase 8 protein. Understanding the mechanisms by which CA16 infection induces apoptosis in both neural and non-neural cells will facilitate a better understanding of CA16 pathogenesis.	[Li, Zhaolong; Yu, Jinghua; Wei, Zhenhong; Liu, Guanchen; Li, Jingliang; Liu, Xin; Wang, Hong; Yu, Xiao-fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Peoples R China; [Liu, Li] Jilin Univ, Hosp 1, Dept Pediat Pulmonol, Changchun 130023, Peoples R China; [Li, Zhaolong] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Ehrlich, Elana S.] Towson Univ, Dept Biol Sci, Towson, MD USA; [Yu, Xiao-fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Jilin University; Jilin University; Jilin University; University System of Maryland; Towson University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, WY (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Peoples R China.	zhangwenyan@jlu.edu.cn			National Natural Science Foundation of China [31270202, 81301416]; Chinese Ministry of Science and Technology [2012CB911102, 2013ZX10001-005]; Health and Family Planning Commission of Jilin Province [2013Z066]; Key Laboratory of Molecular Virology of Jilin Province [20102209]; Chinese Ministry of Education [IRT1016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Health and Family Planning Commission of Jilin Province; Key Laboratory of Molecular Virology of Jilin Province; Chinese Ministry of Education(Ministry of Education, China)	This work was supported in part by funding from the National Natural Science Foundation of China (31270202), Chinese Ministry of Science and Technology (2012CB911102 and 2013ZX10001-005), the National Natural Science Foundation of China (81301416), Health and Family Planning Commission of Jilin Province (2013Z066), Key Laboratory of Molecular Virology of Jilin Province (20102209), and Chinese Ministry of Education (IRT1016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Belov GA, 2003, J VIROL, V77, P45, DOI 10.1128/JVI.77.1.45-56.2003; Brisac C, 2010, J VIROL, V84, P12226, DOI 10.1128/JVI.00994-10; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P629; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chang SC, 2004, J NEUROVIROL, V10, P338, DOI 10.1080/13550280490521032; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Fu QX, 2013, APOPTOSIS, V18, P998, DOI 10.1007/s10495-013-0849-z; Gay RT, 2006, P NATL ACAD SCI USA, V103, P13825, DOI 10.1073/pnas.0605507103; Huang PN, 2014, CURR OPIN VIROL, V5, P98, DOI 10.1016/j.coviro.2014.03.007; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Jia Lei, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P635; Li J, 2014, J GEN VIROL; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lopez-Guerrero JA, 2000, VIROLOGY, V272, P250, DOI 10.1006/viro.2000.0405; Lu JR, 2013, J GEN VIROL, V94, P1477, DOI 10.1099/vir.0.047753-0; Mao QY, 2012, J VIROL, V86, P11967, DOI 10.1128/JVI.00902-12; Martelli AM, 2001, J CELL BIOCHEM, V82, P634, DOI 10.1002/jcb.1186; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Saraste A, 2003, CARDIOVASC PATHOL, V12, P255, DOI 10.1016/S1054-8807(03)00077-2; Shi WF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-327; Shih SR, 2004, ANTIMICROB AGENTS CH, V48, P3523, DOI 10.1128/AAC.48.9.3523-3529.2004; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang SM, 2014, EXPERT REV ANTI-INFE, V12, P447, DOI 10.1586/14787210.2014.895666; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094746; WRIGHT HT, 1963, NEW ENGL J MED, V268, P1041, DOI 10.1056/NEJM196305092681904; Xu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065948; Yang EX, 2012, SCI CHINA LIFE SCI, V55, P336, DOI 10.1007/s11427-012-4313-z; Yang Zhi-hong, 2005, Zhonghua Er Ke Za Zhi, V43, P648; Yen FB, 2009, J MICROBIOL IMMUNOL, V42, P38; Yu JH, 2007, ACTA PHARMACOL SIN, V28, P1975, DOI 10.1111/j.1745-7254.2007.00706.x; Zeng M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002599; Zhang XA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-606; Zhu GG, 2013, BIOCHEM BIOPH RES CO, V441, P856, DOI 10.1016/j.bbrc.2013.10.142	47	11	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111174	10.1371/journal.pone.0111174	http://dx.doi.org/10.1371/journal.pone.0111174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350381	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100060
J	Paulson, NB; Gilbertsen, AJ; Dalluge, JJ; Welchlin, CW; Hughes, J; Han, W; Blackwell, TS; Laguna, TA; Williams, BJ				Paulson, Nick B.; Gilbertsen, Adam J.; Dalluge, Joseph J.; Welchlin, Cole W.; Hughes, John; Han, Wei; Blackwell, Timothy S.; Laguna, Theresa A.; Williams, Bryan J.			The Arginine Decarboxylase Pathways of Host and Pathogen Interact to Impact Inflammatory Pathways in the Lung	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA MUTANTS; CYSTIC-FIBROSIS SPUTUM; NITRIC-OXIDE SYNTHASE; IN-VIVO; AGMATINE; BIOFILM; MACROPHAGES; INFECTION; PRODUCTS; ENHANCE	The arginine decarboxylase pathway, which converts arginine to agmatine, is present in both humans and most bacterial pathogens. In humans agmatine is a neurotransmitter with affinities towards alpha 2-adrenoreceptors, serotonin receptors, and may inhibit nitric oxide synthase. In bacteria agmatine serves as a precursor to polyamine synthesis and was recently shown to enhance biofilm development in some strains of the respiratory pathogen Pseudomonas aeruginosa. We determined agmatine is at the center of a competing metabolism in the human lung during airways infections and is influenced by the metabolic phenotypes of the infecting pathogens. Ultra performance liquid chromatography with mass spectrometry detection was used to measure agmatine in human sputum samples from patients with cystic fibrosis, spent supernatant from clinical sputum isolates, and from bronchoalvelolar lavage fluid from mice infected with P. aeruginosa agmatine mutants. Agmatine in human sputum peaks during illness, decreased with treatment and is positively correlated with inflammatory cytokines. Analysis of the agmatine metabolic phenotype in clinical sputum isolates revealed most deplete agmatine when grown in its presence; however a minority appeared to generate large amounts of agmatine presumably driving sputum agmatine to high levels. Agmatine exposure to inflammatory cells and in mice demonstrated its role as a direct immune activator with effects on TNF-alpha production, likely through NF-kappa B activation. P. aeruginosa mutants for agmatine detection and metabolism were constructed and show the real-time evolution of host-derived agmatine in the airways during acute lung infection. These experiments also demonstrated pathogen agmatine production can upregulate the inflammatory response. As some clinical isolates have adapted to hypersecrete agmatine, these combined data would suggest agmatine is a novel target for immune modulation in the host-pathogen dynamic.	[Paulson, Nick B.; Gilbertsen, Adam J.; Williams, Bryan J.] Univ Minnesota, Pulm Allergy Crit Care & Sleep Div, Minneapolis, MN 55455 USA; [Dalluge, Joseph J.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Welchlin, Cole W.; Laguna, Theresa A.] Univ Minnesota, Div Pediat Pulmonol, Minneapolis, MN USA; [Hughes, John] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Blackwell, Timothy S.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm Crit Care & Med, Nashville, TN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Vanderbilt University	Williams, BJ (corresponding author), Univ Minnesota, Pulm Allergy Crit Care & Sleep Div, Minneapolis, MN 55455 USA.	bjwillia@umn.edu		Laguna, Theresa/0000-0003-4255-0310	National Institutes of Health (NIH) [P30 HL101311-01]; NIH [K08 PA-10-059]; Gold Family Foundation; National Center for Advancing Translational Sciences of the NIH [UL1TR000114]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101311, K08HL105466] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gold Family Foundation; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by National Institutes of Health (NIH) P30 HL101311-01, NIH K08 PA-10-059, Gold Family Foundation, and the National Center for Advancing Translational Sciences of the NIH Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAL AT, 1979, ANNU REV MICROBIOL, V33, P139, DOI 10.1146/annurev.mi.33.100179.001035; AUGUET M, 1995, JPN J PHARMACOL, V69, P285, DOI 10.1254/jjp.69.285; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Boulette ML, 2009, J BACTERIOL, V191, P6329, DOI 10.1128/JB.00817-09; Davies JC, 2009, RESP CARE, V54, P628, DOI 10.4187/aarc0492; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gerova A, 2004, PHYSIOL RES, V53, P357; HAAS D, 1984, MOL GEN GENET, V193, P437, DOI 10.1007/BF00382081; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Jin Y, 2011, ANN OCCUP HYG, V55, P97, DOI 10.1093/annhyg/meq061; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Li YM, 1997, J IMMUNOL METHODS, V201, P183, DOI 10.1016/S0022-1759(96)00224-4; Lortie MJ, 2000, AM J PHYSIOL-CELL PH, V278, pC1191, DOI 10.1152/ajpcell.2000.278.6.C1191; Lu CD, 2002, J BACTERIOL, V184, P3765, DOI 10.1128/JB.184.14.3765-3773.2002; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Nakada Y, 2001, J BACTERIOL, V183, P6517, DOI 10.1128/JB.183.22.6517-6524.2001; Nordenfelt P, 2012, J EXP MED, V209, P2367, DOI 10.1084/jem.20120325; OHMAN DE, 1982, INFECT IMMUN, V37, P662, DOI 10.1128/IAI.37.2.662-669.1982; Palm E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-155; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Piletz JE, 2013, DRUG DISCOV TODAY, V18, P880, DOI 10.1016/j.drudis.2013.05.017; RAASCH W, 1995, LIFE SCI, V56, P2319, DOI 10.1016/0024-3205(95)00226-V; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sud R, 2008, EUR J PHARMACOL, V588, P217, DOI 10.1016/j.ejphar.2008.04.043; VANDERWAUVEN C, 1984, J BACTERIOL, V160, P928, DOI 10.1128/JB.160.3.928-934.1984; Wade CL, 2009, J PHARMACOL EXP THER, V331, P539, DOI 10.1124/jpet.109.155424; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Williams BJ, 2010, MOL MICROBIOL, V76, P104, DOI 10.1111/j.1365-2958.2010.07083.x; Yull FE, 2003, J HISTOCHEM CYTOCHEM, V51, P741, DOI 10.1177/002215540305100605; Zhao SL, 2006, J CHROMATOGR A, V1123, P138, DOI 10.1016/j.chroma.2006.05.038	38	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111441	10.1371/journal.pone.0111441	http://dx.doi.org/10.1371/journal.pone.0111441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350753	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100073
J	Tejada, MA; Stople, K; Bomholtz, SH; Meinild, AK; Poulsen, AN; Klaerke, DA				Tejada, Maria A.; Stople, Kathleen; Bomholtz, Sofia Hammami; Meinild, Anne-Kristine; Poulsen, Asser Nyander; Klaerke, Dan A.			Cell Volume Changes Regulate Slick (Slo2.1), but Not Slack (Slo2.2) K+ Channels	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; ATP RELEASE; EPITHELIAL-CELLS; NA+; TRAFFICKING; INHIBITION; MECHANISM; SURFACE	Slick (Slo2.1) and Slack (Slo2.2) channels belong to the family of high-conductance K+ channels and have been found widely distributed in the CNS. Both channels are activated by Na+ and Cl- and, in addition, Slick channels are regulated by ATP. Therefore, the roles of these channels in regulation of cell excitability as well as ion transport processes, like regulation of cell volume, have been hypothesized. It is the aim of this work to evaluate the sensitivity of Slick and Slack channels to small, fast changes in cell volume and to explore mechanisms, which may explain this type of regulation. For this purpose Slick and Slack channels were co-expressed with aquaporin 1 in Xenopus laevis oocytes and cell volume changes of around 5% were induced by exposure to hypotonic or hypertonic media. Whole-cell currents were measured by two electrode voltage clamp. Our results show that Slick channels are dramatically stimulated (196% of control) by cell swelling and inhibited (57% of control) by a decrease in cell volume. In contrast, Slack channels are totally insensitive to similar cell volume changes. The mechanism underlining the strong volume sensitivity of Slick channels needs to be further explored, however we were able to show that it does not depend on an intact actin cytoskeleton, ATP release or vesicle fusion. In conclusion, Slick channels, in contrast to the similar Slack channels, are the only high-conductance K+ channels strongly sensitive to small changes in cell volume.	[Tejada, Maria A.; Stople, Kathleen; Bomholtz, Sofia Hammami; Poulsen, Asser Nyander; Klaerke, Dan A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Physiol & Biochem IKVH, Copenhagen, Denmark; [Bomholtz, Sofia Hammami; Meinild, Anne-Kristine] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Tejada, MA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Physiol & Biochem IKVH, Copenhagen, Denmark.	tejada@sund.ku.dk		Bomholtz, Sofia Hammami/0000-0001-7221-4532	Danish Medical Research Council [0602-00021B]; Novonordisk Foundation; Lundbeck Foundation (Lucens); Fouger_Hartmann Foundation; Danish National Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novonordisk Foundation(Novo Nordisk Foundation); Lundbeck Foundation (Lucens)(Lundbeckfonden); Fouger_Hartmann Foundation; Danish National Foundation	The work was supported by grants from the Danish Medical Research Council (Grant 0602-00021B), the Novonordisk Foundation, The Lundbeck Foundation (Lucens), The Fouger_Hartmann Foundation and Danish National Foundation for Advanced Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; DRYER SE, 1989, J PHYSIOL-LONDON, V410, P283, DOI 10.1113/jphysiol.1989.sp017533; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; Franco R, 2008, J CELL PHYSIOL, V216, P14, DOI 10.1002/jcp.21406; Grunnet M, 2003, J PHYSIOL-LONDON, V549, P419, DOI 10.1113/jphysiol.2003.038455; Grunnet M, 2002, PFLUG ARCH EUR J PHY, V444, P167, DOI 10.1007/s00424-002-0782-4; Hammami S, 2013, ACTA PHYSIOL, V207, P503, DOI 10.1111/j.1748-1716.2012.02460.x; Hammami S, 2009, J PHYSIOL-LONDON, V587, P2225, DOI 10.1113/jphysiol.2008.163550; Hayashi M, 2012, AM J PHYSIOL-CELL PH, V303, pC151, DOI 10.1152/ajpcell.00089.2012; Hazama A, 1998, PFLUG ARCH EUR J PHY, V437, P31, DOI 10.1007/s004240050742; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Joseph SM, 2003, J BIOL CHEM, V278, P23331, DOI 10.1074/jbc.M302680200; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Lee TH, 1999, MOL BIOL CELL, V10, P1445, DOI 10.1091/mbc.10.5.1445; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Musante L, 1999, J BIOL CHEM, V274, P11701, DOI 10.1074/jbc.274.17.11701; Piron J, 2010, J PHYSIOL-LONDON, V588, P3471, DOI 10.1113/jphysiol.2010.195313; Rizoli SB, 2000, AM J PHYSIOL-CELL PH, V279, pC619, DOI 10.1152/ajpcell.2000.279.3.C619; Santacroce M, 2006, J MICROSC-OXFORD, V223, P57, DOI 10.1111/j.1365-2818.2006.01596.x; Stutzin A, 2006, ACTA PHYSIOL, V187, P27, DOI 10.1111/j.1748-1716.2006.01537.x; Tejada MD, 2012, BIOL-TARGETS THER, V6, P465, DOI 10.2147/BTT.S33827; Tejada MD, 2012, BIOCHEM BIOPH RES CO, V424, P208, DOI 10.1016/j.bbrc.2012.06.038; Vessey JP, 2004, BIOCHEM CELL BIOL, V82, P708, DOI 10.1139/O04-107; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	32	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110833	10.1371/journal.pone.0110833	http://dx.doi.org/10.1371/journal.pone.0110833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347289	Green Submitted, gold, Green Published			2022-12-26	WOS:000347994900031
J	Fernandez-de-las-Penas, C; Palacios-Cena, D; Salom-Moreno, J; Lopez-de-Andres, A; Hernandez-Barrera, V; Jimenez-Trujillo, I; Jimenez-Garcia, R; Gallardo-Pino, C; Garcia-Gomez-de-las-Heras, MS; Carrasco-Garrido, P				Fernandez-de-las-Penas, Cesar; Palacios-Cena, Domingo; Salom-Moreno, Jaime; Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Jimenez-Garcia, Rodrigo; Gallardo-Pino, Carmen; Garcia-Gomez-de-las-Heras, Maria S.; Carrasco-Garrido, Pilar			Has the Prevalence of Migraine Changed over the Last Decade (2003-2012)? A Spanish Population-Based Survey	PLOS ONE			English	Article							NORD-TRONDELAG HEALTH; UNITED-STATES; HEADACHE; EPIDEMIOLOGY; COMORBIDITY; HUNT; DISABILITY; CAUSATION; DIAGNOSIS; BURDEN	Introduction: Information on temporal trends can identify groups of people at risk for any particular condition; however information on temporal trends on migraine headache at population levels is scarce. Our aim was to estimate the time trends in the prevalence of migraine from 2003 to 2012 in Spain. Methods: A population-based national study was conducted. We analyzed data using individualized information taken from national surveys conducted in 2003/4, 2006/7, 2009/10 and 2011/12. A total of 94,158 Spanish adults participated. We considered the presence of self-rated and diagnosed migraine, and we analyzed socio-demographic features, lifestyle habits, self-rated health status, and comorbid diseases using logistic regressions. Results: The prevalence of migraine increased from 6.54% in 2003 to 9.69% in 2012 with significant time trends (adj. OR 1.65; 95% CI 1.50-1.81). The probability of women of suffering migraine was 3 times higher than for men (adj. OR 3.08; 2.82-3.37). There was a declining trend in migraine prevalence as age increased (adj. OR 0.42; 0.35-0.51). Demographic variables associated with migraine were lower educational level (adj. OR 1.32; 1.13-1.54) and not being an immigrant (adj. OR 1.37; 1.15-1.64). A worse self-reported health status was related to higher prevalence of migraine (adj. OR 2.83; 2.59-3.09). The prevalence of migraine also increased as the number of comorbid conditions increased (adj. OR 2.42; 2.05-2.86). Conclusion: The prevalence of migraine has increased in the first decade of the 21st century in Spain. Migraine was associated with being female, mid-age, low educational level, not being an immigrant, worse self-rated health status and presence of comorbid conditions.	[Fernandez-de-las-Penas, Cesar; Salom-Moreno, Jaime] Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Alcorcon, Spain; [Fernandez-de-las-Penas, Cesar; Palacios-Cena, Domingo; Salom-Moreno, Jaime] Univ Rey Juan Carlos, Esthesiol Lab, Alcorcon, Spain; [Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Jimenez-Garcia, Rodrigo; Gallardo-Pino, Carmen; Carrasco-Garrido, Pilar] Univ Rey Juan Carlos, Dept Prevent Med & Publ Hlth, Alcorcon, Spain; [Garcia-Gomez-de-las-Heras, Maria S.] Univ Rey Juan Carlos, Dept Human Histol, Alcorcon, Spain	Universidad Rey Juan Carlos; Universidad Rey Juan Carlos; Universidad Rey Juan Carlos; Universidad Rey Juan Carlos	Fernandez-de-las-Penas, C (corresponding author), Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Alcorcon, Spain.	cesar.fernandez@urjc.es	Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; Jimenez-Trujillo, Isabel/AAP-7746-2021; PALACIOS-CEÑA, DOMINGO/B-6944-2015; Lopez-de-Andres, Ana/AAD-8703-2019	Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Jimenez-Trujillo, Isabel/0000-0002-9394-6799; PALACIOS-CEÑA, DOMINGO/0000-0003-0669-6339; Lopez-de-Andres, Ana/0000-0001-5551-5181; Hernandez-Barrera, Valentin/0000-0001-5790-1959; Fernandez-de-las-Penas, Cesar/0000-0003-3772-9690				Anttila P, 2006, PEDIATRICS, V117, pE1197, DOI 10.1542/peds.2005-2274; Dahlof C, 2001, CEPHALALGIA, V21, P664, DOI 10.1046/j.1468-2982.2001.00218.x; Fernandez-de-las-Penas C, 2010, J HEADACHE PAIN, V11, P97, DOI 10.1007/s10194-009-0176-5; Galanis P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-350; Henry P, 2002, NEUROLOGY, V59, P232, DOI 10.1212/WNL.59.2.232; *INE, 2003, ENC NAC SAL ESP 2003; Instituto Nacional de Estadistica, 2011, ENC NAC SAL 2011; Instituto Nacional de Estadistica, 2009, ENC EUR SAL ESP 2009; Instituto Nacional de Estadistica (INE), 2006, ENC NAC SAL ESP 2006; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Jette N, 2008, HEADACHE, V48, P501, DOI 10.1111/j.1526-4610.2007.00993.x; Jimenez-Sanchez S, 2010, J PAIN, V11, P612, DOI 10.1016/j.jpain.2009.09.015; Lanteri-Minet M, 2011, CEPHALALGIA, V31, P837, DOI 10.1177/0333102411398400; Linde M, 2011, CEPHALALGIA, V31, P585, DOI 10.1177/0333102410391488; Lipton RB, 2002, NEUROLOGY, V58, P885, DOI 10.1212/WNL.58.6.885; LIPTON RB, 1992, ARCH INTERN MED, V152, P1273, DOI 10.1001/archinte.152.6.1273; Lyngberg AC, 2005, EUR J EPIDEMIOL, V20, P243, DOI 10.1007/s10654-004-6519-2; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; Peterlin BL, 2013, NEUROLOGY, V81, P942, DOI 10.1212/WNL.0b013e3182a43ea7; RASMUSSEN BK, 1991, HEADACHE, V31, P290, DOI 10.1111/j.1526-4610.1991.hed3105290.x; Robberstad L, 2010, NEUROLOGY, V75, P712, DOI 10.1212/WNL.0b013e3181eee244; Rozen TD, 1999, NEUROLOGY, V53, P1468, DOI 10.1212/WNL.53.7.1468; Sauro KM, 2009, HEADACHE, V49, P1378, DOI [10.1111/j.1526-4610.2009.01486.x, 10.1111/j.1526-4610.2009.01476.x]; Scher AI, 2005, CURR OPIN NEUROL, V18, P305, DOI 10.1097/01.wco.0000169750.52406.a2; Sjogren P, 2009, EUR J PAIN, V13, P287, DOI 10.1016/j.ejpain.2008.04.007; Stewart WF, 2013, NEUROLOGY, V81, P948, DOI 10.1212/WNL.0b013e3182a43b32; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2010, J HEADACHE PAIN, V30, P1082; Strine TW, 2006, HEADACHE, V46, P223, DOI 10.1111/j.1526-4610.2006.00340.x; Varkey E, 2008, CEPHALALGIA, V28, P1292, DOI 10.1111/j.1468-2982.2008.01678.x; Wang SJ, 2000, CEPHALALGIA, V20, P566, DOI 10.1046/j.1468-2982.2000.00085.x	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110530	10.1371/journal.pone.0110530	http://dx.doi.org/10.1371/journal.pone.0110530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343495	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500035
J	Hassani, M; Kivimaki, M; Elbaz, A; Shipley, M; Singh-Manoux, A; Sabia, S				Hassani, Maliheh; Kivimaki, Mika; Elbaz, Alexis; Shipley, Martin; Singh-Manoux, Archana; Sabia, Severine			Non-Consent to a Wrist-Worn Accelerometer in Older Adults: The Role of Socio-Demographic, Behavioural and Health Factors	PLOS ONE			English	Article							ASSESSED PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; QUESTIONNAIRE; ASSOCIATIONS; VALIDITY; INACTIVITY; COGNITION; WOMEN; SCALE; TIME	Background: Accelerometers, initially waist-worn but increasingly wrist-worn, are used to assess physical activity free from reporting-bias. However, its acceptability by study participants is unclear. Our objective is to assess factors associated with non-consent to a wrist-mounted accelerometer in older adults. Methods: Data are from 4880 Whitehall II study participants (1328 women, age range = 60-83), requested to wear a wrist-worn accelerometer 24 h every day for 9 days in 2012/13. Sociodemographic, behavioral, and health-related factors were assessed by questionnaire and weight, height, blood pressure, cognitive and motor function were measured during a clinical examination. Results: 210 participants had contraindications and 388 (8.3%) of the remaining 4670 participants did not consent. Women, participants reporting less physical activity and less favorable general health were more likely not to consent. Among the clinical measures, cognitive impairment (Odds Ratio = 2.21, 95% confidence interval: 1.22-4.00) and slow walking speed (Odds Ratio = 1.38, 95% confidence interval: 1.02-1.86) were associated with higher odds of non-consent. Conclusions: The rate of non-consent in our study of older adults was low. However, key markers of poor health at older ages were associated with non-consent, suggesting some selection bias in the accelerometer data.	[Hassani, Maliheh; Kivimaki, Mika; Shipley, Martin; Singh-Manoux, Archana; Sabia, Severine] UCL, Dept Epidemiol & Publ Hlth, London, England; [Elbaz, Alexis; Singh-Manoux, Archana] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Elbaz, Alexis; Singh-Manoux, Archana] Univ Paris 11, Villejuif, France; [Singh-Manoux, Archana] Univ Versailles St Quentin, Boulogne, France; [Singh-Manoux, Archana] Hop Ste Perine, AP HP, Ctr Gerontol, Paris, France	University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP	Sabia, S (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	s.sabia@ucl.ac.uk	Sabia, Séverine/G-2966-2017; El-Baz, Ayman/AAC-6689-2019; Elbaz, Alexis/F-8952-2017; Kivimaki, Mika/B-3607-2012; Singh-Manoux, Archana/F-6804-2013	Sabia, Séverine/0000-0003-3109-9720; El-Baz, Ayman/0000-0001-7264-1323; Elbaz, Alexis/0000-0001-9724-5490; Kivimaki, Mika/0000-0002-4699-5627; Singh-Manoux, Archana/0000-0002-1244-5037	US National Institutes of Health [R01AG013196, R01AG034454, R01HL036310]; UK Medical Research Council [K013351]; British Heart Foundation; Economic and Social Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (R01AG013196 to ASM; R01AG034454 to ASM and MK, R01HL036310 to MK) and the UK Medical Research Council (K013351 to MK). MJS is partly supported by the British Heart Foundation. MK is supported by a professorial fellowship from the Economic and Social Research Council. The study sponsor had no role in study design, collection, analysis, and interpretation of data, writing the report, and decision to submit the report for publication.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Barnes DE, 2008, J AM GERIATR SOC, V56, P1658, DOI 10.1111/j.1532-5415.2008.01841.x; Brach JS, 2003, ARCH INTERN MED, V163, P2565, DOI 10.1001/archinte.163.21.2565; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Buchman AS, 2008, AM J GERIAT PSYCHIAT, V16, P697, DOI 10.1097/JGP.0b013e31817945f6; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Ferrari P, 2007, AM J EPIDEMIOL, V166, P832, DOI 10.1093/aje/kwm148; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedson PS, 2013, MED SCI SPORT EXER, V45, P962, DOI 10.1249/MSS.0b013e31827f024d; Friedenreich CM, 2006, AM J EPIDEMIOL, V163, P959, DOI 10.1093/aje/kwj112; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Head J, 2013, PSYCHOL MED, V43, P2649, DOI 10.1017/S0033291713000342; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Jedrziewski AK, 2007, ALZHEIMERS DEMENT, V3, P98, DOI 10.1016/j.jalz.2007.01.009; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kim Y, 2013, PUBLIC HEALTH NUTR, V16, P440, DOI 10.1017/S1368980012002996; King AC, 2010, JAMA-J AM MED ASSOC, V304, P1944, DOI 10.1001/jama.2010.1577; Kozakova M, 2010, EUR HEART J, V31, P1511, DOI 10.1093/eurheartj/ehq092; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2013, GAIT POSTURE, V38, P912, DOI 10.1016/j.gaitpost.2013.04.018; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-81; Loprinzi PD, 2013, J PHYS ACT HEALTH, V10, P79, DOI 10.1123/jpah.10.1.79; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Ottevaere C, 2011, J SCI MED SPORT, V14, P317, DOI 10.1016/j.jsams.2011.02.008; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roth MA, 2013, J PHYS ACT HEALTH, V10, P70, DOI 10.1123/jpah.10.1.70; Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330; Singh-Manoux A, 2011, AGE, V33, P385, DOI 10.1007/s11357-010-9189-x; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vallance JK, 2011, PREV MED, V53, P284, DOI 10.1016/j.ypmed.2011.07.013; Ware J., 1993, SF 36 HLTH SURVEY MA	38	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110816	10.1371/journal.pone.0110816	http://dx.doi.org/10.1371/journal.pone.0110816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343453	Green Published, gold			2022-12-26	WOS:000343943500058
J	Lois, G; Linke, J; Wessa, M				Lois, Giannis; Linke, Julia; Wessa, Michele			Altered Functional Connectivity between Emotional and Cognitive Resting State Networks in Euthymic Bipolar I Disorder Patients	PLOS ONE			English	Article							DEFAULT MODE NETWORK; LARGE-SCALE NETWORKS; PREFRONTAL CORTEX; NEURONAL DYNAMICS; GROUP PICA; AMYGDALA; BRAIN; SCHIZOPHRENIA; ACTIVATION; DEPRESSION	Bipolar disorder is characterized by a functional imbalance between hyperactive ventral/limbic areas and hypoactive dorsal/cognitive brain regions potentially contributing to affective and cognitive symptoms. Resting-state studies in bipolar disorder have identified abnormal functional connectivity between these brain regions. However, most of these studies used a seed-based approach, thus restricting the number of regions that were analyzed. Using data-driven approaches, researchers identified resting state networks whose spatial maps overlap with frontolimbic areas such as the default mode network, the frontoparietal networks, the salient network, and the meso/paralimbic network. These networks are specifically engaged during affective and cognitive tasks and preliminary evidence suggests that functional connectivity within and between some of these networks is impaired in bipolar disorder. The present study used independent component analysis and functional network connectivity approaches to investigate functional connectivity within and between these resting state networks in bipolar disorder. We compared 30 euthymic bipolar I disorder patients and 35 age-and gender-matched healthy controls. Inter-network connectivity analysis revealed increased functional connectivity between the meso/paralimbic and the right frontoparietal network in bipolar disorder. This abnormal connectivity pattern did not correlate with variables related to the clinical course of the disease. The present finding may reflect abnormal integration of affective and cognitive information in ventral-emotional and dorsal-cognitive networks in euthymic bipolar patients. Furthermore, the results provide novel insights into the role of the meso/paralimbic network in bipolar disorder.	[Lois, Giannis; Linke, Julia; Wessa, Michele] Johannes Gutenberg Univ Mainz, Inst Psychol, Dept Clin Psychol & Neuropsychol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Wessa, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Psychol, Dept Clin Psychol & Neuropsychol, D-55122 Mainz, Germany.	wessa@uni-mainz.de	Linke, Julia Olivia/GPF-3605-2022; Linke, Julia/ABD-9110-2020; Wessa, Michele/F-7010-2014	Linke, Julia Olivia/0000-0003-0466-2194; Wessa, Michele/0000-0002-3216-7214	Deutsche Forschungsgemeinschaft [SFB 636/C6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (SFB 636/C6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Anticevic A, 2013, BIOL PSYCHIAT, V73, P565, DOI 10.1016/j.biopsych.2012.07.031; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Chepenik LG, 2010, PSYCHIAT RES-NEUROIM, V182, P207, DOI 10.1016/j.pscychresns.2010.04.002; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Das P, 2014, NEUROIMAGE; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Foland LC, 2008, PSYCHIAT RES-NEUROIM, V162, P27, DOI 10.1016/j.pscychresns.2007.04.007; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Greicius MD, 2003, CURR OPIN NEUROL, V16, P143, DOI 10.1097/00019052-200304000-00004; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Houenou J, 2011, J AFFECT DISORDERS, V132, P344, DOI 10.1016/j.jad.2011.03.016; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Khadka S, 2013, BIOL PSYCHIAT; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Linke J, 2011, BIPOLAR DISORD, V13, P638, DOI 10.1111/j.1399-5618.2011.00956.x; Mamah D, 2013, J AFFECT DISORD; Mann-Wrobel MC, 2011, BIPOLAR DISORD, V13, P334, DOI 10.1111/j.1399-5618.2011.00935.x; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Perlman SB, 2012, BIPOLAR DISORD, V14, P162, DOI 10.1111/j.1399-5618.2012.00999.x; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pompei F, 2011, NEUROIMAGE, V57, P576, DOI 10.1016/j.neuroimage.2011.04.055; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sackeim HA, 2001, J CLIN PSYCHIAT, V62, pS10; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sole B, 2012, CNS NEUROSCI THER, V18, P194, DOI 10.1111/j.1755-5949.2011.00262.x; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Strakowski SM, 2005, AM J PSYCHIAT, V162, P1697, DOI 10.1176/appi.ajp.162.9.1697; Strakowski SM, 2012, BIPOLAR DISORD, V14, P313, DOI 10.1111/j.1399-5618.2012.01022.x; Torrisi S, 2013, BIPOLAR DISORD, V15, P156, DOI 10.1111/bdi.12047; Townsend JD, 2013, BIOL PSYCHIAT, V73, P127, DOI 10.1016/j.biopsych.2012.06.030; Uhlhaas PJ, 2013, CURR OPIN NEUROBIOL, V23, P283, DOI 10.1016/j.conb.2012.11.004; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Vizueta N, 2012, AM J PSYCHIAT, V169, P831, DOI 10.1176/appi.ajp.2012.11030349; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; Wessa M., 2013, RESTOR NEUROL NEUROS; Wessa M, 2009, INT REV PSYCHIATR, V21, P357, DOI 10.1080/09540260902962156; Wright KA, 2008, J ABNORM PSYCHOL, V117, P838, DOI 10.1037/a0013598	58	48	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e107829	10.1371/journal.pone.0107829	http://dx.doi.org/10.1371/journal.pone.0107829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343370	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500003
J	Scholten, AC; Haagsma, JA; Panneman, MJM; van Beeck, EF; Polinder, S				Scholten, Annemieke C.; Haagsma, Juanita A.; Panneman, Martien J. M.; van Beeck, Ed F.; Polinder, Suzanne			Traumatic Brain Injury in the Netherlands: Incidence, Costs and Disability-Adjusted Life Years	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEAD-INJURIES; ECONOMIC BURDEN; HEALTH; WORK; PREVENTION; DISORDERS; MORTALITY; DISEASES; OUTCOMES	Objective: Traumatic brain injury (TBI) is a major cause of death and disability, leading to great personal suffering and huge costs to society. Integrated knowledge on epidemiology, economic consequences and disease burden of TBI is scarce but essential for optimizing healthcare policy and preventing TBI. This study aimed to estimate incidence, cost-of-illness and disability-adjusted life years (DALYs) of TBI in the Netherlands. Methods: This study included data on all TBI patients who were treated at an Emergency Department (ED - National Injury Surveillance System), hospitalized (National Medical Registration), or died due to their injuries in the Netherlands between 2010-2012. Direct healthcare costs and indirect costs were determined using the incidence-based Dutch Burden of Injury Model. Disease burden was assessed by calculating years of life lost (YLL) owing to premature death, years lived with disability (YLD) and DALYs. Incidence, costs and disease burden were stratified by age and gender. Results: TBI incidence was 213.6 per 100,000 person years. Total costs were (sic)314.6 (USD $433.8) million per year and disease burden resulted in 171,200 DALYs (on average 7.1 DALYs per case). Men had highest mean costs per case ((sic)19,540 versus (sic)14,940), driven by indirect costs. 0-24-year-olds had high incidence and disease burden but low economic costs, whereas 25-64-year-olds had relatively low incidence but high economic costs. Patients aged 65+ had highest incidence, leading to considerable direct healthcare costs. 0-24-year-olds, men aged 25-64 years, traffic injury victims (especially bicyclists) and home and leisure injury victims (especially 0-5-year-old and elderly fallers) are identified as risk groups in TBI. Conclusions: The economic and health consequences of TBI are substantial. The integrated approach of assessing incidence, costs and disease burden enables detection of important risk groups in TBI, development of prevention programs that target these risk groups and assessment of the benefits of these programs.	[Scholten, Annemieke C.; Haagsma, Juanita A.; van Beeck, Ed F.; Polinder, Suzanne] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Panneman, Martien J. M.] Consumer & Safety Inst, Res Dept, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Scholten, AC (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	a.scholten@erasmusmc.nl						Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; [Anonymous], 2014, US INFLATION CALCULA; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Consumer and Safety Institute, 2011, FACT SHEET SPORTS IN; Consumer and Safety Institute, 2011, FACT SHEET BIC ACC; Consumer and Safety Institute, 2013, FACT SHEET TRAUM BRA; Consumer and Safety Institute, 2012, FACT SHEET SPORTS IN; Consumer Safety Institute, 2005, DUTCH BURD INJ MOD; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Eurostat, 2014, HICP INFL RAT; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gommer A, 2010, YEARS LIFE LOST MORB; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Haagsma JA, 2012, B WORLD HEALTH ORGAN, V90, P513, DOI 10.2471/BLT.11.095109; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Hoang Hanh T M, 2008, Cost Eff Resour Alloc, V6, P17, DOI 10.1186/1478-7547-6-17; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Meerding WJ, 2010, INT J INJ CONTROL SA, V17, P13, DOI 10.1080/17457300903523237; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mulder S, 2002, INJURY PREV, V8, P74, DOI 10.1136/ip.8.1.74; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Nielen M, 2014, INCIDENCE PREVALENCE; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Oostenbrink JB, 2002, PHARMACOECONOMICS, V20, P443, DOI 10.2165/00019053-200220070-00002; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Polinder S, 2004, SURVEILLANCE BASED A; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; Schulman J, 2002, INJ PREV, V8, P47, DOI 10.1136/ip.8.1.47; Statistics Netherlands (CBS), 2014, POP DAT; Statistics Netherlands (CBS), 2014, MOB NETH; Statistics Netherlands (CBS), 2014, CONS PRIC INFL 1963; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Thurman DJ., 1995, GUIDELINES SURVEILLA; Van der Stegen R, 2009, DISCRIPTION METHODS; World Health Organization, 2004, WORLD REPORT ROAD TR	63	68	68	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110905	10.1371/journal.pone.0110905	http://dx.doi.org/10.1371/journal.pone.0110905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343447	gold, Green Published			2022-12-26	WOS:000343943500064
J	Shridhar, K; Dhillon, PK; Bowen, L; Kinra, S; Bharathi, AV; Prabhakaran, D; Reddy, KS; Ebrahim, S				Shridhar, Krithiga; Dhillon, Preet Kaur; Bowen, Liza; Kinra, Sanjay; Bharathi, Ankalmadugu Venkatsubbareddy; Prabhakaran, Dorairaj; Reddy, Kolli Srinath; Ebrahim, Shah		Indian Migration Study Grp	The Association between a Vegetarian Diet and Cardiovascular Disease (CVD) Risk Factors in India: The Indian Migration Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; ISCHEMIC-HEART-DISEASE; BLOOD-PRESSURE; EPIC-OXFORD; BRITISH VEGETARIANS; RURAL INDIA; MORTALITY; HYPERTENSION; HEALTH; NUTRITION	Background: Studies in the West have shown lower cardiovascular disease (CVD) risk among people taking a vegetarian diet, but these findings may be confounded and only a minority selects these diets. We evaluated the association between vegetarian diets (chosen by 35%) and CVD risk factors across four regions of India. Methods: Study participants included urban migrants, their rural siblings and urban residents, of the Indian Migration Study from Lucknow, Nagpur, Hyderabad and Bangalore (n = 6555, mean age-40.9 yrs). Information on diet (validated interviewer-administered semi-quantitative food frequency questionnaire), tobacco, alcohol, physical history, medical history, as well as blood pressure, fasting blood and anthropometric measurements were collected. Vegetarians ate no eggs, fish, poultry or meat. Using robust standard error multivariate linear regression models, we investigated the association of vegetarian diets with blood cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL), triglycerides, fasting blood glucose (FBG), systolic (SBP) and diastolic blood pressure (DBP). Results: Vegetarians (32.8% of the study population) did not differ from non-vegetarians with respect to age, use of smokeless tobacco, body mass index, and prevalence of diabetes or hypertension. Vegetarians had a higher standard of living and were less likely to smoke, drink alcohol (p<0.0001) and were less physically active (p = 0.04). In multivariate analysis, vegetarians had lower levels of total cholesterol (beta = -0.1 mmol/L (95% CI: -0.03 to -0.2), p = 0.006), triglycerides (beta = -0.05 mmol/L (95% CI: -0.007 to -0.01), p = 0.02), LDL (beta = -0.06 mmol/L (95% CI: -0.005 to -0.1), p = 0.03) and lower DBP (beta = -0.7 mmHg (95% CI: -1.2 to -0.07), p = 0.02). Vegetarians also had decreases in SBP (beta = -0.9 mmHg (95% CI: -1.9 to 0.08), p = 0.07) and FBG level (beta = -0.07 mmol/L (95% CI: -0.2 to 0.01), p = 0.09) when compared to nonvegetarians. Conclusion: We found beneficial association of vegetarian diet with cardiovascular risk factors compared to non-vegetarian diet.	[Shridhar, Krithiga; Dhillon, Preet Kaur; Prabhakaran, Dorairaj] Publ Hlth Fdn India, Ctr Chron Condit & Injuries, New Delhi, India; [Bowen, Liza; Kinra, Sanjay; Ebrahim, Shah] London Sch Hyg & Trop Med, London WC1, England; [Bharathi, Ankalmadugu Venkatsubbareddy] Just Right Obes Clin, Bangalore, Karnataka, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Reddy, Kolli Srinath] Publ Hlth Fdn India, New Delhi, India	Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Shridhar, K (corresponding author), Publ Hlth Fdn India, Ctr Chron Condit & Injuries, New Delhi, India.	g.krithiga@phfi.org	Prabhakaran, Dorairaj/B-4147-2011; Bowen, Liza/AAA-5502-2019	Prabhakaran, Dorairaj/0000-0002-3172-834X; Reddy, K Srinath/0000-0003-3416-3548; Bowen, Liza/0000-0001-8318-8421	Wellcome Trust [GR070797MF]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Wellcome Trust project grant GR070797MF. SE received the funding. Wellcome Trust had no role in the design, data collection, analysis or preparation or publication of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Appleby PN, 2002, PUBLIC HEALTH NUTR, V5, P645, DOI 10.1079/PHN2002332; Arnold F, 2005, NUTR INDIA NATL FAMI; Ashavaid TF, 2005, INDIAN J CLIN BIOCHE, V20, P72, DOI 10.1007/BF02893046; BEILIN LJ, 1988, AM J CLIN NUTR, V48, P806, DOI 10.1093/ajcn/48.3.806; Berkow SE, 2005, NUTR REV, V63, P1, DOI [10.1301/nr.janr.1-8, 10.1111/j.1753-4887.2005.tb00104.x]; Bowen L, 2012, ASIA PAC J CLIN NUTR, V21, P355; Bowen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014822; BURR ML, 1981, J HUM NUTR, V35, P437; Chiplonkar SA, 2004, J AM COLL NUTR, V23, P239, DOI 10.1080/07315724.2004.10719367; Crowe FL, 2013, AM J CLIN NUTR, V97, P597, DOI 10.3945/ajcn.112.044073; Daniel CR, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-12; Das Shyamal Kumar, 2005, Int J Med Sci, V2, P70; Dhillon PK, 2012, INT J EPIDEMIOL, V41, P847, DOI 10.1093/ije/dys046; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Ganguli D, 2011, BRIT J NUTR, V105, P1520, DOI 10.1017/S0007114510005131; Gopalan C., 1971, NUTR VALUE INDIAN FO; Gupta R, 2006, INT J CARDIOL, V108, P291, DOI 10.1016/j.ijcard.2005.05.044; Gupta R, 2012, J EPIDEMIOL COMMUN H, V66, P881, DOI 10.1136/jech-2011-200101; Gupta Rajeev, 2012, J Assoc Physicians India, V60, P11; Gupta R, 2010, INDIAN J MED RES, V132, P531; Huang T, 2012, ANN NUTR METAB, V60, P233, DOI 10.1159/000337301; Jayanthi V, 2001, PERITON DIALYSIS INT, V21, pS322; Jhala C I, 1998, Indian J Clin Biochem, V13, P1, DOI 10.1007/BF02873435; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Juraschek SP, 2012, AM J CLIN NUTR, V95, P1079, DOI 10.3945/ajcn.111.027995; Key TIJ, 2003, AM J CLIN NUTR, V78, p533S, DOI 10.1093/ajcn/78.3.533S; Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Key TJ, 1999, P NUTR SOC, V58, P271, DOI 10.1017/S0029665199000373; Kuriyan R, 1998, INDIAN J MED RES, V107, P37; Marchioni DML, 2007, CAD SAUDE PUBLICA, V23, P2187, DOI 10.1590/S0102-311X2007000900026; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; Millett C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001459; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Parr CL, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-4; Radhika G, 2007, J Assoc Physicians India, V55, P405; Radhika G, 2008, BRIT J NUTR, V99, P398, DOI 10.1017/S0007114507803965; Radhika G, 2011, PUBLIC HEALTH NUTR, V14, P591, DOI 10.1017/S136898001000203X; Rastogi T, 2004, AM J CLIN NUTR, V79, P582; Reddy KS, 2006, B WORLD HEALTH ORGAN, V84, P461, DOI 10.2471/BLT.05.027037; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Sullivan R, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-13; THOROGOOD M, 1987, BMJ-BRIT MED J, V295, P351, DOI 10.1136/bmj.295.6594.351; Tonstad S, 2009, DIABETES CARE, V32, P791, DOI 10.2337/dc08-1886; U.S. Department of Agriculture USDA National Nutrient Database for Standard Reference, 2001, USDA NAT NUTR DAT ST; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; Welch AU., 1995, MCCANCE WIDDOWSONS C; WEST RO, 1968, AM J CLIN NUTR, V21, P853, DOI 10.1093/ajcn/21.8.853; Whitton C, 2011, BRIT J NUTR, V106, P1899, DOI 10.1017/S0007114511002340; Yadav D, 2013, CLIN CHIM ACTA, V426, P145, DOI 10.1016/j.cca.2013.06.004; Zaman MJ, 2012, INT J EPIDEMIOL, V41, P1302, DOI 10.1093/ije/dyr226	57	41	44	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110586	10.1371/journal.pone.0110586	http://dx.doi.org/10.1371/journal.pone.0110586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343719	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000343943500037
J	Lin, LJ; Piao, JJ; Ma, YB; Jin, TF; Quan, CS; Kong, JN; Li, YL; Lin, ZH				Lin, Lijuan; Piao, Junjie; Ma, Yibing; Jin, Tiefeng; Quan, Chengshi; Kong, Jienan; Li, Yulin; Lin, Zhenhua			Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer	PLOS ONE			English	Article							BCL-2 FAMILY; EXPRESSION; P53; ONCOPROTEIN; PROTOONCOGENE; CARCINOMA; CHROMATIN; PROTEIN; CHEMORESISTANCE; TRANSCRIPTION	Our previous study indicated that DEK protein was overexpressed in colorectal carcinoma (CRC) compared with the normal colorectal mucosa. DEK was also significantly correlated with the prognostic characteristics of patients with CRC, demonstrating that DEK played an important role in CRC progression. In this work, we evaluate the effects of DEK on biological behaviors in CRC and explore the related molecular mechanisms. The results showed that DEK was overexpressed in human CRC tissues, and was correlated with the Ki-67 index and the apoptotic index. DEK depletion by RNAi in SW-620 and HCT116 cells significantly decreased cell proliferation, but increased cell apoptosis. Upregulation of DEK was involved in the p53/MDM, Bcl-2 family, and caspase pathways. Our study demonstrates that DEK promotes the growth of CRC, and could be a therapeutic target in CRC.	[Lin, Lijuan; Piao, Junjie; Jin, Tiefeng; Kong, Jienan; Lin, Zhenhua] Yanbian Univ, Dept Pathol, Coll Med, Yanji, Peoples R China; [Lin, Lijuan; Piao, Junjie; Jin, Tiefeng; Kong, Jienan; Lin, Zhenhua] Yanbian Univ, Canc Res Ctr, Coll Med, Yanji, Peoples R China; [Lin, Lijuan] Eastern Liaoning Univ, Dept Med Imaging, Coll Med, Dandong, Peoples R China; [Ma, Yibing] Dandong Ctr Hosp, Dept Pathol, Dandong, Peoples R China; [Quan, Chengshi; Li, Yulin] Jilin Univ, Bethune Med Coll, Key Lab Pathobiol, Minist Educ, Changchun 130023, Peoples R China	Yanbian University; Yanbian University; Liaodong University; Jilin University	Li, YL (corresponding author), Yanbian Univ, Dept Pathol, Coll Med, Yanji, Peoples R China.	ylli@jlu.edu.cn; zhlin720@ybu.edu.cn		Ma, Yibing/0000-0002-9340-8181	National Ministry of Science & Technology of China [2014CB560708]; National Natural Science Funds of China [61371067]; Basic Scientific Research Fund of Jilin University in China [2013-01]	National Ministry of Science & Technology of China; National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Basic Scientific Research Fund of Jilin University in China	This study was supported by the Special Fund of 973 Prophase Research from the National Ministry of Science & Technology of China (2014CB560708), the grants from the National Natural Science Funds of China (61371067), and Basic Scientific Research Fund of Jilin University in China (2013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Borralho PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023787; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Datta A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-234; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Huang LY, 2012, ONCOL REP, V27, P917, DOI 10.3892/or.2011.1598; Jeong KE, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-20; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jin AH, 2014, EXP MOL PATHOL, V96, P54, DOI 10.1016/j.yexmp.2013.11.003; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07; Karam M, 2014, NEOPLASIA, V16, P21, DOI 10.1593/neo.131658; Khan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056020; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Kim DW, 2009, J CELL BIOCHEM, V106, P1048, DOI 10.1002/jcb.22083; Kourennyi DE, 2002, ANN BIOMED ENG, V30, P1196, DOI 10.1114/1.1521415; Kubbutat MHG, 1998, MOL MED TODAY, V4, P250, DOI 10.1016/S1357-4310(98)01260-X; Kurokawa H, 2005, J ORAL PATHOL MED, V34, P602, DOI 10.1111/j.1600-0714.2005.00358.x; Lin LJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-366; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Merkel CA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-316; Ohno K, 2013, INT J MOL SCI, V14, P13129, DOI 10.3390/ijms140713129; Riveiro-Falkenbach E, 2010, CLIN CANCER RES, V16, P2932, DOI 10.1158/1078-0432.CCR-09-2330; Saito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054881; Sammons M, 2006, J BIOL CHEM, V281, P26802, DOI 10.1074/jbc.M600915200; Scovassi AI, 1999, MOL CELL BIOCHEM, V199, P125; Secchiero P, 2010, CLIN CANCER RES, V16, P1824, DOI 10.1158/1078-0432.CCR-09-3031; Shi MD, 2008, CHEM-BIOL INTERACT, V174, P201, DOI 10.1016/j.cbi.2008.06.006; Shibata T, 2010, ONCOGENE, V29, P4671, DOI 10.1038/onc.2010.217; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Vinnedge LMP, 2015, ONCOGENE, V34, P2325, DOI 10.1038/onc.2014.173; Vinnedge LMP, 2013, CELL CYCLE, V12, P51, DOI 10.4161/cc.23121; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Wise-Draper TM, 2009, AM J PATHOL, V174, P71, DOI 10.2353/ajpath.2009.080330; Wu QY, 2008, PATHOL INT, V58, P378, DOI 10.1111/j.1440-1827.2008.02239.x; Xiao CX, 2013, CANCER LETT, V330, P67, DOI 10.1016/j.canlet.2012.11.030; Zheng BB, 2013, BIOL PHARM BULL, V36, P1118, DOI 10.1248/bpb.b13-00058	45	20	21	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111260	10.1371/journal.pone.0111260	http://dx.doi.org/10.1371/journal.pone.0111260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340858	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800099
J	Picoche, C; Le Gendre, R; Flye-Sainte-Marie, J; Francoise, S; Maheux, F; Simon, B; Gangnery, A				Picoche, Coralie; Le Gendre, Romain; Flye-Sainte-Marie, Jonathan; Francoise, Sylvaine; Maheux, Frank; Simon, Benjamin; Gangnery, Aline			Towards the Determination of Mytilus edulis Food Preferences Using the Dynamic Energy Budget (DEB) Theory	PLOS ONE			English	Article							ENGLISH-CHANNEL; SPATIOTEMPORAL VARIABILITY; PHYTOPLANKTON COMPOSITION; REPRODUCTIVE OUTPUT; SEASONAL-VARIATION; MUSSEL; GROWTH; L.; FLOW; PARAMETERS	The blue mussel, Mytilus edulis, is a commercially important species, with production based on both fisheries and aquaculture. Dynamic Energy Budget (DEB) models have been extensively applied to study its energetics but such applications require a deep understanding of its nutrition, from filtration to assimilation. Being filter feeders, mussels show multiple responses to temporal fluctuations in their food and environment, raising questions that can be investigated by modeling. To provide a better insight into mussel-environment interactions, an experiment was conducted in one of the main French growing zones (Utah Beach, Normandy). Mussel growth was monitored monthly for 18 months, with a large number of environmental descriptors measured in parallel. Food proxies such as chlorophyll a, particulate organic carbon and phytoplankton were also sampled, in addition to non-nutritious particles. High-frequency physical data recording (e. g., water temperature, immersion duration) completed the habitat description. Measures revealed an increase in dry flesh mass during the first year, followed by a high mass loss, which could not be completely explained by the DEB model using raw external signals. We propose two methods that reconstruct food from shell length and dry flesh mass variations. The former depends on the inversion of the growth equation while the latter is based on iterative simulations. Assemblages of food proxies are then related to reconstructed food input, with a special focus on plankton species. A characteristic contribution is attributed to these sources to estimate nutritional values for mussels. M. edulis shows no preference between most plankton life history traits. Selection is based on the size of the ingested particles, which is modified by the volume and social behavior of plankton species. This finding reveals the importance of diet diversity and both passive and active selections, and confirms the need to adjust DEB models to different populations and sites.	[Picoche, Coralie; Le Gendre, Romain; Francoise, Sylvaine; Maheux, Frank; Simon, Benjamin; Gangnery, Aline] IFREMER, Lab Environm Ressources Normandie, Port En Bessin, France; [Flye-Sainte-Marie, Jonathan] Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environnement Marin LEMAR, UMR 6539,CNRS,UBO,IRD,IFREMER, Plouzane, France	Ifremer; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Picoche, C (corresponding author), IFREMER, Lab Environm Ressources Normandie, Port En Bessin, France.	cpicoche@gmail.com		Le Gendre, Romain/0000-0001-7015-8290; Flye-Sainte-Marie, Jonathan/0000-0002-6462-0677	BlueDEB project; OGIVE project; French Norwegian Foundation; Basse Normandie region; Hordaland County Council; European Fund for Fisheries; Seine-Normandie Water Agency; departments of Manche and Calvados	BlueDEB project; OGIVE project; French Norwegian Foundation; Basse Normandie region(Region Normandie); Hordaland County Council; European Fund for Fisheries; Seine-Normandie Water Agency; departments of Manche and Calvados	This work was achieved with the financial fundings of BlueDEB and OGIVE projects. BlueDEB was supported by the French Norwegian Foundation, Basse Normandie region and Hordaland County Council. OGIVE is supported by the European Fund for Fisheries, Seine-Normandie Water Agency, Basse Normandie region and the departments of Manche and Calvados. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminot A., 2007, DOSAGE AUTOMATIQUE N; Aminot A., 2004, HYDROLOGIE ECOSYSTEM; [Anonymous], 2012, ISRN ZOOL, DOI DOI 10.5402/2012/902152; BAYNE BL, 1980, MAR ECOL PROG SER, V3, P317, DOI 10.3354/meps003317; BAYNE BL, 1973, J MAR BIOL ASSOC UK, V53, P39, DOI 10.1017/S0025315400056629; Beadman HA, 2002, HELGOLAND MAR RES, V56, P76, DOI 10.1007/s10152-001-0092-9; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Bougrier S, 1997, AQUACULTURE, V150, P123, DOI 10.1016/S0044-8486(96)01457-3; Bourles Y, 2009, J SEA RES, V62, P62, DOI 10.1016/j.seares.2009.03.002; Bracken MES, 2012, MAR ECOL PROG SER, V459, P53, DOI 10.3354/meps09764; BRAND LE, 1984, ESTUAR COAST SHELF S, V18, P543, DOI 10.1016/0272-7714(84)90089-1; Cardoso Joana F. M. E., 2007, Senckenbergiana Maritima, V37, P83; Cardoso JFMF, 2006, J SEA RES, V56, P182, DOI 10.1016/j.seares.2006.03.011; Dabrowski T, 2013, J SEA RES, V76, P5, DOI 10.1016/j.seares.2012.10.012; DARE PJ, 1975, J EXP MAR BIOL ECOL, V18, P89, DOI 10.1016/0022-0981(75)90066-0; De Zwaan A., 1972, Comparative Biochem Physiol (A), V43, P53, DOI 10.1016/0300-9629(72)90468-9; Doherty SD, 2009, J EXP MAR BIOL ECOL, V378, P1, DOI 10.1016/j.jembe.2009.04.022; Duarte P, 2012, J SEA RES, V67, P44, DOI 10.1016/j.seares.2011.09.002; Dueri S, 2012, ECOL MODEL, V245, P55, DOI 10.1016/j.ecolmodel.2012.02.008; Faugeras B, 2003, J MARINE SYST, V40, P99, DOI 10.1016/S0924-7963(03)00015-0; Fearman JA, 2009, J SHELLFISH RES, V28, P305, DOI 10.2983/035.028.0212; Fennel K, 2001, J MARINE SYST, V28, P45, DOI 10.1016/S0924-7963(00)00083-X; Flye Sainte Marie J, 2009, AQUACULTURE EUROPE; Freitas V, 2009, J SEA RES, V62, P75, DOI 10.1016/j.seares.2009.07.004; Garen P, 2004, AQUACULTURE, V232, P511, DOI 10.1016/S0044-8486(03)00535-0; Gillikin DP, 2006, ORG GEOCHEM, V37, P1371, DOI 10.1016/j.orggeochem.2006.03.008; Grangere K, 2009, J SEA RES, V62, P147, DOI 10.1016/j.seares.2009.02.002; Guilloux L, 2013, CAH BIOL MAR, V54, P247; Hagger JA, 2010, ECOTOXICOLOGY, V19, P953, DOI 10.1007/s10646-010-0477-0; Handa A, 2011, J SEA RES, V66, P297, DOI 10.1016/j.seares.2011.05.005; HILBISH TJ, 1986, J EXP MAR BIOL ECOL, V96, P103, DOI 10.1016/0022-0981(86)90236-4; Horner R.A, 2002, TAXONOMIC GUIDE SOME; Hui JA, 1996, J BIOGEOGR, V23, P129; Jouenne F, 2005, ESTUAR COAST SHELF S, V65, P421, DOI 10.1016/j.ecss.2005.05.023; Jouenne F, 2007, MAR BIOL, V151, P805, DOI 10.1007/s00227-006-0440-z; KAUTSKY N, 1982, MAR BIOL, V68, P143, DOI 10.1007/BF00397601; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Lauringson V, 2014, MAR ECOL-EVOL PERSP, V35, P56, DOI 10.1111/maec.12120; Leblanc K, 2012, EARTH SYST SCI DATA, V4, P149, DOI 10.5194/essd-4-149-2012; Lefebvre S, 2009, MAR ECOL PROG SER, V390, P27, DOI 10.3354/meps08187; Lehane C, 2006, ESTUAR COAST SHELF S, V67, P645, DOI 10.1016/j.ecss.2005.12.015; Leonardos N, 2000, AQUACULTURE, V182, P301, DOI 10.1016/S0044-8486(99)00269-0; Li W, 2009, OR INSIGHT, V46, P44; Maloy AP, 2013, MAR BIOL, V160, P479, DOI 10.1007/s00227-012-2105-4; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Marshall HG, 2006, ESTUAR COAST SHELF S, V69, P10, DOI 10.1016/j.ecss.2006.03.019; Marshall HG, 2004, CASTANEA, V69, P272, DOI 10.2179/0008-7475(2004)069<0272:PCWTTF>2.0.CO;2; Masquelier S, 2011, J SEA RES, V66, P111, DOI 10.1016/j.seares.2011.05.004; NEWELL RIE, 1982, BIOL BULL, V162, P299, DOI 10.2307/1540985; PALMER AR, 1981, NATURE, V292, P150, DOI 10.1038/292150a0; Pernet F, 2012, J SEA RES, V68, P20, DOI 10.1016/j.seares.2011.11.004; Pronker AE, 2008, AQUACULT INT, V16, P297, DOI 10.1007/s10499-007-9143-9; RIISGARD H. U., 2011, J MAR BIOL, DOI [DOI 10.1155/2011/312459, 10.1155/2011/312459]; RODHOUSE PG, 1984, J MAR BIOL ASSOC UK, V64, P513, DOI 10.1017/S0025315400030204; Rosland R, 2009, J SEA RES, V62, P49, DOI 10.1016/j.seares.2009.02.007; Rouillon G, 2005, J SHELLFISH RES, V24, P5; Saraiva S, 2012, MAR ECOL PROG SER, V463, P141, DOI 10.3354/meps09801; Saraiva S, 2011, J SEA RES, V66, P289, DOI 10.1016/j.seares.2011.06.002; Saurel C, 2007, LIMNOL OCEANOGR, V52, P1919, DOI 10.4319/lo.2007.52.5.1919; Smaal AC, 1997, MAR ECOL PROG SER, V153, P167, DOI 10.3354/meps153167; Smaal AC, 1997, J EXP MAR BIOL ECOL, V209, P33, DOI 10.1016/S0022-0981(96)02695-0; SPRUNG M, 1983, HELGOLANDER MEERESUN, V36, P243, DOI 10.1007/BF01983629; Strohmeier T, 2012, J EXP MAR BIOL ECOL, V412, P96, DOI 10.1016/j.jembe.2011.11.006; STROMGREN T, 1984, J EXP MAR BIOL ECOL, V76, P23, DOI 10.1016/0022-0981(84)90014-5; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; TANAKA N, 1986, NATURE, V320, P520, DOI 10.1038/320520a0; THACKER WC, 1989, J GEOPHYS RES-OCEANS, V94, P6177, DOI 10.1029/JC094iC05p06177; Thomas Y, 2011, J SEA RES, V66, P308, DOI 10.1016/j.seares.2011.04.015; Thorarinsdottir GG, 2003, POLAR RES, V22, P217, DOI 10.1111/j.1751-8369.2003.tb00108.x; Toro JE, 2002, MAR BIOL, V141, P897, DOI 10.1007/s00227-002-0897-3; Toupoint N, 2012, BIOFOULING, V28, P985, DOI 10.1080/08927014.2012.725202; Toupoint N, 2012, ECOLOGY, V93, P1922, DOI 10.1890/11-1292.1; Troost TA, 2010, PHILOS T R SOC B, V365, P3567, DOI 10.1098/rstb.2010.0074; Trottet A, 2008, J EXP MAR BIOL ECOL, V365, P103, DOI 10.1016/j.jembe.2008.08.001; Ubertini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044155; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; van der Veer HW, 2006, J SEA RES, V56, P107, DOI 10.1016/j.seares.2006.03.005; VAULOT D, 1989, CYTOMETRY, V10, P629, DOI 10.1002/cyto.990100519; WIDDOWS J, 1979, MAR BIOL, V50, P195, DOI 10.1007/BF00394201	79	17	18	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109796	10.1371/journal.pone.0109796	http://dx.doi.org/10.1371/journal.pone.0109796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340793	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800018
J	Rutebemberwa, A; Stevens, MJ; Perez, MJ; Smith, LP; Sanders, L; Cosgrove, G; Robertson, CE; Tuder, RM; Harris, JK				Rutebemberwa, Alleluiah; Stevens, Mark J.; Perez, Mario J.; Smith, Lynelle P.; Sanders, Linda; Cosgrove, Gregory; Robertson, Charles E.; Tuder, Rubin M.; Harris, J. Kirk			Novosphingobium and Its Potential Role in Chronic Obstructive Pulmonary Diseases: Insights from Microbiome Studies	PLOS ONE			English	Article							ACUTE EXACERBATIONS; CYSTIC-FIBROSIS; SPHINGOMONAS-PAUCIMOBILIS; AIRWAY MICROBIOTA; BARCODED PRIMERS; EMPHYSEMA; LUNG; MICE; INFLAMMATION; COPD	Bacterial infection of lung airways underlies some of the main complications of COPD, significantly impacting disease progression and outcome. Colonization by bacteria may further synergize, amplify, or trigger pathways of tissue damage started by cigarette smoke, contributing to the characteristic airway inflammation and alveolar destruction of COPD. We sought to elucidate the presence and types of lung bacterial populations in different stages of COPD, aimed at revealing important insights into the pathobiology of the disease. Sequencing of the bacterial small subunit ribosomal RNA gene in 55 well-characterized clinical lung samples, revealed the presence of Novosphingobium spp. (>2% abundance) in lungs of patients with GOLD 3-GOLD 4 COPD, cystic fibrosis and a subset of control individuals. Novosphingobium-specific quantitative PCR was concordant with the sequence data and high levels of Novosphingobium spp. were quantifiable in advanced COPD, but not from other disease stages. Using a mouse model of subacute lung injury due to inhalation of cigarette smoke, bronchoalveolar lavage neutrophil and macrophage counts were significantly higher in mice challenged intratracheally with N. panipatense compared to control mice (p<0.01). Frequencies of neutrophils and macrophages in lung tissue were increased in mice challenged with N. panipatense at room air compared to controls. However, we did not observe an interaction between N. panipatense and subacute cigarette smoke exposure in the mouse. In conclusion, Novosphingobium spp. are present in more severe COPD disease, and increase inflammation in a mouse model of smoke exposure.	[Rutebemberwa, Alleluiah; Perez, Mario J.; Smith, Lynelle P.; Sanders, Linda; Tuder, Rubin M.] Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Stevens, Mark J.; Harris, J. Kirk] Univ Colorado, Sch Med, Dept Pediat,Childrens Hosp Colorado, Mucosal & Vaccine Res Colorado,Microbiome Res Col, Aurora, CO USA; [Cosgrove, Gregory] Natl Jewish Hlth, Dept Med, Aurora, CO USA; [Cosgrove, Gregory] Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Tuder, RM (corresponding author), Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm Sci & Crit Care Med, Anschutz Med Campus, Aurora, CO 80045 USA.	Rubin.Tuder@ucdenver.edu; Jonathan.Harris@ucdenver.edu		Harris, Jonathan/0000-0002-2378-4202; ROBERTSON, CHARLES/0000-0002-4136-4121	NIH [R21 HL110721, R03 HL 097009, R01 ES016285]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL097009, R21HL110721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016285] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work included in this manuscript was financially supported through the following NIH grants: R21 HL110721 and R03 HL 097009 (to RMT and JKH) and R01 ES016285 (to RMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL P, 1995, CHEST, V108, pS43, DOI 10.1378/chest.108.2_Supplement.43S; BAUGHMAN RP, 1987, CHEST, V91, P233, DOI 10.1378/chest.91.2.233; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harris JK, 2010, APPL ENVIRON MICROB, V76, P3863, DOI 10.1128/AEM.02585-09; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Kaplan MM, 2004, AM J GASTROENTEROL, V99, P2147, DOI 10.1111/j.1572-0241.2004.41121.x; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; Lemaitre D, 1996, J HOSP INFECT, V32, P199, DOI 10.1016/S0195-6701(96)90146-2; MacIntyre Neil, 2008, Proc Am Thorac Soc, V5, P530, DOI 10.1513/pats.200707-088ET; Mannino David M, 2006, Int J Chron Obstruct Pulmon Dis, V1, P219; Martinez Fernando J, 2007, Proc Am Thorac Soc, V4, P647, DOI 10.1513/pats.200707-097TH; Mattner J, 2008, CELL HOST MICROBE, V3, P304, DOI 10.1016/j.chom.2008.03.009; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; National Heart Lung and Blood Institute, 2000, COPD ARE YOU RISK; Patrone JB, 2006, J IMMUNOL, V177, P1314, DOI 10.4049/jimmunol.177.2.1314; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Robertson CE, 2013, BIOINFORMATICS; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Ryan MP, 2010, J HOSP INFECT, V75, P153, DOI 10.1016/j.jhin.2010.03.007; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Sethi S, 2000, CHEST, V117, p286S, DOI 10.1378/chest.117.5_suppl_1.286S; Shi T, 2001, J IND MICROBIOL BIOT, V26, P283, DOI 10.1038/sj.jim.7000130; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Veeramachaneni Sateesh B, 2006, COPD, V3, P109; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2	55	14	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111150	10.1371/journal.pone.0111150	http://dx.doi.org/10.1371/journal.pone.0111150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340840	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800089
J	Smart, HC; Mast, FD; Chilije, MFJ; Tavassoli, M; Dacks, JB; Zaremberg, V				Smart, Heather C.; Mast, Fred D.; Chilije, Maxwell F. J.; Tavassoli, Marjan; Dacks, Joel B.; Zaremberg, Vanina			Phylogenetic Analysis of Glycerol 3-Phosphate Acyltransferases in Opisthokonts Reveals Unexpected Ancestral Complexity and Novel Modern Biosynthetic Components	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PHOSPHATIDIC-ACID; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASES; DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; MAXIMUM-LIKELIHOOD; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; INITIAL STEP; IDENTIFICATION	Glycerolipid synthesis represents a central metabolic process of all forms of life. In the last decade multiple genes coding for enzymes responsible for the first step of the pathway, catalyzed by glycerol 3-phosphate acyltransferase (GPAT), have been described, and characterized primarily in model organisms like Saccharomyces cerevisiae and mice. Notoriously, the fungal enzymes share low sequence identity with their known animal counterparts, and the nature of their homology is unclear. Furthermore, two mitochondrial GPAT isoforms have been described in animal cells, while no such enzymes have been identified in Fungi. In order to determine if the yeast and mammalian GPATs are representative of the set of enzymes present in their respective groups, and to test the hypothesis that metazoan orthologues are indeed absent from the fungal clade, a comparative genomic and phylogenetic analysis was performed including organisms spanning the breadth of the Opisthokonta supergroup. Surprisingly, our study unveiled the presence of 'fungal' orthologs in the basal taxa of the holozoa and 'animal' orthologues in the basal holomycetes. This includes a novel clade of fungal homologues, with putative peroxisomal targeting signals, of the mitochondrial/peroxisomal acyltransferases in Metazoa, thus potentially representing an undescribed metabolic capacity in the Fungi. The overall distribution of GPAT homologues is suggestive of high relative complexity in the ancestors of the opisthokont clade, followed by loss and sculpting of the complement in the descendent lineages. Divergence from a general versatile metabolic model, present in ancestrally deduced GPAT complements, points to distinctive contributions of each GPAT isoform to lipid metabolism and homeostasis in contemporary organisms like humans and their fungal pathogens.	[Smart, Heather C.; Chilije, Maxwell F. J.; Tavassoli, Marjan; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Mast, Fred D.; Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	University of Calgary; University of Alberta	Dacks, JB (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.	dacks@ualberta.ca; vzarembe@ucalgary.ca	Mast, Fred/AAM-2426-2021; Mast, Fred/A-6507-2011; Dacks, Joel/AAE-3308-2021	Mast, Fred/0000-0002-2177-6647; Mast, Fred/0000-0002-2177-6647; Dacks, Joel/0000-0003-4520-5694	National Sciences and Engineering Research Council (NSERC); New Faculty Award from Alberta Innovates Technology Futures	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Faculty Award from Alberta Innovates Technology Futures	This work was supported by operating grants from the National Sciences and Engineering Research Council (NSERC) to JBD and VZ. Work in the Dacks lab is also funded by a New Faculty Award from Alberta Innovates Technology Futures. JBD is the Canada Research Chair in Evolutionary Cell Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Bertolesi GE, 2012, GENE EXPR PATTERNS, V12, P219, DOI 10.1016/j.gep.2012.04.002; Bratschi MW, 2009, EUKARYOT CELL, V8, P1184, DOI 10.1128/EC.00085-09; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Coleman RA, 2007, CELL METAB, V5, P87, DOI 10.1016/j.cmet.2007.01.004; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Daum G, 2011, BIOCH BIOPHYS ACTA M, V1811, P1165, DOI [10.1016/j.bbalip.2011.07.015, DOI 10.1016/J.BBALIP.2011.07.015]; De Smet CH, 2012, MOL BIOL CELL, V23, P1146, DOI 10.1091/mbc.E11-07-0624; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fairn GD, 2008, SCIENCE, V320, P458, DOI 10.1126/science.1158173; Fares MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003176; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kuruma Y, 2009, BBA-BIOMEMBRANES, V1788, P567, DOI 10.1016/j.bbamem.2008.10.017; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; LIGHTNER VA, 1983, J BIOL CHEM, V258, P856; Liu DL, 2005, J LIPID RES, V46, P727, DOI 10.1194/jlr.M400364-JLR200; Luisi PL, 2011, NAT CHEM, V3, P755, DOI 10.1038/nchem.1156; Maddison WP, 2011, MESQUITE MODULAR SYS; Marr N, 2012, J BIOL CHEM, V287, P10251, DOI 10.1074/jbc.M111.314112; Mast FD, 2012, MOL BIOL EVOL, V29, P975, DOI 10.1093/molbev/msr264; MINSKOFF SA, 1994, J LIPID RES, V35, P2254; Mohanty A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00268; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; OFMAN R, 1994, BBA-PROTEIN STRUCT M, V1206, P27, DOI 10.1016/0167-4838(94)90068-X; Ohba Y, 2013, EMBO J, V32, P1265, DOI 10.1038/emboj.2013.77; Patil VA, 2013, ADV EXP MED BIOL, V991, P195, DOI 10.1007/978-94-007-6331-9_11; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Santiago TC, 2004, J BIOL CHEM, V279, P9222, DOI 10.1074/jbc.M310502200; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Shiromoto Y, 2013, RNA, V19, P803, DOI 10.1261/rna.038521.113; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	52	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110684	10.1371/journal.pone.0110684	http://dx.doi.org/10.1371/journal.pone.0110684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340523	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800048
J	Rosado-Lugo, JD; Hampsey, M				Rosado-Lugo, Jesus D.; Hampsey, Michael			The Ssu72 Phosphatase Mediates the RNA Polymerase II Initiation-Elongation Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phosphatase; RNA Polymerase II; Transcription; Transcription Initiation Factor; Transcription Regulation; Transcription Termination	C-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE GENOME; MESSENGER-RNA; TRANSCRIPTION TERMINATION; CTD PHOSPHATASE; ACTIVE-SITE; KINASE; PHOSPHORYLATION; YEAST; COMPLEX	Background: Ssu72 is a RNAPII CTD phosphatase; its function in the transcription cycle has not been established. Results: Ssu72 dephosphorylates Ser(P)(5) at the initiation-elongation transition and regulates Ser(2) phosphorylation status. Conclusion: Ssu72 functions at multiple stages of the RNAPII transcription cycle. Significance: Our results correct two previous misconceptions: (i) that Rtr1 is a Ser(P)(5) phosphatase and (ii) that Ssu72 dephosphorylates Ser(P)(5) only during transcription termination. Transitions between the different stages of the RNAPII transcription cycle involve the recruitment and exchange of factors, including mRNA capping enzymes, elongation factors, splicing factors, 3-end-processing complexes, and termination factors. These transitions are coordinated by the dynamic phosphorylation of the C-terminal domain (CTD) of the largest subunit of RNAPII (Rpb1). The CTD is composed of reiterated heptapeptide repeats ((YSPTSPS7)-S-1-P-2-T-3-S-4-P-5-S-6) that undergo phosphorylation and dephosphorylation as RNAPII transitions through the transcription cycle. An essential phosphatase in this process is Ssu72, which exhibits catalytic specificity for Ser(P)(5) and Ser(P)(7). Ssu72 is unique in that it is specific for Ser(P)(5) in one orientation of the CTD and for Ser(P)(7) when bound in the opposite orientation. Moreover, Ssu72 interacts with components of the initiation machinery and affects start site selection yet is an integral component of the CPF 3-end-processing complex. Here we provide a comprehensive view of the effects of Ssu72 with respect to its Ser(P)(5) phosphatase activity. We demonstrate that Ssu72 dephosphorylates Ser(P)(5) at the initiation-elongation transition. Furthermore, Ssu72 indirectly affects the levels of Ser(P)(2) during the elongation stage of transcription but does so independent of its catalytic activity.	[Rosado-Lugo, Jesus D.; Hampsey, Michael] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Hampsey, M (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 683 Hoes Lane W, Piscataway, NJ 08854 USA.	michael.hampsey@rutgers.edu			National Institutes of Health [R01 GM39484, R01 GM068887]; National Institutes of Health Bridge to Doctoral Degree Program [GM58389]; National Institutes of Health IMSD Award-UMDNJ/Rutgers University Pipeline Program [GM55145]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068887, R01GM039484, R25GM058389, R25GM055145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Bridge to Doctoral Degree Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health IMSD Award-UMDNJ/Rutgers University Pipeline Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM39484 (to M. H.) and R01 GM068887 (to Claire Moore and M. H.).; Supported by the National Institutes of Health Bridge to Doctoral Degree Program (Grant GM58389), by the National Institutes of Health IMSD Award-UMDNJ/Rutgers University Pipeline Program (Grant GM55145), and by a National Institutes of Health Grant R01 GM39484 supplement.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho EJ, 1998, GENE DEV, V12, P3482, DOI 10.1101/gad.12.22.3482; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Costanzo M., SCIENCE, V327, P425; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Ganem C, 2006, MOL GENET GENOMICS, V275, P136, DOI 10.1007/s00438-005-0071-y; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Hanes SD, 2014, BBA-GENE REGUL MECH, V1839, P316, DOI 10.1016/j.bbagrm.2014.02.001; Hausmann S, 2005, J BIOL CHEM, V280, P37681, DOI 10.1074/jbc.M505292200; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Hintermair C, 2012, EMBO J, V31, P2784, DOI 10.1038/emboj.2012.123; Hong SW, 2009, P NATL ACAD SCI USA, V106, P14276, DOI 10.1073/pnas.0903642106; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Hsu PL, 2014, J MOL BIOL, V426, P2970, DOI 10.1016/j.jmb.2014.06.010; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Pappas DL, 2000, MOL CELL BIOL, V20, P8343, DOI 10.1128/MCB.20.22.8343-8351.2000; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Reyes-Reyes M, 2007, MOL CELL BIOL, V27, P926, DOI 10.1128/MCB.01361-06; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; Schwer B, 2014, P NATL ACAD SCI USA, V111, P4185, DOI 10.1073/pnas.1321842111; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Suh MH, 2005, P NATL ACAD SCI USA, V102, P17314, DOI 10.1073/pnas.0507987102; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xiang KH, 2012, GENE DEV, V26, P2265, DOI 10.1101/gad.198853.112; Xiang KH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1947; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	52	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33916	33926		10.1074/jbc.M114.608695	http://dx.doi.org/10.1074/jbc.M114.608695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25339178	hybrid, Green Published			2022-12-26	WOS:000346077600021
J	Nagai, H; Kuwahira, I; Schwenke, DO; Tsuchimochi, H; Nara, A; Inagaki, T; Ogura, S; Fujii, Y; Umetani, K; Shimosawa, T; Yoshida, KI; Pearson, JT; Uemura, K; Shirai, M				Nagai, Hisashi; Kuwahira, Ichiro; Schwenke, Daryl O.; Tsuchimochi, Hirotsugu; Nara, Akina; Inagaki, Tadakatsu; Ogura, Sayoko; Fujii, Yutaka; Umetani, Keiji; Shimosawa, Tatsuo; Yoshida, Ken-ichi; Pearson, James T.; Uemura, Koichi; Shirai, Mikiyasu			beta(2)-Adrenergic Receptor-Dependent Attenuation of Hypoxic Pulmonary Vasoconstriction Prevents Progression of Pulmonary Arterial Hypertension in Intermittent Hypoxic Rats	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SYNCHROTRON-RADIATION MICROANGIOGRAPHY; BETA-ADRENOCEPTOR AGONISTS; BLOOD-FLOW DISTRIBUTION; SYMPATHETIC ACTIVITY; NITRIC-OXIDE; PRESSURE; MICE; CIRCULATION; ENDOTHELIN-1	In sleep apnea syndrome (SAS), intermittent hypoxia (IH) induces repeated episodes of hypoxic pulmonary vasoconstriction (HPV) during sleep, which presumably contribute to pulmonary arterial hypertension (PAH). However, the prevalence of PAH was low and severity is mostly mild in SAS patients, and mild or no right ventricular hypertrophy (RVH) was reported in IH-exposed animals. The question then arises as to why PAH is not a universal finding in SAS if repeated hypoxia of sufficient duration causes cycling HPV. In the present study, rats underwent IH at a rate of 3 min cycles of 4-21% O-2 for 8 h/d for 6w. Assessment of diameter changes in small pulmonary arteries in response to acute hypoxia and drugs were performed using synchrotron radiation microangiography on anesthetized rats. In IH-rats, neither PAH nor RVH was observed and HPV was strongly reversed. Nadolol (a hydrophilic beta(1,2)-blocker) augmented the attenuated HPV to almost the same level as that in N-rats, but atenolol (a hydrophilic beta(1)-blocker) had no effect on the HPV in IH. These beta-blockers had almost no effect on the HPV in N-rats. Chronic administration of nadolol during 6 weeks of IH exposure induced PAH and RVH in IH-rats, but did not in N-rats. Meanwhile, atenolol had no effect on morphometric and hemodynamic changes in N and IH-rats. Protein expression of the beta(1)-adrenergic receptor (AR) was down-regulated while that of beta(2)AR was preserved in pulmonary arteries of IH-rats. Phosphorylation of p85 (chief component of phosphoinositide 3-kinase (PI3K)), protein kinase B (Akt), and endothelial nitric oxide synthase (eNOS) were abrogated by chronic administration of nadolol in the lung tissue of IH-rats. We conclude that IH-derived activation of beta(2)AR in the pulmonary arteries attenuates the HPV, thereby preventing progression of IH-induced PAH. This protective effect may depend on the beta(2)AR-Gi mediated PI3K/Akt/eNOS signaling pathway.	[Nagai, Hisashi; Uemura, Koichi] Tokyo Med & Dent Univ, Dept Forens Med, Tokyo, Japan; [Nagai, Hisashi; Nara, Akina; Ogura, Sayoko; Yoshida, Ken-ichi] Univ Tokyo, Dept Forens Med, Tokyo, Japan; [Kuwahira, Ichiro] Tokai Univ, Tokyo Hosp, Dept Pulm Med, Tokyo, Japan; [Schwenke, Daryl O.] Univ Otago, Dept Physiol Heart Otago, Dunedin, New Zealand; [Tsuchimochi, Hirotsugu; Inagaki, Tadakatsu; Fujii, Yutaka; Shirai, Mikiyasu] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cardiac Physiol, Osaka, Japan; [Ogura, Sayoko] Nihon Univ, Fac Med, Sch Med, Dept Pathol & Microbiol,Div Lab Med, Tokyo, Japan; [Umetani, Keiji] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan; [Shimosawa, Tatsuo] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Yoshida, Ken-ichi] Tokyo Med Univ, Dept Forens Med, Tokyo 1608402, Japan; [Pearson, James T.] Monash Univ, Monash Biomed Imaging Facil, Clayton, Vic, Australia; [Pearson, James T.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Pearson, James T.] Australian Synchrotron, Clayton, Vic, Australia	Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokai University; University of Otago; National Cerebral & Cardiovascular Center - Japan; Nihon University; Japan Synchrotron Radiation Research Institute; University of Tokyo; Tokyo Medical University; Monash University; Monash University	Nagai, H (corresponding author), Tokyo Med & Dent Univ, Dept Forens Med, Tokyo, Japan.	nagai@legalmed.jp	Pearson, James T/B-4631-2012; Tsuchimochi, Hirotsugu/D-8224-2011; Shimosawa, Tatsuo/A-2920-2015	Pearson, James T/0000-0002-3318-5406; Tsuchimochi, Hirotsugu/0000-0001-7591-2520; Shimosawa, Tatsuo/0000-0002-8742-5129	Japan Society for the Promotion of Science (JSPS) [23249038, 23590843]; Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center [22-2-3, 25-3-1];  [23650213];  [24790863];  [24.2221]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center; ; ; 	This study was supported in part by a Grant-in-Aid for Scientific Research (A) and (C) from the Japan Society for the Promotion of Science (JSPS) (Grant No. 23249038 (A), and 23590843 (C)), and was also supported in part by Intramural Research Fund (22-2-3, 25-3-1) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center, and a Grant-in Aid for Scientific Research (No. 23650213, 24790863, and 24.2221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ACS, 3 IM PROPL; Bosc LVG, 2010, J CELL MOL MED, V14, P3, DOI 10.1111/j.1582-4934.2009.00929.x; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Campen MJ, 2005, J APPL PHYSIOL, V99, P2028, DOI 10.1152/japplphysiol.00411.2005; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Dumas JP, 1999, BRIT J PHARMACOL, V127, P421, DOI 10.1038/sj.bjp.0702575; Dumas M, 1998, EUR J PHARMACOL, V348, P223, DOI 10.1016/S0014-2999(98)00146-0; DUPONT AG, 1985, BRIT J CLIN PHARMACO, V20, P93, DOI 10.1111/j.1365-2125.1985.tb05037.x; Fagan KA, 2001, J APPL PHYSIOL, V90, P2502, DOI 10.1152/jappl.2001.90.6.2502; FLETCHER EC, 1992, HYPERTENSION, V19, P555, DOI 10.1161/01.HYP.19.6.555; Fletcher EC, 1996, J APPL PHYSIOL, V81, P2088, DOI 10.1152/jappl.1996.81.5.2088; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; HIRAWA N, 1991, CLIN SCI, V81, P499, DOI 10.1042/cs0810499; HYMAN AL, 1981, CIRC RES, V48, P407, DOI 10.1161/01.RES.48.3.407; Iaccarino G, 2001, HYPERTENSION, V38, P255, DOI 10.1161/01.HYP.38.2.255; Kanagy NL, 2001, HYPERTENSION, V37, P511, DOI 10.1161/01.HYP.37.2.511; Kimura H, 1998, INTERNAL MED, V37, P127, DOI 10.2169/internalmedicine.37.127; Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008; Leuenberger UA, 2005, AUTON NEUROSCI-BASIC, V121, P87, DOI 10.1016/j.autneu.2005.06.003; Marrone O, 2002, SLEEP MED REV, V6, P175, DOI 10.1053/smrv.2001.0185; McGuire M, 1999, RESP PHYSIOL, V117, P53, DOI 10.1016/S0034-5687(99)00047-X; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010; Nisbet RE, 2009, AM J RESP CELL MOL, V40, P601, DOI 10.1165/2008-0145OC; Norton CE, 2011, J APPL PHYSIOL, V111, P980, DOI 10.1152/japplphysiol.01286.2010; Peng H, 2008, FASEB J, V22, P11; Phillips BG, 1999, J HYPERTENS, V17, P61, DOI 10.1097/00004872-199917010-00010; Prabhakar NR, 2012, J APPL PHYSIOL, V113, P1304, DOI 10.1152/japplphysiol.00444.2012; Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P230, DOI 10.1016/j.resp.2010.08.022; Prasad K, 2012, J MED SYST, V36, P2621, DOI 10.1007/s10916-011-9737-7; Priest RM, 1997, BRIT J PHARMACOL, V122, P1375, DOI 10.1038/sj.bjp.0701528; RABINOVITCH M, 1979, AM J PHYSIOL, V236, pH818, DOI 10.1152/ajpheart.1979.236.6.H818; Reinke C, 2011, AM J PHYSIOL-LUNG C, V300, pL266, DOI 10.1152/ajplung.00239.2010; SAEED M, 1982, J CARDIOVASC PHARM, V4, P44, DOI 10.1097/00005344-198201000-00008; Sajkov D, 2009, PROG CARDIOVASC DIS, V51, P363, DOI 10.1016/j.pcad.2008.06.001; Schwenke DO, 2008, J APPL PHYSIOL, V104, P88, DOI 10.1152/japplphysiol.00610.2007; Schwenke DO, 2007, J APPL PHYSIOL, V102, P787, DOI 10.1152/japplphysiol.00596.2006; Schwenke DO, 2009, J HYPERTENS, V27, P1410, DOI 10.1097/HJH.0b013e32832af6a1; Seljeflot I, 1999, J CARDIOVASC PHARM, V34, P584, DOI 10.1097/00005344-199910000-00016; Sharma V, 2011, WORLD J CARDIOL, V3, P281, DOI 10.4330/wjc.v3.i9.281; SHIRAI M, 1994, AM J PHYSIOL, V266, pH1777, DOI 10.1152/ajpheart.1994.266.5.H1777; Shirai M, 2013, CIRC RES, V112, P209, DOI 10.1161/CIRCRESAHA.111.300096; Sica AL, 2000, RESP PHYSIOL, V121, P173, DOI 10.1016/S0034-5687(00)00126-2; Snow JB, 2008, J APPL PHYSIOL, V104, P110, DOI 10.1152/japplphysiol.00698.2005; SVENDSEN TL, 1981, CLIN PHARMACOL THER, V29, P711, DOI 10.1038/clpt.1981.100; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Tamisier R, 2011, EUR RESPIR J, V37, P119, DOI 10.1183/09031936.00204209; Xavier CH, 2010, FASEB J, V24, P20	47	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110693	10.1371/journal.pone.0110693	http://dx.doi.org/10.1371/journal.pone.0110693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350545	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100035
J	Chen, SH; Chang, S; Huang, QJ; He, J; Wang, H; Huang, QG				Chen, Suhang; Chang, Sheng; Huang, Qijun; He, Jin; Wang, Hao; Huang, Qiangui			SVM-Based Synthetic Fingerprint Discrimination Algorithm and Quantitative Optimization Strategy	PLOS ONE			English	Article								Synthetic fingerprints are a potential threat to automatic fingerprint identification systems (AFISs). In this paper, we propose an algorithm to discriminate synthetic fingerprints from real ones. First, four typical characteristic factors-the ridge distance features, global gray features, frequency feature and Harris Corner feature-are extracted. Then, a support vector machine (SVM) is used to distinguish synthetic fingerprints from real fingerprints. The experiments demonstrate that this method can achieve a recognition accuracy rate of over 98% for two discrete synthetic fingerprint databases as well as a mixed database. Furthermore, a performance factor that can evaluate the SVM's accuracy and efficiency is presented, and a quantitative optimization strategy is established for the first time. After the optimization of our synthetic fingerprint discrimination task, the polynomial kernel with a training sample proportion of 5% is the optimized value when the minimum accuracy requirement is 95%. The radial basis function (RBF) kernel with a training sample proportion of 15% is a more suitable choice when the minimum accuracy requirement is 98%.	[Chen, Suhang; Chang, Sheng; Huang, Qijun; He, Jin; Wang, Hao; Huang, Qiangui] Wuhan Univ, Sch Phys & Technol, Wuhan 430072, Peoples R China	Wuhan University	Chang, S (corresponding author), Wuhan Univ, Sch Phys & Technol, Wuhan 430072, Peoples R China.	changsheng@whu.edu.cn			National Natural Science Foundation of China [61204096, J1210061]; Fundamental Research Funds for the Central Universities, Wuhan University [2042014kf0238]; Specialised Research Fund for the Doctoral Program of Higher Education [20110141120074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, Wuhan University; Specialised Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was funded by the National Natural Science Foundation of China (grant nos 61204096 and J1210061), the Fundamental Research Funds for the Central Universities, Wuhan University (grant no 2042014kf0238) and the Specialised Research Fund for the Doctoral Program of Higher Education (grant no 20110141120074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2006, IEEE T INF FOREN SEC, V1, P360, DOI 10.1109/TIFS.2006.879289; Cappelli R, 2004, I C CONT AUTOMAT ROB, P1250; Cappelli R, 2002, INT C PATT RECOG, P744, DOI 10.1109/ICPR.2002.1048096; Cappelli R, 2000, INT C PATT RECOG, P471, DOI 10.1109/ICPR.2000.903586; Cappelli R, 2007, IEEE T PATTERN ANAL, V29, P1489, DOI 10.1109/TPAMI.2007.1087; Capplli R, 2004, INT WORKSH BIOM TECH, P147; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Derakhshani R, 2003, PATTERN RECOGN, V36, P383, DOI 10.1016/S0031-3203(02)00038-9; Feng JJ, 2011, IEEE T PATTERN ANAL, V33, P209, DOI 10.1109/TPAMI.2010.77; Fingerprint Verification Competition (FVC2004), 2004, FVC2004 DAT; Galbally J, 2012, FUTURE GENER COMP SY, V28, P311, DOI 10.1016/j.future.2010.11.024; Harris C., 1988, P ALVEY VISION C, DOI DOI 10.5244/C.2.23; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Hu Jin, 2007, Journal of Software, V18, P517, DOI 10.1360/jos180517; Jain AK, 2005, LECT NOTES COMPUT SC, V3617, P19, DOI 10.1007/11553595_3; Jianjiang Feng, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1622, DOI 10.1109/ICPR.2010.401; Kovacs-Vajna ZM, 2000, PATTERN RECOGN, V33, P69, DOI 10.1016/S0031-3203(99)00040-0; Pereira LFA, 2012, IEEE INT JOINT C NEU, P1; Ratha NK, 2001, LECT NOTES COMPUT SC, V2091, P223; Sandstrom M, 2004, LIVENESS DETECTION F, P39; Soweon Yoon, 2012, 2012 5th IAPR International Conference on Biometrics (ICB), P222, DOI 10.1109/ICB.2012.6199812; Uludag U, 2004, P IEEE, V92, P948, DOI 10.1109/JPROC.2004.827372; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Wong WT, 2006, EUR J OPER RES, V173, P938, DOI 10.1016/j.ejor.2005.08.002; Yoon S, 2012, IEEE T PATTERN ANAL, V34, P451, DOI 10.1109/TPAMI.2011.161; Zhao Q, 2012, IEEE INT C AUTOMAT L, P277, DOI 10.1109/ICAL.2012.6308211	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111099	10.1371/journal.pone.0111099	http://dx.doi.org/10.1371/journal.pone.0111099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347063	Green Submitted, Green Published, gold			2022-12-26	WOS:000347994900045
J	Imbrosci, B; Neitz, A; Mittmann, T				Imbrosci, Barbara; Neitz, Angela; Mittmann, Thomas			Focal Cortical Lesions Induce Bidirectional Changes in the Excitability of Fast Spiking and Non Fast Spiking Cortical Interneurons	PLOS ONE			English	Article							PYRAMIDAL NEURONS; LASER-LESIONS; PARVALBUMIN; INHIBITION; CORTEX; CELLS; SYNCHRONIZATION; DEPOLARIZATION; EXCITOTOXICITY; SOMATOSTATIN	A physiological brain function requires neuronal networks to operate within a well-defined range of activity. Indeed, alterations in neuronal excitability have been associated with several pathological conditions, ranging from epilepsy to neuropsychiatric disorders. Changes in inhibitory transmission are known to play a key role in the development of hyperexcitability. However it is largely unknown whether specific interneuronal subpopulations contribute differentially to such pathological condition. In the present study we investigated functional alterations of inhibitory interneurons embedded in a hyperexcitable cortical circuit at the border of chronically induced focal lesions in mouse visual cortex. Interestingly, we found opposite alterations in the excitability of non fast-spiking (Non Fs) and fast-spiking (Fs) interneurons in acute cortical slices from injured animals. Non Fs interneurons displayed a depolarized membrane potential and a higher frequency of spontaneous excitatory postsynaptic currents (sEPSCs). In contrast, Fs interneurons showed a reduced sEPSCs amplitude. The observed downscaling of excitatory synapses targeting Fs interneurons may prevent the recruitment of this specific population of interneurons to the hyperexcitable network. This mechanism is likely to seriously affect neuronal network function and to exacerbate hyperexcitability but it may be important to protect this particular vulnerable population of GABAegic neurons from excitotoxicity.	[Imbrosci, Barbara; Neitz, Angela; Mittmann, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Imbrosci, B (corresponding author), Charite, Neurowissensch Forschungszentrum, Campus Charite Mitte,Charitepl 1, D-13353 Berlin, Germany.	barbara.imbrosci@charite.de; mittmann@uni-mainz.de	Mittmann, Thomas/AAM-9047-2020		German Research Foundation (DFG) [CRC 1080, TP-A7]; MAIFOR	German Research Foundation (DFG)(German Research Foundation (DFG)); MAIFOR	This work is supported by the German Research Foundation (DFG, CRC 1080, TP-A7) to T.M. and by a MAIFOR grant to B.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Badawy RAB, 2012, NEUROSCIENCE, V222, P89, DOI 10.1016/j.neuroscience.2012.07.015; Barmashenko G, 2001, NEUROREPORT, V12, P3023, DOI 10.1097/00001756-200110080-00009; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bartos M, 2012, J PHYSIOL-LONDON, V590, P669, DOI 10.1113/jphysiol.2011.226175; BuchkremerRatzmann I, 1996, STROKE, V27, P1105, DOI 10.1161/01.STR.27.6.1105; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; CHURN SB, 1993, STROKE, V24, P271, DOI 10.1161/01.STR.24.2.271; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; EYSEL UT, 1991, NEUROSCI LETT, V131, P45, DOI 10.1016/0304-3940(91)90333-O; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Imbrosci B, 2013, NEUROSCIENCE, V250, P208, DOI 10.1016/j.neuroscience.2013.06.063; Imbrosci B, 2014, BRAIN STRUCT FUNCT; Imbrosci B, 2013, PFLUG ARCH EUR J PHY, V465, P879, DOI 10.1007/s00424-012-1191-y; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Merchant H, 2012, PROG NEUROBIOL, V99, P163, DOI 10.1016/j.pneurobio.2012.08.005; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tan ZJ, 2008, P NATL ACAD SCI USA, V105, P2187, DOI 10.1073/pnas.0710628105; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Yan L, 2012, CEREB CORTEX, V22, P2392, DOI 10.1093/cercor/bhr318	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111105	10.1371/journal.pone.0111105	http://dx.doi.org/10.1371/journal.pone.0111105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347396	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900048
J	Qiu, X; Liang, YX; Sellers, RS; Perez-Soler, R; Zou, YY				Qiu, Xuan; Liang, Yuanxin; Sellers, Rani S.; Perez-Soler, Roman; Zou, Yiyu			Aerosol Azacytidine Inhibits Orthotopic Lung Cancers in Mice through Its DNA Demethylation and Gene Reactivation Effects	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; POOR-PROGNOSIS; HYPERMETHYLATION; 5-AZACYTIDINE; EXPRESSION; RASSF1A; P16; CHEMOPREVENTION; ASSOCIATION; EPIGENETICS	We devised an aerosol based demethylation therapy to achieve therapeutic efficacy in premalignant or in situ lesions of lung cancer, without systemic toxicity. Optimum regimens of aerosolized azacytidine (Aza) were designed and used in orthotopic human non- small cell lung cancer xenograft models. The therapeutic efficacy and toxicity of aerosol Aza were compared with intravenously administered Aza. We observed that 80% of the droplets of the aerosol Aza measured similar to 0.1-5 microns, which resulted in deposition in the lower bronchial airways. An animal model that phenocopies field carcinogeneisis in humans was developed by intratracheal inoculation of the human lung cancer cells in mice, thus resulting in their distribution throughout the entire airway space. Aerosolized Aza significantly prolonged the survival of mice bearing endo-bronchial lung tumors. The aerosol treatment did not cause any detectable lung toxicity or systemic toxicity. A pre-pharmacokinetic study in mice demonstrated that lung deposition of aerosolized Aza was significantly higher than the intravenous route. Lung tumors were resected after aerosol treatment and the methylation levels of 24 promoters of tumor-suppresser genes related to lung cancer were analyzed. Aerosol Aza significantly reduced the methylation level in 9 of these promoters and reexpressed several genes tested. In conclusion, aerosol Aza at non-cytotoxic doses appears to be effective and results in DNA demethylation and tumor suppressor gene re-expression. The therapeutic index of aerosol Aza is >100-fold higher than that of intravenous Aza. These results provide a preclinical rationale for a phase I clinical trial of aerosol Aza to be initiated at our Institution.	[Qiu, Xuan; Liang, Yuanxin; Perez-Soler, Roman; Zou, Yiyu] Albert Einstein Coll Med, Dept Med, Div Med Oncol, Bronx, NY 10467 USA; [Sellers, Rani S.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zou, YY (corresponding author), Albert Einstein Coll Med, Dept Med, Div Med Oncol, Bronx, NY 10467 USA.	yiyu.zou@einstein.yu.edu			NIH [5R01CA154755]; NATIONAL CANCER INSTITUTE [R01CA154755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by a NIH grant 5R01CA154755. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040024; Bates D V, 1966, Health Phys, V12, P173; Bauman J, 2012, CANCER CHEMOTH PHARM, V69, P547, DOI 10.1007/s00280-011-1729-2; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Belinsky SA, 2011, COMBINATION THERAPY; Ben-Avraham D, 2012, EPIGENOMICS-UK, V4, P503, DOI [10.2217/EPI.12.41, 10.2217/epi.12.41]; BENNER SE, 1995, CHEST, V107, pS316, DOI 10.1378/chest.107.6_Supplement.316S; CAVALIERE A, 1987, CANCER LETT, V37, P51, DOI 10.1016/0304-3835(87)90145-5; Cecener G, 2008, TUMORI, V94, P845; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Daskalos A, 2011, CANCER LETT, V300, P79, DOI 10.1016/j.canlet.2010.09.009; DAVIES DS, 1979, SCAND J RESPIR DIS, P44; Digel W, 2005, CRIT REV ONCOL HEMAT, V55, P1, DOI 10.1016/j.critrevonc.2005.02.002; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Fischer JR, 2006, LUNG CANCER, V54, P109, DOI 10.1016/j.lungcan.2006.06.017; Fukui T, 2005, ONCOGENE, V24, P6323, DOI 10.1038/sj.onc.1208777; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Jaspers I, 2010, AM J RESP CELL MOL, V43, P368, DOI 10.1165/rcmb.2009-0254OC; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katayama H, 2007, ASIAN PAC J CANCER P, V8, P221; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Keating GM, 2012, DRUGS, V72, P1111, DOI 10.2165/11209430-000000000-00000; Khuri FR, 2004, CLIN CANCER RES, V10, p4249S, DOI 10.1158/1078-0432.CCR-040019; Kim JS, 2006, CANCER RES, V66, P4049, DOI 10.1158/0008-5472.CAN-05-3813; Koga T, 2011, INT J CANCER, V128, P1009, DOI 10.1002/ijc.25447; Kontic M, 2012, CLIN LUNG CANCER, V13, P297, DOI 10.1016/j.cllc.2011.11.003; Lee SM, 2012, MOL MED REP, V5, P239, DOI 10.3892/mmr.2011.608; Lichter P, 2008, INT J CANCER, V123, pIX, DOI 10.1002/ijc.23636; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Lippman SM, 2001, JNCI-J NATL CANCER I, V93, P605, DOI 10.1093/jnci/93.8.605; Mahesh S, 2010, CLIN LUNG CANCER, V11, P405, DOI 10.3816/CLC.2010.n.052; Mahesh Sameer, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P666; Miyamoto K, 2005, JPN J CLIN ONCOL, V35, P293, DOI 10.1093/jjco/hyi088; Miyazu YM, 2005, CANCER RES, V65, P9623, DOI 10.1158/0008-5472.CAN-05-0976; Mufti Ghulam, 2003, Hematology Am Soc Hematol Educ Program, P176; Perez-Soler R, 2009, ONCOGENE, V28, pS38, DOI 10.1038/onc.2009.200; Reed MD, 2013, BRIT J CANCER, V109, P1775, DOI 10.1038/bjc.2013.575; Safar AM, 2007, ARCH PATHOL LAB MED, V131, P936; Sawan C, 2008, MUTAT RES-FUND MOL M, V642, P1, DOI 10.1016/j.mrfmmm.2008.03.002; Seng TJ, 2008, BRIT J CANCER, V99, P375, DOI 10.1038/sj.bjc.6604452; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wakelee H, 2008, SEMIN THORAC CARDIOV, V20, P198, DOI 10.1053/j.semtcvs.2008.09.001; Wang GY, 2008, LUNG CANCER, V62, P162, DOI 10.1016/j.lungcan.2008.03.023; Wu JY, 2008, ANN SURG ONCOL, V15, P3272, DOI 10.1245/s10434-008-0078-9; Zhao M, 2004, J CHROMATOGR B, V813, P81, DOI 10.1016/j.jchromb.2004.09.012; Zhong Y, 2001, CLIN CANCER RES, V7, P1683; Zochbauer-Muller S, 2002, ONCOLOGIST, V7, P451, DOI 10.1634/theoncologist.7-5-451; Zou YY, 2007, CLIN CANCER RES, V13, P4900, DOI 10.1158/1078-0432.CCR-07-0395; Zou YY, 1998, J NATL CANCER I, V90, P1130, DOI 10.1093/jnci/90.15.1130; ZOU YY, 1994, CANCER RES, V54, P1479	55	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109874	10.1371/journal.pone.0109874	http://dx.doi.org/10.1371/journal.pone.0109874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347303	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900015
J	Shi, AM; Liu, HZ; Liu, L; Hu, H; Wang, Q; Adhikari, B				Shi, Aimin; Liu, Hongzhi; Liu, Li; Hu, Hui; Wang, Qiang; Adhikari, Benu			Isolation, Purification and Molecular Mechanism of a Peanut Protein-Derived ACE-Inhibitory Peptide	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ANTIHYPERTENSIVE DRUGS; BIOACTIVE PEPTIDES; CRYSTAL-STRUCTURE; BLOOD-PRESSURE; HYDROLYSATE; BINDING; IDENTIFICATION; METABOLISM; STABILITY	Although a number of bioactive peptides are capable of angiotensin I-converting enzyme (ACE) inhibitory effects, little is known regarding the mechanism of peanut peptides using molecular simulation. The aim of this study was to obtain ACE inhibiting peptide from peanut protein and provide insight on the molecular mechanism of its ACE inhibiting action. Peanut peptides having ACE inhibitory activity were isolated through enzymatic hydrolysis and ultrafiltration. Further chromatographic fractionation was conducted to isolate a more potent peanut peptide and its antihypertensive activity was analyzed through in vitro ACE inhibitory tests and in vivo animal experiments. MALDI-TOF/TOF-MS was used to identify its amino acid sequence. Mechanism of ACE inhibition of P8 was analyzed using molecular docking and molecular dynamics simulation. A peanut peptide (P8) having Lys-Leu-Tyr-Met-Arg-Pro amino acid sequence was obtained which had the highest ACE inhibiting activity of 85.77% (half maximal inhibitory concentration (IC50): 0.0052 mg/ml). This peanut peptide is a competitive inhibitor and show significant short term (12 h) and long term (28 days) antihypertensive activity. Dynamic tests illustrated that P8 can be successfully docked into the active pocket of ACE and can be combined with several amino acid residues. Hydrogen bond, electrostatic bond and Pi-bond were found to be the three main interaction contributing to the structural stability of ACE-peptide complex. In addition, zinc atom could form metal-carboxylic coordination bond with Tyr, Met residues of P8, resulting into its high ACE inhibiting activity. Our finding indicated that the peanut peptide (P8) having a Lys-Leu-Tyr-Met-Arg-Pro amino acid sequence can be a promising candidate for functional foods and prescription drug aimed at control of hypertension.	[Shi, Aimin; Liu, Hongzhi; Liu, Li; Hu, Hui; Wang, Qiang] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Key Lab Agroprod Proc, Minist Agr, Beijing 100193, Peoples R China; [Adhikari, Benu] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Royal Melbourne Institute of Technology (RMIT)	Wang, Q (corresponding author), Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Key Lab Agroprod Proc, Minist Agr, Beijing 100193, Peoples R China.	wangqiang06@caas.cn	SHI, AIMIN/L-7480-2019; shi, aimin/N-4618-2017; Adhikari, Benu P/K-6192-2017	SHI, AIMIN/0000-0001-8275-3185; shi, aimin/0000-0001-8275-3185; Adhikari, Benu P/0000-0002-7571-7968	Key Program for International S&T Cooperation Projects of China [2012DFA31400]; Agricultural Science and Technology Innovation Program in CAAS; National Nature Science Foundation of China [31201458]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAD29B00]; Special Fund for Basic Scientific Research and Operational Costs of Central-level Public Welfare Scientific Research Institutes of CP in CAAS	Key Program for International S&T Cooperation Projects of China; Agricultural Science and Technology Innovation Program in CAAS; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Special Fund for Basic Scientific Research and Operational Costs of Central-level Public Welfare Scientific Research Institutes of CP in CAAS	Funding Support was provided by the Key Program for International S&T Cooperation Projects of China (no. 2012DFA31400), the Agricultural Science and Technology Innovation Program in CAAS, the National Nature Science Foundation of China (no. 31201458), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (no. 2012BAD29B00) and the Special Fund for Basic Scientific Research and Operational Costs of Central-level Public Welfare Scientific Research Institutes of CP in CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CB, 2012, PROCESS BIOCHEM, V47, P2240, DOI 10.1016/j.procbio.2012.08.019; Bamdad F, 2013, MOL NUTR FOOD RES, V57, P493, DOI 10.1002/mnfr.201200252; Chen JW, 2012, PEPTIDES, V33, P52, DOI 10.1016/j.peptides.2011.11.006; CHEUNG HS, 1973, BIOCHIM BIOPHYS ACTA, V293, P451, DOI 10.1016/0005-2744(73)90352-5; Chibale K., 2012, DRUG DISCOVERY AFRIC, Vfirst; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; FAMULOK M, 1994, J AM CHEM SOC, V116, P1698, DOI 10.1021/ja00084a010; Girgih AT, 2014, J AGR FOOD CHEM, V62, P4135, DOI 10.1021/jf5002606; Gobbetti M, 2004, INT J DAIRY TECHNOL, V57, P173, DOI 10.1111/j.1471-0307.2004.00139.x; Guang C, 2009, J AGR FOOD CHEM, V57, P10102, DOI 10.1021/jf901787e; Guy JL, 2003, BIOCHEMISTRY-US, V42, P13185, DOI 10.1021/bi035268s; He R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091051; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Huang WH, 2011, FOOD CHEM, V128, P968, DOI 10.1016/j.foodchem.2011.03.127; Jacques H, 2010, BRIT J NUTR, V103, P1331, DOI 10.1017/S0007114509993278; Jamdar SN, 2010, FOOD CHEM, V121, P178, DOI 10.1016/j.foodchem.2009.12.027; Jimsheena VK, 2011, FOOD CHEM, V125, P561, DOI 10.1016/j.foodchem.2010.09.048; Jimsheena VK, 2010, PEPTIDES, V31, P1165, DOI 10.1016/j.peptides.2010.02.022; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012; KRITCHEVSKY D, 1982, ATHEROSCLEROSIS, V41, P429, DOI 10.1016/0021-9150(82)90208-8; Lee JK, 2009, BIORESOURCE TECHNOL, V100, P5255, DOI 10.1016/j.biortech.2009.05.057; Leoncini G, 2010, J HYPERTENS, V28, P156, DOI 10.1097/HJH.0b013e328332038c; Li CH, 2002, J PEPT SCI, V8, P267, DOI 10.1002/psc.387; Li GH, 2004, NUTR RES, V24, P469, DOI [10.1016/S0271-5317(04)00058-2, 10.1016/j.nutres.2003.10.014]; Li GH, 2006, J PEPT SCI, V12, P509, DOI 10.1002/psc.758; MATSUFUJI H, 1994, BIOSCI BIOTECH BIOCH, V58, P2244, DOI 10.1271/bbb.58.2244; Meisel H, 2005, CURR MED CHEM, V12, P1905, DOI 10.2174/0929867054546618; Miguel M, 2010, MOL NUTR FOOD RES, V54, P1422, DOI 10.1002/mnfr.200900448; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Oxtoby D. W., 2012, PRINCIPLES MODERN CH; Park PJ, 2001, J AM OIL CHEM SOC, V78, P651, DOI 10.1007/s11746-001-0321-0; Pihlanto-Leppala A, 2000, TRENDS FOOD SCI TECH, V11, P347, DOI 10.1016/S0924-2244(01)00003-6; Politi A, 2010, J MOL GRAPH MODEL, V29, P425, DOI 10.1016/j.jmgm.2010.08.003; Quist EE, 2005, THESIS U GEORGIA ATH; Ronquist G, 2004, PROSTATE, V58, P50, DOI 10.1002/pros.10294; Rosivall L, 2009, MOL CELL ENDOCRINOL, V302, P185, DOI 10.1016/j.mce.2008.09.033; Ruiz JAG, 2004, INT DAIRY J, V14, P1075, DOI 10.1016/j.idairyj.2004.04.007; Ruiz-Gimenez P, 2012, FOOD CHEM, V131, P266, DOI 10.1016/j.foodchem.2011.08.076; Sakkiah S, 2012, J BIOMOL STRUCT DYN, V30, P235, DOI 10.1080/07391102.2012.680026; Sheih IC, 2009, FOOD CHEM, V115, P279, DOI 10.1016/j.foodchem.2008.12.019; Sica D.A., 2005, J CLIN HYPERTENS, V7, P17, DOI [10.1111/j.1524-6175.2005.04556.x, DOI 10.1111/J.1524-6175.2005.04556.X]; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Tavares T, 2012, MOL NUTR FOOD RES, V56, P316, DOI 10.1002/mnfr.201100381; Vercruysse L, 2008, PROCESS BIOCHEM, V43, P900, DOI 10.1016/j.procbio.2008.04.014; Wang CY, 2011, EUR FOOD RES TECHNOL, V232, P549, DOI 10.1007/s00217-010-1411-7; Wang CY, 2010, INT J MOL SCI, V11, P4952, DOI 10.3390/ijms11124952; Wu HW, 2009, FOOD RES INT, V42, P343, DOI 10.1016/j.foodres.2008.12.006; Wu JP, 2002, FOOD RES INT, V35, P367, DOI 10.1016/S0963-9969(01)00131-4; Xu Y, 2004, BIOORGAN MED CHEM, V12, P6193, DOI 10.1016/j.bmc.2004.08.045; Yamamoto D, 2007, BIOCHEM BIOPH RES CO, V354, P981, DOI 10.1016/j.bbrc.2007.01.088; YAMAMOTO K, 1992, HYPERTENSION, V19, P692, DOI 10.1161/01.HYP.19.6.692; Yang NC, 2012, FOOD CHEM, V132, P1796, DOI 10.1016/j.foodchem.2011.11.143; Yergey AL, 2002, J AM SOC MASS SPECTR, V13, P784, DOI 10.1016/S1044-0305(02)00393-8; Zhao GL, 2011, FOOD CHEM, V127, P1438, DOI 10.1016/j.foodchem.2011.01.046	58	33	34	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111188	10.1371/journal.pone.0111188	http://dx.doi.org/10.1371/journal.pone.0111188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347076	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900053
J	Boutou, AK; Nair, A; Douraghi-Zadeh, D; Sandhu, R; Hansell, DM; Wells, AU; Polkey, MI; Hopkinson, NS				Boutou, Afroditi K.; Nair, Arjun; Douraghi-Zadeh, Dariush; Sandhu, Ranbir; Hansell, David M.; Wells, Athol U.; Polkey, Michael I.; Hopkinson, Nicholas S.			A Combined Pulmonary Function and Emphysema Score Prognostic Index for Staging in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PREDICT MORTALITY; CO-MORBIDITY; LUNG; CT; ARTERIAL; SURVIVAL; HYPERTENSION	Introduction: Chronic Obstructive Pulmonary Disease (COPD) is characterized by high morbidity and mortality. Lung computed tomography parameters, individually or as part of a composite index, may provide more prognostic information than pulmonary function tests alone. Aim: To investigate the prognostic value of emphysema score and pulmonary artery measurements compared with lung function parameters in COPD and construct a prognostic index using a contingent staging approach. Material-Methods: Predictors of mortality were assessed in COPD outpatients whose lung computed tomography, spirometry, lung volumes and gas transfer data were collected prospectively in a clinical database. Univariate and multivariate Cox proportional hazard analysis models with bootstrap techniques were used. Results: 169 patients were included (59.8% male, 61.1 years old; Forced Expiratory Volume in 1 second % predicted: 40.5 +/- 19.2). 20.1% died; mean survival was 115.4 months. Age (HR = 1.098, 95% Cl = 1.04-1.252) and emphysema score (HR = 1.034, 95% CI = 1.007-1.07) were the only independent predictors of mortality. Pulmonary artery dimensions were not associated with survival. An emphysema score of 55% was chosen as the optimal threshold and 30% and 65% as suboptimals. Where emphysema score was between 30% and 65% (intermediate risk) the optimal lung volume threshold, a functional residual capacity of 210% predicted, was applied. This contingent staging approach separated patients with an intermediate risk based on emphysema score alone into high risk (Functional Residual Capacity >= 210% predicted) or low risk (Functional Residual Capacity <210% predicted). This approach was more discriminatory for survival (HR = 3.123; 95% CI = 1.094-10.412) than either individual component alone. Conclusion: Although to an extent limited by the small sample size, this preliminary study indicates that the composite Emphysema score-Functional Residual Capacity index might provide a better separation of high and low risk patients with COPD, than other individual predictors alone.	[Boutou, Afroditi K.; Nair, Arjun; Hansell, David M.; Wells, Athol U.; Polkey, Michael I.; Hopkinson, Nicholas S.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Boutou, Afroditi K.; Nair, Arjun; Hansell, David M.; Wells, Athol U.; Polkey, Michael I.; Hopkinson, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, London, England; [Douraghi-Zadeh, Dariush] Chelsea & Westminster NHS Fdn Trust, Dept Radiol, London, England; [Sandhu, Ranbir] Imperial Coll Healthcare NHS Trust, Dept Radiol, London, England	Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Imperial College London; Imperial College London	Hopkinson, NS (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England.	n.hopkinson@imperial.ac.uk			European Respiratory Society Fellowship [STRF 2012-258]; NIHR Respiratory Biomedical Research Unit at Royal Brompton; Harefield NHS Foundation Trust and Imperial College, London, UK; National Institute for Health Research [NF-SI-0512-10157] Funding Source: researchfish	European Respiratory Society Fellowship; NIHR Respiratory Biomedical Research Unit at Royal Brompton; Harefield NHS Foundation Trust and Imperial College, London, UK; National Institute for Health Research(National Institute for Health Research (NIHR))	Dr. Boutou is the recipient of a European Respiratory Society Fellowship (STRF 2012-258). The study was supported by NIHR Respiratory Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONISEN NR, 1986, AM REV RESPIR DIS, V133, P14, DOI 10.1164/arrd.1986.133.1.14; Barker BL, 2013, CLIN SCI, V124, P371, DOI 10.1042/CS20120340; Boutou AK, 2013, EUR RESPIR J, V42, P616, DOI 10.1183/09031936.00146012; Boutou AK, 2013, RESPIRATION, V85, P126, DOI 10.1159/000338792; Budweiser S, 2007, CHEST, V131, P1650, DOI 10.1378/chest.06-2124; Celli BR, 2008, RESP MED, V102, pS27, DOI 10.1016/S0954-6111(08)70005-2; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CLARK EH, 1978, CLIN SCI MOL MED, V54, P627, DOI 10.1042/cs0540627; Cote Claudia G, 2009, Pneumonol Alergol Pol, V77, P305; Dawkins PA, 2003, THORAX, V58, P1020, DOI 10.1136/thorax.58.12.1020; Devaraj A, 2010, RADIOLOGY, V254, P609, DOI 10.1148/radiol.09090548; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Hackx M, 2012, RADIOLOGY, V265, P34, DOI 10.1148/radiol.12111270; Haimovici JBA, 1997, ACAD RADIOL, V4, P327; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; HODGKIN JE, 1990, CLIN CHEST MED, V11, P555; Incalzi RA, 1997, EUR RESPIR J, V10, P2794, DOI 10.1183/09031936.97.10122794; Johannessen A, 2013, AM J RESP CRIT CARE, V187, P602, DOI 10.1164/rccm.201209-1722OC; Jones RC, 2009, AM J RESP CRIT CARE, V180, P1189, DOI 10.1164/rccm.200902-0271OC; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Moore AJ, 2010, RESP MED, V104, P1319, DOI 10.1016/j.rmed.2010.03.001; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Ng CS, 1999, J THORAC IMAG, V14, P270, DOI 10.1097/00005382-199910000-00007; Oga T, 2011, INT J CHRONIC OBSTR, V6, P521, DOI 10.2147/COPD.S24420; Pedone C, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-35; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saitoh T, 2000, INVEST RADIOL, V35, P235, DOI 10.1097/00004424-200004000-00004; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Ueda K, 2006, CLIN CANCER RES, V12, P6730, DOI 10.1158/1078-0432.CCR-06-1196; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Zavorsky GS, 2007, RESP PHYSIOL NEUROBI, V155, P268, DOI 10.1016/j.resp.2006.07.002; Zulueta JJ, 2012, CHEST, V141, P1216, DOI 10.1378/chest.11-0101	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111109	10.1371/journal.pone.0111109	http://dx.doi.org/10.1371/journal.pone.0111109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343258	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943500080
J	Lau, HY; Palanisamy, R; Trau, M; Botella, JR				Lau, Han Yih; Palanisamy, Ramkumar; Trau, Matt; Botella, Jose R.			Molecular Inversion Probe: A New Tool for Highly Specific Detection of Plant Pathogens	PLOS ONE			English	Article							REAL-TIME PCR; MULTIPLEX DETECTION; PADLOCK PROBES; DNA; QUANTIFICATION; IDENTIFICATION; INFECTION; UNIVERSAL; ASSAY; OLIGONUCLEOTIDES	Highly specific detection methods, capable of reliably identifying plant pathogens are crucial in plant disease management strategies to reduce losses in agriculture by preventing the spread of diseases. We describe a novel molecular inversion probe (MIP) assay that can be potentially developed into a robust multiplex platform to detect and identify plant pathogens. A MIP has been designed for the plant pathogenic fungus Fusarium oxysporum f.sp. conglutinans and the proof of concept for the efficiency of this technology is provided. We demonstrate that this methodology can detect as little as 2.5 ng of pathogen DNA and is highly specific, being able to accurately differentiate Fusarium oxysporum f.sp. conglutinans from other fungal pathogens such as Botrytis cinerea and even pathogens of the same species such as Fusarium oxysporum f.sp. lycopersici. The MIP assay was able to detect the presence of the pathogen in infected Arabidopsis thaliana plants as soon as the tissues contained minimal amounts of pathogen. MIP methods are intrinsically highly multiplexable and future development of specific MIPs could lead to the establishment of a diagnostic method that could potentially screen infected plants for hundreds of pathogens in a single assay.	[Lau, Han Yih; Botella, Jose R.] Univ Queensland, Sch Agr & Food Sci, Plant Genet Engn Lab, Brisbane, Qld, Australia; [Lau, Han Yih; Palanisamy, Ramkumar; Trau, Matt] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Trau, M (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.	m.trau@uq.edu.au; j.botella@uq.edu.au	LAU, HAN YIH/HGE-7086-2022; Botella, Jose R/D-9766-2011; Trau, Matt/E-3944-2015	Botella, Jose R/0000-0002-4446-3432; Trau, Matt/0000-0001-5516-1280	Malaysian Agricultural Research and Development Institute (MARDI); National Breast Cancer Foundation of Australia [CG-08-07, CG-12-07]	Malaysian Agricultural Research and Development Institute (MARDI); National Breast Cancer Foundation of Australia	Special thanks to Malaysian Agricultural Research and Development Institute (MARDI) for providing the PhD scholarship of HYL. Although not directly funding this work, the Trau laboratory acknowledges funding received from the National Breast Cancer Foundation of Australia (CG-08-07 and CG-12-07). These grants have significantly contributed to creating the environment to enable the research described here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Araujo R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-154; Cazzonelli CI, 1998, AUST J PLANT PHYSIOL, V25, P513, DOI 10.1071/PP98013; Cherepanov A, 2001, J BIOCHEM-TOKYO, V129, P61, DOI 10.1093/oxfordjournals.jbchem.a002837; Chillali M, 1998, MYCOL RES, V102, P533, DOI 10.1017/S0953756297005315; Clark JS, 2009, BAYESIAN ANAL, V4, P337, DOI 10.1214/09-BA413; COMSTOCK JC, 1992, PLANT DIS, V76, P1033, DOI 10.1094/PD-76-1033; Dai J, 2013, J APPL MICROBIOL, V114, P502, DOI 10.1111/jam.12071; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/nmeth.1871, 10.1038/NMETH.1871]; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; FRANKEN AAJM, 1992, NETH J PLANT PATHOL, V98, P81, DOI 10.1007/BF01996321; Ge Z, 2013, CLIN MICROBIOL INFEC, V19, P1042, DOI 10.1111/1469-0691.12149; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hirani R, 2011, ANAL CHEM, V83, P8215, DOI 10.1021/ac2019409; Horsfall J.G., 1977, PLANT DIS ADV TREATI; Hyman RW, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-29; Klosterman SJ, 2012, METHODS MOL BIOL, V835, P121, DOI 10.1007/978-1-61779-501-5_8; Kokoskova Blanka, 2009, V508, P75, DOI 10.1007/978-1-59745-062-1_7; Lee, 2000, J MICROBIOL, V38, P66; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Lievens B, 2006, PLANT SCI, V171, P155, DOI 10.1016/j.plantsci.2006.03.009; Lin SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-712; Lin YH, 2013, EUR J PLANT PATHOL, V135, P395, DOI 10.1007/s10658-012-0096-0; MALIN EM, 1983, PLANT DIS, V67, P645, DOI 10.1094/PD-67-645; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; MAUCHMANI B, 1994, MOL PLANT MICROBE IN, V7, P378, DOI 10.1094/MPMI-7-0378; Miedaner T, 1996, PLANT DIS, V80, P500, DOI 10.1094/PD-80-0500; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Novais RC, 2008, J MICROBIOL METH, V72, P60, DOI 10.1016/j.mimet.2007.10.009; Novakova S, 2006, J VIROL METHODS, V137, P229, DOI 10.1016/j.jviromet.2006.06.020; Palanisamy R, 2011, ANAL CHEM, V83, P2631, DOI 10.1021/ac103016n; Price JA, 2010, J VIROL METHODS, V165, P198, DOI 10.1016/j.jviromet.2010.01.019; Punja ZK, 2007, BIOTECHNOLOGY AND PLANT DISEASE MANAGEMENT, P1, DOI 10.1079/9781845932886.0000; Sikora K, 2012, PHYTOPATHOLOGY, V102, P635, DOI 10.1094/PHYTO-11-11-0309; Sint D, 2012, METHODS ECOL EVOL, V3, P898, DOI 10.1111/j.2041-210X.2012.00215.x; Szemes M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni069; Tooley PW, 1997, APPL ENVIRON MICROB, V63, P1467, DOI 10.1128/AEM.63.4.1467-1475.1997; Trusov Y, 2013, METHODS MOL BIOL, V1043, P67, DOI 10.1007/978-1-62703-532-3_7; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; van Doorn R, 2009, APPL ENVIRON MICROB, V75, P4185, DOI 10.1128/AEM.00071-09; van Doorn R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-276; Vincelli P, 2008, PLANT DIS, V92, P660, DOI 10.1094/PDIS-92-5-0660; Wang Y, 2005, CHEM RES CHINESE U, V21, P183; Ward E, 2004, ANN APPL BIOL, V145, P1, DOI 10.1111/j.1744-7348.2004.tb00354.x; WU DY, 1989, GENE, V76, P245, DOI 10.1016/0378-1119(89)90165-0; Xu YZ, 1999, NUCLEIC ACIDS RES, V27, P875, DOI 10.1093/nar/27.3.875; Yamazaki W, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-94	50	5	5	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111182	10.1371/journal.pone.0111182	http://dx.doi.org/10.1371/journal.pone.0111182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343255	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500086
J	Rashidi, MM; Kavyani, N; Abelman, S; Uddin, MJ; Freidoonimehr, N				Rashidi, Mohammad M.; Kavyani, Neda; Abelman, Shirley; Uddin, Mohammed J.; Freidoonimehr, Navid			Double Diffusive Magnetohydrodynamic (MHD) Mixed Convective Slip Flow along a Radiating Moving Vertical Flat Plate with Convective Boundary Condition	PLOS ONE			English	Article							DIFFERENTIAL-EQUATIONS; THERMAL-RADIATION; TRANSFORM METHOD; SOLID-SURFACES; HEAT-TRANSFER; MASS-TRANSFER; POROUS-MEDIUM; LAYER	In this study combined heat and mass transfer by mixed convective flow along a moving vertical flat plate with hydrodynamic slip and thermal convective boundary condition is investigated. Using similarity variables, the governing nonlinear partial differential equations are converted into a system of coupled nonlinear ordinary differential equations. The transformed equations are then solved using a semi-numerical/analytical method called the differential transform method and results are compared with numerical results. Close agreement is found between the present method and the numerical method. Effects of the controlling parameters, including convective heat transfer, magnetic field, buoyancy ratio, hydrodynamic slip, mixed convective, Prandtl number and Schmidt number are investigated on the dimensionless velocity, temperature and concentration profiles. In addition effects of different parameters on the skin friction factor, Cf-x, local Nusselt number, Nu(x), and local Sherwood number Sh(x) are shown and explained through tables.	[Rashidi, Mohammad M.] Bu Ali Sina Univ, Fac Engn, Dept Mech Engn, Hamadan, Iran; [Rashidi, Mohammad M.] Shanghai Jiao Tong Univ, Univ Michigan, Joint Inst, Shanghai 200030, Peoples R China; [Kavyani, Neda] Islamic Azad Univ, Sama Tech & Vocat Training Coll, Malayer Branch, Malayer, Iran; [Abelman, Shirley] Univ Witwatersrand, Sch Computat & Appl Math, Ctr Differential Equat Continuum Mech & Applicat, Johannesburg, South Africa; [Uddin, Mohammed J.] Amer Int Univ Bangladesh, Dept Math, Dhaka, Bangladesh; [Freidoonimehr, Navid] Islamic Azad Univ, Hamedan Branch, Young Res & Elite Club, Hamadan, Iran	Bu Ali Sina University; Shanghai Jiao Tong University; Islamic Azad University; University of Witwatersrand; American International University Bangladesh (AIUB); Islamic Azad University	Rashidi, MM (corresponding author), Bu Ali Sina Univ, Fac Engn, Dept Mech Engn, Hamadan, Iran.	mm_rashidi@yahoo.com; Shirley.Abelman@wits.ac.za	Rashidi, Mohammad Mehdi/P-2692-2014; Freidoonimehr, Navid/I-2308-2014	Rashidi, Mohammad Mehdi/0000-0002-6309-8688; Freidoonimehr, Navid/0000-0002-2850-7861; Uddin, Dr. Md. Jashim/0000-0002-3243-3455	NRF, Pretoria, South Africa	NRF, Pretoria, South Africa	SA acknowledges support from the NRF, Pretoria, South Africa.	Abd El-Aziz M, 2013, J EGYPT MAT IN PRESS; Ascher U. M., 1995, NUMERICAL SOLUTION B; Ayaz F, 2004, APPL MATH COMPUT, V147, P547, DOI 10.1016/S0096-3003(02)00794-4; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; Baker G.A., 1975, ESSENTIALS PADE APPR; Baker GA, 1981, ENCY MATH ITS APPL 2; Baker Jr. George A., 1981, ENCY MATH ITS APPL 1, V13; Beg O., 2013, INT J APPL MATH MECH, V9, P37; Beg OA, 2014, J ENG THERMOPHYS-RUS, V23, P79, DOI 10.1134/S1810232814020015; Broyden CG, 2000, MATH PROGRAM, V87, P209, DOI 10.1007/s101070050111; BROYDEN CG, 1965, MATH COMPUT, V19, P557; Chen CH, 2004, ACTA MECH, V172, P219, DOI 10.1007/s00707-004-0155-5; Chen CH, 2009, INT J NONLIN MECH, V44, P596, DOI 10.1016/j.ijnonlinmec.2009.02.004; Chen CK, 1999, APPL MATH COMPUT, V106, P171, DOI 10.1016/S0096-3003(98)10115-7; Damseh R. A., 2006, Turkish Journal of Engineering and Environmental Sciences, V30, P83; Emam T., 2012, J EGYPT MATH SOC, V20, P215, DOI [10.1016/j.joems.2012.08.016, DOI 10.1016/J.JOEMS.2012.08.016]; He J, 1997, COMMUN NONLINEAR SCI, V2, P235, DOI DOI 10.1016/S1007-5704(97)90007-1; He JH, 1999, COMPUT METHOD APPL M, V178, P257, DOI 10.1016/S0045-7825(99)00018-3; Ishak A, 2010, APPL MATH COMPUT, V217, P837, DOI 10.1016/j.amc.2010.06.026; Karmishin A.V., 1990, METHODS DYNAMICS CAL; Karniadakis G, 2005, MICROFLOWS NANOFLOWS; Kaya A, 2012, ISI BILIM TEK DERG, V32, P9; Keller H.B., 1992, NUMERICAL METHODS 2; Kim BH, 2010, MICROFLUID NANOFLUID, V9, P31, DOI 10.1007/s10404-009-0515-5; KUZNETSOV AV, 2010, TRANSPORT POROUS MED, V85, P657; Li D., 2008, ENCY MICROFLUIDICS N; Liao S, 2004, APPL MATH COMPUT, V147, P499, DOI [10.1016/S0096-3003(02)00790-7, 10.1016/50096-3003(02)00790-7]; Lyapunov A. M., 1992, GEN PROBLEM STABILIT; Magyari E, 2011, COMMUN NONLINEAR SCI, V16, P599, DOI 10.1016/j.cnsns.2010.03.020; Martin MJ, 2006, J THERMOPHYS HEAT TR, V20, P710, DOI 10.2514/1.22968; NATH O, 1991, ASTROPHYS SPACE SCI, V183, P135, DOI 10.1007/BF00643022; Nguyen NT, 2009, FUNDAMENTALS APPL MI; Noor NFM, 2012, INT J HEAT MASS TRAN, V55, P2122, DOI 10.1016/j.ijheatmasstransfer.2011.12.015; Pal D, 2011, COMMUN NONLINEAR SCI, V16, P1329, DOI 10.1016/j.cnsns.2010.06.008; Rahman MM, 2009, INT J THERM SCI, V48, P2331, DOI 10.1016/j.ijthermalsci.2009.05.003; Rashidi MM, 2010, HEAT TRANSF-ASIAN RE, V39, P575, DOI 10.1002/htj.20317; Rashidi M. M., 2010, MATH PROBL ENG, P1; Rashidi MM, 2013, INT J ENERGY TECH, V5, P1; Rashidi MM, 2010, INT J ENG, V23, P267; Rashidi MM, 2010, INT J THERM SCI, V49, P2405, DOI 10.1016/j.ijthermalsci.2010.07.005; Rashidi MM, 2009, COMMUN NONLINEAR SCI, V14, P2999, DOI 10.1016/j.cnsns.2008.10.030; Rohni AM, 2013, INT J THERM SCI, V64, P264, DOI 10.1016/j.ijthermalsci.2012.08.016; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; SPREITER JR, 1974, ACTA ASTRONAUT, V1, P15, DOI 10.1016/0094-5765(74)90006-X; Thompson PA, 1997, NATURE, V389, P360, DOI 10.1038/38686; Zhou J.K., 1986, DIFFERENTIAL TRANSFO	46	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109404	10.1371/journal.pone.0109404	http://dx.doi.org/10.1371/journal.pone.0109404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343360	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500015
J	Xue, TC; Ge, NL; Zhang, L; Cui, JF; Chen, RX; You, Y; Ye, SL; Ren, ZG				Xue, Tong-Chun; Ge, Ning-Ling; Zhang, Lan; Cui, Jie-Feng; Chen, Rong-Xin; You, Yang; Ye, Sheng-Long; Ren, Zheng-Gang			Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							COLLECTIVE CELL-MIGRATION; NEURAL CREST DELAMINATION; EXTRAHEPATIC METASTASIS; TUMOR-METASTASIS; GENE; GASTRULATION; EXPRESSION; CANCER; MORPHOGENESIS; ORGANIZER	The homeobox gene, goosecoid (GSC), is a transcription factor that participates in cell migration during embryonic development. Because cell migration during development has characteristics similar to cell invasion during metastasis, we evaluated the potential role of GSC in the metastasis of hepatocellular carcinoma (HCC). GSC expression in HCC cell lines and tissues was evaluated, and its effects on the migration potential of HCC cells were determined by GSC knock-down and overexpression methods. In addition, the prognostic role of GSC expression in the metastasis of cancer cells in HCC patients was determined. Our data showed that GSC was highly expressed in several HCC cell lines, particularly in a highly metastatic HCC cell line. Overexpression of GSC promoted cell migration and invasion of HCC cells in vitro. Gain-of-function induced the epithelial-mesenchymal transition but not collective cell migration, whereas loss-of-function induced the reverse change. High-level expression of GSC correlated closely with poor survival and lung metastasis in HCC patients; lung metastases showed more upregulated GSC expression than the primary tumor. We conclude that GSC promotes metastasis of HCC potentially through initiating the epithelial-mesenchymal transition. GSC is also a prognostic factor for poor survival and metastasis of HCC, which suggests its potential as a therapeutic target for metastatic HCC.	[Xue, Tong-Chun; Ge, Ning-Ling; Zhang, Lan; Cui, Jie-Feng; Chen, Rong-Xin; You, Yang; Ye, Sheng-Long; Ren, Zheng-Gang] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China; [Xue, Tong-Chun; Ge, Ning-Ling; Zhang, Lan; Cui, Jie-Feng; Chen, Rong-Xin; You, Yang; Ye, Sheng-Long; Ren, Zheng-Gang] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ren, ZG (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China.	ren.zhenggang@zs-hospital.sh.cn			National Clinical Key Special Subject of China; National Natural Science Foundation of China [81172275, 21272565]; National Basic Research Program of China (973 Program) [2009CB521700]	National Clinical Key Special Subject of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by The National Clinical Key Special Subject of China, The National Natural Science Foundation of China (81172275 and 21272565) and The National Basic Research Program of China (973 Program, 2009CB521700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chuai M, 2012, CURR GENOMICS, V13, P267, DOI 10.2174/138920212800793357; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gritsman K, 2000, DEVELOPMENT, V127, P921; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Luu O, 2008, DEV DYNAM, V237, P1307, DOI 10.1002/dvdy.21522; Nabeshima K, 1998, INT J CANCER, V78, P750, DOI 10.1002/(SICI)1097-0215(19981209)78:6<750::AID-IJC13>3.0.CO;2-#; Nakaya Y, 2008, DEV GROWTH DIFFER, V50, P755, DOI 10.1111/j.1440-169X.2008.01070.x; NIEHRS C, 1993, CELL, V72, P491, DOI 10.1016/0092-8674(93)90069-3; Ogunwobi OO, 2011, CLIN EXP METASTAS, V28, P721, DOI 10.1007/s10585-011-9404-x; Ozen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042717; Shoval I, 2012, DEV DYNAM, V241, P1155, DOI 10.1002/dvdy.23799; Simon R, 2010, METHODS MOL BIOL, V664, P113, DOI 10.1007/978-1-60761-806-5_12; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Xue TC, 2011, ASIAN PAC J CANCER P, V12, P657; Xue TC, 2013, ONCOL REP, V30, P105, DOI 10.3892/or.2013.2442; Xue TC, 2012, EXP THER MED, V3, P117, DOI 10.3892/etm.2011.358; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yasuo H, 2001, DEVELOPMENT, V128, P3783; Zhou Xin-Da, 2002, Hepatobiliary Pancreat Dis Int, V1, P35	29	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109695	10.1371/journal.pone.0109695	http://dx.doi.org/10.1371/journal.pone.0109695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343336	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500021
J	Li, WW; Wang, G; Liang, WL; Kang, K; Guo, KK; Zhang, YM				Li, Weiwei; Wang, Gang; Liang, Wulong; Kang, Kai; Guo, Kangkang; Zhang, Yanming			Integrin beta 3 Is Required in Infection and Proliferation of Classical Swine Fever Virus	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; VASCULAR ENDOTHELIAL-CELLS; HERPES-SIMPLEX-VIRUS; SIN-NOMBRE-VIRUS; WEST-NILE-VIRUS; IN-VIVO; ALPHA(V)BETA(3) INTEGRIN; VITRONECTIN RECEPTOR; HEPARAN-SULFATE; HUMAN PARECHOVIRUS-1	Classical Swine Fever (CSF) is a highly infectious fatal pig disease, resulting in huge economic loss to the swine industry. Integrins are membrane- bound signal mediators, expressed on a variety of cell surfaces and are known as receptors or coreceptors for many viruses. However, the role of integrin beta 3 in CSFV infection is unknown. Here, through quantitive PCR, immunofluorescence (IFC) and immunocytohistochemistry (ICC), we revealed that ST (swine testicles epithelial) cells have a prominent advantage in CSFV proliferation as compared to EC (swine umbilical vein endothelial cell), IEC (swine intestinal epithelial cell) and PK (porcine kidney epithelial) cells. Meanwhile, ST cells had remarkably more integrin beta 3 expression as compared to EC, IEC and PK cells, which was positively correlated with CSFV infection and proliferation. Integrin beta 3 was upregulated post CSFV infection in all the four cell lines, while the CSFV proliferation rate was decreased in integrin beta 3 function- blocked cells. ShRNA1755 dramatically decreased integrin beta 3, with a deficiency of 96% at the mRNA level and 80% at the protein level. CSFV proliferation was dramatically reduced in integrin beta 3 constantly- defected cells (ICDC), with the deficiencies of 92.6%, 99% and 81.7% at 24 h, 48 h and 72 h post CSFV infection, respectively. These results demonstrate that integrin b3 is required in CSFV infection and proliferation, which provide a new insight into the mechanism of CSFV infection.	[Li, Weiwei; Liang, Wulong; Kang, Kai; Guo, Kangkang; Zhang, Yanming] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Wang, Gang] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; Xuzhou Medical University	Zhang, YM (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	zhangym@nwsuaf.edu.cn			National Natural Science Foundation of China [31172339]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by the National Natural Science Foundation of China (No. 31172339). URL:http://www.nsfc.gov.cn/nsfc/cen/xmzn/2014xmzn/ index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensaude E, 2004, J GEN VIROL, V85, P1029, DOI 10.1099/vir.0.19637-0; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Bernard-Trifilo JA, 2006, CURR PROTOC CELL BIO; Blacksell SD, 2006, TROP ANIM HEALTH PRO, V38, P467, DOI 10.1007/s11250-006-4434-0; Bogachek MV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P472, DOI 10.1134/S0006297910040115; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; Campadelli-Fiume G, 2012, CURR OPIN VIROL, V2, P28, DOI 10.1016/j.coviro.2011.12.001; Cayrol C, 2011, WORLD J GASTROENTERO, V17, P4488, DOI 10.3748/wjg.v17.i40.4488; Chiodelli P, 2012, J BIOL CHEM, V287, P20456, DOI 10.1074/jbc.M111.337139; Choi C, 2003, J VET DIAGN INVEST, V15, P35, DOI 10.1177/104063870301500108; Croyle M A, 1998, Pharm Dev Technol, V3, P365, DOI 10.3109/10837459809009864; Croyle MA, 1998, GENE THER, V5, P645, DOI 10.1038/sj.gt.3300645; Dreier S, 2007, J VIROL METHODS, V140, P95, DOI 10.1016/j.jviromet.2006.11.013; Duque H, 2003, J VIROL, V77, P2500, DOI 10.1128/JVI.77.4.2500-2511.2003; Fernandez Catherine, 1998, Frontiers in Bioscience, V3, pD684; Gavrilovskaya IN, 1999, J VIROL, V73, P3951, DOI 10.1128/JVI.73.5.3951-3959.1999; Gianni T, 2012, P NATL ACAD SCI USA, V109, P19792, DOI 10.1073/pnas.1212597109; Gianni T, 2012, J VIROL, V86, P2850, DOI 10.1128/JVI.06689-11; Greiser-Wilke I, 2000, VET MICROBIOL, V77, P17, DOI 10.1016/S0378-1135(00)00253-4; Guerrero CA, 2012, ACTA VIROL, V56, P63, DOI 10.4149/av_2012_01_63; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Hamilton TE, 1997, J PEDIATR SURG, V32, P1695, DOI 10.1016/S0022-3468(97)90508-X; He L, 2012, VIRUS GENES, V45, P274, DOI 10.1007/s11262-012-0773-2; Husser L, 2011, VIRUS RES, V159, P9, DOI 10.1016/j.virusres.2011.04.005; Hulst MM, 2000, J VIROL, V74, P9553, DOI 10.1128/JVI.74.20.9553-9561.2000; Hulst MM, 2001, J VIROL, V75, P9585, DOI 10.1128/JVI.75.20.9585-9595.2001; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jackson T, 1997, J VIROL, V71, P8357, DOI 10.1128/JVI.71.11.8357-8361.1997; Ji P, 1999, BBA-MOL CELL RES, V1448, P543, DOI 10.1016/S0167-4889(98)00160-8; Joki-Korpela P, 2001, J VIROL, V75, P1958, DOI 10.1128/JVI.75.4.1958-1967.2001; Lafrenie RM, 2002, VIROLOGY, V297, P31, DOI 10.1006/viro.2002.1399; Lanthier J, 2006, BIOCHEM CELL BIOL, V84, P684, DOI 10.1139/O06-055; Larson RS, 2005, J VIROL, V79, P7319, DOI 10.1128/JVI.79.12.7319-7326.2005; Larson RS, 2005, BIOCHEMISTRY-US, V44, P4322, DOI 10.1021/bi048187k; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; Majhen D, 2011, LIFE SCI, V89, P241, DOI 10.1016/j.lfs.2011.06.009; Medina RA, 2007, J GEN VIROL, V88, P493, DOI 10.1099/vir.0.82459-0; Naik MU, 2011, J CELL BIOCHEM, V112, P3289, DOI 10.1002/jcb.23255; Neff S, 2000, NEUROSURGERY, V47, P794, DOI 10.1097/00006123-200009000-00065; Neff S, 1998, J VIROL, V72, P3587, DOI 10.1128/JVI.72.5.3587-3594.1998; Neff S, 2001, J VIROL, V75, P527, DOI 10.1128/JVI.75.1.527-532.2001; Nelsen-Salz B, 1999, J GEN VIROL, V80, P2311, DOI 10.1099/0022-1317-80-9-2311; O'Donnell V, 2005, J VIROL, V79, P8506, DOI 10.1128/JVI.79.13.8506-8518.2005; Pfaff M, 2001, J CELL SCI, V114, P2775; Raman S, 2009, J VIROL, V83, P2831, DOI 10.1128/JVI.02368-08; ROIVAINEN M, 1994, VIROLOGY, V203, P357, DOI 10.1006/viro.1994.1494; Ruiz-Saenz J, 2009, INTERVIROLOGY, V52, P201, DOI 10.1159/000226121; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Song JW, 2005, EXP MOL MED, V37, P121, DOI 10.1038/emm.2005.16; Stegeman A, 2000, VET MICROBIOL, V73, P183, DOI 10.1016/S0378-1135(00)00144-9; Stegeman JA, 2002, EPIDEMIOL INFECT, V128, P285, DOI 10.1017/S0950268801006483; Sun DS, 2005, J BIOMED SCI, V12, P937, DOI 10.1007/s11373-005-9016-z; Sun DS, 2005, J BIOMED SCI, V12, P321, DOI 10.1007/s11373-005-0979-6; Tang QH, 2010, VET IMMUNOL IMMUNOP, V133, P237, DOI 10.1016/j.vetimm.2009.07.005; Triantafilou K, 2001, J CELL BIOCHEM, V80, P373, DOI 10.1002/1097-4644(20010301)80:3<373::AID-JCB110>3.0.CO;2-C; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; Tu CC, 2001, VIRUS RES, V81, P29, DOI 10.1016/S0168-1702(01)00366-5; Wang J, 2014, J VIROL METHODS, V202, P87, DOI 10.1016/j.jviromet.2014.03.007; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Wang W, 2012, ARCH VIROL, V157, P1051, DOI 10.1007/s00705-012-1245-7; Xu H, 2007, INTERVIROLOGY, V50, P433, DOI 10.1159/000113467; Zarate S, 2004, J VIROL, V78, P10839, DOI 10.1128/JVI.78.20.10839-10847.2004; Zarate S, 2000, VIROLOGY, V278, P50, DOI 10.1006/viro.2000.0660; Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051; Zhang X, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-31; Zhang ZS, 2007, J VIROL METHODS, V143, P125, DOI 10.1016/j.jviromet.2007.02.012; Zhu Y, 2009, VIRUS RES, V142, P169, DOI 10.1016/j.virusres.2009.02.011	68	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110911	10.1371/journal.pone.0110911	http://dx.doi.org/10.1371/journal.pone.0110911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340775	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800070
J	Tholking, G; Fortmann, C; Koch, R; Gerth, HU; Pabst, D; Pavenstadt, H; Kabar, I; Husing, A; Wolters, H; Reuter, S; Suwelack, B				Thoelking, Gerold; Fortmann, Christian; Koch, Raphael; Gerth, Hans Ulrich; Pabst, Dirk; Pavenstaedt, Hermann; Kabar, Iyad; Huesing, Anna; Wolters, Heiner; Reuter, Stefan; Suwelack, Barbara			The Tacrolimus Metabolism Rate Influences Renal Function After Kidney Transplantation	PLOS ONE			English	Article							CALCINEURIN INHIBITOR NEPHROTOXICITY; CYTOCHROME-P450 3A5; RECIPIENTS; CYP3A5; PHARMACOKINETICS; POLYMORPHISMS; ABSORPTION; EXPRESSION; EVOLUTION; EXPOSURE	The effective calcineurin inhibitor (CNI) tacrolimus (Tac) is an integral part of the standard immunosuppressive regimen after renal transplantation (RTx). However, as a potent CNI it has nephrotoxic potential leading to impaired renal function in some cases. Therefore, it is of high clinical impact to identify factors which can predict who is endangered to develop CNI toxicity. We hypothesized that the Tac metabolism rate expressed as the blood concentration normalized by the dose (C/D ratio) is such a simple predictor. Therefore, we analyzed the impact of the C/D ratio on kidney function after RTx. Renal function was analyzed 1, 2, 3, 6, 12 and 24 months after RTx in 248 patients with an immunosuppressive regimen including basiliximab, tacrolimus, mycophenolate mofetil and prednisolone. According to keep the approach simple, patients were split into three C/D groups: fast, intermediate and slow metabolizers. Notably, compared with slow metabolizers fast metabolizers of Tac showed significantly lower estimated glomerular filtration rate (eGFR) values at all the time points analyzed. Moreover, fast metabolizers underwent more indication renal biopsies (p = 0.006) which revealed a higher incidence of CNI nephrotoxicity (p = 0.015) and BK nephropathy (p = 0.024) in this group. We herein identified the C/D ratio as an easy calculable risk factor for the development of CNI nephrotoxicity and BK nephropathy after RTx. We propose that the simple C/D ratio should be taken into account early in patient's risk management strategies.	[Thoelking, Gerold; Fortmann, Christian; Gerth, Hans Ulrich; Pabst, Dirk; Pavenstaedt, Hermann; Reuter, Stefan; Suwelack, Barbara] Univ Hosp Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med D, Munster, Germany; [Koch, Raphael] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Kabar, Iyad; Huesing, Anna] Univ Hosp Munster, Dept Transplant Med, Munster, Germany; [Wolters, Heiner] Univ Hosp Munster, Dept Gen Surg, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Tholking, G (corresponding author), Univ Hosp Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med D, Munster, Germany.	Gerold.Thoelking@ukmuenster.de	Koch, Raphael/A-7857-2013; Pabst, Dirk/M-6258-2019	Koch, Raphael/0000-0002-5581-5122; 	Deutsche Forschungsgemeinschaft; Open Access Publication Fund of University of Munster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of University of Munster	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Munster.	Acott P, 2012, ANN TRANSPL, V17, P86; Anglicheau D, 2003, NEPHROL DIAL TRANSPL, V18, P2409, DOI 10.1093/ndt/gfg381; Borni-Duval C, 2013, TRANSPLANTATION, V95, P1498, DOI 10.1097/TP.0b013e3182921995; Ekberg H, 2009, AM J TRANSPLANT, V9, P1876, DOI 10.1111/j.1600-6143.2009.02726.x; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Gijsen V, 2011, J HEART LUNG TRANSPL, V30, P1352, DOI 10.1016/j.healun.2011.08.001; Jacobson PA, 2012, TRANSPLANTATION, V93, P624, DOI 10.1097/TP.0b013e3182461288; Ji E, 2012, TRANSPLANTATION, V94, P866, DOI 10.1097/TP.0b013e318263700a; Joy MS, 2007, NEPHROL DIAL TRANSPL, V22, P1963, DOI 10.1093/ndt/gfm133; Karamperis N, 2003, TRANSPLANT P, V35, P1314, DOI 10.1016/S0041-1345(03)00481-0; Kim IW, 2012, BASIC CLIN PHARMACOL, V111, P217, DOI 10.1111/j.1742-7843.2012.00892.x; Kuypers DRJ, 2007, CLIN PHARMACOL THER, V82, P711, DOI 10.1038/sj.clpt.6100216; Kuypers DR, 2008, ANN TRANSPL, V13, P11; Kuypers DRJ, 2004, DRUG METAB DISPOS, V32, P1421, DOI 10.1124/dmd.104.001503; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Metalidis C, 2011, TRANSPLANTATION, V91, P1098, DOI 10.1097/TP.0b013e3182177502; Mourad M, 2006, CLIN CHEM LAB MED, V44, P1192, DOI 10.1515/CCLM.2006.229; Naesens M, 2007, AM J TRANSPLANT, V7, P2504, DOI 10.1111/j.1600-6143.2007.01949.x; Nankivell BJ, 2004, TRANSPLANTATION, V78, P461, DOI 10.1097/01.TP.0000128612.75163.26; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Stratta P, 2012, EUR J CLIN PHARMACOL, V68, P671, DOI 10.1007/s00228-011-1150-0; Tavira B, 2011, CLIN CHEM LAB MED, V49, P825, DOI 10.1515/CCLM.2011.143; Tsuchiya T, 2013, TRANSPLANTATION, V96, P198, DOI 10.1097/TP.0b013e318296c9d5; Watanabe Y, 1998, TRANSPL P, V30, P3777, DOI 10.1016/S0041-1345(98)01233-0	25	64	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111128	10.1371/journal.pone.0111128	http://dx.doi.org/10.1371/journal.pone.0111128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340655	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800086
J	Shaukat, Z; Liu, D; Choo, A; Hussain, R; O'Keefe, L; Richards, R; Saint, R; Gregory, SL				Shaukat, Z.; Liu, D.; Choo, A.; Hussain, R.; O'Keefe, L.; Richards, R.; Saint, R.; Gregory, S. L.			Chromosomal instability causes sensitivity to metabolic stress	ONCOGENE			English	Article							TUMOR-SUPPRESSOR GENE; OXIDATIVE STRESS; CANCER-CELLS; PAS KINASE; ANEUPLOIDY; DROSOPHILA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; DNA; MITOCHONDRIA; DEHYDROGENASE	Chromosomal INstability (CIN), a hallmark of cancer, refers to cells with an increased rate of gain or loss of whole chromosomes or chromosome parts. CIN is linked to the progression of tumors with poor clinical outcomes such as drug resistance. CIN can give tumors the diversity to resist therapy, but it comes at the cost of significant stress to tumor cells. To tolerate this, cancer cells must modify their energy use to provide adaptation against genetic changes as well as to promote their survival and growth. In this study, we have demonstrated that CIN induction causes sensitivity to metabolic stress. We show that mild metabolic disruption that does not affect normal cells, can lead to high levels of oxidative stress and subsequent cell death in CIN cells because they are already managing elevated stress levels. Altered metabolism is a differential characteristic of cancer cells, so our identification of key regulators that can exploit these changes to cause cell death may provide cancer-specific potential drug targets, especially for advanced cancers that exhibit CIN.	[Shaukat, Z.; Liu, D.; Choo, A.; Hussain, R.; O'Keefe, L.; Richards, R.; Saint, R.; Gregory, S. L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5006, Australia	University of Adelaide	Gregory, SL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, N Terrace, Adelaide, SA 5006, Australia.	stephen.gregory@adelaide.edu.au	Choo, Amanda/ABA-9721-2021; Gregory, Stephen L/B-9918-2008; O'Keefe, Louise V/B-9856-2008; Saint, Robert/A-4190-2008; Richards, Robert/ABE-6423-2020	Gregory, Stephen L/0000-0002-0046-5815; Saint, Robert/0000-0002-7989-6043; Choo, Amanda/0000-0002-4510-3615				Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Bauer G, 2012, ANTICANCER RES, V32, P2599; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cheung-Ong K, 2013, CHEM BIOL, V20, P648, DOI 10.1016/j.chembiol.2013.04.007; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Coe JP, 2002, FREE RADICAL BIO MED, V32, P187, DOI 10.1016/S0891-5849(01)00792-4; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hao HX, 2008, IUBMB LIFE, V60, P204, DOI 10.1002/iub.32; Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hockenbery DM, 2010, ENVIRON MOL MUTAGEN, V51, P476, DOI 10.1002/em.20552; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Iijima K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008498; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; KAPLAN O, 1990, CANCER RES, V50, P544; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kuo WY, 2000, INT J CANCER, V85, P857, DOI 10.1002/(SICI)1097-0215(20000315)85:6<857::AID-IJC20>3.3.CO;2-L; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Liu JK, 1996, FASEB J, V10, P1532, DOI 10.1096/fasebj.10.13.8940299; Manganelli Genesia, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P73; MERTENS F, 1994, PEDIATR HEMAT ONCOL, V11, P361, DOI 10.3109/08880019409140536; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; O'Keefe LV, 2011, HUM MOL GENET, V20, P497, DOI 10.1093/hmg/ddq495; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Radyuk SN, 2010, FREE RADICAL BIO MED, V49, P1892, DOI 10.1016/j.freeradbiomed.2010.09.014; Ren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012520; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sajesh BV, 2013, GENETICS, V195, P757, DOI 10.1534/genetics.113.156836; Schlafli P, 2009, CELL MOL LIFE SCI, V66, P876, DOI 10.1007/s00018-009-8699-0; Shaukat Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047447; Sheltzer JM, 2012, P NATL ACAD SCI USA, V109, P12644, DOI 10.1073/pnas.1209227109; Sotgia F, 2013, ONCOTARGET, V4, P1309, DOI 10.18632/oncotarget.1182; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Wang JX, 2012, TUMOR BIOL, V33, P95, DOI 10.1007/s13277-011-0251-9; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wong HW-S, 2013, CELL CYCLE, V13, P1; Wu Defeng, 2005, Toxicol Appl Pharmacol, V207, P70, DOI 10.1016/j.taap.2005.01.057; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang CH, 2014, ANTI-CANCER AGENT ME, V14, P280, DOI 10.2174/18715206113136660337; Zhang JD, 2007, BBA-MOL BASIS DIS, V1772, P1175, DOI 10.1016/j.bbadis.2007.10.001	65	26	26	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	31					4044	4055		10.1038/onc.2014.344	http://dx.doi.org/10.1038/onc.2014.344			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CN9PE	25347746				2022-12-26	WOS:000358780500003
J	Berkowitz, BA; Gorgis, J; Patel, A; Baameur, F; Gurevich, VV; Craft, CM; Kefalov, VJ; Roberts, R				Berkowitz, Bruce A.; Gorgis, Jawan; Patel, Ankit; Baameur, Faiza; Gurevich, Vsevolod V.; Craft, Cheryl M.; Kefalov, Vladimir J.; Roberts, Robin			Development of an MRI biomarker sensitive to tetrameric visual arrestin 1 and its reduction via light-evoked translocation in vivo	FASEB JOURNAL			English	Article						diabetes; magnetic resonance imaging; retina; rod photoreceptors	MANGANESE-ENHANCED MRI; STATIONARY NIGHT BLINDNESS; ARTICULAR-CARTILAGE; RHODOPSIN REGENERATION; DIABETIC-RETINOPATHY; PHOTORECEPTOR CELLS; ROD PHOTORECEPTORS; OGUCHI-DISEASE; FUNCTIONAL MRI; ION REGULATION	Rod tetrameric arrestin 1 ( tet- ARR1), stored in the outer nuclear layer/ inner segments in the dark, modulates photoreceptor synaptic activity; light exposure stimulates a reduction via translocation to the outer segments for terminating G- protein coupled phototransduction signaling. Here, we test the hypothesis that intraretinal spin- lattice relaxation rate in the rotating frame ( 1/ T1r), an endogenous MRI contrast mechanism, has high potential for evaluating rod tet- ARR1 and its reduction via translocation. Dark- and light- exposed mice ( null for the ARR1 gene, overexpressing ARR1, diabetic, or wild type with or without treatment with Mn2+, a calcium channel probe) were studied using 1/ T1r MRI. Immunohistochemistry and single- cell recordings of the retinas were also performed. In wild- type mice with or without treatment with Mn2+, 1/ T1r of avascular outer retina ( 64% to 72% depth) was significantly ( P < 0.05) greater in the dark than in the light; a significant ( P < 0.05) but opposite pattern was noted in the inner retina (< 50% depth). Light- evoked outer retina D1/ T1r was absent in ARR1- null mice and supernormal in overexpressing mice. In diabetic mice, the outer retinal D1/ T1r pattern suggested normal darkto- light tet- ARR1 translocation and chromophore content, conclusions confirmed ex vivo. Light- stimulated D1/ T1r in inner retina was linked to changes in blood volume. Our data support 1/ T1r MRI for noninvasively assessing rod tet- ARR1 and its reduction via protein translocation, which can be combined with other metrics of retinal function in vivo.-	[Berkowitz, Bruce A.; Gorgis, Jawan; Patel, Ankit; Roberts, Robin] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Berkowitz, Bruce A.] Wayne State Univ, Dept Ophthalmol, Detroit, MI 48201 USA; [Baameur, Faiza; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Craft, Cheryl M.] Univ So Calif, Keck Sch Med, USC Eye Inst, Mary Allen Lab Vis Res, Los Angeles, CA USA; [Craft, Cheryl M.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA USA; [Craft, Cheryl M.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA USA; [Kefalov, Vladimir J.] Washington Univ St Louis, Dept Ophthalmol & Visual Sci, St Louis, MO 63103 USA	Wayne State University; Wayne State University; Vanderbilt University; University of Southern California; University of Southern California; University of Southern California; Washington University (WUSTL)	Berkowitz, BA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA.	baberko@med.wayne.edu	Gurevich, Vsevolod/A-3236-2008; Cote, Rick H/G-3363-2013	Gurevich, Vsevolod/0000-0002-3950-5351; Cote, Rick H/0000-0002-1573-6526; Kefalov, Vladimir/0000-0002-1659-008X	NEI NIH HHS [R01 EY019312, EY015851, EY011500, EY019312, EY021126, R01 EY015851, R01 EY011500, P30 EY002687, EY002687, R21 EY021619, R24 EY021126] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY019312, R21EY021619, R01EY015851, P30EY002687, R24EY021126, R01EY011500] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akella SVS, 2001, MAGNET RESON MED, V46, P419, DOI 10.1002/mrm.1208; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Ball SL, 2000, INVEST OPHTH VIS SCI, V41, P610; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P840; Berkowitz BA, 1999, INVEST OPHTH VIS SCI, V40, P2100; Berkowitz BA, 2006, INVEST OPHTH VIS SCI, V47, P2668, DOI 10.1167/iovs.05-1588; Berkowitz Bruce A, 2013, Expert Opin Med Diagn, V7, P393, DOI 10.1517/17530059.2013.814639; Berkowitz BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029619; Berkowitz BA, 2012, MOL VIS, V18, P372; Berkowitz BA, 2010, MOL VIS, V16, P1776; Berkowitz BA, 2008, NMR BIOMED, V21, P957, DOI 10.1002/nbm.1303; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Bissig D., 2012, MOL VIS, V18; Bissig D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056340; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; BRAEKEVELT CR, 1970, AM J ANAT, V127, P281, DOI 10.1002/aja.1001270305; BROWN B, 2010, DES ISSUES, V26, P1; Burns ME, 2006, J NEUROSCI, V26, P1036, DOI 10.1523/JNEUROSCI.3301-05.2006; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Charagundla SR, 2003, J MAGN RESON, V162, P113, DOI 10.1016/S1090-7807(02)00197-0; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Cheng HY, 2006, P NATL ACAD SCI USA, V103, P17525, DOI 10.1073/pnas.0605790103; de Carvalho JER, 2014, SURV OPHTHALMOL, V59, P393, DOI 10.1016/j.survophthal.2013.09.005; Duong TQ, 2014, MAGN RESON MED, V71, P1526, DOI 10.1002/mrm.24797; Garcia-Ramirez M, 2009, DIABETOLOGIA, V52, P2633, DOI 10.1007/s00125-009-1548-8; Godara P, 2012, AM J OPHTHALMOL, V154, P987, DOI 10.1016/j.ajo.2012.06.003; Grohn OHJ, 2000, J CEREBR BLOOD F MET, V20, P1457; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Hanson SM, 2008, BIOCHEMISTRY-US, V47, P1070, DOI 10.1021/bi7021359; Hardarson SH, 2009, INVEST OPHTH VIS SCI, V50, P2308, DOI 10.1167/iovs.08-2576; Huang SP, 2010, J NEUROSCI, V30, P9381, DOI 10.1523/JNEUROSCI.1207-10.2010; Hulvershorn J, 2005, MAGN RESON MED, V54, P1155, DOI 10.1002/mrm.20698; Jin T, 2013, NEUROIMAGE, V78, P385, DOI 10.1016/j.neuroimage.2013.04.045; Kern TS, 2010, MOL VIS, V16, P2121; Kettunen MI, 2002, MAGNET RESON MED, V48, P470, DOI 10.1002/mrm.10233; Kim M, 2011, BIOCHEMISTRY-US, V50, P2235, DOI 10.1021/bi1018607; Kirwin SJ, 2011, INVEST OPHTH VIS SCI, V52, P7654, DOI 10.1167/iovs.10-6609; KNOSPE V, 1988, CURR EYE RES, V7, P1137, DOI 10.3109/02713688809001885; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Magnotta VA, 2012, P NATL ACAD SCI USA, V109, P8270, DOI 10.1073/pnas.1205902109; Mendez A, 2003, J NEUROSCI, V23, P3124; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Nusinowitz S, 1999, INVEST OPHTH VIS SCI, V40, P2848; Ostroy SE, 1998, CURR EYE RES, V17, P979, DOI 10.1076/ceyr.17.10.979.5236; OSTROY SE, 1994, INVEST OPHTH VIS SCI, V35, P3905; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Raya JG, 2010, MAGN RESON MED, V63, P181, DOI 10.1002/mrm.22178; Regatte RR, 2003, J MAGN RESON IMAGING, V17, P114, DOI 10.1002/jmri.10228; Shih YYI, 2013, CURR EYE RES, V38, P292, DOI 10.3109/02713683.2012.756526; Shih YYI, 2011, INVEST OPHTH VIS SCI, V52, P5303, DOI 10.1167/iovs.10-6438; Smith WC, 2013, PROG MOL BIOL TRANSL, V118, P243, DOI 10.1016/B978-0-12-394440-5.00010-3; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Wangsa-Wirawan ND, 2003, ARCH OPHTHALMOL-CHIC, V121, P547, DOI 10.1001/archopht.121.4.547; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; YAMAMOTO F, 1992, EXP EYE RES, V54, P685, DOI 10.1016/0014-4835(92)90023-L; Zhi ZW, 2014, INVEST OPHTH VIS SCI, V55, P1024, DOI 10.1167/iovs.13-12864	60	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					554	564		10.1096/fj.14-254953	http://dx.doi.org/10.1096/fj.14-254953			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25351983	Green Published			2022-12-26	WOS:000349370400018
J	Sand, KMK; Bern, M; Nilsen, J; Dalhus, B; Gunnarsen, KS; Cameron, J; Grevys, A; Bunting, K; Sandlie, I; Andersen, JT				Sand, Kine Marita Knudsen; Bern, Malin; Nilsen, Jeannette; Dalhus, Bjorn; Gunnarsen, Kristin Stoen; Cameron, Jason; Grevys, Algirdas; Bunting, Karen; Sandlie, Inger; Andersen, Jan Terje			Interaction with Both Domain I and III of Albumin Is Required for Optimal pH-dependent Binding to the Neonatal Fc Receptor (FcRn)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Albumin; Biodegradation; Bioengineering; Fc Receptor; pH Regulation; Pharmacokinetics	HUMAN SERUM-ALBUMIN; HALF-LIFE; CRYSTAL-STRUCTURE; HUMAN IGG1; MUTAGENESIS; REVEALS; SITE; EXPRESSION; ANTIBODIES; CONSEQUENCES	Background: FcRn regulates the long serum half-life of albumin. Results: The C-terminal DIII of HSA is the principal domain for FcRn binding, whereas two loops in DI at the N terminus modulate the interaction. Conclusion: DI of albumin contributes to optimal FcRn binding. Significance: We highlight the importance of DI for pH-dependent binding to FcRn. Albumin is an abundant blood protein that acts as a transporter of a plethora of small molecules like fatty acids, hormones, toxins, and drugs. In addition, it has an unusual long serum half-life in humans of nearly 3 weeks, which is attributed to its interaction with the neonatal Fc receptor (FcRn). FcRn protects albumin from intracellular degradation via a pH-dependent cellular recycling mechanism. To understand how FcRn impacts the role of albumin as a distributor, it is of importance to unravel the structural mechanism that determines pH-dependent binding. Here, we show that although the C-terminal domain III (DIII) of human serum albumin (HSA) contains the principal binding site, the N-terminal domain I (DI) is important for optimal FcRn binding. Specifically, structural inspection of human FcRn (hFcRn) in complex with HSA revealed that two exposed loops of DI were in proximity with the receptor. To investigate to what extent these contacts affected hFcRn binding, we targeted selected amino acid residues of the loops by mutagenesis. Screening by in vitro interaction assays revealed that several of the engineered HSA variants showed decreased binding to hFcRn, which was also the case for two missense variants with mutations within these loops. In addition, four of the variants showed improved binding. Our findings demonstrate that both DI and DIII are required for optimal binding to FcRn, which has implications for our understanding of the FcRn-albumin relationship and how albumin acts as a distributor. Such knowledge may inspire development of novel HSA-based diagnostics and therapeutics.	[Sand, Kine Marita Knudsen; Bern, Malin; Grevys, Algirdas; Sandlie, Inger] Univ Oslo, CIR, N-0316 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Grevys, Algirdas; Sandlie, Inger] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Nilsen, Jeannette; Gunnarsen, Kristin Stoen; Grevys, Algirdas; Sandlie, Inger; Andersen, Jan Terje] Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0424 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Nilsen, Jeannette; Gunnarsen, Kristin Stoen; Grevys, Algirdas; Sandlie, Inger; Andersen, Jan Terje] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0424 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Nilsen, Jeannette; Dalhus, Bjorn; Gunnarsen, Kristin Stoen; Grevys, Algirdas; Sandlie, Inger; Andersen, Jan Terje] Univ Oslo, N-0424 Oslo, Norway; [Nilsen, Jeannette; Bunting, Karen] Univ Oslo, Inst Clin Med, N-0424 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Microbiol, N-0424 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Med Biochem, N-0424 Oslo, Norway; [Dalhus, Bjorn; Cameron, Jason] Novozymes Biopharma UK Ltd, Nottingham NG7 1FD, England	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Novozymes	Andersen, JT (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, POB 4956, N-0424 Oslo, Norway.	j.t.andersen@medisin.uio.no	Andersen, Jan Terje/AAB-6209-2020; Dalhus, Bjørn/AAK-2895-2020	Andersen, Jan Terje/0000-0003-1710-1628; Grevys, Algirdas/0000-0001-7350-5841	Research Council of Norway through its Centres of Excellence funding scheme [179573]; University of Oslo; Research Council of Norway [143822, 230526/F20, 179573/V40]; South-Eastern Norway Regional Health Authority [2009100, 2011040, 2012085, 39457]	Research Council of Norway through its Centres of Excellence funding scheme; University of Oslo; Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	This work was supported in part by the Research Council of Norway through its Centres of Excellence funding scheme (Project 179573). I. S., J. T. A., B. D., K. B., and J. C. are co-inventors of pending patent applications related to the data described in this paper.; Supported by the University of Oslo.; Supported by the Research Council of Norway through its programme for Global Health and Vaccination Research (GLOBVAC) (Grant 143822).; Supported by the Research Council of Norway (Grant 230526/F20).; Supported by the South-Eastern Norway Regional Health Authority to establish the Regional Technology Platform for Structural Biology and Bioinformatics (Grants 2009100, 2011040, and 2012085).; Supported by the South-Eastern Norway Regional Health Authority (Grant 39457).; Supported by the Research Council of Norway (Grants 230526/F20 and 179573/V40).	Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2014, J BIOL CHEM, V289, P13492, DOI 10.1074/jbc.M114.549832; Andersen JT, 2013, J BIOL CHEM, V288, P24277, DOI 10.1074/jbc.M113.463000; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2010, CLIN BIOCHEM, V43, P367, DOI 10.1016/j.clinbiochem.2009.12.001; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Cardoso RMF, 2003, PROTEINS, V51, P137, DOI 10.1002/prot.10345; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Flora K, 1998, BIOPHYS J, V75, P1084, DOI 10.1016/S0006-3495(98)77598-8; GALLIANO M, 1990, P NATL ACAD SCI USA, V87, P8721, DOI 10.1073/pnas.87.22.8721; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Kim J, 2007, CLIN IMMUNOL, V122, P146, DOI 10.1016/j.clim.2006.09.001; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; Kragh-Hansen U, 2013, BBA-GEN SUBJECTS, V1830, P5405, DOI 10.1016/j.bbagen.2013.03.026; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Sand KMK, 2014, J BIOL CHEM, V289, P17228, DOI 10.1074/jbc.M113.522565; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TAKAHASHI N, 1987, P NATL ACAD SCI USA, V84, P8001, DOI 10.1073/pnas.84.22.8001; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; Wani MA, 2006, P NATL ACAD SCI USA, V103, P5084, DOI 10.1073/pnas.0600548103; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014	47	32	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34583	34594		10.1074/jbc.M114.587675	http://dx.doi.org/10.1074/jbc.M114.587675			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25344603	Green Published, hybrid			2022-12-26	WOS:000346260800017
J	Lucana, DOD; Fedosov, SN; Wedderhoff, I; Che, EN; Torda, AE				Lucana, Dario Ortiz de Orue; Fedosov, Sergey N.; Wedderhoff, Ina; Che, Edith N.; Torda, Andrew E.			The Extracellular Heme-binding Protein HbpS from the Soil Bacterium Streptomyces reticuli Is an Aquo-cobalamin Binder	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Ligand-binding Protein; Metalloprotein; Microbiology; Spectroscopy	X-RAY-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; ARABIDOPSIS-THALIANA; INTRINSIC-FACTOR; SENSING PROTEIN; VITAMIN-B-12; TRANSCOBALAMIN; BIOSYNTHESIS	Background: Sequence and structure comparisons suggested that the heme-binding protein HbpS from Streptomyces reticuli might bind cobalamin. Results: HbpS binds aquo-cobalamin and the responsible histidine was identified. Conclusion: The calculated K-d of 34 m suggests that HbpS might bind cobalamin in both bacterial cultures and in the Streptomyces natural environment the soil. Significance: The results suggest an evolutionary path between tetrapyrrole binding roles in the HbpS-like protein family. The extracellular protein HbpS from Streptomyces reticuli interacts with iron ions and heme. It also acts in concert with the two-component sensing system SenS-SenR in response to oxidative stress. Sequence comparisons suggested that the protein may bind a cobalamin. UV-visible spectroscopy confirmed binding (K-d = 34 m) to aquo-cobalamin (H(2)OCbl(+)) but not to other cobalamins. Competition experiments with the H(2)OCbl(+)-coordinating ligand CN- and comparison of mutants identified a histidine residue (His-156) that coordinates the cobalt ion of H(2)OCbl(+) and substitutes for water. HbpSCobalamin lacks the Asp-X-His-X-X-Gly motif seen in some cobalamin binding enzymes. Preliminary tests showed that a related HbpS protein from a different species also binds H(2)OCbl(+). Furthermore, analyses of HbpS-heme binding kinetics are consistent with the role of HbpS as a heme-sensor and suggested a role in heme transport. Given the high occurrence of HbpS-like sequences among Gram-positive and Gram-negative bacteria, our findings suggest a great functional versatility among these proteins.	[Lucana, Dario Ortiz de Orue; Wedderhoff, Ina; Che, Edith N.] Univ Osnabruck, Dept Biol Chem, D-49067 Osnabruck, Germany; [Fedosov, Sergey N.] Aarhus Univ, Dept Engn, DK-8000 Aarhus, Denmark; [Torda, Andrew E.] Univ Hamburg, Ctr Bioinformat, D-20146 Hamburg, Germany	University Osnabruck; Aarhus University; University of Hamburg	Lucana, DOD (corresponding author), Univ Osnabruck, Dept Biol Chem, Barbarastr 13, D-49067 Osnabruck, Germany.	ortiz@biologie.uni-osnabrueck.de	Fedosov, Sergey N./J-2340-2019	Fedosov, Sergey N./0000-0002-7016-2959	Deutsche Forschungsgemeinschaft [OR 224/2-1, OR 224/4-1]; Heisenberg Programme from the Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg Programme from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants OR 224/2-1 and OR 224/4-1.; Supported by the Heisenberg Programme from the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed: Applied Genetics of Microorganisms, Dept. of Biology/Chemistry, University of Osnabrueck, Barbarastr. 13, 49067 Osnabrueck, Germany. Tel.: 495419693439; Fax: 495419692804; E-mail: ortiz@biologie.uni-osnabrueck.de.	Allen KD, 2014, ARCH BIOCHEM BIOPHYS, V543, P67, DOI 10.1016/j.abb.2013.12.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Bogel G, 2009, AMINO ACIDS, V37, P681, DOI 10.1007/s00726-008-0188-5; Book AJ, 2014, APPL ENVIRON MICROB, V80, P4692, DOI 10.1128/AEM.01133-14; Borovok I, 2006, J BACTERIOL, V188, P2512, DOI 10.1128/JB.188.7.2512-2520.2006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; DAWSON JH, 1983, J BIOL CHEM, V258, P3637; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2005, BIOCHEMISTRY-US, V44, P3604, DOI 10.1021/bi047936v; Fedosov SN, 1999, J BIOL CHEM, V274, P26015, DOI 10.1074/jbc.274.37.26015; Fedosov SN, 2000, J BIOL CHEM, V275, P11791, DOI 10.1074/jbc.275.16.11791; Fedosov SN, 2003, EUR J BIOCHEM, V270, P3362, DOI 10.1046/j.1432-1033.2003.03716.x; Flinspach K, 2010, BIOPOLYMERS, V93, P823, DOI 10.1002/bip.21493; FRIEDMANN HC, 1970, ANNU REV MICROBIOL, V24, P159, DOI 10.1146/annurev.mi.24.100170.001111; Gruber K, 2011, CHEM SOC REV, V40, P4346, DOI 10.1039/c1cs15118e; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hoffmann B, 1999, EUR J BIOCHEM, V263, P178, DOI 10.1046/j.1432-1327.1999.00482.x; Hopwood D. A., 1985, GENETIC MANIPULATION; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johnson CLV, 2001, J BACTERIOL, V183, P1577, DOI 10.1128/JB.183.5.1577-1584.2001; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Krautler B, 2005, BIOCHEM SOC T, V33, P806; KRAUTLER B, 2006, ENCY INORGANIC CHEM, P1272; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; LOCHHEAD AG, 1956, NATURE, V178, P144, DOI 10.1038/178144a0; LOCHHEAD AG, 1951, NATURE, V167, P1034, DOI 10.1038/1671034a0; Lucana DOD, 2010, J BIOL CHEM, V285, P28086, DOI 10.1074/jbc.M110.127506; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Lucana DODO, 2009, J MOL BIOL, V386, P1108, DOI 10.1016/j.jmb.2009.01.017; Lucana DOD, 2004, MICROBIOL-SGM, V150, P2575, DOI 10.1099/mic.0.27091-0; Margraf T, 2009, NUCLEIC ACIDS RES, V37, pW480, DOI 10.1093/nar/gkp431; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Meschke H, 2010, MICROB BIOTECHNOL, V3, P428, DOI 10.1111/j.1751-7915.2010.00165.x; MOZAFAR A, 1992, PLANT SOIL, V139, P23, DOI 10.1007/BF00012838; MOZAFAR A, 1994, PLANT SOIL, V167, P305, DOI 10.1007/BF00007957; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Parsons JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014009; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Pratt J. M., 1972, INORGANIC CHEM VITAM; Romero D, 2011, CHEM REV, V111, P5492, DOI 10.1021/cr2000509; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Sambrook J., 2002, MOL CLONING LAB MANU; Shibata N, 1999, STRUCTURE, V7, P997, DOI 10.1016/S0969-2126(99)80126-9; Siedenburg G, 2012, ANTIOXID REDOX SIGN, V16, P668, DOI 10.1089/ars.2011.4290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sjuts H, 2013, ACTA CRYSTALLOGR D, V69, P1609, DOI 10.1107/S0907444913011323; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun JB, 2003, BIOTECHNOL PROGR, V19, P263, DOI 10.1021/bp025739m; Torda AE, 2013, FEMS MICROBIOL LETT, V342, P106, DOI 10.1111/1574-6968.12093; Walsh CT, 2006, NAT PROD REP, V23, P517, DOI 10.1039/b605245m; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Wedderhoff I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071579; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Wuerges J, 2007, IUBMB LIFE, V59, P722, DOI 10.1080/15216540701673413; Yin L, 2013, MBIO, V4, DOI 10.1128/mBio.00563-13; Yin L, 2012, J BIOL CHEM, V287, P13850, DOI 10.1074/jbc.M112.346494; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f; Zou P, 2008, ACTA CRYSTALLOGR F, V64, P386, DOI 10.1107/S1744309108008348	69	7	7	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34214	34228		10.1074/jbc.M114.585489	http://dx.doi.org/10.1074/jbc.M114.585489			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342754	Green Published, hybrid			2022-12-26	WOS:000346077600044
J	Darmon, E; Eykelenboom, JK; Lopez-Vernaza, MA; White, MA; Leach, DRF				Darmon, Elise; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; White, Martin A.; Leach, David R. F.			Repair on the Go: E. coli Maintains a High Proliferation Rate while Repairing a Chronic DNA Double-Strand Break	PLOS ONE			English	Article							IRRADIATED ESCHERICHIA-COLI; BACTERIAL-CELL DIVISION; Z-RING FORMATION; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; DAMAGE CHECKPOINT; SOS INDUCTION; FISSION YEAST; LEXA PROTEIN; REPLICATION	DNA damage checkpoints exist to promote cell survival and the faithful inheritance of genetic information. It is thought that one function of such checkpoints is to ensure that cell division does not occur before DNA damage is repaired. However, in unicellular organisms, rapid cell multiplication confers a powerful selective advantage, leading to a dilemma. Is the activation of a DNA damage checkpoint compatible with rapid cell multiplication? By uncoupling the initiation of DNA replication from cell division, the Escherichia coli cell cycle offers a solution to this dilemma. Here, we show that a DNA double-strand break, which occurs once per replication cycle, induces the SOS response. This SOS induction is needed for cell survival due to a requirement for an elevated level of expression of the RecA protein. Cell division is delayed, leading to an increase in average cell length but with no detectable consequence on mutagenesis and little effect on growth rate and viability. The increase in cell length caused by chronic DNA double-strand break repair comprises three components: two types of increase in the unit cell size, one independent of SfiA and SlmA, the other dependent of the presence of SfiA and the absence of SlmA, and a filamentation component that is dependent on the presence of either SfiA or SlmA. These results imply that chronic checkpoint induction in E. coli is compatible with rapid cell multiplication. Therefore, under conditions of chronic low-level DNA damage, the SOS checkpoint operates seamlessly in a cell cycle where the initiation of DNA replication is uncoupled from cell division.	[Darmon, Elise; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; White, Martin A.; Leach, David R. F.] Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Leach, DRF (corresponding author), Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland.	D.Leach@ed.ac.uk	Leach, David R/H-7159-2012	Leach, David R/0000-0003-4964-6913; White, Martin/0000-0001-6482-8462; Lopez Vernaza, Manuel Augusto/0000-0002-9542-7028; Eykelenboom, John/0000-0003-4115-9686	Medical Research Council (UK) [G0901622]; MRC [G0901622] Funding Source: UKRI; Medical Research Council [G0901622] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been funded by grant G0901622 to DL from the Medical Research Council (UK) [http://www.mrc.ac.uk/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204; Cambridge J, 2014, J BACTERIOL, V196, P36, DOI 10.1128/JB.01230-12; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Courcelle J, 2001, GENETICS, V158, P41; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Cromie GA, 2000, GENETICS, V154, P513; Delmas S, 2006, P NATL ACAD SCI USA, V103, P4564, DOI 10.1073/pnas.0509012103; di Domenico EG, 2009, DNA REPAIR, V8, P209, DOI 10.1016/j.dnarep.2008.10.005; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Keller KL, 2001, MUTAT RES-DNA REPAIR, V486, P21, DOI 10.1016/S0921-8777(01)00077-5; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; Lee M, 2008, CELL BIOCHEM FUNCT, V26, P125, DOI 10.1002/cbf.1428; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Maisnier-Patin S, 2001, MOL MICROBIOL, V42, P1371, DOI 10.1046/j.1365-2958.2001.02718.x; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Meddows TR, 2004, MOL MICROBIOL, V52, P119, DOI 10.1111/j.1365-2958.2003.03970.x; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Pham P, 2001, P NATL ACAD SCI USA, V98, P8350, DOI 10.1073/pnas.111007198; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Rudolph CJ, 2007, GENE DEV, V21, P668, DOI 10.1101/gad.417607; SIEDE W, 1993, P NATL ACAD SCI USA, V90, P7985, DOI 10.1073/pnas.90.17.7985; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Spell Rachelle Miller, 2004, Methods Mol Biol, V262, P3; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Thoms B, 1998, J BACTERIOL, V180, P5639, DOI 10.1128/JB.180.21.5639-5645.1998; Tonthat NK, 2013, P NATL ACAD SCI USA, V110, P10586, DOI 10.1073/pnas.1221036110; Vlasic I, 2008, BIOCHIMIE, V90, P1347, DOI 10.1016/j.biochi.2008.04.002; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Walker GC, 2000, BACTERIAL STRESS RESPONSES, P131; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Weinert T, 2007, SCIENCE, V315, P1374, DOI 10.1126/science.1140759; WHITBY MC, 1995, MOL GEN GENET, V246, P174, DOI 10.1007/BF00294680; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671; Zaritsky A, 2011, MICROBIOL-SGM, V157, P1876, DOI 10.1099/mic.0.049403-0	53	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110784	10.1371/journal.pone.0110784	http://dx.doi.org/10.1371/journal.pone.0110784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353327	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200035
J	Proulx, MJ; Parker, MO; Tahir, Y; Brennan, CH				Proulx, Michael J.; Parker, Matthew O.; Tahir, Yasser; Brennan, Caroline H.			Parallel Mechanisms for Visual Search in Zebrafish	PLOS ONE			English	Article							DANIO-RERIO RESPONDS; TOP-DOWN; INTEGRATION; ATTENTION; SALIENCE; MODELS; SYSTEM; SERIAL; FISH; MAP	Parallel visual search mechanisms have been reported previously only in mammals and birds, and not animals lacking an expanded telencephalon such as bees. Here we report the first evidence for parallel visual search in fish using a choice task where the fish had to find a target amongst an increasing number of distractors. Following two-choice discrimination training, zebrafish were presented with the original stimulus within an increasing array of distractor stimuli. We found that zebrafish exhibit no significant change in accuracy and approach latency as the number of distractors increased, providing evidence of parallel processing. This evidence challenges theories of vertebrate neural architecture and the importance of an expanded telencephalon for the evolution of executive function.	[Proulx, Michael J.] Univ Bath, Dept Psychol, Crossmodal Cognit Lab, Bath BA2 7AY, Avon, England; [Parker, Matthew O.; Tahir, Yasser; Brennan, Caroline H.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of Bath; University of London; Queen Mary University London	Brennan, CH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	c.h.brennan@qmul.ac.uk	Proulx, Michael J/A-1045-2008; Parker, Matthew/J-6815-2019	Parker, Matthew/0000-0002-7172-5231; Proulx, Michael/0000-0003-4066-3645	National Centre for the Replacement, Reduction and Refinement of animals in research (NC3Rs; UK) [G1000053]; Medical Research Council (MRC; UK); National Centre for the Replacement [G1000053/1] Funding Source: researchfish	National Centre for the Replacement, Reduction and Refinement of animals in research (NC3Rs; UK); Medical Research Council (MRC; UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement	This research was funded by project grant G1000053 from the National Centre for the Replacement, Reduction and Refinement of animals in research (NC3Rs; UK) and by the Medical Research Council (MRC; UK). CHB is a Royal Society (UK) Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Abaid N, 2010, J R SOC INTERFACE, V7, P1441, DOI 10.1098/rsif.2010.0175; Aoki I, 1980, B OCEAN RES I U TOKY, V12; Beane M, 2004, PROG NEUROBIOL, V74, P167, DOI 10.1016/j.pneurobio.2004.09.001; BLOUGH PM, 1984, PERCEPT PSYCHOPHYS, V35, P344, DOI 10.3758/BF03206338; Botly LC, 2011, CEREB CORTEX; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; de Sousa A, 2012, PROG BRAIN RES, V195, P293, DOI 10.1016/B978-0-444-53860-4.00014-3; Donnelly N, 2007, Q J EXP PSYCHOL, V60, P120, DOI 10.1080/17470210600625362; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Lopez U, 2012, INTERFACE FOCUS, V2, P693, DOI 10.1098/rsfs.2012.0033; Mokeichev A, 2010, P NATL ACAD SCI USA, V107, P16726, DOI 10.1073/pnas.1005446107; Neri P, 2012, ANIM BEHAV, V84, P485, DOI 10.1016/j.anbehav.2012.06.005; Parker MO, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00063; Parker MO, 2012, BEHAV BRAIN RES, V232, P264, DOI 10.1016/j.bbr.2012.04.035; Proulx MJ, 2007, J EXP PSYCHOL HUMAN, V33, P48, DOI 10.1037/0096-1523.33.1.48; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Renninger SL, 2011, NEUROGENETICS, V12, P97, DOI 10.1007/s10048-011-0273-x; Rink E, 2002, BRAIN RES BULL, V57, P385, DOI 10.1016/S0361-9230(01)00696-7; Spaethe J, 2006, J EXP BIOL, V209, P987, DOI 10.1242/jeb.02124; Spence R, 2008, ETHOLOGY, V114, P582, DOI 10.1111/j.1439-0310.2008.01515.x; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; TOWNSEND JT, 1990, PSYCHOL SCI, V1, P46, DOI 10.1111/j.1467-9280.1990.tb00067.x; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsotsos JK, 1997, CONSCIOUS COGN, V6, P429, DOI 10.1006/ccog.1997.0302; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Zirger JM, 2003, GENE EXPR PATTERNS, V3, P747, DOI 10.1016/S1567-133X(03)00126-1	34	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111540	10.1371/journal.pone.0111540	http://dx.doi.org/10.1371/journal.pone.0111540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353168	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200088
J	Mishra, S; Alavilli, H; Lee, BH; Panda, SK; Sahoo, L				Mishra, Sagarika; Alavilli, Hemasundar; Lee, Byeong-Ha; Panda, Sanjib Kumar; Sahoo, Lingaraj			Cloning and Functional Characterization of a Vacuolar Na+/H+ Antiporter Gene from Mungbean (VrNHX1) and Its Ectopic Expression Enhanced Salt Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							SODIUM-TRANSPORT; MOLECULAR-CLONING; SUAEDA-SALSA; STRESS; YEAST; SALINITY; K+; OVEREXPRESSION; TRANSFORMATION; HOMEOSTASIS	Plant vacuolar NHX exchangers play a significant role in adaption to salt stress by compartmentalizing excess cytosolic Na+ into vacuoles and maintaining cellular homeostasis and ionic equilibrium. We cloned an orthologue of the vacuolar Na+/H+ antiporter gene, VrNHX1 from mungbean (Vigna radiata), an important Asiatic grain legume. The VrNHX1 (Genbank Accession number JN656211.1) contains 2095 nucleotides with an open reading frame of 1629 nucleotides encoding a predicted protein of 542 amino acids with a deduced molecular mass of 59.6 kDa. The consensus amiloride binding motif ((LFFIYLLPPI93)-L-84) was observed in the third putative transmembrane domain of VrNHX1. Bioinformatic and phylogenetic analysis clearly suggested that VrNHX1 had high similarity to those of orthologs belonging to Class-I clade of plant NHX exchangers in leguminous crops. VrNHX1 could be strongly induced by salt stress in mungbean as the expression in roots significantly increased in presence of 200 mM NaCl with concomitant accumulation of total [Na+]. Induction of VrNHX1 was also observed under cold and dehydration stress, indicating a possible cross talk between various abiotic stresses. Heterologous expression in salt sensitive yeast mutant AXT3 complemented for the loss of yeast vacuolar NHX1 under NaCl, KCl and LiCl stress indicating that VrNHX1 was the orthologue of ScNHX1. Further, AXT3 cells expressing VrNHX1 survived under low pH environment and displayed vacuolar alkalinization analyzed using pH sensitive fluorescent dye BCECF-AM. The constitutive and stress inducible expression of VrNHX1 resulted in enhanced salt tolerance in transgenic Arabidopsis thaliana lines. Our work suggested that VrNHX1 was a salt tolerance determinant in mungbean.	[Mishra, Sagarika; Sahoo, Lingaraj] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, India; [Alavilli, Hemasundar; Lee, Byeong-Ha] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Panda, Sanjib Kumar] Assam Univ, Dept Life Sci & Bioinformat, Silchar, India; [Panda, Sanjib Kumar] Oklahoma State Univ, Noble Res Ctr, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Sogang University; Assam University; Oklahoma State University System; Oklahoma State University - Stillwater	Sahoo, L (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, India.	ls@iitg.ernet.in	Mishra, Sagarika/W-6314-2019; Mishra, Sagarika/ABF-5875-2021; Lee, Byeong-ha/B-8478-2009	Mishra, Sagarika/0000-0003-1123-2483; Mishra, Sagarika/0000-0003-1123-2483; Lee, Byeong-ha/0000-0001-7633-3264; Panda, Sanjib Kumar/0000-0001-5131-9693	Department of Biotechnology, Government of India [BT/PR10818/AGR/02/591/2008]; Rural Development Administration, Republic of Korea [PJ009104]; MHRD	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); MHRD	LS is grateful to Department of Biotechnology, Government of India for partial support from the grant (BT/PR10818/AGR/02/591/2008) to this work. BhL is grateful to Rural Development Administration, Republic of Korea for its support by Next-Generation BioGreen 21 Program (PJ009104). SM is grateful to MHRD for Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; An BaoYan, 2008, Acta Agronomica Sinica, V34, P557, DOI 10.3724/SP.J.1006.2008.00557; Baltierra F, 2013, BIOCHEM BIOPH RES CO, V430, P535, DOI 10.1016/j.bbrc.2012.11.118; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Bor M, 2003, PLANT SCI, V164, P77, DOI 10.1016/S0168-9452(02)00338-2; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Dernetriou G, 2007, BBA-BIOENERGETICS, V1767, P272, DOI 10.1016/j.bbabio.2007.02.020; Du YH, 2010, J PLANT BIOL, V53, P251, DOI 10.1007/s12374-010-9107-x; Fukuda A, 2004, PLANT CELL PHYSIOL, V45, P146, DOI 10.1093/pcp/pch014; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gouiaa S, 2012, PLANT MOL BIOL, V79, P137, DOI 10.1007/s11103-012-9901-6; Guan B, 2011, MOL BIOL REP, V38, P1889, DOI 10.1007/s11033-010-0307-8; Hamada A, 2001, PLANT MOL BIOL, V46, P35, DOI 10.1023/A:1010603222673; Harris C, 1999, INT J MOL MED, V3, P315; Hasanuzzaman M, 2013, INT CURR PHARM J, V2, P92; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jacoby B., 1999, HDB PLANT CROP STRES, V2, P97; Kinclova-Zimmermannova O, 2004, FOLIA MICROBIOL, V49, P519, DOI 10.1007/BF02931527; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Li JY, 2007, PLANT CELL TISS ORG, V90, P41, DOI 10.1007/s11240-007-9246-z; Li WYF, 2006, PLANT CELL ENVIRON, V29, P1122, DOI 10.1111/j.1365-3040.2005.01487.x; LICHTENTHALER HK, 1987, J PLANT PHYSIOL, V131, P101, DOI 10.1016/S0176-1617(87)80271-7; Ma XL, 2004, BIOL PLANTARUM, V48, P219, DOI 10.1023/B:BIOP.0000033448.96998.44; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Munns R, 2010, METHODS MOL BIOL, V639, P371, DOI 10.1007/978-1-60761-702-0_23; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nair RM, 2013, J SCI FOOD AGR, V93, P1805, DOI 10.1002/jsfa.6110; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Qiao WH, 2007, PLANT CELL REP, V26, P1663, DOI 10.1007/s00299-007-0354-3; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Rajagopal D, 2007, MOL BREEDING, V19, P137, DOI 10.1007/s11032-006-9052-z; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang R, 2010, PLANT MOL BIOL REP, V28, P102, DOI 10.1007/s11105-009-0135-y; Teakle NL, 2010, PHYSIOL PLANTARUM, V139, P358, DOI 10.1111/j.1399-3054.2010.01373.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Wu C, 2009, PLANT MOL BIOL REP, V27, P1, DOI 10.1007/s11105-008-0048-1; Wu GQ, 2011, J PLANT PHYSIOL, V168, P758, DOI 10.1016/j.jplph.2010.10.015; Yang DH, 2012, BIOCHEM BIOPH RES CO, V417, P732, DOI 10.1016/j.bbrc.2011.12.023; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Zhang GH, 2008, PLANT PHYSIOL BIOCH, V46, P117, DOI 10.1016/j.plaphy.2007.10.022; Zhang H, 2012, PLANT CELL TISS ORG, V110, DOI 10.1007/s11240-012-0142-9; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zorb C, 2005, J PLANT PHYSIOL, V162, P55, DOI 10.1016/j.jplph.2004.03.010	58	18	24	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e106678	10.1371/journal.pone.0106678	http://dx.doi.org/10.1371/journal.pone.0106678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350285	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100005
J	Finger, A; Kaiser-Bunbury, CN; Kettle, CJ; Valentin, T; Ghazoul, J				Finger, Aline; Kaiser-Bunbury, Christopher N.; Kettle, Chris J.; Valentin, Terence; Ghazoul, Jaboury			Genetic Connectivity of the Moth Pollinated Tree Glionnetia sericea in a Highly Fragmented Habitat	PLOS ONE			English	Article							POLLEN FLOW; REPRODUCTIVE SUCCESS; SEED DISPERSAL; TROPICAL TREES; DRY FOREST; POPULATION; PLANTS; CONSEQUENCES; METAANALYSIS; DISRUPTION	Long-distance gene flow is thought to be one prerequisite for the persistence of plant species in fragmented environments. Human influences have led to severe fragmentation of native habitats in the Seychelles islands, with many species surviving only in small and isolated populations. The endangered Seychelles endemic tree Glionnetia sericea is restricted to altitudes between 450 m and 900 m where the native forest vegetation has been largely lost and replaced with exotic invasives over the last 200 years. This study explores the genetic and ecological consequences of population fragmentation in this species by analysing patterns of genetic diversity in a sample of adults, juveniles and seeds, and by using controlled pollination experiments. Our results show no decrease in genetic diversity and no increase in genetic structuring from adult to juvenile cohorts. Despite significant inbreeding in some populations, there is no evidence of higher inbreeding in juvenile cohorts relative to adults. A Bayesian structure analysis and a tentative paternity analysis indicate extensive historical and contemporary gene flow among remnant populations. Pollination experiments and a paternity analysis show that Glionnetia sericea is self-compatible. Nevertheless, outcrossing is present with 7% of mating events resulting from pollen transfer between populations. Artificial pollination provided no evidence for pollen limitation in isolated populations. The highly mobile and specialized hawkmoth pollinators (Agrius convolvuli and Cenophodes tamsi; Sphingidae) appear to promote extensive gene flow, thus mitigating the potential negative ecological and genetic effects of habitat fragmentation in this species. We conclude that contemporary gene flow is sufficient to maintain genetic connectivity in this rare and restricted Seychelles endemic, in contrast to other island endemic tree species with limited contemporary gene flow.	[Finger, Aline; Kettle, Chris J.; Ghazoul, Jaboury] Swiss Fed Inst Technol, Zurich, Switzerland; [Kaiser-Bunbury, Christopher N.] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Valentin, Terence] Natl Pk Author, Victoria, Mahe, Seychelles	Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Darmstadt	Finger, A (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.	a.finger@rbge.ac.uk	Kaiser-Bunbury, Christopher/C-5038-2012; Ghazoul, Jaboury/B-2121-2018	Kaiser-Bunbury, Christopher/0000-0001-7254-3491; 	ETH Zurich [ETH-07 08-01]	ETH Zurich(ETH Zurich)	This research was funded under grant number ETH-07 08-01, ETH Zurich (https://www.ethz.ch/en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; Aizen MA, 2002, J VEG SCI, V13, P885, DOI 10.1111/j.1654-1103.2002.tb02118.x; Angeloni F, 2011, BIOL CONSERV, V144, P35, DOI 10.1016/j.biocon.2010.08.016; [Anonymous], 2014, R LANG ENV STAT COMP; Ashworth L, 2004, J ECOL, V92, P717, DOI 10.1111/j.0022-0477.2004.00910.x; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Buschbom J, 2011, J HERED, V102, P464, DOI 10.1093/jhered/esr023; Chase MR, 1996, NATURE, V383, P398, DOI 10.1038/383398a0; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; Dafni A, 1998, SEX PLANT REPROD, V11, P177, DOI 10.1007/s004970050138; Dick CW, 2001, P ROY SOC B-BIOL SCI, V268, P2391, DOI 10.1098/rspb.2001.1781; Diels L, 1922, WISSENSCHAFTLICHE ER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finger A, 2012, MOL ECOL, V21, P2369, DOI 10.1111/j.1365-294X.2012.05543.x; Finger A, 2011, MOL ECOL, V20, P3773, DOI 10.1111/j.1365-294X.2011.05228.x; Finger A, 2012, CONSERV GENET RESOUR, V4, P239, DOI 10.1007/s12686-011-9515-3; Fleischer-Dogley F, 2011, DIVERS DISTRIB, V17, P235, DOI 10.1111/j.1472-4642.2010.00732.x; Fleischmann K, 1997, J VEG SCI, V8, P5, DOI 10.2307/3237236; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Ghazoul J, 2004, BIOTROPICA, V36, P156, DOI 10.1111/j.1744-7429.2004.tb00308.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HABER WA, 1989, BIOTROPICA, V21, P155, DOI 10.2307/2388706; Ismail S, 2011, IUCN RED LIST THREAT; Ismail SA, 2012, MOL ECOL, V21, P5484, DOI 10.1111/mec.12054; JANZEN DH, 1994, TRENDS ECOL EVOL, V9, P365, DOI 10.1016/0169-5347(94)90053-1; Robledo-Arnuncio JJ, 2011, NEW PHYTOL, V190, P222, DOI 10.1111/j.1469-8137.2010.03588.x; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kettle CJ, 2007, MOL ECOL, V16, P3581, DOI 10.1111/j.1365-294X.2007.03419.x; Kueffer C, 2010, PERSPECT PLANT ECOL, V12, P145, DOI 10.1016/j.ppees.2009.06.002; Lander TA, 2010, BIOL CONSERV, V143, P2583, DOI 10.1016/j.biocon.2010.06.028; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; Liepelt S, 2002, P NATL ACAD SCI USA, V99, P14590, DOI 10.1073/pnas.212285399; LINHART YB, 1977, BIOTROPICA, V9, P143, DOI 10.2307/2387672; Lourmas M, 2007, HEREDITY, V99, P151, DOI 10.1038/sj.hdy.6800976; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MOULDS M S, 1981, General and Applied Entomology, V13, P69; Munoz AA, 2008, J ECOL, V96, P459, DOI 10.1111/j.1365-2745.2008.01361.x; Nason JD, 1998, NATURE, V391, P685, DOI 10.1038/35607; Ottewell KM, 2009, BIOL CONSERV, V142, P888, DOI 10.1016/j.biocon.2008.12.019; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Sork VL, 2006, LANDSCAPE ECOL, V21, P821, DOI 10.1007/s10980-005-5415-9; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Van Geert A, 2008, CONSERV GENET, V9, P845, DOI 10.1007/s10592-007-9409-9; White GM, 2002, P NATL ACAD SCI USA, V99, P2038, DOI 10.1073/pnas.042649999	53	16	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111111	10.1371/journal.pone.0111111	http://dx.doi.org/10.1371/journal.pone.0111111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347541	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900049
J	Lakin, MR; Brown, CW; Horwitz, EK; Fanning, ML; West, HE; Stefanovic, D; Graves, SW				Lakin, Matthew R.; Brown, Carl W., III; Horwitz, Eli K.; Fanning, M. Leigh; West, Hannah E.; Stefanovic, Darko; Graves, Steven W.			Biophysically Inspired Rational Design of Structured Chimeric Substrates for DNAzyme Cascade Engineering	PLOS ONE			English	Article							DNA STRAND-DISPLACEMENT; LOGIC GATES; IN-VITRO; MOLECULAR AUTOMATON; AMPLIFIED DETECTION; LIGASE ACTIVITY; RNA; DEOXYRIBOZYME; ENZYME; HYDROLYSIS	The development of large-scale molecular computational networks is a promising approach to implementing logical decision making at the nanoscale, analogous to cellular signaling and regulatory cascades. DNA strands with catalytic activity (DNAzymes) are one means of systematically constructing molecular computation networks with inherent signal amplification. Linking multiple DNAzymes into a computational circuit requires the design of substrate molecules that allow a signal to be passed from one DNAzyme to another through programmed biochemical interactions. In this paper, we chronicle an iterative design process guided by biophysical and kinetic constraints on the desired reaction pathways and use the resulting substrate design to implement heterogeneous DNAzyme signaling cascades. A key aspect of our design process is the use of secondary structure in the substrate molecule to sequester a downstream effector sequence prior to cleavage by an upstream DNAzyme. Our goal was to develop a concrete substrate molecule design to achieve efficient signal propagation with maximal activation and minimal leakage. We have previously employed the resulting design to develop high-performance DNAzyme-based signaling systems with applications in pathogen detection and autonomous theranostics.	[Lakin, Matthew R.; Fanning, M. Leigh; Stefanovic, Darko] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Brown, Carl W., III; Horwitz, Eli K.; West, Hannah E.; Stefanovic, Darko; Graves, Steven W.] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Graves, Steven W.] Univ New Mexico, Dept Chem & Biol Engn, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Stefanovic, D (corresponding author), Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA.	darko@cs.unm.edu; graves@unm.edu		Brown III, Ph.D., Carl W./0000-0002-6524-4140	National Science Foundation [1027877, 1028238, 1318833, DGE-0549500]; New Mexico Cancer Nanoscience and Microsystems Training Center under National Institutes of Health [5R25CA153825]; NATIONAL CANCER INSTITUTE [R25CA153825] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1318833] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1026592] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); New Mexico Cancer Nanoscience and Microsystems Training Center under National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This material is based upon work supported by the National Science Foundation (http://nsf. gov/) under grant numbers 1027877, 1028238, and 1318833, which supported M.R.L., C.W.B., D.S., and S.W.G. C.W.B. gratefully acknowledges support from an Integrative Graduate Education and Research Traineeship in Integrating Nanotechnology with Cell Biology and Neuroscience from the National Science Foundation (http://nsf.gov/) under grant number DGE-0549500. M.R.L. gratefully acknowledges support from the New Mexico Cancer Nanoscience and Microsystems Training Center (http://cntc.unm.edu/) under National Institutes of Health (http://www.nih.gov/) grant number 5R25CA153825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bath J, 2009, SMALL, V5, P1513, DOI 10.1002/smll.200900078; Baum DA, 2008, CELL MOL LIFE SCI, V65, P2156, DOI 10.1007/s00018-008-8029-y; Bois JS, 2005, NUCLEIC ACIDS RES, V33, P4090, DOI 10.1093/nar/gki721; Bonaccio M, 2004, NUCLEIC ACIDS RES, V32, P916, DOI 10.1093/nar/gkh250; Bonnet G, 1998, P NATL ACAD SCI USA, V95, P8602, DOI 10.1073/pnas.95.15.8602; BREAKER RR, 1995, CHEM BIOL, V2, P655, DOI 10.1016/1074-5521(95)90028-4; Brown CW, 2014, ANGEW CHEM INT EDIT, V53, P7183, DOI 10.1002/anie.201402691; Brown CW, 2014, CHEMBIOCHEM, V15, P950, DOI 10.1002/cbic.201400047; Cairns MJ, 2000, ANTISENSE NUCLEIC A, V10, P323, DOI 10.1089/oli.1.2000.10.323; Chandra M, 2009, NAT CHEM BIOL, V5, P718, DOI 10.1038/nchembio.201; CUENOUD B, 1995, NATURE, V375, P611, DOI 10.1038/375611a0; Dass CR, 2002, ANTISENSE NUCLEIC A, V12, P289, DOI 10.1089/108729002761381276; Dirks RM, 2003, J COMPUT CHEM, V24, P1664, DOI 10.1002/jcc.10296; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Eckhoff G., 2010, J SYST CHEM, V1, P13, DOI DOI 10.1186/1759-2208-1-13; Elbaz J, 2012, NANO LETT, V12, P6049, DOI 10.1021/nl300051g; Elbaz J, 2010, NAT NANOTECHNOL, V5, P417, DOI [10.1038/NNANO.2010.88, 10.1038/nnano.2010.88]; Elbaz J, 2009, CHEM-EUR J, V15, P3411, DOI 10.1002/chem.200802004; Emilsson GM, 2003, RNA, V9, P907, DOI 10.1261/rna.5680603; Fanning Leigh M, 2011, P 2 ACM C BIOINF COM, p404 ; Fanning ML, 2014, THESIS U NEW MEXICO; Flynn-Charlebois A, 2003, J AM CHEM SOC, V125, P5346, DOI 10.1021/ja0340331; Flynn-Charlebois A, 2003, J AM CHEM SOC, V125, P2444, DOI 10.1021/ja028774y; Gerasimova YV, 2013, CHEMBIOCHEM, V14, P2087, DOI 10.1002/cbic.201300471; Gu HZ, 2013, J AM CHEM SOC, V135, P9121, DOI 10.1021/ja403585e; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Katz E., 2012, BIOMOLECULAR INFORM; Katz E, 2012, ANAL CHEM, V84, P5463, DOI 10.1021/ac3007076; Katz E, 2010, CHEM SOC REV, V39, P1835, DOI 10.1039/b806038j; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Lakin MR, 2012, J R SOC INTERFACE, V9, P1470, DOI 10.1098/rsif.2011.0800; Lakin MR, 2012, J R SOC INTERFACE, V9, P470, DOI 10.1098/rsif.2011.0343; Lederman H, 2006, BIOCHEMISTRY-US, V45, P1194, DOI 10.1021/bi051871u; Lee CS, 2011, NUCLEIC ACIDS RES, V39, P269, DOI 10.1093/nar/gkq753; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Li YF, 1999, CURR OPIN STRUC BIOL, V9, P315, DOI 10.1016/S0959-440X(99)80042-6; Li YF, 1999, P NATL ACAD SCI USA, V96, P2746, DOI 10.1073/pnas.96.6.2746; Lu CH, 2012, J AM CHEM SOC, V134, P10651, DOI 10.1021/ja3037838; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Macdonald J, 2006, NANO LETT, V6, P2598, DOI 10.1021/nl0620864; Martin CH, 2009, CHEM BIOL, V16, P277, DOI 10.1016/j.chembiol.2009.01.010; Ouldridge TE, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3552946; Parker DJ, 2013, J AM CHEM SOC, V135, P8472, DOI 10.1021/ja4032488; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Pei RJ, 2010, NAT NANOTECHNOL, V5, P773, DOI [10.1038/nnano.2010.194, 10.1038/NNANO.2010.194]; Purtha WE, 2005, J AM CHEM SOC, V127, P13124, DOI 10.1021/ja0533702; Qian L, 2011, J R SOC INTERFACE, V8, P1281, DOI 10.1098/rsif.2010.0729; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schlosser K, 2010, CHEMBIOCHEM, V11, P866, DOI 10.1002/cbic.200900786; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Srinivas N, 2013, NUCLEIC ACIDS RES, V41, P10641, DOI 10.1093/nar/gkt801; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Stojanovic MN, 2003, J SERB CHEM SOC, V68, P321, DOI 10.2298/JSC0305321S; Stojanovic MN, 2003, J AM CHEM SOC, V125, P6673, DOI 10.1021/ja0296632; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Sulc P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4754132; Tian C, 2014, LANGMUIR, V30, P5859, DOI 10.1021/la402326b; Walsh SM, 2013, J AM CHEM SOC, V135, P14928, DOI 10.1021/ja407586u; Wang FA, 2012, J AM CHEM SOC, V134, P5504, DOI 10.1021/ja300616w; Wang FA, 2011, ANGEW CHEM INT EDIT, V50, P295, DOI 10.1002/anie.201005246; Wang YM, 2005, ANGEW CHEM INT EDIT, V44, P5863, DOI 10.1002/anie.200501643; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Willner I, 2008, CHEM SOC REV, V37, P1153, DOI 10.1039/b718428j; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Xiao Y, 2012, NUCLEIC ACIDS RES, V40, P1778, DOI 10.1093/nar/gkr860; Yin P, 2004, ANGEW CHEM INT EDIT, V43, P4906, DOI 10.1002/anie.200460522; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang DY, 2008, J AM CHEM SOC, V130, P13921, DOI 10.1021/ja803318t; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2965; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s; Zhou J, 2009, J PHYS CHEM B, V113, P16065, DOI 10.1021/jp9079052	80	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110986	10.1371/journal.pone.0110986	http://dx.doi.org/10.1371/journal.pone.0110986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347066	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900037
J	Choong, ML; Tan, SH; Tan, TZ; Manesh, S; Ngo, A; Yong, JWY; Yang, HH; Lee, MA				Choong, Meng Ling; Tan, Shan Ho; Tan, Tuan Zea; Manesh, Sravanthy; Ngo, Anna; Yong, Jacklyn W. Y.; Yang, Henry He; Lee, May Ann			Molecular Integrative Clustering of Asian Gastric Cell Lines Revealed Two Distinct Chemosensitivity Clusters	PLOS ONE			English	Article							GENE-EXPRESSION; KINASE 1; CANCER; INHIBITION; CARCINOMA; PROTEIN; INACTIVATION; BORTEZOMIB; SIGNATURES; PATTERNS	Cell lines recapitulate cancer heterogeneity without the presence of interfering tissue found in primary tumor. Their heterogeneous characteristics are reflected in their multiple genetic abnormalities and variable responsiveness to drug treatments. In order to understand the heterogeneity observed in Asian gastric cancers, we have performed array comparative genomic hybridization (aCGH) on 18 Asian gastric cell lines. Hierarchical clustering and single-sample Gene Set Enrichment Analysis were performed on the aCGH data together with public gene expression data of the same cell lines obtained from the Cancer Cell Line Encyclopedia. We found a large amount of genetic aberrations, with some cell lines having 13 fold more aberrations than others. Frequently mutated genes and cellular pathways are identified in these Asian gastric cell lines. The combined analyses of aCGH and expression data demonstrate correlation of gene copy number variations and expression profiles in human gastric cancer cells. The gastric cell lines can be grouped into 2 integrative clusters (ICs). Gastric cells in IC1 are enriched with gene associated with mitochondrial activities and oxidative phosphorylation while cells in IC2 are enriched with genes associated with cell signaling and transcription regulations. The two clusters of cell lines were shown to have distinct responsiveness towards several chemotherapeutics agents such as PI3 K and proteosome inhibitors. Our molecular integrative clustering provides insight into critical genes and pathways that may be responsible for the differences in survival in response to chemotherapy.	[Choong, Meng Ling; Tan, Shan Ho; Manesh, Sravanthy; Ngo, Anna; Yong, Jacklyn W. Y.; Lee, May Ann] Agcy Sci Technol & Res, Ctr Expt Therapeut, Singapore, Singapore; [Tan, Tuan Zea; Yang, Henry He] Natl Univ Singapore, Canc Sci Inst Singapore, Bioinformat Core, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore	Lee, MA (corresponding author), Agcy Sci Technol & Res, Ctr Expt Therapeut, Singapore, Singapore.	malee@etc.a-star.edu.sg	Tan, Tuan Zea/I-9227-2019	Tan, Tuan Zea/0000-0001-6624-1593; Choong, Meng Ling/0000-0002-1818-1597				Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Boussioutas A, 2003, CANCER RES, V63, P2569; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cheng XX, 2005, CLIN EXP METASTAS, V22, P85, DOI 10.1007/s10585-005-4578-8; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Gao M, 2013, ASIAN PAC J TROP MED, V6, P260, DOI 10.1016/S1995-7645(13)60054-1; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gough DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083395; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kaji T, 2010, BIOCHEM BIOPH RES CO, V395, P213, DOI 10.1016/j.bbrc.2010.03.164; Kim B, 2003, CANCER RES, V63, P8248; Kim HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043223; KITADAI Y, 1993, CELL GROWTH DIFFER, V4, P291; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li LH, 2012, ONCOL REP, V27, P1435, DOI 10.3892/or.2012.1664; Li QY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0793-3; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Macdonald JS, 2009, J CLIN ONCOL, V27; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081803; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Philchenkov A, 2004, EXP ONCOL, V26, P82; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Rao R, 2010, CLIN CANCER RES, V16, P4742, DOI 10.1158/1078-0432.CCR-10-0529; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Siegelin MD, 2013, CANCER LETT, V333, P133, DOI 10.1016/j.canlet.2013.01.045; Singapore Cancer Registry, 2011, CANC SURV SING 1968; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-659; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Tay ST, 2003, CANCER RES, V63, P3309; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wu WKK, 2010, CANCER LETT, V295, P144, DOI 10.1016/j.canlet.2010.04.025; Ye B, 2012, INT J IMMUNOPATH PH, V25, P627, DOI 10.1177/039463201202500309	43	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111146	10.1371/journal.pone.0111146	http://dx.doi.org/10.1371/journal.pone.0111146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343454	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500082
J	Ito, M; Hayashi, K; Adachi, E; Minamisawa, T; Homma, S; Koido, S; Shiba, K				Ito, Masaki; Hayashi, Kazumi; Adachi, Eru; Minamisawa, Tamiko; Homma, Sadamu; Koido, Shigeo; Shiba, Kiyotaka			Combinatorial Contextualization of Peptidic Epitopes for Enhanced Cellular Immunity	PLOS ONE			English	Article							MHC CLASS-I; DENDRITIC CELLS; CROSS-PRESENTATION; ARTIFICIAL PROTEINS; VACCINE; ANTIGEN; VIVO; ENDOTOXIN; INTERLEUKIN-2; ACTIVATION	Invocation of cellular immunity by epitopic peptides remains largely dependent on empirically developed protocols, such as interfusion of aluminum salts or emulsification using terpenoids and surfactants. To explore novel vaccine formulation, epitopic peptide motifs were co-programmed with structural motifs to produce artificial antigens using our "motif-programming'' approach. As a proof of concept, we used an ovalbumin (OVA) system and prepared an artificial protein library by combinatorially polymerizing MHC class I and II sequences from OVA along with a sequence that tends to form secondary structures. The purified endotoxin-free proteins were then examined for their ability to activate OVA-specific T-cell hybridoma cells after being processed within dendritic cells. One clone, F37A (containing three MHC I and two MHC II OVA epitopes), possessed a greater ability to evoke cellular immunity than the native OVA or the other artificial antigens. The sensitivity profiles of drugs that interfered with the F37A uptake differed from those of the other artificial proteins and OVA, suggesting that alteration of the cross-presentation pathway is responsible for the enhanced immunogenicity. Moreover, F37A, but not an epitopic peptide, invoked cellular immunity when injected together with monophosphoryl lipid A (MPL), and retarded tumor growth in mice. Thus, an artificially synthesized protein antigen induced cellular immunity in vivo in the absence of incomplete Freund's adjuvant or aluminum salts. The method described here could be potentially used for developing vaccines for such intractable ailments as AIDS, malaria and cancer, ailments in which cellular immunity likely play a crucial role in prevention and treatment.	[Ito, Masaki; Hayashi, Kazumi; Homma, Sadamu] Jikei Univ, Sch Med, Dept Oncol, Tokyo, Japan; [Ito, Masaki; Adachi, Eru; Minamisawa, Tamiko; Shiba, Kiyotaka] Japanese Fdn Canc Res, Inst Canc, Div Prot Engn, Tokyo 170, Japan; [Koido, Shigeo] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan	Jikei University; Japanese Foundation for Cancer Research; Jikei University	Ito, M (corresponding author), Jikei Univ, Sch Med, Dept Oncol, Tokyo, Japan.	mito@jikei.ac.jp; kshiba@jfcr.or.jp	Shiba, Kiyotaka/I-9588-2014	Shiba, Kiyotaka/0000-0001-6459-0204	JST A-STEP [AS221Z01237G]; Jikei University Research Fund;  [22650231];  [12936891]; Grants-in-Aid for Scientific Research [26430172] Funding Source: KAKEN	JST A-STEP; Jikei University Research Fund(Jikei University); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in Aid for Exploratory Research # 22650231 (MI), JST A-STEP #AS221Z01237G (MI), The Jikei University Research Fund (MI), and Grant-in-Aid for Scientific Research (A) # 12936891 (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; EROSHKIN AM, 1995, PROTEIN ENG, V8, P167, DOI 10.1093/protein/8.2.167; Fox CB, 2009, MOLECULES, V14, P3286, DOI 10.3390/molecules14093286; Garulli B, 2008, CLIN VACCINE IMMUNOL, V15, P1497, DOI 10.1128/CVI.00166-08; GRANT EP, 1992, J IMMUNOL, V148, P13; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Jin JO, 2009, BLOOD, V113, P5839, DOI 10.1182/blood-2008-10-184796; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kjerrulf M, 1997, MOL IMMUNOL, V34, P599, DOI 10.1016/S0161-5890(97)00078-3; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Lai YP, 2011, ISRN IMMUNOLOGY, V2011, P1, DOI DOI 10.1166/JNAN.2011.1007; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Murshid A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00063; Palena C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/380697; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rock KL, 2010, J IMMUNOL, V184, P9, DOI 10.4049/jimmunol.0903399; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2010, J IMMUNOTHER, V33, P626, DOI 10.1097/CJI.0b013e3181dac9de; Saito H, 2004, CHEM BIOL, V11, P765, DOI 10.1016/j.chembiol.2004.03.032; Saito H, 2008, CANCER SCI, V99, P398, DOI 10.1111/j.1349-7006.2007.00697.x; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Shanmugam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030839; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shiba K, 1997, P NATL ACAD SCI USA, V94, P3805, DOI 10.1073/pnas.94.8.3805; Shiba K, 2004, J MOL CATAL B-ENZYM, V28, P145, DOI 10.1016/j.molcatb.2003.12.027; Shiba K, 2002, J MOL BIOL, V320, P833, DOI 10.1016/S0022-2836(02)00567-3; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Tsuji T, 2008, P NATL ACAD SCI USA, V105, P16866, DOI 10.1073/pnas.0804277105	40	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110425	10.1371/journal.pone.0110425	http://dx.doi.org/10.1371/journal.pone.0110425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343355	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500033
J	Koblinger, K; Fuzesi, T; Ejdrygiewicz, J; Krajacic, A; Bains, JS; Whelan, PJ				Koblinger, Kathrin; Fuezesi, Tamas; Ejdrygiewicz, Jillian; Krajacic, Aleksandra; Bains, Jaideep S.; Whelan, Patrick J.			Characterization of A11 Neurons Projecting to the Spinal Cord of Mice	PLOS ONE			English	Article							AMINO-ACID DECARBOXYLASE; DIENCEPHALIC DOPAMINE NEURONS; CENTRAL-NERVOUS-SYSTEM; RESTLESS LEGS SYNDROME; RAT DORSAL-HORN; IMMUNOCYTOCHEMICAL LOCALIZATION; TYROSINE-HYDROXYLASE; DEPENDENT MODULATION; RENSHAW CELLS; ACTIVATION	The hypothalamic A11 region has been identified in several species including rats, mice, cats, monkeys, zebrafish, and humans as the primary source of descending dopamine (DA) to the spinal cord. It has been implicated in the control of pain, modulation of the spinal locomotor network, restless leg syndrome, and cataplexy, yet the A11 cell group remains an understudied dopaminergic (DAergic) nucleus within the brain. It is unclear whether A11 neurons in the mouse contain the full complement of enzymes consistent with traditional DA neuronal phenotypes. Given the abundance of mouse genetic models and tools available to interrogate specific neural circuits and behavior, it is critical first to fully understand the phenotype of A11 cells. We provide evidence that, in addition to tyrosine hydroxylase (TH) that synthesizes L-DOPA, neurons within the A11 region of the mouse contain aromatic L-amino acid decarboxylase (AADC), the enzyme that converts L-DOPA to dopamine. Furthermore, we show that the A11 neurons contain vesicular monoamine transporter 2 (VMAT2), which is necessary for packaging DA into vesicles. On the contrary, A11 neurons in the mouse lack the dopamine transporter (DAT). In conclusion, our data suggest that A11 neurons are DAergic. The lack of DAT, and therefore the lack of a DA reuptake mechanism, points to a longer time of action compared to typical DA neurons.	[Koblinger, Kathrin; Fuezesi, Tamas; Ejdrygiewicz, Jillian; Krajacic, Aleksandra; Bains, Jaideep S.; Whelan, Patrick J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Bains, Jaideep S.; Whelan, Patrick J.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Ejdrygiewicz, Jillian; Krajacic, Aleksandra; Whelan, Patrick J.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Whelan, PJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	whelan@ucalgary.ca		Whelan, Patrick/0000-0002-1234-5415; Bains, Jaideep/0000-0002-3634-6463	Canadian Institutes of Health Research [MOP-130528]; Alberta Innovates [201100359] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This study was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) MOP-130528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOYAMAMOTO M, 1987, J BIOCHEM-TOKYO, V101, P405, DOI 10.1093/oxfordjournals.jbchem.a121925; Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; Barriere G, 2004, EUR J NEUROSCI, V19, P1325, DOI 10.1111/j.1460-9568.2004.03210.x; BJORKLUND A, 1979, BRAIN RES, V177, P170, DOI 10.1016/0006-8993(79)90927-2; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P185, DOI 10.1016/j.tins.2007.03.004; BLESSING WW, 1979, NEUROSCI LETT, V11, P35, DOI 10.1016/0304-3940(79)90052-1; Borgkvist A, 2012, INT J NEUROPSYCHOPH, V15, P531, DOI 10.1017/S1461145711000812; Charbit AR, 2009, J NEUROSCI, V29, P12532, DOI 10.1523/JNEUROSCI.2887-09.2009; Christie KJ, 2005, J NEUROPHYSIOL, V94, P1554, DOI 10.1152/jn.00299.2005; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Clemens S, 2004, J NEUROSCI, V24, P11337, DOI 10.1523/JNEUROSCI.3698-04.2004; Clemens S, 2012, J NEUROPHYSIOL, V107, P2250, DOI 10.1152/jn.00366.2011; Clemens S, 2006, NEUROLOGY, V67, P125, DOI 10.1212/01.wnl.0000223316.53428.c9; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Feenstra MGP, 2002, NEUROPHARMACOLOGY, V42, P752, DOI 10.1016/S0028-3908(02)00029-1; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gerin C, 1998, BRAIN RES, V794, P169, DOI 10.1016/S0006-8993(98)00278-9; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gordon IT, 2006, J NEUROPHYSIOL, V96, P3122, DOI 10.1152/jn.00606.2006; Gozal EA, 2008, EFFECTS TRACE AMINES; Han P, 2009, NEUROSCIENCE, V158, P1699, DOI 10.1016/j.neuroscience.2008.11.040; HOKFELT T, 1979, ACTA PHYSIOL SCAND, V107, P393, DOI 10.1111/j.1748-1716.1979.tb06491.x; Howland JG, 2002, J NEUROSCI, V22, P1137, DOI 10.1523/JNEUROSCI.22-03-01137.2002; Humphreys JM, 2012, J NEUROPHYSIOL, V108, P3370, DOI 10.1152/jn.00482.2012; JAEGER CB, 1983, SCIENCE, V219, P1233, DOI 10.1126/science.6131537; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kagan R, 2013, NEUROSCIENCE, V248, P359, DOI 10.1016/j.neuroscience.2013.06.014; Karasawa N, 2007, ACTA HISTOCHEM CYTOC, V40, P83, DOI 10.1267/ahc.06019; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Koblinger K, 2012, CHARACTERIZATION ALL; KOMORI K, 1992, NEUROSCI LETT, V147, P197, DOI 10.1016/0304-3940(92)90594-W; Lambert AM, 2012, J NEUROSCI, V32, P13488, DOI 10.1523/JNEUROSCI.1638-12.2012; Lapointe NP, 2009, J PHYSIOL-LONDON, V587, P1499, DOI 10.1113/jphysiol.2008.166314; LINDVALL O, 1983, ANN NEUROL, V14, P255, DOI 10.1002/ana.410140302; LORANG D, 1994, J NEUROSCI, V14, P4903; Madriaga MA, 2004, J NEUROPHYSIOL, V92, P1566, DOI 10.1152/jn.01181.2003; MAITRA KK, 1993, ACTA PHYSIOL SCAND, V148, P101, DOI 10.1111/j.1748-1716.1993.tb09538.x; McCrea AE, 1997, DEV BRAIN RES, V100, P130, DOI 10.1016/S0165-3806(97)00027-8; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Pappas SS, 2008, BRAIN RES, V1214, P1, DOI 10.1016/j.brainres.2008.03.010; Pappas SS, 2011, NEUROPHARMACOLOGY, V61, P614, DOI 10.1016/j.neuropharm.2011.05.002; Pappas SS, 2010, J COMP NEUROL, V518, P2423, DOI 10.1002/cne.22340; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Peyron C, 1995, NEUROREPORT, V6, P2527, DOI 10.1097/00001756-199512150-00019; Qu S, 2006, EXP BRAIN RES, V168, P152, DOI 10.1007/s00221-005-0075-1; RIDET JL, 1993, NEUROSCIENCE, V52, P143, DOI 10.1016/0306-4522(93)90189-M; RIDET JL, 1994, J NEUROSCI RES, V38, P109, DOI 10.1002/jnr.490380114; Ridet JL, 2000, TRENDS NEUROSCI, V23, P58, DOI 10.1016/S0166-2236(99)01523-4; SETH P, 1993, NEUROSCI LETT, V158, P217, DOI 10.1016/0304-3940(93)90268-P; SICKLES AE, 1992, DEV BRAIN RES, V68, P17, DOI 10.1016/0165-3806(92)90243-P; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; SKAGERBERG G, 1982, BRAIN RES BULL, V9, P237, DOI 10.1016/0361-9230(82)90136-8; Thorpe AJ, 2011, EUR NEUROL, V66, P18, DOI 10.1159/000328431; Ugrumov MV, 2009, J CHEM NEUROANAT, V38, P241, DOI 10.1016/j.jchemneu.2009.08.004; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821	62	66	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109636	10.1371/journal.pone.0109636	http://dx.doi.org/10.1371/journal.pone.0109636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343491	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500018
J	Soma, T; Hayashi, R; Sugiyama, H; Tsujikawa, M; Kanayama, S; Oie, Y; Nishida, K				Soma, Takeshi; Hayashi, Ryuhei; Sugiyama, Hiroaki; Tsujikawa, Motokazu; Kanayama, Shintaro; Oie, Yoshinori; Nishida, Kohji			Maintenance and Distribution of Epithelial Stem/Progenitor Cells after Corneal Reconstruction Using Oral Mucosal Epithelial Cell Sheets	PLOS ONE			English	Article							OCULAR SURFACE DISORDERS; STEM-CELLS; ENDOTHELIAL-CELLS; PROGENITOR CELLS; SELF-RENEWAL; LIMBAL; TRANSPLANTATION; DIFFERENTIATION; DEFICIENCY; EXPRESSION	We assessed the maintenance and distribution of epithelial stem/progenitor cells after corneal reconstruction using tissue-engineered oral mucosal cell sheets in a rat model. Oral mucosal biopsy specimens were excised from green fluorescent protein (GFP) rats and enzymatically treated with Dispase II. These cells were cultured on inserts with mitomycin C-treated NIH/3T3 cells, and the resulting cell sheets were harvested. These tissue-engineered cell sheets from GFP rats were transplanted onto the eyes of a nude rat limbal stem cell deficiency model. Eight weeks after surgery, ocular surfaces were completely covered by the epithelium with GFP-positive cells. Transplanted corneas expressed p63 in the basal layers and K14 in all epithelial layers. Epithelial cells harvested from the central and peripheral areas of reconstructed corneas were isolated for a colony-forming assay, which showed that the colony-forming efficiency of the peripheral epithelial cells was significantly higher than that of the central epithelial cells 8 weeks after corneal reconstruction. Thus, in this rat model, the peripheral cornea could maintain more stem/progenitor cells than the central cornea after corneal reconstruction using oral mucosal epithelial cell sheets.	[Soma, Takeshi; Hayashi, Ryuhei; Sugiyama, Hiroaki; Tsujikawa, Motokazu; Kanayama, Shintaro; Oie, Yoshinori; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan	Osaka University	Nishida, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan.	knishida@ophthal.med.osaka-u.ac.jp	Hayashi, Ryuhei/AAW-4737-2020	Nishida, Kohji/0000-0001-9069-3610; Hayashi, Ryuhei/0000-0002-4699-8617	High-Tech Research Center Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [16300161]; Center of Excellence Program for the 21st Century from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [16300161]; JSPS KAKENHI Grant [15390530]	High-Tech Research Center Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Center of Excellence Program for the 21st Century from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the High-Tech Research Center Program and the Center of Excellence Program for the 21st Century from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (16300161; http://www.mext.go.jp/a_menu/koutou/coe/main6_a3.htm), and JSPS KAKENHI Grant (15390530; http://kaken.nii.ac.jp/d/p/15390530/2003/3/ja.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HCJ, 2009, INVEST OPHTH VIS SCI, V50, P4660, DOI 10.1167/iovs.09-3377; Chen WS, 2007, EXP EYE RES, V84, P626, DOI 10.1016/j.exer.2006.11.006; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Ilari L, 2002, OPHTHALMOLOGY, V109, P1278, DOI 10.1016/S0161-6420(02)01081-3; Inatomi T, 2006, AM J OPHTHALMOL, V141, P267, DOI 10.1016/j.ajo.2005.09.003; Kanayama S, 2007, EXP EYE RES, V85, P772, DOI 10.1016/j.exer.2007.08.011; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Li GG, 2012, INVEST OPHTH VIS SCI, V53, P3357, DOI 10.1167/iovs.11-9414; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nakamura T, 2007, OPHTHALMOLOGY, V114, P1080, DOI 10.1016/j.ophtha.2006.09.034; Nakamura T, 2011, BRIT J OPHTHALMOL, V95, P942, DOI 10.1136/bjo.2010.188714; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Samson CM, 2002, OPHTHALMOLOGY, V109, P862, DOI 10.1016/S0161-6420(02)00994-6; Santos MS, 2005, AM J OPHTHALMOL, V140, P223, DOI 10.1016/j.ajo.2005.03.022; Satake Y, 2011, OPHTHALMOLOGY, V118, P1524, DOI 10.1016/j.ophtha.2011.01.039; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Sekiyama E, 2006, EXP EYE RES, V83, P741, DOI 10.1016/j.exer.2006.02.015; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; TSAI RJF, 1990, OPHTHALMOLOGY, V97, P446, DOI 10.1016/S0161-6420(90)32575-7; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22	27	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110987	10.1371/journal.pone.0110987	http://dx.doi.org/10.1371/journal.pone.0110987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343456	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500070
J	Zhang, Z; Martiny, V; Lagorce, D; Ikeguchi, Y; Alexov, E; Miteva, MA				Zhang, Zhe; Martiny, Virginie; Lagorce, David; Ikeguchi, Yoshihiko; Alexov, Emil; Miteva, Maria A.			Rational Design of Small-Molecule Stabilizers of Spermine Synthase Dimer by Virtual Screening and Free Energy-Based Approach	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SINGLE NUCLEOTIDE POLYMORPHISMS; SNYDER-ROBINSON SYNDROME; DRUG DISCOVERY; IN-SILICO; POLYAMINE METABOLISM; MENTAL-RETARDATION; MISSENSE MUTATION; C2 DOMAIN; BINDING	Snyder-Robinson Syndrome (SRS) is a rare mental retardation disorder which is caused by the malfunctioning of an enzyme, the spermine synthase (SMS), which functions as a homo-dimer. The malfunctioning of SMS in SRS patients is associated with several identified missense mutations that occur away from the active site. This investigation deals with a particular SRS-causing mutation, the G56S mutation, which was shown computationally and experimentally to destabilize the SMS homo-dimer and thus to abolish SMS enzymatic activity. As a proof-of-concept, we explore the possibility to restore the enzymatic activity of the malfunctioning SMS mutant G56S by stabilizing the dimer through small molecule binding at the mutant homo-dimer interface. For this purpose, we designed an in silico protocol that couples virtual screening and a free binding energy-based approach to identify potential small-molecule binders on the destabilized G56S dimer, with the goal to stabilize it and thus to increase SMS G56S mutant activity. The protocol resulted in extensive list of plausible stabilizers, among which we selected and tested 51 compounds experimentally for their capability to increase SMS G56S mutant enzymatic activity. In silico analysis of the experimentally identified stabilizers suggested five distinctive chemical scaffolds. This investigation suggests that druggable pockets exist in the vicinity of the mutation sites at protein-protein interfaces which can be used to alter the disease-causing effects by small molecule binding. The identified chemical scaffolds are druglike and can serve as original starting points for development of lead molecules to further rescue the disease-causing effects of the Snyder-Robinson syndrome for which no efficient treatment exists up to now.	[Zhang, Zhe; Martiny, Virginie; Lagorce, David; Miteva, Maria A.] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMR S 973, Paris, France; [Zhang, Zhe; Martiny, Virginie; Lagorce, David; Miteva, Maria A.] INSERM, U973, Paris, France; [Zhang, Zhe; Alexov, Emil] Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA; [Ikeguchi, Yoshihiko] Josai Univ, Fac Pharmaceut Sci, Togane, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Clemson University; Josai University	Alexov, E (corresponding author), Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA.	ealexov@clemson.edu; maria.miteva@univ-paris-diderot.fr	Miteva, Maria M/N-2419-2018; Zhang, Zhe/J-9434-2014	Miteva, Maria M/0000-0001-6895-1214; Zhang, Zhe/0000-0002-1952-5726; Zhang, Zhe/0000-0002-0744-1314	NIH [NLM R03LM009748]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R03LM009748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Z.Z. and E. A. were supported by a grant from NIH, NLM R03LM009748. Z.Z. thanks the French Embassy in Washington for the Chateaubriand fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Ballester PJ, 2014, J CHEM INF MODEL, V54, P944, DOI 10.1021/ci500091r; Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Basse N, 2010, CHEM BIOL, V17, P46, DOI 10.1016/j.chembiol.2009.12.011; Becerra-Solano LE, 2009, AM J MED GENET A, V149A, P328, DOI 10.1002/ajmg.a.32641; Block P, 2007, PROTEINS, V68, P170, DOI 10.1002/prot.21296; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Bowman AL, 2007, J AM CHEM SOC, V129, P3634, DOI 10.1021/ja068256d; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chettiar SN, 2013, BIOORG MED CHEM LETT, V23, P5429, DOI 10.1016/j.bmcl.2013.07.034; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Engin HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081035; Gautier B, 2011, CHEM BIOL, V18, P1631, DOI 10.1016/j.chembiol.2011.10.016; Geerts D, 2010, INT J CANCER, V126, P2012, DOI 10.1002/ijc.25074; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Heikamp K, 2013, CHEM BIOL DRUG DES, V81, P33, DOI 10.1111/cbdd.12054; Ikeguchi Y, 2006, J BIOCHEM, V139, P1, DOI 10.1093/jb/mvj019; Ikeguchi Y, 2003, BIOCHEM J, V373, P885, DOI 10.1042/BJ20030246; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Johnson DK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002951; Jones R, 2007, CANCER RES, V67, P9134, DOI 10.1158/0008-5472.CAN-07-1528; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Labbe CM, 2013, DRUG DISCOV TODAY, V18, P958, DOI 10.1016/j.drudis.2013.05.003; Lagorce D, 2011, BIOINFORMATICS; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Martiny VY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073587; Metz A, 2012, J CHEM INF MODEL, V52, P120, DOI 10.1021/ci200322s; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Morelli X, 2011, CURR OPIN CHEM BIOL, V15, P475, DOI 10.1016/j.cbpa.2011.05.024; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nervall M, 2008, J MED CHEM, V51, P2657, DOI 10.1021/jm701218j; Nicolaes GAF, 2014, BLOOD, V123, P113, DOI 10.1182/blood-2013-05-503227; Ortiz MA, 1999, P NATL ACAD SCI USA, V96, P2740, DOI 10.1073/pnas.96.6.2740; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Proctor EA, 2012, BIOPHYS J, V102, P144, DOI 10.1016/j.bpj.2011.11.4008; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; Rechfeld F, 2011, CURR TOP MED CHEM, V11, P1305; Ryan CJ, 2013, NAT REV GENET, V14, P865, DOI 10.1038/nrg3574; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Scior T, 2012, J CHEM INF MODEL, V52, P867, DOI 10.1021/ci200528d; Segers K, 2007, P NATL ACAD SCI USA, V104, P12697, DOI 10.1073/pnas.0701051104; SHIRAHATA A, 1993, BIOCHEM PHARMACOL, V45, P1897, DOI 10.1016/0006-2952(93)90449-7; SNYDER RD, 1969, CLIN PEDIATR, V8, P669, DOI 10.1177/000992286900801114; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Sousa SF, 2013, CURR MED CHEM, V20, P2296, DOI 10.2174/0929867311320180002; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; Sperandio O, 2014, THROMB RES; Sperandio O, 2012, CURR PHARM DES; Sperandio O, 2010, EUR BIOPHYS J BIOPHY, V39, P1365, DOI 10.1007/s00249-010-0592-0; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Teng S, 2008, CURR PHARM BIOTECHNO, V9, P123, DOI 10.2174/138920108783955164; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Thiel P, 2012, ANGEW CHEM INT EDIT, V51, P2012, DOI 10.1002/anie.201107616; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; Tomar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043522; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Villoutreix BO, 2008, CURR PHARM BIOTECHNO, V9, P103, DOI 10.2174/138920108783955218; Villoutreix BO, 2013, DRUG DISCOV TODAY, V18, P1081, DOI 10.1016/j.drudis.2013.06.013; Villoutreix BO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021117; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wendt MD, 2007, BIOORG MED CHEM LETT, V17, P3122, DOI 10.1016/j.bmcl.2007.03.042; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Yamazaki K, 2012, ANAL SCI, V28, P621, DOI 10.2116/analsci.28.621; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Zhang QC, 2013, NUCLEIC ACIDS RES, V41, pD828, DOI 10.1093/nar/gks1231; Zhang Z, 2013, J AM MED INFORM ASS; Zhang Z, 2013, HUM MOL GENET, V22, P3789, DOI 10.1093/hmg/ddt229; Zhang Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/805827; Zhang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020373; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	83	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110884	10.1371/journal.pone.0110884	http://dx.doi.org/10.1371/journal.pone.0110884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340632	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800067
J	Tang, B; Wu, W; Wei, XW; Li, Y; Ren, G; Fan, WH				Tang, Bo; Wu, Wei; Wei, Xiaowei; Li, Yang; Ren, Gang; Fan, Wenhai			Activation of Glioma Cells Generates Immune Tolerant NKT Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Immune Response; Glioblastoma; Lymphocyte; RNA; Tolerance	MACROPHAGES	Background: Micro RNA plays a role in the pathogenesis of glioma. Results: Glioma-derived miR-92a induces IL-6(+) IL-10(+) NKT cells, which suppress CD8 cells. Conclusion: Glioma-derived miR-92a compromises the antitumor immunity. Significance: miR-92a may be a therapeutic target in the treatment of glioma. Therapeutic outcomes of glioma are currently not encouraging. Tumor tolerance plays an important role in the pathogenesis of glioma. It is reported that micro RNAs (miR) are associated with tumor development. This study aims to investigate the role of miR-92a in the development of tolerant natural killer T (NKT) cells. In this study, U87 cells (a human glioma cell line) and primary glioma cells were prepared. The assessment of miR-92a was performed by real time RT-PCR. The expression of interleukin (IL)-10 and IL-6 in NKT cells was evaluated by flow cytometry. Results showed that abundant IL-6(+) IL-10(+) NKT cells were detected in glioma tissue. Cultures of glioma cells and NKT cells induced the expression of IL-6 and IL-10 in NKT cells. Glioma cells expressed miR-92a; the latter played a critical role in the induction of IL-6 and IL-10 expression in NKT cells. The expression of the antitumor molecules, including perforin, Fas ligand, and interferon-, was significantly attenuated compared with control NKT cells. The IL-6(+) IL-10(+) NKT cells showed less capability in the induction of apoptosis in glioma cells, but showed the immune suppressor functions on CD8(+) T cell activities. We conclude that glioma-derived miR-92a induces IL-6(+) IL-10(+) NKT cells; this fraction of NKT cells can suppress cytotoxic CD8(+) T cells.	[Tang, Bo; Li, Yang] Guilin Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Guilin 541001, Peoples R China; [Wu, Wei] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130021, Peoples R China; [Wei, Xiaowei; Ren, Gang; Fan, Wenhai] Dalian Univ, Affiliated Zhongshan Hosp, Dalian 116001, Peoples R China	Guilin Medical University; Jilin University; Dalian University	Fan, WH (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, 6 Jiefang St, Dalian 116001, Liaoning, Peoples R China.	wenhairfan@163.com			National Natural Science Foundation of China [81360367]; Guangxi Provincial University Science and Technology Research Projects [2013ZD046]; Health Department of Guangxi Traditional Chinese Medical Science and Technology Special Project [QT2013025]; Guangxi Provincial Key Laboratory of Molecular Medicine of Liver Injury and Repair [*SYS2013009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Provincial University Science and Technology Research Projects; Health Department of Guangxi Traditional Chinese Medical Science and Technology Special Project; Guangxi Provincial Key Laboratory of Molecular Medicine of Liver Injury and Repair	This work was supported by the National Natural Science Foundation of China (No. 81360367), The Guangxi Provincial University Science and Technology Research Projects (2013ZD046), the Health Department of Guangxi Traditional Chinese Medical Science and Technology Special Project (QT2013025), and the development project of Guangxi Provincial Key Laboratory of Molecular Medicine of Liver Injury and Repair (*SYS2013009).	Berzins SP, 2014, NAT REV IMMUNOL, V14, P640, DOI 10.1038/nri3725; Biragyn A., 2014, METHOD MOL BIOL, V1190, P89; Hanin G, 2014, HUM MOL GENET, V23, P4569, DOI 10.1093/hmg/ddu170; Hegde S, 2010, IMMUNOLOGY, V130, P471, DOI 10.1111/j.1365-2567.2010.03293.x; Janz C, 2014, CLIN NEUROL NEUROSUR, V125, P114, DOI 10.1016/j.clineuro.2014.07.013; Li ML, 2014, EXP CELL RES, V323, P1, DOI 10.1016/j.yexcr.2013.12.025; Li RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101903; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pan YF, 2013, HEPATOLOGY, V58, P680, DOI 10.1002/hep.26391; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Sag D, 2014, J CLIN INVEST, V124, P3725, DOI 10.1172/JCI72308; Skinner JPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088997; Wang L, 2014, ONCOTARGET, V5, P5416, DOI 10.18632/oncotarget.2116; Xie N, 2014, J IMMUNOL, V193, P327, DOI 10.4049/jimmunol.1400203; Ye ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105350; Yin ZL, 2014, NEUROREPORT, V25, P199, DOI 10.1097/WNR.0000000000000045	16	23	24	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34595	34600		10.1074/jbc.M114.614503	http://dx.doi.org/10.1074/jbc.M114.614503			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342742	hybrid, Green Published			2022-12-26	WOS:000346260800018
J	Xie, Q; Peng, SY; Tao, L; Ruan, HH; Yang, YL; Li, TM; Adams, U; Meng, SS; Bi, XL; Dong, MQ; Yuan, ZQ				Xie, Qi; Peng, Shengyi; Tao, Li; Ruan, Haihe; Yang, Yanglu; Li, Tie-Mei; Adams, Ursula; Meng, Songshu; Bi, Xiaolin; Dong, Meng-Qiu; Yuan, Zengqiang			E2F Transcription Factor 1 Regulates Cellular and Organismal Senescence by Inhibiting Forkhead Box O Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E2F Transcription Factor; FOXO; Oxidative Stress; Senescence; Transcription Regulation	LIFE-SPAN; PROMOTES TUMORIGENESIS; DNA-DAMAGE; FOXO; APOPTOSIS; DAF-16; CELLS; ROS; ACTIVATION; INDUCTION	Background: E2F1 and FOXO3 are two transcription factors participating in cellular senescence. Results: E2F1 represses FOXO3 transactivity through interaction. Conclusion: E2F1-FOXO3 regulatory mechanism is conserved and participates in regulating cellular senescence. Significance: Drugs and/or therapies that inhibit the physical interaction might be candidates for reducing cellular senescence and increasing longevity. E2F1 and FOXO3 are two transcription factors that have been shown to participate in cellular senescence. Previous report reveals that E2F1 enhanced cellular senescence in human fibroblast cells, while FOXO transcription factors play against senescence by regulation reactive oxygen species scavenging proteins. However, their functional interplay has been unclear. Here we use E2F1 knock-out murine Embryonic fibroblasts (MEFs), knockdown RNAi constructs, and ectopic expression of E2F1 to show that it functions by negatively regulating FOXO3. E2F1 attenuates FOXO3-mediated expression of MnSOD and Catalase without affecting FOXO3 protein stability, subcellular localization, or phosphorylation by Akt. We mapped the interaction between E2F1 and FOXO3 to a region including the DNA binding domain of E2F1 and the C-terminal transcription-activation domain of FOXO3. We propose that E2F1 inhibits FOXO3-dependent transcription by directly binding FOXO3 in the nucleus and preventing activation of its target genes. Moreover, knockdown of the Caenorhabditis elegans E2F1 ortholog efl-1 significantly extends lifespan in a manner that requires the activity of the C. elegans FOXO gene daf-16. We conclude that there is an evolutionarily conserved signaling connection between E2F1 and FOXO3, which regulates cellular senescence and aging by regulating the activity of FOXO3. We speculate that drugs and/or therapies that inhibit this physical interaction might be good candidates for reducing cellular senescence and increasing longevity.	[Xie, Qi; Peng, Shengyi; Ruan, Haihe; Yang, Yanglu; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Tao, Li; Li, Tie-Mei; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Meng, Songshu; Bi, Xiaolin] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian 116044, Peoples R China; [Adams, Ursula] Univ Chicago, Chicago, IL 60637 USA; [Peng, Shengyi; Yang, Yanglu] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing; Dalian Medical University; University of Chicago; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yuan, ZQ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, 15 Datun Rd, Beijing 100101, Peoples R China.	zqyuan@sun5.ibp.ac.cn	Yuan, Zengqiang/G-5245-2017; TAO, Li/HIR-4254-2022; Bi, Xiaolin/E-7469-2010	Bi, Xiaolin/0000-0002-7172-7851; Yuan, Zengqiang/0000-0001-5739-2867; Xie, Qi/0000-0002-2370-2078	Ministry of Science and Technology of China [973-2012CB910701, 2013DFA31990, 973-2010CB835203]; National Science Foundation of China [81125010, 81030025]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (973-2012CB910701 and 2013DFA31990) (to Z. Y.), (973-2010CB835203) (to M. D.), and the National Science Foundation of China (81125010 and 81030025) (to Z. Y.).	Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Espada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051544; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Han YH, 2006, FREE RADICAL RES, V40, P1182, DOI 10.1080/10715760600868552; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kodama R, 2013, GENES CELLS, V18, P32, DOI 10.1111/gtc.12015; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li J., 2008, PLOS BIOL; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Perrot V, 2003, J BIOL CHEM, V278, P26111, DOI 10.1074/jbc.M212750200; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rodicker F, 2001, CANCER RES, V61, P7052; Shats I, 2013, CANCER RES, V73, P6056, DOI 10.1158/0008-5472.CAN-13-0453; Song YS, 2005, MECH AGEING DEV, V126, P580, DOI 10.1016/j.mad.2004.11.008; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Xie Q, 2012, ACTA BIOCH BIOPH SIN, V44, P897, DOI 10.1093/abbs/gms067; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; You H, 2005, CELL CYCLE, V4, P37, DOI 10.4161/cc.4.1.1401; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102	34	24	25	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34205	34213		10.1074/jbc.M114.587170	http://dx.doi.org/10.1074/jbc.M114.587170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25344604	Green Published, hybrid			2022-12-26	WOS:000346077600043
J	Neto, OA; Tassy, O; Biancalana, V; Zanoteli, E; Pourquie, O; Laporte, J				Neto, Osorio Abath; Tassy, Olivier; Biancalana, Valerie; Zanoteli, Edmar; Pourquie, Olivier; Laporte, Jocelyn			Integrative Data Mining Highlights Candidate Genes for Monogenic Myopathies	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; DEPENDENT CALCIUM-CHANNEL; SKELETAL-MUSCLE; CONGENITAL MYOPATHIES; MUTATIONS CAUSE; DIAGNOSIS; PROTEINS; DISORDER; SPECTRUM; ACTIN	Inherited myopathies are a heterogeneous group of disabling disorders with still barely understood pathological mechanisms. Around 40% of afflicted patients remain without a molecular diagnosis after exclusion of known genes. The advent of high-throughput sequencing has opened avenues to the discovery of new implicated genes, but a working list of prioritized candidate genes is necessary to deal with the complexity of analyzing large-scale sequencing data. Here we used an integrative data mining strategy to analyze the genetic network linked to myopathies, derive specific signatures for inherited myopathy and related disorders, and identify and rank candidate genes for these groups. Training sets of genes were selected after literature review and used in Manteia, a public web-based data mining system, to extract disease group signatures in the form of enriched descriptor terms, which include functional annotation, human and mouse phenotypes, as well as biological pathways and protein interactions. These specific signatures were then used as an input to mine and rank candidate genes, followed by filtration against skeletal muscle expression and association with known diseases. Signatures and identified candidate genes highlight both potential common pathological mechanisms and allelic disease groups. Recent discoveries of gene associations to diseases, like B3GALNT2, GMPPB and B3GNT1 to congenital muscular dystrophies, were prioritized in the ranked lists, suggesting a posteriori validation of our approach and predictions. We show an example of how the ranked lists can be used to help analyze high-throughput sequencing data to identify candidate genes, and highlight the best candidate genes matching genomic regions linked to myopathies without known causative genes. This strategy can be automatized to generate fresh candidate gene lists, which help cope with database annotation updates as new knowledge is incorporated.	[Neto, Osorio Abath; Biancalana, Valerie; Laporte, Jocelyn] Univ Strasbourg, Dept Translat Med & Neurogenet, UMR7104, IGBMC,INSERM,CNRS,Coll France,U964, Strasbourg, France; [Neto, Osorio Abath; Zanoteli, Edmar] Fac Med Sao Paulo FMUSP, Dept Neurol, Sao Paulo, Brazil; [Tassy, Olivier; Pourquie, Olivier] Univ Strasbourg, Dept Dev & Stem Cells, UMR7104, IGBMC,INSERM,CNRS,Coll France,U964, Strasbourg, France; [Biancalana, Valerie] Nouvel Hop Civil, Fac Med, Lab Diagnost Genet, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg	Laporte, J (corresponding author), Univ Strasbourg, Dept Translat Med & Neurogenet, UMR7104, IGBMC,INSERM,CNRS,Coll France,U964, Strasbourg, France.	jocelyn@igbmc.fr	Pourquié, Olivier/CAJ-5443-2022; Abath Neto, Osorio/H-1420-2017; Biancalana, Valerie/O-2351-2016; laporte, jocelyn/J-7008-2012; Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019	Pourquié, Olivier/0000-0001-5189-1227; Abath Neto, Osorio/0000-0003-2787-5483; 	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Strasbourg University; Agence Nationale de la Recherche [ANR-11-BSV1-026]; Association Francaise contre les Myopathies [15352]; Muscular Dystrophy Association [186985]; Myotubular Trust; CAPES Foundation; Ministry of Education of Brazil [1286/51-2]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Strasbourg University; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association(Muscular Dystrophy Association); Myotubular Trust; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education of Brazil	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Strasbourg University, Agence Nationale de la Recherche (ANR-11-BSV1-026), Association Francaise contre les Myopathies (15352), Muscular Dystrophy Association (186985), and Myotubular Trust (http://www.myotubulartrust.com/). OAN was supported by a fellowship from CAPES Foundation, Ministry of Education of Brazil, process number 1286/51-2 (http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetturo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012742; Amburgey K, 2011, ANN NEUROL, V70, P662, DOI 10.1002/ana.22510; Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Blandin G, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-3; Bogershausen N, 2013, AM J HUM GENET, V93, P181, DOI 10.1016/j.ajhg.2013.05.028; Bohm J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067527; Bohm J, 2013, AM J HUM GENET, V92, P271, DOI 10.1016/j.ajhg.2012.12.007; Bohm J, 2012, HUM MUTAT, V33, P949, DOI 10.1002/humu.22067; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Burguiere AC, 2011, DEV DYNAM, V240, P1856, DOI 10.1002/dvdy.22677; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009; Chang SH, 2012, PROTEIN CELL, V3, P526, DOI 10.1007/s13238-012-2931-7; Cortese A, 2014, NEUROLOGY; Cuisset JM, 2013, REV NEUROL-FRANCE, V169, P632, DOI 10.1016/j.neurol.2012.11.011; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fernandez-Valle C, 2002, NAT GENET, V31, P354, DOI 10.1038/ng930; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Heatwole CR, 2013, MUSCLE NERVE, V47, P632, DOI 10.1002/mus.23683; ILES DE, 1993, HUM MOL GENET, V2, P863; Kaplan JC, GENETABLE NEUROMUSCU; Kaplan JC, 2013, NEUROMUSCULAR DISORD, V23, P1081, DOI 10.1016/j.nmd.2013.10.006; Kumamoto T, 2000, MUSCLE NERVE, V23, P1686, DOI 10.1002/1097-4598(200011)23:11<1686::AID-MUS3>3.0.CO;2-F; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058116; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Majczenko K, 2012, AM J HUM GENET, V91, P365, DOI 10.1016/j.ajhg.2012.06.012; Melia MJ, 2013, BRAIN, V136, P1508, DOI 10.1093/brain/awt074; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Mohaupt MG, 2009, CAN MED ASSOC J, V181, pE11, DOI 10.1503/cmaj.081785; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nigro Vincenzo, 2012, Acta Myol, V31, P196; Nilsson MI, 2013, AM J PATHOL, V183, P1703, DOI 10.1016/j.ajpath.2013.08.010; Ohkawara B, 2014, HUM MOL GENET, V23, P1856, DOI 10.1093/hmg/ddt578; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Puckelwartz MJ, 2010, J MOL CELL CARDIOL, V48, P600, DOI 10.1016/j.yjmcc.2009.11.006; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; Randazzo D, 2013, J CELL BIOL, V200, P523, DOI 10.1083/jcb.201205118; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Robinson RL, 2000, ANN HUM GENET, V64, P307, DOI 10.1046/j.1469-1809.2000.6440307.x; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Tassy O, 2014, NUCLEIC ACIDS RES, V42, pD882, DOI 10.1093/nar/gkt807; Torella A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063536; Vasli N, 2013, ACTA NEUROPATHOL, V125, P173, DOI 10.1007/s00401-012-1072-7; VAUGHAN KT, 1993, GENOMICS, V16, P34, DOI 10.1006/geno.1993.1136; Wicik Z, 2011, POL J VET SCI, V14, P643, DOI 10.2478/v10181-011-0095-7; Zhang M, 2014, BIOCHEM BIOPH RES CO, V449, P62, DOI 10.1016/j.bbrc.2014.04.156; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	62	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110888	10.1371/journal.pone.0110888	http://dx.doi.org/10.1371/journal.pone.0110888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353622	gold, Green Published, Green Submitted			2022-12-26	WOS:000345204200045
J	Lu, S; Pardini, B; Cheng, B; Naccarati, A; Huhn, S; Vymetalkova, V; Vodickova, L; Buchler, T; Hemminki, K; Vodicka, P; Forsti, A				Lu, Shun; Pardini, Barbara; Cheng, Bowang; Naccarati, Alessio; Huhn, Stefanie; Vymetalkova, Veronika; Vodickova, Ludmila; Buchler, Thomas; Hemminki, Kari; Vodicka, Pavel; Forsti, Asta			Single Nucleotide Polymorphisms within Interferon Signaling Pathway Genes Are Associated with Colorectal Cancer Susceptibility and Survival	PLOS ONE			English	Article							IFN-GAMMA RECEPTOR; PROMOTER POLYMORPHISMS; ALPHA PROMOTES; RISK; COLON; IDENTIFICATION; EXPRESSION; LOCI; POLB	Interferon (IFN) signaling has been suggested to play an important role in colorectal carcinogenesis. Our study aimed to examine potentially functional genetic variants in interferon regulatory factor 3 (IRF3), IRF5, IRF7, type I and type II IFN and their receptor genes with respect to colorectal cancer (CRC) risk and clinical outcome. Altogether 74 single nucleotide polymorphisms (SNPs) were covered by the 34 SNPs genotyped in a hospital-based case-control study of 1327 CRC cases and 758 healthy controls from the Czech Republic. We also analyzed these SNPs in relation to overall survival and event-free survival in a subgroup of 483 patients. Seven SNPs in IFNA1, IFNA13, IFNA21, IFNK, IFNAR1 and IFNGR1 were associated with CRC risk. After multiple testing correction, the associations with the SNPs rs2856968 (IFNAR1) and rs2234711 (IFNGR1) remained formally significant (P = 0.0015 and P<0.0001, respectively). Multivariable survival analyses showed that the SNP rs6475526 (IFNA7/IFNA14) was associated with overall survival of the patients (P = 0.041 and event-free survival among patients without distant metastasis at the time of diagnosis, P = 0.034). The hazard ratios (HRs) for rs6475526 remained statistically significant even after adjustment for age, gender, grade and stage (P = 0.029 and P = 0.036, respectively), suggesting that rs6475526 is an independent prognostic marker for CRC. Our data suggest that genetic variation in the IFN signaling pathway genes may play a role in the etiology and survival of CRC and further studies are warranted.	[Lu, Shun; Cheng, Bowang; Huhn, Stefanie; Hemminki, Kari; Forsti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Pardini, Barbara; Naccarati, Alessio] Human Genet Fdn HuGeF, Turin, Italy; [Naccarati, Alessio; Vymetalkova, Veronika; Vodickova, Ludmila; Vodicka, Pavel] Acad Sci Czech Republ, Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic; [Vymetalkova, Veronika; Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Vodickova, Ludmila] Charles Univ Prague, Fac Med Pilsen, Biomed Ctr, Plzen, Czech Republic; [Buchler, Thomas] Thomayer Hosp, Dept Oncol, Prague, Czech Republic; [Hemminki, Kari; Forsti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Thomayer Hospital; Lund University	Forsti, A (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	a.foersti@dkfz.de	Vymetalkova, Veronika/H-3167-2014; Pardini, Barbara/ABI-2295-2020; Buchler, Tomas/I-6580-2017; Pardini, Barbara/K-9451-2016	Vymetalkova, Veronika/0000-0001-6870-6788; Pardini, Barbara/0000-0001-9571-4257; Buchler, Tomas/0000-0001-6667-994X; Pardini, Barbara/0000-0001-9571-4257	Grant agency of the Czech Republic (GACR) [CZ:GACR:GA P304/10/1286, P304/12/1585]; COST Action [BM1206]	Grant agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); COST Action(European Cooperation in Science and Technology (COST))	This study was supported by the Grant agency of the Czech Republic (GACR) [CZ:GACR:GA P304/10/1286 and P304/12/1585] and COST Action BM1206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2011, GENES IMMUN, V12, P653, DOI 10.1038/gene.2011.43; Burghel GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083859; Canedo P, 2008, GUT, V57, P1504, DOI 10.1136/gut.2007.143578; Castro FA, 2011, EUR J CANCER, V47, P1203, DOI 10.1016/j.ejca.2010.12.011; Chen CG, 2012, AM J PATHOL, V180, P661, DOI 10.1016/j.ajpath.2011.10.040; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Duncan TJ, 2007, CLIN CANCER RES, V13, P4139, DOI 10.1158/1078-0432.CCR-06-2833; Esteban-Jurado C, 2014, WORLD J GASTROENTERO, V20, P1961, DOI 10.3748/wjg.v20.i8.1961; Garrity-Park MM, 2008, AM J GASTROENTEROL, V103, P407, DOI 10.1111/j.1572-0241.2007.01572.x; Hemminki K, 2009, AM J GASTROENTEROL, V104, P789, DOI 10.1038/ajg.2008.100; Hiroishi K, 2000, J IMMUNOL, V164, P567, DOI 10.4049/jimmunol.164.2.567; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Iwatsuki M, 2009, J SURG ONCOL, V100, P261, DOI 10.1002/jso.21275; Juliger S, 2003, IMMUNOGENETICS, V54, P675, DOI 10.1007/s00251-002-0516-y; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Leyva L, 2005, J NEUROIMMUNOL, V163, P165, DOI 10.1016/j.jneuroim.2005.02.010; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lu S, 2013, INT J CANCER, V133, P2325, DOI 10.1002/ijc.28251; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Pardini B, 2011, MUTAT RES-GEN TOX EN, V721, P74, DOI 10.1016/j.mrgentox.2010.12.008; Pechlivanis S, 2009, EUR J ENDOCRINOL, V160, P933, DOI 10.1530/EJE-09-0039; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rosenzweig SD, 2004, CLIN IMMUNOL, V112, P113, DOI 10.1016/j.clim.2004.03.018; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Slattery ML, 2011, CARCINOGENESIS, V32, P1660, DOI 10.1093/carcin/bgr189; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Valle L, 2014, HUM MOL GENET; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang Y, 2008, CANCER RES, V68, P1136, DOI 10.1158/0008-5472.CAN-07-5021; Whiffin N, 2014, HUM MOL GENET, V23, P4729, DOI 10.1093/hmg/ddu177; Wilkening S, 2008, CARCINOGENESIS, V29, P1202, DOI 10.1093/carcin/bgn101; Wong KK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh072; Yang JL, 2005, ONCOLOGY-BASEL, V69, P224, DOI 10.1159/000088070; Yang JL, 2005, CANCER LETT, V225, P61, DOI 10.1016/j.canlet.2004.11.041; Zhou CX, 2012, GENE, V507, P95, DOI 10.1016/j.gene.2012.06.073; Zhou J, 2009, IMMUNOGENETICS, V61, P423, DOI 10.1007/s00251-009-0377-8; Zufferey C, 2009, IMMUNOLOGY, V128, P351, DOI 10.1111/j.1365-2567.2009.03110.x	45	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111061	10.1371/journal.pone.0111061	http://dx.doi.org/10.1371/journal.pone.0111061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350395	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943100052
J	Sengupta, MB; Basu, M; Iswarari, S; Mukhopadhyay, KK; Sardar, KP; Acharyya, B; Mohanty, PK; Mukhopadhyay, D				Sengupta, Mohor Biplab; Basu, Mahashweta; Iswarari, Sourav; Mukhopadhyay, Kiran Kumar; Sardar, Krishna Pada; Acharyya, Biplab; Mohanty, Pradeep K.; Mukhopadhyay, Debashis			CSF Proteomics of Secondary Phase Spinal Cord Injury in Human Subjects: Perturbed Molecular Pathways Post Injury	PLOS ONE			English	Article							AXON REGENERATION; GENE-EXPRESSION; RECEPTORS; NETWORKS; PREVALENCE; ACTIVATION	Recovery of sensory and motor functions following traumatic spinal cord injury (SCI) is dependent on injury severity. Here we identified 49 proteins from cerebrospinal fluid (CSF) of SCI patients, eight of which were differentially abundant among two severity groups of SCI. It was observed that the abundance profiles of these proteins change over a time period of days to months post SCI. Statistical analysis revealed that these proteins take part in several molecular pathways including DNA repair, protein phosphorylation, tRNA transcription, iron transport, mRNA metabolism, immune response and lipid and ATP catabolism. These pathways reflect a set of mechanisms that the system may adopt to cope up with the assault depending on the injury severity, thus leading to observed physiological responses. Apart from putting forward a picture of the molecular scenario at the injury site in a human study, this finding further delineates consequent pathways and molecules that may be altered by external intervention to restrict neural degeneration.	[Sengupta, Mohor Biplab; Mukhopadhyay, Debashis] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, W Bengal, India; [Basu, Mahashweta; Mohanty, Pradeep K.] Saha Inst Nucl Phys, Condensed Matter Phys Div, Kolkata, W Bengal, India; [Iswarari, Sourav] Nil Ratan Sircar Med Coll & Hosp, Dept Phys Med & Rehabil, Kolkata, W Bengal, India; [Mukhopadhyay, Kiran Kumar; Sardar, Krishna Pada; Acharyya, Biplab] Nil Ratan Sircar Med Coll & Hosp, Dept Orthopaed Surg, Kolkata, W Bengal, India	Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics	Mukhopadhyay, D (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, W Bengal, India.	debashis.mukhopadhyay@saha.ac.in	Iswarari, Sourav/J-6322-2019	Mohanty, Pradeep Kumar/0000-0002-5240-8396	Project Title: Integrative Biology on Omics Platform (IBOP), Department of Atomic Energy (DAE), Government of India [12-RD-SIN-5.04-0101]; Council of Scientific and Industrial Research (CSIR), Government of India	Project Title: Integrative Biology on Omics Platform (IBOP), Department of Atomic Energy (DAE), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Grant Number: 12-R&D-SIN-5.04-0101, Project Title: Integrative Biology on Omics Platform (IBOP), Department of Atomic Energy (DAE), Government of India, author receiving funding: DM. MBS acknowledges Council of Scientific and Industrial Research (CSIR), Government of India, for her fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Beattie MS, 2000, TOP SPINAL CORD INJ, V6, P14; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Chakrabarti Arunabha, 2012, Genomics Proteomics & Bioinformatics, V10, P208, DOI 10.1016/j.gpb.2012.07.002; Chan Danny T M, 2004, Asian J Surg, V27, P39, DOI 10.1016/S1015-9584(09)60242-6; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Esposito E, 2012, J NEUROINFLAMM, V9, P1; Fandel D, 2013, BRAIN RES, V1535, P89, DOI 10.1016/j.brainres.2013.08.022; Filbin MT, 2003, NAT REV NEUROSCI, V4, P1019, DOI 10.1038/nrn1288; Floriddia EM, 2012, J NEUROSCI, V32, P13956, DOI 10.1523/JNEUROSCI.1925-12.2012; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Koszyca B, 2002, J CLIN NEUROSCI, V9, P298, DOI 10.1054/jocn.2001.0969; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Light M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-122; Lin YH, 2012, FASEB J, V26, P81, DOI 10.1096/fj.11-192914; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Rabert D, 2004, J CLIN NEUROSCI, V11, P289, DOI 10.1016/j.jocn.2003.05.008; RAZDAN S, 1994, NEUROEPIDEMIOLOGY, V13, P113, DOI 10.1159/000110368; Roy S, 2013, CLIN BIOCHEM, V46, P160, DOI 10.1016/j.clinbiochem.2012.10.028; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi ZX, 2014, J BIOL CHEM, V289, P6415, DOI 10.1074/jbc.M113.515601; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tachibana T, 2002, NEUROSCI LETT, V327, P133, DOI 10.1016/S0304-3940(02)00375-0; Wang HD, 2013, BRIT J PHARMACOL, V170, P796, DOI 10.1111/bph.12301; Yang H, 2012, NEUROCHEM INT, V61, P175, DOI 10.1016/j.neuint.2012.04.020; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhao GJ, 2012, MOL MED, V18, P149, DOI 10.2119/molmed.2011.00183	36	21	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110885	10.1371/journal.pone.0110885	http://dx.doi.org/10.1371/journal.pone.0110885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350754	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100046
J	Wang, B; Yang, XL				Wang, Bo; Yang, Xiaolan			Teasing Apart the Effects of Seed Size and Energy Content on Rodent Scatter-Hoarding Behavior	PLOS ONE			English	Article							OAK-DISPERSAL SYNDROME; CACHING BEHAVIOR; ACORN DISPERSAL; PREDATION; TANNIN; DISTANCE; RAIN; REMOVAL; FOREST; PREFERENCES	Scatter-hoarding rodents are known to play a crucial role in the seed dispersal of many plant species. Numerous studies have indicated that both seed size and the energy content of seeds can affect rodent foraging behavior. However, seed size is usually associated with energy content per seed, making it difficult to isolate how seed size and energy affect rodent foraging preferences. This study used 99 treatments of artificial seeds (11 seed sizesx9 levels of energy content) to tease apart the effect of seed size and energy content on rodent seed-caching behavior. Both seed traits showed significant effects, but their details depended on the stage of the rodent foraging process. Seeds with higher energy content were harvested more rapidly while seed size only had a modest effect on harvest rate. However, after harvesting, seed size showed a much stronger effect on rodent foraging behavior. Rodents' choice of which seeds to remove and cache, as well as seed dispersal distance, seemed to reflect an optimal seed size. Our findings could be adapted in future studies to gain a better understanding of scatter-hoarding rodent foraging behavior, and the co-evolutionary dynamics between plant seed production and seed dispersers.	[Wang, Bo; Yang, Xiaolan] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Mengla, Yunnan Province, Peoples R China; [Yang, Xiaolan] Southwest Forestry Univ, Ecotourism Fac, Kunming, Yunnan Province, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Southwest Forestry University - China	Wang, B (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Mengla, Yunnan Province, Peoples R China.	yangblue@xtbg.org.cn		Wang, Bo/0000-0003-1010-6573	National Natural Science Foundation of China [31470494, 31100315]; Chinese Academy of Sciences [KSCX2-EW-Q-17]; Youth Innovation Promotion Association of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of Chinese Academy of Sciences	This study was supported by the National Natural Science Foundation of China (31470494 & 31100315), Key Project of Chinese Academy of Sciences (KSCX2-EW-Q-17), and the Youth Innovation Promotion Association of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelmess EL, 2001, ETHOL ECOL EVOL, V13, P115; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Beck MJ, 2010, J ECOL, V98, P1300, DOI 10.1111/j.1365-2745.2010.01716.x; Blate GM, 1998, OIKOS, V82, P522, DOI 10.2307/3546373; Chang G, 2012, PLANT ECOL, V213, P1633, DOI 10.1007/s11258-012-0118-1; Forget P.-M., 1998, P25; FORGET PM, 1991, OECOLOGIA, V87, P596, DOI 10.1007/BF00320426; Guimaraes PR, 2003, J CHEM ECOL, V29, P1065, DOI 10.1023/A:1023817203748; Holl KD, 1997, BIOTROPICA, V29, P459, DOI 10.1111/j.1744-7429.1997.tb00040.x; JACOBS LF, 1992, ANIM BEHAV, V43, P522, DOI 10.1016/S0003-3472(05)80111-3; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jansen PA, 2012, P NATL ACAD SCI USA, V109, P12610, DOI 10.1073/pnas.1205184109; Jansen Patrick A., 2002, P209, DOI 10.1079/9780851995250.0209; Jenkins SH, 1998, J MAMMAL, V79, P1221, DOI 10.2307/1383013; KERLEY GIH, 1991, OECOLOGIA, V86, P261, DOI 10.1007/BF00317539; Kollmann J, 1998, FUNCT ECOL, V12, P683, DOI 10.1046/j.1365-2435.1998.00239.x; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Li HJ, 2007, FOREST ECOL MANAG, V242, P511, DOI 10.1016/j.foreco.2007.01.063; LIMA SL, 1985, ANIM BEHAV, V33, P155, DOI 10.1016/S0003-3472(85)80129-9; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; Moles AT, 1999, NEW ZEAL J BOT, V37, P83, DOI 10.1080/0028825X.1999.9512615; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; Munoz A, 2008, ANIM BEHAV, V76, P709, DOI 10.1016/j.anbehav.2008.03.017; Perea R, 2012, EUR J FOREST RES, V131, P623, DOI 10.1007/s10342-011-0536-y; Perea R, 2011, ANIM BEHAV, V82, P717, DOI 10.1016/j.anbehav.2011.07.001; Perea R, 2011, BASIC APPL ECOL, V12, P432, DOI 10.1016/j.baae.2011.05.002; R Development Core Team, 2014, R LANG ENV STAT COMP; Smallwood PD, 2001, AM ZOOL, V41, P840, DOI 10.1668/0003-1569(2001)041[0840:TUBOTC]2.0.CO;2; SMALLWOOD PD, 1986, ECOLOGY, V67, P168, DOI 10.2307/1938515; Steele MA, 2001, AM ZOOL, V41, P852, DOI 10.1668/0003-1569(2001)041[0852:TPBOTO]2.0.CO;2; STEELE MA, 1993, AM MIDL NAT, V130, P229, DOI 10.2307/2426123; Steele Michael A., 1998, Virginia Museum of Natural History Special Publication, V6, P223; Stephens D.W., 1986, pi; Takahashi K, 2007, FOREST ECOL MANAG, V250, P187, DOI 10.1016/j.foreco.2007.05.014; Theimer TC, 2003, J TROP ECOL, V19, P95, DOI 10.1017/S0266467403003110; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Vander Wall SB, 1998, CAN J ZOOL, V76, P154, DOI 10.1139/cjz-76-1-154; Vander Wall SB, 2003, OIKOS, V100, P25, DOI 10.1034/j.1600-0706.2003.11973.x; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; WAITE TA, 1994, ANIM BEHAV, V48, P1466, DOI 10.1006/anbe.1994.1385; Wall SBV, 1995, OIKOS, V74, P533, DOI 10.2307/3545999; Wang B, 2008, ACTA OECOL, V34, P379, DOI 10.1016/j.actao.2008.07.001; Wang B, 2013, OIKOS, V122, P1027, DOI 10.1111/j.1600-0706.2012.20823.x; Wang B, 2012, PLANT ECOL, V213, P1329, DOI 10.1007/s11258-012-0091-8; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040640; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026424; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Xiao ZS, 2008, ANIM BEHAV, V75, P1235, DOI 10.1016/j.anbehav.2007.08.017; Xiao ZS, 2006, FOREST ECOL MANAG, V222, P46, DOI 10.1016/j.foreco.2005.10.020; Xiao ZS, 2005, ACTA OECOL, V28, P221, DOI 10.1016/j.actao.2005.04.006; Xiao ZS, 2004, FOREST ECOL MANAG, V195, P141, DOI 10.1016/j.foreco.2004.02.041	52	22	22	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111389	10.1371/journal.pone.0111389	http://dx.doi.org/10.1371/journal.pone.0111389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350369	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100069
J	Stewart, DS; Pierce, DW; Hotta, M; Stern, AT; Forman, SA				Stewart, Deirdre S.; Pierce, David W.; Hotta, Mayo; Stern, Alex T.; Forman, Stuart A.			Mutations at Beta N265 in gamma-Aminobutyric Acid Type A Receptors Alter Both Binding Affinity and Efficacy of Potent Anesthetics	PLOS ONE			English	Article							GATED ION CHANNELS; GABA(A) RECEPTOR; GENERAL-ANESTHETICS; ETOMIDATE BINDING; GLYCINE RECEPTORS; SUBUNIT INTERFACE; CROSS-LINKING; AMINO-ACID; SITES; MODULATION	Etomidate and propofol are potent general anesthetics that act via GABAA receptor allosteric co-agonist sites located at transmembrane beta+/alpha- inter-subunit interfaces. Early experiments in heteromeric receptors identified beta N265 (M2-15') on beta 2 and beta 3 subunits as an important determinant of sensitivity to these drugs. Mechanistic analyses suggest that substitution with serine, the beta 1 residue at this position, primarily reduces etomidate efficacy, while mutation to methionine eliminates etomidate sensitivity and might prevent drug binding. However, the beta N265 residue has not been photolabeled with analogs of either etomidate or propofol. Furthermore, substituted cysteine modification studies find no propofol protection at this locus, while etomidate protection has not been tested. Thus, evidence of contact between beta N265 and potent anesthetics is lacking and it remains uncertain how mutations alter drug sensitivity. In the current study, we first applied heterologous alpha 1 beta 2N265C gamma 2L receptor expression in Xenopus oocytes, thiol-specific aqueous probe modification, and voltage-clamp electrophysiology to test whether etomidate inhibits probe reactions at the beta-265 sidechain. Using up to 300 mu M etomidate, we found both an absence of etomidate effects on alpha 1 beta 2N265C gamma 2L receptor activity and no inhibition of thiol modification. To gain further insight into anesthetic insensitive beta N265M mutants, we applied indirect structurefunction strategies, exploiting second mutations in alpha 1 beta 2/3 gamma 2L GABAA receptors. Using alpha 1M236C as a modifiable and anesthetic-protectable site occupancy reporter in beta+/alpha- interfaces, we found that beta N265M reduced apparent anesthetic affinity for receptors in both resting and GABA-activated states. beta N265M also impaired the transduction of gating effects associated with alpha 1M236W, a mutation that mimics beta+/alpha- anesthetic site occupancy. Our results show that beta N265M mutations dramatically reduce the efficacy/transduction of anesthetics bound in beta+/alpha- sites, and also significantly reduce anesthetic affinity for resting state receptors. These findings are consistent with a role for beta N265 in anesthetic binding within the beta+/alpha- transmembrane sites.	[Stewart, Deirdre S.; Pierce, David W.; Hotta, Mayo; Stern, Alex T.; Forman, Stuart A.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Forman, SA (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	saforman@partners.org	Forman, Stuart/Q-6590-2019	Forman, Stuart/0000-0001-6340-2478	National Institutes of General Medical Sciences Grant [R01GM089745]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089745, P01GM058448] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of General Medical Sciences Grant R01GM089745 to SAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atucha E, 2009, BIOORG MED CHEM LETT, V19, P4284, DOI 10.1016/j.bmcl.2009.05.065; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2012, J BIOL CHEM, V287, P27762, DOI 10.1074/jbc.M112.363341; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bertaccini EJ, 2013, ANESTHESIOLOGY, V119, P1087, DOI 10.1097/ALN.0b013e31829e47e3; Borghese CM, 2014, J NEUROCHEM, V128, P363, DOI 10.1111/jnc.12476; Borghese CM, 2012, ANESTHESIOLOGY, V117, P765, DOI 10.1097/ALN.0b013e31826a0d93; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Desai R, 2009, ANESTHESIOLOGY, V111, P774, DOI 10.1097/ALN.0b013e3181b55fae; Foadi N, 2010, N-S ARCH PHARMACOL, V381, P477, DOI 10.1007/s00210-010-0506-9; Forman SA, 2012, METHODS MOL BIOL, V796, P317, DOI 10.1007/978-1-61779-334-9_17; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; GODEFROI EF, 1965, J MED CHEM, V8, P220, DOI 10.1021/jm00326a017; Guitchounts G, 2012, ANESTHESIOLOGY, V116, P1235, DOI 10.1097/ALN.0b013e3182567df3; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Husain SS, 2006, J MED CHEM, V49, P4818, DOI 10.1021/jm051207b; Husain SS, 2010, J MED CHEM, V53, P6432, DOI 10.1021/jm100498u; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li JN, 2011, PROTEINS, V79, P2794, DOI 10.1002/prot.23106; Lynagh T, 2014, J NEUROSCI, V34, P2155, DOI 10.1523/JNEUROSCI.4307-13.2014; Lynagh T, 2012, TRENDS PHARMACOL SCI, V33, P432, DOI 10.1016/j.tips.2012.05.002; McCracken ML, 2010, J PHARMACOL EXP THER, V335, P600, DOI 10.1124/jpet.110.170472; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2014, NATURE, DOI [10.1038/nature13293:1-8, DOI 10.1038/NATURE13293:1-8]; Nishikawa K, 2002, NEUROPHARMACOLOGY, V42, P337, DOI 10.1016/S0028-3908(01)00189-7; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Pejo E, 2014, ANESTHESIOLOGY, V121, P290, DOI 10.1097/ALN.0000000000000268; Ruesch D, 2012, ANESTHESIOLOGY, V116, P47, DOI 10.1097/ALN.0b013e31823d0c36; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Siegwart Roberta, 2003, BMC Pharmacol, V3, P13, DOI 10.1186/1471-2210-3-13; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Stewart DS, 2013, J BIOL CHEM, V288, P30373, DOI 10.1074/jbc.M113.494583; Stewart DS, 2013, MOL PHARMACOL, V83, P1200, DOI 10.1124/mol.112.084558; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Zeller Anja, 2007, BMC Pharmacology, V7, P2, DOI 10.1186/1471-2210-7-2	54	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111470	10.1371/journal.pone.0111470	http://dx.doi.org/10.1371/journal.pone.0111470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347186	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900078
J	Huang, S; Rossi, S; Hamalainen, M; Ahveninen, J				Huang, Samantha; Rossi, Stephanie; Haemaelaeinen, Matti; Ahveninen, Jyrki			Auditory Conflict Resolution Correlates with Medial-Lateral Frontal Theta/Alpha Phase Synchrony	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COGNITIVE CONTROL; NEURONAL SYNCHRONIZATION; RESPONSE CONFLICT; VISUAL-ATTENTION; THETA; GAMMA; TASK; OSCILLATIONS	When multiple persons speak simultaneously, it may be difficult for the listener to direct attention to correct sound objects among conflicting ones. This could occur, for example, in an emergency situation in which one hears conflicting instructions and the loudest, instead of the wisest, voice prevails. Here, we used cortically-constrained oscillatory MEG/EEG estimates to examine how different brain regions, including caudal anterior cingulate (cACC) and dorsolateral prefrontal cortices (DLPFC), work together to resolve these kinds of auditory conflicts. During an auditory flanker interference task, subjects were presented with sound patterns consisting of three different voices, from three different directions (45 degrees left, straight ahead, 45 degrees right), sounding out either the letters "A'' or "O''. They were asked to discriminate which sound was presented centrally and ignore the flanking distracters that were phonetically either congruent (50%) or incongruent (50%) with the target. Our cortical MEG/EEG oscillatory estimates demonstrated a direct relationship between performance and brain activity, showing that efficient conflict resolution, as measured with reduced conflict-induced RT lags, is predicted by theta/alpha phase coupling between cACC and right lateral frontal cortex regions intersecting the right frontal eye fields (FEF) and DLPFC, as well as by increased pre-stimulus gamma (60-110 Hz) power in the left inferior fontal cortex. Notably, cACC connectivity patterns that correlated with behavioral conflict-resolution measures were found during both the pre-stimulus and the pre-response periods. Our data provide evidence that, instead of being only transiently activated upon conflict detection, cACC is involved in sustained engagement of attentional resources required for effective sound object selection performance.	[Huang, Samantha; Rossi, Stephanie; Haemaelaeinen, Matti; Ahveninen, Jyrki] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Athinoula A Martinos Ctr Biomed Imaging,Dept Radi, Charlestown, MA 02129 USA; [Haemaelaeinen, Matti] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT)	Huang, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Athinoula A Martinos Ctr Biomed Imaging,Dept Radi, Charlestown, MA 02129 USA.	samhuang@nmr.mgh.harvard.edu	Hamalainen, Matti S/C-8507-2013		National Institutes of Health [R01MH083744, R21DC010060, R21DC014134, R01HD040712, R01NS037462, 5R01EB009048]; National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health; National Center for Research Resources Shared Instrumentation Grants [S10RR014978, S10RR021110, S10RR019307, S10RR014798, S10RR023401]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040712] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218, S10RR014798, S10RR021110, S10RR002340, S10RR019307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015896, R01EB009048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010060, R21DC014134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Center for Research Resources Shared Instrumentation Grants; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Awards R01MH083744, R21DC010060, R21DC014134, R01HD040712, R01NS037462, and 5R01EB009048. This research was carried out at the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies, P41EB015896, and a P41 Biotechnology Resource Grant supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health. The research environment was additionally supported by National Center for Research Resources Shared Instrumentation Grants S10RR014978, S10RR021110, S10RR019307, S10RR014798, and S10RR023401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2013, J COGNITIVE NEUROSCI, V25, P1926, DOI 10.1162/jocn_a_00452; Ahveninen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038511; Alain C, 2000, FRONT BIOSCI-LANDMRK, V5, pD202, DOI 10.2741/Alain; Algazi VR, 2001, IEEE WORKSH APPL SIG, V2001, P99, DOI [DOI 10.1109/ASPAA.2001.969552, 10.1155/S1463924601000141]; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Benedict RHB, 2002, J COGNITIVE NEUROSCI, V14, P637, DOI 10.1162/08989290260045765; Benes FM, 2009, CINGULATE NEUROBIOLO, P679; Bibbig A, 2002, J NEUROPHYSIOL, V88, P1634, DOI 10.1152/jn.2002.88.4.1634; Biehl SC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-107; Bland JM, 1996, BRIT MED J, V312, P770; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Chan JS, 2005, ACTA ACUST UNITED AC, V91, P554; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Cohen MX, 2014, ISS CLIN COGN NEUROP, P15; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DeWitt I, 2012, P NATL ACAD SCI USA, V109, pE505, DOI 10.1073/pnas.1113427109; Doesburg SM, 2012, BRAIN RES, V1431, P77, DOI 10.1016/j.brainres.2011.11.005; Doesburg SM, 2009, BRAIN RES, V1303, P97, DOI 10.1016/j.brainres.2009.09.069; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Espinoza-Varas B, 2011, PSYCHOL RES-PSYCH FO, V75, P159, DOI 10.1007/s00426-010-0295-2; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Ghosh SS, 2010, NEUROIMAGE, V53, P85, DOI 10.1016/j.neuroimage.2010.05.075; Gramfort A, 2013, NEUROIMAGE; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamalainen M. S., 2010, MEG INTRO METHODS, P186, DOI [10.1093/acprof:oso/9780195307238.003., DOI 10.1093/ACPROF:OSO/9780195307238.003, DOI 10.1093/ACPROF:OSO/9780195307238.003.0008]; Haupt S, 2009, HUM BRAIN MAPP, V30, P3043, DOI 10.1002/hbm.20731; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Huang S, 2014, NEUROIMAGE, V86, P461, DOI 10.1016/j.neuroimage.2013.10.043; Huang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044062; Jaaskelainen IP, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/216731; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Kaiser J, 2003, NEUROIMAGE, V20, P816, DOI 10.1016/S1053-8119(03)00350-1; Kenet T, 2012, NEUROIMAGE, V61, P1226, DOI 10.1016/j.neuroimage.2012.03.010; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Klauschen F, 2009, HUM BRAIN MAPP, V30, P1310, DOI 10.1002/hbm.20599; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Larson E, 2013, NEUROIMAGE, V64, P365, DOI 10.1016/j.neuroimage.2012.09.006; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Lesh TA, 2013, NEUROIMAGE-CLIN, V2, P590, DOI 10.1016/j.nicl.2013.04.010; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Luks TL, 2007, NEUROIMAGE, V35, P949, DOI 10.1016/j.neuroimage.2006.11.041; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Machado L, 2013, Q J EXP PSYCHOL, V66, P138, DOI 10.1080/17470218.2012.701651; Mainy N, 2007, HUM BRAIN MAPP, V28, P183, DOI 10.1002/hbm.20264; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miller EK, 2013, CURR OPIN NEUROBIOL, V23, P216, DOI 10.1016/j.conb.2012.11.011; Moore RA, 2006, INT J PSYCHOPHYSIOL, V60, P260, DOI 10.1016/j.ijpsycho.2005.06.003; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; Nigbur R, 2012, J COGNITIVE NEUROSCI, V24, P1264, DOI 10.1162/jocn_a_00128; Orr JM, 2009, CEREB CORTEX, V19, P703, DOI 10.1093/cercor/bhn119; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Sharon D, 2007, NEUROIMAGE, V36, P1225, DOI 10.1016/j.neuroimage.2007.03.066; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Soutschek A, 2013, J NEUROSCI, V33, P5647, DOI 10.1523/JNEUROSCI.4768-12.2013; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Szmalec A, 2008, NEUROSCI LETT, V435, P158, DOI 10.1016/j.neulet.2008.02.023; Szucs D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-35; Taulu S, 2005, IEEE T SIGNAL PROCES, V53, P3359, DOI 10.1109/TSP.2005.853302; Totah NKB, 2012, CEREBRAL CORTEX; van Driel J, 2012, J NEUROSCI, V32, P16795, DOI 10.1523/JNEUROSCI.0802-12.2012; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2010, P NATL ACAD SCI USA, V107, P5248, DOI 10.1073/pnas.0906194107; Yendiki A, 2010, NEUROIMAGE, V53, P119, DOI 10.1016/j.neuroimage.2010.02.084; Yoncheva YN, 2010, CEREB CORTEX, V20, P622, DOI 10.1093/cercor/bhp129	109	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110989	10.1371/journal.pone.0110989	http://dx.doi.org/10.1371/journal.pone.0110989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25343503	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500071
J	Ehman, M; Flood, J; Barry, PM				Ehman, Melissa; Flood, Jennifer; Barry, Pennan M.			Tuberculosis Treatment Managed by Providers outside the Public Health Department: Lessons for the Affordable Care Act	PLOS ONE			English	Article							SURVEILLANCE DATA; DRUG-RESISTANCE; UNITED-STATES; CALIFORNIA; OUTCOMES; ASSOCIATION; REGRESSION; IMPACT; DELAYS; RATES	Introduction: Tuberculosis (TB) requires at least six months of multidrug treatment and necessitates monitoring for response to treatment. Historically, public health departments (HDs) have cared for most TB patients in the United States. The Affordable Care Act (ACA) provides coverage for uninsured persons and may increase the proportion of TB patients cared for by private medical providers and other providers outside HDs (PMPs). We sought to determine whether there were differences in care provided by HDs and PMPs to inform public health planning under the ACA. Methods: We conducted a retrospective, cross-sectional analysis of California TB registry data. We included adult TB patients with culture-positive, pulmonary TB reported in California during 2007-2011. We examined trends, described case characteristics, and created multivariate models measuring two standards of TB care in PMP- and HD-managed patients: documented culture conversion within 60 days, and use of directly observed therapy (DOT). Results: The proportion of PMP-managed TB patients increased during 2007-2011 (p = 0.002). On univariable analysis (N = 4,606), older age, white, black or Asian/Pacific Islander race, and birth in the United States were significantly associated with PMP care (p < 0.05). Younger age, Hispanic ethnicity, homelessness, drug or alcohol use, and cavitary and/or smear-positive TB disease, were associated with HD care. Multivariable analysis showed PMP care was associated with lack of documented culture conversion (adjusted relative risk [aRR] = 1.37, confidence interval [CI] 1.25-1.51) and lack of DOT (aRR = 8.56, CI 6.59-11.1). Conclusion: While HDs cared for TB cases with more social and clinical complexities, patients under PMP care were less likely to receive DOT and have documented culture conversion. This indicates a need for close collaboration between PMPs and HDs to ensure that optimal care is provided to all TB patients and TB transmission is halted. Strategies to enhance collaboration between HDs and PMPs should be included in ACA implementation.	[Ehman, Melissa; Flood, Jennifer; Barry, Pennan M.] Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, TB Control Branch, Richmond, CA 94804 USA; [Ehman, Melissa] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA	California Department of Public Health; University of California System; University of California San Francisco	Ehman, M (corresponding author), Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, TB Control Branch, Richmond, CA 94804 USA.	Melissa.Ehman@cdph.ca.gov						American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; [Anonymous], 2012, SAS VERS 9 3; Binkin NJ, 1999, INT J TUBERC LUNG D, V3, P663; California Department of Health Services (CDHS), 2013, MED RAT; California Department of Public Health California Tuberculosis Controller's Association, 2011, GUID DIR OBS THER PR; Cass Anne, 2013, Public Health Rep, V128, P367, DOI 10.1177/003335491312800507; Centers for Disease Control and Prevention, 2009, 729A CDCP; Centers for Disease Control and Prevention, 2003, 729A CDCP; Centers for Disease Control and Prevention (CDC), 2012, REP TUB US 2011; Curry International Tuberculosis Center, 2012, ENG PRIV SECT TB PRE; Davidow AL, 2009, PUBLIC HEALTH REP, V124, P391, DOI 10.1177/003335490912400308; Ehman M, 2013, J PUBLIC HEALTH MAN, V19, pE29, DOI 10.1097/PHH.0b013e3182751d6f; Erwin PC, 2011, AM J PUBLIC HEALTH, V101, P609, DOI 10.2105/AJPH.2009.177451; Golub JE, 2005, INT J TUBERC LUNG D, V9, P992; Handford CD, 2012, AIDS CARE, V24, P267, DOI 10.1080/09540121.2011.608419; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; Hughes S., 2010, Morbidity and Mortality Weekly Report, V59, P295; *I MED, 2000, END NEGL EL TUB US; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kong DG, 2013, J PUBLIC HEALTH MAN, V19, P169, DOI 10.1097/PHH.0b013e3182550a83; Liu ZY, 1998, CHEST, V113, P1446, DOI 10.1378/chest.113.6.1446; Liu ZY, 1999, ARCH INTERN MED, V159, P1110, DOI 10.1001/archinte.159.10.1110; Mays Glen P, 2004, J Public Health Manag Pract, V10, P435; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Moonan PK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-19; National Cancer Institute, 2013, JOINP REGR PROGR VER; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Porco TC, 2013, CLIN INFECT DIS, V56, P761, DOI 10.1093/cid/cis989; Rao SN, 2000, CHEST, V117, P734, DOI 10.1378/chest.117.3.734; Richardson N L, 2000, J Contin Educ Health Prof, V20, P146, DOI 10.1002/chp.1340200303; SBARBARO JA, 1970, AM REV RESPIR DIS, V101, P463; Schmitt S, 2014, CLIN INFECT DIS, V58, P22, DOI 10.1093/cid/cit610; Silin M, 2010, J PUBLIC HEALTH MAN, V16, pE9, DOI 10.1097/PHH.0b013e3181c87ae5; Sprinson JE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-217; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Tuberculosis Control Branch, 2013, REP TUB CAL 2012; WEIS SE, 1994, NEW ENGL J MED, V330, P1179, DOI 10.1056/NEJM199404283301702; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110645	10.1371/journal.pone.0110645	http://dx.doi.org/10.1371/journal.pone.0110645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340876	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800045
J	Huang, YC; Tsai, YH; Lee, JD; Weng, HH; Lin, LC; Lin, YH; Wu, CY; Huang, YC; Hsu, HL; Lee, M; Yang, HT; Hsu, CY; Pan, YT; Yang, JT				Huang, Yen-Chu; Tsai, Yuan-Hsiung; Lee, Jiann-Der; Weng, Hsu-Huei; Lin, Leng-Chieh; Lin, Ya-Hui; Wu, Chih-Ying; Huang, Ying-Chih; Hsu, Huan-Lin; Lee, Meng; Yang, Hsin-Ta; Hsu, Chia-Yu; Pan, Yi-Ting; Yang, Jen-Tsung			Hemodynamic Factors May Play a Critical Role in Neurological Deterioration Occurring within 72 hrs after Lacunar Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; SMALL VESSEL DISEASE; PROGRESSIVE MOTOR DEFICITS; LENTICULOSTRIATE ARTERY; DIFFUSION; INFARCTION; THROMBOLYSIS; PREDICTION; TERRITORY; ASPIRIN	Background: Whether a perfusion defect exists in lacunar infarct and whether it is related to early neurological deterioration (END) is still under debate. The aim of this study was to evaluate whether END in lacunar infarct is related to a perfusion defect using diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI) and perfusion MR imaging. Methods: One hundred and forty-one consecutive patients had an MRI scan within 30 hours after onset of symptoms and 43 patients with acute lacunar infarct and classic lacunar syndrome were recruited. The MRI sequences included DWI, DTI and cerebral blood flow (CBF) maps to respectively represent the topographic locations of acute infarcts, the corticospinal tract and perfusion defects. The END was defined in reference to the National Institute of Health Stroke Scale (NIHSS) as an increase >= 2 within 72 hours. Cohen's Kappa coefficient was used to examine the reliability between the 2 image readers. A multivariate logistic regression model was constructed adjusting for baseline variables. Results: Ten out of the 43 patients had END. Patients having END was significantly associated with lower chances of favorable and good outcomes at 3 months (p = 0.01 and p = 0.002, respectively). END was predicted when the non-core hypoperfused area overlapped on the corticospinal tract, which is defined as the expected END profile. Cohen's Kappa coefficient between the 2 image readers to define images of expected END profiles was 0.74. In 15 patients with expected END profile, 9 had END clinically, whereas 28 patients had no expected END profile, and only 1 patient had END (p<0.0001). After adjusting for sex, the expected END profile was still associated with END (odds ratio, 42.2; p = 0.002). Conclusion: Our study demonstrated that the END in acute lacunar stroke is likely related to the transformation of non-core hypoperfused area into infarction in the anatomy of corticospinal tracts.	[Huang, Yen-Chu; Lee, Jiann-Der; Lin, Ya-Hui; Wu, Chih-Ying; Huang, Ying-Chih; Hsu, Huan-Lin; Lee, Meng; Yang, Hsin-Ta; Hsu, Chia-Yu; Pan, Yi-Ting] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurol, Chiayi, Taiwan; [Tsai, Yuan-Hsiung; Weng, Hsu-Huei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Diagnost Radiol, Chiayi, Taiwan; [Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Chiayi, Taiwan; [Lin, Leng-Chieh] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Emergency Med, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Yang, JT (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Chiayi, Taiwan.	jents716@ms32.hinet.net	Huang, Yenchu/AAO-1140-2020; Weng, Hsu-Huei/N-8329-2014	Weng, Hsu-Huei/0000-0002-2020-8912	Chang Gung Memorial Hospital [CMRPG690451, CMRPG690452, CORPG690453]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by Chang Gung Memorial Hospital grants CMRPG690451, CMRPG690452 and CORPG690453. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alawneh JA, 2011, BRAIN, V134, P1765, DOI 10.1093/brain/awr100; Alawneh JA, 2009, STROKE, V40, pE443, DOI 10.1161/STROKEAHA.108.532465; Arenillas JF, 2002, STROKE, V33, P2197, DOI 10.1161/01.STR.0000027861.75884.DF; Cocho D, 2006, EUR NEUROL, V55, P70, DOI 10.1159/000091982; Del BA, 2012, INT J STROKE, V7, P321; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; Fuentes B, 2012, EUR J NEUROL, V19, P1568, DOI 10.1111/j.1468-1331.2012.03790.x; Gerraty RP, 2002, STROKE, V33, P2019, DOI 10.1161/01.STR.0000020841.74704.5B; Huang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069085; Hwang YH, 2008, CEREBROVASC DIS, V26, P355, DOI 10.1159/000151638; Lai C, 2007, BRIT J RADIOL, V80, P782, DOI 10.1259/bjr/99366083; Lee JS, 2005, NEUROIMAGE, V26, P771, DOI 10.1016/j.neuroimage.2005.02.036; Mustanoja S, 2011, STROKE, V42, P102, DOI 10.1161/STROKEAHA.110.597534; Nakamura T, 2012, J NEUROL SCI, V313, P22, DOI 10.1016/j.jns.2011.09.038; Ohara T, 2010, J NEUROL SCI, V293, P87, DOI 10.1016/j.jns.2010.02.027; Ois A, 2008, CEREBROVASC DIS, V25, P151, DOI 10.1159/000113732; Poppe AY, 2009, CEREBROVASC DIS, V28, P151, DOI 10.1159/000225908; Siegler JE, 2011, INT J STROKE, V6, P211, DOI 10.1111/j.1747-4949.2011.00596.x; Steinke W, 2002, STROKE, V33, P1510, DOI 10.1161/01.STR.0000016326.78014.FE; Takase K, 2011, EUR NEUROL, V65, P355, DOI 10.1159/000327980; Terasawa Y, 2008, J NEUROL SCI, V269, P35, DOI 10.1016/j.jns.2007.12.014; Wang QS, 2012, ARCH NEUROL-CHICAGO, V69, P1454, DOI 10.1001/archneurol.2012.1633; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Yamada M, 2004, AM J NEURORADIOL, V25, P402; Yamamoto Y, 2011, J NEUROL SCI, V304, P78, DOI 10.1016/j.jns.2011.02.006	28	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e108395	10.1371/journal.pone.0108395	http://dx.doi.org/10.1371/journal.pone.0108395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340713	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800005
J	Lee, PH				Lee, Paul H.			Association between Adolescents' Physical Activity and Sedentary Behaviors with Change in BMI and Risk of Type 2 Diabetes	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; METABOLIC RISK; 21 REGIONS; CHILDREN; OBESITY; POPULATION	This study aims at identifying the association between physical activity (PA) and sedentary behavior (SB) patterns during adolescents on the future increase in BMI and risk of diabetes during young adulthood. A total of 3,717 participants aged 11 to 21 at baseline who completed Waves I (1994-1995), II (1996), III (2001-2002), and IV (2008) surveys of the National Longitudinal Study of Adolescent Health (Add Health) were analyzed. Physical activity and sedentary behavior patterns were assessed using an interviewer-administered questionnaire at Waves I, II, and III. A participant was classified as having diabetes at Wave IV according to WHO guidelines. The k-means cluster analysis was used to identify the number of PA and SB patterns assessed using interviewer-administered questionnaire. The k-means cluster analysis identified three clusters; 575 (15.5%), 2,140 (57.6%), and 1,002 (27.0%) participants belonged to the low PA high SB (LPAHSB), the LPALSB, and the HPALSB cluster respectively. Relative to the LPALSB cluster, the HPALSB cluster had lower increase in BMI from Wave III to Wave IV (P = 0.03), whereas the difference between LPAHSB cluster and LPALSB cluster was not significant (P = 0.09). The odds of developing diabetes at Wave IV was significant for the LPAHSB cluster (OR = 1.69, 95% CI = 1.04, 2.75) but not significant for the HPALSB cluster (OR = 0.87, 95% CI = 0.52, 1.47) relative to the LPALSB cluster. To conclude, PA but not SB during adolescence predicted change in BMI during young adulthood. SB but not PA during adolescence predicted type 2 diabetes during young adulthood.	Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Lee, PH (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	paul.h.lee@polyu.edu.hk	Lee, Paul H/F-2549-2010	Lee, Paul H/0000-0002-5729-6450	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis.	Atlantis E, 2014, CIRC J, V78, P1066, DOI 10.1253/circj.CJ-14-0324; BARANOWSKI T, 1988, RES Q EXERCISE SPORT, V59, P314, DOI 10.1080/02701367.1988.10609379; CDC, 2012, MMWR-MORBID MORTAL W, V61, pSS; Christensen DL, 2012, AM J HUM BIOL, V24, P558, DOI 10.1002/ajhb.22239; Chu AHY, 2013, PREV MED, V57, pS14, DOI 10.1016/j.ypmed.2012.12.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421; Hennig C, 2004, J COMPUT GRAPH STAT, V13, P930, DOI 10.1198/106186004X12740; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; LEE PH, 2013, PUBLIC HEALTH NUTR, V16, P1436; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Magee CA, 2013, J DEV BEHAV PEDIATR, V34, P165, DOI [10.1097/DBP.0b013e318289aa51., 10.1097/DBP.0b013e318289aa51]; Maher CA, 2013, OBESITY, V21, pE730, DOI 10.1002/oby.20430; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Monda KL, 2005, OBES RES, V13, P1042, DOI 10.1038/oby.2005.122; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Reis JP, 2011, ANN INTERN MED, V155, P292, DOI 10.7326/0003-4819-155-5-201109060-00006; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Thorndike R. L., 1953, PSYCHOMETRIKA, V18, P267, DOI [10.1007/BF02289263, DOI 10.1007/BF02289263]; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wiecha JL, 2006, ARCH PEDIAT ADOL MED, V160, P436, DOI 10.1001/archpedi.160.4.436; World Health Organization, 2006, DEF DIAGN DIAB MELL; Zabinski MF, 2007, HEALTH PSYCHOL, V26, P113, DOI 10.1037/0278-6133.26.1.113	36	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110732	10.1371/journal.pone.0110732	http://dx.doi.org/10.1371/journal.pone.0110732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340773	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800052
J	Rotheram-Borus, MJ; Tomlinson, M; le Roux, IM; Harwood, JM; Comulada, S; O'Connor, MJ; Weiss, RE; Worthman, CM				Rotheram-Borus, Mary Jane; Tomlinson, Mark; le Roux, Ingrid M.; Harwood, Jessica M.; Comulada, Scott; O'Connor, Mary J.; Weiss, Robert E.; Worthman, Carol M.			A Cluster Randomised Controlled Effectiveness Trial Evaluating Perinatal Home Visiting among South African Mothers/Infants	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; SUB-SAHARAN AFRICA; NEWBORN CARE; OUTCOMES; INFANTS; PARAPROFESSIONALS; DEPRESSION; PROGRAMS; PACKAGE; NURSES	Background: Interventions are needed to reduce poor perinatal health. We trained community health workers (CHWs) as home visitors to address maternal/infant risks. Methods: In a cluster randomised controlled trial in Cape Town townships, neighbourhoods were randomised within matched pairs to 1) the control, healthcare at clinics (n = 12 neighbourhoods; n = 594 women), or 2) a home visiting intervention by CBW trained in cognitive-behavioural strategies to address health risks (by the Philani Maternal, Child Health and Nutrition Programme), in addition to clinic care (n = 12 neighbourhoods; n = 644 women). Participants were assessed during pregnancy (2% refusal) and 92% were reassessed at two weeks post-birth, 88% at six months and 84% at 18 months later. We analysed 32 measures of maternal/infant well-being over the 18 month follow-up period using longitudinal random effects regressions. A binomial test for correlated outcomes evaluated overall effectiveness over time. The 18 month post-birth assessment outcomes also were examined alone and as a function of the number of home visits received. Results: Benefits were found on 7 of 32 measures of outcomes, resulting in significant overall benefits for the intervention compared to the control when using the binomial test (p = 0.008); nevertheless, no effects were observed when only the 18 month outcomes were analyzed. Benefits on individual outcomes were related to the number of home visits received. Among women living with HIV, intervention mothers were more likely to implement the PMTCT regimens, use condoms during all sexual episodes (OR = 1.25; p = 0.014), have infants with healthy weight-for-age measurements (OR = 1.42; p = 0.045), height-for-age measurements (OR = 1.13, p<0.001), breastfeed exclusively for six months (OR = 3.59; p<0.001), and breastfeed longer (OR = 3.08; p<0.001). Number of visits was positively associated with infant birth weight >= 2500 grams (OR = 1.07; p = 0.012), healthy head-circumference-for-age measurements at 6 months (OR = 1.09, p = 0.017), and improved cognitive development at 18 months (OR = 1.02, p = 0.048). Conclusions: Home visits to neighbourhood mothers by CHWs may be a feasible strategy for enhancing maternal/child outcomes. However, visits likely must extend over several years for persistent benefits.	[Rotheram-Borus, Mary Jane; Harwood, Jessica M.; Comulada, Scott; O'Connor, Mary J.] Univ Calif Los Angeles, Semel Inst, Dept Psychiat & Biobehav Med, Los Angeles, CA 90095 USA; [Tomlinson, Mark] Univ Stellenbosch, Dept Psychol, ZA-7600 Stellenbosch, South Africa; [le Roux, Ingrid M.] Philani Maternal Child Hlth & Nutr Programme, Cape Town, South Africa; [Worthman, Carol M.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Weiss, Robert E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA	University of California System; University of California Los Angeles; Stellenbosch University; Emory University; University of California System; University of California Los Angeles	Rotheram-Borus, MJ (corresponding author), Univ Calif Los Angeles, Semel Inst, Dept Psychiat & Biobehav Med, Los Angeles, CA 90095 USA.	CCHPublications@mednet.ucla.edu		Worthman, Carol M/0000-0002-5397-2298	NIAAA grant [R01 AA017104]; Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant [P30 MH58107]; UCLA Center for AIDS Research (CFAR) grant [P30 AI028697]; National Center for Advancing Translational Sciences through UCLA CSTI Grant [UL1 TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017104, R24AA022919] Funding Source: NIH RePORTER	NIAAA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant; UCLA Center for AIDS Research (CFAR) grant; National Center for Advancing Translational Sciences through UCLA CSTI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIAAA grant R01 AA017104, the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant P30 MH58107; the UCLA Center for AIDS Research (CFAR) grant P30 AI028697; and the National Center for Advancing Translational Sciences through UCLA CSTI Grant UL1 TR000124. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamo S, 2012, AIDS PATIENT CARE ST, V26, P101, DOI 10.1089/apc.2011.0279; Bayley N, 2003, BAYLEY SCALES INFANT; Berggren WL., 2002, FOOD NUTR BULL, V23, P7; Chibanda D, 2010, ARCH WOMEN MENT HLTH, V13, P201, DOI 10.1007/s00737-009-0073-6; Cogill B, 2003, ANTHROPOMETRIC INDIC; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dawson DA, 2005, COMPR PSYCHIAT, V46, P405, DOI 10.1016/j.comppsych.2005.01.006; Flay BR, 2005, PREV SCI, V6, P151, DOI 10.1007/s11121-005-5553-y; Grantham-McGregor S, 2007, LANCET, V369, P824, DOI 10.1016/S0140-6736(07)60404-8; GROSS RT, 1990, JAMA-J AM MED ASSOC, V263, P3035; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Kirkwood BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-58; Langer A, 2011, SUPPORT PREGNANCY WO; le Roux IM, 2013, AIDS, V27, P1461, DOI 10.1097/QAD.0b013e3283601b53; Lewin S., 2006, LAY HLTH WORKERS PRI; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; Narman N, 2007, SAMJ S AFR MED J, V97, P733; Olds D, 1998, JUVENILE JUSTICE B; Olds DL, 2002, PEDIATRICS, V110, P486, DOI 10.1542/peds.110.3.486; Olds DL, 2004, PEDIATRICS, V114, P1560, DOI 10.1542/peds.2004-0961; Peacock S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-17; Rotheram-Borus MJ, 2012, INT J TELEMED APPL, V2012, DOI 10.1155/2012/973237; Rotheram-Borus MJ, 2014, J CLIN CHILD ADOLESC, V43, P229, DOI 10.1080/15374416.2013.836453; Rotheram-Borus MJ, 2012, AM PSYCHOL, V67, P463, DOI 10.1037/a0028180; Rotheram-Borus MJ, 2011, PREV SCI, V12, P372, DOI 10.1007/s11121-011-0238-1; Singh P, 2013, LANCET, V382, P363, DOI 10.1016/S0140-6736(12)62002-9; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stein AD, 2013, J PEDIATR-US, V163, P1740, DOI 10.1016/j.jpeds.2013.08.012; Suri A, 2007, J INFECT DIS, V196, pS505, DOI 10.1086/521122; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Tomlinson M, 2014, TROP MED INT HEALTH, V19, P256, DOI 10.1111/tmi.12257; Tomlinson M, 2013, S AFR J INFORM MANAG, V15, DOI 10.4102/sajim.v15i1.528; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; USAID, MAT HLTH S AFR; World Health Organization, 2011, WORK WHO AFR REG 201	37	52	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e105934	10.1371/journal.pone.0105934	http://dx.doi.org/10.1371/journal.pone.0105934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340337	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800001
J	Tanaka, R; Hino, A; Tsai, IJ; Palomares-Rius, JE; Yoshida, A; Ogura, Y; Hayashi, T; Maruyama, H; Kikuchi, T				Tanaka, Ryusei; Hino, Akina; Tsai, Isheng J.; Palomares-Rius, Juan Emilio; Yoshida, Ayako; Ogura, Yoshitoshi; Hayashi, Tetsuya; Maruyama, Haruhiko; Kikuchi, Taisei			Assessment of Helminth Biodiversity in Wild Rats Using 18S rDNA Based Metagenomics	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; PHYLOGENETIC-RELATIONSHIPS; DIVERSITY; PARASITES; RARE; RESOLUTION; SEQUENCES; SELECTION; REGIONS; PROJECT	Parasite diversity has important implications in several research fields including ecology, evolutionary biology and epidemiology. Wide-ranging analysis has been restricted because of the difficult, highly specialised and time-consuming processes involved in parasite identification. In this study, we assessed parasite diversity in wild rats using 18S rDNA-based metagenomics. 18S rDNA PCR products were sequenced using an Illumina MiSeq sequencer and the analysis of the sequences using the QIIME software successfully classified them into several parasite groups. The comparison of the results with those obtained using standard methods including microscopic observation of helminth parasites in the rat intestines and PCR amplification/sequencing of 18S rDNA from isolated single worms suggests that this new technique is reliable and useful to investigate parasite diversity.	[Tanaka, Ryusei; Hino, Akina; Palomares-Rius, Juan Emilio; Yoshida, Ayako; Maruyama, Haruhiko; Kikuchi, Taisei] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan; [Tsai, Isheng J.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Dept Genom & Bioenvirom Sci, Div Microbial Genom, Miyazaki, Japan	University of Miyazaki; Academia Sinica - Taiwan; University of Miyazaki	Kikuchi, T (corresponding author), Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan.	taisei_kikuchi@med.miyazaki-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020; Palomares-Rius, Juan/K-8004-2015; Tsai, Isheng Jason/ABB-8273-2021	Palomares-Rius, Juan/0000-0003-1776-8131; Tsai, Isheng Jason/0000-0002-2123-5058; Kikuchi, Taisei/0000-0003-2759-9167	JSPS KAKENHI [24780044, 24659190, 26460510, 26292178]; Project of Establishing Medical Research Base Networks against Infectious Diseases in Okinawa [CBB13001]; Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project of Establishing Medical Research Base Networks against Infectious Diseases in Okinawa; Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki	This work was supported in part by JSPS KAKENHI (grants numbers 24780044, 24659190, 26460510 and 26292178), the Project of Establishing Medical Research Base Networks against Infectious Diseases in Okinawa (grants number CBB13001), and the Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Amir A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1070; Bik HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078230; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; COMBES C, 1990, TRENDS ECOL EVOL, V5, P334, DOI 10.1016/0169-5347(90)90181-C; Desai N, 2012, CURR OPIN BIOTECH, V23, P72, DOI 10.1016/j.copbio.2011.12.017; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hugerth LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095567; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Korallo NP, 2007, DIVERS DISTRIB, V13, P353, DOI 10.1111/j.1472-4642.2007.00332.x; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Porazinska DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044641; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukhdeo MVK, 1996, INT J PARASITOL, V26, P483, DOI 10.1016/0020-7519(96)89378-7; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Waeschenbach A, 2007, MOL PHYLOGENET EVOL, V45, P311, DOI 10.1016/j.ympev.2007.03.019; WATERS AP, 1991, P NATL ACAD SCI USA, V88, P3140, DOI 10.1073/pnas.88.8.3140; WEBSTER JP, 1995, PARASITOLOGY, V111, P247, DOI 10.1017/S0031182000081804; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Yamaguti S., 1961, NEMATODES VERTEBRATE; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao XM, 2001, INT J PARASITOL, V31, P715, DOI 10.1016/S0020-7519(01)00136-9	32	34	34	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110769	10.1371/journal.pone.0110769	http://dx.doi.org/10.1371/journal.pone.0110769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340824	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800054
J	Kallemeijn, WW; Witte, MD; Voorn-Brouwer, TM; Walvoort, MTC; Li, KY; Codee, JDC; van der Marel, GA; Boot, RG; Overkleeft, HS; Aerts, JMFG				Kallemeijn, Wouter W.; Witte, Martin D.; Voorn-Brouwer, Tineke M.; Walvoort, Marthe T. C.; Li, Kah-Yee; Codee, Jeroen D. C.; van der Marel, Gijsbert A.; Boot, Rolf G.; Overkleeft, Herman S.; Aerts, Johannes M. F. G.			A Sensitive Gel-based Method Combining Distinct Cyclophellitol-based Probes for the Identification of Acid/Base Residues in Human Retaining beta-Glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gaucher Disease; Glycobiology; Glycoconjugate; Glycolipid; Glycosidase; Acid; Base; Activity-based Probe; Labeling; Nucleophile	LACTASE-PHLORHIZIN HYDROLASE; 2 CATALYTIC SITES; GAUCHER-DISEASE; INTESTINAL LACTASE; ACTIVE-SITE; NONLYSOSOMAL GLUCOSYLCERAMIDASE; GLYCOSIDE-HYDROLASE; MOLECULAR-CLONING; TRPV5 CHANNEL; IN-VIVO	Retaining -exoglucosidases operate by a mechanism in which the key amino acids driving the glycosidic bond hydrolysis act as catalytic acid/base and nucleophile. Recently we designed two distinct classes of fluorescent cyclophellitol-type activity-based probes (ABPs) that exploit this mechanism to covalently modify the nucleophile of retaining -glucosidases. Whereas -epoxide ABPs require a protonated acid/base for irreversible inhibition of retaining -glucosidases, -aziridine ABPs do not. Here we describe a novel sensitive method to identify both catalytic residues of retaining -glucosidases by the combined use of cyclophellitol -epoxide- and -aziridine ABPs. In this approach putative catalytic residues are first substituted to noncarboxylic amino acids such as glycine or glutamine through site-directed mutagenesis. Next, the acid/base and nucleophile can be identified via classical sodium azide-mediated rescue of mutants thereof. Selective labeling with fluorescent -aziridine but not -epoxide ABPs identifies the acid/base residue in mutagenized enzyme, as only the -aziridine ABP can bind in its absence. The Absence of the nucleophile abolishes any ABP labeling. We validated the method by using the retaining -glucosidase GBA (CAZy glycosylhydrolase family GH30) and then applied it to non-homologous (putative) retaining -glucosidases categorized in GH1 and GH116: GBA2, GBA3, and LPH. The described method is highly sensitive, requiring only femtomoles (nanograms) of ABP-labeled enzymes.	[Kallemeijn, Wouter W.; Voorn-Brouwer, Tineke M.; Boot, Rolf G.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Witte, Martin D.; Walvoort, Marthe T. C.; Li, Kah-Yee; Codee, Jeroen D. C.; van der Marel, Gijsbert A.; Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC	Overkleeft, HS (corresponding author), Leiden Univ, Leiden Inst Chem, Einsteinweg 55, NL-2300 RA Leiden, Netherlands.	h.s.overkleeft@chem.leidenuniv.nl; j.m.aerts@amc.uva.nl	Aerts, Johannes/A-1028-2009; Kallemeijn, Wouter W./F-6801-2014; Walvoort, Marthe/AAE-4468-2019; Kallemeijn, W. W./P-2768-2019; Walvoort, Marthe/ABE-8335-2020	Aerts, Johannes/0000-0001-8168-2565; Kallemeijn, Wouter W./0000-0002-3660-2930; Walvoort, Marthe/0000-0003-1101-2659; Kallemeijn, W. W./0000-0002-3660-2930; Overkleeft, Herman/0000-0001-6976-7005; Boot, Rolf/0000-0002-7031-3390	Netherlands Organization for Scientific Research (NWO-CW); European Research Council (ERC AdG)	Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC AdG)(European Research Council (ERC))	This work was supported by The Netherlands Organization for Scientific Research (NWO-CW, Top Grant (to H. S. O. and J. M. F. G. A.) and the European Research Council (ERC AdG; to H. S. O.).	Andersson U, 2000, BIOCHEM PHARMACOL, V59, P821, DOI 10.1016/S0006-2952(99)00384-6; Arribas JCD, 2000, EUR J BIOCHEM, V267, P6996, DOI 10.1046/j.1432-1327.2000.01784.x; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; Bravman T, 2003, J BIOL CHEM, V278, P26742, DOI 10.1074/jbc.M304144200; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Cobucci-Ponzano B, 2010, J BIOL CHEM, V285, P20691, DOI 10.1074/jbc.M109.086470; Dekker N, 2011, BLOOD CELL MOL DIS, V46, P19, DOI 10.1016/j.bcmd.2010.07.009; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; GOPALAN V, 1992, J BIOL CHEM, V267, P14027; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Grabowski GA, 2012, HEMATOL-AM SOC HEMAT, P13, DOI 10.1182/asheducation-2012.1.13; Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; LLOYD M, 1992, J CLIN INVEST, V89, P524, DOI 10.1172/JCI115616; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; MacLeod AM, 1996, BIOCHEMISTRY-US, V35, P13165, DOI 10.1021/bi9610616; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Noguchi J, 2008, BIOCHEM BIOPH RES CO, V374, P549, DOI 10.1016/j.bbrc.2008.07.089; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; SKOVBJERG H, 1981, EUR J BIOCHEM, V114, P653, DOI 10.1111/j.1432-1033.1981.tb05193.x; Sorli SC, 2013, FASEB J, V27, P489, DOI 10.1096/fj.12-215152; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; TULL D, 1991, J BIOL CHEM, V266, P15621; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; WACKER H, 1992, J BIOL CHEM, V267, P18744; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; WITHERS SG, 1988, J BIOL CHEM, V263, P7929; WITHERS SG, 1987, J AM CHEM SOC, V109, P7530, DOI 10.1021/ja00258a047; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Yahata K, 2000, J MOL MED, V78, P389, DOI 10.1007/s001090000131; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zecca L, 1998, FEBS LETT, V435, P225, DOI 10.1016/S0014-5793(98)01076-X	44	16	16	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35351	35362		10.1074/jbc.M114.593376	http://dx.doi.org/10.1074/jbc.M114.593376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25344605	Green Published, hybrid			2022-12-26	WOS:000346660200026
J	Peigneur, S; Paolini-Bertrand, M; Gaertner, H; Biass, D; Violette, A; Stocklin, R; Favreau, P; Tytgat, J; Hartley, O				Peigneur, Steve; Paolini-Bertrand, Marianne; Gaertner, Hubert; Biass, Daniel; Violette, Aude; Stoecklin, Reto; Favreau, Philippe; Tytgat, Jan; Hartley, Oliver			delta-Conotoxins Synthesized Using an Acid-cleavable Solubility Tag Approach Reveal Key Structural Determinants for Na-V Subtype Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Molecular Pharmacology; Natural Product Biosynthesis; Neurotoxin; Peptide Chemical Synthesis; Sodium Channel; Conotoxin	GATED SODIUM-CHANNELS; HYDROPHOBIC PEPTIDES; NATURAL-PRODUCTS; BUILDING-BLOCKS; VENOM PEPTIDES; CONUS-ERMINEUS; INACTIVATION; CONOPEPTIDES; PHARMACOLOGY; PROTEINS	Conotoxins are venom peptides from cone snails with multiple disulfide bridges that provide a rigid structural scaffold. Typically acting on ion channels implicated in neurotransmission, conotoxins are of interest both as tools for pharmacological studies and as potential new medicines. -Conotoxins act by inhibiting inactivation of voltage-gated sodium channels (Na-v). Their pharmacology has not been extensively studied because their highly hydrophobic character makes them difficult targets for chemical synthesis. Here we adopted an acid-cleavable solubility tag strategy that facilitated synthesis, purification, and directed disulfide bridge formation. Using this approach we readily produced three native -conotoxins from Conus consors plus two rationally designed hybrid peptides. We observed striking differences in Na-v subtype selectivity across this group of compounds, which differ in primary structure at only three positions: 12, 23, and 25. Our results provide new insights into the structure-activity relationships underlying the Na-v subtype selectivity of -conotoxins. Use of the acid-cleavable solubility tag strategy should facilitate synthesis of other hydrophobic peptides with complex disulfide bridge patterns.	[Peigneur, Steve; Tytgat, Jan] Catholic Univ, Lab Toxicol & Pharmacol, Dept Pharmaceut Sci, B-3000 Leuven, Belgium; [Paolini-Bertrand, Marianne; Gaertner, Hubert; Hartley, Oliver] Univ Geneva, Fac Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Biass, Daniel; Violette, Aude; Stoecklin, Reto; Favreau, Philippe] Atheris Labs, CH-1233 Bernex, Switzerland; [Favreau, Philippe] Serv Toxicol Environm, Dept Environm Transport & Agr, CH-1211 Geneva, Switzerland	KU Leuven; University Hospital Leuven; University of Geneva	Tytgat, J (corresponding author), Univ Leuven KU Leuven, Campus Gasthuisberg,Herestr 49, B-3000 Leuven, Belgium.	jan.tytgat@pharm.kuleuven.be; oliver.hartley@unige.ch		Tytgat, Jan/0000-0003-1778-6022; Violette, Aude/0000-0002-6048-6992; Peigneur, Steve/0000-0003-0504-5702	LIFESCIHEALTH-6 Integrated Project Grant LSHB-CT; F.W.O. Vlaanderen [G.0433.12, G.A071.10N, G.0257.08]; KU Leuven [OT/12/081]; EU-FP7-MAREX; IUAP from Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy [7/10]	LIFESCIHEALTH-6 Integrated Project Grant LSHB-CT; F.W.O. Vlaanderen(FWO); KU Leuven(KU Leuven); EU-FP7-MAREX; IUAP from Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy	This work was supported in part by LIFESCIHEALTH-6 Integrated Project Grant LSHB-CT-2007 performed as part of the CONCO cone snail genome project for health within the 6th Framework Program.; Supported by Grants G.0433.12, G.A071.10N, and G.0257.08 from F.W.O. Vlaanderen, Grant OT/12/081 from KU Leuven, and Grants EU-FP7-MAREX and IUAP 7/10 from the Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy. To whom correspondence may be addressed: University of Leuven (KU Leuven), Campus Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. Tel.: 32-16-323403; E-mail: jan.tytgat@pharm.kuleuven.be.	Barbier J, 2004, J BIOL CHEM, V279, P4680, DOI 10.1074/jbc.M309576200; Biass D, 2009, J PROTEOMICS, V72, P210, DOI 10.1016/j.jprot.2009.01.019; Bogdanowich-Knipp SJ, 1999, J PEPT RES, V54, P43, DOI 10.1034/j.1399-3011.1999.00091.x; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Bulaj G, 2001, BIOCHEMISTRY-US, V40, P13201, DOI 10.1021/bi010683a; Choma CT, 1998, TETRAHEDRON LETT, V39, P2417, DOI 10.1016/S0040-4039(98)00214-7; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Englebretsen DR, 1999, TETRAHEDRON, V55, P6623, DOI 10.1016/S0040-4020(99)00309-9; Englebretsen DR, 1996, TETRAHEDRON LETT, V37, P8431, DOI 10.1016/0040-4039(96)01910-7; FAINZILBER M, 1995, J BIOL CHEM, V270, P1123, DOI 10.1074/jbc.270.3.1123; Favreau P., 1999, PHYSICOCHEMICAL PHAR; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Hossain MA, 2009, BIOCONJUGATE CHEM, V20, P1390, DOI 10.1021/bc900181a; Johnson ECB, 2007, TETRAHEDRON LETT, V48, P1795, DOI 10.1016/j.tetlet.2007.01.030; Leipold E, 2005, FEBS LETT, V579, P3881, DOI 10.1016/j.febslet.2005.05.077; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Park Y, 2011, NAT PROD COMMUN, V6, P1403; Peigneur S, 2012, FASEB J, V26, P5141, DOI 10.1096/fj.12-218479; Puillandre N, 2012, J MOL EVOL, V74, P297, DOI 10.1007/s00239-012-9507-2; Sampson WR, 1999, J PEPT SCI, V5, P403, DOI 10.1002/(SICI)1099-1387(199909)5:9<403::AID-PSC213>3.0.CO;2-S; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; SHON KJ, 1994, BIOCHEMISTRY-US, V33, P11420, DOI 10.1021/bi00204a003; Smith JJ, 2013, CELL MOL LIFE SCI, V70, P3665, DOI 10.1007/s00018-013-1315-3; Teichert RW, 2010, FUTURE MED CHEM, V2, P731, DOI 10.4155/FMC.10.31; Theile JW, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00054; Tripet B, 2007, J CHROMATOGR A, V1141, P212, DOI 10.1016/j.chroma.2006.12.024; Vetter I, 2012, CURR TOP MED CHEM, V12, P1546, DOI 10.2174/156802612802652457; Volpon L, 2004, J BIOL CHEM, V279, P21356, DOI 10.1074/jbc.M309594200	30	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35341	35350		10.1074/jbc.M114.610436	http://dx.doi.org/10.1074/jbc.M114.610436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352593	Green Published, hybrid			2022-12-26	WOS:000346660200025
J	Abascal, JFPJ; Montesinos, P; Marinetto, E; Pascau, J; Desco, M				Abascal, Juan F. P. J.; Montesinos, Paula; Marinetto, Eugenio; Pascau, Javier; Desco, Manuel			Comparison of Total Variation with a Motion Estimation Based Compressed Sensing Approach for Self-Gated Cardiac Cine MRI in Small Animal Studies	PLOS ONE			English	Article							ACCELERATED DYNAMIC MRI; SPLIT BREGMAN METHOD; IMAGE-RECONSTRUCTION; REGISTRATION; REGULARIZATION; INTERPOLATION; ALGORITHM; SPARSITY	Purpose: Compressed sensing (CS) has been widely applied to prospective cardiac cine MRI. The aim of this work is to study the benefits obtained by including motion estimation in the CS framework for small-animal retrospective cardiac cine. Methods: We propose a novel B-spline-based compressed sensing method (SPLICS) that includes motion estimation and generalizes previous spatiotemporal total variation (ST-TV) methods by taking into account motion between frames. In addition, we assess the effect of an optimum weighting between spatial and temporal sparsity to further improve results. Both methods were implemented using the efficient Split Bregman methodology and were evaluated on rat data comparing animals with myocardial infarction with controls for several acceleration factors. Results: ST-TV with optimum selection of the weighting sparsity parameter led to results similar to those of SPLICS; ST-TV with large relative temporal sparsity led to temporal blurring effects. However, SPLICS always properly corrected temporal blurring, independently of the weighting parameter. At acceleration factors of 15, SPLICS did not distort temporal intensity information but led to some artefacts and slight over-smoothing. At an acceleration factor of 7, images were reconstructed without significant loss of quality. Conclusion: We have validated SPLICS for retrospective cardiac cine in small animal, achieving high acceleration factors. In addition, we have shown that motion modelling may not be essential for retrospective cine and that similar results can be obtained by using ST-TV provided that an optimum selection of the spatiotemporal sparsity weighting parameter is performed.	[Abascal, Juan F. P. J.; Montesinos, Paula; Marinetto, Eugenio; Pascau, Javier; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain; [Abascal, Juan F. P. J.; Montesinos, Paula; Marinetto, Eugenio; Pascau, Javier; Desco, Manuel] IiSGM, Madrid, Spain; [Desco, Manuel] Ctr Invest Red Salud Mental CIBERSAM, Madrid, Spain	Universidad Carlos III de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Abascal, JFPJ (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain.	jabascal@hggm.es	Desco, Manuel/AAD-7137-2019; Pascau, Javier/B-5734-2013; ABASCAL, JUAN FPJ/L-7062-2014	Desco, Manuel/0000-0003-0989-3231; Pascau, Javier/0000-0003-1484-731X; ABASCAL, JUAN FPJ/0000-0002-2757-8676; Marinetto, Eugenio/0000-0001-5970-4780	Cardiovascular Research Network (RIC) from the Ministerio de Economia y Competitividad [RD12/0042/0057]	Cardiovascular Research Network (RIC) from the Ministerio de Economia y Competitividad	JFPJ Abascal and P Montesinos were funded by the Cardiovascular Research Network (RIC, RD12/0042/0057) from the Ministerio de Economia y Competitividad (www.mineco.gob.es/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JFPJ, 2011, MED PHYS, V38, P6275, DOI 10.1118/1.3656063; Abascal JFPJ, 2013, 13 MED C MED BIOL EN, P233; Asif MS, 2013, MAGN RESON MED, V70, P800, DOI 10.1002/mrm.24524; Bilen C, 2011, SIGN PROC MED BIOL S, P1; Blu T, 2003, IEEE T IMAGE PROCESS, V12, P1297, DOI 10.1109/TIP.2003.818018; Blu T, 2001, IEEE T IMAGE PROCESS, V10, P1069, DOI 10.1109/83.931101; Bovens SM, 2011, NMR BIOMED, V24, P307, DOI 10.1002/nbm.1593; Brinegar C, 2009, IEEE ENG MED BIO, P4383, DOI 10.1109/IEMBS.2009.5333482; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Christodoulou AG, 2011, I S BIOMED IMAGING, P57, DOI 10.1109/ISBI.2011.5872353; de Boor C., 1972, Journal of Approximation Theory, V6, P50, DOI 10.1016/0021-9045(72)90080-9; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Goud S, 2010, I S BIOMED IMAGING, P988, DOI 10.1109/ISBI.2010.5490154; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Jung H, 2009, MAGN RESON MED, V61, P103, DOI 10.1002/mrm.21757; Lingala SG, 2011, IEEE T MED IMAGING, V30, P1042, DOI 10.1109/TMI.2010.2100850; Lustig M., 2006, P INT SOC MAG RESON, V14, P2420; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Madore B, 1999, MAGNET RESON MED, V42, P813, DOI 10.1002/(SICI)1522-2594(199911)42:5<813::AID-MRM1>3.0.CO;2-S; Moghari MH, 2011, MAGN RESON MED, V66, P1674, DOI 10.1002/mrm.22950; Montefusco LB, 2011, IEEE T MED IMAGING, V30, P1064, DOI 10.1109/TMI.2010.2068306; Montesinos P, 2014, MAGN RESON MED, V72, P369, DOI 10.1002/mrm.24936; Motaal AG, 2013, NMR BIOMED, V26, P451, DOI 10.1002/nbm.2883; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Tsao J, 2003, MAGNET RESON MED, V50, P1031, DOI 10.1002/mrm.10611; Usman M, 2011, MAGN RESON MED, V66, P1163, DOI 10.1002/mrm.22883; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wech T, 2012, J CARDIOVASC MAGN S1, V14, pP65; Wech T, 2011, J MAGN RESON IMAGING, V34, P1072, DOI 10.1002/jmri.22718; Xie ZY, 2004, IEEE T VIS COMPUT GR, V10, P85, DOI 10.1109/TVCG.2004.1260760; Yang ZQ, 2004, CIRCULATION, V109, P1161, DOI 10.1161/01.CIR.0000118495.88442.32; Zhao B, 2010, IEEE ENG MED BIO, P3390, DOI 10.1109/IEMBS.2010.5627934	37	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110594	10.1371/journal.pone.0110594	http://dx.doi.org/10.1371/journal.pone.0110594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350290	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100032
J	Li, M; Pang, ZY; Xiao, W; Liu, XY; Zhang, Y; Yu, DS; Yang, MJ; Yang, Y; Hu, JS; Luo, KJ				Li, Ming; Pang, Zunyu; Xiao, Wei; Liu, Xinyi; Zhang, Yan; Yu, Dongshuai; Yang, Minjun; Yang, Yang; Hu, Jiansheng; Luo, Kaijun			A Transcriptome Analysis Suggests Apoptosis-Related Signaling Pathways in Hemocytes of Spodoptera litura After Parasitization by Microplitis bicoloratus	PLOS ONE			English	Article							POLYDNAVIRUS INDUCES APOPTOSIS; DNA-DAMAGE; PSEUDOPLUSIA-INCLUDENS; IMMUNE-RESPONSE; GENE-EXPRESSION; CELL-DEATH; RNA-SEQ; PROTEIN; P53; BRACOVIRUS	Microplitis bicoloratus parasitism induction of apoptotic DNA fragmentation of host Spodoptera litura hemocytes has been reported. However, how M. bicoloratus parasitism regulates the host signaling pathways to induce DNA fragmentation during apoptosis remains unclear. To address this question, we performed a new RNAseq-based comparative analysis of the hemocytes transcriptomes of non-parasitized and parasitized S. litura. We were able to assemble a total of more than 11.63 Gbp sequence, to yield 20,571 unigenes. At least six main protein families encoded by M. bicoloratus bracovirus are expressed in the parasitized host hemocytes: Ankyrin-repeat, Ben domain, C-type lectin, Egf-like and Mucin-like, protein tyrosine phosphatase. The analysis indicated that during DNA fragmentation and cell death, 299 genes were up-regulated and 2,441 genes were down-regulated. Data on five signaling pathways related with cell death, the gap junctions, Ca2+, PI3K/Akt, NF-kappa B, ATM/p53 revealed that CypD, which is involved in forming a Permeability Transition Pore Complex (PTPC) to alter mitochondrial membrane permeabilization (MMP), was dramatically up-regulated. The qRT-PCR also provided that the key genes for cell survival were down-regulated under M. bicoloratus parasitism, including those encoding Inx1, Inx2 and Inx3 of the gap junction signaling pathway, p110 subunit of the PI3K/Akt signaling pathway, and the p50 and p65 subunit of the NF-kappa B signaling pathway. These findings suggest that M. bicoloratus parasitism may regulate host mitochondria to trigger internucleosomal DNA fragmentation. This study will facilitate the identification of immunosuppression-related genes and also improves our understanding of molecular mechanisms underlying polydnavirus-parasitoid-host interaction.	[Li, Ming; Pang, Zunyu; Xiao, Wei; Liu, Xinyi; Zhang, Yan; Yu, Dongshuai; Yang, Yang; Hu, Jiansheng; Luo, Kaijun] Yunnan Univ, Sch Life Sci, Kunming, Peoples R China; [Li, Ming; Pang, Zunyu; Xiao, Wei; Liu, Xinyi; Zhang, Yan; Yu, Dongshuai; Yang, Yang; Hu, Jiansheng; Luo, Kaijun] Yunnan Univ, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Kunming, Peoples R China; [Yang, Minjun] Chinese Natl Human Genome Ctr, Shanghai Minist Sci & Technol, Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Yunnan University; Yunnan University	Luo, KJ (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Peoples R China.	kaijun_luo@ynu.edu.cn	Luo, Kaijun/AGL-3479-2022; Yang, Minjun/AGJ-3201-2022; liu, xinyi/GWZ-8739-2022	Yang, Minjun/0000-0002-3324-1498	National Natural Science Foundation of China [31260448, 31060251, 31360454]; Major State Basic Research Development Program [2013CB127600]; Yunnan Department of Science and Technology [2013FA003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Yunnan Department of Science and Technology	This study was supported in part by a grant (31260448; 31060251) from National Natural Science Foundation of China, a grant (2013CB127600) from Major State Basic Research Development Program and a grant (2013FA003) from Yunnan Department of Science and Technology to KL, and a grant (31360454) from National Natural Science Foundation of China to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya KE, 2005, J INSECT PHYSIOL, V51, P505, DOI 10.1016/j.jinsphys.2004.11.019; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beck MH, 2011, J VIROL, V85, P11685, DOI 10.1128/JVI.05726-11; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bouaziz C, 2008, TOXICOLOGY, V254, P19, DOI 10.1016/j.tox.2008.08.020; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Desjardins CA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-61; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Eum JH, 2010, INSECT BIOCHEM MOLEC, V40, P690, DOI 10.1016/j.ibmb.2010.07.003; Fuhrman LE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000657; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Gonzalez-Rodriguez A, 2007, J CELL PHYSIOL, V212, P76, DOI 10.1002/jcp.21004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu JJ, 1999, J BIOL CHEM, V274, P20759, DOI 10.1074/jbc.274.30.20759; Gupta S, 2002, FEBS LETT, V532, P61, DOI 10.1016/S0014-5793(02)03628-1; Halle M, 2007, CELL CYCLE, V6, P2773, DOI 10.4161/cc.6.22.4926; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hsu MJ, 2010, VIRUS RES, V153, P36, DOI 10.1016/j.virusres.2010.07.002; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lee S, 2008, COMP BIOCHEM PHYS A, V149, P351, DOI 10.1016/j.cbpa.2008.01.007; Li Guanghong, 1998, Acta Scientiarum Naturalium Universitatis Sunyatseni, V37, P1; Liu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070456; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; Luo KJ, 2006, ACTA BIOCH BIOPH SIN, V38, P577, DOI 10.1111/j.1745-7270.2006.00195.x; Luo KJ, 2007, BIOCONTROL, V52, P309, DOI 10.1007/s10526-006-9030-8; Luo KJ, 2006, J INSECT PHYSIOL, V52, P795, DOI 10.1016/j.jinsphys.2006.04.007; Luo KJ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0106; Luo Kaijun, 2008, P93; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakamura M, 2007, GENES CELLS, V12, P997, DOI 10.1111/j.1365-2443.2007.01111.x; Ninios YP, 2010, APOPTOSIS, V15, P128, DOI 10.1007/s10495-009-0418-7; Okamura K, 2010, DEV CELL, V18, P692, DOI [10.1016/j.devcel.2010.05.004, 10.1016/j.devce1.2010.05.004]; Prabagar MG, 2013, CELL DEATH DIFFER, V20, P535, DOI 10.1038/cdd.2012.160; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sathyan KM, 2011, J CELL SCI, V124, P3149, DOI 10.1242/jcs.086603; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Stambolsky P, 2006, CELL DEATH DIFFER, V13, P2140, DOI 10.1038/sj.cdd.4401965; STRAND MR, 1995, J GEN VIROL, V76, P283, DOI 10.1099/0022-1317-76-2-283; Strand MR, 2012, PLOS PATHOG, V8, DOI [10.1372/journal.ppat.1002757, DOI 10.1372/JOURNAL.PPAT.1002757]; Suderman RJ, 2008, J GEN VIROL, V89, P1411, DOI 10.1099/vir.0.2008/000307-0; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Xiao W, 2009, VIROLOGY, V391, P83, DOI 10.1016/j.virol.2009.06.007; Yousefi S, 2003, SEMIN IMMUNOL, V15, P195, DOI 10.1016/S1044-5323(03)00033-2; Zhang JH, 2002, TRENDS CELL BIOL, V12, P84, DOI 10.1016/S0962-8924(01)02206-1; Zhou P, 2001, P NATL ACAD SCI USA, V98, P6051, DOI 10.1073/pnas.111145098	59	23	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110967	10.1371/journal.pone.0110967	http://dx.doi.org/10.1371/journal.pone.0110967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350281	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100050
J	Carvalho, GA; Vieira, JL; Haro, MM; Correa, AS; Ribon, AOB; de Oliveira, LO; Guedes, RNC				Carvalho, Gislaine A.; Vieira, Juliana L.; Haro, Marcelo M.; Correa, Alberto S.; Ribon, Andrea Oliveira B.; de Oliveira, Luiz Orlando; Guedes, Raul Narciso C.			Pleiotropic Impact of Endosymbiont Load and Co-Occurrence in the Maize Weevil Sitophilus zeamais	PLOS ONE			English	Article							SYMBIOTIC BACTERIA; INSECTICIDE RESISTANCE; BRAZILIAN POPULATIONS; ORYZAE COLEOPTERA; GUT BACTERIA; RICE WEEVIL; CURCULIONIDAE; APHIDS; MITOCHONDRIAL; WOLBACHIA	Individual traits vary among and within populations, and the co-occurrence of different endosymbiont species within a host may take place under varying endosymbiont loads in each individual host. This makes the recognition of the potential impact of such endosymbiont associations in insect species difficult, particularly in insect pest species. The maize weevil, Sitophilus zeamais Motsch. (Coleoptera: Curculionidae), a key pest species of stored cereal grains, exhibits associations with two endosymbiotic bacteria: the obligatory endosymbiont SZPE ("Sitophilus zeamais Primary Endosymbiont'') and the facultative endosymbiont Wolbachia. The impact of the lack of SZPE in maize weevil physiology is the impairment of nutrient acquisition and energy metabolism, while Wolbachia is an important factor in reproductive incompatibility. However, the role of endosymbiont load and co-occurrence in insect behavior, grain consumption, body mass and subsequent reproductive factors has not yet been explored. Here we report on the impacts of co-occurrence and varying endosymbiont loads achieved via thermal treatment and antibiotic provision via ingested water in the maize weevil. SZPE exhibited strong effects on respiration rate, grain consumption and weevil body mass, with observed effects on weevil behavior, particularly flight activity, and potential consequences for the management of this pest species. Wolbachia directly favored weevil fertility and exhibited only mild indirect effects, usually enhancing the SZPE effect. SZPE suppression delayed weevil emergence, which reduced the insect population growth rate, and the thermal inactivation of both symbionts prevented insect reproduction. Such findings are likely important for strain divergences reported in the maize weevil and their control, aspects still deserving future attention.	[Carvalho, Gislaine A.; Ribon, Andrea Oliveira B.; de Oliveira, Luiz Orlando] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Vieira, Juliana L.; Haro, Marcelo M.; Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Correa, Alberto S.] Univ Sao Paulo, Escola Super Agr Luiz Queiroz, Dept Entomol & Acarol, Piracicaba, SP, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade de Sao Paulo	Guedes, RNC (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	guedes@ufv.br	Ribon, Andrea O. B./C-8318-2017; Correa, Alberto S/C-4683-2014; de Haro, Marcelo Mendes/V-5823-2017; de Haro, Marcelo Mendes/AAK-6570-2021; Carvalho, Gislaine/P-4107-2015; Guedes, Raul Narciso Carvalho/L-3924-2013; Oliveira, Luiz/D-6435-2013	Ribon, Andrea O. B./0000-0001-8485-3075; Correa, Alberto S/0000-0002-3788-7480; de Haro, Marcelo Mendes/0000-0001-7572-532X; Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Oliveira, Luiz/0000-0002-5578-2260; Vieira, Juliana/0000-0002-6586-2117	National Council of Scientific and Technological Development (CNPq, Brazilian Ministry of Science and Technology); CAPES Foundation (Brazilian Ministry of Education); Minas Gerais State Foundation of Research Aid (FAPEMIG)	National Council of Scientific and Technological Development (CNPq, Brazilian Ministry of Science and Technology)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Minas Gerais State Foundation of Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The financial support was provided by the National Council of Scientific and Technological Development (CNPq, Brazilian Ministry of Science and Technology), CAPES Foundation (Brazilian Ministry of Education), and Minas Gerais State Foundation of Research Aid (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme C, 2006, APPL ENVIRON MICROB, V72, P6766, DOI 10.1128/AEM.00942-06; Araujo RA, 2008, B ENTOMOL RES, V98, P417, DOI 10.1017/S0007485308005737; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; Brankatschk R, 2012, APPL ENVIRON MICROB, V78, P4481, DOI 10.1128/AEM.07878-11; Carvalho GA, 2014, J STORED PROD RES, V59, P61, DOI 10.1016/j.jspr.2014.05.004; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Clark TL, 2001, INSECT MOL BIOL, V10, P303, DOI 10.1046/j.0962-1075.2001.00269.x; Correa AS, 2014, ANN APPL BIOL, V165, P137, DOI 10.1111/aab.12127; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Fragoso DB, 2005, J STORED PROD RES, V41, P271, DOI 10.1016/j.jspr.2004.03.008; GASNIERFAUCHET F, 1987, INSECT BIOCHEM, V17, P17, DOI 10.1016/0020-1790(87)90138-7; Gil R, 2008, INT MICROBIOL, V11, P41, DOI 10.2436/20.1501.01.43; GRENIER AM, 1994, ENTOMOL EXP APPL, V70, P201, DOI 10.1007/BF02380553; Guedes NMP, 2015, J STORED PR IN PRESS; Guedes RNC, 2006, PHYSIOL ENTOMOL, V31, P30, DOI 10.1111/j.1365-3032.2005.00479.x; GUEDES RNC, 1995, J STORED PROD RES, V31, P145, DOI 10.1016/0022-474X(94)00043-S; Heddi A, 1998, J MOL EVOL, V47, P52, DOI 10.1007/PL00006362; HEDDI A, 1993, INSECT BIOCHEM MOLEC, V23, P403, DOI 10.1016/0965-1748(93)90024-M; Heddi A, 2001, RES MICROBIOL, V152, P431, DOI 10.1016/S0923-2508(01)01216-5; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Le Clec'h W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060232; Lopes KVG, 2010, J INSECT PHYSIOL, V56, P1050, DOI 10.1016/j.jinsphys.2010.02.020; Mansour K, 1930, Q J MICROSC SCI, V73, P421; Mitchell Randall J., 1993, P211; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Morales JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067283; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Nardon P, 2002, SYMBIOSIS, V33, P227; Nardon P., 1988, CELL CELL SIGNALS PL, P255; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pilon FM, 2013, J COMP PHYSIOL B, V183, P735, DOI 10.1007/s00360-013-0744-5; Ribeiro BM, 2003, J STORED PROD RES, V39, P21, DOI 10.1016/S0022-474X(02)00014-0; Rio RVM, 2003, APPL ENVIRON MICROB, V69, P6825, DOI 10.1128/AEM.69.11.6825-6832.2003; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; SAS Institute, 2008, SAS STAT US GUID; Toju H, 2013, ISME J, V7, P1378, DOI 10.1038/ismej.2013.27; Tome HVV, 2015, CHEMOSPHERE IN PRESS; Trematerra P, 1996, J STORED PROD RES, V32, P315, DOI 10.1016/S0022-474X(96)00035-5; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vigneron A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S14; Visotto LE, 2009, ENVIRON ENTOMOL, V38, P1078, DOI 10.1603/022.038.0415; Visotto LE, 2009, J INSECT PHYSIOL, V55, P185, DOI 10.1016/j.jinsphys.2008.10.017; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WICKER C, 1983, COMP BIOCHEM PHYS A, V76, P177, DOI 10.1016/0300-9629(83)90311-0; Xue X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048148; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	50	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111396	10.1371/journal.pone.0111396	http://dx.doi.org/10.1371/journal.pone.0111396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347417	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900064
J	Stacchiotti, A; Favero, G; Giugno, L; Lavazza, A; Reiter, RJ; Rodella, LF; Rezzani, R				Stacchiotti, Alessandra; Favero, Gaia; Giugno, Lorena; Lavazza, Antonio; Reiter, Russel J.; Rodella, Luigi Fabrizio; Rezzani, Rita			Mitochondrial and Metabolic Dysfunction in Renal Convoluted Tubules of Obese Mice: Protective Role of Melatonin	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; SKELETAL-MUSCLE; OB/OB MICE; ENDOPLASMIC-RETICULUM; INTRINSIC PATHWAY; RAT-KIDNEY; APOPTOSIS; DYNAMICS; BAK	Obesity is a common and complex health problem, which impacts crucial organs; it is also considered an independent risk factor for chronic kidney disease. Few studies have analyzed the consequence of obesity in the renal proximal convoluted tubules, which are the major tubules involved in reabsorptive processes. For optimal performance of the kidney, energy is primarily provided by mitochondria. Melatonin, an indoleamine and antioxidant, has been identified in mitochondria, and there is considerable evidence regarding its essential role in the prevention of oxidative mitochondrial damage. In this study we evaluated the mechanism(s) of mitochondrial alterations in an animal model of obesity (ob/ob mice) and describe the beneficial effects of melatonin treatment on mitochondrial morphology and dynamics as influenced by mitofusin-2 and the intrinsic apoptotic cascade. Melatonin dissolved in 1% ethanol was added to the drinking water from postnatal week 5-13; the calculated dose of melatonin intake was 100 mg/kg body weight/day. Compared to control mice, obesity-related morphological alterations were apparent in the proximal tubules which contained round mitochondria with irregular, short cristae and cells with elevated apoptotic index. Melatonin supplementation in obese mice changed mitochondria shape and cristae organization of proximal tubules, enhanced mitofusin-2 expression, which in turn modulated the progression of the mitochondria-driven intrinsic apoptotic pathway. These changes possibly aid in reducing renal failure. The melatonin-mediated changes indicate its potential protective use against renal morphological damage and dysfunction associated with obesity and metabolic disease.	[Stacchiotti, Alessandra; Favero, Gaia; Giugno, Lorena; Rodella, Luigi Fabrizio; Rezzani, Rita] Univ Brescia, Dept Clin & Expt Sci, Anat & Physiopathol Div, Brescia, Italy; [Lavazza, Antonio] Ist Zooprofilatt Sperimentale Lombardia & Emilia, OIE Reference Lab RHD, Brescia, Italy; [Reiter, Russel J.] UT Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX USA	University of Brescia; IZS Lombardia e Emilia; University of Texas System; University of Texas Health San Antonio	Rezzani, R (corresponding author), Univ Brescia, Dept Clin & Expt Sci, Anat & Physiopathol Div, Brescia, Italy.	rita.rezzani@unibs.it	Stacchiotti, Alessandra/AAA-2193-2019; Lavazza, Antonio/G-8182-2011; Stacchiotti, Alessandra/AAL-7239-2021	Lavazza, Antonio/0000-0002-7646-3592; stacchiotti, alessandra/0000-0002-6767-6617; Rodella, Luigi Fabrizio/0000-0002-9497-4708; Favero, Gaia/0000-0001-6895-7106				Acuna-Castroviejo D., 2014, CELL MOL LIFE SCI; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Cano P, 2008, ENDOCRINE, V33, P118, DOI 10.1007/s12020-008-9066-x; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Cheng ZY, 2014, CELL CYCLE, V13, P890, DOI 10.4161/cc.28189; Cosson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046293; D'Elia JA, 2009, INT J NEPHROL RENOV, V2, P39; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dong F, 2006, J ENDOCRINOL, V188, P25, DOI 10.1677/joe.1.06241; Favero G, 2013, ACTA HISTOCHEM, V115, P783, DOI 10.1016/j.acthis.2013.02.014; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gall J, 2013, PLOS ONE, V7; Galloway CA, 2012, J GEN PHYSIOL, V139, P455, DOI 10.1085/jgp.201210771; Garcia-Ruiz I, 2007, HEPATOLOGY, V46, P414, DOI 10.1002/hep.21687; Ghibelli L, 2010, MITOCHONDRION, V10, P604, DOI 10.1016/j.mito.2010.08.003; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Hsiao CW, 2013, J PINEAL RES, V54, P107, DOI 10.1111/jpi.12004; Hu ZP, 2013, J PINEAL RES, V55, P388, DOI 10.1111/jpi.12085; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jimenez-Aranda A, 2013, J PINEAL RES, V55, P416, DOI 10.1111/jpi.12089; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kelly KJ, 2008, AM J PHYSIOL-RENAL, V294, pF1136, DOI 10.1152/ajprenal.00396.2007; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Lanoix D, 2013, MOL CELL ENDOCRINOL, V381, P35, DOI 10.1016/j.mce.2013.07.010; Leoncini G, 2012, J NEPHROL, V25, P63, DOI 10.5301/JN.2011.7752; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Martin-Cano FE, 2014, J PINEAL RES, V56, P163, DOI 10.1111/jpi.12109; Mendes C, 2013, J PINEAL RES, V55, P229, DOI 10.1111/jpi.12065; Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687; Paradies G, 2010, J PINEAL RES, V48, P297, DOI 10.1111/j.1600-079X.2010.00759.x; Quigley JE, 2009, CLIN EXP PHARMACOL P, V36, P724, DOI 10.1111/j.1440-1681.2009.05139.x; Radogna F, 2008, J PINEAL RES, V44, P316, DOI 10.1111/j.1600-079X.2007.00532.x; Raskind MA, 2007, NEUROPSYCHOPHARMACOL, V32, P284, DOI 10.1038/sj.npp.1301093; Reiter Russel J, 2008, Interdiscip Toxicol, V1, P137, DOI 10.2478/v10102-010-0030-2; Rezzani R, 2013, LIFE SCI, V92, P875, DOI 10.1016/j.lfs.2012.11.011; Rodella LF, 2013, AGE, V35, P103, DOI 10.1007/s11357-011-9336-z; Runkel ED, 2014, EXP GERONTOL, V56, P194, DOI 10.1016/j.exger.2014.02.013; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Solis-Munoz P, 2011, J PINEAL RES, V51, P113, DOI 10.1111/j.1600-079X.2011.00868.x; Stacchiotti A, 2006, J HISTOCHEM CYTOCHEM, V54, P1149, DOI 10.1369/jhc.6A6932.2006; Stacchiotti A, 2009, FOOD CHEM TOXICOL, V47, P2834, DOI 10.1016/j.fct.2009.09.003; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tan DX, 2013, J PINEAL RES, V54, P127, DOI 10.1111/jpi.12026; Tan DX, 1993, ENDOCR J, V1, P57; Tang WX, 2012, ENDOCRINE, V41, P236, DOI 10.1007/s12020-011-9555-1; Tobar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075547; Ulivieri C, 2010, TISSUE CELL, V42, P339, DOI 10.1016/j.tice.2010.10.004; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Zhai XY, 2003, J AM SOC NEPHROL, V14, P611, DOI 10.1097/01.ASN.0000051725.00406.0C; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	58	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111141	10.1371/journal.pone.0111141	http://dx.doi.org/10.1371/journal.pone.0111141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347680	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900050
J	Galli, R; Uckermann, O; Andresen, EF; Geiger, KD; Koch, E; Schackert, G; Steiner, G; Kirsch, M				Galli, Roberta; Uckermann, Ortrud; Andresen, Elisabeth F.; Geiger, Kathrin D.; Koch, Edmund; Schackert, Gabriele; Steiner, Gerald; Kirsch, Matthias			Intrinsic Indicator of Photodamage during Label-Free Multiphoton Microscopy of Cells and Tissues	PLOS ONE			English	Article							RAMAN SCATTERING MICROSCOPY; INFRARED LASER-PULSES; 2ND-HARMONIC GENERATION; BIOLOGICAL TISSUES; FEMTOSECOND LASER; CARS MICROSCOPY; FLUORESCENCE; NANOSURGERY; MECHANISMS; EXCITATION	Multiphoton imaging has evolved as an indispensable tool in cell biology and holds prospects for clinical applications. When addressing endogenous signals such as coherent anti-Stokes Raman scattering (CARS) or second harmonic generation, it requires intense laser irradiation that may cause photodamage. We report that increasing endogenous fluorescence signal upon multiphoton imaging constitutes a marker of photodamage. The effect was studied on mouse brain in vivo and ex vivo, on ex vivo human brain tissue samples, as well as on glioblastoma cells in vitro, demonstrating that this phenomenon is common to a variety of different systems, both ex vivo and in vivo. CARS microscopy and vibrational spectroscopy were used to analyze the photodamage. The development of a standard easy-to-use model that employs rehydrated cryosections allowed the characterization of the irradiation-induced fluorescence and related it to nonlinear photodamage. In conclusion, the monitoring of endogenous two-photon excited fluorescence during label-free multiphoton microscopy enables to estimate damage thresholds ex vivo as well as detect photodamage during in vivo experiments.	[Galli, Roberta; Koch, Edmund; Steiner, Gerald] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany; [Uckermann, Ortrud; Andresen, Elisabeth F.; Schackert, Gabriele; Kirsch, Matthias] Tech Univ Dresden, Carl Gustav Carus Univ Hosp, Dresden, Germany; [Geiger, Kathrin D.] Tech Univ Dresden, Carl Gustav Carus Univ Hosp, Inst Pathol, Dresden, Germany; [Andresen, Elisabeth F.; Kirsch, Matthias] CRTD, DFG, Cluster Excellence, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; German Research Foundation (DFG); Technische Universitat Dresden	Steiner, G (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany.	Gerald.Steiner@tu-dresden.de; Matthias.Kirsch@uniklinikum-dresden.de		Koch, Edmund/0000-0003-0554-2178	German Federal Ministry of Education and Research (MediCARS project) [A.Z. 13N10777]	German Federal Ministry of Education and Research (MediCARS project)	This work was funded by the German Federal Ministry of Education and Research (MediCARS project, A.Z. 13N10777). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begin S, 2011, BIOMED OPT EXPRESS, V2, P1296, DOI 10.1364/BOE.2.001296; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Carriles R, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3184828; Chung SH, 2009, J BIOPHOTONICS, V2, P557, DOI 10.1002/jbio.200910053; Colombelli J, 2006, M S-MED SCI, V22, P651, DOI 10.1051/medsci/20062267651; Dunn KW, 2006, NEPHRON EXP NEPHROL, V103, pE33, DOI 10.1159/000090614; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Ferrari AC, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155306; Fischer F, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2960016; Galbraith JA, 2003, MOL BIOL CELL, V14, P1808, DOI 10.1091/mbc.E02-03-0163; Galli R, 2012, ANAL CHEM, V84, P8707, DOI 10.1021/ac301938m; Gao L, 2011, BIOMED OPT EXPRESS, V2, P915, DOI 10.1364/BOE.2.000915; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Hovhannisyan V, 2008, OPT EXPRESS, V16, P7958, DOI 10.1364/OE.16.007958; Hovhannisyan V, 2010, OPT EXPRESS, V18, P24037, DOI 10.1364/OE.18.024037; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; KIKUGAWA K, 1986, ADV FREE RADICAL BIO, V2, P389, DOI 10.1016/S8755-9668(86)80020-5; Kirkpatrick ND, 2007, CANCER EPIDEM BIOMAR, V16, P2048, DOI 10.1158/1055-9965.EPI-07-0009; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Kohli V, 2009, WIRES NANOMED NANOBI, V1, P11, DOI 10.1002/wnan.29; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Konig K, 1999, OPT LETT, V24, P113, DOI 10.1364/OL.24.000113; KONIG K, 1995, NATURE, V377, P20, DOI 10.1038/377020a0; Konig K, 1996, J MICROSC-OXFORD, V183, P197; Konig K, 1996, HUM REPROD, V11, P2162; Leppert J, 2006, NEUROSURGERY, V58, P759, DOI 10.1227/01.NEU.0000204885.45644.22; Meyer T, 2013, ANAL CHEM, V85, P6703, DOI 10.1021/ac400570w; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Orzekowsky-Schroeder R, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655587; Pestov D, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/8/084006; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Pohling C, 2011, BIOMED OPT EXPRESS, V2, P2110, DOI 10.1364/BOE.2.002110; Ronchi P, 2012, BIOL CHEM, V393, P235, DOI 10.1515/hsz-2011-0237; Saytashev I, 2012, J PHOTOCH PHOTOBIO B, V115, P42, DOI 10.1016/j.jphotobiol.2012.06.009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Straub M, 1998, BIOIMAGING, V6, P177, DOI 10.1002/1361-6374(199812)6:4<177::AID-BIO3>3.0.CO;2-R; SUTHERLAND JC, 1981, RADIAT RES, V86, P399, DOI 10.2307/3575456; Tiede LM, 2006, PHOTOCHEM PHOTOBIOL, V82, P656, DOI 10.1562/2005-09-19-RA-689; Tinevez JY, 2012, METHOD ENZYMOL, V506, P291, DOI 10.1016/B978-0-12-391856-7.00039-1; Veberg A, 2006, LWT-FOOD SCI TECHNOL, V39, P562, DOI 10.1016/j.lwt.2005.03.009; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	53	52	52	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110295	10.1371/journal.pone.0110295	http://dx.doi.org/10.1371/journal.pone.0110295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343251	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500032
J	Gresner, P; Gromadzinska, J; Jablonska, E; Stepnik, M; Quispe, OZ; Twardowska, E; Wasowicz, W				Gresner, Peter; Gromadzinska, Jolanta; Jablonska, Ewa; Stepnik, Maciej; Quispe, Oscar Zambrano; Twardowska, Ewa; Wasowicz, Wojciech			Single Nucleotide Polymorphisms in Noncoding Regions of Rad51C Do Not Change the Risk of Unselected Breast Cancer but They Modulate the Level of Oxidative Stress and the DNA Damage Characteristics: A Case-Control Study	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; GERMLINE MUTATIONS; FANCONI-ANEMIA; SUSCEPTIBILITY GENE; OVARIAN; MAINTENANCE; PROTEIN; REPAIR; ROLES; BRIP1	Deleterious and missense mutations of RAD51C have recently been suggested to modulate the individual susceptibility to hereditary breast and ovarian cancer and unselected ovarian cancer, but not unselected breast cancer (BrC). We enrolled 132 unselected BrC females and 189 cancer-free female subjects to investigate whether common single nucleotide polymorphisms (SNPs) in non-coding regions of RAD51C modulate the risk of BrC, and whether they affect the level of oxidative stress and the extent/characteristics of DNA damage. Neither SNPs nor reconstructed haplotypes were found to significantly affect the unselected BrC risk. Contrary to this, carriers of rs12946522, rs16943176, rs12946397 and rs17222691 rare-alleles were found to present significantly increased level of blood plasma TBARS compared to respective wild-type homozygotes (p<0.05). Furthermore, these carriers showed significantly decreased fraction of oxidatively generated DNA damage (34% of total damaged DNA) in favor of DNA strand breakage, with no effect on total DNA damage, unlike respective wild-types, among which more evenly distributed proportions between oxidatively damaged DNA (48% of total DNA damage) and DNA strand breakage was found (p<0.0005 for the difference). Such effects were found among both the BrC cases and healthy subjects, indicating that they cannot be assumed as causal factors contributing to BrC development.	[Gresner, Peter; Gromadzinska, Jolanta; Jablonska, Ewa; Stepnik, Maciej; Twardowska, Ewa; Wasowicz, Wojciech] Nofer Inst Occupat Med, Dept Toxicol & Carcinogenesis, Lodz, Poland; [Quispe, Oscar Zambrano] Herlev Hosp, Dept Oncol, DK-2730 Herlev, Denmark	Nofer Institute of Occupational Medicine; University of Copenhagen; Herlev & Gentofte Hospital	Gresner, P (corresponding author), Nofer Inst Occupat Med, Dept Toxicol & Carcinogenesis, Lodz, Poland.	pgresner@imp.lodz.pl	Jablonska, Ewa/F-6005-2010; Grešner, Peter/G-5905-2010; Stepnik, Maciej/F-6093-2010	Jablonska, Ewa/0000-0002-3946-3964; Stepnik, Maciej/0000-0003-1586-2482; Wasowicz, Wojciech/0000-0002-2991-9040; Gresner, Peter/0000-0002-7008-396X; Gromadzinska, Jolanta/0000-0001-6878-2297	Nofer Institute of Occupational Medicine fund [IMP1.5/2011]	Nofer Institute of Occupational Medicine fund	The study was supported by the Nofer Institute of Occupational Medicine fund no. IMP1.5/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari MR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2619; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clague J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025632; COLLINS AR, 1993, CARCINOGENESIS, V14, P1733, DOI 10.1093/carcin/14.9.1733; De Leeneer K, 2012, BREAST CANCER RES TR, V133, P393, DOI 10.1007/s10549-012-1998-4; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gresner P, 2014, MUTAT RES-FUND MOL M, V762, P47, DOI 10.1016/j.mrfmmm.2014.02.007; Gresner P, 2012, GENE, V504, P166, DOI 10.1016/j.gene.2012.05.030; Halliwell B, 2002, FREE RADICAL BIO MED, V32, P968, DOI 10.1016/S0891-5849(02)00808-0; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Levy-Lahad E, 2010, NAT GENET, V42, P368, DOI 10.1038/ng0510-368; LEWONTIN RC, 1995, GENETICS, V140, P377; Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MCKELVEYMARTIN VJ, 1993, MUTAT RES, V288, P47, DOI 10.1016/0027-5107(93)90207-V; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Nakabeppu Y, 2004, FREE RADICAL RES, V38, P423, DOI 10.1080/10715760410001688348; Osorio A, 2012, HUM MOL GENET, V21, P2889, DOI 10.1093/hmg/dds115; Pang ZY, 2011, BREAST CANCER RES TR, V129, P1019, DOI 10.1007/s10549-011-1574-3; Pelttari LM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-552; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Romero A, 2011, BREAST CANCER RES TR, V129, P939, DOI 10.1007/s10549-011-1543-x; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Somyajit K, 2012, J BIOL CHEM, V287, P3366, DOI 10.1074/jbc.M111.311241; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Thompson ER, 2012, HUM MUTAT, V33, P95, DOI 10.1002/humu.21625; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; WASOWICZ W, 1993, CLIN CHEM, V39, P2522; Wong MW, 2011, BREAST CANCER RES TR, V127, P853, DOI 10.1007/s10549-011-1443-0; Zheng YL, 2010, BREAST CANCER RES TR, V124, P857, DOI 10.1007/s10549-010-1095-5	48	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110696	10.1371/journal.pone.0110696	http://dx.doi.org/10.1371/journal.pone.0110696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343521	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500048
J	Fernandez, H; Prandoni, N; Fernandez-Pascual, M; Fajardo, S; Morcillo, C; Diaz, E; Carmona, M				Fernandez, Helga; Prandoni, Nicolas; Fernandez-Pascual, Mercedes; Fajardo, Susana; Morcillo, Cesar; Diaz, Eduardo; Carmona, Manuel			Azoarcus sp CIB, an Anaerobic Biodegrader of Aromatic Compounds Shows an Endophytic Lifestyle	PLOS ONE			English	Article							PHOSPHATE SOLUBILIZING BACTERIA; SP STRAIN BH72; PLANT-GROWTH; SP-NOV; NITROGEN-FIXATION; IAA BIOSYNTHESIS; LUPINUS-ALBUS; COLONIZATION; RICE; IDENTIFICATION	Background: Endophytic bacteria that have plant growth promoting traits are of great interest in green biotechnology. The previous thought that the Azoarcus genus comprises bacteria that fit into one of two major eco-physiological groups, either free-living anaerobic biodegraders of aromatic compounds or obligate endophytes unable to degrade aromatics under anaerobic conditions, is revisited here. Methodology/Principal Findings: Light, confocal and electron microscopy reveal that Azoarcus sp. CIB, a facultative anaerobe beta-proteobacterium able to degrade aromatic hydrocarbons under anoxic conditions, is also able to colonize the intercellular spaces of the rice roots. In addition, the strain CIB displays plant growth promoting traits such nitrogen fixation, uptake of insoluble phosphorus and production of indoleacetic acid. Therefore, this work demonstrates by the first time that a free-living bacterium able to degrade aromatic compounds under aerobic and anoxic conditions can share also an endophytic lifestyle. The phylogenetic analyses based on the 16S rDNA and nifH genes confirmed that obligate endophytes of the Azoarcus genus and facultative endophytes, such as Azoarcus sp. CIB, locate into different evolutionary branches. Conclusions/Significance: This is the first report of a bacterium, Azoarcus sp. CIB, able to degrade anaerobically a significant number of aromatic compounds, some of them of great environmental concern, and to colonize the rice as a facultative endophyte. Thus, Azoarcus sp. CIB becomes a suitable candidate for a more sustainable agricultural practice and phytoremediation technology.	[Fernandez, Helga; Prandoni, Nicolas; Diaz, Eduardo; Carmona, Manuel] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain; [Fernandez-Pascual, Mercedes; Fajardo, Susana; Morcillo, Cesar] CSIC, Inst Ciencias Agr, Dept Plant Protect, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA)	Carmona, M (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain.	mcarmona@cib.csic.es	Diaz, Eduardo/F-8605-2016	Diaz, Eduardo/0000-0002-9731-6524; Carmona, Manuel/0000-0002-1591-7618	Ministry of Economy and Competitiveness of Spain [BIO2009-10438, CSD2007-00005, BIO2012-3950, AGL2009-10371]; Castilla-La Mancha Autonomous Community [POII10-0211-5015]; Madrid Autonomous Community Grant [S2009/AMB-1511]; European Union FP7 Grant [311815]	Ministry of Economy and Competitiveness of Spain(Spanish Government); Castilla-La Mancha Autonomous Community; Madrid Autonomous Community Grant; European Union FP7 Grant	This work was supported by Ministry of Economy and Competitiveness of Spain Grants BIO2009-10438, CSD2007-00005, BIO2012-3950, AGL2009-10371, Castilla-La Mancha Autonomous Community Grant POII10-0211-5015, Madrid Autonomous Community Grant S2009/AMB-1511 and European Union FP7 Grant 311815. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS HJ, 1995, INT J SYST BACTERIOL, V45, P327, DOI 10.1099/00207713-45-2-327; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Bacon C. W., 2000, MICROBIAL ENDOPHYTES, DOI 10.1201/9781482277302; Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; BEDMAR EJ, 1979, CURR MICROBIOL, V2, P11, DOI 10.1007/BF02601725; Boll M, 2014, ENVIRON MICROBIOL, V16, P612, DOI 10.1111/1462-2920.12328; BRENT R, 1980, P NATL ACAD SCI-BIOL, V77, P1932, DOI 10.1073/pnas.77.4.1932; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Camerini S, 2008, ARCH MICROBIOL, V190, P67, DOI 10.1007/s00203-008-0365-7; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Chappell J, 1998, PHYTOREMEDIATION TCE; Chen YP, 2006, APPL SOIL ECOL, V34, P33, DOI 10.1016/j.apsoil.2005.12.002; de Lorenzo CA, 1998, PROTOPLASMA, V201, P71, DOI 10.1007/BF01280713; de Maria N, 2005, PLANT PHYSIOL BIOCH, V43, P985, DOI 10.1016/j.plaphy.2005.09.001; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ebenau-Jehle C, 2012, J BACTERIOL, V194, P2894, DOI 10.1128/JB.00250-12; Egener T, 1998, MOL PLANT MICROBE IN, V11, P71, DOI 10.1094/MPMI.1998.11.1.71; Elbeltagy A, 2001, APPL ENVIRON MICROB, V67, P5285, DOI 10.1128/AEM.67.11.5285-5293.2001; Engelhard M, 2000, ENVIRON MICROBIOL, V2, P131, DOI 10.1046/j.1462-2920.2000.00078.x; Fedorova E, 2005, MOL PLANT MICROBE IN, V18, P405, DOI 10.1094/MPMI-18-0405; FERNANDEZPASCUAL M, 1988, J PLANT PHYSIOL, V133, P288, DOI 10.1016/S0176-1617(88)80202-5; Germaine K, 2004, FEMS MICROBIOL ECOL, V48, P109, DOI 10.1016/j.femsec.2003.12.009; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Goldstein A., 1986, American Journal of Alternative Agriculture, V1, P51; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gyaneshwar P, 2001, J BACTERIOL, V183, P2634, DOI 10.1128/JB.183.8.2634-2645.2001; Harms G, 1999, APPL ENVIRON MICROB, V65, P999; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HUREK T, 1995, MOL MICROBIOL, V18, P225, DOI 10.1111/j.1365-2958.1995.mmi_18020225.x; Hurek T, 1997, APPL ENVIRON MICROB, V63, P4331, DOI 10.1128/AEM.63.11.4331-4339.1997; Hurek T, 1997, J BACTERIOL, V179, P4172, DOI 10.1128/jb.179.13.4172-4178.1997; HUREK T, 1995, APPL ENVIRON MICROB, V61, P2257, DOI 10.1128/AEM.61.6.2257-2261.1995; Hurek T, 2003, J BIOTECHNOL, V106, P169, DOI 10.1016/j.jbiotec.2003.07.010; HUREK T, 1994, J BACTERIOL, V176, P1913, DOI 10.1128/jb.176.7.1913-1923.1994; Juarez JF, 2013, ENVIRON MICROBIOL, V15, P148, DOI 10.1111/j.1462-2920.2012.02818.x; Karg T, 1996, J BACTERIOL, V178, P5748, DOI 10.1128/jb.178.19.5748-5754.1996; KLEMENT Z, 1963, NATURE, V199, P299, DOI 10.1038/199299b0; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lewis RS, 2007, GENET RESOUR CROP EV, V54, P727, DOI 10.1007/s10722-006-0024-2; Li LP, 1999, FEMS MICROBIOL LETT, V179, P141, DOI 10.1111/j.1574-6968.1999.tb08719.x; Mano H, 2008, MICROBES ENVIRON, V23, P109, DOI 10.1264/jsme2.23.109; Mitter B, 2013, TRENDS PLANT SCI, V4, P1; Patten CL, 2013, CRIT REV MICROBIOL, V39, P395, DOI 10.3109/1040841X.2012.716819; Phi QT, 2008, J MICROBIOL BIOTECHN, V18, P1235; Porter AW, 2014, ADV APPL MICROBIOL, V88, P167, DOI 10.1016/B978-0-12-800260-5.00005-X; Rabus R, 2005, APPL MICROBIOL BIOT, V68, P580, DOI 10.1007/s00253-005-0030-x; RABUS R, 1995, ARCH MICROBIOL, V163, P96, DOI 10.1007/BF00381782; Rabus R, 2014, APPL MICROBIOL BIOT, V98, P3371, DOI 10.1007/s00253-013-5466-9; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Ramos C, 2000, APPL ENVIRON MICROB, V66, P801, DOI 10.1128/AEM.66.2.801-809.2000; REINHOLD B, 1986, APPL ENVIRON MICROB, V52, P520, DOI 10.1128/AEM.52.3.520-526.1986; Reinhold-Hurek B, 2000, INT J SYST EVOL MICR, V50, P649, DOI 10.1099/00207713-50-2-649; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; REINHOLDHUREK B, 1993, INT J SYST BACTERIOL, V43, P574, DOI 10.1099/00207713-43-3-574; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rhine ED, 2006, ENVIRON MICROBIOL, V8, P899, DOI 10.1111/j.1462-2920.2005.00977.x; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Rodriguez H, 2000, J BIOTECHNOL, V84, P155, DOI 10.1016/S0168-1656(00)00347-3; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ruiz-Diez B, 2012, APPL MICROBIOL BIOT, V96, P543, DOI 10.1007/s00253-011-3832-z; Salkowski E., 1885, Z PHYSL CHEM, V9, P23; Sambrook J., 2001, MOL CLONING LAB MANU; Sessitsch A, 2002, FEMS MICROBIOL ECOL, V39, P23, DOI 10.1111/j.1574-6941.2002.tb00903.x; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Singh OV, 2003, APPL MICROBIOL BIOT, V63, P128, DOI 10.1007/s00253-003-1425-1; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; Verma SC, 2001, J BIOTECHNOL, V91, P127, DOI 10.1016/S0168-1656(01)00333-9; WICHNER S, 1968, PHYSIOL PLANTARUM, V21, P227, DOI 10.1111/j.1399-3054.1968.tb07246.x	71	33	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110771	10.1371/journal.pone.0110771	http://dx.doi.org/10.1371/journal.pone.0110771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340341	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800055
J	Lu, HL; Wamba, PCF; Lapointe, M; Poirier, P; Martin, J; Bastien, M; Cianflone, K				Lu, HuiLing; Wamba, Ponce Cedric Fouejeu; Lapointe, Marc; Poirier, Paul; Martin, Julie; Bastien, Marjorie; Cianflone, Katherine			Increased Vaspin Levels Are Associated with Beneficial Metabolic Outcome Pre- and Post-Bariatric Surgery	PLOS ONE			English	Article							INSULIN SENSITIVITY; ADIPOSE-TISSUE; ADIPOKINE VASPIN; GENE-EXPRESSION; SERUM-LEVELS; WEIGHT-LOSS; OBESITY; INHIBITOR; LIGAND; FAT	Purpose: Vaspin (visceral-adipose-tissue-derived-serine-protease-inhibitor) is a recently identified adipokine with putative insulin-sensitizing properties. Plasma vaspin responses to surgery-induced weight loss are sparse and contradictory. Design and Participants: We evaluated changes in vaspin levels and relationship to post-operative outcomes in men (n = 22) and women (n = 55) undergoing biliopancreatic-diversion/duodenal-switch bariatric surgery. Body composition and plasma parameters were measured at baseline, acutely (1 and 5 days) and medium-term (6 and 12 months) post-surgery. Results: Fasting preoperative vaspin concentrations were comparable in men vs women. The distribution was biphasic (both men and women) with a nadir of 2.5 ng/ml. Subjects were divided into high (>= 2.5 ng/mL, HI-group) and low (<2.5 ng/mL, LO-group) vaspin level. Both groups had comparable sex distribution, age and BMI, but the HI-vaspin group had lower insulin, HOMA, and triglyceride and higher HDL-cholesterol, acylation stimulating protein (ASP) and IL-6 levels (all p, <0.05). Post-operatively, both groups decreased BMI comparably over 12 months; the HI-vaspin group maintained high vaspin levels, while the LO-vaspin group gradually increased their levels with weight loss over 12 months. The HI-vaspin group maintained a better glucose, insulin, HOMA, fructosamine, HDL-cholesterol, and triglyceride profile throughout. The HI-vaspin group also had higher gamma-glutamyltransferase and ASP profiles. Finally, baseline vaspin level inversely correlated significantly with baseline and 12-month insulin, HOMA, triglyceride and positively correlated with HDL and ASP. Twelve-month vaspin also correlated similarly, including an inverse correlation with BMI. Conclusion: Globally, this study supports the concept of vaspin as a beneficial adipokine in obesity, which may potentially lead to possible therapeutic targets.	[Lu, HuiLing; Wamba, Ponce Cedric Fouejeu; Lapointe, Marc; Poirier, Paul; Martin, Julie; Bastien, Marjorie; Cianflone, Katherine] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Cianflone, Katherine] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Poirier, Paul; Martin, Julie; Bastien, Marjorie] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Lu, HuiLing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Pediat, Wuhan 430074, Hubei, Peoples R China; [Wamba, Ponce Cedric Fouejeu] Univ Yaounde, Fac Sci, Lab Nut & Biochim Nutr, Yaounde, Cameroon	Laval University; Laval University; Laval University; Huazhong University of Science & Technology; University of Yaounde I	Cianflone, K (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca		Lapointe, Marc/0000-0003-0461-2576	Canadian Institutes of Health Research (CIHR); National Natural Science Foundation of China (NSFC) [81270949]; Canadian Commonwealth Scholarship Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Canadian Commonwealth Scholarship Program	This study was supported by a grant from Canadian Institutes of Health Research (CIHR) to KC and a grant from National Natural Science Foundation of China (NSFC) #81270949 to HLL.K. Cianflone holds a Canada Research Chair in Adipose Tissue. PC Fouejeu Wamba was supported by a Canadian Commonwealth Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarzadeh S, 2012, DIABETES RES CLIN PR, V95, P132, DOI 10.1016/j.diabres.2011.10.004; Bluher M, 2012, ENDOCRINE, V41, P176, DOI 10.1007/s12020-011-9572-0; Bluher M, 2012, DIABETES CARE, V35, P342, DOI 10.2337/dc11-1267; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Cinar N, 2011, EUR J ENDOCRINOL, V165, P563, DOI 10.1530/EJE-11-0180; DeClercq V., 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P59; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goktas Zeynep, 2013, Front Endocrinol (Lausanne), V4, P69, DOI 10.3389/fendo.2013.00069; Golpaie A, 2011, EUR CYTOKINE NETW, V22, P181, DOI 10.1684/ecn.2011.0295; Goralski KB, 2007, CAN J PHYSIOL PHARM, V85, P113, DOI 10.1139/Y06-092; Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068; Handisurya A, 2010, OBES SURG, V20, P198, DOI 10.1007/s11695-009-9882-y; Heiker JT, 2013, CELL MOL LIFE SCI, V70, P2569, DOI 10.1007/s00018-013-1258-8; Heiker JT, 2014, J PEPT SCI; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Isbell JM, 2010, DIABETES CARE, V33, P1438, DOI 10.2337/dc09-2107; Kadoglou NPE, 2011, REGUL PEPTIDES, V170, P57, DOI 10.1016/j.regpep.2011.05.008; Kim SM, 2011, METABOLISM, V60, P1294, DOI 10.1016/j.metabol.2011.01.013; Kloting N, 2006, BIOCHEM BIOPH RES CO, V339, P430, DOI 10.1016/j.bbrc.2005.11.039; Koiou E, 2011, ENDOCR J, V58, P237, DOI 10.1507/endocrj.K10E-330; Lee JA, 2011, ENDOCR J, V58, P639, DOI 10.1507/endocrj.K11E-073; Marceau P, 2009, SURG OBES RELAT DIS, V5, P43, DOI 10.1016/j.soard.2008.03.244; Maslowska M, 2006, J LIPID RES, V47, P643, DOI 10.1194/jlr.M500500-JLR200; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Munkonda MN, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.13; Nakatsuka A, 2013, CIRC RES, V112, P771, DOI 10.1161/CIRCRESAHA.111.300049; Nakatsuka A, 2012, DIABETES, V61, P2823, DOI 10.2337/db12-0232; Oberbach A, 2010, OBESITY FACTS, V3, P328, DOI 10.1159/000321637; Phalitakul S, 2011, PHARMACOL RES, V64, P493, DOI 10.1016/j.phrs.2011.06.001; Poirier P, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0444-5; Schultz S, 2013, CHEMMEDCHEM, V8, P549, DOI 10.1002/cmdc.201200448; Seeger J, 2008, J CLIN ENDOCR METAB, V93, P247, DOI 10.1210/jc.2007-1853; Tan BK, 2008, DIABETES, V57, P1501, DOI 10.2337/db08-0127; von Loeffelholz C, 2010, EUR J ENDOCRINOL, V162, P507, DOI 10.1530/EJE-09-0737; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111002	10.1371/journal.pone.0111002	http://dx.doi.org/10.1371/journal.pone.0111002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340725	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800077
J	Parnell, EJ; Yu, YX; Lucena, R; Yoon, Y; Bai, L; Kellogg, DR; Stillman, DJ				Parnell, Emily J.; Yu, Yaxin; Lucena, Rafael; Yoon, Youngdae; Bai, Lu; Kellogg, Douglas R.; Stillman, David J.			The Rts1 Regulatory Subunit of PP2A Phosphatase Controls Expression of the HO Endonuclease via Localization of the Ace2 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Gene Regulation; Nuclear Translocation; Phosphatase; Yeast Transcription	SACCHAROMYCES-CEREVISIAE; MITOTIC EXIT; CELL-CYCLE; FACTOR-BINDING; KINASE; GENE; PHOSPHORYLATION; IDENTIFICATION; CHITINASE; PATHWAYS	The RTS1 gene encodes a subunit of the PP2A phosphatase that regulates cell cycle progression. Ace2 and Swi5 are cell cycle-regulated transcription factors, and we recently showed that phosphorylation of Ace2 and Swi5 is altered in an rts1 mutant. Here we examine expression of Ace2 and Swi5 target genes and find that an rts1 mutation markedly reduces expression of the HO gene. The decreased HO expression in an rts1 mutant is significantly restored by an additional ace2 mutation, a surprising result because HO is normally activated by Swi5 but not by Ace2. Ace2 normally accumulates only in daughter cells, and only activates transcription in daughters. However, in an rts1 mutant, Ace2 is present in both mother and daughter cells. One of the genes activated by Ace2 is ASH1, a protein that normally accumulates mostly in daughter cells; Ash1 is a transcriptional repressor, and it blocks HO expression in daughters. We show that in the rts1 mutant, Ace2 accumulation in mother cells results in Ash1 expression in mothers, and the Ash1 can now repress HO expression in mothers.	[Parnell, Emily J.; Yu, Yaxin; Stillman, David J.] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84112 USA; [Lucena, Rafael; Kellogg, Douglas R.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Yoon, Youngdae; Bai, Lu] Penn State Univ, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Yoon, Youngdae; Bai, Lu] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bai, Lu] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Utah System of Higher Education; University of Utah; University of California System; University of California Santa Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Stillman, DJ (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pathol, 15 N Med Dr East, Salt Lake City, UT 84112 USA.	david.stillman@path.utah.edu	Lucena, Rafael/D-2239-2016	Stillman, David/0000-0002-5268-2416; Lucena, Rafael/0000-0003-2050-0611; Mooring, Meghan/0000-0002-8513-7430	National Institutes of Health [GM053959, GM39067]; Penn State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053959, R01GM039067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM053959 (to D. R. K.) and GM39067 (to D. J. S.). This work was also supported by startup funds from Penn State University (to L. B.).	Artiles K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000727; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Jensen TH, 2000, MOL CELL BIOL, V20, P8047, DOI 10.1128/MCB.20.21.8047-8058.2000; Lombardi IM, 2013, CURR BIOL, V23, P1736, DOI 10.1016/j.cub.2013.07.032; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Mazanka E, 2010, MOL BIOL CELL, V21, P2809, DOI 10.1091/mbc.E10-02-0174; Mazanka E, 2008, PLOS BIOL, V6, P1778, DOI 10.1371/journal.pbio.0060203; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Sbia M, 2008, J BIOL CHEM, V283, P11135, DOI 10.1074/jbc.M800196200; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Stillman DJ, 2013, TRENDS BIOCHEM SCI, V38, P467, DOI 10.1016/j.tibs.2013.06.009; Takahata S, 2011, J BIOL CHEM, V286, P34809, DOI 10.1074/jbc.M111.281626; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Voth WP, 2007, EMBO J, V26, P4324, DOI 10.1038/sj.emboj.7601859; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weiss EL, 2012, GENETICS, V192, P1165, DOI 10.1534/genetics.112.145516; Zapata J, 2014, J CELL BIOL, V204, P359, DOI 10.1083/jcb.201309119; Zhang Q, 2013, P NATL ACAD SCI USA, V110, P14012, DOI 10.1073/pnas.1306113110; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256	22	6	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35431	35437		10.1074/jbc.M114.611715	http://dx.doi.org/10.1074/jbc.M114.611715			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352596	Green Published, hybrid			2022-12-26	WOS:000346660200033
J	Lu, JS; Isaji, T; Im, S; Fukuda, T; Hashii, N; Takakura, D; Kawasaki, N; Gu, JG				Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Hashii, Noritaka; Takakura, Daisuke; Kawasaki, Nana; Gu, Jianguo			beta-Galactoside alpha 2,6-Sialyltranferase 1 Promotes Transforming Growth Factor-beta-mediated Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cadherin; Cell Migration; Epithelial-Mesenchymal Transition (EMT); N-Linked Glycosylation; Sialyltransferase	SPONTANEOUS METASTASIS; CELL-MIGRATION; BREAST-CANCER; E-CADHERIN; TGF-BETA; SIALYLATION; EXPRESSION; ST6GAL-I; INVASION; RECEPTOR	Background: Molecular mechanisms underlying the effect of sialylation on tumor progression remain unclear. Results: ST6GAL1 promoted the TGF--induced EMT through down-regulation of E-cadherin-mediated cell adhesion and up-regulation of integrin-mediated cell migration. Conclusion: Expression of ST6GAL1 is critical for sufficient induction of EMT. Significance: 2,6-Sialylation of N-glycans may play a role in EMT. -Galactoside 2,6-sialyltranferase 1 (ST6GAL1) catalyzes the addition of terminal 2,6-sialylation to N-glycans. Increased expression of ST6GAL1 has been reported in diverse carcinomas and highly correlates with tumor progression. Here, we report that St6gal1 transcription and 2,6-sialylated N-glycans are up-regulated during TGF--induced epithelial-mesenchymal transition (EMT) in GE11 cells, requiring the Sp1 element within the St6gal1 promoter. Knockdown of St6gal1 strongly suppressed TGF--induced EMT with a concomitant increase in E-cadherin expression, a major determinant of epithelial cell adherens junctions. Conversely, overexpression of ST6GAL1 increased the turnover of cell surface E-cadherin and promoted TGF--induced EMT. Overexpressing -galactoside 2,3-sialyltranferase 4 had little influence on EMT, indicating specificity for 2,6-sialylation. The basal mesenchymal phenotype of MDA-MB-231 human breast cancer cells was partially reversed by ST6GAL1 silencing. Moreover, ST6GAL1 knockdown inhibited the phosphorylation of Akt, but not Smad2, suggesting that ST6GAL1 contributes to EMT through a non-Smad signaling pathway. Taken together, our data indicate that ST6GAL1 promotes TGF--dependent EMT as well as maintenance of the mesenchymal state by growth signaling, providing a plausible mechanism whereby up-regulated ST6GAL1 may promote malignant progression.	[Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Hashii, Noritaka; Takakura, Daisuke; Kawasaki, Nana] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan	Tohoku Medical & Pharmaceutical University; National Institute of Health Sciences - Japan	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Japan Society for the Promotion of Science [21370059, 24570169, 23651196]; Scientific Research on Innovative Areas Grants [23110002, 23110001]; Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24570169] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research on Innovative Areas Grants; Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research 21370059 (to J. G.) and 24570169 (to T. I.) and Grant-in-Aid for Challenging Exploratory Research 23651196 (to J. G.) from the Japan Society for the Promotion of Science, by Scientific Research on Innovative Areas Grants 23110002 (to J. G.) and 23110001 (to N. K.); and the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bae GY, 2013, ONCOTARGET, V4, P2512, DOI 10.18632/oncotarget.1463; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bull C, 2013, MOL CANCER THER, V12, P1935, DOI 10.1158/1535-7163.MCT-13-0279; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; de Oliveira JT, 2011, INT J DEV BIOL, V55, P823, DOI 10.1387/ijdb.113359jt; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Granovsky M, 2000, NAT MED, V6, P306; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Hay ED, 1995, ACTA ANAT, V154, P8; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lee M, 2008, MOL CANCER RES, V6, P1316, DOI 10.1158/1541-7786.MCR-07-2209; Li SG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070282, 10.1371/journal.pone.0070461]; Lillehoj EP, 2012, J BIOL CHEM, V287, P8214, DOI 10.1074/jbc.M111.292888; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Ma H, 2015, ONCOGENE, V34, P726, DOI 10.1038/onc.2014.7; Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Ranjan A, 2013, J BIOSCIENCES, V38, P867, DOI 10.1007/s12038-013-9382-z; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Saldova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071159; SCHACHTER H, 1983, CAN J BIOCHEM CELL B, V61, P1049, DOI 10.1139/o83-134; Schachter H, 1986, Adv Exp Med Biol, V205, P53; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Shen L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.48; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Tan ZQ, 2014, J PROTEOME RES, V13, P2783, DOI 10.1021/pr401185z; Taniguchi A, 2000, GLYCOBIOLOGY, V10, P623, DOI 10.1093/glycob/10.6.623; Taniguchi A, 1998, FEBS LETT, V441, P191, DOI 10.1016/S0014-5793(98)01548-8; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065218; Zhao YF, 2014, MOL CELL PROTEOMICS, V13, P520, DOI 10.1074/mcp.M113.034025; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	62	74	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34627	34641		10.1074/jbc.M114.593392	http://dx.doi.org/10.1074/jbc.M114.593392			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25344606	Green Published, hybrid			2022-12-26	WOS:000346260800021
J	Romanow, A; Keys, TG; Stummeyer, K; Freiberger, F; Henrissat, B; Gerardy-Schahn, R				Romanow, Angela; Keys, Timothy G.; Stummeyer, Katharina; Freiberger, Friedrich; Henrissat, Bernard; Gerardy-Schahn, Rita			Dissection of Hexosyl- and Sialyltransferase Domains in the Bifunctional Capsule Polymerases from Neisseria meningitidis Wand Y Defines a New Sialyltransferase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Enzyme Catalysis; Glycosyltransferase; Phylogenetics; Polysaccharide; Fluorescence-based Testing of Glycosyltransferases; Neisseria meningitidis Serogroup W and Y; Capsule Polymerases; Hexosyltransferases; Sialyltransferases	ULTRASENSITIVE CHEMICAL METHOD; POLYSIALIC ACID; PSI-BLAST; BIOSYNTHESIS; PROTEIN; POLYSACCHARIDES; PERFORMANCE; EXPRESSION; PREDICTION; ACCURACY	Background: Capsule polymerases of Neisseria meningitidis serogroups W and Y comprise hexosyl- and sialyltransferase activity. Results: Hexosyltransferase activity is encoded by the predicted N-terminal GT-B fold. Sialyltransferase activity requires 168 additional amino acids upstream of the predicted C-terminal GT-B fold. Conclusion: The sialyltransferase domains of NmW/Y define a new glycosyltransferase (CAZy) family. Significance: The new CAZy family comprises sequences from distantly related species. Crucial virulence determinants of disease causing Neisseria meningitidis species are their extracellular polysaccharide capsules. In the serogroups W and Y, these are heteropolymers of the repeating units (6)--d-Gal-(14)--Neu5Ac-(2)(n) in NmW and (6)--d-Glc-(14)--Neu5Ac-(2)(n) in NmY. The capsule polymerases, SiaD(W) and SiaD(Y), which synthesize these highly unusual polymers, are composed of two predicted GT-B fold domains separated by a large stretch of amino acids (aa 399-762). We recently showed that residues critical to the hexosyl- and sialyltransferase activity are found in the predicted N-terminal (aa 1-398) and C-terminal (aa 763-1037) GT-B fold domains, respectively. Here we use a mutational approach and synthetic fluorescent substrates to define the boundaries of the hexosyl- and sialyltransferase domains. Our results reveal that the active sialyltransferase domain extends well beyond the predicted C-terminal GT-B domain and defines a new glycosyltransferase family, GT97, in CAZy (Carbohydrate-Active enZYmes Database).	[Romanow, Angela; Keys, Timothy G.; Stummeyer, Katharina; Freiberger, Friedrich; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR 7257, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21589, Saudi Arabia	Hannover Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Keys, Timothy Gerard/0000-0003-2921-0362	DFG [Ge801/10-1]	DFG(German Research Foundation (DFG))	This work arose as a new research aspect in the frame of Deutsche Forschungsgemeinschaft (DFG) Research Unit 548. This work was supported in part through DFG Grant Ge801/10-1 and in part through impact-derived resources of the Institute for Cellular Chemistry.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; Bravo IG, 2004, TRENDS MICROBIOL, V12, P120, DOI 10.1016/j.tim.2004.01.004; Claus H, 1997, MOL GEN GENET, V257, P28, DOI 10.1007/s004380050620; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; Deole R, 2013, J BIOL CHEM, V288, P581, DOI 10.1074/jbc.M112.420505; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Gilbert M, 1997, BIOTECHNOL LETT, V19, P417, DOI 10.1023/A:1018379607492; Gouveia-Oliveira R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-312; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hao JJ, 2005, BIOCHEM BIOPH RES CO, V338, P1507, DOI 10.1016/j.bbrc.2005.10.113; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Inoue S, 2001, BIOCHIMIE, V83, P605, DOI 10.1016/S0300-9084(01)01307-4; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; Kandiba L, 2013, FEMS MICROBIOL LETT, V345, P110, DOI 10.1111/1574-6968.12193; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keys TG, 2012, ANAL BIOCHEM, V427, P107, DOI 10.1016/j.ab.2012.05.011; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schauer R, 1997, INDIAN J BIOCHEM BIO, V34, P131; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; WEISGERBER C, 1990, J BIOL CHEM, V265, P1578; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; Yamamoto T, 2007, GLYCOBIOLOGY, V17, P1167, DOI 10.1093/glycob/cwm086	42	19	19	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33945	33957		10.1074/jbc.M114.597773	http://dx.doi.org/10.1074/jbc.M114.597773			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342753	Green Published, hybrid			2022-12-26	WOS:000346077600023
J	So, JH; Kim, JD; Yoo, KW; Kim, HT; Jung, SH; Choi, JH; Lee, MS; Jin, SW; Kim, CH				So, Ju-Hoon; Kim, Jun-Dae; Yoo, Kyeong-Won; Kim, Hyun-Taek; Jung, Seung-Hyun; Choi, Jung-Hwa; Lee, Mi-Sun; Jin, Suk-Won; Kim, Cheol-Hee			FIH-1, a Novel Interactor of Mindbomb, Functions as an Essential Anti-Angiogenic Factor during Zebrafish Vascular Development	PLOS ONE			English	Article							HIF-ALPHA; HYPOXIA; NOTCH; VEGF; ACTIVATION; PROTEIN; VHL; RESPONSES; GRIDLOCK; RECEPTOR	Objective: It has been shown that Mindbomb (Mib), an E3 Ubiquitin ligase, is an essential modulator of Notch signaling during development. However, its effects on vascular development remain largely unknown. Approaches and Results: We identified a number of novel proteins that physically interact with Mib, including the Factor Inhibiting Hypoxia Inducible Factor 1 (FIH-1, also known as HIF1AN) from a yeast two hybrid screen, as previously reported. In cultured cells, FIH-1 colocalizes with Mib1, corroborating their potential interaction. In zebrafish embryos, FIH-1 appears to modulate VEGF-A signaling activity; depletion of fih-1 induces ectopic expression of vascular endothelial growth factor-alpha (vegfa) and leads to exuberant ectopic sprouts from intersegmental vessels (ISVs). Conversely, over-expression of fih-1 substantially attenuates the formation of ISVs, which can be rescued by concurrent over-expression of vegfa, indicating that FIH-1/HIF1AN may fine tune VEGF-A signaling. Conclusions: Taken together, our data suggest that FIH-1 interacts with Mib E3 Ubiquitin ligase and modulates vascular development by attenuating VEGF-A signaling activity.	[So, Ju-Hoon; Yoo, Kyeong-Won; Kim, Hyun-Taek; Jung, Seung-Hyun; Choi, Jung-Hwa; Lee, Mi-Sun; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Taejon, South Korea; [So, Ju-Hoon] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Kim, Jun-Dae; Jin, Suk-Won] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Sect Cardiovascul Med, New Haven, CT 06510 USA; [Jin, Suk-Won] Gwangju Inst Sci & Technol, Sch Biol Sci, Kwangju, South Korea	Chungnam National University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Gwangju Institute of Science & Technology (GIST)	Jin, SW (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Sect Cardiovascul Med, New Haven, CT 06510 USA.	suk-won.jin@yale.edu; zebrakim@cnu.ac.kr	Choi, Jung-Hwa/GQQ-6280-2022	Kim, Jun-dae/0000-0002-9747-6288; Kim, Cheol-Hee/0000-0002-3019-0699	KRIBB Research Initiative Program [KGM4611411]; NIH [HL090960, HL119345]; American Heart Association [11POST7440010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090960] Funding Source: NIH RePORTER	KRIBB Research Initiative Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work has been supported by grants from the KRIBB Research Initiative Program (KGM4611411) to CHK, the NIH to S-WJ (HL090960 and HL119345), American Heart Association post-doctoral fellowship to J-DK (11POST7440010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hawighorst T, 2002, AM J PATHOL, V160, P1381, DOI 10.1016/S0002-9440(10)62565-5; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jensen LD, 2012, CELL REP, V2, P231, DOI 10.1016/j.celrep.2012.07.005; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kim JD, 2012, DEV CELL, V23, P441, DOI 10.1016/j.devcel.2012.07.007; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Liang D, 1998, BBA-GENE STRUCT EXPR, V1397, P14, DOI 10.1016/S0167-4781(97)00233-9; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; So JH, 2010, GENES CELLS, V15, P1099, DOI 10.1111/j.1365-2443.2010.01448.x; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tseng LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093394; van Rooijen E, 2010, DIS MODEL MECH, V3, P343, DOI 10.1242/dmm.004036; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	36	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109517	10.1371/journal.pone.0109517	http://dx.doi.org/10.1371/journal.pone.0109517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347788	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000347994900011
J	Wang, LZ; Zhou, HH; Han, J; Milne, RI; Wang, MY; Liu, BB				Wang, Lizhong; Zhou, Haihong; Han, Jin; Milne, Richard I.; Wang, Mingyu; Liu, Bingbing			Genome-Scale Transcriptome Analysis of the Alpine "Glasshouse'' Plant Rheum nobile (Polygonaceae) with Special Translucent Bracts	PLOS ONE			English	Article							PARALLEL EVOLUTION; CELLULAR-RESPONSE; PHOTOSYSTEM-II; HOOK-F; PROTEIN; GENE; BIOSYNTHESIS; RADIATION; PHOSPHORYLATION; RECONSTRUCTION	Background: Rheum nobile is an alpine plant with translucent bracts concealing the inflorescence which produce a "glasshouse'' effect promoting the development of fertile pollen grains in such conditions. The current understanding of the adaptation of such bracts to alpine environments mainly focuses on the phenotypic and physiological changes while the genetic basis is very limited. By sequencing the upper bract and the lower rosulate leaf from the same R. nobile stem, we identified candidate genes that may be involved in alpine adaption of the translucent bract in "glasshouse'' plants and illustrated the changes in gene expression underlying the adaptive and complex evolution of the bracts phenotype. Results: A total of 174.2 million paired-end reads from each transcriptome were assembled into 25,249 unigenes. By comparing the gene expression profiles, we identified 1,063 and 786 genes up-regulated respectively in the upper bract and the lower leaf. Functional enrichment analyses of these genes recovered a number of differential important pathways, including flavonoid biosynthesis, mismatch repair and photosynthesis related pathways. These pathways are mainly involved in three types of functions: 9 genes in the UV protective process, 9 mismatch repair related genes and 88 genes associated with photosynthesis. Conclusions: This study provides the first comprehensive dataset characterizing Rheum nobile gene expression at the transcriptomic scale, and provides novel insights into the gene expression profiles associated with the adaptation of the "glasshouse'' plant bracts. The dataset will be served as a public genetic resources for further functional and evolutionary studies of "glasshouse'' plants.	[Wang, Lizhong; Han, Jin; Liu, Bingbing] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China; [Zhou, Haihong; Wang, Mingyu] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Gansu, Peoples R China; [Milne, Richard I.] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Milne, Richard I.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland	Lanzhou University; Lanzhou University; University of Edinburgh	Wang, MY (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Gansu, Peoples R China.	wangmy09@lzu.cn; liubb2013@gmail.com	liu, bb/GXA-2527-2022	wang, lizhong/0000-0002-3571-8771	Key Project of International Collaboration Program; Ministry of Science and Technology of China [2010DFB63500]; Fundamental Research Funds for the Central Universities [lzujbky-2009-k05, lzujbky-2012-112]; International Collaboration 111 Projects of China	Key Project of International Collaboration Program; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); International Collaboration 111 Projects of China	This work was funded by the Key Project of International Collaboration Program, the Ministry of Science and Technology of China (research grant 2010DFB63500), the Fundamental Research Funds for the Central Universities (lzujbky-2009-k05 and lzujbky-2012-112) and the International Collaboration 111 Projects of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armbruster WS, 1997, ECOLOGY, V78, P1661; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, CONTROL FALSE DISCOV; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Booij-James IS, 2000, PLANT PHYSIOL, V124, P1275, DOI 10.1104/pp.124.3.1275; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; CALDWELL MM, 1983, PHYSIOL PLANTARUM, V58, P445, DOI 10.1111/j.1399-3054.1983.tb04206.x; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Friend A.D., 1990, ADV ECOL RES, V20, P59, DOI [10.1016/S0065-2504(08)60053-7, DOI 10.1016/S0065-2504(08)60053-7]; Gao Y, 2013, PLANT MOL BIOL, V81, P363, DOI 10.1007/s11103-013-0009-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Hanson MA, 1996, GENETICS, V143, P1395; HELLER W, 1980, ARCH BIOCHEM BIOPHYS, V200, P617, DOI 10.1016/0003-9861(80)90395-1; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iwashina T, 2004, J PLANT RES, V117, P101, DOI 10.1007/s10265-003-0134-2; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KUHLBRANDT W, 1984, NATURE, V307, P478, DOI 10.1038/307478a0; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu BB, 2013, J SYST EVOL, V51, P134, DOI 10.1111/j.1759-6831.2012.00225.x; Liu RR, 2010, CARYOLOGIA, V63, P82; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ohba H., 1988, HIMALAYAN PLANTS, Vvol. 1, P19; Omori Y, 1996, BOT J LINN SOC, V122, P269, DOI 10.1111/j.1095-8339.1996.tb02076.x; Omori Y, 2000, BOT J LINN SOC, V132, P19, DOI 10.1111/j.1095-8339.2000.tb01852.x; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson PN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-144; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Shao HB, 2007, COLLOID SURFACE B, V54, P37, DOI 10.1016/j.colsurfb.2006.07.002; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Song B, 2012, OECOLOGIA, P1; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TERASHIMA I, 1993, OECOLOGIA, V95, P194, DOI 10.1007/BF00323490; Tsukaya H, 2002, J PLANT RES, V115, P59, DOI 10.1007/s102650200009; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Wan DS, 2011, BIOCHEM SYST ECOL, V39, P651, DOI 10.1016/j.bse.2011.05.016; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yang MH, 2001, NORD J BOT, V21, P411, DOI 10.1111/j.1756-1051.2001.tb00789.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang DY, 2010, PLANTA, V231, P1505, DOI 10.1007/s00425-010-1133-x; Zhu ZF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3200	64	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110712	10.1371/journal.pone.0110712	http://dx.doi.org/10.1371/journal.pone.0110712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343261	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500050
J	Costa, L; Pinheiro, RO; Dutra, PML; Santos, RF; Cunha, EF; Torres-Santos, EC; da Silva, AJM; Costa, PRR; Da-Silva, SAG				Costa, Luciana; Pinheiro, Roberta O.; Dutra, Patricia M. L.; Santos, Rosiane F.; Cunha-Junior, Edezio F.; Torres-Santos, Eduardo C.; da Silva, Alcides J. M.; Costa, Paulo R. R.; Da-Silva, Silvia A. G.			Pterocarpanquinone LQB-118 Induces Apoptosis in Leishmania (Viannia) braziliensis and Controls Lesions in Infected Hamsters	PLOS ONE			English	Article							MUCOSAL LEISHMANIASIS; DIMETHYL-SULFOXIDE; CURRENT SCENARIO; EFFICACY	Previous results demonstrate that the hybrid synthetic pterocarpanquinone LQB-118 presents antileishmanial activity against Leishmania amazonensis in a mouse model. The aim of the present study was to use a hamster model to investigate whether LQB-118 presents antileishmanial activity against Leishmania (Viannia) braziliensis, which is the major Leishmania species related to American tegumentary leishmaniasis. The in vitro antileishmanial activity of LQB-118 on L. braziliensis was tested on the promastigote and intracellular amastigote forms. The cell death induced by LQB-118 in the L. braziliensis promastigotes was analyzed using an annexin V-FITC/PI kit, the oxidative stress was evaluated by 2',7'-dichlorodihydro-fluorescein diacetate (H(2)DCFDA) and the ATP content by luminescence. In situ labeling of DNA fragments by terminal deoxyribonucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) was used to investigate apoptosis in the intracellular amastigotes. L. braziliensis-infected hamsters were treated from the seventh day of infection with LQB-118 administered intralesionally (26 mu g/kg/day, three times a week) or orally (4,3 mg/kg/day, five times a week) for eight weeks. LQB-118 was active against the L. braziliensis promastigotes and intracellular amastigotes, producing IC50 (50% inhibitory concentration) values of 3,4 +/- 0,1 and 7,5 +/- 0,8 mu M, respectively. LQB-118 induced promastigote phosphatidylserine externalization accompanied by increased reactive oxygen species production and ATP depletion. Intracellular amastigote DNA fragmentation was also observed, without affecting the viability of macrophages. The treatment of L. braziliensis-infected hamsters with LQB-118, either orally or intralesionally, was effective in the control of lesion size, parasite load and increase intradermal reaction to parasite antigen. Taken together, these results show that the antileishmanial effect of LQB-118 extends to L. braziliensis in the hamster model, involves the induction of parasite apoptosis and shows promising therapeutic option by oral or local routes in leishmaniasis.	[Costa, Luciana; Santos, Rosiane F.; Da-Silva, Silvia A. G.] Univ Estado Rio de Janeiro, Lab Imunofarmacol Parasitaria, Dept Microbiol Imunol & Parasitol, BR-20550011 Rio De Janeiro, Brazil; [Pinheiro, Roberta O.] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, BR-21045900 Rio De Janeiro, Brazil; [Dutra, Patricia M. L.] Univ Estado Rio de Janeiro, Lab Bioquim Protozoarios & Imunofisiol Exercicio, Dept Microbiol Imunol & Parasitol, BR-20550011 Rio De Janeiro, Brazil; [Cunha-Junior, Edezio F.; Torres-Santos, Eduardo C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Bioquim Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil; [da Silva, Alcides J. M.] Univ Fed Rio de Janeiro, Lab Catalise Organ, Nucleo Pesquisas Prod Nat, Rio De Janeiro, Brazil; [Costa, Paulo R. R.] Univ Fed Rio de Janeiro, Lab Quim Bioorgan, Nucleo Pesquisas Prod Nat, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Da-Silva, SAG (corresponding author), Univ Estado Rio de Janeiro, Lab Imunofarmacol Parasitaria, Dept Microbiol Imunol & Parasitol, BR-20550011 Rio De Janeiro, Brazil.	silvasag@gmail.com	SAG, Da-Silva/K-3091-2014; Da-Silva, Silvia/AAV-4808-2020; Costa, Paulo Roberto Ribeiro/AAH-4777-2021; Dutra, Patricia M L/J-6431-2014; Torres-Santos, Eduardo Caio/J-9908-2014; da Silva, Alcides José/AAV-6031-2020; Cunha-Junior, Edezio/E-1043-2015; Cunha-Junior, Edezio/F-5200-2018; Costa, Paulo Roberto Ribeiro/F-1153-2013; Pinheiro, R O/A-2525-2013	SAG, Da-Silva/0000-0003-1600-1238; Da-Silva, Silvia/0000-0003-1600-1238; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Torres-Santos, Eduardo Caio/0000-0003-2240-4519; da Silva, Alcides José/0000-0002-3200-0318; Cunha-Junior, Edezio/0000-0002-2833-1771; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Pinheiro, R O/0000-0001-8471-4227; Dutra, Patricia Maria Lourenco/0000-0002-2494-6912	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). PMLD ECTS AJMS PRRC SAGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Ameen M, 2010, CLIN EXP DERMATOL, V35, P699, DOI 10.1111/j.1365-2230.2010.03851.x; Bacelar TD, 2013, ANTI-CANCER DRUG, V24, P73, DOI 10.1097/CAD.0b013e3283592da8; Colucci M, 2008, PHARMACOL RES, V57, P419, DOI 10.1016/j.phrs.2008.04.004; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Croft SL, 2006, INDIAN J MED RES, V123, P399; da Cunha EF, 2011, J ANTIMICROB CHEMOTH, V66, P1555, DOI 10.1093/jac/dkr158; Guerra JAD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000980; DeKrey GK, 1998, INFECT IMMUN, V66, P827, DOI 10.1128/IAI.66.2.827-829.1998; Fonseca-Silva F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014666; Gomes-Silva A, 2013, PARASITOLOGY, V140, P771, DOI 10.1017/S0031182012002156; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Joshi J, 2014, PARASITOL INT, V63, P612, DOI 10.1016/j.parint.2014.04.002; Maia RC, 2011, INVEST NEW DRUG, V29, P1143, DOI 10.1007/s10637-010-9453-z; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Netto CD, 2009, EUR J MED CHEM, V44, P920, DOI 10.1016/j.ejmech.2008.01.027; O'Daly Jose A, 2013, J Parasitol Res, V2013, P657016, DOI 10.1155/2013/657016; Pham TTH, 2013, INT J PHARMACEUT, V454, P539, DOI 10.1016/j.ijpharm.2013.07.035; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Ribeiro GA, 2013, J ANTIMICROB CHEMOTH, V68, P789, DOI 10.1093/jac/dks498; Rocha FJS, 2007, INFECT IMMUN, V75, P3823, DOI 10.1128/IAI.01335-06; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Sinagra A, 1997, AM J TROP MED HYG, V57, P115, DOI 10.4269/ajtmh.1997.57.115; Soto J, 2008, AM J TROP MED HYG, V78, P210, DOI 10.4269/ajtmh.2008.78.210; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070	27	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109672	10.1371/journal.pone.0109672	http://dx.doi.org/10.1371/journal.pone.0109672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340550	Green Published, gold			2022-12-26	WOS:000343662800013
J	Sugawara, Y; Yutani, M; Amatsu, S; Matsumura, T; Fujinaga, Y				Sugawara, Yo; Yutani, Masahiro; Amatsu, Sho; Matsumura, Takuhiro; Fujinaga, Yukako			Functional Dissection of the Clostridium botulinum Type B Hemagglutinin Complex: Identification of the Carbohydrate and E-Cadherin Binding Sites	PLOS ONE			English	Article							C PROGENITOR TOXIN; EPITHELIAL BARRIER; CRYSTAL-STRUCTURE; HA PROTEINS; NEUROTOXIN; ERYTHROCYTES; SUBCOMPONENT; DISRUPTION; ABSORPTION; MECHANISM	Botulinum neurotoxin (BoNT) inhibits neurotransmitter release in motor nerve endings, causing botulism, a condition often resulting from ingestion of the toxin or toxin-producing bacteria. BoNTs are always produced as large protein complexes by associating with a non-toxic protein, non-toxic non-hemagglutinin (NTNH), and some toxin complexes contain another nontoxic protein, hemagglutinin (HA), in addition to NTNH. These accessory proteins are known to increase the oral toxicity of the toxin dramatically. NTNH has a protective role against the harsh conditions in the digestive tract, while HA is considered to facilitate intestinal absorption of the toxin by intestinal binding and disruption of the epithelial barrier. Two specific activities of HA, carbohydrate and E-cadherin binding, appear to be involved in these processes; however, the exact roles of these activities in the pathogenesis of botulism remain unclear. The toxin is conventionally divided into seven serotypes, designated A through G. In this study, we identified the amino acid residues critical for carbohydrate and E-cadherin binding in serotype B HA. We constructed mutants defective in each of these two activities and examined the relationship of these activities using an in vitro intestinal cell culture model. Our results show that the carbohydrate and E-cadherin binding activities are functionally and structurally independent. Carbohydrate binding potentiates the epithelial barrier-disrupting activity by enhancing cell surface binding, while E-cadherin binding is essential for the barrier disruption.	[Sugawara, Yo; Yutani, Masahiro; Amatsu, Sho; Matsumura, Takuhiro; Fujinaga, Yukako] Osaka Univ, Microbial Dis Res Inst, Lab Infect Cell Biol, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan	Osaka University	Fujinaga, Y (corresponding author), Osaka Univ, Microbial Dis Res Inst, Lab Infect Cell Biol, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan.	yukafuji@biken.osaka-u.ac.jp		Amatsu, Sho/0000-0003-0692-264X	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan [20790336, 21390128]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS) and grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20790336, 21390128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatsu S, 2013, J BIOL CHEM, V288, P35617, DOI 10.1074/jbc.M113.521179; Arimitsu H, 2008, MICROB PATHOGENESIS, V45, P142, DOI 10.1016/j.micpath.2008.04.007; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Benefield DA, 2013, P NATL ACAD SCI USA, V110, P5630, DOI [10.1073/pnas.1222139110, 10.1073/pnas.12222139110]; Fujinaga Y, 2004, MICROBIOL-SGM, V150, P1529, DOI 10.1099/mic.0.26805-0; Fujinaga Y, 1997, MICROBIOL-UK, V143, P3841, DOI 10.1099/00221287-143-12-3841; Fujinaga Y, 2000, FEBS LETT, V467, P179, DOI 10.1016/S0014-5793(00)01147-9; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hasegawa K, 2007, J BIOL CHEM, V282, P24777, DOI 10.1074/jbc.M703446200; Inoue K, 2003, MICROBIOL-SGM, V149, P3361, DOI 10.1099/mic.0.26586-0; Inoue K, 1996, INFECT IMMUN, V64, P1589, DOI 10.1128/IAI.64.5.1589-1594.1996; Jin YJ, 2009, MICROBIOL-SGM, V155, P35, DOI 10.1099/mic.0.021246-0; Johnson EA, 2014, J INFECT DIS, V210, P992, DOI 10.1093/infdis/jiu211; Lee K, 2014, SCIENCE, V344, P1405, DOI 10.1126/science.1253823; Lee K, 2014, BIOCHEM BIOPH RES CO, V446, P568, DOI 10.1016/j.bbrc.2014.03.008; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Nakamura T, 2008, J MOL BIOL, V376, P854, DOI 10.1016/j.jmb.2007.12.031; Nakamura T, 2007, BBA-GEN SUBJECTS, V1770, P551, DOI 10.1016/j.bbagen.2006.11.006; Oguma K, 1999, J TOXICOL-TOXIN REV, V18, P17, DOI 10.3109/15569549909036015; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Poulain B, 2008, BOTULINUM J, V1, P14, DOI DOI 10.1504/TBJ.2008.018951; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; SUGII S, 1977, INFECT IMMUN, V16, P910, DOI 10.1128/IAI.16.3.910-914.1977; Yamashita S, 2012, FEBS LETT, V586, P2404, DOI 10.1016/j.febslet.2012.05.055	30	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111170	10.1371/journal.pone.0111170	http://dx.doi.org/10.1371/journal.pone.0111170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340348	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800091
J	Sun, Y; Hou, R; Fu, XT; Sun, CS; Wang, S; Wang, C; Li, N; Zhang, LL; Bao, ZM				Sun, Yan; Hou, Rui; Fu, Xiaoteng; Sun, Changsen; Wang, Shi; Wang, Chen; Li, Ning; Zhang, Lingling; Bao, Zhenmin			Genome-Wide Analysis of DNA Methylation in Five Tissues of Zhikong Scallop, Chlamys farreri	PLOS ONE			English	Article							GENE-EXPRESSION; CPG METHYLATION; AMPLIFICATION; PATTERNS; 5-METHYLCYTOSINE; CONSERVATION; EPIGENETICS; DIVERGENCE; WIDESPREAD; PLANTS	DNA methylation plays a vital role in tissue development and differentiation in eukaryotes. Epigenetic studies have been seldom conducted in the extremely diverse and evolutionarily highly successful bilaterian lineage Mollusca. In the present study, we conducted the genome-wide profiling of DNA methylation for five tissues of a bivalve mollusc, Chlamys farreri using the methylation-sensitive amplification polymorphism (MSAP) technique. The methylation levels were quite similar among tissues, ranging from 20.9% to 21.7%. CG methylation was the dominant type (14.9%-16.5%) in the C. farreri genome, but CHG methylation also accounted for a substantial fraction of total methylation (5.1%-6.3%). Relatively high methylation diversity was observed within tissues. Methylation differentiation between tissues was evaluated and 460 tissue-specific epiloci were identified. Kidney differs from the other tissues in DNA methylation profiles. Our study presents the first look at the tissue-specific DNA methylation patterns in a bivalve mollusc and represents an initial step towards understanding of epigenetic regulatory mechanism underlying tissue development and differentiation in bivalves.	[Sun, Yan; Hou, Rui; Fu, Xiaoteng; Wang, Shi; Wang, Chen; Li, Ning; Zhang, Lingling; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China; [Sun, Changsen] Taizhou Univ, Sch Life Sci, Taizhou, Peoples R China	Ocean University of China; Taizhou University	Zhang, LL (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China.	lingling80@ouc.edu.cn	zhang, lingling/HDM-2189-2022	sun, Yongjun/0000-0002-5266-3645; Zheng, Huaili/0000-0001-8544-6033; Zhai, Jun/0000-0002-4378-0604; zhao, chun/0000-0002-9118-9990	National High Technology Research and Development Program of China [2012AA10A401]; National Basic Research Program of China (973 Program) [2010CB126406]; Natural Science Foundation for Distinguished Young Scholars of Shandong Province [JQ201308]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation for Distinguished Young Scholars of Shandong Province	This work is supported by National High Technology Research and Development Program of China (2012AA10A401), National Basic Research Program of China (973 Program, 2010CB126406), and Natural Science Foundation for Distinguished Young Scholars of Shandong Province (JQ201308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; BIRD AP, 1979, CELL, V17, P889, DOI 10.1016/0092-8674(79)90329-5; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; De Montera B, 2004, CLONING STEM CELLS, V6, P133, DOI 10.1089/1536230041372382; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P3087, DOI 10.1093/nar/11.10.3087; Gavery MR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-483; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Jiao WQ, 2014, DNA RES, V21, P85, DOI 10.1093/dnares/dst043; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Peraza-Echeverria S, 2001, PLANT SCI, V161, P359, DOI 10.1016/S0168-9452(01)00421-6; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Sambrook J, 1989, MOL CLONING; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schrey AW, 2013, INTEGR COMP BIOL, V53, P340, DOI 10.1093/icb/ict012; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Su ZX, 2011, EPIGENETICS-US, V6, P134, DOI 10.4161/epi.6.2.13875; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu Q, 2007, ANIM BIOTECHNOL, V18, P231, DOI 10.1080/10495390701574838; Yang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016229; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	36	69	74	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e86232	10.1371/journal.pone.0086232	http://dx.doi.org/10.1371/journal.pone.0086232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	25347394	gold, Green Published, Green Submitted			2022-12-26	WOS:000329925800057
J	Buendia, P; de Oca, A; Madueno, JA; Merino, A; Martin-Malo, A; Aljama, P; Ramirez, R; Rodriguez, M; Carracedo, J				Buendia, Paula; Montes de Oca, Addy; Madueno, Juan Antonio; Merino, Ana; Martin-Malo, Alejandro; Aljama, Pedro; Ramirez, Rafael; Rodriguez, Mariano; Carracedo, Julia			Endothelial microparticles mediate inflammation-induced vascular calcification	FASEB JOURNAL			English	Article						HUVECs; VSMC calcification; BMP-2 osteogenic differentiation; TNF-alpha	BONE MORPHOGENETIC PROTEIN-2; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; APOPTOTIC CELLS; VESICLES; PROTAGONISTS; ATTRACTION; ACTIVATION; PHAGOCYTES; INITIATION	Stimulation of endothelial cells (ECs) with TNF-alpha causes an increase in the expression of bone morphogenetic protein-2 (BMP-2) and the production of endothelial microparticles (EMPs). BMP-2 is known to produce osteogenic differentiation of vascular smooth muscle cells (VSMCs). It was found that EMPs from TNF-alpha- stimulated endothelial cells (HUVECs) contained a significant amount of BMP-2 and were able to enhance VSMC osteogenesis and calcification. Calcium content was greater in VSMCs exposed to EMPs from TNF-alpha-treated HUVECs than EMPs from nontreated HUVECs (3.56 +/- 0.57 vs. 1.48 +/- 0.56 mu g/mg protein; P < 0.05). The increase in calcification was accompanied by up-regulation of Cbfa1 (osteogenic transcription factor) and down-regulation of SM22 alpha (VSMC lineage marker). Inhibition of BMP-2 by small interfering RNA reduced the VSMC calcification induced by EMPs from TNF-alpha- treated HUVECs. Similar osteogenic capability was observed in EMPs from both patients with chronic kidney disease and senescent cells, which also presented a high level of BMP-2 expression. Labeling of EMPs with CellTracker shows that EMPs are phagocytized by VSMCs under all conditions (with or without high phosphate, control, and EMPs from TNF-alpha-treated HUVECs). Our data suggest that EC damage results in the release of EMPs with a high content of calcium and BMP-2 that are able to induce calcification and osteogenic differentiation of VSMCs.	[Buendia, Paula; Montes de Oca, Addy; Madueno, Juan Antonio; Martin-Malo, Alejandro; Aljama, Pedro; Rodriguez, Mariano; Carracedo, Julia] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba, Fdn Invest Biomed Cordoba, Cordoba 14004, Spain; [Merino, Ana] Hosp Univ Bellvitge, IDIBELL, Lab Expt Nephrol, Barcelona, Spain; [Martin-Malo, Alejandro; Aljama, Pedro; Ramirez, Rafael; Rodriguez, Mariano] Hosp Univ Reina Sofia, Nephrol Unit, Cordoba 14004, Spain; [Ramirez, Rafael] Univ Alcala de Henares, Dept Physiol, Madrid, Spain; [Buendia, Paula; Montes de Oca, Addy; Merino, Ana; Martin-Malo, Alejandro; Aljama, Pedro; Ramirez, Rafael; Rodriguez, Mariano; Carracedo, Julia] Inst Salud Carlos III, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universidad de Alcala; Instituto de Salud Carlos III	Rodriguez, M (corresponding author), Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba, Menendez Pidal S-N, Cordoba 14004, Spain.	juanm.rodriguez.sspa@juntadeandalucia.es	Ramirez, Rafael/B-3249-2019; Carracedo, Julia/ABG-2464-2020; Carracedo, Julia/L-2012-2015; Merino, Ana/L-8347-2017	Carracedo, Julia/0000-0002-8422-812X; Carracedo, Julia/0000-0002-8422-812X; Rodriguez, Mariano/0000-0002-9380-6614; Rafael, Ramirez/0000-0003-4598-339X				Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Al-Aly Z, 2008, TRANSL RES, V151, P233, DOI 10.1016/j.trsl.2007.12.005; Amabile N, 2010, SEMIN THROMB HEMOST, V36, P907, DOI 10.1055/s-0030-1267044; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Au-Yeung KKW, 2004, CIRC RES, V94, P28, DOI 10.1161/01.RES.0000108264.67601.2C; Bellasi A, 2011, J NEPHROL, V24, pS11, DOI 10.5301/JN.2011.7744; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Csiszar A, 2006, AM J PATHOL, V168, P629, DOI 10.2353/ajpath.2006.050284; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; Curtis AM, 2013, VASC MED, V18, P204, DOI 10.1177/1358863X13499773; Dalfino G, 2010, ATHEROSCLEROSIS, V211, P418, DOI 10.1016/j.atherosclerosis.2010.04.023; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Kapustin AN, 2011, CIRC RES, V109, pE1, DOI 10.1161/CIRCRESAHA.110.238808; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Kramann R, 2011, ARTERIOSCL THROM VAS, V31, pE45, DOI 10.1161/ATVBAHA.111.228601; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Lafarge S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-64; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; de Oca AM, 2010, J BONE MINER RES, V25, P1996, DOI 10.1002/jbmr.93; Mueller RB, 2007, AUTOIMMUNITY, V40, P342, DOI 10.1080/08916930701356911; New SEP, 2013, ARTERIOSCL THROM VAS, V33, P1753, DOI 10.1161/ATVBAHA.112.300128; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; New SEP, 2011, CIRC J, V75, P1305, DOI 10.1253/circj.CJ-11-0395; Radcliff K, 2005, CIRC RES, V96, P398, DOI 10.1161/01.RES.0000157671.47477.71; Raida M, 2006, INT J MOL MED, V18, P735; Ramirez R, 2007, CONTRIB NEPHROL, V158, P210, DOI 10.1159/000107252; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Shantsila E, 2010, J THROMB HAEMOST, V8, P2358, DOI 10.1111/j.1538-7836.2010.04007.x; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Tesfamariam B, 2007, VASC PHARMACOL, V46, P229, DOI 10.1016/j.vph.2006.11.005; Wu ZH, 2013, EUR REV MED PHARMACO, V17, P2420	39	94	99	2	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					173	181		10.1096/fj.14-249706	http://dx.doi.org/10.1096/fj.14-249706			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25342130				2022-12-26	WOS:000347378600017
J	Song, HJ; Olsen, OH; Persson, E; Rand, KD				Song, Hongjian; Olsen, Ole H.; Persson, Egon; Rand, Kasper D.			Sites Involved in Intra- and Interdomain Allostery Associated with the Activation of Factor VIIa Pinpointed by Hydrogen-Deuterium Exchange and Electron Transfer Dissociation Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Blood; Coagulation Factor; Conformational Change; Hydrogen Exchange Mass Spectrometry; Serine Protease; Electron Transfer Dissociation	COAGULATION-FACTOR VIIA; SINGLE-RESIDUE RESOLUTION; CALCIUM-BINDING SITE; TISSUE FACTOR; BLOOD-COAGULATION; HYDROGEN/DEUTERIUM EXCHANGE; CAPTURE DISSOCIATION; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; PROTEASE DOMAIN	Factor VIIa (FVIIa) is a trypsin-like protease that plays an important role in initiating blood coagulation. Very limited structural information is available for the free, inactive form of FVIIa that circulates in the blood prior to vascular injury and the molecular details of its activity enhancement remain elusive. Here we have applied hydrogen/deuterium exchange mass spectrometry coupled to electron transfer dissociation to pinpoint individual residues in the heavy chain of FVIIa whose conformation and/or local interaction pattern changes when the enzyme transitions to the active form, as induced either by its cofactor tissue factor or a covalent active site inhibitor. Identified regulatory residues are situated at key sites across one continuous surface of the protease domain spanning the TF-binding helix across the activation pocket to the calcium binding site and are embedded in elements of secondary structure and at the base of flexible loops. Thus these residues are optimally positioned to mediate crosstalk between functional sites in FVIIa, particularly the cofactor binding site and the active site. Our results unambiguously show that the conformational allosteric activation signal extends to the EGF1 domain in the light chain of FVIIa, underscoring a remarkable intra- and interdomain allosteric regulation of this trypsin-like protease.	[Song, Hongjian; Rand, Kasper D.] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen O, Denmark; [Olsen, Ole H.; Persson, Egon] Novo Nordisk AS, Haemostasis Biol, DK-2760 Malov, Denmark	University of Copenhagen; Novo Nordisk	Rand, KD (corresponding author), Univ Copenhagen, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen O, Denmark.	kasper.rand@sund.ku.dk	Rand, Kasper/ABG-7446-2021	Rand, Kasper/0000-0002-6337-5489; Persson, Egon/0000-0003-3005-4926	Marie Curie Actions Programme of the E.U [PCIG09-GA-2011-294214]; Danish Council for Independent Research Natural Sciences [11-104058]	Marie Curie Actions Programme of the E.U; Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by the Marie Curie Actions Programme of the E.U Grant No. PCIG09-GA-2011-294214 (to K. D. R.) and the Danish Council for Independent Research Natural Sciences (Steno Grant No. 11-104058, to K. D. R.).	Abzalimov RR, 2009, J AM SOC MASS SPECTR, V20, P1514, DOI 10.1016/j.jasms.2009.04.006; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Bjelke JR, 2008, J BIOL CHEM, V283, P25863, DOI 10.1074/jbc.M800841200; BODE W, 1975, FEBS LETT, V56, P139, DOI 10.1016/0014-5793(75)80128-1; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Freskgard PO, 1996, PROTEIN SCI, V5, P1531, DOI 10.1002/pro.5560050809; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; Hoofnagle AN, 2001, P NATL ACAD SCI USA, V98, P956, DOI 10.1073/pnas.98.3.956; Jin JP, 2001, J MOL BIOL, V307, P1503, DOI 10.1006/jmbi.2001.4556; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Mosbaek CR, 2010, BIOCHEMISTRY-US, V49, P9739, DOI 10.1021/bi1011207; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; Olsen OH, 2008, CELL MOL LIFE SCI, V65, P953, DOI 10.1007/s00018-007-7480-5; Olsen OH, 2007, PROTEIN SCI, V16, P671, DOI 10.1110/ps.062504907; Pan J, 2008, J AM CHEM SOC, V130, P11574, DOI 10.1021/ja802871c; Persson E, 2001, BIOCHEMISTRY-US, V40, P3251, DOI 10.1021/bi001612z; Persson E, 2011, FRONT BIOSCI-LANDMRK, V16, P3156, DOI 10.2741/3903; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; Rand KD, 2008, J BIOL CHEM, V283, P13378, DOI 10.1074/jbc.M709716200; Rand KD, 2008, J AM CHEM SOC, V130, P1341, DOI 10.1021/ja076448i; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; Rand KD, 2014, ACCOUNTS CHEM RES, V47, P3018, DOI 10.1021/ar500194w; Rand KD, 2013, INT J MASS SPECTROM, V338, P2, DOI 10.1016/j.ijms.2012.08.010; Rand KD, 2012, ANAL CHEM, V84, P1931, DOI 10.1021/ac202918j; Rand KD, 2011, J AM SOC MASS SPECTR, V22, P1784, DOI 10.1007/s13361-011-0196-7; Rand KD, 2009, ANAL CHEM, V81, P5577, DOI 10.1021/ac9008447; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; SABHARWAL AK, 1995, J BIOL CHEM, V270, P15523, DOI 10.1074/jbc.270.26.15523; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; WILDGOOSE P, 1993, BIOCHEMISTRY-US, V32, P114, DOI 10.1021/bi00052a016; Zehl M, 2008, J AM CHEM SOC, V130, P17453, DOI 10.1021/ja805573h	36	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35388	35396		10.1074/jbc.M114.614297	http://dx.doi.org/10.1074/jbc.M114.614297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25344622	hybrid, Green Published			2022-12-26	WOS:000346660200029
J	Diepenhorst, NA; Petrie, EJ; Chen, CZ; Wang, A; Hossain, MA; Bathgate, RAD; Gooley, PR				Diepenhorst, Natalie A.; Petrie, Emma J.; Chen, Catherine Z.; Wang, Amy; Hossain, Mohammed Akhter; Bathgate, Ross A. D.; Gooley, Paul R.			Investigation of Interactions at the Extracellular Loops of the Relaxin Family Peptide Receptor 1 (RXFP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptor (GPCR); Nuclear Magnetic Resonance (NMR); Peptide Hormone; Protein Engineering; Receptor Structure-Function; RXFP1; Relaxin; Serelaxin	CLASS-A MODULE; PROTEIN-COUPLED RECEPTORS; SMALL-MOLECULE AGONISTS; BINDING-SITE; CHEMOKINE-RECEPTOR; CHEMICAL-SYNTHESIS; ACTIVATION; IDENTIFICATION; LGR7; HORMONE	Background: Extracellular loops of the transmembrane domain of the relaxin receptor RXFP1 are predicted to interact with relaxin. Results: RXFP1 extracellular loops displayed on a scaffold protein enabled investigation of ligand interactions. Conclusion: RXFP1 activation involves interactions between the extracellular loops with relaxin and the receptor LDLa module. Significance: Understanding the molecular mechanisms of RXFP1 activation will aid drug design at this receptor. Relaxin, an emerging pharmaceutical treatment for acute heart failure, activates the relaxin family peptide receptor (RXFP1), which is a class A G-protein-coupled receptor. In addition to the classic transmembrane (TM) domain, RXFP1 possesses a large extracellular domain consisting of 10 leucine-rich repeats and an N-terminal low density lipoprotein class A (LDLa) module. Relaxin-mediated activation of RXFP1 requires multiple coordinated interactions between the ligand and various receptor domains including a high affinity interaction involving the leucine-rich repeats and a predicted lower affinity interaction involving the extracellular loops (ELs). The LDLa is essential for signal activation; therefore the ELs/TM may additionally present an interaction site to facilitate this LDLa-mediated signaling. To overcome the many challenges of investigating relaxin and the LDLa module interactions with the ELs, we engineered the EL1 and EL2 loops onto a soluble protein scaffold, mapping specific ligand and loop interactions using nuclear magnetic resonance spectroscopy. Key EL residues were subsequently mutated in RXFP1, and changes in function and relaxin binding were assessed alongside the RXFP1 agonist ML290 to monitor the functional integrity of the TM domain of these mutant receptors. The outcomes of this work make an important contribution to understanding the mechanism of RXFP1 activation and will aid future development of small molecule RXFP1 agonists/antagonists.	[Diepenhorst, Natalie A.; Hossain, Mohammed Akhter; Bathgate, Ross A. D.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Diepenhorst, Natalie A.; Petrie, Emma J.; Bathgate, Ross A. D.; Gooley, Paul R.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Hossain, Mohammed Akhter] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Chen, Catherine Z.; Wang, Amy] NIH, Natl Ctr Adv Translat Sci, Div Preclin Innovat, Rockville, MD 20850 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Bathgate, RAD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.	bathgate@florey.edu.au; prg@unimelb.edu.au	Bathgate, Ross/ABE-6471-2020; Diepenhorst, Natalie/HHS-2496-2022	Bathgate, Ross/0000-0001-6301-861X; Hossain, Mohammed/0000-0002-9961-0006; Gooley, Paul/0000-0002-0323-449X	National Health and Medical Research Council of Australia [628427, 1043750]; Victorian Government Operational Infrastructure Support Program; State of Victoria; Australian Research Council; Rowden White Foundation; Melbourne Research Fellowship (Career Interruptions); National Health and Medical Research Council Research Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; State of Victoria; Australian Research Council(Australian Research Council); Rowden White Foundation; Melbourne Research Fellowship (Career Interruptions); National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Project Grants 628427 and 1043750 (to R. A. D. B. and P. R. G.) by the Victorian Government Operational Infrastructure Support Program, and through instrument funding from the State of Victoria, Australian Research Council, and the Rowden White Foundation.; Recipient of a Melbourne Research Fellowship (Career Interruptions).; Recipient of a National Health and Medical Research Council Research Fellowship. To whom correspondence may be addressed: Florey Inst. of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria 3010, Australia. Tel.: 61-3-9035-6735; E-mail: bathgate@florey.edu.au.	Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bruell Shoni, 2013, Front Endocrinol (Lausanne), V4, P171, DOI 10.3389/fendo.2013.00171; Bullesbach EE, 2000, J BIOL CHEM, V275, P35276, DOI 10.1074/jbc.M005728200; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Chen CZ, 2013, J BIOMOL SCREEN, V18, P670, DOI 10.1177/1087057112469406; Dagil R, 2013, J BIOL CHEM, V288, P4424, DOI 10.1074/jbc.M112.434159; Datta A, 2003, PROTEIN SCI, V12, P2482, DOI 10.1110/ps.03254303; Datta-Mannan A, 2004, BIOCHEMISTRY-US, V43, P14602, DOI 10.1021/bi048990e; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demene H, 2003, BIOCHEMISTRY-US, V42, P8204, DOI 10.1021/bi027358n; Diepenhorst Natalie A, 2013, Ital J Anat Embryol, V118, P1; Dogo-Isonagie C, 2012, J BIOL CHEM, V287, P15076, DOI 10.1074/jbc.M111.332361; Feng S, 2011, INT J ONCOL, V39, P1559, DOI 10.3892/ijo.2011.1159; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Halls ML, 2005, J PHARMACOL EXP THER, V313, P677, DOI 10.1124/jpet.104.080655; Hartley BJ, 2009, ANN NY ACAD SCI, V1160, P67, DOI 10.1111/j.1749-6632.2009.03949.x; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hopkins EJ, 2005, ANN NY ACAD SCI, V1041, P27, DOI 10.1196/annals.1282.006; Hopkins EJ, 2007, J BIOL CHEM, V282, P4172, DOI 10.1074/jbc.M609526200; Hossain MA, 2008, CHEMBIOCHEM, V9, P1816, DOI 10.1002/cbic.200800113; Hossain MA, 2006, INT J PEPT RES THER, V12, P211, DOI 10.1007/s10989-006-9020-9; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kong RCK, 2014, BIOCHEMISTRY-US, V53, P4537, DOI 10.1021/bi500797d; Kong RCK, 2013, J BIOL CHEM, V288, P28138, DOI 10.1074/jbc.M113.499640; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Ott TR, 2002, MOL ENDOCRINOL, V16, P1079, DOI 10.1210/me.16.5.1079; Pritz S, 2008, ANGEW CHEM INT EDIT, V47, P3642, DOI 10.1002/anie.200705718; Scott DJ, 2007, MOL ENDOCRINOL, V21, P1699, DOI 10.1210/me.2007-0097; Scott DJ, 2009, ANN NY ACAD SCI, V1160, P74, DOI 10.1111/j.1749-6632.2009.03950.x; Scott DJ, 2006, J BIOL CHEM, V281, P34942, DOI 10.1074/jbc.M602728200; Shabanpoor F, 2012, BIOCHEM BIOPH RES CO, V420, P253, DOI 10.1016/j.bbrc.2012.02.141; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Walser R, 2012, BIOL CHEM, V393, P1341, DOI 10.1515/hsz-2012-0234; Walser R, 2011, CHEMBIOCHEM, V12, P1690, DOI 10.1002/cbic.201100244; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wurch T, 1998, MOL PHARMACOL, V54, P1088, DOI 10.1124/mol.54.6.1088; Xiao JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2953; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	49	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34938	34952		10.1074/jbc.M114.600882	http://dx.doi.org/10.1074/jbc.M114.600882			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25352603	Green Published, hybrid			2022-12-26	WOS:000346260800043
J	Ke, HJ; Sigala, PA; Miura, K; Morrisey, JM; Mather, MW; Crowley, JR; Henderson, JP; Goldberg, DE; Long, CA; Vaidya, AB				Ke, Hangjun; Sigala, Paul A.; Miura, Kazutoyo; Morrisey, Joanne M.; Mather, Michael W.; Crowley, Jan R.; Henderson, Jeffrey P.; Goldberg, Daniel E.; Long, Carole A.; Vaidya, Akhil B.			The Heme Biosynthesis Pathway Is Essential for Plasmodium falciparum Development in Mosquito Stage but Not in Blood Stages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heme; Insect; Malaria; Mitochondria; Mitochondrial Metabolism	MASS-SPECTROMETRY; MALARIAL PARASITE; METABOLISM; MECHANISM; ACID; DRUG; IRON; IDENTIFICATION; FERROCHELATASE; DECARBOXYLASE	Background: Malaria parasites require heme for growth. Results: Genetic disruption of the P. falciparum heme biosynthesis pathway ablated growth in mosquitoes but had no effect on blood-stage growth. Conclusion: The heme biosynthesis pathway is only essential for exoerythrocytic parasite growth and transmission to mosquitoes. Significance: Pathway inhibition is unlikely to be an effective antimalarial drug strategy. Heme salvage mechanisms likely exist in blood stages. Heme is an essential cofactor for aerobic organisms. Its redox chemistry is central to a variety of biological functions mediated by hemoproteins. In blood stages, malaria parasites consume most of the hemoglobin inside the infected erythrocytes, forming nontoxic hemozoin crystals from large quantities of heme released during digestion. At the same time, the parasites possess a heme de novo biosynthetic pathway. This pathway in the human malaria parasite Plasmodium falciparum has been considered essential and is proposed as a potential drug target. However, we successfully disrupted the first and last genes of the pathway, individually and in combination. These knock-out parasite lines, lacking 5-aminolevulinic acid synthase and/or ferrochelatase (FC), grew normally in blood-stage culture and exhibited no changes in sensitivity to heme-related antimalarial drugs. We developed a sensitive LC-MS/MS assay to monitor stable isotope incorporation into heme from its precursor 5-[C-13(4)]aminolevulinic acid, and this assay confirmed that de novo heme synthesis was ablated in FC knock-out parasites. Disrupting the FC gene also caused no defects in gametocyte generation or maturation but resulted in a greater than 70% reduction in male gamete formation and completely prevented oocyst formation in female Anopheles stephensi mosquitoes. Our data demonstrate that the heme biosynthesis pathway is not essential for asexual blood-stage growth of P. falciparum parasites but is required for mosquito transmission. Drug inhibition of pathway activity is therefore unlikely to provide successful antimalarial therapy. These data also suggest the existence of a parasite mechanism for scavenging host heme to meet metabolic needs.	[Ke, Hangjun; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.] Drexel Univ, Dept Microbiol & Immunol, Ctr Mol Parasitol, Coll Med, Philadelphia, PA 19129 USA; [Sigala, Paul A.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Sigala, Paul A.; Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Miura, Kazutoyo; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Crowley, Jan R.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Henderson, Jeffrey P.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Drexel University; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL); Washington University (WUSTL)	Vaidya, AB (corresponding author), Drexel Univ, Dept Microbiol & Immunol, Ctr Mol Parasitol, Coll Med, 2900 Queen Lane, Philadelphia, PA 19129 USA.	avaidya@drexelmed.edu	Miura, Kazutoyo/AAY-9751-2020; Henderson, Jeffrey P/D-3337-2015	Miura, Kazutoyo/0000-0003-4455-2432; Sigala, Paul/0000-0002-3464-3042; Mather, Michael/0000-0002-1062-0137	National Institutes of Health [R01 AI028398, R01 DK099534]; Burroughs Wellcome Fund Career Award at the Scientific Interface; Burroughs Wellcome Fund Career Award for Medical Scientists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, R01AI028398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI028398 (to A. B. V.) and R01 DK099534 (to J. P. H.).; Recipient of a Burroughs Wellcome Fund Career Award at the Scientific Interface.; Recipient of a Burroughs Wellcome Fund Career Award for Medical Scientists.	ATAMNA H, 1995, J BIOL CHEM, V270, P24876, DOI 10.1074/jbc.270.42.24876; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Bonday ZQ, 2000, NAT MED, V6, P898, DOI 10.1038/78659; Boysen KE, 2011, J BIOL CHEM, V286, P32661, DOI 10.1074/jbc.M111.269399; Celli JP, 2010, CHEM REV, V110, P2795, DOI 10.1021/cr900300p; CHAN RYY, 1993, BIOCHEM J, V292, P343, DOI 10.1042/bj2920343; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dhanasekaran S, 2004, J BIOL CHEM, V279, P6934, DOI 10.1074/jbc.M311409200; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fitch C D, 1998, Trans Am Clin Climatol Assoc, V109, P97; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Ginsburg H, 1999, PARASITOL TODAY, V15, P357, DOI 10.1016/S0169-4758(99)01502-1; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Hino A, 2012, J BIOCHEM, V152, P259, DOI 10.1093/jb/mvs058; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Kresge N, 2006, J BIOL CHEM, V281; Lau AOT, 2009, MOL BIOCHEM PARASIT, V164, P1, DOI 10.1016/j.molbiopara.2008.11.013; LIU SC, 1988, BLOOD, V71, P1755; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Mather MW, 2010, MOL BIOCHEM PARASIT, V174, P150, DOI 10.1016/j.molbiopara.2010.07.006; Meunier B, 2010, ACCOUNTS CHEM RES, V43, P1444, DOI 10.1021/ar100070k; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057909; Nagaraj VA, 2008, J BIOL CHEM, V283, P437, DOI 10.1074/jbc.M706861200; Nagaraj VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003522; Nagaraj VA, 2010, MOL BIOCHEM PARASIT, V174, P44, DOI 10.1016/j.molbiopara.2010.06.012; Nagaraj VA, 2010, PARASITOL INT, V59, P121, DOI 10.1016/j.parint.2009.12.001; Nagaraj VA, 2009, MOL BIOCHEM PARASIT, V168, P109, DOI 10.1016/j.molbiopara.2009.05.008; Nagaraja VA, 2009, INT J PARASITOL, V39, P559, DOI 10.1016/j.ijpara.2008.10.011; Padmanaban G, 2000, BIOCHEM BIOPH RES CO, V268, P665, DOI 10.1006/bbrc.1999.1892; Padmanaban Govinarajan, 2001, Expert Opin Ther Targets, V5, P423, DOI 10.1517/14728222.5.4.423; Padmanaban G, 2007, TRENDS BIOCHEM SCI, V32, P443, DOI 10.1016/j.tibs.2007.09.005; Pashynska VA, 2004, J AM SOC MASS SPECTR, V15, P1181, DOI 10.1016/j.jasms.2004.04.030; Ponka P, 1997, BLOOD, V89, P1; PORRA RJ, 1983, EUR J BIOCHEM, V130, P509, DOI 10.1111/j.1432-1033.1983.tb07179.x; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramya TNC, 2007, ANTIMICROB AGENTS CH, V51, P307, DOI 10.1128/AAC.00808-06; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rivera M, 2004, ANAL BIOANAL CHEM, V378, P1464, DOI 10.1007/s00216-003-2340-0; Robert A, 2013, ANTIMICROB AGENTS CH, V57, P3998, DOI 10.1128/AAC.01064-13; RUTHERFORD T, 1979, P NATL ACAD SCI USA, V76, P833, DOI 10.1073/pnas.76.2.833; SHEMIN D, 1955, J BIOL CHEM, V215, P613; Sigala PA, 2014, ANNU REV MICROBIOL, V68, P259, DOI 10.1146/annurev-micro-091313-103537; Sigala PA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414078; SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; SUROLIA N, 1992, BIOCHEM BIOPH RES CO, V187, P744, DOI 10.1016/0006-291X(92)91258-R; van Dooren GG, 2012, ANTIOXID REDOX SIGN, V17, P634, DOI 10.1089/ars.2012.4539; Varadharajan S, 2002, BIOCHEM J, V367, P321, DOI 10.1042/BJ20020834; Wang Y, 2008, ANAL CHEM, V80, P2599, DOI 10.1021/ac702130n; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WRISTON JC, 1955, J BIOL CHEM, V215, P603; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785	61	83	84	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34827	34837		10.1074/jbc.M114.615831	http://dx.doi.org/10.1074/jbc.M114.615831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25352601	Green Published, hybrid			2022-12-26	WOS:000346260800034
J	Yang, XC; Sabath, I; Kunduru, L; van Wijnen, AJ; Marzluff, WF; Dominski, Z				Yang, Xiao-cui; Sabath, Ivan; Kunduru, Lalitha; van Wijnen, Andre J.; Marzluff, William F.; Dominski, Zbigniew			A Conserved Interaction That Is Essential for the Biogenesis of Histone Locus Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Histone; Nuclear Organization; Protein-Protein Interaction; RNA Processing; Histone Locus Bodies; 3' End Processing; NPAT; FLASH; YARP; mute	PRE-MESSENGER-RNA; LOOP BINDING-PROTEIN; XENOPUS GERMINAL VESICLE; TRANSCRIPTION FACTOR YY1; EMBRYONIC STEM-CELLS; SM CORE STRUCTURE; GENE-EXPRESSION; CAJAL BODIES; NUCLEAR-BODIES; U7 SNRNP	Background: Proteins involved in expression of histone genes co-localize to discrete nuclear structures called histone locus bodies (HLBs). Results: Two main components of HLBs directly interact with each other through their C-terminal regions. Conclusion: Formation of HLBs depends on a subset of critical protein-protein interactions. Significance: Our work may help to understand the mechanisms that integrate transcription of histone genes with maturation of the nascent histone transcripts. Nuclear protein, ataxia-telangiectasia locus (NPAT) and FLICE-associated huge protein (FLASH) are two major components of discrete nuclear structures called histone locus bodies (HLBs). NPAT is a key co-activator of histone gene transcription, whereas FLASH through its N-terminal region functions in 3 end processing of histone primary transcripts. The C-terminal region of FLASH contains a highly conserved domain that is also present at the end of Yin Yang 1-associated protein-related protein (YARP) and its Drosophila homologue, Mute, previously shown to localize to HLBs in Drosophila cells. Here, we show that the C-terminal domain of human FLASH and YARP interacts with the C-terminal region of NPAT and that this interaction is essential and sufficient to drive FLASH and YARP to HLBs in HeLa cells. Strikingly, only the last 16 amino acids of NPAT are sufficient for the interaction. We also show that the C-terminal domain of Mute interacts with a short region at the end of the Drosophila NPAT orthologue, multi sex combs (Mxc). Altogether, our data indicate that the conserved C-terminal domain shared by FLASH, YARP, and Mute recognizes the C-terminal sequence of NPAT orthologues, thus acting as a signal targeting proteins to HLBs. Finally, we demonstrate that the C-terminal domain of human FLASH can be directly joined with its N-terminal region through alternative splicing. The resulting 190-amino acid MiniFLASH, despite lacking 90% of full-length FLASH, contains all regions necessary for 3 end processing of histone pre-mRNA in vitro and accumulates in HLBs.	[Yang, Xiao-cui; Sabath, Ivan; Kunduru, Lalitha; Marzluff, William F.; Dominski, Zbigniew] Univ N Carolina, Dept Biochem & Biophys, Integrat Program Biol & Genome Sci, Chapel Hill, NC 27599 USA; [van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic	Dominski, Z (corresponding author), Univ N Carolina, Integrat Program Biol & Genome Sci, CB 3280, Chapel Hill, NC 27599 USA.	dominski@med.unc.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946	National Institutes of Health [GM29832]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29832.	Abbott J, 1999, MOL BIOL CELL, V10, P487, DOI 10.1091/mbc.10.2.487; Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14802, DOI 10.1073/pnas.0604225103; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Bolisetty MT, 2012, NUCLEIC ACIDS RES, V40, P9244, DOI 10.1093/nar/gks652; Bongiorno-Borbone L, 2008, CELL CYCLE, V7, P2357, DOI 10.4161/cc.6344; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Bulchand S, 2010, J CELL SCI, V123, P2697, DOI 10.1242/jcs.063172; Burch BD, 2011, RNA, V17, P1132, DOI 10.1261/rna.2566811; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Dominski Z, 2013, BBA-GENE REGUL MECH, V1829, P532, DOI 10.1016/j.bbagrm.2013.01.010; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; Erkmann JA, 2005, MOL BIOL CELL, V16, P2960, DOI 10.1091/mbc.E04-11-1023; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GALLINARI P, 1989, MOL CELL BIOL, V9, P1566, DOI 10.1128/MCB.9.4.1566; Ghule PN, 2008, P NATL ACAD SCI USA, V105, P16964, DOI 10.1073/pnas.0809273105; Ghule PN, 2009, J CELL PHYSIOL, V220, P129, DOI 10.1002/jcp.21740; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HEINTZ N, 1991, BIOCHIM BIOPHYS ACTA, V1088, P327, DOI 10.1016/0167-4781(91)90122-3; Horton JR, 2007, PROTEINS, V67, P1198, DOI 10.1002/prot.21352; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Kuryshev VY, 2006, GENOMICS, V88, P143, DOI 10.1016/j.ygeno.2006.02.002; Last TJ, 1999, J CELL BIOCHEM, V72, P507, DOI 10.1002/(SICI)1097-4644(19990315)72:4<507::AID-JCB6>3.0.CO;2-5; Liu JL, 2006, CHROMOSOME RES, V14, P465, DOI 10.1007/s10577-006-1062-5; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Liu YM, 2007, BLOOD, V110, P99, DOI 10.1182/blood-2006-11-059204; Lu P, 2011, J BIOL CHEM, V286, P18311, DOI 10.1074/jbc.M110.133603; Lu P, 2010, J EXP MED, V207, P1359, DOI 10.1084/jem.20100147; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Machyna M, 2013, WIRES RNA, V4, P17, DOI 10.1002/wrna.1139; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Miele A, 2005, MOL CELL BIOL, V25, P6140, DOI 10.1128/MCB.25.14.6140-6153.2005; Mitra P, 2003, MOL CELL BIOL, V23, P8110, DOI 10.1128/MCB.23.22.8110-8123.2003; Nizami ZF, 2010, COLD SH Q B, V75, P313, DOI 10.1101/sqb.2010.75.005; Nizami Z, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000653; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ohtomo T, 2007, AMINO ACIDS, V33, P645, DOI 10.1007/s00726-006-0482-z; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Pillai RS, 2001, EMBO J, V20, P5470, DOI 10.1093/emboj/20.19.5470; Rajendra TK, 2010, COLD SH Q B, V75, P365, DOI 10.1101/sqb.2010.75.043; Sabath I, 2013, RNA, V19, P1726, DOI 10.1261/rna.040360.113; Salzler HR, 2013, DEV CELL, V24, P623, DOI 10.1016/j.devcel.2013.02.014; Schumperli D, 2004, CELL MOL LIFE SCI, V61, P2560, DOI 10.1007/s00018-004-4190-0; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; STEIN GS, 1994, J CELL BIOCHEM, V54, P393, DOI 10.1002/jcb.240540406; Strzelecka M, 2010, NUCLEUS-PHILA, V1, P96, DOI 10.4161/nucl.1.1.10680; Tan DZ, 2013, SCIENCE, V339, P318, DOI 10.1126/science.1228705; Wagner EJ, 2007, MOL CELL, V28, P692, DOI 10.1016/j.molcel.2007.10.009; Walther TN, 1998, RNA, V4, P1034, DOI 10.1017/S1355838298971771; Wang CY, 2004, J BIOL CHEM, V279, P17750, DOI 10.1074/jbc.M310532200; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; White AE, 2011, J CELL BIOL, V193, P677, DOI 10.1083/jcb.201012077; WU CHH, 1993, P NATL ACAD SCI USA, V90, P6257, DOI 10.1073/pnas.90.13.6257; Yang XC, 2013, MOL CELL BIOL, V33, P28, DOI 10.1128/MCB.00653-12; Yang XC, 2011, MOL CELL BIOL, V31, P1492, DOI 10.1128/MCB.00979-10; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016; Yang XC, 2009, MOL CELL BIOL, V29, P31, DOI 10.1128/MCB.00776-08; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003	71	23	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33767	33782		10.1074/jbc.M114.616466	http://dx.doi.org/10.1074/jbc.M114.616466			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25339177	Green Published, hybrid			2022-12-26	WOS:000346077600005
J	Dvorak, K; Stritesky, J; Petrtyl, J; Vitek, L; Sroubkova, R; Lenicek, M; Smid, V; Haluzik, M; Bruha, R				Dvorak, Karel; Stritesky, Jan; Petrtyl, Jaromir; Vitek, Libor; Sroubkova, Renata; Lenicek, Martin; Smid, Vaclav; Haluzik, Martin; Bruha, Radan			Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study	PLOS ONE			English	Article							FATTY LIVER; HYALURONIC-ACID; SCORING SYSTEM; SERUM MARKERS; DISEASE; BIOPSY; CYTOKERATIN-18; METAANALYSIS; VALIDATION; APOPTOSIS	Background: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of a metabolic syndrome. To date, liver biopsy has been the gold standard used to differentiate between simple steatosis and steatohepatitis/fibrosis. Our aim was to compare the relevance of serum non-invasive parameters and scoring systems in the staging of liver fibrosis and nonalcoholic steatohepatitis (NASH) in patients with NAFLD. Methods and Findings: A total of 112 consecutive patients diagnosed with NAFLD were included. A liver biopsy was performed on 56 patients. The Kleiner score was used for the staging and grading of the histology. Non-invasive parameters for fibrosis (hyaluronic acid; AST/ALT; fibrosis scoring indexes OELF, ELF, BARD score, APRI, NAFLD fibrosis score); and inflammation (M30 and M65 cytokeratin-18 fragments) were measured and calculated. The same analyses were performed in 56 patients diagnosed with NAFLD, who were not indicated for liver biopsy. Based on the liver histology, NASH was diagnosed in 38 patients; simple steatosis in 18 patients. A cut-off value of 750 U/L of serum M65 discriminated patients with and without NASH with a 80% sensitivity and 82% specificity (95% CI: 57-95). Fibrosis stage F0-F2 was present in 39 patients; F3-F4 in 17 patients. Serum concentrations of hyaluronic acid were higher in patients with advanced fibrosis (p<0.01); a cut-off value of 25 mg/l discriminated patients with F3-F4 with a 90% sensitivity and 84% specificity from those with F0-F2 (95% CI: 59-99). When applying the non-invasive criteria to those patients without a liver biopsy, NASH could only be diagnosed in 16%; however, advanced fibrosis could be diagnosed in 35% of them. Conclusions: In patients with NAFLD, non-invasive serum parameters with a high accuracy can differentiate those patients with NASH and/or advanced fibrosis from those with simple steatosis. A substantial portion of those patients not indicated for liver biopsy might have undiagnosed advanced fibrosis.	[Dvorak, Karel; Petrtyl, Jaromir; Vitek, Libor; Sroubkova, Renata; Smid, Vaclav; Bruha, Radan] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic; [Stritesky, Jan] Charles Univ Prague, Fac Med 1, Dept Pathol, Prague, Czech Republic; [Vitek, Libor; Lenicek, Martin] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Vitek, Libor; Lenicek, Martin] Charles Univ Prague, Fac Med 1, Diagnost Lab, Prague, Czech Republic; [Haluzik, Martin] Charles Univ Prague, Fac Med 1, Dept Internal Med 3, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague	Bruha, R (corresponding author), Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic.	bruha@cesnet.cz	Sroubkova, Renata/P-4561-2016; Stritesky, Jan/N-3787-2017; Petrtýl, Jaromír/AFY-0958-2022; Smid, Vaclav/B-7724-2017; Haluzik, Martin/I-8190-2017; Bruha, Radan/A-4432-2008; Dvorak, Karel/AAD-8111-2020; Vitek, Libor/A-2645-2008; Lenicek, Martin/A-5495-2009	Sroubkova, Renata/0000-0003-3758-361X; Stritesky, Jan/0000-0002-8200-7155; Petrtýl, Jaromír/0000-0002-1271-5367; Smid, Vaclav/0000-0002-8664-7918; Haluzik, Martin/0000-0002-0201-6888; Bruha, Radan/0000-0001-9924-4301; Vitek, Libor/0000-0002-5318-0151; Lenicek, Martin/0000-0001-6242-3488	Internal Grant Agency, Czech Ministry of Health (IGA MZCR) [NT 11247-4, NT 12290-4]; Charles University in Prague [SVV 260032-2014]	Internal Grant Agency, Czech Ministry of Health (IGA MZCR); Charles University in Prague	This work was supported by: 1) NT 11247-4 and NT 12290-4 given by Internal Grant Agency, Czech Ministry of Health (IGA MZCR)(http://iga.mzcr.cz/publicWeb/) to RB and KD; and 2) SVV 260032-2014 given by Charles University in Prague (http://www.cuni.cz/UKEN-1.html) to LV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen J, 2013, HEPATOL RES; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734; Kalambokis G, 2007, J HEPATOL, V47, P284, DOI 10.1016/j.jhep.2007.05.001; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kwok R, 2014, ALIMENT PHARM THER, V39, P254, DOI 10.1111/apt.12569; Lebensztejn DM, 2011, ACTA BIOCHIM POL, V58, P563; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Merriman RB, 2006, HEPATOLOGY, V44, P874, DOI 10.1002/hep.21346; Nobili V, 2009, GASTROENTEROLOGY, V136, P160, DOI 10.1053/j.gastro.2008.09.013; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Shimada M, 2002, HEPATOL RES, V24, P429, DOI 10.1016/S1386-6346(02)00246-2; Sowa JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062439; Sumida Y, 2014, WORLD J GASTROENTERO, V20, P475, DOI 10.3748/wjg.v20.i2.475; Suzuki A, 2005, LIVER INT, V25, P779, DOI 10.1111/j.1478-3231.2005.01064.x; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yilmaz Y, 2007, WORLD J GASTROENTERO, V13, P837, DOI 10.3748/wjg.v13.i6.837	33	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111551	10.1371/journal.pone.0111551	http://dx.doi.org/10.1371/journal.pone.0111551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350286	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100077
J	Gjoni, E; Brioschi, L; Cinque, A; Coant, N; Islam, MN; Ng, CKY; Verderio, C; Magnan, C; Riboni, L; Viani, P; Le Stunff, H; Giussani, P				Gjoni, Enida; Brioschi, Loredana; Cinque, Alessandra; Coant, Nicolas; Islam, M. Nurul; Ng, Carl K. -Y.; Verderio, Claudia; Magnan, Christophe; Riboni, Laura; Viani, Paola; Le Stunff, Herve; Giussani, Paola			Glucolipotoxicity Impairs Ceramide Flow from the Endoplasmic Reticulum to the Golgi Apparatus in INS-1 beta-Cells	PLOS ONE			English	Article							INSULIN GENE-EXPRESSION; FATTY-ACID; INDUCED APOPTOSIS; STRESS; TRAFFICKING; INHIBITION; PALMITATE; CERT; GLUCOSE; PROTEIN	Accumulating evidence suggests that glucolipotoxicity, arising from the combined actions of elevated glucose and free fatty acid levels, acts as a key pathogenic component in type II diabetes, contributing to beta-cell dysfunction and death. Endoplasmic reticulum (ER) stress is among the molecular pathways and regulators involved in these negative effects, and ceramide accumulation due to glucolipotoxicity can be associated with the induction of ER stress. Increased levels of ceramide in ER may be due to enhanced ceramide biosynthesis and/or decreased ceramide utilization. Here, we studied the effect of glucolipotoxic conditions on ceramide traffic in INS-1 cells in order to gain insights into the molecular mechanism(s) of glucolipotoxicity. We showed that glucolipotoxicity inhibited ceramide utilization for complex sphingolipid biosynthesis, thereby reducing the flow of ceramide from the ER to Golgi. Glucolipotoxicity impaired both vesicular-and CERT-mediated ceramide transport through (1) the decreasing of phospho-Akt levels which in turn possibly inhibits vesicular traffic, and (2) the reducing of the amount of active CERT mainly due to a lower protein levels and increased protein phosphorylation to prevent its localization to the Golgi. In conclusion, our findings provide evidence that glucolipotoxicity-induced ceramide overload in the ER, arising from a defect in ceramide trafficking may be a mechanism that contributes to dysfunction and/or death of beta-cells exposed to glucolipotoxicity.	[Gjoni, Enida; Brioschi, Loredana; Cinque, Alessandra; Riboni, Laura; Viani, Paola; Giussani, Paola] Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy; [Coant, Nicolas; Magnan, Christophe; Le Stunff, Herve] Univ PARIS DIDEROT, Unite Biol Fonctionnelle & Adaptat, UMR CNRS 8251, Paris, France; [Islam, M. Nurul; Ng, Carl K. -Y.] Univ Coll Dublin, Sch Biol & Environm Sci, Belfield, Ireland; [Islam, M. Nurul; Ng, Carl K. -Y.] Univ Coll Dublin, Earth Inst, Belfield, Ireland; [Verderio, Claudia] Univ Milan, CNR, Inst Neurosci, Dept Med Biotechnol & Translat Med, Milan, Italy	University of Milan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University College Dublin; University College Dublin; Consiglio Nazionale delle Ricerche (CNR); University of Milan	Giussani, P (corresponding author), Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy.	paola.giussani@unimi.it	Riboni, Laura/R-4281-2017; Verderio, Claudia/K-4415-2016; magnan, christophe/AAJ-7622-2021; Giussani, Paola/R-4268-2017; VIANI, PAOLA/Q-5955-2017; LE STUNFF, Hervé/AAA-6882-2019; Cinque, Alessandra/AAN-3846-2020	Riboni, Laura/0000-0002-4149-8226; Verderio, Claudia/0000-0001-7216-5873; magnan, christophe/0000-0002-7044-2571; Giussani, Paola/0000-0002-7793-1757; VIANI, PAOLA/0000-0002-5728-6631; Gjoni, Enida/0000-0003-4028-9294; Cinque, Alessandra/0000-0002-5739-742X; Ng, Carl/0000-0001-5832-3265; COANT, Nicolas/0000-0001-9237-2132	University of Milan PUR; Italian Ministry of University and Scientific and Technological Research PRIN; Science Foundation Ireland [SFI/06/RFP/GEN034, SFI/08/RFP/EOB1087]; Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche [ANR-06-JCJC-0040]; Universite Paris Diderot; French Society of Nutrition (SFN)	University of Milan PUR; Italian Ministry of University and Scientific and Technological Research PRIN(Ministry of Education, Universities and Research (MIUR)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite Paris Diderot; French Society of Nutrition (SFN)	This work was supported by grants from the University of Milan PUR to PG, grants from the Italian Ministry of University and Scientific and Technological Research PRIN to PV, and grants from Science Foundation Ireland (SFI/06/RFP/GEN034 and SFI/08/RFP/EOB1087) to CK-YN. This project was partly supported by grants from Centre National de la Recherche Scientifique (CNRS) and Agence Nationale de la Recherche (ANR-06-JCJC-0040) to HLS. NC received a postdoctoral fellowship from the Universite Paris Diderot and the French Society of Nutrition (SFN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Chandran S, 2012, BIOCHEM J, V442, P391, DOI 10.1042/BJ20111461; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Elghazi L, 2009, TRENDS ENDOCRIN MET, V20, P243, DOI 10.1016/j.tem.2009.03.002; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Giussani P, 2008, BBA-MOL CELL BIOL L, V1781, P40, DOI 10.1016/j.bbalip.2007.11.002; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Giussani P, 2009, J BIOL CHEM, V284, P5088, DOI 10.1074/jbc.M808934200; Granero F, 2005, FEBS J, V272, P5291, DOI 10.1111/j.1742-4658.2005.04925.x; Guo J, 2010, CELL PHYSIOL BIOCHEM, V26, P717, DOI 10.1159/000322339; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Lang F, 2011, EXPERT OPIN THER TAR, V15, P1061, DOI 10.1517/14728222.2011.588209; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lei X, 2010, DIABETES OBES METAB, V12, P93, DOI 10.1111/j.1463-1326.2010.01270.x; Lei X, 2012, AM J PHYSIOL-ENDOC M, pE1386; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Pinget M, 2002, DIABETES METAB, V28, pS21; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Riboni L, 2000, J NEUROCHEM, V75, P503, DOI 10.1046/j.1471-4159.2000.0750503.x; Riboni L, 2010, ADV EXP MED BIOL, V688, P24; RICHIERI GV, 1995, J LIPID RES, V36, P229; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Veret J, 2014, J CLIN MED, V3, P646, DOI 10.3390/jcm3020646; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Veret J, 2011, BIOCHEM J, V438, P177, DOI 10.1042/BJ20101386; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83	45	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110875	10.1371/journal.pone.0110875	http://dx.doi.org/10.1371/journal.pone.0110875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350564	gold, Green Published			2022-12-26	WOS:000343943100044
J	Ichijo, T; Izumi, Y; Nakamoto, S; Yamaguchi, N; Nasu, M				Ichijo, Tomoaki; Izumi, Yoko; Nakamoto, Sayuri; Yamaguchi, Nobuyasu; Nasu, Masao			Distribution and Respiratory Activity of Mycobacteria in Household Water System of Healthy Volunteers in Japan	PLOS ONE			English	Article							FREE-LIVING AMEBAS; NONTUBERCULOUS MYCOBACTERIA; DRINKING-WATER; OPPORTUNISTIC PATHOGENS; ACANTHAMOEBA-POLYPHAGA; PULMONARY-DISEASE; RIBOSOMAL-RNA; ASIAN DUST; AVIUM; INTRACELLULARE	The primary infectious source of nontuberculous mycobacteria (NTM), which are known as opportunistic pathogens, appears to be environmental exposure, and it is important to reduce the frequency of exposure from environmental sources for preventing NTM infections. In order to achieve this, the distribution and respiratory activity of NTM in the environments must be clarified. In this study, we determined the abundance of mycobacteria and respiratory active mycobacteria in the household water system of healthy volunteers using quantitative PCR and a fluorescent staining method, because household water has been considered as one of the possible infectious sources. We chose healthy volunteer households in order to lessen the effect of possible residential contamination from an infected patient. We evaluated whether each sampling site (bathroom drain, kitchen drain, bath heater pipe and showerhead) have the potential to be the sources of NTM infections. Our results indicated that drains in the bathroom and kitchen sink are the niche for Mycobacterium spp. and M. avium cells were only detected in the bathtub inlet. Both physicochemical and biologic selective pressures may affect the preferred habitat of Mycobacterium spp. Regional differences also appear to exist as demonstrated by the presence (US) or absence (Japan) of Mycobacterium spp. on showerheads. Understanding of the country specific human activities and water usage will help to elucidate the infectious source and route of nontuberculous mycobacterial disease.	[Ichijo, Tomoaki; Izumi, Yoko; Nakamoto, Sayuri; Yamaguchi, Nobuyasu; Nasu, Masao] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Ichijo, Tomoaki] Res Inst Humanity & Nat, Kyoto, Japan	Osaka University; Research Institute for Humanity & Nature (RIHN)	Yamaguchi, N (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan.	yamaguti@phs.osaka-u.ac.jp		Yamaguchi, Nobuyasu/0000-0003-1201-076X; Ichijo, Tomoaki/0000-0001-6922-2793	JSPS KAKENHI [20249007]; Ohyama Health Foundation; RIHN [C-06]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ohyama Health Foundation; RIHN	This research project was funded by the JSPS KAKENHI (grant number 20249007), Ohyama Health Foundation and the RIHN C-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Aoki M, 2008, FUKUJUJI, V320; Dailloux M, 1999, WATER RES, V33, P2219, DOI 10.1016/S0043-1354(98)00466-7; Delafont V, 2013, WATER RES, V47, P6958, DOI 10.1016/j.watres.2013.07.047; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Falkinham JO, 2003, APPL ENVIRON MICROB, V69, P5685, DOI 10.1128/AEM.69.9.5685-5689.2003; Falkinham JO, 2001, APPL ENVIRON MICROB, V67, P1225, DOI 10.1128/AEM.67.3.1225-1231.2001; Falkinham JO, 2008, J WATER HEALTH, V6, P209, DOI [10.2166/wh.2008.232, 10.2166/wh.2008.032]; Falkinham JO, 2010, FUTURE MICROBIOL, V5, P951, DOI 10.2217/FMB.10.53; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Glassroth J, 2008, CHEST, V133, P243, DOI 10.1378/chest.07-0358; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Ichijo T, 2010, J MICROBIOL METH, V82, P327, DOI 10.1016/j.mimet.2010.06.010; Jacobs J, 2009, APPL ENVIRON MICROB, V75, P7378, DOI 10.1128/AEM.01900-09; Lachnik J, 2002, J CLIN MICROBIOL, V40, P3364, DOI 10.1128/JCM.40.9.3364-3373.2002; Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P5318, DOI 10.1128/AEM.68.11.5318-5325.2002; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Mullis SN, 2013, J APPL MICROBIOL, V115, P908, DOI 10.1111/jam.12272; Mura M, 2006, APPL ENVIRON MICROB, V72, P854, DOI 10.1128/AEM.72.1.854-859.2006; Nishimura Y, 2010, MICROBES ENVIRON, V25, P22, DOI 10.1264/jsme2.ME09166; Nishiuchi Y, 2007, CLIN INFECT DIS, V45, P347, DOI 10.1086/519383; Nishiuchi Y, 2009, JPN J INFECT DIS, V62, P182; Ovrutsky AR, 2013, APPL ENVIRON MICROB, V79, P3185, DOI 10.1128/AEM.03823-12; Radomski N, 2010, APPL ENVIRON MICROB, V76, P7348, DOI 10.1128/AEM.00942-10; Radomski N, 2010, APPL ENVIRON MICROB, V76, P3514, DOI 10.1128/AEM.02659-09; Richardson ET, 2009, J CLIN MICROBIOL, V47, P1497, DOI 10.1128/JCM.01868-08; SCHULZEROBBECKE R, 1992, APPL ENVIRON MICROB, V58, P1869; Schuster FL, 2004, INT J PARASITOL, V34, P1001, DOI 10.1016/j.ijpara.2004.06.004; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Torvinen E, 2004, APPL ENVIRON MICROB, V70, P1973, DOI 10.1128/AEM.70.4.1973-1981.2004; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070, DOI 10.1128/AEM.57.4.1070-1074.1991; van der Wielen PWJJ, 2013, APPL ENVIRON MICROB, V79, P825, DOI 10.1128/AEM.02748-12; Wang H, 2012, APPL ENVIRON MICROB, V78, P6285, DOI 10.1128/AEM.01492-12; Yamaguchi N, 1997, J APPL MICROBIOL, V83, P43, DOI 10.1046/j.1365-2672.1997.00165.x; Yamaguchi N, 2004, BIOIMAGES, V12, P1, DOI [10.11169/bioimages.12.1, DOI 10.11169/BIOIMAGES.12.1]; Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525; Yamaguchi N, 2011, ECOL RES, V26, P893, DOI 10.1007/s11284-010-0707-1	38	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110554	10.1371/journal.pone.0110554	http://dx.doi.org/10.1371/journal.pone.0110554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350137	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100031
J	Li, JW; Xie, XX; Liu, J; Yu, H; Zhang, SH; Zhan, Y; Zhang, HL; Logothetis, DE; An, HL				Li, Junwei; Xie, Xiaoxiao; Liu, Jun; Yu, Hui; Zhang, Suhua; Zhan, Yong; Zhang, Hailin; Logothetis, Diomedes E.; An, Hailong			Lack of Negatively Charged Residues at the External Mouth of Kir2.2 Channels Enable the Voltage-Dependent Block by External Mg2+	PLOS ONE			English	Article							RECTIFIER K+ CHANNELS; PARTICLE MESH EWALD; POTASSIUM CHANNEL; EXTRACELLULAR CATIONS; SWISS-MODEL; INWARD RECTIFICATION; MOLECULAR-DYNAMICS; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; ION SELECTIVITY	Kir channels display voltage-dependent block by cytosolic cations such as Mg2+ and polyamines that causes inward rectification. In fact, cations can regulate K channel activity from both the extracellular and intracellular sides. Previous studies have provided insight into the up-regulation of Kir channel activity by extracellular K+ concentration. In contrast, extracellular Mg2+ has been found to reduce the amplitude of the single-channel current at milimolar concentrations. However, little is known about the molecular mechanism of Kir channel blockade by external Mg2+ and the relationship between the Mg2+ blockade and activity potentiation by permeant K+ ions. In this study, we applied an interactive approach between theory and experiment. Electrophysiological recordings on Kir2.2 and its mutants were performed by heterologous expression in Xenopus laevis oocytes. Our results confirmed that extracellular Mg2+ could reduce heterologously expressed WT Kir2.2 currents in a voltage dependent manner. The kinetics of inhibition and recovery of Mg2+ exhibit a 3 similar to 4s time constant. Molecular dynamics simulation results revealed a Mg2+ binding site located at the extracellular mouth of Kir2.2 that showed voltage-dependent Mg2+ binding. The mutants, G119D, Q126E and H128D, increased the number of permeant K+ ions and reduced the voltage-dependent blockade of Kir2.2 by extracellular Mg2+.	[Li, Junwei; Xie, Xiaoxiao; Liu, Jun; Yu, Hui; Zhang, Suhua; Zhan, Yong; An, Hailong] Hebei Univ Technol, Inst Biophys, Tianjin, Peoples R China; [Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Key Lab Pharmacol & Toxicol New Drug, Key Lab Neural & Vasc Biol,Minist Educ, Shijiazhuang, Hebei Province, Peoples R China; [Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA USA	Hebei University of Technology; Hebei Medical University; Virginia Commonwealth University	Zhan, Y (corresponding author), Hebei Univ Technol, Inst Biophys, Tianjin, Peoples R China.	zhany@hebut.edu.cn; hailong_an@hebut.edu.cn	Li, Junwei/B-6936-2019	Li, Junwei/0000-0002-1724-4752	Natural Science Foundation of the Hebei Province of China [C2012202079]; National Natural Science Foundation of China [11247010, 11175055, 11342002]; NIH R01 grant [HL059949]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	Natural Science Foundation of the Hebei Province of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Natural Science Foundation of the Hebei Province of China (Grant No. C2012202079 to HA), the National Natural Science Foundation of China (Grant No. 11247010 to HA, 11175055 to YZ, 11342002 to SZ) and NIH R01 grant HL059949 to DEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APELL HJ, 1977, J MEMBRANE BIOL, V31, P171, DOI 10.1007/BF01869403; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; BIERMANS G, 1987, PFLUG ARCH EUR J PHY, V410, P604, DOI 10.1007/BF00581320; Claydon TW, 2004, BIOPHYS J, V87, P2407, DOI 10.1529/biophysj.103.039073; D'Avanzo N, 2005, J GEN PHYSIOL, V125, P493, DOI 10.1085/jgp.200409175; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doi T, 1996, J BIOL CHEM, V271, P17261, DOI 10.1074/jbc.271.29.17261; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ELAM TR, 1995, J GEN PHYSIOL, V105, P463, DOI 10.1085/jgp.105.4.463; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Kubo Y, 1996, RECEPTOR CHANNEL, V4, P73; Leung YM, 2000, CAN J PHYSIOL PHARM, V78, P751, DOI 10.1139/cjpp-78-9-751; Liu TA, 2011, BBA-BIOMEMBRANES, V1808, P1772, DOI 10.1016/j.bbamem.2011.02.016; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MATSUDA H, 1991, ANNU REV PHYSIOL, V53, P289, DOI 10.1146/annurev.ph.53.030191.001445; Murata Y, 2002, J PHYSIOL-LONDON, V544, P665, DOI 10.1113/jphysiol.2002.030650; Nichols CG, 1996, CIRC RES, V78, P1, DOI 10.1161/01.RES.78.1.1; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Owen JM, 1999, EXP PHYSIOL, V84, P471, DOI 10.1017/S0958067099018060; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PENNEFATHER P, 1992, BIOPHYS J, V61, P448, DOI 10.1016/S0006-3495(92)81850-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sackin H, 2001, BIOPHYS J, V80, P683, DOI 10.1016/S0006-3495(01)76048-1; Sackin H, 2012, BIOPHYS J, V102, P2742, DOI 10.1016/j.bpj.2012.05.018; Sackin H, 2011, BIOPHYS J, V100, P1207, DOI 10.1016/j.bpj.2011.01.032; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; WORLEY JF, 1986, J GEN PHYSIOL, V87, P327, DOI 10.1085/jgp.87.2.327; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Yang L, 2012, J GEN PHYSIOL, V139, P145, DOI 10.1085/jgp.201110727; Yang L, 2010, J AM SOC NEPHROL, V21, P2109, DOI 10.1681/ASN.2010060617; Zhang YY, 2006, BIOPHYS J, V91, P2901, DOI 10.1529/biophysj.106.087700; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	48	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111372	10.1371/journal.pone.0111372	http://dx.doi.org/10.1371/journal.pone.0111372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350118	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100067
J	Penicaud, C; Landaud, S; Jamme, F; Talbot, P; Bouix, M; Ghorbal, S; Fonseca, F				Penicaud, Caroline; Landaud, Sophie; Jamme, Frederic; Talbot, Pauline; Bouix, Marielle; Ghorbal, Sarrah; Fonseca, Fernanda			Physiological and Biochemical Responses of Yarrowia lipolytica to Dehydration Induced by Air-Drying and Freezing	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; INFRARED-SPECTROSCOPY; FTIR MICROSPECTROSCOPY; PLASMA-MEMBRANE; FLOW-CYTOMETRY; CELLS; STRESS; IDENTIFICATION; SURVIVAL; BACTERIA	Organisms that can withstand anhydrobiosis possess the unique ability to temporarily and reversibly suspend their metabolism for the periods when they live in a dehydrated state. However, the mechanisms underlying the cell's ability to tolerate dehydration are far from being fully understood. The objective of this study was to highlight, for the first time, the cellular damage to Yarrowia lipolytica as a result of dehydration induced by drying/rehydration and freezing/thawing. Cellular response was evaluated through cell cultivability determined by plate counts, esterase activity and membrane integrity assessed by flow cytometry, and the biochemical composition of cells as determined by FT-IR spectroscopy. The effects of the harvesting time (in the log or stationary phase) and of the addition of a protective molecule, trehalose, were investigated. All freshly harvested cells exhibited esterase activity and no alteration of membrane integrity. Cells freshly harvested in the stationary phase presented spectral contributions suggesting lower nucleic acid content and thicker cell walls, as well as longer lipid chains than cells harvested in the log phase. Moreover, it was found that drying/rehydration induced cell plasma membrane permeabilization, loss of esterase activity with concomitant protein denaturation, wall damage and oxidation of nucleic acids. Plasma membrane permeabilization and loss of esterase activity could be reduced by harvesting in the stationary phase and/or with trehalose addition. Protein denaturation and wall damage could be reduced by harvesting in the stationary phase. In addition, it was shown that measurements of loss of membrane integrity and preservation of esterase activity were suitable indicators of loss and preservation of cultivability, respectively. Conversely, no clear effect of freezing/thawing could be observed, probably because of the favorable operating conditions applied. These results give insights into Y. lipolytica mechanisms of cellular response to dehydration and provide a basis to better understand its ability to tolerate anhydrobiosis.	[Penicaud, Caroline; Landaud, Sophie; Talbot, Pauline; Bouix, Marielle; Ghorbal, Sarrah; Fonseca, Fernanda] INRA, UMR782 Genie & Microbiol Proc Alimentaires, F-78850 Thiverval Grignon, France; [Penicaud, Caroline; Landaud, Sophie; Talbot, Pauline; Bouix, Marielle; Ghorbal, Sarrah; Fonseca, Fernanda] AgroParisTech, UMR782 Genie & Microbiol Proc Alimentaires, F-78850 Thiverval Grignon, France; [Jamme, Frederic] Synchrotron SOLEIL, Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Penicaud, C (corresponding author), INRA, UMR782 Genie & Microbiol Proc Alimentaires, F-78850 Thiverval Grignon, France.	caroline.penicaud@grignon.inra.fr	Fonseca, Fernanda/AAR-9094-2020; FONSECA, FERNANDA/HDN-9451-2022; JAMME, Frederic/E-2170-2011	Fonseca, Fernanda/0000-0003-3394-182X; FONSECA, FERNANDA/0000-0002-0315-6479; JAMME, Frederic/0000-0002-7398-7868; Penicaud, Caroline/0000-0002-1161-0272	National Institute of Agronomic Research (Paris, France)	National Institute of Agronomic Research (Paris, France)	This study was supported by the National Institute of Agronomic Research (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adt I, 2010, CAN J MICROBIOL, V56, P793, DOI [10.1139/W10-062, 10.1139/w10-062]; Ando A, 2007, FEMS YEAST RES, V7, P244, DOI 10.1111/j.1567-1364.2006.00162.x; Andrus PGL, 1998, BIOSPECTROSCOPY, V4, P37, DOI 10.1002/(SICI)1520-6343(1998)4:1<37::AID-BSPY4>3.0.CO;2-P; Attfield PV, 2001, MOL MICROBIOL, V40, P1000, DOI 10.1046/j.1365-2958.2001.02444.x; Attfield PV, 2000, J APPL MICROBIOL, V89, P207, DOI 10.1046/j.1365-2672.2000.01100.x; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Beker MJ, 1987, ADV BIOCH ENG BIOTEC, V35, P127, DOI DOI 10.1007/BFB0004428; Beney L, 2001, APPL MICROBIOL BIOT, V57, P34; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Boydston-White S, 1999, BIOSPECTROSCOPY, V5, P219, DOI 10.1002/(SICI)1520-6343(1999)5:4<219::AID-BSPY2>3.0.CO;2-O; Burattini E, 2008, VIB SPECTROSC, V47, P139, DOI 10.1016/j.vibspec.2008.04.007; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Chalmers J.M., 2002, HDB VIBRATIONAL SPEC, V2; Chiriboga L, 2000, APPL SPECTROSC, V54, P1, DOI 10.1366/0003702001948204; Correa-Garcia S, 2014, ANAL METHODS-UK, V6, P1855, DOI 10.1039/c3ay42322k; Corte L, 2011, ANALYST, V136, P2339, DOI 10.1039/c0an00515k; Corte L, 2010, ANAL CHIM ACTA, V659, P258, DOI 10.1016/j.aca.2009.11.035; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Diaz M, 2010, BIOCHEM ENG J, V48, P385, DOI 10.1016/j.bej.2009.07.013; Dupont S, 2010, BBA-BIOMEMBRANES, V1798, P975, DOI 10.1016/j.bbamem.2010.01.015; Ede SM, 2004, APPL SPECTROSC, V58, P317, DOI 10.1366/000370204322886672; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Espindola AD, 2003, CRYOBIOLOGY, V47, P236, DOI 10.1016/j.cryobiol.2003.10.003; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Fickers P, 2011, BIOTECHNOL ADV, V29, P632, DOI 10.1016/j.biotechadv.2011.04.005; Finogenova TV, 2005, APPL BIOCHEM MICRO+, V41, P418, DOI 10.1007/s10438-005-0076-7; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Fu N, 2011, FOOD RES INT, V44, P1127, DOI 10.1016/j.foodres.2011.03.053; Gabier AC, 2005, INT J FOOD MICROBIOL, V105, P97, DOI 10.1016/j.ijfoodmicro.2005.02.005; Galichet A, 2001, FEMS MICROBIOL LETT, V197, P179, DOI 10.1016/S0378-1097(01)00101-X; Gan L, 2014, BBA-MOL BASIS DIS, V1842, P1208, DOI 10.1016/j.bbadis.2013.12.011; Garre E, 2010, INT J FOOD MICROBIOL, V136, P295, DOI 10.1016/j.ijfoodmicro.2009.10.018; Guyot S, 2006, J AGR FOOD CHEM, V54, P8450, DOI 10.1021/jf0620158; Harrick N.J., 1967, INTERNAL REFLECTION; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Hohmann S, 2010, YEAST STRESS RESPONS; Huleihel M, 2002, J BIOCHEM BIOPH METH, V50, P111, DOI 10.1016/S0165-022X(01)00177-4; Jamme F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074421; Kardeh S, 2014, EUR J PHARMACOL, V735, P150, DOI 10.1016/j.ejphar.2014.04.023; Krafft C, 2004, ANALYST, V129, P921, DOI 10.1039/b408934k; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P927, DOI 10.1016/B978-0-444-52149-1.00082-3; Lemetais G, 2012, APPL MICROBIOL BIOT, V96, P471, DOI 10.1007/s00253-012-4014-3; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lopez-Martinez G, 2013, YEAST, V30, P319, DOI 10.1002/yea.2952; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; MALINS DC, 1995, CANCER, V75, P503, DOI 10.1002/1097-0142(19950115)75:2<503::AID-CNCR2820750213>3.0.CO;2-0; MAZUR P, 1968, CRYOBIOLOGY, V5, P1, DOI 10.1016/S0011-2240(68)80138-5; Mordechai S, 2001, PROC SPIE, V4491, P243, DOI 10.1117/12.450167; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; NAUMANN D, 1988, J MOL STRUCT, V174, P165, DOI 10.1016/0022-2860(88)80152-2; Naumova ES, 2010, MICROBIOLOGY+, V79, P229, DOI 10.1134/S0026261710020153; Pacifico A, 2003, VIB SPECTROSC, V32, P107, DOI 10.1016/S0924-2031(03)00051-1; Papanikolaou S, 2010, EUR J LIPID SCI TECH, V112, P639, DOI 10.1002/ejlt.200900197; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Poirier I, 1999, J APPL MICROBIOL, V86, P87, DOI 10.1046/j.1365-2672.1999.00638.x; Polomska X, 2012, POL J FOOD NUTR SCI, V62, P143, DOI 10.2478/v10222-011-0045-1; PRESTRELSKI SJ, 1993, BIOPHYS J, V65, P661, DOI 10.1016/S0006-3495(93)81120-2; R Core Team, 2012, R LANG ENV STAT COMP; Rodriguez-Porrata B, 2008, INT J FOOD MICROBIOL, V126, P116, DOI 10.1016/j.ijfoodmicro.2008.05.016; Roscini L, 2010, ANALYST, V135, P2099, DOI 10.1039/c0an00127a; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Seki S, 2009, CRYOBIOLOGY, V58, P157, DOI 10.1016/j.cryobiol.2008.11.011; Simonin H, 2007, BBA-BIOMEMBRANES, V1768, P1600, DOI 10.1016/j.bbamem.2007.03.017; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Smith AE, 2000, P NATL ACAD SCI USA, V97, P9871, DOI 10.1073/pnas.97.18.9871; Swennen D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-219; ZEROUAL W, 1994, BBA-MOL CELL RES, V1222, P171, DOI 10.1016/0167-4889(94)90166-X; Zheng DQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085022	71	14	14	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111138	10.1371/journal.pone.0111138	http://dx.doi.org/10.1371/journal.pone.0111138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350121	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943100058
J	Shamu, S; Zarowsky, C; Shefer, T; Temmerman, M; Abrahams, N				Shamu, Simukai; Zarowsky, Christina; Shefer, Tamara; Temmerman, Marleen; Abrahams, Naeemah			Intimate Partner Violence after Disclosure of HIV Test Results among Pregnant Women in Harare, Zimbabwe	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SEROSTATUS DISCLOSURE; SOUTH-AFRICA; PREVENTION; CONTEXT; RISK; PREVALENCE; INFECTION; SETTINGS; PROGRAMS	Background: HIV status disclosure is a central strategy in HIV prevention and treatment but in high prevalence settings women test disproportionately and most often during pregnancy. This study reports intimate partner violence (IPV) following disclosure of HIV test results by pregnant women. Methods: In this cross sectional study we interviewed 1951 postnatal women who tested positive and negative for HIV about IPV experiences following HIV test disclosure, using an adapted WHO questionnaire. Multivariate regression models assessed factors associated with IPV after disclosure and controlled for factors such as previous IPV and other known behavioural factors associated with IPV. Results: Over 93% (1817) disclosed the HIV results to their partners (96.5% HIV- vs. 89.3% HIV+, p<0.0001). Overall HIV prevalence was 15.3%, (95% CI: 13.7-16.9), 35.2% among non-disclosers and 14.3% among disclosers. Overall 32.8% reported IPV (40.5% HIV+; 31.5% HIV- women, p = 0.004). HIV status was associated with IPV (partially adjusted 1.43: (95%CI: 1.00-2.05 as well as reporting negative reactions by male partners immediately after disclosure (adjusted OR 5.83, 95%CI: 4.31-7.80). Factors associated with IPV were gender inequity, past IPV, risky sexual behaviours and living with relatives. IPV after HIV disclosure in pregnancy is high but lower than and is strongly related with IPV before pregnancy (adjusted OR 6.18, 95%CI: 3.84-9.93). Conclusion: The study demonstrates the interconnectedness of IPV, HIV status and its disclosure with IPV which was a common experience post disclosure of both an HIV positive and HIV negative result. Health services must give attention to the gendered nature and consequences of HIV disclosure such as enskilling women on how to determine and respond to the risks associated with disclosure. Efforts to involve men in antenatal care must also be strengthened.	[Shamu, Simukai; Abrahams, Naeemah] MRC, Gender & Hlth Res Unit, Cape Town, South Africa; [Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Shamu, Simukai; Zarowsky, Christina; Abrahams, Naeemah] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Shefer, Tamara] Univ Western Cape, Womens & Gender Studies, Cape Town, South Africa; [Zarowsky, Christina] Univ Montreal, Hosp Res Ctr CR CHUM, Montreal, PQ, Canada	Ghent University; University of the Western Cape; University of the Western Cape; Universite de Montreal	Shamu, S (corresponding author), MRC, Gender & Hlth Res Unit, Cape Town, South Africa.	shamuts@yahoo.com	Abrahams, Naeemah/AAF-1144-2020	Zarowsky, Christina/0000-0002-0850-6212; Abrahams, Naeemah/0000-0002-6138-6256; Shamu, Simukai/0000-0002-2290-0515	Flemish Inter-University cooperation (VLIR-UOS); University of the Western Cape (UWC); African Population and Heath Research Centre; International Development Research Centre; South African Medical Research Council (MRC)	Flemish Inter-University cooperation (VLIR-UOS); University of the Western Cape (UWC); African Population and Heath Research Centre; International Development Research Centre; South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SS received funding for PhD studies, towards which this paper contributed, from the Flemish Inter-University cooperation (VLIR-UOS) with the University of the Western Cape (UWC). SS received fieldwork support from the African Doctoral Dissertation Research Fellowship provided by the African Population and Heath Research Centre in partnership with the International Development Research Centre and additional support from the South African Medical Research Council (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Chandra PS, 2003, AIDS CARE, V15, P207, DOI 10.1080/0954012031000068353; Colombini M, 2008, B WORLD HEALTH ORGAN, V86, P635, DOI 10.2471/BLT.07.045906; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Farid M, 2008, INT J GYNECOL OBSTET, V101, P141, DOI 10.1016/j.ijgo.2007.11.015; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; Harling G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014257; Hatcher AM, 2013, CULT HEALTH SEX, V15, P404, DOI 10.1080/13691058.2012.760205; Jasseron C, 2011, AIDS BEHAV, P1; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kissinger PJ, 2003, SEX TRANSM DIS, V30, P75, DOI 10.1097/00007435-200301000-00015; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; Maman S, 2003, GENDER DIMENSIONS HI; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Muhajarine N, 1999, CAN MED ASSOC J, V160, P1007; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Shamu S, 2011, PLOS ONE, V8, P6; Shamu S, 2013, TROP MED INT HEALTH, V18, P696, DOI 10.1111/tmi.12078; Shamu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043148; Simoni Jane M, 2004, Top HIV Med, V12, P109; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; TEMMERMAN M, 1995, LANCET, V345, P969, DOI 10.1016/S0140-6736(95)90707-6; Tsai AC, 2012, AIDS, V26, P381, DOI 10.1097/QAD.0b013e32834e1ccb; Varga CA, 2006, AIDS CARE, V18, P952, DOI 10.1080/09540120500356906; Were E, 2011, AIDS, V25, P2009, DOI 10.1097/QAD.0b013e32834b005d; WHO, 2005, MULT STUD WOM HLTH D; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; World Health Organization, 2001, WHOFCHGWH011; Yount KM, 2009, J MARRIAGE FAM, V71, P1125, DOI 10.1111/j.1741-3737.2009.00659.x; ZIMSTAT ICF, 2012, ZIMB DEM HLTH SURV 2	33	76	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109447	10.1371/journal.pone.0109447	http://dx.doi.org/10.1371/journal.pone.0109447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BH	25350001	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100012
J	Munguia-Rosas, MA; Montiel, S				Munguia-Rosas, Miguel A.; Montiel, Salvador			Patch Size and Isolation Predict Plant Species Density in a Naturally Fragmented Forest	PLOS ONE			English	Article							HABITAT FRAGMENTATION; ISLAND BIOGEOGRAPHY; EQUILIBRIUM-THEORY; DIVERSITY; AREA; CONSERVATION; RICHNESS; EVOLUTIONARY; LANDSCAPE; PATTERNS	Studies of the effects of patch size and isolation on plant species density have yielded contrasting results. However, much of the available evidence comes from relatively recent anthropogenic forest fragments which have not reached equilibrium between extinction and immigration. This is a critical issue because the theory clearly states that only when equilibrium has been reached can the number of species be accurately predicted by habitat size and isolation. Therefore, species density could be better predicted by patch size and isolation in an ecosystem that has been fragmented for a very long time. We tested whether patch area, isolation and other spatial variables explain variation among forest patches in plant species density in an ecosystem where the forest has been naturally fragmented for long periods of time on a geological scale. Our main predictions were that plant species density will be positively correlated with patch size, and negatively correlated with isolation (distance to the nearest patch, connectivity, and distance to the continuous forest). We surveyed the vascular flora (except lianas and epiphytes) of 19 forest patches using five belt transects (50x4 m each) per patch (area sampled per patch = 0.1 ha). As predicted, plant species density was positively associated (logarithmically) with patch size and negatively associated (linearly) with patch isolation (distance to the nearest patch). Other spatial variables such as patch elevation and perimeter, did not explain among-patch variability in plant species density. The power of patch area and isolation as predictors of plant species density was moderate (together they explain 43% of the variation), however, a larger sample size may improve the explanatory power of these variables. Patch size and isolation may be suitable predictors of long-term plant species density in terrestrial ecosystems that are naturally and anthropogenically fragmented.	[Munguia-Rosas, Miguel A.; Montiel, Salvador] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Ecol Humana, Merida, Yucatan, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Munguia-Rosas, MA (corresponding author), Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Ecol Humana, Merida, Yucatan, Mexico.	munguiarma@mda.cinvestav.mx	Montiel, Salvador/A-4738-2008; Munguia-Rosas, Miguel/H-9364-2019	Munguia-Rosas, Miguel A./0000-0003-2319-1666	Consejo NacionaL de Ciencia y Tecnologia [CB-2012-177680]	Consejo NacionaL de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by Consejo NacionaL de Ciencia y Tecnologia (project CB-2012-177680), funds to MAM-R. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Arroyo-Rodriguez V, 2012, J ECOL, V100, P702, DOI 10.1111/j.1365-2745.2011.01952.x; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; Barrera A, 1982, BIOTICA, V2, P163; BOECKLEN WJ, 1984, BIOL CONSERV, V29, P63, DOI 10.1016/0006-3207(84)90014-4; Brokaw N, 2011, ARBOLES MUNDO MAYA; Castillo-Campos G, 2008, BIODIVERS CONSERV, V17, P1701, DOI 10.1007/s10531-008-9375-7; Collins CD, 2009, ECOLOGY, V90, P2577, DOI 10.1890/08-1405.1; CONANP-SEMARNAT, 2006, RES BIOF LOS PET; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cook WM, 2002, ECOL LETT, V5, P619, DOI 10.1046/j.1461-0248.2002.00366.x; Costa-Lugo E, 2010, PLAN CONSERVACION EC; Crawley MJ, 2013, R BOOK, P557; DEBINSKI DM, 2000, CONSERV BIOL, V14, P342, DOI DOI 10.1046/j.1523-1739.2000.98081.x; Duran R, 1987, BIOTICA, V12, P191; DURAN R., 1987, BIOTICA, V12, P199; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Farmilo BJ, 2014, AUSTRAL ECOL, V39, P416, DOI 10.1111/aec.12099; GILBERT FS, 1980, J BIOGEOGR, V7, P209, DOI 10.2307/2844629; Gotelli Nicholas J., 2011, P39; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Hu G, 2013, PLOS ONE, V7; JANZEN DH, 1968, AM NAT, V102, P592, DOI 10.1086/282574; Johansson V, 2013, OECOLOGIA, V172, P607, DOI 10.1007/s00442-012-2509-3; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; Mas J-F., 2000, INVESTIG GEOGR FICAS, V6, P42; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Montiel S, 2006, J TROP ECOL, V22, P267, DOI 10.1017/S026646740500307X; Munguia-Rosas MA, 2014, J TROP ECOL, V30, P323, DOI 10.1017/S0266467414000194; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Palacios-Rios, 1996, ACTA BOT MEX, V34, P53, DOI DOI 10.21829/ABM34.1996.950; Pennington TD, 2005, ARBOLES TROPICALES X; Prugh LR, 2009, ECOL APPL, V19, P1300, DOI 10.1890/08-1524.1; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; RICO-GRAY V, 1982, Biotica (Mexico), V7, P171; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; Rosati L, 2010, PLANT BIOSYST, V144, P38, DOI 10.1080/11263500903429213; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Walter HS, 2004, J BIOGEOGR, V31, P177, DOI 10.1046/j.0305-0270.2003.00989.x; Wettstein W, 1999, J APPL ECOL, V36, P363, DOI 10.1046/j.1365-2664.1999.00404.x; Yamaura Y, 2008, CONSERV BIOL, V22, P1513, DOI 10.1111/j.1523-1739.2008.01024.x	51	33	34	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111742	10.1371/journal.pone.0111742	http://dx.doi.org/10.1371/journal.pone.0111742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347818	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900084
J	Kumar, NP; Sridhar, R; Hanna, LE; Banurekha, VV; Nutman, TB; Babu, S				Kumar, Nathella Pavan; Sridhar, Rathinam; Hanna, Luke E.; Banurekha, Vaithilingam V.; Nutman, Thomas B.; Babu, Subash			Decreased Frequencies of Circulating CD4(+) T Follicular Helper Cells Associated with Diminished Plasma IL-21 in Active Pulmonary Tuberculosis	PLOS ONE			English	Article							FH CELLS	Background: Circulating T follicular helper (Tfh) cells represent a distinct subset of CD4(+) T cells and are important in immunity to infections. Although they have been shown to play a role in experimental models of tuberculosis infection, their role in human tuberculosis remains unexplored. Aims/Methodology: To determine the distribution of circulating Tfh cells in human TB, we measured the frequencies of Tfh cells ex vivo and following TB - antigen or polyclonal stimulation in pulmonary TB (PTB; n = 30) and latent TB (LTB; n = 20) individuals, using the markers CXCR5, PD-1 and ICOS. Results: We found that both ex vivo and TB - antigen induced frequencies of Tfh cell subsets was significantly lower in PTB compared to LTB individuals. Similarly, antigen induced frequencies of Tfh cells expressing IL-21 was also significantly lower in PTB individuals and this was reflected in diminished circulating levels of IL-21 and IFN gamma. This was not accompanied by diminished frequencies of activated or memory B cell subsets. Finally, the diminution in frequency of Tfh cells in PTB individuals was dependent on IL-10, CTLA-4 and PD-L1 in vitro. Conclusions: Thus, PTB is characterized by adiminution in the frequency of Tfh cell subsets.	[Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India; [Kumar, Nathella Pavan; Hanna, Luke E.; Banurekha, Vaithilingam V.] Natl Inst Res TB, Madras, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Madras, Tamil Nadu, India; [Nutman, Thomas B.; Babu, Subash] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India.	sbabu@mail.nih.gov	Kumar, Nathella Pavan/AAU-2328-2021; Babu, Subash/GXG-4746-2022		Division of Intramural Research, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; CS Ma, 2013, IMMUNOL CELL BIOL; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kozakiewicz L, 2013, ADV EXP MED BIOL, V783, P225, DOI 10.1007/978-1-4614-6111-1_12; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Locci M, 2013, IMMUNITY; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Phuah JY, 2012, AM J PATHOL, V181, P508, DOI 10.1016/j.ajpath.2012.05.009; Slight SR, 2013, J CLIN INVEST, V123, P712, DOI 10.1172/JCI65728; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960	21	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111098	10.1371/journal.pone.0111098	http://dx.doi.org/10.1371/journal.pone.0111098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343703	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000343943500079
J	Liu, Y; Nie, L; Zhao, H; Zhang, W; Zhang, YQ; Wang, SS; Cheng, L				Liu, Yi; Nie, Lin; Zhao, Hua; Zhang, Wen; Zhang, Yuan-Qiang; Wang, Shuai-Shuai; Cheng, Lei			Conserved Dopamine Neurotrophic Factor-Transduced Mesenchymal Stem Cells Promote Axon Regeneration and Functional Recovery of Injured Sciatic Nerve	PLOS ONE			English	Article							BRAIN-INJURY; FACTOR CDNF; TRANSPLANTATION; LESIONS; REPAIR	Peripheral nerve injury (PNI) is a common disease that often results in axonal degeneration and the loss of neurons, ultimately leading to limited nerve regeneration and severe functional impairment. Currently, there are no effective treatments for PNI. In the present study, we transduced conserved dopamine neurotrophic factor (CDNF) into mesenchymal stem cells (MSCs) in collagen tubes to investigate their regenerative effects on rat peripheral nerves in an in vivo transection model. Scanning electron microscopy of the collagen tubes demonstrated their ability to be resorbed in vivo. We observed notable overexpression of the CDNF protein in the distal sciatic nerve after application of CDNF-MSCs. Quantitative analysis of neurofilament 200 (NF200) and S100 immunohistochemistry showed significant enhancement of axonal and Schwann cell regeneration in the group receiving CDNF-MSCs (CDNF-MSCs group) compared with the control groups. Myelination thickness, axon diameter and the axon-to fiber diameter ratio (G-ratio) were significantly higher in the CDNF-MSCs group at 8 and 12 weeks after nerve transection surgery. After surgery, the sciatic functional index, target muscle weight, wet weight ratio of gastrocnemius muscle and horseradish peroxidase (HRP) tracing demonstrated functional recovery. Light and electron microscopy confirmed successful regeneration of the sciatic nerve. The greater numbers of HRP-labeled neuron cell bodies and increased sciatic nerve index values (SFI) in the CDNF-MSCs group suggest that CDNF exerts neuroprotective effects in vivo. We also observed higher target muscle weights and a significant improvement in muscle atrophism in the CDNF-MSCs group. Collectively, these findings indicate that CDNF gene therapy delivered by MSCs is capable of promoting nerve regeneration and functional recovery, likely because of the significant neuroprotective and neurotrophic effects of CDNF and the superior environment offered by MSCs and collagen tubes.	[Liu, Yi; Nie, Lin; Zhao, Hua; Zhang, Wen; Zhang, Yuan-Qiang; Wang, Shuai-Shuai; Cheng, Lei] Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan 250100, Peoples R China; [Liu, Yi; Zhao, Hua] Shandong Univ, Qilu Hosp, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China	Shandong University; Shandong University	Cheng, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan 250100, Peoples R China.	chengleiyx@126.com		Zhang, Yuanqiang/0000-0002-4592-4966	Ph.D. Programs Foundation of the Ministry of Education of China [20110131120079]; Natural Science Foundation of Shandong Province [ZR2013HM095]	Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	The study was supported by a grant from the Ph.D. Programs Foundation of the Ministry of Education of China (20110131120079) and Natural Science Foundation of Shandong Province (ZR2013HM095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Bhagavati S, 2004, BIOCHEM BIOPH RES CO, V318, P119, DOI 10.1016/j.bbrc.2004.03.192; Cao JN, 2013, BIOMATERIALS, V34, P1302, DOI 10.1016/j.biomaterials.2012.10.031; Cheng L, 2013, BIOCH BIOPHYS RES CO; Cheng L, 2013, BIOCHEM BIOPH RES CO, V435, P34, DOI 10.1016/j.bbrc.2013.04.029; Cuevas P, 2004, NEUROL RES, V26, P230, DOI 10.1179/016164104225013897; Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002; Guan JJ, 2011, BIOMATERIALS, V32, P5568, DOI 10.1016/j.biomaterials.2011.04.038; Hellman M, 2010, BIOMOLECULAR NMR ASS, V2010; Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029; Kemp SWP, 2007, J NEUROSCI METH, V165, P83, DOI 10.1016/j.jneumeth.2007.05.032; Kretschmer T, 2001, J NEUROSURG, V94, P905, DOI 10.3171/jns.2001.94.6.0905; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; MACKINNON SE, 1992, PLAST RECONSTR SURG, V90, P695, DOI 10.1097/00006534-199210000-00024; Madduri S, 2012, J CONTROL RELEASE, V161, P274, DOI 10.1016/j.jconrel.2011.11.036; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; ORTIGUELA ME, 1987, J HAND SURG-AM, V12A, P1119, DOI 10.1016/S0363-5023(87)80129-6; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Secer HI, 2008, SURG NEUROL, V69, P143, DOI 10.1016/j.surneu.2007.01.032; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Zhao H, 2013, J MOL NEUROSCI	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110993	10.1371/journal.pone.0110993	http://dx.doi.org/10.1371/journal.pone.0110993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343619	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500072
J	Xu, J; Lu, ZG; Xu, MM; Rossi, GC; Kest, B; Waxman, AR; Pasternak, GW; Pan, YX				Xu, Jin; Lu, Zhigang; Xu, Mingming; Rossi, Grace C.; Kest, Benjamin; Waxman, Amanda R.; Pasternak, Gavril W.; Pan, Ying-Xian			Differential Expressions of the Alternatively Spliced Variant mRNAs of the mu Opioid Receptor Gene, OPRM1, in Brain Regions of Four Inbred Mouse Strains	PLOS ONE			English	Article							IMMUNOHISTOCHEMICAL LOCALIZATION; OPIATE RECEPTORS; RAT-BRAIN; AUTORADIOGRAPHIC LOCALIZATION; PHARMACOLOGICAL CHARACTERIZATION; MORPHINE; MOR-1; ANALGESIA; HEROIN; TOLERANCE	The mu opioid receptor gene, OPRM1, undergoes extensive alternative pre-mRNA splicing in rodents and humans, with dozens of alternatively spliced variants of the OPRM1 gene. The present studies establish a SYBR green quantitative PCR (qPCR) assay to more accurately quantify mouse OPRM1 splice variant mRNAs. Using these qPCR assays, we examined the expression of OPRM1 splice variant mRNAs in selected brain regions of four inbred mouse strains displaying differences in mu opioid-induced tolerance and physical dependence: C56BL/6J, 129P3/J, SJL/J and SWR/J. The complete mRNA expression profiles of the OPRM1 splice variants reveal marked differences of the variant mRNA expression among the brain regions in each mouse strain, suggesting region-specific alternative splicing of the OPRM1 gene. The expression of many variants was also strain-specific, implying a genetic influence on OPRM1 alternative splicing. The expression levels of a number of the variant mRNAs in certain brain regions appear to correlate with strain sensitivities to morphine analgesia, tolerance and physical dependence in four mouse strains.	[Xu, Jin; Lu, Zhigang; Xu, Mingming; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Dept Neurol & Mol Pharmacol, New York, NY 10021 USA; [Xu, Jin; Lu, Zhigang; Xu, Mingming; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Chem Program, New York, NY 10021 USA; [Rossi, Grace C.] Long Isl Univ, Dept Psychol, Brookville, NY USA; [Kest, Benjamin; Waxman, Amanda R.] CUNY, Dept Psychol, Staten Isl, NY USA; [Kest, Benjamin; Waxman, Amanda R.] CUNY, Ctr Dev Neurosci, Staten Isl, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; City University of New York (CUNY) System	Pan, YX (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol & Mol Pharmacol, 1275 York Ave, New York, NY 10021 USA.	pany@mskcc.org	Rossi, Grace/AIC-2739-2022		National Institute on Drug Abuse [DA13997, DA029244, DA02615, DA06241, DA07242]; National Cancer Institute [CA08748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002615, R21DA029244, R01DA006241, R01DA013997, R56DA002615, R01DA007242, R37DA007242] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part, by research grants DA13997 & DA029244 (to YXP) and DA02615, DA06241 and DA07242 (to GWP) from the National Institute on Drug Abuse and a core grant from the National Cancer Institute to MSKCC (CA08748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2000, NEUROSCIENCE, V100, P141, DOI 10.1016/S0306-4522(00)00248-7; Abbadie C, 2000, J COMP NEUROL, V419, P244, DOI 10.1002/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R; Abbadie C, 2001, NEUROREPORT, V12, P3069, DOI 10.1097/00001756-200110080-00017; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; ATWEH SF, 1983, BRIT MED BULL, V39, P47, DOI 10.1093/oxfordjournals.bmb.a071789; ATWEH SF, 1977, BRAIN RES, V134, P393, DOI 10.1016/0006-8993(77)90817-4; ATWEH SF, 1977, BRAIN RES, V129, P1, DOI 10.1016/0006-8993(77)90965-9; ATWEH SF, 1977, BRAIN RES, V124, P53, DOI 10.1016/0006-8993(77)90863-0; BELKNAP JK, 1995, LIFE SCI, V57, pPL117, DOI 10.1016/0024-3205(95)02040-P; Belknap JK, 1998, PHARMACOL BIOCHEM BE, V59, P353, DOI 10.1016/S0091-3057(97)00421-8; Bolan EA, 2004, SYNAPSE, V51, P11, DOI 10.1002/syn.10277; Chang A, 1998, EUR J PHARMACOL, V351, P189, DOI 10.1016/S0014-2999(98)00366-5; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHEN Y, 1993, MOL PHARMACOL, V44, P8; Ding YQ, 1996, J COMP NEUROL, V367, P375; Foley KM, 1985, CANC PRINCIPLES PRAC, P1940; GIROS B, 1995, LIFE SCI, V56, pPL369, DOI 10.1016/0024-3205(95)00119-Q; HONDA CN, 1995, NEUROREPORT, V6, P1025, DOI 10.1097/00001756-199505090-00019; KAUFMAN DL, 1995, J BIOL CHEM, V270, P15877, DOI 10.1074/jbc.270.26.15877; Kest B, 2002, NEUROSCIENCE, V115, P463, DOI 10.1016/S0306-4522(02)00458-X; Kest B, 2002, PHARMACOL BIOCHEM BE, V73, P821, DOI 10.1016/S0091-3057(02)00908-5; Klein G, 2008, PHARMACOL BIOCHEM BE, V90, P447, DOI 10.1016/j.pbb.2008.03.030; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Kolesnikov Y, 1998, J PHARMACOL EXP THER, V284, P455; KOZAK CA, 1994, GENOMICS, V21, P659, DOI 10.1006/geno.1994.1331; Leipzig J, 2004, NUCLEIC ACIDS RES, V32, P3977, DOI 10.1093/nar/gkh731; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; LING GSF, 1985, J PHARMACOL EXP THER, V232, P149; LING GSF, 1984, SCIENCE, V226, P462, DOI 10.1126/science.6541807; Liu XY, 2011, CELL, V147, P447, DOI 10.1016/j.cell.2011.08.043; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; MANSOUR A, 1994, REGUL PEPTIDES, V54, P179, DOI 10.1016/0167-0115(94)90449-9; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; MANSOUR A, 1994, BRAIN RES, V643, P245, DOI 10.1016/0006-8993(94)90031-0; MANSOUR A, 1995, J CHEM NEUROANAT, V8, P283, DOI 10.1016/0891-0618(95)00055-C; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; Metten P, 2009, DRUG ALCOHOL DEPEN, V99, P123, DOI 10.1016/j.drugalcdep.2008.07.006; Moriwaki A, 1996, NEUROCHEM RES, V21, P1315, DOI 10.1007/BF02532373; MOULIN DE, 1988, PAIN, V33, P233, DOI 10.1016/0304-3959(88)90095-4; Pan L, 2005, NEUROSCIENCE, V133, P209, DOI 10.1016/j.neuroscience.2004.12.033; Pan YX, 2011, RECEPT SER, P121, DOI 10.1007/978-1-60761-993-2_6; Pan YX, 2009, P NATL ACAD SCI USA, V106, P4917, DOI 10.1073/pnas.0811586106; Pan YX, 1999, MOL PHARMACOL, V56, P396, DOI 10.1124/mol.56.2.396; Pan YX, 2001, P NATL ACAD SCI USA, V98, P14084, DOI 10.1073/pnas.241296098; Pan YX, 2000, FEBS LETT, V466, P337, DOI 10.1016/S0014-5793(00)01095-4; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; PASTERNAK GW, 1993, CLIN NEUROPHARMACOL, V16, P1, DOI 10.1097/00002826-199302000-00001; Paxinos G, 2000, MOUSE BRAIN STEREOTA; Payne R, 1992, PRINCIPLES DRUG THER, P268; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portenoy RK, 1996, PAIN MANAGEMENT THEO, P248; ROSSI GC, 1995, FEBS LETT, V369, P192, DOI 10.1016/0014-5793(95)00757-Z; Rossi GC, 1997, J PHARMACOL EXP THER, V281, P109; Schlussman SD, 2008, NEUROSCI LETT, V440, P284, DOI 10.1016/j.neulet.2008.05.103; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H, 1997, NEUROSCIENCE, V81, P757, DOI 10.1016/S0306-4522(97)00253-4; WANG JB, 1993, P NATL ACAD SCI USA, V90, P10230, DOI 10.1073/pnas.90.21.10230; WANG JB, 1994, FEBS LETT, V338, P217, DOI 10.1016/0014-5793(94)80368-4; Xu J, 2009, SOC NEUROSCI; Xu J, 2014, J NEUROSCI, V34, P11048, DOI 10.1523/JNEUROSCI.3986-13.2014; Xu J, 2013, J BIOL CHEM, V288, P21211, DOI 10.1074/jbc.M113.458687	67	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111267	10.1371/journal.pone.0111267	http://dx.doi.org/10.1371/journal.pone.0111267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343478	Green Published, gold			2022-12-26	WOS:000343943500089
J	Chung, MH; Huang, CC; Vong, SC; Yang, TM; Chen, KT; Lin, HJ; Chen, JH; Su, SB; Guo, HR; Hsu, CC				Chung, Min-Hsien; Huang, Chien-Cheng; Vong, Si-Chon; Yang, Tzu-Meng; Chen, Kuo-Tai; Lin, Hung-Jung; Chen, Jiann-Hwa; Su, Shih-Bin; Guo, How-Ran; Hsu, Chien-Chin			Geriatric Fever Score: A New Decision Rule for Geriatric Care	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; MANAGEMENT; EMERGENCY; GUIDELINES; ADULTS	Background: Evaluating geriatric patients with fever is time-consuming and challenging. We investigated independent mortality predictors of geriatric patients with fever and developed a prediction rule for emergency care, critical care, and geriatric care physicians to classify patients into mortality risk and disposition groups. Materials and Methods: Consecutive geriatric patients (>= 65 years old) visiting the emergency department (ED) of a university-affiliated medical center between June 1 and July 21, 2010, were enrolled when they met the criteria of fever: a tympanic temperature >= 37.2 degrees C or a baseline temperature elevated >= 1.3 degrees C. Thirty-day mortality was the primary endpoint. Internal validation with bootstrap re-sampling was done. Results: Three hundred thirty geriatric patients were enrolled. We found three independent mortality predictors: Leukocytosis (WBC > 12,000 cells/mm(3)), Severe coma (GCS <= 8), and Thrombocytopenia (platelets < 150 10(3)/mm(3)) (LST). After assigning weights to each predictor, we developed a Geriatric Fever Score that stratifies patients into two mortality-risk and disposition groups: low (4.0%) (95% CI: 2.3-6.9%): a general ward or treatment in the ED then discharge and high (30.3%) (95% CI: 17.4-47.3%): consider the intensive care unit. The area under the curve for the rule was 0.73. Conclusions: We found that the Geriatric Fever Score is a simple and rapid rule for predicting 30-day mortality and classifying mortality risk and disposition in geriatric patients with fever, although external validation should be performed to confirm its usefulness in other clinical settings. It might help preserve medical resources for patients in greater need.	[Chung, Min-Hsien; Huang, Chien-Cheng; Vong, Si-Chon; Yang, Tzu-Meng; Chen, Kuo-Tai; Lin, Hung-Jung; Hsu, Chien-Chin] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Huang, Chien-Cheng; Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Huang, Chien-Cheng] Kuo Gen Hosp, Dept Emergency Med, Tainan, Taiwan; [Chen, Kuo-Tai; Lin, Hung-Jung] Taipei Med Univ, Dept Emergency Med, Taipei, Taiwan; [Lin, Hung-Jung; Hsu, Chien-Chin] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Chen, Jiann-Hwa] Cathay Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Chen, Jiann-Hwa] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	Chi Mei Hospital; National Cheng Kung University; Southern Taiwan University of Science & Technology; Taipei Medical University; Southern Taiwan University of Science & Technology; Cathay General Hospital; Fu Jen Catholic University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hrguo@mail.ncku.edu.tw; nych2525@gmail.com	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446	Chi-Mei Medical Center [CMNCKU10305]	Chi-Mei Medical Center	This study was supported by grant CMNCKU10305 from the Chi-Mei Medical Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; [Anonymous], 2004, PLAT COUNT AKA THROM; Cagatay AA, 2010, J AGING RES, V2010; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Department of Statistics Ministry of Interior Taiwan, TABL ELD POP COUNT R; FONTANAROSA PB, 1992, ANN EMERG MED, V21, P842, DOI 10.1016/S0196-0644(05)81032-7; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; High KP, 2009, J AM GERIATR SOC, V57, P375, DOI 10.1111/j.1532-5415.2009.02175.x; Karnofsky D, 1949, EVALUATION CHEMOTHER, P196; Katz ED, 2004, GERIATRIC EMERGENCY, P55; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; MARCO CA, 1995, ANN EMERG MED, V26, P18, DOI 10.1016/S0196-0644(95)70232-6; NORMAN DC, 1985, J AM GERIATR SOC, V33, P859, DOI 10.1111/j.1532-5415.1985.tb05441.x; Norman DC, 2000, CLIN INFECT DIS, V31, P148, DOI 10.1086/313896; O'Sullivan SB, 2007, PHYS REHABILITATION, P385; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; OUSLANDER JG, 1994, ANN INTERN MED, V120, P584, DOI 10.7326/0003-4819-120-7-199404010-00010; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Smith PW, 1997, INFECT CONT HOSP EP, V18, P831; TEASDALE G, 1974, LANCET, V2, P81; WASSERMAN M, 1989, J AM GERIATR SOC, V37, P537, DOI 10.1111/j.1532-5415.1989.tb05686.x	21	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110927	10.1371/journal.pone.0110927	http://dx.doi.org/10.1371/journal.pone.0110927			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340811	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800071
J	Malairaman, U; Dandapani, K; Katyal, A				Malairaman, Udayabanu; Dandapani, Kumaran; Katyal, Anju			Effect of Ca(2)EDTA on Zinc Mediated Inflammation and Neuronal Apoptosis in Hippocampus of an In Vivo Mouse Model of Hypobaric Hypoxia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GLOBAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; NADPH OXIDASE; INDUCIBLE FACTOR-1-ALPHA; OXIDATIVE STRESS; RAT HIPPOCAMPUS; REPERFUSION INJURY; MEMORY IMPAIRMENT; CORTICAL-NEURONS	Background: Calcium overload has been implicated as a critical event in glutamate excitotoxicity associated neurodegeneration. Recently, zinc accumulation and its neurotoxic role similar to calcium has been proposed. Earlier, we reported that free chelatable zinc released during hypobaric hypoxia mediates neuronal damage and memory impairment. The molecular mechanism behind hypobaric hypoxia mediated neuronal damage is obscure. The role of free zinc in such neuropathological condition has not been elucidated. In the present study, we investigated the underlying role of free chelatable zinc in hypobaric hypoxia-induced neuronal inflammation and apoptosis resulting in hippocampal damage. Methods: Adult male Balb/c mice were exposed to hypobaric hypoxia and treated with saline or Ca(2)EDTA (1.25 mM/kg i.p) daily for four days. The effects of Ca(2)EDTA on apoptosis (caspases activity and DNA fragmentation), pro-inflammatory markers (iNOS, TNF-alpha and COX-2), NADPH oxidase activity, poly(ADP ribose) polymerase (PARP) activity and expressions of Bax, Bcl-2, HIF-1 alpha, metallothionein-3, ZnT-1 and ZIP-6 were examined in the hippocampal region of brain. Results: Hypobaric hypoxia resulted in increased expression of metallothionein-3 and zinc transporters (ZnT-1 and ZIP-6). Hypobaric hypoxia elicited an oxidative stress and inflammatory response characterized by elevated NADPH oxidase activity and up-regulation of iNOS, COX-2 and TNF-alpha. Furthermore, hypobaric hypoxia induced HIF-1 alpha protein expression, PARP activation and apoptosis in the hippocampus. Administration of Ca(2)EDTA significantly attenuated the hypobaric hypoxia induced oxidative stress, inflammation and apoptosis in the hippocampus. Conclusion: We propose that hypobaric hypoxia/reperfusion instigates free chelatable zinc imbalance in brain associated with neuroinflammation and neuronal apoptosis. Therefore, zinc chelating strategies which block zinc mediated neuronal damage linked with cerebral hypoxia and other neurodegenerative conditions can be designed in future.	[Malairaman, Udayabanu; Dandapani, Kumaran; Katyal, Anju] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi	Katyal, A (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	anju_katyal@yahoo.com		Malairaman, Udayabanu/0000-0001-7118-1070	Indian Council of Medical Research, India; University Grants Commission India	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); University Grants Commission India(University Grants Commission, India)	The authors AK, DK and UM are thankful to the Indian Council of Medical Research, India for providing research fellowship and University Grants Commission India for funding the project. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhwal K, 2007, EUR J PHARMACOL, V570, P97, DOI 10.1016/j.ejphar.2007.05.063; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Brune B, 2003, CURR MED CHEM, V10, P845, DOI 10.2174/0929867033457746; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chao WH, 1999, J NUTR, V129, P2009, DOI 10.1093/jn/129.11.2009; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Chun YS, 2000, BIOCHEM BIOPH RES CO, V268, P652, DOI 10.1006/bbrc.2000.2180; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Godzich M, 2006, FASEB J, V20, P1519, DOI 10.1096/fj.05-4708fje; Green SP, 2001, J CEREBR BLOOD F MET, V21, P374, DOI 10.1097/00004647-200104000-00006; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hota SK, 2008, NEUROBIOL LEARN MEM, V89, P522, DOI 10.1016/j.nlm.2008.01.003; Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003; Hu RC, 2002, CHINESE MED J-PEKING, V115, P1833; Khurana P, 2002, NEUROCHEM RES, V27, P931, DOI 10.1023/A:1020347732741; Kim I, 2008, NEUROREPORT, V19, P1063, DOI 10.1097/WNR.0b013e328304d9ac; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kondoh M, 2001, LIFE SCI, V69, P2137, DOI 10.1016/S0024-3205(01)01294-2; Kumaran D, 2008, BEHAV BRAIN RES, V192, P178, DOI 10.1016/j.bbr.2008.03.043; LEES GJ, 1990, NEUROSCI LETT, V120, P155, DOI 10.1016/0304-3940(90)90026-6; Li RC, 2004, NEUROBIOL DIS, V17, P44, DOI 10.1016/j.nbd.2004.05.006; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maiti P, 2010, ACTA HISTOCHEM, V112, P222, DOI 10.1016/j.acthis.2008.10.005; Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003; Martinez-Romero R, 2008, J CELL BIOCHEM, V104, P2248, DOI 10.1002/jcb.21781; Maulik N, 2002, J CELL MOL MED, V6, P13, DOI 10.1111/j.1582-4934.2002.tb00308.x; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Mazumdar T, 2005, J IMMUNOL, V174, P2314, DOI 10.4049/jimmunol.174.4.2314; Mishra OP, 2006, NEUROSCI LETT, V401, P81, DOI 10.1016/j.neulet.2006.02.070; Moller P, 2001, FASEB J, V15, P1181, DOI 10.1096/fj.00-0703com; Mori K, 2001, BEHAV BRAIN RES, V120, P159, DOI 10.1016/S0166-4328(00)00371-5; Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004; Noh KM, 2000, J NEUROSCI, V20; Nouette-Gaulain K, 2011, CAN J PHYSIOL PHARM, V89, P58, DOI [10.1139/Y10-105, 10.1139/y10-105]; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Semenov DG, 2009, B EXP BIOL MED+, V147, P185, DOI 10.1007/s10517-009-0467-5; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; Strosznajder R, 2006, ACTA NEUROBIOL EXP, V66, P15; Strosznajder RP, 2003, J MOL NEUROSCI, V20, P61, DOI 10.1385/JMN:20:1:61; Suschek CV, 2004, CURR MOL MED, V4, P763, DOI 10.2174/1566524043359908; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Tran MH, 2001, FASEB J, V15, P1407, DOI 10.1096/fj.00-0719fje; Udayabanu M, 2008, BRAIN RES, V1230, P138, DOI 10.1016/j.brainres.2008.06.081; Udayabanu M, 2012, NEUROSCIENCE, V202, P434, DOI 10.1016/j.neuroscience.2011.11.022; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang Q, 2006, BRAIN RES, V1090, P182, DOI 10.1016/j.brainres.2006.03.060; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011888; Yamada K, 1999, NEUROSCIENCE, V88, P281, DOI 10.1016/S0306-4522(98)00237-1; Yi XY, 2006, AM J PHYSIOL-HEART C, V290, pH1136, DOI 10.1152/ajpheart.00296.2005; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4; Yun YJ, 2010, PROSTATE, V70, P1179, DOI 10.1002/pros.21152	61	22	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110253	10.1371/journal.pone.0110253	http://dx.doi.org/10.1371/journal.pone.0110253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340757	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800024
J	Stahl, P; Ruppert, V; Schwarz, RT; Meyer, T				Stahl, Philipp; Ruppert, Volker; Schwarz, Ralph T.; Meyer, Thomas			Trypanosoma cruzi Evades the Protective Role of Interferon-Gamma-Signaling in Parasite-Infected Cells	PLOS ONE			English	Article							IFN-GAMMA; CHAGAS-DISEASE; PROINFLAMMATORY CYTOKINES; ALPHA/BETA-INTERFERON; GENE-EXPRESSION; KAPPA-B; STAT1; TRANSCRIPTION; MACROPHAGES; ACTIVATION	The protozoan parasite Trypanosoma cruzi is responsible for the zoonotic Chagas disease, a chronic and systemic infection in humans and warm-blooded animals typically leading to progressive dilated cardiomyopathy and gastrointestinal manifestations. In the present study, we report that the transcription factor STAT1 (signal transducer and activator of transcription 1) reduces the susceptibility of human cells to infection with T. cruzi. Our in vitro data demonstrate that interferon -gamma (IFN gamma) pre-treatment causes T. cruzi-infected cells to enter an anti-parasitic state through the activation of the transcription factor STAT1. Whereas stimulation of STAT1-expressing cells with IFN gamma significantly impaired intracellular replication of parasites, no protective effect of IFN gamma was observed in STAT1-deficient U3A cells. The gene encoding indoleamine 2, 3-dioxygenase (ido) was identified as a STAT1-regulated target gene engaged in parasite clearance. Exposure of cells to T. cruzi trypomastigotes in the absence of IFN gamma resulted in both sustained tyrosine and serine phosphorylation of STAT1 and its increased DNA binding. Furthermore, we found that in response to T. cruzi the total amount of intracellular STAT1 increased in an infectious dose-dependent manner, both at the mRNA and protein level. While STAT1 activation is a potent strategy of the host in the fight against the invading pathogen, amastigotes replicating intracellularly antagonize this pathway by specifically promoting the dephosphorylation of STAT1 serine 727, thereby partially circumventing its protective effects. These findings point to the crucial role of the IFN gamma/STAT1 signal pathway in the evolutionary combat between T. cruzi parasites and their host.	[Stahl, Philipp; Schwarz, Ralph T.] Univ Marburg, Inst Virol, AG Parasitol, D-35032 Marburg, Germany; [Ruppert, Volker] Univ Marburg, Kardiol Klin, Marburg, Germany; [Meyer, Thomas] Univ Gottingen, Klin Psychosomat Med & Psychotherapie, D-37073 Gottingen, Germany; [Schwarz, Ralph T.] Univ Lille 1 Sci & Technol, UMR CNRS USTL 8576, Unite Glycobiol Struct & Fonct, Villeneuve Dascq, France	Philipps University Marburg; Philipps University Marburg; University of Gottingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Meyer, T (corresponding author), Univ Gottingen, Klin Psychosomat Med & Psychotherapie, D-37073 Gottingen, Germany.	thomas.meyer@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft; Studienstiftung des Deutschen Volkes; Deutsche Gesellschaft fur Kardiologie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; Deutsche Gesellschaft fur Kardiologie	The authors gratefully acknowledge the excellent technical assistance of Anke Gregus from the University of Gottingen and Nancy Mounogou Kouassi from the University of Marburg. The research on this subject was funded by a grant from the Deutsche Forschungsgemeinschaft to TM, a scholarship from the Studienstiftung des Deutschen Volkes to PS and a grant from the Deutsche Gesellschaft fur Kardiologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; Antunez MI, 2000, IMMUNOL LETT, V71, P103, DOI 10.1016/S0165-2478(99)00172-8; Bastos KRB, 2007, J INTERF CYTOK RES, V27, P399, DOI 10.1089/jir.2007.0128; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Bergeron M, 2006, J IMMUNOL, V177, P6271, DOI 10.4049/jimmunol.177.9.6271; Boscardin SB, 2010, J CELL MOL MED, V14, P1373, DOI 10.1111/j.1582-4934.2010.01007.x; Camargo MM, 1997, J IMMUNOL, V158, P5890; Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711; Ceravolo IP, 1999, INFECT IMMUN, V67, P2233; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; Chessler ADC, 2008, J IMMUNOL, V181, P7917, DOI 10.4049/jimmunol.181.11.7917; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAUBENER W, 1994, J IMMUNOL METHODS, V168, P39, DOI 10.1016/0022-1759(94)90207-0; de Avalos SV, 2002, J BIOL CHEM, V277, P639, DOI 10.1074/jbc.M109037200; Epting CL, 2010, EXP PARASITOL, V126, P283, DOI 10.1016/j.exppara.2010.06.023; Forget G, 2005, J BIOL CHEM, V280, P30542, DOI 10.1074/jbc.M414126200; Goncalves VM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002469; Hall BS, 2000, MOL BIOL CELL, V11, P153, DOI 10.1091/mbc.11.1.153; Holscher C, 1998, INFECT IMMUN, V66, P1208; Hovsepian E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079445; Huang H, 1999, INFECT IMMUN, V67, P5434, DOI 10.1128/IAI.67.10.5434-5440.1999; KIERSZENBAUM F, 1984, J IMMUNOL, V132, P905; Koga R, 2006, J IMMUNOL, V177, P7059, DOI 10.4049/jimmunol.177.10.7059; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Machado FS, 2000, CIRCULATION, V102, P3003, DOI 10.1161/01.CIR.102.24.3003; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PLATA F, 1984, EUR J IMMUNOL, V14, P930, DOI 10.1002/eji.1830141013; Poncini CV, 2010, MOL IMMUNOL, V47, P1981, DOI 10.1016/j.molimm.2010.04.016; Ramachandran A, 2009, J INTERF CYTOK RES, V29, P531, DOI 10.1089/jir.2009.0070; Rodrigues AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001598; Schneider AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060215; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Stahl P, 2013, APOPTOSIS, V18, P653, DOI 10.1007/s10495-013-0822-x; Stephanou A, 2001, J BIOL CHEM, V276, P28340, DOI 10.1074/jbc.M101177200; TRUYENS C, 1994, INFECT IMMUN, V62, P692, DOI 10.1128/IAI.62.2.692-696.1994; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Sanchez LV, 2013, PARASITOLOGY, V140, P147, DOI 10.1017/S0031182012001394; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WIRTH JJ, 1985, INFECT IMMUN, V49, P61, DOI 10.1128/IAI.49.1.61-66.1985	53	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110512	10.1371/journal.pone.0110512	http://dx.doi.org/10.1371/journal.pone.0110512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340519	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800039
J	Won, J; Ju, JW; Kim, SM; Shin, Y; Chung, S; Pak, JH				Won, Jihee; Ju, Jung-Won; Kim, Sun Min; Shin, Yoojin; Chung, Seok; Pak, Jhang Ho			Clonorchis sinensis Infestation Promotes Three-Dimensional Aggregation and Invasion of Cholangiocarcinoma Cells	PLOS ONE			English	Article							EXCRETORY-SECRETORY PRODUCTS; EXCRETORY/SECRETORY PRODUCTS; OPISTHORCHIS-VIVERRINI; MATRIX METALLOPROTEINASES; MICROFLUIDIC ASSAY; LIVER; VINCULIN; METASTASIS; EXPRESSION; INFECTION	Numerous experimental and epidemiological studies have demonstrated a correlation between Clonorchis sinensis (C. sinensis) infestation and cholangiocarcinoma (CCA). However, the role of C. sinensis in the increased invasiveness and proliferation involved in the malignancy of CCA has not been addressed yet. Here, we investigated the possibility that C. sinensis infestation promotes expression of focal and cell-cell adhesion proteins in CCA cells and secretion of matrix metalloproteinases (MMPs). Adhesion proteins help maintain cell aggregates, and MMPs promote the three-dimensional invasion of cells into the neighboring extracellular matrix (ECM). Using a novel microfluidic assay, we quantitatively addressed the role of excretory-secretory products (ESPs) gradients from C. sinensis in promoting the invasion of cells into the neighboring ECM.	[Won, Jihee; Shin, Yoojin; Chung, Seok] Korea Univ, Sch Mech Engn, Seoul, South Korea; [Ju, Jung-Won] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Malaria & Parasit Dis, Osong, South Korea; [Kim, Sun Min; Pak, Jhang Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea	Korea University; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); University of Ulsan; Asan Medical Center	Chung, S (corresponding author), Korea Univ, Sch Mech Engn, Seoul, South Korea.	sidchung@gmail.com; jhpak@amc.seoul.kr	Chung, Seok/B-1501-2015	Ju, Jung-Won/0000-0001-5248-6995; Won, Jihee/0000-0003-0491-8620	Korea National Institute of Health, Ministry of Health and Welfare, Korea [2012-E54008-00]; Korea Ministry of Environment as Projects for Developing Eco-Innovation Technologies [GT-11-G-02-001-1]; Asan Institute for Life Sciences, Korea [2013-349]	Korea National Institute of Health, Ministry of Health and Welfare, Korea; Korea Ministry of Environment as Projects for Developing Eco-Innovation Technologies; Asan Institute for Life Sciences, Korea	This work was supported by a grant from the Korea National Institute of Health, Ministry of Health and Welfare, Korea (2012-E54008-00). S.C. was supported by Korea Ministry of Environment as Projects for Developing Eco-Innovation Technologies (GT-11-G-02-001-1) and J.H.P. was by Asan Institute for Life Sciences, Korea (2013-349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chamberlain RS, 2000, ANN SURG ONCOL, V7, P55, DOI 10.1007/s10434-000-0055-4; Chen WJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-149; Choi D, 2006, J HEPATOL, V44, P1066, DOI 10.1016/j.jhep.2005.11.040; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; GUDESBLATT MS, 1984, CT-J COMPUT TOMOGR, V8, P191, DOI 10.1016/0149-936X(84)90059-6; Han S, 2012, LAB CHIP, V12, P3861, DOI 10.1039/c2lc40445a; Hong ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/j.parint.2011.06.007; ISHAK KG, 1994, HISTOLOGICAL TYPING; Jeong GS, 2011, ANAL CHEM, V83, P8454, DOI 10.1021/ac202170e; Jeong GS, 2011, BIOMED MICRODEVICES, V13, P717, DOI 10.1007/s10544-011-9541-7; Nam JH, 2012, INT J PARASITOL, V42, P103, DOI 10.1016/j.ijpara.2011.11.001; Ju JW, 2009, PROTEOMICS, V9, P3066, DOI 10.1002/pmic.200700613; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; KIM YI, 1989, CANCER, V63, P1562, DOI 10.1002/1097-0142(19890415)63:8<1562::AID-CNCR2820630819>3.0.CO;2-8; Kim YJ, 2008, PARASITOL RES, V102, P411, DOI 10.1007/s00436-007-0778-2; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P1, DOI 10.1007/BF01606425; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; MIYAGIWA M, 1989, IN VITRO CELL DEV B, V25, P503; Ninlawan K, 2010, PARASITOL INT, V59, P616, DOI 10.1016/j.parint.2010.09.008; Pak JH, 2009, J CELL BIOCHEM, V108, P1376, DOI 10.1002/jcb.22368; Pak J, 2009, PARASITOL RES, V104, P1035, DOI 10.1007/s00436-008-1286-8; PARKIN DM, 1991, INT J CANCER, V48, P323, DOI 10.1002/ijc.2910480302; Patel T, 2011, NAT REV GASTRO HEPAT, V8, P189, DOI 10.1038/nrgastro.2011.20; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Prakobwong S, 2009, INT J PARASITOL, V39, P825, DOI 10.1016/j.ijpara.2008.12.002; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Serradell MC, 2007, VET IMMUNOL IMMUNOP, V117, P197, DOI 10.1016/j.vetimm.2007.03.007; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Shin Y, 2011, LAB CHIP, V11, P2175, DOI 10.1039/c1lc20039a; Sirica AE, 2012, NAT REV GASTRO HEPAT, V9, P44, DOI 10.1038/nrgastro.2011.222; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Taylor-Robinson SD, 2001, GUT, V48, P816, DOI 10.1136/gut.48.6.816; Thuwajit C, 2004, PARASITOLOGY, V129, P455, DOI 10.1017/S0031182004005815; Watanapa P, 2002, BRIT J SURG, V89, P962, DOI 10.1046/j.1365-2168.2002.02143.x; Wu W, 2012, PARASITOL RES, V111, P1879, DOI 10.1007/s00436-012-3152-y	39	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110705	10.1371/journal.pone.0110705	http://dx.doi.org/10.1371/journal.pone.0110705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340585	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800049
J	Pedersen, AV; Andreassen, TF; Loland, CJ				Pedersen, Anders V.; Andreassen, Thorvald F.; Loland, Claus J.			A Conserved Salt Bridge between Transmembrane Segments 1 and 10 Constitutes an Extracellular Gate in the Dopamine Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Molecular Pharmacology; Monoamine Transporter; Neuroscience; Neurotransmitter Transport; Protein Structure; Structure-Function Relationship; Zinc Site Engineering	ACID GABA TRANSPORTER-1; SEROTONIN TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; BACTERIAL HOMOLOG; BINDING-SITES; CONFORMATIONAL DYNAMICS; ALTERNATING ACCESS; COCAINE BINDING; LEUT; PERMEATION	Background: The presence of an extracellular gate in the dopamine transporter has been proposed. Results: We use rescue mutations, zinc site engineering, and cysteine-reactive chemistry to establish the presence of the gate. Conclusion: Arg-85 and Asp-476 constitute a functional thin gate in the dopamine transporter. Significance: This gains further insight into the molecular mechanisms behind substrate transport by mammalian neurotransmitter transporters. Neurotransmitter transporters play an important role in termination of synaptic transmission by mediating reuptake of neurotransmitter, but the molecular processes behind translocation are still unclear. The crystal structures of the bacterial homologue, LeuT, provided valuable insight into the structural and dynamic requirements for substrate transport. These structures support the existence of gating domains controlling access to a central binding site. On the extracellular side, access is controlled by the thin gate formed by an interaction between Arg-30 and Asp-404. In the human dopamine transporter (DAT), the corresponding residues are Arg-85 and Asp-476. Here, we present results supporting the existence of a similar interaction in DAT. The DAT R85D mutant has a complete loss of function, but the additional insertion of an arginine in opposite position (R85D/D476R), causing a charge reversal, results in a rescue of binding sites for the cocaine analogue [H-3]CFT. Also, the coordination of Zn2+ between introduced histidines (R85H/D476H) caused a approximate to 2.5-fold increase in [H-3]CFT binding (B-max). Importantly, Zn2+ also inhibited [H-3]dopamine transport in R85H/D476H, suggesting that a dynamic interaction is required for the transport process. Furthermore, cysteine-reactive chemistry shows that mutation of the gating residues causes a higher proportion of transporters to reside in the outward facing conformation. Finally, we show that charge reversal of the corresponding residues (R104E/E493R) in the serotonin transporter also rescues [H-3](S)-citalopram binding, suggesting a conserved feature. Taken together, these data suggest that the extracellular thin gate is present in monoamine transporters and that a dynamic interaction is required for substrate transport.	[Pedersen, Anders V.; Andreassen, Thorvald F.; Loland, Claus J.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Neuropharmacol Lab, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Loland, CJ (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark.	cllo@sund.ku.dk	Loland, Claus/E-5975-2014	Loland, Claus/0000-0002-1773-1446	Danish Independent Research Council, Sapere Aude; Lundbeck Foundation; UNIK Center for Synthetic Biology	Danish Independent Research Council, Sapere Aude; Lundbeck Foundation(Lundbeckfonden); UNIK Center for Synthetic Biology	This work was supported in part by funds from the Danish Independent Research Council, Sapere Aude (to C. J. L.), the Lundbeck Foundation (to C. J. L.), and the UNIK Center for Synthetic Biology (to C. J. L.).	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Ben-Yona A, 2013, J BIOL CHEM, V288, P4549, DOI 10.1074/jbc.M112.430215; Ben-Yona A, 2012, J BIOL CHEM, V287, P7159, DOI 10.1074/jbc.M111.323634; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Borre L, 2014, J BIOL CHEM, V289, P25764, DOI 10.1074/jbc.M114.574269; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen NH, 2004, J NEUROCHEM, V89, P853, DOI 10.1111/j.1471-4159.2004.02386.x; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Kniazeff J, 2005, NEUROPHARMACOLOGY, V49, P715, DOI 10.1016/j.neuropharm.2005.07.003; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; MacAulay N, 2002, J PHYSIOL-LONDON, V544, P447, DOI 10.1113/jphysiol.2002.022897; MacAulay N, 2001, J BIOL CHEM, V276, P40476, DOI 10.1074/jbc.M105578200; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Norregaard L, 2000, BIOCHEMISTRY-US, V39, P15836, DOI 10.1021/bi0018335; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sonders MS, 1997, J NEUROSCI, V17, P960; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	43	15	16	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					35003	35014		10.1074/jbc.M114.586982	http://dx.doi.org/10.1074/jbc.M114.586982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25339174	Green Published, hybrid			2022-12-26	WOS:000346260800048
J	Li, P; Shi, P; Lai, CH; Li, J; Zheng, YY; Xiong, Y; Zhang, LH; Tian, CL				Li, Pan; Shi, Pan; Lai, Chaohua; Li, Juan; Zheng, Yuanyuan; Xiong, Ying; Zhang, Longhua; Tian, Changlin			Solution NMR of MPS-1 Reveals a Random Coil Cytosolic Domain Structure	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; MINK-RELATED PEPTIDE-1; PROTEIN-KINASES; BETA-SUBUNIT; CAENORHABDITIS-ELEGANS; ACCESSORY SUBUNITS; K+ CHANNELS; COMPLEX; FAMILY; MECHANISMS	Caenorhabditis elegans MPS1 is a single transmembrane helical auxiliary subunit that co-localizes with the voltage-gated potassium channel KVS1 in the nematode nervous system. MPS-1 shares high homology with KCNE (potassium voltagegated channel subfamily E member) auxiliary subunits, and its cytosolic domain was reported to have a serine/threonine kinase activity that modulates KVS1 channel function via phosphorylation. In this study, NMR spectroscopy indicated that the full length and truncated MPS-1 cytosolic domain (134-256) in the presence or absence of n-dodecylphosphocholine detergent micelles adopted a highly flexible random coil secondary structure. In contrast, protein kinases usually adopt a stable folded conformation in order to implement substrate recognition and phosphoryl transfer. The highly flexible random coil secondary structure suggests that MPS-1 in the free state is unstructured but may require a substrate or binding partner to adopt stable structure required for serine/threonine kinase activity.	[Li, Pan; Lai, Chaohua; Li, Juan; Zheng, Yuanyuan; Xiong, Ying; Zhang, Longhua; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Microscale Phys Sci, Hefei 230026, Anhui, Peoples R China; [Shi, Pan; Tian, Changlin] Chinese Acad Sci, Hefei Inst Phys Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Zhang, LH (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Microscale Phys Sci, Hefei 230026, Anhui, Peoples R China.	zlhustc@ustc.edu.cn; cltian@ustc.edu.cn	Tian, Changlin/P-1469-2014; Zhang, Longhua/P-1417-2014		National Natural Science Foundation of China [U1332138, 31300685]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China grant U1332138 to CT and National Natural Science Foundation of China young investigator grant 31300685 to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Cai SQ, 2006, CELL BIOCHEM BIOPHYS, V46, P91, DOI 10.1385/CBB:46:1:91; Cai SQ, 2009, EMBO J, V28, P1601, DOI 10.1038/emboj.2009.112; Cai SQ, 2005, NAT NEUROSCI, V8, P1503, DOI 10.1038/nn1557; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kosinska U, 2005, FEBS J, V272, P6365, DOI 10.1111/j.1742-4658.2005.05030.x; Li P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04973; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; Mine S, 2000, PROTEIN SCI, V9, P1669, DOI 10.1110/ps.9.9.1669; Park KH, 2005, J BIOL CHEM, V280, P21893, DOI 10.1074/jbc.M502732200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tian CL, 2007, BIOCHEMISTRY-US, V46, P11459, DOI 10.1021/bi700705j; Tian CL, 2005, METHOD ENZYMOL, V394, P321, DOI 10.1016/S0076-6879(05)94012-3; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; Wang Y, 2007, BIOPHYS J, V93, P3083, DOI 10.1529/biophysj.107.110320; Xiang SQ, 2013, STRUCTURE, V21, P2162, DOI 10.1016/j.str.2013.09.014; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	28	0	0	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111035	10.1371/journal.pone.0111035	http://dx.doi.org/10.1371/journal.pone.0111035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347290	Green Submitted, gold, Green Published			2022-12-26	WOS:000347994900039
J	Santamaria, RD; Shao, MR; Wang, GM; Nino-Liu, DO; Kundariya, H; Wamboldt, Y; Dweikat, I; Mackenzie, SA				Santamaria, Roberto de la Rosa; Shao, Mon-Ray; Wang, Guomei; Nino-Liu, David O.; Kundariya, Hardik; Wamboldt, Yashitola; Dweikat, Ismail; Mackenzie, Sally A.			MSH1-Induced Non-Genetic Variation Provides a Source of Phenotypic Diversity in Sorghum bicolor	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; DNA METHYLATION; EPIGENETICS; VERNALIZATION	MutS Homolog 1 (MSH1) encodes a plant-specific protein that functions in mitochondria and chloroplasts. We showed previously that disruption or suppression of the MSH1 gene results in a process of developmental reprogramming that is heritable and non-genetic in subsequent generations. In Arabidopsis, this developmental reprogramming process is accompanied by striking changes in gene expression of organellar and stress response genes. This developmentally reprogrammed state, when used in crossing, results in a range of variation for plant growth potential. Here we investigate the implications of MSH1 modulation in a crop species. We found that MSH1-mediated phenotypic variation in Sorghum bicolor is heritable and potentially valuable for crop breeding. We observed phenotypic variation for grain yield, plant height, flowering time, panicle architecture, and above-ground biomass. Focusing on grain yield and plant height, we found some lines that appeared to respond to selection. Based on amenability of this system to implementation in a range of crops, and the scope of phenotypic variation that is derived, our results suggest that MSH1 suppression provides a novel approach for breeding in crops.	[Santamaria, Roberto de la Rosa; Shao, Mon-Ray; Kundariya, Hardik; Wamboldt, Yashitola; Mackenzie, Sally A.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Santamaria, Roberto de la Rosa; Shao, Mon-Ray; Dweikat, Ismail; Mackenzie, Sally A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Wang, Guomei; Nino-Liu, David O.] Monsanto Co, Chesterfield Village Res Ctr, Chesterfield, MO USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Monsanto	Mackenzie, SA (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA.	smackenzie2@unl.edu	Kundariya, Hardik/AAE-1911-2021	Kundariya, Hardik/0000-0002-4065-3888	Bill & Melinda Gates Foundation [OPP1059119]; National Science Foundation [IOS-1126935]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Bill & Melinda Gates Foundation (OPP1059119, http://www. gatesfoundation. org) and the National Science Foundation (IOS-1126935, http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnoor RV, 2003, P NATL ACAD SCI USA, V100, P5968, DOI 10.1073/pnas.1037651100; Brown PJ, 2008, GENETICS, V180, P629, DOI 10.1534/genetics.108.092239; Cheptou PO, 2013, HEREDITY, V110, P205, DOI 10.1038/hdy.2012.66; Colome-Tatche M, 2012, P NATL ACAD SCI USA, V109, P16240, DOI 10.1073/pnas.1212955109; Cowling WA, 2013, PLANT BREEDING, V132, P1, DOI 10.1111/pbr.12026; Dooner HK, 2007, CURR OPIN GENET DEV, V17, P486, DOI 10.1016/j.gde.2007.08.010; El-Soda M, 2014, TRENDS PLANT SCI, V19, P390, DOI 10.1016/j.tplants.2014.01.001; Gressel J., 2008, GENETIC GLASS CEILIN; Groszmann M, 2011, BBA-GENE REGUL MECH, V1809, P427, DOI 10.1016/j.bbagrm.2011.03.006; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Heo JB, 2011, EPIGENETICS-US, V6, P544, DOI 10.4161/epi.6.5.15235; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Li ML, 2009, MOL BREEDING, V24, P41, DOI 10.1007/s11032-009-9270-2; Migicovsky Z, 2013, BIOCHEM CELL BIOL, V91, P1, DOI 10.1139/bcb-2012-0046; MILLER FR, 1984, CROP SCI, V24, P1224, DOI 10.2135/cropsci1984.0011183X002400060074x; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Pinheiro J., 2019, NLME LINEAR NONLINEA; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Schloss SJ, 2002, THEOR APPL GENET, V105, P912, DOI 10.1007/s00122-002-0991-4; Schmitz RJ, 2007, BBA-GENE STRUCT EXPR, V1769, P269, DOI 10.1016/j.bbaexp.2007.02.003; Shedge V, 2010, PLANT PHYSIOL, V152, P1960, DOI 10.1104/pp.109.152827; Shivaprasad PV, 2012, EMBO J, V31, P257, DOI 10.1038/emboj.2011.458; Smith AM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00006; Stroud H, 2013, ELIFE, V2, DOI 10.7554/eLife.00354; Tsaftaris AS, 2007, PLANT BREEDING REV, DOI [10.1002/9780470380130.ch2, DOI 10.1002/9780470380130.CH2]; Xu YZ, 2012, PLANT PHYSIOL, V159, P710, DOI 10.1104/pp.112.196055; Xu YZ, 2011, PLANT CELL, V23, P3428, DOI 10.1105/tpc.111.089136; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010	28	23	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e108407	10.1371/journal.pone.0108407	http://dx.doi.org/10.1371/journal.pone.0108407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347794	Green Published, gold			2022-12-26	WOS:000347994900004
J	Novotna, A; Krasulova, K; Bartonkova, I; Korhonova, M; Bachleda, P; Anzenbacher, P; Dvorak, Z				Novotna, Aneta; Krasulova, Kristyna; Bartonkova, Iveta; Korhonova, Martina; Bachleda, Petr; Anzenbacher, Pavel; Dvorak, Zdenek			Dual Effects of Ketoconazole cis-Enantiomers on CYP3A4 in Human Hepatocytes and HepG2 Cells	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; DIABETES-MELLITUS; IN-VITRO; INHIBITION; EXPRESSION; METABOLISM; ACTIVATION; LINES	Antifungal drug ketoconazole causes severe drug-drug interactions by influencing gene expression and catalytic activity of major drug-metabolizing enzyme cytochrome P450 CYP3A4. Ketoconazole is administered in the form of racemic mixture of two cis-enantiomers, i.e. (+)-ketoconazole and (-)-ketoconazole. Many enantiopure drugs were introduced to human pharmacotherapy in last two decades. In the current paper, we have examined the effects of ketoconazole cis-enantiomers on the expression of CYP3A4 in human hepatocytes and HepG2 cells and on catalytic activity of CYP3A4 in human liver microsomes. We show that both ketoconazole enantiomers induce CYP3A4 mRNA and protein in human hepatocytes and HepG2 cells. Gene reporter assays revealed partial agonist activity of ketoconazole enantiomers towards pregnane X receptor PXR. Catalytic activity of CYP3A4/5 towards two prototypic substrates of CYP3A enzymes, testosterone and midazolam, was determined in presence of both (+)-ketoconazole and (-)-ketoconazole in human liver microsomes. Overall, both ketoconazole cis-enantiomers induced CYP3A4 in human cells and inhibited CYP3A4 in human liver microsomes. While interaction of ketoconazole with PXR and induction of CYP3A4 did not display enantiospecific pattern, inhibition of CYP3A4 catalytic activity by ketoconazole differed for ketoconazole cis-enantiomers ((+)-ketoconazole IC50 1.69 mu M, K-i 0.92 mu M for testosterone, IC50 1.46 mu M, K-i 2.52 mu M for midazolam; (-)-ketoconazole IC50 0.90 mu M, K-i 0.17 mu M for testosterone, IC50 1.04 mu M, K-i 1.51 mu M for midazolam).	[Novotna, Aneta; Bartonkova, Iveta; Korhonova, Martina; Dvorak, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Krasulova, Kristyna; Anzenbacher, Pavel] Palacky Univ, Fac Med & Dent, Inst Pharmacol, CR-77147 Olomouc, Czech Republic; [Bachleda, Petr] Univ Hosp Olomouc, Dept Surg 2, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University Hospital Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	moulin@email.cz	Grycova, Aneta/AGH-1515-2022	Grycova, Aneta/0000-0002-2134-1125; Dvorak, Zdenek/0000-0002-3938-3585; Krasulova, Kristyna/0000-0002-8303-6847	Czech Science Agency [GACR 13-01809S]; Palacky University [PrF-2014-004]	Czech Science Agency; Palacky University	This research was supported by the Czech Science Agency [Grant GACR 13-01809S] and by the student project from Palacky University [PrF-2014-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allqvist A, 2007, EUR J CLIN PHARMACOL, V63, P173, DOI 10.1007/s00228-006-0230-z; Arakaki R, 2010, EXPERT OPIN INV DRUG, V19, P185, DOI 10.1517/13543780903381411; Caner H, 2004, DRUG DISCOV TODAY, V9, P105, DOI 10.1016/S1359-6446(03)02904-0; Dilmaghanian S, 2004, CHIRALITY, V16, P79, DOI 10.1002/chir.10294; Duret C, 2006, MOL PHARMACOL, V70, P329, DOI 10.1124/mol.105.022046; Dvorak Z, 2011, TOXICOL LETT, V202, P129, DOI 10.1016/j.toxlet.2011.01.027; Greenblatt DJ, 2011, J PHARM PHARMACOL, V63, P214, DOI 10.1111/j.2042-7158.2010.01202.x; Greenblatt DJ, 2010, XENOBIOTICA, V40, P713, DOI 10.3109/00498254.2010.506224; Gubbins PO, 2010, MYCOSES, V53, P95, DOI 10.1111/j.1439-0507.2009.01820.x; Heeres J, 2010, MOLECULES, V15, P4129, DOI 10.3390/molecules15064129; Huang H, 2007, ONCOGENE, V26, P258, DOI 10.1038/sj.onc.1209788; Korashy HM, 2007, TOXICOL SCI, V97, P32, DOI 10.1093/toxsci/kfm012; Li H, 2013, J BIOL CHEM, V288, P13655, DOI 10.1074/jbc.M113.455485; Lim YP, 2009, PHARMACOGENET GENOM, V19, P11, DOI 10.1097/FPC.0b013e32831665ea; Novotna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101832; Novotna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098711; Phillips I.R., 2006, CYTOCHROME P450 PROT; ROTSTEIN DM, 1992, J MED CHEM, V35, P2818, DOI 10.1021/jm00093a015; Schwartz SL, 2008, CLIN THER, V30, P1081, DOI 10.1016/j.clinthera.2008.05.021; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; Svecova L, 2008, DRUG METAB DISPOS, V36, P339, DOI 10.1124/dmd.107.018341; Venkatesh M, 2011, MOL PHARMACOL, V80, P124, DOI 10.1124/mol.111.071787; Vrzal R, 2013, J BIOCHEM MOL TOXIC, V27, P515, DOI 10.1002/jbt.21516; Wang HW, 2007, CLIN CANCER RES, V13, P2488, DOI 10.1158/1078-0432.CCR-06-1592	25	21	21	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111286	10.1371/journal.pone.0111286	http://dx.doi.org/10.1371/journal.pone.0111286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343516	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500096
J	Quan, JH; Kang, BH; Cha, GH; Zhou, W; Koh, YB; Yang, JB; Yoo, HJ; Lee, MA; Ryu, JS; Noh, HT; Kwon, J; Lee, YH				Quan, Juan-Hua; Kang, Byung-Hun; Cha, Guang-Ho; Zhou, Wei; Koh, Young-Bok; Yang, Jung-Bo; Yoo, Heon-Jong; Lee, Min-A; Ryu, Jae-Sook; Noh, Heung-Tae; Kwon, Jaeyul; Lee, Young-Ha			Trichonomas vaginalis Metalloproteinase Induces Apoptosis of SiHa Cells through Disrupting the Mcl-1/Bim and Bcl-xL/Bim Complexes	PLOS ONE			English	Article							TRICHOMONAS-VAGINALIS; DEPENDENT APOPTOSIS; LEISHMANIA-MEXICANA; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; DEGRADATION; CASPASE-3; 1,10-PHENANTHROLINE; MAINTENANCE; INVOLVEMENT	To elucidate the roles of metalloproteinases and the Bcl-2 family of proteins in Trichovaginalis. vaginalis-induced apoptosis in human cervical cancer cells (SiHa cells) and vaginal epithelial cells (MS74 cells), SiHa cells and MS74 cells were incubated with live T. vaginalis, T. vaginalis excretory and secretory products (ESP), and T. vaginalis lysates, either with or without the specific metalloproteinase inhibitor 1,10-phenanthroline (1,10-PT), and examined apoptotic events and Bcl-2 signaling. The live T. vaginalis and the T. vaginalis ESP induced the release of cytochrome c into the cytosol, the activation of caspase-3 and caspase-9, and the cleavage of PARP. Additionally, the live T. vaginalis, but not the T. vaginalis lysate, induced the cleavage of the proapoptotic Bim protein. The live T. vaginalis and the T. vaginalis ESP, but not the T. vaginalis lysate, induced the dose-dependent cleavage of the antiapoptotic Bcl-xL and Mcl-1 proteins and decreased the association levels of Bcl-xL/Bim and Mcl-1/Bim complexes. We performed gelatin zymography and casein-hydrolysis assays on the live T. vaginalis and the T. vaginalis ESP to identify the apoptosis-inducing factor. Both the live T. vaginalis and the ESP contained high levels of metalloproteinases, of which activities were significantly inhibited by 1,10-PT treatment. Furthermore, the 1,10-PT blocked the cleavage of Bcl-xL, Mcl-1, PARP, caspase-3, and caspase-9, as well as the release of cytochrome c into the cytosol, and it significantly increased the association levels of the Bcl-xL/Bim and Mcl-1/Bim protein complexes, returning them to normal levels. Our results demonstrate that T. vaginalis induces mitochondria-dependent apoptosis in SiHa cells through the dissociation of Bcl-xL/Bim and Mcl-1/Bim complexes and that the apoptosis is blocked by the metalloproteinase inhibitor 1,10-PT. These results expand our understanding of the role of metalloproteinases in T. vaginalis-induced apoptosis and the signaling pathway in trichomoniasis of the cervicovaginal epithelial cells.	[Quan, Juan-Hua] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Guangdong, Peoples R China; [Kang, Byung-Hun; Koh, Young-Bok; Yang, Jung-Bo; Yoo, Heon-Jong; Lee, Min-A; Noh, Heung-Tae] Chungnam Natl Univ Hosp, Dept Obstet & Gynecol, Taejon, South Korea; [Cha, Guang-Ho; Zhou, Wei; Lee, Young-Ha] Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon, South Korea; [Ryu, Jae-Sook] Hanyang Univ, Coll Med, Dept Environm Biol & Med Parasitol, Seoul 133791, South Korea; [Kwon, Jaeyul] Chungnam Natl Univ, Sch Med, Dept Med Educ, Taejon, South Korea	Guangdong Medical University; Chungnam National University; Chungnam National University Hospital; Chungnam National University; Hanyang University; Chungnam National University	Lee, YH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon, South Korea.	yhalee@cnu.ac.kr		Kang, Byung Hun/0000-0001-5037-3225; Kwon, Jaeyul/0000-0002-2452-4111; Yoo, Heon Jong/0000-0003-4808-3450; Cha, Guang-Ho/0000-0003-2639-1727	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2007-0054932]; National Natural Science Foundation of China [81300368]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2007-0054932), and National Natural Science Foundation of China (Grant No. 81300368 to Juan-Hua Quan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderete JF, 1999, MICROB PATHOGENESIS, V27, P93, DOI 10.1006/mpat.1999.0281; BOUVIER J, 1995, METHOD ENZYMOL, V248, P614; Chang JH, 2004, PARASITE IMMUNOL, V26, P141, DOI 10.1111/j.0141-9838.2004.00693.x; CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Correa LM, 2000, DEV BIOL, V225, P124, DOI 10.1006/dbio.2000.9825; FELBER JP, 1962, BIOCHEMISTRY-US, V1, P231, DOI 10.1021/bi00908a006; Figueroa-Angulo EE, 2012, MICROBES INFECT, V14, P1411, DOI 10.1016/j.micinf.2012.09.004; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; Han IH, 2012, PARASITE IMMUNOL, V34, P8, DOI 10.1111/j.1365-3024.2011.01338.x; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Kang JH, 2006, PARASITE IMMUNOL, V28, P439, DOI 10.1111/j.1365-3024.2006.00884.x; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kucknoor A, 2005, CELL MICROBIOL, V7, P887, DOI 10.1111/j.1462-5822.2005.00522.x; Ma LN, 2011, PARASITOL RES, V109, P71, DOI 10.1007/s00436-010-2222-2; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Quan JH, 2013, EXP PARASITOL, V133, P462, DOI 10.1016/j.exppara.2013.01.005; Ryan CM, 2011, ESSAYS BIOCHEM, V51, P161, DOI [10.1042/BSE0510161, 10.1042/bse0510161]; Seay MB, 1996, INFECT IMMUN, V64, P5129, DOI 10.1128/IAI.64.12.5129-5137.1996; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Sommer U, 2005, J BIOL CHEM, V280, P23853, DOI 10.1074/jbc.M501752200; Song HO, 2008, EXP PARASITOL, V118, P59, DOI 10.1016/j.exppara.2007.06.010; Song HO, 2010, KOREAN J PARASITOL, V48, P1, DOI 10.3347/kjp.2010.48.1.1; Soper D, 2004, AM J OBSTET GYNECOL, V190, P281, DOI 10.1016/j.ajog.2003.08.023; Van der Pol B, 2007, CLIN INFECT DIS, V44, P23, DOI 10.1086/509934; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wuilleme-Toumi S, 2007, BIOCHEM BIOPH RES CO, V361, P865, DOI 10.1016/j.bbrc.2007.07.070; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Z, 2012, J BIOL INORG CHEM, V17, P1257, DOI 10.1007/s00775-012-0940-x; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	33	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110659	10.1371/journal.pone.0110659	http://dx.doi.org/10.1371/journal.pone.0110659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343522	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500042
J	Buskirk, AD; Green, BJ; Lemons, AR; Nayak, AP; Goldsmith, WT; Kashon, ML; Anderson, SE; Hettick, JM; Templeton, SP; Germolec, DR; Beezhold, DH				Buskirk, Amanda D.; Green, Brett J.; Lemons, Angela R.; Nayak, Ajay P.; Goldsmith, W. Travis; Kashon, Michael L.; Anderson, Stacey E.; Hettick, Justin M.; Templeton, Steven P.; Germolec, Dori R.; Beezhold, Donald H.			A Murine Inhalation Model to Characterize Pulmonary Exposure to Dry Aspergillus fumigatus Conidia	PLOS ONE			English	Article							RESPONSES; CELLS; ALLERGENS; ASTHMA	Most murine models of fungal exposure are based on the delivery of uncharacterized extracts or liquid conidia suspensions using aspiration or intranasal approaches. Studies that model exposure to dry fungal aerosols using whole body inhalation have only recently been described. In this study, we aimed to characterize pulmonary immune responses following repeated inhalation of conidia utilizing an acoustical generator to deliver dry fungal aerosols to mice housed in a nose only exposure chamber. Immunocompetent female BALB/cJ mice were exposed to conidia derived from Aspergillus fumigatus wild-type (WT) or a melanin-deficient (Delta alb1) strain. Conidia were aerosolized and delivered to mice at an estimated deposition dose of 1 x 10(5) twice a week for 4 weeks (8 total). Histopathological and immunological endpoints were assessed 4, 24, 48, and 72 hours after the final exposure. Histopathological analysis showed that conidia derived from both strains induced lung inflammation, especially at 24 and 48 hour time points. Immunological endpoints evaluated in bronchoalveolar lavage fluid (BALF) and the mediastinal lymph nodes showed that exposure to WT conidia led to elevated numbers of macrophages, granulocytes, and lymphocytes. Importantly, CD8(+) IL17(+) (Tc17) cells were significantly higher in BALF and positively correlated with germination of A. fumigatus WT spores. Germination was associated with specific IgG to intracellular proteins while Delta alb1 spores elicited antibodies to cell wall hydrophobin. These data suggest that inhalation exposures may provide a more representative analysis of immune responses following exposures to environmentally and occupationally prevalent fungal contaminants.	[Buskirk, Amanda D.; Green, Brett J.; Lemons, Angela R.; Nayak, Ajay P.; Anderson, Stacey E.; Hettick, Justin M.; Templeton, Steven P.; Beezhold, Donald H.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [Goldsmith, W. Travis] NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA; [Kashon, Michael L.] NIOSH, Biostat & Epidemiol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA; [Germolec, Dori R.] Natl Inst Environm Hlth Sci, Natl Toxicol Program Div, Toxicol Branch, Res Triangle Pk, NC USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Beezhold, DH (corresponding author), NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA.	zec1@cdc.gov	; Templeton, Steven/I-6635-2013	Beezhold, Donald/0000-0001-5543-5747; Lemons, Angela/0000-0003-3057-9888; Templeton, Steven/0000-0003-3430-7011	intramural National Institute for Occupational Safety and Health (NIOSH); NIEHS IAA [AES 12007-00100000]	intramural National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NIEHS IAA	This study was supported by intramural National Institute for Occupational Safety and Health (NIOSH) funding and by an interagency agreement with NIEHS IAA# AES 12007-00100000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Bakker-Woudenberg IAJM, 2003, J MICROBIOL METH, V54, P295, DOI 10.1016/S0167-7012(03)00118-0; Black PN, 2000, ALLERGY, V55, P501, DOI 10.1034/j.1398-9995.2000.00293.x; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Buskirk AD, 2014, J IMMUNOTOXICOL, V11, P180, DOI 10.3109/1547691X.2013.819054; Carvalho A, 2012, BLOOD, V119, P967, DOI 10.1182/blood-2011-06-362582; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Chakraborty AB, 2007, RAPID COMMUN MASS SP, V21, P730, DOI 10.1002/rcm.2888; Collins C, 2013, J PROTEOME RES, V12, P2552, DOI 10.1021/pr301131t; Crameri R, 2006, CHEM IMMUNOL ALLERGY, V91, P121; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Eduard W, 2009, CRIT REV TOXICOL, V39, P799, DOI 10.3109/10408440903307333; FOGELMARK B, 1991, INT J EXP PATHOL, V72, P387; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Green BJ, 2011, CLIN EXP ALLERGY, V41, P1022, DOI 10.1111/j.1365-2222.2011.03756.x; Green BJ, 2005, J ALLERGY CLIN IMMUN, V115, P1043, DOI 10.1016/j.jaci.2005.02.009; Green BJ, 2003, J ALLERGY CLIN IMMUN, V111, P285, DOI 10.1067/mai.2003.57; Green BJ, 2006, MED MYCOL, V44, pS245, DOI 10.1080/13693780600776308; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Heseltine E., 2009, WHO GUID IND AIR QUA; Hoselton SA, 2010, MED MYCOL, V48, P1056, DOI 10.3109/13693786.2010.485582; Huppler AR, 2014, J IMMUNOL, V192, P1745, DOI 10.4049/jimmunol.1302265; Institute of Medicine (US) Committee on Damp Indoor Spaces and Health, 2004, DAMP IND SPAC HLTH; Jarvis BB, 1998, APPL ENVIRON MICROB, V64, P3620; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; McKinney W, 2009, INHAL TOXICOL, V21, P1053, DOI 10.1080/08958370802712713; Millon L, 2012, J ALLERGY CLIN IMMUN, V130, P803, DOI 10.1016/j.jaci.2012.03.039; Mitakakis TZ, 2001, J ALLERGY CLIN IMMUN, V107, P388, DOI 10.1067/mai.2001.112602; Murdock BJ, 2011, INFECT IMMUN, V79, P125, DOI 10.1128/IAI.00508-10; Nanjappa SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002771; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Raabe OG, 1988, ANN OCCUP HYG, V32, P53, DOI DOI 10.1093/ANNHYG/32.INHALED_; Samarasinghe AE, 2011, FUNGAL BIOL-UK, V115, P21, DOI 10.1016/j.funbio.2010.09.013; Shreiner AB, 2012, INFECT IMMUN, V80, P388, DOI 10.1128/IAI.05530-11; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Templeton SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018777; Templeton SP, 2010, MED MYCOL, V48, P217, DOI 10.3109/13693780903420658; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; van de Veerdonk FL, 2009, BMB REP, V42, P776, DOI 10.5483/BMBRep.2009.42.12.776	41	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109855	10.1371/journal.pone.0109855	http://dx.doi.org/10.1371/journal.pone.0109855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340353	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800019
J	Schwegmann, A; Lindemann, JP; Egelhaaf, M				Schwegmann, Alexander; Lindemann, Jens Peter; Egelhaaf, Martin			Temporal Statistics of Natural Image Sequences Generated by Movements with Insect Flight Characteristics	PLOS ONE			English	Article							OPTIC FLOW; BLOWFLY FLIGHT; VISUAL-SYSTEM; POWER SPECTRA; MOTION-DETECTION; DROSOPHILA; INFORMATION; CONTRAST; BEHAVIOR; REPRESENTATION	Many flying insects, such as flies, wasps and bees, pursue a saccadic flight and gaze strategy. This behavioral strategy is thought to separate the translational and rotational components of self-motion and, thereby, to reduce the computational efforts to extract information about the environment from the retinal image flow. Because of the distinguishing dynamic features of this active flight and gaze strategy of insects, the present study analyzes systematically the spatiotemporal statistics of image sequences generated during saccades and intersaccadic intervals in cluttered natural environments. We show that, in general, rotational movements with saccade-like dynamics elicit fluctuations and overall changes in brightness, contrast and spatial frequency of up to two orders of magnitude larger than translational movements at velocities that are characteristic of insects. Distinct changes in image parameters during translations are only caused by nearby objects. Image analysis based on larger patches in the visual field reveals smaller fluctuations in brightness and spatial frequency composition compared to small patches. The temporal structure and extent of these changes in image parameters define the temporal constraints imposed on signal processing performed by the insect visual system under behavioral conditions in natural environments.	[Schwegmann, Alexander; Lindemann, Jens Peter; Egelhaaf, Martin] Univ Bielefeld, Neurobiol & Cognit Interact Technol Ctr Excellenc, D-33615 Bielefeld, Germany	University of Bielefeld	Schwegmann, A (corresponding author), Univ Bielefeld, Neurobiol & Cognit Interact Technol Ctr Excellenc, D-33615 Bielefeld, Germany.	neurobiologie@uni-bielefeld.de	Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270; Lindemann, Jens Peter/0000-0002-5441-7931	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; Balboa RM, 2003, VISION RES, V43, P2527, DOI 10.1016/S0042-6989(03)00471-1; BEERSMA DGM, 1977, J COMP PHYSIOL, V119, P207, DOI 10.1007/BF00656634; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; Boeddeker N, 2005, J COMP PHYSIOL A, V191, P1143, DOI 10.1007/s00359-005-0038-9; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1899, DOI 10.1098/rspb.2009.2326; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Borst A, 2012, E NEUROFORUM, V3, P59; Braun E, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00001; Braun E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009361; Brinkworth RSA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000555; Bruce NDB, 2006, NEUROCOMPUTING, V69, P1301, DOI 10.1016/j.neucom.2005.12.096; Calow D, 2007, NETWORK-COMP NEURAL, V18, P343, DOI 10.1080/09548980701642277; Collett T.S., 1982, P111; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Dror RO, 2001, J OPT SOC AM A, V18, P241, DOI 10.1364/JOSAA.18.000241; Durant S, 2012, NEURAL COMPUT, V24, P1781, DOI 10.1162/NECO_a_00294; Eckert MP, 2001, MOTION VISION, P333; ECKERT MP, 1993, J OPT SOC AM A, V10, P1582, DOI 10.1364/JOSAA.10.001582; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; Egelhaaf M, 2006, INVERTEBRATE VISION, P399; Egelhaaf Martin, 1993, Reviews of Oculomotor Research, V5, P53; Egelhaaf M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00108; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Geurten BRH, 2010, J EXP BIOL, V213, P2461, DOI 10.1242/jeb.036079; HARDIE RC, 1979, J COMP PHYSIOL, V129, P19, DOI 10.1007/BF00679908; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; Hennig P, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00014, 10.3389/fncir.2012.00108]; Hornstein EP, 2000, P ROY SOC B-BIOL SCI, V267, P2111, DOI 10.1098/rspb.2000.1257; Hoyer P.O, NATURAL IMAGE STAT P; Jinggang Huang, 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P541, DOI 10.1109/CVPR.1999.786990; Karmeier K, 2006, J NEUROPHYSIOL, V96, P1602, DOI 10.1152/jn.00023.2006; Kern R, 2006, J EXP BIOL, V209, P1251, DOI 10.1242/jeb.02127; Kern R, 2005, PLOS BIOL, V3, P1130, DOI 10.1371/journal.pbio.0030171; Kern R, 2012, J EXP BIOL, V215, P2501, DOI 10.1242/jeb.061713; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; Kurtz R, 2012, FRONTIERS IN SENSING: FROM BIOLOGY TO ENGINEERING, P115; LAND MF, 1985, J COMP PHYSIOL A, V156, P525, DOI 10.1007/BF00613976; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; Lindemann JP, 2013, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00092; Meyer HG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021488; Moller R, 2002, J THEOR BIOL, V214, P619, DOI 10.1006/jtbi.2001.2484; Mronz M, 2008, J EXP BIOL, V211, P2026, DOI 10.1242/jeb.008268; NVIDIA Corp, 2001, HIGH RES ANT MULT; O'Carroll DC, 2011, J VISION, V11, DOI 10.1167/11.14.20; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; OCarroll DC, 1997, VISION RES, V37, P3427, DOI 10.1016/S0042-6989(97)00170-3; Okamura JY, 2007, J COMP NEUROL, V500, P189, DOI 10.1002/cne.21195; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Pamplona D, 2013, VISION RES, V83, P66, DOI 10.1016/j.visres.2013.01.011; Perkel D. H., 1968, Bulletin Neurosci Res Progr, V6, P221; Petrowitz R, 2000, J COMP PHYSIOL A, V186, P737, DOI 10.1007/s003590000127; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rothkopf C. A., 2009, ICDL 2009, P1, DOI DOI 10.1109/DEVLRN.2009.5175534; Rothkopf CA, 2009, VISUAL NEUROSCI, V26, P81, DOI 10.1017/S0952523808080978; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Ruderman DL, 1994, NETWORK-COMP NEURAL, V5, P598; Rufli M, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P3121, DOI 10.1109/IROS.2008.4650703; Scaramuzza D., 2006, IEEE INT C COMP VIS, P45, DOI DOI 10.1109/ICVS.2006.3; Scaramuzza D, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P5695, DOI 10.1109/IROS.2006.282372; Schilstra C, 1999, J EXP BIOL, V202, P1481; Schwegmann A, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00083; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; Spalthoff C, 2012, FRONT NEURAL CIRCUIT, V6, P1, DOI 10.3389/fncir.2012.00072; Stavenga DG, 2004, J EXP BIOL, V207, P1703, DOI 10.1242/jeb.00949; Stavenga DG, 2002, J COMP PHYSIOL A, V188, P337, DOI 10.1007/s00359-002-0307-9; Straw AD, 2006, J EXP BIOL, V209, P4339, DOI 10.1242/jeb.02517; Stuerzl W, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/3/036002; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; Tammero LF, 2002, J EXP BIOL, V205, P327; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; Thomas G, 1999, RAD TRANSFER ATMOSPH, DOI 101063/ 11333301; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; vanHateren JH, 1996, P SOC PHOTO-OPT INS, V2657, P139, DOI 10.1117/12.238709; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wardill TJ, 2012, SCIENCE, V336, P925, DOI 10.1126/science.1215317; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Warzecha AK, 2001, MOTION VISION, P239; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Zeil J, 2006, J COMP PHYSIOL A, V192, P1, DOI 10.1007/s00359-005-0048-7; Zeil J, 1997, VISION RES, V37, P3417, DOI 10.1016/S0042-6989(97)00106-5; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008; Zeil J, 2009, FLYING INSECTS AND ROBOTS, P87, DOI 10.1007/978-3-540-89393-6_7; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	100	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110386	10.1371/journal.pone.0110386	http://dx.doi.org/10.1371/journal.pone.0110386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340761	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800033
J	Tanida, I; Ueno, T; Uchiyama, Y				Tanida, Isei; Ueno, Takashi; Uchiyama, Yasuo			A Super-Ecliptic, pHluorin-mKate2, Tandem Fluorescent Protein-Tagged Human LC3 for the Monitoring of Mammalian Autophagy	PLOS ONE			English	Article							CYSTEINE PROTEINASES; IN-VITRO; CELLS; HOMOLOG; GABARAP; GATE-16; COLOCALIZATION; TRANSMISSION; DISSECTION; EXPRESSION	Tandem fluorescent protein-tagged LC3s that were comprised of a protein tag that emits green fluorescence (e. g., EGFP or mWasabi) fused with another tag that emits red fluorescence (e. g. mCherry or TagRFP) were used for monitoring the maturation step of mammalian autophagosomes. A critical point for this tandem fluorescent-tagged LC3 was the sensitivity of green fluorescence at an acidic pH. EGFP and mWasabi continue to emit a weak, but significant, fluorescence at a pH of approximately 6. To overcome this issue, we focused on super-ecliptic pHluorin, which is a more pH-sensitive GFP variation. The green fluorescence of EGFP and mWasabi in the cells was still observed at weakly acidic levels (pH 6.0-6.5). In contrast, the fluorescence of pHluorin was more significantly quenched at pH 6.5, and was almost completely abolished at pH 5.5-6.0, indicating that pHluorin is more suitable for use in a tandem fluorescent protein-tag for monitoring autophagy. A pHluorin-mKate2 tandem fluorescence protein showed pH-sensitive green fluorescence and pH-resistant far-red fluorescence. We therefore generated expression plasmids for pHluorin-mKate2-tagged human LC3 (PK-hLC3), which could be used as a modifier for LC3-lipidation. The green and far-red fluorescent puncta of PK-hLC3 were increased under starvation conditions. Puncta that were green-negative, but far-red positive, were increased when autolysosomes accumulated, but few puncta of the mutant PK-hLC3 Delta G that lacked the carboxyl terminal Gly essential for autophagy were observed in the cells under the same conditions. These results indicated that the PK-hLC3 were more appropriate for the pH-sensitive monitoring of the maturation step of autophagosomes.	[Tanida, Isei] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Tanida, Isei; Ueno, Takashi] Juntendo Univ, Sch Med, Lab Prote & Biomol Sci,Res Support Ctr, Bunkyo Ku, Tokyo 113, Japan; [Uchiyama, Yasuo] Juntendo Univ, Sch Med, Dept Cellular & Mol Neuropathol, Bunkyo Ku, Tokyo 113, Japan	National Institute of Infectious Diseases (NIID); Juntendo University; Juntendo University	Tanida, I (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan.	tanida@nih.go.jp; y-uchi@juntendo.ac.jp		Tanida, Isei/0000-0001-8999-3990	Japan Society for the Promotion of Science [10049091, 18076005]; Ministry of Education, Science, Sports and Culture of Japan (MEXT) [23111004, 23110517]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, [21570155, 14380308, 23390041, 25670099]; Ministry of Health, Labor and Welfare [16271401]; Takeda Science Foundation; Ministry of Health, Labor and Welfare	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan,(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grants-in-Aids for Challenging Exploratory Research (10049091 to YU), Scientific Researches on Priority Areas "Proteolysis in the Regulation of Biological Processes'' (18076005 to IT and TU), Scientific Researches on Innovative Area from the Japan Society for the Promotion of Science and the Ministry of Education, Science, Sports and Culture of Japan (MEXT) (23111004 and 23110517 to YU), a Grant-in-Aid for Scientific Research (C) (21570155 to IT), Grant-in-Aids for Scientific Research (B) (14380308 to TU; 23390041 to YU), a Grant-in-Aid for challenging Exploratory Research (25670099 to YU), a Grant-in-Aid for the "High-Tech Research Center'' Project for Private Universities, a matching fund subsidy (TU) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the MEXT-supported Program for the Strategic Research Foundation at Private Universities (YU), a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare (16271401 to TU), a Research Grant from the Takeda Science Foundation (TU), and by the Ministry of Health, Labor and Welfare (IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Bains M, 2009, METHOD ENZYMOL, V453, P145, DOI 10.1016/S0076-6879(08)04007-X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; FEDORKO ME, 1968, J CELL BIOL, V38, P392, DOI 10.1083/jcb.38.2.392; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MANN SS, 1994, J BIOL CHEM, V269, P11492; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; TAMAI M, 1987, CHEM PHARM BULL, V35, P1098; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2002, BIOCHEM BIOPH RES CO, V292, P256, DOI 10.1006/bbrc.2002.6645; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; UMEZAWA H, 1970, J ANTIBIOT, V23, P514, DOI 10.7164/antibiotics.23.514; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	38	46	46	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110600	10.1371/journal.pone.0110600	http://dx.doi.org/10.1371/journal.pone.0110600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340751	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800042
J	Bajaj, R; Munari, F; Becker, S; Zweckstetter, M				Bajaj, Rakhi; Munari, Francesca; Becker, Stefan; Zweckstetter, Markus			Interaction of the Intermembrane Space Domain of Tim23 Protein with Mitochondrial Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipid; Membrane; Mitochondria; Nuclear Magnetic Resonance (NMR); Protein Translocation; Protein Import	PRESEQUENCE TRANSLOCASE; YEAST MITOCHONDRIA; CHEMICAL-SHIFTS; CONTACT SITES; INNER; BINDING; IMPORT; OUTER; SUPERCOMPLEX; CARDIOLIPIN	Background: Tim23 mediates protein translocation into mitochondria. Results: Tim23 binds to mitochondria-like membranes through a hydrophobic anchor at its N terminus, with cardiolipin enhancing the interaction. Conclusion: The intermembrane space domain of Tim23 can interact with both inner and outer mitochondria-like membranes. Significance: Tim23 provides the central element for formation of the translocation contact. Tim23 mediates protein translocation into mitochondria. Although inserted into the inner membrane, the dynamic association of its intermembrane space (IMS) domain with the outer membrane promotes protein import. However, little is known about the molecular basis of this interaction. Here, we demonstrate that the IMS domain of Tim23 tightly associates with both inner and outer mitochondrial membrane-like membranes through a hydrophobic anchor at its N terminus. The structure of membrane-bound Tim23(IMS) is highly dynamic, allowing recognition of both the incoming presequence and other translocase components at the translocation contact. Cardiolipin enhances Tim23 membrane attachment, suggesting that cardiolipin can influence preprotein import.	[Bajaj, Rakhi; Munari, Francesca; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Munari, Francesca; Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Univ Med Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, D-37073 Gottingen, Germany	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Zweckstetter, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany.	markus.zweckstetter@dzne.de		Zweckstetter, Markus/0000-0002-2536-6581; Munari, Francesca/0000-0002-8217-1481	Deutsche Forschungsgemeinschaft Collaborative Research Center [860]	Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Collaborative Research Center 860 Project B2 (to M. Z.).	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Bajaj R, 2014, STRUCTURE, V22, P1501, DOI 10.1016/j.str.2014.07.015; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; de la Cruz L, 2010, PROTEIN SCI, V19, P2045, DOI 10.1002/pro.482; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Fernandez C, 2003, FEBS LETT, V555, P144, DOI 10.1016/S0014-5793(03)01155-4; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; Hammen PK, 1996, BIOCHEMISTRY-US, V35, P3772, DOI 10.1021/bi951848g; HORST M, 1995, EMBO J, V14, P2293, DOI 10.1002/j.1460-2075.1995.tb07223.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schulke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; SWANSON ST, 1992, BIOCHEMISTRY-US, V31, P5746, DOI 10.1021/bi00140a009; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P15297, DOI 10.1021/bi001774v; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	33	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34620	34626		10.1074/jbc.M114.595702	http://dx.doi.org/10.1074/jbc.M114.595702			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349212	hybrid, Green Published			2022-12-26	WOS:000346260800020
J	Huchzermeyer, C; Schlomberg, J; Welge-Lussen, U; Berendschot, TTJM; Pokorny, J; Kremers, J				Huchzermeyer, Cord; Schlomberg, Juliane; Welge-Luessen, Ulrich; Berendschot, Tos T. J. M.; Pokorny, Joel; Kremers, Jan			Macular Pigment Optical Density Measured by Heterochromatic Modulation Photometry	PLOS ONE			English	Article							FLICKER PHOTOMETRY; GANGLION-CELLS; LUTEIN SUPPLEMENTATION; HUMAN OBSERVERS; IN-VIVO; SENSITIVITY; LUMINANCE; PHOTORECEPTORS; REFLECTOMETRY; DEGENERATION	Purpose: To psychophysically determine macular pigment optical density (MPOD) employing the heterochromatic modulation photometry (HMP) paradigm by estimating 460 nm absorption at central and peripheral retinal locations. Methods: For the HMP measurements, two lights (B: 460 nm and R: 660 nm) were presented in a test field and were modulated in counterphase at medium or high frequencies. The contrasts of the two lights were varied in tandem to determine flicker detection thresholds. Detection thresholds were measured for different R: B modulation ratios. The modulation ratio with minimal sensitivity (maximal threshold) is the point of equiluminance. Measurements were performed in 25 normal subjects (11 male, 14 female; age: 30 +/- 11 years, mean +/- sd) using an eight channel LED stimulator with Maxwellian view optics. The results were compared with those from two published techniques - one based on heterochromatic flicker photometry (Macular Densitometer) and the other on fundus reflectometry (MPR). Results: We were able to estimate MPOD with HMP using a modified theoretical model that was fitted to the HMP data. The resultant MPODHMP values correlated significantly with the MPODMPR values and with the MPODHFP values obtained at 0.25 degrees and 0.5 degrees retinal eccentricity. Conclusions: HMP is a flicker-based method with measurements taken at a constant mean chromaticity and luminance. The data can be well fit by a model that allows all data points to contribute to the photometric equality estimate. Therefore, we think that HMP may be a useful method for MPOD measurements, in basic and clinical vision experiments.	[Huchzermeyer, Cord; Schlomberg, Juliane; Welge-Luessen, Ulrich; Kremers, Jan] Univ Erlangen Nurnberg, Univ Eye Hosp Erlangen, D-91054 Erlangen, Germany; [Schlomberg, Juliane] Univ Med Berlin, Charite, Dept Ophthalmol, Berlin, Germany; [Berendschot, Tos T. J. M.] Univ Eye Clin Maastricht, Maastricht, Netherlands; [Pokorny, Joel] Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA	University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Maastricht University; Maastricht University Medical Centre (MUMC); University of Chicago	Huchzermeyer, C (corresponding author), Univ Erlangen Nurnberg, Univ Eye Hosp Erlangen, D-91054 Erlangen, Germany.	Cord.Huchzermeyer@uk-erlangen.de; Jan.Kremers@uk-erlangen.de	Kremers, Jan/X-3125-2019; Berendschot, Tos TJM/M-8509-2016	Kremers, Jan/0000-0002-9293-7380; Berendschot, Tos TJM/0000-0002-8101-939X; Huchzermeyer, Cord/0000-0002-0408-8981	Erlanger Leistungsbezogene Anschub- und Nachwuchsfinanzierung (ELAN) der Universitat Erlangen; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Erlangen Rotationsstelle	Erlanger Leistungsbezogene Anschub- und Nachwuchsfinanzierung (ELAN) der Universitat Erlangen; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Erlangen Rotationsstelle	Support was provided by Erlanger Leistungsbezogene Anschub- und Nachwuchsfinanzierung (ELAN) der Universitat Erlangen to CH (http://www.elan.med.uni-erlangen.de/); Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Erlangen Rotationsstelle to CH (http://www.izkf.med.uni-erlangen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 1969, P TEL HASHOMER HOSPI, V8, P2; Berendschot TT, 2005, EXP EYE RES, V81, P602, DOI 10.1016/j.exer.2005.03.019; Berendschot TTJM, 2000, INVEST OPHTH VIS SCI, V41, P3322; BONE RA, 1992, VISION RES, V32, P105, DOI 10.1016/0042-6989(92)90118-3; BONE RA, 1985, VISION RES, V25, P1531, DOI 10.1016/0042-6989(85)90123-3; Bone RA, 2004, VISION RES, V44, P3045, DOI 10.1016/j.visres.2004.07.008; Chucair AJ, 2007, INVEST OPHTH VIS SCI, V48, P5168, DOI 10.1167/iovs.07-0037; Delori FC, 2001, J OPT SOC AM A, V18, P1212, DOI 10.1364/JOSAA.18.001212; Engles M, 2007, INVEST OPHTH VIS SCI, V48, P2922, DOI 10.1167/iovs.06-0883; Howells O, 2011, GRAEF ARCH CLIN EXP, V249, P315, DOI 10.1007/s00417-010-1577-5; KAISER PK, 1988, VISION RES, V28, P455, DOI 10.1016/0042-6989(88)90186-1; KREMERS J, 1992, J OPT SOC AM A, V9, P1477, DOI 10.1364/JOSAA.9.001477; KREMERS J, 1993, VISION RES, V33, P1997, DOI 10.1016/0042-6989(93)90023-P; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; LENNIE P, 1993, J OPT SOC AM A, V10, P1283, DOI 10.1364/JOSAA.10.001283; Loughman J, 2012, INVEST OPHTH VIS SCI, V53, P7871, DOI 10.1167/iovs.12-10690; LUTZE M, 1990, VISION RES, V30, P149, DOI 10.1016/0042-6989(90)90134-7; Nolan JM, 2008, INVEST OPHTH VIS SCI, V49, P2134, DOI 10.1167/iovs.07-0933; NYGAARD RW, 1982, VISION RES, V22, P433, DOI 10.1016/0042-6989(82)90189-4; POKORNY J, 1989, J OPT SOC AM A, V6, P1618, DOI 10.1364/JOSAA.6.001618; POKORNY J, 1991, NATO ADV SCI I A-LIF, V203, P23; Pokorny J, 2004, VISUAL NEUROSCI, V21, P263, DOI 10.1017/S0952523804213207; POKORNY J, 1993, J OPT SOC AM A, V10, P1304, DOI 10.1364/JOSAA.10.001304; Puts MJH, 2005, J NEUROSCI METH, V142, P77, DOI 10.1016/j.jneumeth.2004.07.013; RUSHTON WAH, 1964, VISION RES, V4, P75, DOI 10.1016/0042-6989(64)90034-3; Shapiro AG, 1996, J OPT SOC AM A, V13, P2319, DOI 10.1364/JOSAA.13.002319; Sharpe LT, 2005, J VISION, V5, P948, DOI 10.1167/5.11.3; Snodderly DM, 2004, INVEST OPHTH VIS SCI, V45, P531, DOI 10.1167/iovs.03-0762; Stockman A, 2008, J VISION, V8, DOI 10.1167/8.16.1; Stringham JM, 2008, EXP EYE RES, V87, P445, DOI 10.1016/j.exer.2008.08.005; Sun H, 2001, COLOR RES APPL, V26, pS69, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL16>3.0.CO;2-A; van de Kraats J, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2398925; van der Veen RLP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275481; van der Veen RLP, 2009, OPHTHAL PHYSL OPT, V29, P127, DOI 10.1111/j.1475-1313.2008.00618.x; vandeKraats J, 1996, VISION RES, V36, P2229, DOI 10.1016/0042-6989(96)00001-6; WALD G, 1945, SCIENCE, V101, P653, DOI 10.1126/science.101.2635.653; WALD G., 1949, DOCUMENTA OPHTHALMOL, V3, P94, DOI 10.1007/BF00162600; Wallstein R, 1981, THESIS U CHICAGO; Weigert G, 2011, INVEST OPHTH VIS SCI, V52, P8174, DOI 10.1167/iovs.11-7522; WERNER JS, 1987, VISION RES, V27, P257, DOI 10.1016/0042-6989(87)90188-X; Wielgus AR, 2010, PHOTOCHEM PHOTOBIOL, V86, P781, DOI 10.1111/j.1751-1097.2010.00750.x; Woodall AA, 1997, BBA-GEN SUBJECTS, V1336, P33, DOI 10.1016/S0304-4165(97)00006-8; Wooten BR, 1999, INVEST OPHTH VIS SCI, V40, P2481	43	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110521	10.1371/journal.pone.0110521	http://dx.doi.org/10.1371/journal.pone.0110521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354049	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200029
J	Xu, J; Xu, T; Bu, XQ; Peng, H; Li, HM; Zhang, MZ; Zhang, YH				Xu, Juan; Xu, Tian; Bu, Xiaoqing; Peng, Hao; Li, Hongmei; Zhang, Mingzhi; Zhang, Yonghong			The Predictive Value of Waist-To-Height Ratio for Ischemic Stroke in a Population-Based Prospective Cohort Study among Mongolian Men in China	PLOS ONE			English	Article							INNER MONGOLIANS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; OBESITY; CIRCUMFERENCE; HYPERTENSION; ADULTS; TRENDS	Objective: To explore the associations between waist-to-height ratio (WHtR), body mass index (BMI) and waist circumference (WC) and risk of ischemic stroke among Mongolian men in China. Methods: A population-based prospective cohort study was conducted from June 2003 to July 2012 in Inner Mongolia, an autonomous region in north China. A total of 1034 men aged 20 years and older free of cardiovascular disease were included in the cohort and followed up for an average of 9.2 years. The subjects were divided into four groups by WHtR levels (WHtR<0.40, 0.40 <= WHtR <= 0.50, 0.50, WHtR <= 0.60, WHtR>0.60). The cumulative survival rates of ischemic stroke among the four groups were estimated with the Kaplan-Meier curves and compared by log-rank test. Cox proportional hazards models and Receiver Operating Characteristic (ROC) curves were employed to evaluate the associations between obesity indices and ischemic stroke. Results: A total of 47 ischemic stroke patients were observed during the follow-up period. The cumulative incidence and incidence density of ischemic stroke were 4.55% and 507.61/100 000 person-years, respectively. After the major risk factors were adjusted, individuals with WHtR>0.60 had a 3.56-fold increased risk of ischemic stroke compared with those with 0.40 <= WHtR <= 0.50. Hazard ratio (HR) and 95% confidence intervals (CI) of ischemic stroke for a 1-SD increase in WHtR was 1.34(95% CI: 1.00-1.81). After adding BMI or WC to models, higher WHtR remained significantly associated with increased risk of ischemic stroke. The Kaplan-Meier survival curves showed that the cumulative survival rate in the group with WHtR. 0.60 was significantly lower than in the group with 0.40 <= WHtR <= 0.50 (log-rank test, P = 0.025). The areas under the curve for each index were as follows: 0.586 for WHtR, 0.543 for WC; 0.566 for BMI. Conclusions: Higher WHtR is associated with risk of ischemic stroke in Mongolian males. WHtR may be useful in predicting ischemic stroke incidence in males.	[Xu, Juan; Xu, Tian; Bu, Xiaoqing; Peng, Hao; Li, Hongmei; Zhang, Mingzhi; Zhang, Yonghong] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China	Soochow University - China	Zhang, YH (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China.	yhzhang@suda.edu.cn	Peng, Hao/AAB-4759-2022; Peng, Hao/I-1134-2014	Peng, Hao/0000-0001-6277-662X	National Natural Science Foundation of China [81172761, 30972531]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by National Natural Science Foundation of China (Grant Nos. 81172761 and 30972531) and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M., 2011, OPEN OBESITY J, V3, P78, DOI [10.2174/1876823701103010078, DOI 10.2174/1876823701103010078]; Ashwell M, 2011, NUTR TODAY, V46, P85, DOI DOI 10.1097/NT.0B013E3182118779; Bodenant M, 2011, STROKE, V42, P2872, DOI 10.1161/STROKEAHA.111.614099; Chiquete E, 2013, EUR NEUROL, V70, P117, DOI 10.1159/000350762; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; He J, 2014, JAMA-J AM MED ASSOC, V311, P479, DOI 10.1001/jama.2013.282543; He Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092763; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Hu J, 2013, CHIN J DIS CONTROL P, V17, P302; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Shang WY, 2012, J NEUROL SCI, V314, P66, DOI 10.1016/j.jns.2011.10.029; Stepien M, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-29; Tang LY, 2014, J HYPERTENS, V32, P1091, DOI 10.1097/HJH.0000000000000142; Tatsumi Y, 2013, J EPIDEMIOL, V23, P351, DOI 10.2188/jea.JE20130004; Terao S, 2008, STROKE, V39, P943, DOI 10.1161/STROKEAHA.107.494542; Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wu Gui-xian, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P551; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xu T, 2013, STROKE, V44, P2457, DOI 10.1161/STROKEAHA.111.000648; [张春雨 Zhang Chunyu], 2014, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V30, P464; Zhang YH, 2010, J HYPERTENS, V28, P35, DOI 10.1097/HJH.0b013e3283324650; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	30	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110245	10.1371/journal.pone.0110245	http://dx.doi.org/10.1371/journal.pone.0110245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353632	Green Submitted, Green Published, gold			2022-12-26	WOS:000345204200018
J	Martinez-Silva, L; Manjarrez, E; Gutierrez-Ospina, G; Quevedo, JN				Martinez-Silva, Lourdes; Manjarrez, Elias; Gutierrez-Ospina, Gabriel; Quevedo, Jorge N.			Electrophysiological Representation of Scratching CPG Activity in the Cerebellum	PLOS ONE			English	Article							LATERAL RETICULAR NUCLEUS; PURKINJE-CELLS; ANTERIOR LOBE; SPINAL-CORD; CAT CEREBELLUM; SPINOCEREBELLAR PATHWAYS; FUNCTIONAL-ORGANIZATION; CORTICAL ACTIVITY; PARAVERMAL PART; LOCOMOTION	We analyzed the electrical activity of neuronal populations in the cerebellum and the lumbar spinal cord during fictive scratching in adult decerebrate cats before and after selective sections of the Spino-Reticulo Cerebellar Pathway (SRCP) and the Ventral-Spino Cerebellar Tract (VSCT). During fictive scratching, we found a conspicuous sinusoidal electrical activity, called Sinusoidal Cerebellar Potentials (SCPs), in the cerebellar vermis, which exhibited smaller amplitude in the paravermal and hemisphere cortices. There was also a significant spino-cerebellar coherence between these SCPs and the lumbar sinusoidal cord dorsum potentials (SCDPs). However, during spontaneous activity such spino-cerebellar coherence between spontaneous potentials recorded in the same regions decreased. We found that the section of the SRCP and the VSCT did not abolish the amplitude of the SCPs, suggesting that there are additional pathways conveying information from the spinal CPG to the cerebellum. This is the first evidence that the sinusoidal activity associated to the spinal CPG circuitry for scratching has a broad representation in the cerebellum beyond the sensory representation from hindlimbs previously described. Furthermore, the SCPs represent the global electrical activity of the spinal CPG for scratching in the cerebellar cortex.	[Martinez-Silva, Lourdes; Quevedo, Jorge N.] Biofis Neurociencias CINVESTAV, Dept Fisiol, Mexico City, DF, Mexico; [Manjarrez, Elias] BUAP, Inst Fisiol, Puebla, Mexico; [Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico	Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico	Manjarrez, E (corresponding author), BUAP, Inst Fisiol, Puebla, Mexico.	eliasmanjarrez@gmail.com; jquevedo@fisio.cinvestav.mx	Manjarrez, Elias/B-8492-2012	Manjarrez, Elias/0000-0002-3277-0101; Gutierrez Ospina, Gabriel/0000-0002-6286-8281	CONACYT [36219-N, F1-62610]; VIEP-PIFI-Catedra Moshinsky, Mexico	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); VIEP-PIFI-Catedra Moshinsky, Mexico	This work was supported by CONACYT 36219-N (JQ), CONACyT F1-62610 (EM), and VIEP-PIFI-Catedra Moshinsky (EM), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1943, BRAIN, V66, P289, DOI 10.1093/brain/66.4.289; Alstermark B, 2013, J PHYSIOL-LONDON, V591, P5453, DOI 10.1113/jphysiol.2013.256669; ANTZIFEROVA LI, 1980, BRAIN RES, V200, P239, DOI 10.1016/0006-8993(80)90916-6; APPS R, 1989, NEUROSCI LETT, V102, P205, DOI 10.1016/0304-3940(89)90079-7; ARMSTRONG DM, 1984, J PHYSIOL-LONDON, V352, P403, DOI 10.1113/jphysiol.1984.sp015300; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V400, P425, DOI 10.1113/jphysiol.1988.sp017130; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V400, P405, DOI 10.1113/jphysiol.1988.sp017128; Arshavskii Yu. I., 1972, Biophysics, V17, P1169; ARSHAVSKY YI, 1984, BRAIN RES, V290, P33, DOI 10.1016/0006-8993(84)90733-9; ARSHAVSKY YI, 1980, BRAIN RES, V200, P249, DOI 10.1016/0006-8993(80)90917-8; ARSHAVSKY YI, 1984, EXP BRAIN RES, V54, P426; ARSHAVSKY YI, 1978, BRAIN RES, V151, P493, DOI 10.1016/0006-8993(78)91082-X; ARSHAVSKY YI, 1978, BRAIN RES, V151, P479, DOI 10.1016/0006-8993(78)91081-8; CHAMBERS WW, 1955, ARCH NEURO PSYCHIATR, V74, P653, DOI 10.1001/archneurpsyc.1955.02330180071008; CLENDENIN M, 1974, BRAIN RES, V69, P136, DOI 10.1016/0006-8993(74)90378-3; CLENDENIN M, 1974, EXP BRAIN RES, V21, P473; COSTON JA, 1970, J PHYSIOL-PARIS, V62, P264; Cuellar CA, 2009, J NEUROSCI, V29, P798, DOI 10.1523/JNEUROSCI.3408-08.2009; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; DEGTYARENKO A M, 1990, Neirofiziologiya, V22, P123; DEGTYARENKO A M, 1991, Neirofiziologiya, V23, P142; Deliagina T G, 1977, Neirofiziologiia, V9, P619; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; Gallarda BW, 2010, ANN NY ACAD SCI, V1198, P133, DOI 10.1111/j.1749-6632.2010.05437.x; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Grinsted A. M. J., 2004, CROSSWAVELET WAVELET; Hamm TM, 2001, METH NE FRO NEUROSCI, P135; JASMIN L, 1994, NEUROSCIENCE, V58, P275, DOI 10.1016/0306-4522(94)90034-5; KUHTA PC, 1990, J NEUROPHYSIOL, V64, P1653, DOI 10.1152/jn.1990.64.6.1653; LUNDBERG A, 1971, EXP BRAIN RES, V12, P317; LUNDBERG A, 1962, ACTA PHYSIOL SCAND, V54, P252, DOI 10.1111/j.1748-1716.1962.tb02350.x; Malakhovskaya D B, 1965, Fed Proc Transl Suppl, V24, P665; Martinez-Silva L, 2011, FOS LIKE IMMUNOREACT; Mor Y, 2007, J NEUROPHYSIOL, V98, P2807, DOI 10.1152/jn.00740.2007; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; ORLOVSKII G N, 1972, Biophysics (English Translation of Biofizika), V17, P935; Orlovskii G. N., 1972, Biophysics, V17, P1177; Orlovsky GN, 1999, NEURONAL CONTROL LOC, P215; ORSAL D, 1988, BEHAV BRAIN RES, V28, P159, DOI 10.1016/0166-4328(88)90092-7; OSCARSSON O, 1965, PHYSIOL REV, V45, P495, DOI 10.1152/physrev.1965.45.3.495; Ozden I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042650; Perez T, 2009, J NEUROSCI, V29, P10254, DOI 10.1523/JNEUROSCI.1737-09.2009; Person AL, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00097; SCHWARTZ AB, 1987, EXP BRAIN RES, V67, P323; Smith SS, 1998, NEUROSCIENCE, V82, P69; Stecina K, 2013, J PHYSIOL-LONDON, V591, P5433, DOI 10.1113/jphysiol.2012.249110; Tapia JA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.129; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; UDO M, 1980, J NEUROPHYSIOL, V44, P119, DOI 10.1152/jn.1980.44.1.119; UDO M, 1981, EXP BRAIN RES, V41, P292; Valle MS, 2008, EXP BRAIN RES, V187, P359, DOI 10.1007/s00221-008-1311-2; Valle MS, 2012, EXP BRAIN RES, V216, P349, DOI 10.1007/s00221-011-2938-y; VIALA G, 1970, CR ACAD SCI D NAT, V271, P688; VINAY L, 1993, EXP BRAIN RES, V97, P61; XU Q, 1994, J COMP NEUROL, V345, P288, DOI 10.1002/cne.903450210; Xu QY, 2005, EXP BRAIN RES, V162, P250, DOI 10.1007/s00221-004-2132-6	56	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109936	10.1371/journal.pone.0109936	http://dx.doi.org/10.1371/journal.pone.0109936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350378	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100015
J	Torrance, JS; Wincenciak, J; Hahn, AC; DeBruine, LM; Jones, BC				Torrance, Jaimie S.; Wincenciak, Joanna; Hahn, Amanda C.; DeBruine, Lisa M.; Jones, Benedict C.			The Relative Contributions of Facial Shape and Surface Information to Perceptions of Attractiveness and Dominance	PLOS ONE			English	Article							MENS FACES; SEXUAL-DIMORPHISM; BEAUTY; MASCULINITY; SYMMETRY; COLOR; RECOGNITION; COOPERATION; TEXTURES; HEALTH	Although many studies have investigated the facial characteristics that influence perceptions of others' attractiveness and dominance, the majority of these studies have focused on either the effects of shape information or surface information alone. Consequently, the relative contributions of facial shape and surface characteristics to attractiveness and dominance perceptions are unclear. To address this issue, we investigated the relationships between ratings of original versions of faces and ratings of versions in which either surface information had been standardized (i.e., shape-only versions) or shape information had been standardized (i.e., surface-only versions). For attractiveness and dominance judgments of both male and female faces, ratings of shape-only and surface-only versions independently predicted ratings of the original versions of faces. The correlations between ratings of original and shape-only versions and between ratings of original and surface-only versions differed only in two instances. For male attractiveness, ratings of original versions were more strongly related to ratings of surface-only than shape-only versions, suggesting that surface information is particularly important for men's facial attractiveness. The opposite was true for female physical dominance, suggesting that shape information is particularly important for women's facial physical dominance. In summary, our results indicate that both facial shape and surface information contribute to judgments of others' attractiveness and dominance, suggesting that it may be important to consider both sources of information in research on these topics.	[Torrance, Jaimie S.; Wincenciak, Joanna; Hahn, Amanda C.; DeBruine, Lisa M.; Jones, Benedict C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Glasgow	Jones, BC (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	ben.jones@glasgow.ac.uk	DeBruine, Lisa M/A-6990-2008; Hahn, Amanda C/H-8779-2013; Wincenciak, Joanna/N-4422-2013; Jones, Benedict C/A-7850-2008; Hahn, Amanda C/AAH-1106-2021	DeBruine, Lisa M/0000-0002-7523-5539; Hahn, Amanda C/0000-0002-4555-7924; Wincenciak, Joanna/0000-0003-2083-9447; Jones, Benedict C/0000-0001-7777-0220; Hahn, Amanda C/0000-0002-4555-7924	Economic and Social Research Council [ES/I031022/1]; European Research Council [282655]; ESRC [ES/I031022/2, ES/I031022/1] Funding Source: UKRI; Economic and Social Research Council [ES/I031022/2] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council(European Research Council (ERC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by Economic and Social Research Council grant ES/I031022/1, which was awarded to LMD and BCJ, and European Research Council Starting Grant 282655 (OCMATE), which was awarded to BCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coetzee V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048116; DeBruine LM, 2010, J EXP PSYCHOL HUMAN, V36, P751, DOI 10.1037/a0016457; Dixson BJ, 2013, EVOL HUM BEHAV, V34, P236, DOI 10.1016/j.evolhumbehav.2013.02.003; Dixson BJ, 2012, BEHAV ECOL, V23, P481, DOI 10.1093/beheco/arr214; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Hume DK, 2001, EVOL HUM BEHAV, V22, P93, DOI 10.1016/S1090-5138(00)00065-9; Jones BC, 2005, P ROY SOC B-BIOL SCI, V272, P347, DOI 10.1098/rspb.2004.2962; Jones BC, 2007, EVOL HUM BEHAV, V28, P439, DOI 10.1016/j.evolhumbehav.2007.07.006; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lefevre CE, 2014, EUROPEAN J IN PRESS; Little AC, 2002, BRIT J PSYCHOL, V93, P451, DOI 10.1348/000712602761381349; Neave N, 2008, PERS INDIV DIFFER, V45, P373, DOI 10.1016/j.paid.2008.05.007; O'Toole AJ, 1999, VISION RES, V39, P3145, DOI 10.1016/S0042-6989(99)00034-6; O'Toole AJ, 1999, IMAGE VISION COMPUT, V18, P9, DOI 10.1016/S0262-8856(99)00012-8; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 1999, PSYCHOL SCI, V10, P52, DOI 10.1111/1467-9280.00106; Rhodes G, 1998, PSYCHON B REV, V5, P659, DOI 10.3758/BF03208842; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Russell R, 2012, NEUROPSYCHOLOGIA, V50, P334, DOI 10.1016/j.neuropsychologia.2011.12.004; Russell R, 2009, PERCEPTION, V38, P1211, DOI 10.1068/p6331; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stephen ID, 2012, EVOL PSYCHOL-US, V10, P562; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Watkins CD, 2012, EUR J PERSONALITY, V26, P79, DOI 10.1002/per.837; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006	37	20	21	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e104415	10.1371/journal.pone.0104415	http://dx.doi.org/10.1371/journal.pone.0104415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BH	25349994	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000343943100003
J	Chen, HC; Zou, W; Lu, TP; Chen, JJ				Chen, Hung-Chia; Zou, Wen; Lu, Tzu-Pin; Chen, James J.			A Composite Model for Subgroup Identification and Prediction via Bicluster Analysis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; HIGH-DIMENSIONAL DATA; SINGULAR-VALUE DECOMPOSITION; GENE-EXPRESSION DATA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SALMONELLA-SEROTYPES; CLUSTER-ANALYSIS; MICROARRAY DATA; CLASSIFICATION; PATTERNS	Background: A major challenges in the analysis of large and complex biomedical data is to develop an approach for 1) identifying distinct subgroups in the sampled populations, 2) characterizing their relationships among subgroups, and 3) developing a prediction model to classify subgroup memberships of new samples by finding a set of predictors. Each subgroup can represent different pathogen serotypes of microorganisms, different tumor subtypes in cancer patients, or different genetic makeups of patients related to treatment response. Methods: This paper proposes a composite model for subgroup identification and prediction using biclusters. A biclustering technique is first used to identify a set of biclusters from the sampled data. For each bicluster, a subgroup-specific binary classifier is built to determine if a particular sample is either inside or outside the bicluster. A composite model, which consists of all binary classifiers, is constructed to classify samples into several disjoint subgroups. The proposed composite model neither depends on any specific biclustering algorithm or patterns of biclusters, nor on any classification algorithms. Results: The composite model was shown to have an overall accuracy of 97.4% for a synthetic dataset consisting of four subgroups. The model was applied to two datasets where the sample's subgroup memberships were known. The procedure showed 83.7% accuracy in discriminating lung cancer adenocarcinoma and squamous carcinoma subtypes, and was able to identify 5 serotypes and several subtypes with about 94% accuracy in a pathogen dataset. Conclusion: The composite model presents a novel approach to developing a biclustering-based classification model from unlabeled sampled data. The proposed approach combines unsupervised biclustering and supervised classification techniques to classify samples into disjoint subgroups based on their associated attributes, such as genotypic factors, phenotypic outcomes, efficacy/safety measures, or responses to treatments. The procedure is useful for identification of unknown species or new biomarkers for targeted therapy.	[Chen, Hung-Chia; Zou, Wen; Lu, Tzu-Pin; Chen, James J.] US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA; [Chen, Hung-Chia; Chen, James J.] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Chen, Hung-Chia; Chen, James J.] China Med Univ, Ctr Biostat, Taichung, Taiwan; [Lu, Tzu-Pin] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Dept Publ Hlth, Taipei 10764, Taiwan	US Food & Drug Administration (FDA); China Medical University Taiwan; China Medical University Taiwan; National Taiwan University	Chen, JJ (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA.	jamesj.chen@fda.hhs.gov	Lu, Tzupin/ABC-2195-2021	Lu, Tzupin/0000-0003-3697-0386; Zou, Wen/0000-0002-3735-1133	USDOE; USFDA	USDOE(United States Department of Energy (DOE)); USFDA	The research by Hung-Chia and Tzu-Pin was supported by the Post-doctoral Fellowship Program at the NCTR administered by the Oak Ridge Institute for Science and Education through an interagency agreement between USDOE and USFDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek S, 2009, BRIEF BIOINFORM, V10, P537, DOI 10.1093/bib/bbp016; Baker EJ, 2012, NUCLEIC ACIDS RES, V40, pD1067, DOI 10.1093/nar/gkr968; Baker EJ, 2009, GENOMICS, V94, P377, DOI 10.1016/j.ygeno.2009.08.016; Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Barrett TJ, 2006, FOODBORNE PATHOG DIS, V3, P20, DOI 10.1089/fpd.2006.3.20; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Brieman L, 1995, CART CLASSIFICATION; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Carreiro AV, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-175; Chen DT, 2011, JNCI-J NATL CANCER I, V103, P1859, DOI 10.1093/jnci/djr420; Chen HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071680; Chen JJ, 2013, PHARMACOGENOMICS, V14, P969, DOI [10.2217/PGS.13.75, 10.2217/pgs.13.75]; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang G, 2010, BIOCOMPUT-PAC SYM, P145; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gaul SB, 2007, J CLIN MICROBIOL, V45, P472, DOI 10.1128/JCM.00962-06; Geraci J, 2014, BIOINFORMATICS, V30, P712, DOI 10.1093/bioinformatics/btt602; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Kriegel HP, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1497577.1497578; Langreth, 1999, Oncologist, V4, P426; Lee M, 2010, BIOMETRICS, V66, P1087, DOI 10.1111/j.1541-0420.2010.01392.x; LI J, 1994, P NATL ACAD SCI USA, V91, P2552, DOI 10.1073/pnas.91.7.2552; Liebana E, 2001, J CLIN MICROBIOL, V39, P3609, DOI 10.1128/JCM.39.10.3609-3616.2001; Lin WJ, 2013, BRIEF BIOINFORM, V14, P13, DOI 10.1093/bib/bbs006; Lipkovich I, 2011, STAT MED, V30, P2601, DOI 10.1002/sim.4289; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Odibat M, 2013, KNOW INF SYST, DOI 101007/s10115-013-0684-0; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Pui CH, 1999, J CLIN ONCOL, V17, P438, DOI 10.1200/JCO.1999.17.2.438; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rothenberg ML, 2003, NAT REV CANCER, V3, P303, DOI 10.1038/nrc1047; Ruberg SJ, 2010, CLIN TRIALS, V7, P574, DOI 10.1177/1740774510369350; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; Shabalin AA, 2009, ANN APPL STAT, V3, P985, DOI 10.1214/09-AOAS239; Sill M, 2011, BIOINFORMATICS, V27, P2089, DOI 10.1093/bioinformatics/btr322; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Tagkopoulos I, 2005, BIBE 2005: 5TH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, P89; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Urisman A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r78; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vapnik V., 1998, STAT LEARNING THEORY; Wang SJ, 2010, CLIN TRIALS, V7, P525, DOI 10.1177/1740774510375455; Yang WH, 2007, LECT NOTES COMPUT SC, V4819, P194; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang Y, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-110; Zou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059224; Zou W, 2012, J CLIN MICROBIOL, V50, P1524, DOI 10.1128/JCM.00111-12; Zou W, 2010, J CLIN MICROBIOL, V48, P3122, DOI 10.1128/JCM.00645-10	60	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111318	10.1371/journal.pone.0111318	http://dx.doi.org/10.1371/journal.pone.0111318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347824	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900060
J	Li, SY; Zhai, X; Rong, PJ; McCabe, MF; Zhao, JJ; Ben, H; Wang, X; Wang, SX				Li, Shaoyuan; Zhai, Xu; Rong, Peijing; McCabe, Michael F.; Zhao, Jingjun; Ben, Hui; Wang, Xing; Wang, Shuxing			Transcutaneous Auricular Vagus Nerve Stimulation Triggers Melatonin Secretion and Is Antidepressive in Zucker Diabetic Fatty Rats	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; NMDA RECEPTORS; ACUPUNCTURE; HYPNOSIS; INSOMNIA; BEHAVIOR; SYSTEM; MOUSE; TRIAL	Decreased circulating melatonin is implicated in depression. We recently found that Zucker diabetic fatty rats (ZDF, fa/fa) develop depression-like behaviors and that transcutaneous auricular vagus nerve stimulation (taVNS) is antidepressive in ZDF rats. Here we studied whether the ZDF rats could be used as a depression rodent model and whether the antidepressive effect of taVNS is mediated through modulation of melatonin secretion. Adult male ZDF and Zucker lean (ZL, fa/+) littermates were used. 30 min-taVNS procedures (2/15 Hz, 2 mA) were administered once daily under anesthesia for 34 consecutive days in pineal intact ZDF (n = 8) and ZL (n = 6) rats, as well as in pinealectomized ZDF rats (n = 8). Forced swimming test (FST) was used to determine depression-like behavior and ELISA to detect plasma melatonin concentration on day 35. We found that naive ZDF rats had a longer immobility time in FST and that long-term (34 days) taVNS treatment ameliorated the depression-like behavior. In both pineal intact and pinealectomized ZDF rats, taVNS induced acute melatonin secretion, both during and after the taVNS session. A low melatonin level is related to the poor FST performance in ZDF rats (R = -0.544) in contrast to ZL rats (R = 0.247). In conclusion, our results show that ZDF rats are ideal candidates of innate depression and that taVNS is antidepressive through triggering melatonin secretion and increasing its production.	[Li, Shaoyuan; Zhai, Xu; Rong, Peijing; Zhao, Jingjun; Ben, Hui; Wang, Shuxing] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China; [Li, Shaoyuan; Wang, Xing; Wang, Shuxing] Xinxiang Med Univ, Dept Anat, Xinxiang, Henan Province, Peoples R China; [McCabe, Michael F.; Wang, Shuxing] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA	China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; Xinxiang Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Rong, PJ (corresponding author), China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China.	rongpj@hotmail.com; wshuxing@mgh.harvard.edu	zhao, jing/B-3868-2019		National Natural Science Foundation of China [81271243, 81473780]; Natural Science Foundation of Beijing [7111007]; National Basic Research Program of China (973 Program) [2012CB518503]; Project Supported National Science and Technology Ministry [2012BAF14B10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Project Supported National Science and Technology Ministry	This work was supported by National Natural Science Foundation of China-81271243, 81473780; Natural Science Foundation of Beijing, 7111007; National Basic Research Program of China (973 Program)-2012CB518503; and Project Supported National Science and Technology Ministry-2012BAF14B10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett ME, 2010, HYPERTENSION, V55, P284, DOI 10.1161/HYPERTENSIONAHA.109.146605; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Cardinali DP, 2012, J PINEAL RES, V52, P365, DOI 10.1111/j.1600-079X.2011.00962.x; Chao DM, 2001, ACUPUNCTURE ELECTRO, V26, P39, DOI 10.3727/036012901816356027; Conti A, 2000, J PINEAL RES, V28, P193, DOI 10.1034/j.1600-079X.2000.280401.x; DEBENEDITTIS G, 1994, INT J CLIN EXP HYP, V42, P140, DOI 10.1080/00207149408409347; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Ghasemi M, 2010, J PSYCHOPHARMACOL, V24, P585, DOI 10.1177/0269881109104845; Guo M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.9; Huang F, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-203; Kaster MP, 2012, PHARMACOL REP, V64, P706, DOI 10.1016/S1734-1140(12)70865-4; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Liu RP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789674; Lyons Zaza, 2012, Complement Ther Clin Pract, V18, P216, DOI 10.1016/j.ctcp.2012.06.003; Maganhin CC, 2009, ACTA CIR BRAS, V24, P321, DOI 10.1590/S0102-86502009000400013; Mathews DC, 2012, DRUGS, V72, P1313, DOI 10.2165/11633130-000000000-00000; MAURIZI CP, 1984, SOUTH MED J, V77, P1516, DOI 10.1097/00007611-198412000-00010; Mischoulon D, 2012, J AFFECT DISORDERS, V141, P469, DOI 10.1016/j.jad.2012.03.023; NELSON E, 1994, PHARMACOL BIOCHEM BE, V49, P327, DOI 10.1016/0091-3057(94)90429-4; Paul P, 1999, J PHARMACOL EXP THER, V290, P334; Preiss K, 2013, OBES REV, V14, P906, DOI 10.1111/obr.12052; Rong PJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-255; Samuels N, 2005, AM J CLIN HYPN, V47, P243, DOI 10.1080/00029157.2005.10403638; Spence DW, 2004, J NEUROPSYCH CLIN N, V16, P19, DOI 10.1176/appi.neuropsych.16.1.19; Wang SX, 2012, PAIN, V153, P2448, DOI 10.1016/j.pain.2012.08.016; Wang SX, 2009, BRAIN RES, V1288, P42, DOI 10.1016/j.brainres.2009.06.094; Ward KR, 2011, HYPERTENSION, V57, P435, DOI 10.1161/HYPERTENSIONAHA.110.160671; Yeung AS, 2011, J AFFECT DISORDERS, V130, P285, DOI 10.1016/j.jad.2010.07.025; Zeng Q, 2008, BRAIN RES, V1200, P27, DOI 10.1016/j.brainres.2008.01.038; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005	33	16	20	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111100	10.1371/journal.pone.0111100	http://dx.doi.org/10.1371/journal.pone.0111100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347185	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900046
J	Macleod, CA; Meng, L; Conway, BA; Porr, B				Macleod, Catherine A.; Meng, Lin; Conway, Bernard A.; Porr, Bernd			Reflex Control of Robotic Gait Using Human Walking Data	PLOS ONE			English	Article							SPINAL-CORD-INJURY; FUNCTIONAL ELECTRICAL-STIMULATION; CENTRAL PATTERN GENERATORS; SWING PHASE; STEP CYCLE; CUTANEOUS AFFERENTS; NERVE-STIMULATION; SENSORY FEEDBACK; BIPED LOCOMOTION; ASSESSMENT-TOOL	Control of human walking is not thoroughly understood, which has implications in developing suitable strategies for the retraining of a functional gait following neurological injuries such as spinal cord injury (SCI). Bipedal robots allow us to investigate simple elements of the complex nervous system to quantify their contribution to motor control. RunBot is a bipedal robot which operates through reflexes without using central pattern generators or trajectory planning algorithms. Ground contact information from the feet is used to activate motors in the legs, generating a gait cycle visually similar to that of humans. Rather than developing a more complicated biologically realistic neural system to control the robot's stepping, we have instead further simplified our model by measuring the correlation between heel contact and leg muscle activity (EMG) in human subjects during walking and from this data created filter functions transferring the sensory data into motor actions. Adaptive filtering was used to identify the unknown transfer functions which translate the contact information into muscle activation signals. Our results show a causal relationship between ground contact information from the heel and EMG, which allows us to create a minimal, linear, analogue control system for controlling walking. The derived transfer functions were applied to RunBot II as a proof of concept. The gait cycle produced was stable and controlled, which is a positive indication that the transfer functions have potential for use in the control of assistive devices for the retraining of an efficient and effective gait with potential applications in SCI rehabilitation.	[Macleod, Catherine A.; Conway, Bernard A.] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Meng, Lin; Porr, Bernd] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland	University of Strathclyde; University of Glasgow	Macleod, CA (corresponding author), Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland.	c.a.macleod@strath.ac.uk	Conway, Bernard/A-9625-2016; Meng, Lin/C-9628-2017	Conway, Bernard/0000-0002-0069-0131; Meng, Lin/0000-0001-9787-9936; Porr, Bernd/0000-0001-8157-998X	Engineering and Physical Sciences Research Council (EPSRC) through the Doctoral Training Centre (DTC) in Medical Devices, University of Strathclyde; CAM	Engineering and Physical Sciences Research Council (EPSRC) through the Doctoral Training Centre (DTC) in Medical Devices, University of Strathclyde; CAM	Funding was provided by the Engineering and Physical Sciences Research Council (EPSRC) (http://www.epsrc.ac.uk/Pages/default.aspx) through the Doctoral Training Centre (DTC) in Medical Devices, University of Strathclyde (http://www.strath.ac.uk/simd/dtc/). This funding was received by CAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANISS AM, 1992, J NEUROPHYSIOL, V67, P1375, DOI 10.1152/jn.1992.67.5.1375; BAJD T, 1983, PHYS THER, V63, P1116, DOI 10.1093/ptj/63.7.1116; Beer RD, 1997, COMMUN ACM, V40, P31; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Braitenberg V., 1984, VEHICLES EXPT SYNTHE; Braz GP, 2009, NEUROMODULATION, V12, P180, DOI 10.1111/j.1525-1403.2009.00213.x; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Conway BA, 1995, ALPHA AND GAMMA MOTOR SYSTEMS, P593; Conway BA, 2008, CLIN NEUROPHYSIOL, V119, P892, DOI 10.1016/j.clinph.2007.12.015; Cruse H, 1998, NEURAL NETWORKS, V11, P1435, DOI 10.1016/S0893-6080(98)00067-7; Davidson AG, 2007, J NEUROSCI METH, V163, P283, DOI 10.1016/j.jneumeth.2007.03.010; Dietz V, 2002, BRAIN, V125, P2626, DOI 10.1093/brain/awf273; Donelan JM, 2004, CAN J PHYSIOL PHARM, V82, P589, DOI 10.1139/Y04-043; Duysens J, 2000, PHYSIOL REV, V80, P83, DOI 10.1152/physrev.2000.80.1.83; DUYSENS J, 1977, J NEUROPHYSIOL, V40, P737, DOI 10.1152/jn.1977.40.4.737; Duysens J, 2002, J BIOMECH, V35, P447, DOI 10.1016/S0021-9290(01)00187-7; DUYSENS J, 1976, EXP BRAIN RES, V24, P245; EIDELBERG E, 1981, BRAIN, V104, P647, DOI 10.1093/brain/104.4.647-a; Endo G, 2008, INT J ROBOT RES, V27, P213, DOI 10.1177/0278364907084980; Endo Gen, 2005, P 20 NAT C ART INT, P1267; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P911, DOI 10.1097/PHM.0b013e318269d9a3; Faist M, 2006, BRAIN RES, V1076, P87, DOI 10.1016/j.brainres.2005.12.069; Fouad K, 2004, PROG NEUROBIOL, V73, P107, DOI 10.1016/j.pneurobio.2004.04.003; Galen SS, 2011, MED ENG PHYS, V33, P626, DOI 10.1016/j.medengphy.2011.01.003; Geng T, 2006, INT J ROBOT RES, V25, P243, DOI 10.1177/0278364906063822; Geng T, 2006, ADV NEURAL INFORM PR, V18, P243; Geng T, 2014, IEEE T IND ELECTRON, V61, P2326, DOI 10.1109/TIE.2013.2272274; Geyer H, 2003, P ROY SOC B-BIOL SCI, V270, P2173, DOI 10.1098/rspb.2003.2454; GRANAT MH, 1993, J BIOMED ENG, V15, P51, DOI 10.1016/0141-5425(93)90093-E; GRANAT MH, 1995, MED ENG PHYS, V17, P390, DOI 10.1016/1350-4533(95)97321-F; Graupe D, 1997, NEUROL RES, V19, P323, DOI 10.1080/01616412.1997.11740820; Graupe D, 1994, FUNCTIONAL ELECT STI; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; Grillner S, 1975, ANNU REV NEUROSCI, V8, P233; Hardin E, 2007, J REHABIL RES DEV, V44, P333, DOI 10.1682/JRRD.2007.03.0333; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Hermens H.J., 1999, ROESSINGH RES DEV, V8, P11; Hiebert GW, 1996, J NEUROPHYSIOL, V75, P1126, DOI 10.1152/jn.1996.75.3.1126; Hobbelen D.G., 2007, HUMANOID ROBOTS HUMA, P277; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Hultborn H, 2007, ACTA PHYSIOL, V189, P111, DOI 10.1111/j.1748-1716.2006.01651.x; Iida F, 2008, J BIOMECH, V41, P656, DOI 10.1016/j.jbiomech.2007.09.033; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Interlink Electronics, 2013, INT EL FSR FORC SENS; Jezernik S, 2003, NEUROMODULATION, V6, P108, DOI 10.1046/j.1525-1403.2003.03017.x; Kobetic R, 1997, IEEE Trans Rehabil Eng, V5, P23, DOI 10.1109/86.559346; Kojovic J, 2009, J NEUROSCI METH, V181, P100, DOI 10.1016/j.jneumeth.2009.04.005; Kralj A.R., 1989, FUNCTIONAL ELECT STI, DOI DOI 10.1201/9780203755402; Lyons GM, 2002, IEEE T NEUR SYS REH, V10, P260, DOI 10.1109/TNSRE.2002.806832; Macleod CA, 2014, MED ENG PHYS, V36, P541, DOI 10.1016/j.medengphy.2013.11.011; Manoonpong P, 2007, PLOS COMPUT BIOL, V3, P1305, DOI 10.1371/journal.pcbi.0030134; Marchand-Pauvert V, 2002, J PHYSIOL-LONDON, V538, P647, DOI 10.1113/jphysiol.2001.012675; Marchand-Pauvert V, 2002, EXP BRAIN RES, V142, P402, DOI 10.1007/s00221-001-0942-3; MARSOLAIS EB, 1987, J BONE JOINT SURG AM, V69A, P728, DOI 10.2106/00004623-198769050-00014; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; McVea DA, 2005, J NEUROPHYSIOL, V94, P3497, DOI 10.1152/jn.00511.2005; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V228, P285, DOI 10.1113/jphysiol.1973.sp010087; Nakanishi J, 2004, ROBOT AUTON SYST, V47, P79, DOI 10.1016/j.robot.2004.03.003; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; Nielsen JB, 2002, ADV EXP MED BIOL, V508, P369; Owaki D, 2011, IEEE T ROBOT, V27, P156, DOI 10.1109/TRO.2010.2098610; Pang MYC, 2000, J PHYSIOL-LONDON, V528, P389, DOI 10.1111/j.1469-7793.2000.00389.x; Pang MYC, 2001, J PHYSIOL-LONDON, V533, P617, DOI 10.1111/j.1469-7793.2001.0617a.x; Pappas IPI, 2001, IEEE T NEUR SYS REH, V9, P113, DOI 10.1109/7333.928571; Park HW, 2012, IEEE INT CONF ROBOT, P45, DOI 10.1109/ICRA.2012.6225056; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Petiot E, 2001, J PHYSIOL-LONDON, V537, P949; Popovic D, 2003, MED ENG PHYS, V25, P63, DOI 10.1016/S1350-4533(02)00188-1; Popovic D., 2005, PROC 10 ANN C INT FU, P86; Pratt J, 2001, INT J ROBOT RES, V20, P129, DOI 10.1177/02783640122067309; Ragnarsson KT, 2008, SPINAL CORD, V46, P255, DOI 10.1038/sj.sc.3102091; Reeve RE, 2003, PHILOS T R SOC A, V361, P2245, DOI 10.1098/rsta.2003.1274; Rummel J, 2010, IEEE INT CONF ROBOT, P5250, DOI 10.1109/ROBOT.2010.5509500; Sakagami Y, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P2478, DOI 10.1109/IRDS.2002.1041641; Seyfarth A., 2009, International Journal of Robotics Research, V28, P257, DOI 10.1177/0278364908095843; Shiavi R, 1981, Bull Prosthet Res, V10-35, P5; Shiavi R, 1987, J Rehabil Res Dev, V24, P13; SINKJAER T, 1994, EXP BRAIN RES, V98, P542; Sinkjaer T, 2003, MED ENG PHYS, V25, P29, DOI 10.1016/S1350-4533(02)00178-9; Stephens MJ, 1999, EXP BRAIN RES, V124, P363, DOI 10.1007/s002210050633; Thrasher TA, 2006, SPINAL CORD, V44, P357, DOI 10.1038/sj.sc.3101864; Vaughan CL, 2003, J BIOMECH, V36, P513, DOI 10.1016/S0021-9290(02)00419-0; Vukobratovi M., 2004, INT J HUM ROBOT, V01, P157, DOI DOI 10.1142/S0219843604000083; WILLEMSEN ATM, 1990, IEEE T BIO-MED ENG, V37, P1201, DOI 10.1109/10.64463; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williamson R, 2000, IEEE T REHABIL ENG, V8, P312, DOI 10.1109/86.867873; Wilson D. M., 1966, Symposia of the Society for Experimental Biology, V20, P199; WILSON DM, 1961, J EXP BIOL, V38, P471; WILSON DM, 1965, BIOPHYS J, V5, P121, DOI 10.1016/S0006-3495(65)86706-6; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4; YANG JF, 1990, J NEUROPHYSIOL, V63, P1109, DOI 10.1152/jn.1990.63.5.1109; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1	96	6	7	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e109959	10.1371/journal.pone.0109959	http://dx.doi.org/10.1371/journal.pone.0109959			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347544	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900017
J	Bastianelli, G; Bouillon, A; Nguyen, C; Le-Nguyen, D; Nilges, M; Barale, JC				Bastianelli, Giacomo; Bouillon, Anthony; Nguyen, Christophe; Le-Nguyen, Dung; Nilges, Michael; Barale, Jean-Christophe			Computational Design of Protein-Based Inhibitors of Plasmodium vivax Subtilisin-Like 1 Protease	PLOS ONE			English	Article							ELATERIUM TRYPSIN-INHIBITOR; IN-VITRO; SERINE-PROTEASE; CYSTINE KNOT; STRUCTURAL SCAFFOLD; MALARIA PARASITES; PHAGE-DISPLAY; SUB1 PROTEASE; PEPTIDES; SEQUENCE	Background: Malaria remains a major global health concern. The development of novel therapeutic strategies is critical to overcome the selection of multiresistant parasites. The subtilisin-like protease (SUB1) involved in the egress of daughter Plasmodium parasites from infected erythrocytes and in their subsequent invasion into fresh erythrocytes has emerged as an interesting new drug target. Findings: Using a computational approach based on homology modeling, protein-protein docking and mutation scoring, we designed protein-based inhibitors of Plasmodium vivax SUB1 (PvSUB1) and experimentally evaluated their inhibitory activity. The small peptidic trypsin inhibitor EETI-II was used as scaffold. We mutated residues at specific positions (P4 and P1) and calculated the change in free-energy of binding with PvSUB1. In agreement with our predictions, we identified a mutant of EETI-II (EETI-II-P4LP1W) with a Ki in the medium micromolar range. Conclusions: Despite the challenges related to the lack of an experimental structure of PvSUB1, the computational protocol we developed in this study led to the design of protein-based inhibitors of PvSUB1. The approach we describe in this paper, together with other examples, demonstrates the capabilities of computational procedures to accelerate and guide the design of novel proteins with interesting therapeutic applications.	[Bastianelli, Giacomo; Nilges, Michael] Inst Pasteur, Dept Biol Struct & Chim, Unite Bioinformat Struct, Paris, France; [Bastianelli, Giacomo; Nilges, Michael] CNRS, UMR 3528, Paris, France; [Bouillon, Anthony; Barale, Jean-Christophe] Inst Pasteur, Dept Parasitol & Mycol, Unite Immunol Mol Parasites, Paris, France; [Bouillon, Anthony; Barale, Jean-Christophe] CNRS, URA 2581, Paris, France; [Nguyen, Christophe; Le-Nguyen, Dung] CNRS, BioRad, SYSDIAG, UMR3145, Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Nilges, M (corresponding author), Inst Pasteur, Dept Biol Struct & Chim, Unite Bioinformat Struct, Paris, France.	nilges@pasteur.fr; jcb@pasteur.fr	Nilges, Michael/E-4803-2011	Nilges, Michael/0000-0002-1451-8092	Marie Curie Early Stage Research Training Fellowship (EIMID) of European Commission [MEST-CT-05-020311]; "Fond dedie: combattre les maladies parasitaires" - Sanofi-Aventis; French Ministry of Research; Institut Carnot-Pasteur Maladies Infectieuses; SYSDIAG, CNRS UMR3145 CNRS-BioRad	Marie Curie Early Stage Research Training Fellowship (EIMID) of European Commission; "Fond dedie: combattre les maladies parasitaires" - Sanofi-Aventis; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut Carnot-Pasteur Maladies Infectieuses; SYSDIAG, CNRS UMR3145 CNRS-BioRad	This work was partly supported by MEST-CT-05-020311, a Marie Curie Early Stage Research Training Fellowship (EIMID) of the Framework Program 6 by the European Commission. AB is a fellow of the "Direction Generale pour l'Armement" from the French Ministry of Defense. This work was partly supported by the "Fond dedie: combattre les maladies parasitaires" granted by Sanofi-Aventis and the French Ministry of Research and the Institut Carnot-Pasteur Maladies Infectieuses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SYSDIAG, CNRS UMR3145 CNRS-BioRad provided support in the form of salaries and operating costs for authors CN and DLN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bastianelli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021812; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bouillon A, 2013, J BIOL CHEM, V288, P18561, DOI 10.1074/jbc.M113.456764; Case D. A., 2006, AMBER9; Christmann A, 1999, PROTEIN ENG, V12, P797, DOI 10.1093/protein/12.9.797; Chung SY, 1996, STRUCTURE, V4, P1123, DOI 10.1016/S0969-2126(96)00119-0; Craik DJ, 2007, EXPERT OPIN INV DRUG, V16, P595, DOI 10.1517/13543784.16.5.595; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Dagan A, 2002, ANTIMICROB AGENTS CH, V46, P1059, DOI 10.1128/AAC.46.4.1059-1066.2002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; DEBRABANT A, 1992, MOL BIOCHEM PARASIT, V53, P89, DOI 10.1016/0166-6851(92)90010-H; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fulle S, 2013, J CHEM INF MODEL; Genheden S, 2010, J COMPUT CHEM, V31, P837, DOI 10.1002/jcc.21366; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Greenwood BM, 2011, CLIN MICROBIOL INFEC, V17, P1600, DOI 10.1111/j.1469-0691.2011.03612.x; He Mingyue, 2002, Briefings in Functional Genomics & Proteomics, V1, P204, DOI 10.1093/bfgp/1.2.204; HEIDRICH HG, 1989, MOL BIOCHEM PARASIT, V34, P147, DOI 10.1016/0166-6851(89)90006-6; HEITZ A, 1989, BIOCHEMISTRY-US, V28, P2392, DOI 10.1021/bi00432a009; Hilpert K, 2003, J BIOL CHEM, V278, P24986, DOI 10.1074/jbc.M212152200; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keizer DW, 2003, BIOCHEMISTRY-US, V42, P9915, DOI 10.1021/bi034376b; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Komiyama T, 2003, P NATL ACAD SCI USA, V100, P8205, DOI 10.1073/pnas.1032865100; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; LENGUYEN D, 1989, BIOCHEM BIOPH RES CO, V162, P1425, DOI 10.1016/0006-291X(89)90833-4; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; ODEA KP, 1995, MOL BIOCHEM PARASIT, V72, P111, DOI 10.1016/0166-6851(95)00090-N; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Reiss S, 2006, PLATELETS, V17, P153, DOI 10.1080/09537100500436663; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sajid M, 2000, J BIOL CHEM, V275, P631, DOI 10.1074/jbc.275.1.631; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Souriau C, 2005, BIOCHEMISTRY-US, V44, P7143, DOI 10.1021/bi0481592; STAFFORD WHL, 1994, MOL BIOCHEM PARASIT, V66, P157, DOI 10.1016/0166-6851(94)90048-5; Tawk L, 2013, J BIOL CHEM, V288, P33336, DOI 10.1074/jbc.M113.513234; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wentzel A, 1999, J BIOL CHEM, V274, P21037, DOI 10.1074/jbc.274.30.21037; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhu S, 2002, J MED CHEM, V45, P3491, DOI 10.1021/jm020104f	52	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109269	10.1371/journal.pone.0109269	http://dx.doi.org/10.1371/journal.pone.0109269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343504	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500011
J	Chandrasekaran, S; Marshall, JR; Messing, JA; Hsu, JW; King, MR				Chandrasekaran, Siddarth; Marshall, Jocelyn R.; Messing, James A.; Hsu, Jong-Wei; King, Michael R.			TRAIL-Mediated Apoptosis in Breast Cancer Cells Cultured as 3D Spheroids	PLOS ONE			English	Article							TUMOR-CELLS; STEM-CELLS; IN-VITRO; DRUG-RESISTANCE; DEATH RECEPTORS; CYCLOOXYGENASE-2; EXPRESSION; INHIBITION; HYPOXIA; COX-2	TNF-alpha-related-apoptosis-inducing-ligand (TRAIL) has been explored as a therapeutic drug to kill cancer cells. Cancer cells in the circulation are subjected to apoptosis-inducing factors. Despite the presence of these factors, cells are able to extravasate and metastasize. The homotypic and heterotypic cell-cell interactions in a tumor are known to play a crucial role in bestowing important characteristics to cancer cells that leave the primary site. Spheroid cell culture has been extensively used to mimic these physiologically relevant interactions. In this work, we show that the breast cancer cell lines BT20 and MCF7, cultured as 3D tumor spheroids, are more resistant to TRAIL-mediated apoptosis by downregulating the expression of death receptors (DR4 and DR5) that initiate TRAIL-mediated apoptosis. For comparison, we also investigated the effect of TRAIL on cells cultured as a 2D monolayer. Our results indicate that tumor spheroids are enriched for CD44(hi)CD24(lo)ALDH1(hi) cells, a phenotype that is predominantly known to be a marker for breast cancer stem cells. Furthermore, we attribute the TRAIL-resistance and cancer stem cell phenotype observed in tumor spheroids to the upregulation of cyclooxygenase-2 (COX-2)/prostaglandin E-2 (PGE(2)) pathway. We show that inhibition of the COX-2/PGE(2) pathway by treating tumor spheroids with NS-398, a selective COX-2 inhibitor, reverses the TRAIL-resistance and decreases the incidence of a CD44(hi)CD24(lo) population. Additionally, we show that siRNA mediated knockdown of COX-2 expression in MCF7 cells render them sensitive to TRAIL by increasing the expression of DR4 and DR5. Collectively, our results show the effect of the third-dimension on the response of breast cancer cells to TRAIL and suggest a therapeutic target to overcome TRAIL-resistance.	[Chandrasekaran, Siddarth; Marshall, Jocelyn R.; Messing, James A.; Hsu, Jong-Wei; King, Michael R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA	Cornell University	King, MR (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	mike.king@cornell.edu			National Institutes of Health [U54CA143876]; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the following: National Institutes of Health (nih.gov) U54CA143876. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Bhardwaj N, 2007, J CLIN INVEST, V117, P1130, DOI 10.1172/JCI32136; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Cavallo F, 2011, CANCER IMMUNOL IMMUN, V60, P319, DOI 10.1007/s00262-010-0968-0; Chance S, 2012, BIOMATERIALS, P1; Chandrasekaran S., 2012, J BIOENG BIOMED SCI, V2, pe109, DOI [10.4172/2155-9538.1000e109, DOI 10.4172/2155-9538.1000E109]; Chandrasekaran S, 2014, LAB CHIP, V14, P118, DOI 10.1039/c3lc50584g; Chandrasekaran S, 2011, BIOMATERIALS, V32, P9316, DOI 10.1016/j.biomaterials.2011.08.056; Chandrasekaran S, 2011, BIOMATERIALS, V32, P7159, DOI 10.1016/j.biomaterials.2011.06.013; Cui DD, 2009, BRAZ J MED BIOL RES, V42, P854, DOI 10.1590/S0100-879X2009000900013; de Beca FF, 2013, J CLIN PATHOL, V66, P187, DOI 10.1136/jclinpath-2012-201169; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Geng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054959; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Joki T, 2000, CANCER RES, V60, P4926; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kern MA, 2006, CANCER RES, V66, P7059, DOI 10.1158/0008-5472.CAN-06-0325; Koci L, 2011, CYTOKINE, V55, P34, DOI 10.1016/j.cyto.2011.03.013; Kruyt FAE, 2008, CANCER LETT, V263, P14, DOI 10.1016/j.canlet.2008.02.003; Lane D, 2008, INT J GYNECOL CANCER, V18, P670, DOI 10.1111/j.1525-1438.2007.01062.x; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Li JM, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00079, 10.3389/fonc.2012.00029]; Li ZZ, 2010, CURR TOP MICROBIOL, V345, P21, DOI 10.1007/82_2010_75; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mitchell MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015008; Mitchell MJ, 2014, P NATL ACAD SCI USA, V2013, P1; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Nagane M, 2001, APOPTOSIS, V6, P191, DOI 10.1023/A:1011336726649; Nakamoto N, 2006, INT J ONCOL, V29, P625; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Philip B, 2013, CARCINOGENESIS, V34, P1699, DOI 10.1093/carcin/bgt209; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Rana K, 2009, BIOTECHNOL BIOENG, V102, P1692, DOI 10.1002/bit.22204; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Robertson FM, 2010, J BIOMOL SCREEN, V15, P820, DOI 10.1177/1087057110376541; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; Sanlioglu AD, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-54; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Shi J, 2003, CURR MOL MED, V3, P727, DOI 10.2174/1566524033479401; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Szliszka E, 2009, FOLIA HISTOCHEM CYTO, V47, P579, DOI 10.2478/v10042-009-0111-2; Tang XM, 2002, CANCER RES, V62, P4903; Totzke G, 2003, ONCOGENE, V22, P8021, DOI 10.1038/sj.onc.1206837; van Dijk M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.214; Van Geelen CMM, 2010, INT J ONCOL, V37, P1031, DOI 10.3892/ijo_00000755; Vinogradov S, 2012, NANOMEDICINE-UK, V7, P597, DOI [10.2217/NNM.12.22, 10.2217/nnm.12.22]; Vorsmann H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.249; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Xue X, 2013, CARCINOGENESIS, V34, P163, DOI 10.1093/carcin/bgs313; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yamanaka Y, 2006, INT J MOL MED, V18, P41; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P1029, DOI 10.1677/ERC-07-0114; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang S, 2013, ORTHOGONAL POLARIZATION IN LASERS: PHYSICAL PHENOMENA AND ENGINEERING APPLICATIONS, P1, DOI 10.1002/9781118346501; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	66	33	35	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111487	10.1371/journal.pone.0111487	http://dx.doi.org/10.1371/journal.pone.0111487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343626	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500103
J	Meersch, M; Schmidt, C; Van Aken, H; Rossaint, J; Gorlich, D; Stege, D; Malec, E; Januszewska, K; Zarbock, A				Meersch, Melanie; Schmidt, Christoph; Van Aken, Hugo; Rossaint, Jan; Goerlich, Dennis; Stege, Dirk; Malec, Edward; Januszewska, Katarzyna; Zarbock, Alexander			Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury after Pediatric Cardiac Surgery	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CHILDREN; SENESCENCE	Background: The lack of early biomarkers for acute kidney injury (AKI) seriously inhibits the initiation of preventive and therapeutic measures for this syndrome in a timely manner. We tested the hypothesis that insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2), both inducers of G1 cell cycle arrest, function as early biomarkers for AKI after congenital heart surgery with cardiopulmonary bypass (CPB). Methods: We prospectively studied 51 children undergoing cardiac surgery with CPB. Serial urine samples were analyzed for TIMP-2].[IGFBP7]. The primary outcome measure was AKI defined by the pRIFLE criteria within 72 hours after surgery. Results: 12 children (24%) developed AKI within 1.67 (SE 0.3) days after surgery. Children who developed AKI after cardiac surgery had a significant higher urinary [TIMP-2].[IGFBP7] as early as 4 h after the procedure, compared to children who did not develop AKI (mean of 1.93 ((ng/ml)(2)/1000) (SE 0.4) vs 0.47 ((ng/ml)(2)/1000) (SE 0.1), respectively; p<0.05). Urinary [TIMP-2].[IGFBP7] 4 hours following surgery demonstrated an area under the receiver-operating characteristic curve of 0.85. Sensitivity was 0.83, and specificity was 0.77 for a cutoff value of 0.70 ((ng/ml)(2)/1000). Conclusions: Urinary [TIMP-2].[IGFBP7] represent sensitive, specific, and highly predictive early biomarkers for AKI after surgery for congenital heart disease.	[Meersch, Melanie; Schmidt, Christoph; Van Aken, Hugo; Rossaint, Jan; Zarbock, Alexander] Univ Munster, Dept Anaesthesiol Intens Care & Pain Med, D-48149 Munster, Germany; [Goerlich, Dennis] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Stege, Dirk] Univ Munster, Dept Pediat Cardiol, D-48149 Munster, Germany; [Malec, Edward; Januszewska, Katarzyna] Univ Munster, Dept Pediat Heart Surg, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Zarbock, A (corresponding author), Univ Munster, Dept Anaesthesiol Intens Care & Pain Med, D-48149 Munster, Germany.	zarbock@uni-muenster.de	Görlich, Dennis/C-8950-2012	Görlich, Dennis/0000-0002-2574-9419	German Research Foundation [ZA428/6-1]	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation (ZA428/6-1 to A.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; American Society of Nephrology, 2005, J Am Soc Nephrol, V16, P1886; Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Jenkins Kathy J, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P180, DOI 10.1053/j.pcsu.2004.02.009; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Krawczeski CD, 2011, J AM COLL CARDIOL, V58, P2301, DOI 10.1016/j.jacc.2011.08.017; Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093460; Molitoris BA, 2003, J AM SOC NEPHROL, V14, P265, DOI 10.1097/01.ASN.0000048852.53881.D9; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Park M, 2010, AM J NEPHROL, V31, P408, DOI 10.1159/000296277; Pedersen KR, 2008, KIDNEY INT, V73, pS81, DOI 10.1038/sj.ki.5002607; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Siegel NJ, 2003, J AM SOC NEPHROL, V14, P2176, DOI 10.1097/01.ASN.0000079043.01987.34; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Yang QH, 2009, J INFECTION, V58, P459, DOI 10.1016/j.jinf.2009.04.003; Zappitelli M, 2009, KIDNEY INT, V76, P885, DOI 10.1038/ki.2009.270; Zuo SG, 2012, J CANCER RES CLIN, V138, P1045, DOI 10.1007/s00432-012-1153-y	28	65	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110865	10.1371/journal.pone.0110865	http://dx.doi.org/10.1371/journal.pone.0110865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343505	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500060
J	Borges, AF; Fonseca, C; Ferreira, RB; Lourenco, AM; Monteiro, S				Borges, Alexandre Filipe; Fonseca, Catarina; Ferreira, Ricardo Boavida; Lourenco, Ana Maria; Monteiro, Sara			Reference Gene Validation for Quantitative RT-PCR during Biotic and Abiotic Stresses in Vitis vinifera	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; INTERNAL CONTROL; GRAPEVINE; NORMALIZATION; SELECTION; PATHOGEN; IDENTIFICATION	Grapevine is one of the most cultivated fruit crop worldwide with Vitis vinifera being the species with the highest economical importance. Being highly susceptible to fungal pathogens and increasingly affected by environmental factors, it has become an important agricultural research area, where gene expression analysis plays a fundamental role. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) is currently amongst the most powerful techniques to perform gene expression studies. Nevertheless, accurate gene expression quantification strongly relies on appropriate reference gene selection for sample normalization. Concerning V. vinifera, limited information still exists as for which genes are the most suitable to be used as reference under particular experimental conditions. In this work, seven candidate genes were investigated for their stability in grapevine samples referring to four distinct stresses (Erysiphe necator, wounding and UV-C irradiation in leaves and Phaeomoniella chlamydospora colonization in wood). The expression stability was evaluated using geNorm, NormFinder and BestKeeper. In all cases, full agreement was not observed for the three methods. To provide comprehensive rankings integrating the three different programs, for each treatment, a consensus ranking was created using a non-weighted unsupervised rank aggregation method. According to the last, the three most suitable reference genes to be used in grapevine leaves, regardless of the stress, are UBC, VAG and PEP. For the P. chlamydospora treatment, EF1, CYP and UBC were the best scoring genes. Acquaintance of the most suitable reference genes to be used in grapevine samples can contribute for accurate gene expression quantification in forthcoming studies.	[Borges, Alexandre Filipe; Ferreira, Ricardo Boavida] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Dis & Stress Biol Lab, Oeiras, Portugal; [Borges, Alexandre Filipe; Fonseca, Catarina; Ferreira, Ricardo Boavida; Monteiro, Sara] Univ Lisbon, Dis & Stress Biol Lab, Inst Super Agron, P-1699 Lisbon, Portugal; [Lourenco, Ana Maria] Univ Nova Lisboa, Fac Ciencias & Tecnol, REQUIMTE, Dept Quim, Caparica, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa	Borges, AF (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Dis & Stress Biol Lab, Oeiras, Portugal.	afgborges@isa.utl.pt	Lourenço, Ana/C-9024-2013	Lourenço, Ana/0000-0001-7358-3428; Ferreira, Ricardo Boavida/0000-0002-5027-7564; Borges, Alexandre/0000-0002-8130-764X; Monteiro, Sara/0000-0002-7069-0591	Fundacao para a Ciencia e a Tecnologia [PTDC/AGR PRO/112340/2009, SFRH/BD/61903/2009]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support was provided by Project PTDC/AGR PRO/112340/2009 from Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/index.phtml.en). AFB was supported by Fundacao para a Ciencia e a Tecnologia, PhD grant SFRH/BD/61903/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Bonomelli A, 2004, AM J ENOL VITICULT, V55, P51; Borges AF, 2013, PLANT PHYSIOL BIOCH, V68, P71, DOI 10.1016/j.plaphy.2013.03.024; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Castro-Quezada P, 2013, PLANT MOL BIOL REP, V31, P936, DOI 10.1007/s11105-013-0566-3; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Coito Joao L, 2012, BMC Res Notes, V5, P220, DOI 10.1186/1756-0500-5-220; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Ferreira RB, 2004, TRENDS BIOTECHNOL, V22, P168, DOI 10.1016/j.tibtech.2004.02.001; Figueiredo A, 2008, J EXP BOT, V59, P3371, DOI 10.1093/jxb/ern187; Figueiredo Andreia, 2013, BMC Res Notes, V6, P388, DOI 10.1186/1756-0500-6-388; Fischer M, 2003, VITIS, V42, P109; Gaforio L, 2011, VITIS, V50, P123; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Gjetting T, 2004, MOL PLANT MICROBE IN, V17, P729, DOI 10.1094/MPMI.2004.17.7.729; Gonzalez-Aguero M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-878; Goulao LF, 2012, PLANT MOL BIOL REP, V30, P741, DOI 10.1007/s11105-011-0382-6; Iandolino A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-53; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kunz BA, 2006, INT REV CYTOL, V255, P1, DOI 10.1016/S0074-7696(06)55001-6; Le Henanff G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-54; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Lima MRM, 2012, EUR J PLANT PATHOL, V132, P133, DOI 10.1007/s10658-011-9857-4; Logemann E, 2002, P NATL ACAD SCI USA, V99, P2428, DOI 10.1073/pnas.042692199; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pezet R, 2003, J AGR FOOD CHEM, V51, P5488, DOI 10.1021/jf030227o; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Selim M, 2012, PLANT CELL REP, V31, P205, DOI 10.1007/s00299-011-1156-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu G, 2010, J AGR FOOD CHEM, V58, P2812, DOI 10.1021/jf904255b; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; [No title captured]	51	31	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111399	10.1371/journal.pone.0111399	http://dx.doi.org/10.1371/journal.pone.0111399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340748	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800105
J	Chang, SW; Liu, WC; Liao, KY; Tsao, YP; Hsu, PH; Chen, SL				Chang, Szu-Wei; Liu, Wei-Chen; Liao, Kuan-Yu; Tsao, Yeou-Ping; Hsu, Pang-Hung; Chen, Show-Li			Phosphorylation of HPV-16 E2 at Serine 243 Enables Binding to Brd4 and Mitotic Chromosomes	PLOS ONE			English	Article							PAPILLOMAVIRUS E2; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; FUNCTIONAL INTERACTION; ACETYLATED CHROMATIN; BROMODOMAIN PROTEIN; HOST CHROMOSOMES; VIRAL-DNA; GENOME; MITOSIS	The papillomavirus E2 protein is involved in the maintenance of persistent infection and known to bind either to cellular factors or directly to mitotic chromosomes in order to partition the viral genome into the daughter cells. However, how the HPV-16 E2 protein acts to facilitate partitioning of the viral genome remains unclear. In this study, we found that serine 243 of HPV-16 E2, located in the hinge region, is crucial for chromosome binding during mitosis. Bromodomain protein 4 (Brd4) has been identified as a cellular binding target through which the E2 protein of bovine papillomavirus type 1 (BPV-1) tethers the viral genome to mitotic chromosomes. Mutation analysis showed that, when the residue serine 243 was substituted by glutamic acid or aspartic acid, whose negative charges mimic the effect of constitutive phosphorylation, the protein still can interact with Brd4 and colocalize with Brd4 in condensed metaphase and anaphase chromosomes. However, substitution by the polar uncharged residues asparagine or glutamine abrogated Brd4 and mitotic chromosome binding. Moreover, following treatment with the inhibitor JQ1 to release Brd4 from the chromosomes, Brd4 and E2 formed punctate foci separate from the chromosomes, further supporting the hypothesis that the association of the HPV-16 E2 protein with the chromosomes is Brd4-dependent. In addition, the S243A E2 protein has a shorter half-life than the wild type, indicating that phosphorylation of the HPV-16 E2 protein at serine 243 also increases its half-life. Thus, phosphorylation of serine 243 in the hinge region of HPV-16 E2 is essential for interaction with Brd4 and required for host chromosome binding.	[Chang, Szu-Wei; Liu, Wei-Chen; Liao, Kuan-Yu; Chen, Show-Li] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Coll Life Sci, Dept Biosci & Biotechnol, Keelung, Taiwan	National Taiwan University; Mackay Memorial Hospital; National Taiwan Ocean University	Chen, SL (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan.	showlic@ntu.edu.tw	Hsu, Pang-Hung/C-5587-2018	Hsu, Pang-Hung/0000-0001-6873-6434	National Taiwan University [10R891903]; National Science Council [NSC101-2321-B-002-061, NSC102-2320-B-002-033MY3, NSC101-102-2325-B-002-065]; National Health Research Institute [NHRI-EX101-10148SI]	National Taiwan University(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by the National Taiwan University (10R891903), National Science Council (NSC101-2321-B-002-061, NSC102-2320-B-002-033MY3, NSC101-102-2325-B-002-065), and National Health Research Institute (NHRI-EX101-10148SI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Abroi A, 2004, J VIROL, V78, P2100, DOI 10.1128/JVI.78.4.2100-2113.2004; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; Brannon AR, 2005, P NATL ACAD SCI USA, V102, P2998, DOI 10.1073/pnas.0407818102; Chang SW, 2012, VIROLOGY, V423, P38, DOI 10.1016/j.virol.2011.11.015; Chang SW, 2011, J VIROL, V85, P6750, DOI 10.1128/JVI.02453-10; Dao LD, 2006, J VIROL, V80, P4792, DOI 10.1128/JVI.80.10.4792-4800.2006; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Donaldson MM, 2007, J VIROL, V81, P4338, DOI 10.1128/JVI.02353-06; Gagnon D, 2009, J VIROL, V83, P4127, DOI 10.1128/JVI.02468-08; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Hamid NA, 2009, CELL MOL LIFE SCI, V66, P1700, DOI 10.1007/s00018-009-8631-7; Helfer CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077994; Ilves I, 1999, J VIROL, V73, P4404, DOI 10.1128/JVI.73.5.4404-4412.1999; Lee AY, 2009, J BIOL CHEM, V284, P2778, DOI 10.1074/jbc.M805835200; Lee D, 2002, J BIOL CHEM, V277, P6483, DOI 10.1074/jbc.M105085200; Lehman CW, 1998, P NATL ACAD SCI USA, V95, P4338, DOI 10.1073/pnas.95.8.4338; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; McBride AA, 2013, VIROLOGY, V445, P57, DOI 10.1016/j.virol.2013.06.006; McBride AA, 2008, ADV VIRUS RES, V72, P155, DOI 10.1016/S0065-3527(08)00404-1; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; McPhillips MG, 2005, J VIROL, V79, P8920, DOI 10.1128/JVI.79.14.8920-8932.2005; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Muller A, 2002, J VIROL, V76, P11042, DOI 10.1128/JVI.76.21.11042-11053.2002; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Penrose KJ, 2000, J VIROL, V74, P6031, DOI 10.1128/JVI.74.13.6031-6038.2000; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; Poddar A, 2009, J VIROL, V83, P640, DOI 10.1128/JVI.01936-08; Rehtanz M, 2004, MOL CELL BIOL, V24, P2153, DOI 10.1128/MCB.24.5.2153-2168.2004; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Sekhar V, 2012, J VIROL, V86, P10047, DOI 10.1128/JVI.01140-12; Sekhar V, 2010, J VIROL, V84, P543, DOI 10.1128/JVI.01908-09; Senechal H, 2007, VIROLOGY, V358, P10, DOI 10.1016/j.virol.2006.08.035; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Vosa L, 2012, J VIROL, V86, P348, DOI 10.1128/JVI.05606-11; Wang X, 2013, J VIROL, V87, P3871, DOI 10.1128/JVI.03068-12; Wu MH, 2007, INT J BIOCHEM CELL B, V39, P413, DOI 10.1016/j.biocel.2006.09.008; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yao JM, 1998, J VIROL, V72, P1013, DOI 10.1128/JVI.72.2.1013-1019.1998; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2005, J VIROL, V79, P14956, DOI 10.1128/JVI.79.23.14956-14961.2005; Yu T, 2007, J VIROL, V81, P1736, DOI 10.1128/JVI.01638-06; Zheng G, 2009, J VIROL, V83, P8683, DOI 10.1128/JVI.00674-09; Zheng PS, 2005, J VIROL, V79, P1500, DOI 10.1128/JVI.79.3.1500-1509.2005; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	47	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110882	10.1371/journal.pone.0110882	http://dx.doi.org/10.1371/journal.pone.0110882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340539	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800066
J	Ligmann-Zielinska, A; Kramer, DB; Cheruvelil, KS; Soranno, PA				Ligmann-Zielinska, Arika; Kramer, Daniel B.; Cheruvelil, Kendra Spence; Soranno, Patricia A.			Using Uncertainty and Sensitivity Analyses in Socioecological Agent-Based Models to Improve Their Analytical Performance and Policy Relevance	PLOS ONE			English	Article							LAND-COVER CHANGE; CONSERVATION RESERVE PROGRAM; GLOBAL SENSITIVITY; THEORETICAL FRAMEWORK; COMPLEX; SYSTEMS; SIMULATIONS; MANAGEMENT; ECOSYSTEM; DYNAMICS	Agent-based models (ABMs) have been widely used to study socioecological systems. They are useful for studying such systems because of their ability to incorporate micro-level behaviors among interacting agents, and to understand emergent phenomena due to these interactions. However, ABMs are inherently stochastic and require proper handling of uncertainty. We propose a simulation framework based on quantitative uncertainty and sensitivity analyses to build parsimonious ABMs that serve two purposes: exploration of the outcome space to simulate low-probability but high-consequence events that may have significant policy implications, and explanation of model behavior to describe the system with higher accuracy. The proposed framework is applied to the problem of modeling farmland conservation resulting in land use change. We employ output variance decomposition based on quasi-random sampling of the input space and perform three computational experiments. First, we perform uncertainty analysis to improve model legitimacy, where the distribution of results informs us about the expected value that can be validated against independent data, and provides information on the variance around this mean as well as the extreme results. In our last two computational experiments, we employ sensitivity analysis to produce two simpler versions of the ABM. First, input space is reduced only to inputs that produced the variance of the initial ABM, resulting in a model with output distribution similar to the initial model. Second, we refine the value of the most influential input, producing a model that maintains the mean of the output of initial ABM but with less spread. These simplifications can be used to 1) efficiently explore model outcomes, including outliers that may be important considerations in the design of robust policies, and 2) conduct explanatory analysis that exposes the smallest number of inputs influencing the steady state of the modeled system.	[Ligmann-Zielinska, Arika] Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA; [Kramer, Daniel B.] Michigan State Univ, James Madison Coll, E Lansing, MI 48824 USA; [Kramer, Daniel B.; Cheruvelil, Kendra Spence; Soranno, Patricia A.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Cheruvelil, Kendra Spence] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Ligmann-Zielinska, A (corresponding author), Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA.	ligmannz@msu.edu		Soranno, Patricia/0000-0003-1668-9271; Spence Cheruvelil, Kendra/0000-0003-1880-2880	Center for Water Sciences and the Environmental Science; Policy Program at Michigan State University; National Science Foundation Geography and Spatial Sciences Program [BCS 1263477]	Center for Water Sciences and the Environmental Science; Policy Program at Michigan State University; National Science Foundation Geography and Spatial Sciences Program	Financial support for this work was provided by the Center for Water Sciences and the Environmental Science and Policy Program at Michigan State University, as well as the National Science Foundation Geography and Spatial Sciences Program Grant No. BCS 1263477. Any opinion, findings, conclusions, and recommendations expressed in this material are those of the authors(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER ER, 1989, J AM PLANN ASSOC, V55, P323, DOI 10.1080/01944368908975419; An L, 2005, ANN ASSOC AM GEOGR, V95, P54, DOI 10.1111/j.1467-8306.2005.00450.x; Baroni G, 2014, ENVIRON MODELL SOFTW, V51, P26, DOI 10.1016/j.envsoft.2013.09.022; BECKER BJ, 1994, HDB RES SYNTHESIS; Bennett D, 2008, GEOFORUM, V39, P833, DOI 10.1016/j.geoforum.2007.05.009; Berger T, 2001, AGR ECON-BLACKWELL, V25, P245, DOI 10.1111/j.1574-0862.2001.tb00205.x; Bert FE, 2011, ECOL MODEL, V222, P3486, DOI 10.1016/j.ecolmodel.2011.08.007; Beven K, 2002, P ROY SOC A-MATH PHY, V458, P2465, DOI 10.1098/rspa.2002.0986; Beven K. J., 2008, ENV MODELLING UNCERT; Bousquet F, 2004, ECOL MODEL, V176, P313, DOI 10.1016/j.ecolmodel.2004.01.011; Brady M, 2009, ANN M AGR APPL EC AS, P27; Brown DG, 2006, ECOL SOC, V11; Brown DG, 2013, CURR OPIN ENV SUST, V5, P452, DOI 10.1016/j.cosust.2013.07.012; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campolongo F, 2000, SENSITIVITY ANAL, P15; Chan K., 2000, SENSITIVITY ANAL; Chang HH, 2008, AGR ECON-BLACKWELL, V38, P201, DOI 10.1111/j.1574-0862.2008.00294.x; Chen Y, 2013, ENVIRON MODELL SOFTW, V48, P129, DOI 10.1016/j.envsoft.2013.06.010; Chu-Agor ML, 2011, ENVIRON MODELL SOFTW, V26, P593, DOI 10.1016/j.envsoft.2010.12.003; Convertino M, 2014, ENVIRON MODELL SOFTW, V51, P296, DOI 10.1016/j.envsoft.2013.10.001; Couclelis H., 2003, T GIS, V7, P165, DOI [10.1111/1467-9671.00138, DOI 10.1111/1467-9671.00138]; Dancik GM, 2010, J THEOR BIOL, V262, P398, DOI 10.1016/j.jtbi.2009.10.007; DANIEL C, 1958, BIOMETRICS, V14, P430, DOI 10.2307/2527884; Epstein JM, 2008, JASSS-J ARTIF SOC S, V11; Estrada V, 2010, ENVIRON MODELL SOFTW, V25, P1539, DOI 10.1016/j.envsoft.2010.06.009; Evans TP, 2011, J LAND USE SCI, V6, P151, DOI 10.1080/1747423X.2011.558602; Fisher P, 1991, PRINCIPLES APPL, V1, P191; Fonoberova M, 2013, RELIAB ENG SYST SAFE, V118, P8, DOI 10.1016/j.ress.2013.04.004; Goodchild MF, 2008, ENCY GIS; Granger M.., 2009, CLIMATE CHANGE SCI P, P96; Greiner R, 2009, AGR SYST, V99, P86, DOI 10.1016/j.agsy.2008.10.003; Guzy MR, 2008, ECOL SOC, V13; Happe K., 2006, Ecology and Society, V11, P49; Hellerstein D, 2010, CHALLENGES FACING US; Heppenstall AJ, 2012, AGENT BASED MODEL GE, DOI [DOI 10.1007/978-90-481-8927-4, 10.1007/978-90-481-8927-4]; Homma T, 1996, RELIAB ENG SYST SAFE, V52, P1, DOI 10.1016/0951-8320(96)00002-6; Hosack GR, 2009, ECOL MODEL, V220, P1054, DOI 10.1016/j.ecolmodel.2009.01.033; Huang QX, 2013, COMPUT ENVIRON URBAN, V41, P188, DOI 10.1016/j.compenvurbsys.2013.06.004; INSUA DR, 1991, EUR J OPER RES, V54, P176, DOI 10.1016/0377-2217(91)90296-8; Jager W, 2000, ECOL ECON, V35, P357, DOI 10.1016/S0921-8009(00)00220-2; Kingsbury L, 1999, ANN M AM AGR EC ASS, P15; Kocabas V, 2006, COMPUT ENVIRON URBAN, V30, P921, DOI 10.1016/j.compenvurbsys.2006.01.001; Lambert D., 2006, CONSERVATION COMPATI, P14; Lambert D. M., 2007, Journal of Agricultural and Applied Economics, V39, P151; Lambert DM, 2007, LAND USE POLICY, V24, P72, DOI 10.1016/j.landusepol.2005.12.002; Larocque GR, 2008, ECOL MODEL, V219, P400, DOI 10.1016/j.ecolmodel.2008.07.024; Lempert R, 2002, P NATL ACAD SCI USA, V99, P7195, DOI 10.1073/pnas.072079399; Lempert R. J., 2003, MR1626RPC RAND CORP; Ligmann-Zielinska A, 2010, ENCY GEOGRAPHY SAGE; Ligmann-Zielinska A, 2008, LECT NOTES COMPUT SC, V5266, P217; Ligmann-Zielinska A, 2010, INT J GEOGR INF SCI, V24, P1829, DOI 10.1080/13658816.2010.490533; Ligmann-Zielinska A, 2013, INT J GEOGR INF SCI, V27, P1764, DOI 10.1080/13658816.2013.782613; Lilburne L, 2009, INT J GEOGR INF SCI, V23, P151, DOI 10.1080/13658810802094995; Makler-Pick V, 2011, ENVIRON MODELL SOFTW, V26, P124, DOI 10.1016/j.envsoft.2010.06.010; Malczewski J, 1999, GIS MULTICRITERIA DE; Matthews RB, 2007, LANDSCAPE ECOL, V22, P1447, DOI 10.1007/s10980-007-9135-1; McGarigal K., 1995, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Melbourne-Thomas J, 2011, ECOL MODEL, V222, P3320, DOI 10.1016/j.ecolmodel.2011.07.014; Menard A, 2005, ENVIRON PLANN B, V32, P693, DOI 10.1068/b31163; Mosler HJ, 2008, J ENVIRON MANAGE, V88, P805, DOI 10.1016/j.jenvman.2007.04.013; Nossent J, 2011, ENVIRON MODELL SOFTW, V26, P1515, DOI 10.1016/j.envsoft.2011.08.010; Nrc, 2013, ADV LAND CHANG MOD O; Pannell DJ, 1997, AGR ECON, V16, P139, DOI 10.1016/S0169-5150(96)01217-0; Parker DC, 2008, J LAND USE SCI, V3, P41, DOI 10.1080/17474230802048151; Parker DC, 2003, ANN ASSOC AM GEOGR, V93, P314, DOI 10.1111/1467-8306.9302004; Parry HR, 2013, ENVIRON MODELL SOFTW, V45, P104, DOI 10.1016/j.envsoft.2012.08.006; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Polasky S, 2011, TRENDS ECOL EVOL, V26, P398, DOI 10.1016/j.tree.2011.04.007; Pontius RG, 2000, PHOTOGRAMM ENG REM S, V66, P1011; Pontius RG, 2010, SUSTAIN SCI, V5, P39, DOI 10.1007/s11625-009-0095-z; Rindfuss RR, 2008, J LAND USE SCI, V3, P1, DOI 10.1080/17474230802047955; Rinner C, 2002, J GEOGRAPH SYST, V4, P385, DOI [10.1007/s101090300095, DOI 10.1007/S101090300095]; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Saltelli A., 2008, GLOBAL SENSITIVITY A; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Saltelli A., 2013, INT J INNOV POL, V9, P213, DOI DOI 10.1504/IJFIP.2013.058610; Saltelli A, 2014, ISSUES SCI TECHNOL, V30, P79; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Saltelli A, 2010, GLOBAL ENVIRON CHANG, V20, P298, DOI 10.1016/j.gloenvcha.2009.12.003; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Schaetzl RJ, 2012, SOIL SCI, V177, P288, DOI 10.1097/SS.0b013e3182446c88; Schindler J, 2013, JASSS-J ARTIF SOC S, V16, DOI 10.18564/jasss.2274; Schluter M, 2007, ECOL SOC, V12; Schreinemachers P, 2011, ENVIRON MODELL SOFTW, V26, P845, DOI 10.1016/j.envsoft.2011.02.004; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Sengupta R, 2005, ENVIRON PLANN B, V32, P821, DOI 10.1068/b31193; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Soboll A, 2011, MITIG ADAPT STRAT GL, V16, P477, DOI 10.1007/s11027-010-9274-6; Soil Survey Staff, 2013, GRIDD SOIL SURV GEOG; USDA, 2013, US CENS AGR; USDA, 2011, AGR RES MAN SURV ARM; USDA FSA, 2011, CONS RES PROGR SIGN; USDA FSA, 2013, CONS PROGR REP STAT; USDA FSA, 2010, CONS RES PROGR SIGN; USDA FSA, 2010, CRP663 DC US DEP AGR; USDA FSA, 2012, CONS RES PROGR OV; USDA NASS, 2012, CORPL DAT LAY CDL; USGS, 2013, LANDFIRE NAT EL DAT; USGS, 2012, NAT HYDR DAT NHD; Vanuytrecht E, 2014, ENVIRON MODELL SOFTW, V51, P323, DOI 10.1016/j.envsoft.2013.10.017; Verburg PH, 2006, LANDSCAPE ECOL, V21, P1171, DOI 10.1007/s10980-006-0029-4; Verburg PH, 2006, GLO CH IGBP, P117; Warmink JJ, 2010, ENVIRON MODELL SOFTW, V25, P1518, DOI 10.1016/j.envsoft.2010.04.011; Wossink GAA, 2003, EUR REV AGRIC ECON, V30, P461, DOI 10.1093/erae/30.4.461; YAGER RR, 1988, IEEE T SYST MAN CYB, V18, P183, DOI 10.1109/21.87068; Yang J, 2011, ENVIRON MODELL SOFTW, V26, P444, DOI 10.1016/j.envsoft.2010.10.007; Zhang J., 2002, UNCERTAINTY GEOGRAPH	107	46	47	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109779	10.1371/journal.pone.0109779	http://dx.doi.org/10.1371/journal.pone.0109779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340764	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800016
J	Altermatt, F; Alther, R; Fiser, C; Jokela, J; Konec, M; Kury, D; Machler, E; Stucki, P; Westram, AM				Altermatt, Florian; Alther, Roman; Fiser, Cene; Jokela, Jukka; Konec, Marjeta; Kuery, Daniel; Maechler, Elvira; Stucki, Pascal; Westram, Anja Marie			Diversity and Distribution of Freshwater Amphipod Species in Switzerland (Crustacea: Amphipoda)	PLOS ONE			English	Article							GAMMARUS-FOSSARUM COMPLEX; LIFE-HISTORY TRAITS; CRYPTIC DIVERSITY; ADJACENT REGIONS; ASIA CRUSTACEA; NORTH-AFRICA; DIKEROGAMMARUS-VILLOSUS; EUROPE; PERSPECTIVE; METACOMMUNITIES	Amphipods are key organisms in many freshwater systems and contribute substantially to the diversity and functioning of macroinvertebrate communities. Furthermore, they are commonly used as bioindicators and for ecotoxicological tests. For many areas, however, diversity and distribution of amphipods is inadequately known, which limits their use in ecological and ecotoxicological studies and handicaps conservation initiatives. We studied the diversity and distribution of amphipods in Switzerland (Central Europe), covering four major drainage basins, an altitudinal gradient of>2,500 m, and various habitats (rivers, streams, lakes and groundwater). We provide the first provisional checklist and detailed information on the distribution and diversity of all amphipod species from Switzerland. In total, we found 29 amphipod species. This includes 16 native and 13 non-native species, one of the latter (Orchestia cavimana) reported here for the first time for Switzerland. The diversity is compared to neighboring countries. We specifically discuss species of the genus Niphargus, which are often receiving less attention. We also found evidence of an even higher level of hidden diversity, and the potential occurrence of further cryptic species. This diversity reflects the biogeographic past of Switzerland, and suggests that amphipods are ideally suited to address questions on endemism and adaptive radiations, post-glaciation re-colonization and invasion dynamics as well as biodiversity-ecosystem functioning relationships in aquatic systems.	[Altermatt, Florian; Alther, Roman; Jokela, Jukka; Maechler, Elvira; Westram, Anja Marie] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Altermatt, Florian; Jokela, Jukka] ETH Zentrum, Dept Environm Syst Sci, Zurich, Switzerland; [Altermatt, Florian] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Fiser, Cene; Konec, Marjeta] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Kuery, Daniel] Life Sci AG, Basel, Switzerland; [Stucki, Pascal] Aquabug, Neuchatel, Switzerland; [Westram, Anja Marie] Univ Sheffield, Sheffield, S Yorkshire, England	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Ljubljana; University of Sheffield	Altermatt, F (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.	florian.altermatt@eawag.ch	Alther, Roman/H-8545-2019	Alther, Roman/0000-0001-7582-3966; Altermatt, Florian/0000-0002-4831-6958; Westram, Anja Marie/0000-0003-1050-4969; Jokela, Jukka/0000-0002-1731-727X	Swiss National Science Foundation [31003A_135622, PP00P3_150698]; Swiss Federal Office for the Environment (BAFU); Eawag Matching funds; ETH-CCES project BioChange; EAWAG project AquaDivers; Life Science AG; Aquabug	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Office for the Environment (BAFU); Eawag Matching funds; ETH-CCES project BioChange; EAWAG project AquaDivers; Life Science AG; Aquabug	The study was funded by the Swiss National Science Foundation Grants 31003A_135622 and PP00P3_150698 (to FA), the Swiss Federal Office for the Environment (BAFU, to FA), Eawag Matching funds (to FA and RA), ETH-CCES project BioChange (to JJ) and EAWAG project AquaDivers (to JJ). Life Science AG and Aquabug provided support in the form of salaries for authors DK & PS respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alp M, 2012, FRESHWATER BIOL, V57, P969, DOI 10.1111/j.1365-2427.2012.02758.x; Altermatt F, 2013, J BIOGEOGR, V40, P2249, DOI 10.1111/jbi.12178; Altermatt F, 2013, AQUAT ECOL, V47, P365, DOI 10.1007/s10452-013-9450-3; AquaPlus, 2008, BIOL UNT SEIT AAR ZW; Bacela-Spychalska K, 2013, AQUAT CONSERV, V23, P606, DOI 10.1002/aqc.2329; Baden-Wurrtemberg LfU, 2005, WIRBELLOSE NEOZOEN B; BAFU, 2002, SCHRIFT UNW, V345, P101; Balian EV, 2008, HYDROBIOLOGIA, V595, P627, DOI 10.1007/s10750-007-9246-3; Bernasconi R, 1969, STALACTITE S, V3, P76; Bundschuh M, 2011, ECOTOXICOLOGY, V20, P466, DOI 10.1007/s10646-011-0599-z; Bundschuh M, 2011, CHEMOSPHERE, V82, P355, DOI 10.1016/j.chemosphere.2010.10.006; Carrara F, 2012, P NATL ACAD SCI USA, V109, P5761, DOI 10.1073/pnas.1119651109; Colgan DJ, 2000, ZOOL SCR, V29, P29, DOI 10.1046/j.1463-6409.2000.00021.x; de Jong YSDM, 2014, FAUNA EUROPAEA 2 6; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Eberstraller J, 2007, MONITORING ALPENRHEI; Eggers Thomas Ols, 2001, Lauterbornia, V42, P1; Eme D, 2013, MOL ECOL, V22, P5685, DOI 10.1111/mec.12520; Feckler A, 2012, SCI TOTAL ENVIRON, V439, P158, DOI 10.1016/j.scitotenv.2012.09.003; Fiser C, 2008, ZOOL SCR, V37, P665, DOI 10.1111/j.1463-6409.2008.00347.x; Fiser C, 2013, OIKOS, V122, P770, DOI 10.1111/j.1600-0706.2012.20644.x; Fiser C, 2010, ORG DIVERS EVOL, V10, P5, DOI 10.1007/s13127-010-0006-2; Fiser C, 2009, CRUSTACEANA, V82, P593, DOI 10.1163/156854009X407704; Fuchs A, 2007, ERHEBUNG BESCHREIBUN; Gerhardt A, 2011, INT J ZOOLOGY, V2011; Grabowski M, 2007, HYDROBIOLOGIA, V590, P75, DOI 10.1007/s10750-007-0759-6; Hanselmann Almut J., 2008, Lauterbornia, V62, P21; Hartke TR, 2011, J CRUSTACEAN BIOL, V31, P701, DOI 10.1651/10-3434.1; HOLSINGER JR, 1987, CAN J ZOOL, V65, P2202, DOI 10.1139/z87-334; KARAMAN GS, 1987, BIJDR DIERKD, V57, P207, DOI 10.1163/26660644-05702005; KARAMAN GS, 1977, BIJDR DIERKD, V47, P1; KARAMAN GS, 1977, BIJDR DIERKD, V47, P165, DOI 10.1163/26660644-04702003; Karaman GS, 1993, CRUSTACEA AMPHIPODA; Karaman GS, 1980, BIOSISTEMATIKA, V6, P175; Karaman S., 1952, ACAD SCI ARTIUM SLAV, V1, P5; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Ketmaier V, 2010, J CRUSTACEAN BIOL, V30, P307, DOI 10.1651/09-3162.1; Kury D, 2010, ERFOLGSKONTROLLE BIR; Lefebure T, 2007, MOL PHYLOGENET EVOL, V42, P676, DOI 10.1016/j.ympev.2006.08.020; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Leuven RSEW, 2009, BIOL INVASIONS, V11, P1989, DOI 10.1007/s10530-009-9491-7; Lods-Crozet Brigitte, 2006, Journal of Limnology, V65, P141; Lubini V, 2011, BIOLOGISCHE GEWASSER; Lubini V, 2010, UNTERSUCHUNG BENTHOS; Lubini V., 2012, ROTE LISTEN EINTAGSF; MAC ARTHUR ROBERT H., 1967; Macdonald KS, 2005, MOL PHYLOGENET EVOL, V35, P323, DOI 10.1016/j.ympev.2005.01.013; Machler E, 2014, FRESHWATER IN PRESS, DOI [10.1086/678128, DOI 10.1086/678128]; Malard F, 2009, FRESHWATER BIOL, V54, P756, DOI 10.1111/j.1365-2427.2009.02180.x; Moeschler P, 1983, STALACTITE, V39, P75; Moritz C, 2001, FACHBERICHT MAKROZOO; Muller J, 1998, J EVOLUTION BIOL, V11, P79, DOI 10.1046/j.1420-9101.1998.11010079.x; Muller J, 2000, MOL PHYLOGENET EVOL, V15, P260, DOI 10.1006/mpev.1999.0740; Murle U, 2003, NEUER FLOHKREBS BODE, P3; Murle U, 2003, LAUTERBORNIA, V48, P61; NOCENTINI A M, 1967, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V21, P213; Nychka D, 2014, FIELDS TOOLS SPATIAL; Ortlepp J, 2003, BIOLOGISCHE UNTERSUC; PINKSTER S, 1970, Beaufortia, V17, P85; R Development Core Team, 2013, LANG ENV STAT COMP V; Rey P, 2000, MITTEILUNGEN BADISCH, V18, P19; Rey P, 2004, WIRBELLOSE NEOZOEN H; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruffo S, 2014, ITAL J ZOOL, V81, P92, DOI 10.1080/11250003.2014.891662; Ruffo S, 2001, J CRUSTACEAN BIOL, V21, P484, DOI 10.1651/0278-0372(2001)021[0484:IBNSAI]2.0.CO;2; Ruffo S, 1993, B MUSEO CIVICO STORI, V17, P57; RUFFO S, 2006, SEZIONE SCI VITA, V17, P1; Schellenberg A, 1942, KREBSTIERE CRUSTACEA, P81; SKET B, 1974, Bioloski Vestnik, V22, P91; Sket B, 1996, NARAVA SLOVENIJE STA, P222; Steinmann P, 2006, ABKLARUNG DIKEROGAMM; Steinmann P, 2008, MAKROZOOBENTHOS AQUA; Steinmann P, 2006, DIKEROGAMMARUS VILLO; STOCK J H, 1974, Bijdragen tot de Dierkunde, V44, P73; Strinati P, 1966, FAUNE CAVERNICOLE SU; Stucki P, 2010, METHODEN UNTERSUCHUN; Stucki P, 2011, SUIVI QUALITE BIOL C; TARAMELLI ESTER, 1956, MEM IST ITAL IDROBIOL DOTT MARCO DE MARCHI, V9, P61; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Vainola R, 2008, HYDROBIOLOGIA, V595, P241, DOI 10.1007/s10750-007-9020-6; Verovnik R, 2005, MOL ECOL, V14, P4355, DOI 10.1111/j.1365-294X.2005.02745.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Vornatscher J, 1969, MITTEILUNGEN NATURWI, V99, P123; Ward JV, 2003, ECOLOGY GLACIAL FLOO; Weiss M, 2014, HYDROBIOLOGIA, V721, P165, DOI 10.1007/s10750-013-1658-7; Westram AM, 2010, CONSERV GENET RESOUR, V2, P401, DOI 10.1007/s12686-010-9287-1; Westram AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069576; Westram AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023879; Zagmajster M, 2014, GLOBAL ECOLOGY BIOGE; Zaksek V, 2007, MOL PHYLOGENET EVOL, V42, P223, DOI 10.1016/j.ympev.2006.07.009	92	40	44	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110328	10.1371/journal.pone.0110328	http://dx.doi.org/10.1371/journal.pone.0110328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354099	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200021
J	Capitanio, JP; Hawkley, LC; Cole, SW; Cacioppo, JT				Capitanio, John P.; Hawkley, Louise C.; Cole, Steven W.; Cacioppo, John T.			A Behavioral Taxonomy of Loneliness in Humans and Rhesus Monkeys (Macaca mulatta)	PLOS ONE			English	Article							SOCIAL-ISOLATION; ENVIRONMENTAL CONTRIBUTIONS; GLUCOCORTICOID REGULATION; PERSONALITY DIMENSIONS; CHICAGO HEALTH; OLD-AGE; RISK; STABILITY; MORTALITY; RESPONSES	Social relationships endow health and fitness benefits, but considerable variation exists in the extent to which individuals form and maintain salutary social relationships. The mental and physical health effects of social bonds are more strongly related to perceived isolation (loneliness) than to objective social network characteristics. We sought to develop an animal model to facilitate the experimental analysis of the development of, and the behavioral and biological consequences of, loneliness. In Study 1, using a population-based sample of older adults, we examined how loneliness was influenced both by social network size and by the extent to which individuals believed that their daily social interactions reflected their own choice. Results revealed three distinct clusters of individuals: (i) individuals with large networks who believed they had high choice were lowest in loneliness, (ii) individuals with small social networks who believed they had low choice were highest in loneliness, and (iii) the remaining two groups were intermediate and equivalent in loneliness. In Study 2, a similar three-group structure was identified in two separate samples of adult male rhesus monkeys (Macaca mulatta) living in large social groups: (i) those high in sociability who had complex social interaction with a broad range of social partners (putatively low in loneliness), (ii) those low in sociability who showed tentative interactions with certain classes of social partners (putatively high in loneliness), and (iii) those low in sociability who interacted overall at low levels with a broad range of social partners (putatively low or intermediate in loneliness). This taxonomy in monkeys was validated in subsequent experimental social probe studies. These results suggest that, in highly social nonhuman primate species, some animals may show a mismatch between social interest and social attainment that could serve as a useful animal model for experimental and mechanistic studies of loneliness.	[Capitanio, John P.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Capitanio, John P.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Hawkley, Louise C.] Univ Chicago, Natl Opin Res Ctr, Chicago, IL 60637 USA; [Cole, Steven W.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Cole, Steven W.] Univ Calif Los Angeles, Norman Cousins Ctr, Los Angeles, CA USA; [Cacioppo, John T.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Cacioppo, John T.] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Chicago; University of Chicago	Capitanio, JP (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	jpcapitanio@ucdavis.edu			US National Institutes of Health: National Institute on Aging [R01-AG033590, R01-AG034052, R01-AG036433]; National Cancer Institute [R01-CA116778]; National Institute of Mental Health [R01-MH49033]; National Center for Research Resources [P51-RR000169]; NATIONAL CANCER INSTITUTE [R01CA116778] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036433, R01AG034052, R01AG033590] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	US National Institutes of Health: National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the following components of the US National Institutes of Health: National Institute on Aging (R01-AG033590 and R01-AG034052 to JTC and R01-AG036433 to LCH); the National Cancer Institute (R01-CA116778 to SWC); the National Institute of Mental Health (R01-MH49033 to JPC); and the National Center for Research Resources (P51-RR000169 to the California National Primate Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andersson L, 1998, AGING MENT HEALTH, V2, P264, DOI 10.1080/13607869856506; Bartels M, 2008, AM J MED GENET B, V147B, P385, DOI 10.1002/ajmg.b.30608; BERNSTEIN IS, 1981, BEHAV BRAIN SCI, V4, P419, DOI 10.1017/S0140525X00009614; Bondevik M, 1998, WESTERN J NURS RES, V20, P325, DOI 10.1177/019394599802000305; Boomsma DI, 2005, BEHAV GENET, V35, P745, DOI 10.1007/s10519-005-6040-8; Boomsma DI, 2007, TWIN RES HUM GENET, V10, P267, DOI 10.1375/twin.10.2.267; Cacioppo JT, 2006, J RES PERS, V40, P1054, DOI 10.1016/j.jrp.2005.11.007; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cacioppo JT, ANN REV PSYCHOL, P66; Capitanio JP, 2008, BRAIN BEHAV IMMUN, V22, P676, DOI 10.1016/j.bbi.2007.05.006; Capitanio JP, 2006, ILAR J, V47, P294, DOI 10.1093/ilar.47.4.294; Capitanio JP, 2011, AM J PRIMATOL, V73, P507, DOI 10.1002/ajp.20870; Capitanio JP, 1999, AM J PRIMATOL, V47, P299, DOI 10.1002/(SICI)1098-2345(1999)47:4<299::AID-AJP3>3.0.CO;2-P; Capitanio JP, 2005, AM J PRIMATOL, V65, P289, DOI 10.1002/ajp.20116; Capitanio JP, 1998, P NATL ACAD SCI USA, V95, P4714, DOI 10.1073/pnas.95.8.4714; Capitanio JP, 2002, PRIMATES, V43, P169, DOI 10.1007/BF02629645; Capitanio JP, 2011, OXFORD HDB HLTH PSYC, P860; Centers for Disease Control (CDC), 2008, PROM IND FAM COMM CO; Cutrona CE, 1982, LONELINESS SOURCEBOO, P291; Distel MA, 2010, BEHAV GENET, V40, P480, DOI 10.1007/s10519-010-9341-5; Dixson AF, 2012, PRIMATE SEXUALITY: COMPARATIVE STUDIES OF THE PROSIMIANS, MONKEYS, APES, AND HUMANS, 2ND EDITION, P1, DOI 10.1093/acprof:osobl/9780199544646.001.0001; DUGAN E, 1994, GERONTOLOGIST, V34, P340, DOI 10.1093/geront/34.3.340; Dykstra P A, 1999, Tijdschr Gerontol Geriatr, V30, P212; Eysenck HJ, 1947, DIMENSIONS PERSONALI; FREELAND W J, 1976, Biotropica, V8, P12, DOI 10.2307/2387816; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Gawronski B, 2013, PERS SOC PSYCHOL REV, V17, P187, DOI 10.1177/1088868313480096; Gold LH, 1998, J MED PRIMATOL, V27, P104, DOI 10.1111/j.1600-0684.1998.tb00234.x; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Hawkley LC, 2005, PSYCHOL SCI, V16, P798, DOI 10.1111/j.1467-9280.2005.01617.x; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; Hawkley LC, 2008, J GERONTOL B-PSYCHOL, V63, pS375, DOI 10.1093/geronb/63.6.S375; HectorTaylor L, 1996, PSYCHOL REP, V78, P1329, DOI 10.2466/pr0.1996.78.3c.1329; Holmen K, 1992, Vard Nord Utveckl Forsk, V12, P9; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Holwerda TJ, 2012, PSYCHOL MED, V42, P843, DOI 10.1017/S0033291711001772; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; JONES DC, 1992, J SOC PERS RELAT, V9, P219, DOI 10.1177/0265407592092004; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; Kinnally EL, 2010, DEV PSYCHOPATHOL, V22, P35, DOI 10.1017/S0954579409990241; LEARY MR, 1983, J PERS ASSESS, V47, P66, DOI 10.1207/s15327752jpa4701_8; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Maninger N, 2003, AM J PRIMATOL, V61, P73, DOI 10.1002/ajp.10111; McGuire S, 2000, PSYCHOL SCI, V11, P487, DOI 10.1111/1467-9280.00293; Melnick D.J., 1987, P121; MULLINS LC, 1990, GERONTOLOGIST, V30, P377, DOI 10.1093/geront/30.3.377; Nei M, 2002, J HERED, V93, P157, DOI 10.1093/jhered/93.3.157; NOLDUS LPJJ, 1991, BEHAV RES METH INSTR, V23, P415, DOI 10.3758/BF03203406; Nunn CL, 2006, INFECT DIS PRIMATES; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Pinquart M, 2003, ADV PSY RES, V19, P111; Routasalo PE, 2006, GERONTOLOGY, V52, P181, DOI 10.1159/000091828; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Samuelsson G, 1998, J MENTAL HLTH AGING, V4, P361; Savikko N, 2005, ARCH GERONTOL GERIAT, V41, P223, DOI 10.1016/j.archger.2005.03.002; Segrin C, 1999, J SOC CLIN PSYCHOL, V18, P14, DOI 10.1521/jscp.1999.18.1.14; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Weinstein TAR, 2012, J COMP PSYCHOL, V126, P97, DOI 10.1037/a0025607; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Wolff JO, 2007, RODENT SOC ECOLOGICA, P610	67	26	26	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110307	10.1371/journal.pone.0110307	http://dx.doi.org/10.1371/journal.pone.0110307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354040	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200020
J	Hong, YS; Kim, J; Pectasides, E; Fox, C; Hong, SW; Ma, QP; Wong, GS; Peng, S; Stachler, MD; Thorner, AR; Van Hummelen, P; Bass, AJ				Hong, Yong Sang; Kim, Jihun; Pectasides, Eirini; Fox, Cameron; Hong, Seung-Woo; Ma, Qiuping; Wong, Gabrielle S.; Peng, Shouyong; Stachler, Matthew D.; Thorner, Aaron R.; Van Hummelen, Paul; Bass, Adam J.			Src Mutation Induces Acquired Lapatinib Resistance in ERBB2-Amplified Human Gastroesophageal Adenocarcinoma Models	PLOS ONE			English	Article							ADVANCED GASTRIC-CANCER; INHIBITOR SARACATINIB AZD0530; RANDOMIZED PHASE-III; TRASTUZUMAB RESISTANCE; BREAST-CANCER; KINASE INHIBITOR; IN-VIVO; ANTITUMOR-ACTIVITY; COLORECTAL-CANCER; 1ST-LINE THERAPY	ERBB2-directed therapy is now a routine component of therapy for ERBB2-amplified metastatic gastroesophageal adenocarcinomas. However, there is little knowledge of the mechanisms by which these tumors develop acquired resistance to ERBB2 inhibition. To investigate this question we sought to characterize cell line models of ERBB2-amplified gastroesophageal adenocarcinoma with acquired resistance to ERBB2 inhibition. We generated lapatinib-resistant (LR) subclones from an initially lapatinib-sensitive ERBB2-amplified esophageal adenocarcinoma cell line, OE19. We subsequently performed genomic characterization and functional analyses of resistant subclones with acquired lapatinib resistance. We identified a novel, acquired Src(E527K) mutation in a subset of LR OE19 subclones. Cells with this mutant allele harbour increased Src phosphorylation. Genetic and pharmacologic inhibition of Src resensitized these subclones to lapatinib. Biochemically, Src mutations could activate both the phosphatidylinositol 3-kinase and mitogen activated protein kinase pathways in the lapatinib-treated LR OE19 cells. Ectopic expression of Src (E527K) mutation also was sufficient to induce lapatinib resistance in drug-naive cells. These results indicate that pathologic activation of Src is a potential mechanism of acquired resistance to ERBB2 inhibition in ERBB2-amplified gastroesophageal cancer. Although Src mutation has not been described in primary tumor samples, we propose that the Src hyperactivation should be investigated in the settings of acquired resistance to ERBB2 inhibition in esophageal and gastric adenocarcinoma.	[Hong, Yong Sang; Kim, Jihun; Pectasides, Eirini; Fox, Cameron; Ma, Qiuping; Wong, Gabrielle S.; Peng, Shouyong; Stachler, Matthew D.; Bass, Adam J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hong, Yong Sang] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Kim, Jihun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Pectasides, Eirini] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Hong, Seung-Woo] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Peng, Shouyong; Bass, Adam J.] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA USA; [Stachler, Matthew D.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Thorner, Aaron R.; Van Hummelen, Paul] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Bass, Adam J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bass, Adam J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Ulsan; Asan Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Bass, AJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	adam_bass@dfci.harvard.edu		van hummelen, paul/0000-0002-4801-8600; Fox, Cameron/0000-0002-8922-876X	American Gastroenterological Association; Anna Fuller Fund; Phi Beta Psi; American Cancer Society; National Institute of Health [P01 CA098101]; NATIONAL CANCER INSTITUTE [P01CA098101] Funding Source: NIH RePORTER	American Gastroenterological Association; Anna Fuller Fund; Phi Beta Psi; American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Funderburg Research Award in Gastric Biology Related to Cancer from the American Gastroenterological Association, The Anna Fuller Fund, Phi Beta Psi, a Research Scholar Grant from the American Cancer Society and P01 CA098101 from the National Institute of Health, all to A.J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Arcaroli JJ, 2012, CLIN CANCER RES, V18, P2704, DOI 10.1158/1078-0432.CCR-11-3167; Arcaroli JJ, 2010, CLIN CANCER RES, V16, P4165, DOI 10.1158/1078-0432.CCR-10-0066; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bang YJ, 2011, INVEST NEW DRUG, V29, P1449, DOI 10.1007/s10637-010-9438-y; Baselga J, 2010, CLIN CANCER RES, V16, P4876, DOI 10.1158/1078-0432.CCR-10-0748; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bertotti A, 2010, CLIN CANCER RES, V16, P3933, DOI 10.1158/1078-0432.CCR-10-0106; Cavalloni G, 2012, MOL CANCER THER, V11, P1528, DOI 10.1158/1535-7163.MCT-11-1020; Chen CT, 2012, MOL CANCER THER, V11, P660, DOI 10.1158/1535-7163.MCT-11-0754; Dank M, 2008, ANN ONCOL, V19, P1450, DOI 10.1093/annonc/mdn166; De Luca A, 2013, CELL CYCLE, V13; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Ferguson J, 2013, ONCOGENE, V32, P86, DOI 10.1038/onc.2012.25; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Fujisaka Y, 2013, INVEST NEW DRUG, V31, P108, DOI 10.1007/s10637-012-9809-7; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Gucalp A, 2011, CLIN BREAST CANCER, V11, P306, DOI 10.1016/j.clbc.2011.03.021; Han SQ, 2014, MABS-AUSTIN, V6, P403, DOI 10.4161/mabs.27443; Hettmer S, 2013, J PATHOL, V231, P44, DOI 10.1002/path.4229; Hong J, 2012, CANCER RES, V72, P4504, DOI 10.1158/0008-5472.CAN-12-1119; Janjigian YY, 2013, J NUCL MED, V54, P936, DOI 10.2967/jnumed.112.110239; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Kang YK, 2013, INVEST NEW DRUGS; Kim HS, 2013, ANN ONCOL, V24, P2850, DOI 10.1093/annonc/mdt351; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Mackay HJ, 2012, INVEST NEW DRUG, V30, P1158, DOI 10.1007/s10637-011-9650-4; Morrow CJ, 2010, CANCER RES, V70, P5931, DOI 10.1158/0008-5472.CAN-10-0694; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nam HJ, 2013, MOL CANCER THER, V12, P16, DOI 10.1158/1535-7163.MCT-12-0109; Olayioye MA, 2001, EXP CELL RES, V267, P81, DOI 10.1006/excr.2001.5242; Pastuskovas CV, 2012, MOL CANCER THER, V11, P752, DOI 10.1158/1535-7163.MCT-11-0742-T; Rajeshkumar NV, 2009, CLIN CANCER RES, V15, P4138, DOI 10.1158/1078-0432.CCR-08-3021; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Schwartzberg PL, 1998, ONCOGENE, V17, P1463, DOI 10.1038/sj.onc.1202176; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Wainberg ZA, 2010, CLIN CANCER RES, V16, P1509, DOI 10.1158/1078-0432.CCR-09-1112; Wang XL, 2012, ACTA PHARMACOL SIN, V33, P513, DOI 10.1038/aps.2011.205; Wetterskog D, 2013, ONCOGENE; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	49	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109440	10.1371/journal.pone.0109440	http://dx.doi.org/10.1371/journal.pone.0109440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350844	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943100011
J	OuYang, PY; Su, Z; Tang, J; Lan, XW; Mao, YP; Deng, WG; Xie, FY				OuYang, Pu-Yun; Su, Zhen; Tang, Jie; Lan, Xiao-Wen; Mao, Yan-Ping; Deng, Wuguo; Xie, Fang-Yun			Diabetes, Prediabetes and the Survival of Nasopharyngeal Carcinoma: A Study of 5,860 Patients	PLOS ONE			English	Article							FASTING BLOOD-GLUCOSE; INTENSITY-MODULATED RADIOTHERAPY; PROGNOSTIC IMPACT; ALL-CAUSE; CANCER; OUTCOMES; RISK; MELLITUS; EPIDEMIOLOGY; MORTALITY	Background: The incidence of diabetes is increasing. But the impact of diabetes and prediabetes on survival of patients with nasopharyngeal carcinoma (NPC) has received little evaluation. Methods: In a cohort of 5,860 patients, we compared the disease specific survival (DSS), locoregional relapse-free survival (LRFS) and distant metastasis-free survival (DMFS) of patients with diabetes, prediabetes and normoglycemia defined by pretreatment fasting plasma glucose (FPG) using Kaplan-Meier method, log-rank test and Cox proportional hazards model. Results: Comparing to normoglycemic patients, the diabetic and the prediabetic were generally older, fatter, had hypertension, heart diseases and hyperlipaemia and usually received radiotherapy alone. But both the diabetic and the prediabetic had similar DSS, LRFS and DMFS to normoglycemic patients, even adjusting for such important factors as age, gender, smoking, drinking, hypertension, heart diseases, body mass index, hyperlipaemia, titer of VCA-IgA and EA-IgA, pathology, T-stage, N-stage, chemotherapy and radiotherapy (P>0.05 for all). Additionally, the findings remained unchanged in sensitivity analysis by excluding patients with known diabetes history and in subgroups of the various factors. Conclusions: The diabetic and prediabetic NPC patients had similar survival to normoglycemic NPC patients. These data, in the largest reported cohort, are the first to evaluate the association between diabetes, prediabetes and the survival in NPC. The findings are relevant to patient management and provided evidence of the effect on this disease exerted by comorbidities.	[OuYang, Pu-Yun; Su, Zhen; Tang, Jie; Lan, Xiao-Wen; Mao, Yan-Ping; Xie, Fang-Yun] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Expt Res,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xie, FY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	xiefy@sysucc.org.cn						Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Bosetti C, 2012, NUTR CANCER, V64, P643, DOI 10.1080/01635581.2012.676141; Cai Q, 2013, BRIT J CANCER, V108, P380, DOI 10.1038/bjc.2012.566; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chu CK, 2010, ANN SURG ONCOL, V17, P502, DOI 10.1245/s10434-009-0789-6; COX DR, 1972, J R STAT SOC B, V34, P187; Edge SB, 2010, AJCC CANC STAGING MA; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hofner T, 2013, WORLD J UROL; Huang PY, 2013, EUR J CANCER, V49, P1923, DOI 10.1016/j.ejca.2013.01.027; Ioacara S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093132; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kiderlen M, 2013, ANN ONCOL, V24, P3011, DOI 10.1093/annonc/mdt367; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Liu H, 2006, MED ONCOL, V23, P341, DOI 10.1385/MO:23:3:341; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Luo J, 2014, BRIT J CANCER, V110, P1847, DOI 10.1038/bjc.2014.68; Luo JH, 2012, LUNG CANCER, V76, P242, DOI 10.1016/j.lungcan.2011.10.019; Margel D, 2013, J CLIN ONCOL, V31, P3069, DOI 10.1200/JCO.2012.46.7043; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; Minicozzi P, 2013, EUR J CANCER, V49, P3881, DOI 10.1016/j.ejca.2013.08.004; OuYang PY, 2013, BRIT J CANCER, V109, P788, DOI 10.1038/bjc.2013.343; OuYang PY, 2013, CANCER EPIDEM BIOMAR, V22, P2285, DOI 10.1158/1055-9965.EPI-13-0546; Richardson LC, 2005, NAT CLIN PRACT ONCOL, V2, P48, DOI 10.1038/ncponc0062; Schmid D, 2013, EUR J EPIDEMIOL, V28, P945, DOI 10.1007/s10654-013-9865-0; Sonabend RY, 2009, J PEDIATR-US, V155, P73, DOI 10.1016/j.jpeds.2009.01.072; Stott-Miller M, 2012, CANCER EPIDEM BIOMAR, V21, P294, DOI 10.1158/1055-9965.EPI-11-0590; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	33	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111073	10.1371/journal.pone.0111073	http://dx.doi.org/10.1371/journal.pone.0111073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350747	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100055
J	Gavish, Y; Kedem, H; Messika, I; Cohen, C; Toh, E; Munro, D; Dong, QF; Fuqua, C; Clay, K; Hawlena, H				Gavish, Yoni; Kedem, Hadar; Messika, Irit; Cohen, Carmit; Toh, Evelyn; Munro, Daniel; Dong, Qunfeng; Fuqua, Clay; Clay, Keith; Hawlena, Hadas			Association of Host and Microbial Species Diversity across Spatial Scales in Desert Rodent Communities	PLOS ONE			English	Article							HABITAT HETEROGENEITY; ENVIRONMENTAL HETEROGENEITY; EVOLUTION; BACTERIA; FLEAS; BIODIVERSITY; ARTHROPOD; RICHNESS; PATTERNS; DISEASE	Relationships between host and microbial diversity have important ecological and applied implications. Theory predicts that these relationships will depend on the spatio-temporal scale of the analysis and the niche breadth of the organisms in question, but representative data on host-microbial community assemblage in nature is lacking. We employed a natural gradient of rodent species richness and quantified bacterial communities in rodent blood at several hierarchical spatial scales to test the hypothesis that associations between host and microbial species diversity will be positive in communities dominated by organisms with broad niches sampled at large scales. Following pyrosequencing of rodent blood samples, bacterial communities were found to be comprised primarily of broad niche lineages. These communities exhibited positive correlations between host diversity, microbial diversity and the likelihood for rare pathogens at the regional scale but not at finer scales. These findings demonstrate how microbial diversity is affected by host diversity at different spatial scales and suggest that the relationships between host diversity and overall disease risk are not always negative, as the dilution hypothesis predicts.	[Gavish, Yoni; Kedem, Hadar; Messika, Irit; Cohen, Carmit; Hawlena, Hadas] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Toh, Evelyn] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Munro, Daniel; Dong, Qunfeng] Univ N Texas, Dept Biol, Denton, TX 76203 USA; [Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA; [Fuqua, Clay; Clay, Keith] Indiana Univ, Dept Biol, Bloomington, IN USA	Ben Gurion University; Indiana University System; Indiana University-Purdue University Indianapolis; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Indiana University System; Indiana University Bloomington	Hawlena, H (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	hadashaw@bgu.ac.il	Clay, Keith/C-8730-2012; Gavish, Yoni/J-2173-2019; Hawlena, Hadas/F-1669-2012	Gavish, Yoni/0000-0002-6025-5668; Munro, Daniel/0000-0002-0724-218X; Hawlena, Hadas/0000-0002-0634-2920; Toh, Evelyn/0000-0003-2932-4060	Marie Curie Career Integration Grant [FP7-293713]; United States-Israel Binational Science Foundation [2012063]	Marie Curie Career Integration Grant; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This study was supported by Marie Curie Career Integration Grant number FP7-293713 and by United States-Israel Binational Science Foundation (grant number 2012063). The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy KJ, 2003, AM MIDL NAT, V149, P237, DOI 10.1674/0003-0031(2003)149[0237:BFOTTT]2.0.CO;2; Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Brooks GF, 1995, JAWETZ MELNICK ADELB; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caporaso JG, 2011, GENOME BIOL, V12; Carvalho GD, 2008, BIOSCI J, V24, P121; Chevret P, 2005, MOL PHYLOGENET EVOL, V35, P674, DOI 10.1016/j.ympev.2005.01.001; DEGEN AA, 1992, OECOLOGIA, V90, P586, DOI 10.1007/BF01875454; Dehio C, 2004, J CLIN MICROBIOL, V42, P5320, DOI 10.1128/JCM.42.11.5320-5323.2004; Eribe ERK, 2008, ANAEROBE, V14, P131, DOI 10.1016/j.anaerobe.2008.04.004; Fulde M, 2013, CURR TOP MICROBIOL, V368, P49, DOI 10.1007/82_2012_277; Gaastra W, 2010, VET MICROBIOL, V140, P339, DOI 10.1016/j.vetmic.2009.01.040; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Gutierrez R, 2014, ISME J; Hawlena H, 2005, OECOLOGIA, V146, P200, DOI 10.1007/s00442-005-0187-0; Hawlena H, 2013, ISME J, V7, P221, DOI 10.1038/ismej.2012.71; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jenkins DG, 2011, GLOBAL ECOL BIOGEOGR, V20, P486, DOI 10.1111/j.1466-8238.2010.00617.x; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Kedem H, 2014, ECOLOGY, V95, P1173, DOI 10.1890/13-0678.1; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Khokhlova IS, 2012, PARASITOLOGY, V139, P60, DOI 10.1017/S0031182011001703; Krasnov B.R., 2008, FUNCTIONAL EVOLUTION; Kueneman JG, 2014, MOL ECOL, V23, P1238, DOI 10.1111/mec.12510; Leclaire S, 2014, BEHAV ECOLOGY; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Martin MO, 2010, SYMBIOSIS, V51, P97, DOI 10.1007/s13199-010-0078-y; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Motoshima M, 2012, J MED MICROBIOL, V61, P1556, DOI 10.1099/jmm.0.049163-0; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Murphy EC, 2013, FEMS MICROBIOL REV, V37, P520, DOI 10.1111/1574-6976.12005; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Poulin R, 1997, ANNU REV ECOL SYST, V28, P341, DOI 10.1146/annurev.ecolsys.28.1.341; Richard M, 2000, ECOGRAPHY, V23, P231, DOI 10.1111/j.1600-0587.2000.tb00279.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Saag P, 2011, MICROBIAL E IN PRESS; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Soininen J, 2012, ENV MICROBIOL REP, V4, P10, DOI 10.1111/j.1758-2229.2011.00308.x; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tamme R, 2010, J VEG SCI, V21, P796, DOI 10.1111/j.1654-1103.2010.01185.x; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; van Dongen WFD, 2013, BMC ECOLOGY, V13; Voigt CC, 2005, J MAMMAL, V86, P745, DOI 10.1644/1545-1542(2005)086[0745:BBABSS]2.0.CO;2; Wasserberg G, 2007, EVOL ECOL RES, V9, P299	60	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109677	10.1371/journal.pone.0109677	http://dx.doi.org/10.1371/journal.pone.0109677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343259	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943500020
J	Jiang, HL; Chan, CP; Leung, Y; Li, YM; Graham, CA; Rainer, TH				Jiang, Hui-lin; Chan, Cangel Pui-yee; Leung, Yuk-ki; Li, Yun-mei; Graham, Colin A.; Rainer, Timothy H.			Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) Scale in Chinese Patients in Hong Kong	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; VALIDATION; TRENDS; EPIDEMIOLOGY; SUBTYPES; IDENTIFICATION; POPULATION; INSTRUMENT; DIAGNOSIS; PROJECT	Background and Purpose: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong. Methods: This was a prospective cohort study in an urban academic emergency department (ED) over a 7-month period. Patients over 18 years of age with suspected stroke were recruited between June 2011 and December 2011. ROSIER scale assessment was performed in the ED triage area. Logistic regression analysis was used to estimate the impacts of diagnostic variables, including ROSIER scale, past history and ED characteristics. Findings: 715 suspected stroke patients were recruited for assessment, of whom 371 (52%) had acute cerebrovascular disease (302 ischaemic strokes, 24 transient ischaemic attacks (TIA), 45 intracerebral haemorrhages), and 344 (48%) had other illnesses i.e. stroke mimics. Common stroke mimics were spinal neuropathy, dementia, labyrinthitis and sepsis. The suggested cut-off score of. 0 for the ROSIER scale for stroke diagnosis gave a sensitivity of 87% (95% CI 83-90), a specificity of 41% (95% CI 36-47), a positive predictive value of 62% (95% CI 57-66), and a negative predictive value of 75% (95% CI 6881), and the AUC was 0.723. The overall accuracy at cut off>0 was 65% i.e. (323+141)/715. Interpretation: The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity. If the ROSIER scale is to be clinically useful in Chinese suspected stroke patients, it requires further refinement.	[Jiang, Hui-lin; Chan, Cangel Pui-yee; Leung, Yuk-ki; Li, Yun-mei; Graham, Colin A.; Rainer, Timothy H.] Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China; [Jiang, Hui-lin; Li, Yun-mei] Guangzhou Med Univ, Affiliated Hosp 2, Emergency Dept, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Guangzhou Medical University	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China.	thrainer@cuhk.edu.hk	Graham, Colin A/B-4535-2013; Rainer, Timothy/I-2591-2013	Graham, Colin A/0000-0002-4381-7470; Rainer, Timothy/0000-0003-3355-3237	Chinese University of Hong Kong [2041589]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This research study was supported by a Direct Grant for Research of the Chinese University of Hong Kong (reference no. 2041589) (http://www.cuhk.edu.hk/rao/rao_service.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejot Y, 2010, CEREBROVASC DIS, V30, P346, DOI 10.1159/000319569; Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2; BRATINA P, 1995, STROKE, V26, P409, DOI 10.1161/01.STR.26.3.409; Bray JE, 2005, CEREBROVASC DIS, V20, P28, DOI 10.1159/000086201; Byrne B, 2011, INT J NURS STUD, V48, P979, DOI 10.1016/j.ijnurstu.2011.01.015; Census and Statistics Department of Hong Kong, 2007, 2006 POP BY CENS MAI, VI; Chau PH, 2011, CEREBROVASC DIS, V31, P138, DOI 10.1159/000321734; [陈晓辉 Chen Xiaohui], 2013, [中国急救医学, Chinese Journal of Critical Care Medicine], V33, P539; Corso G, 2009, NEUROEPIDEMIOLOGY, V32, P186, DOI 10.1159/000195688; Crocco T J, 1999, Prehosp Emerg Care, V3, P201, DOI 10.1080/10903129908958937; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fothergill RT, 2013, STROKE, V44, P3007, DOI 10.1161/STROKEAHA.13.000851; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Hatzitolios A, 2008, HIPPOKRATIA, V12, P98; He MF, 2012, ANN INDIAN ACAD NEUR, V15, P191, DOI 10.4103/0972-2327.99713; Huff JS, 2002, EMERG MED CLIN N AM, V20, P583, DOI 10.1016/S0733-8627(02)00012-3; Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643; Jackson A, 2008, IRISH J MED SCI, V177, P189, DOI 10.1007/s11845-008-0159-6; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; KOTHARI R, 1995, STROKE, V26, P937, DOI 10.1161/01.STR.26.6.937; Kothari R, 1999, ANN EMERG MED, V33, P3, DOI 10.1016/S0196-0644(99)70431-2; Kothari RU, 1999, ANN EMERG MED, V33, P373, DOI 10.1016/S0196-0644(99)70299-4; Lacy CR, 2001, STROKE, V32, P63, DOI 10.1161/01.STR.32.1.63; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Nor AM, 2004, STROKE, V35, P1355, DOI 10.1161/01.STR.0000128529.63156.c5; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; SIGN, 2008, 108 SIGN; Smith W S, 1998, Prehosp Emerg Care, V2, P170, DOI 10.1080/10903129808958866; Stone J, 2005, J NEUROL NEUROSUR PS, V76, pI2, DOI 10.1136/jnnp.2004.061655; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Wein TH, 2000, STROKE, V31, P1925, DOI 10.1161/01.STR.31.8.1925; Whiteley WN, 2011, J NEUROL NEUROSUR PS, V82, P1006, DOI 10.1136/jnnp.2010.235010; Wojner AW, 2003, AM J CRIT CARE, V12, P411, DOI 10.4037/ajcc2003.12.5.411; Wu ZS, 2001, CIRCULATION, V103, P462; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhang XF, 2006, EUR J CARDIOV PREV R, V13, P429, DOI 10.1097/00149831-200606000-00020	38	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109762	10.1371/journal.pone.0109762	http://dx.doi.org/10.1371/journal.pone.0109762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343496	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000343943500023
J	Chen, X; Sanayei, M; Thiele, A				Chen, Xing; Sanayei, Mehdi; Thiele, Alexander			Stimulus Roving and Flankers Affect Perceptual Learning of Contrast Discrimination in Macaca mulatta	PLOS ONE			English	Article							SPATIAL INTEGRATION; SUPPRESSION; ATTENTION	Stimulus roving' refers to a paradigm in which the properties of the stimuli to be discriminated vary from trial to trial, rather than being kept constant throughout a block of trials. Rhesus monkeys have previously been shown to improve their contrast discrimination performance on a non-roving task, in which they had to report the contrast of a test stimulus relative to that of a fixed-contrast sample stimulus. Human psychophysics studies indicate that roving stimuli yield little or no perceptual learning. Here, we investigate how stimulus roving influences perceptual learning in macaque monkeys and how the addition of flankers alters performance under roving conditions. Animals were initially trained on a contrast discrimination task under non-roving conditions until their performance levels stabilized. The introduction of roving contrast conditions resulted in a pronounced drop in performance, which suggested that subjects initially failed to heed the sample contrast and performed the task using an internal memory reference. With training, significant improvements occurred, demonstrating that learning is possible under roving conditions. To investigate the notion of flanker-induced perceptual learning, flanker stimuli (30% fixed-contrast iso-oriented collinear gratings) were presented jointly with central (roving) stimuli. Presentation of flanker stimuli yielded substantial performance improvements in one subject, but deteriorations in the other. Finally, after the removal of flankers, performance levels returned to their pre-flanker state in both subjects, indicating that the flanker-induced changes were contingent upon the continued presentation of flankers.	[Chen, Xing; Sanayei, Mehdi; Thiele, Alexander] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Thiele, A (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	alex.thiele@ncl.ac.uk	c, x/AAH-5686-2021	Chen, Xing/0000-0002-3589-1750; Thiele, Alexander/0000-0003-4894-0213	Medical Research Council, UK [G0700976]; Medical Research Council [G0700976] Funding Source: researchfish; MRC [G0700976] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Medical Research Council, UK, G0700976 (http://www.mrc.ac.uk/index.htm) to Author: AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adab HZ, 2011, CURR BIOL, V21, P1661, DOI 10.1016/j.cub.2011.08.037; Adini Y, 2004, J VISION, V4, P993, DOI 10.1167/4.12.2; Adini Y, 2002, NATURE, V415, P790, DOI 10.1038/415790a; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chen X, 2013, J VISION, V13, DOI 10.1167/13.13.22; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dorais A, 1997, VISION RES, V37, P1725, DOI 10.1016/S0042-6989(96)00329-X; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Kuai SG, 2005, NAT NEUROSCI, V8, P1497, DOI 10.1038/nn1546; Otto TU, 2006, VISION RES, V46, P3223, DOI 10.1016/j.visres.2006.03.021; Parkosadze K, 2008, J VISION, V8, DOI 10.1167/8.1.5; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Tsodyks M, 2004, NEURAL NETWORKS, V17, P823, DOI 10.1016/j.neunet.2004.03.004; Xiao L.-Q., 2008, CURR BIOL, V18, P1; Yu C, 2004, J VISION, V4, P169, DOI 10.1167/4.3.4; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010; Zhang JY, 2008, PLOS BIOL, V6, P1651, DOI 10.1371/journal.pbio.0060197	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109604	10.1371/journal.pone.0109604	http://dx.doi.org/10.1371/journal.pone.0109604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340335	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800010
J	Gorman, CE; Potts, BM; Schweitzer, JA; Bailey, JK				Gorman, Courtney E.; Potts, Brad M.; Schweitzer, Jennifer A.; Bailey, Joseph K.			Shifts in Species Interactions Due to the Evolution of Functional Differences between Endemics and Non-Endemics: An Endemic Syndrome Hypothesis	PLOS ONE			English	Article							HIGHER-LEVEL RELATIONSHIPS; GENETIC-VARIATION; COMMUNITY; BIODIVERSITY; PATTERNS; DIVERSITY; RICHNESS; BIOLOGY; PLANTS; TRAIT	Species ranges have been shifting since the Pleistocene, whereby fragmentation, isolation, and the subsequent reduction in gene flow have resulted in local adaptation of novel genotypes and the repeated evolution of endemic species. While there is a wide body of literature focused on understanding endemic species, very few studies empirically test whether or not the evolution of endemics results in unique function or ecological differences relative to their widespread congeners; in particular while controlling for environmental variation. Using a common garden composed of 15 Eucalyptus species within the subgenus Symphyomyrtus (9 endemic to Tasmania, 6 non-endemic), here we hypothesize and show that endemic species are functionally and ecologically different from non-endemics. Compared to non-endemics, endemic Eucalyptus species have a unique suite of functional plant traits that have extended effects on herbivores. We found that while endemics occupy many diverse habitats, they share similar functional traits potentially resulting in an endemic syndrome of traits. This study provides one of the first empirical datasets analyzing the functional differences between endemics and non-endemics in a common garden setting, and establishes a foundation for additional studies of endemic/non-endemic dynamics that will be essential for understanding global biodiversity in the midst of rapid species extinctions and range shifts as a consequence of global change.	[Gorman, Courtney E.; Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Potts, Brad M.; Bailey, Joseph K.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia	University of Tennessee System; University of Tennessee Knoxville; University of Tasmania	Gorman, CE (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	cgorman5@utk.edu	Potts, Brad M/C-6489-2013; Gorman, Courtney/M-5219-2019	Potts, Brad M/0000-0001-6244-289X; Gorman, Courtney/0000-0001-7310-8803	Australian Research Council	Australian Research Council(Australian Research Council)	The Australian Research Council funded the Future Fellowship (to JKB), http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole CT, 2003, ANNU REV ECOL EVOL S, V34, P213, DOI 10.1146/annurev.ecolsys.34.030102.151717; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cowling R.M., 2000, ENCY BIODIVERSITY, V2, P497; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dungey H, 2001, AUST FORESTRY, V65, P23; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Ferreira PMA, 2011, CONSERV BIOL, V25, P672, DOI 10.1111/j.1523-1739.2011.01675.x; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Gottlieb L. D., 1979, Topics in plant population biology., P264; Gulias J, 2003, ANN BOT-LONDON, V92, P215, DOI 10.1093/aob/mcg123; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; KRUCKEBERG AR, 1985, ANNU REV ECOL SYST, V16, P447, DOI 10.1146/annurev.es.16.110185.002311; KUNIN WE, 1993, TRENDS ECOL EVOL, V8, P298, DOI 10.1016/0169-5347(93)90259-R; Lavergne S, 2004, OIKOS, V107, P505, DOI 10.1111/j.0030-1299.2004.13423.x; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; McKinnon GE, 2008, AM J BOT, V95, P368, DOI 10.3732/ajb.95.3.368; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Reilly-Wapstra JM, 2002, OECOLOGIA, V130, P289, DOI 10.1007/s004420100797; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 2005, ECOL LETT, V8, P811, DOI 10.1111/j.1461-0248.2005.00779.x; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Schweitzer JA, 2004, ECOL LETT, V7, P127, DOI 10.1111/j.1461-0248.2003.00562.x; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Steane DA, 1999, MOL PHYLOGENET EVOL, V12, P215, DOI 10.1006/mpev.1999.0612; Stebbins G. Ledyard, 1942, MADRONO, V6, P241; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Williams K. J., 1996, Tasforests, V8, P39; Wimp GM, 2004, ECOL LETT, V7, P776, DOI 10.1111/j.1461-0248.2004.00635.x	41	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e111190	10.1371/journal.pone.0111190	http://dx.doi.org/10.1371/journal.pone.0111190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340402	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800092
J	Schirmel, J; Alt, M; Rudolph, I; Entling, MH				Schirmel, Jens; Alt, Martin; Rudolph, Isabell; Entling, Martin H.			Effects of Traditional Flood Irrigation on Invertebrates in Lowland Meadows	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; BIODIVERSITY; GRASSLAND; SPIDERS; PLANT; HETEROGENEITY; CONSERVATION; COMMUNITIES; DISTURBANCE; INDICATORS	Lowland meadow irrigation used to be widespread in Central Europe, but has largely been abandoned during the 20th century. As a result of agri-environment schemes and nature conservation efforts, meadow irrigation is now being re-established in some European regions. In the absence of natural flood events, irrigation is expected to favour fauna typical of lowland wet meadows. We analysed the effects of traditional flood irrigation on diversity, densities and species composition of three invertebrate indicator taxa in lowland meadows in Germany. Unexpectedly, alpha diversity (species richness and Simpson diversity) and beta diversity (multivariate homogeneity of group dispersions) of orthopterans, carabids, and spiders were not significantly different between irrigated and non-irrigated meadows. However, spider densities were significantly higher in irrigated meadows. Furthermore, irrigation and elevated humidity affected species composition and shifted assemblages towards moisture-dependent species. The number of species of conservation concern, however, did not differ between irrigated and non-irrigated meadows. More variable and intensive (higher duration and/or frequency) flooding regimes might provide stronger conservation benefits, additional species and enhance habitat heterogeneity on a landscape scale.	[Schirmel, Jens; Alt, Martin; Rudolph, Isabell; Entling, Martin H.] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany	University of Koblenz & Landau	Schirmel, J (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	schirmel@uni-landau.de	Entling, Martin H/C-6953-2008; Schirmel, Jens/I-3467-2012	Schirmel, Jens/0000-0003-0330-3376	research initiative 'AufLand' of the federal state of Rhineland-Palatinate' (Germany); research and development fund of the University of Koblenz-Landau	research initiative 'AufLand' of the federal state of Rhineland-Palatinate' (Germany); research and development fund of the University of Koblenz-Landau	The study was funded by the research initiative 'AufLand' of the federal state of Rhineland-Palatinate' (Germany) and the research and development fund of the University of Koblenz-Landau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 1996, SPIDERS BRITAIN NO E; Bailey D, 2010, J APPL ECOL, V47, P1003, DOI 10.1111/j.1365-2664.2010.01858.x; Baldi A, 1997, AGR ECOSYST ENVIRON, V66, P121, DOI 10.1016/S0167-8809(97)00068-6; Baur B, 2006, BIOL CONSERV, V132, P261, DOI 10.1016/j.biocon.2006.04.018; Bellmann H., 2006, KOSMOS HEUSCHRECKENF; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bonn A, 2002, RIVER RES APPL, V18, P43, DOI 10.1002/rra.632; Bonn Aletta, 1999, Zeitschrift fuer Oekologie und Naturschutz, V8, P109; Briem E, 2008, HAARDT WEINSTRASSE Q, P114; Curry J.P., 1994, GRASSLAND INVERTEBRA; Duelli P, 2003, BASIC APPL ECOL, V4, P129, DOI 10.1078/1439-1791-00140; Dziock F, 2011, AGR ECOSYST ENVIRON, V145, P85, DOI 10.1016/j.agee.2011.07.015; Ellenberg H., 2012, VEGETATION MITTELEUR; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Gardiner Tim, 2005, Journal of Insect Conservation, V9, P151, DOI 10.1007/s10841-005-2854-1; Gerisch M, 2012, OIKOS, V121, P508, DOI 10.1111/j.1600-0706.2011.19749.x; Google, 2011, GOOGL EARTH 6 1 0 50; Hassler DM, 1995, WASSERWIESEN GESCH T; Horvath R, 2009, AGR ECOSYST ENVIRON, V130, P16, DOI 10.1016/j.agee.2008.11.011; Ingrisch S, 1998, NEUE BREHM BUCHEREI, V629; Irmler Ulrich, 2004, Faunistisch-Oekologische Mitteilungen Supplement, V32, P1; Isselstein J., 2005, Agronomy Research, V3, P139; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Lambeets K, 2008, J ANIM ECOL, V77, P1162, DOI 10.1111/j.1365-2656.2008.01443.x; Leibundgut C, 2004, IAHS-AISH P, P77; Leibundgut C., 2011, JB OBERAARGAUS, V54, P121; Maas S, 2002, GEFAHRDUNGSANALYSE H; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Muller S, 2002, AGR ECOSYST ENVIRON, V89, P261, DOI 10.1016/S0167-8809(01)00235-3; Muller-Motzfeld G, 2006, KAFER MITTELEUROPAS, V2; Nahrig D, 2003, ROTE LISTEN CHECKLIS; Nyffeler M, 1999, J ARACHNOL, V27, P317; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pfeifer MA, 2011, FLORA FAUNA RHEINLAN, V41, P1; Plum N, 2005, WETLANDS, V25, P721, DOI 10.1672/0277-5212(2005)025[0721:TIIFGA]2.0.CO;2; Pollock MM, 1998, ECOLOGY, V79, P94; Poschlod P, 2002, BIOL CONSERV, V104, P361, DOI 10.1016/S0006-3207(01)00201-4; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Riedener E, 2013, AGR ECOSYST ENVIRON, V164, P62, DOI 10.1016/j.agee.2012.09.020; Rounsevell MDA, 2005, AGR ECOSYST ENVIRON, V107, P117, DOI 10.1016/j.agee.2004.12.002; Schellberg S, 2005, INTEGRATED LAND WATE, V2, P123; Schirmel J, 2011, BIODIVERS CONSERV, V20, P1469, DOI 10.1007/s10531-011-0038-8; Schirmel J, 2011, J INSECT CONSERV, V15, P633, DOI 10.1007/s10841-010-9362-7; Schule P, 2000, ROTE LISTE RHEINLAND; Scott AG, 2006, BIOL CONSERV, V127, P420, DOI 10.1016/j.biocon.2005.09.001; Siemann E, 1998, ECOLOGY, V79, P2057, DOI 10.1890/0012-9658(1998)079[2057:ETOEOP]2.0.CO;2; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Ssymank Axel, 1998, Schriftenreihe fuer Landschaftspflege und Naturschutz, V53, P1; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; Vanbergen AJ, 2005, ECOGRAPHY, V28, P3, DOI 10.1111/j.0906-7590.2005.03991.x; VANWINGERDEN WKRE, 1992, J APPL ENTOMOL, V113, P138, DOI 10.1111/j.1439-0418.1992.tb00647.x; Wise DH, 1993, SPIDERS ECOLOGICAL W; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zuur Alain F., 2009, P1; [No title captured]	59	6	7	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e0110854	10.1371/journal.pone.0110854	http://dx.doi.org/10.1371/journal.pone.0110854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340872	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800063
J	Singh, SM; Bandi, S; Shah, DD; Armstrong, G; Mallela, KMG				Singh, Surinder M.; Bandi, Swati; Shah, Dinen D.; Armstrong, Geoffrey; Mallela, Krishna M. G.			Missense Mutation Lys18Asn in Dystrophin that Triggers X-Linked Dilated Cardiomyopathy Decreases Protein Stability, Increases Protein Unfolding, and Perturbs Protein Structure, but Does Not Affect Protein Function	PLOS ONE			English	Article							CALPONIN-HOMOLOGY DOMAIN; ACTIN-BINDING DOMAINS; SPECTRIN-LIKE REPEAT; FREE-ENERGY CHANGES; THERMODYNAMIC STABILITY; LINEAR EXTRAPOLATION; GENE; UTROPHIN; DUCHENNE; FAMILY	Genetic mutations in a vital muscle protein dystrophin trigger X-linked dilated cardiomyopathy (XLDCM). However, disease mechanisms at the fundamental protein level are not understood. Such molecular knowledge is essential for developing therapies for XLDCM. Our main objective is to understand the effect of disease-causing mutations on the structure and function of dystrophin. This study is on a missense mutation K18N. The K18N mutation occurs in the N-terminal actin binding domain (N-ABD). We created and expressed the wild-type (WT) N-ABD and its K18N mutant, and purified to homogeneity. Reversible folding experiments demonstrated that both mutant and WT did not aggregate upon refolding. Mutation did not affect the protein's overall secondary structure, as indicated by no changes in circular dichroism of the protein. However, the mutant is thermodynamically less stable than the WT (denaturant melts), and unfolds faster than the WT (stopped-flow kinetics). Despite having global secondary structure similar to that of the WT, mutant showed significant local structural changes at many amino acids when compared with the WT (heteronuclear NMR experiments). These structural changes indicate that the effect of mutation is propagated over long distances in the protein structure. Contrary to these structural and stability changes, the mutant had no significant effect on the actin-binding function as evident from co-sedimentation and depolymerization assays. These results summarize that the K18N mutation decreases thermodynamic stability, accelerates unfolding, perturbs protein structure, but does not affect the function. Therefore, K18N is a stability defect rather than a functional defect. Decrease in stability and increase in unfolding decrease the net population of dystrophin molecules available for function, which might trigger XLDCM. Consistently, XLDCM patients have decreased levels of dystrophin in cardiac muscle.	[Singh, Surinder M.; Bandi, Swati; Shah, Dinen D.; Mallela, Krishna M. G.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA; [Armstrong, Geoffrey] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Mallela, Krishna M. G.] Univ Colorado, Program Struct Biol & Biochem, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus	Mallela, KMG (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA.	krishna.mallela@ucdenver.edu		Mallela, Krishna/0000-0001-8308-5318	American Heart Association [11SDG4880046]; Jane and Charlie Butcher grants in Genomics and Biotechnology; ALSAM Foundation through the Skaggs	American Heart Association(American Heart Association); Jane and Charlie Butcher grants in Genomics and Biotechnology; ALSAM Foundation through the Skaggs	This work was funded by the American Heart Association grant 11SDG4880046, Jane and Charlie Butcher grants in Genomics and Biotechnology, and the ALSAM Foundation through the Skaggs Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Acsadi G, 2012, J BIOL CHEM, V287, P18153, DOI 10.1074/jbc.M111.284521; Bandi S, 2014, BIOCHEMISTRY-US, V53, P2209, DOI 10.1021/bi500120e; BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; Bies RD, 1997, J MOL CELL CARDIOL, V29, P3175, DOI 10.1006/jmcc.1997.0568; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1; Ferlini A, 1998, AM J HUM GENET, V63, P436, DOI 10.1086/301952; FRANZ WM, 1995, ANN NY ACAD SCI, V752, P470, DOI 10.1111/j.1749-6632.1995.tb17457.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Henderson DM, 2011, HUM MOL GENET, V20, P2955, DOI 10.1093/hmg/ddr199; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kahana E, 1997, CELL MOTIL CYTOSKEL, V36, P246; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Legardinier S, 2009, J BIOL CHEM, V284, P8822, DOI 10.1074/jbc.M805846200; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Milasin J, 1996, HUM MOL GENET, V5, P73, DOI 10.1093/hmg/5.1.73; Mirza A, 2008, BBA-PROTEINS PROTEOM, V1784, P1301, DOI 10.1016/j.bbapap.2008.05.010; Mirza A, 2010, BBA-PROTEINS PROTEOM, V1804, P1796, DOI 10.1016/j.bbapap.2010.03.009; MUNTONI F, 1995, AM J HUM GENET, V56, P151; MUNTONI F, 1995, J CLIN INVEST, V96, P693, DOI 10.1172/JCI118112; Muntoni F, 1997, HEART, V78, P608, DOI 10.1136/hrt.78.6.608; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Muthu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040066; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; Pace C N, 1986, Methods Enzymol, V131, P266; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Ruszczak C, 2009, BBA-PROTEINS PROTEOM, V1794, P921, DOI 10.1016/j.bbapap.2009.02.016; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Sahni N, 2012, BBA-PROTEINS PROTEOM, V1824, P1080, DOI 10.1016/j.bbapap.2012.06.011; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Singh SM, 2014, BIOCHEMISTRY-US, V53, P1801, DOI 10.1021/bi500149q; Singh SM, 2012, BIOPHYS J, V103, P1970, DOI 10.1016/j.bpj.2012.08.066; Singh SM, 2012, PROTEINS, V80, P1377, DOI 10.1002/prot.24033; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; Sutherland-Smith AJ, 2003, J MOL BIOL, V329, P15, DOI 10.1016/S0022-2836(03)00422-4; Sweeney HL, 2000, P NATL ACAD SCI USA, V97, P13464, DOI 10.1073/pnas.011510597; TAL M, 1985, J BIOL CHEM, V260, P9976; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Toledo D, 2011, J BIOL CHEM, V286, P39993, DOI 10.1074/jbc.M110.201517; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; Winder SJ, 1997, J MUSCLE RES CELL M, V18, P617, DOI 10.1023/A:1018627705273; Yoshida K, 1998, HUM MOL GENET, V7, P1129, DOI 10.1093/hmg/7.7.1129; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	54	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110439	10.1371/journal.pone.0110439	http://dx.doi.org/10.1371/journal.pone.0110439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340340	gold, Green Published, Green Submitted			2022-12-26	WOS:000343662800037
J	Upadhyaya, JD; Singh, N; Sikarwar, AS; Chakraborty, R; Pydi, SP; Bhullar, RP; Dakshinamurti, S; Chelikani, P				Upadhyaya, Jasbir D.; Singh, Nisha; Sikarwar, Anurag S.; Chakraborty, Raja; Pydi, Sai P.; Bhullar, Rajinder P.; Dakshinamurti, Shyamala; Chelikani, Prashen			Dextromethorphan Mediated Bitter Taste Receptor Activation in the Pulmonary Circuit Causes Vasoconstriction	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; GASTROINTESTINAL-TRACT; NORMOTENSIVE RATS; CELLS; VESSELS; MODULATION; EXPRESSION; RESPONSES; MYOCYTES; INSIGHTS	Activation of bitter taste receptors (T2Rs) in human airway smooth muscle cells leads to muscle relaxation and bronchodilation. This finding led to our hypothesis that T2Rs are expressed in human pulmonary artery smooth muscle cells and might be involved in regulating the vascular tone. RT-PCR was performed to reveal the expression of T2Rs in human pulmonary artery smooth muscle cells. Of the 25 T2Rs, 21 were expressed in these cells. Functional characterization was done by calcium imaging after stimulating the cells with different bitter agonists. Increased calcium responses were observed with most of the agonists, the largest increase seen for dextromethorphan. Previously in site-directed mutational studies, we have characterized the response of T2R1 to dextromethorphan, therefore, T2R1 was selected for further analysis in this study. Knockdown with T2R1 specific shRNA decreased mRNA levels, protein levels and dextromethorphan-induced calcium responses in pulmonary artery smooth muscle cells by up to 50%. To analyze if T2Rs are involved in regulating the pulmonary vascular tone, ex vivo studies using pulmonary arterial and airway rings were pursued. Myographic studies using porcine pulmonary arterial and airway rings showed that stimulation with dextromethorphan led to contraction of the pulmonary arterial and relaxation of the airway rings. This study shows that dextromethorphan, acting through T2R1, causes vasoconstrictor responses in the pulmonary circuit and relaxation in the airways.	[Upadhyaya, Jasbir D.; Singh, Nisha; Chakraborty, Raja; Pydi, Sai P.; Bhullar, Rajinder P.; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada; [Sikarwar, Anurag S.; Dakshinamurti, Shyamala] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Manitoba Inst Child Hlth, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada.	Prashen.Chelikani@umanitoba.ca	Upadhyaya, Jasbir/L-4724-2019; Chakraborty, Raja/L-6316-2017; Pydi, sai Prasad/M-9017-2016	Upadhyaya, Jasbir/0000-0003-0815-2108; Pydi, sai Prasad/0000-0001-7170-6519; Chelikani, Prashen/0000-0003-1129-7957; Singh, Nisha/0000-0003-0330-6411	Manitoba Institute of Child Health [OG 2011-0]; Natural Sciences and Engineering Research Council of Canada [RGPIN 356285]; MHRC/MICH; MMSF Allen Rouse Career Award	Manitoba Institute of Child Health; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MHRC/MICH; MMSF Allen Rouse Career Award	This work was supported by grants from the Manitoba Institute of Child Health (OG 2011-0), and Natural Sciences and Engineering Research Council of Canada (RGPIN 356285) to PC. Graduate studentships from MHRC/MICH to AS, RC and PSP, and a MMSF Allen Rouse Career Award to PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2008, BRIT J PHARMACOL, V153, P926, DOI 10.1038/sj.bjp.0707575; Angus JA, 2000, J PHARMACOL TOX MET, V44, P395, DOI 10.1016/S1056-8719(00)00121-0; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Carrillo-Sepulveda MA, 2010, MOL CELL BIOCHEM, V341, P279, DOI 10.1007/s11010-010-0459-9; Chakraborty R, 2013, MOL CELL BIOL, V33, P184, DOI 10.1128/MCB.00725-12; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Colombo M, 2012, J ANIM SCI, V90, P128, DOI 10.2527/jas.53793; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Fediuk J, 2012, AM J PHYSIOL-LUNG C, V302, pL13, DOI 10.1152/ajplung.00016.2011; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Gong Y, 2010, FREE RADICAL BIO MED, V48, P882, DOI 10.1016/j.freeradbiomed.2010.01.009; Hao S, 2009, AM J PHYSIOL-REG I, V296, pR528, DOI 10.1152/ajpregu.90423.2008; Hinton M, 2007, AM J PHYSIOL-LUNG C, V292, pL654, DOI 10.1152/ajplung.00229.2006; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Lund TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058945; Manson ML, 2014, EUR J PHARMACOL, V740, P302, DOI 10.1016/j.ejphar.2014.07.005; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Munzel T, 2002, ARTERIOSCL THROM VAS, V22, P1761, DOI 10.1161/01.ATV.0000034022.11764.EC; Pydi SP, 2012, CURR PROTEIN PEPT SC, V13, P501; Pydi SP, 2012, J NEUROCHEM, V122, P537, DOI 10.1111/j.1471-4159.2012.07808.x; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shimoda LA, 2000, AM J PHYSIOL-LUNG C, V279, pL884, DOI 10.1152/ajplung.2000.279.5.L884; SILVER PJ, 1986, J CARDIOVASC PHARM, V8, pS34; Singh N, 2011, J BIOL CHEM, V286, P36032, DOI 10.1074/jbc.M111.246983; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Wu TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046067; Xu J, 2013, MOL HUM REPROD, V19, P17, DOI 10.1093/molehr/gas040; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang W, 2004, FASEB J, V18, P395, DOI 10.1096/fj.04-1586fje	38	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110373	10.1371/journal.pone.0110373	http://dx.doi.org/10.1371/journal.pone.0110373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340739	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800032
J	Kazami, T; Nie, H; Satoh, M; Kuga, T; Matsushita, K; Kawasaki, N; Tomonaga, T; Nomura, F				Kazami, T.; Nie, H.; Satoh, M.; Kuga, T.; Matsushita, K.; Kawasaki, N.; Tomonaga, T.; Nomura, F.			Nuclear accumulation of annexin A2 contributes to chromosomal instability by coilin-mediated centromere damage	ONCOGENE			English	Article							PRIMARY COLORECTAL-CANCER; EARLY PROTEIN VMW110; MITOTIC CHECKPOINT; DNA-REPLICATION; BREAST-CANCER; HUMAN-CELLS; ANEUPLOIDY; OVEREXPRESSION; EXPRESSION; SEGREGATION	Most human cancers show chromosomal instability (CIN), but the precise mechanisms remain uncertain. Annexin A2 is frequently overexpressed in human cancers, and its relationship to tumorigenesis is poorly understood. We found that annexin A2 is overexpressed in the nuclei of CIN cells compared with cells with microsatellite instability (MIN). Ectopic annexin A2 expression in MIN cells results in a high level of aneuploidy and induces lagging chromosomes; suppression of annexin A2 in CIN cells reduces such CIN signatures with apoptosis of highly aneuploid cells. Ectopic expression of annexin A2 in MIN cells reduces the expression of centromere proteins. Conversely, annexin A2-knockdown in CIN cells increases the expression of centromere proteins. Moreover, the endogenous expression levels of centromere proteins in CIN cells were greatly reduced compared with MIN cell lines. The reduced expression of centromere proteins likely occurred due to aberrant centromere localization of coilin, a major component of the Cajal bodies. These results suggest that nuclear accumulation of annexin A2 has a crucial role in CIN by disrupting centromere function.	[Kazami, T.; Nie, H.; Satoh, M.; Matsushita, K.; Kawasaki, N.; Tomonaga, T.; Nomura, F.] Chiba Univ, Dept Mol Diag F8, Grad Sch Med, Chuo Ku, Chiba, Japan; [Kuga, T.; Kawasaki, N.; Tomonaga, T.] Natl Inst Biomed Innovat, Lab Proteome Res, Ibaraki, Osaka 5670085, Japan	Chiba University; National Institute of Health Sciences - Japan	Tomonaga, T (corresponding author), Natl Inst Biomed Innovat, Lab Proteome Res, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	tomonaga@nibio.go.jp	Kuga, Takahisa/AAX-9334-2020; Matsushita, Kazuyuki/AAJ-5380-2020	Matsushita, Kazuyuki/0000-0001-6742-0761	Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [26460081] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Masumi Ishibashi and Nobuko Tanaka for technical assistance. This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan.	Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bayani J, 2007, SEMIN CANCER BIOL, V17, P5, DOI 10.1016/j.semcancer.2006.10.006; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chuthapisith S, 2007, INT J ONCOL, V30, P1545; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Eberhard DA, 2001, J CELL SCI, V114, P3155; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Everett RD, 1999, EMBO J, V18, P1526, DOI 10.1093/emboj/18.6.1526; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kalitsis P, 1998, P NATL ACAD SCI USA, V95, P1136, DOI 10.1073/pnas.95.3.1136; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kuga T, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.6; KUMBLE KD, 1992, J CELL SCI, V101, P35; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu Jie, 2003, BMC Biochem, V4, P10, DOI 10.1186/1471-2091-4-10; Lomonte P, 1999, J VIROL, V73, P9456, DOI 10.1128/JVI.73.11.9456-9467.1999; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Nishimori T, 2006, PROTEOMICS, V6, P1011, DOI 10.1002/pmic.200500262; RASKA I, 1991, EXP CELL RES, V195, P27, DOI 10.1016/0014-4827(91)90496-H; Sawyers CL, 2001, SCIENCE, V294, P1834; Seimiya M, 2008, HEPATOLOGY, V48, P519, DOI 10.1002/hep.22364; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Takano S, 2008, ANN SURG ONCOL, V15, P3157, DOI 10.1245/s10434-008-0061-5; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tomas A, 2004, J CELL BIOL, V165, P813, DOI 10.1083/jcb.200311054; Tomonaga T, 2007, HISTOL HISTOPATHOL, V22, P191, DOI 10.14670/HH-22.191; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Tomonaga T, 2004, CLIN CANCER RES, V10, P2007, DOI 10.1158/1078-0432.CCR-03-0321; Tomonaga T, 2003, CANCER RES, V63, P3511; VISHWANATHA JK, 1993, J CELL SCI, V105, P533; Wang JL, 2004, BBA-GEN SUBJECTS, V1673, P75, DOI 10.1016/j.bbagen.2004.03.013; Wang TL, 2004, P NATL ACAD SCI USA, V101, P3089, DOI 10.1073/pnas.0308716101; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	48	11	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4177	4189		10.1038/onc.2014.345	http://dx.doi.org/10.1038/onc.2014.345			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25347736				2022-12-26	WOS:000359199800004
J	Kapogiannis, D; Boxer, A; Schwartz, JB; Abner, EL; Biragyn, A; Masharani, U; Frassetto, L; Petersen, RC; Miller, BL; Goetzl, EJ				Kapogiannis, Dimitrios; Boxer, Adam; Schwartz, Janice B.; Abner, Erin L.; Biragyn, Arya; Masharani, Umesh; Frassetto, Lynda; Petersen, Ronald C.; Miller, Bruce L.; Goetzl, Edward J.			Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease	FASEB JOURNAL			English	Article						insulin resistance; dementia; senescence	SERINE/THREONINE PHOSPHORYLATION; TAU-HYPERPHOSPHORYLATION; GLUCOSE-METABOLISM; CLINICAL-TRIALS; ADAS-COG; IN-VIVO; RESISTANCE; IRS-1; MECHANISMS; SENSITIVITY	Insulin resistance causes diminished glucose uptake in similar regions of the brain in Alzheimer's disease (AD) and type 2 diabetes mellitus (DM2). Brain tissue studies suggested that insulin resistance is caused by low insulin receptor signaling attributable to its abnormal association with more phospho (P)-serine-type 1 insulin receptor substrate (IRS-1) and less P-tyrosine-IRS-1. Plasma exosomes enriched for neural sources by immunoabsorption were obtained once from 26 patients with AD, 20 patients with DM2, 16 patients with frontotemporal dementia (FTD), andmatched case control subjects. At 2 time points, they were obtained from 22 others when cognitively normal and 1 to 10 yr later when diagnosed with AD. Mean exosomal levels of extracted P-serine 312-IRS-1 and P-pantyrosine- IRS-1 by ELISA and the ratio of P-serine 312-IRS-1 to P-pan-tyrosine-IRS-1 (insulin resistance factor, R) for AD and DM2 and P-serine 312-IRS-1 and R for FTD were significantly different from those for case control subjects. The levels of R for AD were significantly higher than those for DM2 or FTD. Stepwise discriminant modeling showed correct classification of 100% of patients with AD, 97.5% of patients with DM2, and 84% of patients with FTD. In longitudinal studies of 22 patients with AD, exosomal levels of P-serine 312-IRS-1, P-pan-tyrosine-IRS-1, and R were significantly different 1 to 10 yr before and at the time of diagnosis comparedwith control subjects. Insulin resistance reflected in R values from this blood test is higher for patients with AD, DM2, and FTD than case control subjects; higher for patients with AD than patients with DM2 or FTD; and accurately predicts development of AD up to 10 yr prior to clinical onset.-Kapogiannis, D., Boxer, A., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U., Frassetto, L., Petersen, R. C., Miller, B. L., Goetzl, E. J. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.	[Kapogiannis, Dimitrios; Biragyn, Arya; Goetzl, Edward J.] NIA, Intramural Res Program, Baltimore, MD 21224 USA; [Boxer, Adam; Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Schwartz, Janice B.; Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Schwartz, Janice B.; Masharani, Umesh; Frassetto, Lynda; Goetzl, Edward J.] Jewish Home San Francisco, San Francisco, CA USA; [Abner, Erin L.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Petersen, Ronald C.] Mayo Clin, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Kentucky; Mayo Clinic	Goetzl, EJ (corresponding author), UCSF, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Schwartz, Janice/K-6354-2019; frassetto, lynda/AAY-7834-2020; Kapogiannis, Dimitrios/AAW-4934-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118	U.S.National Institutes of Health (NIH) NIA; United Kingdom Alzheimer's Disease Center [P30-AG028383]; NATIONAL INSTITUTE ON AGING [ZIAAG000975, P50AG023501, P30AG028383, R01AG038791] Funding Source: NIH RePORTER	U.S.National Institutes of Health (NIH) NIA; United Kingdom Alzheimer's Disease Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to Lynn Kane (JHSF), Anna Karydas (UCSF MAC), Dana Swenson-Dravis and Matthew Miller (Mayo Clinic), Sonya Anderson (University of Kentucky), and Olga Carlson and Melissa Swaby Intramural Research Program of the National Institute on Aging (NIA) for organizing and distributing clinical materials and data and for providing access to analytical systems.They also thank Judith H.Goetzl for expert preparation of graphic illustrations.This studywas funded by the U.S.National Institutes of Health (NIH) NIA (to A.Bi., D.K.), United Kingdom Alzheimer's Disease Center grant P30-AG028383 (to E.L.A.), and an unrestricted supply grant for methodologic development from Nanosomix, Incorporated (to E.J.G.).D.K., J.B.S., E.L.A., A.Bi., U.M., L.F., R.C.P., and B.L.M.declare no potential conflicts of interest. E.J.G. has filed a provisional application with the U.S. Patent Office for the methodology described in this report; Nanosomix, Incorporated, supports the research but provides no salary, expense reimbursement, or fees and does not influence the processes of research or publication. A. B. reports grants from the NIH/NIA; grants from Tau Research Consortium; grants from Corticobasal Degeneration Solutions; grants, personal fees, and nonfinancial support from Archer Biosciences; grants from Allon Therapeutics; personal fees from Acetylon; personal fees from Ipierian; grants from Genentech; grants from Bristol-Myers Squibb; grants from TauRx; grants from Alzheimer's Association; grants from Bluefield Project to Cure FTD; grants from Association for Frontotemporal Degeneration; grants from Alzheimer's Drug Discovery Foundation; grants from EnVivo; grants from C2N Diagnostics; grants from Pfizer; grants from Eli Lilly for support outside the submitted work.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Amoui M, 2001, J ENDOCRINOL, V171, P153, DOI 10.1677/joe.0.1710153; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Bosco D, 2011, J CELL MOL MED, V15, P1807, DOI 10.1111/j.1582-4934.2011.01318.x; Cano SJ, 2010, J NEUROL NEUROSUR PS, V81, P1363, DOI 10.1136/jnnp.2009.204008; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Dhe-Paganon S, 1999, P NATL ACAD SCI USA, V96, P8378, DOI 10.1073/pnas.96.15.8378; Duarte Ana I, 2012, J Aging Res, V2012, P384017, DOI 10.1155/2012/384017; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Fiandaca M. S., ALZHEIMERS DEMENT, DOI [10.1016/j.jalz.2014.06.008, DOI 10.1016/J.JALZ.2014.06.008]; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Gorno-Tempini M. L., NEUROLOGY, V76, P1006; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Irizarry MC, 2008, J ALZHEIMERS DIS, V14, P301; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Neumann KF, 2008, CURR ALZHEIMER RES, V5, P438, DOI 10.2174/156720508785908919; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Yamada M, 1997, J BIOL CHEM, V272, P30334, DOI 10.1074/jbc.272.48.30334; Yi ZP, 2007, DIABETES, V56, P1508, DOI 10.2337/db06-1355; Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015	39	219	224	0	50	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					589	596		10.1096/fj.14-262048	http://dx.doi.org/10.1096/fj.14-262048			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25342129	Green Published			2022-12-26	WOS:000349370400021
J	Aijima, R; Wang, B; Takao, T; Mihara, H; Kashio, M; Ohsaki, Y; Zhang, JQ; Mizuno, A; Suzuki, M; Yamashita, Y; Masuko, S; Goto, M; Tominaga, M; Kido, MA				Aijima, Reona; Wang, Bing; Takao, Tomoka; Mihara, Hiroshi; Kashio, Makiko; Ohsaki, Yasuyoshi; Zhang, Jing-Qi; Mizuno, Atsuko; Suzuki, Makoto; Yamashita, Yoshio; Masuko, Sadahiko; Goto, Masaaki; Tominaga, Makoto; Kido, Mizuho A.			The thermosensitive TRPV3 channel contributes to rapid wound healing in oral epithelia	FASEB JOURNAL			English	Article						ambient temperature; oral mucosa; wound repair	GROWTH-FACTOR-RECEPTOR; OLMSTED SYNDROME; CALCIUM INFLUX; EGF RECEPTOR; ION CHANNELS; ATP RELEASE; SKIN; KERATINOCYTES; ACTIVATION; CELLS	The oral cavity provides an entrance to the alimentary tract to serve as a protective barrier against harmful environmental stimuli. The oral mucosa is susceptible to injury because of its location; nonetheless, it has faster wound healing than the skin and less scar formation. However, the molecular pathways regulating this wound healing are unclear. Here, we show that transient receptor potential vanilloid 3 (TRPV3), a thermosensitive Ca2+-permeable channel, is more highly expressed in murine oral epithelia than in the skin by quantitative RT-PCR. We found that temperatures above 33 degrees C activated TRPV3 and promoted oral epithelial cell proliferation. The proliferation rate in the oral epithelia of TRPV3 knockout (TRPV3KO) mice was less than that of wild-type (WT) mice. We investigated the contribution of TRPV3 to wound healing using a molar tooth extraction model and found that oral wound closure was delayed in TRPV3KO mice compared with that in WT mice. TRPV3 mRNA was up-regulated in wounded tissues, suggesting that TRPV3 may contribute to oral wound repair. We identified TRPV3 as an essential receptor in heat-induced oral epithelia proliferation and wound healing. Our findings suggest that TRPV3 activation could be a potential therapeutic target for wound healing in skin and oral mucosa.	[Aijima, Reona; Wang, Bing; Takao, Tomoka; Ohsaki, Yasuyoshi; Zhang, Jing-Qi; Kido, Mizuho A.] Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 8128582, Japan; [Aijima, Reona; Yamashita, Yoshio; Goto, Masaaki] Saga Univ, Fac Med, Dept Oral & Maxillofacial Surg, Saga 840, Japan; [Aijima, Reona; Masuko, Sadahiko] Saga Univ, Fac Med, Dept Anat & Physiol, Div Histol & Neuroanat, Saga 840, Japan; [Mihara, Hiroshi; Kashio, Makiko; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448585, Japan; [Mizuno, Atsuko; Suzuki, Makoto] Jichi Med Univ, Dept Pharmacol, Shimotsuke, Japan	Kyushu University; Saga University; Saga University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Jichi Medical University	Kido, MA (corresponding author), Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kido@dent.kyushu-u.ac.jp	Takao, Tomoka/K-1568-2015; Mihara, Hiroshi/AAE-3961-2021	Takao, Tomoka/0000-0002-6519-2301; Kashio, Makiko/0000-0001-6404-2339	Grants-in-Aid for Scientific Research [25462562] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Block ER, 2004, J BIOL CHEM, V279, P24307, DOI 10.1074/jbc.M401058200; Cals-Grierson MM, 2004, NITRIC OXIDE-BIOL CH, V10, P179, DOI 10.1016/j.niox.2004.04.005; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen L, 2012, J DENT RES, V91, P871, DOI 10.1177/0022034512454435; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Cordeiro JV, 2013, NAT REV MOL CELL BIO, V14, P249, DOI 10.1038/nrm3541; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Danso-Abeam D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-79; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; Gonzales CB, 2014, ORAL ONCOL, V50, P437, DOI 10.1016/j.oraloncology.2013.12.023; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Kido MA, 2003, J DENT RES, V82, P393, DOI 10.1177/154405910308200513; Lai-Cheong JE, 2012, BRIT J DERMATOL, V167, P440, DOI 10.1111/j.1365-2133.2012.11115.x; Lansdown ABG, 2002, WOUND REPAIR REGEN, V10, P271, DOI 10.1046/j.1524-475X.2002.10502.x; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Mashu S., 2004, PAIN RES, V19, P123; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; Mihara H, 2011, J PHYSIOL-LONDON, V589, P3471, DOI 10.1113/jphysiol.2011.207829; Miyamoto T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1371; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Nilius B, 2014, J PHYSIOL-LONDON, V592, P295, DOI 10.1113/jphysiol.2013.255968; Oudhoff MJ, 2009, J DENT RES, V88, P846, DOI 10.1177/0022034509342951; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; RATH EM, 1990, J ORAL MAXIL SURG, V48, P1181, DOI 10.1016/0278-2391(90)90534-9; Repertinger SK, 2004, J INVEST DERMATOL, V123, P982, DOI 10.1111/j.0022-202X.2004.23478.x; SCIUBBA JJ, 1978, J ORAL PATHOL MED, V7, P214, DOI 10.1111/j.1600-0714.1978.tb01596.x; Shimohira D, 2009, HISTOCHEM CELL BIOL, V132, P423, DOI 10.1007/s00418-009-0616-y; Steinhoff M, 2009, J INVEST DERMATOL, V129, P531, DOI 10.1038/jid.2008.440; STOSCHECK CM, 1992, J INVEST DERMATOL, V99, P645, DOI 10.1111/1523-1747.ep12668143; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Ueda T, 2009, BIOCHEM BIOPH RES CO, V383, P130, DOI 10.1016/j.bbrc.2009.03.143; Wang B, 2011, J DENT RES, V90, P163, DOI 10.1177/0022034510385459; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Xu SH, 2011, CURR BIOL, V21, P1960, DOI 10.1016/j.cub.2011.10.050; Yamada T, 2010, EXP EYE RES, V90, P121, DOI 10.1016/j.exer.2009.09.020; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389	53	51	52	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					182	192		10.1096/fj.14-251314	http://dx.doi.org/10.1096/fj.14-251314			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25351988				2022-12-26	WOS:000347378600018
J	Mariappan, MM; Prasad, S; D'Silva, K; Cedillo, E; Sataranatarajan, K; Barnes, JL; Choudhury, GG; Kasinath, BS				Mariappan, Meenalakshmi M.; Prasad, Sanjay; D'Silva, Kristin; Cedillo, Esteban; Sataranatarajan, Kavithalakshmi; Barnes, Jeffrey L.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.			Activation of Glycogen Synthase Kinase 3 beta Ameliorates Diabetes-induced Kidney Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Eukaryotic Translation Initiation; Extracellular Matrix Protein; Glycogen Synthase Kinase 3 (GSK-3); Kidney; Mammalian Target of Rapamycin (mTOR); Type 1 Diabetes; Diabetic Nephropathy; Sodium Nitroprusside; Kidney Hypertrophy	MESSENGER-RNA TRANSLATION; RENAL EPITHELIAL-CELLS; PROTEIN-SYNTHESIS; HIGH GLUCOSE; HIGH INSULIN; AKT KINASE; PHOSPHORYLATION; NEPHROPATHY; INITIATION; GROWTH	Increase in protein synthesis contributes to kidney hypertrophy and matrix protein accumulation in diabetes. We have previously shown that high glucose-induced matrix protein synthesis is associated with inactivation of glycogen synthase kinase 3 (GSK3) in renal cells and in the kidneys of diabetic mice. We tested whether activation of GSK3 by sodium nitroprusside (SNP) mitigates kidney injury in diabetes. Studies in kidney-proximal tubular epithelial cells showed that SNP abrogated high glucose-induced laminin increment by stimulating GSK3 and inhibiting Akt, mTORC1, and events in mRNA translation regulated by mTORC1 and ERK. NONOate, an NO donor, also activated GSK3, indicating that NO may mediate SNP stimulation of GSK3. SNP administered for 3 weeks to mice with streptozotocin-induced type 1 diabetes ameliorated kidney hypertrophy, accumulation of matrix proteins, and albuminuria without changing blood glucose levels. Signaling studies showed that diabetes caused inactivation of GSK3 by activation of Src, Pyk2, Akt, and ERK; GSK3 inhibition activated mTORC1 and downstream events in mRNA translation in the kidney cortex. These reactions were abrogated by SNP. We conclude that activation of GSK3 by SNP ameliorates kidney injury induced by diabetes.	[Mariappan, Meenalakshmi M.; Prasad, Sanjay; D'Silva, Kristin; Cedillo, Esteban; Sataranatarajan, Kavithalakshmi; Barnes, Jeffrey L.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78245 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA; [Mariappan, Meenalakshmi M.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] South Texas Vet Hlth Care Syst, Med Serv, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Kasinath, BS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med MC7882, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	kasinath@uthscsa.edu		D'Silva, Kristin/0000-0001-8370-4166	Veterans Affairs Merit Review Program; National Institutes of Health [DK077295, RC2AG036613, DK050190]; American Diabetes Association; Juvenile Diabetes Research Foundation; Veterans Affairs Merit Review Grant [5I01BX000926]; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050190, R01DK077295, R01DK050190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036613] Funding Source: NIH RePORTER	Veterans Affairs Merit Review Program(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Veterans Affairs Merit Review Program (to B. S. K.), National Institutes of Health Grants DK077295 (to B. S. K.) and RC2AG036613 (to B. S. K.). This work was also supported by the American Diabetes Association (to B. S. K.) and the Juvenile Diabetes Research Foundation (to M. M. M.).; Supported by National Institutes of Health R01 Grant DK050190 and Veterans Affairs Merit Review Grant 5I01BX000926; recipient of a Veterans Affairs Senior Research Career Scientist Award.	Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73; Bandyopadhyay G, 2000, J BIOL CHEM, V275, P40817, DOI 10.1074/jbc.M007920200; Bao H, 2014, J AM SOC NEPHROL, V25, P488, DOI 10.1681/ASN.2013040350; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Brion JP, 2001, BIOCHEM SOC SYMP, V67, P81; Covington MD, 2012, KIDNEY INT, V81, P391, DOI 10.1038/ki.2011.356; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089835; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Day RT, 2013, AM J PHYSIOL-RENAL, V304, pF788, DOI 10.1152/ajprenal.00306.2012; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Ge Y, 2011, LAB INVEST, V91, P85, DOI 10.1038/labinvest.2010.142; Ghosh C, 2004, CELL SIGNAL, V16, P31, DOI DOI 10.1016/S0898-6568(03)00094-9; Goc A, 2014, ONCOTARGET, V5, P775, DOI 10.18632/oncotarget.1770; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Lin L, 2010, AM J PATHOL, V177, P1687, DOI 10.2353/ajpath.2010.100213; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062844; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Mariappan MM, 2014, AM J PHYSIOL-CELL PH, V306, pC202, DOI 10.1152/ajpcell.00144.2013; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Sataranatarajan K, 2012, AGING CELL, V11, P1065, DOI 10.1111/acel.12008; Senthil D, 2003, KIDNEY INT, V64, P468, DOI 10.1046/j.1523-1755.2003.00135.x; Sonomura K, 2012, KIDNEY INT, V81, P449, DOI 10.1038/ki.2011.403; Sorokin A, 2001, J BIOL CHEM, V276, P21521, DOI 10.1074/jbc.M008869200; Sun WX, 2014, FREE RADICAL BIO MED, V68, P22, DOI 10.1016/j.freeradbiomed.2013.11.015; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Urbanska K, 2007, ONCOGENE, V26, P2308, DOI 10.1038/sj.onc.1210018; Wang XM, 2008, MOL CELL BIOL, V28, P1429, DOI 10.1128/MCB.01512-07; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Zdychova J, 2008, PHYSIOL RES, V57, P709, DOI 10.33549/physiolres.931337; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang YH, 2005, FEBS LETT, V579, P6230, DOI 10.1016/j.febslet.2005.09.095; Zhou JB, 2013, J CLIN INVEST, V123, P1821, DOI 10.1172/JCI64398	51	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35363	35375		10.1074/jbc.M114.587840	http://dx.doi.org/10.1074/jbc.M114.587840			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25339176	Green Published, hybrid			2022-12-26	WOS:000346660200027
J	Miramontes, O; DeSouza, O; Paiva, LR; Marins, A; Orozco, S				Miramontes, Octavio; DeSouza, Og; Paiva, Leticia Ribeiro; Marins, Alessandra; Orozco, Sirio			Levy Flights and Self-Similar Exploratory Behaviour of Termite Workers: Beyond Model Fitting	PLOS ONE			English	Article							ANOMALOUS DIFFUSION; PATTERNS; DISTRIBUTIONS; TURBULENCE; LAWS; WALK	Animal movements have been related to optimal foraging strategies where self-similar trajectories are central. Most of the experimental studies done so far have focused mainly on fitting statistical models to data in order to test for movement patterns described by power-laws. Here we show by analyzing over half a million movement displacements that isolated termite workers actually exhibit a range of very interesting dynamical properties -including Levy flights- in their exploratory behaviour. Going beyond the current trend of statistical model fitting alone, our study analyses anomalous diffusion and structure functions to estimate values of the scaling exponents describing displacement statistics. We evince the fractal nature of the movement patterns and show how the scaling exponents describing termite space exploration intriguingly comply with mathematical relations found in the physics of transport phenomena. By doing this, we rescue a rich variety of physical and biological phenomenology that can be potentially important and meaningful for the study of complex animal behavior and, in particular, for the study of how patterns of exploratory behaviour of individual social insects may impact not only their feeding demands but also nestmate encounter patterns and, hence, their dynamics at the social scale.	[Miramontes, Octavio; Orozco, Sirio] Univ Nacl Autonoma Mexico, Inst Fis, Dept Sistemas Complejos, Mexico City, DF, Mexico; [Miramontes, Octavio] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [DeSouza, Og; Paiva, Leticia Ribeiro; Marins, Alessandra] Univ Fed Vicosa, Lab Termitol, Vicosa, MG, Brazil; [Paiva, Leticia Ribeiro] Univ Fed Ouro Preto, Dept Fis, Ouro Preto, MG, Brazil	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade Federal de Vicosa; Universidade Federal de Ouro Preto	Miramontes, O (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis, Dept Sistemas Complejos, Mexico City, DF, Mexico.	octavio@fisica.unam.mx	DeSouza, Og/A-7140-2008; Miramontes, Octavio/A-1870-2012; Orozco-Fuentes, Sirio/AAG-7746-2021; miramontes, octavio/ABG-8963-2020; de Paiva, Leticia Ribeiro/X-6730-2019	DeSouza, Og/0000-0002-7108-0242; Orozco-Fuentes, Sirio/0000-0002-6192-7710; miramontes, octavio/0000-0001-8306-0014; Paiva, Leticia/0000-0002-3469-5889	DGAPA-PAPIIT [IN101712]; Brazilian Ciencia Sem Fronteiras program (CSF-CAPES) [0148/2012]; CNPq-Brasil [305736/2013-2]	DGAPA-PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Brazilian Ciencia Sem Fronteiras program (CSF-CAPES); CNPq-Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	OM thanks DGAPA-PAPIIT Grant IN101712 and the Brazilian Ciencia Sem Fronteiras program (CSF-CAPES) 0148/2012. ODS is supported by CNPq-Brasil, fellowship 305736/2013-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2006, P NATL ACAD SCI USA, V103, P4352, DOI 10.1073/pnas.0600482103; Bardunias P, 2009, ANIM BEHAV, V78, P755, DOI 10.1016/j.anbehav.2009.06.024; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; BENZI R, 1993, PHYS REV E, V48, pR29, DOI 10.1103/PhysRevE.48.R29; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Brunow GS, 2005, BRAZ ARCH BIOL TECHN, V48, P575, DOI 10.1590/S1516-89132005000500010; Chapman SC, 2005, NONLINEAR PROC GEOPH, V12, P767, DOI 10.5194/npg-12-767-2005; Chechkin AV, 2000, PHYSICA A, V277, P312, DOI 10.1016/S0378-4371(99)00392-1; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DeSouza O, 2004, SOCIOBIOLOGY, V44, P527; FRISCH U, 1991, P R SOC-MATH PHYS SC, V434, P89, DOI 10.1098/rspa.1991.0082; JANDER R, 1974, INSECT SOC, V21, P45, DOI 10.1007/BF02222979; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Klafter J, 2005, PHYS WORLD, V18, P29; KLAFTER J, 1987, PHYS REV A, V35, P3081, DOI 10.1103/PhysRevA.35.3081; Miramontes O, 2001, INT J BIFURCAT CHAOS, V11, P1655, DOI 10.1142/S0218127401002912; Miramontes O, 1998, P ROY SOC B-BIOL SCI, V265, P785, DOI 10.1098/rspb.1998.0361; Miramontes O, 2014, 14046267 ARXIV, P232; Miramontes Octavio, 2008, Journal of Insect Science (Tucson), V8, P1, DOI 10.1673/031.008.2201; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Padoan P, 2003, ASTROPHYS J, V583, P308, DOI 10.1086/345351; Padoan P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.191102; Padoan P, 2002, ASTROPHYS J, V580, pL57, DOI 10.1086/345403; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Schmitt FG, 2001, PHYSICA A, V301, P375, DOI 10.1016/S0378-4371(01)00429-0; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; SOLOMON TH, 1993, PHYS REV LETT, V71, P3975, DOI 10.1103/PhysRevLett.71.3975; SU NY, 1990, SOCIOBIOLOGY, V17, P77; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan G. M., 2011, PHYS FORAGING; Wearmouth VJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2997; Yu CX, 2003, PHYS PLASMAS, V10, P2772, DOI 10.1063/1.1583711; ZUMOFEN G, 1995, PHYS REV E, V51, P1818, DOI 10.1103/PhysRevE.51.1818	36	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111183	10.1371/journal.pone.0111183	http://dx.doi.org/10.1371/journal.pone.0111183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353958	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000345204200064
J	Dey, S; Roy, D; Majumder, GC; Bhattacharyya, D				Dey, Souvik; Roy, Debarun; Majumder, Gopal C.; Bhattacharyya, Debdas			Extracellular Regulation of Sperm Transmembrane Adenylyl Cyclase by a Forward Motility Stimulating Protein	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; EPIDIDYMAL SPERMATOZOA; SEMINAL PLASMA; IDENTIFICATION; CAPACITATION; MEMBRANE; GLYCOPROTEIN; PURIFICATION; FERTILITY; INHIBITOR	Forward motility stimulating factor (FMSF), a glycoprotein isolated from buffalo serum, binds to the surface of the mature sperm cells to promote their progressive motility. This article reports the mode of signal transduction of this extracellular factor in goat sperm. The mechanism was investigated by assaying intracellular second messenger level and forward motility in presence of different pharmacological modulators. Mg++-dependent Forskolin responsive form of transmembrane adenylyl cyclase (tmAC) of goat spermatozoa was probed for its involvement in FMSF action. Dideoxyadenosine, a selective inhibitor of tmACs, was used to identify the role of this enzyme in the scheme of FMSF-signaling. Involvement of the a-subunit of G-protein in this regard has been inspected using GTPcS. Participation of protein kinase A (PKA) and tyrosine kinase was checked using IP20 and genistein, respectively. FMSF promotes tmAC activity in a dose-dependent manner through receptor/G-protein activation to enhance intracellular cAMP and forward motility. Motility boosting effects of this glycoprotein are almost lost in presence of dideoxyadenosine. But, FMSF displayed substantial motility promoting activity when movement of spermatozoa was inhibited with KH7, the specific inhibitor of soluble adenylyl cyclase indicating tmAC to be the primary target of FMSF action. Involvement of cAMP in mediating FMSF action was confirmed by the application of dibutyryl cAMP. Observed motility regulatory effects with IP20 and genistein indicate contribution of PKA and tyrosine kinase in FMSF activity; enhanced phosphorylation of a tyrosine containing approximate to 50 kDa protein was detected in this regard. FMSF initiates a novel signaling cascade to stimulate tmAC activity that augments intracellular cAMP, which through downstream crosstalk of phosphokinases leads to enhanced forward motility in mature spermatozoa. Thus, this article for the first time describes conventional tmAC-dependent profound activation of progressive motility by a physiologic extracellular factor in a mammalian species.	[Dey, Souvik; Roy, Debarun; Majumder, Gopal C.; Bhattacharyya, Debdas] Jadavpur Univ, Ctr Rural & Cryogen Technol, Div Cryobiol, Kolkata, W Bengal, India	Jadavpur University	Bhattacharyya, D (corresponding author), Jadavpur Univ, Ctr Rural & Cryogen Technol, Div Cryobiol, Kolkata, W Bengal, India.	ddbhattacharyya@gmail.com	Dey, Souvik/AAB-2252-2021	Dey, Souvik/0000-0003-1799-5270; Roy, Debarun/0000-0003-3579-7497	Department of Biotechnology (DBT), Government of India [BT/PR13167/AAQ/01/416/2009]; Council of Scientific and Industrial Research (CSIR), Human Resource Development Group, Government of India [37 [1406]/10/EMR-II]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Human Resource Development Group, Government of India	This work was supported by Department of Biotechnology (DBT), Government of India (grant number: BT/PR13167/AAQ/01/416/2009) URL:http://dbtindia.nic.in/index.asp and Council of Scientific and Industrial Research (CSIR), Human Resource Development Group, Government of India (grant number: 37 [1406]/10/EMR-II). URL: http://csirhrdg.res.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Barbonetti A, 2010, ASIAN J ANDROL, V12, P853, DOI 10.1038/aja.2010.52; BAVISTER BD, 1975, J REPROD FERTIL, V43, P363; Bharshankar Rajay N., 2000, Indian Journal of Physiology and Pharmacology, V44, P456; BISWAS R, 1984, J BIOSCIENCE, V6, P69, DOI 10.1007/BF02702858; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; Chatterjee M, 2010, MOL CELL BIOCHEM, V336, P39, DOI 10.1007/s11010-009-0261-8; CHENG HC, 1986, J BIOL CHEM, V261, P989; Das K, 2012, ANDROLOGIA, V44, P807, DOI 10.1111/j.1439-0272.2011.01161.x; Dey S, 2014, P 2 PHARM TECH IAPST, P113; Dey S, 2014, BIOCHEM CELL BIOL, V92, P43, DOI 10.1139/bcb-2013-0080; Ding ZD, 2007, MOL REPROD DEV, V74, P1124, DOI 10.1002/mrd.20624; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Flesch FM, 2001, MOL REPROD DEV, V60, P107, DOI 10.1002/mrd.1067; GAUR RD, 1975, INT J FERTIL, V20, P133; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2010, J CELL PHYSIOL, V222, P254, DOI 10.1002/jcp.21947; JALAL F, 1992, BIOCHEM J, V288, P945, DOI 10.1042/bj2880945; Leclerc P, 1996, BIOL REPROD, V55, P684, DOI 10.1095/biolreprod55.3.684; Liu JH, 2003, ASIAN J ANDROL, V5, P113; Livera G, 2005, MOL ENDOCRINOL, V19, P1277, DOI 10.1210/me.2004-0318; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJUMDER GC, 1984, J REPROD FERTIL, V70, P235, DOI 10.1530/jrf.0.0700235; Majumder GC, 2001, India, Patent No. 185383; MAJUMDER GC, 1999, COMP ENDOCRINOLOGY R, P242; Majumder GC, 2003, Patent No. [6613737 (USA), 6613737]; MANDAL M, 1989, BIOL REPROD, V41, P983, DOI 10.1095/biolreprod41.6.983; Mandal M, 2006, J CELL PHYSIOL, V209, P353, DOI 10.1002/jcp.20734; MORITA Z, 1971, J REPROD FERTIL, V24, P247, DOI 10.1530/jrf.0.0240247; Mortimer D, 1995, REPROD FERT DEVELOP, V7, P951, DOI 10.1071/RD9950951; MORTON B, 1973, J REPROD FERTIL, V35, P255, DOI 10.1530/jrf.0.0350255; MORTON BE, 1979, FERTIL STERIL, V32, P107; O'Brien ED, 2011, DEV BIOL, V350, P80, DOI 10.1016/j.ydbio.2010.11.019; Posternak T, 1974, Methods Enzymol, V38, P399; RANA APS, 1987, PREP BIOCHEM, V17, P261, DOI 10.1080/00327488708062493; RANA APS, 1989, PREP BIOCHEM, V19, P167, DOI 10.1080/10826068908544906; ROY N, 1989, BIOCHIM BIOPHYS ACTA, V991, P114, DOI 10.1016/0304-4165(89)90036-6; Saha S, 2013, FERTIL STERIL, V100, P269, DOI 10.1016/j.fertnstert.2013.03.012; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SHETH AR, 1981, ANDROLOGIA, V13, P142; Shiu PJ, 2013, PROTEIN EXPRES PURIF, V89, P219, DOI 10.1016/j.pep.2013.03.011; Sivars U, 2000, BBA-GEN SUBJECTS, V1474, P133, DOI 10.1016/S0304-4165(99)00208-1; SOKOLOSKI JE, 1977, FERTIL STERIL, V28, P1337; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Thomsen W, 2005, CURR OPIN BIOTECH, V16, P655, DOI 10.1016/j.copbio.2005.10.008; Tomar AK, 2011, DIS MARKERS, V31, P379, DOI [10.1155/2011/798072, 10.3233/DMA-2011-0853]; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; VIJAYARAGHAVAN S, 1985, BIOL REPROD, V32, P489, DOI 10.1095/biolreprod32.3.489; Williams R J, 1995, Methods Mol Biol, V41, P63; Wojtczak M, 2007, COMP BIOCHEM PHYS B, V148, P426, DOI 10.1016/j.cbpb.2007.07.011; YANAGIMA.R, 1970, J REPROD FERTIL, V23, P193, DOI 10.1530/jrf.0.0230193	53	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110669	10.1371/journal.pone.0110669	http://dx.doi.org/10.1371/journal.pone.0110669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350397	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943100034
J	Nakakura, S; Yamamoto, M; Terao, E; Nagasawa, T; Tabuchi, H; Kiuchi, Y				Nakakura, Shunsuke; Yamamoto, Minami; Terao, Etsuko; Nagasawa, Toshihiko; Tabuchi, Hitoshi; Kiuchi, Yoshiaki			The Whole Macular Choroidal Thickness in Subjects with Primary Open Angle Glaucoma	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NORMAL-TENSION GLAUCOMA; SWEPT-SOURCE; HEALTHY-SUBJECTS; EYES; PROGRESSION; NERVE; DISC; APPEARANCES; VOLUME	Purpose: We investigated the whole macular choroidal thickness in subjects with glaucoma in order to evaluate the effects of glaucoma and glaucoma visual field damage on the choroidal thickness. Subjects and Methods: We examined 40 primary open angle glaucoma patients with only superior visual field defects and 48 normal controls. The macular choroidal thickness was measured using swept-source optical coherence tomography according to the three-dimensional raster scan protocol (6x6 mm). We used the choroidal thickness within a 1.0-mm circle measured on ETDRS grids as the central sector and then used a 6x6 rectangular grid to divide the area into six sectors. Results: No significant differences were found in the choroidal thickness values between the glaucoma and normal subjects in any of the sectors after adjusting for the age and axial length (all P>0.4, ANCOVA). According to a stepwise analysis of the glaucoma subjects performed using the parameters of age, axial length, central corneal thickness and mean deviation (MD value) obtained by static perimetry, age was the most predictive and significant factor in all sectors (coefficient = -3.091 to -4.091 and F value = 15.629 to 22.245), followed by axial length (coefficient = -10.428 to -23.458 and F value = 2.454 to 6.369). The central corneal thickness and MD values were not significant predictive factors in any of the sectors. No significant predictive factors were found for the differences in the choroidal thickness values observed between the superior and inferior field sectors. Conclusions: Neither the glaucoma-related visual field damage nor glaucoma itself have any apparent associations with the whole macular choroidal thickness.	[Nakakura, Shunsuke; Yamamoto, Minami; Terao, Etsuko; Nagasawa, Toshihiko; Tabuchi, Hitoshi] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	Hiroshima University	Nakakura, S (corresponding author), Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	shunsukenakakura@yahoo.co.jp						Aksoy Y, 2014, INVEST OPHTH VIS SCI, V55, P1311, DOI 10.1167/iovs.13-13820; Alm A., 1992, ADLERS PHYSL EYE, P198; Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P7813, DOI 10.1167/iovs.12-10483; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Hirooka K, 2012, CLIN EXP OPHTHALMOL, V40, P576, DOI 10.1111/j.1442-9071.2012.02762.x; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Kanamori A, 2013, INVEST OPHTH VIS SCI, V54, P6401, DOI 10.1167/iovs.13-12805; Kim DY, 2013, ACTA OPHTHALMOL, V91, P183, DOI 10.1111/j.1755-3768.2011.02305.x; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Manjunath V, 2011, OPHTHALMOLOGY, V118, P531, DOI 10.1016/j.ophtha.2010.07.013; Mansouri K, 2014, AM J OPHTHALMOL, V157, P1022, DOI 10.1016/j.ajo.2014.02.008; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Mwanza JC, 2012, INVEST OPHTH VIS SCI, V53, P6695, DOI 10.1167/iovs.12-10388; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P3430, DOI 10.1167/iovs.10-6600; Nagasawa T, 2013, INVEST OPHTH VIS SCI, V54, P7068, DOI 10.1167/iovs.13-12350; Nakazawa T, 2012, J GLAUCOMA, V21, P426, DOI 10.1097/IJG.0b013e3182182897; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Ohno-Matsui K, 2011, INVEST OPHTH VIS SCI, V52, P9644, DOI 10.1167/iovs.11-8597; Rhew JY, 2014, J GLAUCOMA, V23, P46, DOI 10.1097/IJG.0b013e31825af772; Roberts KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P980, DOI 10.1001/archophthalmol.2012.371; Sogawa K, 2012, AM J OPHTHALMOL, V153, P1129, DOI 10.1016/j.ajo.2011.11.005; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1037, DOI 10.1097/IAE.0b013e318242b9c0; Suh W, 2014, JPN J OPHTHALMOL, V58, P62, DOI 10.1007/s10384-013-0290-4; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Usui S, 2012, INVEST OPHTH VIS SCI, V53, P2300, DOI 10.1167/iovs.11-8383; Usui S, 2012, AM J OPHTHALMOL, V153, P10, DOI 10.1016/j.ajo.2011.05.037; Wong IY, 2013, RETINA-J RET VIT DIS, V33, P423, DOI 10.1097/IAE.0b013e3182753b5a	30	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110265	10.1371/journal.pone.0110265	http://dx.doi.org/10.1371/journal.pone.0110265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350379	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100024
J	Hedley, JD; McMahon, K; Fearns, P				Hedley, John D.; McMahon, Kathryn; Fearns, Peter			Seagrass Canopy Photosynthetic Response Is a Function of Canopy Density and Light Environment: A Model for Amphibolis griffithii	PLOS ONE			English	Article							RADIATIVE-TRANSFER MODEL; THALASSIA-TESTUDINUM; AQUATIC VEGETATION; OPTICAL-PROPERTIES; WATER-QUALITY; ECOSYSTEMS; THRESHOLDS; IRRADIANCE; GROWTH; FLOW	A three-dimensional computer model of canopies of the seagrass Amphibolis griffithii was used to investigate the consequences of variations in canopy structure and benthic light environment on leaf-level photosynthetic saturation state. The model was constructed using empirical data of plant morphometrics from a previously conducted shading experiment and validated well to in-situ data on light attenuation in canopies of different densities. Using published values of the leaf-level saturating irradiance for photosynthesis, results show that the interaction of canopy density and canopy-scale photosynthetic response is complex and non-linear, due to the combination of self-shading and the non-linearity of photosynthesis versus irradiance (P-I) curves near saturating irradiance. Therefore studies of light limitation in seagrasses should consider variation in canopy structure and density. Based on empirical work, we propose a number of possible measures for canopy scale photosynthetic response that can be plotted to yield isoclines in the space of canopy density and light environment. These plots can be used to interpret the significance of canopy changes induced as a response to decreases in the benthic light environment: in some cases canopy thinning can lead to an equivalent leaf level light environment, in others physiological changes may also be required but these alone may be inadequate for canopy survival. By providing insight to these processes the methods developed here could be a valuable management tool for seagrass conservation during dredging or other coastal developments.	[Hedley, John D.] Environm Comp Sci Ltd, Tiverton, Devon, England; [McMahon, Kathryn] Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia; [McMahon, Kathryn] Edith Cowan Univ, Ctr Marine Ecosyst Res, Joondalup, WA, Australia; [Fearns, Peter] Curtin Univ Technol, Dept Imaging & Appl Phys, Perth, WA, Australia	Edith Cowan University; Edith Cowan University; Curtin University	Hedley, JD (corresponding author), Environm Comp Sci Ltd, Tiverton, Devon, England.	j.d.hedley@envirocs.com	McMahon, Kathryn M/A-6619-2008	McMahon, Kathryn M/0000-0003-4355-6247	Edith Cowan University (ECU) Industry Collaboration Scheme; BMT Oceanica Pty. Ltd.; ECU Faculty Visiting Fellow Scheme; ECU Collaborative Research Network; Environmental Computer Science Ltd.	Edith Cowan University (ECU) Industry Collaboration Scheme; BMT Oceanica Pty. Ltd.; ECU Faculty Visiting Fellow Scheme; ECU Collaborative Research Network; Environmental Computer Science Ltd.	This research was funded by an Edith Cowan University (ECU) Industry Collaboration Scheme with BMT Oceanica Pty. Ltd., the industry partner, awarded to KM, JH, and PF. ECU Faculty Visiting Fellow Scheme supported JH for travel to ECU. KM was supported by the ECU Collaborative Research Network. Environmental Computer Science Ltd. provided support in the form of salary for author JH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Brun FG, 2003, FUNCT PLANT BIOL, V30, P551, DOI 10.1071/FP03010; Carruthers TJB, 1997, OECOLOGIA, V109, P335, DOI 10.1007/s004420050091; Cayabyab NM, 2007, NEW PHYTOL, V176, P108, DOI 10.1111/j.1469-8137.2007.02147.x; Collier CJ, 2012, ECOL INDIC, V23, P211, DOI 10.1016/j.ecolind.2012.04.005; Collier CJ, 2007, MAR ECOL PROG SER, V337, P103, DOI 10.3354/meps337103; Collier CJ, 2012, MAR POLLUT BULL, V65, P342, DOI 10.1016/j.marpolbul.2011.06.017; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; DENNISON WC, 1985, MAR ECOL PROG SER, V25, P51, DOI 10.3354/meps025051; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Duarte CM, 2007, ESTUAR COAST, V30, P652, DOI 10.1007/BF02841962; Durako MJ, 2007, AQUAT BOT, V87, P83, DOI 10.1016/j.aquabot.2007.03.005; Enriquez S, 2002, MAR BIOL, V140, P891, DOI 10.1007/s00227-001-0760-y; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; FOURQUREAN JW, 1991, MAR ECOL PROG SER, V69, P161, DOI 10.3354/meps069161; Gacia E, 2012, MAR ECOL PROG SER, V466, P69, DOI 10.3354/meps09928; Grant RH, 1996, AGR FOREST METEOROL, V82, P267, DOI 10.1016/0168-1923(95)02327-5; Grech A, 2011, MAR POLICY, V35, P560, DOI 10.1016/j.marpol.2011.03.003; Grech A, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024006; Hedley J, 2010, LIMNOL OCEANOGR, V55, P1537, DOI 10.4319/lo.2010.55.4.1537; Hedley J, 2008, OPT EXPRESS, V16, P21887, DOI 10.1364/OE.16.021887; Hedley JD, 2012, REMOTE SENS-BASEL, V4, P271, DOI 10.3390/rs4010271; House DH, 2000, CLOTH MODELLING ANIM; Kemp WM, 2004, ESTUARIES, V27, P363; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Koch EW, 1999, MAR ECOL PROG SER, V184, P63, DOI 10.3354/meps184063; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lavery PS, 2009, MAR ECOL PROG SER, V394, P21, DOI 10.3354/meps08242; Masini RJ, 1997, AQUAT BOT, V58, P21, DOI 10.1016/S0304-3770(97)00008-9; Mayer B, 2005, ATMOS CHEM PHYS, V5, P1855, DOI 10.5194/acp-5-1855-2005; McMahon K, 2014, J EXP MAR BIOL ECOL, V455, P38, DOI 10.1016/j.jembe.2014.02.015; McMahon K, 2013, ECOL INDIC, V30, P7, DOI 10.1016/j.ecolind.2013.01.030; Mobley C.D., 1994, LIGHT WATER; MOBLEY CD, 2000, HYDROLIGHT 4 1 USERS; O'Brien KR, 2011, 19TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2011), P4127; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pedersen TM, 2012, ESTUAR COAST SHELF S, V106, P93, DOI 10.1016/j.ecss.2012.04.027; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Short, 2004, WORLD ATLAS SEAGRASS; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zimmerman RC, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P303	40	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111454	10.1371/journal.pone.0111454	http://dx.doi.org/10.1371/journal.pone.0111454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347849	gold, Green Published, Green Submitted			2022-12-26	WOS:000347994900076
J	Gradoville, MR; White, AE; Letelier, RM				Gradoville, Mary R.; White, Angelicque E.; Letelier, Ricardo M.			Physiological Response of Crocosphaera watsonii to Enhanced and Fluctuating Carbon Dioxide Conditions	PLOS ONE			English	Article							NITROGEN-FIXATION; OCEAN ACIDIFICATION; N-2 FIXATION; CALCIUM-CARBONATE; ELEVATED CO2; GROWTH; TRICHODESMIUM; PCO(2); SEAWATER; ACID	We investigated the effects of elevated pCO(2) on cultures of the unicellular N-2-fixing cyanobacterium Crocosphaera watsonii WH8501. Using CO2-enriched air, cultures grown in batch mode under high light intensity were exposed to initial conditions approximating current atmospheric CO2 concentrations (similar to 400 ppm) as well as CO2 levels corresponding to low-and high-end predictions for the year 2100 (similar to 750 and 1000 ppm). Following acclimation to CO2 levels, the concentrations of particulate carbon (PC), particulate nitrogen (PN), and cells were measured over the diurnal cycle for a six-day period spanning exponential and early stationary growth phases. High rates of photosynthesis and respiration resulted in biologically induced pCO(2) fluctuations in all treatments. Despite this observed pCO(2) variability, and consistent with previous experiments conducted under stable pCO(2) conditions, we observed that elevated mean pCO(2) enhanced rates of PC production, PN production, and growth. During exponential growth phase, rates of PC and PN production increased by similar to 1.2-and similar to 1.5-fold in the mid-and high-CO2 treatments, respectively, when compared to the low-CO2 treatment. Elevated pCO(2) also enhanced PC and PN production rates during early stationary growth phase. In all treatments, PC and PN cellular content displayed a strong diurnal rhythm, with particulate C:N molar ratios reaching a high of 22:1 in the light and a low of 5.5:1 in the dark. The pCO(2) enhancement of metabolic rates persisted despite pCO(2) variability, suggesting a consistent positive response of Crocosphaera to elevated and fluctuating pCO(2) conditions.	[Gradoville, Mary R.; White, Angelicque E.; Letelier, Ricardo M.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Gradoville, MR (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	rgradoville@coas.oregonstate.edu	Letelier, Ricardo/A-6953-2009	Letelier, Ricardo/0000-0003-3376-4026; Gradoville, Mary/0000-0002-2468-000X; White, angelicque/0000-0002-0938-7948	National Science Foundation [OCE 08-50827]; Center for Microbial Oceanography: Research and Education (C-MORE); Alfred P. Sloan Foundation	National Science Foundation(National Science Foundation (NSF)); Center for Microbial Oceanography: Research and Education (C-MORE); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Support for this project was provided by the National Science Foundation (nsf.gov) grant OCE 08-50827 (to RML), the Center for Microbial Oceanography: Research and Education (C-MORE, to RML and AW), and the Alfred P. Sloan Foundation (to AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Bandstra L, 2006, MAR CHEM, V100, P24, DOI 10.1016/j.marchem.2005.10.009; Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363; Bottjer D, 2014, GLOBAL BIOGEOCHEM CY, V28, P601, DOI 10.1002/2013GB004690; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Dron A, 2012, AQUAT MICROB ECOL, V68, P43, DOI 10.3354/ame01600; Dron A, 2012, ENVIRON MICROBIOL, V14, P967, DOI 10.1111/j.1462-2920.2011.02675.x; Egleston ES, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003407; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Fu FX, 2014, AQUAT MICROB ECOL, V72, P33, DOI 10.3354/ame01683; Fu FX, 2008, LIMNOL OCEANOGR, V53, P2472, DOI 10.4319/lo.2008.53.6.2472; GALLON JR, 1992, NEW PHYTOL, V122, P571; Garcia NS, 2013, LIMNOL OCEANOGR, V58, P1501, DOI 10.4319/lo.2013.58.4.1501; Geider RJ, 2009, PLANT ECOL DIVERS, V2, P165, DOI 10.1080/17550870903300949; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Gradoville MR, 2014, LIMNOL OCEANOGR, V59, P645, DOI 10.4319/lo.2014.59.3.0645; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Hutchins DA, 2013, NAT GEOSCI, V6, P790, DOI [10.1038/NGEO1858, 10.1038/ngeo1858]; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Kranz SA, 2010, LIMNOL OCEANOGR, V55, P2563, DOI 10.4319/lo.2010.55.6.2563; Kranz SA, 2009, LIMNOL OCEANOGR, V54, P548, DOI 10.4319/lo.2009.54.2.0548; Law CS, 2012, GLOBAL CHANGE BIOL, V18, P3004, DOI 10.1111/j.1365-2486.2012.02777.x; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Lomas MW, 2012, AQUAT MICROB ECOL, V66, P211, DOI 10.3354/ame01576; Luo YW, 2012, EARTH SYST SCI DATA, V4, P47, DOI 10.5194/essd-4-47-2012; Mahadevan A, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002102; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Mohr W, 2010, ENVIRON MICROBIOL, V12, P412, DOI 10.1111/j.1462-2920.2009.02078.x; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Raven JA, 2012, PHILOS T R SOC B, V367, P493, DOI 10.1098/rstb.2011.0212; REDDY MM, 1977, J CRYST GROWTH, V41, P287, DOI 10.1016/0022-0248(77)90057-4; REDFIELD AC, 1958, AM SCI, V46, P205; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Robbins L.L., 2010, CO2CALC USER FRIENDL, DOI 10.3133/ofr20101280; Shi DL, 2012, P NATL ACAD SCI USA, V109, pE3094, DOI 10.1073/pnas.1216012109; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; *US EPA, 1983, 3501 US EPA; Wolf-Gladrow DA, 2007, MAR CHEM, V106, P287, DOI 10.1016/j.marchem.2007.01.006	46	10	10	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110660	10.1371/journal.pone.0110660	http://dx.doi.org/10.1371/journal.pone.0110660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343645	gold, Green Submitted, Green Published			2022-12-26	WOS:000343943500043
J	Aguer, C; McCoin, CS; Knotts, TA; Thrush, AB; Ono-Moore, K; McPherson, R; Dent, R; Hwang, DH; Adams, SH; Harper, ME				Aguer, Celine; McCoin, Colin S.; Knotts, Trina A.; Thrush, A. Brianne; Ono-Moore, Kikumi; McPherson, Ruth; Dent, Robert; Hwang, Daniel H.; Adams, Sean H.; Harper, Mary-Ellen			Acylcarnitines: potential implications for skeletal muscle insulin resistance	FASEB JOURNAL			English	Article						fatty acid beta-oxidation; mitochondria; inflammation; oxidative stress; myotubes	CARNITINE ACETYLTRANSFERASE; SUPEROXIDE-PRODUCTION; GLUCOSE-TOLERANCE; BETA-OXIDATION; FAT OXIDATION; INHIBITION; PALMITATE; HUMANS; CELLS; EXPRESSION	Insulin resistance may be linked to incomplete fatty acid beta-oxidation and the subsequent increase in acylcarnitine species in different tissues including skeletal muscle. It is not known if acylcarnitines participate in muscle insulin resistance or simply reflect dysregulated metabolism. The aims of this study were to determine whether acylcarnitines can elicit muscle insulin resistance and to better understand the link between incomplete muscle fatty acid beta-oxidation, oxidative stress, inflammation, and insulin-resistance development. Differentiated C2C12, primary mouse, and human myotubes were treated with acylcarnitines (C4: 0, C14: 0, C16: 0) or with palmitate with or without carnitine acyltransferase inhibition by mildronate. Treatment with C4: 0, C14: 0, and C16: 0 acylcarnitines resulted in 20-30% decrease in insulin response at the level of Akt phosphorylation and/or glucose uptake. Mildronate reversed palmitate-induced insulin resistance concomitant with an similar to 25% decrease in short-chain acylcarnitine and acetylcarnitine secretion. Although proinflammatory cytokines were not affected under these conditions, oxidative stress was increased by 2-3 times by short-or long-chain acylcarnitines. Acylcarnitine-induced oxidative stress and insulin resistance were reversed by treatment with antioxidants. Results are consistent with the conclusion that incomplete muscle fatty acid beta-oxidation causes acylcarnitine accumulation and associated oxidative stress, raising the possibility that these metabolites play a role in muscle insulin resistance.	[Aguer, Celine; Thrush, A. Brianne; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [McCoin, Colin S.; Adams, Sean H.] Univ Calif Davis, Mol Cellular & Integrat Physiol Grad Program, Davis, CA 95616 USA; [McCoin, Colin S.; Knotts, Trina A.; Ono-Moore, Kikumi; Adams, Sean H.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Knotts, Trina A.; Ono-Moore, Kikumi; Hwang, Daniel H.; Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [McPherson, Ruth] Univ Ottawa Heart Inst, Div Cardiol, Ottawa, ON, Canada; [Dent, Robert] Ottawa Hosp, Weight Management Clin, Ottawa, ON, Canada; [Hwang, Daniel H.] ARS, Immun & Dis Prevent Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA USA	University of Ottawa; University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute; United States Department of Agriculture (USDA)	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	seanharrisonadams@gmail.com; mharper@uottawa.ca	Aguer, Celine/U-7848-2019; ADAMS, SEAN/N-9262-2018	Aguer, Celine/0000-0001-8828-8472; Harper, Mary-Ellen/0000-0003-3864-5886; McCoin, Colin/0000-0002-8557-6441; ADAMS, SEAN/0000-0002-9515-2319	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER; CIHR [MOP57810] Funding Source: Medline; NIDDK NIH HHS [R01DK078328-02S1, R01 DK078328, R01DK078328-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CIHR(Canadian Institutes of Health Research (CIHR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, 2010, DIABETOLOGIA, V53, P1151, DOI 10.1007/s00125-010-1708-x; Aguer C, 2013, FASEB J, V27, P4213, DOI 10.1096/fj.13-234302; Aguer C, 2013, BBA-MOL BASIS DIS, V1832, P1624, DOI 10.1016/j.bbadis.2013.05.008; Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Baillet L, 2000, J BIOL CHEM, V275, P36766, DOI 10.1074/jbc.M008265200; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Costford SR, 2009, DIABETOLOGIA, V52, P2405, DOI 10.1007/s00125-009-1480-y; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Georges B, 2000, BIOCHEM PHARMACOL, V59, P1357, DOI 10.1016/S0006-2952(00)00265-3; Gillingham MB, 2013, AM J PHYSIOL-ENDOC M, V305, pE1299, DOI 10.1152/ajpendo.00225.2013; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Jaudzems K, 2009, J ENZYM INHIB MED CH, V24, P1269, DOI 10.3109/14756360902829527; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Keung W, 2013, DIABETES, V62, P711, DOI 10.2337/db12-0259; Knotts TA, 2009, PPAR RES, V2009, DOI 10.1155/2009/867678; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krogh-Madsen R, 2006, AM J PHYSIOL-ENDOC M, V291, pE108, DOI 10.1152/ajpendo.00471.2005; Lambertucci RH, 2008, J CELL PHYSIOL, V216, P796, DOI 10.1002/jcp.21463; Mailloux RJ, 2011, BIOCHEM J, V437, P301, DOI 10.1042/BJ20110571; Melegh B, 1999, J INHERIT METAB DIS, V22, P827, DOI 10.1023/A:1005562209034; Minkler P. E. S. M., 2012, 60 ASMS C MASS SPECT; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Nowotny B, 2013, DIABETES, V62, P2240, DOI 10.2337/db12-1179; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; POURFARZAM M, 1994, CLIN CHEM, V40, P2267; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Wolf M, 2013, J CLIN ENDOCR METAB, V98, pE1137, DOI 10.1210/jc.2012-3976; Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014	45	140	143	2	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					336	345		10.1096/fj.14-255901	http://dx.doi.org/10.1096/fj.14-255901			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25342132	Green Published			2022-12-26	WOS:000347378600031
J	Ho, AL; Mouminah, A; Du, R				Ho, Allen L.; Mouminah, Amr; Du, Rose			Posterior Cerebral Artery Angle and the Rupture of Basilar Tip Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; WALL SHEAR-STRESS; ASPECT RATIO; SURGICAL-TREATMENT; BOTTLENECK FACTOR; NATURAL-HISTORY; RISK-FACTORS; BLOOD-FLOW; SHAPE; GEOMETRY	Since the initial publication of the International Study of Unruptured Intracranial Aneurysms (ISUIA), management of unruptured intracranial aneurysms has been mainly based on the size of the aneurysm. The contribution of morphological characteristics to treatment decisions of unruptured aneurysms has not been well studied in a systematic and location specific manner. We present a large sample of basilar artery tip aneurysms (BTA) that were assessed using a diverse array of morphological variables to determine the parameters associated with ruptured aneurysms. Demographic and clinical risk factors of aneurysm rupture were obtained from chart review. CT angiograms (CTA) were evaluated with Slicer, an open source visualization and image analysis software, to generate 3-D models of the aneurysms and surrounding vascular architecture. Morphological parameters examined in each model included aneurysm volume, aspect ratio, size ratio, aneurysm angle, basilar vessel angle, basilar flow angle, and vessel to vessel angles. Univariate and multivariate analyses were performed to determine statistical significance. From 2008-2013, 54 patients with BTA aneurysms were evaluated in a single institution, and CTAs from 33 patients (15 ruptured, 18 unruptured) were available and analyzed. Aneurysms that underwent reoperation, that were associated with arteriovenous malformations, or that lacked preoperative CTA were excluded. Multivariate logistic regression revealed that a larger angle between the posterior cerebral arteries (P1-P1 angle, p = 0.037) was most strongly associated with aneurysm rupture after adjusting for other morphological variables. In this location specific study of BTA aneurysms, the larger the angle formed between posterior cerebral arteries was found to be a new morphological parameter significantly associated with ruptured BTA aneurysms. This is a physically intuitive parameter that can be measured easily and readily applied in the clinical setting.	[Ho, Allen L.; Mouminah, Amr; Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Ho, Allen L.; Du, Rose] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Du, R (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Du, Rose/AAJ-2873-2020; Du, Rose/I-5402-2012	Du, Rose/0000-0003-2641-6496	American Heart Association Scholarship in Cerebrovascular Disease and Stroke	American Heart Association Scholarship in Cerebrovascular Disease and Stroke(American Heart Association)	This work was supported by the American Heart Association Scholarship in Cerebrovascular Disease and Stroke (http://my.americanheart.org) (ALH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjmandi-Tash O, 2012, BIOIMPACTS, V2, P195, DOI 10.5681/bi.2012.023; Backes D, 2014, DIFFERENCE ANEURYSM; Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770; Barakat AI, 1998, CHEST, V114, p58S, DOI 10.1378/chest.114.1_Supplement.58S; Beck J, 2003, ACTA NEUROCHIR, V145, P861, DOI 10.1007/s00701-003-0124-0; de Rooij NK, 2009, J NEUROL, V256, P45, DOI 10.1007/s00415-009-0028-x; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Drake CG, 1996, SURG VERTEBROBASILAR; Ecker Robert D, 2004, Neurosurg Focus, V17, pE4; Ford MD, 2008, J BIOMECH, V41, P241, DOI 10.1016/j.jbiomech.2007.09.032; Gabriel RA, 2010, STROKE, V41, P21, DOI 10.1161/STROKEAHA.109.566018; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Ho A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094837; Hoh BL, 2007, NEUROSURGERY, V61, P716, DOI 10.1227/01.NEU.0000298899.77097.BF; Huang MC, 2011, STROKE, V42, P1730, DOI 10.1161/STROKEAHA.110.603803; Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674; Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838; Kaiser D, 1997, BIOCHEM BIOPH RES CO, V231, P586, DOI 10.1006/bbrc.1997.6146; Komotar RJ, 2008, NEUROSURGERY, V62, P183, DOI 10.1227/01.NEU.0000311076.64109.2E; Laaksamo E, 2012, NEUROSURGERY, V70, P1565, DOI 10.1227/NEU.0b013e31824c057e; Lauric A, 2012, NEUROSURGERY, V71, P38, DOI 10.1227/NEU.0b013e3182503bf9; Lin N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079635; Lin N, 2012, J NEUROSURG, V117, P913, DOI 10.3171/2012.7.JNS111766; Ma BS, 2004, ANN BIOMED ENG, V32, P264, DOI 10.1023/B:ABME.0000012746.31343.92; Ma D, 2010, NEUROL RES, V32, P482, DOI 10.1179/016164109X12581096796558; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Matsukawa H, 2012, J NEUROSURG; Matsukawa H, 2014, J NEUROSURG, V120, P104, DOI 10.3171/2013.9.JNS13921; Meng H, 2007, STROKE, V38, P1924, DOI 10.1161/STROKEAHA.106.481234; Mocco J, 2004, Neurosurg Focus, V17, pE3; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Nader-Sepahi A, 2004, NEUROSURGERY, V54, P1343, DOI 10.1227/01.NEU.0000124482.03676.8B; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Nguyen KT, 2008, J BIOMECH, V41, P11, DOI 10.1016/j.jbiomech.2007.08.012; Parlea L, 1999, AM J NEURORADIOL, V20, P1079; PERKTOLD K, 1991, J BIOMED ENG, V13, P507, DOI 10.1016/0141-5425(91)90100-L; Piccinelli M, 2012, ANN BIOMED ENG, V40, P2188, DOI 10.1007/s10439-012-0577-5; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Pieper S, 2006, I S BIOMED IMAGING, P698; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Ryu CW, 2011, NEURORADIOLOGY, V53, P883, DOI 10.1007/s00234-010-0804-4; Sadatomo T, 2008, NEUROSURGERY, V62, P602, DOI 10.1227/01.NEU.0000311347.35583.0C; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wells DR, 1996, J VASC SURG, V23, P667, DOI 10.1016/S0741-5214(96)80048-6; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401	51	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110946	10.1371/journal.pone.0110946	http://dx.doi.org/10.1371/journal.pone.0110946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353989	Green Submitted, Green Published, gold			2022-12-26	WOS:000345204200047
J	Schrimpf, R; Dierks, C; Martinsson, G; Sieme, H; Distl, O				Schrimpf, Rahel; Dierks, Claudia; Martinsson, Gunilla; Sieme, Harald; Distl, Ottmar			Genome-Wide Association Study Identifies Phospholipase C zeta 1 (PLCz1) as a Stallion Fertility Locus in Hanoverian Warmblood Horses	PLOS ONE			English	Article							TRIGGERS CA2+ OSCILLATIONS; CHILDHOOD ABSENCE EPILEPSY; EXONIC SPLICING ENHANCER; MESSENGER-RNA DECAY; C-ZETA; CANDIDATE GENES; EGG ACTIVATION; NUCLEAR TRANSLOCATION; OOCYTE ACTIVATION; MOLECULAR-CLONING	A consistently high level of stallion fertility plays an economically important role in modern horse breeding. We performed a genome-wide association study for estimated breeding values of the paternal component of the pregnancy rate per estrus cycle (EBV-PAT) in Hanoverian stallions. A total of 228 Hanoverian stallions were genotyped using the Equine SNP50 Beadchip. The most significant association was found on horse chromosome 6 for a single nucleotide polymorphism (SNP) within phospholipase C zeta 1 (PLCz1). In the close neighbourhood to PLCz1 is located CAPZA3 (capping protein (actin filament) muscle Z-line, alpha 3). The gene PLCz1 encodes a protein essential for spermatogenesis and oocyte activation through sperm induced Ca2+-oscillation during fertilization. We derived equine gene models for PLCz1 and CAPZA3 based on cDNA and genomic DNA sequences. The equine PLCz1 had four different transcripts of which two contained a premature termination codon. Sequencing all exons and their flanking sequences using genomic DNA samples from 19 Hanoverian stallions revealed 47 polymorphisms within PLCz1 and one SNP within CAPZA3. Validation of these 48 polymorphisms in 237 Hanoverian stallions identified three intronic SNPs within PLCz1 as significantly associated with EBV-PAT. Bioinformatic analysis suggested regulatory effects for these SNPs via transcription factor binding sites or microRNAs. In conclusion, non-coding polymorphisms within PLCz1 were identified as conferring stallion fertility and PLCz1 as candidate locus for male fertility in Hanoverian warmblood. CAPZA3 could be eliminated as candidate gene for fertility in Hanoverian stallions.	[Schrimpf, Rahel; Dierks, Claudia; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Martinsson, Gunilla] State Stud Celle Lower Saxony, Celle, Germany; [Sieme, Harald] Univ Vet Med Hannover, Reprod Med Unit, Clin Horses, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de		Dierks, Claudia/0000-0003-1299-6063	Mehl-Mulhens Stiftung, Koln [DI-MM/1-1]	Mehl-Mulhens Stiftung, Koln	This study was supported by the Mehl-Mulhens Stiftung, Koln (DI-MM/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Halima M, 2014, FERTIL STERIL, V101, P78, DOI 10.1016/j.fertnstert.2013.09.009; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arraiano Cecilia Maria, 2003, Molecular Microbiology, V49, P267, DOI 10.1046/j.1365-2958.2003.03545.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bedford-Guaus SJ, 2011, BIOL REPROD, V85, P78, DOI 10.1095/biolreprod.110.089466; Bedford-Guaus SJ, 2012, J EQUINE VET SCI, V32, P445, DOI 10.1016/j.jevs.2012.06.002; Blazquez L, 2013, HUM MUTAT, V34, P1387, DOI 10.1002/humu.22379; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chen X, 2014, CURR DRUG TARGETS, V15, P361, DOI 10.2174/1389450115666140120102935; Coward K, 2005, REPRODUCTION, V130, P157, DOI 10.1530/rep.1.00707; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Ferlin A, 2004, FERTIL STERIL, V81, P1013, DOI 10.1016/j.fertnstert.2003.08.053; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Geyer CB, 2009, DEV BIOL, V330, P142, DOI 10.1016/j.ydbio.2009.03.020; Giesecke K, 2011, ANIM REPROD SCI, V126, P200, DOI 10.1016/j.anireprosci.2011.05.007; Giesecke K, 2010, REPROD DOMEST ANIM, V45, pE124, DOI 10.1111/j.1439-0531.2009.01533.x; Giesecke K, 2010, REPROD DOMEST ANIM, V45, P342, DOI 10.1111/j.1439-0531.2008.01325.x; Giesecke K, 2009, ANIM GENET, V40, P359, DOI 10.1111/j.1365-2052.2008.01844.x; Gould PS, 2014, RNA, V20, P373, DOI 10.1261/rna.041574.113; Gradil C, 2006, ANIM REPROD SCI, V94, P23, DOI 10.1016/j.anireprosci.2006.03.095; Guido C, 2011, J CELL PHYSIOL, V226, P3403, DOI 10.1002/jcp.22703; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hamann H, 2007, ANIM GENET, V38, P259, DOI 10.1111/j.1365-2052.2007.01594.x; Hamann H, 2005, ANIM REPROD SCI, V89, P201; Harti M, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00051; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Heytens E, 2009, HUM REPROD, V24, P2417, DOI 10.1093/humrep/dep207; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Homolova K, 2010, HUM MUTAT, V31, P437, DOI 10.1002/humu.21206; Hossain MM, 2012, CELL TISSUE RES, V349, P679, DOI 10.1007/s00441-012-1469-6; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ito M, 2008, BIOL REPROD, V78, P1081, DOI 10.1095/biolreprod.108.067801; Johnson AD, 2005, PHARMACOL THERAPEUT, V106, P19, DOI 10.1016/j.pharmthera.2004.11.001; Kaewmala K, 2012, REPROD DOMEST ANIM, V47, P213, DOI 10.1111/j.1439-0531.2011.01831.x; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kashir J, 2012, FERTIL STERIL, V98, P423, DOI 10.1016/j.fertnstert.2012.05.002; Kashir J, 2012, HUM REPROD, V27, P222, DOI 10.1093/humrep/der384; Kashir J, 2011, HUM REPROD, V26, P3372, DOI 10.1093/humrep/der336; Kasimanickam V, 2012, THERIOGENOLOGY, V78, P2007, DOI 10.1016/j.theriogenology.2012.07.016; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Kosova G, 2012, AM J HUM GENET, V90, P950, DOI 10.1016/j.ajhg.2012.04.016; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuroda K, 2006, J BIOL CHEM, V281, P27794, DOI 10.1074/jbc.M603473200; Kurokawa M, 2004, BIOL CELL, V96, P37, DOI 10.1016/j.biolcel.2003.11.003; L'Hote D, 2007, GENETICS, V176, P1907, DOI 10.1534/genetics.107.072157; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Layman LC, 2003, ENDOCRIN METAB CLIN, V32, P549, DOI 10.1016/S0889-8529(03)00040-9; Layman LC, 2002, J MED GENET, V39, P153, DOI 10.1136/jmg.39.3.153; Lee Chung-Tien, 2006, Birth Defects Research, V78, P129, DOI 10.1002/bdrc.20072; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26818; Miyagawa Y, 2002, MOL HUM REPROD, V8, P531, DOI 10.1093/molehr/8.6.531; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Nomikos M, 2013, FERTIL STERIL, V99, P76, DOI 10.1016/j.fertnstert.2012.08.035; Nomikos M, 2012, BIOESSAYS, V34, P126, DOI 10.1002/bies.201100127; Nomikos M, 2011, BIOCHEM J, V434, P211, DOI 10.1042/BJ20101772; Pan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058795; Penagaricano F, 2012, ANIM GENET, V43, P65, DOI 10.1111/j.1365-2052.2012.02350.x; Pentikainen V, 2000, J CLIN ENDOCR METAB, V85, P2057, DOI 10.1210/jc.85.5.2057; Peterlin B, 2006, MOL HUM REPROD, V12, P777, DOI 10.1093/molehr/gal088; Quadros L, 2008, HAEMOPHILIA, V14, P628, DOI 10.1111/j.1365-2516.2008.01704.x; Raudsepp T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003139; Russo A, 2010, BBA-GENE REGUL MECH, V1799, P419, DOI 10.1016/j.bbagrm.2010.01.008; Sato K, 2013, ANIM SCI J, V84, P359, DOI 10.1111/asj.12044; Saunders CM, 2007, BIOCHEM SOC SYMP, V74, P23, DOI 10.1042/BSS2007c03; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Sieme H, 2012, J EQUINE VET SCI, V32, P467, DOI 10.1016/j.jevs.2012.06.016; Skok DJ, 2013, ANIM GENET, V44, P669, DOI 10.1111/age.12072; Swann K, 2006, SEMIN CELL DEV BIOL, V17, P264, DOI 10.1016/j.semcdb.2006.03.009; Swann K, 2013, CELL CALCIUM, V53, P55, DOI 10.1016/j.ceca.2012.11.001; Tian MN, 2012, J NEUROSCI, V32, P5937, DOI 10.1523/JNEUROSCI.5332-11.2012; Truong BN, 2003, ASIAN J ANDROL, V5, P137; Vickers KC, 2014, CLIN SCI, V126, P183, DOI 10.1042/CS20130203; Walenkamp MJE, 2013, HORM RES PAEDIAT, V80, P406, DOI 10.1159/000355928; Wang JCW, 2000, J BIOL CHEM, V275, P18418, DOI 10.1074/jbc.M910211199; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Yoneda A, 2006, REPRODUCTION, V132, P393, DOI 10.1530/rep.1.01018; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	88	18	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109675	10.1371/journal.pone.0109675	http://dx.doi.org/10.1371/journal.pone.0109675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354211	gold, Green Submitted, Green Published			2022-12-26	WOS:000345204200013
J	Yan, S; Zhu, JL; Zhu, WL; Zhang, XF; Li, Z; Liu, XX; Zhang, QW				Yan, Shuo; Zhu, Jialin; Zhu, Weilong; Zhang, Xinfang; Li, Zhen; Liu, Xiaoxia; Zhang, Qingwen			The Expression of Three Opsin Genes from the Compound Eye of Helicoverpa armigera (Lepidoptera: Noctuidae) Is Regulated by a Circadian Clock, Light Conditions and Nutritional Status	PLOS ONE			English	Article							MESSENGER-RNA; COLOR-VISION; MOLECULAR-CLONING; VISUAL PIGMENTS; SENSITIVE PHOTORECEPTORS; CYSTEINE RESIDUE-110; MANDUCA-SEXTA; PROTEIN; RETINA; PHEROMONE	Visual genes may become inactive in species that inhabit poor light environments, and the function and regulation of opsin components in nocturnal moths are interesting topics. In this study, we cloned the ultraviolet (UV), blue (BL) and long-wavelength-sensitive (LW) opsin genes from the compound eye of the cotton bollworm and then measured their mRNA levels using quantitative real-time PCR. The mRNA levels fluctuated over a daily cycle, which might be an adaptation of a nocturnal lifestyle, and were dependent on a circadian clock. Cycling of opsin mRNA levels was disturbed by constant light or constant darkness, and the UV opsin gene was up-regulated after light exposure. Furthermore, the opsin genes tended to be down-regulated upon starvation. Thus, this study illustrates that opsin gene expression is determined by multiple endogenous and exogenous factors and is adapted to the need for nocturnal vision, suggesting that color vision may play an important role in the sensory ecology of nocturnal moths.	[Yan, Shuo; Zhu, Weilong; Zhang, Xinfang; Li, Zhen; Liu, Xiaoxia; Zhang, Qingwen] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Zhu, Jialin] Beijing Entry Exit Inspect & Quarantine Bur, Beijing, Peoples R China	China Agricultural University	Liu, XX (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	liuxiaoxia611@cau.edu.cn; zhangqingwen@263.net			Natural Science Foundation of China [31371943]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by Natural Science Foundation of China (31371943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa K, 2005, J NEUROSCI, V25, P5935, DOI 10.1523/JNEUROSCI.1364-05.2005; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Battelle BA, 2013, INTEGR COMP BIOL, V53, P144, DOI 10.1093/icb/ict020; Battelle BA, 2000, VISUAL NEUROSCI, V17, P217, DOI 10.1017/S0952523800172049; Battelle BA, 2013, J EXP BIOL, V216, P1837, DOI 10.1242/jeb.083519; Bentrop J, 1997, EMBO J, V16, P1600, DOI 10.1093/emboj/16.7.1600; Bobu C, 2013, MOL VIS, V19, P1060; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2008, J EXP BIOL, V211, P1805, DOI 10.1242/jeb.013045; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chase MR, 1997, J EXP BIOL, V200, P2469; Choi MY, 1998, J INSECT PHYSIOL, V44, P653, DOI 10.1016/S0022-1910(98)00029-8; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CRAFT CM, 1990, J NEUROCHEM, V55, P1461, DOI 10.1111/j.1471-4159.1990.tb04927.x; CUTLER DE, 1995, J EXP BIOL, V198, P1909; Egan ES, 1999, J NEUROSCI, V19, P3665; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Eriksson BJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-186; Everett A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-232; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Frentiu FD, 2007, P NATL ACAD SCI USA, V104, P8634, DOI 10.1073/pnas.0701447104; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; GORDON WC, 1977, Z NATURFORSCH C, V32, P662; Hill GE, 2004, ANIM BEHAV, V67, P27, DOI 10.1016/j.anbehav.2003.02.002; Hillier NK, 2011, J CHEM ECOL, V37, P1127, DOI 10.1007/s10886-011-0017-2; Hillier NK, 2004, CHEM SENSES, V29, P499, DOI 10.1093/chemse/bjh052; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Ikeno T, 2008, GENE, V419, P56, DOI 10.1016/j.gene.2008.05.002; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kihara J, 2009, FEMS MICROBIOL LETT, V295, P289, DOI 10.1111/j.1574-6968.2009.01609.x; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kitamoto J, 1998, J EXP BIOL, V201, P1255; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; Langham GM, 2004, EVOLUTION, V58, P2783; Laver CRJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-81; Leboulle G, 2013, INSECT BIOCHEM MOLEC, V43, P959, DOI 10.1016/j.ibmb.2013.07.006; Lecomte C, 1998, J CHEM ECOL, V24, P655, DOI 10.1023/A:1022390102631; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda T, 2003, ZOOL SCI, V20, P989, DOI 10.2108/zsj.20.989; Merlin C, 2007, J BIOL RHYTHM, V22, P502, DOI 10.1177/0748730407307737; Nagy AD, 2007, GEN COMP ENDOCR, V152, P144, DOI 10.1016/j.ygcen.2007.01.019; Nowinszky L, 2011, INDIAN J AGR SCI, V81, P154; Ogawa Y, 2013, J EXP BIOL, V216, P1916, DOI 10.1242/jeb.083485; Ogawa Y, 2012, J COMP PHYSIOL A, V198, P857, DOI 10.1007/s00359-012-0756-8; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Sasagawa H, 2003, EUR J NEUROSCI, V17, P963, DOI 10.1046/j.1460-9568.2003.02528.x; Seki T, 1998, COMP BIOCHEM PHYS B, V119, P53, DOI 10.1016/S0305-0491(97)00322-2; SILVER R, 1988, CELL TISSUE RES, V253, P189; Takeuchi Y, 2011, COMP BIOCHEM PHYS A, V160, P486, DOI 10.1016/j.cbpa.2011.08.007; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053907; WANG JK, 1980, BIOCHEMISTRY-US, V19, P5111, DOI 10.1021/bi00563a027; Wei Guoshu, 1999, Acta Biophysica Sinica, V15, P682; White RH, 2003, J EXP BIOL, V206, P3337, DOI 10.1242/jeb.00571; Wu Kunjun, 1997, Entomologia Sinica, V4, P277; Xu PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078140; Yan Shuo, 2012, Acta Entomologica Sinica, V55, P1337; [闫硕 Yan Shuo], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1808; Yan S, 2013, J ECON ENTOMOL, V106, P708, DOI 10.1603/EC12402; Yan S, 2013, J ECON ENTOMOL, V106, P450, DOI 10.1603/EC12290; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	68	32	44	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111683	10.1371/journal.pone.0111683	http://dx.doi.org/10.1371/journal.pone.0111683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353953	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200091
J	Arendt, LM; Laurent, JS; Wronski, A; Caballero, S; Lyle, SR; Naber, SP; Kuperwasser, C				Arendt, Lisa M.; Laurent, Jessica St.; Wronski, Ania; Caballero, Silvia; Lyle, Stephen R.; Naber, Stephen P.; Kuperwasser, Charlotte			Human Breast Progenitor Cell Numbers Are Regulated by WNT and TBX3	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; ESTROGEN-RECEPTOR-ALPHA; STEM-CELLS; CANCER-CELLS; PROGESTERONE-RECEPTOR; MENSTRUAL-CYCLE; MOUSE MODEL; PROLIFERATION; GENE; EXPRESSION	Background: Although human breast development is mediated by hormonal and non-hormonal means, the mechanisms that regulate breast progenitor cell activity remain to be clarified. This limited understanding of breast progenitor cells has been due in part to the lack of appropriate model systems to detect and characterize their properties. Methods: To examine the effects of WNT signaling and TBX3 expression on progenitor activity in the breast, primary human mammary epithelial cells (MEC) were isolated from reduction mammoplasty tissues and transduced with lentivirus to overexpress WNT1 or TBX3 or reduce expression of their cognate receptors using shRNA. Changes in progenitor activity were quantified using characterized assays. We identified WNT family members expressed by cell populations within the epithelium and assessed alterations in expression of WNT family ligands by MECs in response to TBX3 overexpression and treatment with estrogen and progesterone. Results: Growth of MECs on collagen gels resulted in the formation of distinct luminal acinar and basal ductal colonies. Overexpression of TBX3 in MECs resulted in increased ductal colonies, while shTBX3 expression diminished both colony types. Increased WNT1 expression led to enhanced acinar colony formation, shLRP6 decreased both types of colonies. Estrogen stimulated the formation of acinar colonies in control MEC, but not shLRP6 MEC. Formation of ductal colonies was enhanced in response to progesterone. However, while shLRP6 decreased MEC responsiveness to progesterone, shTBX3 expression did not alter this response. Conclusions: We identified two phenotypically distinguishable lineage-committed progenitor cells that contribute to different structural elements and are regulated via hormonal and non-hormonal mechanisms. WNT signaling regulates both types of progenitor activity. Progesterone favors the expansion of ductal progenitor cells, while estrogen stimulates the expansion of acinar progenitor cells. Paracrine WNT signaling is stimulated by estrogen and progesterone, while autocrine WNT signaling is induced by the embryonic T-box transcription factor TBX3.	[Arendt, Lisa M.; Laurent, Jessica St.; Wronski, Ania; Caballero, Silvia; Kuperwasser, Charlotte] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dev Mol & Chem Biol Dept, Boston, MA 02111 USA; [Arendt, Lisa M.; Laurent, Jessica St.; Wronski, Ania; Caballero, Silvia; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Lyle, Stephen R.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Naber, Stephen P.] Tufts Med Ctr, Dept Pathol, Boston, MA USA	Tufts University; Tufts Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Tufts Medical Center	Kuperwasser, C (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dev Mol & Chem Biol Dept, Boston, MA 02111 USA.	Charlotte.Kuperwasser@tufts.edu		Arendt, Lisa/0000-0002-7954-3635	Breast Cancer Research Foundation; NIH/NICHD [HD073035]; NIH/NCI [CA125554, CA170851]; NCRR [K01-RR021858]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA125554, R01CA170851] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR021858] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the Breast Cancer Research Foundation (C. K.), the NIH/NICHD HD073035 (C. K.), the NIH/NCI CA125554 and CA170851 (C. K.), and the NCRR K01-RR021858 (L. M. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Brisken C, 2000, GENE DEV, V14, P650; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Clarke RB, 1997, CANCER RES, V57, P4987; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Diaz J, 2012, J ENDOCRINOL, V214, P165, DOI 10.1530/JOE-11-0310; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Douglas NC, 2013, J MAMMARY GLAND BIOL, V18, P143, DOI 10.1007/s10911-013-9282-8; Eblaghie MC, 2004, J ANAT, V205, P1, DOI 10.1111/j.0021-8782.2004.00309.x; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Hilton HN, 2012, MOL CELL ENDOCRINOL, V361, P191, DOI 10.1016/j.mce.2012.04.010; Hilton HN, 2014, BREAST CANCER RES TR, V143, P423, DOI 10.1007/s10549-013-2817-2; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; HUSEBY RA, 1984, CANCER RES, V44, P2654; Iyer V, 2012, CANCER RES, V72, P2705, DOI 10.1158/0008-5472.CAN-11-3287; Jarde T, 2011, ACTA PHYSL OXF, V204, P118; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; KATZENELLENBOGEN BS, 1987, CANCER RES, V47, P4355; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kenney NJ, 2003, BREAST CANCER RES TR, V79, P161, DOI 10.1023/A:1023938510508; King M, 2006, AM J MED GENET A, V140A, P1407, DOI 10.1002/ajmg.a.31250; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu J, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-65; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; MISHELL DR, 1971, AM J OBSTET GYNECOL, V111, P60, DOI 10.1016/0002-9378(71)90927-6; NARDULLI AM, 1988, ENDOCRINOLOGY, V122, P1532, DOI 10.1210/endo-122-4-1532; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Raafat AM, 2001, J CELL PHYSIOL, V187, P81, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1056>3.0.CO;2-0; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004; Rowley M, 2004, J MAMMARY GLAND BIOL, V9, P109, DOI 10.1023/B:JOMG.0000037156.64331.3f; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; SCHATZ RW, 1985, J CELL PHYSIOL, V124, P386, DOI 10.1002/jcp.1041240305; SOULE HD, 1990, CANCER RES, V50, P6075; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Tanos T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005654; Uehara J, 1998, INT J GYNECOL OBSTET, V62, P77, DOI 10.1016/S0020-7292(98)00050-2; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	61	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111442	10.1371/journal.pone.0111442	http://dx.doi.org/10.1371/journal.pone.0111442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350852	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100074
J	Bernardo, SM; Allen, CP; Waller, A; Young, SM; Oprea, T; Sklar, LA; Lee, SA				Bernardo, Stella M.; Allen, Christopher P.; Waller, Anna; Young, Susan M.; Oprea, Tudor; Sklar, Larry A.; Lee, Samuel A.			An Automated High-Throughput Cell-Based Multiplexed Flow Cytometry Assay to Identify Novel Compounds to Target Candida albicans Virulence-Related Proteins	PLOS ONE			English	Article							REDUCED SUSCEPTIBILITY; OPPORTUNISTIC YEAST; ANTIFUNGAL AGENTS; ABC TRANSPORTER; RESISTANCE; ECHINOCANDIN; MECHANISMS; INFECTIONS; TRENDS; CONTRIBUTES	Although three major classes of systemic antifungal agents are clinically available, each is characterized by important limitations. Thus, there has been considerable ongoing effort to develop novel and repurposed agents for the therapy of invasive fungal infections. In an effort to address these needs, we developed a novel high-throughput, multiplexed screening method that utilizes small molecules to probe candidate drug targets in the opportunistic fungal pathogen Candida albicans. This method is amenable to high-throughput automated screening and is based upon detection of changes in GFP levels of individually tagged target proteins. We first selected four GFP-tagged membrane-bound proteins associated with virulence or antifungal drug resistance in C. albicans. We demonstrated proof-of-principle that modulation of fluorescence intensity can be used to assay the expression of specific GFP-tagged target proteins to inhibitors (and inducers), and this change is measurable within the HyperCyt automated flow cytometry sampling system. Next, we generated a multiplex of differentially color-coded C. albicans strains bearing C-terminal GFP-tags of each gene encoding candidate drug targets incubated in the presence of small molecules from the Prestwick Chemical Library in 384-well microtiter plate format. Following incubation, cells were sampled through the HyperCyt system and modulation of protein levels, as indicated by changes in GFP-levels of each strain, was used to identify compounds of interest. The hit rate for both inducers and inhibitors identified in the primary screen did not exceed 1% of the total number of compounds in the small-molecule library that was probed, as would be expected from a robust target-specific, high-throughput screening campaign. Secondary assays for virulence characteristics based on null mutant strains were then used to further validate specificity. In all, this study presents a method for the identification and verification of new antifungal drugs targeted to fungal virulence proteins using C. albicans as a model fungal pathogen.	[Bernardo, Stella M.; Lee, Samuel A.] New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA; [Bernardo, Stella M.; Lee, Samuel A.] Univ New Mexico Hlth Sci Ctr, Div Infect Dis, Albuquerque, NM USA; [Allen, Christopher P.; Waller, Anna; Young, Susan M.; Oprea, Tudor; Sklar, Larry A.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico	Lee, SA (corresponding author), New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA.	SamALee@salud.unm.edu	cao, miao/ABT-0929-2022; Oprea, Tudor/A-5746-2011	Allen, Christopher/0000-0003-3808-5209; Waller, Anna/0000-0003-3676-2501; Oprea, Tudor/0000-0002-6195-6976	Department of Veterans' Affairs [5I01BX001130]; Biomedical Research Institute of New Mexico; National Institutes of Health [1U54MH084690-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	Department of Veterans' Affairs(US Department of Veterans Affairs); Biomedical Research Institute of New Mexico; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by funding from the Department of Veterans' Affairs (Merit Award 5I01BX001130), Biomedical Research Institute of New Mexico (SAL), and the National Institutes of Health (1U54MH084690-01) (LAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Alvarez FJ, 2008, MOL BIOL CELL, V19, P5214, DOI 10.1091/mbc.E08-05-0479; BANERJEE SN, 1991, AM J MED, V91, pS86, DOI 10.1016/0002-9343(91)90349-3; Bernardo SM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-133; Beyda ND, 2012, ANN PHARMACOTHER, V46, P1086, DOI 10.1345/aph.1R020; Black CB, 2011, ASSAY DRUG DEV TECHN, V9, P13, DOI 10.1089/adt.2010.0308; Chavez-Dozal AA, 2014, INT J ANTIMICROB AG, V43, P86, DOI 10.1016/j.ijantimicag.2013.08.018; Chen J, 2012, ACS CHEM BIOL, V7, P715, DOI 10.1021/cb200452r; Cheng G, 2006, EUKARYOT CELL, V5, P180, DOI 10.1128/EC.5.1.180-191.2006; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Douglas LM, 2012, MBIO, V3, DOI 10.1128/mBio.00254-11; Eder J, 2007, CURR PHARM DESIGN, V13, P271, DOI 10.2174/138161207779313560; Edwards BS, 2007, EXPERT OPIN DRUG DIS, V2, P685, DOI 10.1517/17460441.2.5.685; EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428, DOI 10.1128/CMR.6.4.428-442.1993; Fanos V, 2000, J CHEMOTHERAPY, V12, P463, DOI 10.1179/joc.2000.12.6.463; Fothergill AW, 2014, J CLIN MICROBIOL, V52, P994, DOI 10.1128/JCM.03044-13; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Holmes AR, 2008, ANTIMICROB AGENTS CH, V52, P3851, DOI 10.1128/AAC.00463-08; JARVIS WR, 1995, CLIN INFECT DIS, V20, P1526, DOI 10.1093/clinids/20.6.1526; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Karnani N, 2004, YEAST, V21, P219, DOI 10.1002/yea.1067; Knight SAB, 2005, INFECT IMMUN, V73, P5482, DOI 10.1128/IAI.73.9.5482-5492.2005; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Kuckuck FW, 2001, CYTOMETRY, V44, P83, DOI 10.1002/1097-0320(20010501)44:1<83::AID-CYTO1085>3.3.CO;2-F; Lee SA, 2005, MED MYCOL, V43, P423, DOI 10.1080/13693780400013340; Liang Y, 2009, FEMS YEAST RES, V9, P270, DOI 10.1111/j.1567-1364.2008.00468.x; Mateus C, 2004, ANTIMICROB AGENTS CH, V48, P3358, DOI 10.1128/AAC.48.9.3358-3366.2004; Miceli MH, 2011, MYCOSES, V54, pE666, DOI 10.1111/j.1439-0507.2011.02032.x; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Orasch C, 2013, CLIN MICROBIOL INFEC; Park S, 2005, ANTIMICROB AGENTS CH, V49, P3264, DOI 10.1128/AAC.49.8.3264-3273.2005; Pfaller MA, 2013, J CLIN MICROBIOL, V51, P2571, DOI 10.1128/JCM.00308-13; Pierce CG, 2013, EXPERT OPIN DRUG DIS, V8, P1117, DOI 10.1517/17460441.2013.807245; Ramage G, 2005, METH MOLEC MED, V118, P71; Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI 10.1093/jac/dkf049; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Robinson JP, 2012, EXPERT OPIN DRUG DIS, V7, P679, DOI 10.1517/17460441.2012.693475; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Saville SP, 2006, ANTIMICROB AGENTS CH, V50, P3312, DOI 10.1128/AAC.00628-06; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; Srinivasan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019036; Theiss S, 2002, MOL MICROBIOL, V43, P571, DOI 10.1046/j.1365-2958.2002.02769.x; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wiederhold NP, 2008, ANTIMICROB AGENTS CH, V52, P4145, DOI 10.1128/AAC.00959-08; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	49	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110354	10.1371/journal.pone.0110354	http://dx.doi.org/10.1371/journal.pone.0110354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350399	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100025
J	Domingues, MR; Matijasevich, A; Barros, AJD; Santos, IS; Horta, BL; Hallal, PC				Domingues, Marlos R.; Matijasevich, Alicia; Barros, Aluisio J. D.; Santos, Ina S.; Horta, Bernardo L.; Hallal, Pedro C.			Physical Activity during Pregnancy and Offspring Neurodevelopment and IQ in the First 4 Years of Life	PLOS ONE			English	Article							PRETERM BIRTH; EXERCISE; WOMEN; COHORT; CHILDREN; OBESITY; IMPACT	Background: Maternal physical activity during pregnancy could alter offspring's IQ and neurodevelopment in childhood. Methods: Children belonging to a birth cohort were followed at 3, 12, 24 and 48 months of age. Physical activity during pregnancy was assessed retrospectively at birth. Neurodevelopment was evaluated by Battelle's Development Inventory (12, 24 and 48 months) and IQ by the Weschler's Intelligence Scale (48 months). Neurodevelopment was based on Battelles' (90th percentile) and also analyzed as a continuous outcome. IQ was analyzed as a continuous outcome. Potential confounders were: family income, mother's age, schooling, skin color, number of previous births and smoking; and newborns': preterm birth, sex and low birth weight. Results: was slightly higher (5 points) among children from active women. The Battelle's score at 12 and 24 months was higher among offspring from active mothers. After controlling for confounders, physical activity during pregnancy was positively associated to the Battelle's Inventory at 12 months IQ, however, at 48 months no association was observed. Conclusion: Physical activity during pregnancy does not seem to impair children's neurodevelopment and children from active mothers presented better performance at 12 months.	[Domingues, Marlos R.; Hallal, Pedro C.] Univ Fed Pelotas, Sports Dept, Pelotas, RS, Brazil; [Matijasevich, Alicia; Barros, Aluisio J. D.; Santos, Ina S.; Horta, Bernardo L.; Hallal, Pedro C.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, RS, Brazil; [Matijasevich, Alicia] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade de Sao Paulo	Domingues, MR (corresponding author), Univ Fed Pelotas, Sports Dept, Pelotas, RS, Brazil.	marlosufpel@gmail.com	Domingues, Marlos R/A-4758-2009; Matijasevich, Alicia/C-5576-2009; Barros, Aluisio JD/A-7417-2008; Horta, Bernardo/A-7604-2008; Hallal, Pedro C/A-3249-2011; Santos, Ina S/C-2001-2009	Domingues, Marlos R/0000-0002-2503-2944; Matijasevich, Alicia/0000-0003-0060-1589; Barros, Aluisio JD/0000-0002-2022-8729; Horta, Bernardo/0000-0001-9843-412X; Hallal, Pedro C/0000-0003-1470-6461; 	Wellcome Trust Initiative [086974/Z/08/Z]; World Health Organization; National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Brazilian Ministry of Health; Children's Mission	Wellcome Trust Initiative(Wellcome Trust); World Health Organization(World Health Organization); National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health; Children's Mission	The 2004 birth cohort study is currently supported by the Wellcome Trust Initiative entitled Major Awards for Latin America on Health Consequences of Population Change, grant entitled: "Implications of early life and contemporary exposures on body composition, human capital, mental health and precursors of complex chronic diseases in three Brazilian cohorts (1982, 1993 and 2004)", grant No 086974/Z/08/Z. Previous phases of the study were supported by the World Health Organization, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq), the Brazilian Ministry of Health, and the Children's Mission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Barros AJD, 2006, REV SAUDE PUBL, V40, P402, DOI 10.1590/S0034-89102006000300007; Barros AJD, 2010, INT J EPIDEMIOL, V39, P285, DOI 10.1093/ije/dyp272; Clapp JF, 2006, PLACENTA, V27, P527, DOI 10.1016/j.placenta.2005.07.010; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Clapp JF, 1999, AM J OBSTET GYNECOL, V180, P91, DOI 10.1016/S0002-9378(99)70155-9; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; Clapp JF, 1998, AM J OBSTET GYNECOL, V178, P594, DOI 10.1016/S0002-9378(98)70444-2; Comm Obstetric Practice, 2002, INT J GYNECOL OBSTET, V77, P79; Devlieger R, 2008, OBES REV, V9, P181, DOI 10.1111/j.1467-789X.2007.00460.x; Domingues MR, 2008, INT J GYNECOL OBSTET, V103, P9, DOI 10.1016/j.ijgo.2008.05.029; Domingues MR, 2007, REV SAUDE PUBL, V41, P173, DOI 10.1590/s0034-89102007000200002; Domingues MR, 2009, SPORTS MED, V39, P961, DOI 10.2165/11317900-000000000-00000; Duncombe D, 2009, MIDWIFERY, V25, P430, DOI 10.1016/j.midw.2007.03.002; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; Gerardin P, 2011, J CLIN PSYCHIAT, V72, P378, DOI 10.4088/JCP.09m05724blu; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Haakstad LAH, 2009, ACTA OBSTET GYN SCAN, V88, P1267, DOI 10.3109/00016340903284901; Hernandez-Martinez C, 2008, EARLY HUM DEV, V84, P745, DOI 10.1016/j.earlhumdev.2008.05.002; Huisman M, 2010, EUR J EPIDEMIOL, V25, P569, DOI 10.1007/s10654-010-9473-1; Newborg J., 1988, BATTELLE DEV INVENTO; Ornoy A, 2001, J PEDIATR ENDOCR MET, V14, P681; Pivarnik JM, 2006, MED SCI SPORT EXER, V38, P989, DOI 10.1249/01.mss.0000218147.51025.8a; Poudevigne MS, 2006, SPORTS MED, V36, P19, DOI 10.2165/00007256-200636010-00003; Santos DN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-202; Santos IS, 2010, INT J EPIDEMIOL; Silverman BL, 1998, DIABETES CARE, V21, pB142; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; To T, 2004, ARCH PEDIAT ADOL MED, V158, P643, DOI 10.1001/archpedi.158.7.643; Wechsler, 2012, WPPSI 4 WECHSLER PRE	30	19	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110050	10.1371/journal.pone.0110050	http://dx.doi.org/10.1371/journal.pone.0110050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350666	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943100018
J	Connolly, CG; Bischoff-Grethe, A; Jordan, SJ; Woods, SP; Ellis, RJ; Paulus, MP; Grant, I				Connolly, Colm G.; Bischoff-Grethe, Amanda; Jordan, Stephan J.; Woods, Steven Paul; Ellis, Ronald J.; Paulus, Martin P.; Grant, Igor		Translational Methamphetamine AIDS	Altered Functional Response to Risky Choice in HIV Infection	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; IMMUNODEFICIENCY-VIRUS-INFECTION; OBSESSIVE-COMPULSIVE DISORDER; SOMATIC MARKER HYPOTHESIS; TAKING DECISION-MAKING; PREFRONTAL CORTEX; NEUROCOGNITIVE IMPAIRMENT; ANTIRETROVIRAL THERAPY; SENSATION SEEKING	Background: Risky decision-making is commonly observed in persons at risk for and infected with HIV and is associated with executive dysfunction. Yet it is currently unknown whether HIV alters brain processing of risk-taking decision-making. Methods: This study examined the neural substrate of a risky decision-making task in 21 HIV seropositive (HIV+) and 19 seronegative (HIV-) comparison participants. Functional magnetic resonance imaging was conducted while participants performed the risky-gains task, which involves choosing among safe (20 cents) and risky (40/80 cent win or loss) choices. Linear mixed effects analyses examining group and decision type were conducted. Robust regressions were performed to examine the relationship between nadir CD4 count and Kalichman sexual compulsivity and brain activation in the HIV+ group. The overlap between the task effects and robust regressions was explored. Results: Although there were no serostatus effects in behavioral performance on the risky-gains task, HIV+ individuals exhibited greater activation for risky choices in the basal ganglia, i.e. the caudate nucleus, but also in the anterior cingulate, dorsolateral prefrontal cortex, and insula relative to the HIV-group. The HIV+ group also demonstrated reduced functional responses to safe choices in the anterior cingulate and dorsolateral prefrontal cortex relative to the HIV-group. HIV+ individuals with higher nadir CD4 count and greater sexual compulsivity displayed lower differential responses to safe versus risky choices in many of these regions. Conclusions: This study demonstrated fronto-striatal loop dysfunction associated with HIV infection during risky decision-aking. Combined with similar between-group task behavior, this suggests an adaptive functional response in regions critical to reward and behavioral control in the HIV+ group. HIV-infected individuals with higher CD4 nadirs demonstrated activation patterns more similar to seronegative individuals. This suggests that the severity of past immunosuppression (CD4 nadir) may exert a legacy effect on processing of risky choices in the HIV-infected brain.	[Connolly, Colm G.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Bischoff-Grethe, Amanda; Jordan, Stephan J.; Woods, Steven Paul; Paulus, Martin P.; Grant, Igor] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Paulus, Martin P.] VA San Diego Healthcare Syst, Psychiat Serv, La Jolla, CA USA; [Woods, Steven Paul; Grant, Igor] Univ Calif San Diego, HIV Neurobehav Res Program, San Diego, CA 92103 USA; [Ellis, Ronald J.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of California System; University of California San Francisco; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Bischoff-Grethe, A (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	agrethe@ucsd.edu; igrant@ucsd.edu	Ellis, Ronald/K-3543-2015; Connolly, Colm G./H-5917-2019	Ellis, Ronald/0000-0003-4931-752X; Connolly, Colm G./0000-0002-4051-3682; Scadeng, Miriam/0000-0002-9593-2956; Fennema-Notestine, Christine/0000-0002-6527-6361; Woods, Steven Paul/0000-0003-0776-4233	National Institute on Drug Abuse (NIDA) [P50DA026306]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA026306] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Translational Methamphetamine AIDS Research Center (TMARC) is supported by Center award P50DA026306 from the National Institute on Drug Abuse (NIDA). The funding agency played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The views expressed in this article are those of the authors and do not reflect the official policy or position of the United States Government.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexander WH, 2010, TOP COGN SCI, V2, P658, DOI 10.1111/j.1756-8765.2010.01085.x; Allais M, 1979, THEORY DECISION LIB, V21, P437, DOI [10.1007/978-94-015-7629-1_17, DOI 10.1007/978-94-015-7629-1_17]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, NONLINEAR REGISTRATI; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; Basso MR, 2003, J CLIN EXP NEUROPSYC, V25, P893, DOI 10.1076/jcen.25.7.893.16489; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Becker JT, 2012, J NEUROVIROL, V18, P423, DOI 10.1007/s13365-012-0115-0; Becker JT, 2012, BRAIN IMAGING BEHAV, V6, P366, DOI 10.1007/s11682-012-9149-4; Becker JT, 2012, J NEUROSCI METH, V206, P176, DOI 10.1016/j.jneumeth.2012.02.022; Becker JT, 2011, BRAIN IMAGING BEHAV, V5, P77, DOI 10.1007/s11682-011-9113-8; Benotsch EG, 2001, SEXUAL ADDICTION COM, V8, P83, DOI [DOI 10.1080/10720160127561, 10.1080/10720160127561]; Berger JR, 2000, J PSYCHOPHARMACOL, V14, P214, DOI 10.1177/026988110001400304; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Brown JW, 2011, NEUROIMAGE, V57, P314, DOI 10.1016/j.neuroimage.2011.04.028; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Chang L, 2008, J NEUROIMMUNE PHARM, V3, P95, DOI 10.1007/s11481-007-9092-0; Chang L, 2004, ANN NEUROL, V56, P259, DOI 10.1002/ana.20190; Chang L, 2001, NEUROLOGY, V57, P1001, DOI 10.1212/WNL.57.6.1001; Cohen RA, 2010, J NEUROVIROL, V16, P25, DOI 10.3109/13550280903552420; Cooper ML, 2002, J STUD ALCOHOL, P101, DOI 10.15288/jsas.2002.s14.101; Costafreda SG, 2007, J MAGN RESON IMAGING, V26, P1122, DOI 10.1002/jmri.21118; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Cysique LAJ, 2006, NEUROLOGY, V66, P1447, DOI 10.1212/01.wnl.0000210477.63851.d3; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Du Plessis S, 2014, AIDS, V28, P803, DOI 10.1097/QAD.0000000000000151; Duarte NA, 2012, J PSYCHIATR RES, V46, P492, DOI 10.1016/j.jpsychires.2012.01.006; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Ernst T, 2009, ANN NEUROL, V65, P316, DOI 10.1002/ana.21594; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Fox J, 2002, COX PROPORTIONAL HAZ; Fukunaga R, 2012, COGN AFFECT BEHAV NE, V12, P479, DOI 10.3758/s13415-012-0102-1; Glover GH, 2012, J MAGN RESON IMAGING, V36, P39, DOI 10.1002/jmri.23572; Gonzalez R, 2005, J INT NEUROPSYCH SOC, V11, P121, DOI 10.1017/S1355617705050186; Gountouna VE, 2010, NEUROIMAGE, V49, P552, DOI 10.1016/j.neuroimage.2009.07.026; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hardy DJ, 2006, NEUROPSYCHOLOGY, V20, P355, DOI 10.1037/0894-4105.20.3.355; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK., 1994, NEUROPSYCHOLOGY HIV, P188; Hedges LV, 2014, STAT METHODS META AN; Hershberger SL, 2004, ADDICT BEHAV, V29, P623, DOI 10.1016/j.addbeh.2003.08.016; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Hu SH, 2014, J SEX MED, V11, P2474, DOI 10.1111/jsm.12639; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Iudicello JE, 2013, CLIN NEUROPSYCHOL, V27, P256, DOI 10.1080/13854046.2012.740077; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jernigan TL, 2011, J NEUROVIROL, V17, P248, DOI 10.1007/s13365-011-0032-7; Jernigan TL, 2005, AM J PSYCHIAT, V162, P1461, DOI 10.1176/appi.ajp.162.8.1461; KALICHMAN SC, 1994, J PERS ASSESS, V62, P385, DOI 10.1207/s15327752jpa6203_1; Kalichman SC, 1996, ARCH SEX BEHAV, V25, P141, DOI 10.1007/BF02437933; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lee TMC, 2008, SOC COGN AFFECT NEUR, V3, P7, DOI 10.1093/scan/nsm033; LEIGH BC, 1993, AM PSYCHOL, V48, P1035, DOI 10.1037/0003-066X.48.10.1035; Leland DS, 2005, DRUG ALCOHOL DEPEN, V78, P83, DOI 10.1016/j.drugalcdep.2004.10.001; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P625, DOI 10.1016/0306-4522(94)90182-1; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maki PM, 2009, NEUROLOGY, V72, P1661, DOI 10.1212/WNL.0b013e3181a55f65; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Martin EM, 2004, J INT NEUROPSYCH SOC, V10, P931, DOI 10.1017/S1355617704107054; Martin EM, 2003, NEUROPSYCHOLOGY, V17, P283, DOI 10.1037/0894-4105.17.2.283; Mellers BA, 1997, CHOICE, DECISION, AND MEASUREMENT: ESSAYS IN HONOR OF R. DUNCAN LUCE, P57; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Munoz-Moreno JA, 2008, AIDS RES HUM RETROV, V24, P1301, DOI 10.1089/aid.2007.0310; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2006, NEUROIMAGE, V30, P668, DOI 10.1016/j.neuroimage.2005.09.061; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paulus MP, 2001, NEUROIMAGE, V13, P91, DOI 10.1006/nimg.2000.0667; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; POLLOCK V, 1979, J NERV MENT DIS, V167, P612, DOI 10.1097/00005053-197910000-00004; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabkin Judith G, 2008, Curr HIV/AIDS Rep, V5, P163, DOI 10.1007/s11904-008-0025-1; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Ruchsow M, 2002, NEUROSCI LETT, V325, P203, DOI 10.1016/S0304-3940(02)00288-4; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Saxena S, 2000, PSYCHIAT CLIN N AM, V23, P563, DOI 10.1016/S0193-953X(05)70181-7; Shuter J, 2008, NICOTINE TOB RES, V10, P731, DOI 10.1080/14622200801908190; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stewart JL, 2014, PSYCHIAT RES-NEUROIM, V223, P129, DOI 10.1016/j.pscychresns.2014.04.014; Stewart JL, 2014, ADDICTION, V109, P460, DOI 10.1111/add.12403; Stout JC, 1998, ARCH NEUROL-CHICAGO, V55, P161, DOI 10.1001/archneur.55.2.161; Suckling J, 2008, HUM BRAIN MAPP, V29, P1111, DOI 10.1002/hbm.20451; Sutton BP, 2008, J MAGN RESON IMAGING, V28, P21, DOI 10.1002/jmri.21419; Talairach J., 1988, COPLANAR STEREOTAXIC; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; Tozzi V, 2005, J NEUROVIROL, V11, P265, DOI 10.1080/13550280590952790; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Valcour V, 2006, J NEUROVIROL, V12, P387, DOI 10.1080/13550280600915339; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Walsh V, 2005, TRANSCRANIAL MAGNETI; Weinhardt L S, 2000, Annu Rev Sex Res, V11, P125; Wilkinson GS, 2006, WRAT 4 4; Wilson TW, 2013, J NEUROIMMUNE PHARM, V8, P965, DOI 10.1007/s11481-013-9477-1; Wilson TW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066241, 10.137/journal.pone.0066241]; World Health Organization (WHO), 1998, COMP INT DIAGN INT C	150	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111583	10.1371/journal.pone.0111583	http://dx.doi.org/10.1371/journal.pone.0111583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1JF	25347679	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900082
J	Murgiano, L; Jagannathan, V; Calderoni, V; Joechler, M; Gentile, A; Drogemuller, C				Murgiano, Leonardo; Jagannathan, Vidhya; Calderoni, Valerio; Joechler, Monika; Gentile, Arcangelo; Droegemueller, Cord			Looking the Cow in the Eye: Deletion in the NID1 Gene Is Associated with Recessive Inherited Cataract in Romagnola Cattle	PLOS ONE			English	Article							BASEMENT-MEMBRANE PROTEIN; CONGENITAL CATARACTS; MOLECULAR-GENETICS; MOUSE NIDOGEN-2; GENOME; CRYSTALLIN; BINDING; PSEUDOMYOTONIA; PREVALENCE; EXPRESSION	Cataract is a known condition leading to opacification of the eye lens causing partial or total blindness. Mutations are known to cause autosomal dominant or recessive inherited forms of cataracts in humans, mice, rats, guinea pigs and dogs. The use of large-sized animal models instead of those using mice for the study of this condition has been discussed due to the small size of rodent lenses. Four juvenile-onset cases of bilateral incomplete immature nuclear cataract were recently observed in Romagnola cattle. Pedigree analysis suggested a monogenic autosomal recessive inheritance. In addition to the cataract, one of the cases displayed abnormal head movements. Genome-wide association and homozygosity mapping and subsequent whole genome sequencing of a single case identified two perfectly associated sequence variants in a critical interval of 7.2 Mb on cattle chromosome 28: a missense point mutation located in an uncharacterized locus and an 855 bp deletion across the exon 19/intron 19 border of the bovine nidogen 1 (NID1) gene (c.3579_3604+829del). RT-PCR showed that NID1 is expressed in bovine lenses while the transcript of the second locus was absent. The NID1 deletion leads to the skipping of exon 19 during transcription and is therefore predicted to cause a frameshift and premature stop codon (p.1164fs27X). The truncated protein lacks a C-terminal domain essential for binding with matrix assembly complexes. Nidogen 1 deficient mice show neurological abnormalities and highly irregular crystal lens alterations. This study adds NID1 to the list of candidate genes for inherited cataract in humans and is the first report of a naturally occurring mutation leading to non-syndromic catarct in cattle provides a potential large animal model for human cataract.	[Murgiano, Leonardo; Jagannathan, Vidhya; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Joechler, Monika; Gentile, Arcangelo] Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, Italy	University of Bern; University of Bologna	Drogemuller, C (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019	Jagannathan, Vidhya/0000-0002-8155-0041; Drogemuller, Cord/0000-0001-9773-522X				Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3; Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Bose K, 2006, J BIOL CHEM, V281, P39620, DOI 10.1074/jbc.M607886200; Breitkreutz D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/179784; CARLIN B, 1981, J BIOL CHEM, V256, P5209; Chang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016867; Chew EY, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12914; Churchill A, 2011, PHILOS T R SOC B, V366, P1234, DOI 10.1098/rstb.2010.0227; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark JI, 1999, EYE, V13, P417, DOI 10.1038/eye.1999.116; Darbro BW, 2013, HUM MUTAT, V34, P1075, DOI 10.1002/humu.22351; Deng H, 2014, EUR J MED GENET, V57, P113, DOI 10.1016/j.ejmg.2013.12.006; Detlefson JA, 1920, AM NAT, V54, P277, DOI 10.1086/279759; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GELATT KN, 1984, CURR EYE RES, V3, P765, DOI 10.3109/02713688409065600; Gregory PW, 1943, J HERED, V34, P125, DOI 10.1093/oxfordjournals.jhered.a105263; Gresham HD, 1996, J BIOL CHEM, V271, P30587, DOI 10.1074/jbc.271.48.30587; Hassig M, 2009, SCHWEIZ ARCH TIERH, V151, P471, DOI 10.1024/0036-7281.151.10.471; He WG, 2000, HUM GENET, V106, P1, DOI 10.1007/s004390051002; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hirano T, 2012, ANIM GENET, V43, P11, DOI 10.1111/j.1365-2052.2011.02209.x; Huang BY, 2010, EUR J MED GENET, V53, P347, DOI 10.1016/j.ejmg.2010.07.001; Hunter L, 2006, MOL VIS, V12, P588; Kimura N, 1998, EXP CELL RES, V241, P36, DOI 10.1006/excr.1998.4016; Koenigsberg R, 1989, CHURCHILLS MED DICT; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Krump L, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang JJN, 2004, PROTEIN SCI, V13, P2476, DOI 10.1110/ps.04815104; Liu BF, 2008, EXP EYE RES, V87, P515, DOI 10.1016/j.exer.2008.08.021; Marchitti SA, 2008, AN MOD EYE RES; May CA, 2012, ISRN OPHTHALMOL, DOI 10.5402; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mesa R, 2013, INVEST OPHTH VIS SCI, V54, P6789, DOI 10.1167/iovs.13-12644; Miosge N, 2002, MATRIX BIOL, V21, P611, DOI 10.1016/S0945-053X(02)00070-7; Miosge N, 2001, HISTOCHEM J, V33, P523, DOI 10.1023/A:1014995523521; Morton JD, 2013, INVEST OPHTH VIS SCI, V54, P389, DOI 10.1167/iovs.12-11088; Murgiano L, 2014, VET J, V200, P459, DOI 10.1016/j.tvjl.2014.03.020; Murgiano L, 2013, VET J, V195, P238, DOI 10.1016/j.tvjl.2012.04.021; Murgiano L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-186; Murshed M, 2000, MOL CELL BIOL, V20, P7007, DOI 10.1128/MCB.20.18.7007-7012.2000; Neu R, 2006, DIFFERENTIATION, V74, P573, DOI 10.1111/j.1432-0436.2006.00100.x; Petrash JM, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12940; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Schymeinsky J, 2002, MOL CELL BIOL, V22, P6820, DOI 10.1128/MCB.22.19.6820-6830.2002; Shiels A, 2010, MOL VIS, V16, P2007; Sinha R, 2009, INDIAN J OPHTHALMOL, V57, P245; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; Talla V, 2006, INVEST OPHTH VIS SCI, V47, P5212, DOI 10.1167/iovs.06-0427; Testoni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045634; TIMPL R, 1983, EUR J BIOCHEM, V137, P455, DOI 10.1111/j.1432-1033.1983.tb07849.x; Tripathi B J, 1991, Lens Eye Toxic Res, V8, P373; Untergrasser A, 2012, NUCLEIC ACIDS RES, V40, pe115; Vasudevan A, 2010, HIPPOCAMPUS, V20, P608, DOI 10.1002/hipo.20660; Wilson GRS, 2012, MOL VIS, V18, P1384; Yi J, 2011, INT J OPHTHALMOL-CHI, V4, P422, DOI 10.3980/j.issn.2222-3959.2011.04.20; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	62	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110628	10.1371/journal.pone.0110628	http://dx.doi.org/10.1371/journal.pone.0110628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347398	Green Published, Green Submitted, gold			2022-12-26	WOS:000347994900024
J	Stangl, M; Unger, S; Keller, S; Schneider, D				Stangl, Michael; Unger, Sebastian; Keller, Sandro; Schneider, Dirk			Sequence-Specific Dimerization of a Transmembrane Helix in Amphipol A8-35	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; RESONANCE ENERGY-TRANSFER; SECONDARY STRUCTURE ANALYSES; SODIUM DODECYL-SULFATE; MIXED MICELLES; ALPHA-HELICES; AQUEOUS-SOLUTIONS; STABILITY; POLYMERS; ASSOCIATION	As traditional detergents might destabilize or even denature membrane proteins, amphiphilic polymers have moved into the focus of membrane-protein research in recent years. Thus far, Amphipols are the best studied amphiphilic copolymers, having a hydrophilic backbone with short hydrophobic chains. However, since stabilizing as well as destabilizing effects of the Amphipol belt on the structure of membrane proteins have been described, we systematically analyze the impact of the most commonly used Amphipol A8-35 on the structure and stability of a well-defined transmembrane protein model, the glycophorin A transmembrane helix dimer. Amphipols are not able to directly extract proteins from their native membranes, and detergents are typically replaced by Amphipols only after protein extraction from membranes. As Amphipols form mixed micelles with detergents, a better understanding of Amphipol-detergent interactions is required. Therefore, we analyze the interaction of A8-35 with the anionic detergent sodium dodecyl sulfate and describe the impact of the mixed-micelle-like system on the stability of a transmembrane helix dimer. As A8-35 may highly stabilize and thereby rigidify a transmembrane protein structure, modest destabilization by controlled addition of detergents and formation of mixed micellar systems might be helpful to preserve the function of a membrane protein in Amphipol environments.	[Stangl, Michael; Schneider, Dirk] Johannes Gutenberg Univ Mainz, Dept Biochem & Pharm, D-55122 Mainz, Germany; [Unger, Sebastian; Keller, Sandro] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany	Johannes Gutenberg University of Mainz; University of Kaiserslautern	Schneider, D (corresponding author), Johannes Gutenberg Univ Mainz, Dept Biochem & Pharm, D-55122 Mainz, Germany.	Dirk.Schneider@uni-mainz.de	Keller, Sandro/T-3487-2019; Keller, Sandro/G-7202-2016	Keller, Sandro/0000-0001-5469-8772; Keller, Sandro/0000-0001-5469-8772				ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027; Anbazhagan V, 2010, ARCH BIOCHEM BIOPHYS, V495, P159, DOI 10.1016/j.abb.2010.01.006; Bordag N, 2010, CHEM PHYS LIPIDS, V163, P1, DOI 10.1016/j.chemphyslip.2009.07.009; Diab C, 2007, BBA-BIOMEMBRANES, V1768, P2737, DOI 10.1016/j.bbamem.2007.07.007; Diab C, 2007, LANGMUIR, V23, P3025, DOI 10.1021/la062522j; Duarte AMS, 2008, J PEPT SCI, V14, P389, DOI 10.1002/psc.996; Etzkorn M, 2014, J MEMBR BIOL; Faham S, 2004, J MOL BIOL, V335, P297, DOI 10.1016/j.jmb.2003.10.041; Fisher LE, 1999, J MOL BIOL, V293, P639, DOI 10.1006/jmbi.1999.3126; Fisher LE, 2003, BIOPHYS J, V85, P3097, DOI 10.1016/S0006-3495(03)74728-6; Giusti F, 2012, LANGMUIR, V28, P10372, DOI 10.1021/la300774d; Gohon Y, 2006, LANGMUIR, V22, P1281, DOI 10.1021/la052243g; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; Keller S, 2006, J AM CHEM SOC, V128, P1279, DOI 10.1021/ja056389d; Keller S, 2006, BIOPHYS J, V90, P4509, DOI 10.1529/biophysj.105.077867; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; Merzlyakov M, 2008, METHOD ENZYMOL, V450, P107, DOI 10.1016/S0076-6879(08)03406-X; Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7; Picard M, 2006, BIOCHEMISTRY-US, V45, P1861, DOI 10.1021/bi051954a; Planchard N, 2014, J MEMBR BIOL; Pocanschi CL, 2013, EUR BIOPHYS J; Pocanschi CL, 2006, BIOCHEMISTRY-US, V45, P13954, DOI 10.1021/bi0616706; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; Sehgal P, 2006, PROTEIN SCI, V15, P890, DOI 10.1110/ps.052031306; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; SHIRAKI K, 1995, J MOL BIOL, V245, P180, DOI 10.1006/jmbi.1994.0015; Stangl M, 2014, BIOCHEMISTRY-US, V53, P1410, DOI 10.1021/bi401611f; Stangl M, 2012, BIOPHYS J, V103, P2455, DOI 10.1016/j.bpj.2012.11.004; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Tribet C, 2009, LANGMUIR, V25, P12623, DOI 10.1021/la9018772; Tribet C, 1997, LANGMUIR, V13, P5570, DOI 10.1021/la970136j; Weber M, 2011, J MOL BIOL, V407, P594, DOI 10.1016/j.jmb.2011.02.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yohannan S, 2004, J MOL BIOL, V341, P1, DOI 10.1016/j.jmb.2004.06.025; Zoonens M, 2007, BIOCHEMISTRY-US, V46, P10392, DOI 10.1021/bi7007596; Zoonens M, 2013, J AM CHEM SOC, V135, P15174, DOI 10.1021/ja407424v	48	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110970	10.1371/journal.pone.0110970	http://dx.doi.org/10.1371/journal.pone.0110970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347769	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900035
J	Franco, JS; Molano-Gonzalez, N; Rodriguez-Jimenez, M; Acosta-Ampudia, Y; Mantilla, RD; Amaya-Amaya, J; Rojas-Villarraga, A; Anaya, JM				Franco, Juan-Sebastian; Molano-Gonzalez, Nicolas; Rodriguez-Jimenez, Monica; Acosta-Ampudia, Yeny; Mantilla, Ruben D.; Amaya-Amaya, Jenny; Rojas-Villarraga, Adriana; Anaya, Juan-Manuel			The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; PRIMARY SJOGRENS-SYNDROME; ANTICARDIOLIPIN ANTIBODIES; CLINICAL-SIGNIFICANCE; RISK-FACTORS; CLASSIFICATION CRITERIA; AUTOIMMUNE-DISEASES; CHILEAN PATIENTS; PREGNANCY LOSS; PREVALENCE	Objectives: To examine the prevalence and associated factors related to the coexistence of antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) in a cohort of Colombian patients with SLE, and to discuss the coexistence of APS with other autoimmune diseases (ADs). Method: A total of 376 patients with SLE were assessed for the presence of the following: 1) confirmed APS; 2) positivity for antiphospholipid (aPL) antibodies without a prior thromboembolic nor obstetric event; and 3) SLE patients without APS nor positivity for aPL antibodies. Comparisons between groups 1 and 3 were evaluated by bivariate and multivariate analysis. Results: Although the prevalence of aPL antibodies was 54%, APS was present in just 9.3% of SLE patients. In our series, besides cardiovascular disease (AOR 3.38, 95% CI 1.11-10.96, p = 0.035), pulmonary involvement (AOR 5.06, 95% CI 1.56-16.74, p = 0.007) and positivity for rheumatoid factor (AOR 4.68, 95%IC 1.63-14.98, p = 0.006) were factors significantly associated with APS-SLE. APS also may coexist with rheumatoid arthritis, Sjogren's syndrome, autoimmune thyroid diseases, systemic sclerosis, systemic vasculitis, dermatopolymyositis, primary biliary cirrhosis and autoimmune hepatitis. Conclusions: APS is a systemic AD that may coexist with other ADs, the most common being SLE. Awareness of this polyautoimmunity should be addressed promptly to establish strategies for controlling modifiable risk factors in those patients.	[Franco, Juan-Sebastian; Molano-Gonzalez, Nicolas; Rodriguez-Jimenez, Monica; Acosta-Ampudia, Yeny; Mantilla, Ruben D.; Amaya-Amaya, Jenny; Rojas-Villarraga, Adriana; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia; [Franco, Juan-Sebastian; Mantilla, Ruben D.; Amaya-Amaya, Jenny; Rojas-Villarraga, Adriana; Anaya, Juan-Manuel] Hosp Univ Mayor, Bogota, Colombia	Universidad del Rosario	Franco, JS (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.	francoa.juan@gmail.com; juan.anaya@urosario.edu.co	Rodríguez-Jiménez, Mónica/J-1899-2016; Molano-Gonzalez, Nicolas/I-6806-2016; Anaya, Juan-Manuel/J-1960-2016; Acosta-Ampudia, Yeny/J-2401-2016; Rojas-Villarraga, Adriana/T-7070-2018; Rojas-Villarraga, Adriana/J-2404-2016	Rodríguez-Jiménez, Mónica/0000-0002-8536-1491; Molano-Gonzalez, Nicolas/0000-0001-7002-8795; Anaya, Juan-Manuel/0000-0002-6444-1249; Acosta-Ampudia, Yeny/0000-0001-8491-9134; Rojas-Villarraga, Adriana/0000-0003-3145-2440; Rojas-Villarraga, Adriana/0000-0003-3145-2440; Universidad del Rosario, Biblioteca/0000-0003-3491-9392	School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia	School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia	This work was supported by the School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2012, AUTOIMMUN REV, V11, P593, DOI 10.1016/j.autrev.2011.10.020; Agmon-Levin N, 2014, CLIN RHEUMATOL, V33, P293, DOI 10.1007/s10067-014-2486-5; Aguirre V, 2001, LUPUS, V10, P75, DOI 10.1191/096120301674376357; ALARCONSEGOVIA D, 1989, MEDICINE, V68, P353, DOI 10.1097/00005792-198911000-00003; ALARCONSEGOVIA D, 1992, SEMIN ARTHRITIS RHEU, V21, P275, DOI 10.1016/0049-0172(92)90021-5; Amaya-Amaya J, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/794383; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Anaya JM, 2014, AUTOIMMUN REV, V4-5, P4; Anaya JM, 2013, AUTOIMUNITY BENCH, P237; Anaya JM, 2012, AUTOIMMUNE DIS, V2012; Anaya Juan-Manuel, 2007, Expert Rev Clin Immunol, V3, P623, DOI 10.1586/1744666X.3.4.623; Anaya JM, 2012, CLIN REV ALLERG IMMU, V43, P256, DOI 10.1007/s12016-012-8317-z; Anaya JM, 2012, AUTOIMMUN REV, V11, P781, DOI 10.1016/j.autrev.2012.02.002; Anaya JM, 2011, CLIN REV ALLERG IMMU, V40, P199, DOI 10.1007/s12016-010-8249-4; Anaya JM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3175; [Anonymous], 1999, Arthritis Rheum, V42, P1785; ASHERSON RA, 1990, J RHEUMATOL, V17, P1292; Assous N, 2005, CLIN EXP RHEUMATOL, V23, P199; Calixto OJ, 2014, AUTOIMMUN REV, V13, P641, DOI 10.1016/j.autrev.2013.12.002; Cardenas-Roldan J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-73; Cefle A, 2011, RHEUMATOL INT, V31, P183, DOI 10.1007/s00296-009-1255-2; Cervera R, 1997, CLIN EXP RHEUMATOL, V15, P361; Cifuentes RA, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/792106; Clowse MEB, 2006, OBSTET GYNECOL, V107, P293, DOI 10.1097/01.AOG.0000194205.95870.86; Cuadrado MJ, 1997, ARTHRITIS RHEUM-US, V40, P834, DOI 10.1002/art.1780400509; Cugno M, 2010, J AUTOIMMUN, V34, P105, DOI 10.1016/j.jaut.2009.07.004; Diez J J, 1993, J Clin Lab Immunol, V40, P125; Efe C, 2012, EUR J GASTROEN HEPAT, V24, P531, DOI 10.1097/MEG.0b013e328350f95b; Enzenauer RJ, 2006, JCR-J CLIN RHEUMATOL, V12, P324, DOI 10.1097/01.rhu.0000250295.34519.b9; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Fauchais AL, 2004, LUPUS, V13, P245, DOI 10.1191/0961203304lu1006oa; FELDMAN D, 1989, J RHEUMATOL, V16, P618; Gao N, 2013, LUPUS, V22, P453, DOI 10.1177/0961203313477226; Gould T, 2006, SCAND J RHEUMATOL, V35, P29, DOI 10.1080/03009740510026913; Gupta R, 2009, RHEUMATOL INT, V30, P277, DOI 10.1007/s00296-009-1107-0; Hasunuma Y, 1997, CLIN EXP IMMUNOL, V107, P569, DOI 10.1046/j.1365-2249.1997.d01-948.x; HERRICK AL, 1994, ANN RHEUM DIS, V53, P540, DOI 10.1136/ard.53.8.540; HILL GS, 1978, AM J MED, V64, P61, DOI 10.1016/0002-9343(78)90180-8; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; JEDRYKAGORAL A, 1992, ANN RHEUM DIS, V51, P889, DOI 10.1136/ard.51.7.889; Jeleniewicz R, 2012, POL ARCH MED WEWN, V122, P480, DOI 10.20452/pamw.1415; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Liaskos C, 2005, J AUTOIMMUN, V24, P251, DOI 10.1016/j.jaut.2005.01.016; Lopez-Pedrera C, 2008, ARTHRITIS RHEUM-US, V58, P2835, DOI 10.1002/art.23756; Pego-Reigosa JM, 2009, BEST PRACT RES CL RH, V23, P469, DOI 10.1016/j.berh.2009.01.002; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; Merkel PA, 1996, AM J MED, V101, P576, DOI 10.1016/S0002-9343(96)00335-X; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mok CC, 2013, MEDICINE, V92, P217, DOI 10.1097/MD.0b013e31829cae47; Murthy V, 2013, ARTHRITIS RHEUM-US, V65, P3186, DOI 10.1002/art.38131; Nabriski D, 2000, AM J HEMATOL, V64, P73, DOI 10.1002/(SICI)1096-8652(200005)64:1<73::AID-AJH14>3.0.CO;2-U; Nikpour M, 2013, LUPUS, V22, P1243, DOI 10.1177/0961203313493031; Nikpour Mandana, 2009, Curr Rheumatol Rep, V11, P248; Osundeko O, 2001, Endocr Pract, V7, P181; PAGGI A, 1994, CLIN ENDOCRINOL, V40, P329; Palomo I, 2006, J CLIN LAB ANAL, V20, P190, DOI 10.1002/jcla.20131; Paran D, 2004, AUTOIMMUN REV, V3, P70, DOI 10.1016/S1568-9972(03)00090-9; Pasoto SG, 2012, CLIN RHEUMATOL, V31, P1331, DOI 10.1007/s10067-012-2019-z; Perez-Sanchez C, 2015, ANN RHEUM DIS, V74, P1441, DOI 10.1136/annrheumdis-2013-204600; Perez-Sanchez C, 2012, BLOOD, V119, P5859, DOI 10.1182/blood-2011-12-400986; Picillo U, 1997, CLIN RHEUMATOL, V16, P378, DOI 10.1007/BF02242455; Ramos-Casals M, 2006, SEMIN ARTHRITIS RHEU, V35, P312, DOI 10.1016/j.semarthrit.2005.12.004; Rees JD, 2006, ANN RHEUM DIS, V65, P109, DOI 10.1136/ard.2004.034231; Rojas-Villarraga A, 2013, AUTOIMUNITY BENCH BE, P322; Rojas-Villarraga A, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/254319; Rojas-Villarraga A, 2010, AUTOIMMUN REV, V9, P229, DOI 10.1016/j.autrev.2009.10.001; Ruiz-Irastorza G, 2004, ARCH INTERN MED, V164, P77, DOI 10.1001/archinte.164.1.77; Sato S, 2003, ANN RHEUM DIS, V62, P771, DOI 10.1136/ard.62.8.771; Seriolo B, 1999, RHEUMATOLOGY, V38, P675, DOI 10.1093/rheumatology/38.7.675; Seriolo B, 2001, CLIN EXP RHEUMATOL, V19, P561; Sherer Y, 2000, LUPUS, V9, P42, DOI 10.1177/096120330000900108; SHOENFELD Y, 1989, IMMUNOL TODAY, V10, P123, DOI 10.1016/0167-5699(89)90245-4; Signorelli F. V., 2011, LUPUS, V20; Skare TL, 2009, CLIN EXP RHEUMATOL, V27, P894; Soares M, 2003, LUPUS, V12, P788, DOI 10.1191/0961203303lu447xx; Spadaro A, 2000, LUPUS, V9, P56, DOI 10.1177/096120330000900110; Stoianovich L, 2006, AUTOIMMUN REV, V5, P344, DOI 10.1016/j.autrev.2006.02.002; Stone NJ, 2005, AM J CARDIOL, V96, p53E, DOI 10.1016/j.amjcard.2005.06.006; Taraborelli M, 2012, BEST PRACT RES CL RH, V26, P79, DOI 10.1016/j.berh.2012.01.006; Team RC, 2013, R LANGUAGE ENV STAT; Toloza SMA, 2004, ARTHRITIS RHEUM-US, V50, P3947, DOI 10.1002/art.20622; Toure AO, 2013, TURK J HEMATOL, V30, P32, DOI 10.4274/tjh.2012.0059; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Urowitz MB, 2008, J RHEUMATOL, V35, P2152, DOI 10.3899/jrheum.080214; VIANNA JL, 1992, ANN RHEUM DIS, V51, P160, DOI 10.1136/ard.51.2.160; Vittecoq O, 2000, RHEUMATOLOGY, V39, P481, DOI 10.1093/rheumatology/39.5.481; WOLF P, 1994, BRIT J DERMATOL, V131, P48, DOI 10.1111/j.1365-2133.1994.tb08456.x; Zachou K, 2006, CLIN IMMUNOL, V119, P203, DOI 10.1016/j.clim.2006.01.002	88	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110242	10.1371/journal.pone.0110242	http://dx.doi.org/10.1371/journal.pone.0110242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343509	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500029
J	Mi, RS; Wang, XJ; Huang, Y; Zhou, P; Liu, YX; Chen, YJ; Chen, J; Zhu, W; Chen, ZG				Mi, Rongsheng; Wang, Xiaojuan; Huang, Yan; Zhou, Peng; Liu, Yuxuan; Chen, Yongjun; Chen, Jun; Zhu, Wei; Chen, Zhaoguo			Prevalence and Molecular Characterization of Cryptosporidium in Goats across Four Provincial Level Areas in China	PLOS ONE			English	Article							GIARDIA-DUODENALIS; RISK-FACTORS; SPP.; PARVUM; HUMANS; EPIDEMIOLOGY; INFECTION; SUBTYPES; KIDS; GENOTYPES	This study assessed the prevalence, species and subtypes of Cryptosporidium in goats from Guangdong Province, Hubei Province, Shandong Province, and Shanghai City of China. Six hundred and four fecal samples were collected from twelve goat farms, and the overall infection rate was 11.4% (69/604). Goats infected with Cryptosporidium were found in eleven farms across four provincial areas, and the infection rate ranged from 2.9% (1/35) to 25.0% (9/36). Three Cryptosporidium species were identified. Cryptosporidium xiaoi (45/69, 65.2%) was the dominant species, followed by C. parvum (14/69, 20.3%) and C. ubiquitum (10/69, 14.5%). The infection rate of Cryptosporidium spp. was varied with host age and goat kids were more susceptible to be infected than adult goats. Subtyping C. parvum and C. ubiquitum positive samples revealed C. parvum subtype IIdA19G1 and C. ubiquitum subtype XIIa were the most common subtypes. Other C. parvum subtypes were detected as well, such as IIaA14G2R1, IIaA15G1R1, IIaA15G2R1 and IIaA17G2R1. All of these subtypes have also been detected in humans, suggesting goats may be a potential source of zoonotic cryptosporidiosis. This was the first report of C. parvum subtypes IIaA14G2R1, IIaA15G1R1 and IIaA17G2R1 infecting in goats and the first molecular identification of C. parvum and its subtypes in Chinese goats.	[Mi, Rongsheng; Wang, Xiaojuan; Huang, Yan; Zhou, Peng; Liu, Yuxuan; Chen, Yongjun; Chen, Zhaoguo] Chinese Acad Agr Sci, Anim Borne Food Safety Res Ctr, Shanghai Vet Res Inst, Key Lab Anim Parasitol,Minist Agr, Shanghai, Peoples R China; [Mi, Rongsheng; Wang, Xiaojuan; Huang, Yan; Zhou, Peng; Liu, Yuxuan; Chen, Yongjun; Chen, Zhaoguo] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China; [Chen, Jun] Lvxiang Town Agr Technol Extens Stn Jinshan Dist, Shanghai, Peoples R China; [Zhu, Wei] Tengzhou Anim Husb & Vet Technol Serv Ctr, Tengzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Chen, ZG (corresponding author), Chinese Acad Agr Sci, Anim Borne Food Safety Res Ctr, Shanghai Vet Res Inst, Key Lab Anim Parasitol,Minist Agr, Shanghai, Peoples R China.	zhaoguochen@shvri.ac.cn			National S & T Major Program of the People's Republic of China [2012ZX10004220]; Opening Foundation of State Key Laboratory of Veterinary Etiological Biology [SKLVEB2013KFKT017]; Shanghai Municipal Agriculture Commission [2005-3-4]; Minhang District Human Resources and Social Security; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2013JB13]	National S & T Major Program of the People's Republic of China; Opening Foundation of State Key Laboratory of Veterinary Etiological Biology; Shanghai Municipal Agriculture Commission; Minhang District Human Resources and Social Security; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China	This study was supported in part by National S & T Major Program of the People's Republic of China (Grant No. 2012ZX10004220), Opening Foundation of State Key Laboratory of Veterinary Etiological Biology (Grant No. SKLVEB2013KFKT017), Shanghai Municipal Agriculture Commission (Grant No. 2005-3-4), Minhang District Human Resources and Social Security and Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China (Grant No. 2013JB13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002831; Alves M, 2006, PARASITOL RES, V99, P287, DOI 10.1007/s00436-006-0164-5; Banda Z, 2009, ONDERSTEPOORT J VET, V76, P363; Bomfim TCB, 2005, VET PARASITOL, V134, P9, DOI 10.1016/j.vetpar.2005.05.067; Broglia A, 2008, VET PARASITOL, V154, P8, DOI 10.1016/j.vetpar.2008.02.029; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Castro-Hermida JA, 2007, PARASITOL RES, V101, P1443, DOI 10.1007/s00436-007-0624-6; Chalmers RM, 2011, PARASITOL RES, V108, P1321, DOI 10.1007/s00436-010-2199-x; Chen ZG, 2011, VET PARASITOL, V181, P113, DOI 10.1016/j.vetpar.2011.04.037; Cicek Mutalip, 2008, Turkiye Parazitoloji Dergisi, V32, P8; Diaz P, 2010, VET PARASITOL, V172, P132, DOI 10.1016/j.vetpar.2010.04.029; Drumo R, 2012, APPL ENVIRON MICROB, V78, P3523, DOI 10.1128/AEM.07686-11; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng Y, 2007, APPL ENVIRON MICROB, V73, P6475, DOI 10.1128/AEM.01034-07; Feng YY, 2013, INT J PARASITOL, V43, P1141, DOI 10.1016/j.ijpara.2013.09.002; Galvan AL, 2014, SCI TOTAL ENVIRON, V468, P368, DOI 10.1016/j.scitotenv.2013.08.053; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Geurden T, 2008, VET PARASITOL, V155, P142, DOI 10.1016/j.vetpar.2008.05.002; Giadinis ND, 2012, TROP ANIM HEALTH PRO, V44, P1561, DOI 10.1007/s11250-012-0106-4; Goma FY, 2007, SMALL RUMINANT RES, V72, P77, DOI 10.1016/j.smallrumres.2006.08.010; Hajdusek O, 2004, VET PARASITOL, V122, P183, DOI 10.1016/j.vetpar.2004.04.005; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; Karanis P, 2007, PARASITOL RES, V101, P1575, DOI 10.1007/s00436-007-0681-x; Koinari M, 2014, EXP PARASITOL, V141, P134, DOI 10.1016/j.exppara.2014.03.021; Lange H, 2013, EPIDEMIOL INFECT; Li N, 2014, EMERG INFECT DIS, V20, P217, DOI 10.3201/eid2002.121797; Ma JB, 2014, VET PARASITOL, V202, P113, DOI 10.1016/j.vetpar.2014.03.030; Ma L, 2014, PARASITOL RES; MASON RW, 1981, AUST VET J, V57, P386, DOI 10.1111/j.1751-0813.1981.tb00529.x; Maurya PS, 2013, TROP ANIM HEALTH PRO, V45, P941, DOI 10.1007/s11250-012-0311-1; Mi RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074985; Ng J, 2010, EXP PARASITOL, V125, P348, DOI 10.1016/j.exppara.2010.02.017; Ngouanesavanh T, 2006, J EUKARYOT MICROBIOL, V53, pS33, DOI 10.1111/j.1550-7408.2006.00166.x; Noordeen F, 2002, VET PARASITOL, V103, P217, DOI 10.1016/S0304-4017(01)00578-7; Noordeen F, 2001, VET PARASITOL, V99, P79, DOI 10.1016/S0304-4017(01)00449-6; Paraud C, 2014, VET PARASITOL, V202, P301, DOI 10.1016/j.vetpar.2014.03.024; Park Jae-Hwan, 2006, Korean Journal of Parasitology, V44, P27, DOI 10.3347/kjp.2006.44.1.27; Quilez J, 2008, APPL ENVIRON MICROB, V74, P6026, DOI 10.1128/AEM.00606-08; Rieux A, 2013, VET PARASITOL, V192, P268, DOI 10.1016/j.vetpar.2012.11.008; Santin M, 2013, NEW ZEAL VET J, V61, P1, DOI 10.1080/00480169.2012.731681; Ceballos LS, 2009, PARASITE, V16, P315, DOI 10.1051/parasite/2009164315; Shoukry Nahla M., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P479; Smith RP, 2010, PREV VET MED, V94, P9, DOI 10.1016/j.prevetmed.2009.12.005; Soba B, 2008, PARASITOLOGY, V135, P1263, DOI 10.1017/S0031182008004800; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Tzanidakis N, 2014, PARASITE, V21, DOI 10.1051/parasite/2014048; Waldron LS, 2009, EXP PARASITOL, V122, P124, DOI 10.1016/j.exppara.2009.02.006; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Wang RJ, 2014, EXP PARASITOL, V142, P11, DOI 10.1016/j.exppara.2014.04.001; Wang RJ, 2011, J CLIN MICROBIOL, V49, P1077, DOI 10.1128/JCM.02194-10; Wang YL, 2010, PARASITOL RES, V106, P341, DOI 10.1007/s00436-009-1664-x; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Ye JB, 2013, VET PARASITOL, V197, P627, DOI 10.1016/j.vetpar.2013.07.021	60	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111164	10.1371/journal.pone.0111164	http://dx.doi.org/10.1371/journal.pone.0111164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343501	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500083
J	Yamamichi, N; Hirano, C; Shimamoto, T; Minatsuki, C; Takahashi, Y; Nakayama, C; Matsuda, R; Fujishiro, M; Konno-Shimizu, M; Kato, J; Kodashima, S; Ono, S; Niimi, K; Mochizuki, S; Tsuji, Y; Sakaguchi, Y; Asada-Hirayama, I; Takeuchi, C; Yakabi, S; Kakimoto, H; Wada, R; Mitsushima, T; Ichinose, M; Koike, K				Yamamichi, Nobutake; Hirano, Chigaya; Shimamoto, Takeshi; Minatsuki, Chihiro; Takahashi, Yu; Nakayama, Chiemi; Matsuda, Rie; Fujishiro, Mitsuhiro; Konno-Shimizu, Maki; Kato, Jun; Kodashima, Shinya; Ono, Satoshi; Niimi, Keiko; Mochizuki, Satoshi; Tsuji, Yosuke; Sakaguchi, Yoshiki; Asada-Hirayama, Itsuko; Takeuchi, Chihiro; Yakabi, Seiichi; Kakimoto, Hikaru; Wada, Ryoichi; Mitsushima, Toru; Ichinose, Masao; Koike, Kazuhiko			Associated Factors of Atrophic Gastritis Diagnosed by Double-Contrast Upper Gastrointestinal Barium X-Ray Radiography: A Cross-Sectional Study Analyzing 6,901 Healthy Subjects in Japan	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SERUM PEPSINOGEN TEST; INTESTINAL METAPLASIA; RANDOMIZED-TRIAL; STOMACH-CANCER; ERADICATION; RISK; PREVALENCE; EPIDEMIOLOGY; PROGRESSION	Background: Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection. Methods: We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach. Results: Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients (beta) and odds ratio (OR) demonstrated that serum HP IgG (beta = 1.499, OR = 4.48), current smoking (beta = 0.526, OR = 1.69), age (beta = 0.401, OR = 1.49), low serum pepsinogen I/II ratio (beta = 0.339, OR = 1.40), and male gender (beta = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H-2-receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects. Conclusions: The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not.	[Yamamichi, Nobutake; Shimamoto, Takeshi; Minatsuki, Chihiro; Takahashi, Yu; Nakayama, Chiemi; Matsuda, Rie; Fujishiro, Mitsuhiro; Konno-Shimizu, Maki; Kodashima, Shinya; Ono, Satoshi; Niimi, Keiko; Mochizuki, Satoshi; Tsuji, Yosuke; Sakaguchi, Yoshiki; Asada-Hirayama, Itsuko; Takeuchi, Chihiro; Yakabi, Seiichi; Kakimoto, Hikaru; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Hirano, Chigaya; Shimamoto, Takeshi; Wada, Ryoichi; Mitsushima, Toru] Kameda Med Ctr Makuhari, Dept Gastroenterol, Chiba, Japan; [Kato, Jun; Ichinose, Masao] Wakayama Med Univ, Dept Internal Med 2, Wakayama, Japan	University of Tokyo; Wakayama Medical University	Yamamichi, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	nyamamic-tky@umin.ac.jp	Ono, Satoshi/H-7900-2019; 藤城, 光弘/AAN-3131-2020; Ono, Satoshi/AFP-6208-2022; Ichinose, Masao/HAB-1645-2022; Takahashi, Yu/I-4665-2015	Ono, Satoshi/0000-0002-9864-348X; Takahashi, Yu/0000-0002-3066-9501; Takeuchi, Chihiro/0000-0002-2746-9189	Takeda Science Foundation; Daiwa Security Health Foundation; Japan Society for the Promotion of Science	Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiwa Security Health Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a research grant from Takeda Science Foundation, in part by a research grant from the Daiwa Security Health Foundation, and also in part by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; Bures J, 2012, WORLD J GASTROENTERO, V18, P4412, DOI 10.3748/wjg.v18.i32.4412; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dheer S, 2002, BRIT J RADIOL, V75, P805, DOI 10.1259/bjr.75.898.750805; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; HISAMICHI S, 1984, JPN J CLIN ONCOL, V14, P211; Hosokawa O, 2008, SCAND J GASTROENTERO, V43, P1112, DOI 10.1080/00365520802085395; Ito M, 2002, ALIMENT PHARM THER, V16, P1449, DOI 10.1046/j.1365-2036.2002.01311.x; Kato M, 2013, DIGEST ENDOSC, V25, P264, DOI 10.1111/j.1443-1661.2012.01385.x; KIMURA K, 1972, GASTROENTEROLOGY, V63, P584; Kimura K, 1969, ENDOSCOPY, V1, P87, DOI DOI 10.1055/S-0028-1098086; Lee KJ, 2006, INT J CANCER, V118, P2315, DOI 10.1002/ijc.21664; Lee SY, 2007, HEPATO-GASTROENTEROL, V54, P630; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Miki K, 2003, AM J GASTROENTEROL, V98, P735, DOI 10.1016/S0002-9270(03)00128-X; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Mizoue T, 2003, INT J CANCER, V106, P103, DOI 10.1002/ijc.11183; Nakajima S, 2010, J GASTROEN HEPATOL, V25, pS99, DOI 10.1111/j.1440-1746.2009.06214.x; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Ohkusa T, 2001, ANN INTERN MED, V134, P380, DOI 10.7326/0003-4819-134-5-200103060-00010; Oishi Y, 2006, AM J EPIDEMIOL, V163, P629, DOI 10.1093/aje/kwj088; OSHIMA A, 1986, INT J CANCER, V38, P829, DOI 10.1002/ijc.2910380608; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Rubesin SE, 2008, RADIOLOGY, V246, P33, DOI 10.1148/radiol.2461061245; Satoh K, 1996, AM J GASTROENTEROL, V91, P963; Shimamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065996; Shiota S, 2010, EXPERT REV GASTROENT, V4, P149, DOI [10.1586/egh.10.7, 10.1586/EGH.10.7]; Sung JJY, 2000, GASTROENTEROLOGY, V119, P7, DOI 10.1053/gast.2000.8550; Takahashi Y, 2013, J GASTROENTEROL; Tatemichi M, 2009, HELICOBACTER, V14, P231, DOI 10.1111/j.1523-5378.2009.00681.x; Tsubono Yoshitaka, 2000, Gastric Cancer, V3, P9, DOI 10.1007/PL00011692; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Yamaji Y, 2001, GUT, V49, P335, DOI 10.1136/gut.49.3.335; Yamamichi N, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-140; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601	43	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111359	10.1371/journal.pone.0111359	http://dx.doi.org/10.1371/journal.pone.0111359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343257	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500098
J	Burrell, TC; Divekar, SD; Weeber, EJ; Rebeck, GW				Burrell, Teal C.; Divekar, Shailaja D.; Weeber, Edwin J.; Rebeck, G. William			Fyn Tyrosine Kinase Increases Apolipoprotein E Receptor 2 Levels and Phosphorylation	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; REELIN SIGNALING PATHWAY; FAMILY-MEMBERS VLDLR; SYNAPTIC PLASTICITY; BRAIN-DEVELOPMENT; PLASMA-MEMBRANE; DIFFERENTIAL FUNCTIONS; CORTICAL-NEURONS; KNOCKOUT MICE	Apolipoprotein E Receptor 2 (ApoER2) and the tyrosine kinase Fyn are both members of the Reelin pathway, a signaling pathway essential for the laminar formation of the cortex during development and proper dendritic spine density and long-term potential (LTP) in the adult brain. In the presence of extracellular Reelin, ApoER2 binds the intracellular protein Dab1, an adaptor protein that is phosphorylated by Fyn. However, direct interactions between ApoER2 and Fyn are not well defined. Here, we show that total levels of ApoER2 and surface levels of ApoER2 are increased by active Fyn. Via a separate mechanism, ApoER2 is also phosphorylated by Fyn, an event that peaks in the postnatal cortex at day 5 and can occur at multiple ApoER2 tyrosine residues. Dab1 is also involved in this phosphorylation, promoting the phosphorylation of ApoER2 by Fyn when it is itself phosphorylated. These results elucidate some of the intracellular mechanisms that give rise to a functional Reelin pathway.	[Burrell, Teal C.; Divekar, Shailaja D.; Rebeck, G. William] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Weeber, Edwin J.] Univ S Florida, Univ South Florida Hlth Byrd Alzheimers Inst, Dept Mol Pharmacol & Physiol, Tampa, FL USA	Georgetown University; State University System of Florida; University of South Florida	Rebeck, GW (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	gwr2@georgetown.edu	Rebeck, George William/J-2192-2012; Weeber, Edwin J/A-5396-2012	Rebeck, George William/0000-0001-6276-248X; 	National Institutes of Health [R01 AG035379, R01 AG030128, T32 NS041218]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035379, P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by National Institutes of Health, R01 AG035379 (GWR EJW); National Institutes of Health, R01 AG030128 (GWT EJW); National Institutes of Health T32 NS041218 (TCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Babus LW, 2011, BRAIN RES, V1415, P96, DOI 10.1016/j.brainres.2011.07.059; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chen KL, 2004, J CELL SCI, V117, P4527, DOI 10.1242/jcs.01320; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Divekar SD, 2014, J BIOL CHEM, V289, P15894, DOI 10.1074/jbc.M113.537548; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Dumanis SB, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-9; Dumanis SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017203; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Feng LB, 2009, MOL CELL BIOL, V29, P324, DOI 10.1128/MCB.00663-08; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Huang YC, 2004, BIOCHEM BIOPH RES CO, V318, P204, DOI 10.1016/j.bbrc.2004.04.023; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Liu ML, 2010, J LIPID RES, V51, P2611, DOI 10.1194/jlr.M006635; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; Minami SS, 2011, J NEUROCHEM, V118, P879, DOI 10.1111/j.1471-4159.2011.07296.x; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Reddy SS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-30; Rice DS, 1998, DEVELOPMENT, V125, P3719; Riddell DR, 2001, J LIPID RES, V42, P998; Sekine K, 2012, NEURON, V76, P353, DOI 10.1016/j.neuron.2012.07.020; Sekine K, 2011, J NEUROSCI, V31, P9426, DOI 10.1523/JNEUROSCI.0650-11.2011; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Sun XM, 1999, EUR J BIOCHEM, V262, P230, DOI 10.1046/j.1432-1327.1999.00394.x; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trotter J, 2013, J NEUROSCI, V33, P15652, DOI 10.1523/JNEUROSCI.2010-13.2013; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhou J, 2006, J PROTEOME RES, V5, P2547, DOI 10.1021/pr060112a	57	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e0110845	10.1371/journal.pone.0110845	http://dx.doi.org/10.1371/journal.pone.0110845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340851	Green Published, gold, Green Submitted			2022-12-26	WOS:000343662800062
J	Liu, TT; Shen, CF; Wang, Y; Huang, CK; Shi, JY				Liu, Tingting; Shen, Chaofeng; Wang, Yi; Huang, Canke; Shi, Jiyan			New Insights into Regulation of Proteome and Polysaccharide in Cell Wall of Elsholtzia splendens in Response to Copper Stress	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; LEAF APOPLAST; PECTIN METHYLESTERASE; EXTRACELLULAR-MATRIX; MALATE-DEHYDROGENASE; OXIDATIVE STRESS; PROTEINS; PLANT; GROWTH; IDENTIFICATION	Background and Aims: Copper (Cu) is an essential micronutrient for plants. However, excess amounts of Cu are toxic and result in a wide range of harmful effects on the physiological and biochemical processes of plants. Cell wall has a crucial role in plant defense response to toxic metals. To date, the process of cell wall response to Cu and the detoxification mechanism have not been well documented at the proteomic level. Methods: An recently developed 6-plex Tandem Mass Tag was used for relative and absolute quantitation methods to achieve a comprehensive understanding of Cu tolerance/detoxification molecular mechanisms in the cell wall. LC-MS/MS approach was performed to analyze the Cu-responsive cell wall proteins and polysaccharides. Key Results: The majority of the 22 up-regulated proteins were involved in the antioxidant defense pathway, cell wall polysaccharide remodeling, and cell metabolism process. Changes in polysaccharide amount, composition, and distribution could offer more binding sites for Cu ions. The 33 down-regulated proteins were involved in the signal pathway, energy, and protein synthesis. Conclusions: Based on the abundant changes in proteins and polysaccharides, and their putative functions, a possible protein interaction network can provide new insights into Cu stress response in root cell wall. Cu can facilitate further functional research on target proteins associated with metal response in the cell wall.	[Liu, Tingting; Shen, Chaofeng; Wang, Yi; Huang, Canke; Shi, Jiyan] Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Shi, JY (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China.	shijiyan@zju.edu.cn	Shen, Chaofeng/I-7138-2013	Shen, Chaofeng/0000-0002-6394-7416	National Natural Science Foundation of China [11179025, 21177109]; Program for New Century Excellent Talents in University [NCET-11-0455]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The work was supported by the National Natural Science Foundation of China (11179025, 21177109) and Program for New Century Excellent Talents in University (NCET-11-0455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan N, 2007, CHEMOSPHERE, V67, P1182, DOI 10.1016/j.chemosphere.2006.10.075; Alves M, 2006, PLANT SOIL, V279, P1, DOI 10.1007/s11104-005-3154-y; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Bhushan D, 2007, MOL CELL PROTEOMICS, V6, P1868, DOI 10.1074/mcp.M700015-MCP200; Blinda A, 1997, PLANT CELL ENVIRON, V20, P969, DOI 10.1111/j.1365-3040.1997.tb00674.x; Bona E, 2007, PROTEOMICS, V7, P1121, DOI 10.1002/pmic.200600712; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNE A, 1994, J EXP BOT, V45, P1189, DOI 10.1093/jxb/45.9.1189; Carafoli E, 2009, HDB NEUROCHEMISTRY M, P581; Chivasa S, 2005, PLANT CELL, V17, P3019, DOI 10.1105/tpc.105.036806; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Dani V, 2005, PROTEOMICS, V5, P737, DOI 10.1002/pmic.200401119; Day A, 2013, PROTEOMICS; Dronnet VM, 1996, PROGR BIOTECHNOL, V14, P535, DOI 10.1016/S0921-0423(96)80283-8; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fecht-Christoffers MM, 2006, PLANT PHYSIOL, V140, P1451, DOI 10.1104/pp.105.070474; Fecht-Christoffers MM, 2003, PLANT PHYSIOL, V133, P1935, DOI 10.1104/pp.103.029215; Feiz L, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-10; Floerl S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-129; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Goulet C, 2010, PROTEOMICS, V10, P2536, DOI 10.1002/pmic.200900382; GROSS GG, 1977, PHYTOCHEMISTRY, V16, P319, DOI 10.1016/0031-9422(77)80055-1; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; HARRISON SJ, 1979, Z PFLANZENPHYSIOL, V94, P27, DOI 10.1016/S0044-328X(79)80245-7; Hossain Z, 2012, J PROTEOME RES, V11, P37, DOI 10.1021/pr200863r; Howard LR, 2000, J AGR FOOD CHEM, V48, P1713, DOI 10.1021/jf990916t; Imin N, 2004, PROTEOMICS, V4, P1873, DOI 10.1002/pmic.200300738; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; Jamet Elisabeth, 2008, V425, P187, DOI 10.1007/978-1-60327-210-0_17; Jarvis MC, 2009, STRUCT CHEM, V20, P245, DOI 10.1007/s11224-009-9427-y; Jensen KA, 2001, APPL ENVIRON MICROB, V67, P2705, DOI 10.1128/AEM.67.6.2705-2711.2001; Kataoka T, 2003, BIOL PLANTARUM, V46, P445, DOI 10.1023/A:1024302924984; KEITH B, 1991, P NATL ACAD SCI USA, V88, P8821, DOI 10.1073/pnas.88.19.8821; Komatsu S, 2010, AMINO ACIDS, V39, P1435, DOI 10.1007/s00726-010-0608-1; Kong FJ, 2010, BBA-PROTEINS PROTEOM, V1804, P124, DOI 10.1016/j.bbapap.2009.09.023; Krzeslowska M, 2011, ACTA PHYSIOL PLANT, V33, P35, DOI 10.1007/s11738-010-0581-z; Kwon HK, 2005, PLANT CELL PHYSIOL, V46, P843, DOI 10.1093/pcp/pci089; Li F, 2009, PLANT MOL BIOL, V71, P251, DOI 10.1007/s11103-009-9521-y; LI ZC, 1989, PLANT PHYSIOL, V90, P185, DOI 10.1104/pp.90.1.185; Liszkay A, 2003, PLANTA, V217, P658, DOI 10.1007/s00425-003-1028-1; Lou LQ, 2004, ENVIRON EXP BOT, V51, P111, DOI 10.1016/j.envexpbot.2003.08.002; Maksymiec W, 1997, PHOTOSYNTHETICA, V34, P321, DOI 10.1023/A:1006818815528; Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Odou MF, 1998, FEMS MICROBIOL LETT, V166, P347, DOI 10.1111/j.1574-6968.1998.tb13911.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pandey A, 2010, J PROTEOME RES, V9, P3443, DOI 10.1021/pr901098p; Paynel F, 2009, ANN BOT-LONDON, V104, P1363, DOI 10.1093/aob/mcp254; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Petersen J, 2003, J MOL EVOL, V57, P16, DOI 10.1007/s00239-002-2441-y; Qu ZL, 2006, PLANT CELL PHYSIOL, V47, P1058, DOI 10.1093/pcp/pcj076; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Soares NC, 2009, J PROTEOME RES, V8, P2298, DOI 10.1021/pr8009353; SPAIN JC, 1979, BIOCHEM BIOPH RES CO, V88, P634, DOI 10.1016/0006-291X(79)92095-3; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; Teisseire H, 2000, PLANT SCI, V153, P65, DOI 10.1016/S0168-9452(99)00257-5; Thounaojam TC, 2012, PLANT PHYSIOL BIOCH, V53, P33, DOI 10.1016/j.plaphy.2012.01.006; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Vinit-Dunand F, 2002, PLANT SCI, V163, P53, DOI 10.1016/S0168-9452(02)00060-2; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Wang SB, 2004, PROTEOMICS, V4, P692, DOI 10.1002/pmic.200300634; Watson BS, 2004, PHYTOCHEMISTRY, V65, P1709, DOI 10.1016/j.phytochem.2004.04.026; Xiong J, 2009, PLANTA, V230, P755, DOI 10.1007/s00425-009-0984-5; Yang JL, 2011, PLANT PHYSIOL, V155, P1885, DOI 10.1104/pp.111.172221; Yang MJ, 2002, J PLANT NUTR, V25, P1359, DOI 10.1081/PLN-120005395; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu M, 2009, J PLANT NUTR SOIL SC, V172, P528, DOI 10.1002/jpln.200800039; Zhang HX, 2009, ANN BOT-LONDON, V103, P923, DOI 10.1093/aob/mcp012; ZHONG HL, 1993, J EXP BOT, V44, P773, DOI 10.1093/jxb/44.4.773; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016723; Zhou XJ, 2010, PLANT MOL BIOL REP, V28, P692, DOI 10.1007/s11105-010-0200-6; Zhu JM, 2006, PLANT PHYSIOL, V140, P311, DOI 10.1104/pp.105.070219	76	25	28	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e109573	10.1371/journal.pone.0109573	http://dx.doi.org/10.1371/journal.pone.0109573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340800	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800009
J	Morais-de-Jesus, M; Daltro-Oliveira, R; Pettersen, KM; Dantas-Duarte, A; Amaral, LD; Cavalcanti-Ribeiro, P; Santos, CT; Schinoni, MI; Netto, LR; Araujo-de-Freitas, L; Parana, R; Miranda-Scippa, A; Koenen, KC; Quarantini, LC				Morais-de-Jesus, Mychelle; Daltro-Oliveira, Renato; Pettersen, Karine Miranda; Dantas-Duarte, Adriana; Amaral, Luciana Di-Domizio; Cavalcanti-Ribeiro, Patricia; Santos, Carlos Teles; Schinoni, Maria Isabel; Netto, Liana R.; Araujo-de-Freitas, Lucas; Parana, Raymundo; Miranda-Scippa, Angela; Koenen, Karestan C.; Quarantini, Lucas C.			Hepatitis C Virus Infection as a Traumatic Experience	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; CENTRAL-NERVOUS-SYSTEM; CROATIAN WAR VETERANS; VIROLOGICAL RESPONSE; COGNITIVE FUNCTION; ADVANCED FIBROSIS; IMPACT; HCV; DEPRESSION	Objective: The purpose of this study was to evaluate whether individuals consider their HCV infection to be a potentially traumatic experience. Additionally, we investigated its association with Post-Traumatic Stress Disorder (PTSD) and the impact of PTSD diagnosis on health-related quality of life (HRQoL) in HCV infected subjects. Methods: We conducted a cross-sectional survey of 127 HCV-infected outpatients recruited at a University Hospital in Salvador, Brazil. All subjects answered an orally-administered questionnaire to gather clinical and socio-demographic data. We investigated traumatic experiences and the subject's perception of the disease using the Trauma History Questionnaire. PTSD and other psychiatric diagnoses were assessed through the Mini International Neuropsychiatric Interview-Brazilian Version 5.0.0 (M.I.N.I. PLUS). HRQoL was assessed using Short-Form 36 (SF-36). Results: Approximately 38.6% of the patients considered hepatitis C to be a traumatic experience. Of these, 60.7% had a PTSD diagnosis. PTSD was associated with significant impairment in quality of life for individuals in seven SF-36 domains as shown bymultivariate analysis: Role-Physical (beta: -24.85; 95% CI: -42.08; -27.61), Bodily Pain (beta: -19.36; 95% CI: -31.28; -7.45), General Health (beta: -20.79; 95% CI: -29.65; -11.92), Vitality (beta: -11.92; 95% CI: -20.74; -3.1), Social Functioning (beta: -34.73; 95% CI: -46.79; -22.68), Role-Emotional (beta: -26.07; 95% CI: -44.61; -7.53), Mental Health (beta: -17.46; 95% CI: -24.38; -10.54). Conclusion: HCV is frequently a traumatic experience and it is strongly associated with PTSD diagnosis. PTSD significantly impaired HRQoL.	[Morais-de-Jesus, Mychelle; Pettersen, Karine Miranda; Dantas-Duarte, Adriana; Cavalcanti-Ribeiro, Patricia; Schinoni, Maria Isabel; Netto, Liana R.; Parana, Raymundo; Miranda-Scippa, Angela; Quarantini, Lucas C.] Univ Fed Bahia, Fac Med, Programa Posgrad Med & Saude, Salvador, BA, Brazil; [Daltro-Oliveira, Renato; Parana, Raymundo] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Amaral, Luciana Di-Domizio] Pontificia Univ Catolica Sao Paulo, Sao Paulo, Brazil; [Santos, Carlos Teles] Univ Estadual Feira de Santana, Dept Ciencias Exatas, Feira De Santana, BA, Brazil; [Santos, Carlos Teles] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Araujo-de-Freitas, Lucas; Miranda-Scippa, Angela; Quarantini, Lucas C.] Univ Fed Bahia, Univ Hosp, Salvador, BA, Brazil; [Araujo-de-Freitas, Lucas; Miranda-Scippa, Angela; Quarantini, Lucas C.] Univ Fed Bahia, Fac Med Bahia, Dept Neurociencias & Saude Mental, Salvador, BA, Brazil; [Koenen, Karestan C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Universidade Federal da Bahia; Universidade Federal da Bahia; Pontificia Universidade Catolica de Sao Paulo; Universidade Estadual de Feira de Santana; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Columbia University	Quarantini, LC (corresponding author), Univ Fed Bahia, Fac Med, Programa Posgrad Med & Saude, Salvador, BA, Brazil.	lcq@ufba.br	quarantini, l/K-8483-2014	Daltro de Oliveira, Renato/0000-0002-8940-9130	National Council of Technological and Scientific Development (CNPq) - Edital Universal MCT/CNPq [474869/2010-5, 14/2010]; Coordination for the Improvement of Higher Level Personnel (CAPES)	National Council of Technological and Scientific Development (CNPq) - Edital Universal MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was partially supported by the National Council of Technological and Scientific Development (CNPq): [474869/2010-5] - Edital Universal MCT/CNPq 14/2010. The rest of the funding (totalizing 100% with the funding above) was supported by the scholarships of the Coordination for the Improvement of Higher Level Personnel (CAPES) of the following authors: Mychelle Morais-de-Jesus; Karine Miranda Pettersen; Adriana Dantas-Duarte; Patricia Cavalcanti-Ribeiro; and Liana R. Netto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amodio P, 2012, WORLD J GASTROENTERO, V18, P2295, DOI 10.3748/wjg.v18.i19.2295; Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Ayuso-Mateos JL., 2002, GLOBAL BURDEN POSTTR; Batista-Neves S, 2009, BRAZ J INFECT DIS, V13, P40, DOI 10.1590/S1413-86702009000100009; Batista-Neves SC, 2008, GEN HOSP PSYCHIAT, V30, P80, DOI 10.1016/j.genhosppsych.2007.08.014; Bonkovsky HL, 2007, J HEPATOL, V46, P420, DOI 10.1016/j.jhep.2006.10.009; Bonkovsky HL, 1999, HEPATOLOGY, V29, P264, DOI 10.1002/hep.510290124; Bras M, 2011, COLLEGIUM ANTROPOL, V35, P681; Butt AA, 2006, J HEPATOL, V44, P864, DOI 10.1016/j.jhep.2006.01.024; Cavalcanti-Ribeire P, 2012, EXPERT REV NEUROTHER, V12, P1023, DOI 10.1586/ERN.12.77; Chopra MP, 2012, AM J GERIAT IN PRESS; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Cordoba J, 2003, J HEPATOL, V39, P231, DOI 10.1016/S0168-8278(03)00189-2; Daltron-Oliveira R, 2013, ANN HEPATOL, V12, P399, DOI 10.1016/S1665-2681(19)31002-6; Dieperink E, 2008, PSYCHOSOMATICS, V49, P225, DOI 10.1176/appi.psy.49.3.225; Fiszman Adriana, 2005, Rev. Bras. Psiquiatr., V27, P63, DOI 10.1590/S1516-44462005000100014; Fontana RJ, 2005, J HEPATOL, V43, P614, DOI 10.1016/j.jhep.2005.04.006; Forton DA, 2005, AIDS, V19, pS53, DOI 10.1097/01.aids.0000192071.72948.77; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Foster GR, 2009, J VIRAL HEPATITIS, V16, P605, DOI 10.1111/j.1365-2893.2009.01154.x; Foster GR, 1998, HEPATOLOGY, V27, P209, DOI 10.1002/hep.510270132; Fry M, 2012, PSYCHOL HEALTH, V27, P460, DOI 10.1080/08870446.2011.592982; Gallegos-Orozco JF, 2003, ARCH MED RES, V34, P124, DOI 10.1016/S0188-4409(03)00003-1; Giacco D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060991; Ginzburg K, 2011, GEN HOSP PSYCHIAT, V33, P565, DOI 10.1016/j.genhosppsych.2011.08.015; Glaesmer H, 2011, GEN HOSP PSYCHIAT, V33, P177, DOI 10.1016/j.genhosppsych.2010.12.006; Goenjian AK, 2011, J AFFECT DISORDERS, V133, P509, DOI 10.1016/j.jad.2011.04.053; Golden J, 2005, GEN HOSP PSYCHIAT, V27, P431, DOI 10.1016/j.genhosppsych.2005.06.006; Helbling B, 2008, GUT, V57, P1597, DOI 10.1136/gut.2007.142844; Hilsabeck RC, 2003, J INT NEUROPSYCH SOC, V9, P847, DOI 10.1017/S1355617703960048; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lekas HM, 2011, QUAL HEALTH RES, V21, P1205, DOI 10.1177/1049732311405684; Lim JK, 2006, J CLIN GASTROENTEROL, V40, P528, DOI 10.1097/00004836-200607000-00012; Mak IWC, 2010, GEN HOSP PSYCHIAT, V32, P590, DOI 10.1016/j.genhosppsych.2010.07.007; Martins T, 2011, REV ASSOC MED BRAS, V57, P107, DOI 10.1590/S0104-42302011000100024; Navines R, 2012, J AFFECT DISORDERS, V138, P343, DOI 10.1016/j.jad.2012.01.018; Netto LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078677; Oser M, 2012, J BEHAV MED; Pantalone DW, 2012, J BEHAV MED, V35, P520, DOI 10.1007/s10865-011-9381-1; Papic N, 2011, CROAT MED J, V52, P35, DOI 10.3325/cmj.2011.52.35; Quarantini LC, 2008, LIVER INT, V28, P893, DOI 10.1111/j.1478-3231.2008.01719.x; Quarantini LC, 2008, J MED VIROL, V80, P419, DOI 10.1002/jmv.21094; Quarantini Lucas C., 2006, Braz J Infect Dis, V10, P406, DOI 10.1590/S1413-86702006000600010; Quarantini LC, 2007, MOVEMENT DISORD, V22, P747, DOI 10.1002/mds.21302; Quarantini LC, 2009, J MED VIROL, V81, P1184, DOI 10.1002/jmv.21508; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Ramos-Casals M, 2005, CURR OPIN RHEUMATOL, V17, P447; Ribeiro WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063545; Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504; Scott KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080573; Seeff Leonard B, 2003, Clin Liver Dis, V7, P261, DOI 10.1016/S1089-3261(02)00078-8; Spiegel BMR, 2005, HEPATOLOGY, V41, P790, DOI 10.1002/hep.20659; Stein MB, 2000, BEHAV RES THER, V38, P619, DOI 10.1016/S0005-7967(99)00098-4; Strauss E, 2006, LIVER INT, V26, P755, DOI 10.1111/j.1478-3231.2006.01331.x; Tassiopoulos K, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-20; Ware JE, 1994, INT J MENT HLTH; Westphal M, 2011, DEPRESS ANXIETY, V28, P686, DOI 10.1002/da.20842; World Health Organization, 2004, PROM MENT HLTH CONC; World Health Organization and World Organization of Family Doctors (Wonca), 2008, INT MENT HLTH PRIM C, V89, P89; Zaidi MA, 2012, CULT HEALTH SEX, V14, P379, DOI 10.1080/13691058.2011.646304	61	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e110529	10.1371/journal.pone.0110529	http://dx.doi.org/10.1371/journal.pone.0110529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZY	25340574	Green Submitted, Green Published, gold			2022-12-26	WOS:000343662800040
J	Cai, LM; Lyu, XM; Luo, WR; Cui, XF; Ye, YF; Yuan, CC; Peng, QX; Wu, DH; Liu, TF; Wang, E; Marincola, FM; Yao, KT; Fang, WY; Cai, HB; Li, X				Cai, L-M; Lyu, X-M; Luo, W-R; Cui, X-F; Ye, Y-F; Yuan, C-C; Peng, Q-X; Wu, D-H; Liu, T-F; Wang, E.; Marincola, F-M; Yao, K-T; Fang, W-Y; Cai, H-B; Li, X.			EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN	ONCOGENE			English	Article							EPSTEIN-BARR-VIRUS; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; ENCODED MICRORNAS; TARGETING PTEN; LUNG-CANCER; E-CADHERIN; EXPRESSION; PROTEIN; INVASION	The epithelial-mesenchymal transition (EMT) is crucial to cancer progression and metastasis. Although multiple cellular miRNAs have been identified to regulate the EMT and metastasis in cancers, the role of viral miRNAs in cancer progression remains largely unknown. Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated malignancy typically characterized by its early metastasis. In the present study, we have discovered the involvement of a viral miRNA, EBV-miR-BART7-3p, in the EMT and metastasis of NPC cells. Initially, we observed that EBV-miR-BART7-3p was highly expressed in NPC and positively correlated with lymph node metastasis and clinical stage of NPC. Subsequently, we demonstrated that EBV-miR-BART7-3p enhanced cell migration/invasion in vitro, cancer metastasis in vivo, and particularly the EMT characterized by loss of epithelial markers and gain of mesenchymal features in NPC cells. Furthermore, mechanistic studies disclosed that EBV-miR-BART7-3p targeted a major human tumor suppressor PTEN, modulating PI3K/Akt/GSK-3 beta signaling and eventually leading to the high expression and nuclear accumulation of Snail and beta-catenin, which favor EMT. Knockdown of PTEN could phenocopy the effect of EBV-miR-BART7-3p, whereas re-expression of PTEN resulted in a phenotypic reversion. Moreover, these findings were supported by an observation of an EBV-positive cell model in which silencing of endogenous EBV-miR-BART7-3p partially attenuated cell migration/invasion and altered EMT protein expression pattern via reverting PI3K/Akt, Snail and beta-catenin expression. Thus, this study suggests a novel mechanism by which EBV-miR-BART7-3p modulates the EMT and metastasis of NPC cells, and a clinical implication of EBV-miR-BART7-3p as a potential biomarker or therapeutic target.	[Cai, L-M; Lyu, X-M; Luo, W-R; Ye, Y-F; Yuan, C-C; Yao, K-T; Fang, W-Y; Li, X.] Southern Med Univ, Canc Res Inst, Guangzhou 510515, Guangdong, Peoples R China; [Lyu, X-M] Southern Med Univ, Dept Lab Med, Affiliated Hosp 3, Guangzhou 510515, Guangdong, Peoples R China; [Cui, X-F] 463 Hosp Chinese PLA, Dept ENT, Shenyang, Peoples R China; [Peng, Q-X; Cai, H-B] Southern Med Univ, Sch Chinese Tradit Med, Guangzhou 510515, Guangdong, Peoples R China; [Wu, D-H] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China; [Liu, T-F] Southern Med Univ, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China; [Wang, E.; Marincola, F-M] NIH, Infect Dis & Immunogenet Sect, DTM, Ctr Clin, Bethesda, MD 20892 USA	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Li, X (corresponding author), Southern Med Univ, Canc Res Inst, Guangzhou 510515, Guangdong, Peoples R China.	fangweiyi1975@yahoo.com.cn; chbing2008@126.com; xinli268@gmail.com	Luo, Weiren/AAI-8364-2020; Lyu, Xiaoming/AAC-8564-2020	Luo, Weiren/0000-0002-2762-6332; Lyu, Xiaoming/0000-0002-6243-3536; Li, Xin/0000-0003-0958-1078	National Natural Science Foundation of China [81372895, 81172586]; Research Fund for the Doctoral Program of Higher Education of China [20134433110013]; Natural Science Foundation of Guangdong Province [S2011010004157]; Guangzhou Science and Technology research project [2014J4100149]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou Science and Technology research project	This study was financially supported by grants from National Natural Science Foundation of China (No. 81372895, 81172586), Research Fund for the Doctoral Program of Higher Education of China (No. 20134433110013), Natural Science Foundation of Guangdong Province (No. S2011010004157) and Guangzhou Science and Technology research project (No. 2014J4100149).	Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cao MR, 2012, INT J ONCOL, V41, P869, DOI 10.3892/ijo.2012.1535; Chan JYW, 2012, ANTICANCER RES, V32, P3201; Chen DY, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-50; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056929; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; Choi H, 2013, J VIROL, V87, P8135, DOI 10.1128/JVI.03159-12; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Colangelo T, 2013, NEOPLASIA, V15, P1204, DOI 10.1593/neo.13998; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; HAUSEN HZ, 1991, SCIENCE, V254, P1167, DOI 10.1126/science.1659743; Ho FCH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-98; Ho MY, 2012, MOL CANCER RES, V10, P1109, DOI 10.1158/1541-7786.MCR-12-0160; Hsu CY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003974; Ikeda A, 2003, J VIROL, V77, P5529, DOI 10.1128/JVI.77.9.5529-5534.2003; Iwakiri D, 2005, ONCOGENE, V24, P1767, DOI 10.1038/sj.onc.1208357; Johansson J, 2013, ONCOGENE, V32, P5614, DOI 10.1038/onc.2013.322; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Ke Y, 2013, BIOCHEM RES INT, V2013, DOI 10.1155/2013/506731; Kim DN, 2007, J VIROL, V81, P1033, DOI 10.1128/JVI.02271-06; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lei T, 2013, INT J CANCER, V133, P79, DOI 10.1002/ijc.28007; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Liu HO, 2012, CANCER SCI, V103, P2072, DOI 10.1111/cas.12017; Lo AKF, 2012, J PATHOL, V227, P392, DOI 10.1002/path.4025; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Luo Zhaohui, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P604, DOI 10.3969/j.issn.1672-7347.2011.07.004; Lyu XM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-51; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; MIN HQ, 1994, INT J RADIAT ONCOL, V30, P1037; Mishra Prajna, 2010, J Mol Signal, V5, P9, DOI 10.1186/1750-2187-5-9; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; Pan YR, 2008, CELL MICROBIOL, V10, P2447, DOI 10.1111/j.1462-5822.2008.01221.x; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Portis T, 2004, ONCOGENE, V23, P8619, DOI 10.1038/sj.onc.1207905; Qiu J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002193; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Ramakrishnan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027271; Rosano L, 2005, CANCER RES, V65, P11649, DOI 10.1158/0008-5472.CAN-05-2123; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Villarejo A, 2014, J BIOL CHEM, V289, P930, DOI 10.1074/jbc.M113.528026; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Wong AMG, 2012, CANCER-AM CANCER SOC, V118, P698, DOI 10.1002/cncr.26309; Yang HJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-314; Ye YF, 2013, BIOCHEM BIOPH RES CO, V436, P19, DOI 10.1016/j.bbrc.2013.05.008; Zhang GJ, 2014, DIGEST DIS SCI, V59, P98, DOI 10.1007/s10620-013-2858-8; Zhang J. P., 2013, ONCOGENE, V33, P4069; Zhang JS, 2012, CANCER METAST REV, V31, P653, DOI 10.1007/s10555-012-9368-6; Zhang LY, 2013, CARCINOGENESIS, V34, P454, DOI 10.1093/carcin/bgs346; Zheng HX, 2013, EUR J CANCER, V49, P2734, DOI 10.1016/j.ejca.2013.03.014	63	141	150	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2156	2166		10.1038/onc.2014.341	http://dx.doi.org/10.1038/onc.2014.341			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	25347742				2022-12-26	WOS:000353473000002
J	Korkegian, A; Roberts, DM; Blair, R; Parish, T				Korkegian, Aaron; Roberts, David M.; Blair, Rachel; Parish, Tanya			Mutations in the Essential Arabinosyltransferase EmbC Lead to Alterations in Mycobacterium tuberculosis Lipoarabinomannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Wall; Glycolipid; Infectious Disease; Mycobacteria; Mycobacterium tuberculosis; Arabinosyltransferase; Essential Gene; Ethambutol	TERMINAL HEXAARABINOFURANOSYL MOTIF; CELL-WALL; BIOSYNTHESIS; BIOGENESIS; ETHAMBUTOL; GENES; ARABINOGALACTAN; RECOGNITION; EXTENSION; ARABINAN	The Mycobacterium tuberculosis cell wall is a complex structure essential for the viability of the organism and its interaction with the host. The glycolipid lipoarabinomannan (LAM) plays an important role in mediating host-bacteria interactions and is involved in modulation of the immune response. The arabinosyltransferase EmbC required for LAM biosynthesis is essential. We constructed recombinant strains of M. tuberculosis expressing a variety of alleles of EmbC. We demonstrated that EmbC has a functional signal peptide in M. tuberculosis. Over- or underexpression of EmbC resulted in reduced or increased sensitivity to ethambutol, respectively. The C-terminal domain of EmbC was essential for activity because truncated alleles were unable to mediate LAM production in Mycobacterium smegmatis and were unable to complement an embC deletion in M. tuberculosis. The C-terminal domain of the closely related arabinosyltransferase EmbB was unable to complement the function of the EmbC C-terminal domain. Two functional motifs were identified. The GT-C motif contains two aspartate residues essential for function in the DDX motif. The proline-rich region contains two highly conserved asparagines (Asn-638 and Asn-652). Mutation of these residues was tolerated, but loss of Asn-638 resulted in the synthesis of truncated LAM, which appeared to lack arabinose branching. All embC alleles that were incapable of complementing LAM production in M. smegmatis were not viable in M. tuberculosis, supporting the hypothesis that LAM itself is essential in M. tuberculosis.	[Korkegian, Aaron; Roberts, David M.; Blair, Rachel; Parish, Tanya] Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98102 USA		Parish, T (corresponding author), Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98102 USA.	tanya.parish@idri.org			NIAID/National Institutes of Health [R21AI81111]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081111] Funding Source: NIH RePORTER	NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NIAID/National Institutes of Health Grant R21AI81111.	Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; Amin AG, 2008, MICROBIOL-SGM, V154, P240, DOI 10.1099/mic.0.2007/012153-0; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Berg S, 2005, J BIOL CHEM, V280, P5651, DOI 10.1074/jbc.M411418200; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; DENG LY, 1995, ANTIMICROB AGENTS CH, V39, P694, DOI 10.1128/AAC.39.3.694; Escuyer VE, 2001, J BIOL CHEM, V276, P48854, DOI 10.1074/jbc.M102272200; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Goude R, 2009, ANTIMICROB AGENTS CH, V53, P4138, DOI 10.1128/AAC.00162-09; Goude R, 2008, J BACTERIOL, V190, P4335, DOI 10.1128/JB.01825-07; Goude Renan, 2008, V465, P203, DOI [10.1007/978-1-59745-207-6_13, 10.3791/761]; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jankute M, 2012, FUTURE MICROBIOL, V7, P129, DOI [10.2217/fmb.11.123, 10.2217/FMB.11.123]; Kaur D, 2002, MICROBIOL-SGM, V148, P3049, DOI 10.1099/00221287-148-10-3049; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Ollinger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060531; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Rademacher C, 2007, J AM CHEM SOC, V129, P10489, DOI 10.1021/ja0723380; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; Shi Libin, 2008, V465, P23, DOI 10.1007/978-1-59745-207-6_3; Sirgel Frederick A., 2008, V465, P173, DOI 10.1007/978-1-59745-207-6_11; STOKES RW, 1995, J IMMUNOL, V155, P1361; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Verbelen C, 2006, FEMS MICROBIOL LETT, V264, P192, DOI 10.1111/j.1574-6968.2006.00443.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	41	12	12	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35172	35181		10.1074/jbc.M114.583112	http://dx.doi.org/10.1074/jbc.M114.583112			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352598	Green Published, hybrid			2022-12-26	WOS:000346660200011
J	Huang, GC; Stock, C; Bommelje, CC; Weeda, VB; Shah, K; Bains, S; Buss, E; Shaha, M; Rechler, W; Ramanathan, SY; Singh, B				Huang, Guochang; Stock, Cameron; Bommelje, Claire C.; Weeda, Viola B.; Shah, Kushyup; Bains, Sarina; Buss, Elizabeth; Shaha, Manish; Rechler, Willi; Ramanathan, Suresh Y.; Singh, Bhuvanesh			SCCRO3 (DCUN1D3) Antagonizes the Neddylation and Oncogenic Activity of SCCRO (DCUN1D1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Head and Neck Cancer; Lung Cancer; Oncogene; Tumor Suppressor Gene; Ubiquitin	SQUAMOUS-CELL-CARCINOMA; CULLIN-RING LIGASES; PROTEIN UBIQUITINATION; NEDD8; MECHANISMS; METHYLATION; CONJUGATION; PROGRESSION; ACTIVATION; SYSTEM	Background: SCCRO3/DCUN1D3 is proposed to function as a tumor suppressor. However, the mechanisms are not well defined. Results: SCCRO3 inhibits SCCRO-promoted nuclear translocation and neddylation of cullins by sequestering them to the cell membrane. Conclusion: SCCRO3 putatively functions as a tumor suppressor by antagonizing the activity of SCCRO. Significance: Understanding how SCCRO and its family members cooperatively regulate cullin neddylation is important for neddylation-targeted cancer therapy. The activity of cullin-RING type ubiquitination E3 ligases is regulated by neddylation, a process analogous to ubiquitination that culminates in covalent attachment of the ubiquitin-like protein Nedd8 to cullins. As a component of the E3 for neddylation, SCCRO/DCUN1D1 plays a key regulatory role in neddylation and, consequently, cullin-RING ligase activity. The essential contribution of SCCRO to neddylation is to promote nuclear translocation of the cullin-ROC1 complex. The presence of a myristoyl sequence in SCCRO3, one of four SCCRO paralogues present in humans that localizes to the membrane, raises questions about its function in neddylation. We found that although SCCRO3 binds to CAND1, cullins, and ROC1, it does not efficiently bind to Ubc12, promote cullin neddylation, or conform to the reaction processivity paradigms, suggesting that SCCRO3 does not have E3 activity. Expression of SCCRO3 inhibits SCCRO-promoted neddylation by sequestering cullins to the membrane, thereby blocking its nuclear translocation. Moreover, SCCRO3 inhibits SCCRO transforming activity. The inhibitory effects of SCCRO3 on SCCRO-promoted neddylation and transformation require both an intact myristoyl sequence and PONY domain, confirming that membrane localization and binding to cullins are required for in vivo functions. Taken together, our findings suggest that SCCRO3 functions as a tumor suppressor by antagonizing the neddylation activity of SCCRO.	[Huang, Guochang; Stock, Cameron; Bommelje, Claire C.; Weeda, Viola B.; Shah, Kushyup; Bains, Sarina; Buss, Elizabeth; Shaha, Manish; Rechler, Willi; Ramanathan, Suresh Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Lab Epithelial Canc Biol, Dept Surg, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	singhb@mskcc.org	Buss, Elizabeth J./AAN-8932-2021	Buss, Elizabeth/0000-0002-5635-3513	National Institutes of Health/NCI Cancer Center Support Grant [P30 CA008748]; Catherine van Tussenbroek Fonds; foundation Vrijvrouwe van Renswoude; Fulbright, The Dutch Cancer Society; Prins Bernhard Culture Foundation; Flight Attendants Medical Research Institute; Hackers for Hope; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health/NCI Cancer Center Support Grant; Catherine van Tussenbroek Fonds; foundation Vrijvrouwe van Renswoude; Fulbright, The Dutch Cancer Society; Prins Bernhard Culture Foundation; Flight Attendants Medical Research Institute; Hackers for Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health/NCI Cancer Center Support Grant P30 CA008748 (to B. S.). This work was also supported in part by grants from the Catherine van Tussenbroek Fonds and the foundation Vrijvrouwe van Renswoude (to C. C. B.); Fulbright, The Dutch Cancer Society, and the Prins Bernhard Culture Foundation (to V. B. W.); and the Clinical Innovator Award from the Flight Attendants Medical Research Institute and a research grant from the Hackers for Hope.	Bommelje CC, 2014, CLIN CANCER RES, V20, P372, DOI 10.1158/1078-0432.CCR-13-1252; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Broderick SR, 2010, NEOPLASIA, V12, P476, DOI 10.1593/neo.10202; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Chen M, 2009, INT J CANCER, V125, P2342, DOI 10.1002/ijc.24642; Desouki MM, 2011, J CANCER RES CLIN, V137, P795, DOI 10.1007/s00432-010-0937-1; DOBROVIC A, 1988, SOMAT CELL MOLEC GEN, V14, P55, DOI 10.1007/BF01535049; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Estilo CL, 2003, CLIN CANCER RES, V9, P2300; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Huang GC, 2013, CLIN CANCER RES, V19, P5549, DOI 10.1158/1078-0432.CCR-13-2117; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jung SH, 2009, EXP MOL MED, V41, P462, DOI 10.3858/emm.2009.41.7.051; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Ma T, 2008, CANCER SCI, V99, P2128, DOI 10.1111/j.1349-7006.2008.00929.x; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Wang J, 2013, CLIN CANCER RES, V19, P5580, DOI 10.1158/1078-0432.CCR-13-0594; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200	39	14	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34728	34742		10.1074/jbc.M114.585505	http://dx.doi.org/10.1074/jbc.M114.585505			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349211	Green Published, hybrid			2022-12-26	WOS:000346260800028
J	Clement, G; Wood, SJ				Clement, Gilles; Wood, Scott J.			Rocking or Rolling - Perception of Ambiguous Motion after Returning from Space	PLOS ONE			English	Article							VERTICAL AXIS ROTATION; LINEAR ACCELERATION; SPATIAL ORIENTATION; SELF-MOTION; PROLONGED WEIGHTLESSNESS; TILT PERCEPTION; EYE-MOVEMENTS; TRANSLATION; MICROGRAVITY; SPACEFLIGHT	The central nervous system must resolve the ambiguity of inertial motion sensory cues in order to derive an accurate representation of spatial orientation. Adaptive changes during spaceflight in how the brain integrates vestibular cues with other sensory information can lead to impaired movement coordination, vertigo, spatial disorientation, and perceptual illusions after return to Earth. The purpose of this study was to compare tilt and translation motion perception in astronauts before and after returning from spaceflight. We hypothesized that these stimuli would be the most ambiguous in the low-frequency range (i.e., at about 0.3 Hz) where the linear acceleration can be interpreted either as a translation or as a tilt relative to gravity. Verbal reports were obtained in eleven astronauts tested using a motion-based tilt-translation device and a variable radius centrifuge before and after flying for two weeks on board the Space Shuttle. Consistent with previous studies, roll tilt perception was overestimated shortly after spaceflight and then recovered with 1-2 days. During dynamic linear acceleration (0.15-0.6 Hz, +/- 1.7 m/s(2)) perception of translation was also overestimated immediately after flight. Recovery to baseline was observed after 2 days for lateral translation and 8 days for fore-aft translation. These results suggest that there was a shift in the frequency dynamic of tilt-translation motion perception after adaptation to weightlessness. These results have implications for manual control during landing of a space vehicle after exposure to microgravity, as it will be the case for human asteroid and Mars missions.	[Clement, Gilles] Int Space Univ, Illkirch Graffenstaden, France; [Clement, Gilles] Lyon Neurosci Res Ctr, Bron, France; [Wood, Scott J.] Azusa Pacific Univ, Azusa, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm)	Clement, G (corresponding author), Int Space Univ, Illkirch Graffenstaden, France.	gilles.clement@isunet.edu	Clement, Gilles/I-1973-2017		National Aeronautics and Space Administration Human Research Program Human Health Countermeasures Element; European Space Agency; Centre National d'Etudes Spatiales	National Aeronautics and Space Administration Human Research Program Human Health Countermeasures Element; European Space Agency(European Space AgencyEuropean Commission); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	This research was supported by the National Aeronautics and Space Administration Human Research Program Human Health Countermeasures Element (SW), the European Space Agency (GC), and the Centre National d'Etudes Spatiales (GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2003, J VESTIBUL RES-EQUIL, V13, P245; Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; ARROTT AP, 1990, AVIAT SPACE ENVIR MD, V61, P319; Benson AJ, 1997, J VESTIBUL RES-EQUIL, V7, P453, DOI 10.1016/S0957-4271(96)00167-X; Benson AJ, 2003, AVIATION MED, P419; CLARK B, 1966, AM J PSYCHOL, V79, P377, DOI 10.2307/1420878; Clemens IAH, 2011, J NEUROSCI, V31, P5365, DOI 10.1523/JNEUROSCI.6472-10.2011; Clement G, 2001, EXP BRAIN RES, V138, P410, DOI 10.1007/s002210100706; Clement G., 2008, NEUROSCIENCE SPACE; Clement G, 2007, J VESTIBUL RES-EQUIL, V17, P209; Clement G, 2013, J VESTIBUL RES-EQUIL, V23, P13, DOI 10.3233/VES-130471; Dai MJ, 2010, EXP BRAIN RES, V204, P207, DOI 10.1007/s00221-010-2305-4; Denise P, 1996, NEUROSCI LETT, V203, P183, DOI 10.1016/0304-3940(96)12303-X; Glasauer S, 1998, BRAIN RES REV, V28, P185, DOI 10.1016/S0165-0173(98)00038-1; GLASAUER S, 1995, ACTA OTO-LARYNGOL, P37; GRAYBIEL A, 1952, AMA ARCH OPHTHALMOL, V48, P605; GRESTY MA, 1992, NEUROSCI LETT, V140, P63, DOI 10.1016/0304-3940(92)90682-W; GUEDRY FE, 1992, ANN NY ACAD SCI, V656, P315, DOI 10.1111/j.1749-6632.1992.tb25218.x; Guedry FE, 1998, BRAIN RES BULL, V47, P475, DOI 10.1016/S0361-9230(98)00087-2; GUEDRY FE, 1974, HDB SENSORY PHYSL, V2, P3; Harm D L, 1993, J Vestib Res, V3, P297; Mayne R, 1974, HDB SENSORY PHYSL, VVI/2, P493; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Merfeld DM, 2003, J VESTIBUL RES-EQUIL, V13, P309; Merfeld DM, 1996, J APPL PHYSIOL, V81, P50, DOI 10.1152/jappl.1996.81.1.50; Paloski W.H., 2018, J GRAVIT PHYSL, V15, P1; PALOSKI WH, 1993, AM J OTOL, V14, P9; PARKER DE, 1985, AVIAT SPACE ENVIR MD, V56, P601; RESCHKE MF, 1987, AVIAT SPACE ENVIR MD, V58, pA153; Reschke MF, 2013, BIOMEDICAL RESULTS S, P171; SCHONE H, 1964, AEROSPACE MED, V35, P764; Seidman SH, 1998, EXP BRAIN RES, V119, P307, DOI 10.1007/s002210050346; Wertheim AH, 2001, PERCEPTION, V30, P733, DOI 10.1068/p3092; Wood SJ, 2007, EXP BRAIN RES, V182, P365, DOI 10.1007/s00221-007-0994-0; Wood SJ, 2002, NEUROSCI LETT, V323, P41, DOI 10.1016/S0304-3940(02)00118-0; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215; Zupan LH, 2005, J VESTIBUL RES-EQUIL, V15, P173	38	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111107	10.1371/journal.pone.0111107	http://dx.doi.org/10.1371/journal.pone.0111107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354042	Green Submitted, Green Published, gold			2022-12-26	WOS:000345204200056
J	Dehon, M; Michez, D; Nel, A; Engel, MS; De Meulemeester, T				Dehon, Manuel; Michez, Denis; Nel, Andre; Engel, Michael S.; De Meulemeester, Thibaut			Wing Shape of Four New Bee Fossils (Hymenoptera: Anthophila) Provides Insights to Bee Evolution	PLOS ONE			English	Article							BALTIC AMBER HYMENOPTERA; GEOMETRIC MORPHOMETRICS; MIDDLE EOCENE; DIVERSIFICATION; PHYLOGENY; CTENOPLECTRELLA; BIOGEOGRAPHY; OLIGOCENE; HISTORY; MIOCENE	Bees (Anthophila) are one of the major groups of angiosperm-pollinating insects and accordingly are widely studied in both basic and applied research, for which it is essential to have a clear understanding of their phylogeny, and evolutionary history. Direct evidence of bee evolutionary history has been hindered by a dearth of available fossils needed to determine the timing and tempo of their diversification, as well as episodes of extinction. Here we describe four new compression fossils of bees from three different deposits (Miocene of la Cerdanya, Spain; Oligocene of Cereste, France; and Eocene of the Green River Formation, U.S.A.). We assess the similarity of the forewing shape of the new fossils with extant and fossil taxa using geometric morphometrics analyses. Predictive discriminant analyses show that three fossils share similar forewing shapes with the Apidae [one of uncertain tribal placement and perhaps near Euglossini, one definitive bumble bee (Bombini), and one digger bee (Anthophorini)], while one fossil is more similar to the Andrenidae. The corbiculate fossils are described as Euglossopteryx biesmeijeri De Meulemeester, Michez, & Engel, gen. nov. sp. nov. (type species of Euglossopteryx Dehon & Engel, n. gen.) and Bombus cerdanyensis Dehon, De Meulemeester, & Engel, sp. nov. They provide new information on the distribution and timing of particular corbiculate groups, most notably the extension into North America of possible Eocene-Oligocene cooling-induced extinctions. Protohabropoda pauli De Meulemeester & Michez, gen. nov. sp. nov. (type species of Protohabropoda Dehon & Engel, n. gen.) reinforces previous hypotheses of anthophorine evolution in terms of ecological shifts by the Oligocene from tropical to mesic or xeric habitats. Lastly, a new fossil of the Andreninae, Andrena antoinei Michez & De Meulemeester, sp. nov., further documents the presence of the today widespread genus Andrena Fabricius in the Late Oligocene of France.	[Dehon, Manuel; Michez, Denis; De Meulemeester, Thibaut] Univ Mons, Res Inst Biosci, Zool Lab, B-7000 Mons, Belgium; [Nel, Andre] Museum Natl Hist Nat, CNRS, Unite Mixte Rech, Dept Entomol, Paris, France; [Engel, Michael S.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Engel, Michael S.] Univ Kansas, Museum Nat Hist, Div Entomol Paleoentomol, Lawrence, KS 66045 USA; [Engel, Michael S.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [De Meulemeester, Thibaut] Nat Biodivers Ctr, Leiden, Netherlands	University of Mons; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); American Museum of Natural History (AMNH); University of Kansas; University of Kansas; Naturalis Biodiversity Center	Dehon, M (corresponding author), Univ Mons, Res Inst Biosci, Zool Lab, B-7000 Mons, Belgium.	manuel.dehon@umons.ac.be	Michez, Denis/L-1370-2019; Engel, Michael S/C-5461-2012	Michez, Denis/0000-0001-8880-1838; Engel, Michael S/0000-0003-3067-077X	Naturalis Biodiversity Museum, Leiden, The Netherlands; Division of Entomology, University of Kansas, Kansas, United States of America	Naturalis Biodiversity Museum, Leiden, The Netherlands; Division of Entomology, University of Kansas, Kansas, United States of America	Funding provided by Naturalis Biodiversity Museum, Leiden, The Netherlands. Represented by Dr. Thibaut and De Meulemeester. The NBC allowed the authors to do a sampling of diverse bee tribes with three submarginal cells. Funding also provided by the Division of Entomology, University of Kansas, Kansas, United States of America. Represented by Prof. Engel. This co-funder provided us one of the four fossils described and analysed: Euglossopteryx biesmeijeri sp. nov.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alexander B.A., 1992, Journal of Hymenoptera Research, V1, P25; Arillo Antonio, 2001, Coloquios de Paleontologia, V52, P79; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Cardinal S, 2007, CLADISTICS, V23, P99, DOI 10.1111/j.1096-0031.2006.00137.x; Cardinal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2686; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; Collomb FM, 2008, ANN SOC ENTOMOL FR, V44, P161, DOI 10.1080/00379271.2008.10697553; Danforth BN, 2013, ANNU REV ENTOMOL, V58, P57, DOI 10.1146/annurev-ento-120811-153633; De Meulemeester T, 2012, J SYST PALAEONTOL, V10, P755, DOI 10.1080/14772019.2011.628701; Dewulf A, 2014, ZOOKEYS, P35, DOI 10.3897/zookeys.389.7076; Dieguez C, 1996, REV PALAEOBOT PALYNO, V94, P329, DOI 10.1016/S0034-6667(96)00004-8; Dubitzky A, 2007, SYST ENTOMOL, V32, P585, DOI 10.1111/j.1365-3113.2007.00397.x; Engel MS, 2008, ACTA ZOOL ACAD SCI H, V54, P319; Engel Michael S., 2004, Transactions of the Kansas Academy of Science, V107, P97, DOI 10.1660/0022-8443(2004)107[0097:NOAMBH]2.0.CO;2; Engel Michael S., 2013, Journal of Melittology, V16, P1; Engel Michael S., 2014, Journal of Melittology, V30, P1; Engel Michael S., 2014, Novitates Paleoentomologicae, V7, P1; Engel Michael S., 2013, Journal of Melittology, V25, P1; Engel MS, 2012, AM MUS NOVIT, P1; Engel MS, 2011, SYST ENTOMOL, V36, P2, DOI 10.1111/j.1365-3113.2010.00544.x; Engel Michael S., 2009, Proceedings of the California Academy of Sciences, V60, P23; Engel Michael S., 2000, American Museum Novitates, V3296, P1, DOI 10.1206/0003-0082(2000)3296<0001:ANIOTO>2.0.CO;2; Engel MS, 1996, J KANSAS ENTOMOL SOC, V69, P334; Engel MS, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)504[0001:AGHBFT]2.0.CO;2; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Engel MS, 2002, NEUES JAHRB GEOL P-A, V225, P251; Engel MS, 2001, T AM ENTOMOL SOC, V127, P245; Engel MS, 2001, P NATL ACAD SCI USA, V98, P1661, DOI 10.1073/pnas.98.4.1661; Engel MS, 1999, AM MUSEUM NOVIT, V3272; Engel MS, 2004, REV TECNOLOGIA AMBIE, V10, P9; Forest CE, 1999, GEOL SOC AM BULL, V111, P497, DOI 10.1130/0016-7606(1999)111<0497:PIAPAB>2.3.CO;2; Franczyk KJ, 1992, US GEOL SURV B Q, V1787-Q; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Gonzalez VH, 2013, SYST ENTOMOL, V38, P645, DOI 10.1111/syen.12029; Gonzalez VH, 2011, ZOOKEYS, P41, DOI 10.3897/zookeys.111.1593; Hail Jr WJ, 1997, 2529 IMAP US GEOL SU; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hinojosa-Diaz IA, 2011, ZOOKEYS, P11, DOI 10.3897/zookeys.97.1106; Huberty C., 2006, APPL MANOVA DISCRIMI; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Kandemir I, 2011, APIDOLOGIE, V42, P618, DOI 10.1007/s13592-011-0063-3; Kotthoff U, 2011, ZOOKEYS, P11, DOI 10.3897/zookeys.96.752; MacGinitie H.D., 1969, U CALIF PUBLS GEOL S, V83, P1; Mayr G, 2000, GEOBIOS-LYON, V33, P625, DOI 10.1016/S0016-6995(00)80034-0; Melo Gabriel A.R., 1999, Scientific Papers Natural History Museum the University of Kansas, V14, P1; MICHENER C D, 1988, American Museum Novitates, P1; Michener C.D., 2007, BEES WORLD, Vsecond; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; Michener CD, 1944, B AM MUS NAT HIST, V82, P152; Michez D, 2007, ZOOL J LINN SOC-LOND, V150, P701, DOI 10.1111/j.1096-3642.2007.00307.x; Michez Denis, 2012, Systematics Association Special Volume Series, V81, P103; Michez D, 2009, ZOOL SCR, V38, P171, DOI 10.1111/j.1463-6409.2008.00362.x; Nel A, 1999, PALAEONTOLOGY, V42, P243, DOI 10.1111/1475-4983.00073; Ohl M., 2007, Denisia, P687; Pavlinov IY, 2001, INFORM TECHNOLOGY BI, P41; Penalver Enrique, 1999, Revista Espanola de Paleontologia, V14, P231; R Development Core Team, 2013, LANG ENV STAT COMP V; Rasmont P, 1988, MONOGRAPHIE ECOLOGIQ; Roberts DW, 2008, ECOLOGY, V89, P1246, DOI 10.1890/07-0136.1; Rohlf, 2013, TPSDIG VERSION 2 17; Rohlf F.J., 2013, TPSSMALL VERSION 1 2; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2013, TPSUTIL VERSION 1 56; Roig-Alsina Arturo, 1993, University of Kansas Science Bulletin, V55, P123; Roil H. H., 1936, Annals of the Entomological Society of America, V29, P99; SCHMIDT-KILLER N, 1985, Senckenbergiana Lethaea, V66, P89; Yazdi F, 2013, J ZOOL SYST EVOL RES, V51, P239, DOI 10.1111/jzs.12020; von Grego H-J, 2002, FLORA TERTIARIA MEDI, V4, P1; Wappler T, 2012, SYST ENTOMOL, V37, P784, DOI 10.1111/j.1365-3113.2012.00642.x; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; Zeuner F. E., 1976, Bulletin of the British Museum (Natural History), Geology, V27, P149	75	20	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e108865	10.1371/journal.pone.0108865	http://dx.doi.org/10.1371/journal.pone.0108865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354170	Green Published, Green Submitted, gold			2022-12-26	WOS:000345204200005
J	Zohdy, S; Gerber, BD; Tecot, S; Blanco, MB; Winchester, JM; Wright, PC; Jernvall, J				Zohdy, Sarah; Gerber, Brian D.; Tecot, Stacey; Blanco, Marina B.; Winchester, Julia M.; Wright, Patricia C.; Jernvall, Jukka			Teeth, Sex, and Testosterone: Aging in the World's Smallest Primate	PLOS ONE			English	Article							RANOMAFANA NATIONAL-PARK; NATURAL-POPULATIONS; MOUSE LEMUR; NEUROFIBRILLARY CHANGES; BALANCE PERFORMANCE; MICROCEBUS-RUFUS; TOOTH WEAR; SURVIVAL; AGE; SENESCENCE	Mouse lemurs (Microcebus spp.) are an exciting new primate model for understanding human aging and disease. In captivity, Microcebus murinus develops human-like ailments of old age after five years (e.g., neurodegeneration analogous to Alzheimer's disease) but can live beyond 12 years. It is believed that wild Microcebus follow a similar pattern of senescence observed in captive animals, but that predation limits their lifespan to four years, thus preventing observance of these diseases in the wild. Testing whether this assumption is true is informative about both Microcebus natural history and environmental influences on senescence, leading to interpretation of findings for models of human aging. Additionally, the study of Microcebus longevity provides an opportunity to better understand mechanisms of sex-biased longevity. Longevity is often shorter in males of species with high male-male competition, such as Microcebus, but mouse lemurs are sexually monomorphic, suggesting similar lifespans. We collected individual-based observations of wild brown mouse lemurs (Microcebus rufus) from 2003-2010 to investigate sex-differences in survival and longevity. Fecal testosterone was measured as a potential mechanism of sex-based differences in survival. We used a combination of high-resolution tooth wear techniques, mark-recapture, and hormone enzyme immunoassays. We found no dental or physical signs of senescence in M. rufus as old as eight years (N = 189, ages 1-8, mean = 2.59 +/- 1.63 SE), three years older than captive, senescent congeners (M. murinus). Unlike other polygynandrous vertebrates, we found no sex difference in age-dependent survival, nor sex or age differences in testosterone levels. While elevated male testosterone levels have been implicated in shorter lifespans in several species, this is one of the first studies to show equivalent testosterone levels accompanying equivalent lifespans. Future research on captive aged individuals can determine if senescence is partially a condition of their captive environment, and studies controlling for various environmental factors will further our understanding of senescence.	[Zohdy, Sarah; Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Zohdy, Sarah; Tecot, Stacey; Blanco, Marina B.; Wright, Patricia C.] Ctr ValBio Res Stn, Ranomafana, Ifanadiana, Madagascar; [Zohdy, Sarah] Emory Univ, Sch Publ Hlth, Dept Environm Studies, Atlanta, GA USA; [Gerber, Brian D.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Colorado Cooperat Fish & Wildlife Res Unit, Ft Collins, CO 80523 USA; [Tecot, Stacey] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [Blanco, Marina B.] Duke Lemur Ctr, Durham, NC USA; [Winchester, Julia M.; Wright, Patricia C.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA	University of Helsinki; Emory University; Colorado State University; University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zohdy, S (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	sarahzohdy@gmail.com	Tecot, Stacey/AAN-6933-2020	TECOT, STACEY/0000-0002-6640-5049; Zohdy, Sarah/0000-0001-5316-0567	Academy of Finland; Juselius Foundation; Viikki Graduate School of Biosciences; EU [MEST-CT-2005-020546]	Academy of Finland(Academy of Finland); Juselius Foundation; Viikki Graduate School of Biosciences; EU(European Commission)	This project was funded by The Academy of Finland, Juselius Foundation, Viikki Graduate School of Biosciences, and EU Marie Curie Early Stage Training, grant number: MEST-CT-2005-020546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM GE, 1972, ANAL LETT, V5, P509, DOI 10.1080/00032717208062116; [Anonymous], 1956, BIOL SENESCENCE; Atsalis S, 1999, INT J PRIMATOL, V20, P193, DOI 10.1023/A:1020518419038; Atsalis S, 1999, INT J PRIMATOL, V20, P883, DOI 10.1023/A:1020826502103; Aujard F, 2004, PHYSIOL BEHAV, V81, P639, DOI 10.1016/j.physbeh.2004.03.003; BARTON RA, 1992, ANIM BEHAV, V43, P831, DOI 10.1016/S0003-3472(05)80206-4; Beltran WA, 2007, VET OPHTHALMOL, V10, P43, DOI 10.1111/j.1463-5224.2007.00491.x; Blanco MB, 2008, INT J PRIMATOL, V29, P323, DOI 10.1007/s10764-008-9238-9; Bonduriansky R, 2002, NATURE, V420, P377, DOI 10.1038/420377a; Bons N, 2006, GENES BRAIN BEHAV, V5, P120, DOI 10.1111/j.1601-183X.2005.00149.x; BONS N, 1991, CR ACAD SCI III-VIE, V313, P213; BONS N, 1994, NEUROBIOL AGING, V15, P215, DOI 10.1016/0197-4580(94)90115-5; Bons N, 1999, NEUROBIOL AGING, V20, P455, DOI 10.1016/S0197-4580(99)00075-5; BONS N, 1992, NEUROBIOL AGING, V13, P99, DOI 10.1016/0197-4580(92)90016-Q; Braude S, 1998, J MAMMAL, V79, P360, DOI 10.2307/1382873; Bronikowski AM, 2011, SCIENCE, V331, P1325, DOI 10.1126/science.1201571; Bryant MJ, 2004, AM NAT, V163, P55, DOI 10.1086/380650; Burnham K.P., 1987, American Fisheries Society Monograph, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Cuozzo FP, 2006, J HUM EVOL, V51, P490, DOI 10.1016/j.jhevol.2006.07.001; D'Agostino P, 1999, ANN NY ACAD SCI, V876, P426, DOI 10.1111/j.1749-6632.1999.tb07667.x; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Galbany J, 2011, AM J PHYS ANTHROPOL, V144, P51, DOI 10.1002/ajpa.21368; Goodman SM., 2003, NATURAL HIST MADAGAS, P1221; Hayflick L, 2000, NATURE, V403, P365, DOI 10.1038/35000303; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; Kendall WL, 1997, ECOLOGY, V78, P563; King SJ, 2005, P NATL ACAD SCI USA, V102, P16579, DOI 10.1073/pnas.0508377102; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Kraus C, 2008, P ROY SOC B-BIOL SCI, V275, P1635, DOI 10.1098/rspb.2008.0200; LYMAN CP, 1981, SCIENCE, V212, P668, DOI 10.1126/science.7221552; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Nemoz-Bertholet F, 2004, EXP GERONTOL, V39, P841, DOI 10.1016/j.exger.2004.01.010; Nemoz-Bertolet F, 2003, EXP GERONTOL, V38, P407, DOI 10.1016/S0531-5565(02)00244-9; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; OTIS DL, 1978, WILDLIFE MONOGR, P1; Owens IP, 2002, SCI SAGE KE, P12; Perret M, 2005, EXP GERONTOL, V40, P582, DOI 10.1016/j.exger.2005.05.002; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Radespiel L, 2003, ANIM BEHAV, V65, P709, DOI 10.1006/anbe.2003.2121; Radespiel U, 2001, AM J PRIMATOL, V54, P181, DOI 10.1002/ajp.1029; Rapaport LG, 2002, INT J PRIMATOL, V23, P1063, DOI 10.1023/A:1019650032735; Ricklefs RE, 2001, EXP GERONTOL, V36, P845, DOI 10.1016/S0531-5565(00)00245-X; ROBERTS SB, 2001, FUNCTIONAL NEUROBIOL, P829; Rose MR, 1994, EVOLUTIONARY BIOL AG; Schmid J, 1998, BEHAV ECOL SOCIOBIOL, V43, P125, DOI 10.1007/s002650050474; SKOGLAND T, 1988, OIKOS, V51, P238, DOI 10.2307/3565648; Tecot SR, 2013, BEHAV ECOL, V24, P987, DOI 10.1093/beheco/art008; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Trivers R. L., 1985, SOCIAL EVOLUTION; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitten PL, 1998, YEARB PHYS ANTHROPOL, V41, P1, DOI 10.1002/(SICI)1096-8644(1998)107:27+<1::AID-AJPA2>3.0.CO;2-H; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Wright P. C., 2003, NATURAL HIST MADAGAS; Wright Patricia C., 1992, Evolutionary Anthropology, V1, P25, DOI 10.1002/evan.1360010108; YOUNG AL, 1990, AM NAT, V135, P473, DOI 10.1086/285057; Ziegler TE, 1996, BIOL REPROD, V54, P91, DOI 10.1095/biolreprod54.1.91	64	24	24	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109528	10.1371/journal.pone.0109528	http://dx.doi.org/10.1371/journal.pone.0109528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354041	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200011
J	Jung, JI; Premraj, S; Cruz, PE; Ladd, TB; Kwak, Y; Koo, EH; Felsenstein, KM; Golde, TE; Ran, Y				Jung, Joo In; Premraj, Sasha; Cruz, Pedro E.; Ladd, Thomas B.; Kwak, Yewon; Koo, Edward H.; Felsenstein, Kevin M.; Golde, Todd E.; Ran, Yong			Independent Relationship between Amyloid Precursor Protein (APP) Dimerization and gamma-Secretase Processivity	PLOS ONE			English	Article							A-BETA PEPTIDES; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; SUBSTRATE SEQUENCE; SENILE PLAQUES; PRESENILIN-1; DEPOSITION; MODULATORS; MUTATIONS; A-BETA-42	Altered production of beta-amyloid (A beta) from the amyloid precursor protein (APP) is closely associated with Alzheimer's disease (AD). APP has a number of homo- and hetero-dimerizing domains, and studies have suggested that dimerization of beta-secretase derived APP carboxyl terminal fragment (CTF beta, C99) impairs processive cleavage by gamma-secretase increasing production of long A beta s (e. g., A beta 1-42, 43). Other studies report that APP CTF beta dimers are not gamma-secretase substrates. We revisited this issue due to observations made with an artificial APP mutant referred to as 3xK-APP, which contains three lysine residues at the border of the APP ectodomain and transmembrane domain (TMD). This mutant, which dramatically increases production of long A beta, was found to form SDS-stable APP dimers, once again suggesting a mechanistic link between dimerization and increased production of long A beta. To further evaluate how multimerization of substrate affects both initial gamma-secretase cleavage and subsequent processivity, we generated recombinant wild type- (WT) and 3xK-C100 substrates, isolated monomeric, dimeric and trimeric forms of these proteins, and evaluated both epsilon-cleavage site utilization and A beta production. These show that multimerization significantly impedes gamma-secretase cleavage, irrespective of substrate sequence. Further, the monomeric form of the 3xK-C100 mutant increased long A beta production without altering the initial epsilon-cleavage utilization. These data confirm and extend previous studies showing that dimeric substrates are not efficient gamma-secretase substrates, and demonstrate that primary sequence determinants within APP substrate alter gamma-secretase processivity.	[Jung, Joo In; Premraj, Sasha; Cruz, Pedro E.; Ladd, Thomas B.; Kwak, Yewon; Felsenstein, Kevin M.; Golde, Todd E.; Ran, Yong] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Jung, Joo In; Cruz, Pedro E.; Ladd, Thomas B.; Felsenstein, Kevin M.; Golde, Todd E.; Ran, Yong] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Jung, Joo In; Cruz, Pedro E.; Ladd, Thomas B.; Felsenstein, Kevin M.; Golde, Todd E.; Ran, Yong] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA; [Premraj, Sasha] Univ Florida, Coll Pharm, Gainesville, FL USA; [Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California San Diego	Golde, TE (corresponding author), Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA.	tgolde@mbi.ufl.edu; yran@ufl.edu			National Institutes of Health (NIH) [AG202063]; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) Grant AG202063 to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Conicella AE, 2014, BIOCHEMISTRY; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jumpertz T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030484; Jung JI, 2014, BIOCHEMISTRY-US, V53, P1947, DOI 10.1021/bi401521t; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matsumura N, 2014, J BIOL CHEM, V289, P5109, DOI 10.1074/jbc.M113.510131; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Moore BD, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt121; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murayama O, 1999, NEUROSCI LETT, V265, P61, DOI 10.1016/S0304-3940(99)00187-1; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Pozdnyakov N, 2013, J BIOL CHEM, V288, P9710, DOI 10.1074/jbc.M112.398602; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; So Pauline Pl, 2012, Am J Neurodegener Dis, V1, P75; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wang H, 2011, J MOL BIOL, V408, P879, DOI 10.1016/j.jmb.2011.03.028; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	53	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111553	10.1371/journal.pone.0111553	http://dx.doi.org/10.1371/journal.pone.0111553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350374	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943100078
J	Flynn, N; Getz, A; Visser, F; Janes, TA; Syed, NI				Flynn, Nichole; Getz, Angela; Visser, Frank; Janes, Tara A.; Syed, Naweed I.			Menin: A Tumor Suppressor That Mediates Postsynaptic Receptor Expression and Synaptogenesis between Central Neurons of Lymnaea stagnalis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; NEOPLASIA TYPE-1 MEN1; GENE-EXPRESSION; SYNAPTIC PLASTICITY; TYROSINE KINASES; MOLLUSK LYMNAEA; MURINE HOMOLOG; NUCLEUS; CASCADE; PROTEIN	Neurotrophic factors (NTFs) support neuronal survival, differentiation, and even synaptic plasticity both during development and throughout the life of an organism. However, their precise roles in central synapse formation remain unknown. Previously, we demonstrated that excitatory synapse formation in Lymnaea stagnalis requires a source of extrinsic NTFs and receptor tyrosine kinase (RTK) activation. Here we show that NTFs such as Lymnaea epidermal growth factor (L-EGF) act through RTKs to trigger a specific subset of intracellular signalling events in the postsynaptic neuron, which lead to the activation of the tumor suppressor menin, encoded by Lymnaea MEN1 (L-MEN1) and the expression of excitatory nicotinic acetylcholine receptors (nAChRs). We provide direct evidence that the activation of the MAPK/ERK cascade is required for the expression of nAChRs, and subsequent synapse formation between pairs of neurons in vitro. Furthermore, we show that L-menin activation is sufficient for the expression of postsynaptic excitatory nAChRs and subsequent synapse formation in media devoid of NTFs. By extending our findings in situ, we reveal the necessity of EGFRs in mediating synapse formation between a single transplanted neuron and its intact presynaptic partner. Moreover, deficits in excitatory synapse formation following EGFR knock-down can be rescued by injecting synthetic L-MEN1 mRNA in the intact central nervous system. Taken together, this study provides the first direct evidence that NTFs functioning via RTKs activate the MEN1 gene, which appears sufficient to regulate synapse formation between central neurons. Our study also offers a novel developmental role for menin beyond tumour suppression in adult humans.	[Syed, Naweed I.] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB, Canada; Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Syed, NI (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB, Canada.	nisyed@ucalgary.ca		Flynn, Nichole/0000-0002-4876-1103; Getz, Angela/0000-0003-1332-2941	Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Innovates - Health Solutions (AI-HS); NSERC; Alberta Innovates [201000307, 200900656] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates - Health Solutions (AI-HS); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant to NIS. NF was funded by Alberta Innovates - Health Solutions (AI-HS), NSERC, and Dr. T. Chen Fong studentships. AG was funded by AI-HS and NSERC studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2007, NEOPLASIA, V9, P101, DOI 10.1593/neo.06706; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Balogh K, 2006, TRENDS ENDOCRIN MET, V17, P357, DOI 10.1016/j.tem.2006.09.004; Bassett JHD, 1999, J BONE MINER RES, V14, P3, DOI 10.1359/jbmr.1999.14.1.3; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Falchetti A, 2009, GENET MED, V11, P825, DOI 10.1097/GIM.0b013e3181be5c97; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guru SC, 1999, MAMM GENOME, V10, P592, DOI 10.1007/s003359901051; Guru SC, 2001, GENE, V263, P31, DOI 10.1016/S0378-1119(00)00562-X; Hamakawa T, 1999, J NEUROSCI, V19, P9306; Hermann PM, 2000, J NEUROSCI, V20, P6355, DOI 10.1523/JNEUROSCI.20-17-06355.2000; Karges W, 1999, BBA-GENE STRUCT EXPR, V1446, P286, DOI 10.1016/S0167-4781(99)00089-5; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kharchenko OA, 2010, NEUROBIOL LEARN MEM, V94, P158, DOI 10.1016/j.nlm.2010.05.002; Kim H, 2003, CANCER RES, V63, P6135; La P, 2006, ONCOGENE, V25, P3537, DOI 10.1038/sj.onc.1209400; Lopez-Egido JR, 2002, EXP CELL RES, V278, P175, DOI 10.1006/excr.2002.5575; Manganelli F, 2014, J NEUROL; Manickam P, 2000, MAMM GENOME, V11, P448, DOI 10.1007/s003350010085; Maruyama K, 1999, MOL CELL ENDOCRINOL, V156, P25, DOI 10.1016/S0303-7207(99)00150-1; Matkar S, 2013, TRENDS BIOCHEM SCI, V38, P394, DOI [10.1016/j.tibs.2013.0S.005, 10.1016/j.tibs.2013.05.005]; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RIDGWAY RL, 1991, J NEUROBIOL, V22, P377, DOI 10.1002/neu.480220406; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Shi L, 2012, TRENDS NEUROSCI, V35, P441, DOI 10.1016/j.tins.2012.04.005; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Stewart C, 1998, ONCOGENE, V17, P2485, DOI 10.1038/sj.onc.1202164; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; SYED NI, 1989, COMP BIOCHEM PHYS A, V93, P633, DOI 10.1016/0300-9629(89)90024-8; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; van Kesteren RE, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0004.2001; van Kesteren RE, 2008, EUR J NEUROSCI, V27, P2043, DOI 10.1111/j.1460-9568.2008.06189.x; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; van Nierop P, 2005, J NEUROSCI, V25, P10617, DOI 10.1523/JNEUROSCI.2015-05.2005; Wautot V, 2000, INT J CANCER, V85, P877, DOI 10.1002/(SICI)1097-0215(20000315)85:6<877::AID-IJC23>3.0.CO;2-F; Wuescher L, 2011, AM J PHYSIOL-ENDOC M, V301, pE474, DOI 10.1152/ajpendo.00022.2011; Xu FL, 2009, J NEUROSCI, V29, P2167, DOI 10.1523/JNEUROSCI.4682-08.2009; Xu S, 2012, NEUROSCIENCE, V223, P473, DOI 10.1016/j.neuroscience.2012.07.036; Zhang H, 2011, CHINESE MED J-PEKING, V124, P1556, DOI 10.3760/cma.j.issn.0366-6999.2011.10.022; Zhang XQ, 2010, CELL MOL NEUROBIOL, V30, P885, DOI 10.1007/s10571-010-9517-9	43	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111103	10.1371/journal.pone.0111103	http://dx.doi.org/10.1371/journal.pone.0111103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347295	gold, Green Submitted, Green Published			2022-12-26	WOS:000347994900047
J	Spenle, C; Lefebvre, O; Lacroute, J; Mechine-Neuville, A; Barreau, F; Blottiere, HM; Duclos, B; Arnold, C; Hussenet, T; Hemmerle, J; Gullberg, D; Kedinger, M; Sorokin, L; Orend, G; Simon-Assmann, P				Spenle, Caroline; Lefebvre, Olivier; Lacroute, Joel; Mechine-Neuville, Agnes; Barreau, Frederick; Blottiere, Herve M.; Duclos, Bernard; Arnold, Christiane; Hussenet, Thomas; Hemmerle, Joseph; Gullberg, Donald; Kedinger, Michele; Sorokin, Lydia; Orend, Gertraud; Simon-Assmann, Patricia			The Laminin Response in Inflammatory Bowel Disease: Protection or Malignancy?	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; NF-KAPPA-B; ULCERATIVE-COLITIS; BASEMENT-MEMBRANE; EXTRACELLULAR-MATRIX; COLORECTAL-CARCINOMA; ALTERED EXPRESSION; TREFOIL PEPTIDES; GENE-EXPRESSION; CROHNS-DISEASE	Laminins (LM), basement membrane molecules and mediators of epithelial-stromal communication, are crucial in tissue homeostasis. Inflammatory Bowel Diseases (IBD) are multifactorial pathologies where the microenvironment and in particular LM play an important yet poorly understood role in tissue maintenance, and in cancer progression which represents an inherent risk of IBD. Here we showed first that in human IBD colonic samples and in murine colitis the LM alpha 1 and LM alpha 5 chains are specifically and ectopically overexpressed with a concomitant nuclear p53 accumulation. Linked to this observation, we provided a mechanism showing that p53 induces LM alpha 1 expression at the promoter level by ChIP analysis and this was confirmed by knockdown in cell transfection experiments. To mimic the human disease, we induced colitis and colitis-associated cancer by chemical treatment (DSS) combined or not with a carcinogen (AOM) in transgenic mice overexpressing LM alpha 1 or LM alpha 5 specifically in the intestine. We demonstrated that high LM alpha 1 or LM alpha 5 expression decreased susceptibility towards experimentally DSS-induced colon inflammation as assessed by histological scoring and decrease of pro-inflammatory cytokines. Yet in a pro-oncogenic context, we showed that LM would favor tumorigenesis as revealed by enhanced tumor lesion formation in both LM transgenic mice. Altogether, our results showed that nuclear p53 and associated overexpression of LM alpha 1 and LM alpha 5 protect tissue from inflammation. But in a mutation setting, the same LM molecules favor progression of IBD into colitis-associated cancer. Our transgenic mice represent attractive new models to acquire knowledge about the paradoxical effect of LM that mediate either tissue reparation or cancer according to the microenvironment. In the early phases of IBD, reinforcing basement membrane stability/ organization could be a promising therapeutic approach.	[Spenle, Caroline; Lefebvre, Olivier; Lacroute, Joel; Arnold, Christiane; Hussenet, Thomas; Kedinger, Michele; Orend, Gertraud; Simon-Assmann, Patricia] MNT3 Team, Inserm U1109, Strasbourg, France; [Spenle, Caroline; Lefebvre, Olivier; Lacroute, Joel; Arnold, Christiane; Hussenet, Thomas; Hemmerle, Joseph; Kedinger, Michele; Orend, Gertraud; Simon-Assmann, Patricia] Univ Strasbourg, Strasbourg, France; [Spenle, Caroline; Lefebvre, Olivier; Arnold, Christiane; Hussenet, Thomas; Orend, Gertraud; Simon-Assmann, Patricia] Univ Strasbourg, LabEx Med, Strasbourg, France; [Spenle, Caroline; Lefebvre, Olivier; Arnold, Christiane; Hussenet, Thomas; Hemmerle, Joseph; Orend, Gertraud; Simon-Assmann, Patricia] FMTS, Strasbourg, France; [Lacroute, Joel; Duclos, Bernard] CHRU Hautepierre, Dept Gastroenterol, Strasbourg, France; [Mechine-Neuville, Agnes] CHRU Hautepierre, Dept Anat & Pathol, Strasbourg, France; [Barreau, Frederick] Inserm U843, Paris, France; [Blottiere, Herve M.] INRA, UMR1319, Jouy En Josas, France; [Blottiere, Herve M.] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Hemmerle, Joseph] Inserm U1121, Strasbourg, France; [Gullberg, Donald] Univ Bergen, Dept Biomed, Bergen, Norway; [Sorokin, Lydia] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bergen; University of Munster	Simon-Assmann, P (corresponding author), MNT3 Team, Inserm U1109, Strasbourg, France.	Patricia.Simon-Assmann@inserm.fr	Spenlé, Caroline/Z-6177-2019; BLOTTIERE, Hervé M/C-6120-2011; Lefebvre, Olivier/I-2388-2016; Lefebvre, Olivier/S-6436-2019; Spenle, Caroline/P-6284-2016; Orend, Gertraud/E-8446-2015; Gullberg, Donald/H-2495-2016	Spenlé, Caroline/0000-0002-6353-3109; BLOTTIERE, Hervé M/0000-0002-8390-0607; Lefebvre, Olivier/0000-0001-9130-9174; Lefebvre, Olivier/0000-0001-9130-9174; Spenle, Caroline/0000-0002-6353-3109; Orend, Gertraud/0000-0003-2522-1195; Gullberg, Donald/0000-0002-7245-4437; Barreau, Frederick/0000-0002-7150-9619; Sorokin, Lydia/0000-0001-7704-7921	Ligue Contre le Cancer; Association pour La Recherche sur le Cancer; Institut National du Cancer; Inserm and the University of Strasbourg; Cells-in-Motion Cluster of Excellence, University of Muenster, Germany; French Ministry of Research and Education	Ligue Contre le Cancer(Ligue nationale contre le cancer); Association pour La Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Inserm and the University of Strasbourg; Cells-in-Motion Cluster of Excellence, University of Muenster, Germany; French Ministry of Research and Education	This work has been supported in part by research grants from the Ligue Contre le Cancer (PSA), the Association pour La Recherche sur le Cancer (GO), the Institut National du Cancer (PSA, GO) and by institutional funding from Inserm and the University of Strasbourg. LS is supported by the Cells-in-Motion Cluster of Excellence, University of Muenster, Germany. CS was recipient of fellowships from the French Ministry of Research and Education and the Ligue contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam D, 2000, MICROSC RES TECHNIQ, V51, P228, DOI 10.1002/1097-0029(20001101)51:3<228::AID-JEMT3>3.0.CO;2-9; Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Bouatrouss Y, 2000, AM J PATHOL, V156, P45, DOI 10.1016/S0002-9440(10)64704-9; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Burstein E, 2008, J CLIN INVEST, V118, P464, DOI [10.1172/JC134831, 10.1172/JCI34831]; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; De Arcangelis A, 2001, INT J CANCER, V94, P44, DOI 10.1002/ijc.1444; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Francoeur C, 2004, AM J PHYSIOL-GASTR L, V287, pG592, DOI 10.1152/ajpgi.00535.2003; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Halfter W, 2013, CELL ADHES MIGR, V7, P64, DOI 10.4161/cam.22479; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Holmberg J, 2013, CELL ADHES MIGR, V7, P111, DOI 10.4161/cam.22618; Itzkowitz SH, 2004, GASTROENTEROLOGY, V126, P1634, DOI 10.1053/j.gastro.2004.03.025; Kaci G, 2011, APPL ENVIRON MICROB, V77, P4681, DOI 10.1128/AEM.03021-10; Kaneko Y, 2008, J MOL HISTOL, V39, P161, DOI 10.1007/s10735-007-9149-7; Katz E, 2007, INT J BIOCHEM CELL B, V39, P715, DOI 10.1016/j.biocel.2006.11.004; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Lange K, 2007, CANCER RES, V67, P6163, DOI 10.1158/0008-5472.CAN-06-3348; Lashner BA, 1999, AM J GASTROENTEROL, V94, P456, DOI 10.1016/S0002-9270(98)00758-8; Leedham SJ, 2009, GASTROENTEROLOGY, V136, P542, DOI 10.1053/j.gastro.2008.10.086; Longman RJ, 2000, GUT, V47, P792, DOI 10.1136/gut.47.6.792; Lotz MM, 1997, AM J PATHOL, V150, P747; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Orian-Rousseau V, 1998, J CELL SCI, V111, P1993; Piccinni SA, 2004, J BIOL CHEM, V279, P9103, DOI 10.1074/jbc.M305804200; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RIEDL SE, 1992, GASTROENTEROLOGY, V103, P400, DOI 10.1016/0016-5085(92)90827-L; RILEY SA, 1991, GUT, V32, P174, DOI 10.1136/gut.32.2.174; Schmehl K, 2000, INT J COLORECTAL DIS, V15, P39, DOI 10.1007/s003840050006; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Simon-Assmann P, 2010, PROG MOL BIOL TRANSL, V96, P175, DOI 10.1016/S1877-1173(10)96008-0; Simon-Assmann P, 2013, CELL ADHES MIGR, V7, P44, DOI 10.4161/cam.23276; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Spenle C, 2012, PATHOL BIOL, V60, P41, DOI 10.1016/j.patbio.2011.10.005; Takeba Y, 2007, J PHARMACOL SCI, V104, P232, DOI 10.1254/jphs.FP0070442; Teller I C, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003623; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thompson AI, 2011, INFLAMM BOWEL DIS, V17, P831, DOI 10.1002/ibd.21375; Turck N, 2005, EXP CELL RES, V303, P494, DOI 10.1016/j.yexcr.2004.10.025; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; WRIGHT NA, 1990, NATURE, V343, P82, DOI 10.1038/343082a0; WRIGHT NA, 1992, SCAND J GASTROENTERO, V27, P76, DOI 10.3109/00365529209096010; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378; Yoshida T, 2003, J PATHOL, V199, P166, DOI 10.1002/path.1264; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Yurchenco P.D., 2011, COLD SPRING HARB PER, V3; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	57	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111336	10.1371/journal.pone.0111336	http://dx.doi.org/10.1371/journal.pone.0111336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347196	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900062
J	Dong, Z; Luo, Y; Zhang, ZW; Cai, HS; Li, YB; Chan, T; Wu, L; Li, ZP; Feng, ST				Dong, Zhi; Luo, Yanji; Zhang, Zhongwei; Cai, Huasong; Li, Yanbing; Chan, Tao; Wu, Ling; Li, Zi-Ping; Feng, Shi-Ting			MR Quantification of Total Liver Fat in Patients with Impaired Glucose Tolerance and Healthy Subjects	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; SAMPLING VARIABILITY; HEPATIC STEATOSIS; DISEASE; ADULTS; EPIDEMIOLOGY; SPECTROSCOPY; FIBROSIS	Objective: To explore the correlations between liver fat content and clinical index in patients with impaired glucose tolerance (IGT) and healthy subjects. Materials and Methods: 56 subjects were enrolled and each of them underwent upper-abdominal MRI examination that involved a T1 VIBE Dixon sequence. 14 was clinically diagnosed with IGT (collectively as IGT group) while 42 showed normal glucose tolerance,(collectively as NGT group). NGT group was further divided into NGTFat (BMI >= 25, 18 subjects) and NGTLean (BMI<25, 24 subjects). The total liver fat contents was measured and compared with clinical findings and laboratory results in order to determine statistical correlations between these parameters. Differences among IGT, NGTFat and NGTLean groups were evaluated. Results: For all the subjects, fat volume fractions (FVFs) ranged from 4.2% to 24.2%, positive correlations was observed with BMI, waist hip ratio(WHR), low density lipoprotein(LDL), fasting plasma insulin(FPI), homeostasis model assessment insulin resistance (HOMA-IR) and homeostasis model assessment beta(HOMA beta). FVFs of IGT group (p = 0.004) and NGTFat group (p = 0.006) were significantly higher than those of NGTLean group. Conclusions: People with higher BMI, WHR and LDL levels tend to have higher liver fat content. Patients with BMI >= 25 are more likely to develop IGT. Patients with higher FVF showed higher resistance to insulin, thus obtained a higher risk of developing type 2 diabetes mellitus.	[Dong, Zhi; Luo, Yanji; Cai, Huasong; Li, Zi-Ping; Feng, Shi-Ting] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Zhongwei] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Diabet, Guangzhou 510275, Guangdong, Peoples R China; [Chan, Tao] Union Hosp, Dept Med Imaging, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University; Sun Yat Sen University	Li, ZP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China.	liziping163@163.com; fst1977@163.com	li, yan/GTI-4638-2022		National Natural Science Foundation of China [81000626]; Natural Science Foundation of Guangdong Province [S2013010016004]; Zhujiang Scientific and Technological New Star Foundation [2012J2200084]; Fundamental Research Funds for the Central Universities [10ykpy11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Zhujiang Scientific and Technological New Star Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by National Natural Science Foundation of China (81000626), Natural Science Foundation of Guangdong Province (S2013010016004), Zhujiang Scientific and Technological New Star Foundation (2012J2200084), and the Fundamental Research Funds for the Central Universities (10ykpy11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bernard CP, 2008, J MAGN RESON IMAGING, V27, P192, DOI 10.1002/jmri.21201; Bydder M, 2008, MAGN RESON IMAGING, V26, P347, DOI 10.1016/j.mri.2007.08.012; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; Fernandez-Salazar L, 2011, SCAND J GASTROENTERO, V46, P727, DOI 10.3109/00365521.2011.558112; Guiu B, 2009, RADIOLOGY, V250, P95, DOI 10.1148/radiol.2493080217; Hu HH, 2010, OBESITY, V18, P841, DOI 10.1038/oby.2009.352; Kammen BF, 2001, AM J ROENTGENOL, V177, P1035, DOI 10.2214/ajr.177.5.1771035; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Leporq B, 2013, EUR RADIOL, V23, P2175, DOI 10.1007/s00330-013-2826-x; Ligabue G, 2013, QUANT IMAGING MED SU, V3, P192, DOI 10.3978/j.issn.2223-4292.2013.08.01; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Meisamy S, 2011, RADIOLOGY, V258, P767, DOI 10.1148/radiol.10100708; Monteiro Paula A, 2013, BMC Res Notes, V6, P89, DOI 10.1186/1756-0500-6-89; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Reeder SB, 2009, J MAGN RESON IMAGING, V29, P1332, DOI 10.1002/jmri.21751; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Yokoo T, 2011, RADIOLOGY, V258, P749, DOI 10.1148/radiol.10100659; Yokoo T, 2009, RADIOLOGY, V251, P67, DOI 10.1148/radiol.2511080666	28	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111283	10.1371/journal.pone.0111283	http://dx.doi.org/10.1371/journal.pone.0111283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343445	Green Published, gold, Green Submitted			2022-12-26	WOS:000343943500094
J	Goncalves, E; Herrera, I; Duarte, M; Bustamante, RO; Lampo, M; Velasquez, G; Sharma, GP; Garcia-Rangel, S				Goncalves, Estefany; Herrera, Ileana; Duarte, Milen; Bustamante, Ramiro O.; Lampo, Margarita; Velasquez, Grisel; Sharma, Gyan P.; Garcia-Rangel, Shaenandhoa			Global Invasion of Lantana camara : Has the Climatic Niche Been Conserved across Continents?	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; RANGE EXPANSION; EVOLUTION; SHIFTS; PREDICTION; RARE	Lantana camara, a native plant from tropical America, is considered one of the most harmful invasive species worldwide. Several studies have identified potentially invasible areas under scenarios of global change, on the assumption that niche is conserved during the invasion process. Recent studies, however, suggest that many invasive plants do not conserve their niches. Using Principal Components Analyses (PCA), we tested the hypothesis of niche conservatism for L. camara by comparing its native niche in South America with its expressed niche in Africa, Australia and India. Using MaxEnt, the estimated niche for the native region was projected onto each invaded region to generate potential distributions there. Our results demonstrate that while L. camara occupied subsets of its original native niche in Africa and Australia, in India its niche shifted significantly. There, 34% of the occurrences were detected in warmer habitats nonexistent in its native range. The estimated niche for India was also projected onto Africa and Australia to identify other vulnerable areas predicted from the observed niche shift detected in India. As a result, new potentially invasible areas were identified in central Africa and southern Australia. Our findings do not support the hypothesis of niche conservatism for the invasion of L. camara. The mechanisms that allow this species to expand its niche need to be investigated in order to improve our capacity to predict long-term geographic changes in the face of global climatic changes.	[Goncalves, Estefany; Herrera, Ileana; Lampo, Margarita; Velasquez, Grisel] Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Venezuela; [Goncalves, Estefany; Garcia-Rangel, Shaenandhoa] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela; [Duarte, Milen; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, Dept Cs Ecol, Santiago, Chile; [Duarte, Milen; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile; [Sharma, Gyan P.] Univ Delhi, Dept Environm Studies, Delhi 110007, India	Venezuelan Institute Science Research; Simon Bolivar University; Universidad de Chile; Universidad de Chile; University of Delhi	Herrera, I (corresponding author), Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Venezuela.	herrera.ita@gmail.com; rbustama@uchile.cl; mlampo@ivic.gob.ve	BUSTAMANTE, RAMIRO/I-7353-2019; Herrera, Ileana/F-8732-2017	Herrera, Ileana/0000-0002-7201-7085; Duarte, Milen/0000-0003-4784-9880; Lampo, Margarita/0000-0002-3669-701X	Instituto Venezolano de Investigaciones Cientificas, Venezuela; Instituto de Ecologia y Biodiversidad-Universidad de Chile, Chile [ICM P05-002]; Centre of Excellence for Invasion Biology (CIB), University of Stellenbosch, South Africa; University of Delhi, India	Instituto Venezolano de Investigaciones Cientificas, Venezuela; Instituto de Ecologia y Biodiversidad-Universidad de Chile, Chile; Centre of Excellence for Invasion Biology (CIB), University of Stellenbosch, South Africa; University of Delhi, India(University of Delhi)	This project received financial support from Instituto Venezolano de Investigaciones Cientificas, Venezuela (to IH); Instituto de Ecologia y Biodiversidad-Universidad de Chile, Chile (project ICM P05-002 to ROB), Centre of Excellence for Invasion Biology (CIB), University of Stellenbosch, South Africa for the Post Doctoral funding (to GPS) and a seed and research grant -University of Delhi, India (to GPS). UniSig-Instituto Venezolano de Investigaciones Cientificas provided the computers used in modeling. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2003, ACIAR MONOGRAPH; [Anonymous], 2011, ECOLOGICAL NICHES GE; Baars JR, 2003, BIOCONTROL, V48, P743, DOI 10.1023/A:1026389207517; BAKER AJ, 1987, EVOLUTION, V41, P525, DOI 10.1111/j.1558-5646.1987.tb05823.x; Bhagwat SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032407; Bradley BA, 2013, BIOL INVASIONS, V15, P1417, DOI 10.1007/s10530-012-0380-0; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; EASTEAL S, 1989, BIOL J LINN SOC, V37, P281, DOI 10.1111/j.1095-8312.1989.tb01906.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Ensbey R, 2003, MANAGING LANTANA; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; GISIN, 2013, GLOB INV SPEC INF NE; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; HOWARD R A, 1969, Arnoldia (Jamaica Plain), V29, P73; Johnson S, 2008, REV DECLARATION LANT; Lowe S., 2000, ENCY BIOL INVASIONS; Lui XiangRong, 2011, Computational Ecology and Software, V1, P60; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Mukherjee A, 2012, BIOL INVASIONS, V14, P1415, DOI 10.1007/s10530-011-0168-7; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; Parsons W.T., 2001, NOXIOUS WEEDS AUSTR, Vsecond; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Ray A, 2014, PLANT BIOLOGY, V16, P651, DOI 10.1111/plb.12087; Rouget M, 2004, DIVERS DISTRIB, V10, P475, DOI 10.1111/j.1366-9516.2004.00118.x; Sanders Roger W., 2006, SIDA Contributions to Botany, V22, P381; SANDERS RW, 1987, AM J BOT, V74, P914, DOI 10.2307/2443872; Sharma GR, 2005, WEED BIOL MANAG, V5, P157, DOI 10.1111/j.1445-6664.2005.00178.x; Smith L.S., 1982, QUEENSLAND BOT B, V1, P1; Stirton C. H., 1977, Proceedings of the Second National Weeds Conference of South Africa., P321; Swarbrick J. T., 1995, Plant Protection Quarterly, V10, P82; Taylor S, 2012, WEED RES, V52, P391, DOI 10.1111/j.1365-3180.2012.00930.x; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Van Oosterhout E., 2004, LANTANA CONTROL MANU; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Webber BL, 2012, SCIENCE, V338, DOI 10.1126/science.1225980; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x	51	48	49	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111468	10.1371/journal.pone.0111468	http://dx.doi.org/10.1371/journal.pone.0111468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343481	gold, Green Published, Green Submitted			2022-12-26	WOS:000343943500101
J	Clark, AA; Dotson, CD; Elson, AET; Voigt, A; Boehm, U; Meyerhof, W; Steinle, NI; Munger, SD				Clark, Adam A.; Dotson, Cedrick D.; Elson, Amanda E. T.; Voigt, Anja; Boehm, Ulrich; Meyerhof, Wolfgang; Steinle, Nanette I.; Munger, Steven D.			TAS2R bitter taste receptors regulate thyroid function	FASEB JOURNAL			English	Article						G protein-coupled receptor; iodide; thyroxine; thyrocyte; T2R	OLD ORDER AMISH; IODIDE EFFLUX; ALCOHOL-CONSUMPTION; CHEMOSENSORY CELLS; EATING BEHAVIOR; GENE TAS2R38; FAMILY; PHENYLTHIOCARBAMIDE; SENSITIVITY; EXPRESSION	Dysregulation of thyroid hormones triiodothyronine and thyroxine (T3/T4) can impact metabolism, body composition, and development. Thus, it is critical to identify novel mechanisms that impact T3/T4 production. We found that type 2 taste receptors (TAS2Rs), which are activated by bitter-tasting compounds such as those found in many foods and pharmaceuticals, negatively regulate thyroid-stimulating hormone (TSH)-dependent Ca2+ increases and TSH-dependent iodide efflux in thyrocytes. Immunohistochemical Tas2r-dependent reporter expression and real-time PCR analyses reveal that human and mouse thyrocytes and the Nthy-Ori 3-1 human thyrocyte line express several TAS2Rs. Five different agonists for thyrocyte-expressed TAS2Rs reduced TSH-dependent Ca2+ release in Nthy-Ori 3-1 cells, but not basal Ca2+ levels, in a dose-dependent manner. Ca2+ responses were unaffected by 6-n-propylthiouracil, consistent with the expression of an unresponsive variant of its cognate receptor, TAS2R38, in these cells. TAS2R agonists also inhibited basal and TSH-dependent iodide efflux. Furthermore, a common TAS2R42 polymorphism is associated with increased serum T4 levels in a human cohort. Our findings indicate that TAS2Rs couple the detection of bitter-tasting compounds to changes in thyrocyte function and T3/T4 production. Thus, TAS2Rs may mediate a protective response to overingestion of toxic materials and could serve as new druggable targets for therapeutic treatment of hypo-or hyperthyroidism.	[Clark, Adam A.; Dotson, Cedrick D.; Elson, Amanda E. T.; Munger, Steven D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Clark, Adam A.; Munger, Steven D.] Univ Maryland, Sch Med, Toxicol Program, Baltimore, MD 21201 USA; [Elson, Amanda E. T.; Munger, Steven D.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Steinle, Nanette I.; Munger, Steven D.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Voigt, Anja; Meyerhof, Wolfgang] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany; [Boehm, Ulrich] Univ Saarland, Sch Med, Dept Pharmacol & Toxicol, Homburg, Germany	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Saarland University	Munger, SD (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, 1200 Newell Dr,ARB 5-204,POB 100267, Gainesville, FL 32610 USA.	steven.munger@ufl.edu		Dotson, Cedrick/0000-0003-0992-1191; Elson, Amanda/0000-0002-5744-5954	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010110] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC010110] Funding Source: Medline; NIDDK NIH HHS [P30 DK072488] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Allen AL, 2013, CHEM SENSES, V38, P379, DOI 10.1093/chemse/bjt017; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Behrens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040304; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Campa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045232; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; CORDA D, 1985, J BIOL CHEM, V260, P9230; Crofton KM, 2008, INT J ANDROL, V31, P209, DOI 10.1111/j.1365-2605.2007.00857.x; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dotson CD, 2012, CHEM SENSES, V37, P737, DOI 10.1093/chemse/bjs063; Dotson CD, 2010, APPETITE, V54, P93, DOI 10.1016/j.appet.2009.09.011; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; Dumont J., 2011, ONTOGENY ANATOMY MET; Fong PY, 2011, J PHYSIOL-LONDON, V589, P5929, DOI 10.1113/jphysiol.2011.218594; Foster SR, 2014, FASEB J, V28, P4497, DOI 10.1096/fj.14-256305; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Franklyn JA, 2012, LANCET, V379, P1155, DOI 10.1016/S0140-6736(11)60782-4; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Hinrichs AL, 2006, AM J HUM GENET, V78, P103, DOI 10.1086/499253; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; NAGASAKA A, 1976, J CLIN ENDOCR METAB, V43, P152, DOI 10.1210/jcem-43-1-152; Pfaffl MW., 2006, REAL TIME PCR, P63; Powell JG, 2004, ONCOGENE, V23, P3634, DOI 10.1038/sj.onc.1207399; Prandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082820; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; RASPE E, 1994, ENDOCRINOLOGY, V135, P986, DOI 10.1210/en.135.3.986; Robinett KS, 2011, AM J RESP CELL MOL, V45, P1069, DOI 10.1165/rcmb.2011-0061OC; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Timpson NJ, 2005, AM J CLIN NUTR, V81, P1005; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Wang JC, 2007, ALCOHOL CLIN EXP RES, V31, P209, DOI 10.1111/j.1530-0277.2006.00297.x; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1108, DOI 10.1210/endo-114-4-1108; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Xu J, 2013, MOL HUM REPROD, V19, P17, DOI 10.1093/molehr/gas040; Yang RB, 2007, J COMP NEUROL, V502, P883, DOI 10.1002/cne.21317	59	90	91	1	74	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					164	172		10.1096/fj.14-262246	http://dx.doi.org/10.1096/fj.14-262246			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25342133	Green Published			2022-12-26	WOS:000347378600016
J	Choi, YJ; Lai, WS; Fedic, R; Stumpo, DJ; Huang, WC; Li, LP; Perera, L; Brewer, BY; Wilson, GM; Mason, JM; Blackshear, PJ				Choi, Youn-Jeong; Lai, Wi S.; Fedic, Robert; Stumpo, Deborah J.; Huang, Weichun; Li, Leping; Perera, Lalith; Brewer, Brandy Y.; Wilson, Gerald M.; Mason, James M.; Blackshear, Perry J.			The Drosophila Tis11 Protein and Its Effects on mRNA Expression in Flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; mRNA Decay; Post-transcriptional Regulation; RNA-binding Protein; Zinc Finger; AU-rich Elements; Deadenylation	ZINC-FINGER PROTEINS; AU-RICH ELEMENT; TRISTETRAPROLIN FAMILY; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; FORCE-FIELD; BINDING; DEGRADATION; DEADENYLATION; STABILITY	Members of the mammalian tristetraprolin family of CCCH tandem zinc finger proteins can bind to certain AU-rich elements (AREs) in mRNAs, leading to their deadenylation and destabilization. Mammals express three or four members of this family, but Drosophila melanogaster and other insects appear to contain a single gene, Tis11. We found that recombinant Drosophila Tis11 protein could bind to ARE-containing RNA oligonucleotides with low nanomolar affinity. Remarkably, co-expression in mammalian cells with target RNAs demonstrated that Tis11 could promote destabilization of ARE-containing mRNAs and that this was partially dependent on a conserved C-terminal sequence resembling the mammalian NOT1 binding domain. Drosophila Tis11 promoted both deadenylation and decay of a target transcript in this heterologous cell system. We used chromosome deletion/duplication and P element insertion to produce two types of Tis11 deficiency in adult flies, both of which were viable and fertile. To address the hypothesis that Tis11 deficiency would lead to the abnormal accumulation of potential target transcripts, we analyzed gene expression in adult flies by deep mRNA sequencing. We identified 69 transcripts from 56 genes that were significantly up-regulated more than 1.5-fold in both types of Tis11-deficient flies. Ten of the up-regulated transcripts encoded probable proteases, but many other functional classes of proteins were represented. Many of the up-regulated transcripts contained potential binding sites for tristetraprolin family member proteins that were conserved in other Drosophila species. Tis11 is thus an ARE-binding, mRNA-destabilizing protein that may play a role in post-transcriptional gene expression in Drosophila and other insects.	[Choi, Youn-Jeong; Lai, Wi S.; Stumpo, Deborah J.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Fedic, Robert; Mason, James M.] NIEHS, Lab Mol Genet, NIH, Res Triangle Pk, NC 27709 USA; [Huang, Weichun; Li, Leping] NIEHS, Lab Biostat, NIH, Res Triangle Pk, NC 27709 USA; [Perera, Lalith] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Brewer, Brandy Y.; Wilson, Gerald M.] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University System of Maryland; University of Maryland Baltimore; Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, NIH, 111 Alexander Dr,F1-13, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	perera, Lalith/B-6879-2012; Perera, Lalith/ABB-9995-2021; Wilson, Gerald/AAF-3874-2019; Li, Leping/F-6497-2019; Blackshear, Perry J./C-6206-2019	perera, Lalith/0000-0003-0823-1631; Li, Leping/0000-0003-4208-0259; Blackshear, Perry J./0000-0002-9561-8529; Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health (NIH), NIEHS, Intramural Research Program; NIH [R01 CA102428]; Oliver Smithies Visiting Professorship at Balliol College, Oxford; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZICES043010, ZIAES101765, ZIAES090080] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIEHS, Intramural Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oliver Smithies Visiting Professorship at Balliol College, Oxford; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health (NIH), NIEHS, Intramural Research Program and by NIH Grant R01 CA102428 (to G. M. W.). This work was also supported by an Oliver Smithies Visiting Professorship at Balliol College, Oxford (to P. J. B.).	Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Blackshear PJ, 2014, J INTERF CYTOK RES, V34, P297, DOI 10.1089/jir.2013.0150; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cairrao F, 2009, MOL CELL BIOL, V29, P2636, DOI 10.1128/MCB.01506-08; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen HH, 2007, BIOCHEM BIOPH RES CO, V357, P56, DOI 10.1016/j.bbrc.2007.03.113; Chen HX, 2004, FEBS LETT, V561, P181, DOI 10.1016/S0014-5793(04)00161-9; Ciais D, 2013, CELL MOL LIFE SCI, V70, P2031, DOI 10.1007/s00018-012-1150-y; Cuthbertson BJ, 2008, J BIOL CHEM, V283, P2586, DOI 10.1074/jbc.M707154200; De J, 1999, GENE, V228, P133, DOI 10.1016/S0378-1119(98)00617-9; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; Huang WC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr592; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAMESON DM, 1995, METHOD ENZYMOL, V246, P283; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2013, AM J PHYSIOL-REG I, V305, pR689, DOI 10.1152/ajpregu.00310.2013; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1998, J BIOL CHEM, V273, P506, DOI 10.1074/jbc.273.1.506; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lauwers A, 2009, J BIOL CHEM, V284, P8973, DOI 10.1074/jbc.M806778200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA QF, 1994, ONCOGENE, V9, P3329; NAKANISHI Y, 1986, GENE, V46, P79; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; RAHA D, 1990, DEV GENET, V11, P310, DOI 10.1002/dvg.1020110410; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Soller M, 2005, MOL CELL BIOL, V25, P7580, DOI 10.1128/MCB.25.17.7580-7591.2005; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Toba G, 2002, J CELL SCI, V115, P2413; Twyffels L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071686; Wei YH, 2009, NUCLEIC ACIDS RES, V37, P6550, DOI 10.1093/nar/gkp693; Wells ML, 2012, MOL CELL BIOL, V32, P4206, DOI 10.1128/MCB.00325-12; WILSON GM, 2005, REV FLUORESC, P223; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Yeh PA, 2012, INT J BIOL SCI, V8, P606, DOI 10.7150/ijbs.3782	60	16	16	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35042	35060		10.1074/jbc.M114.593491	http://dx.doi.org/10.1074/jbc.M114.593491			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25342740	Green Published, hybrid			2022-12-26	WOS:000346660200001
J	Klop, B; van der Pol, P; van Bruggen, R; Wang, YA; de Vries, MA; van Santen, S; O'Flynn, J; van de Geijn, GJM; Njo, TL; Janssen, HW; de Man, P; Jukema, JW; Rabelink, TJ; Rensen, PCN; van Kooten, C; Cabezas, MC				Klop, Boudewijn; van der Pol, Pieter; van Bruggen, Robin; Wang, Yanan; de Vries, Marijke A.; van Santen, Selvetta; O'Flynn, Joseph; van de Geijn, Gert-Jan M.; Njo, Tjin L.; Janssen, Hans W.; de Man, Peter; Jukema, J. Wouter; Rabelink, Ton J.; Rensen, Patrick C. N.; van Kooten, Cees; Cabezas, Manuel Castro			Differential Complement Activation Pathways Promote C3b Deposition on Native and Acetylated LDL thereby Inducing Lipoprotein Binding to the Complement Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Complement; Erythrocyte; Leukocyte; Lipoprotein; Low-density Lipoprotein (LDL); C3b; CR1; Complement Activation; Receptor	RED-BLOOD-CELLS; LECTIN PATHWAY; IMMUNOLOGY; CLEARANCE; CR-1; C1Q	Lipoproteins can induce complement activation resulting in opsonization and binding of these complexes to complement receptors. We investigated the binding of opsonized native LDL and acetylated LDL (acLDL) to the complement receptor 1 (CR1). Binding of complement factors C3b, IgM, C1q, mannose-binding lectin (MBL), and properdin to LDL and acLDL were investigated by ELISA. Subsequent binding of opsonized LDL and acLDL to CR1 on CR1-transfected Chinese Hamster Ovarian cells (CHO-CR1) was tested by flow cytometry. Both native LDL and acLDL induced complement activation with subsequent C3b opsonization upon incubation with normal human serum. Opsonized LDL and acLDL bound to CR1. Binding to CHO-CR1 was reduced by EDTA, whereas MgEGTA only reduced the binding of opsonized LDL, but not of acLDL suggesting involvement of the alternative pathway in the binding of acLDL to CR1. In vitro incubations showed that LDL bound C1q, whereas acLDL bound to C1q, IgM, and properdin. MBL did neither bind to LDL nor to acLDL. The relevance of these findings was demonstrated by the fact that ex vivo up-regulation of CR1 on leukocytes was accompanied by a concomitant increased binding of apolipoprotein B-containing lipoproteins to leukocytes without changes in LDL-receptor expression. In conclusion, CR1 is able to bind opsonized native LDL and acLDL. Binding of LDL to CR1 is mediated via the classical pathway, whereas binding of acLDL is mediated via both the classical and alternative pathways. Binding of lipoproteins to CR1 may be of clinical relevance due to the ubiquitous cellular distribution of CR1.	[Klop, Boudewijn; de Vries, Marijke A.; van Santen, Selvetta] St Franciscus Gasthuis, Dept Internal Med, Diabet & Vasc Ctr, NL-3004 BA Rotterdam, Netherlands; [van de Geijn, Gert-Jan M.; Njo, Tjin L.; Janssen, Hans W.] St Franciscus Gasthuis, Dept Clin Chem, NL-3004 BA Rotterdam, Netherlands; [de Man, Peter] St Franciscus Gasthuis, Dept Med Microbiol, NL-3004 BA Rotterdam, Netherlands; [van der Pol, Pieter; O'Flynn, Joseph; Rabelink, Ton J.; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, NL-1006 AN Leiden, Netherlands; [Wang, Yanan; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-1006 AN Leiden, Netherlands; [Wang, Yanan; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, NL-1006 AN Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-1006 AN Leiden, Netherlands; [van Bruggen, Robin] Sanquin Res, NL-1006 AN Amsterdam, Netherlands	Franciscus Gasthuis; Franciscus Gasthuis; Franciscus Gasthuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cabezas, MC (corresponding author), Sint Franciscus Gasthuis Rotterdam, Dept Internal Med, Ctr Diabet & Vasc Med, POB 10900, NL-3004 BA Rotterdam, Netherlands.	m.castrocabezas@sfg.nl	van Kooten, Cees/E-5694-2018; Wang, Yanan/C-4143-2019; Rabelink, Ton J./A-5316-2008; Jukema, J. Wouter/ABD-6503-2021; Rensen, Patrick C.N./D-7176-2018	van Kooten, Cees/0000-0002-6257-0899; Wang, Yanan/0000-0002-0327-0458; Rabelink, Ton J./0000-0001-6780-5186; Jukema, J. Wouter/0000-0002-3246-8359; Rensen, Patrick C.N./0000-0002-8455-4988				Alipour A, 2009, ATHEROSCLEROSIS, V206, P444, DOI 10.1016/j.atherosclerosis.2009.03.007; Alipour A, 2008, ARTERIOSCL THROM VAS, V28, P792, DOI 10.1161/ATVBAHA.107.159749; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Biro A, 2007, MOL IMMUNOL, V44, P1169, DOI 10.1016/j.molimm.2006.06.013; Bovenberg SA, 2010, ATHEROSCLEROSIS SUPP, V11, P25, DOI 10.1016/j.atherosclerosissup.2010.04.003; Bovenberg SA, 2012, EUR J CLIN INVEST, V42, P365, DOI 10.1111/j.1365-2362.2011.02591.x; CORNACOFF JB, 1983, J CLIN INVEST, V71, P236, DOI 10.1172/JCI110764; Ebrahimi KB, 2013, J PATHOL, V229, P729, DOI 10.1002/path.4128; Faro J, 2008, CLIN EXP IMMUNOL, V151, P275, DOI 10.1111/j.1365-2249.2007.03538.x; FEARON DT, 1983, ANNU REV IMMUNOL, V1, P243, DOI 10.1146/annurev.iy.01.040183.001331; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; Fraser DA, 2010, J IMMUNOL, V185, P3932, DOI 10.4049/jimmunol.1002080; Gaarkeuken H, 2008, AM J PHYSIOL-RENAL, V295, pF1397, DOI 10.1152/ajprenal.90313.2008; Gauvreau D, 2012, MOL IMMUNOL, V51, P73, DOI 10.1016/j.molimm.2012.02.110; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hinderling PH, 1997, PHARMACOL REV, V49, P279; Hung KT, 2012, ARTERIOSCL THROM VAS, V32, P1460, DOI 10.1161/ATVBAHA.112.248971; Klop B, 2013, INT J LAB HEMATOL, V35, P644, DOI 10.1111/ijlh.12103; Klop B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075573; Kojima M, 2003, ADV EXP MED BIOL, V535, P229; Langeggen H, 2002, INFLAMMATION, V26, P103, DOI 10.1023/A:1015585530204; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Nickells M, 1998, CLIN EXP IMMUNOL, V112, P27; Oksjoki R, 2003, CURR OPIN LIPIDOL, V14, P477, DOI 10.1097/00041433-200310000-00008; QUADRI RA, 1992, SCAND J IMMUNOL, V36, P125, DOI 10.1111/j.1365-3083.1992.tb02948.x; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; VANBERKEL TJC, 1982, BIOCHEM J, V208, P493, DOI 10.1042/bj2080493; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WAXMAN FJ, 1984, J CLIN INVEST, V74, P1329, DOI 10.1172/JCI111543; WILSON JG, 1982, NEW ENGL J MED, V307, P981, DOI 10.1056/NEJM198210143071604; Ye Q, 2014, INFLAMMATION, V37, P555, DOI 10.1007/s10753-013-9769-x	39	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35421	35430		10.1074/jbc.M114.573840	http://dx.doi.org/10.1074/jbc.M114.573840			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25349208	hybrid, Green Published			2022-12-26	WOS:000346660200032
J	Goel, S; Muthusamy, A; Miao, J; Cui, LW; Salanti, A; Winzeler, EA; Gowda, DC				Goel, Suchi; Muthusamy, Arivalagan; Miao, Jun; Cui, Liwang; Salanti, Ali; Winzeler, Elizabeth A.; Gowda, D. Channe			Targeted Disruption of a Ring-infected Erythrocyte Surface Antigen (RESA)-like Export Protein Gene in Plasmodium falciparum Confers Stable Chondroitin 4-Sulfate Cytoadherence Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Surface Protein; Chondroitin Sulfate; Glycosaminoglycan; Malaria; Parasite; Plasmodium	MUTUALLY EXCLUSIVE EXPRESSION; MALARIA PARASITE; SULFATE PROTEOGLYCANS; MEMBRANE PROTEIN-1; VIRULENCE GENES; HUMAN PLACENTA; ADHERENCE; VAR2CSA; BINDING; PFEMP1	Background: Factors that influence the cytoadherence property of P. falciparum are not completely understood. Results: Targeted disruption of the gene that encodes a RESA-like protein in P. falciparum results in stable and increased chondroitin 4-sulfate-dependent cytoadherence capacity. Conclusion: A RESA-like protein gene regulates PfEMP1 expression and cytoadherence of P. falciparum. Significance: Our findings provide a significant insight into the regulation of P. falciparum cytoadherence. The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family proteins mediate the adherence of infected erythrocytes to microvascular endothelia of various organs, including the placenta, thereby contributing to cerebral, placental, and other severe malaria pathogenesis. Several parasite proteins, including KAHRP and PfEMP3, play important roles in the cytoadherence by mediating the clustering of PfEMP1 in rigid knoblike structures on the infected erythrocyte surface. The lack of a subtelomeric region of chromosome 2 that contains kahrp and pfemp3 causes reduced cytoadherence. In this study, microarray transcriptome analysis showed that the absence of a gene cluster, comprising kahrp, pfemp3, and four other genes, results in the loss of parasitized erythrocytes adhering to chondroitin 4-sulfate (C4S). The role of one of these genes, PF3D7_0201600/PFB0080c, which encodes PHISTb (Plasmodium helical interspersed subtelomeric b) domain-containing RESA-like protein 1 expressed on the infected erythrocyte surface, was investigated. Disruption of PFB0080c resulted in increased var2csa transcription and VAR2CSA surface expression, leading to higher C4S-binding capacity of infected erythrocytes. Further, PFB0080c-knock-out parasites stably maintained the C4S adherence through many generations of growth. Although the majority of PFB0080c-knock-out parasites bound to C4S even after culturing for 6 months, a minor population bound to both C4S and CD36. These results strongly suggest that the loss of PFB0080c markedly compromises the var gene switching process, leading to a marked reduction in the switching rate and additional PfEMP1 expression by a minor population of parasites. PFB0080c interacts with VAR2CSA and modulates knob-associated Hsp40 expression. Thus, PFB0080c may regulate VAR2CSA expression through these processes. Overall, we conclude that PFB0080c regulates PfEMP1 expression and the parasite's cytoadherence.	[Goel, Suchi; Muthusamy, Arivalagan; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Miao, Jun; Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Salanti, Ali] Copenhagen Univ Hosp, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, DK-2014 Copenhagen, Denmark; [Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Copenhagen; University of California System; University of California San Diego	Goel, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17165 Stockholm, Sweden.	suchigoel@gmail.com; gowda@psu.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113; Gowda, Channe/0000-0002-6860-5108; MIAO, JUN/0000-0001-9374-6749; Salanti, Ali/0000-0003-2207-5575	National Institutes of Health, NIAID [R01 AI45086, R01 AI10358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045086] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grants R01 AI45086 (to D. C. G.) and R01 AI10358 (to E. A. W.).	Acharya P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044605; Achur RN, 2008, BIOCHEMISTRY-US, V47, P12635, DOI 10.1021/bi801643m; Achur RN, 2003, J BIOL CHEM, V278, P11705, DOI 10.1074/jbc.M211015200; Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brolin KJM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r117; Cooke BM, 2002, BRIT J HAEMATOL, V117, P203, DOI 10.1046/j.1365-2141.2002.03404.x; Cowman A F, 1984, Mol Biol Med, V2, P207; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dzikowski R, 2007, EMBO REP, V8, P959, DOI 10.1038/sj.embor.7401063; Flick K, 2004, MOL BIOCHEM PARASIT, V134, P3, DOI 10.1016/j.molbiopara.2003.09.010; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Goel S, 2010, P NATL ACAD SCI USA, V107, P16643, DOI 10.1073/pnas.1002568107; Gowda ASP, 2007, J BIOL CHEM, V282, P916, DOI 10.1074/jbc.M604741200; GREENWALT DE, 1992, BLOOD, V80, P1105; Grover M, 2013, PARASITE, V20, DOI 10.1051/parasite/2012002; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kilili GK, 2011, EUKARYOT CELL, V10, P1439, DOI 10.1128/EC.05180-11; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; LANZER M, 1994, NUCLEIC ACIDS RES, V22, P4176, DOI 10.1093/nar/22.20.4176; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Le Roch KG, 2002, AM J TROP MED HYG, V67, P233, DOI 10.4269/ajtmh.2002.67.233; Madhunapantula SV, 2007, INFECT IMMUN, V75, P4409, DOI 10.1128/IAI.00478-07; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Parish LA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-160; Pei XH, 2007, BLOOD, V110, P1036, DOI 10.1182/blood-2007-02-076919; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Silva MD, 2005, MOL MICROBIOL, V56, P990, DOI 10.1111/j.1365-2958.2005.04603.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2003, BLOOD, V102, P1911, DOI 10.1182/blood-2002-11-3513; Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35; World Heath Organization, 2012, WORLD MAL REP 2013; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013; Zhou YY, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-3	58	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34408	34421		10.1074/jbc.M114.615393	http://dx.doi.org/10.1074/jbc.M114.615393			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342752	Green Published, hybrid			2022-12-26	WOS:000346077600059
J	Bai, B; Wang, YQ; Meng, J; Li, Q; Jin, X				Bai, Bin; Wang, Yuanqing; Meng, Jin; Li, Qian; Jin, Xun			New Early Eocene Basal tapiromorph from Southern China and Its Phylogenetic Implications	PLOS ONE			English	Article							EARLY TERTIARY; MIDDLE EOCENE; PERISSODACTYLA; MAMMALIA; PAKISTAN; SYSTEMATICS; RADIATION; ORIGIN	A new Early Eocene tapiromorph, Meridiolophus expansus gen. et sp. nov., from the Sanshui Basin, Guangdong Province, China, is described and discussed. It is the first reported Eocene mammal from the basin. The new taxon, represented by a left fragmentary mandible, is characterized by an expanded anterior symphyseal region, a long diastema between c1 and p1, a rather short diastema between p1 and p2, smaller premolars relative to molars, an incipient metaconid appressed to the protoconid on p3, a prominent entoconid on p4, molar metaconid not twinned, cristid obliqua extending mesially and slightly lingually from the hypoconid, inclined metalophid and hypolophid, and small hypoconulid on the lower preultimate molars. Meridiolophus is morphologically intermediate between basal Homogalax-like taxa and derived tapiromorphs (such as Heptodon). Phylogenetic analysis indicates Equidae is more closely related to Tapiromorpha than to Palaeotheriidae, although the latter is only represented by a single species Pachynolophus eulaliensis. 'Isectolophidae', with exception of Meridiolophus and Karagalax, has the closest affinity with Chalicotherioidea. Furthermore, the majority rule consensus tree shows that Meridiolophus is closer to Karagalax than to any other 'isectolophid', and both genera represent stem taxa to crown group Ceratomorpha.	[Bai, Bin; Wang, Yuanqing; Meng, Jin; Li, Qian; Jin, Xun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Bai, Bin; Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH)	Bai, B (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	baibin@ivpp.ac.cn; wangyuanqing@ivpp.ac.cn	Bai, Bin/D-6898-2013	Bai, Bin/0000-0003-4394-8689	China Scholarship Council; Chinese Academy of Sciences [KZCX2-EW-106]; National Basic Research Program of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [41002009]; Special Fund for Fossil Excavation and Preparation, CAS; China Geological Survey [1212011120115, 1212011120142]; Frick Funds from the Division of Paleontology, American Museum of Natural History	China Scholarship Council(China Scholarship Council); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Fossil Excavation and Preparation, CAS; China Geological Survey(China Geological Survey); Frick Funds from the Division of Paleontology, American Museum of Natural History	This research was supported by China Scholarship Council, Chinese Academy of Sciences (KZCX2-EW-106), National Basic Research Program of China (973 Program) (2012CB821900), the National Natural Science Foundation of China (41002009), the Special Fund for Fossil Excavation and Preparation, CAS, the China Geological Survey (Nos. 1212011120115 and 1212011120142) and the Frick Funds from the Division of Paleontology, American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiola A, 2005, GEOBIOS-LYON, V38, P1, DOI 10.1016/j.geobios.2003.07.005; Bai B, 2010, AM MUS NOVIT, P1, DOI 10.1206/678.1; Colbert MW, 1998, EVOLUTION TERTIARY M, P569; Danilo L, 2013, J VERTEBR PALEONTOL, V33, P195, DOI 10.1080/02724634.2012.711404; Froehlich DJ, 1999, J VERTEBR PALEONTOL, V19, P140, DOI 10.1080/02724634.1999.10011129; Froehlich DJ, 2002, ZOOL J LINN SOC-LOND, V134, P141, DOI 10.1046/j.1096-3642.2002.00005.x; GINGERICH P D, 1991, Contributions from the Museum of Paleontology University of Michigan, V28, P181; Gingerich P.D., 1989, U MICHIGAN PAPERS PA, V28, P1; Gingerich PD, 2003, J VERTEBR PALEONTOL, V23, P643, DOI 10.1671/2409; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Holbrook LT, 2004, J VERTEBR PALEONTOL, V24, P951, DOI 10.1671/0272-4634(2004)024[0951:SOTEPM]2.0.CO;2; Holbrook LT, 2001, ZOOL J LINN SOC-LOND, V132, P1, DOI 10.1006/zjls.2000.0262; Holbrook LT, 2011, J VERTEBR PALEONTOL, V31, P895, DOI 10.1080/02724634.2011.579669; Hooker J.J., 2010, MONOGRAPH PALAEONTOG, V165, P1; Hooker Jeremy J., 2005, P199; Hooker J, 2007, J VERTEBR PALEONTOL, V27, p91A; Hooker JJ, 2004, PALAEONTOLOGY, V47, P1363, DOI 10.1111/j.0031-0239.2004.00421.x; HOOKER JJ, 1984, ZOOL J LINN SOC-LOND, V82, P229, DOI 10.1111/j.1096-3642.1984.tb00545.x; HOOKER JJ, 1989, EVOLUTION PERISSODAC, P00079; LI CK, 1979, VERTEBRAT PALASIATIC, V17, P71; Maas MC, 2001, J PALEONTOL, V75, P407, DOI 10.1666/0022-3360(2001)075<0407:ANITPM>2.0.CO;2; Maddison WP, 2011, MESQUITE MODULAR SYS; Missiaen P, 2013, GEOL BELG, V16, P262; Missiaen P, 2012, ACTA PALAEONTOL POL, V57, P21, DOI 10.4202/app.2010.0093; RADINSKY LEONARD, 1963, PEABODY MUS NAT HIST BULL, V17, P1; ROSE KD, 2006, BEGINNING AGE MAMMAL; SIMPSON GEORGE GAYLORD, 1941, AMER MUS NOVITATES, V1136, P1; Steiner CC, 2011, ZOOL J LINN SOC-LOND, V163, P1289, DOI 10.1111/j.1096-3642.2011.00752.x; [孙勃 SUN Bo], 2009, [地层学杂志, Journal of Stratigraphy], V33, P62; Thewissen JGM, 2001, J VERTEBR PALEONTOL, V21, P347, DOI 10.1671/0272-4634(2001)021[0347:EMFFNI]2.0.CO;2; Ting Su-Yin, 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V3, P201; Ting Suyin, 1998, Bulletin of Carnegie Museum of Natural History, V34, P124; Tong Y.S., 2006, PALEONT SIN NEW SER, V28, P1; Wang Banyue, 1997, Vertebrata Palasiatica, V35, P44; Wang JK, 1981, GUANGDONG PALAEONT C, V22, P1; Wang M, 2012, ACTA PALAEONTOL POL, V57, P519, DOI 10.4202/app.2011.0061; Wang Yuan, 1995, Vertebrata Palasiatica, V33, P138; Wang Yuan-Qing, 2011, Vertebrata Palasiatica, V49, P123; Wang YQ, 2010, SCI CHINA EARTH SCI, V53, P1918, DOI 10.1007/s11430-010-4095-8; Young CC, 1944, AM MUS NOVIT, P1; Zdansky O., 1930, PALAEONTOL SINICA, V6, P5; Zhang X., 1993, DIVISION CORRELATION, P179; Zhang Xian-qiu, 2010, Acta Palaeontologica Sinica, V49, P487; Zhang Xianqiu, 1999, Guangdong Geology, V14, P53	44	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110806	10.1371/journal.pone.0110806	http://dx.doi.org/10.1371/journal.pone.0110806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353987	gold, Green Published, Green Submitted			2022-12-26	WOS:000345204200038
J	Chen, JR; Liu, F; Tang, YH; Yuan, YM; Guo, QQ				Chen, Jianrong; Liu, Fang; Tang, Yinghong; Yuan, Youmei; Guo, Qingquan			Transcriptome Sequencing and Profiling of Expressed Genes in Phloem and Xylem of Ramie (Boehmeria nivea L. Gaud)	PLOS ONE			English	Article							FIBER QUALITY; YIELD; RNA; GROWTH; IDENTIFICATION; BIOSYNTHESIS; REGULATORS; LIBRARY	Ramie (Boehmeria nivea L. Gaud) is a highly versatile herbaceous plant which is widely cropped in southern China. The success of this herbaceous plant relies on wide use in modern industry. Understanding the profiling of expressed genes in phloem and xylem of ramie is crucial for improving its industrial performance. Herein, we uncover the transcriptome profile in phloem and xylem in present study. Using Illumina paired-end sequencing technology, 57 million high quality reads were generated. De novo assembly yielded 87,144 unigenes with an average length of 635 bp. By sequence similarity searching for public databases, a total of 32,541 (41.77%) unigenes were annotated for their function. Among these genes, 57,873 (66.4%) and 28,678 (32.9%) unigenes were assigned to categories of Gene Ontology and Orthologous Groups database, respectively. By searching against the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG), 18,331 (21.0%) unigenes were mapped to 125 pathways. The metabolic pathways were assigned the most unigene (4,793, 26.2%). Furthermore, Pol II and Pol III subunits as well as the genes of Galactose metabolism pathway had higher expression in phloem compared to xylem. In addition, fatty acid metabolism pathway genes showed more abundant in xylem than phloem. These results suggest that high activities of RNA synthesis and Galactose metabolism pathway promises fiber synthesis in phloem. The present study is the initial exploration to uncover the fiber biosynthesis difference between phloem and xylem in ramie through the analysis of deep sequencing data.	[Chen, Jianrong; Liu, Fang; Tang, Yinghong; Yuan, Youmei; Guo, Qingquan] Changsha Univ, Dept Biotechnol & Environm Sci, Changsha, Hunan, Peoples R China	Changsha University	Guo, QQ (corresponding author), Changsha Univ, Dept Biotechnol & Environm Sci, Changsha, Hunan, Peoples R China.	jrchenramie@163.com			National Natural Science Foundation of China [31071457, 31301374]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 31071457 and 31301374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini LG, 2000, IND CROP PROD, V11, P145, DOI 10.1016/S0926-6690(99)00059-X; Angelini LG, 2013, IND CROP PROD, V51, P138, DOI 10.1016/j.indcrop.2013.09.009; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Carlsbecker A, 2005, CURR OPIN PLANT BIOL, V8, P512, DOI 10.1016/j.pbi.2005.07.001; Dahlke B, 1998, J CELL PLAST, V34, P361, DOI 10.1177/0021955X9803400406; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; Foucart C, 2006, NEW PHYTOL, V170, P739, DOI 10.1111/j.1469-8137.2006.01705.x; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; KALCKAR HM, 1965, SCIENCE, V150, P305, DOI 10.1126/science.150.3694.305; Kimura M, 1997, J BIOL CHEM, V272, P25851, DOI 10.1074/jbc.272.41.25851; Liu F, 2008, SCI AGR SINICA, V11; Liu FH, 2001, FIELD CROP RES, V69, P41, DOI 10.1016/S0378-4290(00)00132-5; Liu JX, 2009, AGR SCI CHINA, V8, P664, DOI 10.1016/S1671-2927(08)60262-X; Liu LJ, 2013, IND CROP PROD, V44, P677, DOI 10.1016/j.indcrop.2012.09.003; Liu LJ, 2012, J INTEGR AGR, V11, P1199, DOI 10.1016/S2095-3119(12)60115-4; Liu TM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-130; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Liu XY, 2010, REACT FUNCT POLYM, V70, P972, DOI 10.1016/j.reactfunctpolym.2010.10.007; Mukhopadhyay A, 2013, BIORESOURCE TECHNOL, V137, P202, DOI 10.1016/j.biortech.2013.03.139; OHLROGGE JB, 1994, PLANT PHYSIOL, V104, P821, DOI 10.1104/pp.104.3.821; Roy S, 2012, WOODHEAD PUBL SER TE, P47; Schuster S. C., 2007, NATURE, V200; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang XX, 2010, MOL BIOL REP, V37, P2099, DOI 10.1007/s11033-009-9671-7; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Zhao CS, 2005, PLANT PHYSIOL, V138, P803, DOI 10.1104/pp.105.060202; Zhong RQ, 2001, PLANT PHYSIOL, V126, P477, DOI 10.1104/pp.126.2.477	31	16	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110623	10.1371/journal.pone.0110623	http://dx.doi.org/10.1371/journal.pone.0110623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354139	gold, Green Submitted, Green Published			2022-12-26	WOS:000345204200030
J	Noordmans, GA; Huang, Y; Savage, H; van Dijk, MCRF; Schaart, G; Weerman, MAV; Heeringa, P; Hillebrands, JL; Korstanje, R; van Goor, H				Noordmans, Gerda A.; Huang, Yuan; Savage, Holly; van Dijk, Marcory C. R. F.; Schaart, Gert; Weerman, Marius A. van den Bergh; Heeringa, Peter; Hillebrands, Jan-Luuk; Korstanje, Ron; van Goor, Harry			Genetic Analysis of Intracapillary Glomerular Lipoprotein Deposits in Aging Mice	PLOS ONE			English	Article							GAMMA ERR-GAMMA; RECEPTOR-GAMMA; DEFICIENT MICE; NEPHROPATHY; CHANNEL; MOUSE; MODEL; POLYMORPHISM; METABOLISM; REGULATOR	Background: Renal aging is characterized by functional and structural changes like decreased glomerular filtration rate, and glomerular, tubular and interstitial damage. To gain insight in pathways involved in renal aging, we studied aged mouse strains and used genetic analysis to identify genes associated with aging phenotypes. Methods: Upon morphological screening in kidneys from 20-month-old mice from 26 inbred strains we noted intracapillary PAS-positive deposits. The severity of these deposits was quantified by scoring of a total of 50 glomeruli per section (grade 0-4). Electron microscopy and immunohistochemical staining for apoE, apoB, apoA-IV and perilipin-2 was performed to further characterize the lesions. To identify loci associated with these PAS-positive intracapillary glomerular deposits, we performed haplotype association mapping. Results: Six out of 26 mouse strains showed glomerular PAS-positive deposits. The severity of these deposits varied: NOD(0.97), NZW(0.41), NON(0.30), B10(0.21), C3 H(0.9) and C57BR(0.7). The intracapillary deposits were strongly positive for apoE and weakly positive for apoB and apoA-IV. Haplotype association mapping showed a strong association with a 30-Kb haplotype block on Chr 1 within the Esrrg gene. We investigated 1 Mb on each site of this region, which includes the genes Spata17, Gpatch2, Esrrg, Ush2a and Kctd3. Conclusions: By analyzing 26 aged mouse strains we found that some strains developed an intracapillary PAS and apoE-positive lesion and identified a small haplotype block on Chr 1 within the Esrrg gene to be associated with these lipoprotein deposits. The region spanning this haplotype block contains the genes Spata17, Gpatch2, Esrrg, Ush2a and Kctd3, which are all highly expressed in the kidney. Esrrg might be involved in the evolvement of these glomerular deposits by influencing lipid metabolism and possibly immune reponses.	[Noordmans, Gerda A.; Huang, Yuan; van Dijk, Marcory C. R. F.; Heeringa, Peter; Hillebrands, Jan-Luuk; van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Savage, Holly; Korstanje, Ron] Jackson Lab, Bar Harbor, ME 04609 USA; [Weerman, Marius A. van den Bergh] Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Schaart, Gert] Maastricht Univ, Med Ctr, Dept Human Movement Sci, NUTRIM, Maastricht, Netherlands	University of Groningen; Jackson Laboratory; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Noordmans, GA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	g.a.noordmans@umcg.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X; van Goor, Harry/0000-0002-6670-1577; Hillebrands, Jan-Luuk/0000-0003-3135-3274	University of Groningen Graduate School of Medical Sciences; NIGMS [GM076468]; NIA [AG038070]; National Cancer Institute Cancer Core grant [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038070] Funding Source: NIH RePORTER	University of Groningen Graduate School of Medical Sciences; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute Cancer Core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the University of Groningen Graduate School of Medical Sciences (GAN), GM076468 from the NIGMS (RK), AG038070 from NIA (RK), and the National Cancer Institute Cancer Core grant (CA034196) to The Jackson Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Berry R, 2011, HUM MOL GENET, V20, P917, DOI 10.1093/hmg/ddq530; Boguski MS, 2002, NATURE, V420, P515, DOI 10.1038/420515a; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cao-Ehlker X, 2013, J BIOL CHEM, V288, P7580, DOI 10.1074/jbc.M112.434803; ELLIS D, 1995, J AM SOC NEPHROL, V6, P1170; Eto M, 2002, AM J KIDNEY DIS, V40, P243, DOI 10.1053/ajkd.2002.34502; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Glassock RJ, 2012, KIDNEY INT; Hu ZX, 2014, KIDNEY INT, V85, P416, DOI 10.1038/ki.2013.335; Hurtado R, 2010, KIDNEY INT, V77, P500, DOI 10.1038/ki.2009.483; Ishigaki Y, 2000, J BIOL CHEM, V275, P31269, DOI 10.1074/jbc.M005906200; Ishimura A, 2009, CLIN EXP NEPHROL, V13, P430, DOI 10.1007/s10157-009-0195-1; Kanamuru Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015615.14428.67; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; KEANE WF, 1988, AM J NEPHROL, V8, P261, DOI 10.1159/000167599; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Lin ML, 2009, CANCER SCI, V100, P1443, DOI 10.1111/j.1349-7006.2009.01185.x; Misra J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086342; Misra J, 2013, NUCLEIC ACIDS RES, V41, P6960, DOI 10.1093/nar/gkt429; Mochizuki S, 2001, CLIN EXP NEPHROL, V5, P240; MOORHEAD JF, 1991, KIDNEY INT S, V31, pS35; Mooyaart AL, 2011, DIABETOLOGIA, V54, P544, DOI 10.1007/s00125-010-1996-1; Noordmans GA, 2013, J AM SOC NEPHROL; Percy CJ, 2008, NEPHROLOGY, V13, P147, DOI 10.1111/j.1440-1797.2008.00924.x; Perry DJ, 2012, J IMMUNOL, V189, P793, DOI 10.4049/jimmunol.1200411; SAITO T, 1989, AM J KIDNEY DIS, V13, P148, DOI 10.1016/S0272-6386(89)80134-9; Saito T, 2006, AM J KIDNEY DIS, V47, P199, DOI 10.1053/j.ajkd.2005.10.017; Sanoudou D, 2010, PHARMACOGENOMICS J, V10, P165, DOI 10.1038/tpj.2009.51; Schmitt R, 2008, AM J PHYSIOL-RENAL, V294, pF1265, DOI 10.1152/ajprenal.00543.2007; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; Tsaih SW, 2010, KIDNEY INT, V77, P201, DOI 10.1038/ki.2009.434; Tsaih SW, 2009, METHODS MOL BIOL, V573, P213, DOI 10.1007/978-1-60761-247-6_12; Tsimihodimos V, 2011, CURR OPIN LIPIDOL, V22, P262, DOI 10.1097/MOL.0b013e328345ebb0; VANGOOR H, 1993, AM J PATHOL, V142, P1804; WATANABE Y, 1991, NEPHRON, V58, P210, DOI 10.1159/000186417; WATANABE Y, 1989, NEPHRON, V51, P265, DOI 10.1159/000185297; Wen M, 2002, LAB INVEST, V82, P999, DOI 10.1097/01.LAB.0000022222.03120.D4; Wilson Karen H S, 2005, BMC Nephrol, V6, P17, DOI 10.1186/1471-2369-6-17; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yorioka N, 1999, NEPHRON, V83, P246, DOI 10.1159/000045517; Yuan R, 2011, ILAR J, V52, P4, DOI 10.1093/ilar.52.1.4; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x	44	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111308	10.1371/journal.pone.0111308	http://dx.doi.org/10.1371/journal.pone.0111308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353171	Green Published, gold, Green Submitted			2022-12-26	WOS:000345204200070
J	Sharma, V; Sivapackiam, J; Harpstrite, SE; Prior, JL; Gu, H; Rath, NP; Piwnica-Worms, D				Sharma, Vijay; Sivapackiam, Jothilingam; Harpstrite, Scott E.; Prior, Julie L.; Gu, Hannah; Rath, Nigam P.; Piwnica-Worms, David			A Generator-Produced Gallium-68 Radiopharmaceutical for PET Imaging of Myocardial Perfusion	PLOS ONE			English	Article							MDR1 P-GLYCOPROTEIN; BLOOD-BRAIN-BARRIER; MULTIDRUG-RESISTANCE; GALLIUM(III) COMPLEXES; BIOLOGICAL EVALUATION; TRANSPORT; AGENTS; METAL; TECHNETIUM-99M-SESTAMIBI; MITOCHONDRIAL	Lipophilic cationic technetium-99m-complexes are widely used for myocardial perfusion imaging (MPI). However, inherent uncertainties in the supply chain of molybdenum-99, the parent isotope required for manufacturing Mo-99/Tc-99m generators, intensifies the need for discovery of novel MPI agents incorporating alternative radionuclides. Recently, germanium/gallium (Ge/Ga) generators capable of producing high quality Ga-68, an isotope with excellent emission characteristics for clinical PET imaging, have emerged. Herein, we report a novel Ga-68-complex identified through mechanism-based cell screening that holds promise as a generator-produced radiopharmaceutical for PET MPI.	[Sharma, Vijay; Sivapackiam, Jothilingam; Harpstrite, Scott E.; Prior, Julie L.; Gu, Hannah; Piwnica-Worms, David] Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, BRIGHT Inst,Mol Imaging Ctr, St Louis, MO 63110 USA; [Sharma, Vijay] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Rath, Nigam P.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Missouri System; University of Missouri Saint Louis	Sharma, V (corresponding author), Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, BRIGHT Inst,Mol Imaging Ctr, St Louis, MO 63110 USA.	sharmav@mir.wustl.edu; dpiwnica-worms@mdanderson.org	Sivapackiam, Jothilingam/O-9387-2014	Sivapackiam, Jothilingam/0000-0001-7979-1893	National Institutes of Health (NIH) [RO1 HL111163, R33 AG033328, P50 CA94056]; American Health Assistance Foundation [A2007-383]; NATIONAL CANCER INSTITUTE [P30CA091842, P50CA094056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R33AG033328] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by National Institutes of Health (NIH) grants RO1 HL111163 (VS), R33 AG033328 (VS), P50 CA94056 (DPW), and the American Health Assistance Foundation A2007-383 (VS). The Small Animal Imaging Core of Washington University Medical School is gratefully acknowledged (P30 CA91842). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atcher R, 2011, RSNA NEWS, V21, P9; Beller GA, 2010, HEART LUNG CIRC, V19, P193, DOI 10.1016/j.hlc.2009.11.003; Benard F, 2014, J NUCL MED, V55, P1017, DOI 10.2967/jnumed.113.133413; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; Bonow RO, 2009, NEW ENGL J MED, V361, P990, DOI 10.1056/NEJMcp0902177; Chen WS, 2000, BIOCHEM PHARMACOL, V60, P413, DOI 10.1016/S0006-2952(00)00341-5; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Cutler CS, 1999, NUCL MED BIOL, V26, P305, DOI 10.1016/S0969-8051(98)00108-5; Damiani D, 1998, HAEMATOLOGICA, V83, P290; DelVecchio S, 1997, J NUCL MED, V38, P1348; Fellner M, 2011, MOL IMAGING BIOL, V13, P985, DOI 10.1007/s11307-010-0410-1; Gould P, 2009, NATURE, V460, P312, DOI 10.1038/460312a; Harpstrite SE, 2007, J INORG BIOCHEM, V101, P1347, DOI 10.1016/j.jinorgbio.2007.04.013; Hendrikse NH, 1998, BRIT J CANCER, V77, P353, DOI 10.1038/bjc.1998.57; HERMAN LW, 1995, J MED CHEM, V38, P2955, DOI 10.1021/jm00015a018; Hsiao YM, 2009, NUCL MED BIOL, V36, P39, DOI 10.1016/j.nucmedbio.2008.10.010; Jin Z, 2010, ORGANOMETALLICS, V29, P6578, DOI 10.1021/om100906n; Luker GD, 1997, BIOCHEMISTRY-US, V36, P14218, DOI 10.1021/bi971931z; Luker GD, 2001, J BIOL CHEM, V276, P49053, DOI 10.1074/jbc.M105192200; Luker GD, 1997, J NUCL MED, V38, P369; Madar I, 2007, EUR J NUCL MED MOL I, V34, P2057, DOI 10.1007/s00259-007-0500-8; Pagou M, 2009, HELL J NUCL MED, V12, P102; PIWNICAWORMS D, 1993, CANCER RES, V53, P977; PIWNICAWORMS D, 1988, J NUCL MED, V29, P55; PIWNICAWORMS D, 1990, CIRCULATION, V82, P1826, DOI 10.1161/01.CIR.82.5.1826; Plossl K, 2008, NUCL MED BIOL, V35, P83, DOI 10.1016/j.nucmedbio.2007.08.002; Purohit A, 2008, J MED CHEM, V51, P2954, DOI 10.1021/jm701443n; Radeke H, 2007, J MED CHEM, V50, P4304, DOI 10.1021/jm0701831; Rowland DJ, 2008, SEMIN NUCL MED, V38, P209, DOI 10.1053/j.semnuclmed.2008.01.004; SCHINKEL AH, 1995, EUR J CANCER, V31A, P1295, DOI 10.1016/0959-8049(95)00130-B; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Sharma V, 2005, J NUCL MED, V46, P354; Sharma V, 1996, J MED CHEM, V39, P3483, DOI 10.1021/jm950823c; Sharma V, 2000, CHEM BIOL, V7, P335, DOI 10.1016/S1074-5521(00)00111-3; Sharma V., 1996, Journal of Nuclear Medicine, V37, p51P; Sharma V, 2004, BIOCONJUGATE CHEM, V15, P1464, DOI 10.1021/bc0498469; Sharma V, 1999, CHEM REV, V99, P2545, DOI 10.1021/cr980429x; Sivapackiam J, 2010, DALTON T, V39, P5842, DOI 10.1039/c002361b; Sivapackiam J, 2010, METHODS MOL BIOL, V596, P141, DOI 10.1007/978-1-60761-416-6_8; Slart RHJA, 2006, INT J CARDIOVAS IMAG, V22, P63, DOI 10.1007/s10554-005-7514-8; Tarkia M, 2012, NUCL MED BIOL, V39, P715, DOI 10.1016/j.nucmedbio.2011.11.007; TSANG BW, 1993, J NUCL MED, V34, P1127; TSANG BW, 1994, J MED CHEM, V37, P4400, DOI 10.1021/jm00051a018; Wong E, 1996, INORG CHEM, V35, P715, DOI 10.1021/ic951019j	44	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109361	10.1371/journal.pone.0109361	http://dx.doi.org/10.1371/journal.pone.0109361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353349	gold, Green Published, Green Submitted			2022-12-26	WOS:000345204200008
J	Alluin, O; Delivet-Mongrain, H; Gauthier, MK; Fehlings, MG; Rossignol, S; Karimi-Abdolrezaee, S				Alluin, Olivier; Delivet-Mongrain, Hugo; Gauthier, Marie-Krystel; Fehlings, Michael G.; Rossignol, Serge; Karimi-Abdolrezaee, Soheila			Examination of the Combined Effects of Chondroitinase ABC, Growth Factors and Locomotor Training following Compressive Spinal Cord Injury on Neuroanatomical Plasticity and Kinematics	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; NEUROLOGICAL RECOVERY; AXONAL REGENERATION; CORTICOSPINAL TRACT; FORELIMB FUNCTION; CONTUSION INJURY; BLADDER FUNCTION; GENE-EXPRESSION; RATS; CELLS	While several cellular and pharmacological treatments have been evaluated following spinal cord injury (SCI) in animal models, it is increasingly recognized that approaches to address the glial scar, including the use of chondroitinase ABC (ChABC), can facilitate neuroanatomical plasticity. Moreover, increasing evidence suggests that combinatorial strategies are key to unlocking the plasticity that is enabled by ChABC. Given this, we evaluated the anatomical and functional consequences of ChABC in a combinatorial approach that also included growth factor (EGF, FGF2 and PDGF-AA) treatments and daily treadmill training on the recovery of hindlimb locomotion in rats with mid thoracic clip compression SCI. Using quantitative neuroanatomical and kinematic assessments, we demonstrate that the combined therapy significantly enhanced the neuroanatomical plasticity of major descending spinal tracts such as corticospinal and serotonergic-spinal pathways. Additionally, the pharmacological treatment attenuated chronic astrogliosis and inflammation at and adjacent to the lesion with the modest synergistic effects of treadmill training. We also observed a trend for earlier recovery of locomotion accompanied by an improvement of the overall angular excursions in rats treated with ChABC and growth factors in the first 4 weeks after SCI. At the end of the 7-week recovery period, rats from all groups exhibited an impressive spontaneous recovery of the kinematic parameters during locomotion on treadmill. However, although the combinatorial treatment led to clear chronic neuroanatomical plasticity, these structural changes did not translate to an additional longterm improvement of locomotor parameters studied including hindlimb-forelimb coupling. These findings demonstrate the beneficial effects of combined ChABC, growth factors and locomotor training on the plasticity of the injured spinal cord and the potential to induce earlier neurobehavioral recovery. However, additional approaches such as stem cell therapies or a more adapted treadmill training protocol may be required to optimize this repair strategy in order to induce sustained functional locomotor improvement.	[Alluin, Olivier; Delivet-Mongrain, Hugo; Rossignol, Serge] Univ Montreal, CIHR, Multidisciplinary Team Locomotor Rehabil, Montreal, PQ, Canada; [Alluin, Olivier; Delivet-Mongrain, Hugo; Rossignol, Serge] Univ Montreal, FRQS, GRSNC, Montreal, PQ, Canada; [Gauthier, Marie-Krystel; Karimi-Abdolrezaee, Soheila] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Gauthier, Marie-Krystel; Karimi-Abdolrezaee, Soheila] Univ Manitoba, Spinal Cord Res Ctr, Winnipeg, MB, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg & Spinal Program, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Karimi-Abdolrezaee, Soheila] Regenerat Med Program, Winnipeg, MB, Canada; [Karimi-Abdolrezaee, Soheila] Manitoba Inst Child Hlth, Winnipeg, MB, Canada	Universite de Montreal; Universite de Montreal; University of Manitoba; University of Manitoba; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Karimi-Abdolrezaee, S (corresponding author), Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada.	soheila.karimi@med.umanitoba.ca		Karimi-Abdolrezaee, Soheila/0000-0002-0683-2663; Fehlings, Michael/0000-0002-5722-6364	Craig H. Neilsen Foundation; Christopher and Dana Reeve Foundation; Manitoba Health Research Council (MHRC); Canadian Institutes of Health Research (Sensorimotor Rehabilitation Research Team - SMRRT - grant); Canadian Institutes of Health Research (Canada Research Chair); Fonds de Recherche du Quebec-Sante; Sensorimotor Rehabilitation Research Team - SMRRT; Halbert Chair in Neural Repair and Regeneration; Krembil Foundation; Dezwirek Foundation	Craig H. Neilsen Foundation; Christopher and Dana Reeve Foundation; Manitoba Health Research Council (MHRC); Canadian Institutes of Health Research (Sensorimotor Rehabilitation Research Team - SMRRT - grant); Canadian Institutes of Health Research (Canada Research Chair)(Canada Research ChairsCanadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Sensorimotor Rehabilitation Research Team - SMRRT; Halbert Chair in Neural Repair and Regeneration; Krembil Foundation; Dezwirek Foundation	This work was supported by the operating grants from the following: 1) the Craig H. Neilsen Foundation to SKA, MGF and SR; 2) the Christopher and Dana Reeve Foundation to SKA, MGF and SR; 3) the Manitoba Health Research Council (MHRC) to SKA; 4) the Canadian Institutes of Health Research (Sensorimotor Rehabilitation Research Team - SMRRT - grant and Canada Research Chair) to SR; 5) OA was supported by a postdoctoral fellowship from the Fonds de Recherche du Quebec-Sante and Sensorimotor Rehabilitation Research Team - SMRRT; and 6) MGF is supported by the Halbert Chair in Neural Repair and Regeneration and by grants from the Krembil and Dezwirek Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Alluin O, 2011, J NEUROTRAUM, V28, P1963, DOI 10.1089/neu.2011.1840; Barriere G, 2008, J NEUROSCI, V28, P3976, DOI 10.1523/JNEUROSCI.5692-07.2008; Barriere G, 2010, J NEUROPHYSIOL, V104, P1119, DOI 10.1152/jn.00255.2010; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; Carter LM, 2011, EXP NEUROL, V228, P149, DOI 10.1016/j.expneurol.2010.12.023; Caudle KL, 2011, NEUROREHAB NEURAL RE, V25, P729, DOI 10.1177/1545968311407519; Cha J, 2007, J NEUROTRAUM, V24, P1000, DOI 10.1089/neu.2006.0233; Ciranna L, 2006, CURR NEUROPHARMACOL, V4, P101, DOI 10.2174/157015906776359540; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fouad K, 2009, SPINAL CORD, V47, P727, DOI 10.1038/sc.2009.10; Fouad K, 2000, BEHAV BRAIN RES, V115, P107, DOI 10.1016/S0166-4328(00)00244-8; Garcia-Alias G, 2011, J NEUROSCI, V31, P17788, DOI 10.1523/JNEUROSCI.4308-11.2011; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Gauthier MK, 2013, EUR J NEUROSCI; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Heng C, 2009, EXP NEUROL, V216, P139, DOI 10.1016/j.expneurol.2008.11.023; Husch A, 2012, J NEUROSCI, V32, P13145, DOI 10.1523/JNEUROSCI.2995-12.2012; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Ichiyama R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006862; Jakeman LB, 2011, BRAIN RES BULL, V84, P317, DOI 10.1016/j.brainresbull.2010.06.002; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kanno H, 2014, J NEUROSCI, V34, P1838, DOI 10.1523/JNEUROSCI.2661-13.2014; Karim F, 2001, BRAIN RES REV, V36, P204, DOI 10.1016/S0165-0173(01)00096-0; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Karimi-Abdolrezaee S, 2002, J NEUROSCI, V22, P1816, DOI 10.1523/JNEUROSCI.22-05-01816.2002; Karimi-Abdolrezaee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037589; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kuerzi J, 2010, EXP NEUROL, V224, P178, DOI 10.1016/j.expneurol.2010.03.008; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Lu P, 2012, J NEUROSCI, V32, P8208, DOI 10.1523/JNEUROSCI.0308-12.2012; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; Martinez M, 2013, J NEUROPHYSIOL, V109, P2909, DOI 10.1152/jn.01044.2012; Martinez M, 2012, J NEUROSCI, V32, P10961, DOI 10.1523/JNEUROSCI.1578-12.2012; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Mountney A, 2013, J NEUROTRAUM, V30, P181, DOI 10.1089/neu.2012.2353; Novotna I, 2011, CELL MOL NEUROBIOL, V31, P1129, DOI 10.1007/s10571-011-9714-1; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Rossignol SS B.J., 2014, TXB NEURAL REPAIR RE; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Seif GI, 2007, J NEUROTRAUM, V24, P1513, DOI 10.1089/neu.2007.0323; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Smith RR, 2009, J NEUROTRAUM, V26, P1017, DOI [10.1089/neu.2008.0829, 10.1089/neu.2008-0829]; Starkey ML, 2012, EUR J NEUROSCI, V36, P3665, DOI 10.1111/ejn.12017; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Tom VJ, 2009, J NEUROTRAUM, V26, P2323, DOI 10.1089/neu.2009.1047; van Hedel HJA, 2010, RESTOR NEUROL NEUROS, V28, P123, DOI 10.3233/RNN-2010-0508; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Wilson JR, 2012, J NEUROTRAUM, V29, P2263, DOI 10.1089/neu.2012.2417; Yang YG, 2009, J INT MED RES, V37, P1097, DOI 10.1177/147323000903700414	60	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111072	10.1371/journal.pone.0111072	http://dx.doi.org/10.1371/journal.pone.0111072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350665	Green Submitted, gold, Green Published			2022-12-26	WOS:000343943100054
J	Ek-Ramos, MJ; Avila, J; Dittrich, ACN; Su, D; Gray, JW; Devarenne, TP				Ek-Ramos, Maria J.; Avila, Julian; Dittrich, Anna C. Nelson; Su, Dongyin; Gray, Joel W.; Devarenne, Timothy P.			The Tomato Cell Death Suppressor Adi3 Is Restricted to the Endosomal System in Response to the Pseudomonas syringae Effector Protein AvrPto	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RECOGNITION RECEPTOR FLS2; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; DEPENDENT ENDOCYTOSIS; NUCLEAR TRAFFICKING; BAX INHIBITOR-1; HEAT-SHOCK; IN-VIVO; ARABIDOPSIS; KINASE	The tomato (Solanum lycopersicum) AGC protein kinase Adi3 functions as a suppressor of cell death and was first identified as an interactor with the tomato resistance protein Pto and the Pseudomonas syringae effector protein AvrPto. Models predict that loss of Adi3 cell death suppression (CDS) activity during Pto/AvrPto interaction leads to the cell death associated with the resistance response initiated from this interaction. Nuclear localization is required for Adi3 CDS. Prevention of nuclear accumulation eliminates Adi3 CDS and induces cell death by localizing Adi3 to intracellular punctate membrane structures. Here we use several markers of the endomembrane system to show that the punctate membrane structures to which non-nuclear Adi3 is localized are endosomal in nature. Wild-type Adi3 also localizes in these punctate endosomal structures. This was confirmed by the use of endosomal trafficking inhibitors, which were capable of trapping wild-type Adi3 in endosomal-like structures similar to the non-nuclear Adi3. This suggests Adi3 may traffic through the cell using the endomembrane system. Additionally, Adi3 was no longer found in the nucleus but was visualized in these punctate endosomal-like membranes during the cell death induced by the Pto/AvrPto interaction. Therefore we propose that inhibiting nuclear import and constraining Adi3 to the endosomal system in response to AvrPto is a mechanism to initiate the cell death associated with resistance.	[Ek-Ramos, Maria J.; Avila, Julian; Dittrich, Anna C. Nelson; Su, Dongyin; Gray, Joel W.; Devarenne, Timothy P.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Devarenne, TP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	tpd8@tamu.edu	Ramos, Maria Julissa Ek/W-1017-2018	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Devarenne, Timothy/0000-0001-6032-8049; Avila, Julian/0000-0001-9388-3946	U.S. Department of Agriculture, Agriculture and Food Research Initiative [2010-65108-20526, 2014-67013-21560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	U.S. Department of Agriculture, Agriculture and Food Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. Department of Agriculture, Agriculture and Food Research Initiative, grant no. 2010-65108-20526 and 2014-67013-21560 to TPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Avila J, 2013, BIOCHEM BIOPH RES CO, V430, P119, DOI 10.1016/j.bbrc.2012.11.043; BAKER CJ, 1994, PLANT CELL TISS ORG, V39, P7, DOI 10.1007/BF00037585; Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Beck M, 2012, PLANT CELL, V24, P4205, DOI 10.1105/tpc.112.100263; Bogdanove AJ, 2000, P NATL ACAD SCI USA, V97, P8836, DOI 10.1073/pnas.97.16.8836; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Borlido J, 2009, TRAFFIC, V10, P1209, DOI 10.1111/j.1600-0854.2009.00922.x; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Choi SW, 2013, PLANT CELL, V25, P1174, DOI 10.1105/tpc.112.108803; Devarenne TP, 2007, PLANT SIGNAL BEHAV, V2, P188, DOI 10.4161/psb.2.3.4150; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Di Sansebastiano GP, 2014, INT J MOL SCI, V15, P4565, DOI 10.3390/ijms15034565; Ek-Ramos MJ, 2010, J BIOL CHEM, V285, P17584, DOI 10.1074/jbc.M110.117416; Frey NFD, 2009, CURR OPIN PLANT BIOL, V12, P437, DOI 10.1016/j.pbi.2009.06.002; Geldner N, 2004, PLANTA, V219, P547, DOI 10.1007/s00425-004-1302-x; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Gu YN, 2011, PLANT PHYSIOL, V155, P1827, DOI 10.1104/pp.110.171785; Henriksson ML, 2000, BIOCHEM J, V347, P217, DOI 10.1042/0264-6021:3470217; Irani NG, 2009, CURR OPIN PLANT BIOL, V12, P653, DOI 10.1016/j.pbi.2009.09.011; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kang HG, 2010, PLANT CELL, V22, P918, DOI 10.1105/tpc.109.071662; Kasai K, 2011, J BIOL CHEM, V286, P6175, DOI 10.1074/jbc.M110.184929; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Koukalova B, 1997, FEBS LETT, V414, P289, DOI 10.1016/S0014-5793(97)01008-9; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lam SK, 2007, TRENDS PLANT SCI, V12, P497, DOI 10.1016/j.tplants.2007.09.001; Leborgne-Castel N, 2010, PROTOPLASMA, V247, P177, DOI 10.1007/s00709-010-0195-8; Lee G.J., 2004, PLANT CELL PHYSIOL, V45, P1211, DOI 10.1093/pcp/pch142; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Murphy JE, 2009, P NATL ACAD SCI US; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Oh CS, 2011, TRENDS PLANT SCI, V16, P132, DOI 10.1016/j.tplants.2010.11.001; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Robatzek S, 2007, CELL MICROBIOL, V9, P1, DOI 10.1111/j.1462-5822.2006.00829.x; Robert HS, 2008, CURR OPIN PLANT BIOL, V11, P495, DOI 10.1016/j.pbi.2008.06.004; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Sharfman M, 2011, PLANT J, V68, P413, DOI 10.1111/j.1365-313X.2011.04696.x; Speth EB, 2009, PLANT PHYSIOL, V149, P1824, DOI 10.1104/pp.108.132092; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Vacca RA, 2006, PLANT PHYSIOL, V141, P208, DOI 10.1104/pp.106.078683; van der Goot FG, 1997, ELECTROPHORESIS, V18, P2689, DOI 10.1002/elps.1150181426; van Gisbergen PAC, 2008, J MICROSC-OXFORD, V231, P284, DOI 10.1111/j.1365-2818.2008.02041.x; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Virbasius JV, 2001, P NATL ACAD SCI USA, V98, P12908, DOI 10.1073/pnas.221352898; Voigt B, 2005, EUR J CELL BIOL, V84, P609, DOI 10.1016/j.ejcb.2004.12.029; Walz HA, 2010, J BIOL CHEM, V285, P14101, DOI 10.1074/jbc.M110.110536; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Zhang Y, 2009, TRENDS PLANT SCI, V14, P689, DOI 10.1016/j.tplants.2009.09.006; Zuppini A, 2006, FUNCT PLANT BIOL, V33, P617, DOI 10.1071/FP06015	72	7	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110807	10.1371/journal.pone.0110807	http://dx.doi.org/10.1371/journal.pone.0110807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350368	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100042
J	Schilling, S; Fusco, FM; De Iaco, G; Bannister, B; Maltezou, HC; Carson, G; Gottschalk, R; Brodt, HR; Brouqui, P; Puro, V; Ippolito, G				Schilling, Stefan; Fusco, Francesco Maria; De Iaco, Giuseppina; Bannister, Barbara; Maltezou, Helena C.; Carson, Gail; Gottschalk, Rene; Brodt, Hans-Reinhard; Brouqui, Philippe; Puro, Vincenzo; Ippolito, Giuseppe		European Network Highly Infectious	Isolation Facilities for Highly Infectious Diseases in Europe - A Cross-Sectional Analysis in 16 Countries	PLOS ONE			English	Article							LEVEL ISOLATION UNITS; MANAGEMENT; NETWORK; CONSENSUS; CORONAVIRUS	Background: Highly Infectious Diseases (HIDs) are (i) easily transmissible form person to person; (ii) cause a life-threatening illness with no or few treatment options; and (iii) pose a threat for both personnel and the public. Hence, even suspected HID cases should be managed in specialised facilities minimizing infection risks but allowing state-of-the-art critical care. Consensus statements on the operational management of isolation facilities have been published recently. The study presented was set up to compare the operational management, resources, and technical equipment among European isolation facilities. Due to differences in geography, population density, and national response plans it was hypothesized that adherence to recommendations will vary. Methods and Findings: Until mid of 2010 the European Network for Highly Infectious Diseases conducted a cross-sectional analysis of isolation facilities in Europe, recruiting 48 isolation facilities in 16 countries. Three checklists were disseminated, assessing 44 items and 148 specific questions. The median feedback rate for specific questions was 97.9% (n = 47/48) (range: n = 7/48 (14.6%) to n = 48/48 (100%). Although all facilities enrolled were nominated specialised facilities' serving countries or regions, their design, equipment and personnel management varied. Eighteen facilities fulfilled the definition of a High Level Isolation Unit'. In contrast, 24 facilities could not operate independently from their co-located hospital, and five could not ensure access to equipment essential for infection control. Data presented are not representative for the EU in general, as only 16/27 (59.3%) of all Member States agreed to participate. Another limitation of this study is the time elapsed between data collection and publication; e. g. in Germany one additional facility opened in the meantime. Conclusion: There are disparities both within and between European countries regarding the design and equipment of isolation facilities. With regard to the International Health Regulations, terminology, capacities and equipment should be standardised.	[Schilling, Stefan] Staedt Kliniken Moenchengladbach, Dept Internal Med, Monchengladbach, Germany; [Fusco, Francesco Maria; Puro, Vincenzo; Ippolito, Giuseppe] Natl Inst Infect Dis Lazarro Spallanzani, Dept Infect Dis, Rome, Italy; [De Iaco, Giuseppina] Univ Osped Riuniti Marche, Azienda Osped, Dept Internal Med, Torrette, Italy; [Bannister, Barbara] Royal Free Hosp, Dept Infect Dis, London NW3 2QG, England; [Maltezou, Helena C.] Hellen Ctr Dis Control & Prevent, Dept Intervent Healthcare Facil, Athens, Greece; [Carson, Gail] Hlth Protect Agcy, Dept Rare & Imported Pathogens, Porton Down, England; [Gottschalk, Rene] Port Hlth Author, Dept Infect Dis, Frankfurt, Germany; [Brodt, Hans-Reinhard] Goethe Univ Frankfurt, Dept Infect Dis, D-60054 Frankfurt, Germany; [Brouqui, Philippe] Marseilles Univ, Dept Infect Dis & Trop Med, Marseille, France	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Health Protection Agency; Goethe University Frankfurt; UDICE-French Research Universities; Aix-Marseille Universite	Schilling, S (corresponding author), Staedt Kliniken Moenchengladbach, Dept Internal Med, Monchengladbach, Germany.	stefan.schilling@kgu.de	Ippolito, Giuseppe/J-7207-2017; Brouqui, Philippe/P-5771-2016; Fusco, Francesco Maria/AFO-1279-2022; Lanini, Simone/C-7523-2012	Fusco, Francesco Maria/0000-0002-1293-5976; Lanini, Simone/0000-0002-6743-4001; Ippolito, Giuseppe/0000-0002-1076-2979; puro, vincenzo/0000-0003-0291-4490; Gottschalk, Professor M. D., Ph. D, Rene/0000-0003-0422-6456	European Commission/DG SANCO under the EU [2006205]	European Commission/DG SANCO under the EU	The "European Network for Highly Infectious Diseases - EuroNHID" is co-funded by the European Commission/DG SANCO under the EU contract number 2006205. Neither the Commission nor DG SANCO had an influence on the study design, data collection, or interpretation of results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin S, 2009, EUROSURVEILLANCE, V14; Baka A, 2007, Euro Surveill, V12, pE5; Bannister B, 2009, LANCET INFECT DIS, V9, P45, DOI 10.1016/S1473-3099(08)70304-9; Barr DA, 2013, LANCET, V382, P1458, DOI 10.1016/S0140-6736(13)61718-3; Bork KH, 2006, EURO SURVEILL, V11; Brouqui P, 2009, LANCET INFECT DIS, V9, P301, DOI 10.1016/S1473-3099(09)70070-2; Danielsson N, 2012, EUROSURVEILLANCE, V17, P9; De Iaco G, 2012, INFECT CONT HOSP EP, V33, P1008, DOI 10.1086/667729; Drosten C, 2003, TRENDS MOL MED, V9, P325, DOI 10.1016/S1471-4914(03)00133-3; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; European Commission, 1989, OFFICIAL J, V183; Fusco FM, 2009, J HOSP INFECT, V73, P15, DOI 10.1016/j.jhin.2009.06.009; Fusco FM, 2009, CLIN MICROBIOL INFEC, V15, P711, DOI 10.1111/j.1469-0691.2009.02874.x; Fusco FM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-27; Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298; Kaji AH, 2007, JAMA-J AM MED ASSOC, V298, P2188, DOI 10.1001/jama.298.18.2188; Kitching A, 2009, EUROSURVEILLANCE, V14; Maltezou HC, 2012, J HOSP INFECT, V81, P184, DOI 10.1016/j.jhin.2012.04.019; Menne J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4565; Nisii C, 2009, CLIN MICROBIOL INFEC, V15, P720, DOI 10.1111/j.1469-0691.2009.02946.x; Rodier G, 2006, EURO SURVEILL, V11; Schilling S, 2019, CLIN MICROBIOL INFEC, V21, pE1, DOI 10.1111/1469-0691.12290; Smith PW, 2006, BIOSECUR BIOTERROR, V4, P351, DOI 10.1089/bsp.2006.4.351; Thiberville Simon-Djamel, 2012, BMC Res Notes, V5, P527, DOI 10.1186/1756-0500-5-527; U.S. Department of Health and Human Services, 2005, NAT BIOT HOSP PERP P; van Paassen J, 2012, LANCET INFECT DIS, V12, P635, DOI 10.1016/S1473-3099(12)70018-X; World Health Organization Regional Office for Europe, 2012, ASS HEATH SYST CRIS; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	28	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e100401	10.1371/journal.pone.0100401	http://dx.doi.org/10.1371/journal.pone.0100401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350843	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100002
J	Wang, SP; Geng, ZR; Shi, N; Li, XL; Wang, ZL				Wang, Shuping; Geng, Zhirong; Shi, Nan; Li, Xiangli; Wang, Zhilin			The Functions of Crucial Cysteine Residues in the Arsenite Methylation Catalyzed by Recombinant Human Arsenic (III) Methyltransferase	PLOS ONE			English	Article							OXIDATION-STATE METHYLTRANSFERASE; S-ADENOSYLMETHIONINE METHYLTRANSFERASE; TRIVALENT ARSENICALS; PROTEIN FUNCTION; SERUM-ALBUMIN; BINDING; CARCINOGENESIS; IDENTIFICATION; FLUORESCENCE; GLUTATHIONE	Arsenic (III) methyltransferase (AS3MT) is a cysteine (Cys)-rich enzyme that catalyzes the biomethylation of arsenic. To investigate how these crucial Cys residues promote catalysis, we used matrix-assisted laser desorption ionization-time of flight-mass spectrometry (MALDI-TOF-MS) to analyze Cys residues in recombinant human arsenic (III) methyltransferase (hAS3MT). We detected two disulfide bonds, Cys250-Cys32 and Cys368-Cys369, in hAS3MT. The Cys250-Cys32 disulfide bond was reduced by glutathione (GSH) or other disulfide bond reductants before the enzymatic methylation of arsenite (iAs(3+)). In addition to exposing residues around the active sites, cleavage of the Cys250-Cys32 pair modulated the conformation of hAS3MT. This adjustment may stabilize the binding of S-Adenosyl-L-methionine (AdoMet) and favor iAs(3+) binding to hAS3MT. Additionally, we observed the intermediate of Cys250-S-adenosylhomocysteine (AdoHcy), suggesting that Cys250 is involved in the transmethylation. In recovery experiments, we confirmed that trivalent arsenicals were substrates for hAS3MT, methylation of arsenic occurred on the enzyme, and an intramolecular disulfide bond might be formed after iAs(3+) was methylated to dimethylarsinous acid (DMA(3+)). In this work, we clarified both the functional roles of GSH and the crucial Cys residues in iAs(3+) methylation catalyzed by hAS3MT.	[Wang, Shuping; Geng, Zhirong; Shi, Nan; Li, Xiangli; Wang, Zhilin] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Geng, ZR (corresponding author), Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China.	gengzr@nju.edu.cn; wangzl@nju.edu.cn	Geng, Zhirong/HGC-1447-2022	Geng, Zhirong/0000-0003-3766-9034	National Basic Research Program of China [2013CB922102]; National Natural Science Foundation of China [21275072, 21201101]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (2013CB922102) and the National Natural Science Foundation of China (21275072 and 21201101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2012, BIOCHEMISTRY-US, V51, P5476, DOI 10.1021/bi3004632; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bi SY, 2005, SPECTROCHIM ACTA A, V61, P629, DOI 10.1016/j.saa.2004.05.028; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Cui FL, 2008, PESTIC BIOCHEM PHYS, V90, P126, DOI 10.1016/j.pestbp.2007.11.002; Cui X, 2008, CURR MED CHEM, V15, P2293, DOI 10.2174/092986708785747526; Cullen W.R., 2014, CHEM RES TOXICOL, V176, P127; CULLEN WR, 1984, J INORG BIOCHEM, V21, P179, DOI 10.1016/0162-0134(84)83002-0; Ding L, 2012, TOXICOL APPL PHARM, V264, P121, DOI 10.1016/j.taap.2012.07.024; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Kitchin KT, 2008, J INORG BIOCHEM, V102, P532, DOI 10.1016/j.jinorgbio.2007.10.021; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Li JX, 2005, TOXICOL APPL PHARM, V204, P164, DOI 10.1016/j.taap.2004.12.002; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084231; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076709; Li XL, 2013, FEBS LETT, V587, P2232, DOI 10.1016/j.febslet.2013.05.052; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; Nagahara N, 2011, AMINO ACIDS, V41, P59, DOI 10.1007/s00726-010-0508-4; Nakanishi T, 2005, J PROTEOME RES, V4, P743, DOI 10.1021/pr0497834; Naranmandura H, 2006, CHEM RES TOXICOL, V19, P1010, DOI 10.1021/tx060053f; Song XL, 2011, BIOCHIMIE, V93, P369, DOI 10.1016/j.biochi.2010.10.010; Song XL, 2010, BIOCHIMIE, V92, P1397, DOI 10.1016/j.biochi.2010.07.002; Song XL, 2009, CHEM-BIOL INTERACT, V179, P321, DOI 10.1016/j.cbi.2008.12.018; Suzuki KT, 2007, TOXICOL APPL PHARM, V218, P166, DOI 10.1016/j.taap.2006.10.027; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Thomas DJ, 2007, TOXICOL APPL PHARM, V222, P365, DOI 10.1016/j.taap.2007.02.007; Thomas DJ, 2010, TOXICOL SCI, V113, P70, DOI 10.1093/toxsci/kfp250; Thomas DJ, 2009, TOXICOL SCI, V107, P309, DOI 10.1093/toxsci/kfn257; Thomas DJ, 2004, TOXICOL APPL PHARM, V198, P319, DOI 10.1016/j.taap.2003.10.020; Watanabe T, 2013, ARCH TOXICOL, V87, P969, DOI 10.1007/s00204-012-0904-5; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhang YZ, 2008, J FLUORESC, V18, P109, DOI 10.1007/s10895-007-0247-4	41	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110924	10.1371/journal.pone.0110924	http://dx.doi.org/10.1371/journal.pone.0110924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25349987	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100048
J	Zhang, YH; Wang, YF; Yu, SX				Zhang, Yuhua; Wang, Yongfan; Yu, Shixiao			Interspecific Neighbor Interactions Promote the Positive Diversity-Productivity Relationship in Experimental Grassland Communities	PLOS ONE			English	Article							FITNESS DIFFERENCES RELATE; PLANT DIVERSITY; SPECIES RICHNESS; ECOSYSTEM FUNCTION; BIODIVERSITY; COMPETITION; COMPLEMENTARITY; MAINTENANCE; SELECTION; PATTERNS	Because the frequency of heterospecific interactions inevitably increases with species richness in a community, biodiversity effects must be expressed by such interactions. However, little is understood how heterospecific interactions affect ecosystem productivity because rarely are biodiversity ecosystem functioning experiments spatially explicitly manipulated. To test the effect of heterospecific interactions on productivity, direct evidence of heterospecific neighborhood interaction is needed. In this study we conducted experiments with a detailed spatial design to investigate whether and how heterospecific neighborhood interactions promote primary productivity in a grassland community. The results showed that increasing the heterospecific: conspecific contact ratio significantly increased productivity. We found there was a significant difference in the variation in plant height between monoculture and mixture communities, suggesting that height-asymmetric competition for light plays a central role in promoting productivity. Heterospecific interactions make tall plants grow taller and short plants become smaller in mixtures compared to monocultures, thereby increasing the efficiency of light interception and utilization. Overyielding in the mixture communities arises from the fact that the loss in the growth of short plants is compensated by the increased growth of tall plants. The positive correlation between species richness and primary production was strengthened by increasing the frequency of heterospecific interactions. We conclude that species richness significantly promotes primary ecosystem production through heterospecific neighborhood interactions.	[Zhang, Yuhua; Wang, Yongfan; Yu, Shixiao] Sun Yat Sen Univ, Dept Ecol, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, YF (corresponding author), Sun Yat Sen Univ, Dept Ecol, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsswyf@mail.sysu.edu.cn		Yu, Shixiao/0000-0003-1943-0185	National Natural Science Foundation of China [30970472, 31230013]; Zhang-Hongda Science Foundation in Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhang-Hongda Science Foundation in Sun Yat-sen University	The research was funded by the National Natural Science Foundation of China (Project 30970472, 31230013) and by the Zhang-Hongda Science Foundation in Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Carroll IT, 2011, ECOLOGY, V92, P1157; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Fargione J, 2006, FUNCT ECOL, V20, P533, DOI 10.1111/j.1365-2435.2006.01116.x; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loreau M, 2012, ECOLOGY, V93, P1482; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Potvin C, 2009, ECOLOGY, V90, P321, DOI 10.1890/08-0353.1; Sapijanskas J, 2013, ECOLOGY, V94, P941, DOI 10.1890/12-0337.1; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stoll P, 2001, ECOLOGY, V82, P319, DOI 10.1890/0012-9658(2001)082[0319:IAACII]2.0.CO;2; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Wang YF, 2007, ECOL LETT, V10, P401, DOI 10.1111/j.1461-0248.2007.01031.x; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Yachi S, 2007, ECOL LETT, V10, P54, DOI 10.1111/j.1461-0248.2006.00994.x	34	6	6	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111434	10.1371/journal.pone.0111434	http://dx.doi.org/10.1371/journal.pone.0111434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350670	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943100072
J	de la Iglesia, D; Garcia-Remesal, M; Anguita, A; Munoz-Marmol, M; Kulikowski, C; Maojo, V				de la Iglesia, Diana; Garcia-Remesal, Miguel; Anguita, Alberto; Munoz-Marmol, Miguel; Kulikowski, Casimir; Maojo, Victor			A Machine Learning Approach to Identify Clinical Trials Involving Nanodrugs and Nanodevices from ClinicalTrials.gov	PLOS ONE			English	Article							REGISTRATION; NANOINFORMATICS; ALGORITHM; DRUG; CLASSIFICATION; DATABASE; LASSO; STATE; NEED; SIZE	Background: Clinical Trials (CTs) are essential for bridging the gap between experimental research on new drugs and their clinical application. Just like CTs for traditional drugs and biologics have helped accelerate the translation of biomedical findings into medical practice, CTs for nanodrugs and nanodevices could advance novel nanomaterials as agents for diagnosis and therapy. Although there is publicly available information about nanomedicine-related CTs, the online archiving of this information is carried out without adhering to criteria that discriminate between studies involving nanomaterials or nanotechnology-based processes (nano), and CTs that do not involve nanotechnology (non-nano). Finding out whether nanodrugs and nanodevices were involved in a study from CT summaries alone is a challenging task. At the time of writing, CTs archived in the well-known online registry ClinicalTrials.gov are not easily told apart as to whether they are nano or non-nano CTs-even when performed by domain experts, due to the lack of both a common definition for nanotechnology and of standards for reporting nanomedical experiments and results. Methods: We propose a supervised learning approach for classifying CT summaries from ClinicalTrials.gov according to whether they fall into the nano or the non-nano categories. Our method involves several stages: i) extraction and manual annotation of CTs as nano vs. non-nano, ii) pre-processing and automatic classification, and iii) performance evaluation using several state-of-the-art classifiers under different transformations of the original dataset. Results and Conclusions: The performance of the best automated classifier closely matches that of experts (AUC over 0.95), suggesting that it is feasible to automatically detect the presence of nanotechnology products in CT summaries with a high degree of accuracy. This can significantly speed up the process of finding whether reports on ClinicalTrials.gov might be relevant to a particular nanoparticle or nanodevice, which is essential to discover any precedents for nanotoxicity events or advantages for targeted drug therapy.	[de la Iglesia, Diana; Garcia-Remesal, Miguel; Anguita, Alberto; Munoz-Marmol, Miguel; Maojo, Victor] Univ Politecn Madrid, Escuela Tecn Super Ingenieros Informat, Dept Inteligencia Artificial, Biomed Informat Grp, Madrid, Spain; [Kulikowski, Casimir] Rutgers State Univ, Dept Comp Sci, Piscataway, NJ USA	Universidad Politecnica de Madrid; Rutgers State University New Brunswick	de la Iglesia, D (corresponding author), Univ Politecn Madrid, Escuela Tecn Super Ingenieros Informat, Dept Inteligencia Artificial, Biomed Informat Grp, Madrid, Spain.	diglesia@infomed.dia.fi.upm.es	Garcia-Remesal, Miguel/ABG-6470-2020		European Commission; Spanish Ministry of Economy and Competitiveness [FIS/AES PS09/00069]; Consejo Social of the Universidad Politecnica de Madrid	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness(Spanish Government); Consejo Social of the Universidad Politecnica de Madrid	This work has been partially funded by the European Commission (p-medicine FP7-ICT-270089, EURECA FP7-ICT-288048), the Spanish Ministry of Economy and Competitiveness (FIS/AES PS09/00069) and the Consejo Social of the Universidad Politecnica de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, PLoS Med, V1, pe46; Bach FR, 2008, J MACH LEARN RES, V9, P1179; Baker JR, 2011, WIRES NANOMED NANOBI, V3, P341, DOI 10.1002/wnan.141; Baker NA, 2013, NAT NANOTECHNOL, V8, P73, DOI 10.1038/nnano.2013.12; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bawa R, 2007, NANOMEDICINE-UK, V2, P351, DOI 10.2217/17435889.2.3.351; Bawarski WE, 2008, NANOMED-NANOTECHNOL, V4, P273, DOI 10.1016/j.nano.2008.06.002; Bird S., 2009, NATURAL LANGUAGE PRO; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Cancedda N, 2003, J MACH LEARN RES, V3, P1059, DOI 10.1162/153244303322533197; Candes EJ, 2009, ANN STAT, V37, P2145, DOI 10.1214/08-AOS653; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Cepeda MS, 2013, CLIN TRIALS, V10, P347, DOI 10.1177/1740774513475849; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chen CY, 2012, RECENT PAT NANOTECH, V6, P114, DOI 10.2174/187221012800270144; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Covitz PA, 2003, BIOINFORMATICS, V19, P2404, DOI 10.1093/bioinformatics/btg335; de la Iglesia D, 2011, METHOD INFORM MED, V50, P84, DOI 10.3414/ME10-02-0012; de la lglesia D., 2013, COMPUT SCI DISCOV, V6, DOI [10.1088/1749-4699/6/1/014011., DOI 10.1088/1749-4699/6/1/014011]; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013; European Commission, 2010, DRAFT COMM REC DEF T; European Commission - Directorate General for Health & Consumers, 2010, SCI BAS DEF TERM NAN; European Commission - Joint Research Centre, 2010, CONS DEF NAN REG PUR; Evans T, 2004, LANCET, V363, P1413, DOI 10.1016/S0140-6736(04)16136-9; Fadeel B, 2010, J INTERN MED, V267, P2, DOI 10.1111/j.1365-2796.2009.02186.x; Fischer HC, 2007, CURR OPIN BIOTECH, V18, P565, DOI 10.1016/j.copbio.2007.11.008; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Fukunaga K., 1972, INTRO STAT PATTERN R, V2nd; Gabizon AA, 2001, CANCER INVEST, V19, P424, DOI 10.1081/CNV-100103136; Garcia-Remesal M, 2013, BIOMED RES INT, V2013; Garla V, 2013, J BIOMED INFORM, V46, P869, DOI 10.1016/j.jbi.2013.06.014; Green DM, 1966, SIGNAL DETECTION THE; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hahn U, 2012, BRIEF BIOINFORM, V13, P460, DOI 10.1093/bib/bbs018; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Horton R, 1999, LANCET, V354, P1138, DOI 10.1016/S0140-6736(99)00328-1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; International Organization for Standardization, 2010, 8000412010 ISOTS; Joachims T., 2002, SPRINGER INT SERIES, V668; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Jones DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083932; Karve S, 2012, P NATL ACAD SCI USA, V109, P8230, DOI 10.1073/pnas.1120508109; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kibriya AM, 2004, LECT NOTES ARTIF INT, V3339, P488; Kirillova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037847; Krall R, 2005, BMJ-BRIT MED J, V330, P479, DOI 10.1136/bmj.330.7489.479-b; Krleza-Jeric K, 2005, PLOS MED, V2, P1093, DOI 10.1371/journal.pmed.0020378; LACHENBRUCH PA, 1968, BIOMETRICS, V24, P823, DOI 10.2307/2528873; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Li ZH, 2009, CHEM MATER, V21, P5578, DOI 10.1021/cm9020673; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Luo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082119; Maojo V, 2012, INT J NANOMED, V7, P3867, DOI 10.2147/IJN.S24582; Maojo V, 2012, COMPUTING, V94, P521, DOI 10.1007/s00607-012-0191-2; Maojo V, 2010, PEDIATR RES, V67, P481, DOI 10.1203/PDR.0b013e3181d6245e; Marshall MJ, 2012, MICROSC MICROANAL, V18, P844; Moon Sungrim, 2012, AMIA Annu Symp Proc, V2012, P1310; National Nanotechnology Initiative, 2007, WHAT IS NAN; Ostraat M, 2012, NANOTECHNOLOGY 2012, VOL 3: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND ENERGY, P273; Platt J, 1998, ADV KERNEL METHODS S, V185, P208; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rennie J.D., 2003, P 20 INT C MACH LEAR, DOI 10.5555/3041838.3041916; Roco MC, 2000, NANOTECHNOLOGY RES D, P153; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Salton G, 1983, INTRO MODERN INFORM; Scalf K, 2009, INTRO NANOPART UNPUB; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Slomkowski S, 2011, PURE APPL CHEM, V83, P2229, DOI 10.1351/PAC-REC-10-06-03; Tahan C, 2007, ADV COMPUT, V71, P251, DOI 10.1016/S0065-2458(06)71005-1; Tasneem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033677; Theis T, 2006, NAT NANOTECHNOL, V1, P8, DOI 10.1038/nnano.2006.77; Thomas DG, 2011, WIRES NANOMED NANOBI, V3, P511, DOI 10.1002/wnan.152; Thomas DG, 2011, J BIOMED INFORM, V44, P59, DOI 10.1016/j.jbi.2010.03.001; Tibshirani RJ, 2013, ELECTRON J STAT, V7, P1456, DOI 10.1214/13-EJS815; U.S. FDA, 2011, CONS WHETH FDA REG P; Wang RB, 2013, J NANOMATER, V2013, DOI 10.1155/2013/629681; Waterhouse Dawn N., 2001, Drug Safety, V24, P903, DOI 10.2165/00002018-200124120-00004; Watson Rory, 2006, BMJ, V332, P1232, DOI 10.1136/bmj.332.7552.1232-c; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Witten I. H., 2005, MORGAN KAUFMANN SERI; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	89	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110331	10.1371/journal.pone.0110331	http://dx.doi.org/10.1371/journal.pone.0110331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347075	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000347994900021
J	Lv, MY; Wang, JW; Zhang, JY; Zhang, B; Wang, XD; Zhu, YZ; Zuo, T; Liu, DL; Li, XJ; Wu, JX; Zhang, HH; Yu, B; Wu, H; Zhao, XH; Kong, W; Yu, XH				Lv, Mingyu; Wang, Jiawen; Zhang, Jingyao; Zhang, Biao; Wang, Xiaodan; Zhu, Yingzi; Zuo, Tao; Liu, Donglai; Li, Xiaojun; Wu, Jiaxin; Zhang, Haihong; Yu, Bin; Wu, Hui; Zhao, Xinghong; Kong, Wei; Yu, Xianghui			Epitope Tags beside the N-Terminal Cytoplasmic Tail of Human BST-2 Alter Its Intracellular Trafficking and HIV-1 Restriction	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INHIBITS HIV-1; VPU PROTEIN; ENVELOPE GLYCOPROTEIN; KAPPA-B; MEMBRANE-PROTEIN; PARTICLE RELEASE; FACTOR SAMHD1; HOST-CELL; TETHERIN	BST-2 blocks the particle release of various enveloped viruses including HIV-1, and this antiviral activity is dependent on the topological arrangement of its four structural domains. Several functions of the cytoplasmic tail (CT) of BST-2 have been previously discussed, but the exact role of this domain remains to be clearly defined. In this study, we investigated the impact of truncation and commonly-used tags addition into the CT region of human BST-2 on its intracellular trafficking and signaling as well as its anti-HIV-1 function. The CT-truncated BST-2 exhibited potent inhibition on Vpu-defective HIV-1 and even wild-type HIV-1. However, the N-terminal HA-tagged CT-truncated BST-2 retained little antiviral activity and dramatically differed from its original protein in the cell surface level and intracellular localization. Further, we showed that the replacement of the CT domain with a hydrophobic tag altered BST-2 function possibly by preventing its normal vesicular trafficking. Notably, we demonstrated that a positive charged motif "KRXK'' in the conjunctive region between the cytotail and the transmembrane domain which is conserved in primate BST-2 is important for the protein trafficking and the antiviral function. These results suggest that although the CT of BST-2 is not essential for its antiviral activity, the composition of residues in this region may play important roles in its normal trafficking which subsequently affected its function. These observations provide additional implications for the structure-function model of BST-2.	[Lv, Mingyu; Wang, Jiawen; Zhang, Jingyao; Wang, Xiaodan; Zhu, Yingzi; Zuo, Tao; Liu, Donglai; Li, Xiaojun; Wu, Jiaxin; Zhang, Haihong; Yu, Bin; Wu, Hui; Zhao, Xinghong; Kong, Wei; Yu, Xianghui] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China; [Wang, Jiawen] Changchun Univ Chinese Med, Ctr New Med Res, Changchun, Peoples R China; [Zhang, Biao] Jilin Univ, Sch Pharmaceut Sci, Changchun 130023, Peoples R China	Jilin University; Changchun University of Chinese Medicine; Jilin University	Kong, W (corresponding author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China.	weikong@jlu.edu.cn; xianghui@jlu.edu.cn	Wu, Jiaxin/GVT-3486-2022		National Natural Science Foundation of China: NSFC [31270807]; NSFC-NIH [812111027]; Jilin University [20121054]	National Natural Science Foundation of China: NSFC(National Natural Science Foundation of China (NSFC)); NSFC-NIH; Jilin University(Jilin University)	This work was supported by grants from the National Natural Science Foundation of China: NSFC Project (31270807) of XY, NSFC-NIH International Project (812111027) of XY and Graduate Innovation Fund of Jilin University (20121054) of J. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Arnaud F, 2010, J VIROL, V84, P4415, DOI 10.1128/JVI.00029-10; Billcliff PG, 2013, BIOL OPEN, V2, P1253, DOI 10.1242/bio.20135793; Celestino M, 2012, J VIROL, V86, P6688, DOI 10.1128/JVI.07037-11; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Freed EO, 2004, TRENDS MICROBIOL, V12, P170, DOI 10.1016/j.tim.2004.02.001; Fukuma A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018247; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Gustin JK, 2012, J BIOL CHEM, V287, P14837, DOI 10.1074/jbc.M112.349928; Hauser H, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-85; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lim ES, 2010, J VIROL, V84, P7124, DOI 10.1128/JVI.00468-10; Lv MY, 2013, PROTEIN EXPRES PURIF, V91, P112, DOI 10.1016/j.pep.2013.07.015; Lv MY, 2013, FEBS LETT, V587, P37, DOI 10.1016/j.febslet.2012.11.022; Lv MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020890; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mattiuzzo G, 2010, J VIROL, V84, P2618, DOI 10.1128/JVI.01928-09; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Tirabassi RS, 1999, J VIROL, V73, P2717, DOI 10.1128/JVI.73.4.2717-2728.1999; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wang JW, 2011, J VIROL, V85, P12482, DOI 10.1128/JVI.05218-11; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	57	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e111422	10.1371/journal.pone.0111422	http://dx.doi.org/10.1371/journal.pone.0111422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347789	Green Submitted, Green Published, gold			2022-12-26	WOS:000347994900067
J	Mesentier-Louro, LA; Zaverucha-do-Valle, C; da Silva, AJ; Nascimento-dos-Santos, G; Gubert, F; de Figueiredo, ABP; Torres, AL; Paredes, BD; Teixeira, C; Tovar-Moll, F; Mendez-Otero, R; Santiago, MF				Mesentier-Louro, Louise Alessandra; Zaverucha-do-Valle, Camila; da Silva-Junior, Almir Jordao; Nascimento-dos-Santos, Gabriel; Gubert, Fernanda; Padilha de Figueiredo, Ana Beatriz; Torres, Ana Luiza; Paredes, Bruno D.; Teixeira, Camila; Tovar-Moll, Fernanda; Mendez-Otero, Rosalia; Santiago, Marcelo F.			Distribution of Mesenchymal Stem Cells and Effects on Neuronal Survival and Axon Regeneration after Optic Nerve Crush and Cell Therapy	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MARROW MONONUCLEAR-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CILIARY NEUROTROPHIC FACTOR; AMYLOID-BETA DEPOSITION; BONE-MARROW; STROMAL CELLS; LENS INJURY; SPINAL-CORD; ALZHEIMERS-DISEASE	Bone marrow-derived cells have been used in different animal models of neurological diseases. We investigated the therapeutic potential of mesenchymal stem cells (MSC) injected into the vitreous body in a model of optic nerve injury. Adult (3-5 months old) Lister Hooded rats underwent unilateral optic nerve crush followed by injection of MSC or the vehicle into the vitreous body. Before they were injected, MSC were labeled with a fluorescent dye or with superparamagnetic iron oxide nanoparticles, which allowed us to track the cells in vivo by magnetic resonance imaging. Sixteen and 28 days after injury, the survival of retinal ganglion cells was evaluated by assessing the number of Tuj1-or Brn3a-positive cells in flat-mounted retinas, and optic nerve regeneration was investigated after anterograde labeling of the optic axons with cholera toxin B conjugated to Alexa 488. Transplanted MSC remained in the vitreous body and were found in the eye for several weeks. Cell therapy significantly increased the number of Tuj1-and Brn3a-positive cells in the retina and the number of axons distal to the crush site at 16 and 28 days after optic nerve crush, although the RGC number decreased over time. MSC therapy was associated with an increase in the FGF-2 expression in the retinal ganglion cells layer, suggesting a beneficial outcome mediated by trophic factors. Interleukin-1 beta expression was also increased by MSC transplantation. In summary, MSC protected RGC and stimulated axon regeneration after optic nerve crush. The long period when the transplanted cells remained in the eye may account for the effect observed. However, further studies are needed to overcome eventually undesirable consequences of MSC transplantation and to potentiate the beneficial ones in order to sustain the neuroprotective effect overtime.	[Mesentier-Louro, Louise Alessandra; Zaverucha-do-Valle, Camila; da Silva-Junior, Almir Jordao; Nascimento-dos-Santos, Gabriel; Gubert, Fernanda; Padilha de Figueiredo, Ana Beatriz; Torres, Ana Luiza; Paredes, Bruno D.; Mendez-Otero, Rosalia; Santiago, Marcelo F.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Mesentier-Louro, Louise Alessandra; Zaverucha-do-Valle, Camila; da Silva-Junior, Almir Jordao; Nascimento-dos-Santos, Gabriel; Gubert, Fernanda; Padilha de Figueiredo, Ana Beatriz; Torres, Ana Luiza; Paredes, Bruno D.; Mendez-Otero, Rosalia; Santiago, Marcelo F.] INBEB, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Teixeira, Camila; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, Brazil; [Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil; [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci ICB, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro	Santiago, MF (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	marcelo.santiago@biof.ufrj.br	Santiago, Marcelo Felippe/AAZ-3553-2020; Santiago, Marcelo F/H-3943-2011; Moll, Fernanda Tovar/N-3320-2018; Silva-Junior, Almir/AAX-5736-2020; Mendez-Otero, Rosalia/AAL-7551-2020; Paredes, Bruno/ABE-6217-2021; Moll, Fernanda Tovar/AAF-8477-2021; Gubert, Fernanda/G-7619-2014	Santiago, Marcelo Felippe/0000-0003-2428-9606; Santiago, Marcelo F/0000-0003-2428-9606; Moll, Fernanda Tovar/0000-0002-0292-5985; Mendez-Otero, Rosalia/0000-0002-1798-9930; Paredes, Bruno/0000-0001-5711-0604; Moll, Fernanda Tovar/0000-0002-0292-5985; Nascimento dos Santos, Gabriel/0000-0001-6362-8573; Gubert, Fernanda/0000-0002-0568-7935	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Brazilian Ministry of Health; Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem, INBEB	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Ministry of Health; Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem, INBEB	This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (www. faperj. br), and the Brazilian Ministry of Health (www. saude. gov. br). The study was supported from grants from the Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem, INBEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, NEUROBIOL DIS, V37, P441, DOI 10.1016/j.nbd.2009.10.024; Akiyama Y, 2002, J NEUROSCI, V22, P6623; Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Benowitz L, 2008, EXP NEUROL, V209, P389, DOI 10.1016/j.expneurol.2007.05.025; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Cen LP, 2012, NEUROREPORT, V23, P692, DOI 10.1097/WNR.0b013e328355f1d6; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; de Lima S, 2012, INT REV NEUROBIOL, V106, P153, DOI 10.1016/B978-0-12-407178-0.00007-7; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094; Dreyfus H, 1998, ANN NY ACAD SCI, V845, P240, DOI 10.1111/j.1749-6632.1998.tb09677.x; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002; Giraldi-Guimaraes A., 2009, BRAIN RES; Giunti D, 2012, STEM CELLS, V30, P2044, DOI 10.1002/stem.1174; Hauk TG, 2010, INVEST OPHTH VIS SCI, V51, P459, DOI 10.1167/iovs.09-4203; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Isenmann S, 1997, EUR J NEUROSCI, V9, P1763, DOI 10.1111/j.1460-9568.1997.tb01534.x; Jasmin, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-4; JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kassis I, 2011, CURR STEM CELL RES T, V6, P63, DOI 10.2174/157488811794480762; Kaushik DK, 2013, J NEUROCHEM, V127, P233, DOI 10.1111/jnc.12382; Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4; Kermer P, 1999, FEBS LETT, V453, P361, DOI 10.1016/S0014-5793(99)00747-4; Kikuchi M, 2000, J NEUROSCI, V20, P5037; Kim H, 2010, NEUROSCI LETT, V468, P190, DOI 10.1016/j.neulet.2009.10.074; Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Laroni A., 2013, J NEUROIMMUNE PHARM; Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee JK, 2009, NEUROSCI LETT, V450, P136, DOI 10.1016/j.neulet.2008.11.059; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.310; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Leibinger M, 2012, NEUROBIOL DIS, V46, P314, DOI 10.1016/j.nbd.2012.01.004; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Levkovitch-Verbin H, 2010, INVEST OPHTH VIS SCI, V51, P6394, DOI 10.1167/iovs.09-4310; Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; Liu R, 2013, STEM CELLS DEV, V22, P1053, DOI 10.1089/scd.2012.0463; Lorber B, 2005, EUR J NEUROSCI, V21, P2029, DOI 10.1111/j.1460-9568.2005.04034.x; Lu LL, 2005, BRAIN RES PROTOC, V15, P46, DOI 10.1016/j.brainresprot.2005.03.002; Magharious M, 2011, J PROTEOME RES, V10, P3344, DOI 10.1021/pr2004055; Mesentier-Louro LA, 2012, INVEST OPHTH VIS SCI, V53, P4720, DOI 10.1167/iovs.11-8198; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; PERRY VH, 1980, PROC R SOC SER B-BIO, V208, P415, DOI 10.1098/rspb.1980.0060; Petcu EB, 2008, CURR NEUROVASC RES, V5, P214, DOI 10.2174/156720208786413424; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Pirouzmand F, 2012, J CRANIOFAC SURG, V23, P516, DOI 10.1097/SCS.0b013e31824cd4a7; Pousset F, 2000, EUR CYTOKINE NETW, V11, P427; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ribeiro-Resende VT, 2009, NEUROSCIENCE, V159, P540, DOI 10.1016/j.neuroscience.2008.12.059; Rosado-de-Castro PH, 2013, STEM CELLS DEV; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Smith JNP, 2013, STEM CELLS, V31, P1044, DOI 10.1002/stem.1370; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Suzuki M, 2008, MOL THER, V16, P2002, DOI 10.1038/mt.2008.197; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Uccelli A, 2012, MOL MED, V18, P794, DOI 10.2119/molmed.2011.00498; Wong EV, 2003, J NEUROSCI, V23, P3112; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yanai A, 2012, CELL TRANSPLANT, V21, P1137, DOI 10.3727/096368911X627435; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R; Yu S, 2006, BIOCHEM BIOPH RES CO, V344, P1071, DOI 10.1016/j.bbrc.2006.03.231; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zaverucha-do-Valle C, 2011, CELL TRANSPLANT, V20, P391, DOI 10.3727/096368910X524764; Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413	111	71	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2014	9	10							e110722	10.1371/journal.pone.0110722	http://dx.doi.org/10.1371/journal.pone.0110722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1JF	25347773	Green Published, gold, Green Submitted			2022-12-26	WOS:000347994900027
J	Bertelli, R; Di Donato, A; Cioni, M; Grassi, F; Ikehata, M; Bonanni, A; Rastaldi, MP; Ghiggeri, GM				Bertelli, Roberta; Di Donato, Armando; Cioni, Michela; Grassi, Fabio; Ikehata, Masami; Bonanni, Alice; Rastaldi, Maria Pia; Ghiggeri, Gian Marco			LPS Nephropathy in Mice Is Ameliorated by IL-2 Independently of Regulatory T Cells Activity	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MONOCLONAL-ANTIBODY; RECEPTOR; INFLAMMATION; MUTATIONS; INDUCTION; EXPANSION; INJURY; PATHOGENESIS; ADRIAMYCIN	Immunosuppressive regulatory T cells (Tregs) have been hypothesized to exert a protective role in animal models of spontaneous (Buffalo/Mna) and/or drug induced (Adriamycin) nephrotic syndrome. In this study, we thought to define whether Tregs can modify the outcome of LPS nephropathy utilizing IL-2 as inducer of tissue and circulating Tregs. LPS (12 mg/Kg) was given as single shot in C57BL/6, p2rx7(-/-) and Foxp3(EGFP); free IL-2 (18.000 U) or, in alternative, IL-2 coupled with JES6-1 mAb (IL-2/anti-IL-2) were injected before LPS. Peripheral and tissue Tregs/total CD4+ cell ratio, urinary parameters and renal histology were evaluated for 15 days. IL-2 administration to wild type mice had no effect on peripheral Tregs number, whereas a significant increase was induced by the IL-2/anti-IL-2 immunocomplex after 5 days. Spleen and lymph nodes Tregs were comparably increased. In p2rx7(-/-) mice, IL-2/anti-IL-2 treatment resulted in increase of peripheral Tregs but did not modify the spleen and lymph nodes quota. LPS induced comparable and transient proteinuria in both wild type and p2rx7(-/-) mice. Proteinuria was inhibited by co-infusion of human IL-2, with reduction at each phase of the disease (24 248 and 72 hours) whereas IL-2/anti-IL-2 produced weaker effects. In all mice (wild type and p2rx7(-/-)) and irrespective of treatment (IL-2, IL-2/anti-IL-2), LPS was associated with progressive signs of renal pathologic involvement resulting in glomerulosclerosis. In conclusion, IL-2 plays a transient protective effect on proteinuria induced by LPS independent of circulating or tissue Tregs but does not modify the outcome of renal degenerative renal lesions.	[Bertelli, Roberta; Di Donato, Armando; Cioni, Michela; Bonanni, Alice; Ghiggeri, Gian Marco] Giannina Gaslini Children Hosp, Div Nephrol Dialysis Transplantat, Genoa, Italy; [Grassi, Fabio] Inst Res Biomed, Bellinzona, Switzerland; [Grassi, Fabio; Ikehata, Masami] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Rastaldi, Maria Pia] Ca Granda Osped Maggiore Policlinico, Fdn Ist Ric & Cura Carattere Sci IRCCS, Renal Res Lab, Milan, Italy; [Rastaldi, Maria Pia] Fdn DAmico Ric Malattie Renali, Milan, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Universita della Svizzera Italiana; University of Milan	Ghiggeri, GM (corresponding author), Giannina Gaslini Children Hosp, Div Nephrol Dialysis Transplantat, Genoa, Italy.	GMarcoGhiggeri@ospedale-gaslini.ge.it	cioni, michela/AAA-4554-2019; Bertelli, Roberta/AAA-7207-2020; IKEHATA, Masami/HHR-9052-2022; Ghiggeri, Gian Marco/N-4712-2015; Coviello, Domenico/J-9477-2016; Bonanni, Alice/K-4453-2016	cioni, michela/0000-0003-3628-014X; IKEHATA, Masami/0000-0001-9835-9991; Ghiggeri, Gian Marco/0000-0003-3659-9062; Coviello, Domenico/0000-0001-8440-865X; Bonanni, Alice/0000-0002-4878-6271; GRASSI, FABIO/0000-0003-3348-1712	Italian Ministry of Health 'Ricerca Corrente'; Renal Child Foundation; Fondazione La Nuova Speranza	Italian Ministry of Health 'Ricerca Corrente'(Ministry of Health, Italy); Renal Child Foundation; Fondazione La Nuova Speranza	This work was also supported by the Italian Ministry of Health 'Ricerca Corrente' and from contributions derived from 'Cinque per mille dell'IRPEF'(5xMIL RIC 12 D.74/13L.2.). Contributions also were obtained from the Renal Child Foundation (FMRB; www.fmrb.it) and from Fondazione La Nuova Speranza (www.lanuovasperanza.org) supporting the grant:'Progetto integrato per la definizione dei meccanismi implicati nella glomerulosclerosi focale'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alachkar N, 2014, NEW ENGL J MED, V370, P1263, DOI 10.1056/NEJMc1400502; Araya C, 2009, PEDIATR NEPHROL, V24, P1691, DOI 10.1007/s00467-009-1214-x; BERTANI T, 1982, LAB INVEST, V46, P16; Bertelli R, 2011, CLIN EXP IMMUNOL, V166, P55, DOI 10.1111/j.1365-2249.2011.04441.x; BERTELLI R, 1991, IN VITRO CELL DEV B, V27, P799; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; BRENNER BM, 1978, NEW ENGL J MED, V298, P826, DOI 10.1056/NEJM197804132981507; BRENNER BM, 1977, NEW ENGL J MED, V297, P148; Candiano G, 2006, J AM SOC NEPHROL, V17, P3139, DOI 10.1681/ASN.2006050486; Caridi G, 2014, NEPHROL DIAL TRANSPL, V29, P80, DOI 10.1093/ndt/gfu071; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Couser WG, 2012, J AM SOC NEPHROL, V23, P381, DOI 10.1681/ASN.2011030304; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Frascoli M, 2012, J IMMUNOL, V189, P174, DOI 10.4049/jimmunol.1101582; Geertsen PF, 1998, CLIN SCI, V95, P73, DOI 10.1042/CS19980015; Ghiggeri GM, 2003, AM J KIDNEY DIS, V41, P95, DOI 10.1053/ajkd.2003.50028; Huang GH, 2012, CELL MOL IMMUNOL, V9, P287, DOI 10.1038/cmi.2012.10; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kim MG, 2013, J AM SOC NEPHROL, V24, P1529, DOI 10.1681/ASN.2012080784; KOYAMA A, 1991, KIDNEY INT, V40, P453, DOI 10.1038/ki.1991.232; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Le Berre L, 2009, J AM SOC NEPHROL, V20, P57, DOI 10.1681/ASN.2007111244; Mai JT, 2010, FRONT BIOSCI-LANDMRK, V15, P986, DOI 10.2741/3657; Musante L, 2007, J AM SOC NEPHROL, V18, P799, DOI 10.1681/ASN.2006090965; Musante L, 2006, BIOCHEM BIOPH RES CO, V349, P668, DOI 10.1016/j.bbrc.2006.08.079; Ohkura N, 2011, TRENDS PHARMACOL SCI, V32, P158, DOI 10.1016/j.tips.2010.12.004; Polhill T, 2012, J AM SOC NEPHROL, V23, P1303, DOI 10.1681/ASN.2011111130; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Sanna-Cherchi S, 2011, KIDNEY INT, V80, P389, DOI 10.1038/ki.2011.148; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; SHALHOUB RJ, 1974, LANCET, V2, P556; Shevach EM, 2012, TRENDS IMMUNOL, V33, P626, DOI 10.1016/j.it.2012.07.007; Solini A, 2013, J PATHOL, V231, P342, DOI 10.1002/path.4237; Takabatake Y, 2011, MOL MED, V17, P686, DOI 10.2119/molmed.2010.00229; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vincenti F, 2005, AM J TRANSPLANT, V5, P1179, DOI 10.1111/j.1600-6143.2005.00968.x; Wang YM, 2006, J AM SOC NEPHROL, V17, P697, DOI 10.1681/ASN.2005090978; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942; Yu CC, 2013, NEW ENGL J MED, V369, P2416, DOI 10.1056/NEJMoa1304572; Zhao JJ, 2013, ARTHRITIS RHEUM-US, V65, P3176, DOI 10.1002/art.38174	47	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111285	10.1371/journal.pone.0111285	http://dx.doi.org/10.1371/journal.pone.0111285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343479	gold, Green Published			2022-12-26	WOS:000343943500095
J	Ming, AG; Jia, HY; Zhao, JL; Tao, Y; Li, YF				Ming, Angang; Jia, Hongyan; Zhao, Jinlong; Tao, Yi; Li, Yuanfa			Above- and Below-Ground Carbon Stocks in an Indigenous Tree (Mytilaria laosensis) Plantation Chronosequence in Subtropical China	PLOS ONE			English	Article							MIXED STANDS; ACACIA PLANTATIONS; PINE PLANTATIONS; FOREST BIOMASS; ORGANIC-CARBON; EUROPEAN BEECH; AGE-SEQUENCE; STORAGE; SOIL; ALLOCATION	More than 60% of the total area of tree plantations in China is in subtropical, and over 70% of subtropical plantations consist of pure stands of coniferous species. Because of the poor ecosystem services provided by pure coniferous plantations and the ecological instability of these stands, a movement is under way to promote indigenous broadleaf plantation cultivation as a promising alternative. However, little is known about the carbon (C) stocks in indigenous broadleaf plantations and their dependence on stand age. Thus, we studied above-and below-ground biomass and C stocks in a chronosequence of Mytilaria laosensis plantations in subtropical China; stands were 7, 10, 18, 23, 29 and 33 years old. Our assessments included tree, shrub, herb and litter layers. We used plot-level inventories and destructive tree sampling to determine vegetation C stocks. We also measured soil C stocks by analyses of soil profiles to 100 cm depth. C stocks in the tree layer dominated the above-ground ecosystem C pool across the chronosequence. C stocks increased with age from 7 to 29 years and plateaued thereafter due to a reduction in tree growth rates. Minor C stocks were found in the shrub and herb layers of all six plantations and their temporal fluctuations were relatively small. C stocks in the litter and soil layers increased with stand age. Total above-ground ecosystem C also increased with stand age. Most increases in C stocks in below-ground and total ecosystems were attributable to increases in soil C content and tree biomass. Therefore, considerations of C sequestration potential in indigenous broadleaf plantations must take stand age into account.	[Ming, Angang; Jia, Hongyan; Tao, Yi] Chinese Acad Forestry, Expt Ctr Trop Forestry, Pingxiang, Guangxi, Peoples R China; [Ming, Angang] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Ming, Angang; Jia, Hongyan] Guangxi Youyiguan Forest Ecosyst Res Stn, Pingxiang, Guangxi, Peoples R China; [Zhao, Jinlong] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Li, Yuanfa] Guangxi Univ, Coll Forestry, Nanning 530004, Guangxi, Peoples R China	Chinese Academy of Forestry; Experimental Center of Tropical Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Beijing Forestry University; Guangxi University	Li, YF (corresponding author), Guangxi Univ, Coll Forestry, Nanning 530004, Guangxi, Peoples R China.	43294659@qq.com		Li, Yuanfa/0000-0001-9677-0752	Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB2014QA033]; Nature Science Foundation of Guangxi [2014jjBA30073]; Ministry of Science and Technology [2012BAD22B01]; National Science Foundation of China [31400542]; Director Foundation Project of the Experimental Centre of Tropical Forestry, Chinese Academy of Forestry [RL2011-02]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF; Nature Science Foundation of Guangxi; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Director Foundation Project of the Experimental Centre of Tropical Forestry, Chinese Academy of Forestry	Our research was financially supported by the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (No. CAFYBB2014QA033), Nature Science Foundation of Guangxi (No 2014jjBA30073), The Ministry of Science and Technology (2012BAD22B01), National Science Foundation of China (No 31400542), and the Director Foundation Project of the Experimental Centre of Tropical Forestry, Chinese Academy of Forestry (No. RL2011-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borken W, 2006, EUR J SOIL SCI, V57, P617, DOI 10.1111/j.1365-2389.2005.00752.x; Borken W, 2005, CAN J FOREST RES, V35, P2756, DOI 10.1139/X05-192; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; Choi SD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001914; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Department of Forest Resources Management S, 2010, FOR RESOUR MANAG, V1, P3; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Gower ST, 2003, ANNU REV ENV RESOUR, V28, P169, DOI 10.1146/annurev.energy.28.050302.105515; GRIGAL DF, 1992, SOIL SCI SOC AM J, V56, P935, DOI 10.2136/sssaj1992.03615995005600030042x; Guo Wen-fu, 2006, Forest Research, V19, P585; He YJ, 2013, FOREST ECOL MANAG, V295, P193, DOI 10.1016/j.foreco.2013.01.020; He YouJun, 2008, Chinese Forestry Science and Technology, V7, P1; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Jagger P, 2003, FOREST POLICY ECON, V5, P83, DOI 10.1016/S1389-9341(01)00078-8; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jonard M, 2007, ANN FOREST SCI, V64, P141, DOI 10.1051/forest:2006098; Kang B, 2006, ACTA ECOL SIN, V26, P1321; Kasel S, 2007, GEODERMA, V137, P401, DOI 10.1016/j.geoderma.2006.09.002; Kraenzel M, 2002, FOREST ECOL MANAG, V5863, P1; Kurz WA, 1996, CAN J FOREST RES, V26, P1973, DOI 10.1139/x26-223; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Li Y. X., 1988, Forest Research, V1, P206; [梁宏温 LIANG Hong-Wen], 2009, [生态学报, Acta Ecologica Sinica], V29, P4242; Liang R. L., 2007, GUANGXI FORESTRY SCI, V36, P5; Lin DeXi, 2000, Journal of Fujian College of Forestry, V20, P62; Lin Jin-guo, 2004, Journal of Plant Resources and Environment, V13, P50; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Liu En, 2012, Yingyong Shengtai Xuebao, V23, P335; Lu LiHua, 2009, Scientia Silvae Sinicae, V45, P1; Ming An-gang, 2014, Yingyong Shengtai Xuebao, V25, P940; Ming An-gang, 2012, Shengtaixue Zazhi, V31, P1050; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Peichl M, 2007, FOREST ECOL MANAG, V253, P68, DOI 10.1016/j.foreco.2007.07.003; Peichl M, 2006, AGR FOREST METEOROL, V140, P51, DOI 10.1016/j.agrformet.2006.08.004; [彭舜磊 PENG Shunlei], 2008, [西北林学院学报, Journal of Northwest Forestry College], V23, P184; POORE MED, 1985, FAO FOREST, V59, P1; SFA (State Forestry Administration), 2007, CHIN FOR 1999 2005; Soil Survey Staff of USDA, 2006, KEYS SOIL TAX; State Soil Survey Service of China, 1998, CHIN SOIL; Taylor AR, 2007, CAN J FOREST RES, V37, P2260, DOI 10.1139/X07-080; [田大伦 Tian Dalun], 2010, [生态学报, Acta Ecologica Sinica], V30, P6297; Vesterdal L, 2008, FOREST ECOL MANAG, V255, P35, DOI 10.1016/j.foreco.2007.08.015; VOGT K, 1991, TREE PHYSIOL, V9, P69, DOI 10.1093/treephys/9.1-2.69; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Wang H, 2013, FOREST ECOL MANAG, V300, P43, DOI 10.1016/j.foreco.2012.12.015; Wang H, 2010, PLANT SOIL, V335, P213, DOI 10.1007/s11104-010-0408-0; Wang H, 2010, ECOL RES, V25, P1071, DOI 10.1007/s11284-010-0730-2; [王卫霞 Wang Weixia], 2013, [生态学报, Acta Ecologica Sinica], V33, P925; Yuan SF, 2013, J TROP FOR SCI, V25, P79; Zhang H, 2012, FOREST ECOL MANAG, V277, P90, DOI 10.1016/j.foreco.2012.04.016; Zhao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094966; Zhou Y.R., 2000, CHIN J PLANT ECOL, V24, P518	54	25	27	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e109730	10.1371/journal.pone.0109730	http://dx.doi.org/10.1371/journal.pone.0109730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343446	Green Submitted, Green Published, gold			2022-12-26	WOS:000343943500022
J	Schwenk, R; Debot, M; Porter, M; Nikki, J; Rein, L; Spaccapelo, R; Crisanti, A; Wightman, PD; Ockenhouse, CF; Dutta, S				Schwenk, Robert; Debot, Margot; Porter, Michael; Nikki, Jennifer; Rein, Lisa; Spaccapelo, Roberta; Crisanti, Andrea; Wightman, Paul D.; Ockenhouse, Christian F.; Dutta, Sheetij			IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice	PLOS ONE			English	Article							T-CELL RESPONSES; MALARIA-NAIVE ADULTS; RECEPTOR 4 AGONIST; PHASE 2A TRIAL; CIRCUMSPOROZOITE PROTEIN; ESCHERICHIA-COLI; DENDRITIC CELLS; SIGNALING PATHWAY; INFLUENZA VACCINE; TLR SYNERGY	The availability of a highly purified and well characterized circumsporozoite protein (CSP) is essential to improve upon the partial success of recombinant CSP-based malaria vaccine candidates. Soluble, near full-length, Plasmodium falciparum CSP vaccine antigen (CS/D) was produced in E. coli under bio-production conditions that comply with current Good Manufacturing Practices (cGMP). A mouse immunogenicity study was conducted using a stable oil-in-water emulsion (SE) of CS/D in combination with the Toll-Like Receptor 4 (TLR4) agonist Glucopyranosyl Lipid A (GLA/SE), or one of two TLR7/8 agonists: R848 (un-conjugated) or 3M-051 (covalently conjugated). Compared to Alum and SE, GLA/SE induced higher CS/D specific antibody response in Balb/c mice. Subclass analysis showed higher IgG2:IgG1 ratio of GLA/SE induced antibodies as compared to Alum and SE. TLR synergy was not observed when soluble R848 was mixed with GLA/SE. Antibody response of 3M051 formulations in Balb/c was similar to GLA/SE, except for the higher IgG2: IgG1 ratio and a trend towards higher T cell responses in 3M051 containing groups. However, no synergistic enhancement of antibody and T cell response was evident when 3M051 conjugate was mixed with GLA/SE. In C57Bl/6 mice, CS/D adjuvanted with 3M051/SE or GLA/SE induced higher CSP repeat specific titers compared to SE. While, 3M051 induced antibodies had high IgG2c:IgG1 ratio, GLA/SE promoted high levels of both IgG1 and IgG2c. GLA/SE also induced more potent T-cell responses compared to SE in two independent C57/BL6 vaccination studies, suggesting a balanced and productive T-H1/T-H2 response. GLA and 3M-051 similarly enhanced the protective efficacy of CS/D against challenge with a transgenic P. berghei parasite and most importantly, high levels of cytophilic IgG2 antibodies were associated with protection in this model. Our data indicated that the cGMP-grade, soluble CS/D antigen combined with the TLR4-containing adjuvant GLA/SE warrants further evaluation for protective responses in humans.	[Schwenk, Robert; Debot, Margot; Porter, Michael; Nikki, Jennifer; Rein, Lisa; Ockenhouse, Christian F.; Dutta, Sheetij] Walter Reed Army Inst Res, Malaria Vaccine Branch, Silver Spring, MD 20910 USA; [Wightman, Paul D.] 3M Drug Delivery Syst, St Paul, MN USA; [Spaccapelo, Roberta] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, London, England	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); 3M; University of Perugia; Imperial College London	Dutta, S (corresponding author), Walter Reed Army Inst Res, Malaria Vaccine Branch, Silver Spring, MD 20910 USA.	Sheetij.dutta.civ@mail.mil		Nicki, Jennifer/0000-0002-5440-2991; Crisanti, Andrea/0000-0002-2406-4426; Spaccapelo, Roberta/0000-0003-2100-6172	US Army; United States Agency for International Development Malaria Vaccine Program	US Army(United States Department of DefenseUnited States Army); United States Agency for International Development Malaria Vaccine Program(United States Agency for International Development (USAID))	Funding for this work was provided by the US Army and the United States Agency for International Development Malaria Vaccine Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032524; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Behzad H, 2012, J INFECT DIS, V205, P466, DOI 10.1093/infdis/jir769; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; BLUMTIROUVANZIAM U, 1995, J IMMUNOL, V154, P3922; BLUMTIROUVANZIAM U, 1994, J IMMUNOL, V153, P4134; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; DOOLAN DL, 1992, INFECT IMMUN, V60, P675, DOI 10.1128/IAI.60.2.675-682.1992; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Fujita Y, 2012, THER DELIV, V3, P749, DOI 10.4155/TDE.12.52; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Kaba SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048304; Kastenmuller K, 2013, INFECT IMMUN, V81, P789, DOI 10.1128/IAI.01108-12; Kastenmuller K, 2011, J CLIN INVEST, V121, P1782, DOI 10.1172/JCI45416; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kolodny N, 2001, J CHROMATOGR B, V762, P77, DOI 10.1016/S0378-4347(01)00340-1; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Orr MT, 2013, EUR J IMMUNOL; Othoro C, 2009, INFECT IMMUN, V77, P739, DOI 10.1128/IAI.00974-08; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Porter MD, 2013, CLIN VACCINE IMMUNOL, V20, P803, DOI 10.1128/CVI.00066-13; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604; Tafalla C, 2008, MOL IMMUNOL, V45, P1439, DOI 10.1016/j.molimm.2007.08.015; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Tomai MA, 2011, EXPERT REV VACCINES, V10, P405, DOI [10.1586/erv.11.26, 10.1586/ERV.11.26]; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; Vaughan K, 2009, PARASITE IMMUNOL, V31, P78, DOI 10.1111/j.1365-3024.2008.01077.x; WALDMANN H, 1989, ANNU REV IMMUNOL, V7, P407, DOI 10.1146/annurev.iy.07.040189.002203; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; Wille-Reece U, 2005, J IMMUNOL, V174, P7676, DOI 10.4049/jimmunol.174.12.7676; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; YOUNG JF, 1985, SCIENCE, V228, P958, DOI 10.1126/science.2988125	50	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e111020	10.1371/journal.pone.0111020	http://dx.doi.org/10.1371/journal.pone.0111020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BL	25343487	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500077
J	Hu, LP; Xiang, LX; Zhang, L; Zhou, XT; Zou, ZR; Hu, XH				Hu, Lipan; Xiang, Lixia; Zhang, Li; Zhou, Xiaoting; Zou, Zhirong; Hu, Xiaohui			The Photoprotective Role of Spermidine in Tomato Seedlings under Salinity-Alkalinity Stress	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; EXOGENOUS SPERMIDINE; SALT STRESS; THYLAKOID MEMBRANES; CUCUMIS-SATIVUS; ABIOTIC STRESS; POLYAMINES; ZEAXANTHIN; LEAVES	Polyamines are small, ubiquitous, nitrogenous compounds that scavenge reactive oxygen species and stabilize the structure and function of the photosynthetic apparatus in response to abiotic stresses. Molecular details underlying polyamine-mediated photoprotective mechanisms are not completely resolved. This study investigated the role of spermidine (Spd) in the structure and function of the photosynthetic apparatus. Tomato seedlings were subjected to salinity-alkalinity stress with and without foliar application of Spd, and photosynthetic and morphological parameters were analyzed. Leaf dry weight and net photosynthetic rate were reduced by salinity-alkalinity stress. Salinity-alkalinity stress reduced photochemical quenching parameters, including maximum photochemistry efficiency of photosystem II, quantum yield of linear electron flux, and coefficient of photochemical quenching (qP). Salinity-alkalinity stress elevated nonphotochemical quenching parameters, including the de-epoxidation state of the xanthophyll cycle and nonphotochemical quenching (NPQ). Microscopic analysis revealed that salinity-alkalinity stress disrupted the internal lamellar system of granal and stromal thylakoids. Exogenous Spd alleviated the stress-induced reduction of leaf dry weight, net photosynthetic rate, and qP parameters. The NPQ parameters increased by salinity-alkalinity stress were also alleviated by Spd. Seedlings treated with exogenous Spd had higher zeaxanthin (Z) contents than those without Spd under salinity-alkalinity stress. The chloroplast ultrastructure had a more ordered arrangement in seedlings treated with exogenous Spd than in those without Spd under salinity-alkalinity stress. These results indicate that exogenous Spd can alleviate the growth inhibition and thylakoid membrane photodamage caused by salinity-alkalinity stress. The Spd-induced accumulation of Z also may have an important role in stabilizing the photosynthetic apparatus.	[Hu, Lipan; Xiang, Lixia; Zhang, Li; Zhou, Xiaoting; Zou, Zhirong; Hu, Xiaohui] Northwest Agr & Forest Univ, Coll Hort, Yangling, Peoples R China; [Hu, Lipan; Xiang, Lixia; Zhang, Li; Zhou, Xiaoting; Zou, Zhirong; Hu, Xiaohui] Minist Agr, Key Lab Protected Hort Engn Northwest, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Zou, ZR (corresponding author), Northwest Agr & Forest Univ, Coll Hort, Yangling, Peoples R China.	zouzhirong2005@hotmail.com; hxh1977@163.com			National Key Technology R&D Program in the 12th Five-year Plan of China [2011BAD29B01]; Scientific Research Special Fund of Northwest Agriculture & Forestry University [QN2013018]; China Agriculture Research System [CARS-25-D-02]	National Key Technology R&D Program in the 12th Five-year Plan of China(National Key Technology R&D Program); Scientific Research Special Fund of Northwest Agriculture & Forestry University; China Agriculture Research System	This work was supported by grants from the National Key Technology R&D Program in the 12th Five-year Plan of China (No. 2011BAD29B01), the Scientific Research Special Fund of Northwest Agriculture & Forestry University (QN2013018), and the China Agriculture Research System (No. CARS-25-D-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Begcy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044697; Belle NAV, 2004, BRAIN RES, V1008, P245, DOI 10.1016/j.brainres.2004.02.036; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; Chen CS, 2012, PLANT PHYSIOL BIOCH, V60, P12, DOI 10.1016/j.plaphy.2012.07.016; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Deng C, 2011, J AGR SCI TECH-IRAN, V13, P687; Dernetriou G, 2007, BBA-BIOENERGETICS, V1767, P272, DOI 10.1016/j.bbabio.2007.02.020; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; GALSTON AW, 1990, PLANT PHYSIOL, V94, P406, DOI 10.1104/pp.94.2.406; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Guo YP, 2006, PHOTOSYNTHETICA, V44, P439, DOI 10.1007/s11099-006-0048-z; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hamdani S, 2011, J PHOTOCH PHOTOBIO B, V104, P314, DOI 10.1016/j.jphotobiol.2011.02.007; Hamdani S, 2011, PLANT CELL PHYSIOL, V52, P866, DOI 10.1093/pcp/pcr040; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Hu XH, 2012, PLANT PHYSIOL BIOCH, V57, P200, DOI 10.1016/j.plaphy.2012.05.015; Hussain SS, 2011, BIOTECHNOL ADV, V29, P300, DOI 10.1016/j.biotechadv.2011.01.003; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Li RL, 2010, SOIL SCI PLANT NUTR, V56, P725, DOI 10.1111/j.1747-0765.2010.00506.x; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078196; Liu ZX, 2012, PHOTOSYNTHETICA, V50, P152, DOI 10.1007/s11099-012-0007-9; Mittal S, 2012, PLANT PHYSIOL BIOCH, V54, P17, DOI 10.1016/j.plaphy.2012.02.003; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Ogweno JO, 2010, PLANT GROWTH REGUL, V60, P175, DOI 10.1007/s10725-009-9439-z; Paramonova NV, 2004, RUSS J PLANT PHYSL+, V51, P86, DOI 10.1023/B:RUPP.0000011307.95130.8f; Parida AK, 2003, PHOTOSYNTHETICA, V41, P191, DOI 10.1023/B:PHOT.0000011951.37231.69; Shu S, 2013, PLANT PHYSIOL BIOCH, V63, P209, DOI 10.1016/j.plaphy.2012.11.028; Shu S, 2012, PHYSIOL PLANTARUM, V146, P285, DOI 10.1111/j.1399-3054.2012.01623.x; Shu Sheng, 2012, African Journal of Biotechnology, V11, P6064; Tian J, 2012, J AM SOC HORTIC SCI, V137, P11, DOI 10.21273/JASHS.137.1.11; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Wrona M, 2004, FREE RADICAL BIO MED, V36, P1094, DOI 10.1016/j.freeradbiomed.2004.02.005; Yadav DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045883; Yang JY, 2011, PHOTOSYNTHETICA, V49, P275, DOI 10.1007/s11099-011-0037-8; [李阳 Yang Li], 2009, [植物学报, Chinese Bulletin of Botany], V44, P571; Yin Y, 2010, J PLANT PHYSIOL, V167, P959, DOI 10.1016/j.jplph.2009.12.021; Zhang R, 2011, PHOTOSYNTH RES, V108, P171, DOI 10.1007/s11120-011-9672-y; Zhang RH, 2009, PHOTOSYNTH RES, V100, P155, DOI 10.1007/s11120-009-9441-3; Zhang Y, 2013, J AM SOC HORTIC SCI, V138, P38, DOI 10.21273/JASHS.138.1.38	51	28	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2014	9	10							e0110855	10.1371/journal.pone.0110855	http://dx.doi.org/10.1371/journal.pone.0110855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZY	25340351	Green Published, Green Submitted, gold			2022-12-26	WOS:000343662800064
J	Liu, HH; Rossi, S; Zhou, HX; Chen, BG				Liu, Huanhuan; Rossi, Sonja; Zhou, Huixia; Chen, Baoguo			Electrophysiological Evidence for Domain-General Inhibitory Control during Bilingual Language Switching	PLOS ONE			English	Article							HIGHLY PROFICIENT BILINGUALS; COGNITIVE CONTROL; BRAIN; PERFORMANCE; MECHANISMS; ATTENTION; ERP	This paper presents an experiment that explored the role of domain-general inhibitory control on language switching. Reaction times (RTs) and event-related brain potentials (ERPs) were recorded when low-proficient bilinguals with high and low inhibitory control (IC) switched between overt picture naming in both their L1 and L2. Results showed that the language switch costs of bilinguals with high-IC were symmetrical, while that of bilinguals with low-IC were not. The N2 component failed to show a significant interaction between group, language and task, indicating that inhibition may not comes into play during the language task schema competition phase. The late positive component (LPC), however, showed larger amplitudes for L2 repeat and switch trials than for L1 trials in the high-IC group, indicating that inhibition may play a key role during the lexical response selection phase. These findings suggest that domain-general inhibitory control plays an important role in modulating language switch costs and its influence can be specified in lexical selection phase.	[Liu, Huanhuan; Zhou, Huixia; Chen, Baoguo] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Rossi, Sonja] Med Univ Innsbruck, Dept Med Psychol, A-6020 Innsbruck, Austria; [Rossi, Sonja] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Beijing Normal University; Medical University of Innsbruck; Max Planck Society	Chen, BG (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	Chenbg@bnu.edu.cn	Rossi, Sonja/D-1453-2016	Rossi, Sonja/0000-0002-3278-8993	National Social Science Fund [11BYY039]; Program for New Century Excellent Talents of Ministry of Education in China [NECT-11-0028]; Beijing Key Laboratory of Applied Experimental Psychology	National Social Science Fund; Program for New Century Excellent Talents of Ministry of Education in China; Beijing Key Laboratory of Applied Experimental Psychology	This research was supported by the National Social Science Fund [11BYY039], the Program for New Century Excellent Talents of Ministry of Education in China [NECT-11-0028] and Beijing Key Laboratory of Applied Experimental Psychology to Baoguo Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Berkman ET, 2009, NEUROIMAGE, V47, P705, DOI 10.1016/j.neuroimage.2009.04.084; Bialystok E, 2006, CAN J EXP PSYCHOL, V60, P68, DOI 10.1037/cjep2006008; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Calabria M, 2012, FRONT PSYCHOL, V2, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.3389/FPSYG.2011; Christoffels IK, 2007, BRAIN RES, V1147, P192, DOI 10.1016/j.brainres.2007.01.137; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Costa A, 2004, J MEM LANG, V50, P491, DOI 10.1016/j.jml.2004.02.002; Costa A, 2006, J EXP PSYCHOL LEARN, V32, P1057, DOI 10.1037/0278-7393.32.5.1057; de Bruin A, 2014, NEUROIMAGE, V90, P348, DOI 10.1016/j.neuroimage.2013.12.049; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Guo TM, 2013, ACTA PSYCHOL, V143, P277, DOI 10.1016/j.actpsy.2013.04.002; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hosoda C, 2012, J NEUROLINGUIST, V25, P44, DOI 10.1016/j.jneuroling.2011.08.007; Jackson GM, 2001, BILING-LANG COGN, V4, P169, DOI [10.1017/S1366728901000268, DOI 10.1017/S1366728901000268]; Linck JA, 2012, BILING-LANG COGN, V15, P651, DOI 10.1017/S136672891100054X; Luk G, 2012, LANG COGNITIVE PROC, V27, P1479, DOI 10.1080/01690965.2011.613209; Martin CD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00815; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Umebayashi K, 2010, BRAIN RES, V1346, P165, DOI 10.1016/j.brainres.2010.05.050; Verhoef K, 2009, COGNITION, V110, P84, DOI 10.1016/j.cognition.2008.10.013; Verhoef KMW, 2010, J COGNITIVE NEUROSCI, V22, P1832, DOI 10.1162/jocn.2009.21291; [张清芳 Zhang Qingfang], 2003, [心理学报, Acta Psychologica Sinica], V35, P447	28	86	93	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110887	10.1371/journal.pone.0110887	http://dx.doi.org/10.1371/journal.pone.0110887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25369471	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943500062
J	Liu, HX; Su, YY; Zhu, L; Xing, JN; Wu, J; Wang, N				Liu, Huixin; Su, Yingying; Zhu, Lin; Xing, Jiannan; Wu, Jing; Wang, Ning			Effectiveness of ART and Condom Use for Prevention of Sexual HIV Transmission in Serodiscordant Couples: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL TREATMENT; INFECTION; THERAPY; DECLINE; COHORT; RISK; INITIATION; PROVINCE; IMPACT	Background: Consistent and correct condom use and suppressive antiretroviral therapy for the infected partner are two of the primary strategies recommended for prevention of heterosexual HIV transmission in serodiscordant couples today. The applied effectiveness of treatment as a prevention strategy in China is still under investigation, and much less is known about its effects in the presence of other prevention strategies such as consistent condom use. Methods: We conducted a systematic search in PubMed and three Chinese language databases to identify relevant articles for the estimation of relative effectiveness of a) consistent condom use and b) ART use by index partners for preventing HIV transmission in serodiscordant couples. We also estimated the prevention effectiveness of ART stratified by condom use level and the prevention effectiveness of consistent condom use stratified by ART use level. Results: Pooled results from the eleven eligible studies found a pooled HIV seroconversion incidence of 0.92 cases per 100 person years (PY) among HIV-negative spouses whose index partners were taking ART versus 2.45 cases per 100 PY in untreated couples. The IRR comparing seroconversion in couples where the index-partner was on ART versus not on ART was 0.47 (95% CI: 0.43, 0.52), while stratified by condom use, the IRR was 0.33(0.17, 0.64). The IRR comparing incidence in couples reporting "consistent condom use'' versus those reporting otherwise was 0.02(95% CI: 0.01, 0.04), after stratified by ART use level, the IRR was 0.01(95% CI: 0.00, 0.06). Conclusions: ART use by index partners could reduce HIV transmission in serodiscordant couples, and the effectiveness of this prevention strategy could be further increased with consistent condom use.	[Liu, Huixin; Su, Yingying; Zhu, Lin; Xing, Jiannan; Wu, Jing; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com	Rossi, Sonja/D-1453-2016	Rossi, Sonja/0000-0002-3278-8993	mega-projects of national science research for the 12th Five-Year Plan of China [2012ZX10001-001]	mega-projects of national science research for the 12th Five-Year Plan of China	Supported by the mega-projects of national science research for the 12th Five-Year Plan (2012ZX10001-001) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Duan Song, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P997; El-Sadr WM, 2011, AIDS, V25, P2295, DOI 10.1097/QAD.0b013e32834c4c22; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Gray R, 2011, AIDS, V25, P863, DOI 10.1097/QAD.0b013e3283448790; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; He N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077981; Heymer KJ, 2011, SEX HEALTH, V8, P280, DOI 10.1071/SH10084; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Li Jing-yun, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P192; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; [毛宇嵘 Mao Yurong], 2004, [中华流行病学杂志, Chinese Journal of Epidemiology], V25, P322; Ministry of Health of the People's Republic of China Joint United Nations Program on HIV/AIDS WHO, 2011, 2011 EST HIV AIDS EP; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Pan Xiao-hong, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P1023; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Qiao XiaoChun, 2009, Chinese Preventive Medicine, V10, P976; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; R Core Team, 2021, R LANGUAGE ENV STAT; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wang L, 2013, CHINESE MED J-PEKING, V126, P3694, DOI 10.3760/cma.j.issn.0366-6999.20123311; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; Wells G., 2014, S SYST REV BAS; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang K, 2001, CHINA J AIDS STD, V7, P286; Zheng Xi-Wen, 1993, Biomedical and Environmental Sciences, V6, P348; Zheng XW, 1994, CHIN J EPID, V15, P3	39	86	93	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111175	10.1371/journal.pone.0111175	http://dx.doi.org/10.1371/journal.pone.0111175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369471	Green Submitted, Green Published, gold			2022-12-26	WOS:000344402000041
J	Wang, AT; Fan, JQ; Van Houten, HK; Tilburt, JC; Stout, NK; Montori, VM; Shah, ND				Wang, Amy T.; Fan, Jiaquan; Van Houten, Holly K.; Tilburt, Jon C.; Stout, Natasha K.; Montori, Victor M.; Shah, Nilay D.			Impact of the 2009 US Preventive Services Task Force Guidelines on Screening Mammography Rates on Women in Their 40s	PLOS ONE			English	Article							BREAST-CANCER; RECOMMENDATIONS; OLDER	Background: The 2009 US Preventive Services Task Force breast cancer screening update recommended against routine screening mammography for women aged 40-49; confusion and release of conflicting guidelines followed. We examined the impact of the USPSTF update on population-level screening mammography rates in women ages 40-49. Methods and Findings: We conducted a retrospective, interrupted time-series analysis using a nationally representative, privately-insured population from 1/1/2006-12/31/2011. Women ages 40-64 enrolled for >= 1 month were included. The primary outcome was receipt of screening mammography, identified using administrative claims-based algorithms. Time-series regression models were estimated to determine the effect of the guideline change on screening mammography rates. 5.5 million women ages 40-64 were included. A 1.8 per 1,000 women (p = 0.003) decrease in monthly screening mammography rates for 40-49 year-old women was observed two months following the guideline change; no initial effect was seen for 50-64 year-old women. However, two years following the guideline change, a slight increase in screening mammography rates above expected was observed in both age groups. Conclusions: We detected a modest initial drop in screening mammography rates in women ages 40-49 immediately after the 2009 USPSTF guideline followed by an increase in screening rates. Unfavorable public reactions and release of conflicting statements may have tempered the initial impact. Renewal of the screening debate may have brought mammography to the forefront of women's minds, contributing to the observed increase in mammography rates two years after the guideline change. This pattern is unlikely to reflect informed choice and underscores the need for improved translation of evidence-based care and guidelines into practice.	[Wang, Amy T.; Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Wang, Amy T.; Tilburt, Jon C.; Montori, Victor M.; Shah, Nilay D.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Fan, Jiaquan; Van Houten, Holly K.; Montori, Victor M.; Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Stout, Natasha K.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Montori, Victor M.] Mayo Clin, Div Endocrinol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Mayo Clinic	Shah, ND (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA.	shah.nilay@mayo.edu	amy.tu.wang, amy.tu.wang/F-8331-2014	amy.tu.wang, amy.tu.wang/0000-0002-0929-1399; Montori, Victor/0000-0003-0595-2898	Small Grants Program; Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota	Small Grants Program; Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota	This work was supported by the Small Grants Program sponsored by the Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM COLL OBST GYN, 2009, OBSTET GYNECOL, V114, P1409; American College of Obstetricians and Gynecologists, 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.1220B1013-318277C318292A; American College of Surgeons, 2010, B AM COLL SURG, V95, P51; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Block LD, 2013, J GEN INTERNAL MED; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Dorn SD, 2012, CLIN GASTROENTEROL H, V10, P278, DOI 10.1016/j.cgh.2011.11.020; Fenton JJ, 2012, MED CARE; IMS Health, 2012, IMS RXBENCHMARK PHAR; Institute KPCM, 2010, BREAST CANC SCREEN C; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Pace LE, 2013, CANCER-AM CANCER SOC, V119, P2518, DOI 10.1002/cncr.28105; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Randolph WM, 2002, HEALTH SERV RES, V37, P1643, DOI 10.1111/1475-6773.10912; Smith-Bindman R, 2006, MED CARE, V44, P463, DOI 10.1097/01.mlr.0000207436.07513.79; Squiers LB, 2011, AM J PREV MED, V40, P497, DOI 10.1016/j.amepre.2010.12.027; Stempel DA, 2001, RESP MED, V95, P227, DOI 10.1053/rmed.2000.1027; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	18	127	128	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91399	10.1371/journal.pone.0091399	http://dx.doi.org/10.1371/journal.pone.0091399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	25343354	Green Published, Green Submitted, gold			2022-12-26	WOS:000332842400087
J	Wang, MC; Chien, HF; Tsai, YL; Liu, MC; Liaw, SJ				Wang, Min-Cheng; Chien, Hsiung-Fei; Tsai, Yi-Lin; Liu, Ming-Che; Liaw, Shwu-Jen			The RNA Chaperone Hfq Is Involved in Stress Tolerance and Virulence in Uropathogenic Proteus mirabilis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; POLYMYXIN-B RESISTANCE; ESCHERICHIA-COLI; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; EPITHELIAL-CELLS; MOUSE MODEL; BACTERIA; MACROPHAGES	Hfq is a bacterial RNA chaperone involved in the riboregulation of diverse genes via small noncoding RNAs. Here, we show that Hfq is critical for the uropathogenic Proteus mirabilis to effectively colonize the bladder and kidneys in a murine urinary tract infection (UTI) model and to establish burned wound infection of the rats. In this regard, we found the hfq mutant induced higher IL-8 and MIF levels of uroepithelial cells and displayed reduced intra-macrophage survival. The loss of hfq affected bacterial abilities to handle H2O2 and osmotic pressures and to grow at 50 degrees C. Relative to wild-type, the hfq mutant had reduced motility, fewer flagella and less hemolysin expression and was less prone to form biofilm and to adhere to and invade uroepithelial cells. The MR/P fimbrial operon was almost switched to the off phase in the hfq mutant. In addition, we found the hfq mutant exhibited an altered outer membrane profile and had higher RpoE expression, which indicates the hfq mutant may encounter increased envelope stress. With the notion of envelope disturbance in the hfq mutant, we found increased membrane permeability and antibiotic susceptibilities in the hfq mutant. Finally, we showed that Hfq positively regulated the RpoS level and tolerance to H2O2 in the stationary phase seemed largely mediated through the Hfq-dependent RpoS expression. Together, our data indicate that Hfq plays a critical role in P. mirabilis to establish UTIs by modulating stress responses, surface structures and virulence factors. This study suggests Hfq may serve as a scaffold molecule for development of novel anti-P. mirabilis drugs and P. mirabilis hfq mutant is a vaccine candidate for preventing UTIs.	[Wang, Min-Cheng; Tsai, Yi-Lin; Liu, Ming-Che; Liaw, Shwu-Jen] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Chien, Hsiung-Fei] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Liaw, Shwu-Jen] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Liaw, SJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	sjliaw@ntu.edu.tw		LIAW, SHWU-JEN/0000-0002-2666-5284	National Science Council [NSC101-2320-B-002-028]; National Taiwan University Hospital, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taipei, Taiwan	This work was supported by grants from National Science Council (NSC101-2320-B-002-028) and National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 1996, EUR RESPIR J, V9, P1713, DOI 10.1183/09031936.96.09081713; Alamuri P, 2010, INFECT IMMUN, V78, P4882, DOI 10.1128/IAI.00718-10; Asakawa R, 2003, MOL MICROBIOL, V50, P1125, DOI 10.1046/j.1365-2958.2003.03748.x; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Caiola MG, 2004, ANN MICROBIOL, V54, P365; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chiang MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022248; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FUKUOKA T, 1991, ANTIMICROB AGENTS CH, V35, P529, DOI 10.1128/AAC.35.3.529; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Hamrick TS, 2000, INFECT IMMUN, V68, P125, DOI 10.1128/IAI.68.1.125-132.2000; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jansen AM, 2004, INFECT IMMUN, V72, P7294, DOI 10.1128/IAI.72.12.7294-7305.2004; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P1564, DOI 10.1128/AAC.01219-09; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Li X, 2002, MOL MICROBIOL, V45, P865, DOI 10.1046/j.1365-2958.2002.03067.x; LISSNER CR, 1985, J IMMUNOL, V135, P544; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mobley HLT, 1996, INFECT IMMUN, V64, P5332, DOI 10.1128/IAI.64.12.5332-5340.1996; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Nishino K, 2011, J ANTIMICROB CHEMOTH, V66, P291, DOI 10.1093/jac/dkq420; Odenbreit S, 2009, INFECT IMMUN, V77, P3782, DOI 10.1128/IAI.00364-09; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pearson MM, 2007, J MED MICROBIOL, V56, P1277, DOI 10.1099/jmm.0.47314-0; Richards GR, 2011, BBA-GENE REGUL MECH, V1809, P525, DOI 10.1016/j.bbagrm.2011.07.013; Rocha SPD, 2007, FEMS IMMUNOL MED MIC, V51, P319, DOI 10.1111/j.1574-695X.2007.00308.x; Roger T, 2013, J INFECT DIS, V207, P331, DOI 10.1093/infdis/jis673; Roscetto E, 2012, J BACTERIOL, V194, P5864, DOI 10.1128/JB.00746-12; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Thompson KM, 2007, J BACTERIOL, V189, P4243, DOI 10.1128/JB.00020-07; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Van Puyvelde S, 2013, RNA BIOL, V10, P185, DOI 10.4161/rna.23341; Vogel J, 2009, MOL MICROBIOL, V73, P737, DOI 10.1111/j.1365-2958.2009.06806.x; Xiao B, 2009, CURR MICROBIOL, V58, P258, DOI 10.1007/s00284-008-9318-2; Yamada J, 2010, J ANTIMICROB CHEMOTH, V65, P853, DOI 10.1093/jac/dkq067; Zhong M, 2013, J BACTERIOL, V195, P1061, DOI 10.1128/JB.01143-12	52	49	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85626	10.1371/journal.pone.0085626	http://dx.doi.org/10.1371/journal.pone.0085626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454905	Green Submitted, Green Published, gold			2022-12-26	WOS:000330235100108
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-26	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-26	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-26	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-26	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-26	WOS:000343943100017
